PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, N; Kisiswa, L; Ramanujan, A; Li, Z; Sim, EW; Tian, XB; Yuan, WS; Ibanez, CF; Lin, Z				Zhang, Ning; Kisiswa, Lilian; Ramanujan, Ajeena; Li, Zhen; Sim, Eunice Weiling; Tian, Xianbin; Yuan, Wensu; Ibanez, Carlos F.; Lin, Zhi			Structural basis of NF-kappa B signaling by the p75 neurotrophin receptor interaction with adaptor protein TRADD through their respective death domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; MOLECULAR-CLONING; NMR STRUCTURE; GENE-TRANSFER; EXPRESSION; ASSIGNMENT; P75(NTR); SYSTEM; VISUALIZATION; RESONANCES	The p75 neurotrophin receptor (p75(NTR)) is a critical mediator of neuronal death and tissue remodeling and has been implicated in various neurodegenerative diseases and cancers. The death domain (DD) of p75(NTR) is an intracellular signaling hub and has been shown to interact with diverse adaptor proteins. In breast cancer cells, binding of the adaptor protein TRADD to p75(NTR) depends on nerve growth factor and promotes cell survival. However, the structural mechanism and functional significance of TRADD recruitment in neuronal p75(NTR) signaling remain poorly understood. Here we report an NMR structure of the p75(NTR)-DD and TRADD-DD complex and reveal the mechanism of specific recognition of the TRADD-DD by the p75(NTR)-DD mainly through electrostatic interactions. Furthermore, we identified spatiotemporal overlap of p75(NTR) and TRADD expression in developing cerebellar granule neurons (CGNs) at early postnatal stages and discover the physiological relevance of the interaction between TRADD and p75(NTR) in the regulation of canonical NF-kappa B signaling and cell survival in CGNs. Our results provide a new structural framework for understanding how the recruitment of TRADD to p75(NTR) through DD interactions creates a membrane proximal platform, which can be efficiently regulated by various neurotrophic factors through extracellular domains of p75(NTR), to propagate downstream signaling in developing neurons.	[Zhang, Ning; Li, Zhen; Tian, Xianbin; Yuan, Wensu; Lin, Zhi] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China; [Zhang, Ning; Li, Zhen; Tian, Xianbin; Yuan, Wensu; Lin, Zhi] Tianjin Univ, Sch Life Sci, Tianjin Key Lab Funct & Applicat Biol Macromol St, Tianjin, Peoples R China; [Kisiswa, Lilian; Ramanujan, Ajeena; Sim, Eunice Weiling; Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Kisiswa, Lilian; Ramanujan, Ajeena; Sim, Eunice Weiling; Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Life Sci Inst, Singapore, Singapore; [Kisiswa, Lilian] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Ibanez, Carlos F.] Peking Univ, Peking Tsinghua Ctr Life Sci, PKU IDG McGovern Inst Brain Res, Sch Life Sci, Beijing, Peoples R China; [Ibanez, Carlos F.] Chinese Inst Brain Res, Beijing, Peoples R China	Tianjin University; Tianjin University; National University of Singapore; National University of Singapore; Aarhus University; Karolinska Institutet; Peking University	Lin, Z (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.; Lin, Z (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin Key Lab Funct & Applicat Biol Macromol St, Tianjin, Peoples R China.; Lin, Z (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore, Singapore.; Lin, Z (corresponding author), Natl Univ Singapore, Life Sci Inst, Singapore, Singapore.	linzhi@linzhi.net		Sim, Eunice/0000-0002-0955-8807; Ramanujan, Ajeena/0000-0002-6843-5372; Kisiswa, Lilian/0000-0002-1800-0645	National Natural Science Foundation of China [21974093]; Singapore National Medical Research Council [NMRC/CBRG/0107/2016]; Singapore Ministry of Education [MOE2018-T2-1-129]; Swedish Research Council [VR-2016-01538]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by funds from National Natural Science Foundation of China (Grant No. 21974093) to Z. L.; as well as Singapore National Medical Research Council (NMRC/CBRG/0107/2016), Singapore Ministry of Education (MOE2018-T2-1-129), and Swedish Research Council (VR-2016-01538) to C. F. I.	Bittner S, 2017, FEBS LETT, V591, P2543, DOI 10.1002/1873-3468.12747; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demir IE, 2016, BBA-REV CANCER, V1866, P37, DOI 10.1016/j.bbcan.2016.05.003; El Yazidi-Belkoura I, 2003, J BIOL CHEM, V278, P16952, DOI 10.1074/jbc.M300631200; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Fernandez-Suarez D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1970-x; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Kisiswa L, 2018, CELL REP, V24, P1013, DOI 10.1016/j.celrep.2018.06.098; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Ledoux AC, 2014, BIOCHEM SOC T, V42, P76, DOI 10.1042/BST20130156; LEE KF, 1994, DEVELOPMENT, V120, P1027; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; Natoli G, 2008, NAT IMMUNOL, V9, P1015, DOI 10.1038/ni0908-1015; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pobezinskaya YL, 2012, CELL CYCLE, V11, P871, DOI 10.4161/cc.11.5.19300; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tsao DHH, 2000, MOL CELL, V5, P1051, DOI 10.1016/S1097-2765(00)80270-1; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Vilar M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001918; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; Xu DC, 2020, NATURE, V587, P133, DOI 10.1038/s41586-020-2757-z; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2005, J AM CHEM SOC, V127, P11920, DOI 10.1021/ja053539b; Yuan WS, 2019, BIOL REV, V94, P1282, DOI 10.1111/brv.12502; Zanin JP, 2019, J NEUROSCI, V39, P9119, DOI 10.1523/JNEUROSCI.0990-19.2019; Zanin JP, 2016, ELIFE, V5, DOI 10.7554/eLife.16654; Zhang N, 2017, BIOMOL NMR ASSIGN, V11, P281, DOI 10.1007/s12104-017-9763-6; Zhang N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07348-9	45	4	4	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100916	10.1016/j.jbc.2021.100916	http://dx.doi.org/10.1016/j.jbc.2021.100916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34175311	Green Published, gold			2022-12-26	WOS:000690873500009
J	Cilleros-Mane, V; Just-Borras, L; Polishchuk, A; Duran, M; Tomas, M; Garcia, N; Tomas, JM; Lanuza, MA				Cilleros-Mane, V; Just-Borras, L.; Polishchuk, A.; Duran, M.; Tomas, M.; Garcia, N.; Tomas, J. M.; Lanuza, M. A.			M-1 and M-2 mAChRs activate PDK1 and regulate PKC beta I and epsilon and the exocytotic apparatus at the NMJ	FASEB JOURNAL			English	Article						muscarinic receptors; neuromuscular junction; PDK1; PKC; SNAP-25	PROTEIN-KINASE-C; SYNAPTOSOME-ASSOCIATED PROTEIN; EPIDERMAL-GROWTH-FACTOR; NEUROTRANSMITTER RELEASE; NEUROMUSCULAR-JUNCTION; POSSIBLE INVOLVEMENT; DEPENDENT PHOSPHORYLATION; MUSCARINIC AUTORECEPTORS; TRANSMITTER RELEASE; SYNAPTIC ACTIVITY	Neuromuscular junctions (NMJ) regulate cholinergic exocytosis through the M-1 and M-2 muscarinic acetylcholine autoreceptors (mAChR), involving the crosstalk between receptors and downstream pathways. Protein kinase C (PKC) regulates neurotransmission but how it associates with the mAChRs remains unknown. Here, we investigate whether mAChRs recruit the classical PKC beta I and the novel PKC epsilon isoforms and modulate their priming by PDK1, translocation and activity on neurosecretion targets. We show that each M-1 and M-2 mAChR activates the master kinase PDK1 and promotes a particular priming of the presynaptic PKC beta I and epsilon isoforms. M-1 recruits both primed-PKCs to the membrane and promotes Munc18-1, SNAP-25, and MARCKS phosphorylation. In contrast, M-2 downregulates PKC epsilon through a PKA-dependent pathway, which inhibits Munc18-1 synthesis and PKC phosphorylation. In summary, our results discover a co-dependent balance between muscarinic autoreceptors which orchestrates the presynaptic PKC and their action on ACh release SNARE-SM mechanism. Altogether, this molecular signaling explains previous functional studies at the NMJ and guide toward potential therapeutic targets.	[Cilleros-Mane, V; Just-Borras, L.; Polishchuk, A.; Duran, M.; Tomas, M.; Garcia, N.; Tomas, J. M.; Lanuza, M. A.] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, Reus, Spain	Universitat Rovira i Virgili	Tomas, JM; Lanuza, MA (corresponding author), Univ Rovira & Virgili, Dept Ciencies Med Basiques, Unitat Histol & Neurobiol UHNEUROB, C St Llorenc 21, Reus 43201, Spain.	josepmaria.tomas@urv.cat; mariaangel.lanuza@urv.cat	Cilleros-Mañé, Víctor/G-5251-2018	Cilleros-Mañé, Víctor/0000-0001-5690-9932; Tomas, Josep/0000-0002-0406-0006; Polishchuk, Aleksandra/0000-0001-6445-1538	Ministerio de Economia y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF) [SAF2015-67143-P, PID2019-106332GB-I00]; Universitat Rovira i Virgili (URV) [2017PFR-URV-B2-85]; Catalan Government [2017SGR704]; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ) [LE1511314-2014PEJ-04, LE1911587-2019PEJ-04]; Spanish Ministerio de Ciencia Innovacion y Universidades [PID2019-106332GB-I00, PRE2020-092084]; Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio [2018PMF-PIPF-18]	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF)(European Commission); Universitat Rovira i Virgili (URV); Catalan Government; European Social Fund (ESF)(European Social Fund (ESF)); Iniciativa de Empleo Juvenil (IEJ); Spanish Ministerio de Ciencia Innovacion y Universidades(Spanish Government); Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio	Ministerio de Economia y Competitividad (MINECO); Agencia Estatal de Investigacion (AEI); European Regional Development Fund (ERDF), Grant/Award Number: SAF2015-67143-P and PID2019-106332GB-I00; Universitat Rovira i Virgili (URV), Grant/Award Number: 2017PFR-URV-B2-85; Catalan Government, Grant/Award Number: 2017SGR704; European Social Fund (ESF); Iniciativa de Empleo Juvenil (IEJ), Grant/Award Number: LE1511314-2014PEJ-04 and LE1911587-2019PEJ-04; Spanish Ministerio de Ciencia Innovacion y Universidades, Grant/Award Number: PRE2020-092084 and PID2019-106332GB-I00; Universitat Rovira i Virgili (URV); Contractes de personal investigador predoctoral en formacio, Grant/Award Number: 2018PMF-PIPF-18	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; Barclay JW, 2003, J BIOL CHEM, V278, P10538, DOI 10.1074/jbc.M211114200; Besalduch N, 2010, J COMP NEUROL, V518, P211, DOI 10.1002/cne.22220; Brazhnik E, 2004, J NEUROSCI, V24, P9313, DOI 10.1523/JNEUROSCI.1618-04.2004; Callaghan B, 2004, CIRC RES, V94, P626, DOI 10.1161/01.RES.0000118248.17466.B7; Caulfield MP, 1998, PHARMACOL REV, V50, P279; CAZAUBON SM, 1993, J BIOL CHEM, V268, P17559; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Cilleros-Mane V, 2020, FASEB J, V34, P4934, DOI 10.1096/fj.201902113R; de Vries KJ, 2000, EUR J NEUROSCI, V12, P385, DOI 10.1046/j.1460-9568.2000.00931.x; Denning MF, 2012, PIGM CELL MELANOMA R, V25, P466, DOI 10.1111/j.1755-148X.2012.01015.x; Di-Capua N, 2003, J NEUROCHEM, V84, P409, DOI 10.1046/j.1471-4159.2003.01563.x; Disatnik MH, 2004, J CELL SCI, V117, P4469, DOI 10.1242/jcs.01309; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Ersvaer E, 2010, TOXINS, V2, P174, DOI 10.3390/toxins2010174; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Garcia N, 2005, HISTOL HISTOPATHOL, V20, P733, DOI 10.14670/HH-20.733; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; Heise C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00035; Hepp R, 2002, FEBS LETT, V532, P52, DOI 10.1016/S0014-5793(02)03629-3; HERGET T, 1995, EUR J BIOCHEM, V233, P448, DOI 10.1111/j.1432-1033.1995.448_2.x; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00270; Hurtado E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00147; Iwasaki S, 2000, J BIOCHEM-TOKYO, V128, P407, DOI 10.1093/oxfordjournals.jbchem.a022768; Johnson JA, 1996, J BIOL CHEM, V271, P24962, DOI 10.1074/jbc.271.40.24962; Just-Borras L, 2019, MOL NEUROBIOL, V56, P6856, DOI 10.1007/s12035-019-1550-1; Kang BS, 2000, ONCOGENE, V19, P4263, DOI 10.1038/sj.onc.1203779; Kataoka M, 2000, J NEUROCHEM, V74, P2058, DOI 10.1046/j.1471-4159.2000.0742058.x; Katayama N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08237-x; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; Knoch KP, 2006, CELL METAB, V3, P123, DOI 10.1016/j.cmet.2005.12.008; KRAFT AS, 1982, J BIOL CHEM, V257, P13193; Lanuza MA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121578; Lanuza MA, 2014, J ANAT, V224, P61, DOI 10.1111/joa.12106; Lee HW, 1996, J BIOL CHEM, V271, P20973, DOI 10.1074/jbc.271.35.20973; Leenders AGM, 2005, PHARMACOL THERAPEUT, V105, P69, DOI 10.1016/j.pharmthera.2004.10.012; Liu GS, 1999, J MOL CELL CARDIOL, V31, P1937, DOI 10.1006/jmcc.1999.1026; Lou XL, 2008, J NEUROSCI, V28, P8257, DOI 10.1523/JNEUROSCI.0550-08.2008; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Valenzuela IMPY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081311; Minic J, 2002, EUR J NEUROSCI, V15, P439, DOI 10.1046/j.0953-816x.2001.01875.x; Mochly-Rosen D, 1998, FASEB J, V12, P35; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Morgan A., 2004, CELL BIOL CHROMAFFIN, V1, P65; Nadal L, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00024; Nadal L, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0248-9; Nagy G, 2002, J NEUROSCI, V22, P9278; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; NAKANO S, 1992, MUSCLE NERVE, V15, P496, DOI 10.1002/mus.880150414; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0171-5; Obis T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0098-x; OLIVIER AR, 1992, J CELL PHYSIOL, V152, P240, DOI 10.1002/jcp.1041520204; Osto E, 2008, CIRCULATION, V118, P2174, DOI 10.1161/CIRCULATIONAHA.108.789537; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Rapaport D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009759; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; ROSS EM, 1993, LIFE SCI, V52, P413, DOI 10.1016/0024-3205(93)90296-F; Santafe MM, 2007, NEUROSCIENCE, V148, P432, DOI 10.1016/j.neuroscience.2007.06.017; Santafe MM, 2009, J NEUROSCI RES, V87, P683, DOI 10.1002/jnr.21885; Santafe MM, 2004, NEUROSCIENCE, V123, P61, DOI 10.1016/j.neuroscience.2003.09.012; Shen A, 1998, BIOCHEM PHARMACOL, V56, P1529, DOI 10.1016/S0006-2952(98)00242-1; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Shirai Y, 1998, JPN J PHARMACOL, V78, P411, DOI 10.1254/jjp.78.411; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Simo A, 2019, MOL NEUROBIOL, V56, P5346, DOI 10.1007/s12035-018-1462-5; Simo A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00207; Slutsky I, 1999, J PHYSIOL-LONDON, V514, P769, DOI 10.1111/j.1469-7793.1999.769ad.x; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Sons MS, 2003, ANN NY ACAD SCI, V998, P404, DOI 10.1196/annals.1254.052; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Wang YX, 1999, J BIOL CHEM, V274, P13859, DOI 10.1074/jbc.274.20.13859; Way KJ, 2000, TRENDS PHARMACOL SCI, V21, P181, DOI 10.1016/S0165-6147(00)01468-1; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001; Willets JM, 2007, J NEUROCHEM, V103, P2268, DOI 10.1111/j.1471-4159.2007.04931.x; Wright MC, 2009, J NEUROSCI, V29, P14942, DOI 10.1523/JNEUROSCI.2276-09.2009; Yang Y, 2007, J GEN PHYSIOL, V129, P233, DOI 10.1085/jgp.200609685; Zhang Y, 2015, J BIOL CHEM, V290, P8644, DOI 10.1074/jbc.M114.615021; Zhao LX, 2019, FASEB J, V33, P6622, DOI 10.1096/fj.201802351R; Zhou JZ, 2003, J BIOL CHEM, V278, P5388, DOI 10.1074/jbc.M209695200	90	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21724	10.1096/fj.202002213R	http://dx.doi.org/10.1096/fj.202002213R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34133802				2022-12-26	WOS:000667814100058
J	Sawada, N; Ueno, S; Takeda, K				Sawada, Naoya; Ueno, Shiori; Takeda, Kojiro			Regulation of inorganic polyphosphate is required for proper vacuolar proteolysis in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC PHOSPHATE HOMEOSTASIS; NITROGEN LIMITATION ADAPTATION; SACCHAROMYCES-CEREVISIAE; MEDIATES DEGRADATION; CELL-DIVISION; VTC PROTEINS; DNA-DAMAGE; E3 LIGASE; AUTOPHAGY; COMPLEX	Regulation of cellular proliferation and quiescence is a central issue in biology that has been studied using model unicellular eukaryotes, such as the fission yeast Schizosaccharomyces pombe. We previously reported that the ubiquitin/proteasome pathway and autophagy are essential to maintain quiescence induced by nitrogen deprivation in S. pombe; however, specific ubiquitin ligases that maintain quiescence are not fully understood. Here we investigated the SPX-RING-type ubiquitin ligase Pqr1, identified as required for quiescence in a genetic screen. Pqr1 is found to be crucial for vacuolar proteolysis, the final step of autophagy, through proper regulation of phosphate and its polymer polyphosphate. Pqr1 restricts phosphate uptake into the cell through ubiquitination and subsequent degradation of phosphate transporters on plasma membranes. We hypothesized that Pqr1 may act as the central regulator for phosphate control in S. pombe, through the function of the SPX domain involved in phosphate sensing. Deletion of pqr1(+) resulted in hyperaccumulation of intracellular phosphate and polyphosphate and in improper autophagy-dependent proteolysis under conditions of nitrogen starvation. Polyphosphate hyperaccumulation in pqr1(+)-deficient cells was mediated by the polyphosphate synthase VTC complex in vacuoles. Simultaneous deletion of VTC complex subunits rescued Pqr1 mutant phenotypes, including defects in proteolysis and loss of viability during quiescence. We conclude that excess polyphosphate may interfere with proteolysis in vacuoles by mechanisms that as yet remain unknown. The present results demonstrate a connection between polyphosphate metabolism and vacuolar functions for proper autophagy-dependent proteolysis, and we propose that polyphosphate homeostasis contributes to maintenance of cellular viability during quiescence.	[Sawada, Naoya; Ueno, Shiori; Takeda, Kojiro] Konan Univ, Grad Sch Nat Sci, Kobe, Hyogo, Japan; [Takeda, Kojiro] Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo, Japan	Konan University; Konan University	Takeda, K (corresponding author), Konan Univ, Grad Sch Nat Sci, Kobe, Hyogo, Japan.; Takeda, K (corresponding author), Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo, Japan.	takeda@konan-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS) [19K06647]; Foundation of the Kinoshita Memorial Enterprise	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation of the Kinoshita Memorial Enterprise	The initial phase of this study was carried out in the G0 Cell Unit (Prof. Mitsuhiro Yanagida) at Okinawa Institute of Science and Technology (OIST), Japan. We are greatly indebted to Drs Yanagida, Kenichi Sajiki (OIST), and Shigeaki Saitoh (Kurume University) for valuable discussions. We thank Ms Sayaka Kanzaki, Ms Yurika Kourogi, and Ms Hina Habara for technical assistance and especially Mr Yosuke Ishihara (Tokai Electron Microscopy, Inc) for his assistance on TEM analysis, and we are grateful to the National Bio-Resource Project (NBRP, Japan) for S. pombe strains. Parts of this study were supported by Special Ordinary Expense Subsidies for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by a Grant-in-Aid for Scientific Research (C) 19K06647 provided by the Japan Society for the Promotion of Science (JSPS), and by the Foundation of the Kinoshita Memorial Enterprise.	Aono S, 2019, GENES CELLS, V24, P172, DOI 10.1111/gtc.12665; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Azevedo C, 2015, MOL CELL, V58, P71, DOI 10.1016/j.molcel.2015.02.010; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beckley JR, 2015, MOL CELL PROTEOMICS, V14, P3132, DOI 10.1074/mcp.M115.050039; Bentley-DeSousa A, 2018, CELL REP, V22, P3427, DOI 10.1016/j.celrep.2018.02.104; Breus NA, 2012, FEMS YEAST RES, V12, P617, DOI 10.1111/j.1567-1364.2012.00812.x; Bru S, 2017, DNA REPAIR, V57, P171, DOI 10.1016/j.dnarep.2017.08.001; Bru S, 2017, MICROB CELL, V4, P6, DOI 10.15698/mic2017.01.551; Carter-O'Connell I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-697; Desfougeres Y, 2016, J BIOL CHEM, V291, P22262, DOI 10.1074/jbc.M116.746784; Eskes E, 2018, CURR GENET, V64, P155, DOI 10.1007/s00294-017-0743-2; Estill M, 2015, CURR GENET, V61, P175, DOI 10.1007/s00294-014-0466-6; Estrella LA, 2008, J BIOL CHEM, V283, P5327, DOI 10.1074/jbc.M703630200; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Garg A, 2018, J BIOL CHEM, V293, P4456, DOI 10.1074/jbc.RA117.001352; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Jimenez J, 2016, INT MICROBIOL, V19, P133, DOI 10.2436/20.1501.01.271; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin WY, 2013, PLANT CELL, V25, P4061, DOI 10.1105/tpc.113.116012; Liu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139045; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lorenz B, 1997, BBA-GEN SUBJECTS, V1335, P51, DOI 10.1016/S0304-4165(96)00121-3; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; McCarthy L, 2019, FEBS LETT, V279, P17289; Mochida S, 2006, GENES CELLS, V11, P13, DOI 10.1111/j.1365-2443.2005.00917.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrissey JH, 2015, J THROMB HAEMOST, V13, pS92, DOI 10.1111/jth.12896; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Murray JM, 2000, GENETICS, V154, P155; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Nakamura A, 2018, GENES CELLS, V23, P904, DOI 10.1111/gtc.12639; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nakase Y, 2013, J CELL SCI, V126, P3972, DOI 10.1242/jcs.128355; Nakashima A, 2006, CURR GENET, V49, P403, DOI 10.1007/s00294-006-0067-0; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Otsubo Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030050; Park BS, 2014, PLANT CELL, V26, P454, DOI 10.1105/tpc.113.120311; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Sajiki K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5685; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Shibata M, 2013, PLANT CELL, V25, P4967, DOI 10.1105/tpc.113.116947; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Su SSY, 1996, J CELL SCI, V109, P1347; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takeda K, 2011, P NATL ACAD SCI USA, V108, P16950, DOI 10.1073/pnas.1103617108; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 2017, METHOD ENZYMOL, V587, P87, DOI 10.1016/bs.mie.2016.09.054; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; van Leeuwen W, 2018, J CELL BIOL, V217, P2261, DOI 10.1083/jcb.201802003; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Xie LH, 2019, J BIOL CHEM, V294, P2180, DOI 10.1074/jbc.REV118.002808; Yanagida M, 2011, PHILOS T R SOC B, V366, P3508, DOI 10.1098/rstb.2011.0124; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	89	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100891	10.1016/j.jbc.2021.100891	http://dx.doi.org/10.1016/j.jbc.2021.100891			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34147496	Green Published, gold			2022-12-26	WOS:000678068400086
J	Yokota, M; Haffner, N; Kassier, M; Brunner, M; Shambat, SM; Brennecke, F; Schniering, J; Maggio, EM; Distler, O; Zinkernagel, AS; Maurer, B				Yokota, Masaya; Haeffner, Nicola; Kassier, Matthew; Brunner, Matthias; Shambat, Srikanth Mairpady; Brennecke, Fabian; Schniering, Janine; Maggio, Ewerton Marques; Distler, Oliver; Zinkernagel, Annelies Sophie; Maurer, Britta			Staphylococcus aureus impairs dermal fibroblast functions with deleterious effects on wound healing	FASEB JOURNAL			English	Article						fibroblasts; staphyloccous aureus; wound healing	SYSTEMIC-SCLEROSIS; DIGITAL ULCERS; INVASION; INFLAMMASOME; MICROBIOME; EXPRESSION; INFECTION; KINASE; REPAIR; CELLS	Chronic wounds are a major disease burden worldwide. The breach of the epithelial barrier facilitates transition of skin commensals to invasive facultative pathogens. Therefore, we investigated the potential effects of Staphylococcus aureus (SA) on dermal fibroblasts as key cells for tissue repair. In co-culture systems combining live or heat-killed SA with dermal fibroblasts derived from the BJ-5ta cell line, healthy individuals, and patients with systemic sclerosis, we assessed tissue repair including pro-inflammatory cytokines, matrix metalloproteases (MMPs), myofibroblast functions, and host defense responses. Only live SA induced the upregulation of IL-1 beta/-6/-8 and MMP1/3 as co-factors of tissue degradation. Additionally, the increased cell death reduced collagen production, proliferation, migration, and contractility, prerequisite mechanisms for wound closure. Intracellular SA triggered inflammatory and type I IFN responses via intracellular dsDNA sensor molecules and MyD88 and STING signaling pathways. In conclusion, live SA affected various key tissue repair functions of dermal fibroblasts from different sources to a similar extent. Thus, SA infection of dermal fibroblasts should be taken into account for future wound management strategies.	[Yokota, Masaya; Kassier, Matthew; Brunner, Matthias; Brennecke, Fabian; Schniering, Janine; Distler, Oliver; Maurer, Britta] Univ Hosp Zurich, Ctr Expt Rheumatol, Dept Rheumatol, Zurich, Switzerland; [Yokota, Masaya] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba, Japan; [Haeffner, Nicola; Shambat, Srikanth Mairpady; Zinkernagel, Annelies Sophie] Univ Zurich, Univ Hosp Zurich, Dept Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Maggio, Ewerton Marques] Univ Hosp Zurich, Inst Pathol & Mol Pathol, Zurich, Switzerland; [Maurer, Britta] Univ Bern, Univ Hosp Bern, Dept Rheumatol & Immunol, Bern, Switzerland	University of Zurich; University Zurich Hospital; Chiba University; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Maurer, B (corresponding author), Ctr Expt Rheumatol, Dept Rheumatol, Gloriastr 25, CH-8091 Zurich, Switzerland.	Britta.Maurer@usz.ch		Mairpady Shambat, Srikanth/0000-0002-0527-3978	Prof. Max Cloetta Foundation; Abbvie \ AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [31003A_176252]	Prof. Max Cloetta Foundation; Abbvie \ AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF)	Prof. Max Cloetta Foundation; Abbvie vertical bar AbbVie Deutschland (AbbVie Germany); Novartis Stiftung fur Medizinisch-Biologische Forschung (Novartis Foundation for Medical-Biological Research); Olga Mayenfisch Foundation; Vontobel-Stiftung (Vontobel Foundation); EMDO Stiftung (EMDO-Stiftung); Herzog Egli Foundation; Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 31003A_176252	Agerer F, 2005, J CELL SCI, V118, P2189, DOI 10.1242/jcs.02328; Amano A, 2006, J BIOCHEM, V140, P161, DOI 10.1093/jb/mvj162; Bergstrom B, 2015, J IMMUNOL, V195, P1100, DOI 10.4049/jimmunol.1403176; Bettenworth D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107317; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Denton CP, 2012, ANN RHEUM DIS, V71, P718, DOI 10.1136/annrheumdis-2011-200631; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fraunholz M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00043; Giuggioli D, 2018, AUTOIMMUN REV, V17, P155, DOI 10.1016/j.autrev.2017.11.020; Giuggioli D, 2013, CLIN RHEUMATOL, V32, P623, DOI 10.1007/s10067-012-2161-7; Giuggioli D, 2012, ARTHRIT CARE RES, V64, P295, DOI 10.1002/acr.20673; Grice EA, 2012, ADV EXP MED BIOL, V946, P55, DOI 10.1007/978-1-4614-0106-3_4; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hanamsagar R, 2014, J NEUROCHEM, V129, P704, DOI 10.1111/jnc.12669; Horn J, 2018, INT J MED MICROBIOL, V308, P607, DOI 10.1016/j.ijmm.2017.11.009; Hruz P, 2009, P NATL ACAD SCI USA, V106, P12873, DOI 10.1073/pnas.0904958106; Josse J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02433; Leimer N, 2016, J INFECT DIS, V213, P305, DOI 10.1093/infdis/jiv388; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; LURIA SE, 1946, P SOC EXP BIOL MED, V61, P46, DOI 10.3181/00379727-61-15222; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Nunan R, 2014, DIS MODEL MECH, V7, P1205, DOI 10.1242/dmm.016782; Parker D, 2012, J IMMUNOL, V189, P4040, DOI 10.4049/jimmunol.1201055; Pei JW, 2019, CANCER LETT, V450, P110, DOI 10.1016/j.canlet.2019.02.029; Quiblier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063513; Rahim K, 2017, MICROB ECOL, V73, P710, DOI 10.1007/s00248-016-0867-9; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Sayedyahossein S, 2015, FASEB J, V29, P711, DOI 10.1096/fj.14-262774; Scales BS, 2013, J PATHOL, V229, P323, DOI 10.1002/path.4118; Scumpia PO, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006496; Seidl K, 2013, J MICROBIOL METH, V92, P307, DOI 10.1016/j.mimet.2012.12.018; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Smith RS, 1997, AM J PATHOL, V151, P317; Strobel M, 2016, CLIN MICROBIOL INFEC, V22, P799, DOI 10.1016/j.cmi.2016.06.020; Surewaard BGJ, 2016, J EXP MED, V213, P1141, DOI 10.1084/jem.20160334; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Wirz EG, 2016, ANN RHEUM DIS, V75, P1285, DOI 10.1136/annrheumdis-2015-207271; Xia YY, 1997, AM J PATHOL, V151, P375; Zhang XP, 2017, MICROBIOL RES, V205, P19, DOI 10.1016/j.micres.2017.08.006	47	3	3	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21695	10.1096/fj.201902836R	http://dx.doi.org/10.1096/fj.201902836R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160101	Green Published, hybrid			2022-12-26	WOS:000667814100069
J	Dalske, KA; Raymond-Pope, CJ; McFaline-Figueroa, J; Basten, AM; Call, JA; Greising, SM				Dalske, Kyle A.; Raymond-Pope, Christiana J.; McFaline-Figueroa, Jennifer; Basten, Alec M.; Call, Jarrod A.; Greising, Sarah M.			Independent of physical activity, volumetric muscle loss injury in a murine model impairs whole-body metabolism	PLOS ONE			English	Article							FATTY-ACID OXIDATION; INDUCED MITOCHONDRIAL DYSFUNCTION; SKELETAL-MUSCLE; INSULIN-RESISTANCE; DIAPHRAGM MUSCLE; IMMOBILIZATION; FLEXIBILITY; DENERVATION; ADAPTATIONS; INTENSITY	Volumetric muscle loss (VML) injuries result in a non-recoverable loss of muscle tissue and function due to trauma or surgery. Reductions in physical activity increase the risk of metabolic comorbidities over time, and it is likely that VML may reduce whole-body activity. However, these aspects remain uncharacterized following injury. Our goal was to characterize the impact of VML on whole-body physical activity and metabolism, and to further investigate possible muscle-specific metabolic changes. Adult male C57Bl/6J (n = 28) mice underwent a standardized VML injury to the posterior compartment of the hind limb, or served as injury naive controls. Mice underwent longitudinal evaluation of whole-body physical activity and metabolism in specialized cages up to three times over the course of 8 weeks. At terminal time points of 4- and 8-weeks post-VML in vivo muscle function of the posterior compartment was evaluated. Additionally, the gastrocnemius muscle was collected to understand histological and biochemical changes in the muscle remaining after VML. The VML injury did not alter the physical activity of mice. However, there was a noted reduction in whole-body metabolism and diurnal fluctuations between lipid and carbohydrate oxidation were also reduced, largely driven by lower carbohydrate utilization during active hours. Following VML, muscle-specific changes indicate a decreased proportion of fast (i.e., type IIb and IIx) and a greater proportion of slow (i.e., type I and IIa) fibers. However, there were minimal changes in the capillarity and metabolic biochemical activity properties of the gastrocnemius muscle, suggesting a miss-match in capacity to support the physiologic needs of the fibers. These novel findings indicate that following VML, independent of changes in physical activity, there is whole-body diurnal metabolic inflexibility. Supporting future investigations into the chronic and overlooked co-morbidities of VML injury.	[Dalske, Kyle A.; Raymond-Pope, Christiana J.; Basten, Alec M.; Greising, Sarah M.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [McFaline-Figueroa, Jennifer; Call, Jarrod A.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [McFaline-Figueroa, Jennifer; Call, Jarrod A.] Univ Georgia, Regenerat Biosci Ctr, Athens, GA 30602 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Greising, SM (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	grei0064@umn.edu		Raymond-Pope, Christiana/0000-0003-3930-5904; Call, Jarrod/0000-0002-1094-4940; Basten, Alec M./0000-0003-1827-2007	Clinical & Rehabilitative Medicine Research Program [W81XWH-18-1-0710]; National Institutes of Health [T32-AR050938]; Congressionally Directed Medical Research Program	Clinical & Rehabilitative Medicine Research Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Program(United States Department of Defense)	Funding through the Congressionally Directed Medical Research Program, Clinical & Rehabilitative Medicine Research Program: W81XWH-18-1-0710 (JAC and SMG) and the National Institutes of Health T32-AR050938 (CJRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhihetty PJ, 2007, J APPL PHYSIOL, V102, P1143, DOI 10.1152/japplphysiol.00768.2006; Aguilar CA, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0027-8; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Aurora A, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-41; Baskin KK, 2015, CELL METAB, V21, P237, DOI 10.1016/j.cmet.2014.12.021; Booth FW, 2011, J APPL PHYSIOL, V111, P1199, DOI 10.1152/japplphysiol.01034.2011; Burke R E, 1975, Exerc Sport Sci Rev, V3, P31; Ceroni D, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-87; Chao T, 2019, J APPL PHYSIOL, V126, P1541, DOI 10.1152/japplphysiol.00026.2019; Corona BT, 2018, MUSCLE NERVE, V57, P799, DOI 10.1002/mus.26016; Corona BT, 2018, CTS-CLIN TRANSL SCI, V11, P208, DOI 10.1111/cts.12519; Corona BT, 2015, CELLS TISSUES ORGANS, V202, P180, DOI 10.1159/000443925; DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486; Demine S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080795; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Greising SM, 2020, INT J SPORTS MED, V41, P495, DOI 10.1055/a-1128-7128; Greising SM, 2019, TISSUE ENG PART B-RE, V25, P510, DOI [10.1089/ten.teb.2019.0207, 10.1089/ten.TEB.2019.0207]; Greising SM, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2095-6; Greising SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13306-2; Greising SM, 2015, MUSCLE NERVE, V52, P76, DOI 10.1002/mus.24641; Greising SM, 2013, EXP GERONTOL, V48, P881, DOI 10.1016/j.exger.2013.06.001; Greising SM, 2012, WIRES SYST BIOL MED, V4, P457, DOI 10.1002/wsbm.1184; Grogan BF, 2011, J AM ACAD ORTHOP SUR, V19, pS35, DOI 10.5435/00124635-201102001-00007; Harcombe H, 2016, PHYS THER, V96, P1885, DOI 10.2522/ptj.20160038; Hoffman DB, 2022, CONNECT TISSUE RES, V63, P124, DOI 10.1080/03008207.2021.1886285; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kang C, 2013, J APPL PHYSIOL, V115, P1618, DOI 10.1152/japplphysiol.01354.2012; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Leverve Xavier, 2007, Novartis Found Symp, V280, P108; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lusk G, 1917, ELEMENTS SCI NUTR, V3d; Ma WX, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5136957; Maggio AB, 2017, J PEDIATR ORTHOP B, V26, P217, DOI 10.1097/BPB.0000000000000389; Mase Vincent J Jr, 2010, Orthopedics, V33, P511, DOI 10.3928/01477447-20100526-24; Mckeehen JN, 2013, MED SCI SPORT EXER, V45, P1051, DOI 10.1249/MSS.0b013e3182811947; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Novotny SA, 2012, J MUSCULOSKEL NEURON, V12, P16; O'Leary MFN, 2012, AM J PHYSIOL-CELL PH, V303, pC447, DOI 10.1152/ajpcell.00451.2011; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Pollot BE, 2016, METHODS MOL BIOL, V1460, P19, DOI 10.1007/978-1-4939-3810-0_2; Porter C, 2016, BURNS, V42, P112, DOI 10.1016/j.burns.2015.10.026; Punsoni M, 2017, APPL IMMUNOHISTO M M, V25, P645, DOI 10.1097/PAI.0000000000000432; Reidy PT, 2021, J APPL PHYSIOL, V130, P537, DOI 10.1152/japplphysiol.00954.2020; Reinke H, 2019, NAT REV MOL CELL BIO, V20, P227, DOI 10.1038/s41580-018-0096-9; Rynders CA, 2018, J PHYSIOL-LONDON, V596, P1319, DOI 10.1113/JP273282; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SELIGMAN AM, 1954, J HISTOCHEM CYTOCHEM, V2, P441; Smith RL, 2018, ENDOCR REV, V39, P489, DOI 10.1210/er.2017-00211; Song YM, 2017, EXP THER MED, V13, P1209, DOI 10.3892/etm.2017.4105; Southern WM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40606-6; Thome T, 2019, AM J PHYSIOL-CELL PH, V317, pC701, DOI 10.1152/ajpcell.00098.2019; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	63	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253629	10.1371/journal.pone.0253629	http://dx.doi.org/10.1371/journal.pone.0253629			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170933	gold, Green Published			2022-12-26	WOS:000671694400003
J	Ficetola, GF; Silva-Rocha, I; Carretero, MA; Vignoli, L; Sacchi, R; Melotto, A; Scali, S; Salvi, D				Ficetola, Gentile Francesco; Silva-Rocha, Iolanda; Carretero, Miguel A.; Vignoli, Leonardo; Sacchi, Roberto; Melotto, Andrea; Scali, Stefano; Salvi, Daniele			Status of the largest extant population of the critically endangered Aeolian lizard Podarcis raffonei (Capo Grosso, Vulcano island)	PLOS ONE			English	Article							WAGLERIANA REPTILIA; WALL LIZARD; DIVERSITY; HYBRIDIZATION; LACERTIDAE; PATTERNS; SICULA	The Aeolian wall lizard Podarcis raffonei is an island endemic that survives only on three tiny islets, and on the Capo Grosso peninsula of the Vulcano island, thus is among the European vertebrates with the smallest range and one of the most threatened by extinction. This species is declining due to competition and hybridization with the non-native lizard Podarcis siculus, but a regular monitoring program is lacking. Here we assessed the size and status of the Capo Grosso population of P. raffonei on Vulcano. In September 2015 we captured 30 individuals showing the typical brown phenotype of P. raffonei, while one single male showed a green phenotype, apparently intermediate between P. raffonei and the non-native Podarcis siculus. In May 2017, only 47% of 131 individuals showed the typical brown phenotype (P. raffonei-like) and 53% showed the green phenotype (P. siculus-like). Based on N-mixture models and removal sampling the estimated size of the Capo Grosso population was of 800-1300 individuals in 2017, being similar to 2015; available data suggest that the total range of the species could be as small as 2 ha. The frequency of individuals with the typical P. raffonei phenotype dramatically dropped between two samplings with a parallel increase of individuals displaying the green phenotype. Observation on outdoor captive-bred individuals demonstrates plasticity for colouration in P. raffonei individuals from Capo Grosso, with several individuals showing the typical brown pattern in September 2017 and a green pattern in March 2021. Non-exclusive hypotheses, including hybridization with P. siculus and plasticity in colour pattern of P. raffonei, are discussed to explain the phenotypic shifts of the P. raffonei population of Capo Grosso. While genomic evidence is required to reach conclusions and investigate eventual hybridization, it is urgent to undertake a programme for the monitoring and management of this lizard.	[Ficetola, Gentile Francesco] Univ Milan, Dept Environm Sci & Policy, Milan, Italy; [Ficetola, Gentile Francesco] Univ Grenoble Aloes, Lab Ecol Alpine LECA, CNRS, Grenoble, France; [Silva-Rocha, Iolanda; Carretero, Miguel A.] Univ Porto, InBio Lab Associado, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Carretero, Miguel A.] Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal; [Vignoli, Leonardo] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Sacchi, Roberto] Univ Pavia, Dept Earth & Environm Sci, Pavia, Italy; [Melotto, Andrea] Stellenbosch Univ, Dept Bot & Zool, Ctr Excellence Invas Biol, Stellenbosch, Western Cape, South Africa; [Scali, Stefano] Museo Storia Nat Milano, Milan, Italy; [Salvi, Daniele] Univ LAquila, Dept Hlth Life & Environm Sci, Laquila, Italy	University of Milan; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Universidade do Porto; Universidade do Porto; Roma Tre University; University of Pavia; Stellenbosch University; University of L'Aquila	Salvi, D (corresponding author), Univ LAquila, Dept Hlth Life & Environm Sci, Laquila, Italy.	danielesalvi.bio@gmail.com	Vignoli, Leonardo/F-2663-2011; Salvi, Daniele/I-6360-2013; SACCHI, ROBERTO/E-2141-2011	Vignoli, Leonardo/0000-0002-1599-092X; Salvi, Daniele/0000-0002-3804-2690; SACCHI, ROBERTO/0000-0002-6199-0074	Mohamed bin Zayed Species Conservation Fund [162514415]; FCT, Portugal [28014 02/SAICT/2017, SFRH/BD/95745/2013]; University of Milan through the APC initiative	Mohamed bin Zayed Species Conservation Fund; FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); University of Milan through the APC initiative	This study was funded by the Mohamed bin Zayed Species Conservation Fund (Project 162514415). MAC and ISR are supported by grant 28014 02/SAICT/2017 and SFRH/BD/95745/2013 from FCT, Portugal. The authors acknowledge support from the University of Milan through the APC initiative.	Andrade P, 2019, P NATL ACAD SCI USA, V116, P5633, DOI 10.1073/pnas.1820320116; Capula M, 2002, ORYX, V36, P66, DOI 10.1017/S0030605302000108; CAPULA M, 1993, BIOCHEM SYST ECOL, V21, P373, DOI 10.1016/0305-1978(93)90028-P; CAPULA M, 1994, BIOL J LINN SOC, V52, P177; Capula M., 2006, ATLAS ITALIAN AMPHIB, P480; Capula M, 2014, MONOGRAPHIE SOC HERP, VIII, P39; Capula Massimo, 2004, Italian Journal of Zoology (Modena), V71, P161; Caruso Y, 2021, HERPETOL J, V31, P70, DOI 10.33256/hj31.2.7076; Chao A, 1999, ENVIRON ECOL STAT, V6, P313, DOI 10.1023/A:1009687514770; Corti C, 2011, FAUNA ITALIA, VXLV; Corti C, 2009, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.009.RLTS.T61552A12514822.en, DOI 10.2305/IUCN.UK.009.RLTS.T61552A12514822.EN]; Cuervo JJ, 2013, AMPHIBIA-REPTILIA, V34, P525, DOI 10.1163/15685381-00002912; D'Amico M, 2018, HERPETOL CONSERV BIO, V13, P146; Damas-Moreira I, 2019, ANIM BEHAV, V151, P195, DOI 10.1016/j.anbehav.2019.03.008; Damas-Moreira I, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0532; Della Croce P, 2016, MOL ECOL RESOUR, V16, P1287, DOI 10.1111/1755-0998.12520; Downes S, 2002, ANIM BEHAV, V63, P1037, DOI 10.1006/anbe.2002.3022; Faraone FP, 2006, 6 C NAZ SOC HERP IT; Ficetola GF, 2018, ANIM CONSERV, V21, P221, DOI 10.1111/acv.12356; Ficetola GF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28432-8; Ficetola GF, 2014, GLOBAL ECOL BIOGEOGR, V23, P1303, DOI 10.1111/geb.12201; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Galan Pedro, 1995, Revista Espanola de Herpetologia, V9, P57; Gippoliti S, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00130; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; IUCN, GUID US IUCN RED LIS; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kaliontzopoulou A, 2011, BIOL J LINN SOC, V103, P779, DOI 10.1111/j.1095-8312.2011.01703.x; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lo Cascio P., 2011, FAUNA ITALIA REPTILI, P401, DOI [10.1001/jama.2011.207, DOI 10.1001/JAMA.2011.207]; Lo Cascio P., 2016, MANUALI MONITORAGGIO, P280; Lo Cascio P., 2014, NAT SICILIANO, V38, P355; Lo Cascio Pietro, 2010, Naturalista Siciliano, V34, P295; Lo Cascio Pietro, 2006, Naturalista Siciliano, V30, P495; Lo Cascio Pietro, 2006, P91; Marta S, 2019, BIODIVERS CONSERV, V28, P2891, DOI 10.1007/s10531-019-01803-x; Mittermeier R.A., 2004, HOTSPOTS REVISITED; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Pellitteri-Rosa D, 2020, BIOL OPEN, V9, DOI 10.1242/bio.052415; Piras P, 2011, J EVOLUTION BIOL, V24, P2705, DOI 10.1111/j.1420-9101.2011.02396.x; Psonis N, 2017, MOL PHYLOGENET EVOL, V106, P6, DOI 10.1016/j.ympev.2016.09.007; Purse BV, 2015, BIOL J LINN SOC, V115, P664, DOI 10.1111/bij.12567; Reynolds JH, 2011, BIOL CONSERV, V144, P1278, DOI 10.1016/j.biocon.2010.12.002; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rosauer DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P168, DOI 10.1111/geb.12237; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Salvi D, 2021, MOL PHYLOGENET EVOL, V161, DOI 10.1016/j.ympev.2021.107169; Sillero N, 2014, AMPHIBIA-REPTILIA, V35, P1, DOI 10.1163/15685381-00002935; Silva-Rocha I, 2014, ACTA HERPETOL, V9, P253; Silva-Rocha IR, 2019, DIVERS DISTRIB, V25, P995, DOI 10.1111/ddi.12911; Todesco M, 2016, EVOL APPL, V9, P892, DOI 10.1111/eva.12367; Yang WZ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22949-9; Yang WZ, 2020, EVOLUTION, V74, P1289, DOI 10.1111/evo.14001; Yang WZ, 2018, MOL ECOL, V27, P4213, DOI 10.1111/mec.14861; Yang WJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P1284, DOI 10.1111/geb.12225; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	57	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253631	10.1371/journal.pone.0253631	http://dx.doi.org/10.1371/journal.pone.0253631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161384	gold, Green Published			2022-12-26	WOS:000671691900017
J	Smith, DM; Vogel, C; Campbell, M; Alwan, N; Moon, G				Smith, Dianna M.; Vogel, Christina; Campbell, Monique; Alwan, Nisreen; Moon, Graham			Adult diet in England: Where is more support needed to achieve dietary recommendations?	PLOS ONE			English	Article							SMALL-AREA; BEVERAGES; IMPACT; POPULATION; PREVALENCE; SMOKING; RISK	Background Small-area estimation models are regularly commissioned by public health bodies to identify areas of greater inequality and target areas for intervention in a range of behaviours and outcomes. Such local modelling has not been completed for diet consumption in England despite diet being an important predictor of health status. The study sets out whether aspects of adult diet can be modelled from previously collected data to define and evaluate area-level interventions to address obesity and ill-health. Methods Adults aged 16 years and over living in England. Consumption of fruit, vegetables, and sugar-sweetened beverages (SSB) are modelled using small-area estimation methods in English neighbourhoods (Middle Super Output Areas [MSOA]) to identify areas where reported portions are significantly different from recommended levels of consumption. The selected aspects of diet are modelled from respondents in the National Diet and Nutrition Survey using pooled data from 2008-2016. Results Estimates indicate that the average prevalence of adults consuming less than one portion of fruit, vegetables or 100% juice each day by MSOA is 6.9% (range of 4.3 to 14.7%, SE 0.06) and the average prevalence of drinking more than 330ml/day of SSB is 11.5% (range of 5.7 to 30.5%, SE 0.03). Credible intervals around the estimates are wider for SSB consumption. The results identify areas including regions in London, urban areas in the North of England and the South coast which may be prioritised for targeted interventions to support reduced consumption of SSB and/or an increase in portions of fruit and vegetables. Conclusion These estimates provide valuable information at a finer spatial scale than is presently feasible, allowing for within-country and locality prioritisation of resources to improve diet. Local, targeted interventions to improve fruit and vegetable consumption such as subsidies or voucher schemes should be considered where consumption of these foods is predicted to be low.	[Smith, Dianna M.; Campbell, Monique; Moon, Graham] Univ Southampton, Geog & Environm Sci, Southampton, Hants, England; [Smith, Dianna M.; Vogel, Christina; Alwan, Nisreen] NIHR Appl Res Collaborat ARC Wessex, Southampton, Hants, England; [Vogel, Christina] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Vogel, Christina; Alwan, Nisreen] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Vogel, Christina; Alwan, Nisreen] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Alwan, Nisreen] Univ Southampton, Sch Primary Care Populat Sci & Med Educ, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Smith, DM (corresponding author), Univ Southampton, Geog & Environm Sci, Southampton, Hants, England.; Smith, DM (corresponding author), NIHR Appl Res Collaborat ARC Wessex, Southampton, Hants, England.	d.m.smith@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022	Alwan, Nisreen A./0000-0002-4134-8463; Vogel, Christina/0000-0002-3897-3786; Smith, Dianna/0000-0002-0650-6606; Campbell, MoniqueA/0000-0002-6123-7170	ESRC South Coast Doctoral Training Programme [ES/P000673/1]	ESRC South Coast Doctoral Training Programme	Funding: MC is funded by the ESRC South Coast Doctoral Training Programme (ES/P000673/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandra Rose Charity, 2017, ROS VOUCH ROS VOUCH; Bambra C., 2016, HLTH DIVIDES YOU LIV; Birkin M., 2002, RETAIL GEOGRAPHY INT, DOI [10.1021/ac010964o, DOI 10.1021/AC010964O]; British Dietetic Association, 2017, SUG FOOD FACT SHEET SUG FOOD FACT SHEET; Buchan IE, 2017, J EPIDEMIOL COMMUN H, V71, P928, DOI 10.1136/jech-2017-209195; Butler MJ, 2020, BRAIN BEHAV IMMUN, V87, P53, DOI 10.1016/j.bbi.2020.04.040; Cade JE, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0962-x; Campbell M, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00230; Campbell M, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00447-6; Colantuoni F, 2015, CONTEMP ECON POLICY, V33, P714, DOI 10.1111/coep.12101; Collins B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130770; Congdon P, 2006, J PUBLIC HEALTH, V28, P71, DOI 10.1093/pubmed/fdi068; Congdon P., 2010, J DATA SCI, V8, P235, DOI [10.6339/JDS.2010.08(2).583, DOI 10.6339/JDS.2010.08(2).583]; Congdon P, 2020, HEALTH PLACE, V63, DOI 10.1016/j.healthplace.2020.102340; Department for Environment Food and Rural Affairs National Statistics, 2017, FAM FOOD 2015; Department of Health and Social Care, 2020, NEW OB STRAT UNV COU; Edwards KL, 2009, SOC SCI MED, V69, P1127, DOI 10.1016/j.socscimed.2009.07.037; England NHS., 2016, HLTH START VOUCH WHA HLTH START VOUCH WHA; England Sport, ACTIVE LIVES SURVEY; ESRI, 2020, MOD SPAT REL MOD SPAT REL; Gibson S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-9; Heath S, 2014, LOCAL AUTHORITIES PU; Lavin R., 2013, EXPLORING ACCEPTABIL; Lee Y, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002761; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Moon G, 2007, SOC SCI MED, V65, P20, DOI 10.1016/j.socscimed.2007.02.046; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; NatCen Social Research UCLU, 2017, NATL DIET NUTR SURVE, V8th; National Statistics, 2015, NAT STAT SOC CLASS U NAT STAT SOC CLASS U; NHS Digital, 2016, HLTH SURVEY ENGLAND; Office for National Statistics, 2011, 2011 CENS BOUND DAT; Office for National Statistics, 2011, 2011 CENS DAT 2011 CENS DAT; Office for National Statistics, 2017, MOD BAS EST HOUS POV MOD BAS EST HOUS POV; Office for National Statistics, 2018, MIDDL SUP OUTP AR PO MIDDL SUP OUTP AR PO; Office for National Statistics, 2020, HLTH STAT LIF EXP NA; Pechey R, 2013, SOC SCI MED, V92, P22, DOI 10.1016/j.socscimed.2013.05.012; Popkin BM, 2012, TRENDS ENDOCRIN MET, V23, P591, DOI 10.1016/j.tem.2012.07.003; Public Health England, 2014, NEW NAT DIET NUTR SU NEW NAT DIET NUTR SU; Public Health England, 2018, EATW GUID; Public Health England, 2018, LOC HLTH LOC HLTH; Public Health England Agency FS, 2018, NATL DIET NUTR SURVE; Riva M, 2012, SOC PSYCH PSYCH EPID, V47, P745, DOI 10.1007/s00127-011-0376-6; Scarborough P, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003025; Scarborough P, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013182; Smith DM, 2011, HEALTH PLACE, V17, P618, DOI 10.1016/j.healthplace.2011.01.001; Smith DM, 2009, ENVIRON PLANN A, V41, P1251, DOI 10.1068/a4147; Tomintz MN, 2008, AREA, V40, P341, DOI 10.1111/j.1475-4762.2008.00837.x; Treasury HM., 2016, SOFT DRINKS IND LEV SOFT DRINKS IND LEV; Twigg L, 2000, SOC SCI MED, V50, P1109, DOI 10.1016/S0277-9536(99)00359-7; Voas D., 2001, GEOG ENV MODEL, V5, P177, DOI [10.1080/13615930120086078, DOI 10.1080/13615930120086078]; Whitworth A, 2017, COMPUT ENVIRON URBAN, V63, P50, DOI 10.1016/j.compenvurbsys.2016.06.004; World Health Organisation, 2020, HLTH DIET; Wright A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4497-z; Zhang DL, 2014, AM J PUBLIC HEALTH, V104, P1217, DOI 10.2105/AJPH.2014.301934	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252877	10.1371/journal.pone.0252877	http://dx.doi.org/10.1371/journal.pone.0252877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161358	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000671691900060
J	Karawekpanyawong, N; Kaewkitikul, K; Maneeton, B; Maneeton, N; Siriaree, S				Karawekpanyawong, Nuntaporn; Kaewkitikul, Kewalee; Maneeton, Benchalak; Maneeton, Narong; Siriaree, Sitthicha			The prevalence of depressive disorder and its association in Thai cervical cancer patients	PLOS ONE			English	Article							QUALITY-OF-LIFE; EUROPEAN-ORGANIZATION; SOCIAL SUPPORT; RISK-FACTORS; CHRONIC-FATIGUE; WOMEN; ANXIETY; SURVIVORS; IMPACT; PAIN	Purpose The purpose of this study is to examine the prevalence, associated factors and quality of life associated with depressive disorder in cervical cancer patients. Patients and methods This cross-sectional study was carried out in a gynecologic oncology clinic of a university hospital in Northern Thailand from October 2018 to August 2019. Two-hundred cervical cancer patients were screened for depressive disorder using the nine-item Patient Health Questionnaire (PHQ-9), and psychiatrists interviewed eligible patients to confirm diagnoses. We measured the quality of life using questionnaires from the European Organisation for the Research and Treatment of Cancer: Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) and Cervical Cancer Module 24 (EORTC QLQ-Cx24). Associated factors, including comorbidity, fatigue, and pain, were collected using the Charlson Comorbidity Index (CCI), the eleven-item Chalder Fatigue Scale (CFQ 11), and the visual analog scale (VAS) for pain, respectively. Results Twenty-seven (13.5%) cervical cancer patients were diagnosed with depressive disorder by psychiatrists according to the DSM-5. Depressive disorder was related to a worse quality of life in these patients. A binary logistic regression analysis revealed that depressive disorder among these patients was linked with these factors: high fatigue score (aOR: 1.35; CI: 1.18-1.53), high pain score (aOR: 1.25; CI: 1.02-1.54), no perception of social support, (aOR: 3.12; CI: 1.11-8.81), and no previous surgical treatment for cervical cancer (aOR: 2.99; CI: 1.08-8.29). Conclusion The depressive disorder prevalence was 13.5% in Northern Thai cervical cancer patients. In this demographic, cervical cancer patients-who reported high fatigue or pain scores, did not perceive social support, or had no previous cervical cancer surgery- were more likely to have depressive disorder.	[Karawekpanyawong, Nuntaporn; Kaewkitikul, Kewalee; Maneeton, Benchalak; Maneeton, Narong] Chiang Mai Univ, Fac Med, Dept Psychiat, Chiang Mai, Thailand; [Siriaree, Sitthicha] Chiang Mai Univ, Fac Med, Dept Obstet & Gynecol, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University	Karawekpanyawong, N (corresponding author), Chiang Mai Univ, Fac Med, Dept Psychiat, Chiang Mai, Thailand.	nuntaporn.karawek@cmu.ac.th	Karawekpanyawong, Nuntaporn/AAT-9208-2021	Karawekpanyawong, Nuntaporn/0000-0002-9063-0991	Faculty of Medicine, Chiang Mai University, Thailand [043/2562]; Chiang Mai University, Thailand [4/2564]	Faculty of Medicine, Chiang Mai University, Thailand; Chiang Mai University, Thailand	This work was supported by a grant from the Faculty of Medicine, Chiang Mai University, Thailand to NK (grant number 043/2562), and Chiang Mai University, Thailand to BM (grant number 4/2564). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; AHLES TA, 1984, J PSYCHOSOM RES, V28, P121, DOI 10.1016/0022-3999(84)90004-7; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; [Anonymous], 2016, SEER CANC STAT REV 1; Aoki ES, 2020, J GYNECOL ONCOL, V31, DOI 10.3802/jgo.2020.31.e55; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Ay-Woan P, 2006, QUAL LIFE RES, V15, P39, DOI 10.1007/s11136-005-0381-x; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Bao YJ, 2019, SUPPORT CARE CANCER, V27, P257, DOI 10.1007/s00520-018-4321-z; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Burnard P, 2006, J PSYCHIATR MENT HLT, V13, P742, DOI 10.1111/j.1365-2850.2006.01028.x; Carpenter KM, 2010, ANN BEHAV MED, V39, P79, DOI 10.1007/s12160-010-9160-1; Carter J, 2005, GYNECOL ONCOL, V97, P90, DOI 10.1016/j.ygyno.2004.12.019; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Colleoni M, 2000, LANCET, V356, P1326, DOI 10.1016/S0140-6736(00)02821-X; Ebede CC, 2017, MED CLIN N AM, V101, P1085, DOI 10.1016/j.mcna.2017.06.007; Gariepy G, 2016, BRIT J PSYCHIAT, V209, P286, DOI 10.1192/bjp.bp.115.169094; Greimel ER, 2006, CANCER-AM CANCER SOC, V107, P1812, DOI 10.1002/cncr.22217; Hall A, 1999, EUR J CANCER, V35, P79, DOI 10.1016/S0959-8049(98)00308-6; Hanprasertpong J, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e72; Hengrasmee P., 2004, Prevalence and Associated Factors, V87, P6; Hong JS, 2014, SUPPORT CARE CANCER, V22, P453, DOI 10.1007/s00520-013-1997-y; Imsamran W., 2018, CANC THAILAND, V202, P19; Jyani G, 2020, INT J GYNECOL CANCER, V30, P1887, DOI 10.1136/ijgc-2020-001455; Kim S, 2009, J CLIN ONCOL, V27; Kim SH, 2010, INT J GYNECOL CANCER, V20, P1017, DOI 10.1111/IGC.0b013e3181e4a704; Kirmayer LJ, 2001, J CLIN PSYCHIAT, V62, P22; Kittirattanapaiboon P., 2005, J MENTAL HLTH THAILA, V13, P125; Klapheke AK, 2020, J GERIATR ONCOL, V11, P820, DOI 10.1016/j.jgo.2019.10.001; Klugel S, 2017, INT J WOMENS HEALTH, V9, P795, DOI 10.2147/IJWH.S143368; Koh WJ, 2019, J NATL COMPR CANC NE, V17, P64, DOI 10.6004/jnccn.2019.0001; Kongsuk T, WORLD PSYCH ASS SECT, P11; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lau K L, 2013, East Asian Arch Psychiatry, V23, P144; Lotrakul M., 1996, ASEAN J PSYCHIATR, V4, P24; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Lu DH, 2019, CANCER RES, V79, P3965, DOI 10.1158/0008-5472.CAN-19-0116; Manea L, 2015, GEN HOSP PSYCHIAT, V37, P67, DOI 10.1016/j.genhosppsych.2014.09.009; Maneeton B, 2014, ONCOTARGETS THER, V7, P815, DOI 10.2147/OTT.S60000; Maneeton B, 2012, ASIAN PAC J CANCER P, V13, P2039, DOI 10.7314/APJCP.2012.13.5.2039; Manne SL, 2018, QUAL LIFE RES, V27, P2991, DOI 10.1007/s11136-018-1953-x; McCorkle Ruth, 2006, Health Care Women Int, V27, P45, DOI 10.1080/07399330500377507; Meyerowitz BE, 2000, J SOC CLIN PSYCHOL, V19, P352, DOI 10.1521/jscp.2000.19.3.352; Minimum Wage Commission Republic of Korea., 2021, MIN WAG SYST; Morriss RK, 1998, J PSYCHOSOM RES, V45, P411, DOI 10.1016/S0022-3999(98)00022-1; Nuhu FT, 2009, AFR J PSYCHIATRY, V12, P64; Olisah VO, 2011, AJAR-AFR J AIDS RES, V10, P247, DOI 10.2989/16085906.2011.626294; Osann K, 2014, GYNECOL ONCOL, V135, P266, DOI 10.1016/j.ygyno.2014.08.036; Ozbay Fatih, 2007, Psychiatry (Edgmont), V4, P35; Park B, 2017, PSYCHIAT INVEST, V14, P618, DOI 10.4306/pi.2017.14.5.618; Paul R., 2016, IOSR J DENT MED SCI, V15, P2279; Petersen RW, 2005, J OBSTET GYNAECOL RE, V31, P152, DOI 10.1111/j.1341-8076.2005.00263.x; Phanwattana P, J OFFICE DPC7 KHON K, V26, P93; Pinquart M, 2010, PSYCHOL MED, V40, P1797, DOI 10.1017/S0033291709992285; Prasongvej Pichita, 2017, Asian Pac J Cancer Prev, V18, P385; Prieto JM, 2002, J CLIN ONCOL, V20, P1907, DOI 10.1200/JCO.2002.07.101; Sadock B.J., 2015, KAPLAN SADOCKS SYNOP, P509; Satin JR, 2009, CANCER-AM CANCER SOC, V115, P5349, DOI 10.1002/cncr.24561; Sekse RJT, 2015, J CLIN NURS, V24, P546, DOI 10.1111/jocn.12647; Shyu IL, 2019, INT J WOMENS HEALTH, V11, P135, DOI 10.2147/IJWH.S193003; Silpakit C, 2006, QUAL LIFE RES, V15, P167, DOI 10.1007/s11136-005-0449-7; Singh U, 2019, J CANCER RES THER, V15, P1338, DOI 10.4103/jcrt.JCRT_1028_17; Vistad I, 2007, BJOG-INT J OBSTET GY, V114, P1150, DOI 10.1111/j.1471-0528.2007.01445.x; Vorn R, 2019, INT J HEALTH PLAN M, V34, pE1747, DOI 10.1002/hpm.2888; Wen Q, 2017, EUR J OBSTET GYN R B, V216, P85, DOI 10.1016/j.ejogrb.2017.07.004; Widyastuty Arsusy, 2019, Open Access Maced J Med Sci, V7, P2634, DOI [10.3889/oa, 10.3889/oamjms.2019.473]; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094804; Yoo H, 2017, JPN J CLIN ONCOL, V47, P728, DOI 10.1093/jjco/hyx064	68	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252779	10.1371/journal.pone.0252779	http://dx.doi.org/10.1371/journal.pone.0252779			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BF	34153051	Green Published, gold			2022-12-26	WOS:000671691000005
J	Gloor, AD; Chollet, L; Christ, LA; Cullmann, JL; Bonel, HM; Villiger, PM				Gloor, Andrea D.; Chollet, Laureve; Christ, Lisa A.; Cullmann, Jennifer L.; Bonel, Harald M.; Villiger, Peter M.			Takayasu arteritis: Prevalence and clinical presentation in Switzerland	PLOS ONE			English	Article							GIANT-CELL ARTERITIS; CLASSIFICATION; NOMENCLATURE; EPIDEMIOLOGY	Objective Takayasu arteritis (TAK) is a rare immune-mediated vasculitis of the aorta and its branches. Aims were to calculate prevalence and incidence in Switzerland, to assess disease activity and performance of MR-Angiography (MRA). Methods 31 patients were recorded in a database, 27 were followed prospectively up to 3 years. Prevalence was calculated based on data of the national statistical bureau. Disease activity was defined using the revised EULAR criteria. MRA depicted stenotic changes and aortic wall enhancement. Results A disease prevalence of 14.5/1.000.000 inhabitants and an incidence of 0.3/1.000.000 per year was calculated. Aortic wall enhancement was found in 10 patients while in clinical and serological remission. EULAR criteria missed 5 patients with disease activity with isolated elevations of ESR/CRP. Arterial stenosis did not change over time in 5 cases, it improved in 2 and increased in 7. At follow-up 16 patients were treated with tocilizumab, 11/16 in monotherapy, 5 patients were treatment-free, 25/27 stayed in remission. Conclusion In addition to prevalence and incidence, our data show that MRA qualifies to detect subclinical disease activity, but, on the other hand, that EULAR criteria may miss disease activity in case of isolated elevation of ESR/CRP.	[Gloor, Andrea D.; Chollet, Laureve; Christ, Lisa A.; Villiger, Peter M.] Univ Hosp, Dept Rheumatol Immunol & Allergol, Inselspital, Bern, Switzerland; [Gloor, Andrea D.; Chollet, Laureve; Christ, Lisa A.; Cullmann, Jennifer L.; Bonel, Harald M.; Villiger, Peter M.] Univ Bern, Bern, Switzerland; [Cullmann, Jennifer L.; Bonel, Harald M.] Univ Hosp, Dept Diagnost & Intervent Radiol, Inselspital, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Villiger, PM (corresponding author), Univ Hosp, Dept Rheumatol Immunol & Allergol, Inselspital, Bern, Switzerland.; Villiger, PM (corresponding author), Univ Bern, Bern, Switzerland.	peter.villiger@hin.ch	Villiger, Peter/AAV-8132-2021	Gloor, Andrea/0000-0001-7271-7981; Bonel, Harald Marcel/0000-0002-3033-6248	Division of Rheumatology, Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, Switzerland	Division of Rheumatology, Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, Switzerland	The study was funded by the Research Funds of the Division of Rheumatology, Department of Rheumatology, Immunology and Allergology, University Hospital of Bern, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, SHAP BUND LAND SWISS SHAP BUND LAND SWISS; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Borchers AT, 2012, AUTOIMMUN REV, V11, pA544, DOI 10.1016/j.autrev.2012.01.003; Dejaco C, 2018, ANN RHEUM DIS, V77, P636, DOI 10.1136/annrheumdis-2017-212649; Hata A, 1996, INT J CARDIOL, V54, pS155, DOI 10.1016/S0167-5273(96)02813-6; Hellmich B, 2018, ANN RHEUM DIS; Isaacs JD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4397; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; Koide K, 1992, Heart Vessels Suppl, V7, P48, DOI 10.1007/BF01744544; Mohammad AJ, 2015, J RHEUMATOL, V42, P853, DOI 10.3899/jrheum.140843; Onen F, 2017, PRESSE MED, V46, pE197, DOI 10.1016/j.lpm.2017.05.034; Quinn KA, 2018, ANN RHEUM DIS, V77, P1166, DOI 10.1136/annrheumdis-2018-213102; Reichenbach S, 2018, RHEUMATOLOGY, V57, P982, DOI 10.1093/rheumatology/key015; Saritas F, 2016, RHEUMATOL INT, V36, P911, DOI 10.1007/s00296-016-3445-z; Toshihiko N, 1996, INT J CARDIOL, V54, pS91, DOI 10.1016/S0167-5273(96)88777-8; Villiger PM, 2017, Z RHEUMATOL, V76, P509, DOI 10.1007/s00393-017-0331-3; Watts R, 2009, RHEUMATOLOGY, V48, P1008, DOI 10.1093/rheumatology/kep153	19	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0250025	10.1371/journal.pone.0250025	http://dx.doi.org/10.1371/journal.pone.0250025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143786	Green Published, gold			2022-12-26	WOS:000671690700052
J	Liang, HL; Tao, DB; Zhang, Q; Zhang, S; Wang, JY; Liu, LF; Wu, ZX; Sun, WT				Liang, Hanling; Tao, Dongbing; Zhang, Qi; Zhang, Shuang; Wang, Jiayi; Liu, Lifei; Wu, Zhaoxia; Sun, Wentao			Nitrogen fertilizer application rate impacts eating and cooking quality of rice after storage	PLOS ONE			English	Article							TEXTURAL PROPERTIES; PASTING PROPERTIES; FINE-STRUCTURE; STARCH; TEMPERATURE; GRAIN; PROTEINS; LEVEL; BROWN	The effect of nitrogen fertilizer application on the quality of rice post-storage is not well understood. The eating and cooking quality (ECQ) of rice treated with 0 (CK, control), 160 (IN, insufficient nitrogen), 260 (AN, adequate nitrogen), and 420 (EN, excessive nitrogen) kg N/ha was analyzed over 12 months of storage. Results showed that the rate of nitrogen fertilizer application had no significant impact on the changes in taste value during storage. However, EN application significantly increased the hardness (p < 0.05), reduced the gumminess (p < 0.05), and delayed the decline in the viscosity of rice paste by two months after one-year storage, compared with other treatments. In conclusion, although EN application resulted in an inferior texture of rice, it delayed the quality change by two months during storage. It was demonstrated that a rational nitrogen application rate (0-260 kg N/ha) for rice cultivation is particularly important to obtain high ECQ; however, EN may be beneficial for the stability of the ECQ during storage.	[Liang, Hanling; Tao, Dongbing; Zhang, Qi; Zhang, Shuang; Liu, Lifei; Wu, Zhaoxia] Shenyang Agr Univ, Coll Food Sci, Shenyang, Peoples R China; [Wang, Jiayi] Shaoyang Univ, Coll Food & Chem Engn, Shaoyang, Peoples R China; [Sun, Wentao] Liaoning Academay Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Peoples R China	Shenyang Agricultural University; Shaoyang University	Wu, ZX (corresponding author), Shenyang Agr Univ, Coll Food Sci, Shenyang, Peoples R China.; Sun, WT (corresponding author), Liaoning Academay Agr Sci, Inst Plant Nutr & Environm Resources, Shenyang, Peoples R China.	wuzxsau@163.com; wentaosw@163.com		Liang, Hanling/0000-0003-3358-8827	National Key Research and Development Program of China [2018YFD0300300]; Science and Technology Innovation Talents Training Project of Liaoning Province [XLYC1802044]	National Key Research and Development Program of China; Science and Technology Innovation Talents Training Project of Liaoning Province	This work was supported by grants from the National Key Research and Development Program of China (Grant No. 2018YFD0300300), and Science and Technology Innovation Talents Training Project of Liaoning Province (Grant No. XLYC1802044).	Ahmad U, 2017, LWT-FOOD SCI TECHNOL, V75, P386, DOI 10.1016/j.lwt.2016.09.014; Alvaro-Fuentes J, 2016, SOIL SCI SOC AM J, V80, P662, DOI 10.2136/sssaj2015.04.0156; Cao XM, 2018, J SCI FOOD AGR, V98, P2332, DOI 10.1002/jsfa.8723; Champagne ET, 2009, CEREAL CHEM, V86, P274, DOI 10.1094/CCHEM-86-3-0274; Champagne ET, 1999, CEREAL CHEM, V76, P764, DOI 10.1094/CCHEM.1999.76.5.764; Champagne ET, 1996, CEREAL CHEM, V73, P290; CHRASTIL J, 1990, J AGR FOOD CHEM, V38, P1804, DOI 10.1021/jf00099a005; Derycke V, 2005, CEREAL CHEM, V82, P468, DOI 10.1094/CC-82-0468; Fitzgerald MA, 2003, J AGR FOOD CHEM, V51, P2295, DOI 10.1021/jf020574i; Genkawa T, 2008, BIOSYST ENG, V99, P515, DOI 10.1016/j.biosystemseng.2007.12.011; Gu FT, 2019, FOOD CHEM, V295, P484, DOI 10.1016/j.foodchem.2019.05.168; Gujral HS, 2003, J FOOD ENG, V59, P117, DOI 10.1016/S0260-8774(02)00438-7; Guo YB, 2015, CEREAL CHEM, V92, P384, DOI 10.1094/CCHEM-05-14-0104-R; Hamonts K, 2013, SOIL BIOL BIOCHEM, V65, P1, DOI 10.1016/j.soilbio.2013.05.006; Huang YC, 2014, FOOD CHEM, V152, P432, DOI 10.1016/j.foodchem.2013.11.144; Kaur A, 2016, J FOOD SCI TECH MYS, V53, P2452, DOI 10.1007/s13197-016-2230-z; Keawpeng I, 2015, INT FOOD RES J, V22, P2180; 김훈, 2007, 한국식품저장유통학회지, V14, P18; Kim YJ, 2010, J KOREAN SOC APPL BI, V53, P508, DOI 10.3839/jksabc.2010.077; Li HY, 2019, INT J BIOL MACROMOL, V128, P49, DOI 10.1016/j.ijbiomac.2019.01.113; Li HY, 2016, FOOD CHEM, V196, P702, DOI 10.1016/j.foodchem.2015.09.112; Liu HJ., 2002, J JAPANESE SOC AGR M, DOI [10.11357/jsam1937.64.52, DOI 10.11357/JSAM1937.64.52]; Makani MN, 2017, HORTSCIENCE, V52, P1390, DOI 10.21273/HORTSCI11870-17; Nath S, 2009, AMA-AGR MECH ASIA AF, V40, P46; Park CE, 2012, J STORED PROD RES, V48, P25, DOI 10.1016/j.jspr.2011.08.005; Patindol J, 2005, STARCH-STARKE, V57, P197, DOI 10.1002/star.200400367; Ramesh M, 2000, CRIT REV FOOD SCI, V40, P449, DOI 10.1080/10408690091189220; Singh N, 2011, CARBOHYD POLYM, V86, P219, DOI 10.1016/j.carbpol.2011.04.039; Sodhi NS, 2003, J FOOD PROCESS PRES, V27, P387, DOI 10.1111/j.1745-4549.2003.tb00525.x; Tulyathan V, 2007, J FOOD BIOCHEM, V31, P415, DOI 10.1111/j.1745-4514.2007.00125.x; Unlu H, 2010, AFR J BIOTECHNOL, V9, P7909; Wang F, 2018, FOOD CHEM, V239, P23, DOI 10.1016/j.foodchem.2017.06.082; Yang XY, 2016, J CEREAL SCI, V71, P230, DOI 10.1016/j.jcs.2016.09.003; Zhang N, 2019, INT J BIOL MACROMOL, V135, P394, DOI 10.1016/j.ijbiomac.2019.05.184; Zhou Z, 2002, J CEREAL SCI, V35, P65, DOI 10.1006/jcrs.2001.0418; Zhou Z, 2007, FOOD CHEM, V105, P491, DOI 10.1016/j.foodchem.2007.04.005; Zhou ZK, 2003, FOOD RES INT, V36, P625, DOI 10.1016/S0963-9969(03)00013-9; Zhu DW, 2017, J INTEGR AGR, V16, P1018, DOI [10.1016/S2095-3119(16)61577-0, 10.1016/s2095-3119(16)61577-0]; Zhu DW, 2017, FOOD HYDROCOLLOID, V63, P525, DOI 10.1016/j.foodhyd.2016.09.042	39	5	5	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253189	10.1371/journal.pone.0253189	http://dx.doi.org/10.1371/journal.pone.0253189			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143820	gold, Green Published			2022-12-26	WOS:000671690700036
J	Pandita, A; Gillani, FS; Shi, YY; Hardesty, A; McCarthy, M; Aridi, J; Farmakiotis, D; Chiang, SS; Beckwith, CG				Pandita, Aakriti; Gillani, Fizza S.; Shi, Yiyun; Hardesty, Anna; McCarthy, Meghan; Aridi, Jad; Farmakiotis, Dimitrios; Chiang, Silvia S.; Beckwith, Curt G.			Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island	PLOS ONE			English	Article							NEW-YORK-CITY; OUTCOMES	Background In order for healthcare systems to prepare for future waves of COVID-19, an in-depth understanding of clinical predictors is essential for efficient triage of hospitalized patients. Methods We performed a retrospective cohort study of 259 patients admitted to our hospitals in Rhode Island to examine differences in baseline characteristics (demographics and comorbidities) as well as presenting symptoms, signs, labs, and imaging findings that predicted disease progression and in-hospital mortality. Results Patients with severe COVID-19 were more likely to be older (p = 0.02), Black (47.2% vs. 32.0%, p = 0.04), admitted from a nursing facility (33.0% vs. 17.9%, p = 0.006), have diabetes (53.9% vs. 30.4%, p<0.001), or have COPD (15.4% vs. 6.6%, p = 0.02). In multivariate regression, Black race (adjusted odds ratio [aOR] 2.0, 95% confidence interval [CI]: 1.1-3.9) and diabetes (aOR 2.2, 95%CI: 1.3-3.9) were independent predictors of severe disease, while older age (aOR 1.04, 95% CI: 1.01-1.07), admission from a nursing facility (aOR 2.7, 95% CI 1.1-6.7), and hematological co-morbidities predicted mortality (aOR 3.4, 95% CI 1.1-10.0). In the first 24 hours, respiratory symptoms (aOR 7.0, 95% CI: 1.4-34.1), hypoxia (aOR 19.9, 95% CI: 2.6-152.5), and hypotension (aOR 2.7, 95% CI) predicted progression to severe disease, while tachypnea (aOR 8.7, 95% CI: 1.1-71.7) and hypotension (aOR 9.0, 95% CI: 3.1-26.1) were associated with increased in-hospital mortality. Conclusions Certain patient characteristics and clinical features can help clinicians with early identification and triage of high-risk patients during subsequent waves of COVID-19.	[Pandita, Aakriti] Univ Colorado, Sch Med, Dept Med, Denver, CO 80202 USA; [Gillani, Fizza S.; McCarthy, Meghan; Aridi, Jad; Farmakiotis, Dimitrios; Beckwith, Curt G.] Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA; [Shi, Yiyun; Hardesty, Anna] Brown Univ, Warren Alpert Med Sch, Dept Internal Med, Providence, RI 02912 USA; [Chiang, Silvia S.] Brown Univ, Warren Alpert Med Sch, Dept Pediat, Div Pediat Infect Dis, Providence, RI 02912 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Brown University; Brown University; Brown University	Pandita, A (corresponding author), Univ Colorado, Sch Med, Dept Med, Denver, CO 80202 USA.; Beckwith, CG (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Infect Dis, Providence, RI 02912 USA.	aakriti.pandita@cuanschutz.edu; CBeckwith@lifespan.org						Allen D., 2020, ROADMAP PANDEMIC RES; [Anonymous], COVID RACIAL DATA TR; Aziz M, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02995-3; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Cao W, 2020, CELL RES, V30, P367, DOI 10.1038/s41422-020-0327-4; CDC, 2020, CAS US; Cheng YC, 2020, KIDNEY INT, V97, P829, DOI 10.1016/j.kint.2020.03.005; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P545, DOI 10.15585/mmwr.mm6918e1; Goldman JD, 2020, NEW ENGL J MED, V383, P1827, DOI 10.1056/NEJMoa2015301; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Hodgson K, 2015, IMMUNOLOGY, V144, P171, DOI 10.1111/imm.12394; Holmes L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124322; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hu L, 2020, CLIN INFECT DIS, V71, P2089, DOI 10.1093/cid/ciaa539; Imam Z, 2020, J GEN INTERN MED, V35, P2516, DOI 10.1007/s11606-020-05937-5; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Kalligeros M, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa319; Lassale Camille, 2020, medRxiv, DOI 10.1101/2020.05.19.20106344; Madhuripan N, 2020, J AM COLL RADIOL, V17, P855, DOI 10.1016/j.jacr.2020.05.026; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Myers LC, 2020, JAMA-J AM MED ASSOC, V323, P2195, DOI 10.1001/jama.2020.7202; Olender Susan A, 2021, Clin Infect Dis, V73, pe4166, DOI 10.1093/cid/ciaa1041; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Pandita A, 2021, CLIN INFECT DIS, V73, P356, DOI 10.1093/cid/ciaa1349; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Ritchie AI, 2020, LANCET, V395, P1111, DOI 10.1016/S0140-6736(20)30691-7; Rivera DR, 2020, CANCER DISCOV, V10, P1514, DOI 10.1158/2159-8290.CD-20-0941; Shi YY, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13926; Spinner CD, 2020, JAMA-J AM MED ASSOC, V324, P1048, DOI 10.1001/jama.2020.16349; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; White CNV, 2020, CORONAVIRUS COVID 19; Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yan YL, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001343; Zhang Y, 2020, DIABETES OBES METAB, V22, P1443, DOI 10.1111/dom.14086; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhu LH, 2020, CELL METAB, V31, P1068, DOI 10.1016/j.cmet.2020.04.021; Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490	45	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252411	10.1371/journal.pone.0252411	http://dx.doi.org/10.1371/journal.pone.0252411			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143791	gold, Green Published			2022-12-26	WOS:000671690700033
J	Shumway, SG; Hopper, JD; Tolman, ER; Ferguson, DG; Hubble, G; Patterson, D; Jensen, JL				Shumway, Spencer G.; Hopper, Jonas D.; Tolman, Ethan R.; Ferguson, Daniel G.; Hubble, Gabriella; Patterson, David; Jensen, Jamie L.			Predictors of compliance with COVID-19 related non-pharmaceutical interventions among university students in the United States	PLOS ONE			English	Article								The world is currently dealing with a devastating pandemic. Although growing COVID-19 case numbers, deaths, and hospitalizations are concerning, this spread is particularly alarming in the United States where polarizing opinions, changing policies, and misinformation abound. In particular, American college campuses have been a venue of rampant transmission, with concerning spillover into surrounding, more vulnerable, communities. We surveyed over 600 college students from across the United States and modeled predictors of compliance with non-pharmaceutical interventions. We identified concern with severity, constitutionalism, news exposure, and religiosity as significant positive correlates with compliance, and general trust in science as a significant negative correlate. To determine how applicable nationwide modeling might be to individual local campuses we also administered this same survey to nearly 600 students at two large universities in Utah County. In this population, concern with severity was the only significant positive correlate with compliance; Additionally, feelings of inconvenience were negatively correlated. The effects of feelings of inconvenience, and news exposure were significantly different between populations. These results suggest that we should focus our efforts on increasing knowledge about the pandemic's effects on our society and informing about constitutionality amongst college students. However, we also show that nationwide surveys and modeling are informative, but if campuses are to efficiently curb the spread of COVID-19 this coming semester, they would be best served to utilize data collected from their student populations as these might significantly differ from general consensus data.	[Shumway, Spencer G.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Hopper, Jonas D.; Ferguson, Daniel G.; Hubble, Gabriella; Patterson, David; Jensen, Jamie L.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Tolman, Ethan R.] Brigham Young Univ, Dept Plant & Wildlife Sci, Provo, UT 84602 USA	Brigham Young University; Brigham Young University; Brigham Young University	Jensen, JL (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	Jamie.Jensen@byu.edu		Tolman, Ethan/0000-0002-2594-2833	Life Sciences College Undergraduate Research Award (CURA) at Brigham Young University	Life Sciences College Undergraduate Research Award (CURA) at Brigham Young University	This study was funded by a Life Sciences College Undergraduate Research Award (CURA) at Brigham Young University. The funders had no role in the study design, data collection and analysis, decisions to publish, or preparation of the manuscript.	A. Imlay Deseret News, 2020, DESERET NEWS; Aguirre AA, 2020, WORLD MED HEALTH POL, V12, P256, DOI 10.1002/wmh3.348; Aizenman N., 2020, CAN MASKS SAVE US MO; Alberty E, SALT LAKE TRIBUNE; Alfonso F., THE CNN; [Anonymous], 2020, NATURE, V586, P335, DOI 10.1038/d41586-020-02852-x; [Anonymous], 2020, NEW ENGL J MED, V383, P1479, DOI 10.1056/NEJMe2029812; [Anonymous], NCES FAST FACTS TOOL; [Anonymous], CAS COUNTS COR; [Anonymous], 2020, UTAH AREA UPDATES CO; [Anonymous], COR DIS COVID 19 DAS; [Anonymous], GOV GARY HERBERT DEC; [Anonymous], COVID DAT TRACK; [Anonymous], 2020, CHURCH NEWS; BB Contributing, DO UT GET THEIR NEWS; Benneyan James C, 2020, medRxiv, DOI 10.1101/2020.08.29.20184366; Blendon RJ, 2008, EMERG INFECT DIS, V14, P778, DOI 10.3201/eid1405.071437; Breslow, FAUCI MIXED MESSAGIN; Campbell BC, 2017, EVOL EDUC OUTREACH, V10, P1, DOI DOI 10.1186/s12052-017-0068-0; Canham M., 2017, SALT LAKE TRIBUNE; Chen JY, 2007, J COMMUN HEALTH, V32, P5, DOI 10.1007/s10900-006-9031-7; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Clark Cory, 2020, Glob Transit, V2, P76, DOI 10.1016/j.glt.2020.06.003; Cnaan R., 2012, MORMONS CIVIC LIFE; Cooper|AP JJ, WASH POST; Dunk RDP, 2019, NAT ECOL EVOL, V3, P327, DOI 10.1038/s41559-019-0802-9; Faulders, ABC NEWS; Fink Jenni, 2020, NEWSWEEK; Gatter Robert, 2020, WASH LEE, V77, P17; Georgiou N, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110201; Hanaei S, 2020, ARCH MED RES, V51, P582, DOI 10.1016/j.arcmed.2020.04.021; Hohwy, 2020, PSYARXIV; Howard JR, 2020, SUNY Series Afr Amer, P1; Igielnik, 2020, FACT TANK; IHME, COVID 19 PROJ; Jan T, WASH POST; Jensen J.L., 2015, EVOL EDUC OUTREACH, V8, P23, DOI [10.1186/s12052-015-0051-6, DOI 10.1186/s12052-015-0051-6]; Jensen JL, 2019, BIOSCIENCE, V69, P292, DOI 10.1093/biosci/biz014; Johnson DK, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7020039; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Koenig HG, 2010, RELIGIONS, V1, P78, DOI 10.3390/rel1010078; Konda M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.8932; Leidner AJ, 2021, MMWR-MORBID MORTAL W, V70, P14, DOI 10.15585/mmwr.mm7001a4; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; McKellar, 2020, DESERET NEWS; Mello EmilyJ., 2020, INFLUENCES ATTITUDES; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nabi G, 2020, ENVIRON RES, V185, DOI 10.1016/j.envres.2020.109460; Nadelson L, 2014, SCHOOL SCI MATH, V114, P76, DOI 10.1111/ssm.12051; Nguyen H., DO MASKS MAE VOTERS; Nyhan B, 2015, VACCINE, V33, P459, DOI 10.1016/j.vaccine.2014.11.017; Nyhan B, 2014, PEDIATRICS, V133, pE835, DOI 10.1542/peds.2013-2365; O'Keefe S.M, 2020, ONE 3 AM WOULD NOT G; Pak A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00241; Parker Kim, 2019, GENERATION LOOKS LOT; Peeples L, 2020, NATURE, V586, P186, DOI 10.1038/d41586-020-02801-8; Pew Research Center, 2009, SECT 4 SCI POL REL; Pew Research Center, 2018, TRENDS PART AFF DEM; Pew Research Center, KEY FIND ONL NEW LAD; Pew Research Center, CONF SCI IS STRONG T; Plohl N, 2021, PSYCHOL HEALTH MED, V26, P1, DOI 10.1080/13548506.2020.1772988; Qiu, 2020, 3569098 SOC SCI RES; Reiner RC, 2021, NAT MED, V27, P94, DOI 10.1038/s41591-020-1132-9; Ritter, 2020, NEW APRIL GUIDELINES; Safford T., 2020, IDEOLOGY AFFECTS TRU; Sanger-Katz, 2020, NEW YORK TIMES; Schrimpf P, 2020, ARXIV200514168ECONST; Scott E., WASH POST; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Stephenson H, 2020, NEW YORK TIMES; Thomas K., 2020, NEW YORK TIMES; Times TNY, NEW YORK TIMES; Trussler M., 2020, 3633934 SOC SCI RES; Udow-Phillips M, 2020, J HOSP MED, V15, P431, DOI 10.12788/jhm.3474; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Viglione G, 2020, NATURE, V586, P654, DOI 10.1038/d41586-020-02963-5; WALKE H, 2020, JAMA INTERNET, DOI DOI 10.1001/JAMA.2020.20027; Whitehurst L., 2020, KUTV; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Yelin D, 2020, LANCET INFECT DIS, V20, P1115, DOI 10.1016/S1473-3099(20)30701-5; Zhao E, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003323; Zhu PF, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100065	82	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252185	10.1371/journal.pone.0252185	http://dx.doi.org/10.1371/journal.pone.0252185			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BC	34143776	Green Published, gold			2022-12-26	WOS:000671690700005
J	Yan, XX; Imano, N; Tamaki, K; Sano, M; Shinmura, K				Yan, Xiaoxiang; Imano, Natsumi; Tamaki, Kayoko; Sano, Motoaki; Shinmura, Ken			The effect of caloric restriction on the increase in senescence-associated T cells and metabolic disorders in aged mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; IMPACT; INHIBITION; ONSET; RATS	Aging is associated with functional decline in the immune system and increases the risk of chronic diseases owing to smoldering inflammation. In the present study, we demonstrated an age-related increase in the accumulation of Programmed Death-1 (PD-1)(+) memory-phenotype T cells that are considered "senescence-associated T cells" in both the visceral adipose tissue and spleen. As caloric restriction is an established intervention scientifically proven to exert anti-aging effects and greatly affects physiological and pathophysiological alterations with advanced age, we evaluated the effect of caloric restriction on the increase in this T-cell subpopulation and glucose tolerance in aged mice. Long-term caloric restriction significantly decreased the number of PD-1(+) memory-phenotype cluster of differentiation (CD) 4(+) and CD8(+) T cells in the spleen and visceral adipose tissue, decreased M1-type macrophage accumulation in visceral adipose tissue, and improved insulin resistance in aged mice. Furthermore, the immunological depletion of PD-1(+) T cells reduced adipose inflammation and improved insulin resistance in aged mice. Taken together with our previous report, these results indicate that senescence-related T-cell subpopulations are involved in the development of chronic inflammation and insulin resistance in the context of chronological aging and obesity. Thus, long-term caloric restriction and specific deletion of senescence-related T cells are promising interventions to regulate age-related chronic diseases.	[Yan, Xiaoxiang] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Inst Cardiovasc Dis, Shanghai, Peoples R China; [Yan, Xiaoxiang] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiol, Shanghai, Peoples R China; [Yan, Xiaoxiang; Tamaki, Kayoko; Sano, Motoaki; Shinmura, Ken] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Imano, Natsumi; Tamaki, Kayoko; Shinmura, Ken] Hyogo Coll Med, Dept Gen Internal Med, Nishinomiya, Hyogo, Japan; [Imano, Natsumi] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Japan	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Keio University; Hyogo College of Medicine; Kwansei Gakuin University	Shinmura, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.; Shinmura, K (corresponding author), Hyogo Coll Med, Dept Gen Internal Med, Nishinomiya, Hyogo, Japan.	ke-shimmura@hyo-med.ac.jp			Japan Society for the Promotion of Science (JSPS KAKENHI) [22590814]; Takeda Medical Research Foundation; Research Grants in the Natural Sciences from the Mitsubishi Foundation	Japan Society for the Promotion of Science (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Medical Research Foundation; Research Grants in the Natural Sciences from the Mitsubishi Foundation	This study was funded by the Japan Society for the Promotion of Science (JSPS KAKENHI Grant Number 22590814) to KS, a research grant from Takeda Medical Research Foundation to KS, and Research Grants in the Natural Sciences from the Mitsubishi Foundation to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 2011, NAT REV IMMUNOL, V11, P289, DOI 10.1038/nri2959; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Goldberg EL, 2015, AGING CELL, V14, P130, DOI 10.1111/acel.12280; Heilbronn LK, 2003, AM J CLIN NUTR, V78, P361, DOI 10.1093/ajcn/78.3.361; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kasagi S, 2010, J IMMUNOL, V184, P2337, DOI 10.4049/jimmunol.0901652; Khan S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00267; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lumeng CN, 2011, J IMMUNOL, V187, P6208, DOI 10.4049/jimmunol.1102188; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Messaoudi I, 2006, P NATL ACAD SCI USA, V103, P19448, DOI 10.1073/pnas.0606661103; Messaoudi I, 2008, AGING CELL, V7, P908, DOI 10.1111/j.1474-9726.2008.00440.x; Minato N, 2020, INT IMMUNOL, V32, P223, DOI 10.1093/intimm/dxaa006; Montecino-Rodriguez E, 2013, J CLIN INVEST, V123, P958, DOI 10.1172/JCI64096; Palmer AK, 2019, AGING CELL, V18, DOI 10.1111/acel.12950; Pawelec G, 2007, EMBO REP, V8, P220, DOI 10.1038/sj.embor.7400922; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Shimatani K, 2009, P NATL ACAD SCI USA, V106, P15807, DOI 10.1073/pnas.0908805106; Shinmura K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/528935; Shinmura K, 2015, AM J PHYSIOL-HEART C, V308, pH894, DOI 10.1152/ajpheart.00333.2014; Shinmura K, 2011, J MOL CELL CARDIOL, V50, P117, DOI 10.1016/j.yjmcc.2010.10.018; Shirakawa K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186303; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Rojas JXS, 2016, J GERONTOL A-BIOL, V71, P310, DOI 10.1093/gerona/glv117; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Trott DW, 2018, EXP GERONTOL, V109, P99, DOI 10.1016/j.exger.2016.12.016; Wang HY, 2016, AM J PHYSIOL-REG I, V310, pR449, DOI 10.1152/ajpregu.00449.2015; White Matthew J, 2016, Front Immunol, V7, P667, DOI 10.3389/fimmu.2016.00667; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Yoshida S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16347-w	35	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252547	10.1371/journal.pone.0252547	http://dx.doi.org/10.1371/journal.pone.0252547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143796	Green Published, gold			2022-12-26	WOS:000671690700014
J	Zeineddine, M; Kharroubi, S; Chalak, A; Hassan, H; Abiad, MG				Zeineddine, Myra; Kharroubi, Samer; Chalak, Ali; Hassan, Hussein; Abiad, Mohamad G.			Post-consumer food waste generation while dining out: A close-up view	PLOS ONE			English	Article							MANAGEMENT	Food loss and food waste occur along the food supply chain, negatively impacting the environment, global economy, and food security. There is a growing global interest in tackling this issue to mitigate or handle the waste generated and limit its repercussions, as one in eight people suffer from undernourishment worldwide. In the Arab world, where there is a high dependency on imports and limited potential of increasing local food production, addressing food loss and waste becomes substantial. Research has mainly been focused on household food waste generation, while data on post-consumer plate food waste in the foodservice sector remains scarce. In this study, managers from a representative sample of 222 restaurants located in Municipal Beirut, Lebanon, were surveyed about food waste generation. Plate food waste was measured to establish baseline information. Multiple Tobit regression analyses were performed to explore the determinants for plate food waste generation. Plate waste generation was also compared between Lebanese and non-Lebanese cuisine restaurants. Results revealed that 1,620 tons of plate food waste are generated per year in Beirut, equivalent to 0.15% of Lebanon's total organic waste. Furthermore, Lebanese cuisine restaurants serving Mediterranean Mezze were found to generate 34 kg of organic waste per day more than restaurants that serve international non-Lebanese cuisine. The type of cuisine, kind of service, and menu planning were significantly associated with post-consumer food waste generation. This study revealed an increasing concern towards the amount of plate waste generated in Beirut, and thereby further research is needed to create baseline information at the national level.	[Zeineddine, Myra; Kharroubi, Samer; Abiad, Mohamad G.] Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon; [Chalak, Ali] Amer Univ Beirut, Fac Agr & Food Sci, Dept Agr, Beirut, Lebanon; [Hassan, Hussein] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Nutr Program, Beirut, Lebanon	American University of Beirut; American University of Beirut; Lebanese American University	Abiad, MG (corresponding author), Amer Univ Beirut, Fac Agr & Food Sci, Dept Nutr & Food Sci, Beirut, Lebanon.	ma192@aub.edu.lb	Hassan, Hussein F./AAH-1605-2019; Chalak, Ali/G-2221-2011	Hassan, Hussein F./0000-0003-4215-6815; Abiad, Mohamad Ghassan/0000-0001-7263-7471; Chalak, Ali/0000-0001-7111-6674				Abiad MG, 2018, FOOD SECUR, V10, P311, DOI 10.1007/s12571-018-0782-7; Abouabdillah A., 2015, Sixth International Scientific Agricultural Symposium "Agrosym 2015", Jahorina, Bosnia and Herzegovina, October 15-18, 2015. Book of Proceedings, P1353; Adamashvili N., 2019, EC AGRO ALIMENT, V21, P825, DOI [10.3280/ECAG2019-003014, DOI 10.3280/ECAG2019-003014]; Al-Bugamy M., 2015, 900 FOOD WASTE CONTA; Amore MD, 2021, GLOB STRATEG J, V11, P331, DOI 10.1002/gsj.1363; [Anonymous], 2018, FOODS FOOD WAST ACT; [Anonymous], 2012, FOOD WASTE CAUSES IM; Arous S.A., 2017, AGROFOR, V2; Barre M., 2013, 23 AFR COMM AGR STAT 23 AFR COMM AGR STAT; Barrera E.L., 2020, FOOD POLICY; Capone R., 2016, AM J FOOD NUTR, V4, P40, DOI [10.12691/ajfn-4-2-2, DOI 10.12691/AJFN-4-2-2]; Chalak A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225789; Chalak A, 2016, WASTE MANAGE, V48, P418, DOI 10.1016/j.wasman.2015.11.040; Charbel L., 2016, J FOOD SECURITY, V4, P131, DOI [10.12691/jfs-4-6-2, DOI 10.12691/JFS-4-6-2]; Charlebois S, 2015, INT J CULT TOUR HOSP, V9, P278, DOI 10.1108/IJCTHR-12-2014-0100; El Bilali H, 2020, FOODS, V9, DOI 10.3390/foods9040463; El-Fadel M, 2001, J ENVIRON MANAGE, V61, P281, DOI 10.1006/jema.2000.0413; Elmenofi A. G. G., 2015, P 6 INT SCI AGR S AG P 6 INT SCI AGR S AG, P15; FAO, 2013, SUST EUR 2030; FAO, 2015, REG OV FOOD INS NEAR; FAO, 2015, GLOB IN FOOD LOSS WA, V8; FAO, 2013, STATE HUNGER BUILDIN; FAO LADA, 2011, 17 FAO LADA 17 FAO LADA; Filimonau V, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120975; Filimonau V, 2020, J CLEAN PROD, V258, DOI 10.1016/j.jclepro.2020.120775; Filimonau V, 2019, TOUR MANAG PERSPECT, V32, DOI 10.1016/j.tmp.2019.100577; Filimonau V, 2019, INT J HOSP MANAG, V76, P48, DOI 10.1016/j.ijhm.2018.04.010; Gazette S, 2018, ARTICLE APPEARED DAI; Girotto F, 2015, WASTE MANAGE, V45, P32, DOI 10.1016/j.wasman.2015.06.008; Gustafsson J., 2013, METHODOLOGY FAO STUD; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; HLPE (High-Level Panel of Experts on Food Security and Nutrition), 2014, FOOD LOSSES WASTE CO; LeGrand T., 2018, OVERVIEWS FOOD SYSTE; Lipinski B., 2013, REDUCING FOOD LOSS W, V1, P1, DOI DOI 10.2499/9780896295827_03; Maalouf A, 2019, WASTE MANAGE RES, V37, P14, DOI 10.1177/0734242X18815951; Mattar L, 2018, J CLEAN PROD, V198, P1219, DOI 10.1016/j.jclepro.2018.07.085; Matzembacher DE, 2020, WASTE MANAGE, V114, P263, DOI 10.1016/j.wasman.2020.07.014; Oelofse S., 2020, FOOD WASTE S AFRICA; Oelofse SHH, 2013, WASTE MANAGE RES, V31, P80, DOI 10.1177/0734242X12457117; Parry M. L., 2007, CONTRIBUTION WORKING, P976; Principato L, 2018, INT J HOSP MANAG, V74, P130, DOI 10.1016/j.ijhm.2018.02.022; Sakaguchi L, 2018, J CLEAN PROD, V180, P430, DOI 10.1016/j.jclepro.2017.12.136; Sassi K., 2016, AGROFOR, V1; Schmidt K, 2018, RESOUR CONSERV RECY, V139, P1, DOI 10.1016/j.resconrec.2018.07.023; Since, 1946, WE BRING TOG ENTR OW WE BRING TOG ENTR OW	45	4	4	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0251947	10.1371/journal.pone.0251947	http://dx.doi.org/10.1371/journal.pone.0251947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143777	gold, Green Published			2022-12-26	WOS:000671690700039
J	Dayrell, JS; Magnusson, WE; Bobrowiec, PED; Lima, AP				Dayrell, Jussara Santos; Magnusson, William Ernest; Dineli Bobrowiec, Paulo Estefano; Lima, Albertina Pimentel			Impacts of an Amazonian hydroelectric dam on frog assemblages	PLOS ONE			English	Article							TREE SPECIES DISTRIBUTION; SOUTHERN WESTERN-GHATS; VARZEA FORESTS; MADEIRA RIVER; R PACKAGE; DIVERSITY; AMPHIBIANS; PATTERNS; BRAZIL; GEOMORPHOLOGY	About 90% of the Amazon's energy potential remains unexploited, with many large hydroelectric dams yet to be built, so it is important to understand how terrestrial vertebrates are affected by reservoir formation and habitat loss. We investigated the influence of the construction of the Santo Antonio Hydroelectric dam on the Madeira River in southwestern Amazonia on the structure of frog assemblages based on samples collected in two years before the dam flooded (pre-stage) and one (post1-stage) and four years (post2-stage) after its construction. We surveyed five 500-ha plot systems three times during each stage; in the pre-stage we sampled 19 plots in low-lying areas that would be flooded by the dam, (from now called flooded pre-stage plots) and 45 plots in terra-firme forest (from now called unflooded pre-stage plots). At the post1-stage we sampled the 45 unflooded plots and in the post2-stage we sampled the remaining 39 unflooded plots. We detected frogs by active visual and acoustic searches standardized by both time and sampling area. Few species recorded in the pre-stage flooded plots were not found in the pre-stage unflooded plots or in stages after flooding. However, the composition of frog assemblages based on relative densities in flooded pre-stage plots did not re-establish in plots on the new river margins. In unflooded areas, frog assemblages were distinct among the flooding stages with no tendency to return to the original assemblage compositions even four years after the dam was filled. For the areas that were not flooded, there was an increase in species richness in 82% of the plots between the surveys before dam construction and the first surveys after dam completion, and 65% between the pre-stage and surveys four years after dam completion. Lack of understanding by the controlling authorities of the long-term effects of landscape changes, such as water-table rises, means that studies covering appropriate periods post construction are not required in legislation, but the data from Santo Antonio indicate that changes due to dam construction are either long-term or difficult to distinguish from natural fluctuations. Future environmental-impact studies should follow strict BACI designs.	[Dayrell, Jussara Santos] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Magnusson, William Ernest; Dineli Bobrowiec, Paulo Estefano; Lima, Albertina Pimentel] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Institute Nacional de Pesquisas da Amazonia	Dayrell, JS (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	jussaradayrell@gmail.com		Dayrell, Jussara/0000-0003-4211-421X	CAPES; CNPq; PNPD/CAPES; Wildlife Conservation Program of Santo Antonio Energia	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Wildlife Conservation Program of Santo Antonio Energia	J. S. Dayrell was supported by a scholarship provided by CAPES and CNPq that also provided productivity grants for A. P. Lima and W. E. Magnusson. P. Bobrowiec was supported by a postdoctoral scholarship provided by PNPD/CAPES. The Wildlife Conservation Program of Santo Antonio Energia financed the construction of plot systems and data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu TLS, 2020, J APPL ECOL, V57, P1124, DOI 10.1111/1365-2664.13607; Adamy A., 2016, PORTO VELHO CULTURA, P120; Albernaz AL, 2012, J BIOGEOGR, V39, P869, DOI 10.1111/j.1365-2699.2011.02640.x; Alho Clever J.R., 2011, Oecologia Australis, V15, P593; Alvarenga GC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198120; [Anonymous], PONCHO R FIGSHARE SO, DOI [10.6084/m9.figshare.753347.v3.2014, DOI 10.6084/M9.FIGSHARE.753347.V3.2014]; Ayres JG, 1994, INDOOR BUILT ENVIRON, V3, P318, DOI [10.1177/1420326X9400300605, DOI 10.1177/1420326X9400300605]; Beja P, 2010, BIODIVERS CONSERV, V19, P129, DOI 10.1007/s10531-009-9711-6; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Bennett AF, 2010, CONSERVATION BIOLOGY FOR ALL, P88; Bobrowiec PED, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183036; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; Brandao RA, 2008, BIOTROPICA, V40, P263, DOI 10.1111/j.1744-7429.2007.00356.x; Castello L., 2013, CONSERV LETT, V6, P217, DOI [10.1111/conl.12008, DOI 10.1111/conl.12008]; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Cochrane Sheila M. V., 2017, Remote Sensing Applications: Society and Environment, V7, P1, DOI 10.1016/j.rsase.2017.04.005; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Dalecky A, 2002, REV ECOL-TERRE VIE, P145; Damme Paul A. Van, 2019, Neotrop. ichthyol., V17, pe190118, DOI 10.1590/1982-0224-20190118; de Sa RO, 2014, S AM J HERPETOL, V9, pS1, DOI 10.2994/SAJH-D-13-00022.1; dos Santos EA, 2020, FOREST ECOL MANAG, V463, DOI 10.1016/j.foreco.2020.118032; Dray S., 2019, R PACKAGE; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P255; ECOA, 2012, EC AC; Fearnside PM, 2015, CLIMATIC CHANGE, V131, P575, DOI 10.1007/s10584-015-1393-3; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fisher R, 2019, METHODS ECOL EVOL, V10, P1843, DOI 10.1111/2041-210X.13287; Fouquet A, 2012, MOL PHYLOGENET EVOL, V65, P547, DOI 10.1016/j.ympev.2012.07.012; Gascon C, 1996, BIOTROPICA, V28, P136, DOI 10.2307/2388779; Goulding M, 2003, SMITHSONIAN ATLAS AM; Grant T., 2006, B AM MUS NAT HIST, V299, P1, DOI DOI 10.1206/0003-0090(2006)299[; Guzy JC, 2018, ECOL EVOL, V8, P2268, DOI 10.1002/ece3.3750; Hamilton SK, 2007, GEOMORPHOLOGY, V89, P23, DOI 10.1016/j.geomorph.2006.07.024; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; Haugaasen Torbjørn, 2006, Acta Amaz., V36, P25, DOI 10.1590/S0044-59672006000100005; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hui FKC, 2015, METHODS ECOL EVOL, V6, P399, DOI 10.1111/2041-210X.12236; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jungfer KH, 2013, ZOOL SCR, V42, P351, DOI 10.1111/zsc.12015; Junk WJ, 2012, WETL ECOL MANAG, V20, P461, DOI 10.1007/s11273-012-9268-0; Landeiro VL, 2014, NAT CONSERVACAO, V12, P42, DOI 10.4322/natcon.2014.008; Latrubesse EM, 2008, GEOMORPHOLOGY, V101, P130, DOI 10.1016/j.geomorph.2008.05.035; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Legendre P, 2019, FOR ECOSYST, V6, DOI 10.1186/s40663-019-0164-4; Lima AP., 2008, GUIDE FROGS RESERVA, V2nd ed; Magnusson W.E., 2013, BIODIVERSIDADE MONIT; Marchant R, 2002, J N AM BENTHOL SOC, V21, P311, DOI 10.2307/1468417; Menendez-Guerrero PA, 2020, ECOGRAPHY, V43, P222, DOI 10.1111/ecog.04510; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Moraes LJCL, 2016, J BIOGEOGR, V43, P2113, DOI 10.1111/jbi.12756; Moser P, 2014, BIOTROPICA, V46, P367, DOI 10.1111/btp.12111; Naniwadekar Rohit, 2014, Diversity-Basel, V6, P567; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; Parolin P, 2004, FOLIA GEOBOT, V39, P371, DOI 10.1007/BF02803209; Plummer M., 2003, P 3 INT WORKSH DISTR; R Core Team, 2020, R LANG ENV STAT COMP; Ribeiro J, 2017, LANDSCAPE ECOL, V32, P1599, DOI 10.1007/s10980-017-0525-8; Santos RE, 2018, FISHERIES MANAG ECOL, V25, P380, DOI 10.1111/fme.12305; Schneck F, 2011, AUSTRAL ECOL, V36, P839, DOI 10.1111/j.1442-9993.2010.02224.x; Sgarbi LF, 2020, ECOL INDIC, V110, DOI 10.1016/j.ecolind.2019.105937; Skelly DK, 1996, COPEIA, P599; SMITH EP, 1993, CAN J FISH AQUAT SCI, V50, P627, DOI 10.1139/f93-072; Vasudevan K, 2008, HERPETOLOGICA, V64, P207, DOI 10.1655/07-066.1; Vauchel P, 2017, J HYDROL, V553, P35, DOI 10.1016/j.jhydrol.2017.07.018; VITT LJ, 1990, BIOSCIENCE, V40, P418, DOI 10.1093/bioscience/40.6.418; von May R, 2010, J TROP ECOL, V26, P509, DOI 10.1017/S0266467410000301; Wang Y., 2020, MVABUND STAT METHODS, P97; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Wittmann F, 2004, FOREST ECOL MANAG, V196, P199, DOI 10.1016/j.foreco.2004.02.060; Wu HP, 2019, J CLEAN PROD, V221, P480, DOI 10.1016/j.jclepro.2019.03.001; Yu ZD, 2017, ECOL EVOL, V7, P1583, DOI 10.1002/ece3.2798	74	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0244580	10.1371/journal.pone.0244580	http://dx.doi.org/10.1371/journal.pone.0244580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138858	Green Published, gold			2022-12-26	WOS:000671690200036
J	Playford, RJ; Weiser, MJ; Marchbank, T				Playford, Raymond John; Weiser, Michael James; Marchbank, Tania			Methods to improve efficacy of orally administered bioactive peptides using bovine colostrum as an exemplar	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; TRYPSIN-INHIBITOR; COLITIS; PROLIFERATION; INCREASE; MODEL; MICE	Background Oral administration of bioactive peptides has potential clinical advantages, but its applicability is limited due to gastric and pancreatic enzyme proteolysis. Objective To examine whether the co-packaging of bovine colostrum (BC), a rich source of IgG, immune and growth factors, with the food additives trehalose (carbohydrate), stearine (fat), casein (protein present in BC) or soy flour (plant based with high protease inhibitory activity) enhances the stability of BC against digestion. Design Samples alone and in combination (BC+ 10% wt/wt trehalose, stearine, casein or soy) were exposed to HCl/pepsin, followed by trypsin and chymotrypsin ("CT"). Assessment of proliferation used gastric AGS cells (Alamar blue), IgG function measured bovine IgG anti-E.coli binding and ELISAs quantified growth factor constituents. In vivo bioassay assessed ability of BC alone or with soy to reduce injury caused by dextran sodium sulphate (DSS, 4% in drinking water, 7 days, test products started 2 days prior to DSS). Results Proliferative activity of BC reduced 61% following HCl/pepsin and CT exposure. This was truncated 50% if soy was co-present, and also protected against loss of total IgG, IgG E.coli binding, TGF beta, lactoferrin and EGF (all P<0.01 vs BC alone). Co-packaging with trehalose was ineffective in preventing digestion whereas casein or stearine provided some intermediate protective effects. Rats given BC alone showed beneficial effects on weight gain, disease activity index, tissue histology and colonic MPO. Soy alone was ineffective. BC+ soy combination showed the greatest benefit with a dose of 7 mg/kg (6.4 BC + 0.6 soy flour) having the same degree of benefit as using 20 mg/kg BC alone. Conclusion Soy, and to a lesser extent casein, enhanced the biostability of BC against digestive enzymes. Co-packaging of BC with other food products such as soy flour could result in a decreased dose being required, improving cost-effectiveness and patient compliance.	[Playford, Raymond John; Marchbank, Tania] Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England; [Playford, Raymond John; Weiser, Michael James] PanTheryx Inc, Dept R&D, Boulder, CO 80301 USA	University of London; Queen Mary University London	Playford, RJ (corresponding author), Queen Mary Univ London, Ctr Immunobiol, Barts & London Sch Med, Blizard Inst, London, England.; Playford, RJ (corresponding author), PanTheryx Inc, Dept R&D, Boulder, CO 80301 USA.	r.playford@qmul.ac.uk		Playford, Raymond/0000-0003-1235-8504	PanTheryx Inc.	PanTheryx Inc.	Partially funded by PanTheryx Inc. This external funder provided support in the form of salaries for authors (RJP, MJW) and provided partial funding for TM in her role as an external consultant. The specific roles of these authors are articulated in the "author contributions" section and relevant conflict of interests declared including the facts that MJW was a full-time employee and RJP a part time employee of Pantheryx at the time of study. Remaining funding was derived from internal institutional support. There was no additional external funding received for this study.	Ascenzi P, 2003, CURR PROTEIN PEPT SC, V4, P231, DOI 10.2174/1389203033487180; BARRANCO SC, 1983, CANCER RES, V43, P1703; Calnan DP, 2000, GUT, V47, P622, DOI 10.1136/gut.47.5.622; COOPER HS, 1993, LAB INVEST, V69, P238; Edy S., 2020, INT J SCI TECHNOL RE, V9, P2593; Egger B, 2000, DIGESTION, V62, P240, DOI 10.1159/000007822; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FitzGerald AJ, 2004, PEPTIDES, V25, P793, DOI 10.1016/j.peptides.2003.12.022; Godden SM, 2019, VET CLIN N AM-FOOD A, V35, P535, DOI 10.1016/j.cvfa.2019.07.005; HAGIWARA T, 1995, BIOSCI BIOTECH BIOCH, V59, P1875, DOI 10.1271/bbb.59.1875; Jones AW, 2014, BRAIN BEHAV IMMUN, V39, P194, DOI 10.1016/j.bbi.2013.10.032; Khan Z, 2002, ALIMENT PHARM THER, V16, P1917, DOI 10.1046/j.1365-2036.2002.01354.x; Marchbank T, 2011, AM J PHYSIOL-GASTR L, V300, pG477, DOI 10.1152/ajpgi.00281.2010; Marchbank T, 2009, AM J PHYSIOL-GASTR L, V296, pG697, DOI 10.1152/ajpgi.90565.2008; Nishinari K., 2018, PROTEINS FOOD PROCES, V2nd ed., P149, DOI DOI 10.1016/B978-0-08-100722-8.00007-3; Playford RJ, 2020, J NUTR, V150, P1434, DOI 10.1093/jn/nxaa083; Playford RJ, 2021, NUTRIENTS, V13, DOI 10.3390/nu13010265; PLAYFORD RJ, 1993, LANCET, V341, P843, DOI 10.1016/0140-6736(93)93057-8; PLAYFORD RJ, 1995, GASTROENTEROLOGY, V108, P92, DOI 10.1016/0016-5085(95)90012-8; Playford RJ, 1996, GUT, V39, P262, DOI 10.1136/gut.39.2.262; Playford RJ, 2001, CLIN SCI, V100, P627, DOI 10.1042/CS20010015; Playford RJ, MARKED VARIABILITY B; Rathe M, 2020, JPEN-PARENTER ENTER, V44, P337, DOI 10.1002/jpen.1528; Schiraldi C, 2002, TRENDS BIOTECHNOL, V20, P420, DOI 10.1016/S0167-7799(02)02041-3; Sinha A, 2003, NEW ENGL J MED, V349, P350, DOI 10.1056/NEJMoa013136; Tai FWD, 2021, CLIN MED, V21, P131, DOI 10.7861/clinmed.2021-0039; Wilborn CD, 2013, J SPORT SCI MED, V12, P74; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; ZHOU JM, 1989, BIOCHEMISTRY-US, V28, P1070, DOI 10.1021/bi00429a022	29	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253422	10.1371/journal.pone.0253422	http://dx.doi.org/10.1371/journal.pone.0253422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138960	Green Published, gold			2022-12-26	WOS:000671690200089
J	Puty, B; Bittencourt, LO; Nogueira, IC; Buzalaf, MAR; Oliveira, EH; Lima, RR				Puty, Bruna; Bittencourt, Leonardo Oliveira; Nogueira, Iago Cesar; Rabelo Buzalaf, Marilia Afonso; Oliveira, Edivaldo Herculano; Lima, Rafael Rodrigues			Human cultured IMR-32 neuronal-like and U87 glial-like cells have different patterns of toxicity under fluoride exposure	PLOS ONE			English	Article							NECROTIC DNA-DEGRADATION; MOLECULAR-MECHANISMS; OXIDATIVE STRESS; DRINKING-WATER; APOPTOSIS; EXPRESSION; DAMAGE; CHILDREN; PLASMA; KIDNEY	Background Fluoride (F) is a naturally exists in nature but several studies have indicated it as an environmental toxicant to all leaving beings. Human F exposure has increased over the years since this ion has been used by industry on foods, beverages, toothpastes and on water supply. Although F is safe at optimal concentrations in water supply, human exposure to high levels could trigger neurofunctional deficits. Materials and methods In this study, human glial-like (U87) and neuronal-like (IMR-32) cells lineages were used to access F toxicity and CNS cell sensibility on both cell facing the same protocol. Cells were exposed to F over 3, 5 and 10 days on two different F concentrations. Fluoride exposed cells were evaluated by standard toxicity assays to cell viability, apoptosis, necrosis and general cell metabolism. Oxidative stress parameters were evaluated by ATP and ROS levels, lipid peroxidation, GSH/GSSG ratio and comet assay. Results No changes were observed in IMR-32 at any given time while after 10 days of exposure to 0.22 mu g/mL, U87 glial-like cells showed signs of toxicity such as decreased cell viability by necrosis while general cell metabolism was increased. Oxidative stress parameters were next evaluated only on U87 glial-like cells after 10 days of exposure. F induced a decrease on ATP levels while no changes were observed on reactive oxygen species and lipid peroxidation. GSH/GSSG ratio was decreased followed by DNA damage both on 0.22 mu g/mL F. Conclusions Our results suggest an important differential behavior of the distinct types of cells exposed to the different fluoride concentrations, pointing that the U87 glial-like cells as more susceptible to damage triggered by this ion.	[Puty, Bruna; Bittencourt, Leonardo Oliveira; Lima, Rafael Rodrigues] Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil; [Puty, Bruna; Nogueira, Iago Cesar; Oliveira, Edivaldo Herculano] Evandro Chagas Inst, Environm Sect, Lab Cell Culture & Cytogenet, Ananindeua, Brazil; [Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Bauru Dent Sch, Dept Biol Sci, Bauru, SP, Brazil	Universidade Federal do Para; Instituto Evandro Chagas; Universidade de Sao Paulo	Lima, RR (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Funct & Struct Biol, Belem, Para, Brazil.	rfalima@ufpa.br	Buzalaf, Marilia Afonso Rabelo/C-5228-2012; Lima, Rafael Rodrigues/M-7726-2019; de Oliveira, Edivaldo H. C./C-3368-2013; Bittencourt, Leonardo O/N-4526-2017; Buzalaf, Marilia Afonso Rabelo/AAU-2554-2021	Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951; Lima, Rafael Rodrigues/0000-0003-1486-4013; de Oliveira, Edivaldo H. C./0000-0001-6315-3352; Bittencourt, Leonardo O/0000-0002-9525-2723; Buzalaf, Marilia Afonso Rabelo/0000-0002-5985-3951	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [435093/2018-5]; Coordination of Personal Improvement of Higher Education - (CAPES) Brasil [001]; Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Personal Improvement of Higher Education - (CAPES) Brasil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) (grant no. 435093/2018-5) and the Coordination of Personal Improvement of Higher Education - (CAPES) Brasil (Finance Code 001). The APC was funded by Pro-Reitoria de Pesquisa e Pos-graduacao da Universidade Federal do Para (PROPESP-UFPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahid E, 2011, BBA-MOL CELL RES, V1813, P597, DOI 10.1016/j.bbamcr.2010.10.008; Ahmed I, 2012, FLUORIDE, V45, P384; Akinrinade Ibukun Dorcas, 2015, Pathophysiology, V22, P39, DOI 10.1016/j.pathophys.2014.12.001; Anuradha CD, 2001, FREE RADICAL BIO MED, V31, P367, DOI 10.1016/S0891-5849(01)00591-3; Araujo TT, 2019, CHEMOSPHERE, V236, DOI 10.1016/j.chemosphere.2019.124357; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Pereira HABD, 2018, TOXICOL APPL PHARM, V358, P68, DOI 10.1016/j.taap.2018.09.010; Bartos M, 2015, PHYSIOL BEHAV, V147, P205, DOI 10.1016/j.physbeh.2015.04.044; Basha PM, 2012, BIOL TRACE ELEM RES, V150, P306, DOI 10.1007/s12011-012-9489-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauchle E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04698; Campos-Pereira FD, 2017, CHEM-BIOL INTERACT, V264, P25, DOI 10.1016/j.cbi.2017.01.005; Choi AL, 2015, NEUROTOXICOL TERATOL, V47, P96, DOI 10.1016/j.ntt.2014.11.001; Choi AL, 2012, ENVIRON HEALTH PERSP, V120, P1362, DOI 10.1289/ehp.1104912; COLLIER TJ, 1987, BRAIN RES, V409, P316, DOI 10.1016/0006-8993(87)90717-7; de Souza Melo C.G, 2017, Scientific reports, V7, P1, DOI 10.1038/s41598-016-0028-x; Dec K, 2017, BIOL TRACE ELEM RES, V177, P224, DOI 10.1007/s12011-016-0871-4; Didenko VV, 2003, AM J PATHOL, V162, P1571, DOI 10.1016/S0002-9440(10)64291-5; Dionizio AS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21533-4; FAIRBAIRN DW, 1995, IN VITRO CELL DEV-AN, V31, P171, DOI 10.1007/BF02639429; Fawell J., 2006, FLUORIDE DRINKING WA; Flores-Mendez M, 2014, TOXICOL LETT, V229, P126, DOI 10.1016/j.toxlet.2014.06.022; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Iano FG, 2014, J FLUORINE CHEM, V168, P212, DOI 10.1016/j.jfluchem.2014.09.029; Jakel S, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00024; Kravtsova V. V., 2004, Ukrainskii Biokhimicheskii Zhurnal, V76, P39; Li Hongxia, 2010, Wei Sheng Yan Jiu, V39, P86; LI Y, 1995, J DENT RES, V74, P1468, DOI 10.1177/00220345950740080601; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu YJ, 2011, TOXICOL LETT, V204, P183, DOI 10.1016/j.toxlet.2011.04.030; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Malin AJ, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0003-1; Mason EF, 2011, BBA-MOL CELL RES, V1813, P645, DOI 10.1016/j.bbamcr.2010.08.011; McDonagh MS, 2000, BRIT MED J, V321, P855, DOI 10.1136/bmj.321.7265.855; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Niu RY, 2008, FLUORIDE, V41, P276; Miranda GHN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/8379123; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Qian W, 2013, BIOL TRACE ELEM RES, V155, P253, DOI 10.1007/s12011-013-9773-x; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P1, DOI 10.1159/000325101; Buzalaf MAR, 2011, MONOGR ORAL SCI, V22, P20, DOI 10.1159/000325107; Rai Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19930-w; Rasband MN, 2016, MOL CELL PROTEOMICS, V15, P355, DOI 10.1074/mcp.R115.053744; Sener Y., 2007, EUROPEAN J DENT, V1, P21; SINGER L, 1960, J APPL PHYSIOL, V15, P508, DOI 10.1152/jappl.1960.15.3.508; Singh NP, 1997, MUTAT RES-DNA REPAIR, V383, P167, DOI 10.1016/S0921-8777(96)00056-0; Song GH, 2015, BIOL TRACE ELEM RES, V166, P173, DOI 10.1007/s12011-015-0265-z; SUKETA Y, 1995, BIOL PHARM BULL, V18, P273; Tan PP, 2018, BIOL TRACE ELEM RES, V185, P440, DOI 10.1007/s12011-018-1265-6; Tang DL, 2019, CELL RES, V29, P347, DOI 10.1038/s41422-019-0164-5; Tang Sha, 2017, Wei Sheng Yan Jiu, V46, P472; Tu W, 2018, TOXICOL APPL PHARM, V347, P60, DOI 10.1016/j.taap.2018.03.030; von Bartheld CS, 2016, J COMP NEUROL, V524, P3865, DOI 10.1002/cne.24040; Wei Y, 2018, TOXICOL LETT, V291, P39, DOI 10.1016/j.toxlet.2018.04.006; Xia Tao, 2007, Zhonghua Yufang Yixue Zazhi, V41, P475; Xu H, 2007, BIOL TRACE ELEM RES, V116, P279, DOI 10.1007/BF02698012; Xu ZX, 2013, ENVIRON TOXICOL, V28, P307, DOI 10.1002/tox.20721; Yuan JY, 2016, CELL, V167, P1693, DOI 10.1016/j.cell.2016.11.047; Zhang M, 2008, TOXICOL LETT, V179, P1, DOI 10.1016/j.toxlet.2008.03.002; Zhang M, 2007, TOXICOLOGY, V236, P208, DOI 10.1016/j.tox.2007.04.007	60	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0251200	10.1371/journal.pone.0251200	http://dx.doi.org/10.1371/journal.pone.0251200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138870	Green Published, gold			2022-12-26	WOS:000671690200018
J	van Manen, ELM; Hollander, M; Feijen-de Jong, E; De Jonge, A; Verhoeven, C; Gitsels, J				van Manen, Eline L. M.; Hollander, Martine; Feijen-de Jong, Esther; de Jonge, Ank; Verhoeven, Corine; Gitsels, Janneke			Experiences of Dutch maternity care professionals during the first wave of COVID-19 in a community based maternity care system	PLOS ONE			English	Article								Background and objective During the COVID-19 pandemic the organization of maternity care changed drastically; this study into the experiences of maternity care professionals with these changes provides suggestions for the organization of care during and after pandemics. Design An online survey among Dutch midwives, obstetricians and obstetric residents. Multinomial logistic regression analyses were used to investigate associations between the respondents' characteristics and answers. Results Reported advantages of the changes were fewer prenatal and postpartum consultations (50.1%). The necessity and safety of medical interventions and ultrasounds were considered more critically (75.9%); 14.8% of community midwives stated they referred fewer women to the hospital for decreased fetal movements, whereas 64.2% of the respondents working in hospital-based care experienced fewer consultations for this indication. Respondents felt that women had more confidence in giving birth at home (57.5%). Homebirths seemed to have increased according to 38.5% of the community midwives and 65.3% of the respondents working in hospital-based care. Respondents appreciated the shift to more digital consultations rather than face-to-face consultations. Mentioned disadvantages were that women had appointments alone, (71.1%) and that the community midwife was not allowed to join a woman to obstetric-led care during labour and subsequently stay with her (56.8%). Fewer postpartum visits by family and friends led to more tranquility (59.8%). Overall, however, 48.0% of the respondents felt that the safety of maternity care was compromised due to policy changes. Conclusions Maternity care professionals were positive about the decrease in routine care and the increased confidence of women in home birth, but also felt that safety in maternity care was sometimes compromised. According to the respondents in a future crisis situation it should be possible for community midwives to continue to deliver a personal handover after the referral of women to the hospital, and to stay with them.	[van Manen, Eline L. M.; Hollander, Martine] Radboud Univ Nijmegen, Amalia Childrens Hosp, Dept Obstet, Med Ctr, Nijmegen, Netherlands; [Feijen-de Jong, Esther; de Jonge, Ank; Verhoeven, Corine; Gitsels, Janneke] Vrije Univ Amsterdam, Amsterdam Univ, AVAG Acad Midwifery Amsterdam & Groningen, Amsterdam Publ Hlth Res Inst,Med Ctr,Midwifery Sc, Amsterdam, Netherlands; [Feijen-de Jong, Esther] Univ Groningen, Univ Med Ctr Groningen, AVAG Acad Midwifery Amsterdam & Groningen, Dept Gen Practice & Elderly Med, Groningen, Netherlands; [Verhoeven, Corine] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Verhoeven, Corine] Univ Nottingham, Sch Hlth Sci, Div Midwifery, Nottingham, England	Radboud University Nijmegen; University of Amsterdam; Vrije Universiteit Amsterdam; University of Groningen; Maxima Medical Center; University of Nottingham	van Manen, ELM (corresponding author), Radboud Univ Nijmegen, Amalia Childrens Hosp, Dept Obstet, Med Ctr, Nijmegen, Netherlands.	eline.vanmanen@radboudumc.nl	de Jonge, Ank/F-6475-2013	Gitsels - van der Wal, Janneke/0000-0002-5742-7246				Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Aviram A, 2016, BIRTH-ISS PERINAT C, V43, P42, DOI 10.1111/birt.12205; Bohren MA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003766.pub6; Bolten N, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1130-6; CBS. NUTS, REG IND VOOR EUR STA REG IND VOOR EUR STA; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Cito G, 2005, ACTA OBSTET GYN SCAN, V84, P335, DOI 10.1111/j.0001-6349.2005.00644.x; Coxon K, 2020, MIDWIFERY, V88, DOI 10.1016/j.midw.2020.102779; de Jonge A, 2015, BJOG-INT J OBSTET GY, V122, P720, DOI 10.1111/1471-0528.13084; de Jonge A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180846; de Jonge A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-103; Downe S, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012392.pub2; Dowswell T, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000934.pub3; Feijen-de Jong EI., 2015, CHAPTER 7 GEN DISCUS; Hedermann G., 2020, MEDRXIV2020052220109; Hollander M, 2018, WOMEN BIRTH, V31, P505, DOI 10.1016/j.wombi.2018.01.010; KNOV, 2018, TIM TASK MATR CONS P TIM TASK MATR CONS P; KNOV, 2008, KNOV STAND PREN VERL KNOV STAND PREN VERL; KNOV, 2020, COVID 19 PAND DRAAIB; Kozhimannil KB, 2014, AM J MANAG CARE, V20, pE340; Linde A, 2017, WOMEN BIRTH, V30, P376, DOI 10.1016/j.wombi.2017.02.007; Matar R, 2021, CLIN INFECT DIS, V72, P521, DOI 10.1093/cid/ciaa828; Merz WM, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02962-4; Mullins E, 2020, ULTRASOUND OBST GYN, V55, P586, DOI 10.1002/uog.22014; NICE, 2020, ANT CAR UNC PREGN SC ANT CAR UNC PREGN SC; Nivel, 2018, VERL AANT WERKZ STAA VERL AANT WERKZ STAA; NVOG, 2020, AFSCH PREN ZORG PREN; NZa, AANV MAATR NOODZ ZOR AANV MAATR NOODZ ZOR; Patane L, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100145; Perdok H, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0975-z; Perined, 2010, PER ZORG NED ANN 202; Pflugeisen BM, 2016, MCN-AM J MATERN-CHIL, V41, P24, DOI 10.1097/NMC.0000000000000199; Pflugeisen BM, 2017, MATERN CHILD HLTH J, V21, P1544, DOI 10.1007/s10995-017-2284-1; Philip RK., 2020, MEDRXIV2020060320121; RIVM, ACT INF OV HET NIEUW ACT INF OV HET NIEUW; RIVM, 2021, WEK UPD EP SIT COVID; Sandall J, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004667.pub3, 10.1002/14651858.CD004667.pub5]; Sanden Evd., 2020, BEVALLEN ALS ER GEVA; van den Heuvel JFM, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9262; Visser GHA, 2012, J OBSTET GYNAECOL CA, V34, P971, DOI 10.1016/S1701-2163(16)35410-X; WHO, 2022, WHO RECOMMENDATIONS	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252735	10.1371/journal.pone.0252735	http://dx.doi.org/10.1371/journal.pone.0252735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138877	gold, Green Published			2022-12-26	WOS:000671690200051
J	Goroshchuk, O; Kolosenko, I; Kunold, E; Vidarsdottir, L; Pirmoradian, M; Azimi, A; Jafari, R; Palm-Apergi, C				Goroshchuk, Oksana; Kolosenko, Iryna; Kunold, Elena; Vidarsdottir, Linda; Pirmoradian, Mohammad; Azimi, Alireza; Jafari, Rozbeh; Palm-Apergi, Caroline			Thermal proteome profiling identifies PIP4K2A and ZADH2 as off-targets of Polo-like kinase 1 inhibitor volasertib	FASEB JOURNAL			English	Article						acute leukemia; CETSA; Polo-like kinase 1; thermal proteome profiling; volasertib; ZADH2	BI 6727; GENE; PLK1; EXPRESSION; NMS-P937; AURORA; GROWTH; POTENT; CELLS	Polo-like kinase 1 (PLK1) is an important cell cycle kinase and an attractive target for anticancer treatments. An ATP-competitive small molecular PLK1 inhibitor, volasertib, has reached phase III in clinical trials in patients with refractory acute myeloid leukemia as a combination treatment with cytarabine. However, severe side effects limited its use. The origin of the side effects is unclear and might be due to insufficient specificity of the drug. Thus, identifying potential off-targets to volasertib is important for future clinical trials and for the development of more specific drugs. In this study, we used thermal proteome profiling (TPP) to identify proteome-wide targets of volasertib. Apart from PLK1 and proteins regulated by PLK1, we identified about 200 potential volasertib off-targets. Comparison of this result with the mass-spectrometry analysis of volasertib-treated cells showed that phosphatidylinositol phosphate and prostaglandin metabolism pathways are affected by volasertib. We confirmed that PIP4K2A and ZADH2-marker proteins for these pathways-are, indeed, stabilized by volasertib. PIP4K2A, however, was not affected by another PLK1 inhibitor onvansertib, suggesting that PIP4K2A is a true off-target of volasertib. Inhibition of these proteins is known to impact both the immune response and fatty acid metabolism and could explain some of the side effects seen in volasertib-treated patients.	[Goroshchuk, Oksana; Kolosenko, Iryna; Vidarsdottir, Linda; Azimi, Alireza; Palm-Apergi, Caroline] Karolinska Inst, Dept Lab Med Biomol & Cellular Med, Solna, Sweden; [Kunold, Elena; Pirmoradian, Mohammad; Jafari, Rozbeh] Karolinska Inst, Dept Oncol Pathol, Clin Prote Mass Spectrometry, Solna, Sweden	Karolinska Institutet; Karolinska Institutet	Jafari, R (corresponding author), Karolinska Inst, Sci Life Lab, Clin Prote Mass Spectrometry, Dept Oncol Pathol, Tomtebodavagen 23A, S-17165 Solna, Sweden.; Palm-Apergi, C (corresponding author), Karolinska Inst, Dept Lab Med Biomol & Cellular Med, Halsovagen 7, S-14157 Huddinge, Sweden.; Palm-Apergi, C (corresponding author), Karolinska Univ Hosp, Huddinge, Sweden.	rozbeh.jafari@ki.se; caroline.palm.apergi@ki.se		Goroshchuk, Oksana/0000-0002-1585-1962; Palm Apergi, Caroline/0000-0003-2236-2099; Vidarsdottir, Linda/0000-0003-3082-1320; Jafari, Rozbeh/0000-0002-3396-4709	Stiftelsen for Strategisk Forskning (SSF); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR); Cancerfonden (Swedish Cancer Society)	Stiftelsen for Strategisk Forskning (SSF)(Swedish Foundation for Strategic Research); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR)(Swedish Research Council); Cancerfonden (Swedish Cancer Society)(Swedish Cancer Society)	Stiftelsen for Strategisk Forskning (SSF); Ake Wiberg Stiftelse (Ake Wiberg Foundation); Dr Ake Olssons Stiftelse for Haematologisk Forskning (Dr Ake Olsson Foundation); Karolinska Institutet (KI); Magnus Bergvalls Stiftelse (Magnus Bergvall Foundation); Gunvor and Josef Aner's Foundation; Robert Lundbergs Minnesstiftelse (Robert Lundberg Memorial Foundation); Vetenskapsradet (VR); Cancerfonden (Swedish Cancer Society)	ANDERSON RJ, 1976, KIDNEY INT, V10, P205, DOI 10.1038/ki.1976.99; [Anonymous], BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours-Full Text View; Benetatos L, 2011, ANN HEMATOL, V90, P1037, DOI 10.1007/s00277-011-1193-4; Beria I, 2011, BIOORG MED CHEM LETT, V21, P2969, DOI 10.1016/j.bmcl.2011.03.054; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Branca RMM, 2014, NAT METHODS, V11, P59, DOI [10.1038/NMETH.2732, 10.1038/nmeth.2732]; Casolaro A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058424; Chen IJ, 2018, FREE RADICAL BIO MED, V115, P113, DOI 10.1016/j.freeradbiomed.2017.11.016; Childs D, 2019, MOL CELL PROTEOMICS, V18, P2506, DOI 10.1074/mcp.TIR119.001481; Cholewa BD, 2014, J PROTEOME RES, V13, P5041, DOI 10.1021/pr5002516; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; de Carcer G, 2011, CELL CYCLE, V10, P2255, DOI 10.4161/cc.10.14.16494; Dohner H, 2014, BLOOD, V124, P1426, DOI 10.1182/blood-2014-03-560557; Emerling BM, 2013, CELL, V155, P844, DOI 10.1016/j.cell.2013.09.057; Farfsing A, 2009, LEUKEMIA, V23, P2018, DOI 10.1038/leu.2009.144; Fiume R, 2015, BBA-MOL CELL BIOL L, V1851, P898, DOI 10.1016/j.bbalip.2015.02.014; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Goroshchuk O, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59653-5; Goroshchuk O, 2019, ONCOGENE, V38, P1, DOI 10.1038/s41388-018-0443-5; Granholm V, 2014, J PROTEOME RES, V13, P890, DOI 10.1021/pr400937n; Holman Jerry D, 2014, Curr Protoc Bioinformatics, V46, DOI 10.1002/0471250953.bi1324s46; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6277; Klaeger S, 2017, SCIENCE, V358, DOI 10.1126/science.aan4368; Kobayashi T, 2020, BLOOD, V136, P3004, DOI 10.1182/blood.2020005602; Kolosenko I, 2021, FASEB J, V35, DOI 10.1096/fj.202002454RR; Kolosenko I, 2020, FUTURE MED CHEM, V12, P1457, DOI 10.4155/fmc-2020-0128; Kolosenko I, 2017, J CONTROL RELEASE, V261, P199, DOI 10.1016/j.jconrel.2017.07.002; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lima K, 2019, CANCER GENET-NY, V233, P56, DOI 10.1016/j.cancergen.2019.04.002; Lima K, 2015, BLOOD CELL MOL DIS, V55, P228, DOI 10.1016/j.bcmd.2015.06.014; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Maffei R, 2013, HAEMATOLOGICA, V98, P1115, DOI 10.3324/haematol.2012.073080; Mathre S, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20182210; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nagasawa I, 2020, CELL CHEM BIOL, V27, P186, DOI 10.1016/j.chembiol.2019.11.010; Oncoheroes Biosciences Inc, 2020, ONCOHEROES BIOSCI; Raab M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1395; Reinhard FBM, 2015, NAT METHODS, V12, P1129, DOI 10.1038/nmeth.3652; Rolf MG, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.175; Rudolph D, 2009, CLIN CANCER RES, V15, P3094, DOI 10.1158/1078-0432.CCR-08-2445; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sharma S, 2019, CELL REP, V27, P1979, DOI 10.1016/j.celrep.2019.04.084; Shim H, 2016, P NATL ACAD SCI USA, V113, P7596, DOI 10.1073/pnas.1600934113; Shin YJ, 2019, J EXP MED, V216, P1120, DOI 10.1084/jem.20172170; Sivakumaren SC, 2020, CELL CHEM BIOL, V27, P525, DOI 10.1016/j.chembiol.2020.02.003; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Syed N, 2006, BLOOD, V107, P250, DOI 10.1182/blood-2005-03-1194; Valsasina B, 2012, MOL CANCER THER, V11, P1006, DOI 10.1158/1535-7163.MCT-11-0765; Wilson CL, 2015, CHILDREN-BASEL, V2, P1, DOI 10.3390/children2010001; Woo SH, 2015, CLIN J AM SOC NEPHRO, V10, P372, DOI 10.2215/CJN.02390314; Wu YH, 2008, STRUCTURE, V16, P1714, DOI 10.1016/j.str.2008.09.007; Yeung SLA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005619; Yu YH, 2013, J LIPID RES, V54, P2391, DOI 10.1194/jlr.M037556; Zhu YF, 2020, MOL CELL PROTEOMICS, V19, P1047, DOI 10.1074/mcp.TIR119.001646	62	2	2	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21741	10.1096/fj.202100457RR	http://dx.doi.org/10.1096/fj.202100457RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143546				2022-12-26	WOS:000667814100005
J	Tu, S; Jiang, YZ; Cheng, HH; Yuan, XN; He, Y; Peng, Y; Peng, XQ; Peng, ZZ; Tao, LJ; Yang, HX				Tu, Sha; Jiang, Yanzhi; Cheng, Haihua; Yuan, Xiangning; He, Ying; Peng, Yu; Peng, Xiongqun; Peng, Zhangzhe; Tao, Lijian; Yang, Huixiang			Fluorofenidone protects liver against inflammation and fibrosis by blocking the activation of NF-kappa B pathway	FASEB JOURNAL			English	Article						AKF-PD; inflammation; liver fibrosis; NF-kappa B	HEPATIC-FIBROSIS; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; INJURY; ALPHA; INHIBITION; LOSARTAN; CELLS	Despite the increasing understanding of the pathophysiology of hepatic fibrosis, the therapies to combat it remain inadequate. Fluorofenidone (AKF-PD) is a novel pyridone agent able to ameliorate hepatic fibrosis in an experimental hepatic fibrosis model induced by dimethylnitrosamine. However, the underlying mechanism remains to be further elucidated. In light of the critical role of the NF-kappa B pathway in inflammation and hepatic fibrosis, together with the preliminary finding that AKF-PD decreases the release of proinflammatory cytokines in the endotoxemia and unilateral ureteral occlusion model, the aim of this study was to explore whether AKF-PD exerts an antifibrotic effect in hepatic fibrosis by inhibiting inflammation and suppressing the activation of the NF-kappa B pathway in vivo and in vitro. To test this possibility, the effect of AKF-PD on hepatic fibrosis models induced by both carbon tetrachloride (CCL4) and porcine serum (PS) was investigated. Our results showed that AKF-PD treatment ameliorated hepatic injury and fibrosis in both models. Furthermore, the administration of AKF-PD induced a robust anti-inflammatory reaction revealed by the downregulation of the proinflammatory cytokines as well as the suppression of the infiltration of inflammatory cells in the fibrotic liver. The analysis of the mechanism of action demonstrated that the attenuation of the production of proinflammatory cytokines and chemokines mediated by AKF-PD in vivo and in vitro were accompanied by the suppression in the activation of the NF-kappa B signaling pathway. In conclusion, AKF-PD might be considered as an antifibrotic agent attenuating hepatic inflammation and fibrosis potentially through the suppression of the NF-kappa B pathway.	[Tu, Sha; Jiang, Yanzhi; Cheng, Haihua; He, Ying; Peng, Yu; Yang, Huixiang] Cent South Univ, Xiangya Hosp, Dept Gastroenterol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China; [Tu, Sha; Yuan, Xiangning; Peng, Zhangzhe; Tao, Lijian; Yang, Huixiang] Cent South Univ, Hunan Key Lab Organ Fibrosis, Changsha, Peoples R China; [Peng, Xiongqun] Changsha Cent Hosp, Dept Gastroenterol, Changsha, Peoples R China; [Peng, Zhangzhe; Tao, Lijian] Cent South Univ, Xiangya Hosp, Dept Nephrol, Changsha, Peoples R China	Central South University; Central South University; Central South University	Yang, HX (corresponding author), Cent South Univ, Xiangya Hosp, Dept Gastroenterol, 87 Xiangya Rd, Changsha, Hunan, Peoples R China.	yang_hx430@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [81370547, 81873585]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81370547 and 81873585	Armendariz-Borunda J, 2006, GUT, V55, P1663, DOI 10.1136/gut.2006.107136; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bhunchet E, 1996, HEPATOLOGY, V23, P811, DOI 10.1002/hep.510230423; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Croquet V, 2002, J HEPATOL, V37, P773, DOI 10.1016/S0168-8278(02)00307-0; Di Pascoli M, 2013, J HEPATOL, V58, P904, DOI 10.1016/j.jhep.2012.12.012; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fiorucci S, 2001, P NATL ACAD SCI USA, V98, P8897, DOI 10.1073/pnas.151136298; Flores-Contreras L, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-131; Gao B, 2010, GASTROENTEROLOGY, V139, P27, DOI 10.1053/j.gastro.2010.05.018; Garcia L, 2002, J HEPATOL, V37, P797, DOI 10.1016/S0168-8278(02)00272-6; Huang L, 2014, AM J MED SCI, V348, P75, DOI 10.1097/MAJ.0000000000000187; Ibrahim SH, 2018, GUT, V67, P963, DOI 10.1136/gutjnl-2017-315691; Inao M, 2004, J HEPATOL, V41, P584, DOI 10.1016/j.jhep.2004.06.033; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Lancaster LH, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0057-2017; Liu CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129283; Liu JJ, 2015, SHOCK, V43, P201, DOI 10.1097/SHK.0000000000000273; Maher JJ, 2008, HEPATOLOGY, V48, P670, DOI 10.1002/hep.22399; Peng Y, 2014, AM J PHYSIOL-GASTR L, V306, pG253, DOI 10.1152/ajpgi.00471.2012; Peng Y, 2013, EUR J CLIN INVEST, V43, P358, DOI 10.1111/eci.12053; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Qin J, 2015, KIDNEY BLOOD PRESS R, V40, P89, DOI 10.1159/000368485; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Seki E, 2015, HEPATOLOGY, V61, P1066, DOI 10.1002/hep.27332; Song C, 2016, J CELL MOL MED, V20, P2064, DOI 10.1111/jcmm.12898; Sun B, 2008, ONCOGENE, V27, P6228, DOI 10.1038/onc.2008.300; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Tang YT, 2015, AM J MED SCI, V350, P195, DOI 10.1097/MAJ.0000000000000501; Tang YT, 2010, INT IMMUNOPHARMACOL, V10, P580, DOI 10.1016/j.intimp.2010.02.005; Tomita K, 2006, GUT, V55, P415, DOI 10.1136/gut.2005.071118; Yuan QJ, 2011, AM J NEPHROL, V34, P181, DOI 10.1159/000329080	34	3	4	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21497	10.1096/fj.202002402R	http://dx.doi.org/10.1096/fj.202002402R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34152015				2022-12-26	WOS:000667814100068
J	Morris, ME; Kuehn, KS; Brown, J; Nurius, PS; Zhang, H; Sefidgar, YS; Xu, XH; Riskin, EA; Dey, AK; Consolvo, S; Mankoff, JC				Morris, Margaret E.; Kuehn, Kevin S.; Brown, Jennifer; Nurius, Paula S.; Zhang, Han; Sefidgar, Yasaman S.; Xu, Xuhai; Riskin, Eve A.; Dey, Anind K.; Consolvo, Sunny; Mankoff, Jennifer C.			College from home during COVID-19: A mixed-methods study of heterogeneous experiences	PLOS ONE			English	Article							INVENTORY; VALIDITY; VERSION; HEALTH	This mixed-method study examined the experiences of college students during the COVID-19 pandemic through surveys, experience sampling data collected over two academic quarters (Spring 2019 n(1) = 253; Spring 2020 n(2) = 147), and semi-structured interviews with 27 undergraduate students. There were no marked changes in mean levels of depressive symptoms, anxiety, stress, or loneliness between 2019 and 2020, or over the course of the Spring 2020 term. Students in both the 2019 and 2020 cohort who indicated psychosocial vulnerability at the initial assessment showed worse psychosocial functioning throughout the entire Spring term relative to other students. However, rates of distress increased faster in 2020 than in 2019 for these individuals. Across individuals, homogeneity of variance tests and multi-level models revealed significant heterogeneity, suggesting the need to examine not just means but the variations in individuals' experiences. Thematic analysis of interviews characterizes these varied experiences, describing the contexts for students' challenges and strategies. This analysis highlights the interweaving of psychosocial and academic distress: Challenges such as isolation from peers, lack of interactivity with instructors, and difficulty adjusting to family needs had both an emotional and academic toll. Strategies for adjusting to this new context included initiating remote study and hangout sessions with peers, as well as self-learning. In these and other strategies, students used technologies in different ways and for different purposes than they had previously. Supporting qualitative insight about adaptive responses were quantitative findings that students who used more problem-focused forms of coping reported fewer mental health symptoms over the course of the pandemic, even though they perceived their stress as more severe. These findings underline the need for interventions oriented towards problem-focused coping and suggest opportunities for peer role modeling.	[Morris, Margaret E.; Xu, Xuhai; Dey, Anind K.] Univ Washington, Informat Sch, Seattle, WA 98195 USA; [Kuehn, Kevin S.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Brown, Jennifer] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Nurius, Paula S.] Univ Washington, Sch Social Work, Seattle, WA 98195 USA; [Zhang, Han; Sefidgar, Yasaman S.; Mankoff, Jennifer C.] Univ Washington, Comp Sci & Engn, Seattle, WA 98195 USA; [Riskin, Eve A.] Univ Washington, Dept Elect & Comp Engn, Seattle, WA 98195 USA; [Consolvo, Sunny] Google, Mountain View, CA 94043 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Google Incorporated	Morris, ME (corresponding author), Univ Washington, Informat Sch, Seattle, WA 98195 USA.	margiemm@uw.edu	Kuehn, Kevin S/GNM-5254-2022	Kuehn, Kevin S/0000-0002-7985-613X; Brown, Jennifer/0000-0002-8856-784X; Zhang, Han/0000-0002-1377-1168; Morris, Margaret/0000-0002-8925-9718; Xu, Xuhai/0000-0001-5930-3899	National Science Foundation [EDA-2009977, CHS-2016365, CHS-1941537]; Samsung; National Research Service Award from the National Institute of Mental Health [F31MH117827]; Google Security and Privacy unrestricted gift award	National Science Foundation(National Science Foundation (NSF)); Samsung(Samsung); National Research Service Award from the National Institute of Mental Health; Google Security and Privacy unrestricted gift award	This material is based upon work supported by the National Science Foundation under Grant Nos. EDA-2009977 awarded to JM, PN, AD, and ER, CHS-2016365, and CHS1941537, awarded to JM. Funding was also provided through a grant from Samsung awarded to JM, PN, AD, and ER. KSK (the second author) was supported by a National Research Service Award from the National Institute of Mental Health (F31MH117827). Additional support came from a Google Security and Privacy unrestricted gift awarded to JM that provided consulting income for researcher MM. SC, a researcher at Google, is an author on this paper who contributed to study design, analysis, and manuscript preparation. The specific role of this author is articulated in the `author contributions' section. The manuscript was approved by an internal Google review.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Aucejo EM, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104271; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett DA, 2001, AUST NZ J PUBL HEAL, V25, P464, DOI 10.1111/j.1467-842X.2001.tb00294.x; Bieling PJ, 1998, BEHAV RES THER, V36, P777, DOI 10.1016/S0005-7967(98)00023-0; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bryan CJ, 2020, SUICIDE LIFE-THREAT, V50, P1223, DOI 10.1111/sltb.12653; Chirikov I, 2020, REPORTS TITLE UNDERG; Clement L, 2016, J MICROBIOL BIOL EDU, V17, P351, DOI 10.1128/jmbe.v17i3.1077; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Compas BE, 2017, PSYCHOL BULL, V143, P939, DOI 10.1037/bul0000110; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fitzpatrick KK, 2017, JMIR MENT HEALTH, V4, DOI 10.2196/mental.7785; Folk D, 2020, COLLABRA-PSYCHOL, V6, DOI 10.1525/collabra.365; Gastwirth JL, 2009, STAT SCI, V24, P343, DOI 10.1214/09-STS301; Gruber J, 2021, AM PSYCHOL, V76, P409, DOI 10.1037/amp0000707; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Isumi A, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104680; Kalman R, 2020, J CHEM EDUC, V97, P3353, DOI 10.1021/acs.jchemed.0c00712; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuh GD, 2008, J HIGH EDUC-UK, V79, P540, DOI 10.1353/jhe.0.0019; Malouff JM, 2007, CLIN PSYCHOL REV, V27, P46, DOI 10.1016/j.cpr.2005.12.005; Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021; Morens DM, 2020, AM J TROP MED HYG, V103, P955, DOI 10.4269/ajtmh.20-0849; Morris ME, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1371; Neustaedter C., 2012, P SIGCHI C HUM FACT, P753, DOI [10.1145/2207676.2207785, DOI 10.1145/2207676.2207785]; Oldenburg R., 2001, CELEBRATING 3 PLACE; Pike GR, 2011, RES HIGH EDUC, V52, P300, DOI 10.1007/s11162-010-9192-1; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Schroeder J, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3173972; Sefidgar Yasaman S, 2019, Proc ACM Hum Comput Interact, V3, P1, DOI 10.1145/3359216; Siraj-Blatchford I, 2004, EUR EARLY CHILD EDUC, V21, P5, DOI DOI 10.1080/13502930485209391; Taylor CB, 2020, J MED INTERNET RES, V22, DOI 10.2196/17493; Ye Z, 2020, APPL PSYCHOL-HLTH WE, V12, P1074, DOI 10.1111/aphw.12211	37	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0251580	10.1371/journal.pone.0251580	http://dx.doi.org/10.1371/journal.pone.0251580			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9DB	34181650	gold, Green Published			2022-12-26	WOS:000671695800033
J	Rodpai, R; Sanpool, O; Thanchomnang, T; Laoraksawong, P; Sadaow, L; Boonroumkaew, P; Wangwiwatsin, A; Wongkham, C; Laummaunwai, P; Ittiprasert, W; Brindley, PJ; Intapan, PM; Maleewong, W				Rodpai, Rutchanee; Sanpool, Oranuch; Thanchomnang, Tongjit; Laoraksawong, Pokkamol; Sadaow, Lakkhana; Boonroumkaew, Patcharaporn; Wangwiwatsin, Arporn; Wongkham, Chaisiri; Laummaunwai, Porntip; Ittiprasert, Wannaporn; Brindley, Paul J.; Intapan, Pewpan M.; Maleewong, Wanchai			Exposure to dexamethasone modifies transcriptomic responses of free-living stages of Strongyloides stercoralis	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; C. ELEGANS; EXPRESSION; VENEZUELENSIS; CELLS; APOPTOSIS; STRINGTIE; ALIGNMENT; GENOME; TOOLS	Hyperinfection and disseminated infection by the parasitic nematode Strongyloides stercoralis can be induced by iatrogenic administration of steroids and immunosuppression and lead to an elevated risk of mortality. Responses of free-living stages of S. stercoralis to the therapeutic corticosteroid dexamethasone (DXM) were investigated using RNA-seq transcriptomes of DXM-treated female and male worms. A total of 17,950 genes representing the transcriptome of these free-living adult stages were obtained, among which 199 and 263 were differentially expressed between DXM-treated females and DXM-treated males, respectively, compared with controls. According to Gene Ontology analysis, differentially expressed genes from DXM-treated females participate in developmental process, multicellular organismal process, cell differentiation, carbohydrate metabolic process and embryonic morphogenesis. Others are involved in signaling and signal transduction, including cAMP, cGMP-dependent protein kinase pathway, endocrine system, and thyroid hormone pathway, as based on Kyoto Encyclopedia of Genes and Genomes analysis. The novel findings warrant deeper investigation of the influence of DXM on growth and other pathways in this neglected tropical disease pathogen, particularly in a setting of autoimmune and/or allergic disease, which may require the clinical use of steroid-like hormones during latent or covert strongyloidiasis.	[Rodpai, Rutchanee; Sanpool, Oranuch; Sadaow, Lakkhana; Boonroumkaew, Patcharaporn; Laummaunwai, Porntip; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand; [Rodpai, Rutchanee; Sanpool, Oranuch; Sadaow, Lakkhana; Boonroumkaew, Patcharaporn; Laummaunwai, Porntip; Intapan, Pewpan M.; Maleewong, Wanchai] Khon Kaen Univ, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand; [Thanchomnang, Tongjit] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand; [Laoraksawong, Pokkamol] Sukhothai Thammathirat Open Univ, Sch Hlth Sci, Nonthaburi, Thailand; [Wangwiwatsin, Arporn; Wongkham, Chaisiri] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Ittiprasert, Wannaporn; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA; [Ittiprasert, Wannaporn; Brindley, Paul J.] George Washington Univ, Sch Med & Hlth Sci, Res Ctr Neglected Dis Poverty, Washington, DC 20052 USA	Khon Kaen University; Khon Kaen University; Mahasarakham University; Sukhothai Thammathirat Open University; Khon Kaen University; George Washington University; George Washington University	Maleewong, W (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand.; Maleewong, W (corresponding author), Khon Kaen Univ, Mekong Hlth Sci Res Inst, Khon Kaen, Thailand.	wanch_ma@kku.ac.th		Rodpai, Rutchanee/0000-0003-0281-2101; Wangwiwatsin, Arporn/0000-0003-4536-4492	Thailand Research Fund [DPG6280002, PHD/0053/2556]; Khon Kaen University [RP64010, IN61150, DR63101]	Thailand Research Fund(Thailand Research Fund (TRF)); Khon Kaen University	The grants from Thailand Research Fund, [Distinguished Research Professor grant no. DPG6280002; The Royal Golden Jubilee Ph.D. Program, grant no. PHD/0053/2556] and Khon Kaen University [Research and Graduate Studies Affairs grant no. RP64010; Faculty of Medicine grants no., IN61150 and DR63101]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ES, 2001, J BIOL CHEM, V276, P10320, DOI 10.1074/jbc.M006589200; Al-Wadei HAN, 2005, EUR J CANCER, V41, P2745, DOI 10.1016/j.ejca.2005.09.001; Albarqi MMY, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005358; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakaki T., 1988, Japanese Journal of Tropical Medicine and Hygiene, V16, P11; Armenti Stephen T, 2012, Subcell Biochem, V60, P279, DOI 10.1007/978-94-007-4186-7_12; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bao Y, 2008, INFECT IMMUN, V76, P4757, DOI 10.1128/IAI.00527-08; Barnes TM, 1996, J NEUROCHEM, V67, P46; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bryant AS, 2018, CURR BIOL, V28, P2338, DOI 10.1016/j.cub.2018.05.063; Buonfrate D, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9060468; Chen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004699; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cummings BS, 2000, J PHARMACOL EXP THER, V293, P677; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Fischer NJ, 2015, TROP MED SURG, V3, P180; Gang SS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006675; GENTA RM, 1992, CLIN MICROBIOL REV, V5, P345, DOI 10.1128/CMR.5.4.345-355.1992; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greaves D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4610; Halaschek-Wiener J, 2005, GENOME RES, V15, P603, DOI 10.1101/gr.3274805; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hunt VL, 2016, NAT GENET, V48, P299, DOI 10.1038/ng.3495; Ittiprasert W, 2019, ELIFE, V8, DOI 10.7554/eLife.41337; Jaleta TG, 2017, EXP PARASITOL, V180, P112, DOI 10.1016/j.exppara.2016.12.003; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; KAUSHAL DC, 1980, NATURE, V286, P490, DOI 10.1038/286490a0; Keshwani MM, 2015, P NATL ACAD SCI USA, V112, P12681, DOI 10.1073/pnas.1516057112; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Krolewiecki A, 2019, INFECT DIS CLIN N AM, V33, P135, DOI 10.1016/j.idc.2018.10.006; Kurokawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022492; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lettre G, 2004, CELL DEATH DIFFER, V11, P1198, DOI 10.1038/sj.cdd.4401488; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liachko N, 2009, DEV BIOL, V327, P97, DOI 10.1016/j.ydbio.2008.11.019; Lima Wania Rezende, 2016, Genes Cancer, V7, P323, DOI 10.18632/genesandcancer.118; Lischer HEL, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1911-6; Liu F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00630-w; Lok JB, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00656; Ruano AL, 2015, ACTA TROP, V152, P90, DOI 10.1016/j.actatropica.2015.08.019; Machado ER, 2011, AM J TROP MED HYG, V84, P957, DOI 10.4269/ajtmh.2011.10-0490; Nagayasu E, 2013, PARASITOL INT, V62, P57, DOI 10.1016/j.parint.2012.09.006; Patton JB, 2018, P NATL ACAD SCI USA, V115, P204, DOI 10.1073/pnas.1712235114; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Qiu CH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-172; R Core Team, R LANG ENV STAT COMP; Savas U, 2003, ARCH BIOCHEM BIOPHYS, V409, P212, DOI 10.1016/S0003-9861(02)00499-X; Schar F, 2013, ACTA TROP, V126, P89, DOI 10.1016/j.actatropica.2012.12.012; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Scott E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09350-7; Senchuk MM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007268; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Swierczewski BE, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000505; Syin C, 2001, EUR J BIOCHEM, V268, P4842, DOI 10.1046/j.1432-1327.2001.02403.x; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Tefe-Silva C, 2008, AM J TROP MED HYG, V79, P571, DOI 10.4269/ajtmh.2008.79.571; Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497; VINEY ME, 1992, J HELMINTHOL, V66, P45, DOI 10.1017/S0022149X00012554; Wan QL, 2019, AGING-US, V11, P3993, DOI 10.18632/aging.102033; Wang Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005027; Xu C, 2009, MOL ENDOCRINOL, V23, P1161, DOI 10.1210/me.2008-0464; Ye J, 2018, NUCLEIC ACIDS RES, V46, pW71, DOI 10.1093/nar/gky400	66	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253701	10.1371/journal.pone.0253701	http://dx.doi.org/10.1371/journal.pone.0253701			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181669	gold, Green Published			2022-12-26	WOS:000671695800039
J	Hsieh, PS; Ho, HH; Tsao, SP; Hsieh, SH; Lin, WY; Chen, JF; Kuo, YW; Tsai, SY; Huang, HY				Hsieh, Pei-Shan; Ho, Hsieh-Hsun; Tsao, Shu Ping; Hsieh, Shih-Hung; Lin, Wen-Yang; Chen, Jui-Fen; Kuo, Yi-Wei; Tsai, Shin-Yu; Huang, Hui-Yu			Multi-strain probiotic supplement attenuates streptozotocin-induced type-2 diabetes by reducing inflammation and beta-cell death in rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; OXIDATIVE STRESS; OBESITY; MOUSE; MECHANISMS; SECRETION; MUTATION; GLUCOSE; MODELS; GENE	Probiotics are health beneficial bacterial populations colonizing the human gut and skin. Probiotics are believed to be involved in immune system regulation, gut microbiota stabilization, prevention of infectious diseases, and adjustments of host metabolic activities. Probiotics such as Lactobacillus and Bifidobacterium affect glycemic levels, blood lipids, and protein metabolism. However, the interactions between probiotics and metabolic diseases as well as the underlying mechanisms remain unclear. We used streptozotocin (STZ)-induced diabetic animal models to study the effect of Probioglu(TM), a multi-strain probiotic supplement including Lactobaccilus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, L. reuteri GL-104, and Bifidobacterium animalis subsp. lactis CP-9, on the regulation of physiochemical parameters related to type-2 diabetes. Experimental rats were randomly assigned into five groups, control group, streptozotocin (STZ)-treated rats (STZ group), STZ + 1x Probioglu(TM) group, STZ + 5x Probioglu(TM) group, and STZ + 10x Probioglu(TM) group, and physiological data were measured at weeks 0, 2, 4, 6, and 8. Our results indicate that supplementation with Probioglu(TM) significantly improved glucose tolerance, glycemic levels, insulin levels, and insulin resistance (HOMA-IR). Furthermore, we observed reduction in urea and blood lipid levels, including low-density lipoprotein (LDL), triglycerides (TG), and total cholesterol (TC). Probioglu(TM) administration increased the beta-cell mass in STZ-induced diabetic animal models, whereas it reduced the levels of proinflammatory cytokines TNF-alpha, IL-6, and IL-1 beta. In addition, the enhancement of oxidative stress biomarkers and superoxide dismutase (SOD) activities was associated with a decrease in malondialdehyde (MDA) levels. We conclude that Probioglu(TM) attenuates STZ-induced type-2 diabetes by protecting beta-cells, stabilizing glycemic levels, and reducing inflammation. Among all probiotic treating groups, the 10xProbioglu(TM) treatment revealed the best results. However, these experimental results still need to be validated by different animal models of type-2 diabetes and human clinical trials in the future.	[Hsieh, Pei-Shan; Ho, Hsieh-Hsun; Hsieh, Shih-Hung; Lin, Wen-Yang; Chen, Jui-Fen; Kuo, Yi-Wei] Bioflag Biotech Co Ltd, Funct Res Div, Dept Res & Design, Tainan, Taiwan; [Tsao, Shu Ping] Taipei Med Univ, Coll Pharm, Dept Drug Discovery & Dev Ind, Taipei, Taiwan; [Tsai, Shin-Yu] Dept Res & Design Bioflag Biotech Co Ltd, Prod Div, Tainan, Taiwan; [Huang, Hui-Yu] Taipei Med Univ, Grad Inst Metab & Obes Sci, Taipei, Taiwan	Taipei Medical University; Taipei Medical University	Huang, HY (corresponding author), Taipei Med Univ, Grad Inst Metab & Obes Sci, Taipei, Taiwan.	maggieh323@tmu.edu.tw		LIN, WEN-YANG/0000-0001-5631-9836	Bio-flag Biotech Co., Ltd, Taiwan	Bio-flag Biotech Co., Ltd, Taiwan	This study was funded by Bio-flag Biotech Co., Ltd, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [P.S. Hsieh, H.H. Ho, S. H. Hsieh, W. Y. Lin, J. F. Chen, Y. W. Kuo and S.Y.Tsai], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ammouri AA, 2018, INT J NURS PRACT, V24, DOI 10.1111/ijn.12610; Barriere DA, 2018, SCI REP, V8, P1, DOI 10.1038/s41598-017-17765-5; Bayrasheva VK, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8317850; Berchtold LA, 2016, ADV CLIN CHEM, V75, P99, DOI 10.1016/bs.acc.2016.02.001; Chavez-Carbajal A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010094; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; De Baere S, 2013, J PHARMACEUT BIOMED, V80, P107, DOI 10.1016/j.jpba.2013.02.032; De Magalhaes DA, 2019, AN ACAD BRAS CIENC, V91, DOI 10.1590/0001-3765201920180314; de Oliveira RB, 2019, LIFE SCI, V238, DOI 10.1016/j.lfs.2019.116971; Salgado Ana Lúcia Farias de Azevedo, 2010, Arq. Gastroenterol., V47, P165, DOI 10.1590/S0004-28032010000200009; Gundamaraju Rohit, 2014, Euroasian J Hepatogastroenterol, V4, P51, DOI 10.5005/jp-journals-10018-1096; Guo W, 2018, INT J ORAL SCI, V10, DOI 10.1038/ijos.2017.51; Hsieh PS, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2019-001028; Huang HY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856381; IKEDA H, 1994, DIABETES RES CLIN PR, V24, pS313, DOI 10.1016/0168-8227(94)90268-2; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kajimoto Y, 2004, ANN NY ACAD SCI, V1011, P168, DOI 10.1196/annals.1293.017; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Knopp Jennifer L, 2019, J Diabetes Sci Technol, V13, P597, DOI 10.1177/1932296818805074; LeBlanc JG, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0691-z; Lee MY, 2011, DIABETES METAB J, V35, P130, DOI 10.4093/dmj.2011.35.2.130; Leiter EH, 2004, DIABETES, V53, pS4, DOI 10.2337/diabetes.53.2007.S4; Lin CL, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071972; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Markowiak-Kopec P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041107; Olaogun I, 2020, CUREUS, V12, DOI 10.7759/cureus.7614; Pasquier F, 2010, DIABETES METAB, V36, pS100, DOI 10.1016/S1262-3636(10)70475-4; Phillips MS, 1996, NAT GENET, V13, P18, DOI 10.1038/ng0596-18; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Ripsin CM, 2009, AM FAM PHYSICIAN, V79, P29; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Sakaguchi K, 2016, DIABETOL INT, V7, P53, DOI 10.1007/s13340-015-0212-4; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Shah R., 2018, BRAZ J PHARM SCI, V54; Shu CJ, 2012, SEMIN IMMUNOL, V24, P436, DOI 10.1016/j.smim.2012.12.001; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weng Y, 2014, J ETHNOPHARMACOL, V152, P553, DOI 10.1016/j.jep.2014.02.001; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Yang L, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080203; Zhang M, 2008, EXP DIABETES RES, DOI 10.1155/2008/704045; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zraika S, 2006, DIABETOLOGIA, V49, P1254, DOI 10.1007/s00125-006-0212-9	45	8	8	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0251646	10.1371/journal.pone.0251646	http://dx.doi.org/10.1371/journal.pone.0251646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166387	Green Published, gold			2022-12-26	WOS:000671692800040
J	Vazquez, C; Swanson, SE; Negatu, SG; Dittmar, M; Miller, J; Ramage, HR; Cherry, S; Jurado, KA				Vazquez, Christine; Swanson, Sydnie E.; Negatu, Seble G.; Dittmar, Mark; Miller, Jesse; Ramage, Holly R.; Cherry, Sara; Jurado, Kellie A.			SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; HOST GENE-EXPRESSION; NF-KAPPA-B; EFFICIENT PROPAGATION; I INTERFERON; RIG-I; REPLICATION; HELICASE; NUCLEUS; TBK1	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a devastating global pandemic, infecting over 43 million people and claiming over 1 million lives, with these numbers increasing daily. Therefore, there is urgent need to understand the molecular mechanisms governing SARS-CoV-2 pathogenesis, immune evasion, and disease progression. Here, we show that SARS-CoV-2 can block IRF3 and NF-kappa B activation early during virus infection. We also identify that the SARS-CoV-2 viral proteins NSP1 and NSP13 can block interferon activation via distinct mechanisms. NSP1 antagonizes interferon signaling by suppressing host mRNA translation, while NSP13 downregulates interferon and NF-kappa B promoter signaling by limiting TBK1 and IRF3 activation, as phospho-TBK1 and phospho-IRF3 protein levels are reduced with increasing levels of NSP13 protein expression. NSP13 can also reduce NF-kappa B activation by both limiting NF-kappa B phosphorylation and nuclear translocation. Last, we also show that NSP13 binds to TBK1 and downregulates IFIT1 protein expression. Collectively, these data illustrate that SARS-CoV-2 bypasses multiple innate immune activation pathways through distinct mechanisms.	[Vazquez, Christine; Swanson, Sydnie E.; Negatu, Seble G.; Jurado, Kellie A.] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dittmar, Mark; Miller, Jesse; Cherry, Sara] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA; [Ramage, Holly R.] Thomas Jefferson Univ, Dept Microbiol & Immunol, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Jefferson University	Jurado, KA (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	Kellie.jurado@pennmedicine.upenn.edu		Miller, Jesse/0000-0002-7990-4912; Dittmar, Mark/0000-0003-2884-5630; Negatu, Seble/0000-0002-6195-0312; cherry, sara/0000-0003-3956-6610; Vazquez, Christine/0000-0001-7647-1966				Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmad L, 2016, TRENDS MOL MED, V22, P511, DOI 10.1016/j.molmed.2016.04.006; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Chiang HS, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03086; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; GEY GO, 1952, CANCER RES, V12, P264; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kamitani W, 2009, NAT STRUCT MOL BIOL, V16, P1134, DOI 10.1038/nsmb.1680; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Li JY, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198074; Lokugamage KG, 2015, J VIROL, V89, P10970, DOI 10.1128/JVI.01352-15; Lokugamage KG, 2012, J VIROL, V86, P13598, DOI 10.1128/JVI.01958-12; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matthews KL, 2014, J GEN VIROL, V95, P874, DOI 10.1099/vir.0.062059-0; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Ramasamy S, 2016, P NATL ACAD SCI USA, V113, P1871, DOI 10.1073/pnas.1511380113; Schubert K, 2020, NAT STRUCT MOL BIOL, V27, P959, DOI 10.1038/s41594-020-0511-8; Shuai HP, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.07.016; Siu KL, 2014, J VIROL, V88, P4866, DOI 10.1128/JVI.03649-13; Siu KL, 2014, CELL MOL IMMUNOL, V11, P141, DOI 10.1038/cmi.2013.61; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Tanaka T, 2012, J VIROL, V86, P11128, DOI 10.1128/JVI.01700-12; Terada Y, 2017, VIROLOGY, V511, P95, DOI 10.1016/j.virol.2017.08.026; Thoms M, 2020, SCIENCE, V369, P1249, DOI 10.1126/science.abc8665; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; White Mark Andrew, 2020, bioRxiv, DOI 10.1101/2020.08.09.243246; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xia HJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108234; Yan LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19770-1; Yang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17554; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2	42	36	36	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253089	10.1371/journal.pone.0253089	http://dx.doi.org/10.1371/journal.pone.0253089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166398	gold, Green Published			2022-12-26	WOS:000671692800086
J	El-Samad, LM; El-Ashram, S; Kheirallah, DA; Abdul-Aziz, KK; Toto, NA; Mokhamer, EM				El-Samad, Lamia M.; El-Ashram, Saeed; Kheirallah, Dalia A.; Abdul-Aziz, Karolin K.; Toto, Noura A.; Mokhamer, El Hassan M.			Relative gene expression, micronuclei formation, and ultrastructure alterations induced by heavy metal contamination in Pimelia latreillei (Coleoptera: Tenebrionidae) in an urban-industrial area of Alexandria, Egypt	PLOS ONE			English	Article							SEMINAL FLUID PROTEINS; SHOCK-PROTEIN; DROSOPHILA-MELANOGASTER; TRIBOLIUM-CASTANEUM; THERMAL-STRESS; MOLECULAR CHARACTERIZATION; DIFFERENT TEMPERATURE; OOGENESIS ANOMALIES; APOLYGUS-LUCORUM; BLAPS-POLYCRESTA	The present research aims to evaluate the impact of industrial processes and anthropogenic activities on the beetle Pimelia latreillei inhabiting the polluted site at Zawya Abd El- Qader, Alexandria, Egypt. Beetles were collected from the vicinity of five factories. The genotoxic effects of environmental exposures to industrial heavy metals were monitored using a broad range of assays, including energy-dispersive X ray microanalysis and X-ray diffraction (SEM and EDX)), qRT-PCR gene expression assay, micronuclei formation, and transmission electron microscope (TEM). Energy dispersive X-ray microanalysis for the soil and testicular tissues of beetles collected from the polluted site revealed a higher percentage of heavy metals than the beetles collected from the reference site (Sidi Kirier, Alexandria, Egypt). To analyze/monitor genotoxicity in P. latreillei sampled from the polluted site, the transcription levels of levels of heat shock proteins (Hsps) and accessory gland seminal fluid protein (AcPC01) in testicular tissues were recorded. The incidence of micronuclei (MN) formation in the testicular cells was also observed. Quantitative RT-PCR (RT-qPCR) analysis was carried out to detect the changes in the gene expression of the aforementioned proteins. Genes encoding heat shock proteins (Hsp60, Hsp70, and Hsp90) were significantly overexpressed (> 2-fold) in specimens sampled from the polluted site; however, AcPC01 gene expression was under-expressed (<1.5-folds). The incidence of MN was significantly increased in specimens sampled from the polluted site. Ultrastructure anomalies (nuclear and cytoplasmic disruption) were also observed in the testicular cells of the beetles sampled from the polluted site compared to those sampled from the unpolluted site. Our results, therefore, advocate a need for adequate measures to reduce increasing environmental pollution in the urban-industrial areas.	[El-Samad, Lamia M.; Kheirallah, Dalia A.] Alexandria Univ, Fac Sci, Dept Zool, Alexandria, Egypt; [El-Ashram, Saeed] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China; [El-Ashram, Saeed] Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt; [Abdul-Aziz, Karolin K.; Toto, Noura A.; Mokhamer, El Hassan M.] Damanhour Univ, Fac Sci, Dept Zool, El Beheira, Damanhour, Egypt	Egyptian Knowledge Bank (EKB); Alexandria University; Foshan University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University; Egyptian Knowledge Bank (EKB); Damanhour University	El-Samad, LM (corresponding author), Alexandria Univ, Fac Sci, Dept Zool, Alexandria, Egypt.; El-Ashram, S (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.; El-Ashram, S (corresponding author), Kafrelsheikh Univ, Fac Sci, Kafr Al Sheikh, Egypt.	dr_lamialina11@yahoo.com; saeed_elashram@yahoo.com	El-Ashram, Saeed/AAC-6060-2021; mokhamer, hassan/GXV-3539-2022; ElSamad, Lamia M/AAT-3379-2020; Kheirallah, Dalia Abdel Moneim/ABE-1232-2021	El-Ashram, Saeed/0000-0003-0389-1980; mokhamer, hassan/0000-0003-2257-3929; ElSamad, Lamia M/0000-0002-4352-5742; Kheirallah, Dalia Abdel Moneim/0000-0002-8747-2478	Foshan University, Foshan city, Guangdong province; Guangdong Science and Technology Plan Project [1244 0600 4560 7389XC]; School of Life Science and Engineering fund [KLPREAD201801-02]	Foshan University, Foshan city, Guangdong province; Guangdong Science and Technology Plan Project; School of Life Science and Engineering fund	S.E. Start-up Research Grant Program provided by Foshan University, Foshan city, Guangdong province for distinguished researchers, Guangdong Science and Technology Plan Project (Grant No:1244 0600 4560 7389XC) and School of Life Science and Engineering fund (Grant No: KLPREAD201801-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama A., 2013, INT WATER TECHNOL J, V3, P158; Ahmadi M, 2015, APPL RADIAT ISOTOPES, V101, P135, DOI 10.1016/j.apradiso.2015.03.021; Almeida FC, 2009, GENETICS, V181, P235, DOI 10.1534/genetics.108.096263; Andres JA, 2008, P ROY SOC B-BIOL SCI, V275, P1975, DOI 10.1098/rspb.2008.0423; Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186; Au DWT, 2001, ENVIRON POLLUT, V111, P11, DOI 10.1016/S0269-7491(00)00036-1; Augustyniak M, 2009, J INSECT PHYSIOL, V55, P735, DOI 10.1016/j.jinsphys.2009.04.009; Avgin Sakine Serap, 2010, Munis Entomology & Zoology, V5, P209; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Azam I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/942751; Baer B, 2009, PROTEOMICS, V9, P2085, DOI 10.1002/pmic.200800708; BAIRATI A, 1968, Monitore Zoologico Italiano, V2, P105; Barnes JA, 2002, ENVIRON MOL MUTAGEN, V40, P236, DOI 10.1002/em.10116; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Benvindo-Souza M, 2019, ENVIRON POLLUT, V245, P504, DOI 10.1016/j.envpol.2018.11.015; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Bi XL, 2013, ENVIRON SCI TECHNOL, V47, P7593, DOI 10.1021/es402545j; Bolognesi C, 2013, MUTAT RES-REV MUTAT, V753, P100, DOI 10.1016/j.mrrev.2013.07.002; Bolognesi C, 2011, MUTAGENESIS, V26, P19, DOI 10.1093/mutage/geq070; Bombail V, 2001, CHEMOSPHERE, V44, P383, DOI 10.1016/S0045-6535(00)00300-3; Braeckman B, 1997, CELL BIOL TOXICOL, V13, P389, DOI 10.1023/A:1007425925726; Braeckman B, 1997, CELL BIOL INT, V21, P823, DOI 10.1006/cbir.1998.0194; Cai ZL, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex082; Castro S. V., 2013, Acta Veterinaria Brasilica, V7, P261; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; Chapuis MP, 2011, J INSECT PHYSIOL, V57, P1562, DOI 10.1016/j.jinsphys.2011.08.011; Cheng J, 2018, J THERM BIOL, V78, P114, DOI 10.1016/j.jtherbio.2018.09.008; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Cogo AJD., 2009, NAT ONLINE, V7, P37; Condamine FL, 2011, SYST ENTOMOL, V36, P340, DOI 10.1111/j.1365-3113.2010.00567.x; Crane M, 2002, ECOTOX ENVIRON SAFE, V53, P361, DOI 10.1016/S0147-6513(02)00038-6; Dallai R, 2004, TISSUE CELL, V36, P233, DOI 10.1016/j.tice.2004.03.002; Dallai R, 2014, ARTHROPOD STRUCT DEV, V43, P257, DOI 10.1016/j.asd.2014.04.002; Dias G, 2015, MICRON, V73, P21, DOI 10.1016/j.micron.2015.03.003; Dias G, 2013, ARTHROPOD STRUCT DEV, V42, P379, DOI 10.1016/j.asd.2013.04.002; Dias G, 2013, TISSUE CELL, V45, P227, DOI 10.1016/j.tice.2013.03.006; Dias G, 2012, NATURWISSENSCHAFTEN, V99, P773, DOI 10.1007/s00114-012-0949-6; Doganlar ZB, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2104-9; Dou W, 2017, COMP BIOCHEM PHYS B, V213, P8, DOI 10.1016/j.cbpb.2017.07.005; Duan QN, 2016, B ENVIRON CONTAM TOX, V97, P303, DOI 10.1007/s00128-016-1857-9; El-Samad LM, 2019, ENVIRON SCI POLLUT R, V26, P6557, DOI 10.1007/s11356-018-4016-5; Evans HJ, 1997, MUTAT RES-GEN TOX EN, V392, P5, DOI 10.1016/S0165-1218(97)00040-2; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fontanetti CS, 2011, SOIL CONTAMINATION, P143; Gupta SC, 2007, TOXICOLOGY, V238, P1, DOI 10.1016/j.tox.2007.05.017; Hamed YA, 2013, LIFE SCI J, V10, P86; Hartmann A, 2001, FOOD CHEM TOXICOL, V39, P843, DOI 10.1016/S0278-6915(01)00031-X; Henderson L, 2000, MUTAT RES-GEN TOX EN, V464, P123, DOI 10.1016/S1383-5718(99)00173-4; Hsiao W., 2011, SUBFERTILITY HDB CLI, V2nd ed, P43; Ilijin L, 2017, ENVIRON SCI POLLUT R, V24, P20818, DOI 10.1007/s11356-017-9898-0; Joshi A, 2000, GENETICA, V109, P211, DOI 10.1023/A:1017541901690; Ju RT, 2018, CELL STRESS CHAPERON, V23, P195, DOI 10.1007/s12192-017-0840-7; Rodriguez-Garcia MJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1619-9; Kafel A, 2012, ECOTOX ENVIRON SAFE, V78, P22, DOI 10.1016/j.ecoenv.2011.10.024; Kamel A, 2018, AFR ENTOMOL, V26, P495, DOI 10.4001/003.026.0495; Kheirallah, 2016, J CELL TISSUE RES, V16, P5741; Kheirallah DA, 2015, EGYPT J BIOSCI APPL, V1, P326; Kheirallah DA, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7517-x; Kheirallah DA, 2019, FOLIA BIOL-KRAKOW, V67, P9, DOI 10.3409/fb_67-1.02; Kheirallah DAM, 2019, TOXICOL IND HEALTH, V35, P688, DOI 10.1177/0748233719893200; Kheirallah Dalia Abel-Moneim, 2016, Journal of Entomology, V13, P55, DOI 10.3923/je.2016.55.71; Kirkpatrick L.A., 2013, ASIMPLE GUIDE IBM SP, VStudent ed.; Kirsch-Volders M, 2000, ENVIRON MOL MUTAGEN, V35, P167, DOI 10.1002/(SICI)1098-2280(2000)35:3<167::AID-EM3>3.0.CO;2-G; Klobucar GIV, 2003, AQUAT TOXICOL, V64, P15, DOI 10.1016/S0166-445X(03)00009-2; Lai HY, 2011, SOIL CONTAMINATION, P107; Lauverjat S., 1989, Biology of Metals, V2, P97, DOI 10.1007/BF01129208; Miller B, 1997, MUTAT RES-GEN TOX EN, V392, P45, DOI 10.1016/S0165-1218(97)00044-X; Mokhamer ELHM., 2015, J ADV BIOL, V7, P1153, DOI [10.1007/s11356-015-4606-4, DOI 10.1007/S11356-015-4606-4]; Morgan R., 2010, SOILS HUMAN HLTH, P59, DOI [10.1201/ b13683, DOI 10.1201/B13683]; Noditi M., 2000, S N TATE PUBLIC TIMI, V7, P279; Offer T, 2005, ANN NY ACAD SCI, V1054, P439, DOI 10.1196/annals.1345.050; Pigino G, 2006, ECOTOX ENVIRON SAFE, V64, P257, DOI 10.1016/j.ecoenv.2005.12.012; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Rencuzogullari Eyyup, 2000, Cytologia (Tokyo), V65, P83, DOI 10.1508/cytologia.65.83; Sekeroglu V., 2011, Turk Hijyen ve Deneysel Biyoloji Dergisi, V68, P241, DOI 10.5505/TurkHijyen.2011.06977; Shonouda M, 2018, ENVIRON SCI POLLUT R, V25, P7896, DOI 10.1007/s11356-017-1172-y; Shonouda Mourad L., 2016, Journal of Entomology, V13, P122, DOI 10.3923/je.2016.122.131; Shu YH, 2011, COMP BIOCHEM PHYS A, V158, P102, DOI 10.1016/j.cbpa.2010.09.006; South A, 2011, INSECT MOL BIOL, V20, P447, DOI 10.1111/j.1365-2583.2011.01083.x; Sun Y, 2016, INSECT SCI, V23, P37, DOI 10.1111/1744-7917.12193; Sun Y, 2014, CELL STRESS CHAPERON, V19, P725, DOI 10.1007/s12192-014-0500-0; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Umamaheswari P., 2005, STUDIES IMPACT SEED; Vandenbulcke F, 1998, INT J INSECT MORPHOL, V27, P111, DOI 10.1016/S0020-7322(98)00034-8; Venter C., 2014, OVO INVESTIGATION CE; Venter C, 2017, MICROSC RES TECHNIQ, V80, P878, DOI 10.1002/jemt.22877; Wolf KW, 1997, EUR J ENTOMOL, V94, P263; World Health Organization, 2014, BURD DIS AMB AIR POL; World Health Organization (WHO), 2014, 7000000 DEATHS ANN L; Xie GQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087639; Xu DX, 2014, COMP BIOCHEM PHYS B, V171, P49, DOI 10.1016/j.cbpb.2014.03.009; Yeh SP, 2005, AQUACULTURE, V243, P383, DOI 10.1016/j.aquaculture.2004.10.017; Zhao LM, 2010, J MED ENTOMOL, V47, P1053, DOI 10.1603/ME10028	95	2	2	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253238	10.1371/journal.pone.0253238	http://dx.doi.org/10.1371/journal.pone.0253238			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161380	gold, Green Published			2022-12-26	WOS:000671691900014
J	Maskarinec, G; Raquinio, P; Kristal, BS; Setiawan, VW; Wilkens, LR; Franke, AA; Lim, U; Le Marchand, L; Randolph, TW; Lampe, JW; Hullar, MAJ				Maskarinec, Gertraud; Raquinio, Phyllis; Kristal, Bruce S.; Setiawan, Veronica W.; Wilkens, Lynne R.; Franke, Adrian A.; Lim, Unhee; Le Marchand, Loic; Randolph, Timothy W.; Lampe, Johanna W.; Hullar, Meredith A. J.			The gut microbiome and type 2 diabetes status in the Multiethnic Cohort	PLOS ONE			English	Article							DIET-QUALITY INDEXES; METFORMIN; RISK; COMMUNITIES; METAGENOME; BACTERIA; SEARCH	Background The gut microbiome may play a role in inflammation associated with type 2 diabetes (T2D) development. This cross-sectional study examined its relation with glycemic status within a subset of the Multiethnic Cohort (MEC) and estimated the association of circulating bacterial endotoxin (measured as plasma lipopolysaccharide-binding protein (LBP)) with T2D, which may be mediated by C-reactive protein (CRP). Methods In 2013-16, cohort members from five ethnic groups completed clinic visits, questionnaires, and stool and blood collections. Participants with self-reported T2D and/or taking medication were considered T2D cases. Those with fasting glucose >125 and 100-125 mg/dL were classified as undiagnosed (UT2D) and pre-diabetes (PT2D) cases, respectively. We characterized the gut microbiome through 16S rRNA gene sequencing and measured plasma LBP and CRP by standard assays. Linear regression was applied to estimate associations of the gut microbiome community structure and LBP with T2D status adjusting for relevant confounders. Results Among 1,702 participants (59.9-77.4 years), 735 (43%) were normoglycemic (NG), 506 (30%) PT2D, 154 (9%) UT2D, and 307 (18%) T2D. The Shannon diversity index decreased (p(trend) = 0.05), while endotoxin, measured as LBP, increased (p(trend) = 0.0003) from NG to T2D. Of 10 phyla, Actinobacteria (p(trend) = 0.007), Firmicutes (p(trend) = 0.003), and Synergistetes (p(trend) = 0.02) were inversely associated and Lentisphaerae (p(trend) = 0.01) was positively associated with T2D status. Clostridium sensu stricto 1, Lachnospira, and Peptostreptococcaceae were less, while Escherichia-Shigella and Lachnospiraceae were more abundant among T2D patients, but the associations with Actinobacteria, Clostridium sensu stricto 1, and Escherichia-Shigella may be due metformin use. PT2D/UT2D values were closer to NG than T2D. No indication was detected that CRP mediated the association of LBP with T2D. Conclusions T2D but not PT2D/UT2D status was associated with lower abundance of SCFA-producing genera and a higher abundance of gram-negative endotoxin-producing bacteria suggesting that the gut microbiome may contribute to chronic systemic inflammation and T2D through bacterial translocation.	[Maskarinec, Gertraud; Raquinio, Phyllis; Wilkens, Lynne R.; Franke, Adrian A.; Lim, Unhee; Le Marchand, Loic] Univ Hawaii, Canc Ctr, Populat Sci Pacific, Honolulu, HI 96822 USA; [Kristal, Bruce S.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Kristal, Bruce S.] Harvard Med Sch, Boston, MA 02115 USA; [Setiawan, Veronica W.] Univ Southern Calif, Dept Prevent Med, Los Angeles, CA 90007 USA; [Randolph, Timothy W.; Lampe, Johanna W.; Hullar, Meredith A. J.] Fred Hutchinson Canc Res Ctr, Publ Hlth Sci Div, 1124 Columbia St, Seattle, WA 98104 USA	Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Southern California; Fred Hutchinson Cancer Center	Maskarinec, G (corresponding author), Univ Hawaii, Canc Ctr, Populat Sci Pacific, Honolulu, HI 96822 USA.	gertraud@cc.hawaii.edu	Lim, Unhee/AEA-8591-2022	Lim, Unhee/0000-0001-6221-7190; Maskarinec, Gertraud/0000-0002-8129-958X	National Cancer Institute [P01CA169530, U01CA164973, P30CA071789, P30CA015704]; National Center for Advancing Translational Sciences [UL1TR000130]; National Institute of Diabetes and Digestive and Kidney Diseases [R01HL140335]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by the following grants: National Cancer Institute (https://www.cancer.gov/) P01CA169530 (LLM) U01CA164973 (LLM) P30CA071789 (RH) P30CA015704 (TJL) National Center for Advancing Translational Sciences (https://ncats.nih.gov/) UL1TR000130 (TAB) National Institute of Diabetes and Digestive and Kidney Diseases (https://www.niddk.nih.gov/) R01HL140335 (BSK) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226372; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Brunkwall L, 2017, DIABETOLOGIA, V60, P943, DOI 10.1007/s00125-017-4278-3; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chapkin RS, 2020, DIGEST DIS SCI, V65, P840, DOI 10.1007/s10620-020-06106-8; Chavez-Carbajal A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010094; Chen L, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00761; Citronberg JS, 2018, ISME J, V12, P1631, DOI 10.1038/s41396-018-0064-6; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Clooney AG, 2021, GUT, V70, P499, DOI 10.1136/gutjnl-2020-321106; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Di Fusco D, 2018, CLIN SCI, V132, P1155, DOI 10.1042/CS20180167; Doumatey AP, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00063; Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericson U, 2020, J NUTR, V150, P861, DOI 10.1093/jn/nxz293; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fu BC, 2019, CANCER EPIDEM BIOMAR, V28, P154, DOI 10.1158/1055-9965.EPI-18-0348; Gaike AH, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00578-19; Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Guo PT, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-019-0402-1; Harmon BE, 2015, AM J CLIN NUTR, V101, P587, DOI 10.3945/ajcn.114.090688; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Huang C, 2015, J NUTR, V145, P2774, DOI 10.3945/jn.115.217406; Jacobs S, 2017, BRIT J NUTR, V118, P312, DOI [10.1017/S0007114517002033, 10.1017/s0007114517002033]; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005; Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lambeth Stacey M, 2015, J Diabetes Obes, V2, P1; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Marchand L, 2020, CANCER EPIDEM BIOMAR, V29, P966, DOI 10.1158/1055-9965.EPI-19-1469; Lim U, 2019, GASTROENTEROLOGY, V156, P966, DOI 10.1053/j.gastro.2018.11.021; Luo HZ, 2018, BIORESOURCE TECHNOL, V253, P343, DOI 10.1016/j.biortech.2018.01.007; Ma X, 2012, J ANIM SCI, V90, P266, DOI 10.2527/jas.50965; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pedersen C, 2016, BRIT J NUTR, V116, P1869, DOI 10.1017/S0007114516004086; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sepp E, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.22857; Shoaie S, 2015, CELL METAB, V22, P320, DOI 10.1016/j.cmet.2015.07.001; Skovso S, 2015, INT J OBESITY, V39, P1531, DOI 10.1038/ijo.2015.92; Song RS, 2016, DIABETES CARE, V39, P187, DOI 10.2337/dci15-0013; Thingholm LB, 2019, CELL HOST MICROBE, V26, P252, DOI 10.1016/j.chom.2019.07.004; Utzschneider KM, 2016, J CLIN ENDOCR METAB, V101, P2622, DOI 10.1210/jc.2015-4251; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34360; Wen L, 2017, J NUTR, V147, p1468S, DOI 10.3945/jn.116.240754; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu XK, 2010, CURR MICROBIOL, V61, P69, DOI 10.1007/s00284-010-9582-9; Zhang FH, 2019, ENDOCRINE, V66, P485, DOI 10.1007/s12020-019-02041-5; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071108; Zhang YQ, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqaa078	68	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0250855	10.1371/journal.pone.0250855	http://dx.doi.org/10.1371/journal.pone.0250855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161346	gold, Green Published			2022-12-26	WOS:000671691900032
J	Oh, WS; Yu, DJ; Muneepeerakul, R				Oh, Woi Sok; Yu, David J.; Muneepeerakul, Rachata			Efficiency-fairness trade-offs in evacuation management of urban floods: The effects of the shelter capacity and zone prioritization	PLOS ONE			English	Article							AGENT-BASED MODEL; SIMULATION; LOCATION; LIFE; ALLOCATION; BENEFITS; HAZARDS; SYSTEMS; RISK; TIME	With increasing flood risk, evacuation has become an important research topic in urban flood management. Urban flood evacuation is a complex problem due to i) the complex interactions among several components within a city and ii) the need to consider multiple, often competing, dimensions/objectives in evacuation analysis. In this study, we focused on the interplay between two such objectives: efficiency and fairness. We captured the evacuation process in a conceptual agent-based model (ABM), which was analyzed under different hard infrastructure and institutional arrangement conditions, namely, various shelter capacity distributions as a hard infrastructure property and simultaneous/staged evacuation as an institutional arrangement. Efficiency was measured as the time it takes for a person to evacuate to safety. Fairness was defined by how equally residents suffered from floods, and the level of suffering depended on the perceived risk and evacuation time. Our findings suggested that efficiency is more sensitive to the shelter capacity distribution, while fairness changes more notably according to the evacuation priority assigned to the divided zones in staged evacuation. Simultaneous evacuation generally tended to be more efficient but unfairer than staged evacuation. The efficiency-fairness trade-off was captured by Pareto-optimal strategies, among which uniform capacity cases led to a higher efficiency while prioritizing high-risk residents increases fairness. Strategies balancing efficiency and fairness featured a uniform capacity and prioritized high-risk residents at an intermediate time delay. These findings more clearly exposed the interactions between different factors and could be adopted as benchmarks to inform more complicated evacuation ABMs.	[Oh, Woi Sok; Muneepeerakul, Rachata] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Yu, David J.] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA; [Yu, David J.] Purdue Univ, Dept Polit Sci, W Lafayette, IN 47907 USA; [Yu, David J.] Purdue Univ, Ctr Environm, W Lafayette, IN 47907 USA	State University System of Florida; University of Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Muneepeerakul, R (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	rmuneepe@ufl.edu	Oh, Woi Sok/AAA-1823-2022	Oh, Woi Sok/0000-0003-1666-0700; Yu, David J./0000-0001-9929-1933	Army Research Office/Army Research Laboratory (Multidisciplinary University Research Initiative) [W911NF1810267]	Army Research Office/Army Research Laboratory (Multidisciplinary University Research Initiative)	WO and RM were supported by the Army Research Office/Army Research Laboratory (https://www.arl.army.mil/) under award no. W911NF1810267 (Multidisciplinary University Research Initiative). The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies either expressed or implied by the Army Research Office or the US Government.	Abebe YA, 2019, J ENVIRON MANAGE, V248, DOI 10.1016/j.jenvman.2019.109317; Abebe YA, 2019, ENVIRON MODELL SOFTW, V111, P483, DOI 10.1016/j.envsoft.2018.10.015; Alsnih R, 2004, TRANSPORT RES REC, P89, DOI 10.3141/1865-13; [Anonymous], 1997, TURTLES TERMITES TRA; Baer RD, 2019, HUM ORGAN, V78, P133; Bayram V, 2015, TRANSPORT RES B-METH, V72, P146, DOI 10.1016/j.trb.2014.11.010; Bin O, 2008, J RISK INSUR, V75, P63, DOI 10.1111/j.1539-6975.2007.00248.x; Brisset S., 2015, ECO FRIENDLY INNOVAT, P83, DOI [10.1016/b978-1-78242-010-1.00004-5, DOI 10.1016/B978-1-78242-010-1.00004-5]; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; CRAWFORD SES, 1995, AM POLIT SCI REV, V89, P582, DOI 10.2307/2082975; Dawson RJ, 2011, NAT HAZARDS, V59, P167, DOI 10.1007/s11069-011-9745-4; de Koning K, 2019, GLOBAL ENVIRON CHANG, V59, DOI 10.1016/j.gloenvcha.2019.101981; Di Mauro M., 2008, FLOODRISK 2008; Du EH, 2017, WATER RESOUR RES, V53, P9164, DOI 10.1002/2017WR021192; Du E, 2017, J AM WATER RESOUR AS, V53, P316, DOI 10.1111/1752-1688.12475; Flotterod G., 2010, P INT C EVOL COMPUT; Ghorbani A, 2013, JASSS-J ARTIF SOC S, V16, DOI 10.18564/jasss.2166; Hu X., 2004, AUTOMATIC ROAD EXTRA, P320; Johnstone WM., 2012, LIFE SAFETY MODELLIN, DOI [10.14288/1.0073328, DOI 10.14288/1.0073328]; Jun Xie, 2014, Annals of GIS, V20, P159, DOI 10.1080/19475683.2014.942363; Kakinuma K, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/abc586; Kazancioglu E., 2003, P ASME DES ENG TECHN, DOI [10.1115/detc2003/dac-48714, DOI 10.1115/DETC2003/DAC-48714]; Kongsomsaksakul S., 2005, J E ASIA SOC TRANSP, V6; Kulshrestha A., 2011, J TRANSP SAF SECUR, V3, P272, DOI DOI 10.1080/19439962.2011.609323; Lence B., 2011, DAMS RESERVOIRS, V21, P31, DOI [10.1680/dare.2011.21.1.31, DOI 10.1680/DARE.2011.21.1.31]; Li ACY, 2012, TRANSPORT RES E-LOG, V48, P715, DOI 10.1016/j.tre.2011.12.004; Lim H., 2013, J E ASIA SOC TRANSP, V10, P147, DOI DOI 10.11175/EASTS.10.147; Litman T, 2006, J TRANSP ENG, V132, P11, DOI 10.1061/(ASCE)0733-947X(2006)132:1(11); Liu Y, 2006, TRANSPORT RES REC, P127, DOI 10.3141/1964-14; Lumbroso D, 2018, J FLOOD RISK MANAG, V11, pS419, DOI 10.1111/jfr3.12230; Lumbroso D.M., 2010, MODELLING MASS EVACU, P21; Lumbroso D, 2021, NAT HAZARD EARTH SYS, V21, P21, DOI 10.5194/nhess-21-21-2021; Miyagawa M, 2009, ANN OPER RES, V172, P349, DOI 10.1007/s10479-009-0630-4; Miyaji M, 2020, JPN ARCHIT REV, V3, P590, DOI 10.1002/2475-8876.12177; Na L., 1985, SYST ENG PROCEDIA, V5, P1, DOI [10.1016/j.sepro.2012.04.001, DOI 10.1016/J.SEPRO.2012.04.001]; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Ng M, 2010, COMPUT-AIDED CIV INF, V25, P547, DOI 10.1111/j.1467-8667.2010.00669.x; North D. C., 1990, I I CHANGE EC PERFOR, DOI [10.1017/CBO9780511606892.012, DOI 10.1017/CBO9780511606892.012]; Nygren A, 2016, J LAT AM STUD, V48, P335, DOI 10.1017/S0022216X15001170; Pareto V., 1964, COURS EC POLITIQUE, P299, DOI [10.3917/droz.paret.1964.01, DOI 10.3917/DROZ.PARET.1964.01]; Perez I, 2016, GLOBAL ENVIRON CHANG, V40, P82, DOI 10.1016/j.gloenvcha.2016.07.005; Quader MA, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080831; Rees W.E., 2012, SUSTAIN SCI, P247, DOI [10.1007/978-1-4614-3188-6_12, DOI 10.1007/978-1-4614-3188-6_12]; SHERALI HD, 1991, TRANSPORT RES B-METH, V25, P439, DOI 10.1016/0191-2615(91)90037-J; Shirvani M., PHYS SOC; Sima RJ., EOS, V2021, P102, DOI [10.1029/2021EO154550, DOI 10.1029/2021EO154550]; Struebig MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05983-y; Suffian S, 2020, WOOD PUBL SER CIVIL, P63, DOI 10.1016/B978-0-08-102704-2.00003-2; Tate E., 2021, EOS T AM GEOPHYS UN, V102, DOI [10.1029/2021EO154548, DOI 10.1029/2021EO154548]; Thaler T, 2018, REG ENVIRON CHANGE, V18, P353, DOI 10.1007/s10113-017-1229-y; Wang F, 1998, ENVIRON PLANN B, V25, P265, DOI 10.1068/b250265; Wang HZ, 2016, TRANSPORT RES C-EMER, V64, P86, DOI 10.1016/j.trc.2015.11.010; Wang M, 2015, RISK ANAL FLOOD EVEN; Wang Y., 2014, ICCSS 2014 P 2014 IN, DOI [10.1109/ICCSS.2014, DOI 10.1109/ICCSS.2014]; Watanabe D, 2010, LECT NOTES OPER RES, V12, P112; Wilensky U., 2015, INTRO AGENT BASED MO; Wood NJ, 2013, NAT HAZARDS, V65, P1603, DOI 10.1007/s11069-012-0434-8; Xie C, 2009, TRANSPORT RES REC, P79, DOI 10.3141/2091-09; Xin Q, 2011, DIESEL ENGINE SYSTEM DESIGN, P1, DOI 10.1533/9780857090836; Yamori K, 2020, INT J DISAST RISK SC, V11, P751, DOI 10.1007/s13753-020-00319-1; Yan XD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207916; Yao XH, 2012, J CENT SOUTH UNIV T, V19, P586, DOI 10.1007/s11771-012-1043-0; Yin WH, 2014, TRANSPORT RES C-EMER, V42, P44, DOI 10.1016/j.trc.2014.02.015; Zevenbergen C, 2008, J FLOOD RISK MANAG, V1, P81, DOI 10.1111/j.1753-318X.2008.00010.x; Zhang L, 2004, TRANSPORT RES REC, P28, DOI 10.3141/1898-04; Zhao X, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/1273508	66	1	1	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253395	10.1371/journal.pone.0253395	http://dx.doi.org/10.1371/journal.pone.0253395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157044	gold, Green Published			2022-12-26	WOS:000671691200006
J	Rahman, S; Wathington, D; Waterboer, T; Pawlita, M; Villa, LL; Lazcano-Ponce, E; Willhauck-Fleckenstein, M; Brenner, N; Giuliano, AR				Rahman, Shams; Wathington, Deanna; Waterboer, Tim; Pawlita, Michael; Villa, Luisa L.; Lazcano-Ponce, Eduardo; Willhauck-Fleckenstein, Martina; Brenner, Nicole; Giuliano, Anna R.			Seroprevalence of Chlamydia trachomatis, herpes simplex 2, Epstein-Barr virus, hepatitis C and associated factors among a cohort of men ages 18-70 years from three countries	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; HUMAN-PAPILLOMAVIRUS INFECTION; UNITED-STATES; GLOBAL EPIDEMIOLOGY; PREVALENCE; PREVENTION; HPV	Objectives To estimate the seroprevalence of Chlamydia trachomatis (CT), herpes simplex type-2 (HSV2), hepatitis C (HCV), Epstein-Barr virus (EBV) and nine human papilloma virus (HPV) types, and investigated factors associated with the seropositivity among men from three countries (Brazil, Mexico and U.S). Methods Archived serum specimens collected at enrollment for n = 600 men were tested for antibodies against CT, HSV2, HCV, EBV, and 9-valent HPV vaccine types (6/11/16/18/31/33/45/52/58) using multiplex serologic assays. Socio-demographic, lifestyle and sexual behavior data at enrollment were collected through a questionnaire. Results Overall, 39.3% of the men were seropositive for CT, 25.4% for HSV2, 1.3% for HCV, 97.3% for EBV, 14.0% for at least one of the seven oncogenic HPV (types: 16/18/31/33/45/52/58), and 17.4% for HPV 6/11. In the unadjusted models, age, race, smoking, sexual behavior variables, and seropositivity for high-risk HPV were significantly associated with the seropositivity for CT. In multivariable analyses, self-reported black race, higher numbers of lifetime female/male sexual partners, current smoking, and seropositivity to high-risk HPV were significantly associated with increased odds of CT seropositivity. Odds of HSV2 seroprevalence were elevated among older men and those seropositive for high risk HPV. Conclusion Exposure to STIs is common among men. Prevention and screening programs should target high-risk groups to reduce the disease burden among men, and to interrupt the disease transmission to sexual partners.	[Rahman, Shams; Wathington, Deanna] Bethune Cookman Univ, Daytona Beach, FL USA; [Waterboer, Tim; Pawlita, Michael; Willhauck-Fleckenstein, Martina; Brenner, Nicole] German Canc Res Ctr, Heidelberg, Germany; [Villa, Luisa L.] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; [Lazcano-Ponce, Eduardo] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33612 USA	Bethune-Cookman University; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade de Sao Paulo; Instituto Nacional de Salud Publica; H Lee Moffitt Cancer Center & Research Institute	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Ctr Infect Res Canc, Tampa, FL 33612 USA.	anna.giuliano@moffitt.org	VILLA, LUISA/AAH-4761-2019	VILLA, LUISA/0000-0003-4074-2335; Giuliano, Anna R/0000-0002-5440-8859	National Cancer Institute, National Institutes of Health [R03: CA176743, R01: CA098803]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from the National Cancer Institute, National Institutes of Health (R03: CA176743, PI: Anna R. Giuliano), and the HIM Study cohort infrastructure was supported through a grant from the National Cancer Institute, National Institutes of Health (R01: CA098803, PI: Anna R. Giuliano).	Alberts CJ, 2013, SEX TRANSM DIS, V40, P508, DOI 10.1097/OLQ.0b013e318289c186; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Bagaitkar Juhi, 2008, Tob Induc Dis, V4, P12, DOI 10.1186/1617-9625-4-12; Balfour HH, 2013, J INFECT DIS, V208, P1286, DOI 10.1093/infdis/jit321; Barbosa MJ, 2010, REV SOC BRAS MED TRO, V43, P500, DOI 10.1590/S0037-86822010000500005; Beal EW, 2018, WORLD J SURG, V42, P835, DOI 10.1007/s00268-017-4194-1; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brenner N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209379; Casillas-Vega N, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0428-5; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; Fenton KA, 2001, LANCET, V358, P1851, DOI 10.1016/S0140-6736(01)06886-6; Gerbase AC, 1998, LANCET, V351, P2, DOI 10.1016/S0140-6736(98)90001-0; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; Giuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2; Gottlieb SL, 2014, VACCINE, V32, P1527, DOI 10.1016/j.vaccine.2013.07.087; Gravitz L, 2011, NATURE, V474, pS2, DOI 10.1038/474S2a; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hjalgrim H., 2007, EPIDEMIOLOGY EBV ITS; Holmes K SP., 2008, SEXUALLY TRANSMITTED, V4; Laurent R., 2005, EMC MED, V2, P265, DOI [10.1016/j.emcmed.2005.04.003, DOI 10.1016/J.EMCMED.2005.04.003]; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Rahman S, 2016, J GEN VIROL, V97, P3291, DOI 10.1099/jgv.0.000620; Rahman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167173; Summerton J, 2007, CLIN VACCINE IMMUNOL, V14, P1545, DOI 10.1128/CVI.00120-07; Torrone E, 2014, MMWR-MORBID MORTAL W, V63, P834; Vriend HJ, 2015, CANCER MED-US, V4, P1589, DOI 10.1002/cam4.496; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Woodhall SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0152810; Workowski KA, 2015, CLIN INFECT DIS, V61, pS759, DOI 10.1093/cid/civ771; Xu F., 2010, Morbidity and Mortality Weekly Report, V59, P456	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253005	10.1371/journal.pone.0253005	http://dx.doi.org/10.1371/journal.pone.0253005			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157055	gold, Green Published			2022-12-26	WOS:000671691200033
J	Harvey, D; Valkenburg, W; Amara, A				Harvey, David; Valkenburg, Wessel; Amara, Amara			Predicting malaria epidemics in Burkina Faso with machine learning	PLOS ONE			English	Article								Accurately forecasting the case rate of malaria would enable key decision makers to intervene months before the onset of any outbreak, potentially saving lives. Until now, methods that forecast malaria have involved complicated numerical simulations that model transmission through a community. Here we present the first data-driven malaria epidemic early warning system that can predict the 13-week case rate in a primary health facility in Burkina Faso. Using the extraordinarily high-fidelity data of infant consultations taken from the Integrated e-Diagnostic Approach (IeDA) system that has been rolled out throughout Burkina Faso, we train a combination of Gaussian Processes and Random Forest Regressors to estimate the weekly number of malaria cases over a 13 week period. We test our algorithm on historical epidemics and find that for our lowest threshold for an epidemic alert, our algorithm has 30% precision with > 99% recall at raising an alert. This rises to > 99% precision and 5% recall for the high alert threshold. Our two-tailed predictions have an average 1 sigma and 2 sigma precision of 5 cases and 30 cases respectively.	[Harvey, David] Leiden Univ, Lorentz Inst, Leiden, Netherlands; [Valkenburg, Wessel; Amara, Amara] Terre Des Hommes, Lausanne, Switzerland	Leiden University; Leiden University - Excl LUMC	Harvey, D (corresponding author), Leiden Univ, Lorentz Inst, Leiden, Netherlands.	harvey@lorentz.leidenuniv.nl			Cloudera Foundation; Marguerite Foundation; Delta ITP institute; Tableau Foundation	Cloudera Foundation; Marguerite Foundation; Delta ITP institute; Tableau Foundation	This work was in part funded by Cloudera Foundation, the Marguerite Foundation and the Delta ITP institute, and technically supported by Cloudera Foundation and Tableau Foundation.	Alghamdi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179805; Bakary T, 2018, J BIOL DYNAM, V12, P400, DOI 10.1080/17513758.2018.1468935; Blanchet K, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0476-5; Breiman L., 2001, MACH LEARN, V45, P5; Delahanty RJ, 2019, ANN EMERG MED, V73, P334, DOI 10.1016/j.annemergmed.2018.11.036; Fang G, 2019, J AM MED INFORM ASSN, V26, P977, DOI 10.1093/jamia/ocz036; Flaxman AD, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002702; Gadekallu TR, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9020274; Ghilardi L, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03425-z; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hammoudeh A, 2018, PROCEDIA COMPUT SCI, V141, P484, DOI 10.1016/j.procs.2018.10.138; Kalipe Godson, 2018, 2018 International Conference on Information Technology (ICIT), P33, DOI 10.1109/ICIT.2018.00019; Obabiyi OS., 2013, INT J PURE APPL MATH, V88, P125, DOI [10.12732/ijpam.v88i1.10, DOI 10.12732/IJPAM.V88I1.10, 10.12732/ijpam.v88il.10, DOI 10.12732/IJPAM.V88IL.10]; Odongo-Aginya E, 2005, Afr Health Sci, V5, P238; Organization WH, 2019, WORLD MALARIA REPORT; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reddy BG, 2020, AMCIS 2020 P; Reddy GT, 2020, EVOL INTELL, V13, P185, DOI 10.1007/s12065-019-00327-1; Rehman ZU, 2020, MED HYPOTHESES, V141, DOI 10.1016/j.mehy.2020.109705; Smith TA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025460; Thomson MC, 2005, AM J TROP MED HYG, V73, P214, DOI 10.4269/ajtmh.2005.73.214; Wiemken TL, 2020, ANNU REV PUBL HEALTH, V41, P21, DOI 10.1146/annurev-publhealth-040119-094437; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	23	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253302	10.1371/journal.pone.0253302	http://dx.doi.org/10.1371/journal.pone.0253302			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143829	gold, Green Published			2022-12-26	WOS:000671690700034
J	Hasler, RM; Rauer, T; Pape, HC; Zwahlen, M				Hasler, Rebecca M.; Rauer, Thomas; Pape, Hans-Christoph; Zwahlen, Marcel			Inter-hospital transfer of polytrauma and severe traumatic brain injury patients: Retrospective nationwide cohort study using data from the Swiss Trauma Register	PLOS ONE			English	Article							SYSTOLIC BLOOD-PRESSURE; PREHOSPITAL TRIAGE; CENTER CARE; INCREASED MORTALITY; FIELD TRIAGE; 110 MMHG; OVERTRIAGE; AGE; PROTOCOLS; SYSTEMS	Introduction Polytrauma and traumatic brain injury (TBI) patients are among the most vulnerable patients in trauma care and exhibit increased morbidity and mortality. Timely care is essential for their outcome. Severe TBI with initially high scores on the Glasgow Coma (GCS) scores is difficult to recognise on scene and referral to a Major Trauma Center (MTC) might be delayed. Therefore, we examined current referral practice, injury patterns and mortality in these patients. Materials and methods Retrospective, nationwide cohort study with Swiss Trauma Register (STR) data between 01/012015 and 31/12/2018. STR includes patients >= 16 years with an Injury Severity Score (ISS) >15 and/or an Abbreviated Injury Scale (AIS) for head >2. We performed Cox proportional hazard models with injury type as the primary outcome and mortality as the dependent variable. Secondary outcomes were inter-hospital transfer and age. Results 9,595 patients were included. Mortality was 12%. 2,800 patients suffered from isolated TBI. 69% were men. Median age was 61 years and median ISS 21. Two thirds of TBI patients had a GCS of 13-15 on admission to the Emergency Department (ED). 26% of patients were secondarily transferred to an MTC. Patients with isolated TBI and those aged >= 65 years were transferred more often. Crude analysis showed a significantly elevated hazard for death of 1.48 (95%CI 1.28-1.70) for polytrauma patients with severe TBI and a hazard ratio (HR) of 1.82 (95%CI 1.58-2.09) for isolated severe TBI, compared to polytrauma patients without TBI. Patients directly admitted to the MTC had a significantly elevated HR for death of 1.63 (95%CI 1.40-1.89), compared to those with secondary transfer. Conclusions A high initial GCS does not exclude the presence of severe TBI and triage to an MTC should be seriously considered for elderly TBI patients.	[Hasler, Rebecca M.; Rauer, Thomas; Pape, Hans-Christoph] Univ Hosp Zurich, Dept Traumatol, Zurich, Switzerland; [Hasler, Rebecca M.; Zwahlen, Marcel] Bern Univ, Inst Social & Prevent Med ISPM, Bern, Switzerland	University of Zurich; University Zurich Hospital; University of Bern	Hasler, RM (corresponding author), Univ Hosp Zurich, Dept Traumatol, Zurich, Switzerland.; Hasler, RM (corresponding author), Bern Univ, Inst Social & Prevent Med ISPM, Bern, Switzerland.	rebecca.hasler@usz.ch	Zwahlen, Marcel/AFF-8559-2022	Zwahlen, Marcel/0000-0002-6772-6346; Hasler, Rebecca Maria/0000-0002-0616-2313; Pape, Hans-Christoph/0000-0002-2059-4980	Furstlicher Kommerzienrat Guido Feger Foundation	Furstlicher Kommerzienrat Guido Feger Foundation	RMH has received funding from the Furstlicher Kommerzienrat Guido Feger Foundation.	AAAM AAAM, 2008, C ISA ADV AUT MED AB C ISA ADV AUT MED AB; [Anonymous], 2011, GUIDELINES FIELD TRI; [Anonymous], 2014, REGIONAL TRAUMA SYST; Brown J, 2017, SURG CLIN N AM, V97, P961, DOI 10.1016/j.suc.2017.06.007; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Claridge JA, 2013, SURGERY, V154, P875, DOI 10.1016/j.surg.2013.07.013; Faul M, 2012, PREHOSP EMERG CARE, V16, P222, DOI 10.3109/10903127.2011.615013; Follin A, 2016, INJURY, V47, P1555, DOI 10.1016/j.injury.2016.04.024; Gomez D, 2012, J TRAUMA ACUTE CARE, V73, P1288, DOI 10.1097/TA.0b013e318265cec2; Gupta R, 2010, J TRAUMA, V69, P253, DOI 10.1097/TA.0b013e3181e4d579; Haas B, 2010, J AM COLL SURGEONS, V211, P804, DOI 10.1016/j.jamcollsurg.2010.08.014; Hasler R., 2012, EUR SPINE J, V21, P2384; Hasler RM, 2014, J TRAUMA ACUTE CARE, V77, P757, DOI 10.1097/TA.0000000000000452; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hasler RM, 2011, RESUSCITATION, V82, P1202, DOI 10.1016/j.resuscitation.2011.04.021; Jensen KO., 2020, EUR J TRAUMA EMERG S; Kondo Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10348; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lefering R, 2009, EUR J TRAUMA EMERG S, V35, P437, DOI 10.1007/s00068-009-9122-0; Lehmann R, 2009, ARCH SURG-CHICAGO, V144, P853, DOI 10.1001/archsurg.2009.153; Lehmann R, 2009, AM J SURG, V197, P571, DOI 10.1016/j.amjsurg.2008.12.037; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2003, J TRAUMA, V55, P444, DOI 10.1097/01.TA.0000047809.64699.59; Newgard CD, 2013, HEALTH AFFAIR, V32, P1591, DOI 10.1377/hlthaff.2012.1142; Rogers A, 2012, AM SURGEON, V78, P711; Rogers FB, 1999, J TRAUMA, V46, P328, DOI 10.1097/00005373-199902000-00022; Ruge T, 2020, UPSALA J MED SCI, V125, P58, DOI 10.1080/03009734.2019.1706674; Sartorius D, 2010, CRIT CARE MED, V38, P831, DOI 10.1097/CCM.0b013e3181cc4a67; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Staudenmayer K, 2016, J TRAUMA ACUTE CARE, V80, P412, DOI 10.1097/TA.0000000000000956; TEASDALE G, 1974, LANCET, V2, P81; van Olden GDJ, 2004, AM J EMERG MED, V22, P522, DOI 10.1016/j.ajem.2004.08.013; van Rein EAJ, 2017, J TRAUMA ACUTE CARE, V83, P328, DOI 10.1097/TA.0000000000001516	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253504	10.1371/journal.pone.0253504	http://dx.doi.org/10.1371/journal.pone.0253504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143842	Green Published, gold, Green Accepted			2022-12-26	WOS:000671690700030
J	Inoue, K; Kashima, S				Inoue, Kazuo; Kashima, Saori			Association of the past epidemic of Mycobacterium tuberculosis with mortality and incidence of COVID-19	PLOS ONE			English	Article							BCG VACCINATION; PREVENTION; INFECTION	The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has created a remarkable and varying impact in every country, inciting calls for broad attention. Recently, the Bacillus Calmette-Guerin (BCG) vaccination has been regarded as a potential candidate to explain this difference. Herein, we hypothesised that the past epidemic of Mycobacterium tuberculosis (M. tuberculosis) may act as a latent explanatory factor for the worldwide differences seen in COVID-19 impact on mortality and incidence. We compared two indicators of past epidemic of M. tuberculosis, specifically, incidence (90 countries in 1990) and mortality (28 countries in 1950), with the mortality and incidence of COVID-19. We determined that an inverse relationship existed between the past epidemic indicators of M. tuberculosis and current COVID-19 impact. The rate ratio of the cumulative COVID-19 mortality per 1 million was 2.70 (95% confidence interval [CI]: 1.09-6.68) per 1 unit decrease in the incidence rate of tuberculosis (per 100,000 people). The rate ratio of the cumulative COVID-19 incidence per 1 million was 2.07 (95% CI: 1.30-3.30). This association existed even after adjusting for potential confounders (rate of people aged 65 over, diabetes prevalence, the mortality rate from cardiovascular disease, and gross domestic product per capita), leading to an adjusted rate ratio of COVID-19 mortality of 2.44, (95% CI: 1.32-4.52) and a COVID-19 incidence of 1.31 (95% CI: 0.97-1.78). After latent infection, Mycobacterium survives in the human body and may continue to stimulate trained immunity. This study suggests a possible mechanism underlying the region-based variation in the COVID-19 impact.	[Inoue, Kazuo] Teikyo Univ, Chiba Med Ctr, Dept Community Med, Sch Med, Ichihara, Chiba, Japan; [Kashima, Saori] Hiroshima Univ, Grad Sch Adv Sci & Engn, Environm Hlth Sci Lab, Higashihiroshima, Hiroshima, Japan	Teikyo University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Grad Sch Adv Sci & Engn, Environm Hlth Sci Lab, Higashihiroshima, Hiroshima, Japan.	kashima@hiroshima-u.ac.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191				Arnesen TM, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01123-2018; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; COLDITZ GA, 1995, PEDIATRICS, V96, P29; Committee on Government Operations United States Congress Senate, 1959, STAT WORLD HLTH OUTL STAT WORLD HLTH OUTL, P10; De Vrieze J., 2020, SCIENCE; Global Note, TUBERCULOSIS INCIDEN; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; Inoue K, 2001, INT J TUBERC LUNG D, V5, P873; Japan Anti-Tuberculosis Association, 2016, STAT TB JAP 2016 STAT TB JAP 2016, P127; Joy M, 2021, CLIN EPIDEMIOL GLOB, V9, P202, DOI 10.1016/j.cegh.2020.08.015; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Kim JH, 2015, EMERG INFECT DIS, V21, P1913, DOI 10.3201/eid2111.141894; Lowell AM, 1976, TUBERCULOSIS WORLD T; Madan M, 2020, PUBLIC HEALTH, V185, P91, DOI 10.1016/j.puhe.2020.05.042; Mori T, 2000, EMERG INFECT DIS, V6, P566, DOI 10.3201/eid0606.000602; Murray JF, 2018, TUBERCULOSIS WAR LES; Redelman-Sidi G, 2020, NAT REV UROL, V17, P316, DOI 10.1038/s41585-020-0325-9; Ritchie H., 2020, OURWORLD DATA; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Sharma A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2720-9; Swinscow TDV, 1997, STAT SQUARE ONE, VNinth; Takamatsu I, 1999, JAPANESE J PEDIAT PU, V10, P77; WHO, 2020, TUBERCULOSIS; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; World Health Organization Regional Office for Africa, 2020, 8 WHO REG OFF AFR 8 WHO REG OFF AFR; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	26	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253169	10.1371/journal.pone.0253169	http://dx.doi.org/10.1371/journal.pone.0253169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143810	gold, Green Submitted, Green Published			2022-12-26	WOS:000671690700072
J	Oh, H				Oh, HyungSeon			Distributed optimal power flow	PLOS ONE			English	Article								Objective The objectives of this paper are to 1) construct a new network model compatible with distributed computation, 2) construct the full optimal power flow (OPF) in a distributed fashion so that an effective, non-inferior solution can be found, and 3) develop a scalable algorithm that guarantees the convergence to a local minimum. Existing challenges Due to the nonconvexity of the problem, the search for a solution to OPF problems is not scalable, which makes the OPF highly limited for the system operation of large-scale real-world power grids-"the curse of dimensionality". The recent attempts at distributed computation aim for a scalable and efficient algorithm by reducing the computational cost per iteration in exchange of increased communication costs. Motivation A new network model allows for efficient computation without increasing communication costs. With the network model, recent advancements in distributed computation make it possible to develop an efficient and scalable algorithm suitable for large-scale OPF optimizations. Methods We propose a new network model in which all nodes are directly connected to the center node to keep the communication costs manageable. Based on the network model, we suggest a nodal distributed algorithm and direct communication to all nodes through the center node. We demonstrate that the suggested algorithm converges to a local minimum rather than a point, satisfying the first optimality condition. Results The proposed algorithm identifies solutions to OPF problems in various IEEE model systems. The solutions are identical to those using a centrally optimized and heuristic approach. The computation time at each node does not depend on the system size, and N-iter does not increase significantly with the system size. Conclusion Our proposed network model is a star network for maintaining the shortest node-to-node distances to allow a linear information exchange. The proposed algorithm guarantees the convergence to a local minimum rather than a maximum or a saddle point, and it maintains computational efficiency for a large-scale OPF, scalable algorithm.	[Oh, HyungSeon] US Naval Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA	United States Department of Defense; United States Navy; United States Naval Academy	Oh, H (corresponding author), US Naval Acad, Dept Elect & Comp Engn, Annapolis, MD 21402 USA.	hoh@usna.edu						Abboud A, 2014, INT CONF ACOUST SPEE; Bauschke HH, 2017, MATH OPER RES, V42, P330, DOI 10.1287/moor.2016.0817; Chakrabarti S, 2014, CLEM UNIV POWER SYST; Dall'Anese E, 2013, IEEE T SMART GRID, V4, P1464, DOI 10.1109/TSG.2013.2248175; Engelmann A, 2019, IEEE T POWER SYST, V34, P584, DOI 10.1109/TPWRS.2018.2867682; Erseghe T., DISTRIBUTED PROCESSI; Erseghe T, 2014, IEEE T POWER SYST, V29, P2370, DOI 10.1109/TPWRS.2014.2306495; Gan LW, 2015, IEEE T AUTOMAT CONTR, V60, P72, DOI 10.1109/TAC.2014.2332712; GRANT M., CVX MATLAB SOFTWARE; Guo J., 2017, IEEE T POWER SYST, DOI [10.1109/TPWRS.2016.2613479, DOI 10.1109/TPWRS.2016.2613479]; Guo JY, 2016, IEEE T SMART GRID, V7, P1249, DOI 10.1109/TSG.2015.2490553; Kraning Matt, 2014, Foundations and Trends in Optimization, V1, P73, DOI 10.1561/2400000002; Loukarakis E, 2015, IEEE T POWER SYST, V30, P2566, DOI 10.1109/TPWRS.2014.2365959; Madani R, 2015, IEEE DECIS CONTR P, P5932, DOI 10.1109/CDC.2015.7403152; Molzahn DK, 2017, IEEE T SMART GRID, V8, P2941, DOI 10.1109/TSG.2017.2720471; Molzahn DK, 2013, IEEE T POWER SYST, V28, P3987, DOI 10.1109/TPWRS.2013.2258044; Ng AY, 2002, ADV NEUR IN, V14, P849; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; Oh H, 2019, ENERGIES, V12, DOI 10.3390/en12122425; Peng Q., 2016, IEEE T SMART GRID, DOI [10.1109/TSG.2016.2546305, DOI 10.1109/TSG.2016.2546305]; Peng QY, 2014, IEEE DECIS CONTR P, P167, DOI 10.1109/CDC.2014.7039376; Scutari G., 2018, LECT NOTES MATH, DOI [10.1007/978-3-319-97142-1%5F3, DOI 10.1007/978-3-319-97142-1%5F3]; Sun AX, 2013, IEEE POW ENER SOC GE; Vandenberghe L., 2005, LECT NOTES CONTROL I, DOI [10.1007/10997703%5F12, DOI 10.1007/10997703%5F12]; Verma DB, ARXIV151207315; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang YM, 2017, ELECTR POW SYST RES, V144, P127, DOI 10.1016/j.epsr.2016.11.025; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang M, 2019, ELECTR POW SYST RES, V174, DOI 10.1016/j.epsr.2019.105867; Zheng WY, 2016, IEEE T SMART GRID, V7, P1021, DOI 10.1109/TSG.2015.2396493; Zimmerman RD, 2011, IEEE T POWER SYST, V26, P12, DOI 10.1109/TPWRS.2010.2051168	31	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0251948	10.1371/journal.pone.0251948	http://dx.doi.org/10.1371/journal.pone.0251948			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143782	gold, Green Submitted, Green Published			2022-12-26	WOS:000671690700038
J	Schwiertz, G; Bauer, J; Muehlbauer, T				Schwiertz, Gerrit; Bauer, Julian; Muehlbauer, Thomas			Upper Quarter Y Balance test performance: Normative values for healthy youth aged 10 to 17 years	PLOS ONE			English	Article							FUNDAMENTAL MOVEMENT; PUBERTAL CHANGES; DYNAMIC BALANCE; RELIABILITY; PATTERN; GROWTH	Background The Upper Quarter Y Balance test (YBT-UQ) is a field test for measuring shoulder mobility/stability. However, there is a lack of information regarding age- and sex-specific reference values for classifying the YBT-UQ performance of children and adolescents. Objective The aim was to investigate YBT-UQ performance in youth and to provide age- and sex-specific normative values. Method Six hundred and sixty-five persons (325 girls, 340 boys) aged between 10 and 17 years carried out the YBT-UQ test. Following this, maximum reach values, normalised in terms of arm length, were calculated for each arm (i.e., left and right) and reach direction (i.e., medial [MD], inferolateral [IL], superolateral [SL]), and the composite score (CS) per arm. Additionally, percentiles were displayed graphically and in tabular form, distinguished according to age and gender. Results In boys, those aged 14-15 years showed a higher achievement (e.g., MD direction) compared with both younger (12-13-year-olds) and older (16-17-year-olds) persons. In girls, differences related to age could only be observed for the IL direction and the CS, where the youngest age group (10-11-year-olds) achieved better results than the older groups. Sex-specific differences to the girls' advantage could be observed in 12-13-year-olds (i.e., SL and CS), and to the boys' advantage in 14-15-year-olds (i.e., for all reach directions) and 16-17-year-olds (i.e., IL and SL direction and CS). Further, curvilinear developments were observed with regard to the 10(th), 50(th), and 90(th) percentiles, and were more strongly marked in boys than in girls. Conclusions The obtained age- and sex-specific normative values for the YBT-UQ can be used by teachers, coaches, and therapists to classify the level of shoulder mobility/stability among 10-17 year-old children and adolescents.	[Schwiertz, Gerrit; Bauer, Julian; Muehlbauer, Thomas] Univ Duisburg Essen, Div Movement & Training Sci Biomech Sport, Essen, Germany	University of Duisburg Essen	Schwiertz, G (corresponding author), Univ Duisburg Essen, Div Movement & Training Sci Biomech Sport, Essen, Germany.	gerrit.schwiertz@uni-due.de						Borms D, 2018, INT J SPORTS MED, V39, P433, DOI 10.1055/a-0573-1388; Bullock GS, 2017, J STRENGTH COND RES, V31, P1544, DOI 10.1519/JSC.0000000000001627; Butler R, 2014, J ATHL TRAINING, V49, P442, DOI 10.4085/1062-6050-49.3.17; CAMERON N, 1982, ANN HUM BIOL, V9, P211, DOI 10.1080/03014468200005701; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cramer J, 2017, INT J SPORTS PHYS TH, V12, P117; Gorman PP, 2012, J STRENGTH COND RES, V26, P3043, DOI 10.1519/JSC.0b013e3182472fdb; Kim Y, 2020, PHYS THER SPORT, V42, P53, DOI 10.1016/j.ptsp.2019.12.007; Krysak S, 2019, INT J SPORTS PHYS TH, V14, P537, DOI 10.26603/ijspt20190537; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; MALINA RM, 1988, ANNU REV ANTHROPOL, V17, P187, DOI 10.1146/annurev.an.17.100188.001155; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; Plisky PJ., 2010, Y BALANCE TEST HOME; Schwiertz G, 2020, BMC SPORTS SCI MED R, V12, DOI 10.1186/s13102-020-00220-w; Schwiertz G, 2019, INT J SPORTS PHYS TH, V14, P927, DOI 10.26603/ijspt20190927; TANNER JM, 1985, J PEDIATR-US, V107, P317, DOI 10.1016/S0022-3476(85)80501-1; Tanner JM., 1982, NORMAL VARIATION GRO; Taylor JB, 2016, J SPORT REHABIL, V25, P146, DOI [10-1123/jsr.2014-0296, 10.1123/jsr.2014-0296]; Teyhen DS, 2020, SPORTS HEALTH, V12, P564, DOI 10.1177/1941738120902991; Teyhen DS, 2014, MIL MED, V179, P413, DOI 10.7205/MILMED-D-13-00362; Westrick RB, 2012, INT J SPORTS PHYS TH, V7, P139	22	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253144	10.1371/journal.pone.0253144	http://dx.doi.org/10.1371/journal.pone.0253144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143826	gold, Green Published			2022-12-26	WOS:000671690700027
J	Shatov, VM; Sluchanko, NN; Gusev, NB				Shatov, Vladislav M.; Sluchanko, Nikolai N.; Gusev, Nikolai B.			Replacement of Arg in the conserved N-terminal RLFDQxFG motif affects physico-chemical properties and chaperone-like activity of human small heat shock protein HspB8 (Hsp22)	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; MAMMALIAN HSP22; DOMAIN; PHOSPHORYLATION; RECOGNITION; SUPERFAMILY; MECHANISMS; SEQUENCES; MEMBER; H11	The small heat shock protein (sHsp) called HspB8 (formerly, Hsp22) is one of the least typical sHsp members, whose oligomerization status remains debatable. Here we analyze the effect of mutations in a highly conservative sequence located in the N-terminal domain of human HspB8 on its physico-chemical properties and chaperone-like activity. According to size-exclusion chromatography coupled to multi-angle light scattering, the wild type (WT) HspB8 is present as dominating monomeric species (similar to 24 kDa) and a small fraction of oligomers (similar to 60 kDa). The R29A amino acid substitution leads to the predominant formation of 60-kDa oligomers, leaving only a small fraction of monomers. Deletion of the 28-32 pentapeptide (Delta mutant) results in the formation of minor quantities of dimers (similar to 49 kDa) and large quantities of the 24-kDa monomers. Both the WT protein and its Delta mutant efficiently bind a hydrophobic probe bis-ANS and are relatively rapidly hydrolyzed by chymotrypsin, whereas the R29A mutant weakly binds bis-ANS and resists chymotrypsinolysis. In contrast to HspB8 WT and its Delta mutant, which are well phosphorylated by cAMP-dependent and ERK1 protein kinases, the R29A mutant is poorly phosphorylated. R29A mutation affects the chaperone-like activity of HspB8 measured in vitro. It is concluded that the irreplaceable Arg residue located in the only highly conservative motif in the N-terminal domain of all sHsp proteins affects the oligomeric structure and key properties of HspB8.	[Shatov, Vladislav M.; Gusev, Nikolai B.] Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow, Russia; [Sluchanko, Nikolai N.] Russian Acad Sci, Fed Res Ctr Biotechnol, AN Bach Inst Biochem, Moscow, Russia	Lomonosov Moscow State University; Research Center of Biotechnology RAS; Russian Academy of Sciences	Gusev, NB (corresponding author), Moscow MV Lomonosov State Univ, Sch Biol, Dept Biochem, Moscow, Russia.	NBGusev@mail.ru	Sluchanko, Nikolai/R-4110-2016; Shatov, Vladislav/AAN-6976-2020	Sluchanko, Nikolai/0000-0002-8608-1416; 	Russian Foundation for Basic Science [19-04-00038]; Program of the Russian Ministry of Science and Higher Education; Interdisciplinary Scientific and Educational School of Moscow University	Russian Foundation for Basic Science(Russian Foundation for Basic Research (RFBR)); Program of the Russian Ministry of Science and Higher Education; Interdisciplinary Scientific and Educational School of Moscow University	This investigation was supported by Russian Foundation for Basic Science (grant 1904-00038). MALS was done at the Shared-Access Equipment Centre "Industrial Biotechnology" of the Federal Research Center "Fundamentals of Biotechnology" of the Russian Academy of Sciences and was partially supported by the Program of the Russian Ministry of Science and Higher Education (N.N.S.). This research has been supported by the Interdisciplinary Scientific and Educational School of Moscow University << Molecular Technologies of the Living Systems and Synthetic Biology >>. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alderson TR, 2020, J MOL BIOL, V432, P3033, DOI 10.1016/j.jmb.2020.02.003; Alderson TR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08557-8; Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Benndorf R, 2001, J BIOL CHEM, V276, P26753, DOI 10.1074/jbc.M103001200; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Clark AR, 2018, J MOL BIOL, V430, P3297, DOI 10.1016/j.jmb.2018.06.047; Clouser AF, 2019, ELIFE, V8, DOI 10.7554/eLife.50259; Cristofani R, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020335; Delbecq SP, 2015, BIOCHEMISTRY-US, V54, P4276, DOI 10.1021/acs.biochem.5b00490; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Fontaine JM, 2003, CELL STRESS CHAPERON, V8, P62, DOI 10.1379/1466-1268(2003)8<62:TSODFP>2.0.CO;2; Fuchs M, 2010, BIOCHEM J, V425, P245, DOI 10.1042/BJ20090907; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Heirbaut M, 2017, J BIOL CHEM, V292, P9944, DOI 10.1074/jbc.M116.773515; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Janowska MK, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a034025; Jehle S, 2011, P NATL ACAD SCI USA, V108, P6409, DOI 10.1073/pnas.1014656108; Kaiser CJO, 2019, NAT STRUCT MOL BIOL, V26, P1141, DOI 10.1038/s41594-019-0332-9; Kappe G, 2003, CELL STRESS CHAPERON, V8, P53, DOI 10.1379/1466-1268(2003)8<53:THGECS>2.0.CO;2; Kasakov AS, 2007, FEBS J, V274, P5628, DOI 10.1111/j.1742-4658.2007.06086.x; Kazakov AS, 2009, BIOPHYS CHEM, V145, P79, DOI 10.1016/j.bpc.2009.09.003; Kim MV, 2006, ARCH BIOCHEM BIOPHYS, V454, P32, DOI 10.1016/j.abb.2006.07.014; Kim MV, 2004, BIOCHEM BIOPH RES CO, V315, P796, DOI 10.1016/j.bbrc.2004.01.130; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Mymrikov EV, 2017, J BIOL CHEM, V292, P672, DOI 10.1074/jbc.M116.760413; Mymrikov EV, 2012, CELL STRESS CHAPERON, V17, P157, DOI 10.1007/s12192-011-0296-0; Mymrikov EV, 2010, CELL STRESS CHAPERON, V15, P365, DOI 10.1007/s12192-009-0151-8; PERRIE WT, 1970, BIOCHEM J, V119, P31, DOI 10.1042/bj1190031; Shatov VM, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124248; Shatov VM, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072112; Shemetov AA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P200, DOI 10.1134/S0006297908020120; Shemetov AA, 2011, ARCH BIOCHEM BIOPHYS, V513, P1, DOI 10.1016/j.abb.2011.06.014; Shemetov AA, 2011, MOL CELL BIOCHEM, V355, P47, DOI 10.1007/s11010-011-0837-y; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Vos MJ, 2009, BBA-MOL CELL RES, V1793, P1343, DOI 10.1016/j.bbamcr.2009.05.005; Waters ER, 2020, NEW PHYTOL, V227, P24, DOI 10.1111/nph.16536; Webster JM, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01047; Yu CY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23338-y; Zobel ATC, 2003, HUM MOL GENET, V12, P1609, DOI 10.1093/hmg/ddg173	45	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253432	10.1371/journal.pone.0253432	http://dx.doi.org/10.1371/journal.pone.0253432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143841	gold, Green Published			2022-12-26	WOS:000671690700020
J	Zhao, SL; Guan, BJ; Mi, YS; Shi, DB; Wei, P; Gu, YZ; Cai, SJ; Xu, Y; Li, XX; Yan, DW; Huang, MZ; Li, DW				Zhao, Senlin; Guan, Bingjie; Mi, Yushuai; Shi, Debing; Wei, Ping; Gu, Yanzi; Cai, Sanjun; Xu, Ye; Li, Xinxiang; Yan, Dongwang; Huang, Mingzhu; Li, Dawei			LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit	ONCOGENE			English	Article								Glycolysis plays a crucial role in reprogramming the metastatic tumor microenvironment. A series of lncRNAs have been identified to function as oncogenic molecules by regulating glycolysis. However, the roles of glycolysis-related lncRNAs in regulating colorectal cancer liver metastasis (CRLM) remain poorly understood. In the present study, the expression of the glycolysis-related lncRNA MIR17HG gradually increased from adjacent normal to CRC to the paired liver metastatic tissues, and high MIR17HG expression predicted poor survival, especially in patients with liver metastasis. Functionally, MIR17HG promoted glycolysis in CRC cells and enhanced their invasion and liver metastasis in vitro and in vivo. Mechanistically, MIR17HG functioned as a ceRNA to regulate HK1 expression by sponging miR-138-5p, resulting in glycolysis in CRC cells and leading to their invasion and liver metastasis. More interestingly, lactate accumulated via glycolysis activated the p38/Elk-1 signaling pathway to promote the transcriptional expression of MIR17HG in CRC cells, forming a positive feedback loop, which eventually resulted in persistent glycolysis and the invasion and liver metastasis of CRC cells. In conclusion, the present study indicates that the lactate-responsive lncRNA MIR17HG, acting as a ceRNA, promotes CRLM through a glycolysis-mediated positive feedback circuit and might be a novel biomarker and therapeutic target for CRLM.	[Zhao, Senlin; Shi, Debing; Cai, Sanjun; Xu, Ye; Li, Xinxiang; Li, Dawei] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China; [Zhao, Senlin; Shi, Debing; Wei, Ping; Cai, Sanjun; Xu, Ye; Li, Xinxiang; Huang, Mingzhu; Li, Dawei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China; [Guan, Bingjie; Yan, Dongwang] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China; [Mi, Yushuai] Shandong Univ, Hosp 2, Cheeloo Coll Med, Dept Gastrointestinal Surg, Jinan, Peoples R China; [Wei, Ping] Fudan Univ, Canc Inst, Shanghai Canc Ctr, Shanghai, Peoples R China; [Wei, Ping] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China; [Gu, Yanzi] Fudan Univ, Shanghai Canc Ctr, Dept Biobank, Shanghai, Peoples R China; [Huang, Mingzhu] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University; Shandong University; Fudan University; Fudan University; Fudan University; Fudan University	Li, DW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China.; Huang, MZ; Li, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.; Yan, DW (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Gen Surg, Shanghai, Peoples R China.; Huang, MZ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China.	yandw70@163.com; mingzhuhuang0718@163.com; li_dawei@fudan.edu.cn	xu, ye/GQO-8972-2022		National Nature Science Foundation of China [81772583, 81871931, 81802420, 81972293, 82003088]; Shanghai Sailing Program [19YF1409600]; Nature Science Foundation of Shandong Province [ZR2019PH008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Nature Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This research was supported by grants from the National Nature Science Foundation of China (81772583, 81871931, 81802420, 81972293, 82003088), Shanghai Sailing Program (19YF1409600), the Nature Science Foundation of Shandong Province (ZR2019PH008).	Alspach E, 2014, CANCER DISCOV, V4, P716, DOI 10.1158/2159-8290.CD-13-0743; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen C, 2019, ONCOGENE, V38, P4527, DOI 10.1038/s41388-019-0735-4; Chen F, 2019, NAT CELL BIOL, V21, P498, DOI 10.1038/s41556-019-0299-0; Chen JA, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0947-9; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Fakih MG, 2015, J CLIN ONCOL, V33, P1809, DOI 10.1200/JCO.2014.59.7633; Ganesh K, 2019, NAT REV GASTRO HEPAT, V16, P361, DOI 10.1038/s41575-019-0126-x; Graziano F, 2017, PHARMACOGENOMICS J, V17, P258, DOI 10.1038/tpj.2016.13; He D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13911-x; Hu QS, 2019, NAT IMMUNOL, V20, P835, DOI 10.1038/s41590-019-0400-7; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Ippolito L, 2019, TRENDS BIOCHEM SCI, V44, P153, DOI 10.1016/j.tibs.2018.10.011; Jiao Lin, 2018, Autophagy, V14, P671, DOI 10.1080/15548627.2017.1381804; Koutsioumpa M, 2019, GUT, V68, P1271, DOI 10.1136/gutjnl-2017-315690; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Lee HJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10374-y; Lee YS, 2018, CELL HOST MICROBE, V24, P833, DOI 10.1016/j.chom.2018.11.002; Li Q, 2019, HEPATOLOGY, V70, P1298, DOI 10.1002/hep.30671; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Liu QH, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-020-01021-x; Miranda-Goncalves V, 2013, NEURO-ONCOLOGY, V15, P172, DOI 10.1093/neuonc/nos298; Olivero CE, 2020, MOL CELL, V77, P761, DOI 10.1016/j.molcel.2019.12.014; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Puccini A, 2018, NAT REV CLIN ONCOL, V15, P77, DOI 10.1038/nrclinonc.2017.185; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Rapino F, 2018, NATURE, V558, P605, DOI 10.1038/s41586-018-0243-7; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Wei S, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1112-3; Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005; Xiao GA, 2019, EUR UROL, V76, P315, DOI 10.1016/j.eururo.2018.11.012; Xie LYJ, 2019, CELL CYCLE, V18, P2110, DOI 10.1080/15384101.2019.1641388; Xu J, 2019, CANCER RES, V79, P4882, DOI 10.1158/0008-5472.CAN-18-3880; Zhao X, 2020, AUTOPHAGY, V16, P70, DOI 10.1080/15548627.2019.1598750; Zhuang M, 2019, EBIOMEDICINE, V41, P286, DOI 10.1016/j.ebiom.2018.12.049; Zhuo W, 2019, GASTROENTEROLOGY, V156, P676, DOI 10.1053/j.gastro.2018.10.054	40	16	16	5	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4709	4724		10.1038/s41388-021-01859-6	http://dx.doi.org/10.1038/s41388-021-01859-6		JUN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34145399	Green Published, hybrid			2022-12-26	WOS:000663295300004
J	Alonso-Maranon, J; Villanueva, A; Piulats, JM; Martinez-Iniesta, M; Sole, L; Martin-Liberal, J; Segura, S; Pujol, RM; Iglesias, M; Bigas, A; Gallardo, F; Espinosa, L				Alonso-Maranon, Josune; Villanueva, Alberto; Piulats, Josep Maria; Martinez-Iniesta, Maria; Sole, Laura; Martin-Liberal, Juan; Segura, Sonia; Pujol, Ramon M.; Iglesias, Mar; Bigas, Anna; Gallardo, Fernando; Espinosa, Lluis			Combination of chemotherapy with BRAF inhibitors results in effective eradication of malignant melanoma by preventing ATM-dependent DNA repair	ONCOGENE			English	Article								Invasive malignant melanoma (MM) is an aggressive tumor with no curative therapy in advanced stages. Chemotherapy has not demonstrated its efficacy in MM and current treatment for tumors carrying the most frequent BRAFV600E mutation consists of BRAF inhibitors alone or in combination with MAPK pathway inhibitors. We previously found that BRAF inhibition prevents activation of the DNA-damage repair (DDR) pathway in colorectal cancer thus potentiating the effect of chemotherapy. We now show that different chemotherapy agents inflict DNA damage in MM cells, which is efficiently repaired, associated with activation of the ATM-dependent DDR machinery. Pharmacologic inhibition of BRAF impairs ATM and DDR activation in these cells, leading to sustained DNA damage. Combination treatments involving DNA-damaging agents and BRAF inhibitors increase tumor cell death in vitro and in vivo, and impede MM regrowth after treatment cessation. We propose to reconsider the use of chemotherapy in combination with BRAF inhibitors for MM treatment.	[Alonso-Maranon, Josune; Sole, Laura; Bigas, Anna; Espinosa, Lluis] CIBERONC, Stem Cells & Canc Res Lab IMIM, Barcelona, Spain; [Alonso-Maranon, Josune; Sole, Laura; Pujol, Ramon M.; Bigas, Anna; Gallardo, Fernando; Espinosa, Lluis] Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain; [Villanueva, Alberto; Martinez-Iniesta, Maria] IDIBELL, Grp Chemoresistance & Predict Factors, Subprogram Canc Therapeut Resistance ProCURE, ICO,Oncobell Program, Barcelona, Spain; [Piulats, Josep Maria; Martin-Liberal, Juan] CIBERONC, Med Oncol Dept, Catalan Inst Canc ICO, IDIBELL OncoBell, Barcelona, Spain; [Segura, Sonia; Pujol, Ramon M.; Gallardo, Fernando] Inst Hosp del Mar Investigac Med IMIM, Dept Dermatol, Barcelona, Spain; [Segura, Sonia; Pujol, Ramon M.; Gallardo, Fernando] Univ Autonoma Barcelona, Barcelona, Spain; [Iglesias, Mar] Univ Autonoma Barcelona, Inst Mar Investigac Med, Dept Pathol, CIBERONC, Barcelona, Spain; [Bigas, Anna] Inst Josep Carreras Leucemia IJC, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC	Bigas, A; Espinosa, L (corresponding author), CIBERONC, Stem Cells & Canc Res Lab IMIM, Barcelona, Spain.; Bigas, A; Gallardo, F; Espinosa, L (corresponding author), Hosp del Mar Med Res Inst IMIM, Canc Res Program, Barcelona, Spain.; Villanueva, A (corresponding author), IDIBELL, Grp Chemoresistance & Predict Factors, Subprogram Canc Therapeut Resistance ProCURE, ICO,Oncobell Program, Barcelona, Spain.; Gallardo, F (corresponding author), Inst Hosp del Mar Investigac Med IMIM, Dept Dermatol, Barcelona, Spain.; Gallardo, F (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.; Bigas, A (corresponding author), Inst Josep Carreras Leucemia IJC, Barcelona, Spain.	avillanueva@iconcologia.net; abigas@imim.es; fgallardo@parcdesalutmar.cat; lespinosa@imim.es	Piulats, Josep M/F-2862-2019	Piulats, Josep M/0000-0002-3606-1724; Sole Font, Laura/0000-0002-3195-0565; Alonso, Josune/0000-0001-6783-5166; Martinez-Iniesta, Maria/0000-0001-6252-6671; Bigas, Anna/0000-0003-4801-6899	Instituto de Salud Carlos III FEDER [PI19/00013, PI19/01320, PI19/01210]; Generalitat de Catalunya [2017SGR135]; Pla Director d'Oncologia de Catalunya (XBTC); Fundacion hna; Javier Lamas Miralles grant	Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission); Generalitat de Catalunya(Generalitat de Catalunya); Pla Director d'Oncologia de Catalunya (XBTC); Fundacion hna; Javier Lamas Miralles grant	We want to thank the Bigas' and Espinosa's lab members for constructive discussions and suggestions and technical support. This work was funded by grants from Instituto de Salud Carlos III FEDER PI19/00013 to LE, PI19/01320 to AV and PI19/01210 to JM-L, Generalitat de Catalunya 2017SGR135 and the "Xarxa de Bancs de tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC) and Fundacion hna to AV research team in the development of orthoxenografts/PDOX. JA-M is a recipient of Javier Lamas Miralles grant.	Buecher B, 2010, FAM CANCER, V9, P663, DOI 10.1007/s10689-010-9379-9; Colombino M, 2012, J CLIN ONCOL, V30, P2522, DOI 10.1200/JCO.2011.41.2452; Colomer C, 2019, MOL CELL, V75, P669, DOI 10.1016/j.molcel.2019.05.036; Colomer C, 2018, BRIT J CANCER, V118, P839, DOI 10.1038/bjc.2017.459; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gallardo F, 2015, ONCOTARGET, V6, P9284, DOI 10.18632/oncotarget.3252; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Luke JJ, 2013, CLIN DERMATOL, V31, P290, DOI 10.1016/j.clindermatol.2012.08.016; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Margalef P, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005886; Margalef P, 2012, CELL REP, V2, P840, DOI 10.1016/j.celrep.2012.08.028; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Nogueira C, 2010, ONCOGENE, V29, P6222, DOI 10.1038/onc.2010.349; Planchard D, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.107; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Robb R, 2019, CLIN CANCER RES, V25, P4749, DOI 10.1158/1078-0432.CCR-18-3625; Schreck KC, 2018, ONCOLOGY-NY, V32, P555; Toll A, 2015, ARCH DERMATOL RES, V307, P721, DOI 10.1007/s00403-015-1579-6; Wilson MA, 2016, CANCER TREAT RES, V167, P209, DOI 10.1007/978-3-319-22539-5_8; Zaman A, 2019, CANCERS, V11, DOI 10.3390/cancers11081197; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982	23	1	1	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					5042	5048		10.1038/s41388-021-01879-2	http://dx.doi.org/10.1038/s41388-021-01879-2		JUN 2021	7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34140639				2022-12-26	WOS:000662838900006
J	Begy, RC; Savin, CF; Kelemen, S; Veres, D; Muntean, OL; Malos, CV; Kovacs, T				Begy, Robert-Csaba; Savin, Codrin F.; Kelemen, Szabolcs; Veres, Daniel; Muntean, Octavian-Liviu; Malos, Cristian, V; Kovacs, Tibor			Investigation of the effect of anthropogenic land use on the Panazii Lake (Romania) catchment area using Cs-137 and Pb-210 radionuclides	PLOS ONE			English	Article							TRANSYLVANIAN PLAIN; SOIL CONSERVATION; EROSION RATES; DEPOSITION; SEDIMENTS; CARBONATE; IGNITION; MODEL	The problem of soil degradation has accentuated over recent decades. Aspects related to soil erosion and its relation to changes in land use as well as anthropogenic influence constitute a topic of great interest. The current study is focused on a soil erosion assessment in relation to land use activities in the Panazii Lake catchment area. Fallout radionuclides were used to provide information on soil erosion as well as redistribution rates and patterns. Variations in the sedimentation rate of the lake were also investigated as these reflect periods in which massive erosion events occurred in the lake catchment area. The novelty of this study is the construction of a timescale with regard to the soil erosion events to better understand the relationship between soil erosion and land use activities. In this study, 10 soil profiles and one sediment core from the lake were taken. Soil parameters were determined for each sample. The activities of Pb-210, Cs-137 and Ra-226 were measured by gamma spectroscopy. For low Pb-210 activities, measurements via Po-210 using an alpha spectrometer were performed. Soil erosion rates were determined by the Cs-137 method and the sedimentation rate calculated by the Constant Rate of Supply (CRS) model. A soil erosion rate of 13.5 t center dot ha(-1)center dot yr(-1) was obtained. Three distinct periods could be observed in the evolution of the sedimentation rate. For the first period, between 1880 and 1958, the average deposition rate was 9.2 tons/year, followed by a high deposition period (1960-1991) of 29.6 tons/year and a third period, consisting of the last 30 years, during which the sedimentation rate was 15.7 tons/year. These sedimentation rates fluctuated depending on the main land use activity, which can also be seen in the soil erosion rates that had almost doubled by the time agricultural activities were performed in the area.	[Begy, Robert-Csaba; Savin, Codrin F.; Kelemen, Szabolcs; Muntean, Octavian-Liviu; Malos, Cristian, V] Univ Babes Bolyai, Fac Environm Sci & Engn, Cluj Napoca, Romania; [Begy, Robert-Csaba; Kelemen, Szabolcs; Veres, Daniel] Univ Babes Bolyai, Interdisciplinary Res Inst Bionano Sci, Cluj Napoca, Romania; [Veres, Daniel] Romanian Acad, Inst Speol Emil Racovita, Cluj Napoca, Romania; [Kovacs, Tibor] Univ Pannonia, Inst Radiochem & Radioecol, Veszprem, Hungary	Babes Bolyai University from Cluj; Babes Bolyai University from Cluj; Emil Racovita Institute of Speleology; Romanian Academy of Sciences; University of Pannonia	Kovacs, T (corresponding author), Univ Pannonia, Inst Radiochem & Radioecol, Veszprem, Hungary.	kt@almos.uni-pannon.hu	Veres, Daniel S/GNH-2578-2022; Veres, Daniel/AAX-3319-2020; Malos, Cristian Valeriu V/A-5305-2015; Veres, Daniel/GNH-2718-2022; Kovacs, Tibor/H-1564-2017	Veres, Daniel/0000-0003-3932-577X; Malos, Cristian Valeriu V/0000-0002-7698-1314; Kovacs, Tibor/0000-0003-2606-0397	National Research, Development and Innovation Fund of Hungary [TKP2020-IKA-07, 2020-4.1.1-TKP2020]; Romanian - EEA Research Program [EEARO-NO-2018-0126];  [PN-III-P1-1.1-TE-2016-0814]	National Research, Development and Innovation Fund of Hungary; Romanian - EEA Research Program; 	We acknowledge support from the projects TKP2020-IKA-07 project financed under the 2020-4.1.1-TKP2020 Thematic Excellence Program by the National Research, Development and Innovation Fund of Hungary (T. Kovacs) and PN-III-P1-1.1-TE-2016-0814 entitled "Studies on the effects of land use changes on soil erosion and increased sedimentation using radionuclides" National Research program (R-Cs. Begy) and EEARO-NO-2018-0126 entitled "Cave deposits as archives of climate and environmental changes. A Center of Excellence in speleological research", The Romanian - EEA Research Program. (R-Cs. Begy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler M-J., 1997, P INT S RAB MOR P INT S RAB MOR, V245, P135; Arata L, 2016, J ENVIRON RADIOACTIV, V162, P45, DOI 10.1016/j.jenvrad.2016.05.008; Begy RC, 2018, J ENVIRON RADIOACTIV, V192, P95, DOI 10.1016/j.jenvrad.2018.06.010; Begy RC, 2015, J RADIOANAL NUCL CH, V303, P2553, DOI 10.1007/s10967-014-3703-z; Bilasco S, 2009, CARPATH J EARTH ENV, V4, P123; Boardman J., 2007, NAKLADATELSTI P3K PR, P205; Dazzi C., 2019, SOIL GENETIC EROSION, DOI [10.1016/j.iswcr.2019.08.001, DOI 10.1016/J.ISWCR.2019.08.001]; Dazzi C, 2019, INT SOIL WATER CONSE, V7, P102, DOI 10.1016/j.iswcr.2018.11.003; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dellaville NB., 1992, HDB REFERENCE METHOD HDB REFERENCE METHOD; Didone EJ, 2019, AGR ECOSYST ENVIRON, V284, DOI 10.1016/j.agee.2019.106588; Dotterweich M, 2013, GEOMORPHOLOGY, V201, P1, DOI 10.1016/j.geomorph.2013.07.021; Gharibreza M, 2020, INT SOIL WATER CONSE, V8, P393, DOI 10.1016/j.iswcr.2020.07.006; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Ionita I., 2000, Acta Geologica Hispanica, V35, P311; Iurian AR, 2013, J ENVIRON RADIOACTIV, V125, P40, DOI 10.1016/j.jenvrad.2013.02.009; Laker M. C., 1982, Agroplantae, V14, P17; Legarda F, 2011, J ENVIRON RADIOACTIV, V102, P589, DOI 10.1016/j.jenvrad.2011.03.007; Lingala RR., 2019, INT J ENG ADV TECHNO, V8, p3S; Mabit L, 2014, EARTH-SCI REV, V138, P335, DOI 10.1016/j.earscirev.2014.06.007; Matisoff G, 2011, ADV ISOTOP GEOCHEM, P487, DOI 10.1007/978-3-642-10637-8_25; Meliho M, 2019, J ENVIRON RADIOACTIV, V208, DOI 10.1016/j.jenvrad.2019.106021; Mitasova H, 1996, INT J GEOGR INF SYST, V10, P629, DOI 10.1080/026937996137918; MOORE ID, 1992, J SOIL WATER CONSERV, V47, P423; Motoc M., 2002, EVALUAREA FACTORILOR; Muica C., 1996, Geojournal, V38, P207; Nagai H, 2000, NUCL INSTRUM METH B, V172, P796, DOI 10.1016/S0168-583X(00)00124-5; Nearing MA, 2017, INT SOIL WATER CONSE, V5, P77, DOI 10.1016/j.iswcr.2017.04.001; Oldfield, 1978, CATENA, V5, P1, DOI DOI 10.1016/S0341-8162(78)80002-2; Panagos P, 2016, LAND DEGRAD DEV, V27, P1547, DOI 10.1002/ldr.2538; Poreba GJ, 2011, GEOCHRONOMETRIA, V38, P77, DOI 10.2478/s13386-011-0008-7; Porto P, 2018, LAND DEGRAD DEV, V29, P1819, DOI 10.1002/ldr.2815; Posea G., 1975, GEOFORUM, V6, P15; RENARD KG, 1991, J SOIL WATER CONSERV, V46, P30; Rosian G, 2016, Z GEOMORPHOL, V60, P359, DOI 10.1127/zfg/2016/0404; Salako FK., 2003, SUSCEPTIBILITY COARS; Simon H, 2017, J ENVIRON RADIOACTIV, V173, P11, DOI 10.1016/j.jenvrad.2016.09.001; Somboon S, 2018, J ENVIRON RADIOACTIV, V195, P40, DOI 10.1016/j.jenvrad.2018.09.003; Standards Association of Australia, 1289C621976 AS 1289C621976 AS; Toy TJ., 1998, CONSTRUCTION SITES R; Uri ND, 2000, J SUSTAIN AGR, V16, P71, DOI 10.1300/J064v16n04_07; Walling D.E., 2012, ENCY SUSTAINABILITY, P3705; Wang X., 2019, J ENVIRON RADIOACTIV, P208; WISCHMEIER WALTER H., 1959, SOIL SCI SOC AMER PROC, V23, P246; WISCHMEIER WH, 1969, SOIL SCI SOC AM PRO, V33, P131, DOI 10.2136/sssaj1969.03615995003300010035x; Zapata F, 2010, RADIOACTIV ENVIRONM, V16, P295, DOI 10.1016/S1569-4860(09)01607-6	46	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0251603	10.1371/journal.pone.0251603	http://dx.doi.org/10.1371/journal.pone.0251603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138856	Green Published, gold			2022-12-26	WOS:000671690200001
J	Ch'ng, JH; Moll, K; Wyss, K; Hammar, U; Ryden, M; Kampe, O; Farnert, A; Wahlgren, M				Ch'ng, Jun-Hong; Moll, Kirsten; Wyss, Katja; Hammar, Ulf; Ryden, Mikael; Kampe, Olle; Farnert, Anna; Wahlgren, Mats			Enhanced virulence of Plasmodium falciparum in blood of diabetic patients	PLOS ONE			English	Article							HEMORHEOLOGICAL DISORDERS; ERYTHROCYTE AGGREGATION; SIALIC-ACID; MALARIA; FIBRINOGEN; MELLITUS; CELLS; MECHANISM; ADHESION; HEALTH	Rising prevalence of diabetes in sub-Saharan Africa, coupled with continued malaria transmission, has resulted more patients dealing with both communicable and non-communicable diseases. We previously reported that travelers with type 2 diabetes mellitus (T2DM) infected with Plasmodium falciparum were three times more likely to develop severe malaria than non-diabetics. Here we explore the biological basis for this by testing blood from uninfected subjects with type 1 and type 2 diabetes, ex vivo, for their effects on parasite growth and rosetting (binding of infected erythrocytes to uninfected erythrocytes). Rosetting was associated with type 2 diabetes, blood glucose and erythrocyte sedimentation rate (ESR), while parasite growth was positively associated with blood glucose, glycated hemoglobin (HbA1c), body mass index (BMI), fibrinogen and triglycerides. This study establishes a link between diabetes and malaria virulence assays, potentially explaining the protective effect of good glycemic control against severe malaria in subjects with diabetes.	[Ch'ng, Jun-Hong; Moll, Kirsten; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Ch'ng, Jun-Hong] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore, Singapore; [Wyss, Katja; Kampe, Olle; Farnert, Anna] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Wyss, Katja; Farnert, Anna] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Hammar, Ulf] Karolinska Inst, Inst Environm Med, Dept Epidemiol, Stockholm, Sweden; [Ryden, Mikael] Dept Med Huddinge, Stockholm, Sweden; [Ryden, Mikael; Kampe, Olle] Karolinska Univ Hosp, Dept Endocrinol, Stockholm, Sweden	Karolinska Institutet; National University of Singapore; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Wahlgren, M (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.; Farnert, A (corresponding author), Karolinska Inst, Dept Med Solna, Stockholm, Sweden.; Farnert, A (corresponding author), Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden.	anna.farnert@ki.se; mats.wahlgren@ki.se		Farnert, Anna/0000-0001-7583-282X	Swedish Research Council [VR/2012-2016/5212011-3377, VR/2016-2018/2015-09277]; Stockholm County Council [20150135]; Swedish Strategic Foundation [SB12-0026.005]; Strategic Research Program in Diabetes at the Karolinska Institute; National University of Singapore	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Swedish Strategic Foundation; Strategic Research Program in Diabetes at the Karolinska Institute; National University of Singapore(National University of Singapore)	This study was supported by the Swedish Research Council (M.W.: VR/2012-2016/5212011-3377 and A.F.: VR/2016-2018/2015-09277), the Stockholm County Council (A.F.: 20150135) and the Swedish Strategic Foundation (M.W: SB12-0026.005). M.R. is supported by a grant from the Strategic Research Program in Diabetes at the Karolinska Institute. J.H.C. is supported by Swedish Strategic Foundation and National University of Singapore.	Akhouri RR, 2016, CELL REP, V14, P723, DOI 10.1016/j.celrep.2015.12.067; [Anonymous], 2013, METHODS MALARIA RES; [Anonymous], 2016, GLOBAL REPORT DIABET; Atun R, 2017, LANCET DIABETES ENDO, V5, P622, DOI 10.1016/S2213-8587(17)30181-X; Baskurt O., 2012, RED BLOOD CELL AGGRE, P304; Baskurt O, 2008, MICROCIRCULATION, V15, P585, DOI 10.1080/10739680802107447; Brust M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04348; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Ch'ng JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29317; CHIEN S, 1967, SCIENCE, V157, P829, DOI 10.1126/science.157.3790.829; Cho Young I, 2008, J Diabetes Sci Technol, V2, P1130; Danquah I, 2010, EMERG INFECT DIS, V16, P1601, DOI 10.3201/eid1610.100399; Davidson R, 1993, ESTIMATION INFERENCE; ELIAS AN, 1989, J MED, V20, P297; FABRY TL, 1987, BLOOD, V70, P1572; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; Grossin N, 2009, BIORHEOLOGY, V46, P63, DOI 10.3233/BIR-2009-0519; Hernandez-Romieu AC, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000304; Holley L, 1999, BIORHEOLOGY, V36, P287; JAN KM, 1973, J GEN PHYSIOL, V61, P638, DOI 10.1085/jgp.61.5.638; JENSEN MD, 1983, J PARASITOL, V69, P1060, DOI 10.2307/3280864; Kalra S, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-2; KULANE A, 1992, AM J TROP MED HYG, V46, P589, DOI 10.4269/ajtmh.1992.46.589; Mantskava M, 2006, CLIN HEMORHEOL MICRO, V35, P307; MERRILL EW, 1966, CIRC RES, V18, P437, DOI 10.1161/01.RES.18.4.437; Moles E, 2016, J CONTROL RELEASE, V241, P57, DOI 10.1016/j.jconrel.2016.09.006; Momtselidze N, 2006, CLIN HEMORHEOL MICRO, V35, P261; NASH GB, 1992, BRIT J HAEMATOL, V82, P757, DOI 10.1111/j.1365-2141.1992.tb06955.x; Quintana MD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21026-4; Restrepo BI, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0023-2016; ROGERS ME, 1992, CLIN SCI, V82, P309, DOI 10.1042/cs0820309; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Salcedo-Sora JE, 2014, TRENDS PARASITOL, V30, P170, DOI 10.1016/j.pt.2014.02.001; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Soedamah-Muthu SS, 2008, DIABETOLOGIA, V51, P493, DOI 10.1007/s00125-007-0905-8; Steffen P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.018102; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; Visser BJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-442; Wahlgren M, 2017, NAT REV MICROBIOL, V15, P479, DOI 10.1038/nrmicro.2017.47; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Williams R., 2019, IDF ATLAS; Wyss K, 2017, CLIN INFECT DIS, V65, P949, DOI 10.1093/cid/cix437	47	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0249666	10.1371/journal.pone.0249666	http://dx.doi.org/10.1371/journal.pone.0249666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138868	Green Published, gold			2022-12-26	WOS:000671690200096
J	Chen, DQ; Moar, WJ; Jerga, A; Gowda, A; Milligan, JS; Bretsynder, EC; Rydel, TJ; Baum, JA; Semeao, A; Fu, XR; Guzov, V; Gabbert, K; Head, GP; Haas, JA				Chen, Danqi; Moar, William J.; Jerga, Agoston; Gowda, Anilkumar; Milligan, Jason S.; Bretsynder, Eric C.; Rydel, Timothy J.; Baum, James A.; Semeao, Altair; Fu, Xiaoran; Guzov, Victor; Gabbert, Karen; Head, Graham P.; Haas, Jeffrey A.			Bacillus thuringiensis chimeric proteins Cry1A.2 and Cry1B.2 to control soybean lepidopteran pests: New domain combinations enhance insecticidal spectrum of activity and novel receptor contributions	PLOS ONE			English	Article							DAS-81419-2 EXPRESSING CRY1F; BINDING-SITES; TOXIN BINDING; CYT TOXINS; BT CROPS; RESISTANCE; MODE; NOCTUIDAE; CONSUMPTION; MANAGEMENT	Two new chimeric Bacillus thuringiensis (Bt) proteins, Cry1A.2 and Cry1B.2, were constructed using specific domains, which provide insecticidal activity against key lepidopteran soybean pests while minimizing receptor overlaps between themselves, current, and soon to be commercialized plant incorporated protectants (PIP's) in soybean. Results from insect diet bioassays demonstrate that the recombinant Cry1A.2 and Cry1B.2 are toxic to soybean looper (SBL) Chrysodeixis includens Walker, velvetbean caterpillar (VBC) Anticarsia gemmatalis Hubner, southern armyworm (SAW) Spodoptera eridania, and black armyworm (BLAW) Spodoptera cosmioides with LC50 values < 3,448 ng/cm(2). Cry1B.2 is of moderate activity with significant mortality and stunting at > 3,448 ng/cm(2), while Cry1A.2 lacks toxicity against old-world bollworm (OWB) Helicoverpa armigera. Results from disabled insecticidal protein (DIP) bioassays suggest that receptor utilization of Cry1A.2 and Cry1B.2 proteins are distinct from each other and from current, and yet to be commercially available, Bt proteins in soy such as Cry1Ac, Cry1A.105, Cry1F.842, Cry2Ab2 and Vip3A. However, as Cry1A.2 contains a domain common to at least one commercial soybean Bt protein, resistance to this common domain in a current commercial soybean Bt protein could possibly confer at least partial cross resistance to Cry1A2. Therefore, Cry1A.2 and Cry1B.2 should provide two new tools for controlling many of the major soybean insect pests described above.	[Chen, Danqi; Moar, William J.; Jerga, Agoston; Gowda, Anilkumar; Milligan, Jason S.; Bretsynder, Eric C.; Rydel, Timothy J.; Baum, James A.; Semeao, Altair; Fu, Xiaoran; Guzov, Victor; Gabbert, Karen; Head, Graham P.; Haas, Jeffrey A.] Bayer Crop Sci, Chesterfield, MO 63017 USA	Bayer AG; Bayer CropScience	Jerga, A (corresponding author), Bayer Crop Sci, Chesterfield, MO 63017 USA.	agoston.jerga@bayer.com		Gabbert, Karen/0000-0002-0702-7340; Head, Graham/0000-0003-0521-0616; Jerga, Agoston/0000-0002-8943-319X	Bayer Crop Science	Bayer Crop Science(Bayer AG)	The authors are employees of Bayer Crop Science, and the work was funded by Bayer Crop Science.	Anderson JA, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00024; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09866-y; Bass C, 2015, PESTIC BIOCHEM PHYS, V121, P78, DOI 10.1016/j.pestbp.2015.04.004; Baum JA, 2004, APPL ENVIRON MICROB, V70, P4889, DOI 10.1128/AEM.70.8.4889-4898.2004; Bel Y., 2017, TOXICITY BINDING STU, V83; Bernardi O, 2012, PEST MANAG SCI, V68, P1083, DOI 10.1002/ps.3271; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Blanco CA, 2016, CURR OPIN INSECT SCI, V15, P131, DOI 10.1016/j.cois.2016.04.012; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Brookes G, 2018, GM CROPS FOOD, V9, P140, DOI 10.1080/21645698.2018.1479560; Bueno AD, 2008, CIENC RURAL, V38, P1495, DOI 10.1590/S0103-84782008000600001; Caccia S, 2012, APPL ENVIRON MICROB, V78, P5690, DOI 10.1128/AEM.00523-12; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Davolos CC, 2015, J INVERTEBR PATHOL, V127, P32, DOI 10.1016/j.jip.2015.01.013; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; Dively GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169115; dos Santos KB, 2005, NEOTROP ENTOMOL, V34, P903, DOI 10.1590/S1519-566X2005000600005; Dourado PM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161388; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Estela A, 2004, APPL ENVIRON MICROB, V70, P1378, DOI 10.1128/AEM.70.3.1378-1384.2004; FAO, 2020, GLOBAL FOREST RESOUR; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flagel L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25491-9; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Gomis-Cebolla J, 2020, TOXINS, V12, DOI 10.3390/toxins12020099; Gouffon C, 2011, APPL ENVIRON MICROB, V77, P3182, DOI 10.1128/AEM.02791-10; Hawkins NJ, 2019, BIOL REV, V94, P135, DOI 10.1111/brv.12440; Heinrichs E. A., 2018, CAB Reviews, V13, P1, DOI 10.1079/PAVSNNR201813055; Hernandez-Maritnez P, 2014, APPL ENVIRON MICROB, V80, P7545, DOI 10.1128/AEM.02514-14; International Service for the Acquisition of Agri-biotech Applications, 2017, China Biotechnology, V37, P1; Ives AR, 2011, ECOL APPL, V21, P503, DOI 10.1890/09-1869.1; Jakka SRK, 2016, APPL ENVIRON MICROB, V82, P1023, DOI 10.1128/AEM.02871-15; Jerga A, 2019, INSECT BIOCHEM MOLEC, V105, P79, DOI 10.1016/j.ibmb.2018.12.006; Keeton TP, 1998, APPL ENVIRON MICROB, V64, P2158; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Koch MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00283; Liu Li, 2018, J Proteomics Bioinform, V11, P201, DOI 10.4172/0974-276X.1000487; Macrae TC, 2005, J ECON ENTOMOL, V98, P577, DOI 10.1603/0022-0493-98.2.577; Maredia K. M., 2003, Integrated pest management in the global arena, DOI 10.1079/9780851996523.0000; Marques LH, 2016, J ECON ENTOMOL, V109, P1922, DOI 10.1093/jee/tow153; Marques LH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191567; Marques LH, 2017, CROP PROT, V96, P109, DOI 10.1016/j.cropro.2017.02.014; Martinez-Solis M, 2018, INSECT BIOCHEM MOLEC, V101, P47, DOI 10.1016/j.ibmb.2018.07.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mushtaq R, 2018, TOXINS, V10, DOI 10.3390/toxins10030095; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Bueno RCOD, 2011, PEST MANAG SCI, V67, P170, DOI 10.1002/ps.2047; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panizzi AR, 2013, NEOTROP ENTOMOL, V42, P119, DOI 10.1007/s13744-013-0111-y; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Pena-Cardena A, 2018, J BIOL CHEM, V293, P20263, DOI 10.1074/jbc.RA118.005101; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Pinos D., 2019, SPODOPTERA EXIGUA AB, V11; Pinto FA, 2017, INSECTS, V8, DOI 10.3390/insects8030087; Rodrigues-Silva N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-35965-5; Sellami S, 2018, INT J BIOL MACROMOL, V117, P752, DOI 10.1016/j.ijbiomac.2018.05.161; Stacke RF, 2019, J ECON ENTOMOL, V112, P1378, DOI 10.1093/jee/toz031; Storer Nicholas P, 2012, GM Crops Food, V3, P154, DOI 10.4161/gmcr.20945; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Wang YF, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00579-19; Xiao YT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005450; Yano SAC, 2016, PEST MANAG SCI, V72, P1578, DOI 10.1002/ps.4191; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	70	6	6	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0249150	10.1371/journal.pone.0249150	http://dx.doi.org/10.1371/journal.pone.0249150			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138865	Green Published, gold			2022-12-26	WOS:000671690200111
J	Lemken, D				Lemken, Dominic			The price penalty for red meat substitutes in popular dishes and the diversity in substitution	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CONSUMPTION; BEHAVIOR; PROTEIN	Life cycle assessments (LCA) often highlight the environmental and health benefits for consumers if western diets substitute red meat. However, the specific trade-off consumer face when asked to substitute a red meat dish is scarcely researched, often neglecting the bouquet of substitution options and/or the price component involved. Four substitution strategies are evaluated within an individually adapted choice based conjoint: the substitution by (1) the same red meat dishes with a halved meat portion size, (2) novel plant-based products that mimic the functionality and taste, (3) authentic plant-based components that just mimic the functionality, and (4) vegetarian dishes that just neglect the meat component if still familiar to consumers. The analysis is executed for three popular red meat dishes to account for consistency across meal scenarios, namely Meatballs, Spaghetti Bolognese and Sausage Buns. The analysis is sensitive to red meat consumption habits to better understand the preferences of consumers that can actually substitute a red meat intake.	[Lemken, Dominic] Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany	University of Gottingen	Lemken, D (corresponding author), Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany.	dlemken@gwdg.de			DFG project,Key food choices and climate change" [431972934]	DFG project,Key food choices and climate change"	D.L. -The article is fully financed by the DFG project,Key food choices and climate change", project no. 431972934 (German Research Association, https://www.dfg.de/en/index.jsp).The DFG had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Bolzmann L, 2000, J ADVERTISING, V29, P35, DOI 10.1080/00913367.2000.10673602; BEATTY SE, 1994, J CONSUM RES, V21, P332, DOI 10.1086/209401; Bundesregierung, 2020, FERNS KANZL 18 03 20 FERNS KANZL 18 03 20; Carlsson F, 2003, HEALTH ECON, V12, P281, DOI 10.1002/hec.729; Clark M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6cd5; de Boer J, 2019, FOOD QUAL PREFER, V73, P171, DOI 10.1016/j.foodqual.2018.11.012; DEStatis. federal bureau of statistics, 2020, INT AG GROUPS INT AG GROUPS; Elzerman JE, 2013, BRIT FOOD J, V115, P700, DOI 10.1108/00070701311331490; EUROSTAT, 2019, FIN CONS EXP HOUS CO FIN CONS EXP HOUS CO; FAOSTAT, 2018, FAO STAT STAT DAT; Gensler S, 2012, EUR J OPER RES, V219, P368, DOI 10.1016/j.ejor.2012.01.002; Grunert K.G., 2001, FOOD PEOPLE SOC, P211, DOI DOI 10.1007/978-3-662-04601-2_14; Hartmann C, 2017, TRENDS FOOD SCI TECH, V61, P11, DOI 10.1016/j.tifs.2016.12.006; Hoek AC, 2011, APPETITE, V56, P662, DOI 10.1016/j.appet.2011.02.001; Jallinoja P, 2016, FUTURES, V83, P4, DOI 10.1016/j.futures.2016.03.006; Jones AD, 2016, ADV NUTR, V7, P641, DOI 10.3945/an.115.011015; Lemken D, 2019, APPETITE, V143, DOI 10.1016/j.appet.2019.104412; Lusk JL, 2003, AM J AGR ECON, V85, P840, DOI 10.1111/1467-8276.00492; McFadden D, 1973, FRONTIERS ECONOMETRI; Nam KC, 2010, MEAT SCI, V86, P95, DOI 10.1016/j.meatsci.2010.04.026; Neville M, 2017, FOOD SCI NUTR, V5, P852, DOI 10.1002/fsn3.466; Reinders MJ, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0496-9; Reinhardt G., 2020, ECOLOGICAL FOOTPRINT; Schlereth C., 2012, QUANTITATIVE MARKETI, P225, DOI [10.1007/978-3-8349-3722-3%5F11, 10.1007/978-3-8349-3722-3_11, DOI 10.1007/978-3-8349-3722-3_11]; Schosler H, 2012, APPETITE, V58, P39, DOI 10.1016/j.appet.2011.09.009; Shepon A, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/10/105002; Spencer M, 2018, FOOD QUAL PREFER, V68, P50, DOI 10.1016/j.foodqual.2018.02.003; Stoll-Kleemann S, 2017, REG ENVIRON CHANGE, V17, P1261, DOI 10.1007/s10113-016-1057-5; Taufik D, 2019, TRENDS FOOD SCI TECH, V93, P281, DOI 10.1016/j.tifs.2019.09.019; Van Loo EJ, 2020, FOOD POLICY, V95, DOI 10.1016/j.foodpol.2020.101931; Wakefield KL, 2003, J RETAILING, V79, P199, DOI 10.1016/j.jretai.2003.09.004; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Zaharia S., 2019, ONLINE SHOPPING MOTI, P333	33	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252675	10.1371/journal.pone.0252675	http://dx.doi.org/10.1371/journal.pone.0252675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138892	gold, Green Published			2022-12-26	WOS:000671690200119
J	Montgomery, MK; David, J; Zhang, HK; Ram, S; Deng, SB; Premkumar, V; Manzuk, L; Jiang, ZK; Giddabasappa, A				Montgomery, Mary Katherine; David, John; Zhang, Haikuo; Ram, Sripad; Deng, Shibing; Premkumar, Vidya; Manzuk, Lisa; Jiang, Ziyue Karen; Giddabasappa, Anand			Mouse lung automated segmentation tool for quantifying lung tumors after micro-computed tomography	PLOS ONE			English	Article							CANCER MODELS; CT; QUANTIFICATION; DELIVERY; THERAPY; BURDEN	Unlike the majority of cancers, survival for lung cancer has not shown much improvement since the early 1970s and survival rates remain low. Genetically engineered mice tumor models are of high translational relevance as we can generate tissue specific mutations which are observed in lung cancer patients. Since these tumors cannot be detected and quantified by traditional methods, we use micro-computed tomography imaging for longitudinal evaluation and to measure response to therapy. Conventionally, we analyze microCT images of lung cancer via a manual segmentation. Manual segmentation is time-consuming and sensitive to intra- and inter-analyst variation. To overcome the limitations of manual segmentation, we set out to develop a fully-automated alternative, the Mouse Lung Automated Segmentation Tool (MLAST). MLAST locates the thoracic region of interest, thresholds and categorizes the lung field into three tissue categories: soft tissue, intermediate, and lung. An increase in the tumor burden was measured by a decrease in lung volume with a simultaneous increase in soft and intermediate tissue quantities. MLAST segmentation was validated against three methods: manual scoring, manual segmentation, and histology. MLAST was applied in an efficacy trial using a Kras/Lkb1 non-small cell lung cancer model and demonstrated adequate precision and sensitivity in quantifying tumor growth inhibition after drug treatment. Implementation of MLAST has considerably accelerated the microCT data analysis, allowing for larger study sizes and mid-study readouts. This study illustrates how automated image analysis tools for large datasets can be used in preclinical imaging to deliver high throughput and quantitative results.	[Montgomery, Mary Katherine; David, John; Premkumar, Vidya; Manzuk, Lisa; Jiang, Ziyue Karen; Giddabasappa, Anand] Pfizer Inc, Comparat Med, La Jolla, CA 92121 USA; [Zhang, Haikuo] Pfizer Inc, Oncol Res Unit, La Jolla, CA USA; [Ram, Sripad] Pfizer Inc, Drug Safety Res Unit, La Jolla, CA USA; [Deng, Shibing] Pfizer Inc, Early Clin Dev, La Jolla, CA USA	Pfizer; Pfizer; Pfizer; Pfizer	Giddabasappa, A (corresponding author), Pfizer Inc, Comparat Med, La Jolla, CA 92121 USA.	anand.giddabasappa@pfizer.com			Pfizer, Inc.; Pfizer Inc.	Pfizer, Inc.(Pfizer); Pfizer Inc.(Pfizer)	This project was funded by Pfizer, Inc. Pfizer Inc. provided financial support in the form of research materials and salaries for authors [MKM, JD, HZ, SR, SD, VP, LM, KJ, AG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ai Xiaojuan, 2018, Oncotarget, V9, P37589, DOI 10.18632/oncotarget.26428; Armbrust LJ, 2005, AM J VET RES, V66, P835, DOI 10.2460/ajvr.2005.66.835; Barck KH, 2015, TRANSL ONCOL, V8, P126, DOI 10.1016/j.tranon.2015.03.003; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Dawe DE, 2020, CURR ONCOL, V27, pS78, DOI 10.3747/co.27.5183; Du SS, 2016, INT J RADIAT ONCOL, V96, P529, DOI 10.1016/j.ijrobp.2016.07.008; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fushiki H, 2009, CANCER SCI, V100, P1544, DOI 10.1111/j.1349-7006.2009.01199.x; Gallastegui A, 2018, LAB ANIM-UK, V52, P457, DOI 10.1177/0023677218756457; Gibson-Corley KN, 2013, VET PATHOL, V50, P1007, DOI 10.1177/0300985813485099; Gilhodes JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170561; Gu YH, 2013, PATTERN RECOGN, V46, P692, DOI 10.1016/j.patcog.2012.10.005; Guo Y, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/401201; Haines BB, 2009, NEOPLASIA, V11, P39, DOI 10.1593/neo.81030; Hu ZY, 2019, TRANSL LUNG CANCER R, V8, P1091, DOI 10.21037/tlcr.2019.10.17; Hutchinson BD, 2019, SEMIN ULTRASOUND CT, V40, P255, DOI 10.1053/j.sult.2018.11.009; Jiang J, 2019, IEEE T MED IMAGING, V38, P134, DOI 10.1109/TMI.2018.2857800; Kellar A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/621324; Kunimasa K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020597; Lalwani K, 2013, COMPARATIVE MED, V63, P482; Leung K, 2018, J NUCL MED, V59; Ma YM, 2019, AM J CANCER RES, V9, P1546; Oser MG, 2015, LANCET ONCOL, V16, pE165, DOI 10.1016/S1470-2045(14)71180-5; Park J, 2020, J DIGIT IMAGING, V33, P221, DOI 10.1007/s10278-019-00223-1; Pirker R, 2020, PULMONOLOGY, V26, P283, DOI 10.1016/j.pulmoe.2020.02.005; Schulte H, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01466; Schwartz LH, 2016, EUR J CANCER, V62, P132, DOI 10.1016/j.ejca.2016.03.081; Simmons BH, 2012, CANCER CHEMOTH PHARM, V70, P213, DOI 10.1007/s00280-012-1899-6; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Subhawong TK, 2010, AM J ROENTGENOL, V194, P1559, DOI 10.2214/AJR.09.3736; Sun SH, 2012, IEEE T MED IMAGING, V31, P449, DOI 10.1109/TMI.2011.2171357; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Yang RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060279; Zhou JH, 2015, COMPUT MED IMAG GRAP, V46, P47, DOI 10.1016/j.compmedimag.2015.07.003; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	36	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252950	10.1371/journal.pone.0252950	http://dx.doi.org/10.1371/journal.pone.0252950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138905	gold, Green Published			2022-12-26	WOS:000671690200121
J	Phillips, SP; Wei, XJ; Kwong, JC; Gubbay, J; Schwartz, KL; Majury, A; Groome, PA				Phillips, Susan P.; Wei, Xuejiao; Kwong, Jeffrey C.; Gubbay, Jonathan; Schwartz, Kevin L.; Majury, Anna; Groome, Patti A.			Duration of SARS-CoV-2 shedding: A population-based, Canadian study	PLOS ONE			English	Article							COVID-19; LOAD	Introduction There is an evidence gap regarding the duration of SARS-CoV-2 shedding and of its variability across different care settings and by age, sex, income, and co-morbidities. Such evidence is part of understanding of infectivity and reinfection. We examine direct measures of viral shedding using a linked population-based health administrative dataset. Methods Laboratory and sociodemographic databases for Ontario, Canada were linked to identify those testing positive (RT-PCR) between Jan. 15 and April 30, 2020 who underwent subsequent testing by May 31, 2020. To maximise use of available data, we computed two shedding duration estimates defined as the time between initial positive and most recent positive (documented shedding) or second of two negative tests (documented resolution). We also report multivariable results using quantile regression to examine subgroup differences. Results In Ontario, of the 16,595 who tested positive before April 30, 2020, 6604 had sufficient subsequent testing to allow shedding duration calculation. Documented shedding median duration calculated in 4,889 (29% of 16,595) patients was 19 days (IQR 12-28). Documented resolution median duration calculated in 3,219 (19% of the 16,595) patients was 25 days (IQR 18-34). Long-term care residents had 3-5 day longer shedding durations using both definitions. Shorter documented shedding durations of 2-4 days were observed in those living in higher income neighbourhoods. Shorter documented resolution durations of 2-3 days were observed at the 25(th)% of the distribution in those aged 20-49. Only 11.5% of those with definitive negative test results reverted to negative status by day 14. Conclusions Viral shedding continued well beyond 14 days among this large subset of a population-based group with COVID-19, and longer still for long-term care residents and those living in less affluent neighborhoods. Our findings do not speak to duration of infectivity but are useful for understanding the expected duration of RT-PCR positivity and for identifying reinfection.	[Phillips, Susan P.] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Phillips, Susan P.; Groome, Patti A.] Queens Univ, Publ Hlth Sci, Kingston, ON, Canada; [Wei, Xuejiao; Groome, Patti A.] Queens Univ, ICES Queens, Kingston, ON, Canada; [Kwong, Jeffrey C.; Schwartz, Kevin L.] ICES, Toronto, ON, Canada; [Kwong, Jeffrey C.; Schwartz, Kevin L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gubbay, Jonathan] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Majury, Anna] Queens Univ, Fac Hlth Sci, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Toronto; University of Toronto; University of Toronto; Queens University - Canada	Phillips, SP (corresponding author), Queens Univ, Dept Family Med, Kingston, ON, Canada.; Phillips, SP (corresponding author), Queens Univ, Publ Hlth Sci, Kingston, ON, Canada.	phillip@queensu.ca			ICES - Ontario Ministry of Health (MOH); Ministry of LongTerm Care (MLTC); Canadian Institutes of Health Research (CIHR) [PJT 159516]; Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine	ICES - Ontario Ministry of Health (MOH); Ministry of LongTerm Care (MLTC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine	This work received no direct funding support. It was supported indirectly by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of LongTerm Care (MLTC). One author (KS) was supported by an operating grant from the Canadian Institutes of Health Research (CIHR PJT 159516). JCK is supported by a Clinician Scientist Award from the University of Toronto Department of Family and Community Medicine. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI). The analyses, conclusions, opinions, and statement expressed herein are those of the authors, and not necessarily those of CIHI. No endorsement by ICES, PHO, MOHLTC, or CIHI is intended or should be inferred nor did they have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank IQVIA Solutions Canada Inc. for use of their Drug Information File. IQVIA Solutions Canada Inc. also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests:	Agarwal V, 2020, CELL DEATH DISCOV, V6, DOI [10.1101/2020.06.02.20120774, 10.1038/s41420-020-00375-y]; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bullard J, 2020, CLIN INFECT DIS, V71, P2663, DOI 10.1093/cid/ciaa638; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Gombar S, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104477; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Joynt GM, 2020, LANCET INFECT DIS, V20, P635, DOI 10.1016/S1473-3099(20)30237-1; Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2; Miyamae Y, 2020, INT J INFECT DIS, V97, P293, DOI 10.1016/j.ijid.2020.06.020; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2020, ONT COVID 19 DAT TOO; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2020, EP SUMM COVID 19 ONT; Rhee C., 2020, CLIN INFECT DIS, V72, P1467, DOI [10.1093/cid/ciaa1249, DOI 10.1093/CID/CIAA1249]; Saurabh S, 2020, QJM-INT J MED, V113, P556, DOI 10.1093/qjmed/hcaa212; Takahashi Takehiro, 2020, medRxiv, DOI 10.1101/2020.06.06.20123414; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wei L, 2020, MEDRXIV, DOI DOI 10.1101/2020.04.28.20083139; Wolf RC, 2020, NEUROPSYCHOBIOLOGY, V79, P335, DOI 10.1159/000505601; Xiao AT, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104346; Zhang N, 2020, VIRUS SHEDDING PATTE, DOI 10.1101/2020.03.28.20043059; Zhou B, 2020, CLIN INFECT DIS, V71, P2240, DOI 10.1093/cid/ciaa451; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	23	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252217	10.1371/journal.pone.0252217	http://dx.doi.org/10.1371/journal.pone.0252217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138906	gold, Green Published			2022-12-26	WOS:000671690200085
J	Werhahn, SM; Kreusser, JS; Hagenmuller, M; Beckendorf, J; Diemert, N; Hoffmann, S; Schultz, JH; Backs, J; Dewenter, M				Werhahn, Stefanie Maria; Kreusser, Julia S.; Hagenmuller, Marco; Beckendorf, Jan; Diemert, Nathalie; Hoffmann, Sophia; Schultz, Jobst-Hendrik; Backs, Johannes; Dewenter, Matthias			Adaptive versus maladaptive cardiac remodelling in response to sustained beta-adrenergic stimulation in a new 'ISO on/off model'	PLOS ONE			English	Article							HISTONE DEACETYLASE 5; MYOCARDIAL INJURY; ISOPROTERENOL; HEART; HYPERTROPHY; PHOSPHORYLATION; CONTRACTILITY; PROTEOLYSIS; DYSFUNCTION; ACTIVATION	On the one hand, sustained beta-adrenergic stress is a hallmark of heart failure (HF) and exerts maladaptive cardiac remodelling. On the other hand, acute beta-adrenergic stimulation maintains cardiac function under physiological stress. However, it is still incompletely understood to what extent the adaptive component of beta-adrenergic signaling contributes to the maintenance of cardiac function during chronic beta-adrenergic stress. We developed an experimental catecholamine-based protocol to distinguish adaptive from maladaptive effects. Mice were for 28 days infused with 30 mg/kg body weight/day isoproterenol (ISO) by subcutaneously implanted osmotic minipumps ('ISO on'). In a second and third group, ISO infusion was stopped after 26 days and the mice were observed for additional two or seven days without further ISO infusion ('ISO off short', 'ISO off long'). In this setup, 'ISO on' led to cardiac hypertrophy and slightly improved cardiac contractility. In stark contrast, 'ISO off' mice displayed progressive worsening of left ventricular ejection fraction that dropped down below 40%. While fetal and pathological gene expression (increase in Nppa, decrease in Myh6/Myh7 ratios, increase in Xirp2) was not induced in 'ISO on', it was activated in 'ISO off' mice. After ISO withdrawal, phosphorylation of phospholamban (PLN) at the protein kinase A (PKA) phosphorylation site Ser-16 dropped down to 20% as compared to only 50% at the Ca2+/Calmodulin-dependent kinase II (CaMKII) phosphorylation site Thr-17 in 'ISO off' mice. PKA-dependent cardioprotective production of the N-terminal proteolytic product of histone deacetylase 4 (HDAC4-NT) was reduced in 'ISO off' as compared to 'ISO on'. Taken together, these data indicate that chronic ISO infusion induces besides maladaptive remodelling also adaptive PKA signalling to maintain cardiac function. The use of the 'ISO on/off' model will further enable the separation of the underlying adaptive from maladaptive components of beta-adrenergic signalling and may help to better define and test therapeutic targets downstream of beta-adrenergic receptors.	[Werhahn, Stefanie Maria; Kreusser, Julia S.; Hagenmuller, Marco; Beckendorf, Jan; Diemert, Nathalie; Hoffmann, Sophia; Backs, Johannes; Dewenter, Matthias] Heidelberg Univ Hosp, Inst Expt Cardiol, Heidelberg, Germany; [Werhahn, Stefanie Maria; Kreusser, Julia S.; Hagenmuller, Marco; Beckendorf, Jan; Diemert, Nathalie; Hoffmann, Sophia; Backs, Johannes; Dewenter, Matthias] DZHK German Ctr Cardiovasc Res, Partner Site, Heidelberg, Germany; [Werhahn, Stefanie Maria] Univ Med Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Werhahn, Stefanie Maria] DZHK German Ctr Cardiovasc Res, Partner Site, Gottingen, Germany; [Kreusser, Julia S.; Beckendorf, Jan] Heidelberg Univ Hosp, Dept Cardiol Angiol & Pneumol, Heidelberg, Germany; [Schultz, Jobst-Hendrik] Heidelberg Univ, Dept Gen Internal Med & Psychosomat, Heidelberg, Germany	Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; University of Gottingen; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Backs, J (corresponding author), Heidelberg Univ Hosp, Inst Expt Cardiol, Heidelberg, Germany.; Backs, J (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site, Heidelberg, Germany.	Johannes.backs@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft [BA 2258/9-1, SFB 1118, 236360313]; European Commission (FP7-Health-2010) [MEDIA261409]; DZHK (Deutsches Zentrum fur Herz Kreislauf-Forschung - German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Physician Scientist Program of the Medical Faculty of Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission (FP7-Health-2010)(European Commission); DZHK (Deutsches Zentrum fur Herz Kreislauf-Forschung - German Centre for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research); Physician Scientist Program of the Medical Faculty of Heidelberg	J.B. was supported by grants from the Deutsche Forschungsgemeinschaft (BA 2258/9-1; SFB 1118, project number 236360313), the European Commission (FP7-Health-2010; MEDIA261409), the DZHK (Deutsches Zentrum fur Herz Kreislauf-Forschung - German Centre for Cardiovascular Research) and the BMBF (German Ministry of Education and Research). M.D. was supported by the DZHK (Deutsches Zentrum fur Herz-Kreislauf-Forschung - German Centre for Cardiovascular Research) and the Physician Scientist Program of the Medical Faculty of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2008, PERFUSION-UK, V23, P231, DOI 10.1177/0267659108100708; Backs J, 2011, J CELL BIOL, V195, P403, DOI 10.1083/jcb.201105063; Brooks WW, 2009, COMPARATIVE MED, V59, P339; Chang CWJ, 2013, J BIOL CHEM, V288, P192, DOI 10.1074/jbc.M112.382358; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Chang SC, 2018, METHODS MOL BIOL, V1816, P207, DOI 10.1007/978-1-4939-8597-5_16; Dewenter M, 2017, CIRC RES, V121, P1000, DOI 10.1161/CIRCRESAHA.117.310355; Di Carlo MN, 2014, J MOL CELL CARDIOL, V74, P274, DOI 10.1016/j.yjmcc.2014.06.004; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Du M, 2008, MOL CELL BIOL, V28, P2952, DOI 10.1128/MCB.00248-08; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Errami M, 2008, J PHARMACOL EXP THER, V324, P1196, DOI 10.1124/jpet.107.133975; Faulx MD, 2005, AM J PHYSIOL-HEART C, V289, pH30, DOI 10.1152/ajpheart.00636.2004; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Ha CH, 2010, P NATL ACAD SCI USA, V107, P15467, DOI 10.1073/pnas.1000462107; Haghighi K, 2014, J MOL CELL CARDIOL, V77, P160, DOI 10.1016/j.yjmcc.2014.10.005; He T, 2020, J MOL CELL CARDIOL, V145, P88, DOI 10.1016/j.yjmcc.2020.05.018; Hohimer AR, 2005, CAN J PHYSIOL PHARM, V83, P191, DOI 10.1139/y04-137; Jebessa ZH, 2019, NAT METAB, V1, P1157, DOI 10.1038/s42255-019-0138-4; Kitagawa Y, 2004, AM J PHYSIOL-HEART C, V287, pH277, DOI 10.1152/ajpheart.00073.2004; Kreusser MM, 2014, CIRCULATION, V130, P1262, DOI 10.1161/CIRCULATIONAHA.114.006185; Kronlage M, 2019, CIRCULATION, V140, P580, DOI 10.1161/CIRCULATIONAHA.117.031942; Lam MPY, 2014, J CLIN INVEST, V124, P1734, DOI 10.1172/JCI73787; Lehmann LH, 2018, NAT MED, V24, P62, DOI 10.1038/nm.4452; Lehmann LH, 2014, CELL MOL LIFE SCI, V71, P1673, DOI 10.1007/s00018-013-1516-9; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Ma XW, 2011, SCI CHINA LIFE SCI, V54, P493, DOI 10.1007/s11427-011-4183-9; Maack C, 2019, EUR HEART J, V40, P3626, DOI 10.1093/eurheartj/ehy600; Mosterd A, 2007, HEART, V93, P1137, DOI 10.1136/hrt.2003.025270; Nichtova Z, 2012, GEN PHYSIOL BIOPHYS, V31, P141, DOI 10.4149/gpb_2012_015; Ocaranza MP, 2002, J CARDIOVASC PHARM, V40, P246, DOI 10.1097/00005344-200208000-00010; PACKER M, 1988, CIRCULATION, V77, P721, DOI 10.1161/01.CIR.77.4.721; Ponikowski P, 2016, EUR J HEART FAIL, V18, P891, DOI 10.1002/ejhf.592; Rau CD, 2017, CELL SYST, V4, P121, DOI 10.1016/j.cels.2016.10.016; Rau CD, 2015, CIRC-CARDIOVASC GENE, V8, P40, DOI 10.1161/CIRCGENETICS.113.000732; Ren SX, 2019, JOVE-J VIS EXP, DOI 10.3791/59646; Spaich S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00202; Sucharov CC, 2011, J CARD FAIL, V17, P592, DOI 10.1016/j.cardfail.2011.03.006; Tang MX, 2010, AM J PHYSIOL-HEART C, V299, pH519, DOI 10.1152/ajpheart.00265.2010; Wang ER, 2014, GENE THER, V21, P496, DOI 10.1038/gt.2014.23; Wang JJC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006038; Wang XX, 2014, MOL PHARMACOL, V85, P105, DOI 10.1124/mol.113.087122; Weeks KL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.004861; Weinreuter M, 2014, EMBO MOL MED, V6, P1231, DOI 10.15252/emmm.201403848; Xu B, 2020, CIRC RES, V127, P796, DOI 10.1161/CIRCRESAHA.119.316319; Yoshida T, 2014, J BIOL CHEM, V289, P26107, DOI 10.1074/jbc.M114.582809; Zahabi A, 2003, J BIOL CHEM, V278, P47694, DOI 10.1074/jbc.M309661200; Zou YZ, 1999, J BIOL CHEM, V274, P9760, DOI 10.1074/jbc.274.14.9760	48	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0248933	10.1371/journal.pone.0248933	http://dx.doi.org/10.1371/journal.pone.0248933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138844	Green Published, gold			2022-12-26	WOS:000671690200019
J	Zhao, PC; Xu, SN; Huang, ZS; Deng, PC; Zhang, YM				Zhao, Pengcheng; Xu, Shaonian; Huang, Zhenshan; Deng, Pengcheng; Zhang, Yongming			Identify specific gene pairs for subarachnoid hemorrhage based on wavelet analysis and genetic algorithm	PLOS ONE			English	Article							HYPOXIA; SEARCH; CANCER	Subarachnoid hemorrhage (SAH) is a fatal stroke caused by bleeding in the brain. SAH can be caused by a ruptured aneurysm or head injury. One-third of patients will survive and recover. One-third will survive with disability; one-third will die. The focus of treatment is to stop bleeding, restore normal blood flow, and prevent vasospasm. Treatment for SAH varies, depending on the bleeding's underlying cause and the extent of damage to the brain. Treatment may include lifesaving measures, symptom relief, repair of the bleeding vessel, and complication prevention. However, the useful diagnostic biomarkers of SAH are still limited due to the instability of gene marker expression. To overcome this limitation, we developed a new protocol pairing genes and screened significant gene pairs based on the feature selection algorithm. A classifier was constructed with the selected gene pairs and achieved a high performance.	[Zhao, Pengcheng; Xu, Shaonian; Huang, Zhenshan; Deng, Pengcheng; Zhang, Yongming] Anhui 2 Prov Peoples Hosp, Dept Neurosurg, Hefei, Anhui, Peoples R China		Zhang, YM (corresponding author), Anhui 2 Prov Peoples Hosp, Dept Neurosurg, Hefei, Anhui, Peoples R China.	zymhf2966@163.com			Key Research and Development Projects in Anhui Province [201904a07020108]	Key Research and Development Projects in Anhui Province	Key Research and Development Projects in Anhui Province (No. 201904a07020108).	AlAbdi L, 2018, J BIOL CHEM, V293, P11109, DOI 10.1074/jbc.RA118.002911; Baresova P, 2014, MOL CELL BIOL, V34, P386, DOI 10.1128/MCB.01011-13; Bourgeois B, 2020, P NATL ACAD SCI USA, V117, P8503, DOI 10.1073/pnas.1918944117; Burger NB, 2015, PRENATAL DIAG, V35, P517, DOI 10.1002/pd.4586; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Du K, 2019, AGING-US, V11, P2762, DOI 10.18632/aging.101948; Feng H, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0508-2; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ge Y, 2018, NEURON, V97, P596, DOI 10.1016/j.neuron.2017.12.038; Guo K, 2001, CELL DEATH DIFFER, V8, P367, DOI 10.1038/sj.cdd.4400810; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Heinsberg LW, 2020, NEUROCRIT CARE, V32, P550, DOI 10.1007/s12028-019-00787-4; Huang CB, 2019, CLIN CANCER RES, V25, P4091, DOI 10.1158/1078-0432.CCR-18-3533; Inoue K, 2019, J CANCER RES CLIN, V145, P851, DOI 10.1007/s00432-019-02843-0; Janiszewska M, 2010, J BIOL CHEM, V285, P30548, DOI 10.1074/jbc.M109.075838; Keryanov S, 2002, GENE, V292, P151, DOI 10.1016/S0378-1119(02)00647-9; Kimes PK, 2017, BIOMETRICS, V73, P811, DOI 10.1111/biom.12647; Kong XY, 2017, MAR POLLUT BULL, V119, P307, DOI 10.1016/j.marpolbul.2017.04.022; Korbar B, 2017, J PATHOLOGY INFORN, P8, DOI [10.4103/jpi.jpi_34_1728828201, DOI 10.4103/JPI.JPI_34_1728828201]; Kroll-Hermi A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911861; Li FT, 2020, CANCERS, V12, DOI 10.3390/cancers12061582; Li ZY, 2012, BRIEF FUNCT GENOMICS, V11, P25, DOI 10.1093/bfgp/elr035; Majumder A, 2019, KNOWL-BASED SYST, V172, P104, DOI 10.1016/j.knosys.2019.02.016; Mansson R, 2004, J BIOL CHEM, V279, P17905, DOI 10.1074/jbc.M400589200; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Nagy S, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007623; Paavola J, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102608; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Scrucca L, 2016, R J, V8, P289; Shahid M, 2018, CELL CYCLE, V17, P2802, DOI 10.1080/15384101.2018.1557496; Sherwani SI, 2016, BIOMARK INSIGHTS, V11, P95, DOI [10.4137/BMIMI.S38440, 10.4137/BMI.S38440]; Smyth GK., 2018, WALTER ELIZA HALL I WALTER ELIZA HALL I; Sutton JR, 2017, HUM MOL GENET, V26, P1419, DOI 10.1093/hmg/ddx039; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Wu CY, 2001, J CELL BIOL, V155, P505, DOI 10.1083/jcb.200108077; Xu HC, 2020, NEUROCRIT CARE, V33, P82, DOI 10.1007/s12028-019-00861-x; Zhang T, 2018, CANCER LETT, V415, P151, DOI 10.1016/j.canlet.2017.12.010; Zou ZM, 2010, ARTERIOSCL THROM VAS, V30, P1378, DOI 10.1161/ATVBAHA.109.200428	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253219	10.1371/journal.pone.0253219	http://dx.doi.org/10.1371/journal.pone.0253219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138931	Green Published, gold			2022-12-26	WOS:000671690200011
J	Lv, MZ; Zhang, SM; Jiang, B; Cao, SR; Dong, YQ; Cao, L; Guo, S				Lv, Mengzhu; Zhang, Simeng; Jiang, Bo; Cao, Sunrun; Dong, Yuqing; Cao, Liu; Guo, Shu			Adipose-derived stem cells regulate metabolic homeostasis and delay aging by promoting mitophagy	FASEB JOURNAL			English	Article						adipose-derived mesenchymal stem cells; aging; metabolism; mitophagy; stem cell transplantation	MITOCHONDRIA; THERAPIES; FRAILTY	Tissues undergo a process of degeneration as the body ages. Mesenchymal stem cells (MSCs) have been found to have major potential in delaying the aging process in tissues and organs. However, the mechanism underlying the anti-aging effects of MSC is not clear which limits clinical applications. In this study, we used adipose-derived mesenchymal stem cells (ADSCs) to perform anti-aging treatments on senescent cells and progeroid animal models. Following intervention with ADSCs, replicative senescence was delayed and metabolic homeostasis was transformed from catabolism to anabolism. Metabolomic tests were used to analyze different metabolites. We found that ADSCs acted to accelerate mitophagy which eliminated intracellular ROS and improved the quality of mitochondria. These processes acted to regulate the cellular metabolic homeostasis and ultimately delayed the process of aging. Allogeneic stem cell therapy in a Progeria animal model (DNA polymerase gamma (POLG) knockin, mitochondrial dysfunction) also showed that ADSC therapy can improve alopecia and kyphosis by promoting mitophagy. Our research confirms for the first time that allogeneic stem cell therapy can improve aging-related symbols and phenotypes through mitochondrial quality control. These results are highly significant for the future applications of stem cells in aging-related diseases.	[Lv, Mengzhu; Dong, Yuqing; Guo, Shu] China Med Univ, Dept Plast Surg, Hosp 1, 155 Nan Jing St, Shenyang 110001, Liaoning, Peoples R China; [Zhang, Simeng] China Med Univ, Dept Med Oncol, Hosp 1, Shenyang, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] Minist Educ, Key Lab Med Cell Biol, Shenyang, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] China Med Univ, Inst Translat Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Jiang, Bo; Cao, Sunrun; Cao, Liu] Liaoning Prov Collaborat Innovat Ctr Aging Relate, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Guo, S (corresponding author), China Med Univ, Dept Plast Surg, Hosp 1, 155 Nan Jing St, Shenyang 110001, Liaoning, Peoples R China.; Cao, L (corresponding author), China Med Univ, Inst Translat Med, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	1021815514@qq.com; sguo@cmu.edu.cn		Guo, Shu/0000-0001-9094-1602; Mengzhu, Lv/0000-0002-7804-2636	National Natural Science Foundation of China (NSFC) [51872332]; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation) [20170541040]; China Medical University (CMU) [111/1210519020]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation); China Medical University (CMU)(China Medical University)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 51872332; Natural Science Foundation of Liaoning Province (Liaoning Natural Science Foundation), Grant/Award Number: 20170541040; China Medical University (CMU), Grant/Award Number: 111/1210519020	Bakula D, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00239; Bateman ME, 2018, STEM CELLS, V36, P1311, DOI 10.1002/stem.2847; Dillin A, 2014, CURR OPIN CELL BIOL, V26, P107, DOI 10.1016/j.ceb.2013.12.003; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Golpanian S, 2016, ONCOTARGET, V7, P11899, DOI 10.18632/oncotarget.7727; Goradel NH, 2018, J CELL BIOCHEM, V119, P95, DOI 10.1002/jcb.26169; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Huang L, 2020, STEM CELLS DEV, V29, P555, DOI 10.1089/scd.2019.0237; Hur W, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0520-7; Jankowski M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081783; Jung WY, 2015, TISSUE CELL, V47, P86, DOI 10.1016/j.tice.2014.12.001; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Li-Harms X, 2015, BLOOD, V125, P162, DOI 10.1182/blood-2014-07-586396; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; Oyewole AO, 2015, FASEB J, V29, P4766, DOI 10.1096/fj.15-275404; Pourakbari R, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118181; Prockop DJ, 2007, CLIN PHARMACOL THER, V82, P241, DOI 10.1038/sj.clpt.6100313; Shi RY, 2018, TRENDS CARDIOVAS MED, V28, P246, DOI 10.1016/j.tcm.2017.11.008; Sneddon JB, 2018, CELL STEM CELL, V22, P810, DOI 10.1016/j.stem.2018.05.016; Stepien A, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5302120; Sugaya K, 2018, ADV EXP MED BIOL, V1056, P61, DOI 10.1007/978-3-319-74470-4_5; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Tompkins BA, 2017, J GERONTOL A-BIOL, V72, P1513, DOI 10.1093/gerona/glx137; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Yang SD, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/1351860; Yi X, 2020, J CELL PHYSIOL, V235, P349, DOI 10.1002/jcp.28974; Zhao LF, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1893-4; Ziegler DV, 2015, AGING CELL, V14, P1, DOI 10.1111/acel.12287	31	8	8	4	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21709	10.1096/fj.202100332R	http://dx.doi.org/10.1096/fj.202100332R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143518				2022-12-26	WOS:000667814100024
J	Graham, AD; Lin, MC				Graham, Andrew D.; Lin, Meng C.			The relationship of pre-corneal to pre-contact lens non-invasive tear breakup time	PLOS ONE			English	Article							TFOS INTERNATIONAL WORKSHOP; FILM THICKNESS; DISCOMFORT REPORT; IN-VIVO; UP TIME; PRECORNEAL; STABILITY; UTILITY; WEAR	Purpose To examine the relationship between pre-corneal and pre-contact lens tear film stability (TFS), and to determine whether pre-corneal TFS is a reliable predictor of subsequent pre-lens TFS after a contact lens is placed on the eye. Methods 667 records met inclusion criteria and were extracted from a soft contact lens multi-study database. Multivariable linear mixed effects models were fit to examine the association between pre-corneal and pre-lens TFS, adjusting for potential confounders and accounting for repeated measures. Receiver Operating Characteristic (ROC) analysis was employed to assess the predictive performance of pre-corneal TFS for subsequent pre-lens TFS. TFS was quantified for this analysis as the non-invasive tear breakup time (NITBUT). Results Pre-corneal NITBUT was significantly related to the pre-lens NITBUT at both 10 min (p<0.001) and 2-6 hrs (p<0.001) post-lens insertion. However, the sensitivities of pre-corneal NITBUT for predicting symptom-associated thresholds of pre-lens NITBUT ranged from 50-65%, and specificities ranged from 57-72%, suggesting poor-to-moderate diagnostic performance. Conclusions Despite the association of pre-corneal and pre-lens TFS, the inherent lability and sensitivity to environmental exposures of the tear film introduce significant variability into NITBUT measurements. Using pre-corneal NITBUT to identify likely successful contact lens candidates prior to fitting is thus not sufficiently accurate to be relied upon in the clinical setting.	[Graham, Andrew D.; Lin, Meng C.] Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA; [Lin, Meng C.] Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lin, MC (corresponding author), Univ Calif Berkeley, Sch Optometry, Clin Res Ctr, Berkeley, CA 94720 USA.; Lin, MC (corresponding author), Univ Calif Berkeley, Vis Sci Grp, Berkeley, CA 94720 USA.	mlin@berkeley.edu			Roberta J. Smith Research Fund; UCB CRC Unrestricted Fund	Roberta J. Smith Research Fund; UCB CRC Unrestricted Fund	The Roberta J. Smith Research Fund (MCL) and the UCB CRC Unrestricted Fund (MCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Best N, 2013, CONTACT LENS ANTERIO, V36, P232, DOI 10.1016/j.clae.2013.02.013; Borchman D, 2009, EYE CONTACT LENS, V35, P32, DOI 10.1097/ICL.0b013e318193f4fc; Brown B., 1994, CLIN EXPT OPTOM, V77, P15; Bruce AS, 2001, BIOMATERIALS, V22, P3249, DOI 10.1016/S0142-9612(01)00162-4; Canavan K., 2018, CONTACT LENS ANT EYE, V41, pS2; Craig JP, 2013, INVEST OPHTH VIS SCI, V54, P123, DOI 10.1167/iovs.13-13235; Creech JL, 1998, CURR EYE RES, V17, P1058, DOI 10.1076/ceyr.17.11.1058.5233; DANJO Y, 1994, JPN J OPHTHALMOL, V38, P260; Doane MG., 1994, CLIN CONTACT LENS PR, VRev. ed, P1; Dogru M, 2011, CONTACT LENS ANTERIO, V34, P77, DOI 10.1016/j.clae.2010.12.001; Dumbleton K, 2013, INVEST OPHTH VIS SCI, V54, P20, DOI 10.1167/iovs.13-13125; Dumbleton K, 2013, EYE CONTACT LENS, V39, P93, DOI 10.1097/ICL.0b013e318271caf4; Elliott M, 1998, Cont Lens Anterior Eye, V21, P98, DOI 10.1016/S1367-0484(98)80002-7; Fogt N, 1998, J OPT SOC AM A, V15, P268, DOI 10.1364/JOSAA.15.000268; Glasson M J, 2006, Cont Lens Anterior Eye, V29, P41, DOI 10.1016/j.clae.2005.12.006; Graham AD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190752; Guillon M, 2019, CONTACT LENS ANTERIO, V42, P246, DOI 10.1016/j.clae.2019.02.001; King-Smith PE, 2000, INVEST OPHTH VIS SCI, V41, P3348; King-Smith PE, 2004, CURR EYE RES, V29, P357, DOI 10.1080/02713680490516099; Kopf M., 2008, J OPTOM, V1, P14, DOI 10.3921/joptom.2008.14; Lin MC, 1999, INVEST OPHTH VIS SCI, V40, P2833; Llorens-Quintana C, 2018, CONTACT LENS ANTERIO, V41, P18, DOI 10.1016/j.clae.2017.08.005; Mann A, 2013, EXP EYE RES, V117, P88, DOI 10.1016/j.exer.2013.07.013; Markoulli M, 2017, CLIN OPTOM, V9, P41, DOI 10.2147/OPTO.S111130; Martin R, 2010, J OPTOM, V3, P169; MENGHER LS, 1985, CURR EYE RES, V4, P1, DOI 10.3109/02713688508999960; MENGHER LS, 1986, ACTA OPHTHALMOL, V64, P441; Mousavi M, 2018, CONTACT LENS ANTERIO, V41, P105, DOI 10.1016/j.clae.2017.08.003; Nagahara Y, 2015, EYE CONTACT LENS, V41, P318, DOI 10.1097/ICL.0000000000000134; Nichols JJ, 2006, INVEST OPHTH VIS SCI, V47, P1319, DOI 10.1167/iovs.05-1392; Nichols JJ, 2003, INVEST OPHTH VIS SCI, V44, P68, DOI 10.1167/iovs.02-0377; Petroll W Matthew, 2003, Eye Contact Lens, V29, pS110; Richdale K, 2007, CORNEA, V26, P168, DOI 10.1097/01.ico.0000248382.32143.86; Rohit A, 2017, OPTOMETRY VISION SCI, V94, P174, DOI 10.1097/OPX.0000000000000996; Siddireddy JS, 2018, OPTOMETRY VISION SCI, V95, P1035, DOI 10.1097/OPX.0000000000001290; Sullivan BD, 2012, CORNEA, V31, P1000, DOI 10.1097/ICO.0b013e318242fd60; Tonge S., 1991, J BR CONT LENS ASS, V14, P201, DOI [10.1016/0141-7037(91)80022-E, DOI 10.1016/0141-7037(91)80022-E]; Truong TN, 2014, OPTOMETRY VISION SCI, V91, P133, DOI 10.1097/OPX.0000000000000138; Vidal-Rohr M, 2018, CONTACT LENS ANTERIO, V41, P117, DOI 10.1016/j.clae.2017.09.009; Wang JH, 2003, INVEST OPHTH VIS SCI, V44, P2524, DOI 10.1167/iovs.02-0731; Weissman B.A., OPTOMETRIC CLIN PRAC, V2nd Ed; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001; Wong H, 1996, J COLLOID INTERF SCI, V184, P44, DOI 10.1006/jcis.1996.0595; Wong Miu Kit, 2002, Clin Exp Optom, V85, P350; Yeh TN, 2015, OPTOMETRY VISION SCI, V92, pE264, DOI 10.1097/OPX.0000000000000649; YOUNG G, 1991, OPHTHAL PHYSL OPT, V11, P53, DOI 10.1111/j.1475-1313.1991.tb00195.x	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0247877	10.1371/journal.pone.0247877	http://dx.doi.org/10.1371/journal.pone.0247877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181641	gold, Green Published			2022-12-26	WOS:000671695800027
J	Subramanian, A				Subramanian, Arjunan			Harnessing digital technology to improve agricultural productivity?	PLOS ONE			English	Article							IMPACT; INFORMATION; PIGEONPEA; EXTENSION; VIRUS; ICT	Can improving access to mobile extension improve agricultural productivity? Recent evidence suggests both significant and insignificant ways in which SMS-based agricultural information could affect farming outcomes. It is unclear if variations in the programs' design or the methodological challenges in evaluating the programs cause wide-ranging impacts. Extension hotline services provide rapid, unambiguous information by agricultural experts over the phone, tailored to time- and crop-specific shocks. Using methods from experimental economics, we randomly distributed the hotline number to generate exogenous variation in the access to farming information. We conducted our study among 300 farmers in the South Indian state of Karnataka. Our results show that eliminating informational inefficiencies increases farmers' average yields for a high-stakes pigeon pea crop that faced adverse aggregate shock. The impact on the yield is through the adoption of cost-effective and improved farming practices. However, we do not observe any effect on the crops that were not affected by the shock. Our findings reveal that advisory recommendations customized to time- and crop-specific shocks are associated with a greater impact on agricultural productivity.	[Subramanian, Arjunan] Univ Glasgow, Adam Smith Business Sch, Glasgow, Lanark, Scotland	University of Glasgow	Subramanian, A (corresponding author), Univ Glasgow, Adam Smith Business Sch, Glasgow, Lanark, Scotland.	arjunan.subramanian@glasgow.ac.uk			ESRC-DFID; ESRC [ES/J009334/1]	ESRC-DFID(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The author thankfully acknowledges the support of the ESRC-DFID funded research project with ESRC Grant Reference: ES/J009334/1. The views expressed in this paper are entirely those of the author and in no way represent either the official policy of funders or the policy of any other part of the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aker JC, 2016, AGR ECON-BLACKWELL, V47, P35, DOI 10.1111/agec.12301; Ameu C, 1994, WORLD BANK TECHNICAL; Antle JM, 2008, ENVIRON DEV ECON, V13, P327, DOI 10.1017/S1355770X08004324; Arouna A., 2020, AM J AGR EC; Ayalew H., 2020, 0620 TEP TRIN COLL D; Babu S. C., 2013, Agricultural Economics Research Review, V26, P159; Barrows G, 2014, ENVIRON DEV ECON, V19, P676, DOI 10.1017/S1355770X14000400; BIRKHAEUSER D, 1991, ECON DEV CULT CHANGE, V39, P607, DOI 10.1086/451893; Birner R., 2007, INT FOOD POLICY RES, V729; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Casaburi Lorenzo., 2019, HARNESSING ICT INCRE; Clarke D., 2019, IZA DP; Cole S., 2012, 13047 HARV BUS SCH F; DeSouza SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104895; Fabregas R, 2019, SCIENCE, V366, P1328, DOI 10.1126/science.aay3038; Fafchamps M, 2012, WORLD BANK ECON REV, V26, P383, DOI 10.1093/wber/lhr056; Feder G., 2010, IFPRI DISCUSSION PAP, V959; Ganapathy K. N., 2012, Australian Journal of Crop Science, V6, P1154; Government of India, 2015, POL FRAM AGR EXT; Jones AT, 2004, PLANT DIS, V88, P436, DOI 10.1094/PDIS.2004.88.5.436; Kumar P.L., 2004, ANN REV PLANT PATHOL, V3, P1; Kumar PL, 2003, PHYTOPATHOLOGY, V93, P71, DOI 10.1094/PHYTO.2003.93.1.71; Nakasone E, 2016, AGR ECON-BLACKWELL, V47, P49, DOI 10.1111/agec.12314; Nakasone E, 2014, ANNU REV RESOUR ECON, V6, P533, DOI 10.1146/annurev-resource-100913-012714; National Sample Survey Organisation, 2005, 49959332 NSSO MIN ST; Norton GW, 2020, APPL ECON PERSPECT P, V42, P8, DOI 10.1002/aepp.13008; Pamuk H, 2015, EUR REV AGRIC ECON, V42, P99, DOI 10.1093/erae/jbu007; Ragasa C., 2017, TECHNICAL REPORT; Ragasa C, 2016, IFPRI DISCUSSION PAP; Rivera W., 2001, AGR RURAL EXTENSION; Van Campenhout B, 2021, AM J AGR ECON, V103, P317, DOI 10.1002/ajae.12089	31	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253377	10.1371/journal.pone.0253377	http://dx.doi.org/10.1371/journal.pone.0253377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181659	gold, Green Published, Green Accepted			2022-12-26	WOS:000671695800024
J	Suda, N; Hernandez, JC; Poulton, J; Jones, JP; Konsoula, Z; Smith, C; Parker, W				Suda, Navneet; Hernandez, Jasmine Cendejas; Poulton, John; Jones, John P.; Konsoula, Zacharoula; Smith, Caroline; Parker, William			Therapeutic doses of acetaminophen with co-administration of cysteine and mannitol during early development result in long term behavioral changes in laboratory rats	PLOS ONE			English	Article							OXIDATIVE STRESS; PARACETAMOL; EXPOSURE; BRAIN; CHILDREN	Based on several lines of evidence, numerous investigators have suggested that acetaminophen exposure during early development can induce neurological disorders. We had previously postulated that acetaminophen exposure early in life, if combined with antioxidants that prevent accumulation of NAPQI, the toxic metabolite of acetaminophen, might be innocuous. In this study, we administered acetaminophen at or below the currently recommended therapeutic dose to male laboratory rat pups aged 4-10 days. The antioxidants cysteine and mannitol were included to prevent accumulation of NAPQI. In addition, animals were exposed to a cassette of common stress factors: an inflammatory diet, psychological stress, antibiotics, and mock infections using killed bacteria. At age 37-49 days, observation during introduction to a novel conspecific revealed increased rearing behavior, an asocial activity, in animals treated with acetaminophen plus antioxidants, regardless of their exposure to oxidative stress factors (2-way ANOVA; P < 0.0001). This observation would suggest that the initial hypothesis is incorrect, and that oxidative stress mediators do not entirely eliminate the effects of acetaminophen on neurodevelopment. This study provides additional cause for caution when considering the use of acetaminophen in the pediatric population, and provides evidence that the effects of acetaminophen on neurodevelopment need to be considered both in the presence and in the absence of oxidative stress.	[Suda, Navneet; Hernandez, Jasmine Cendejas; Poulton, John; Jones, John P.; Konsoula, Zacharoula; Parker, William] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Suda, Navneet; Hernandez, Jasmine Cendejas; Poulton, John; Jones, John P.; Konsoula, Zacharoula; Parker, William] Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA; [Suda, Navneet; Hernandez, Jasmine Cendejas; Poulton, John; Jones, John P.; Konsoula, Zacharoula; Parker, William] Duke Univ, Med Ctr, Durham, NC 27708 USA; [Smith, Caroline] Duke Univ, Duke Inst Brain Sci, Dept Psychol & Neurosci, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Parker, W (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.; Parker, W (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC 27708 USA.; Parker, W (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.	William.Parker@Duke.edu		Parker, William/0000-0003-3644-9152				Auberval N, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-130; Avella-Garcia CB, 2016, INT J EPIDEMIOL, V45, P1987, DOI 10.1093/ije/dyw115; Birmingham PK, 2001, ANESTHESIOLOGY, V94, P385; Bittker SS, 2018, NEUROPSYCH DIS TREAT, V14, P1399, DOI 10.2147/NDT.S158811; Brandlistuen RE, 2013, INT J EPIDEMIOL, V42, P1702, DOI 10.1093/ije/dyt183; Casas Ivan A., 2000, Microbial Ecology in Health and Disease, V12, P247; Cendejas-Hernandez J., 2020, PARACETAMOL ACETAMIN, DOI [10.20944/preprints202011.0173.v1, DOI 10.20944/PREPRINTS202011.0173.V1]; Dean SL, 2012, EUR J NEUROSCI, V35, P1218, DOI 10.1111/j.1460-9568.2012.08032.x; Eick SM, 2018, PAEDIATR PERINAT EP, V32, P318, DOI 10.1111/ppe.12465; El-Ansary A, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0054-4; FDA, 2005, GUID IND EST MAX SAF; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Ji YL, 2020, JAMA PSYCHIAT, V77, P180, DOI 10.1001/jamapsychiatry.2019.3259; Kalemci O, 2017, J KOREAN NEUROSURG S, V60, P355, DOI 10.3340/jkns.2016.0505.015; Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055; Liew Z, 2016, INT J EPIDEMIOL, V45, P2009, DOI 10.1093/ije/dyw296; Liew Z, 2016, EPIDEMIOLOGY, V27, P912, DOI 10.1097/EDE.0000000000000540; Liew Z, 2016, AUTISM RES, V9, P951, DOI 10.1002/aur.1591; Liew Z, 2014, JAMA PEDIATR, V168, P313, DOI 10.1001/jamapediatrics.2013.4914; MacKenzie DA, 2010, MICROBIOL-SGM, V156, P3368, DOI 10.1099/mic.0.043265-0; Novaes RD, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/8159562; Parker W, 2017, J INT MED RES, V45, P407, DOI 10.1177/0300060517693423; Philippot G, 2017, J APPL TOXICOL, V37, P1174, DOI 10.1002/jat.3473; Prescott L., 1996, HEPATOTOXICITY ACETA, P319; SALGADO AS, 1977, MEDICINA-BUENOS AIRE, V37, P38; Schiavone S, 2013, ANTIOXID REDOX SIGN, V18, P1475, DOI 10.1089/ars.2012.4720; Schultz ST, 2008, AUTISM, V12, P293, DOI 10.1177/1362361307089518; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Skovlund E, 2017, PHARMACOEPIDEM DR S, V26, P625, DOI 10.1002/pds.4170; Stergiakouli E, 2016, JAMA PEDIATR, V170, P964, DOI 10.1001/jamapediatrics.2016.1775; Thompson JMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108210; Veenema AH, 2013, PSYCHONEUROENDOCRINO, V38, P2554, DOI 10.1016/j.psyneuen.2013.06.002; Viberg H, 2014, TOXICOL SCI, V138, P139, DOI 10.1093/toxsci/kft329; Vlenterie R, 2016, INT J EPIDEMIOL, V45, P1998, DOI 10.1093/ije/dyw192; Ystrom E, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3840	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253543	10.1371/journal.pone.0253543	http://dx.doi.org/10.1371/journal.pone.0253543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170958	gold, Green Published			2022-12-26	WOS:000671694400031
J	Xu, GG; Dong, CZ; Zhao, T; Yin, HC; Chen, X				Xu, Gaogui; Dong, Chunzhu; Zhao, Tao; Yin, Hongcheng; Chen, Xuan			Acceleration of shooting and bouncing ray method based on OptiX and normal vectors correction	PLOS ONE			English	Article							EQUIVALENT EDGE CURRENTS; PHYSICAL OPTICS; RCS; COMPUTATION; ELIMINATION; INFINITIES; SIMULATION; TRAVERSAL	The present paper deals with a new efficient shooting and bouncing ray (SBR) method based on OptiX and normal vectors correction. The basic idea is to make full use of the computing resources of the RTX series graphics cards. For ray tracing, the algorithm uses OptiX to invoke the built-in RT Cores of hardware. Thus, a fast intersection test can be implemented. To reduce the error of ray tracing caused by the facetted surface characterizing the curved surface, the direction of the reflected ray is corrected by normal vectors correction. Additionally, multiple GPU cores are invoked to accelerate the calculation of far-field integration of millions of ray tubes, which can improve the efficiency of the algorithm while reducing the data transmission time of heterogeneous devices. Simulation results show that the ray path after normal vectors correction is consistent with the theoretical results, and the algorithm can predict the RCS of arbitrary facetted geometries, which is 60 times faster than the SBR method based on kd-tree.	[Xu, Gaogui; Dong, Chunzhu; Zhao, Tao; Yin, Hongcheng; Chen, Xuan] Sci & Technol Electromagnet Scattering Lab, Beijing, Peoples R China; [Xu, Gaogui; Yin, Hongcheng] Commun Univ China, Sch Informat Engn, Beijing, Peoples R China	Communication University of China	Xu, GG (corresponding author), Sci & Technol Electromagnet Scattering Lab, Beijing, Peoples R China.; Xu, GG (corresponding author), Commun Univ China, Sch Informat Engn, Beijing, Peoples R China.	edward2016@cuc.edu.cn						[Anonymous], 2004, P VIS MOD VIS MOD VI; CHATTERJEE A, 1993, IEEE T ANTENN PROPAG, V41, P221, DOI 10.1109/8.214614; Dammertz H, 2008, COMPUT GRAPH FORUM, V27, P1225, DOI 10.1111/j.1467-8659.2008.01261.x; Dandekar KR, 2003, IEEE T VEH TECHNOL, V52, P733, DOI 10.1109/TVT.2003.814936; Garanzha K, 2010, COMPUT GRAPH FORUM, V29, P289, DOI 10.1111/j.1467-8659.2009.01598.x; Guan Y, 2009, ELECTRON LETT, V45, P1092, DOI 10.1049/el.2009.1449; HARRINGTON RF, 1968, FIELD COMPUTATIONS M; Jin J. M., 1993, FINITE ELEMENT METHO; Jin KS, 2006, J ELECTROMAGNET WAVE, V20, P119, DOI 10.1163/156939306775777341; Jiri B., 2013, COMPUT GRAPH FORUM, V32; KNOTT EF, 1985, P IEEE, V73, P252, DOI 10.1109/PROC.1985.13137; KOUYOUMJ.RG, 1965, PR INST ELECTR ELECT, V53, P864, DOI 10.1109/PROC.1965.4065; LING H, 1989, IEEE T ANTENN PROPAG, V37, P194, DOI 10.1109/8.18706; MICHAELI A, 1984, IEEE T ANTENN PROPAG, V32, P252, DOI 10.1109/TAP.1984.1143303; MICHAELI A, 1986, IEEE T ANTENN PROPAG, V34, P912, DOI 10.1109/TAP.1986.1143913; MICHAELI A, 1986, IEEE T ANTENN PROPAG, V34, P1034, DOI 10.1109/TAP.1986.1143941; MITTRA R, 1965, PR INST ELECTR ELECT, V53, P1279, DOI 10.1109/PROC.1965.4229; Parini CG, 2018, APPL COMPUT ELECTROM, V33, P127; Park KK, 2009, J ELECTROMAGNET WAVE, V23, P1657; Parker SG, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778803; PEREZ J, 1994, IEEE T ANTENN PROPAG, V42, P1404, DOI 10.1109/8.320747; Popov S, 2007, COMPUT GRAPH FORUM, V26, P415, DOI 10.1111/j.1467-8659.2007.01064.x; Shevtsov M, 2007, COMPUT GRAPH FORUM, V26, P395, DOI 10.1111/j.1467-8659.2007.01062.x; Shi D, 2017, APPL COMPUT ELECTROM, V32, P614; Stratton J., 1941, ELECTROMAGNETIC THEO; Sullivan, 2015, FERTILIZING BIOSOLID; Tamayama Y, 2008, OPT EXPRESS, V16, P20869, DOI 10.1364/OE.16.020869; Tao YB, 2008, PROG ELECTROMAGN RES, V81, P329, DOI 10.2528/PIER08011305; Tao YB, 2010, IEEE T ANTENN PROPAG, V58, P494, DOI 10.1109/TAP.2009.2037694; Uluisik C, 2008, IEEE ANTENN PROPAG M, V50, P115, DOI 10.1109/MAP.2008.4494511	30	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253743	10.1371/journal.pone.0253743	http://dx.doi.org/10.1371/journal.pone.0253743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170926	Green Published, gold			2022-12-26	WOS:000671694400026
J	Yoshimura, S; Sugimoto, S; Takeuchi, T; Murai, K; Kiuchi, M				Yoshimura, Satoru; Sugimoto, Satoshi; Takeuchi, Takae; Murai, Kensuke; Kiuchi, Masato			Identification of fragment ions produced by the decomposition of tetramethyltin and the production of low-energy Sn+ ion beam	PLOS ONE			English	Article							CHEMICAL-VAPOR-DEPOSITION; TIN OXIDE; THIN-FILMS; OPTICAL-PROPERTIES; SILICON; PYROLYSIS; GERMANIUM; KINETICS; GROWTH; GAAS	Tetramethyltin was decomposed in an ion source and the fragment ions produced were identified using a low-energy mass-selected ion beam machine. Dominant fragment ions were found to be H+, CH2+, and Sn+. Subsequently, fragment ions were mass-selected. The mass spectrum of the selected ions indicated that only a single peak appeared at the mass number of 120 u, being suggestive of the presence of Sn-120(+) ions. The ion energy was set at the range of 20-100 eV. The Sn+ ion beam was irradiated to a Si substrate, and a film was then found deposited on the substrate after the ion beam irradiation. An X-ray diffraction measurement showed that the film obtained was metallic Sn. Then, the Sn+ ion beam was irradiated to a quartz crystal microbalance substrate. We found that most of the irradiated Sn+ ions were adhered to the substrate, at the ion energy levels of 25 and 58 eV, producing the Sn film, whereas a 107 eV Sn+ beam caused a significant proportion of Sn atoms in the film to detach from the substrate, probably due to sputtering.	[Yoshimura, Satoru; Sugimoto, Satoshi; Kiuchi, Masato] Osaka Univ, Ctr Atom & Mol Technol, Grad Sch Engn, Suita, Osaka, Japan; [Takeuchi, Takae] Nara Womens Univ, Fac Sci, Dept Chem Biol & Environm Sci, Nara, Japan; [Murai, Kensuke] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka, Japan	Osaka University; Nara Womens University; National Institute of Advanced Industrial Science & Technology (AIST)	Yoshimura, S (corresponding author), Osaka Univ, Ctr Atom & Mol Technol, Grad Sch Engn, Suita, Osaka, Japan.	yosimura@ppl.eng.osaka-u.ac.jp			JSPS KAKENHI [JP17H02997]; Iketani Science and Technology Foundation [0321021-A]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Iketani Science and Technology Foundation	This work was partially supported by JSPS KAKENHI (Grant number JP17H02997) and Iketani Science and Technology Foundation (Grant number 0321021-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta DR, 1996, THIN SOLID FILMS, V288, P1, DOI 10.1016/S0040-6090(96)08815-3; ASHWORTH AP, 1987, J CHEM SOC CHEM COMM, P782, DOI 10.1039/c39870000782; FARBER Y, 1994, THIN SOLID FILMS, V241, P282, DOI 10.1016/0040-6090(94)90442-1; FISHWICK M, 1971, J CHEM SOC A, P57, DOI 10.1039/j19710000057; FONTELL A, 1969, CAN J PHYS, V47, P2405, DOI 10.1139/p69-293; GORDON RG, 1989, SOL ENERG MATER, V18, P263, DOI 10.1016/0165-1633(89)90042-7; Himanshu, 2020, SOL ENERGY, V199, P772, DOI 10.1016/j.solener.2020.02.066; Hu JJ, 2005, THIN SOLID FILMS, V472, P58, DOI 10.1016/j.tsf.2004.06.100; JOHNSON RP, 1972, CAN J CHEMISTRY, V50, P50, DOI 10.1139/v72-008; Kikuchi N, 2002, VACUUM, V66, P365, DOI 10.1016/S0042-207X(02)00156-2; LANE DW, 1992, THIN SOLID FILMS, V221, P262, DOI 10.1016/0040-6090(92)90824-U; Liu PY, 2004, VACUUM, V76, P7, DOI 10.1016/j.vacuum.2004.05.004; Liu PY, 2001, J VAC SCI TECHNOL B, V19, P1085, DOI 10.1116/1.1373642; MIYAKE K, 1994, SURF COAT TECH, V65, P208, DOI 10.1016/S0257-8972(94)80034-0; Morscheidt W, 2003, THIN SOLID FILMS, V427, P219, DOI 10.1016/S0040-6090(02)01215-4; OEHR C, 1987, THIN SOLID FILMS, V155, P65, DOI 10.1016/0040-6090(87)90453-6; OGAWA H, 1982, J APPL PHYS, V53, P4448, DOI 10.1063/1.331230; Ohno H, 1999, NUCL INSTRUM METH B, V148, P673, DOI 10.1016/S0168-583X(98)00874-X; PARK SS, 1995, THIN SOLID FILMS, V258, P268, DOI 10.1016/0040-6090(94)06404-0; Premchander P, 2006, PHYSICA B, V376, P507, DOI 10.1016/j.physb.2005.12.129; PROSCIA J, 1992, THIN SOLID FILMS, V214, P175, DOI 10.1016/0040-6090(92)90767-6; Pulpytel J, 2007, J APPL PHYS, V101, DOI 10.1063/1.2561749; Radecka M, 2001, THIN SOLID FILMS, V391, P247, DOI 10.1016/S0040-6090(01)00990-7; SHANTHI E, 1980, J APPL PHYS, V51, P6243, DOI 10.1063/1.327610; TAREY RD, 1985, THIN SOLID FILMS, V128, P181, DOI 10.1016/0040-6090(85)90070-7; THOMPSON JH, 1993, J APPL PHYS, V74, P4375, DOI 10.1063/1.354405; THOMPSON JH, 1992, SURF SCI, V267, P69, DOI 10.1016/0039-6028(92)91091-O; Tran TT, 2017, MAT SCI SEMICON PROC, V62, P192, DOI 10.1016/j.mssp.2016.10.049; Tyczkowski J, 1997, APPL SURF SCI, V113, P534, DOI 10.1016/S0169-4332(96)00943-9; YAJIMA T, 1991, DENKI KAGAKU, V59, P257, DOI 10.5796/kogyobutsurikagaku.59.257; YING TH, 1995, J APPL POLYM SCI, V55, P1537, DOI 10.1002/app.1995.070551105; Yoshimura S, 2006, JPN J APPL PHYS 1, V45, P1813, DOI 10.1143/JJAP.45.1813; Yoshimura S, 2013, NUCL INSTRUM METH B, V315, P222, DOI 10.1016/j.nimb.2013.04.072; Yoshimura S, 2006, JPN J APPL PHYS 1, V45, P8204, DOI 10.1143/JJAP.45.8204; Yoshimura S, 2019, AIP ADV, V9, DOI 10.1063/1.5084181; Yoshimura S, 2018, NUCL INSTRUM METH B, V430, P1, DOI 10.1016/j.nimb.2018.05.040; Yoshimura S, 2018, THIN SOLID FILMS, V655, P22, DOI 10.1016/j.tsf.2018.04.003; Yoshimura S, 2017, SURF COAT TECH, V313, P402, DOI 10.1016/j.surfcoat.2017.02.009; Yoshimura S, 2016, J APPL PHYS, V119, DOI 10.1063/1.4943497; Yoshimura S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.108001; ZAWADZKI AG, 1992, J PHYS CHEM-US, V96, P5364, DOI 10.1021/j100192a035; Zhuo Y, 2018, JPN J APPL PHYS, V57, DOI 10.7567/JJAP.57.01AE03	42	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253870	10.1371/journal.pone.0253870	http://dx.doi.org/10.1371/journal.pone.0253870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170975	gold, Green Published			2022-12-26	WOS:000671694400008
J	AbuAlSamen, MM; El-Elimat, T; Almomani, BA; Al-Sawalha, NA				AbuAlSamen, Mahmoud M.; El-Elimat, Tamam; Almomani, Basima A.; Al-Sawalha, Nour A.			Knowledge and perceptions of synthetic cannabinoids among university students in Jordan	PLOS ONE			English	Article							IDENTIFICATION; PREVALENCE	The emergence of blends of synthetic cannabinoids (SC) is an alarming public health concern in Jordan and worldwide. This study aimed to assess the knowledge and perceptions of university students of SC. A cross-sectional study employing a self-administered questionnaire was used to collect data from 1,789 university students in Jordan. The questionnaire measured the knowledge and perceptions of students of SC. Bivariate and multivariate logistic regression were used to investigate the potential predictors of good knowledge of SC. Perceptions of students regarding SC use, prevalence and availability were investigated using principal component analysis. Self-reported familiarity with SC was high (92.5%), while good knowledge was only demonstrated by (33.6%) of students. Predictors of good knowledge included being a smoker (aOR = 1.369, 95% Cl = 11.041-1.871, p = .026), an alcohol user (aOR = 2.134, 95% CI = 1.362-3.346, p = .001), being informed by traditional media (aOR = 1.367, 95% CI = 11.113-1.679, p = .003), social media (aOR = 1.241, 95% CI = 1.161-1.403, p = .021) and self-familiarity with SC (aOR = 2.499, 95% CI = 1.518-4.114, p < .0001). Students perceived SC use to be prevalent and ethically unacceptable, for religious, social, and legal reasons. There were significant differences in the ethical perceptions against the use of SC detected by gender (p < .0001), smoking (p < .0001) or alcohol use (p = .001), and being informed by both traditional media (p-.001) and social media (p = .001), but there were no differences by the level of knowledge (p = .057). Those of good knowledge and those of low knowledge did not differ on their ethical perceptions of using SC. This study showed that there was a low level of knowledge regarding SC among university students in Jordan, which may play a role in the use of SC in the country. Herein, many opportunities exist for public health education to raise awareness against SC use.	[AbuAlSamen, Mahmoud M.; El-Elimat, Tamam; Almomani, Basima A.; Al-Sawalha, Nour A.] Jordan Univ Sci & Technol, Fac Pharm, Irbid, Jordan	Jordan University of Science & Technology	El-Elimat, T (corresponding author), Jordan Univ Sci & Technol, Fac Pharm, Irbid, Jordan.	telimat@just.edu.jo		AbuAlSamen, MPH, Mahmoud/0000-0003-3218-8303; Al-Sawalha, Nour/0000-0002-7401-8065	Deanship of Research, Jordan University of Science and Technology, Irbid, Jordan [281]	Deanship of Research, Jordan University of Science and Technology, Irbid, Jordan	This research was supported by the Deanship of Research, Jordan University of Science and Technology, Irbid, Jordan [grant number 281, 2017]. TE received the grant. URL: https://www.just.edu.jo/Deanships/DeanshipofResearch/Pages/welcome.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajunaidi S, 2016, LEGAL REV DRUGS PSYC; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Baggio S, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13805; Beyhun NE, 2016, J FORENSIC LEG MED, V38, P1, DOI 10.1016/j.jflm.2015.11.014; Brents LK, 2014, DRUG METAB REV, V46, P72, DOI 10.3109/03602532.2013.839700; Bybaris S., 2016, OFFICIAL STUDY REVEA; Castaneto MS, 2014, DRUG ALCOHOL DEPEN, V144, P12, DOI 10.1016/j.drugalcdep.2014.08.005; Cooks T, 2016, PEDIATR NEPHROL, V31, P61, DOI 10.1007/s00467-014-2978-1; Drug Rehabilitation Center Drug Enforcement Administration., PUBL SEC DIR; Egan KL, 2015, AM J DRUG ALCOHOL AB, V41, DOI 10.3109/00952990.2015.1043438; Forensic and Criminal Evidence Lab, 2016, PUBL SEC DIR; Heckman CJ, 2011, HEALTH EDUC J, V70, P383, DOI 10.1177/0017896910379694; Huffman John W., 2009, P49, DOI 10.1007/978-1-59745-503-9_3; Kandel D, 2015, ACTA PAEDIATR, V104, P130, DOI 10.1111/apa.12851; Khader Y. S., 2008, Eastern Mediterranean Health Journal, V14, P897; Loeffler G, 2016, BRAIN RES BULL, V126, P8, DOI 10.1016/j.brainresbull.2016.04.013; Palamar JJ, 2015, DRUG ALCOHOL DEPEN, V149, P194, DOI 10.1016/j.drugalcdep.2015.01.044; Pechmann Cornelia, 2015, J Med Internet Res, V17, pe50, DOI 10.2196/jmir.3772; Rochefoucauld MdL., 2014, JORD DRUG SIT POL; Salani DA, 2015, J PSYCHOSOC NURS MEN, V53, P36, DOI 10.3928/02793695-20150422-01; Spaderna M, 2013, PSYCHOPHARMACOLOGY, V228, P525, DOI 10.1007/s00213-013-3188-4; Stephens JL., 2011, SYNTHETIC CANNABINOI; Sullivan Gail M, 2013, J Grad Med Educ, V5, P541, DOI 10.4300/JGME-5-4-18; U.S. Department of Justice Drug Enforcement Administration: National Forensic Laboratory Information System, 2016, SYNTH CANN SYNTH CAT; U.S. Department of Justice Drug Enforcement Administration: National Forensic Laboratory Information System, 2014, SYNTH CANN SYNTH CAT; Uchiyama N, 2009, CHEM PHARM BULL, V57, P439, DOI 10.1248/cpb.57.439; United Nations Office on Drugs and Crime, SYNTH CANN HERB PROD; Wiley JL, 2014, LIFE SCI, V97, P55, DOI 10.1016/j.lfs.2013.09.011; Wiley JL, 2012, DRUG ALCOHOL DEPEN, V123, P148, DOI 10.1016/j.drugalcdep.2011.11.001; World Health Organization, 2017, WHO REP GLOB TOB EP	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253632	10.1371/journal.pone.0253632	http://dx.doi.org/10.1371/journal.pone.0253632			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166423	gold, Green Published			2022-12-26	WOS:000671692800008
J	Belok, SH; Bosch, NA; Klings, ES; Walkey, AJ				Belok, Samuel H.; Bosch, Nicholas A.; Klings, Elizabeth S.; Walkey, Allan J.			Evaluation of leukopenia during sepsis as a marker of sepsis-defining organ dysfunction	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS	Background Although both leukocytosis and leukopenia have been considered Systemic Inflammatory Response Syndrome criteria, leukopenia is not generally considered a normal response to infection. We sought to evaluate the prognostic validity of leukopenia as a sign of sepsis-defining hematological organ dysfunction within the Sepsis-3 framework. We hypothesized that leukopenia is associated with higher risk of mortality than leukocytosis among patients with suspected infection. Methods We performed a retrospective cohort study using the Medical Information Mart v1.4 in Intensive Care-III database. Multivariable regression models were used to evaluate the association between leukopenia and mortality in patients with suspected infection defined by Sepsis-3. Results We identified 5,909 ICU patients with suspected infection; 250 (4.2%) had leukopenia. Leukopenia was associated with increased in-hospital mortality compared with leukocytosis (OR, 1.5; 95% CI 1.1-1.9). After adjusting for demographics and comorbidities in the Sepsis-3 consensus model, leukopenia remained associated with increased risk of mortality compared with leukocytosis (OR 1.6, 95% CI 1.2-2.2). Further adjustment for the platelet component of the SOFA attenuated the association between leukopenia and mortality (OR decreased from 1.5 to 1.1). However, 83 (1.4%) of patients had leukopenia without thrombocytopenia and 14 had leukopenia prior to thrombocytopenia. Conclusions Among ICU patients with suspected infection, leukopenia was associated with increased risk of death compared with leukocytosis. Due to correlation with thrombocytopenia, leukopenia did not independently improve the prognostic validity of SOFA; however, leukopenia may present as a sign of sepsis prior to thrombocytopenia in a small subset of patients.	[Belok, Samuel H.; Bosch, Nicholas A.; Klings, Elizabeth S.; Walkey, Allan J.] Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA	Boston University	Belok, SH (corresponding author), Boston Univ, Sch Med, Pulm Ctr, Boston, MA 02118 USA.	samuel.belok@bmc.org		Belok, Samuel/0000-0002-9461-7022; Bosch, Nicholas/0000-0001-7161-5254	NHLBI NIH HHS [T32 HL007035] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Dewitte A, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0337-7; Francois B, 1997, AM J MED, V103, P114, DOI 10.1016/S0002-9343(97)00136-8; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Georges H, 1999, INTENS CARE MED, V25, P198, DOI 10.1007/s001340050816; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Johnson AEW, 2018, J AM MED INFORM ASSN, V25, P32, DOI 10.1093/jamia/ocx084; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; KNAUS WA, 1992, CHEST, V101, P1656, DOI 10.1378/chest.101.6.1656; LEIBOVICI L, 1995, QJM-INT J MED, V88, P181; McDonald B, 2017, BLOOD, V129, P1357, DOI 10.1182/blood-2016-09-741298; Russwurm S, 2002, SHOCK, V17, P263, DOI 10.1097/00024382-200204000-00004; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5	17	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252206	10.1371/journal.pone.0252206	http://dx.doi.org/10.1371/journal.pone.0252206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166406	gold, Green Published			2022-12-26	WOS:000671692800075
J	Mouftah, SF; Cobo-Diaz, JF; Alvarez-Ordonez, A; Elserafy, M; Saif, NA; Sadat, A; El-Shibiny, A; Elhadidy, M				Mouftah, Shaimaa F.; Cobo-Diaz, Jose F.; Alvarez-Ordonez, Avelino; Elserafy, Menattallah; Saif, Nehal A.; Sadat, Asmaa; El-Shibiny, Ayman; Elhadidy, Mohamed			High-throughput sequencing reveals genetic determinants associated with antibiotic resistance in Campylobacter spp. from farm-to-fork	PLOS ONE			English	Article							EFFLUX PUMP CMEABC; MOLECULAR CHARACTERIZATION; MACROLIDE RESISTANCE; JEJUNI; ALIGNMENT; ANIMALS; IDENTIFICATION; SYSTEM; LEVEL	Campylobacter species are one of the most common causative agents of gastroenteritis worldwide. Resistance against quinolone and macrolide antimicrobials, the most commonly used therapeutic options, poses a serious risk for campylobacteriosis treatment. Owing to whole genome sequencing advancements for rapid detection of antimicrobial resistance mechanisms, phenotypic and genotypic resistance trends along the "farm-to-fork" continuum can be determined. Here, we examined the resistance trends in 111 Campylobacter isolates (90 C. jejuni and 21 C. coli) recovered from clinical samples, commercial broiler carcasses and dairy products in Cairo, Egypt. Multidrug resistance (MDR) was observed in 10% of the isolates, mostly from C. coli. The prevalence of MDR was the highest in isolates collected from broiler carcasses (13.3%), followed by clinical isolates (10.5%), and finally isolates from dairy products (4%). The highest proportion of antimicrobial resistance in both species was against quinolones (ciprofloxacin and/or nalidixic acid) (68.4%), followed by tetracycline (51.3%), then erythromycin (12.6%) and aminoglycosides (streptomycin and/or gentamicin) (5.4%). Similar resistance rates were observed for quinolones, tetracycline, and erythromycin among isolates recovered from broiler carcasses and clinical samples highlighting the contribution of food of animal sources to human illness. Significant associations between phenotypic resistance and putative gene mutations was observed, with a high prevalence of the gyrA T86I substitution among quinolone resistant isolates, tet(O), tet(W), and tet(32) among tetracycline resistant isolates, and 23S rRNA A2075G and A2074T mutations among erythromycin resistant isolates. Emergence of resistance was attributed to the dissemination of resistance genes among various lineages, with the dominance of distinctive clones. For example, sub-lineages of CC828 in C. coli and CC21 in C. jejuni and the genetically related clonal complexes 'CC206 and CC48' and 'CC464, CC353, CC354, CC574', respectively, propagated across different niches sharing semi-homogenous resistance patterns.	[Mouftah, Shaimaa F.; Elserafy, Menattallah; Saif, Nehal A.; El-Shibiny, Ayman; Elhadidy, Mohamed] Univ Sci & Technol, Zewail City Sci & Technol, Biomed Sci Program, Giza, Egypt; [Cobo-Diaz, Jose F.; Alvarez-Ordonez, Avelino] Univ Leon, Dept Food Hyg & Technol, Leon, Spain; [Cobo-Diaz, Jose F.; Alvarez-Ordonez, Avelino] Univ Leon, Inst Food Sci & Technol, Leon, Spain; [Elserafy, Menattallah] Zewail City Sci & Technol, Ctr Genom, Helmy Inst Med Sci, Giza, Egypt; [Sadat, Asmaa; Elhadidy, Mohamed] Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura, Egypt; [El-Shibiny, Ayman] Arish Univ, Fac Environm Agr Sci, Arish, Egypt	Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology; Universidad de Leon; Universidad de Leon; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Mansoura University	Elhadidy, M (corresponding author), Univ Sci & Technol, Zewail City Sci & Technol, Biomed Sci Program, Giza, Egypt.; Elhadidy, M (corresponding author), Mansoura Univ, Fac Vet Med, Dept Bacteriol Mycol & Immunol, Mansoura, Egypt.	melhadidy@zewailcity.edu.eg	Elserafy, Menattallah/U-4761-2017; Díaz, José Francisco Cobo/S-4150-2017	Elserafy, Menattallah/0000-0002-0272-8498; Díaz, José Francisco Cobo/0000-0002-0898-2358; Mouftah, Shaimaa/0000-0002-4143-509X; Saif, Nehal/0000-0003-3663-0293	Zewail City internal research fund [ZC 004-2019, 1110]	Zewail City internal research fund	This work was partially funded by the Zewail City internal research fund (agreement number ZC 004-2019) and joint ASRT-BA research grant (project number 1110) awarded to Dr. Mohamed Elhadidy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Monsef A., 2019, ZAGAZIG VET J, P21, DOI [10.21608/zvjz.2019.6003.1008, DOI 10.21608/ZVJZ.2019.6003.1008]; Alfredson DA, 2005, ANTIMICROB AGENTS CH, V49, P2515, DOI 10.1128/AAC.49.6.2515-2518.2005; Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Asuming-Bediako N, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8020087; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Cagliero C, 2006, ANTIMICROB AGENTS CH, V50, P3893, DOI 10.1128/AAC.00616-06; Corcoran D, 2006, INT J ANTIMICROB AG, V27, P40, DOI 10.1016/j.ijantimicag.2005.08.019; Dai L, 2020, TRANSL RES, V223, P76, DOI 10.1016/j.trsl.2020.04.009; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Divsalar G, 2019, COMP IMMUNOL MICROB, V65, P194, DOI 10.1016/j.cimid.2019.06.001; Elhadidy M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227833; Elhadidy M, 2019, TRANSBOUND EMERG DIS, V66, P463, DOI 10.1111/tbed.13046; Ellington MJ, 2017, CLIN MICROBIOL INFEC, V23, P2, DOI 10.1016/j.cmi.2016.11.012; European Food Safety Authority, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5598; Giacomelli M, 2012, AVIAN PATHOL, V41, P579, DOI 10.1080/03079457.2012.734915; Hao HH, 2013, ANTIMICROB AGENTS CH, V57, P1369, DOI 10.1128/AAC.01927-12; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Krawczyk PS, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gkx1321; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lin J, 2005, ANTIMICROB AGENTS CH, V49, P1067, DOI 10.1128/AAC.49.3.1067-1075.2005; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Marotta F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223804; McCormick Benjamin J J, 2016, Trop Dis Travel Med Vaccines, V2, P11, DOI 10.1186/s40794-016-0028-7; Mourkas E, 2019, ENVIRON MICROBIOL, V21, P4597, DOI 10.1111/1462-2920.14760; Newell DG, 2017, CAMPYLOBACTER: FEATURES, DETECTION, AND PREVENTION OF FOODBORNE DISEASE, P85, DOI 10.1016/B978-0-12-803623-5.00005-8; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Piddock LJV, 2003, J ANTIMICROB CHEMOTH, V51, P19, DOI 10.1093/jac/dkg033; Proietti PC, 2020, VET MICROBIOL, V241, DOI 10.1016/j.vetmic.2019.108553; Reddy S, 2017, ONDERSTEPOORT J VET, V84, DOI 10.4102/ojvr.v84i1.1411; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Sheppard SK, 2014, MOL ECOL, V23, P2442, DOI 10.1111/mec.12742; Sheppard SK, 2009, INT J FOOD MICROBIOL, V134, P96, DOI 10.1016/j.ijfoodmicro.2009.02.010; Silva J, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00200; Sproston EL, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000198; Tang YZ, 2017, ANIM HEALTH RES REV, V18, P87, DOI 10.1017/S1466252317000135; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Wysok B, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01799; Zahin M, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/340605, 10.1155/2013/263509, 10.1155/2013/605831, 10.1155/2013/510736]; Zankari E, 2017, J ANTIMICROB CHEMOTH, V72, P2764, DOI 10.1093/jac/dkx217; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang J, 2015, J CLIN MICROBIOL, V53, P1765, DOI 10.1128/JCM.00051-15; Zhao S, 2016, APPL ENVIRON MICROB, V82, P459, DOI 10.1128/AEM.02873-15	52	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253797	10.1371/journal.pone.0253797	http://dx.doi.org/10.1371/journal.pone.0253797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166472	gold, Green Published			2022-12-26	WOS:000671692800051
J	Nishida, S; Nagaishi, K; Motoya, M; Kumagai, A; Terada, N; Kasuga, A; Kubota, N; Iesato, K; Kimizuka, M; Miyajima, S; Koyama, M; Ohnishi, H; Narimatsu, E; Masumori, N; Tsuchihashi, K; Tsukamoto, T; Tsuji, Y				Nishida, Sachiyo; Nagaishi, Kanna; Motoya, Masayo; Kumagai, Ayako; Terada, Noriko; Kasuga, Ai; Kubota, Narumi; Iesato, Kotoe; Kimizuka, Motonobu; Miyajima, Satsuki; Koyama, Masayuki; Ohnishi, Hirofumi; Narimatsu, Eichi; Masumori, Naoya; Tsuchihashi, Kazufumi; Tsukamoto, Taiji; Tsuji, Yoshihisa			Dilemma of physician-mothers faced with an increased home burden and clinical duties in the hospital during the COVID-19 pandemic	PLOS ONE			English	Article							WOMEN	Purpose Since December 2019, coronavirus disease 2019 (COVID-19) has spread rapidly across the world. During the pandemic, physicians in our hospital have had to respond both to the issue of treating the patients and the increasing domestic burden associated with social disruption. The purpose of this study was to assess how much the burden on our doctors, especially female doctors, was increasing. Material and methods The Physicians' Career Support Committee in Sapporo Medical University conducted a questionnaire survey. The questionnaire inquired about a wide range of subjects with regard to working style and family life during the first and second waves of the COVID-19 pandemic, and was sent to all medical/dental physicians working in Sapporo Medical University. Results A total of 266 (42.7%) physicians in our hospital responded to our questionnaire and the data for 264 data were analyzed. The total numbers of males, females, and others, including those who did not want to specify, were 178 (67.4%), 82 (31.0%), and 4 (1.5%), respectively. Among them, 62 (23.5%) and 23 (8.7%) answered that their domestic burden was slightly or markedly increased. The increase in the domestic burden showed a significant difference between genders (p = 0.04). Even after correction for background differences using multivariate analysis, being female (p<0.001), having child dependents (p<0.001), and treating COVID-19 patients (p = 0.03) were significantly related to an increased domestic burden. Regarding family style, 58.1% of the physician-fathers were from two-income families (i.e., families with both parents in employment), and they answered that their partner mainly cared for the children. In contrast, 97.3% of physician-mothers were from two-income families, and 94.6% of the physician-mothers had to take care of children by themselves. Conclusion Physician-mothers are caught in a dilemma between an increased home burden and clinical duties in the hospital, with a significantly higher ratio than physician-fathers during the pandemic. As we showed, female doctors could have not continued their careers and take responsible positions in the same way as male doctors. This is a social risk in the timing of a crisis, such as a pandemic.	[Nishida, Sachiyo; Nagaishi, Kanna; Motoya, Masayo; Kumagai, Ayako; Terada, Noriko; Kasuga, Ai; Kubota, Narumi; Iesato, Kotoe; Kimizuka, Motonobu; Miyajima, Satsuki; Tsuji, Yoshihisa] Sapporo Med Univ, Phys Career Support Comm, Sapporo, Hokkaido, Japan; [Nishida, Sachiyo; Masumori, Naoya] Sapporo Med Univ, Dept Urol, Sapporo, Hokkaido, Japan; [Nagaishi, Kanna] Sapporo Med Univ, Dept Anat, Sapporo, Hokkaido, Japan; [Motoya, Masayo] Sapporo Med Univ, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Kumagai, Ayako] Sapporo Med Univ, Dept Dermatol, Sapporo, Hokkaido, Japan; [Terada, Noriko] Sapporo Med Univ, Dept Gynecol, Sapporo, Hokkaido, Japan; [Kasuga, Ai; Iesato, Kotoe] Sapporo Med Univ, Dept Pediat, Sapporo, Hokkaido, Japan; [Kubota, Narumi; Narimatsu, Eichi] Sapporo Med Univ, Dept Emergency Med, Sapporo, Hokkaido, Japan; [Kimizuka, Motonobu] Sapporo Med Univ, Dept Anesthesiol, Sapporo, Hokkaido, Japan; [Miyajima, Satsuki] Sapporo Med Univ, Dept Resp Med, Sapporo, Hokkaido, Japan; [Koyama, Masayuki; Ohnishi, Hirofumi] Sapporo Med Univ, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Koyama, Masayuki; Tsuchihashi, Kazufumi] Sapporo Med Univ, Dept Cardiovasc Renal & Metab Med, Sapporo, Hokkaido, Japan; [Tsuchihashi, Kazufumi] Sapporo Med Univ, Sch Med, Div Hlth Care Adm & Management, Sapporo, Hokkaido, Japan; [Tsukamoto, Taiji] Sapporo Med Univ, Dept Univ Adm, Sapporo, Hokkaido, Japan; [Tsuji, Yoshihisa] Sapporo Med Univ, Dept Gen Med, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Tsuji, Y (corresponding author), Sapporo Med Univ, Phys Career Support Comm, Sapporo, Hokkaido, Japan.; Tsuji, Y (corresponding author), Sapporo Med Univ, Dept Gen Med, Sapporo, Hokkaido, Japan.	ytsuji@sapmed.ac.jp	Koyama, Masayuki/GQP-8789-2022; 西田, 幸代/ADH-2461-2022; Yoshihisa, Tsuji/AAW-2327-2021	Koyama, Masayuki/0000-0002-8165-5855; Nishida, Sachiyo/0000-0002-3608-3931				[Anonymous], 2020, NBER WORKING PAPER S; [Anonymous], 2020, IMP COVID 19 WOM; [Anonymous], 2021, GLOBAL GENDER GAP RE; [Anonymous], 2020, COR IS NOT GEND BLIN; Jones Y, 2020, J HOSP MED, V15, P507, DOI 10.12788/jhm.3470; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawase K, 2018, SURG TODAY, V48, P308, DOI 10.1007/s00595-017-1586-7; McEwan JR, 2010, QJM-INT J MED, V103, P635, DOI 10.1093/qjmed/hcq101; Mobilos Sophia, 2008, Can Fam Physician, V54, P1285; Parsons WL, 2009, CAN FAM PHYSICIAN, V55, P808; Tsukada YT, 2009, CIRC J, V73, P2076, DOI 10.1253/circj.CJ-09-0206	11	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253646	10.1371/journal.pone.0253646	http://dx.doi.org/10.1371/journal.pone.0253646			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166439	Green Published, gold			2022-12-26	WOS:000671692800090
J	Attanasio, LB; Ranchoff, BL; Geissler, KH				Attanasio, Laura B.; Ranchoff, Brittany L.; Geissler, Kimberley H.			Perceived discrimination during the childbirth hospitalization and postpartum visit attendance and content: Evidence from the Listening to Mothers in California survey	PLOS ONE			English	Article							PRENATAL-CARE; HEALTH-CARE; ADHERENCE	Objective Postpartum visits are an important opportunity to address ongoing maternal health. Experiences of discrimination in healthcare can impact healthcare use, including postpartum visits. However, it is unknown whether discrimination is associated with postpartum visit content. This study aimed to examine the relationship between perceived discrimination during the childbirth hospitalization and postpartum visit attendance and content. Research design Data were from Listening to Mothers in California, a population-based survey of people with a singleton hospital birth in California in 2016. Adjusted logistic regression models estimated the association between perceived discrimination during the childbirth hospitalization and 1) postpartum visit attendance, and 2) topics addressed at the postpartum visit (birth control, depression and breastfeeding) for those who attended. Results 90.6% of women attended a postpartum visit, and 8.6% reported discrimination during the childbirth hospitalization. In adjusted models, any discrimination and insurance-based discrimination were associated with 7 and 10 percentage point (pp) lower predicted probabilities of attending a postpartum visit, respectively. There was a 7pp lower predicted probability of discussing birth control for women who had experienced discrimination (81% vs. 88%), a 15pp lower predicted probability of being asked about depression (64% vs. 79%), and a 9 pp lower predicted probability of being asked about breastfeeding (57% vs. 66%). Conclusions Amid heightened attention to the importance of postpartum care, there is a need to better understand determinants of postpartum care quality. Our findings highlight the potential consequences of healthcare discrimination in the perinatal period, including lower quality of postpartum care.	[Attanasio, Laura B.; Ranchoff, Brittany L.; Geissler, Kimberley H.] Univ Massachusetts, Amherst Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Attanasio, LB (corresponding author), Univ Massachusetts, Amherst Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA.	lattanasio@mass.edu			National Heart Lung and Blood Institute [R56 HL151636-01]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grant R56 HL151636-01 from the National Heart Lung and Blood Institute (https://www.nhlbi.nih.gov/), awarded to LBA and KHG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 2001, PUBLIC HEALTH REP, V116, P306; [Anonymous], 2016, Obstet Gynecol, V127, pe187, DOI 10.1097/AOG.0000000000001487; [Anonymous], 2018, OBSTET GYNECOL, V131, DOI [10.1097/AOG.0000000000002633 29683911, DOI 10.1097/AOG.000000000000263329683911]; [Anonymous], 2018, LISTENING MOTHERS CA; [Anonymous], 2020, PUBLIC USE DATA FILE; Atrash H, 2008, AM J OBSTET GYNECOL, V199, pS259, DOI 10.1016/j.ajog.2008.08.059; Attanasio L, 2017, MED CARE, V55, P830, DOI 10.1097/MLR.0000000000000773; Ben J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189900; Benjamins MR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215976; Bleich SN, 2019, HEALTH SERV RES, V54, P1399, DOI 10.1111/1475-6773.13220; Bryant AS, 2006, MATERN CHILD HLTH J, V10, P511, DOI 10.1007/s10995-006-0128-5; Burgess DJ, 2008, J HEALTH CARE POOR U, V19, P894, DOI 10.1353/hpu.0.0063; Casagrande SS, 2007, J GEN INTERN MED, V22, P389, DOI 10.1007/s11606-006-0057-4; Coley SL, 2018, WOMEN HEALTH ISS, V28, P158, DOI 10.1016/j.whi.2017.10.014; Danilack VA, 2019, MATERN CHILD HLTH J, V23, P903, DOI 10.1007/s10995-018-02716-x; de Bocanegra HT, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.02.040; De PK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239482; Declercq ER., 2013, LISTENING MOTHERS; Declercq E, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03137-x; Declercq E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235262; Declercq ER, 2014, J PERINAT EDUC, V23, P17, DOI 10.1891/1058-1243.23.1.17; Declercq ER, 2020, J MIDWIFERY WOM HEAL, V65, P45, DOI 10.1111/jmwh.13027; DiBari JN, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/530769; Dyer J, 2018, MATERN CHILD HLTH J, V22, P679, DOI 10.1007/s10995-018-2436-y; Findling MG, 2019, HEALTH SERV RES, V54, P1409, DOI 10.1111/1475-6773.13216; Geissler K, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25095; Han XX, 2015, AM J PUBLIC HEALTH, V105, pS517, DOI 10.2105/AJPH.2015.302668; Hausmann LRM, 2011, MED CARE, V49, P626, DOI 10.1097/MLR.0b013e318215d93c; Haywood C, 2014, J GEN INTERN MED, V29, P1657, DOI 10.1007/s11606-014-2986-7; Henderson V, 2016, MATERN CHILD HLTH J, V20, pS132, DOI 10.1007/s10995-016-2044-7; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Krishnamurti T, 2020, BMC HEALTH SERV RES, V2, P1; MacDonald S., 2018, MED CARE, V55, P1, DOI [10.1097/MLR.0000000000000746.Associations, DOI 10.1097/MLR.0000000000000746.ASSOCIATIONS]; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Masho SW, 2018, J WOMENS HEALTH, V27, P836, DOI 10.1089/jwh.2016.6137; Mays VM, 2016, MED CARE, V00, P1; McMurtry CL, 2019, HEALTH SERV RES, V54, P1419, DOI 10.1111/1475-6773.13225; Morgan I, 2018, MATERN CHILD HLTH J, V22, P589, DOI 10.1007/s10995-018-2428-y; Noonan K, 2013, MATERN CHILD HLTH J, V17, P189, DOI 10.1007/s10995-012-0966-2; Sakala C, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03095-4; Shulman HB, 2018, AM J PUBLIC HEALTH, V108, P1305, DOI 10.2105/AJPH.2018.304563; Siddique J, 2012, MATERN CHILD HLTH J, V16, P51, DOI 10.1007/s10995-010-0723-3; Sword W, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-29; Wilcox A, 2016, MATERN CHILD HLTH J, V20, pS22, DOI 10.1007/s10995-016-2184-9	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253055	10.1371/journal.pone.0253055	http://dx.doi.org/10.1371/journal.pone.0253055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161359	Green Published, gold			2022-12-26	WOS:000671691900037
J	Chong, KM; Chen, JW; Lien, WC; Yang, MF; Wang, HC; Liu, SSH; Chen, YP; Chi, CY; Wu, MCH; Wu, CY; Liao, ECW; Huang, EPC; He, HC; Yang, HW; Huang, CH; Ko, PCI				Chong, Kah-Meng; Chen, Jiun-Wei; Lien, Wan-Ching; Yang, Mei-Fen; Wang, Hui-Chih; Liu, Sot Shih-Hung; Chen, Yen-Pin; Chi, Chien-Yu; Wu, Marvin Chih-Hsien; Wu, Cheng-Yi; Liao, Edward Che-Wei; Huang, Edward Pei-Chuan; He, Hsien-Chin; Yang, Hsiang-Wen; Huang, Chien-Hua; Ko, Patrick Chow-In			Attitude and behavior toward bystander cardiopulmonary resuscitation during COVID-19 outbreak	PLOS ONE			English	Article							HOSPITAL CARDIAC-ARREST; WILLINGNESS; CPR; KNOWLEDGE; OUTCOMES; RISK	Background Outbreaks of emerging infectious diseases, such as COVID-19, have negative impacts on bystander cardiopulmonary resuscitation (BCPR) for fear of transmission while breaking social distancing rules. The latest guidelines recommend hands-only cardiopulmonary resuscitation (CPR) and facemask use. However, public willingness in this setup remains unknown. Methods A cross-sectional, unrestricted volunteer Internet survey was conducted to assess individuals' attitudes and behaviors toward performing BCPR, pre-existing CPR training, occupational identity, age group, and gender. The raking method for weights and a regression analysis for the predictors of willingness were performed. Results Among 1,347 eligible respondents, 822 (61%) had negative attitudes toward performing BCPR. Healthcare providers (HCPs) and those with pre-existing CPR training had fewer negative attitudes (p < 0.001); HCPs and those with pre-existing CPR training and unchanged attitude showed more positive behaviors toward BCPR (p < 0.001). Further, 9.7% of the respondents would absolutely refuse to perform BCPR. In contrast, 16.9% would perform BCPR directly despite the outbreak. Approximately 9.9% would perform it if they were instructed, 23.5%, if they wore facemasks, and 40.1%, if they were to perform hands-only CPR. Interestingly, among the 822 respondents with negative attitudes, over 85% still tended to perform BCPR in the abovementioned situations. The weighted analysis showed similar results. The adjusted predictors for lower negative attitudes toward BCPR were younger age, being a man, and being an HCP; those for more positive behaviors were younger age and being an HCP. Conclusions Outbreaks of emerging infectious diseases, such as COVID-19, have negative impacts on attitudes and behaviors toward BCPR. Younger individuals, men, HCPs, and those with pre-existing CPR training tended to show fewer negative attitudes and behaviors. Meanwhile, most individuals with negative attitudes still expressed positive behaviors under safer measures such as facemask protection, hands-only CPR, and available dispatch instructions.	[Chong, Kah-Meng; Lien, Wan-Ching; Yang, Mei-Fen; Wang, Hui-Chih; Liu, Sot Shih-Hung; Chen, Yen-Pin; Wu, Cheng-Yi; Liao, Edward Che-Wei; Huang, Edward Pei-Chuan; Huang, Chien-Hua; Ko, Patrick Chow-In] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Emergency Med, Coll Med, Taipei, Taiwan; [Chen, Jiun-Wei; Liu, Sot Shih-Hung; Wu, Marvin Chih-Hsien; Wu, Cheng-Yi; Huang, Edward Pei-Chuan] Natl Taiwan Univ Hosp, Dept Emergency Med, Hsin Chu Branch, Hsinchu, Taiwan; [Chi, Chien-Yu] Natl Taiwan Univ Hosp, Dept Emergency Med, Yunlin Branch, Huwei Township, Yunlin, Taiwan; [He, Hsien-Chin] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Family Med, Coll Med, Taipei, Taiwan; [Yang, Hsiang-Wen] Natl Taiwan Univ, Civil Engn, Grad Comp Aided Engn Grp, Taipei, Taiwan; [Ko, Patrick Chow-In] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Ko, PCI (corresponding author), Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Emergency Med, Coll Med, Taipei, Taiwan.; Ko, PCI (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei, Taiwan.	patrick.patko@gmail.com		HUANG, CHIEN-HUA/0000-0003-2981-4537; Wang, Hui-Chih/0000-0001-9279-5688; Liu, Shih-Hung/0000-0003-4178-1694; Chong, Kah Meng/0000-0001-8129-9021; LIEN, WAN-CHING/0000-0001-9448-5093; Pei-Chuan Huang, Edward/0000-0002-4800-2561; Chen, Yen-Pin/0000-0002-2473-0847	National Taiwan University Hospital Top-Down Project [107-109 T07]; National Science Council Project [104-2314-B-002-034, 105-2314-B-002171, 108-2320-B002-053-MY2]	National Taiwan University Hospital Top-Down Project; National Science Council Project	This study was supported by grants from the National Taiwan University Hospital Top-Down Project 107-109 T07; and National Science Council Project (104-2314-B-002-034, 105-2314-B-002171, and 108-2320-B002-053-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Baldi E, 2020, NEW ENGL J MED, V383, P496, DOI 10.1056/NEJMc2010418; Baldi E, 2014, RESUSCITATION, V85, pE195, DOI 10.1016/j.resuscitation.2014.10.001; Birkun A, 2020, RESUSCITATION, V152, P105, DOI 10.1016/j.resuscitation.2020.05.023; Bottiger BW, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017230; Caves ND, 2006, RESUSCITATION, V68, P93, DOI 10.1016/j.resuscitation.2005.05.014; Cheng HY, 2020, J FORMOS MED ASSOC, V119, P771, DOI 10.1016/j.jfma.2020.03.007; Coons SJ, 2009, RESUSCITATION, V80, P334, DOI 10.1016/j.resuscitation.2008.11.024; Couper K, 2020, RESUSCITATION, V151, P59, DOI 10.1016/j.resuscitation.2020.04.022; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; Dobbie F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193391; Edelson DP, 2020, CIRCULATION, V141, pE933, DOI 10.1161/CIRCULATIONAHA.120.047463; Fabrigar LR, 2006, J PERS SOC PSYCHOL, V90, P556, DOI 10.1037/0022-3514.90.4.556; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Govindarajan P, 2012, RESUSCITATION, V83, P76, DOI 10.1016/j.resuscitation.2011.06.026; Hsu YC, 2017, HEALTH SECUR, V15, P165, DOI 10.1089/hs.2016.0111; Huang EPC, 2019, J FORMOS MED ASSOC, V118, P572, DOI 10.1016/j.jfma.2018.07.018; Huang IYF, 2020, PUBLIC ADMIN REV, V80, P665, DOI 10.1111/puar.13239; Islam MS, 2020, INFECT CONT HOSP EP, V41, P1196, DOI 10.1017/ice.2020.237; Kiguchi T, 2020, RESUSCITATION, V152, P39, DOI 10.1016/j.resuscitation.2020.02.044; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Kuramoto N, 2008, RESUSCITATION, V79, P475, DOI 10.1016/j.resuscitation.2008.07.005; Lam KK, 2007, PREHOSPITAL DISASTER, V22, P325, DOI 10.1017/S1049023X00004957; Lee MJ, 2013, RESUSCITATION, V84, P889, DOI 10.1016/j.resuscitation.2013.01.009; Marijon E, 2020, LANCET PUBLIC HEALTH, V5, pE437, DOI 10.1016/S2468-2667(20)30117-1; Moon S, 2020, AM J EMERG MED, V38, P1760, DOI 10.1016/j.ajem.2020.05.108; Nolan JP, 2020, RESUSCITATION, V153, P45, DOI 10.1016/j.resuscitation.2020.06.001; ORNATO JP, 1990, ANN EMERG MED, V19, P151, DOI 10.1016/S0196-0644(05)81800-1; Perkins GD, 2020, LANCET PUBLIC HEALTH, V5, pE415, DOI 10.1016/S2468-2667(20)30134-1; Perman SM, 2020, CIRCULATION, V142, P1233, DOI 10.1161/CIRCULATIONAHA.120.048909; Pranata R, 2020, INTERN EMERG MED, V15, P875, DOI 10.1007/s11739-020-02428-7; Riggs M, 2019, RESUSCITATION, V138, P259, DOI 10.1016/j.resuscitation.2019.03.019; Savastano S, 2011, RESUSCITATION, V82, P568, DOI 10.1016/j.resuscitation.2010.12.010; Scquizzato T, 2020, RESUSCITATION, V150, P92, DOI 10.1016/j.resuscitation.2020.03.019; Shekhar AC, 2020, RESUSCITATION, V154, P50, DOI 10.1016/j.resuscitation.2020.06.032; Wang CJ, 2020, JAMA-J AM MED ASSOC, V323, P1341, DOI 10.1001/jama.2020.3151; Wang PW, 2020, J MED INTERNET RES, V22, DOI 10.2196/20021; White IM, 2008, OPT EXPRESS, V16, P1020, DOI 10.1364/OE.16.001020	41	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252841	10.1371/journal.pone.0252841	http://dx.doi.org/10.1371/journal.pone.0252841			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161378	Green Published, gold			2022-12-26	WOS:000671691900044
J	Nader, D; Fletcher, N; Curley, GF; Kerrigan, SW				Nader, Danielle; Fletcher, Nicola; Curley, Gerard F.; Kerrigan, Steven W.			SARS-CoV-2 uses major endothelial integrin alpha v beta 3 to cause vascular dysregulation in-vitro during COVID-19	PLOS ONE			English	Article							TNF-ALPHA; INFECTION; ACE2	The unprecedented global COVID-19 pandemic has prompted a desperate international effort to accelerate the development of anti-viral candidates. For unknown reasons, COVID-19 infections are associated with adverse cardiovascular complications, implicating that vascular endothelial cells are essential in viral propagation. The etiological pathogen, SARS-CoV-2, has a higher reproductive number and infection rate than its predecessors, indicating it possesses novel characteristics that infers enhanced transmissibility. A unique K403R spike protein substitution encodes an Arg-Gly-Asp (RGD) motif, introducing a potential role for RGD-binding host integrins. Integrin alpha V beta 3 is widely expressed across the host, particularly in the endothelium, which acts as the final barrier before microbial entry into the bloodstream. This mutagenesis creates an additional binding site, which may be sufficient to increase SARS-CoV-2 pathogenicity. Here, we investigate how SARS-CoV-2 passes from the epithelium to endothelium, the effects of alpha V beta 3 antagonist, Cilengitide, on viral adhesion, vasculature permeability and leakage, and also report on a simulated interaction between the viral and host protein in-silico.	[Nader, Danielle; Kerrigan, Steven W.] RCSI Univ Med & Hlth Sci, Royal Coll Surg Ireland, Sch Pharm & Biomol Sci, Cardiovasc Infect Res Grp, Dublin 2, Ireland; [Fletcher, Nicola] Univ Coll Dublin, Vet Sci Ctr, Sch Vet Med, Dublin 4, Ireland; [Curley, Gerard F.] RCSI Univ Med & Hlth Sci, Beaumont Hosp, Royal Coll Surg Ireland, Dept Anaesthesia & Crit Care Med, Dublin, Ireland	Royal College of Surgeons - Ireland; University College Dublin; Royal College of Surgeons - Ireland	Kerrigan, SW (corresponding author), RCSI Univ Med & Hlth Sci, Royal Coll Surg Ireland, Sch Pharm & Biomol Sci, Cardiovasc Infect Res Grp, Dublin 2, Ireland.	skerrigan@rcsi.ie		Nader, Danielle/0000-0001-5876-8096; Fletcher, Nicola/0000-0001-5593-9742	Enterprise Ireland (EI) [SI/2020/3044]; 3M Global Giving [PT20306A01]	Enterprise Ireland (EI); 3M Global Giving(3M)	This publication has emanated from research conducted with the financial support of Enterprise Ireland (EI) under Grant Number SI/2020/3044 (SWK) and 3M & Global Giving under grant number PT20306A01 (SWK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep21759; Borczuk AC, 2020, MODERN PATHOL, V33, P2156, DOI 10.1038/s41379-020-00661-1; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cui W, 2010, BRAZ J MED BIOL RES, V43, P330, DOI [10.1590/S0100-879X2010007500020, 10.1590/S0100-879X2010000400002]; European Centre for Disease Prevention and Control, 2020, RAP INCR SARS COV 2; Feldmann M, 2020, LANCET, V395, P1407, DOI 10.1016/S0140-6736(20)30858-8; Fiala M, 1997, MOL MED, V3, P553, DOI 10.1007/BF03401701; Garciarena CD, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1838-3; Giustino G, 2020, J AM COLL CARDIOL, V76, P2043, DOI 10.1016/j.jacc.2020.08.069; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Inyoo S, 2017, JPN J INFECT DIS, V70, P186, DOI [10.7883/yoken.JJID.2016.123, 10.7883/yoken.jjid.2016.123]; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Lozano-Sepulveda SA, 2020, ANN HEPATOL, V19, P590, DOI 10.1016/j.aohep.2020.08.062; Mallapaty S, 2020, NATURE, V587, P340, DOI 10.1038/d41586-020-03218-z; McDonnell CJ, 2016, J THROMB HAEMOST, V14, P2536, DOI 10.1111/jth.13501; McHale TM, 2018, CRIT CARE MED, V46, pE805, DOI 10.1097/CCM.0000000000003219; Nader D, 2020, DRUG DISCOV TODAY, V25, P2317, DOI 10.1016/j.drudis.2020.09.038; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Porfidia A, 2020, J THROMB HAEMOST, V18, P1516, DOI 10.1111/jth.14842; Sarelius IH, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.985954; Schaefer IM, 2020, MODERN PATHOL, V33, P2104, DOI 10.1038/s41379-020-0595-z; Singh B, 2000, AM J PHYSIOL-LUNG C, V278, pL217, DOI 10.1152/ajplung.2000.278.1.L217; Sokalingam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040410; Su G, 2012, AM J RESP CRIT CARE, V185, P58, DOI 10.1164/rccm.201108-1381OC; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Wang YJ, 2020, J HEPATOL, V73, P807, DOI 10.1016/j.jhep.2020.05.002; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yan SJ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00912; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	37	19	19	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253347	10.1371/journal.pone.0253347	http://dx.doi.org/10.1371/journal.pone.0253347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161337	Green Published, gold			2022-12-26	WOS:000671691900027
J	Mares, AG; Pacassoni, G; Marti, JS; Pujals, S; Albertazzi, L				Mares, Adrianna Glinkowska; Pacassoni, Gaia; Marti, Josep Samitier; Pujals, Silvia; Albertazzi, Lorenzo			Formulation of tunable size PLGA-PEG nanoparticles for drug delivery using microfluidic technology	PLOS ONE			English	Article							IN-VITRO; FUNCTIONAL NANOPARTICLES; POLYMERIC NANOPARTICLES; CONTROLLED-RELEASE; SURFACE-CHEMISTRY; ENCAPSULATION; DOXORUBICIN; SHAPE; NANOPRECIPITATION; PHARMACOKINETICS	Amphiphilic block co-polymer nanoparticles are interesting candidates for drug delivery as a result of their unique properties such as the size, modularity, biocompatibility and drug loading capacity. They can be rapidly formulated in a nanoprecipitation process based on self-assembly, resulting in kinetically locked nanostructures. The control over this step allows us to obtain nanoparticles with tailor-made properties without modification of the co-polymer building blocks. Furthermore, a reproducible and controlled formulation supports better predictability of a batch effectiveness in preclinical tests. Herein, we compared the formulation of PLGA-PEG nanoparticles using the typical manual bulk mixing and a microfluidic chip-assisted nanoprecipitation. The particle size tunability and controllability in a hydrodynamic flow focusing device was demonstrated to be greater than in the manual dropwise addition method. We also analyzed particle size and encapsulation of fluorescent compounds, using the common bulk analysis and advanced microscopy techniques: Transmission Electron Microscopy and Total Internal Reflection Microscopy, to reveal the heterogeneities occurred in the formulated nanoparticles. Finally, we performed in vitro evaluation of obtained NPs using MCF-7 cell line. Our results show how the microfluidic formulation improves the fine control over the resulting nanoparticles, without compromising any appealing property of PLGA nanoparticle. The combination of microfluidic formulation with advanced analysis methods, looking at the single particle level, can improve the understanding of the NP properties, heterogeneities and performance.	[Mares, Adrianna Glinkowska; Pacassoni, Gaia; Marti, Josep Samitier; Pujals, Silvia; Albertazzi, Lorenzo] Barcelona Inst Sci & Technol BIST, Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Pacassoni, Gaia] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Marti, Josep Samitier; Pujals, Silvia] Univ Barcelona, Fac Phys, Dept Elect & Biomed Engn, Barcelona, Spain; [Marti, Josep Samitier] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Madrid, Spain; [Albertazzi, Lorenzo] Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst ICMS, Eindhoven, Netherlands	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; Polytechnic University of Turin; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Eindhoven University of Technology	Albertazzi, L (corresponding author), Barcelona Inst Sci & Technol BIST, Inst Bioengn Catalonia IBEC, Barcelona, Spain.; Albertazzi, L (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Inst Complex Mol Syst ICMS, Eindhoven, Netherlands.	l.albertazzi@tue.nl	; Albertazzi, Lorenzo/E-8323-2013; Pujals, Silvia/G-3193-2016	Glinkowska Mares, Adrianna/0000-0002-1560-3918; Albertazzi, Lorenzo/0000-0002-6837-0812; Pujals, Silvia/0000-0003-1776-4296	Spanish Ministry of Science and Innovation [PID2019-109450RB-I00]; Generalitat de Catalunya through the CERCA program [SGR 01536]; foundation Obra Social La Caixa [100010434]; European Research Council [ERC-StG-757397]; CERCA Programme; Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya [2017 SGR 1079]; Spanish Ministry of Economy and Competitiveness (MINECO) [TEC2015-70104-P, TEC2015-72718-EXP, EuUONANOMED II PCIN-2016-025]; "la Caixa" Foundation [1000010434, LCF/BQ/DI17/11620054]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [713673]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya through the CERCA program; foundation Obra Social La Caixa(La Caixa Foundation); European Research Council(European Research Council (ERC)European Commission); CERCA Programme; Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); "la Caixa" Foundation(La Caixa Foundation); European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa)	LA and SP thank the Spanish Ministry of Science and Innovation (PID2019-109450RB-I00/AEI/10.13039/501100011033) and the Generalitat de Catalunya through the CERCA program and 2017 SGR 01536. The authors also acknowledge the the foundation Obra Social La Caixa (ID 100010434) and the European Research Council (ERC-StG-757397). JSM has support from the CERCA Programme and by the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (2017 SGR 1079). This work was partially funded by the Spanish Ministry of Economy and Competitiveness (MINECO) through the projects MINDS (Proyectos I+D Excelencia + FEDER): TEC2015-70104-P, BIOBOT (Programa Explora Ciencia/Tecnologi ' a): TEC2015-72718-EXP and EuUONANOMED II PCIN-2016-025. The project that gave rise to these results received the support of a fellowship from "la Caixa" Foundation (ID 1000010434). The fellowship code of AGM is LCF/BQ/DI17/11620054. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 713673.	Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Amoyav B, 2018, APPL NANOSCI, P10; Anderson JM, 2012, ADV DRUG DELIVER REV, V64, P72, DOI 10.1016/j.addr.2012.09.004; Avgoustakis K, 2002, J CONTROL RELEASE, V79, P123, DOI 10.1016/S0168-3659(01)00530-2; Baby T, 2017, CHEM ENG SCI, V169, P128, DOI 10.1016/j.ces.2017.04.046; Bains A, 2016, J COLLOID INTERF SCI, V475, P136, DOI 10.1016/j.jcis.2016.04.010; Bally F, 2012, POLYMER, V53, P5045, DOI 10.1016/j.polymer.2012.08.039; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Bobo D, 2016, PHARM RES-DORDR, V33, P2373, DOI 10.1007/s11095-016-1958-5; Brzezinski M, 2021, COLLOID SURFACE B, V201, DOI 10.1016/j.colsurfb.2021.111598; Brzezinski M, 2019, POLYM INT, V68, P997, DOI 10.1002/pi.5753; Chen S, 2011, MACROMOL BIOSCI, V11, P576, DOI 10.1002/mabi.201000427; Cieslewicz M, 2013, P NATL ACAD SCI USA, V110, P15919, DOI 10.1073/pnas.1312197110; D'Souza S, 2014, J DRUG DELIV, V2014, DOI 10.1155/2014/620464; Ding SK, 2016, EXPERT OPIN DRUG DEL, V13, P1447, DOI 10.1080/17425247.2016.1193151; Donahue ND, 2019, ADV DRUG DELIVER REV, V143, P68, DOI 10.1016/j.addr.2019.04.008; Eliaz RE, 2000, J BIOMED MATER RES, V50, P388, DOI 10.1002/(SICI)1097-4636(20000605)50:3<388::AID-JBM13>3.0.CO;2-F; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Farokhzad OC, 2006, ADV DRUG DELIVER REV, V58, P1456, DOI 10.1016/j.addr.2006.09.011; Feng Q, 2016, NANOSCALE, V8, P12430, DOI 10.1039/c5nr07964k; Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034; Golombek SK, 2018, ADV DRUG DELIVER REV, V130, P17, DOI 10.1016/j.addr.2018.07.007; He J, 2013, ACS APPL MATER INTER, V5, P9746, DOI 10.1021/am4028839; He J, 2013, ANGEW CHEM INT EDIT, V52, P2463, DOI 10.1002/anie.201208425; Hornig S, 2009, J MATER CHEM, V19, P3838, DOI 10.1039/b906556n; Jafarifar E, 2017, PHARM DEV TECHNOL, V22, P836, DOI 10.1080/10837450.2016.1221426; Jo DH, 2015, NANOMED-NANOTECHNOL, V11, P1603, DOI 10.1016/j.nano.2015.04.015; Johnson BK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118302; Johnson BK, 2003, AUST J CHEM, V56, P1021, DOI 10.1071/CH03115; Kamaly N, 2016, CHEM REV, V116, P2602, DOI 10.1021/acs.chemrev.5b00346; Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q; Lababidi N, 2019, BEILSTEIN J NANOTECH, V10, P2280, DOI 10.3762/bjnano.10.220; Lallana E, 2018, INT J PHARMACEUT, V548, P530, DOI 10.1016/j.ijpharm.2018.07.031; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; Lee JH, 2015, CHEM ENG SCI, V125, P75, DOI 10.1016/j.ces.2014.08.046; Li XY, 2018, ADV DRUG DELIVER REV, V128, P101, DOI 10.1016/j.addr.2017.12.015; Liu DF, 2018, ADV DRUG DELIVER REV, V128, P54, DOI 10.1016/j.addr.2017.08.003; Liu Y, 2020, IND ENG CHEM RES, V59, P4134, DOI 10.1021/acs.iecr.9b04747; Ma JP, 2017, LAB CHIP, V17, P209, DOI 10.1039/c6lc01049k; Machatschek R, 2020, J CONTROL RELEASE, V319, P276, DOI 10.1016/j.jconrel.2019.12.044; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Maksimenko O, 2019, INT J PHARMACEUT, V572, DOI 10.1016/j.ijpharm.2019.118733; Figueroa SM, 2020, MACROMOL BIOSCI, V20, DOI 10.1002/mabi.201900427; McClements DJ, 2018, ADV COLLOID INTERFAC, V253, P1, DOI 10.1016/j.cis.2018.02.002; Mout R, 2012, CHEM SOC REV, V41, P2539, DOI 10.1039/c2cs15294k; Musumeci T, 2006, INT J PHARMACEUT, V325, P172, DOI 10.1016/j.ijpharm.2006.06.023; Narvekar M, 2014, AAPS PHARMSCITECH, V15, P822, DOI 10.1208/s12249-014-0107-x; Orienti I, 2005, DRUG DELIV, V12, P15, DOI 10.1080/10717540590889574; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Panagi Z, 2001, INT J PHARM, V221, P143, DOI 10.1016/S0378-5173(01)00676-7; Pannuzzo M., 2020, PREDICTING MISCIBILI, P12; Park K, 2019, J CONTROL RELEASE, V304, P125, DOI 10.1016/j.jconrel.2019.05.003; Parsa MK, 2014, COMPUT FLUIDS, V105, P82, DOI 10.1016/j.compfluid.2014.09.024; Rabanel JM, 2019, NANOSCALE, V11, P383, DOI 10.1039/c8nr04916e; Rezvantalab S, 2019, RSC ADV, V9, P2055, DOI 10.1039/c8ra08972h; Sah H, 2013, INT J NANOMED, V8, P747, DOI 10.2147/IJN.S40579; Salatin S, 2015, CELL BIOL INT, V39, P881, DOI 10.1002/cbin.10459; Salvioni L, 2019, CANCERS, V11, DOI 10.3390/cancers11121855; Schmid D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01830-8; Sharma S, 2016, TRAC-TREND ANAL CHEM, V80, P30, DOI 10.1016/j.trac.2015.06.014; Shen H, 2011, J NANOPART RES, V13, P4109, DOI 10.1007/s11051-011-0354-7; Shi JJ, 2017, NAT REV CANCER, V17, P20, DOI 10.1038/nrc.2016.108; Sindhwani S, 2021, J INTERN MED, V290, P486, DOI 10.1111/joim.13254; Steichen SD, 2013, EUR J PHARM SCI, V48, P416, DOI 10.1016/j.ejps.2012.12.006; Streck S, 2019, INT J PHARM-X, V1, DOI 10.1016/j.ijpx.2019.100030; Suk JS, 2016, ADV DRUG DELIVER REV, V99, P28, DOI 10.1016/j.addr.2015.09.012; Swider E, 2018, ACTA BIOMATER, V73, P38, DOI 10.1016/j.actbio.2018.04.006; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Tomeh MA, 2020, MOL PHARMACEUT, V17, P4421, DOI 10.1021/acs.molpharmaceut.0c00913; Upponi J.R., 2014, NANOONCOLOGICALS NEW, P3, DOI DOI 10.1007/978-3-319-08084-0_1; Valencia PM, 2013, ACS NANO, V7, P10671, DOI 10.1021/nn403370e; Wais U, 2016, NANOSCALE, V8, P1746, DOI 10.1039/c5nr07161e; Walkey CD, 2012, J AM CHEM SOC, V134, P2139, DOI 10.1021/ja2084338; Wang L, 2015, LAB CHIP, V15, P4383, DOI 10.1039/c5lc90116b; Wilkosz N, 2018, J PHYS CHEM B, V122, P7080, DOI 10.1021/acs.jpcb.8b03742; Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042; Yoo HS, 2000, J CONTROL RELEASE, V68, P419, DOI 10.1016/S0168-3659(00)00280-7; Zhang B, 2014, BIOMATERIALS, V35, P4088, DOI 10.1016/j.biomaterials.2014.01.046; Zhong H, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10040263; Zhu ZX, 2013, BIOMATERIALS, V34, P10238, DOI 10.1016/j.biomaterials.2013.09.015	81	5	5	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0251821	10.1371/journal.pone.0251821	http://dx.doi.org/10.1371/journal.pone.0251821			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143792	gold, Green Published			2022-12-26	WOS:000671690700067
J	Khan, MT; Islam, R; Jerin, TJ; Mahmud, A; Khatun, S; Kobir, A; Islam, MN; Akter, A; Mondal, SI				Khan, Md Tahsin; Islam, Rahatul; Jerin, Tarhima Jahan; Mahmud, Araf; Khatun, Sahara; Kobir, Ahasanul; Islam, Md Nahidul; Akter, Arzuba; Mondal, Shakhinur Islam			Immunoinformatics and molecular dynamics approaches: Next generation vaccine design against West Nile virus	PLOS ONE			English	Article							T-CELL-EPITOPES; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODY; CHIMERIC VACCINE; IMMUNE-RESPONSE; PEPTIDE VACCINE; NEURAL-NETWORKS; PROTEIN; PREDICTION; ENCEPHALITIS	West Nile Virus (WNV) is a life threatening flavivirus that causes significant morbidity and mortality worldwide. No preventive therapeutics including vaccines against WNV are available for human use. In this study, immunoinformatics approach was performed to design a multi epitope-based subunit vaccine against this deadly pathogen. Human (HLA) and Mice (H-2) allele specific potential T-cell and B-cell epitopes were shortlisted through a stringent procedure. Molecular docking showed selected epitopes that have stronger binding affinity with human TLR-4. Molecular dynamics simulation confirmed the stable nature of the docked complex. Furthermore, in silico cloning analysis ensures efficient expression of desired gene in the microbial system. Interestingly, previous studies showed that two of our selected epitopes have strong immune response against WNV. Therefore, selected epitopes could be strong vaccine candidates to prevent WNV infections in human. However, further in vitro and in vivo investigations could be strengthening the validation of the vaccine candidate against WNV.	[Khan, Md Tahsin; Islam, Rahatul; Mahmud, Araf; Khatun, Sahara; Mondal, Shakhinur Islam] Shahjalal Univ Sci & Technol, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh; [Jerin, Tarhima Jahan] Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Tangail, Bangladesh; [Kobir, Ahasanul] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA; [Islam, Md Nahidul] Natl Univ Ireland Galway, Sch Nat Sci, Dept Biochem, Galway, Ireland; [Akter, Arzuba] Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh	Shahjalal University of Science & Technology (SUST); Mawlana Bhashani Science & Technology University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Ollscoil na Gaillimhe-University of Galway; Shahjalal University of Science & Technology (SUST)	Mondal, SI (corresponding author), Shahjalal Univ Sci & Technol, Dept Genet Engn & Biotechnol, Sylhet, Bangladesh.; Akter, A (corresponding author), Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh.	arzuba-bmb@sust.edu; shakhin200-gen@sust.edu	Khan, Tahsin/ABD-8568-2021; Mondal, Shakhinur Islam/AAT-6529-2021	Khan, Tahsin/0000-0003-3309-3218; Mahmud, Araf/0000-0002-0325-6904; Jerin, Tarhima Jahan/0000-0001-9415-9335; Islam, Rahatul/0000-0002-1889-3316; Mondal, Shakhin/0000-0002-8366-7745				Ali M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09199-w; Allen M.P., 2004, COMPUTATIONAL SOFT M, V23, P1; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; [Anonymous], 2019, FINAL CUMULATIVE MAP; [Anonymous], 2019, REP, V9, P1, DOI [10.1038/s41598-019-47810-4, DOI 10.1038/S41598-019-49354-Z, 10.1038/s41598-019-49354-z, DOI 10.1038/S41598-019-40561-2]; Anukumar B, 2014, J CLIN VIROL, V61, P152, DOI 10.1016/j.jcv.2014.06.003; Bahrami AA, 2019, INT REV IMMUNOL, V38, P307, DOI 10.1080/08830185.2019.1657426; Barrett ADT, 2014, AM J TROP MED HYG, V90, P389, DOI 10.4269/ajtmh.14-0009; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361; Bui HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-153; Calis JJA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003266; CAMENGA DL, 1974, J INFECT DIS, V130, P634, DOI 10.1093/infdis/130.6.634; Chauhan V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39299-8; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Cherryholmes GA, 2015, VACCINE, V33, P7408, DOI 10.1016/j.vaccine.2015.06.116; Coller B-A., 2012, GOOGLE PATENTS; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Dayan GH, 2013, VIRUSES-BASEL, V5, P3048, DOI 10.3390/v5123048; Deng F., 2019, BIORXIV2019719724 BIORXIV2019719724, P719724; Deng F., 2018, J IMMUNOLOGICAL SCI, V2, P36, DOI [10.29245/2578-3009/2018/2.1118, DOI 10.29245/2578-3009/2018/2.1118]; Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Diez-Rivero CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043674; Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4; DOUGLAS MW, 1994, IMMUNOLOGY, V82, P561; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Dubitzky W., 2013, ENCY SYSTEMBIOL; Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Farnos O, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020338; Ghaderi D, 2012, BIOTECHNOL GENET ENG, V28, P147, DOI 10.5661/bger-28-147; Ghaffari-Nazari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142563; GOVERDHAN MK, 1992, ACTA VIROL, V36, P277, DOI 10.1016/0166-0934(92)90058-L; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guleria V, 2020, GENOMICS, V112, P796, DOI 10.1016/j.ygeno.2019.05.018; Gupta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073957; Hajighahramani N, 2017, INFECT GENET EVOL, V48, P83, DOI 10.1016/j.meegid.2016.12.010; HALEVY M, 1994, ARCH VIROL, V137, P355, DOI 10.1007/BF01309481; HALL RA, 1991, IMMUNOL CELL BIOL, V69, P47, DOI 10.1038/icb.1991.7; HASE T, 1990, INT J EXP PATHOL, V71, P493; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hebditch M, 2017, BIOINFORMATICS, V33, P3098, DOI [10.1093/bioinformatics/btx345, 10.1093/BIOINFORMATICS/BTX345]; Hoque H., 2021, IMPLEMENTATION SILIC, V7, pE06396; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; IMAM SH, 1992, CURR MICROBIOL, V25, P1, DOI 10.1007/BF01570075; Islam R., 2020, DELINEATING BLUEPRIN, V20, P100430; Iyer AV, 2013, INT J ENV RES PUB HE, V10, P4200, DOI 10.3390/ijerph10094200; Jiang PF, 2017, VACCINE, V35, P3096, DOI 10.1016/j.vaccine.2017.04.031; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallel H, 2015, BIOTECHNOL J, V10, P741, DOI 10.1002/biot.201400390; Kalyanaraman N, 2018, MOL IMMUNOL, V93, P193, DOI 10.1016/j.molimm.2017.11.024; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; Kashyap M, 2017, INFECT GENET EVOL, V53, P107, DOI 10.1016/j.meegid.2017.05.022; Kazi A, 2018, PATHOG GLOB HEALTH, V112, P123, DOI 10.1080/20477724.2018.1446773; KESSON AM, 1987, J GEN VIROL, V68, P2001, DOI 10.1099/0022-1317-68-7-2001; Khan Md Tahsin, 2021, Inform Med Unlocked, V24, P100578, DOI 10.1016/j.imu.2021.100578; Khan SA, 2011, EMERG INFECT DIS, V17, P947, DOI 10.3201/eid1705.100479; Khatun T, 2017, T ROY SOC TROP MED H, V111, P178, DOI 10.1093/trstmh/trx033; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Kramer LD, 2008, ANNU REV ENTOMOL, V53, P61, DOI 10.1146/annurev.ento.53.103106.093258; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kui X, 2015, HUM VACC IMMUNOTHER, V11, P1209, DOI 10.1080/21645515.2015.1016674; KULKARNI A B, 1991, Viral Immunology, V4, P73, DOI 10.1089/vim.1991.4.73; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Lanteri MC, 2008, J INFECT DIS, V197, P1296, DOI 10.1086/586898; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424; Larsen MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012697; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lei XN, 2020, EXPERT REV VACCINES, V19, P235, DOI 10.1080/14760584.2020.1738227; Li HL, 2015, J BIOSCIENCES, V40, P79, DOI 10.1007/s12038-014-9495-z; Li XM, 2005, INT IMMUNOL, V17, P1293, DOI 10.1093/intimm/dxh305; Lin XY, 2016, CELL MOL IMMUNOL, V13, P492, DOI 10.1038/cmi.2015.29; Liu F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60783-z; LIU Y, 1989, J GEN VIROL, V70, P565, DOI 10.1099/0022-1317-70-3-565; Majid M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55613-w; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037; Michel-Todo L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02698; Milligan I., 2016, IMMUNOGENICITY REACT, V315; Mohan T, 2013, INDIAN J MED RES, V138, P779; Mohan T, 2014, IMMUNOL RES, V58, P139, DOI 10.1007/s12026-013-8428-5; Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041; Monath TP, 2001, ANN NY ACAD SCI, V951, P1; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; Murray KO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102953; Napp S, 2018, PATHOG GLOB HEALTH, V112, P233, DOI 10.1080/20477724.2018.1483567; Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Nathanson N, 1970, Adv Virus Res, V16, P397, DOI 10.1016/S0065-3527(08)60028-7; National Institute of Allergy and Infectious Diseases, 2020, CORONAVIRUSES; Nezafat N, 2016, COMPUT BIOL CHEM, V62, P82, DOI 10.1016/j.compbiolchem.2016.04.006; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374; Ojha R, 2019, ACS OMEGA, V4, P13069, DOI 10.1021/acsomega.9b00944; Olafsdottir G, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-44; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Pandey RK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00206; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Parvizpour S, 2020, DRUG DISCOV TODAY, V25, P1034, DOI 10.1016/j.drudis.2020.03.006; PAVRI KM, 1965, INDIAN J MED RES, V53, P501; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; PRUITT AA, 1991, NEUROL CLIN, V9, P867, DOI 10.1016/S0733-8619(18)30254-8; Pumchan A., 2020, SCI REP-UK, V10, P1; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rana A, 2016, IMMUNOBIOLOGY, V221, P544, DOI 10.1016/j.imbio.2015.12.004; Rapaport D.C., 2004, ART MOL DYNAMICS SIM, DOI 10.1017/CBO9780511816581; Reginald K, 2018, CURR PHARM DESIGN, V24, P1157, DOI 10.2174/1381612823666170913163904; REINHERZ EL, 1980, CELL, V19, P821, DOI 10.1016/0092-8674(80)90072-0; Rodrigues F.M., 1980, Indian Journal of Parasitology, V4, P149; Ronca SE, 2019, EMERG INFECT DIS, V25, P325, DOI 10.3201/eid2502.180765; Saha S, 2006, NUCLEIC ACIDS RES, V34, pW202, DOI 10.1093/nar/gkl343; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Shukla J, 2012, INT J INFECT DIS, V16, pE53, DOI 10.1016/j.ijid.2011.09.020; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Sivalingam GN, 2012, MOL IMMUNOL, V51, P304, DOI 10.1016/j.molimm.2012.03.030; SnapGene, INS SCI INS SCI; Solanki V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26689-7; Staples JE, 2014, AM J TROP MED HYG, V90, P402, DOI 10.4269/ajtmh.13-0206; Tandel K, 2019, J MED VIROL, V91, P493, DOI 10.1002/jmv.25325; Tyler KL, 2014, CURR OPIN NEUROL, V27, P342, DOI 10.1097/WCO.0000000000000088; Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/FMB.14.67, 10.2217/fmb.14.67]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Voter AF, 1997, J CHEM PHYS, V106, P4665, DOI 10.1063/1.473503; Waller FM, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/7235742; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Weatherhead JE, 2015, AM J TROP MED HYG, V92, P1006, DOI 10.4269/ajtmh.14-0616; Wilkins MR, 1999, METH MOL B, V112, P531; Wu CY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-88; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224; Yang Y, 2015, HUM VACC IMMUNOTHER, V11, P795, DOI 10.1080/21645515.2015.1012017; Zeller HG, 2004, EUR J CLIN MICROBIOL, V23, P147, DOI 10.1007/s10096-003-1085-1; Zhang LF, 2018, CELL MOL IMMUNOL, V15, P182, DOI 10.1038/cmi.2017.92; Zhu SL, 2014, APPL MICROBIOL BIOT, V98, P4107, DOI 10.1007/s00253-014-5517-x	148	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253393	10.1371/journal.pone.0253393	http://dx.doi.org/10.1371/journal.pone.0253393			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138958	gold, Green Published			2022-12-26	WOS:000671690200058
J	Muttamba, W; Lusiba, J; Namakula, LO; Byakika-Kibwika, P; Ssali, F; Ddungu, H; Mugenyi, L; Kiwanuka, N; Sekibira, R; Kityo, C; Keyune, D; Acana, S; Musinguzi, A; Masasi, A; Byamugisha, J; Mpanju, D; Musoki, WJ; Tukamuhebwa, HA; Nakwagala, F; Bagaya, BS; Kayongo, A; Kimuli, I; Nantanda, R; Katagira, W; Buregyeya, E; Byanyima, R; Byarugaba, B; Siddharthan, T; Mwebesa, H; Charles, O; Joloba, ML; Bazeyo, W; Kirenga, B				Muttamba, Winters; Lusiba, John; Namakula, Loryndah Olive; Byakika-Kibwika, Pauline; Ssali, Francis; Ddungu, Henry; Mugenyi, Levicatus; Kiwanuka, Noah; Sekibira, Rogers; Kityo, Cissy; Keyune, Dorothy; Acana, Susan; Musinguzi, Ambrose; Masasi, Ayub; Byamugisha, Joseph; Mpanju, David; Musoki, Walter Jack; Tukamuhebwa, Hellen Aanyu; Nakwagala, Fred; Bagaya, Bernard Sentalo; Kayongo, Alex; Kimuli, Ivan; Nantanda, Rebecca; Katagira, Winceslaus; Buregyeya, Esther; Byanyima, Rosemary; Byarugaba, Baterana; Siddharthan, Trishul; Mwebesa, Henry; Charles, Olaro; Joloba, Moses Lutaakome; Bazeyo, William; Kirenga, Bruce			Feasibility of collecting and processing of COVID-19 convalescent plasma for treatment of COVID-19 in Uganda	PLOS ONE			English	Article								Introduction Evidence that supports the use of COVID-19 convalescent plasma (CCP) for treatment of COVID-19 is increasingly emerging. However, very few African countries have undertaken the collection and processing of CCP. The aim of this study was to assess the feasibility of collecting and processing of CCP, in preparation for a randomized clinical trial of CCP for treatment of COVID-19 in Uganda. Methods In a cross-sectional study, persons with documented evidence of recovery from COVID-19 in Uganda were contacted and screened for blood donation via telephone calls. Those found eligible were asked to come to the blood donation centre for further screening and consent. Whole blood collection was undertaken from which plasma was processed. Plasma was tested for transfusion transmissible infections (TTIs) and anti-SARS CoV-2 antibody titers. SARS-CoV-2 testing was also done on nasopharyngeal swabs from the donors. Results 192 participants were contacted of whom 179 (93.2%) were eligible to donate. Of the 179 eligible, 23 (12.8%) were not willing to donate and reasons given included: having no time 7(30.4%), fear of being retained at the COVID-19 treatment center 10 (43.5%), fear of stigma in the community 1 (4.3%), phobia for donating blood 1 (4.3%), religious issues 1 (4.4%), lack of interest 2 (8.7%) and transport challenges 1 (4.3%). The median age was 30 years and females accounted for 3.7% of the donors. A total of 30 (18.5%) donors tested positive for different TTIs. Antibody titer testing demonstrated titers of more than 1:320 for all the 72 samples tested. Age greater than 46 years and female gender were associated with higher titers though not statistically significant. Conclusion CCP collection and processing is possible in Uganda. However, concerns about stigma and lack of time, interest or transport need to be addressed in order to maximize donations.	[Muttamba, Winters; Namakula, Loryndah Olive; Mugenyi, Levicatus; Sekibira, Rogers; Kayongo, Alex; Kimuli, Ivan; Nantanda, Rebecca; Katagira, Winceslaus; Kirenga, Bruce] Makerere Univ, Lung Inst, Kampala, Uganda; [Lusiba, John; Musinguzi, Ambrose] Uganda Peoples Def Forces Med Serv, Kampala, Uganda; [Lusiba, John] Uganda Heart Inst, Kampala, Uganda; [Byakika-Kibwika, Pauline; Byamugisha, Joseph; Mpanju, David; Musoki, Walter Jack; Kirenga, Bruce] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Ssali, Francis; Kityo, Cissy] Joint Clin Res Ctr, Kampala, Uganda; [Ddungu, Henry] Uganda Canc Inst, Kampala, Uganda; [Kiwanuka, Noah; Buregyeya, Esther] Makerere Univ, Sch Publ Hlth, Coll Hlth Sci, Kampala, Uganda; [Keyune, Dorothy; Acana, Susan] Uganda Blood Transfus Serv, Kampala, Uganda; [Masasi, Ayub; Tukamuhebwa, Hellen Aanyu; Nakwagala, Fred; Byanyima, Rosemary; Byarugaba, Baterana] Mulago Natl Referral Hosp, Kampala, Uganda; [Bagaya, Bernard Sentalo; Joloba, Moses Lutaakome] Makerere Univ, Immunol & Mol Biol, Coll Hlth Sci, Kampala, Uganda; [Siddharthan, Trishul] Johns Hopkins Univ, Pulm & Crit Care, Baltimore, MD USA; [Mwebesa, Henry; Charles, Olaro] Republ Uganda, Minist Hlth, Kampala, Uganda; [Bazeyo, William] Makerere Univ, Kampala, Uganda	Makerere University; Makerere University; Joint Clinic Research Center - United Arab Emirates; Makerere University; Mulago National Referral Hospital; Makerere University; Johns Hopkins University; Makerere University	Kirenga, B (corresponding author), Makerere Univ, Lung Inst, Kampala, Uganda.; Kirenga, B (corresponding author), Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda.	brucekirenga@yahoo.co.uk			Government of Uganda through the Makerere University Research and Innovations Fund	Government of Uganda through the Makerere University Research and Innovations Fund	This study was funded by the Government of Uganda through the Makerere University Research and Innovations Fund under a grant to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabb, UPD IMP 2019 NOV COR; [Anonymous], SOC STIGM THREAT COV; Arcot PJ, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102877; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Blackall D, 2020, TRANSFUSION, V60, P2203, DOI 10.1111/trf.16026; Bloch EM, 2021, VOX SANG, V116, P18, DOI [10.1111/vox.12910, 10.1111/vox.12970]; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; Del Fante C, 2021, TRANSFUSION, V61, P830, DOI 10.1111/trf.16208; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Epstein J, 2020, VOX SANG, V115, P485, DOI 10.1111/vox.12939; Gharbharan A, 2020, CONVALESCENT PLASMA, DOI 10.1101/2020.07.01.20139857; Joyner MJ, 2020, MAYO CLIN PROC, V95, P1888, DOI 10.1016/j.mayocp.2020.06.028; Li L, 2020, JAMA-J AM MED ASSOC, V324, P519, DOI 10.1001/jama.2020.13216; Li L, 2020, TRANSFUSION, V60, P1773, DOI 10.1111/trf.15921; Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139; Migliori, 2020, DEMYSTIFY COVID 19 R, DOI [10.5588/ijtld.20.0233, DOI 10.5588/IJTLD.20.0233]; NNAJI CA, 2020, PAN AFR MED J, V35, DOI DOI 10.11604/PAMJ.SUPP.2020.35.2.24157; Olum R, 2020, INT J INFECT DIS, V96, P517, DOI 10.1016/j.ijid.2020.05.073; Phua Jason, 2020, Lancet Respir Med, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Salazar Eric, 2020, medRxiv, DOI 10.1101/2020.05.08.20095471; Seghatchian J, 2020, Transfus Apher Sci, P102792, DOI 10.1016/j.transci.2020.102792; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Silvano Wendel A., 2020, CONV PLAS TREAT COVI; Tanne JH, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1090; Vaught, BIOBANKING COVID 19, DOI [10.1089/bio.2020.29069.jjv, DOI 10.1089/BIO.2020.29069.JJV]; Vieira CM, 2020, MATURITAS, V136, P38, DOI 10.1016/j.maturitas.2020.04.004; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; Ye MX, 2020, J MED VIROL, V92, P1890, DOI 10.1002/jmv.25882; Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252306	10.1371/journal.pone.0252306	http://dx.doi.org/10.1371/journal.pone.0252306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138909	Green Submitted, Green Published, gold			2022-12-26	WOS:000671690200107
J	Nikiema, MEM; de la Gandara, MP; Compaore, KAM; Ba, AK; Soro, KD; Nikiema, PA; Barro, N; Sangare, L; Weill, FX				Nikiema, Marguerite E. M.; de la Gandara, Maria Pardos; Compaore, Kiswensida A. M.; Ba, Absetou Ky; Soro, Karna D.; Nikiema, Philippe A.; Barro, Nicolas; Sangare, Lassana; Weill, Francois-Xavier			Contamination of street food with multidrug-resistant Salmonella, in Ouagadougou, Burkina Faso	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; POULTRY FECES; ENTERICA; PREVALENCE; INFECTIONS; CARCASSES; QUALITY; MEAT	Background Gastrointestinal infections are a global public health problem. In Burkina Faso, West Africa, exposure to Salmonella through the consumption of unhygienic street food represents a major risk of infection requiring detailed evaluation. Methods Between June 2017 and July 2018, we sampled 201 street food stalls, in 11 geographic sectors of Ouagadougou, Burkina Faso. We checked for Salmonella contamination in 201 sandwiches (one per seller), according to the ISO 6579:2002 standard. All Salmonella isolates were characterized by serotyping and antimicrobial susceptibility testing, and whole-genome sequencing was performed on a subset of isolates, to investigate their phylogenetic relationships and antimicrobial resistance determinants. Results The prevalence of Salmonella enterica was 17.9% (36/201) and the Salmonella isolates belonged to 16 different serotypes, the most frequent being Kentucky, Derby and Tennessee, with five isolates each. Six Salmonella isolates from serotypes Brancaster and Kentucky were multidrug-resistant (MDR). Whole-genome sequencing revealed that four of these MDR isolates belonged to the emergent S. enterica serotype Kentucky clone ST198-X1 and to an invasive lineage of S. enterica serotype Enteritidis (West African clade). Conclusion This study reveals a high prevalence of Salmonella spp. in sandwiches sold in Ouagadougou. The presence of MDR Salmonella in food on sale detected in this study is also matter of concern.	[Nikiema, Marguerite E. M.; Compaore, Kiswensida A. M.; Soro, Karna D.; Nikiema, Philippe A.; Barro, Nicolas] Univ Joseph Ki Zerbo, Lab Epidemiol & Surveillance Bacteries & Virus Tr, Ecole Doctorale Sci & Technol EDST, Ouagadougou, Burkina Faso; [Nikiema, Marguerite E. M.; de la Gandara, Maria Pardos; Weill, Francois-Xavier] Inst Pasteur, Ctr Natl Reference Escherichia Coli Shigella & Sa, Unite Bacteries Pathogenes Enter, Paris, France; [Compaore, Kiswensida A. M.] Lab Natl Sante Publ, Ouagadougou, Burkina Faso; [Ba, Absetou Ky; Sangare, Lassana] Univ Joseph Ki Zerbo, Unite Format & Rech Sci Sante UFR SDS, Ecole Doctorale Sci & Sante EDSS, Ouagadougou, Burkina Faso; [Sangare, Lassana] Ctr Hosp Univ Yalgado Ouedraogo, Lab Bacteriol Virol, Ouagadougou, Burkina Faso	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nikiema, MEM (corresponding author), Univ Joseph Ki Zerbo, Lab Epidemiol & Surveillance Bacteries & Virus Tr, Ecole Doctorale Sci & Technol EDST, Ouagadougou, Burkina Faso.; Nikiema, MEM; Weill, FX (corresponding author), Inst Pasteur, Ctr Natl Reference Escherichia Coli Shigella & Sa, Unite Bacteries Pathogenes Enter, Paris, France.	edithnikiema26@gmail.com; francois-xavier.weill@pasteur.fr	de la Gandara, Maria Pardos/AAQ-1054-2020	de la Gandara, Maria Pardos/0000-0002-3273-6392; Kiswendsida Abdou Muller, COMPAORE/0000-0001-8798-1136; Weill, Francois-Xavier/0000-0001-9941-5799	Cooperation and Cultural Action Service of the French Embassy of France, Burkina Faso; Institut Pasteur; French government's Investissement d'Avenir programme, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]	Cooperation and Cultural Action Service of the French Embassy of France, Burkina Faso; Institut Pasteur(European Commission); French government's Investissement d'Avenir programme, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases'(French National Research Agency (ANR))	NMEM was supported by a grant from the Cooperation and Cultural Action Service of the French Embassy of France, Burkina Faso. This study was partly supported by the Institut Pasteur and the French government's Investissement d'Avenir programme, Laboratoire d'Excellence `Integrative Biology of Emerging Infectious Diseases' (grant number ANR-10-LABX-62-IBEID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-El-Malek A. M., 2014, Global Veterinaria, V13, P1097; Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; Alikhan NF, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007261; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3502; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P521; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barro Nicolas, 2002, Sante, V12, P369; Bawa I. H., 2015, Journal of Applied Biosciences, V95, P8966, DOI 10.4314/jab.v95i1.6; Bonkoungou IJO, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-36; CA-SFM. EUCAST, 2018, COM ANT SOC FRANC MI; Canet C, 1996, FNA ANA, V17, P4; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Caroline Bouda S., 2019, INT J MOL BIOL, V4, P64, DOI [10.11648/j.ijmb.20190403.12, DOI 10.11648/J.IJMB.20190403.12]; Chardon H., 2014, CAHIERS SECURITE SAN; Compaore M. K. A., 2020, African Journal of Agricultural Research, V16, P1141, DOI 10.5897/AJAR2020.14917; Cummings KJ, 2020, VET MED SCI, V6, P975, DOI 10.1002/vms3.320; Djibrine M. A., 2018, International Journal of Biological and Chemical Sciences, V12, P1113; Drabo K M, 2009, Bull Soc Pathol Exot, V102, P36; Edwards PR, 1938, J HYG-CAMBRIDGE, V38, P306, DOI 10.1017/S0022172400011177; Fadlalla I. M. T., 2012, Journal of Public Health and Epidemiology, V4, P19; Feasey NA, 2016, NAT GENET, V48, P1211, DOI 10.1038/ng.3644; FRICKER CR, 1987, J APPL BACTERIOL, V63, P99, DOI 10.1111/j.1365-2672.1987.tb02692.x; Hassanin F. S., 2014, BENHA VET MED J, V27, P84; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Kagambega A, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02085-6; Kagambega A, 2018, FOOD SCI NUTR, V6, P1601, DOI 10.1002/fsn3.725; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Kagambega A, 2012, FOODBORNE PATHOG DIS, V9, P589, DOI 10.1089/fpd.2011.1071; Kagambega A, 2011, J FOOD PROTECT, V74, P1547, DOI 10.4315/0362-028X.JFP-11-124; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Post AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007782; Pulford CV, 2021, NAT MICROBIOL, V6, P327, DOI 10.1038/s41564-020-00836-1; Ricosse J H, 1979, Med Trop (Mars), V39, P381; Sevellec Y, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00889; Sheth AN, 2011, CLIN INFECT DIS, V53, P356, DOI 10.1093/cid/cir407; Sodagari HR, 2015, J INFECT DEV COUNTR, V9, P463, DOI 10.3855/jidc.5945; Tay MYF, 2019, FOODBORNE PATHOG DIS, V16, P531, DOI 10.1089/fpd.2018.2604; Traore O, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0484-7; Weill F-X, 2007, ANTIGENIC FORMULAE S, V9th edition.; Xie TF, 2019, FOOD SCI NUTR, V7, P2847, DOI 10.1002/fsn3.1126; Zadernowska A, 2011, SALMONELLA - A DANGEROUS FOODBORNE PATHOGEN, P393; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou Z., 2020, HIERCC MULTILEVEL CL, DOI [10.1101/2020.11.25.397539, DOI 10.1101/2020.11.25.397539]; Zhou ZM, 2020, GENOME RES, V30, P138, DOI 10.1101/gr.251678.119	47	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253312	10.1371/journal.pone.0253312	http://dx.doi.org/10.1371/journal.pone.0253312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138936	Green Published, gold			2022-12-26	WOS:000671690200065
J	Wilson, A; Gicas, K; Stevens, WD; Sergio, L; Wojtowicz, M				Wilson, Alyssia; Gicas, Kristina; Stevens, W. Dale; Sergio, Lauren; Wojtowicz, Magdalena			Substance use is associated with worse mental health and altered resting state functional connectivity in female university athletes at baseline: A pilot study	PLOS ONE			English	Article							EMOTION REGULATION; CANNABIS USE; DEPRESSION; PREVALENCE; MARIJUANA; SYMPTOMS; ALCOHOL; RISK	University athletes are at high risk for both substance use and mental health problems. This study examined associations between substance use, mental health symptoms, and the resting state functional connectivity (rsFC) of key neural regions involved in self-monitoring and emotional regulation in a sample of female varsity athletes. 31 female university athletes completed measures of substance use, mental health symptoms, and underwent functional MRI scans during the pre-season. Athletes who were substance users had higher symptoms of depression than non-users (p = 0.04; Hedge's g = 0.81). RsFC differences were observed between users and non-users in orbital frontal cortex (OFC) and bilateral hippocampal seeds, and negative associations between depression symptoms and rsFC in the left hippocampus and posterior cingulate cortex were observed in cannabis users. In female athletes, substance use is associated with greater self-reported depression symptoms and altered rsFC in self-monitoring and emotional regulation regions of the brain.	[Wilson, Alyssia; Gicas, Kristina; Stevens, W. Dale; Wojtowicz, Magdalena] York Univ, Dept Psychol, Toronto, ON, Canada; [Sergio, Lauren] York Univ, Sch Kinesiol, Toronto, ON, Canada	York University - Canada; York University - Canada	Wojtowicz, M (corresponding author), York Univ, Dept Psychol, Toronto, ON, Canada.	magdawoj@yorku.ca						Alcock Bradey, 2018, Addict Behav Rep, V7, P58, DOI 10.1016/j.abrep.2018.02.001; Amstadter A, 2008, J ANXIETY DISORD, V22, P211, DOI 10.1016/j.janxdis.2007.02.004; Babor TF, 2001, PRIMARY CARE; Cheng W, 2016, BRAIN, V139, P3296, DOI 10.1093/brain/aww255; Coutinho JF, 2016, BRAIN IMAGING BEHAV, V10, P147, DOI 10.1007/s11682-015-9375-7; Cox C. E., 2017, SCIENCE, V5, P14, DOI [DOI 10.17265/2332-7839/2017.01.002, 10.17265/2332-7839/2017.01.002]; Crane NA, 2018, DRUG ALCOHOL DEPEN, V192, P208, DOI 10.1016/j.drugalcdep.2018.07.044; Davey CG, 2016, NEUROIMAGE, V132, P390, DOI 10.1016/j.neuroimage.2016.02.022; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Filbey FM, 2014, P NATL ACAD SCI USA, V111, P16913, DOI 10.1073/pnas.1415297111; Ford JA, 2007, SUBST USE MISUSE, V42, P1367, DOI 10.1080/10826080701212402; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Grecucci A, 2013, CEREB CORTEX, V23, P399, DOI 10.1093/cercor/bhs028; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hilderbrand RL, 2011, J ANAL TOXICOL, V35, P624, DOI 10.1093/anatox/35.9.624; Joormann J, 2010, COGNITION EMOTION, V24, P281, DOI 10.1080/02699930903407948; Kornelsen J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00048; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Nelson TF, 2001, MED SCI SPORT EXER, V33, P43; Newman SD, 2019, J NEUROTRAUM, DOI 10.1089/neu.2019.6550; Nieto-Castanon A., 2020, HDB FUNCTIONAL CONNE; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rolls ET, 2015, CORTEX, V62, P119, DOI 10.1016/j.cortex.2013.12.005; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wolanin A, 2016, BRIT J SPORT MED, V50, P167, DOI 10.1136/bjsports-2015-095756; Wolanin A, 2015, CURR SPORT MED REP, V14, P56, DOI 10.1249/JSR.0000000000000123; Yurasek Ali M, 2017, Curr Addict Rep, V4, P184, DOI 10.1007/s40429-017-0149-8	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253261	10.1371/journal.pone.0253261	http://dx.doi.org/10.1371/journal.pone.0253261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138920	Green Published, gold			2022-12-26	WOS:000671690200082
J	Goyal, P; Pai, HV; Kodali, P; Vats, B; Vajpai, N; Annegowda, S; Mane, K; Mohan, S; Saxena, S; Veerabhadraia, AB; Palande, M; Nair, PS; More, DC; Karudumpa, UR; Jyothirmai, K; Bhattacharya, A; Almeida, F; Khyade, SG; Gouda, S; Ranayhossaini, DJ; Moole, PR; Smith, JP; Barve, A; Melarkode, R; Ullanat, R				Goyal, Parag; Pai, Harish Venkatraman; Kodali, Phanichand; Vats, Bhavesh; Vajpai, Navratna; Annegowda, Shankara; Mane, Krishnappa; Mohan, Shamini; Saxena, Shruti; Veerabhadraia, Anil Bangalore; Palande, Milee; Nair, Preethy Sasankan; More, Digvijay Chandrashekar; Karudumpa, Umamaheshwara Rao; Jyothirmai, Kunala; Bhattacharya, Adroha; Almeida, Frida; Khyade, Santosh Gulab; Gouda, Shankara; Ranayhossaini, Daniel J.; Moole, Praveen Reddy; Smith, Jeffrey P.; Barve, Abhijit; Melarkode, Ramakrishnan; Ullanat, Rajesh			Physicochemical and functional characterization of MYL-1501D, a proposed biosimilar to insulin glargine	PLOS ONE			English	Article							PICHIA-PASTORIS; SECONDARY STRUCTURE; MEMBRANE-PROTEINS; EXPRESSION	Insulin glargine is a long-acting analogue of human insulin that has been used to manage hyperglycemia in patients with diabetes mellitus (DM) for nearly 20 years. Insulin glargine has a relatively constant concentration-time profile that mimics basal levels of insulin and allows for once-daily administration. MYL-1501D is a biosimilar insulin glargine designed to offer greater access of insulin glargine to patients, with comparable efficacy and safety to the marketed reference product. We conducted a comprehensive panel of studies based on a formal analysis of critical quality attributes to characterize the structural and functional properties of MYL-1501D and reference insulin glargine products available in the United States and European Union. MYL-1501D was comprehensively shown to have high similarity to the reference products in terms of protein structure, metabolic activity (both in vitro cell-based assays and in vivo rabbit bioassays), and in vitro cell-based assays for mitogenic activity. The structural analyses demonstrated that the primary protein sequence was identical, and secondary and tertiary structures are similar between the proposed biosimilar and the reference products. Insulin receptor binding affinity and phosphorylation studies also established analytical similarity. MYL-1501D demonstrated high similarity in different metabolic assays of glucose uptake, adipogenesis activity, and inhibition of stimulated lipolysis. Rabbit bioassay studies showed MYL-1501D and EU-approved insulin glargine are highly similar to US-licensed insulin glargine. These product quality studies show high similarity between MYL-1501D and licensed or approved insulin glargine products and suggest the potential of MYL-1501D as an alternative cost-effective treatment option for patients and clinicians.	[Goyal, Parag; Ranayhossaini, Daniel J.; Smith, Jeffrey P.; Barve, Abhijit] Viatris Inc, Canonsburg, PA 15317 USA; [Pai, Harish Venkatraman; Kodali, Phanichand; Vajpai, Navratna; Annegowda, Shankara; Mane, Krishnappa; Mohan, Shamini; Saxena, Shruti; Veerabhadraia, Anil Bangalore; Palande, Milee; Nair, Preethy Sasankan; More, Digvijay Chandrashekar; Karudumpa, Umamaheshwara Rao; Jyothirmai, Kunala; Bhattacharya, Adroha; Almeida, Frida; Khyade, Santosh Gulab; Moole, Praveen Reddy; Melarkode, Ramakrishnan] Biocon Res Ltd, Bangalore, Karnataka, India; [Vats, Bhavesh; Gouda, Shankara; Ullanat, Rajesh] Viatris Inc, Hyderabad, India	Biocon Limited	Goyal, P (corresponding author), Viatris Inc, Canonsburg, PA 15317 USA.; Melarkode, R (corresponding author), Biocon Res Ltd, Bangalore, Karnataka, India.	Parag.Goyal@viatris.com; ramakrishnan.melarkode@biocon.com	Goyal, Parag/ABH-1136-2021	Goyal, Parag/0000-0002-5678-8592; Vats, Bhavesh/0000-0003-3141-0355	Viatris Inc, Canonsburg, PA; Biocon Limited, Bangalore, India	Viatris Inc, Canonsburg, PA; Biocon Limited, Bangalore, India	Financial support for this study was provided by Viatris Inc, Canonsburg, PA (https://www.viatris.com/en), and Biocon Limited, Bangalore, India (https://www.biocon.com/).PG, BV, SG, DJR, JPS, ABa, and RU are paid employees of Viatris Inc. HVP, PK, NV, SA, KM, SM, SS, ABV, MP, PSN, DCM, URK, KJ, ABh, FA, SGK, PRM, and RM are paid employees of Biocon Research Limited. The sponsors had a role in the study design, data collection and analysis, and preparation of the manuscript.	Aguilar Marie-Isabel, 2004, Methods Mol Biol, V251, P9; [Anonymous], 2019, LANT PACK INS; [Anonymous], 2009, ICH DAT; [Anonymous], 2005, ICH DAT; Blevins TC, 2019, DIABETES OBES METAB, V21, P129, DOI 10.1111/dom.13495; Blevins TC, 2018, DIABETES OBES METAB, V20, P1944, DOI 10.1111/dom.13322; Bolli GB, 2012, DIABETES CARE, V35, P2626, DOI 10.2337/dc12-0270; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; C.M.C. Biotech Working Group, 2009, A MAB CAS STUD BIOPR; European Food Safety Authority European Food Safety Authority, 2020, QUAL PRES SAF QPS; European Medicines Agency, 2015, GUIDELINE NONCLINICA; European Medicines Agency European Medicines Agency, 2000, LANT AUTH DET; Fonseca VA, 2017, ENDOCR PRACT, V23, P1345, DOI 10.4158/EP-2017-0052; Hartmann L, 2017, METHODS MOL BIOL, V1635, P45, DOI 10.1007/978-1-4939-7151-0_3; Hartmann L, 2016, METHODS MOL BIOL, V1432, P143, DOI 10.1007/978-1-4939-3637-3_10; Heinemann Lutz, 2014, J Diabetes Sci Technol, V8, P6; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, 2020, WELC ICH OFF WEBS; Laranjeira FO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194801; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maier K., 2018, IMPROVING INSULIN AC; Mamat U, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0241-5; Porcellati F, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006022; Rasmussen JT, 2019, ANN PHARMACOTHER, V53, P204, DOI 10.1177/1060028018795834; Rosskamp RH, 1999, DIABETES CARE, V22, pB109; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0; Tieu C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195012; US Food and Drug Administration US Food and Drug Administration.Center for Drug Evaluation and Research, 2000, APPL NUMB 21 081 APP; US Pharmacopeia US Pharmacopeia, 2020, INS ASS; Vajo Z, 2000, PHARMACOL REV, V52, P1; Verma M, 2011, INT J DIABETES DEV C, V31, P26, DOI 10.1007/s13410-010-0010-2; Weinacker D, 2013, BRAZ J MICROBIOL, V44, P1043, DOI 10.1590/S1517-83822013000400004	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253168	10.1371/journal.pone.0253168	http://dx.doi.org/10.1371/journal.pone.0253168			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133466	Green Published, gold			2022-12-26	WOS:000671682700049
J	Sempere-Rubio, N; Aguilar-Rodriguez, M; Ingles, M; Izquierdo-Alventosa, R; Serra-Ano, P				Sempere-Rubio, Nuria; Aguilar-Rodriguez, Marta; Ingles, Marta; Izquierdo-Alventosa, Ruth; Serra-Ano, Pilar			Thermal imaging ruled out as a supplementary assessment in patients with fibromyalgia: A cross-sectional study	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; MITOCHONDRIAL DYSFUNCTION; TRAPEZIUS MUSCLE; PAIN MODULATION; TEMPERATURE; SKIN; INFLAMMATION; WOMEN; QUANTIFICATION; CLASSIFICATION	Background The diagnosis of fibromyalgia syndrome (FMS) syndrome is often complicated and relies on diagnostic criteria based mostly on the symptoms reported by patients. Implementing objective complementary tests would be desirable to better characterize this population. Objective The purpose of this cross-sectional study was to compare the skin temperature at rest using thermography in women with FMS and healthy women. Methods Eighty-six women with FMS and 92 healthy controls volunteered to participate. The temperature of all participants was measured by infra-red thermography, registering the skin surface temperature (minimum, maximum and average) at rest in different areas: neck, upper and lower back, chest, knees and elbows. In order to analyze the differences in the skin temperature between groups, inferential analyses of the data were performed using Mann-Whitney U test. Results The results showed no significant difference in skin temperature between groups in the neck, upper back, chest and elbows (p>0.05). The lower back and knees areas showed significant differences between groups (p<0.05), although these differences did not reach a minimum of clinically detectable change. Conclusions Women with fibromyalgia presented no clinically meaningful reduction or difference in skin temperature at rest when compared with a group of healthy women. The infra-red thermography is not an effective supplementary assessment tool in women with fibromyalgia.	[Sempere-Rubio, Nuria; Aguilar-Rodriguez, Marta; Ingles, Marta; Izquierdo-Alventosa, Ruth; Serra-Ano, Pilar] Univ Valencia, Dept Physiotherapy, Valencia, Spain; [Sempere-Rubio, Nuria; Aguilar-Rodriguez, Marta; Serra-Ano, Pilar] Univ Valencia, Fac Physiotherapy, Dept Physiotherapy, UBIC Res Grp, Valencia, Spain	University of Valencia; University of Valencia	Serra-Ano, P (corresponding author), Univ Valencia, Dept Physiotherapy, Valencia, Spain.; Serra-Ano, P (corresponding author), Univ Valencia, Fac Physiotherapy, Dept Physiotherapy, UBIC Res Grp, Valencia, Spain.	pilar.serra@uv.es	Serra-Ano, Pilar/L-6085-2014	Serra-Ano, Pilar/0000-0002-0743-3445; Ingles, Marta/0000-0002-5328-2692	Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain [GV2016/140]	Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain	This work was supported by Conselleria d'Educacio, Ciencia i Esports [Valencian Regional Department of Education, Science and Sports], Valencia, Spain [Grant GV2016/140]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qudah Zaid A, 2015, J Vasc Interv Neurol, V8, P43; Ammer K., 2008, THERMOL INT, V18, P125; Ammer K., 1995, BIOMED THERMOL, V15, P77; Ammer K., 2008, THERMOL INT, V18, P45; Backryd E, 2017, J PAIN RES, V10, DOI 10.2147/JPR.S128508; Bazzichi L, 2007, CLIN EXP RHEUMATOL, V25, P225; Biasi G, 1994, Minerva Med, V85, P451; Borchers AT, 2015, CLIN REV ALLERG IMMU, V49, P100, DOI 10.1007/s12016-015-8509-4; Brenner M, 2006, ANN RHEUM DIS, V65, P306, DOI 10.1136/ard.2004.035246; Charkoudian N, 2017, CLIN AUTON RES, V27, P149, DOI 10.1007/s10286-017-0420-z; Choi E, 2013, SKIN RES TECHNOL, V19, P189, DOI 10.1111/srt.12032; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Cordero MD, 2013, ANTIOXID REDOX SIGN, V18, P800, DOI 10.1089/ars.2012.4892; Denoble AE, 2010, CLIN MED INSIGHTS-AR, V3, P69, DOI 10.4137/CMAMD.S5916; Dibai AV, 2012, J MANIP PHYSIOL THER, V35, P413, DOI 10.1016/j.jmpt.2012.04.006; Elmas O, 2016, LIFE SCI, V145, P51, DOI 10.1016/j.lfs.2015.12.029; Ericsson A, 2016, PAIN MANAG, V6, P331, DOI 10.2217/pmt-2016-0015; Fernandez-Cuevas I, 2015, INFRARED PHYS TECHN, V71, P28, DOI 10.1016/j.infrared.2015.02.007; Moreira DG, 2017, J THERM BIOL, V69, P155, DOI 10.1016/j.jtherbio.2017.07.006; Groven N, 2017, EUR NEUROPSYCHOPHARM, V27, pS634, DOI 10.1016/S0924-977X(17)31194-X; Haddad DS, 2012, DENTOMAXILLOFAC RAD, V41, P621, DOI 10.1259/dmfr/98504520; Hermans L, 2018, PAIN PRACT, V18, P418, DOI 10.1111/papr.12613; Iwase S, 2002, NEUROSCI LETT, V327, P37, DOI 10.1016/S0304-3940(02)00374-9; Kang JH, 2016, ANN REHABIL MED-ARM, V40, P301, DOI 10.5535/arm.2016.40.2.301; Larson AA, 2014, CLIN J PAIN, V30, P544, DOI 10.1097/AJP.0b013e3182a0e383; Larsson A, 2017, J REHABIL MED, V49, P744, DOI 10.2340/16501977-2278; Leando P, 2003, MEDITHERM INC, P1, DOI [10.1007/978-981-10-3147-2%5F21, DOI 10.1007/978-981-10-3147-2%5F21]; Littlejohn G, 2015, NAT REV RHEUMATOL, V11, P639, DOI 10.1038/nrrheum.2015.100; Ludwig N, 2014, INFRARED PHYS TECHN, V62, P1, DOI 10.1016/j.infrared.2013.09.011; Miyakoshi N, 1998, J SHOULDER ELB SURG, V7, P625, DOI 10.1016/S1058-2746(98)90012-X; Nahm FS, 2009, KOREAN J PAIN, V22, P146, DOI 10.3344/kjp.2009.22.2.146; Nahm FS, 2013, KOREAN J PAIN, V26, P219, DOI 10.3344/kjp.2013.26.3.219; Neves Eduardo Borba, 2015, Open Neurol J, V9, P24, DOI 10.2174/1874205X01509010024; Niehof SP, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-30; Nielsen LA, 2007, BEST PRACT RES CL RH, V21, P465, DOI 10.1016/j.berh.2007.03.007; Olausson P, 2016, J PAIN RES, V9, P345, DOI 10.2147/JPR.S102275; RAJAPAKSE C, 1981, RHEUMATOL REHABIL, V20, P81, DOI 10.1093/rheumatology/20.2.81; Ring EFJ, 2012, PHYSIOL MEAS, V33, pR33, DOI 10.1088/0967-3334/33/3/R33; Rizzi M, 2017, CLIN EXP RHEUMATOL, V35, pS74; Ruggiero L, 2018, CURR OPIN SUPPORT PA, V12, P382, DOI 10.1097/SPC.0000000000000355; Sanchez-Dominguez B, 2015, MITOCHONDRION, V21, P69, DOI 10.1016/j.mito.2015.01.010; Schurmann M, 2007, CLIN J PAIN, V23, P449; Scolnik M, 2016, RHEUMATOL INT, V36, P1371, DOI 10.1007/s00296-016-3483-6; Selfe J., 2008, THERMOL INT, V18, P41; Selvan AN, 2017, SER BIOENG, P377, DOI 10.1007/978-981-10-3147-2_21; Sluka KA, 2016, NEUROSCIENCE, V338, P114, DOI 10.1016/j.neuroscience.2016.06.006; Szentkuti A, 2011, PERIOD BIOL, V113, P385; Thieme K, 2004, PSYCHOSOM MED, V66, P837, DOI 10.1097/01.psy.0000146329.63158.40; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; UEMATSU S, 1988, J NEUROSURG, V69, P552, DOI 10.3171/jns.1988.69.4.0552; Vargas JVC, 2009, INFRARED PHYS TECHN, V52, P42, DOI 10.1016/j.infrared.2008.11.003; VECCHIO PC, 1992, CLIN RHEUMATOL, V11, P382, DOI 10.1007/BF02207197; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; 팽성화, 2009, Neurospine, V6, P274	59	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253281	10.1371/journal.pone.0253281	http://dx.doi.org/10.1371/journal.pone.0253281			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133467	gold, Green Published			2022-12-26	WOS:000671682700044
J	Fukumoto, Y; Ikeuchi, M; Qu, L; Hoshino, T; Yamaguchi, N; Nakayama, Y; Ogra, Y				Fukumoto, Yasunori; Ikeuchi, Masayoshi; Qu, Liang; Hoshino, Tyuji; Yamaguchi, Naoto; Nakayama, Yuji; Ogra, Yasumitsu			Nuclear translocation promotes proteasomal degradation of human Rad17 protein through the N-terminal destruction boxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CELL-CYCLE; MITOTIC EXIT; ATR; CLAMP; CHK1; PROTEOLYSIS; INHIBITOR; REGULATOR; INTERACTS	The ATR pathway is one of the major DNA damage checkpoints, and Rad17 is a DNA-binding protein that is phosphorylated upon DNA damage by ATR kinase. Rad17 recruits the 9-1-1 complex that mediates the checkpoint activation, and proteasomal degradation of Rad17 is important for recovery from the ATR pathway. Here, we identified several Rad17 mutants deficient in nuclear localization and resistant to proteasomal degradation. The nuclear localization signal was identified in the central basic domain of Rad17. Rad17 Delta 230-270 and R240A/L243A mutants that were previously postulated to lack the destruction box, a sequence that is recognized by the ubiquitin ligase/anaphase-promoting complex that mediates degradation of Rad17, also showed cytoplasmic localization. Our data indicate that the nuclear translocation of Rad17 is functionally linked to the proteasomal degradation. The ATP-binding activity of Rad17, but not hydrolysis, is essential for the nuclear translocation, and the ATPase domain orchestrates the nuclear translocation, the proteasomal degradation, as well as the interaction with the 9-1-1 complex. The Rad17 mutant that lacked a nuclear localization signal was proficient in the interaction with the 9-1-1 complex, suggesting cytosolic association of Rad17 and the 9-1-1 complex. Finally, we identified two tandem canonical and noncanonical destruction boxes in the N-terminus of Rad17 as the bona fide destruction box, supporting the role of anaphase-promoting complex in the degradation of Rad17. We propose a model in which Rad17 is activated in the cytoplasm for translocation into the nucleus and continuously degraded in the nucleus even in the absence of exogenous DNA damage.	[Fukumoto, Yasunori; Qu, Liang; Hoshino, Tyuji; Yamaguchi, Naoto; Ogra, Yasumitsu] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Ikeuchi, Masayoshi; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Chiba University; Kyoto Pharmaceutical University	Fukumoto, Y (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan.	fukumoto@faculty.chiba-u.jp	Ogra, Yasumitsu/A-2747-2017	Ogra, Yasumitsu/0000-0002-8268-1828	Japanese Ministry of Education, Culture, Sports, Science and Technology [15K07920, 16K08253, 18K07138, 19H05772, 19K07079]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology [15K07920 (Y. F.), 16K08253 (Y. N.), 18K07138 (T. H.), 19H05772 (Y. O.), 19K07079 (Y. F.)].	Alfieri C, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170204; Bao SD, 1998, CELL GROWTH DIFFER, V9, P961; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Fukumoto Y, 2019, BIOCHEM BIOPH RES CO, V517, P310, DOI 10.1016/j.bbrc.2019.07.076; Fukumoto Y, 2018, BIOCHEM BIOPH RES CO, V504, P380, DOI 10.1016/j.bbrc.2018.06.038; Fukumoto Y, 2017, BIOCHEM BIOPH RES CO, V490, P1147, DOI 10.1016/j.bbrc.2017.06.159; Fukumoto Y, 2016, BIOCHEM BIOPH RES CO, V477, P982, DOI 10.1016/j.bbrc.2016.07.014; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Huh J, 2013, MOL CELL BIOL, V33, P213, DOI 10.1128/MCB.00847-12; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mohni KN, 2013, J VIROL, V87, P531, DOI 10.1128/JVI.02504-12; Neuwald AF, 1999, GENOME RES, V9, P27; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Post SM, 2003, NUCLEIC ACIDS RES, V31, P5568, DOI 10.1093/nar/gkg765; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Qi F, 2018, J PHYS CHEM B, V122, P8503, DOI 10.1021/acs.jpcb.8b04800; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Wang QH, 2014, EMBO J, V33, P862, DOI 10.1002/embj.201386064; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; Zhou Z, 2013, J BIOL CHEM, V288, P18134, DOI 10.1074/jbc.M113.456962; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	47	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100831	10.1016/j.jbc.2021.100831	http://dx.doi.org/10.1016/j.jbc.2021.100831			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34174284	Green Published, gold			2022-12-26	WOS:000690873500012
J	Owens, V; Saw, HW				Owens, Victoria; Saw, Htay-Wah			Black Americans demonstrate comparatively low levels of depression and anxiety during the COVID-19 pandemic	PLOS ONE			English	Article							UNITED-STATES; MENTAL-HEALTH; AFRICAN-AMERICANS; HURRICANE KATRINA; CES-D; SCALE; COMORBIDITY; PREVALENCE; ETHNICITY; VALIDITY	Introduction During public health crises like the COVID-19 pandemic, populations can experience worsening mental health. Prior reports have suggested that Black Americans experienced lower rates of anxiety and depression than White Americans before the pandemic; however, during the pandemic, outcomes may be different as Black Americans have been disproportionately affected in terms of mortality, hospitalization, COVID-19 infection, and job loss. We documented the differential mental health impact of COVID-19 on Black and Non-Black Americans. Methods We analyzed nationally representative longitudinal data from the Understanding America Study COVID-19 Tracking Survey spanning March through November of 2020 to assess differences over time in prevalence of anxiety and depression between Black and non-Black Americans. Results We found that Black Americans were significantly less likely to report symptoms for anxiety, depression, or both during the pandemic. In a given month between March through November of 2020, the odds of Black Americans reporting such symptoms was on average about half that of Non-Black Americans. We also found that in September 2020, the gap in reporting symptoms for depression began to widen gradually. Specifically, since that time, prevalence of depression remained stable among non-Black Americans while it declined gradually among Black Americans. Our main results were robust to adjusting for demographics, risk perceptions, and baseline pre-pandemic mental health status. Conclusions Black Americans maintained significantly better mental health than Non-Black Americans despite their struggle against economic, health, and racial inequalities during the pandemic. We discuss the significance and implications of our results and identify opportunities for future research.	[Owens, Victoria] Univ Maryland & Westat, Joint Program Survey Methodol JPSM, College Pk, MD 20742 USA; [Saw, Htay-Wah] Univ Michigan, Inst Social Res, Survey Res Ctr, Michigan Program Survey Methodol, Ann Arbor, MI 48109 USA; [Saw, Htay-Wah] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA 90007 USA	University of Michigan System; University of Michigan; University of Southern California	Owens, V (corresponding author), Univ Maryland & Westat, Joint Program Survey Methodol JPSM, College Pk, MD 20742 USA.	vila@umd.edu		Owens, Victoria/0000-0002-1048-8201	National Institute on Aging [U01AG054580]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Htay-Wah Saw acknowledges support by the National Institute on Aging through grant U01AG054580.	Adams RE, 2006, SOC SCI MED, V62, P176, DOI 10.1016/j.socscimed.2005.05.008; Adams RE, 2005, PSYCHIATRY, V68, P250, DOI 10.1521/psyc.2005.68.3.250; Alcendor DJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082442; Alvarez K, 2019, SOC PSYCH PSYCH EPID, V54, P553, DOI 10.1007/s00127-018-1644-5; Angrisani M, 2019, SAMPLING WEIGHTING U; Breslau J, 2021, PREV MED, V143, DOI 10.1016/j.ypmed.2020.106362; Brodie M, 2006, AM J PUBLIC HEALTH, V96, P1402, DOI 10.2105/AJPH.2005.084475; Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51 Spec No, P16; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Daly M, 2021, J AFFECT DISORDERS, V278, P131, DOI 10.1016/j.jad.2020.09.065; Davidson TM, 2013, AM J COMMUN PSYCHOL, V52, P97, DOI 10.1007/s10464-013-9579-1; de Bruin WB, 2018, RISK ANAL, V38, P2128, DOI 10.1111/risa.13138; Fitzpatrick KM, 2020, SUICIDE LIFE-THREAT, V50, P1241, DOI 10.1111/sltb.12655; Fothergill A, 1999, DISASTERS, V23, P156, DOI 10.1111/1467-7717.00111; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Gollust SE, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106278; Graham C, 2019, J POPUL ECON, V32, P665, DOI 10.1007/s00148-018-0687-y; Hales CM., 2017, HYPERTENSION PREVALE; Himle JA, 2009, J ANXIETY DISORD, V23, P578, DOI 10.1016/j.janxdis.2009.01.002; Holingue C, 2020, AM J PUBLIC HEALTH, V110, P1628, DOI 10.2105/AJPH.2020.305857; Kapteyn A, 2020, SURV RES METHODS-GER, V14, P179, DOI 10.18148/srm/2020.v14i2.7737; Karim J, 2015, CURR PSYCHOL, V34, P681, DOI 10.1007/s12144-014-9281-y; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Mann FD, 2020, PERS INDIV DIFFER, V167, DOI 10.1016/j.paid.2020.110233; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P2555, DOI 10.1001/jama.2020.21231; Milette K, 2010, RHEUMATOLOGY, V49, P789, DOI 10.1093/rheumatology/kep443; Mouzon DM, 2017, RACE SOC PROBL, V9, P63, DOI 10.1007/s12552-017-9198-9; Picou JS, 2010, SOCIOL INQ, V80, P513, DOI 10.1111/j.1475-682X.2010.00345.x; Proto E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244419; Raifman MA, 2020, AM J PREV MED, V59, P137, DOI 10.1016/j.amepre.2020.04.003; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; SCHAEFFER NC, 1991, PUBLIC OPIN QUART, V55, P395, DOI 10.1086/269270; Schneider S, 2016, QUAL LIFE RES, V25, P2511, DOI 10.1007/s11136-016-1293-7; Schwarz N, 1999, AM PSYCHOL, V54, P93, DOI 10.1037/0003-066X.54.2.93; USC Dornsife Center for Economic and Social Research, 2019, UND AM STUD RECR PRO; van der Velden PG., 2021, PREVALENCE INCIDENCE; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Weissman Judith F, 2015, NCHS Data Brief, P1	42	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253654	10.1371/journal.pone.0253654	http://dx.doi.org/10.1371/journal.pone.0253654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170956	gold, Green Published			2022-12-26	WOS:000671694400047
J	Papagianis, PC; Ahmadi-Noorbakhsh, S; Lim, R; Wallace, E; Polglase, G; Pillow, JJ; Moss, TJ				Papagianis, Paris Clarice; Ahmadi-Noorbakhsh, Siavash; Lim, Rebecca; Wallace, Euan; Polglase, Graeme; Pillow, J. Jane; Moss, Timothy J.			The effect of human amnion epithelial cells on lung development and inflammation in preterm lambs exposed to antenatal inflammation	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; INTRAAMNIOTIC ENDOTOXIN; ELASTIN CONTENT; INJURY; VENTILATION; SHEEP; MORPHOMETRY; INTRAUTERINE; SURFACTANT; PREMATURE	Background Lung inflammation and impaired alveolarization are hallmarks of bronchopulmonary dysplasia (BPD). We hypothesize that human amnion epithelial cells (hAECs) are anti-inflammatory and reduce lung injury in preterm lambs born after antenatal exposure to inflammation. Methods Pregnant ewes received either intra-amniotic lipopolysaccharide (LPS, from E.coli 055:B5; 4mg) or saline (Sal) on day 126 of gestation. Lambs were delivered by cesarean section at 128 d gestation (term similar to 150 d). Lambs received intravenous hAECs (LPS/hAECs: n = 7; 30x10(6) cells) or equivalent volumes of saline (LPS/Sal, n = 10; or Sal/Sal, n = 9) immediately after birth. Respiratory support was gradually de-escalated, aimed at early weaning from mechanical ventilation towards unassisted respiration. Lung tissue was collected 1 week after birth. Lung morphology was assessed and mRNA levels for inflammatory mediators were measured. Results Respiratory support required by LPS/hAEC lambs was not different to Sal/Sal or LPS/Sal lambs. Lung tissue:airspace ratio was lower in the LPS/Sal compared to Sal/Sal lambs (P<0.05), but not LPS/hAEC lambs. LPS/hAEC lambs tended to have increased septation in their lungs versus LPS/Sal (P = 0.08). Expression of inflammatory cytokines was highest in LPS/hAECs lambs. Conclusions Postnatal administration of a single dose of hAECs stimulates a pulmonary immune response without changing ventilator requirements in preterm lambs born after intrauterine inflammation.	[Papagianis, Paris Clarice; Lim, Rebecca; Wallace, Euan; Polglase, Graeme; Moss, Timothy J.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Papagianis, Paris Clarice; Lim, Rebecca; Wallace, Euan; Polglase, Graeme; Moss, Timothy J.] Monash Univ, Sch Clin Hlth Sci, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Papagianis, Paris Clarice; Ahmadi-Noorbakhsh, Siavash; Pillow, J. Jane] Univ Western Australia, Sch Human Sci, Crawley, WA, Australia; [Papagianis, Paris Clarice] RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia; [Papagianis, Paris Clarice] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; University of Western Australia; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Institute of Technology (RMIT)	Papagianis, PC (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.; Papagianis, PC (corresponding author), Monash Univ, Sch Clin Hlth Sci, Dept Obstet & Gynaecol, Clayton, Vic, Australia.; Papagianis, PC (corresponding author), Univ Western Australia, Sch Human Sci, Crawley, WA, Australia.; Papagianis, PC (corresponding author), RMIT Univ, Sch Hlth Sci, Melbourne, Vic, Australia.; Papagianis, PC (corresponding author), RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic, Australia.	pariscpapagianis@gmail.ccom	Papagianis, Paris/GRR-4541-2022; , Siavash/J-6446-2015; moss, timothy/A-6633-2008; Pillow, Jane/A-3335-2009	, Siavash/0000-0001-6293-670X; Papagianis, Paris/0000-0002-4709-6017; moss, timothy/0000-0002-9408-4027; Pillow, Jane/0000-0002-6500-0138	NHMRC [1077769, 1077691: TJM 1043294]; NHMRC Centre for Research Excellence [1057514]; Victorian Government's Operational Infrastructure Support Program; West Australian Government's Medical and Health Research Infrastructure Fund; Chiesi Farmaceutici S.p.A.; Fisher & Paykel Healthcare; ICU Medical	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Centre for Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; West Australian Government's Medical and Health Research Infrastructure Fund; Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc); Fisher & Paykel Healthcare; ICU Medical	This research was supported by an NHMRC Project Grant (1077769), NHMRC Centre for Research Excellence (1057514), two NHMRC Senior Research Fellowships (JJP; 1077691: TJM 1043294), the Victorian Government's Operational Infrastructure Support Program, and the West Australian Government's Medical and Health Research Infrastructure Fund. Unrestricted equipment and consumable support was provided by Chiesi Farmaceutici S.p.A. (poractant alfa); Fisher & Paykel Healthcare (ventilator circuits); and ICU Medical (arterial monitoring lines). None of the commercial industry funders had any input into study design, data collection and analysis, decision to publish or preparation of the manuscript. Chiesi Farmaceutici S.p.A. reviewed the final manuscript for technical accuracy pertaining to description and use of their surfactant, in accordance with a Material Transfer Agreement associated with the provision of surfactant for study animals. The University of Western Australia (via JJP) has consultancy agreements with Chiesi Farmaceutici S.p.A. unrelated to the subject of this study. Fisher & Paykel Healthcare have material transfer agreements with Hudson Research Institute that are also unrelated to this work. There are no other relevant interests relating to employment, consultancy, patents, or products in development or marketed products to declare. These material transfer agreements do not alter our adherence to PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrons GA, 2005, RADIOGRAPHICS, V25, P1047, DOI 10.1148/rg.254055019; Albertine KH, 1999, AM J RESP CRIT CARE, V159, P945, DOI 10.1164/ajrccm.159.3.9804027; Allison BJ, 2008, PEDIATR RES, V64, P387, DOI 10.1203/PDR.0b013e318181e05e; Baker EK, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026265; Barton SK, 2015, DEV NEUROSCI-BASEL, V37, P338, DOI 10.1159/000371415; Barton SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112402; Been JV, 2010, J PEDIATR-US, V156, P10, DOI 10.1016/j.jpeds.2009.07.044; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Choi CW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035250500404085; Council NHaMR, 2013, AUSTR COD CAR US AN, V8th; Galinsky R, 2013, J PREGNANCY, V2013, DOI 10.1155/2013/412831; Gresham K, 2011, RESP PHYSIOL NEUROBI, V178, P414, DOI 10.1016/j.resp.2011.05.008; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hillman NH, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-124; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; HISLOP AA, 1987, EARLY HUM DEV, V15, P147, DOI 10.1016/0378-3782(87)90003-X; Hodges RJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.038; Husain AN, 1998, HUM PATHOL, V29, P710, DOI 10.1016/S0046-8177(98)90280-5; Inocencio IM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13113-9; Jobe AH, 2006, NEOREVIEWS, V7, pe531; Joyce BJ, 2003, AM J PHYSIOL-LUNG C, V284, pL643, DOI 10.1152/ajplung.00090.2002; Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Lahra MM, 2009, ARCH DIS CHILD-FETAL, V94, pF13, DOI 10.1136/adc.2007.135889; Lim R, 2018, CYTOTHERAPY, V20, pS21, DOI 10.1016/j.jcyt.2018.02.046; Lindahl P, 1997, DEVELOPMENT, V124, P3943; Lock MC, 2015, J HISTOCHEM CYTOCHEM, V63, P866, DOI 10.1369/0022155415600201; Mank A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164817; McDonald CA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt495; Melville JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173572; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Moss TJM, 2002, AM J RESP CRIT CARE, V165, P805, DOI 10.1164/ajrccm.165.6.2108053; Moss TJM, 2002, EARLY HUM DEV, V66, P11, DOI 10.1016/S0378-3782(01)00227-4; Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Pearl DL, 2014, ILAR J, V55, P486, DOI 10.1093/ilar/ilu034; Polglase GR, 2007, PEDIATR RES, V62, P32, DOI 10.1203/PDR.0b013e3180686433; Polglase GR, 2017, J APPL PHYSIOL, V123, P1195, DOI 10.1152/japplphysiol.00783.2016; Robertson B, 1987, Perspect Pediatr Pathol, V11, P6; Stojanovska V, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00026; Tan JL, 2014, CELL TRANSPLANT, V23, P319, DOI 10.3727/096368912X661409; TENG LJ, 1994, J CLIN MICROBIOL, V32, P1464, DOI 10.1128/JCM.32.6.1464-1469.1994; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vergnano S, 2005, Arch Dis Child Fetal Neonatal Ed, V90, pF220, DOI 10.1136/adc.2002.022863; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Vosdoganes P, 2013, CELL TRANSPLANT, V22, P1337, DOI 10.3727/096368912X657657; Vosdoganes P, 2013, CYTOTHERAPY, V15, P1021, DOI 10.1016/j.jcyt.2013.03.004; Vosdoganes P, 2012, PEDIATRICS, V130, P727, DOI 10.1542/peds.2011-2576; Vosdoganes P, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.054; Watterberg KL, 1996, PEDIATRICS, V97, P210; Westover A, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00871; Willet KE, 1999, PEDIATR RES, V45, P615, DOI 10.1203/00006450-199905010-00002; Willet KE, 2000, PEDIATR RES, V48, P782, DOI 10.1203/00006450-200012000-00014; Yawno T, 2013, DEV NEUROSCI-BASEL, V35, P272, DOI 10.1159/000346683; Zhu D, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0689-9; Zhu DD, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4565612	57	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253456	10.1371/journal.pone.0253456	http://dx.doi.org/10.1371/journal.pone.0253456			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170941	Green Published, gold			2022-12-26	WOS:000671694400046
J	Albee, LJ; Gao, XL; Majetschak, M				Albee, Lauren J.; Gao, Xianlong; Majetschak, Matthias			Plasticity of seven-transmembrane-helix receptor heteromers in human vascular smooth muscle cells	PLOS ONE			English	Article							ADRENERGIC VASOCONSTRICTION; VASOPRESSIN; COMPLEXES; POTENTIATION; DIMERIZATION; MOLECULE; REVEALS	Recently, we reported that the chemokine (C-X-C motif) receptor 4 (CXCR4) and atypical chemokine receptor 3 (ACKR3) heteromerize with alpha(1A/B/D)-adrenoceptors (ARs) and arginine vasopressin receptor 1A (AVPR1A) in recombinant systems and in rodent and human vascular smooth muscle cells (hVSMCs). In these studies, we observed that heteromerization between two receptor partners may depend on the presence and the expression levels of other partnering receptors. To test this hypothesis and to gain initial insight into the formation of these receptor heteromers in native cells, we utilized proximity ligation assays in hVSMCs to visualize receptor-receptor proximity and systematically studied how manipulation of the expression levels of individual protomers affect heteromerization patterns among other interacting receptor partners. We confirmed subtype-specific heteromerization between endogenously expressed alpha(1A/B/D)-ARs and detected that AVPR1A also heteromerizes with alpha(1A/B/D)-ARs. siRNA knockdown of CXCR4 and of ACKR3 resulted in a significant re-arrangement of the heteromerization patterns among alpha(1)-AR subtypes. Similarly, siRNA knockdown of AVPR1A significantly increased heteromerization signals for seven of the ten receptor pairs between CXCR4, ACKR3, and alpha(1A/B/D)-ARs. Our findings suggest plasticity of seven transmembrane helix (7TM) receptor heteromerization in native cells and could be explained by a supramolecular organization of these receptors within dynamic clusters in the plasma membrane. Because we previously observed that recombinant CXCR4, ACKR3, alpha(1a)-AR and AVPR1A form hetero-oligomeric complexes composed of 2-4 different protomers, which show signaling properties distinct from individual protomers, re-arrangements of receptor heteromerization patterns in native cells may contribute to the phenomenon of context-dependent GPCR signaling. Furthermore, these findings advise caution in the interpretation of functional consequences after 7TM receptor knockdown in experimental models. Alterations of the heteromerization patterns among other receptor partners may alter physiological and pathological responses, in particular in more complex systems, such as studies on the function of isolated organs or in in vivo experiments.	[Albee, Lauren J.] Loyola Univ, Burn & Shock Trauma Res Inst, Dept Surg, Chicago Stritch Sch Med, Maywood, IL USA; [Gao, Xianlong; Majetschak, Matthias] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA; [Majetschak, Matthias] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Albee, Lauren J.] Kings Coll London, Cardiovasc Res, London, England	Loyola University Chicago; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; University of London; King's College London	Majetschak, M (corresponding author), Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL 33620 USA.; Majetschak, M (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	majetschak@usf.edu			National Institutes of Health [R01GM139811, R21AA025750, R21AI139827]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institutes of Health under award numbers R01GM139811, R21AA025750 and R21AI139827 to MM. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albee LJ, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170207; Albee LJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006575; Alexander SPH, 2017, BRIT J PHARMACOL, V174, pS17, DOI 10.1111/bph.13878; BARTELSTONE HJ, 1965, AM J PHYSIOL, V208, P754, DOI 10.1152/ajplegacy.1965.208.4.754; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Coke CJ, 2016, J BIOL CHEM, V291, P9991, DOI 10.1074/jbc.M115.712661; de Poorter C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058075; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Evans AE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060971; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Franco R, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00076; Gaitonde SA, 2017, CURR OPIN PHARMACOL, V32, P23, DOI 10.1016/j.coph.2016.10.006; Gao XL, 2021, FEBS LETT, V595, P1863, DOI 10.1002/1873-3468.14135; Gao XL, 2020, J BIOL CHEM, V295, P14893, DOI 10.1074/jbc.RA120.015355; Gao XL, 2020, BIOCHEM BIOPH RES CO, V528, P368, DOI 10.1016/j.bbrc.2020.02.094; Gao XL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21096-4; Gomes I, 2016, ANNU REV PHARMACOL, V56, P403, DOI 10.1146/annurev-pharmtox-011613-135952; Heuninck J, 2019, MOL PHARMACOL, V96, P778, DOI 10.1124/mol.118.115477; Kwon EK, 2017, BBA-MOL CELL RES, V1864, P1, DOI 10.1016/j.bbamcr.2016.10.008; LaRocca TJ, 2010, J CARDIOVASC PHARM, V56, P548, DOI 10.1097/FJC.0b013e3181f713fe; Martinez-Munoz L, 2018, MOL CELL, V70, P106, DOI 10.1016/j.molcel.2018.02.034; Niswender CM, 2010, MOL PHARMACOL, V77, P459, DOI 10.1124/mol.109.058768; Noguera I, 1997, BRIT J PHARMACOL, V122, P431, DOI 10.1038/sj.bjp.0701397; Pello OM, 2008, EUR J IMMUNOL, V38, P537, DOI 10.1002/eji.200737630; Quitterer U, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00009; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Sharman JL, 2013, NUCLEIC ACIDS RES, V41, pD1083, DOI 10.1093/nar/gks960; Sleno R, 2019, NEUROPHARMACOLOGY, V152, P4, DOI 10.1016/j.neuropharm.2019.01.018; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Steppan J, 2012, ANESTH ANALG, V115, P1290, DOI 10.1213/ANE.0b013e3182691c11; Tripathi A, 2015, P NATL ACAD SCI USA, V112, pE1659, DOI 10.1073/pnas.1417564112; Tripathi A, 2014, CYTOKINE, V65, P121, DOI 10.1016/j.cyto.2013.12.008; Uberti MA, 2003, MOL PHARMACOL, V64, P1379, DOI 10.1124/mol.64.6.1379; Watts AO, 2013, BRIT J PHARMACOL, V168, P1662, DOI 10.1111/bph.12064; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253821	10.1371/journal.pone.0253821	http://dx.doi.org/10.1371/journal.pone.0253821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166476	gold, Green Published			2022-12-26	WOS:000671692800061
J	Lee, JW; Hwang, JS; Chung, WJ; Lee, HJ; Park, JG; Lee, CH; Kim, BS; Song, JE; Kweon, YO; Tak, WY; Park, SY; Jang, SY; Suh, JI; Jang, BK				Lee, Jin Wook; Hwang, Jae Seok; Chung, Woo Jin; Lee, Heon Ju; Park, Jung Gil; Lee, Chang Hyeong; Kim, Byung Seok; Song, Jeong Eun; Kweon, Young Oh; Tak, Won Young; Park, Soo Young; Jang, Se Young; Suh, Jeong Ill; Jang, Byoung Kuk			Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites	PLOS ONE			English	Article							NATURAL-HISTORY; LIVER-CIRRHOSIS; SODIUM; SARCOPENIA; PARACENTESIS; EXCRETION; CARE	Background and aims The low-salt diet is considered important for control of ascites in cirrhotic patients. To validate whether the spot urine sodium (Na)/potassium (K) ratio could replace 24-h urine Na (uNa) excretion in assessing low-salt diet compliance. Methods We prospectively studied 175 patients. 24-h urine collection and spot urine collection were performed. Subsequently, 24-h uNa, urine creatinine (uCr), and spot urine Na and K were assessed. A complete urine collection was confirmed based on 24-h uCr excretion levels of 15mg/kg/day for men and 10mg/kg/day for women. The area under the receiver operating characteristic (AUROC) curve analysis was performed to evaluate the feasibility of spot urine Na/K ratio in predicting 24-h uNa greater than 78mmol/day. Results Out of 175 patients, 24-h urine samples were completely collected in 57 patients only. Moreover, urine samples were not completely collected in 118 patients because their 24-h uCr excretion level was less than the established criteria. In complete urine collection group, AUROC curve for spot urine Na/K ratio in predicting 24-h uNa greater than 78mmol/day was 0.874 +/- 0.051 (P<0.001). In the incomplete urine collection group, the AUROC was 0.832 +/- 0.039 (P<0.001). In complete urine collection group, the classical cutoff value greater than 1.0 of spot urine Na/K ratio showed 90.9% sensitivity and 56.0% specificity. Conclusions The spot urine Na/K ratio reflects 24-h uNa, but the AUROC value obtained in this study is lower than that of a previous study. Considered the large number of patients with incomplete urine collection, validating 24-h complete urine collection criteria is necessary.	[Lee, Jin Wook; Hwang, Jae Seok; Chung, Woo Jin; Jang, Byoung Kuk] Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Lee, Heon Ju] Bokwang Hosp, Dept Internal Med, Daegu, South Korea; [Park, Jung Gil] Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea; [Lee, Chang Hyeong; Kim, Byung Seok; Song, Jeong Eun] Daegu Catholic Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kweon, Young Oh; Tak, Won Young; Park, Soo Young; Jang, Se Young] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Internal Med, Daegu, South Korea; [Suh, Jeong Ill] Dongguk Univ, Dept Internal Med, Coll Med, Gyeongju, South Korea	Keimyung University; Yeungnam University; Catholic University of Daegu; Kyungpook National University; Kyungpook National University Hospital; Dongguk University	Jang, BK (corresponding author), Keimyung Univ, Dept Internal Med, Sch Med, Daegu, South Korea.	jangha106@gmail.com		Lee, Jin Wook/0000-0002-5312-4053	Daegu-Gyeongbuk Branch of the Korea Association	Daegu-Gyeongbuk Branch of the Korea Association	This study was supported by the DaeguGyeongbuk Branch of the Korea Association for the study of the Liver, through the Clinical Medicine Research Program Grant received by BKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo Vicente, 2002, Ann Hepatol, V1, P72; BERNARDI M, 1993, LIVER, V13, P156; BERNARDI M, 1985, DIGESTION, V31, P189, DOI 10.1159/000199198; Cholongitas E, 2012, LIVER INT, V32, P172, DOI 10.1111/j.1478-3231.2011.02669.x; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; El-Bokl MA, 2009, WORLD J GASTROENTERO, V15, P3631, DOI 10.3748/wjg.15.3631; Gines P, 2002, GASTROENTEROLOGY, V123, P1839, DOI 10.1053/gast.2002.37073; GINES P, 1987, HEPATOLOGY, V7, P122, DOI 10.1002/hep.1840070124; Gu DH, 2018, CLIN MOL HEPATOL, V24, P319, DOI 10.3350/cmh.2017.0077; Heer M, 2000, AM J PHYSIOL-RENAL, V278, pF585, DOI 10.1152/ajprenal.2000.278.4.F585; Jassal SK, 2015, J RENAL NUTR, V25, P97, DOI 10.1053/j.jrn.2014.07.005; Lucena MI, 2002, EUR J CLIN PHARMACOL, V58, P435, DOI 10.1007/s00228-002-0474-1; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; Park Jae Eun, 2010, Korean J Hepatol, V16, P66, DOI 10.3350/kjhep.2010.16.1.66; Periyalwar P, 2012, CLIN LIVER DIS, V16, P95, DOI 10.1016/j.cld.2011.12.009; Planas R, 2006, CLIN GASTROENTEROL H, V4, P1385, DOI 10.1016/j.cgh.2006.08.007; Rossle M, 2000, NEW ENGL J MED, V342, P1701, DOI 10.1056/NEJM200006083422303; Runyon B., 1996, HEPATOLOGY; RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508; Runyon BA, 2012, AASLD, V3, P5; Silva Otávio Marcos da, 2014, J Port Gastrenterol., V21, P15, DOI 10.1016/j.jpg.2013.04.006; Stiehm A., 2002, HEPATOLOGY; Suk Ki Tae, 2012, Korean J Hepatol, V18, P1, DOI 10.3350/kjhep.2012.18.1.1; WALSER M, 1987, JPEN-PARENTER ENTER, V11, pS73, DOI 10.1177/014860718701100510; Wielgosz A, 2016, J CLIN HYPERTENS, V18, P581, DOI 10.1111/jch.12716	25	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253886	10.1371/journal.pone.0253886	http://dx.doi.org/10.1371/journal.pone.0253886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166456	Green Published, gold			2022-12-26	WOS:000671692800093
J	Sebastian, JA; Moore, MJ; Berndl, ESL; Kolios, MC				Sebastian, Joseph A.; Moore, Michael J.; Berndl, Elizabeth S. L.; Kolios, Michael C.			An image-based flow cytometric approach to the assessment of the nucleus-to-cytoplasm ratio	PLOS ONE			English	Article							NUCLEAR/CYTOPLASMIC RATIO; CELLS; HOECHST-33342; CHALLENGE; ACCURACY; ADHESION	The nucleus-to-cytoplasm ratio (N:C) can be used as one metric in histology for grading certain types of tumor malignancy. Current N:C assessment techniques are time-consuming and low throughput. Thus, in high-throughput clinical contexts, there is a need for a technique that can assess cell malignancy rapidly. In this study, we assess the N:C ratio of four different malignant cell lines (OCI-AML-5-blood cancer, CAKI-2-kidney cancer, HT-29-colon cancer, SK-BR-3-breast cancer) and a non-malignant cell line (MCF-10A -breast epithelium) using an imaging flow cytometer (IFC). Cells were stained with the DRAQ-5 nuclear dye to stain the cell nucleus. An Amnis ImageStreamX (R) IFC acquired brightfield/fluorescence images of cells and their nuclei, respectively. Masking and gating techniques were used to obtain the cell and nucleus diameters for 5284 OCI-AML-5 cells, 1096 CAKI-2 cells, 6302 HT-29 cells, 3159 SK-BR-3 cells, and 1109 MCF-10A cells. The N:C ratio was calculated as the ratio of the nucleus diameter to the total cell diameter. The average cell and nucleus diameters from IFC were 12.3 +/- 1.2 mu m and 9.0 +/- 1.1 mu m for OCI-AML5 cells, 24.5 +/- 2.6 mu m and 15.6 +/- 2.1 mu m for CAKI-2 cells, 16.2 +/- 1.8 mu m and 11.2 +/- 1.3 mu m for HT-29 cells, 18.0 +/- 3.7 mu m and 12.5 +/- 2.1 mu m for SK-BR-3 cells, and 19.4 +/- 2.2 mu m and 10.1 +/- 1.8 mu m for MCF-10A cells. Here we show a general N:C ratio of similar to 0.6-0.7 across varying malignant cell lines and a N:C ratio of similar to 0.5 for a non-malignant cell line. This study demonstrates the use of IFC to assess the N:C ratio of cancerous and non-cancerous cells, and the promise of its use in clinically relevant high-throughput detection scenarios to supplement current workflows used for cancer cell grading.	[Sebastian, Joseph A.; Moore, Michael J.; Berndl, Elizabeth S. L.; Kolios, Michael C.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Sebastian, Joseph A.; Moore, Michael J.; Berndl, Elizabeth S. L.; Kolios, Michael C.] Inst Biomed Engn Sci & Technol iBEST, Toronto, ON, Canada; [Sebastian, Joseph A.; Moore, Michael J.; Berndl, Elizabeth S. L.; Kolios, Michael C.] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	Toronto Metropolitan University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Sebastian, JA; Kolios, MC (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.; Sebastian, JA; Kolios, MC (corresponding author), Inst Biomed Engn Sci & Technol iBEST, Toronto, ON, Canada.; Sebastian, JA; Kolios, MC (corresponding author), St Michaels Hosp, Keenan Res Ctr Biomed Sci, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	j.sebastian@mail.utoronto.ca; mkolios@ryerson.ca	Kolios, Michael C./F-1767-2010	Kolios, Michael C./0000-0002-9994-8293; Moore, Michael/0000-0002-8798-393X; Sebastian, Joseph/0000-0002-8061-797X	Natural Science and Engineering Research Council of Canada [RGPIN-201706486]; Canadian Foundation for Innovation; Ontario Ministry for Research and Innovation [11525]; Terry Fox Foundation [1034]	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Terry Fox Foundation	This research was supported in part by the Natural Science and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant (RGPIN-201706486), the Canadian Foundation for Innovation (https://www.innovation.ca/) and the Ontario Ministry for Research and Innovation (Project #11525), and the Terry Fox Foundation (https://terryfox.org/, TFRI Project #1034) funding agencies. All grants were awarded to M.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Amnis, IDEAS IMAGESTREAM AN; Bancroft JD., 1982, THEORY PRACTICE HIST, V2nd; Beaton LA, 2013, MUTAT RES-GEN TOX EN, V756, P192, DOI 10.1016/j.mrgentox.2013.04.002; Beaton-Green LA, 2016, METHODS MOL BIOL, P97, DOI 10.1007/978-1-4939-3302-0_6; Blasi T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10256; Caicedo JC, 2018, PROC CVPR IEEE, P9309, DOI 10.1109/CVPR.2018.00970; Chu FY, 2017, P NATL ACAD SCI USA, V114, P10338, DOI 10.1073/pnas.1702226114; Creager AJ, 2002, AM J CLIN PATHOL, V117, P217; Doan M., 2018, BIOINFORMATICS, DOI [10.1101/256180, DOI 10.1101/256180]; Doan M, 2020, P NATL ACAD SCI USA, V117, P21381, DOI 10.1073/pnas.2001227117; Doan M, 2020, CYTOM PART A, V97, P407, DOI 10.1002/cyto.a.23987; Doan M, 2017, BLOOD, V130; Doan M, 2018, TRENDS BIOTECHNOL, V36, P649, DOI 10.1016/j.tibtech.2017.12.008; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P117, DOI 10.1177/30.2.6174559; Friedrich MJ, 2017, JAMA-J AM MED ASSOC, V318, P1095, DOI 10.1001/jama.2017.10203; Geltmeier A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134999; Gomes CJ, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0039-z; Grabner R, 2000, CYTOMETRY, V40, P238, DOI 10.1002/1097-0320(20000701)40:3<238::AID-CYTO9>3.0.CO;2-3; Grimwade LF, 2017, METHODS, V112, P39, DOI 10.1016/j.ymeth.2016.06.023; Han YY, 2016, LAB CHIP, V16, P4639, DOI 10.1039/c6lc01063f; Hang JF, 2017, CANCER CYTOPATHOL, V125, P710, DOI 10.1002/cncy.21883; Hennig H, 2017, METHODS, V112, P201, DOI 10.1016/j.ymeth.2016.08.018; Huang H-C, 2019, IMAGING MANIPULATION, P27; Huang HL, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-36; Huang HC, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.8.080502; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; Layfield LJ, 2017, DIAGN CYTOPATHOL, V45, P107, DOI 10.1002/dc.23639; Lim CS, 2015, SCI REP-UK, V5, DOI 10.1038/srep18521; Liu YY, 2016, ONCOTARGET, V7, P81410, DOI 10.18632/oncotarget.12937; Liu ZB, 2015, SCI REP-UK, V5, DOI 10.1038/srep14272; Lo K, 2008, CYTOM PART A, V73A, P321, DOI 10.1002/cyto.a.20531; MAIZEL A, 1975, J CELL PHYSIOL, V86, P71, DOI 10.1002/jcp.1040860109; McIntire PJ, 2019, CANCER CYTOPATHOL, V127, P120, DOI 10.1002/cncy.22061; Moore MJ, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.10.106502; Nandakumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029230; Pinto RN, 2019, CYTOM PART A, V95, P976, DOI 10.1002/cyto.a.23846; Ponomarev Eugene D, 2011, BMC Res Notes, V4, P517, DOI 10.1186/1756-0500-4-517; Rahmadwati, 2010, INT C COMPUT ENG APP, P515, DOI 10.1109/ICCEA.2010.105; Rajan R, 2015, CYTOM PART A, V87A, P451, DOI 10.1002/cyto.a.22652; REVEL JP, 1974, EXP CELL RES, V84, P207, DOI 10.1016/0014-4827(74)90398-X; Rosenthal DL., 2015, PARIS SYSTEM REPORTI, V1st, P151; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; Sebastian JA., 2019, PHOTONS PLUS ULTRASO, P87, DOI [10.1117/12.2506434.full, DOI 10.1117/12.2506434.FULL]; Sebastian JA, 2019, PROC SPIE, V10878, DOI 10.1117/12.2507508; Shambayati B., 2011, CYTOPATHOLOGY, P417; Smith PJ, 2000, CYTOMETRY, V40, P280, DOI 10.1002/1097-0320(20000801)40:4<280::AID-CYTO4>3.0.CO;2-7; Strohm EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40895-x; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; SWANSON JA, 1991, J CELL BIOL, V115, P941, DOI 10.1083/jcb.115.4.941; Takahashi M., 1981, COLOR ATLAS CANC CYT, V2nd, P575; Tsuji PA, 2011, NUTRIENTS, V3, P805, DOI 10.3390/nu3090805; Vaickus LJ, 2015, CANCER CYTOPATHOL, V123, P524, DOI 10.1002/cncy.21585; Xu JF, 2017, CANCER MED-US, V6, P2063, DOI 10.1002/cam4.1144; Zhang MJL, 2016, CANCER CYTOPATHOL, V124, P669, DOI 10.1002/cncy.21735; Zou CF, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-22	56	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253439	10.1371/journal.pone.0253439	http://dx.doi.org/10.1371/journal.pone.0253439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166419	gold, Green Published			2022-12-26	WOS:000671692800028
J	Jin, G; Kwon, O				Jin, Guangxun; Kwon, Ohbyung			Impact of chart image characteristics on stock price prediction with a convolutional neural network	PLOS ONE			English	Article							FINANCIAL NEWS	Stock price prediction has long been the subject of research because of the importance of accuracy of prediction and the difficulty in forecasting. Traditionally, forecasting has involved linear models such as AR and MR or nonlinear models such as ANNs using standardized numerical data such as corporate financial data and stock price data. Due to the difficulty of securing a sufficient variety of data, researchers have recently begun using convolutional neural networks (CNNs) with stock price graph images only. However, we know little about which characteristics of stock charts affect the accuracy of predictions and to what extent. The purpose of this study is to analyze the effects of stock chart characteristics on stock price prediction via CNNs. To this end, we define the image characteristics of stock charts and identify significant differences in prediction performance for each characteristic. The results reveal that the accuracy of prediction is improved by utilizing solid lines, color, and a single image without axis marks. Based on these findings, we describe the implications of making predictions only with images, which are unstructured data, without using large amounts of standardized data. Finally, we identify issues for future research.	[Jin, Guangxun] Kyung Hee Univ, Dept Management, Seoul, South Korea; [Kwon, Ohbyung] Kyung Hee Univ, Sch Management, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Kwon, O (corresponding author), Kyung Hee Univ, Sch Management, Seoul, South Korea.	obkwon@khu.ac.kr		Kwon, Ohbyung/0000-0001-9686-6586	Ministry of Education of the Republic of Korea; National Research Foundation of Korea [NRF-2020S1A5B8103855]	Ministry of Education of the Republic of Korea(Ministry of Education (MOE), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the Ministry of Education of the Republic of Korea and the National Research Foundation of Korea (NRF-2020S1A5B8103855).	Ballings M, 2015, EXPERT SYST APPL, V42, P7046, DOI 10.1016/j.eswa.2015.05.013; Bessembinder H, 1997, J FINANC QUANT ANAL, V32, P287, DOI 10.2307/2331201; Box GEP., 2015, TIME SERIES ANAL FOR, V37, P709, DOI [10.1111/jtsa.12194, DOI 10.1111/JTSA.12194]; Cao JS, 2019, INT J COMMUN SYST, V32, DOI 10.1002/dac.3987; CARPENTER GA, 1992, IEEE T NEURAL NETWOR, V3, P698, DOI 10.1109/72.159059; Chen Q, 2018, 2018 IEEE SYMPOSIUM ON SECURITY AND PRIVACY WORKSHOPS (SPW 2018), P140, DOI 10.1109/SPW.2018.00029; Chung H, 2020, NEURAL COMPUT APPL, V32, P7897, DOI 10.1007/s00521-019-04236-3; De Gooijer JG, 2006, INT J FORECASTING, V22, P443, DOI 10.1016/j.ijforecast.2006.01.001; Deng SM, 2019, COMPANION OF THE WORLD WIDE WEB CONFERENCE (WWW 2019 ), P678, DOI 10.1145/3308560.3317701; Di Persio Luca, 2016, International Journal of Circuits, Systems and Signal Processing, V10, P403; Eapen J, 2019, 2019 IEEE 9TH ANNUAL COMPUTING AND COMMUNICATION WORKSHOP AND CONFERENCE (CCWC), P264, DOI 10.1109/CCWC.2019.8666592; Feurer M, 2015, 20 9 AAAI C ART INT, V14, P135; Feurer M, 2019, SPRING SER CHALLENGE, P3, DOI 10.1007/978-3-030-05318-5_1; Fischer T, 2018, EUR J OPER RES, V270, P654, DOI 10.1016/j.ejor.2017.11.054; Gadekallu TR, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-01963-7; Gunduz H, 2017, KNOWL-BASED SYST, V137, P138, DOI 10.1016/j.knosys.2017.09.023; Guo S, 2019, PROC CVPR IEEE, P1712, DOI 10.1109/CVPR.2019.00181; Guresen E, 2011, EXPERT SYST APPL, V38, P10389, DOI 10.1016/j.eswa.2011.02.068; Hagenau M, 2013, DECIS SUPPORT SYST, V55, P685, DOI 10.1016/j.dss.2013.02.006; Hoseinzade E, 2019, EXPERT SYST APPL, V129, P273, DOI 10.1016/j.eswa.2019.03.029; Jain S, INT C ADV COMP TEL, V10, P1, DOI [10.1109/ICACAT.2018.8933791, DOI 10.1109/ICACAT.2018.8933791]; Jerripothula KR, 2017, PROC CVPR IEEE, P3881, DOI 10.1109/CVPR.2017.413; Jin XJ, 2019, ACCOUNT FINANC, V58, P1291, DOI 10.1111/acfi.12455; Keras Team, KER 2 0 REL NOT 2020; Kingma DP, 2013, ADAM METHOD STOCHAST; Lakhe S., 2017, IND ENG J, V10, P154, DOI [10.26488/IEJ.10.1.9, DOI 10.26488/IEJ.10.1.9]; Lan RS, 2021, SIGNAL IMAGE VIDEO P, V15, P1, DOI 10.1007/s11760-019-01537-x; Loni M, 2020, MICROPROCESS MICROSY, V73, DOI 10.1016/j.micpro.2020.102989; Menon VK, 2016, LECT NOTES COMPUT SC, V9714, P137, DOI 10.1007/978-3-319-40973-3_13; Mester T., PANDAS TUTORIAL 1 PA; Naik N, 2020, NATL ACAD SCI LETT, V43, P241, DOI 10.1007/s40009-019-00859-1; Nelson DMQ, 2017, IEEE IJCNN, P1419, DOI 10.1109/IJCNN.2017.7966019; Pang XW, 2020, J SUPERCOMPUT, V76, P2098, DOI 10.1007/s11227-017-2228-y; Paracchini M, 2020, PATTERN RECOGN LETT, V131, P322, DOI 10.1016/j.patrec.2019.12.021; Patel J, 2015, EXPERT SYST APPL, V42, P2162, DOI 10.1016/j.eswa.2014.10.031; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Qiu MY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155133; Reddy GT, 2020, IEEE ACCESS, V8, P54776, DOI 10.1109/ACCESS.2020.2980942; Reddy GT, 2022, MULTIMED TOOLS APPL, V81, P41429, DOI 10.1007/s11042-020-09988-y; Saha PK, 2016, PATTERN RECOGN LETT, V76, P3, DOI 10.1016/j.patrec.2015.04.006; Schumaker RP, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1462198.1462204; Selvin S, 2017, 2017 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1643; Sezer OB, 2020, INTELL AUTOM SOFT CO, V26, P323, DOI 10.31209/2018.100000065; Shastri M, 2019, EAI ENDORSED TRANS S, V6, DOI 10.4108/eai.19-12-2018.156085; Sim HS, 2019, COMPLEXITY, DOI 10.1155/2019/4324878; Song Y, 2018, FUZZY SYSTEMS DATA M, V309, P646; The Matplotlib Development Team, 2018, MATPL VERS 3 0 2; Wang J, 2015, NEUROCOMPUTING, V156, P68, DOI 10.1016/j.neucom.2014.12.084; Wang Y, 2019, IEEE T VEH TECHNOL, V68, P4074, DOI 10.1109/TVT.2019.2900460; Zhong X, 2017, EXPERT SYST APPL, V67, P126, DOI 10.1016/j.eswa.2016.09.027	51	0	0	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253121	10.1371/journal.pone.0253121	http://dx.doi.org/10.1371/journal.pone.0253121			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161352	gold, Green Published			2022-12-26	WOS:000671691900052
J	Chen, YY; Roberts, CS; Ou, WM; Petigara, T; Goldmacher, GV; Fancourt, N; Knoll, MD				Chen, Yiyun; Roberts, Craig S.; Ou, Wanmei; Petigara, Tanaz; Goldmacher, Gregory, V; Fancourt, Nicholas; Knoll, Maria Deloria			Deep learning for classification of pediatric chest radiographs by WHO's standardized methodology	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PNEUMONIA ETIOLOGY RESEARCH; DIAGNOSIS; CHILDREN; IMPACT	Background The World Health Organization (WHO)-defined radiological pneumonia is a preferred endpoint in pneumococcal vaccine efficacy and effectiveness studies in children. Automating the WHO methodology may support more widespread application of this endpoint. Methods We trained a deep learning model to classify pneumonia CXRs in children using the World Health Organization (WHO)'s standardized methodology. The model was pretrained on CheXpert, a dataset containing 224,316 adult CXRs, and fine-tuned on PERCH, a pediatric dataset containing 4,172 CXRs. The model was then tested on two pediatric CXR datasets released by WHO. We also compared the model's performance to that of radiologists and pediatricians. Results The average area under the receiver operating characteristic curve (AUC) for primary endpoint pneumonia (PEP) across 10-fold validation of PERCH images was 0.928; average AUC after testing on WHO images was 0.977. The model's classification performance was better on test images with high inter-observer agreement; however, the model still outperformed human assessments in AUC and precision-recall spaces on low agreement images. Conclusion A deep learning model can classify pneumonia CXR images in children at a performance comparable to human readers. Our method lays a strong foundation for the potential inclusion of computer-aided readings of pediatric CXRs in vaccine trials and epidemiology studies.	[Chen, Yiyun; Roberts, Craig S.; Ou, Wanmei; Petigara, Tanaz; Goldmacher, Gregory, V] Merck & Co Inc, Kenilworth, NJ 07033 USA; [Fancourt, Nicholas] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; [Knoll, Maria Deloria] Johns Hopkins Bloomberg Sch Publ Hlth, Int Vaccine Access Ctr, Dept Int Hlth, Baltimore, MD USA	Merck & Company; Charles Darwin University; Menzies School of Health Research; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chen, YY (corresponding author), Merck & Co Inc, Kenilworth, NJ 07033 USA.	star.chen@merck.com	Roberts, Craig S/GLQ-8814-2022	Roberts, Craig S/0000-0002-5852-9770; Chen, Star/0000-0001-9239-5721; Goldmacher, Gregory/0000-0001-7310-6146	Bill & Melinda Gates Foundation [48968]; Merck Co.	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Merck Co.(Merck & Company)	The PERCH study was supported by grant 48968 from the Bill & Melinda Gates Foundation (https://www.gatesfoundation.org/) to the International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA). Maria Deloria Knoll received a small grant from Merck & Co. to cover expenses related to preparing the PERCH dataset shared for use in the study, and for consulting on the manuscript. Yiyun Chen, Tanaz Petigara, Wanmei Ou, Craig S. Robert, Gregory V. Goldmacher were employees of Merck & Co., Inc. during the conduct of the study. Nicholas Fancourt has no affiliations with or involvement in any organization or entity with any financial interest.	Ben-Shimol S., 2019, CLIN INFECT DIS; Ben-Shimol S, 2020, CLIN INFECT DIS, V71, P177, DOI 10.1093/cid/ciz768; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deloria-Knoll M, 2012, CLIN INFECT DIS, V54, pS117, DOI 10.1093/cid/cir1066; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Fancourt N, 2017, CLIN INFECT DIS, V64, pS253, DOI 10.1093/cid/cix082; Fancourt N, 2017, CLIN INFECT DIS, V64, pS262, DOI 10.1093/cid/cix089; Gentile A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199989; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; He K., 2015, ARXIV151203385V1; Huang G., 2018, ARXIV160806993; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Klugman KP, 2017, CLIN INFECT DIS, V64, pS185, DOI 10.1093/cid/cix075; Laaksonen N, 2016, ACTA PAEDIATR, V105, P1487, DOI 10.1111/apa.13580; Levy C, 2017, VACCINE, V35, P5058, DOI 10.1016/j.vaccine.2017.06.057; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Mahomed N, 2020, PEDIATR RADIOL, V50, P482, DOI 10.1007/s00247-019-04593-0; Mahomed N, 2017, PEDIATR RADIOL, V47, P1399, DOI 10.1007/s00247-017-3834-9; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; O'Brien KL, 2017, CLIN INFECT DIS, V64, pS179, DOI 10.1093/cid/cix142; Ouldali N, 2019, JAMA PEDIATR, V173, P362, DOI 10.1001/jamapediatrics.2018.5273; Rajaraman S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242301; Rajpurkar P, 2017, RADIOLOGIST LEVEL PN; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Simonyan K., 2015, PROC 3 INT C LEARN R; Szegedy C., 2015, P CVPR BOST MA US 7, P1, DOI DOI 10.1109/CVPR.2015.7298594; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Torrey L., 2009, TRANSFER LEARNING; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; Yadav O, 2018, IEEE INT C BIOINFORM, P2368, DOI 10.1109/BIBM.2018.8621525; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253239	10.1371/journal.pone.0253239	http://dx.doi.org/10.1371/journal.pone.0253239			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153076	gold, Green Published			2022-12-26	WOS:000671691000014
J	Gardner, MH; Uffing, E; Van Vaeck, N; Szmrecsanyi, B				Gardner, Matt Hunt; Uffing, Eva; Van Vaeck, Nicholas; Szmrecsanyi, Benedikt			Variation isn't that hard: Morphosyntactic choice does not predict production difficulty	PLOS ONE			English	Article							SYNTACTIC FLEXIBILITY; GRAMMATICAL VARIATION; SENTENCE PRODUCTION; LEXICAL ACCESS; FILLED PAUSES; ENGLISH; INFORMATION; AMERICAN; WORDS; CONSTRUCTIONS	The following paper explores the link between production difficulty and grammatical variability. Using a sub-sample of the Switchboard Corpus of American English (285 transcripts, 34 speakers), this paper shows that the presence of variable contexts does not positively correlate with two metrics of production difficulty, namely filled pauses (um and uh) and unfilled pauses (speech planning time). When 20 morphosyntactic variables are considered collectively (N= 6,268), there is no positive effect. In other words, variable contexts do not correlate with measurable production difficulties. These results challenge the view that grammatical variability is somehow sub-optimal for speakers, with additional burdensome cognitive planning.	[Gardner, Matt Hunt; Uffing, Eva; Van Vaeck, Nicholas; Szmrecsanyi, Benedikt] Katholieke Univ Leuven, Dept Linguist, Leuven, Belgium	KU Leuven	Gardner, MH (corresponding author), Katholieke Univ Leuven, Dept Linguist, Leuven, Belgium.	matt.gardner@kuleuven.be	Gardner, Matt Hunt/GMX-3521-2022	Gardner, Matt Hunt/0000-0002-1878-4232	Research Foundation Flanders (FWO) [G.0C59.13N]	Research Foundation Flanders (FWO)(FWO)	BS:Grant#G.0C59.13N; Research Foundation Flanders (FWO); https://www.fwo.be/en/; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel JC, 2015, THESIS U BRIT COLUMB; ABRAMOVICI S, 1988, NEW IDEAS PSYCHOL, V6, P99, DOI 10.1016/0732-118X(88)90027-X; Acton E. K., 2011, U PENNSYLVANIA WORKI, V17, P2; Aijmer, 2002, STUDIES CORPUS LINGU, V10; Angermeyer PS., 2003, LANG VAR CHANGE, V15, P171, DOI 10.1017/S0954394503152027; Anttila A, 2010, LANG COGNITIVE PROC, V25, P946, DOI 10.1080/01690960903525481; Arnold JE, 2000, LANGUAGE, V76, P28, DOI 10.2307/417392; Auer P, 2009, LANG SCI, V31, P1, DOI 10.1016/j.langsci.2007.10.004; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bailey KGD, 2003, J MEM LANG, V49, P183, DOI 10.1016/S0749-596X(03)00027-5; Bargh J. A., 1994, HDB SOCIAL COGNITION, V1, P1, DOI DOI 10.1007/S00572-005-0022-9; Bates D., 2020, LME4; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEATTIE GW, 1979, LANG SPEECH, V22, P201, DOI 10.1177/002383097902200301; BELL A, 1984, LANG SOC, V13, P145, DOI 10.1017/S004740450001037X; Berglund Y., 1997, ICAME J, Vvol. 21, P7; Berthold A, 1999, CISM COUR L, P235; Berthold A., 1998, THESIS U SAARLANDES; BLYTH C, 1990, AM SPEECH, V65, P215, DOI 10.2307/455910; Boersma P., 2020, PRAAT DOING PHONETIC; Bohmann A, 2011, P 19 ANN S LANGUAGE, P88; Bolinger D., 1977, FORM MEANING; Bortfeld H, 2001, LANG SPEECH, V44, P123, DOI 10.1177/00238309010440020101; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BRENNAN SE, 1995, J MEM LANG, V34, P383, DOI 10.1006/jmla.1995.1017; Bresnan J, 2008, LINGUA, V118, P245, DOI 10.1016/j.lingua.2007.02.007; Bresnan J, 2010, LANGUAGE, V86, P168; Bresnan J, 2007, STUD GENERAT GRAMM, V96, P75; Bresnan Joan, 2007, KNAW ACAD C COGNITIV, P69; Brook M, 2016, AM SPEECH, V91, P301, DOI 10.1215/00031283-3701026; Buchstaller I, 2006, J SOCIOLING, V10, P3, DOI 10.1111/j.1360-6441.2006.00315.x; Buchstaller I., 2014, QUOTATIVES NEW TREND; Cacoullos RT, 2009, LANGUAGE, V85, P321; Cappelle B, 2009, CONSTR APPROACH LANG, V9, P145; Chambers J. K., 2004, DIALECTOLOGY MEETS T, P127; Chater N, 2006, TRENDS COGN SCI, V10, P287, DOI 10.1016/j.tics.2006.05.007; Childs C., 2015, PENN WORKING PAPERS, V21; Childs C, 2017, GLOSSA-UK, V2, DOI 10.5334/gjgl.287; Christenfeld N., 1994, J LANG SOC PSYCHOL, V13, P192, DOI [10.1177/0261927X94132005, DOI 10.1177/0261927X94132005]; Christodoulides G., 2016, THESIS U CATHOLIQUE; Clark HH, 2002, COGNITION, V84, P73, DOI 10.1016/S0010-0277(02)00017-3; Clark HH, 1998, COGNITIVE PSYCHOL, V37, P201, DOI 10.1006/cogp.1998.0693; Close J., 2004, THESIS U YORK; COLLINS P, 1995, LINGUISTICS, V33, P35, DOI 10.1515/ling.1995.33.1.35; Collins P, 2008, STUD LANG VAR, V2, P129; Cooper W.E., 1980, SYNTAX SPEECH; Crowell TL, 1955, AM SPEECH, V34, P280; Cuyckens Hubert, 2014, LATE MODERN ENGLISH, P182; D'Arcy A., 2015, GRAMMATICAL CHANGE E, P43; D'Arcy A, 2015, LANG VAR CHANGE, V27, P255, DOI 10.1017/S0954394515000101; D'Arcy A, 2014, J ENGL LINGUIST, V42, P218, DOI 10.1177/0075424214539702; D'Arcy A, 2013, LANG VAR CHANGE, V25, P287, DOI 10.1017/S0954394513000148; Davies Mark, 2012, VERB PHRASE ENGLISH, P46, DOI DOI 10.1017/CB09781139060998.004; de Leeuw E., 2007, J GER LINGUIST, V19, P85; De Smet H, 2018, COGN LINGUIST, V29, P197, DOI 10.1515/cog-2016-0025; Debeer D, 2021, PERMIMP CONDITIONAL; Dehe N., 2002, PARTICLE VERBS ENGLI; Denis D, 2018, ENGL LANG LINGUIST, V22, P403, DOI 10.1017/S1360674316000551; Denison David., 1999, CAMBRIDGE HIST ENGLI, V4, P92; Deshors SC, 2016, INT J CORPUS LINGUIS, V21, P192, DOI 10.1075/ijcl.21.2.03des; Donaher P., 2015, AINTHOLOGY, P1; Edmonds JE., 1986, FESTSCHRIFT SOL SAPO, P92; Ehret K., 2017, THESIS U FREIBURG; ELSNESS J, 1984, ENGL STUD, V65, P519, DOI 10.1080/00138388408598357; Engelhardt PE, 2013, ACTA PSYCHOL, V144, P424, DOI 10.1016/j.actpsy.2013.08.002; Engelhardt PE, 2009, J ABNORM CHILD PSYCH, V37, P995, DOI 10.1007/s10802-009-9323-3; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FERREIRA F, 1991, J MEM LANG, V30, P210, DOI 10.1016/0749-596X(91)90004-4; Ferreira F., 2006, HDB PSYCHOLINGUISTIC, V2nd, P61, DOI [10.1016/B978-012369374-7/50004-3, DOI 10.1016/B978-012369374-7/50004-3]; Ferreira VS, 2007, ADV BEHAV BRAIN SCI, P63; Ferreira VS, 1996, J MEM LANG, V35, P724, DOI 10.1006/jmla.1996.0038; Finegan E., 1995, VERB CONT ENGLISH, P241; Fowler HW., 2009, DICT MODERN ENGLISH; Fox J., 2019, R COMPANION APPL REG, V.; Freeman V., 2015, THESIS U WASHINGTON; Gardner MH, 2021, ENGL LANG LINGUIST, V25, P281, DOI 10.1017/S1360674320000076; Garrod S, 2004, TRENDS COGN SCI, V8, P8, DOI 10.1016/j.tics.2003.10.016; Garrod S, 2007, ADV BEHAV BRAIN SCI, P1; Godfrey J. J., 1992, ICASSP-92: 1992 IEEE International Conference on Acoustics, Speech and Signal Processing (Cat. No.92CH3103-9), P517, DOI 10.1109/ICASSP.1992.225858; Goldberg AE, 2016, SYNTAX SEMANTICS, V41, P110, DOI 10.1163/9789004307094_006; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Goldman-Eisler F., 1968, PSYCHOLINGUISTICS; GOLDMANEISLER F, 1958, Q J EXP PSYCHOL, V10, P96, DOI 10.1080/17470215808416261; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Grafmiller Jason, 2018, JGMERMOD CUSTOM FUNC; Gramley S., 1992, SURVEY MODERN ENGLIS, P289; Granno T., 2006, THESIS STANDFORD U; Grezause E., 2017, THESIS U WASHINGTON; Gries S.Th., 2020, PRACTICAL HDB CORPUS; Gries ST, 2005, J PSYCHOLINGUIST RES, V34, P365, DOI 10.1007/s10936-005-6139-3; Gries ST, 2020, CORPUS LINGUIST LING, V16, P617, DOI 10.1515/cllt-2018-0078; GROSJEAN F, 1979, COGNITIVE PSYCHOL, V11, P58, DOI 10.1016/0010-0285(79)90004-5; GUY GR, 1995, AM SPEECH, V70, P148, DOI 10.2307/455813; HAIMAN J, 1980, LANGUAGE, V56, P515, DOI 10.2307/414448; Hartsuiker RJ, 2010, EXP PSYCHOL, V57, P169, DOI 10.1027/1618-3169/a000021; Herrero-Zorita C, 2013, PROCD SOC BEHV, V95, P482, DOI 10.1016/j.sbspro.2013.10.672; HIEKE AE, 1983, LANG SPEECH, V26, P203, DOI 10.1177/002383098302600302; Hilton K., 2016, U PENN WORKING PAPER, V22; Hinrichs L, 2015, LANGUAGE, V91, P806; Hommerberg Charlotte., 2007, ICAME J, V31, P45; Honeybone P., 2011, ANAL VARIATION ENGLI, P151; Horton WS, 1996, COGNITION, V59, P91, DOI 10.1016/0010-0277(96)81418-1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hout Roeland van, 2016, CHALLENGE CHANCE, P249, DOI DOI 10.1007/978-3-319-26300-7_14; Huddleston Rodney, 2002, CAMBRIDGE GRAMMAR EN, DOI 10.1017/9781316423530; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Jacobs RA, 1999, VISION RES, V39, P3621, DOI 10.1016/S0042-6989(99)00088-7; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Jaeger TF, 2006, THESIS STANDFORD U; Jankowski BL, 2014, ENGL LANG LINGUIST, V18, P305, DOI 10.1017/S1360674314000045; Johansson S., 1999, LONGMAN GRAMMAR SPOK; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; Kaltenbock G., 2006, PLANNING GLUING PAIN, P69; Kaltenbock G, 2006, ENGL LANG LINGUIST, V10, P371, DOI 10.1017/S1360674306001961; Knill DC, 1998, VISION RES, V38, P1655, DOI 10.1016/S0042-6989(97)00324-6; Knill DC, 1996, PERCEPTION BAYESIAN; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Kreyer Rolf., 2003, INT J CORPUS LINGUIS, V8, P169, DOI [10.1075/ijcl.8.2.02kre, DOI 10.1075/IJCL.8.2.02KRE]; Kuhn M, 2021, CARET CLASSIFICATION, DOI DOI 10.1887/0750303123/B365C43; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Labov W., 1972, SOCIOLINGUISTIC PATT; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leech G., 1997, EXPLAIN PRESENT STUD, P125; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Levshina N., 2015, DO LINGUISTICS R; Lewis ML, 2016, COGNITION, V153, P182, DOI 10.1016/j.cognition.2016.04.003; Lickley RJ, 2015, BLACKW HBK LINGUIST, P445; LIND A, 1983, ENGL STUD, V64, P550, DOI 10.1080/00138388308598291; Lohse B, 2004, LANGUAGE, V80, P238, DOI 10.1353/lan.2004.0089; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; MacKenzie L, 2013, LANG VAR CHANGE, V25, P17, DOI 10.1017/S0954394512000257; Mair Christian, 2003, DETERMINANTS GRAMMAT, P329; McDavid V, 1964, AM SPEECH, V39, P102, DOI 10.2307/453112; McWhorter John H, 2001, LINGUIST TYPOL, V5, P125; Merja Kyto, 1997, COMPETING FORMS ADJE, P329; Merlo S, 2004, J COMMUN DISORD, V37, P489, DOI 10.1016/j.jcomdis.2004.03.002; Meteer MarieW., 1995, DYSFLUENCY ANNOTATIO; Miestamo Matti, 2008, LANGUAGE COMPLEXITY, P23; MuMIn Barton K, 2019, MULTIMODAL INFERENCE; Muysken, 1986, SUBSTRATA VERSUS UNI, P57, DOI [10.1075/CLL.1.05SEU, DOI 10.1075/CLL.1.05SEU]; Myachykov A, 2013, Q J EXP PSYCHOL, V66, P1601, DOI 10.1080/17470218.2012.754910; Nichols Johanna, 2013, SPACE LANGUAGE LINGU, P38; Oomen CCE, 2001, J SPEECH LANG HEAR R, V44, P997, DOI 10.1044/1092-4388(2001/078); OVIATT S, 1995, COMPUT SPEECH LANG, V9, P19, DOI 10.1006/csla.1995.0002; Ozon G, 2006, LANG COMPUT, P243; PARKER F, 1988, AM SPEECH, V63, P214, DOI 10.2307/454819; Peters P, 2008, STUD LANG VAR, V2, P147; Poplack S, 2018, STUD FUNCT STRUCT, V76, P7, DOI 10.1075/sfsl.76.02pop; Pouget A, 2013, NAT NEUROSCI, V16, P1170, DOI 10.1038/nn.3495; Quinn H., 2005, PRONOUN CASE FORMS E; Quirk R., 1985, COMPREHENSIVE GRAMMA; R Core Team, 2020, R LANG ENV STAT COMP; Raumolin-Brunberg Helena, 1997, GRAMMATICALIZATION W, V24, P17, DOI [10.1515/9783110810745.17, DOI 10.1515/9783110810745.17]; Rohdenburg G., 1996, COGN LINGUIST, V7, P149, DOI [10.1515/cogl.1996.7.2.149, DOI 10.1515/COGL.1996.7.2.149]; Rosenbach A, 2005, LANGUAGE, V81, P613, DOI 10.1353/lan.2005.0149; Rosenbach Anette, 2002, GENITIVE VARIATION E, DOI lio.1515/9783110899818; Rothlisberger M, 2017, COGN LINGUIST, V28, P673, DOI 10.1515/cog-2016-0051; Schleef E, 2019, LINGUA, V228, DOI 10.1016/j.lingua.2019.06.008; Schnadt M. J., 2006, P 28 M COGN SCI SOC, P750; Shih Stephanie., 2015, RHYTHM COGNITION GRA, P207; Shriberg E. E., 1994, THESIS U CALIFORNIA; Shriberg Elizabeth, 1996, P 4 INT C SPOKEN LAN, P11; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002; Steger M, 2012, LINGUAE LITT, V13, P156; Steyvers M, 2006, TRENDS COGN SCI, V10, P327, DOI 10.1016/j.tics.2006.05.005; Storms G., 1966, ENGL STUD, V47, P249, DOI 10.1080/00138386608597258; Szmrecsanyi B, 2006, TRENDS LINGUIST-STUD, V177, P1, DOI 10.1515/9783110197808; Szmrecsanyi B, 2017, GLOSSA-UK, V2, DOI 10.5334/gjgl.310; Tagliamonte S, 2004, J SOCIOLING, V8, P493, DOI 10.1111/j.1467-9841.2004.00271.x; Tagliamonte S.A., 1999, J SOCIOLING, V3, P147, DOI [10.1111/1467-9481.00070, DOI 10.1111/1467-9481.00070]; Tagliamonte SA, 2016, LANGUAGE, V92, P824, DOI 10.1353/lan.2016.0074; Tagliamonte SA, 2010, LANG VAR CHANGE, V22, P149, DOI 10.1017/S0954394510000050; Tagliamonte Sali A., 2005, LANG VAR CHANGE, V17, P75, DOI 10.1017/S0954394505050040; Tagliamonte Sali A., 1998, LANG VAR CHANGE, V10, P153, DOI 10.1017/S0954394500001277; Tagliamonte SaliA., 2006, DIACHRONICA, V23, P341, DOI 10.1075/dia.23.2.06tag; Tannen D., 1986, DIRECT INDIRECT SPEE, P311, DOI [DOI 10.1515/9783110871968.311, 10.1515/9783110871968.311]; TANNENBAUM PH, 1968, J VERB LEARN VERB BE, V7, P246, DOI 10.1016/S0022-5371(68)80197-5; Tenenbaum JB, 2006, TRENDS COGN SCI, V10, P309, DOI 10.1016/j.tics.2006.05.009; Thomas ER, 2011, WIRES COGN SCI, V2, P701, DOI 10.1002/wcs.152; Thompson SandraA., 2001, FREQUENCY EMERGENCE, P27, DOI [10.1075/tsl.45.03tho, DOI 10.1075/TSL.45.03THO]; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tomaschek F, 2018, J PHONETICS, V71, P249, DOI 10.1016/j.wocn.2018.09.004; Tree JEF, 1995, J MEM LANG, V34, P709, DOI 10.1006/jmla.1995.1032; Trudgill P., 2009, LANGUAGE COMPLEXITY, P252; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Wasow Thomas, 2002, POSTVERBAL BEHAV; Weinreich Uriel, 1968, DIRECTIONS HIST LING, P95; WHEELDON LR, 1995, J MEM LANG, V34, P311, DOI 10.1006/jmla.1995.1014; Wieling M, 2016, LANG DYN CHANG, V6, P199, DOI 10.1163/22105832-00602001; William Labov, 1966, SOCIAL STRATIFICATIO; William Labov, 2001, PRINCIPLES LINGUISTI, V2; Wolk C, 2013, DIACHRONICA, V30, P382, DOI 10.1075/dia.30.3.04wol; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Xiao R, 2008, HANDB SPRACH KOMMUN, V29, P383	199	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252602	10.1371/journal.pone.0252602	http://dx.doi.org/10.1371/journal.pone.0252602			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BF	34153033	Green Published, gold			2022-12-26	WOS:000671691000017
J	Musselwhite, MN; Shen, TY; Rose, MJ; Iceman, KE; Poliacek, I; Pitts, T; Bolser, DC				Musselwhite, M. Nicholas; Shen, Tabitha Y.; Rose, Melanie J.; Iceman, Kimberly E.; Poliacek, Ivan; Pitts, Teresa; Bolser, Donald C.			Differential effects of acute cerebellectomy on cough in spontaneously breathing cats	PLOS ONE			English	Article							FASTIGIAL NUCLEUS; PRESSURE CHANGES; TRACHEOBRONCHIAL COUGH; NEURAL-CONTROL; FICTIVE COUGH; BRAIN-STEM; STIMULATION; MODULATION; RECEPTORS; PATHWAY	The role of the cerebellum in controlling the cough motor pattern is not well understood. We hypothesized that cerebellectomy would disinhibit motor drive to respiratory muscles during cough. Cough was induced by mechanical stimulation of the tracheobronchial airways in anesthetized, spontaneously breathing adult cats (8 male, 1 female), and electromyograms (EMGs) were recorded from upper airway, chest wall, and abdominal respiratory muscles. Cough trials were performed before and at two time points after total cerebellectomy (10 minutes and >1 hour). Unlike a prior report in paralyzed, decerebrated, and artificially ventilated animals, we observed that cerebellectomy had no effect on cough frequency. After cerebellectomy, thoracic inspiratory muscle EMG magnitudes increased during cough (diaphragm EMG increased by 14% at 10 minutes, p = 0.04; parasternal by 34% at 10 minutes and by 32% at >1 hour, p = 0.001 and 0.03 respectively). During cough at 10 minutes after cerebellectomy, inspiratory esophageal pressure was increased by 44% (p = 0.004), thyroarytenoid (laryngeal adductor) muscle EMG amplitude increased 13% (p = 0.04), and no change was observed in the posterior cricoarytenoid (laryngeal abductor) EMG. Cough phase durations did not change. Blood pressure and heart rate were reduced after cerebellectomy, and respiratory rate also decreased due to an increase in duration of the expiratory phase of breathing. Changes in cough-related EMG magnitudes of respiratory muscles suggest that the cerebellum exerts inhibitory control of cough motor drive, but not cough number or phase timing in response to mechanical stimuli in this model early after cerebellectomy. However, results varied widely at >1 hour after cerebellectomy, with some animals exhibiting enhancement or suppression of one or more components of the cough motor behavior. These results suggest that, while the cerebellum and behavior-related sensory feedback regulate cough, it may be difficult to predict the nature of the modulation based on total cerebellectomy.	[Musselwhite, M. Nicholas; Shen, Tabitha Y.; Rose, Melanie J.; Bolser, Donald C.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA; [Iceman, Kimberly E.; Pitts, Teresa] Univ Louisville, Dept Neurol Surg, Coll Med, Louisville, KY 40292 USA; [Iceman, Kimberly E.; Pitts, Teresa] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Coll Med, Louisville, KY 40292 USA; [Poliacek, Ivan] Comenius Univ, Jessenius Fac Med Martin, Inst Med Biophys, Martin, Slovakia	State University System of Florida; University of Florida; University of Louisville; University of Louisville; Comenius University Bratislava	Musselwhite, MN (corresponding author), Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA.; Pitts, T (corresponding author), Univ Louisville, Dept Neurol Surg, Coll Med, Louisville, KY 40292 USA.; Pitts, T (corresponding author), Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Coll Med, Louisville, KY 40292 USA.	nick.musselwhite@louisville.edu; t.pitts@louisville.edu	Bolser, Donald/CAI-2644-2022	Musselwhite, Matthew/0000-0002-5116-8669; Iceman, Kimberly/0000-0002-9004-3893; Shen, Tabitha/0000-0002-5333-2776	National Institute of Health Heart, Lung, and Blood Institute [HL131716, 3OT2OD023854]	National Institute of Health Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Institute of Health Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov) HL131716 (DCB) and the Office of The Director, (https://www.nih.gov/institutes-nih/nihoffice-director) 3OT2OD023854 (DCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; [Anonymous], 2022, NLME LINEAR NONLINEA; Baekey DM, 2003, J APPL PHYSIOL, V94, P93, DOI 10.1152/japplphysiol.00341.2002; BASMAJIAN JV, 1962, J APPL PHYSIOL, V17, P849, DOI 10.1152/jappl.1962.17.5.849; Bolser DC, 2000, J APPL PHYSIOL, V89, P785, DOI 10.1152/jappl.2000.89.2.785; Bolser DC, 1999, J APPL PHYSIOL, V86, P1017, DOI 10.1152/jappl.1999.86.3.1017; BOLSER DC, 1991, J APPL PHYSIOL, V71, P2325, DOI 10.1152/jappl.1991.71.6.2325; Bostan AC, 2013, TRENDS COGN SCI, V17, P241, DOI 10.1016/j.tics.2013.03.003; Bostan AC, 2010, P NATL ACAD SCI USA, V107, P8452, DOI 10.1073/pnas.1000496107; Canning B. J., 2009, V187, P23, DOI 10.1007/978-3-540-79842-2_2; Canning BJ, 2010, FASEB J, V24, P3916, DOI 10.1096/fj.09-151068; Coutinho P, 2006, ARCH NEUROL-CHICAGO, V63, P553, DOI 10.1001/archneur.63.4.553; ECCLES JC, 1967, P NATL ACAD SCI USA, V58, P336, DOI 10.1073/pnas.58.1.336; Einthoven W, 1912, LANCET, V1, P853; Feldman JL., 2009, ENCY NEUROSCIENCE, P463; Giuditta M, 2003, BLOOD PRESSURE, V12, P175, DOI 10.1080/08037050310010912; GLASSER RL, 1966, NATURE, V209, P810, DOI 10.1038/209810b0; HANACEK J, 1984, RESPIRATION, V45, P161, DOI 10.1159/000194614; Hanacek J, 2006, RESP PHYSIOL NEUROBI, V152, P282, DOI 10.1016/j.resp.2006.02.014; Hegland KW, 2012, J APPL PHYSIOL, V113, P39, DOI 10.1152/japplphysiol.01299.2011; HENNEMANN HE, 1978, PFLUG ARCH EUR J PHY, V375, P119, DOI 10.1007/BF00584233; HUANG Q, 1991, J PHYSIOL-LONDON, V436, P385, DOI 10.1113/jphysiol.1991.sp018556; Juby AG, 2014, AGE AGEING, V43, P877, DOI 10.1093/ageing/afu066; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kollarik M, 2006, RESP PHYSIOL NEUROBI, V152, P243, DOI 10.1016/j.resp.2005.12.008; Kotmanova Z, 2018, RESP PHYSIOL NEUROBI, V257, P100, DOI 10.1016/j.resp.2018.02.009; Kubin L, 2006, J APPL PHYSIOL, V101, P618, DOI 10.1152/japplphysiol.00252.2006; LAM RL, 1952, LARYNGOSCOPE, V62, P486; Lenth RV., 2021, EMMEANS ESTIMATED MA; LUTHERER LO, 1986, AM J PHYSIOL, V250, pR418, DOI 10.1152/ajpregu.1986.250.3.R418; Man WDC, 2003, AM J RESP CRIT CARE, V168, P714, DOI 10.1164/rccm.200303-334BC; Mazzone Stuart B, 2013, Cough, V9, P7, DOI 10.1186/1745-9974-9-7; Mazzone SB, 2011, J NEUROSCI, V31, P2948, DOI 10.1523/JNEUROSCI.4597-10.2011; Mazzone SB, 2009, J NEUROSCI, V29, P13662, DOI 10.1523/JNEUROSCI.4354-08.2009; MIURA M, 1970, AM J PHYSIOL, V219, P1330, DOI 10.1152/ajplegacy.1970.219.5.1330; MIURA M, 1969, BRAIN RES, V13, P595, DOI 10.1016/0006-8993(69)90269-8; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; OSCARSSON O, 1965, PHYSIOL REV, V45, P495, DOI 10.1152/physrev.1965.45.3.495; Passot JB, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00095; Pearce JMS, 2008, EUR NEUROL, V60, P312, DOI 10.1159/000159929; Pitts T, 2016, J APPL PHYSIOL, V121, P268, DOI 10.1152/japplphysiol.00790.2015; Poliacek I, 2003, ACTIVITY LARYNGEAL A, V52, P14; Poliacek I, 2016, RESP PHYSIOL NEUROBI, V229, P43, DOI 10.1016/j.resp.2016.04.008; Poliacek I, 2011, J APPL PHYSIOL, V111, P861, DOI 10.1152/japplphysiol.00458.2011; R Core Team, 2020, R LANG ENV STAT COMP; RAMU A, 1967, EXPERIENTIA, V23, P383, DOI 10.1007/BF02144532; RAMU A, 1972, EUR J PHARMACOL, V19, P160, DOI 10.1016/0014-2999(72)90004-0; Reed MD, 2019, LUNG, V197, P235, DOI 10.1007/s00408-018-00192-2; RStudio Team, 2020, RSTUDIO INT DEV ENV; THOMAS DM, 1956, J ANAT, V90, P371; WALBERG F, 1962, J COMP NEUROL, V119, P187, DOI 10.1002/cne.901190205; Wang Cheng, 2009, Cough, V5, P12, DOI 10.1186/1745-9974-5-12; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Widdicombe J, 2011, PULM PHARMACOL THER, V24, P344, DOI 10.1016/j.pupt.2010.12.010; Widdicombe J, 2006, RESP PHYSIOL NEUROBI, V152, P320, DOI 10.1016/j.resp.2006.02.018; WILLIAMS B, 1976, BRAIN, V99, P331, DOI 10.1093/brain/99.2.331; WILLIAMS JL, 1986, BRAIN RES, V399, P224, DOI 10.1016/0006-8993(86)91512-X; Xu F, 1995, BRAIN RES, V705, P53, DOI 10.1016/0006-8993(95)01138-2; Xu Fadi, 2002, Cerebellum, V1, P35, DOI 10.1080/147342202753203078; XU FD, 1995, J APPL PHYSIOL, V79, P1181, DOI 10.1152/jappl.1995.79.4.1181; XU FD, 1994, J APPL PHYSIOL, V77, P1232, DOI 10.1152/jappl.1994.77.3.1232; Xu FD, 1997, J APPL PHYSIOL, V83, P391, DOI 10.1152/jappl.1997.83.2.391; XU FD, 1993, J APPL PHYSIOL, V75, P675, DOI 10.1152/jappl.1993.75.2.675; Xu FD, 1997, J APPL PHYSIOL, V82, P1853, DOI 10.1152/jappl.1997.82.6.1853; ZANCHETTI A, 1954, J NEUROPHYSIOL, V17, P475, DOI 10.1152/jn.1954.17.5.475	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253060	10.1371/journal.pone.0253060	http://dx.doi.org/10.1371/journal.pone.0253060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153070	Green Published, gold			2022-12-26	WOS:000671691000035
J	Nagoshi, RN; Koffi, D; Agboka, K; Adjevi, AKM; Meagher, RL; Goergen, G				Nagoshi, Rodney N.; Koffi, Djima; Agboka, Komi; Adjevi, Anani Kossi Mawuko; Meagher, Robert L.; Goergen, Georg			The fall armyworm strain associated with most rice, millet, and pasture infestations in the Western Hemisphere is rare or absent in Ghana and Togo	PLOS ONE			English	Article							SPODOPTERA-FRUGIPERDA LEPIDOPTERA; NOCTUIDAE HOST STRAINS; FIELD COLLECTIONS; IDENTIFICATION; POPULATIONS; SPECIATION; ARGENTINA; BRAZIL; GENE; CORN	The moth pest fall armyworm, Spodoptera frugiperda (J.E. Smith) (Lepidoptera: Noctuidae) is now present throughout much of the Eastern Hemisphere where it poses a significant economic threat to a number of crops. Native to the Western Hemisphere, fall armyworm is one of the primary pests of corn in the Americas and periodically causes significant economic damage to sorghum, millet, cotton, rice, and forage grasses. This broad host range is in part the result of two populations historically designated as host strains (C-strain and R-strain) that differ in their host plant preferences. Reports of infestations in Africa have to date mostly been limited to the C-strain preferred crops of corn and sorghum, with little evidence of an R-strain presence. However, this could reflect a bias in monitoring intensity, with the R-strain perhaps being more prevalent in other crop systems that have not been as routinely examined for the pest. Because knowledge of whether and to what extent both strains are present is critical to assessments of crops at immediate risk, we analyzed specimens obtained from a systematic survey of pasture grass and rice fields, habitats typically preferred by the R-strain, done contemporaneously with collections from corn fields in Ghana and Togo. Substantial larval infestations were only observed in corn, while pheromone trap capture numbers were high only in corn and rice habitats. Little to no fall armyworm were found in the pasture setting. Comparisons with a meta-analysis of studies from South America identified differences in the pattern of strain-specific markers typically found in fall armyworm collected from rice habitats between the two hemispheres. Genetic tests of specimens from rice and corn area traps failed to show evidence of differential mating between strains. These results are consistent with the R-strain being rare or even absent in Africa and, at least for the Ghana-Togo area, this R-strain lack does not appear to be due to limitations in pest monitoring. The implications of these results to the crops at risk in Africa and the accuracy of existing molecular markers of strain identity are discussed.	[Nagoshi, Rodney N.; Meagher, Robert L.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA; [Koffi, Djima] Univ Ghana, African Reg Postgrad Programme Insect Sci, Accra, Ghana; [Koffi, Djima; Agboka, Komi; Adjevi, Anani Kossi Mawuko] Univ Lome, Ecole Super Agron, Lome, Togo; [Goergen, Georg] Int Inst Trop Agr IITA, Cotonou, Benin	United States Department of Agriculture (USDA); University of Ghana	Nagoshi, RN (corresponding author), USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL 32608 USA.	rodney.nagoshi@usda.gov		Meagher, Robert/0000-0003-2769-1043; Goergen, Georg/0000-0003-4496-0495	Agricultural Research Service of the United States Department of Agriculture [6036-2200-30-00D]; USAID PASA [908-0210-012]; Deutsche Gesellschaft fur Internationale Zusammenarbeit [81235252 GA]	Agricultural Research Service of the United States Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USAID PASA; Deutsche Gesellschaft fur Internationale Zusammenarbeit	The author R.N.N. received support came from the Agricultural Research Service of the United States Department of Agriculture (6036-2200-30-00D) and USAID PASA (908-0210-012). The author G.G. received funding from the Deutsche Gesellschaft fur Internationale Zusammenarbeit (81235252 GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dumas P, 2015, GENETICA, V143, P305, DOI 10.1007/s10709-015-9829-2; Facon B, 2011, CURR BIOL, V21, P424, DOI 10.1016/j.cub.2011.01.068; Murua MG, 2015, J ECON ENTOMOL, V108, P2305, DOI 10.1093/jee/tov203; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gouin A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10461-4; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Industries DoP, FALL ARM 2020; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Koffi D, 2021, J ECON ENTOMOL, V114, P1138, DOI 10.1093/jee/toab048; Koffi D, 2020, ENVIRON ENTOMOL, V49, P645, DOI 10.1093/ee/nvaa048; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Kost S, 2016, EVOLUTION, V70, P1418, DOI 10.1111/evo.12940; Juarez ML, 2012, J ECON ENTOMOL, V105, P573, DOI 10.1603/EC11184; LUGINBILL PHILIP, 1928, U S DEPT AGRIC TECH BULL, V34, P1; Machado V, 2008, ANN ENTOMOL SOC AM, V101, P619, DOI 10.1603/0013-8746(2008)101[619:MCOHSO]2.0.CO;2; Meagher RL, 2004, ECOL ENTOMOL, V29, P614, DOI 10.1111/j.0307-6946.2004.00629.x; Meagher RL, 2019, ENTOMOL EXP APPL, V167, P507, DOI 10.1111/eea.12795; Montezano DG, 2018, AFR ENTOMOL, V26, P286, DOI 10.4001/003.026.0286; Nagoshi RN, 2006, J ECON ENTOMOL, V99, P671, DOI 10.1603/0022-0493-99.3.671; Nagoshi RN, 2004, ENVIRON ENTOMOL, V33, P881, DOI 10.1603/0046-225X-33.4.881; Nagoshi RN, 2007, ANN ENTOMOL SOC AM, V100, P394, DOI 10.1603/0013-8746(2007)100[394:IACOFA]2.0.CO;2; Nagoshi RN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58249-3; Nagoshi RN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44744-9; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217755; Nagoshi RN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208966; Nagoshi RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21954-1; Nagoshi RN, 2017, J ECON ENTOMOL, V110, P2568, DOI 10.1093/jee/tox229; Nagoshi RN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181982; Nagoshi RN, 2012, ANN ENTOMOL SOC AM, V105, P351, DOI 10.1603/AN11138; Nagoshi RN, 2010, ANN ENTOMOL SOC AM, V103, P283, DOI 10.1603/AN09046; Pashley D.P., 1989, Systematics Association Special Volume Series, P103; PASHLEY DP, 1988, EVOLUTION, V42, P93, DOI 10.1111/j.1558-5646.1988.tb04110.x; PASHLEY DP, 1987, LA AGR, V30, P8; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Schlum KA, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07492-7; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Sharanabasappa KCM., 2018, PEST MANAGEMENT HORT, V24, P23; Stokstad E, 2017, SCIENCE, V356, P473, DOI 10.1126/science.356.6337.473; Sun XX, 2021, J INTEGR AGR, V20, P664, DOI 10.1016/S2095-3119(19)62839-X	39	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253528	10.1371/journal.pone.0253528	http://dx.doi.org/10.1371/journal.pone.0253528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153077	Green Published, gold			2022-12-26	WOS:000671691000006
J	Shu, Z; Xiao, JG; Dai, XH; Han, Y; Liu, YL				Shu, Zhan; Xiao, Jinguang; Dai, Xianhua; Han, Yu; Liu, Yingli			Effect of family "upward" intergenerational support on the health of rural elderly in China: Evidence from Chinese Longitudinal Healthy Longevity Survey	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; SELF-RATED HEALTH; OLDER-PEOPLE; LIVING ARRANGEMENTS; DEPRESSIVE SYMPTOMS; SOCIAL SUPPORT; SOLIDARITY; EXCHANGES; TRANSFERS; PATTERNS	As health challenging rural elderly in an aging population, more attention is being paid on impact of family intergenerational support on the health of the elderly. This paper investigates the effects of children's intergenerational economic support and non-economic support on physical, mental, and functional health of rural elderly in China in the mean while. This paper applies the 2014 Chinese Longitudinal Healthy Longevity Survey (CLHLS), in particular, applying exploratory factor analysis to ascertain latent variables and Structural Equation Model (SEM), and analyzes the impacts of "Upward" intergenerational support on health of rural elderly. As resulted, after controlling the socioeconomic status of the rural elderly, the family "upward" intergenerational support influences the elderly's physical health at a percentage of 11.7%, mental health 29.8%, and physiological function 12.6%. Moreover, "Upward" economic support has a positive effect on physiological function (P<0.05). "Upward" non-economic support has negative effects on physiological function and mental health (P<0.05), while it has a positive effect on physical health. In addition, economically independent rural elderly are more likely to benefit from the health of "upward" intergenerational support, especially mental health. In particular, those results are robust. "Upward" intergenerational support plays an important role for the health of rural elderly. For the rural elderly of economic independence, to improve the quality of care and spiritual support, it is important to solve the health problems. In addition, it is necessary to build a comprehensive old-age security and support system for family, community, and society jointly to improve the health of the rural elderly.	[Shu, Zhan; Xiao, Jinguang; Dai, Xianhua; Han, Yu; Liu, Yingli] Cent China Normal Univ, Sch Publ Adm, Wuhan, Hubei, Peoples R China; [Shu, Zhan; Dai, Xianhua] Cent China Normal Univ, Ctr Labor & Social Secur, Wuhan, Hubei, Peoples R China	Central China Normal University; Central China Normal University	Dai, XH (corresponding author), Cent China Normal Univ, Sch Publ Adm, Wuhan, Hubei, Peoples R China.; Dai, XH (corresponding author), Cent China Normal Univ, Ctr Labor & Social Secur, Wuhan, Hubei, Peoples R China.	shrdai@sina.com	liu, ying/GXF-4294-2022; LIU, YING/GZL-7252-2022		Humanities and Social Science Research Fund of the Ministry of Education in China [18YJA790018]; Philosophical and Social Science Research Key Fund of the Department of Education in Hubei Province [17ZD018]; Fundamental Research Funds for the Central Universities in Central China Normal University, China [CCNU19TS047]; Education Science Twelfth Five-year Plan program in Hubei Province [2010B040]	Humanities and Social Science Research Fund of the Ministry of Education in China; Philosophical and Social Science Research Key Fund of the Department of Education in Hubei Province; Fundamental Research Funds for the Central Universities in Central China Normal University, China; Education Science Twelfth Five-year Plan program in Hubei Province	This work was supported in part by the Humanities and Social Science Research Fund of the Ministry of Education in China under Grant 18YJA790018, in part by the Philosophical and Social Science Research Key Fund of the Department of Education in Hubei Province under Grant 17ZD018, in part by the Fundamental Research Funds for the Central Universities in Central China Normal University, China under Grant CCNU19TS047, and in part by Education Science Twelfth Five-year Plan program in Hubei Province under Grant 2010B040. Those grants are received by Xianhua DAI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertini M, 2007, J EUR SOC POLICY, V17, P319, DOI 10.1177/0958928707081068; Attias-Donfut Claudine, 2005, Eur J Ageing, V2, P161, DOI 10.1007/s10433-005-0008-7; BECKER GS, 1981, ECONOMICA, V48, P1, DOI 10.2307/2552939; BENGTSON VL, 1991, J MARRIAGE FAM, V53, P856, DOI 10.2307/352993; Bingshui Li., 2013, J JIANGSU U SOCIAL S, V15, P62; Bo Xiong., 2014, POPULATION DEV, V20, P59; BRODY EM, 1985, GERONTOLOGIST, V25, P19, DOI 10.1093/geront/25.1.19; Brown J., 1999, AUST NZ J FAM THER, V20, P94, DOI [10.1002/j.1467-8438.1999.tb00363.x, DOI 10.1002/J.1467-8438.1999.TB00363.X]; Chen Bai., 2019, SOCIAL SECURITY STUD, P3; Chuanchuan Zhang., 2014, EC RES J, V49, P102; Cong Z, 2008, RES HUM DEV, V5, P6, DOI 10.1080/15427600701853749; Dewen Wang., 2006, J CHINESE WOMENS STU, P21; Djundeva M., 2014, J GERONTOL B-PSYCHOL; Dongxia Zhou., 2014, TRIBUNE SOCIAL SCI, P202; Fingerman KL, 2008, J GERONTOL B-PSYCHOL, V63, pP362, DOI 10.1093/geronb/63.6.P362; Fox J., 1987, CAN STUD POPUL, V14, P257; GEORGE LK, 1985, J AM GERIATR SOC, V33, P607, DOI 10.1111/j.1532-5415.1985.tb06317.x; Ghuman S., 2004, POPULATION STUDIES E, P563; Habib Rima R, 2006, Eur J Ageing, V3, P137, DOI 10.1007/s10433-006-0031-3; Haifeng Zhang., 2018, POPULATION EC, P21; Hao LIU., 2019, J HUNAN AGR U SOCIAL, V20, P49; Haywood KL, 2005, J EVAL CLIN PRACT, V11, P315, DOI 10.1111/j.1365-2753.2005.00538.x; He Z., 2011, POPUL EC, P1; HOGAN DP, 1993, AM J SOCIOL, V98, P1428, DOI 10.1086/230194; Hongyao Wei., 2016, J NANJING AGR U SOCI, V16, P144; Hongyun Zhou., 2018, STAT DECISION, V34, P98; Huiqiang Luo., 2017, J SICHUAN U MED SCI, V48, P263; Idler EL, 2003, GERONTOLOGIST, V43, P372, DOI 10.1093/geront/43.3.372; Jia-huan Liu., 2013, J HEBEI AGR U AGR FO, V15, P105; Jian Zhang., 2000, HIST CHINESE PHILOS, P74; Jianmin Xue., 1987, EC PROBLEMS, P63; Jing Zhou., 2016, CHINESE RURAL EC, P81; Juanjuan Sun., 2017, POPULATION RES, V41, P34; Junwu Mu., 1988, CHINESE J SOCIAL MED, P24; KATZ S, 1983, NEW ENGL J MED, V309, P1218, DOI 10.1056/NEJM198311173092005; Kendig EBHL, 1992, FAMILY SUPPORT ELDER; Kessler R. C., 1985, SOCIAL SUPPORT HLTH, P219; Krause N, 1998, PSYCHOL AGING, V13, P58, DOI 10.1037/0882-7974.13.1.58; LEE YJ, 1994, AM J SOCIOL, V99, P1010, DOI 10.1086/230370; Lianjie Wang., 2018, MODERN EC RES, P101; Ling Yang., 2020, NW POPULATION J, V41, P72; Litwin H, 2004, RES AGING, V26, P202, DOI 10.1177/0164027503260631; Liu Lan QI., 2020, NW POPULATION J, V41, P1; LIU X, 1995, SOC SCI MED, V41, P1175, DOI 10.1016/0277-9536(94)00427-U; Long Xue., 2020, STAT DECISION, V36, P73; Lu Song., 2006, CHINESE J GERONTOLOG, P1453; McChesney K.Y., 1988, SOLIDARITY INTEGRATI; Mei Li., 2007, CHINESE MENTAL HLTH, P871; Meng Wei., 2017, POPULATION DEV, V23, P74; Ming Xu., 2014, J SHANXI U FINANCE E, V36, P12; Oppong C, 2006, RES AGING, V28, P654, DOI 10.1177/0164027506291744; Organization WH, 2015, SUMM WORLD REP AG HL; Park KS, 2005, J CROSS-CULT GERONTO, V20, P285, DOI 10.1007/s10823-006-9007-1; Ping Wang., 2011, POPULATION RES, V35, P44; Ping Wang., 2011, POPULATION EC, P13; Ping Wang., 2011, POPULATION J, P70; Ping Wang., 2012, POPULATION DEV, V18, P61; Qingbo Huang., 2017, POPULATION DEV, V23, P43; Reinhardt JP, 2000, J APPL GERONTOL, V19, P345, DOI 10.1177/073346480001900306; Renbing Shi., 2020, SOCIAL SECURITY STUD, P34; Ribang Li., 2004, HUMAN GEOGRAPHY, P64; Rogers RG, 1996, J HEALTH SOC BEHAV, V37, P326, DOI 10.2307/2137260; Schroder-Butterfill E, 2004, AGEING SOC, V24, P497, DOI 10.1017/S0144686X0400234X; Schumacker RE., 1996, LEA; Silverstein M, 1996, J MARRIAGE FAM, V58, P970, DOI 10.2307/353984; Silverstein M, 1997, AM J SOCIOL, V103, P429, DOI 10.1086/231213; Silverstein M, 2006, J GERONTOL B-PSYCHOL, V61, pS256, DOI 10.1093/geronb/61.5.S256; Spiers Nicola, 2003, GERONTOLOGIST; STONE R, 1987, GERONTOLOGIST, V27, P616, DOI 10.1093/geront/27.5.616; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Sun Juan Juan JiYun., 2017, POPULATION RES, V41, P98; Teerawichitchainan B, 2015, SOC SCI MED, V136, P106, DOI 10.1016/j.socscimed.2015.05.019; Tkacheva ON, 2018, CLIN INTERV AGING, V13, P251, DOI 10.2147/CIA.S153389; Torres CH, 2017, EUR UROL FOCUS, V3, P330, DOI 10.1016/j.euf.2017.10.010; Tseng L A., 2014, J GERONTOL, P93; van Rijn M, 2016, AGE AGEING, V45, P894, DOI 10.1093/ageing/afw157; Wenjuan Zhang., 2005, POPULATION RES, P73; Wenjuan Zhang., 2004, CHINESE J POPULATION, P39; Wenling Chen., 2008, J CHINESE YOUTH SOCI, P134; Wenqian Zhang., 2021, CHINESE J HLTH STAT, V38, P188; WHEATON B, 1987, SOCIOL METHOD RES, V16, P118, DOI 10.1177/0049124187016001005; Wong OMH, 2005, J AGING STUD, V19, P375, DOI 10.1016/j.jaging.2004.07.007; World Health Organization, 2005, CONST WHO, DOI [10.1177/10253823050120030139, DOI 10.1177/10253823050120030139]; Wu FY, 2022, SOC INDIC RES, V160, P1071, DOI 10.1007/s11205-021-02672-0; Wu Z., 2007, DEMOGRAPHIC METHODS, V20, P197; Xiao QY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187941; Xiaotong Fei., 1983, J PEKING U PHILOS SO, P7; Xiaoyue Chen., 1998, CHINESE J POPULATION, P3; Xiguo Liu., 2016, NW POPULATION J, P45; Xiguo Liu., 2015, POPULATION EC, P116; Yajie Xu., 2018, INFLUENCE CHILDRENS; Yang Y., 2018, SINGAP ECON REV; Yanhui Xu., 2016, JILIN U J SOCIAL SCI, V56, P82; Yanji Zhang., 2018, ACTA GEOGRAPHICA SIN, V73, P333; Yimei Hu., 2016, CHONGQING SOCIAL SCI, P83; Yinan Yang., 2020, CHINESE J POPULATION, P44; Ying Bo, 2017, HLTH EFFECT INTERGEN; Yong-Cheng Chen., 2009, RURAL EC, P102; Youmei Feng., 2017, AGING GLOBAL HLTH, P77; Yuchun Tao., 2014, POPULATION EC, P3; Zhang W, 2015, INTERGENERATIONAL SU; Zhang Yue., 2017, J HUNAN AGR U SOCIAL, V18, P74; Zhen Lei., 2014, J SHANDONG U HLTH SC, V52, P93; Zhilei Shi., 2015, SOCIOLOGICAL STUDIES, V30, P189; Zhong Zhao., 2005, J WORLD EC, P33; Zhou Lv, 2012, POPULATION DEV, V18, P82; Zi Zhou., 2018, CHINESE J HLTH STAT, V35, P500; Zunzunegui MV, 2001, INT J EPIDEMIOL, V30, P1090, DOI 10.1093/ije/30.5.1090	108	7	7	66	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253131	10.1371/journal.pone.0253131	http://dx.doi.org/10.1371/journal.pone.0253131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143838	gold, Green Published			2022-12-26	WOS:000671690700048
J	Goc, A; Sumera, W; Rath, M; Niedzwiecki, A				Goc, Anna; Sumera, Waldemar; Rath, Matthias; Niedzwiecki, Aleksandra			Phenolic compounds disrupt spike-mediated receptor-binding and entry of SARS-CoV-2 pseudo-virions	PLOS ONE			English	Article							SARS CORONAVIRUS; CATHEPSIN-B; CELL ENTRY; PROTEIN; ACTIVATION; TMPRSS2; POLYPHENOLS; INHIBITION; OUTBREAK; CLEAVAGE	In the pursuit of suitable and effective solutions to SARS-CoV-2 infection, we investigated the efficacy of several phenolic compounds in controlling key cellular mechanisms involved in its infectivity. The way the SARS-CoV-2 virus infects the cell is a complex process and comprises four main stages: attachment to the cognate receptor, cellular entry, replication and cellular egress. Since, this is a multi-part process, it creates many opportunities to develop effective interventions. Targeting binding of the virus to the host receptor in order to prevent its entry has been of particular interest. Here, we provide experimental evidence that, among 56 tested polyphenols, including plant extracts, brazilin, theaflavin-3,3'-digallate, and curcumin displayed the highest binding with the receptor-binding domain of spike protein, inhibiting viral attachment to the human angiotensin-converting enzyme 2 receptor, and thus cellular entry of pseudo-typed SARS-CoV-2 virions. Both, theaflavin-3,3'-digallate at 25 mu g/ml and curcumin above 10 mu g/ml concentration, showed binding with the angiotensin-converting enzyme 2 receptor reducing at the same time its activity in both cell-free and cell-based assays. Our study also demonstrates that brazilin and theaflavin-3,3'-digallate, and to a still greater extent, curcumin, decrease the activity of transmembrane serine protease 2 both in cell-free and cell-based assays. Similar pattern was observed with cathepsin L, although only theaflavin-3,3'-digallate showed a modest diminution of cathepsin L expression at protein level. Finally, each of these three compounds moderately increased endosomal/lysosomal pH. In conclusion, this study demonstrates pleiotropic anti-SARS-CoV-2 efficacy of specific polyphenols and their prospects for further scientific and clinical investigations.	[Goc, Anna; Sumera, Waldemar; Rath, Matthias; Niedzwiecki, Aleksandra] Dr Rath Res Inst, Dept Infect Dis, San Jose, CA 95138 USA		Goc, A; Niedzwiecki, A (corresponding author), Dr Rath Res Inst, Dept Infect Dis, San Jose, CA 95138 USA.	a.niedz@drrath.com; a.goc@drrath.com		Goc, Anna/0000-0001-8736-2941				Anggakusuma, 2014, GUT, V63, P1137, DOI 10.1136/gutjnl-2012-304299; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bosch BJ, 2003, J VIROL, V77, P8801, DOI 10.1128/JVI.77.16.8801-8811.2003; Chen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062482; Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681; Chowdhury P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198226; Cory H, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00087; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Cui XL, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.514313; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Goc A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84850-1; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Iwata-Yoshikawa N, 2019, J VIROL, V93, DOI 10.1128/JVI.01815-18; Jaimes JA, 2020, J MOL BIOL, V432, P3309, DOI 10.1016/j.jmb.2020.04.009; Jaruga E, 1998, BIOCHEM PHARMACOL, V56, P961, DOI 10.1016/S0006-2952(98)00144-0; Jena AB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81462-7; Liu TX, 2020, PHARMACOL THERAPEUT, V213, DOI 10.1016/j.pharmthera.2020.107587; Lung J., 2020, POTENTIAL SARS COV 2, DOI [DOI 10.1101/2020.03.26.009803V1, 10.1101/2020.03.26.009803v1]; Maiti S, 2021, DRUG DEVELOP RES, V82, P86, DOI 10.1002/ddr.21730; Masters P, 2013, FIELDS VIROLOGY, P825; Mollica V, 2020, FUTURE ONCOL, V16, P2029, DOI 10.2217/fon-2020-0571; Nelson EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005540; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Paraiso IL, 2020, CURR OPIN FOOD SCI, V32, P149, DOI 10.1016/j.cofs.2020.08.004; Paszti-Gere E, 2016, J ENZYM INHIB MED CH, V31, P123, DOI 10.1080/14756366.2016.1193732; Patel A, 2022, J BIOMOL STRUCT DYN, V40, P5138, DOI 10.1080/07391102.2020.1868338; Patil UK, 2014, ARCH DERMATOL RES, V306, P419, DOI 10.1007/s00403-014-1445-y; Perrotta F, 2020, RESP MED, V168, DOI 10.1016/j.rmed.2020.105996; Ravish I, 2014, MED CHEM RES, V23, P2847, DOI 10.1007/s00044-013-0872-1; Rehman MT, 2021, CURR PHARM DESIGN, V27, P3577, DOI 10.2174/1381612826999201116195851; Shrimp JH, 2020, ACS PHARMACOL TRANSL, V3, P997, DOI 10.1021/acsptsci.0c00106; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Taggart CC, 2001, J BIOL CHEM, V276, P33345, DOI 10.1074/jbc.M103220200; Upadhyay S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/504253; Verma S, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.561334; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wang XM, 2021, POTENTIAL ANAL, V54, P153, DOI 10.1007/s11118-019-09821-8; WHO, 2020, WHO COR COVID 19 DAS; Wolters P J, 2000, Respir Res, V1, P170, DOI 10.1186/rr29; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Xia S, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0184-0; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yoo J., 2012, END ABSTR, V29, pP1226; Zhang DW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-154; Zhang JJ., 2020, DISCOVERY ANTISARS C, DOI DOI 10.31219/OSF.IO/VJCH2; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	53	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253489	10.1371/journal.pone.0253489	http://dx.doi.org/10.1371/journal.pone.0253489			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138966	gold, Green Published			2022-12-26	WOS:000671690200118
J	Majimbi, M; Brook, E; Galettis, P; Eden, E; Al-Salami, H; Mooranian, A; Al-Sallami, H; Lam, V; Mamo, JCL; Takechi, R				Majimbi, Maimuna; Brook, Emily; Galettis, Peter; Eden, Edward; Al-Salami, Hani; Mooranian, Armin; Al-Sallami, Hesham; Lam, Virginie; Mamo, John C. L.; Takechi, Ryusuke			Sodium alginate microencapsulation improves the short-term oral bioavailability of cannabidiol when administered with deoxycholic acid	PLOS ONE			English	Article								Background Cannabidiol (CBD) confers therapeutic effects in some neurological disorders via modulation of inflammatory, oxidative and cell-signalling pathways. However, CBD is lipophilic and highly photooxidative with low oral bioavailability in plasma and brain. In this study, we aimed to design and test a CBD microencapsulation method as a drug delivery strategy to improve the absorption of CBD. Additionally, we evaluated the brain uptake of CBD capsules when administered alongside capsules containing a permeation-modifying bile acid, deoxycholic acid (DCA). Methods Microcapsules containing either CBD or DCA were formed using the ionic gelation method with 1.5% sodium alginate formulations and 100 mM calcium chloride. C57BL/6J wild type mice randomly assigned to three treatment groups (3-4 mice per group) were administered CBD in the following preparations: 1) CBD capsules, 2) CBD capsules + DCA capsules and 3) naked CBD oil (control). To assess the short-term bioavailability of CBD, plasma and brain samples were collected at 0.3, 1 and 3 hours post administration and CBD levels were analysed with liquid chromatography mass spectrometer. Results We produced spherical capsules at 400 +/- 50 mu m in size. The CBD capsules were calculated to have a drug loading of 2% and an encapsulation efficiency of 23%. Mice that received CBD capsules + DCA capsules showed a 40% and 47% increase in CBD plasma concentration compared to mice on CBD capsules and naked CBD oil, respectively. Furthermore, the CBD capsules + DCA capsules group showed a 48% and 25% increase in CBD brain concentration compared to mice on CBD capsules and naked CBD oil, respectively. In mice treated with CBD capsules + DCA capsules, the brain CBD concentration peaked at 0.3 hours with a 300% increased availability compared to CBD capsules and naked CBD oil groups, which peaked at 1 hour after administration. Conclusions The microencapsulation method combined with a permeation enhancer, DCA increased the short-term bioavailability of CBD in plasma and brain.	[Majimbi, Maimuna; Brook, Emily; Al-Salami, Hani; Mooranian, Armin; Lam, Virginie; Mamo, John C. L.; Takechi, Ryusuke] Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia; [Majimbi, Maimuna; Lam, Virginie; Mamo, John C. L.; Takechi, Ryusuke] Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA, Australia; [Brook, Emily; Al-Salami, Hani; Mooranian, Armin] Curtin Univ, Fac Hlth Sci, Curtin Med Sch, Perth, WA, Australia; [Galettis, Peter; Eden, Edward] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Galettis, Peter; Eden, Edward] Australian Ctr Cannabinoid Clin & Res Excellence, Newcastle, NSW, Australia; [Al-Sallami, Hesham] Univ Otago, Sch Pharm, Otago, New Zealand	Curtin University; Curtin University; Curtin University; University of Newcastle; University of Otago	Takechi, R (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Perth, WA, Australia.; Takechi, R (corresponding author), Curtin Univ, Fac Hlth Sci, Sch Populat Hlth, Perth, WA, Australia.	R.Takechi@curtin.edu.au	Takechi, Ryu/T-9970-2019; Takechi, Ryusuke/D-3692-2012	Takechi, Ryu/0000-0001-6359-3382; Takechi, Ryusuke/0000-0001-6359-3382; Mooranian, Armin/0000-0001-7103-2067; Al-Sallami, Hesham/0000-0002-0685-327X; Lam, Virginie/0000-0001-8463-645X; Mamo, John/0000-0002-5741-7849	Zelira Therapeutics Ltd	Zelira Therapeutics Ltd	Zelira Therapeutics Ltd provided financial support for the study to cover all experimental cost. The authors do not have any ownership of stocks or shares; paid employment or consultancy; or board membership; nor received any research grants; travel grants or honoraria for speaking or participation at meetings; research materials; or gifts from the company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LL, 2019, J NAT PROD, V82, P3047, DOI 10.1021/acs.jnatprod.9b00600; [Anonymous], 2016, ASIA-PAC J CLIN ONCO; Bartner LR., 2018, CAN J VET RES; Bih CI, 2015, NEUROTHERAPEUTICS, V12, P699, DOI 10.1007/s13311-015-0377-3; Bruni N, 2018, MOLECULES, V23, DOI 10.3390/molecules23102478; Cabral GA, 2014, INT REV NEUROBIOL, V118, P199, DOI 10.1016/B978-0-12-801284-0.00008-7; Chan LW., 2000, J MICROENCAPSUL, DOI [10.1080/02652040050161747, DOI 10.1080/02652040050161747]; Chiang JYL, 2013, COMPR PHYSIOL, V3, P1191, DOI 10.1002/cphy.c120023; Deiana S., 2012, PSYCHOPHARMACOLOGY; Horvth B., 2012, AM J PATHOL; Iffland K, 2017, CANNABIS CANNABINOID, V2, P139, DOI 10.1089/can.2016.0034; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Long LE, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034129, 10.1371/journal.pone.0051782]; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Mamo JCL, 2018, THER DELIV, V9, P703, DOI 10.4155/tde-2018-0033; Martin-Moreno AM, 2011, MOL PHARMACOL, V79, P964, DOI 10.1124/mol.111.071290; Millar SA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01365; Mooranian A., 2019, THER DELIV; Mooranian A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-53999-1; Mooranian A, 2014, DRUG DES DEV THER, V8, P1003, DOI 10.2147/DDDT.S65396; Pavlovic N, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01283; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; Ruiz-Valdepenas L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-5; Wagle SR, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12080708; Wagle SR, 2020, EXPERT OPIN DRUG DEL, V17, P1361, DOI 10.1080/17425247.2020.1789587; Wagle SR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64355-z; Xu C, 2019, ENVIRON TOXICOL PHAR, V70, DOI 10.1016/j.etap.2019.103202; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	29	2	3	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0243858	10.1371/journal.pone.0243858	http://dx.doi.org/10.1371/journal.pone.0243858			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138862	Green Published, gold			2022-12-26	WOS:000671690200060
J	Beaudoin, N; Isayenka, I; Ducharme, A; Massie, S; Gagnon, A; Hogue, R; Beaulieu, C; Michaud, D				Beaudoin, Nathalie; Isayenka, Iauhenia; Ducharme, Audrey; Massie, Sophie; Gagnon, Andre; Hogue, Richard; Beaulieu, Carole; Michaud, Dominique			Habituation to thaxtomin A increases resistance to common scab in 'Russet Burbank' potato	PLOS ONE			English	Article							CELLULOSE SYNTHESIS; CELL-DEATH; PATHOGENICITY; DISEASE; GROWTH; BIOSYNTHESIS; INHIBITION; MUTANTS	Common scab is a potato disease characterized by the formation of scab-like lesions on the surface of potato tubers. The actinobacterium Streptomyces scabiei is the main causal agent of common scab. During infection, this bacterium synthesizes the phytotoxin thaxtomin A which is essential for the production of disease symptoms. While thaxtomin A can activate an atypical programmed cell death in plant cell suspensions, it is possible to gradually habituate plant cells to thaxtomin A to provide resistance to lethal phytotoxin concentrations. Potato 'Russet Burbank' calli were habituated to thaxtomin A to regenerate the somaclone RB9 that produced tubers more resistant to common scab than those obtained from the original cultivar. Compared to the Russet Burbank cultivar, somaclone RB9 generated up to 22% more marketable tubers with an infected tuber area below the 5% threshold. Enhanced resistance was maintained over at least two years of cultivation in the field. However, average size of tubers was significantly reduced in somaclone RB9 compared to the parent cultivar. Small RB9 tubers had a thicker phellem than Russet Burbank tubers, which may contribute to improving resistance to common scab. These results show that thaxtomin A-habituation in potato is efficient to produce somaclones with increased and durable resistance to common scab.	[Beaudoin, Nathalie; Isayenka, Iauhenia; Ducharme, Audrey; Beaulieu, Carole] Univ Sherbrooke, Ctr SEVE, Dept Biol, Sherbrooke, PQ, Canada; [Massie, Sophie; Gagnon, Andre] Progest 2001, St Croix, PQ, Canada; [Hogue, Richard] Inst Rech & Dev Agroenvironm Inc IRDA, Quebec City, PQ, Canada; [Michaud, Dominique] Univ Laval, Ctr Rech & Innovat Vegetaux, Quebec City, PQ, Canada	University of Sherbrooke; Laval University	Beaudoin, N (corresponding author), Univ Sherbrooke, Ctr SEVE, Dept Biol, Sherbrooke, PQ, Canada.	Nathalie.Beaudoin@usherbrooke.ca		Hogue, Richard/0000-0002-2768-0857; Beaudoin, Nathalie/0000-0001-7835-4077	Ministere de l'Agriculture, Pecheries et Alimentation Quebec, Programme Innov'Action agroalimentaire, Partenariat canadien pour l'agriculture [IA113034/IA117757]; Fonds de Recherche Nature et Technologies Quebec -Fonds de recherche en Agriculture Nordique [FQRNT - FRAN02, 2015-NA-186904]; Progest 2001	Ministere de l'Agriculture, Pecheries et Alimentation Quebec, Programme Innov'Action agroalimentaire, Partenariat canadien pour l'agriculture; Fonds de Recherche Nature et Technologies Quebec -Fonds de recherche en Agriculture Nordique; Progest 2001	This research was funded by Ministere de l'Agriculture, Pecheries et Alimentation Quebec, Programme Innov'Action agroalimentaire, Partenariat canadien pour l'agriculture to NB (https://www.mapaq.gouv.qc.ca/fr/Productions/md/programmesliste/RDinnovation/Pages/InnovActionagroalimentaire.aspx; IA113034/IA117757), Fonds de Recherche Nature et Technologies Quebec -Fonds de recherche en Agriculture Nordique to NB (FQRNT -FRAN02 http://www.frqnt.gouv.qc.ca/bourses-etsubventions/concours-anterieurs/bourse/programme-de-recherche-en-partenariat-surlagriculture-nordique-du-saguenay-lac-saint-jean-ii-4supesup-concours-c3h0cwmc1513368727218: 2015-NA-186904) and Progest 2001 to NB (http://Progest2001.com).The funder Progest 2001, which is owned by author AG, provided support in the form of salaries (AG and SM) and research material for some of the field experiments, data collection and preliminary analysis. The specific roles of these authors are articulated in the `author contributions' section. Progest 2001 had no implication in the study design, final data analysis, decision to publish and preparation of manuscript for publication. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awwad F, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2130-2; Awwad F, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8090332; Beausejour J, 2003, PLANT SOIL, V256, P463, DOI 10.1023/A:1026177714855; Bischoff V, 2009, J EXP BOT, V60, P955, DOI 10.1093/jxb/ern344; Braun S, 2017, AM J POTATO RES, V94, P283, DOI 10.1007/s12230-017-9575-3; Brochu V, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-272; Duval I, 2005, PLANTA, V222, P820, DOI 10.1007/s00425-005-0016-z; Duval I, 2009, PLANT CELL REP, V28, P811, DOI 10.1007/s00299-009-0670-x; Errakhi R, 2008, J EXP BOT, V59, P4259, DOI 10.1093/jxb/ern267; FAUCHER E, 1992, CAN J PLANT PATHOL, V14, P197, DOI 10.1080/07060669209500874; Fofana B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235018; Fry BA, 2002, PHYSIOL MOL PLANT P, V60, P1, DOI 10.1006/pmpp.2001.0371; Goyer C, 1998, PHYTOPATHOLOGY, V88, P442, DOI 10.1094/PHYTO.1998.88.5.442; Hamel L-P, 2013, BACTERIA AGROBIOLOGY, P309; Hiltunen LH, 2011, PLANT PATHOL, V60, P426, DOI 10.1111/j.1365-3059.2010.02386.x; Hiltunen LH, 2006, J AGR FOOD CHEM, V54, P3372, DOI 10.1021/jf060270m; Huang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3558; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; JayaSree T, 2001, PLANT CELL TISS ORG, V64, P13, DOI 10.1023/A:1010697608689; Joglekar S, 2018, PLANT CELL PHYSIOL, V59, P1592, DOI 10.1093/pcp/pcy106; Joshi MV, 2007, MOL MICROBIOL, V66, P633, DOI 10.1111/j.1365-2958.2007.05942.x; KING RR, 1991, AM POTATO J, V68, P675, DOI 10.1007/BF02853743; KING RR, 1989, J CHEM SOC CHEM COMM, P849, DOI 10.1039/c39890000849; Krishna H, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0389-7; Labidi S, 2020, THESIS U SHERBROOKE; LAWRENCE CH, 1990, PHYTOPATHOLOGY, V80, P606, DOI 10.1094/Phyto-80-606; Lerat S, 2009, PLANT CELL REP, V28, P1895, DOI 10.1007/s00299-009-0792-1; Li XQ, 2016, CURR ISSUES MOL BIOL, V20, P29; Loria R, 2003, PHYSIOL MOL PLANT P, V62, P65, DOI 10.1016/S0885-5765(03)00041-9; Loria R, 2008, ANTON LEEUW INT J G, V94, P3, DOI 10.1007/s10482-008-9240-4; Scheible WR, 2003, PLANT CELL, V15, P1781, DOI 10.1105/tpc.013342; Tegg RS, 2008, PLANT DIS, V92, P1321, DOI 10.1094/PDIS-92-9-1321; Tegg RS, 2010, EUR J PLANT PATHOL, V128, P143, DOI 10.1007/s10658-010-9648-3; Tegg RS, 2005, PLANT CELL PHYSIOL, V46, P638, DOI 10.1093/pcp/pci069; Thangavel T, 2016, PHYTOPATHOLOGY, V106, P474, DOI 10.1094/PHYTO-08-15-0191-R; Thangavel T, 2014, SCI WORLD J, DOI 10.1155/2014/417697; THIEME R, 2005, POTATO RES, V48, P153, DOI [DOI 10.1007/BF02742373, 10.1007/BF02742373]; Wilson CR, 2009, PLANT PATHOL, V58, P137, DOI 10.1111/j.1365-3059.2008.01903.x; Wilson CR, 2010, PHYTOPATHOLOGY, V100, P460, DOI 10.1094/PHYTO-100-5-0460	39	2	2	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253414	10.1371/journal.pone.0253414	http://dx.doi.org/10.1371/journal.pone.0253414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133457	gold, Green Published			2022-12-26	WOS:000671682700034
J	Hardmeier, I; Aeberhard, N; Qi, WH; Schoenbaechler, K; Kraettli, H; Hatt, JM; Fraefel, C; Kubacki, J				Hardmeier, Isabelle; Aeberhard, Nadja; Qi, Weihong; Schoenbaechler, Katja; Kraettli, Hubert; Hatt, Jean-Michel; Fraefel, Cornel; Kubacki, Jakub			Metagenomic analysis of fecal and tissue samples from 18 endemic bat species in Switzerland revealed a diverse virus composition including potentially zoonotic viruses	PLOS ONE			English	Article							INSECTIVOROUS BATS; EMERGING VIRUSES; RESERVOIR HOSTS; EUROPEAN BATS; FLYING FOXES; CORONAVIRUSES; EVOLUTION; VIROME; INFECTION; ROTAVIRUS	Many recent disease outbreaks in humans had a zoonotic virus etiology. Bats in particular have been recognized as reservoirs to a large variety of viruses with the potential to cross-species transmission. In order to assess the risk of bats in Switzerland for such transmissions, we determined the virome of tissue and fecal samples of 14 native and 4 migrating bat species. In total, sequences belonging to 39 different virus families, 16 of which are known to infect vertebrates, were detected. Contigs of coronaviruses, adenoviruses, hepeviruses, rotaviruses A and H, and parvoviruses with potential zoonotic risk were characterized in more detail. Most interestingly, in a ground stool sample of a Vespertilio murinus colony an almost complete genome of a Middle East respiratory syndrome-related coronavirus (MERS-CoV) was detected by Next generation sequencing and confirmed by PCR. In conclusion, bats in Switzerland naturally harbour many different viruses. Metagenomic analyses of non-invasive samples like ground stool may support effective surveillance and early detection of viral zoonoses.	[Hardmeier, Isabelle; Aeberhard, Nadja; Fraefel, Cornel; Kubacki, Jakub] Univ Zurich, Inst Virol, Zurich, Switzerland; [Qi, Weihong] Funct Genom Ctr Zurich, Zurich, Switzerland; [Schoenbaechler, Katja; Kraettli, Hubert] Bat Fdn Switzerland, Zurich, Switzerland; [Hatt, Jean-Michel] Univ Zurich, Exot Pets & Wildlife, Clin Zoo Anim, Zurich, Switzerland	University of Zurich; University of Zurich	Fraefel, C; Kubacki, J (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	cornel.fraefel@uzh.ch; jakub.kubacki@uzh.ch	Qi, Weihong/ABC-7380-2021	Kubacki, Jakub/0000-0001-7085-3533; Qi, Weihong/0000-0001-8581-908X	Foundation for Research in Science and the Humanities at the University of Zurich [STWF-19-013]	Foundation for Research in Science and the Humanities at the University of Zurich	C.F. was supported by the Foundation for Research in Science and the Humanities at the University of Zurich (Grant number STWF-19-013) (https://www.research.uzh.ch/en/funding/researchers/stwf.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amador LI, 2018, J MAMM EVOL, V25, P37, DOI 10.1007/s10914-016-9363-8; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; ANDERSON MJ, 1985, J INFECT DIS, V152, P257, DOI 10.1093/infdis/152.2.257; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; [Anonymous], 2020, CHINA DBATVIR DATABA; [Anonymous], 2020, BATLIFE EUROPE BAT C; August TA, 2012, VECTOR-BORNE ZOONOT, V12, P530, DOI 10.1089/vbz.2011.0829; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Barbour R., BATS AM, P1969; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Bonny Tania S, 2017, Diseases, V5, DOI 10.3390/diseases5010007; BROSSET A, 1990, MAMMALIA, V54, P207; Bumungsri S, 2013, ACTA CHIROPTEROL, V15, P95, DOI 10.3161/150811013X667894; Burgin CJ, 2018, J MAMMAL, V99, P1, DOI 10.1093/jmammal/gyx147; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; De Benedictis P, 2014, VIRUS GENES, V48, P366, DOI 10.1007/s11262-013-1008-x; Lima FED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118070; Diakoudi G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060523; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Drexler JF, 2012, J VIROL, V86, P9134, DOI 10.1128/JVI.00800-12; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Esona MD, 2010, EMERG INFECT DIS, V16, P1844, DOI 10.3201/eid1612.101089; Falcon A, 2011, ARCH VIROL, V156, P1883, DOI 10.1007/s00705-011-1057-1; Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Finoketti F, 2019, ARCH VIROL, V164, P1015, DOI 10.1007/s00705-018-04129-1; Frick WF, 2020, ANN NY ACAD SCI, V1469, P5, DOI 10.1111/nyas.14045; Frutos R, 2020, INFECT GENET EVOL, V84, DOI 10.1016/j.meegid.2020.104493; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Gonzalez JP, 2007, CURR TOP MICROBIOL, V315, P363; Griffin D. R., 1970, P233; Grozinger CM, 2019, ANNU REV ENTOMOL, V64, P205, DOI 10.1146/annurev-ento-011118-111942; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Han HJ, 2017, ZOONOSES PUBLIC HLTH, V64, P636, DOI 10.1111/zph.12358; Hayman DTS, 2016, ANNU REV VIROL, V3, P77, DOI 10.1146/annurev-virology-110615-042203; He B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061950; Hu B, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0422-1; Hu D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11384-w; IUCN (Internation Union for Conservation of Nature), 2020, INT UNION CONSERVATI; Janoska M, 2011, VET J, V189, P118, DOI 10.1016/j.tvjl.2010.06.020; Kemenesi G, 2014, ACTA VIROL, V58, P95, DOI 10.4149/av_2014_01_95; Kim HK, 2016, TRANSBOUND EMERG DIS, V63, P365, DOI 10.1111/tbed.12515; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kivisto I, 2020, VECTOR-BORNE ZOONOT, V20, P155, DOI 10.1089/vbz.2018.2367; Kobayashi T, 2018, VIRUS GENES, V54, P599, DOI 10.1007/s11262-018-1577-9; Kohl C, 2014, VIRUSES-BASEL, V6, P3110, DOI 10.3390/v6083110; Kohl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043106; Kohl C, 2012, J VIROL, V86, P1888, DOI 10.1128/JVI.05974-11; Kubacki J, 2021, J VET DIAGN INVEST, V33, P235, DOI 10.1177/1040638720982630; Kubacki J, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12090929; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kuno G, 2001, REV MED VIROL, V11, P165, DOI 10.1002/rmv.314; Lelli D, 2013, VIRUSES-BASEL, V5, P2679, DOI 10.3390/v5112679; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Lina PH, 2016, COMMON NAMES EUROPEA; Lukashov VV, 2001, J VIROL, V75, P2729, DOI 10.1128/JVI.75.6.2729-2740.2001; Luo CM, 2018, J VIROL, V92, DOI 10.1128/JVI.00116-18; Male MF, 2016, INFECT GENET EVOL, V39, P279, DOI 10.1016/j.meegid.2016.02.009; Matthijnssens J, 2009, FUTURE MICROBIOL, V4, P1303, DOI [10.2217/fmb.09.96, 10.2217/FMB.09.96]; Megali A, 2010, ARCH VIROL, V155, P1655, DOI 10.1007/s00705-010-0750-9; Mendenhall IH, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030250; Mollentze N, 2020, P NATL ACAD SCI USA, V117, P9423, DOI 10.1073/pnas.1919176117; Monath TP, 1999, J INFECT DIS, V179, pS127, DOI 10.1086/514281; Moreno A, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0907-1; NCBI, US NAT CTR BIOT INF; O'Shea TJ, 2014, EMERG INFECT DIS, V20, P741, DOI 10.3201/eid2005.130539; Olival K. J., 2012, NEW DIRECTIONS CONSE, P195, DOI [10.1002/9781118818824.ch11, DOI 10.1002/9781118818824.CH11]; Paraskevis D, 2020, INFECT GENET EVOL, V79, DOI 10.1016/j.meegid.2020.104212; Pauly M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-25; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Podlutsky AJ, 2005, J GERONTOL A-BIOL, V60, P1366, DOI 10.1093/gerona/60.11.1366; Reusken CBEM, 2010, VECTOR-BORNE ZOONOT, V10, P785, DOI 10.1089/vbz.2009.0173; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Riccucci Marco, 2014, Vespertilio, V17, P161; Rihtaric D, 2010, ARCH VIROL, V155, P507, DOI 10.1007/s00705-010-0612-5; Ripellino P, 2017, CASE REP J, V1, DOI DOI 10.5167/UZH-148669; Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898; Sendow I, 2006, EMERG INFECT DIS, V12, P711, DOI 10.3201/eid1204.051181; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Shackelton LA, 2007, J GEN VIROL, V88, P3294, DOI 10.1099/vir.0.83255-0; Shankar V, 2005, VECTOR-BORNE ZOONOT, V5, P330, DOI 10.1089/vbz.2005.5.330; Shi ZL, 2010, PROTEIN CELL, V1, P109, DOI 10.1007/s13238-010-0029-7; Shipley R, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4010031; Simic I, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080891; Simmons NBaALC, 2020, BAT SPEC WORLD TAX G; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Sonntag M, 2009, EMERG INFECT DIS, V15, P2052, DOI 10.3201/eid1512.090646; Sulkin S E, 1974, Monogr Virol, V8, P1; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Teeling EC, 2018, ANNU REV ANIM BIOSCI, V6, P23, DOI 10.1146/annurev-animal-022516-022811; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vidovszky MZ, 2015, ACTA VET HUNG, V63, P508, DOI 10.1556/004.2015.047; Vijgen Leen, 2008, V454, P3, DOI 10.1007/978-1-59745-181-9_1; Wang B, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0706-8; Wang LF, 2019, CURR OPIN VIROL, V34, P79, DOI 10.1016/j.coviro.2018.12.007; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Wilkinson GS, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2018.0860; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wimsatt WA., 1970, BIOL BATS, P1, DOI [10.1002/aja.1001290107, DOI 10.1002/AJA.1001290107]; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Wu ZQ, 2016, ISME J, V10, P609, DOI 10.1038/ismej.2015.138; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Yang Fanli, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P586; Yinda CK, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey008; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zana B, 2018, ACTA VET HUNG, V66, P151, DOI 10.1556/004.2018.014; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zheng XY, 2018, ARCH VIROL, V163, P73, DOI 10.1007/s00705-017-3570-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	120	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252534	10.1371/journal.pone.0252534	http://dx.doi.org/10.1371/journal.pone.0252534			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133435	Green Published, gold			2022-12-26	WOS:000671682700021
J	Ye, YY; Xu, LL; Ding, H; Wang, X; Luo, J; Zhang, Y; Zen, K; Fang, Y; Dai, CS; Wang, YW; Zhou, Y; Jiang, L; Yang, JW				Ye, Yinyin; Xu, Lingling; Ding, Hao; Wang, Xiao; Luo, Jing; Zhang, Yu; Zen, Ke; Fang, Yi; Dai, Chunsun; Wang, Yuwei; Zhou, Yang; Jiang, Lei; Yang, Junwei			Pyruvate kinase M2 mediates fibroblast proliferation to promote tubular epithelial cell survival in acute kidney injury	FASEB JOURNAL			English	Article						acute kidney injury; fibroblast; PKM2; tubular epithelial cell	HEPATOCYTE GROWTH-FACTOR; METABOLIC REQUIREMENTS; PROXIMAL TUBULE; FACTOR RECEPTOR; ACTIVATION; MECHANISMS; REPAIR; TISSUE; MYOFIBROBLAST; FIBROSIS	Acute kidney injury (AKI) is a devastating condition with high morbidity and mortality rates. The pathological features of AKI are tubular injury, infiltration of inflammatory cells, and impaired vascular integrity. Pyruvate kinase is the final rate-limiting enzyme in the glycolysis pathway. We previously showed that pyruvate kinase M2 (PKM2) plays an important role in regulating the glycolytic reprogramming of fibroblasts in renal interstitial fibrosis. The present study aimed to determine the role of PKM2 in fibroblast activation during the pathogenesis of AKI. We found increased numbers of S100A4 positive cells expressing PKM2 in renal tissues from mice with AKI induced via folic acid or ischemia/reperfusion (I/R). The loss of PKM2 in fibroblasts impaired fibroblast proliferation and promoted tubular epithelial cell death including apoptosis, necroptosis, and ferroptosis. Mechanistically, fibroblasts produced less hepatocyte growth factor (HGF) in response to a loss of PKM2. Moreover, in two AKI mouse models, fibroblast-specific deletion of PKM2 blocked HGF signal activation and aggravated AKI after it was induced in mice via ischemia or folic acid. Fibroblast proliferation mediated by PKM2 elicits pro-survival signals that repress tubular cell death and may help to prevent AKI progression. Fibroblast activation mediated by PKM2 in AKI suggests that targeting PKM2 expression could be a novel strategy for treating AKI.	[Ye, Yinyin; Xu, Lingling; Ding, Hao; Wang, Xiao; Luo, Jing; Zhang, Yu; Fang, Yi; Dai, Chunsun; Zhou, Yang; Jiang, Lei; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China; [Ye, Yinyin; Wang, Yuwei] Wannan Med Coll, Yijishan Hosp, Dept Nephrol, Wuhu, Peoples R China; [Zen, Ke] Nanjing Univ, Adv Inst Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Peoples R China	Nanjing Medical University; Wannan Medical College; Nanjing University	Jiang, L; Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, 262 N Zhongshan Rd, Nanjing 210003, Jiangsu, Peoples R China.	jianglei@njmu.eu.cn; jwyang@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [81870502, 81873618, 81800651]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870502, 81873618 and 81800651	Al-Jaghbeer M, 2018, J AM SOC NEPHROL, V29, P654, DOI 10.1681/ASN.2017070765; Belavgeni A, 2020, CELL CHEM BIOL, V27, P448, DOI 10.1016/j.chembiol.2020.03.016; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Boor P, 2012, NEPHROL DIAL TRANSPL, V27, P3027, DOI 10.1093/ndt/gfs296; Chen JC, 2018, J AM SOC NEPHROL, V29, P2372, DOI 10.1681/ASN.2017121272; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; Ding H, 2017, AM J PHYSIOL-RENAL, V313, pF561, DOI 10.1152/ajprenal.00036.2017; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Gerarduzzi C, 2017, INFLAMM RES, V66, P451, DOI 10.1007/s00011-016-1019-x; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Gui Y, 2019, CELL DEATH DIFFER, V26, P2774, DOI 10.1038/s41418-019-0336-3; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; He F, 2008, COLLOID SURFACE B, V61, P290, DOI 10.1016/j.colsurfb.2007.09.009; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hinz B, 2016, CURR RES TRANSL MED, V64, P171, DOI 10.1016/j.retram.2016.09.003; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Humphreys BD, 2011, P NATL ACAD SCI USA, V108, P9226, DOI 10.1073/pnas.1100629108; Israelsen WJ, 2015, SEMIN CELL DEV BIOL, V43, P43, DOI 10.1016/j.semcdb.2015.08.004; Kaissling B, 2008, HISTOCHEM CELL BIOL, V130, P247, DOI 10.1007/s00418-008-0452-5; Karihaloo A, 2001, J BIOL CHEM, V276, P9166, DOI 10.1074/jbc.M009963200; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; KURTZ A, 1989, CONTRIB NEPHROL, V76, P14; Kurtz A, 2011, ANNU REV PHYSIOL, V73, P377, DOI 10.1146/annurev-physiol-012110-142238; Liu YH, 2004, AM J PHYSIOL-RENAL, V287, pF7, DOI 10.1152/ajprenal.00451.2003; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2013, MOL CELL, V52, P340, DOI 10.1016/j.molcel.2013.09.004; Maddaluno L, 2017, DEVELOPMENT, V144, P4047, DOI 10.1242/dev.152587; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Muller T, 2017, CELL MOL LIFE SCI, V74, P3631, DOI 10.1007/s00018-017-2547-4; Neto MM, 2004, CLIN TRANSPLANT, V18, P156, DOI 10.1046/j.1399-0012.2003.00140.x; Otto AM, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0145-9; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Priante G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143598; Qin N, 2019, J PATHOL, V247, P392, DOI 10.1002/path.5198; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Rewa O, 2014, NAT REV NEPHROL, V10, P193, DOI 10.1038/nrneph.2013.282; Schiessl IM, 2018, J AM SOC NEPHROL, V29, P1383, DOI 10.1681/ASN.2017101069; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shen Y, 2020, AM J PHYSIOL-RENAL, V318, pF689, DOI 10.1152/ajprenal.00229.2019; TAKAHASHIIWANAGA H, 1991, CELL TISSUE RES, V264, P269, DOI 10.1007/BF00313964; Tan RJ, 2016, KIDNEY DIS-BASEL, V2, P136, DOI 10.1159/000446336; Tanimura S, 2002, J BIOL CHEM, V277, P28256, DOI 10.1074/jbc.M202866200; Van De Water L, 2013, ADV WOUND CARE, V2, P122, DOI 10.1089/wound.2012.0393; Vincent IS, 2014, NEPHRON CLIN PRACT, V127, P10, DOI 10.1159/000363714; Yang WW, 2015, J CELL SCI, V128, P1655, DOI 10.1242/jcs.166629; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Zeisberg M, 2015, CLIN J AM SOC NEPHRO, V10, P1831, DOI 10.2215/CJN.00640114; Zhou D, 2019, FASEB J, V33, P12576, DOI 10.1096/fj.201900651RR; Zhou D, 2018, J AM SOC NEPHROL, V29, P1257, DOI 10.1681/ASN.2017080903; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	56	4	4	6	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21706	10.1096/fj.202100040R	http://dx.doi.org/10.1096/fj.202100040R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160104				2022-12-26	WOS:000667814100019
J	Shimizu, Y; Sasaki, T; Takeshita, J; Watanabe, M; Shizu, R; Hosaka, T; Yoshinari, K				Shimizu, Yuki; Sasaki, Takamitsu; Takeshita, Jun-ichi; Watanabe, Michiko; Shizu, Ryota; Hosaka, Takuomi; Yoshinari, Kouichi			Identification of average molecular weight (AMW) as a useful chemical descriptor to discriminate liver injury-inducing drugs	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; ORAL MEDICATIONS; RISK; CELLS	Drug-induced liver injury (DILI) is one of major causes of discontinuing drug development and withdrawing drugs from the market. In this study, we investigated chemical properties associated with DILI using in silico methods, to identify a physicochemical property useful for DILI screening at the early stages of drug development. Total of 652 drugs, including 432 DILI-positive drugs (DILI drugs) and 220 DILI-negative drugs (no-DILI drugs) were selected from Liver Toxicity Knowledge Base of US Food and Drug Administration. Decision tree models were constructed using 2,473 descriptors as explanatory variables. In the final model, the descriptor AMW, representing average molecular weight, was found to be at the first node and showed the highest importance value. With AMW alone, 276 DILI drugs (64%) and 156 no-DILI drugs (71%) were correctly classified. Discrimination with AMW was then performed using therapeutic category information. The performance of discrimination depended on the category and significantly high performance (>0.8 balanced accuracy) was obtained in some categories. Taken together, the present results suggest AMW as a novel descriptor useful for detecting drugs with DILI risk. The information presented may be valuable for the safety assessment of drug candidates at the early stage of drug development.	[Shimizu, Yuki; Sasaki, Takamitsu; Takeshita, Jun-ichi; Watanabe, Michiko; Shizu, Ryota; Hosaka, Takuomi; Yoshinari, Kouichi] Univ Shizuoka, Sch Pharmaceut Sci, Lab Mol Toxicol, Shizuoka, Japan; [Takeshita, Jun-ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan	University of Shizuoka; National Institute of Advanced Industrial Science & Technology (AIST)	Yoshinari, K (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Mol Toxicol, Shizuoka, Japan.	yoshinari@u-shizuoka-ken.ac.jp	Yoshinari, Kouichi/X-8070-2019; Shizu, Ryota/ACP-9957-2022; Takeshita, Jun-ichi/L-7806-2016	Yoshinari, Kouichi/0000-0002-2027-2017; Shizu, Ryota/0000-0002-0465-5077; Takeshita, Jun-ichi/0000-0002-3471-1594	Ministry of Education, Culture, Sports, Sciences and Technology of Japan [17K08419]; Mochida Memorial Foundation for Medical and Pharmaceutical Research	Ministry of Education, Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan (grant numbers 17K08419) (TS, KY) and a grant from The Mochida Memorial Foundation for Medical and Pharmaceutical Research (FY 2020) (TS, KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuceanu R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062114; Chalasani N, 2010, GASTROENTEROLOGY, V138, P2246, DOI 10.1053/j.gastro.2010.04.001; Chen MJ, 2016, DRUG DISCOV TODAY, V21, P648, DOI 10.1016/j.drudis.2016.02.015; Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016; Chen MJ, 2014, ARCH TOXICOL, V88, P1439, DOI 10.1007/s00204-014-1276-9; Chen MJ, 2013, TOXICOL SCI, V136, P242, DOI 10.1093/toxsci/kft189; Chen MJ, 2013, HEPATOLOGY, V58, P388, DOI 10.1002/hep.26208; Chen MJ, 2011, DRUG DISCOV TODAY, V16, P697, DOI 10.1016/j.drudis.2011.05.007; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Endo S, 2012, DRUG METAB PHARMACOK, V27, P621, DOI 10.2133/dmpk.DMPK-12-RG-019; Garcia-Cortes M, 2020, ARCH TOXICOL, V94, P3381, DOI 10.1007/s00204-020-02885-1; Garside H, 2014, TOXICOL IN VITRO, V28, P171, DOI 10.1016/j.tiv.2013.10.015; Hirata K, 2008, PHARMACOGENOMICS J, V8, P29, DOI 10.1038/sj.tpj.6500442; Hong HX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17701-7; Hosoya R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172057; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kato R, 2017, CHEM RES TOXICOL, V30, P1327, DOI 10.1021/acs.chemrestox.7b00065; Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951; Lammert C, 2008, HEPATOLOGY, V47, P2003, DOI 10.1002/hep.22272; Lammert C, 2010, HEPATOLOGY, V51, P615, DOI 10.1002/hep.23317; Li X, 2019, BIOMED RES INT, V2019, DOI [10.1155/2019/8764093, 10.1155/2019/2728952]; Liu J, 2015, CHEM RES TOXICOL, V28, P738, DOI 10.1021/tx500501h; Low Y, 2011, CHEM RES TOXICOL, V24, P1251, DOI 10.1021/tx200148a; McEuen K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071335; MORIGUCHI I, 1994, CHEM PHARM BULL, V42, P976; MORIGUCHI I, 1992, CHEM PHARM BULL, V40, P127; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Park BK, 2011, NAT REV DRUG DISCOV, V10, P292, DOI 10.1038/nrd3408; R Core Team, 2020, R LANG ENV STAT COMP; Stepan AF, 2011, CHEM RES TOXICOL, V24, P1345, DOI 10.1021/tx200168d; Therneau TM., 2019, MAYO CLIN SECT BIOST, V61, P33; US Food and Drug Administration. Guidance for Industry, 2009, DRUG IND LIV INJ PRE DRUG IND LIV INJ PRE; Wang YY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174106; Wilke RA, 2007, NAT REV DRUG DISCOV, V6, P904, DOI 10.1038/nrd2423	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253855	10.1371/journal.pone.0253855	http://dx.doi.org/10.1371/journal.pone.0253855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170966	gold, Green Published			2022-12-26	WOS:000671694400041
J	Omondi, I; Odiere, MR; Rawago, F; Mwinzi, PN; Campbell, C; Musuva, R				Omondi, Isaiah; Odiere, Maurice R.; Rawago, Fredrick; Mwinzi, Pauline N.; Campbell, Carl; Musuva, Rosemary			Socioeconomic determinants of Schistosoma mansoni infection using multiple correspondence analysis among rural western Kenyan communities: Evidence from a household-based study	PLOS ONE			English	Article								Background Socioeconomic inequality including wealth distribution is a barrier to implementation of health policies. Wealth distribution can be measured effectively using household data on durable assets. Compared to other methods of analysing Socio-economic Status (SES) using durable assets, Multiple Correspondence Analysis (MCA) can create more reliable wealth quintiles. We therefore evaluated socioeconomic determinants of Schistosoma mansoni using MCA on household data among adult population in western Kenya. The hypothesis of this study was that MCA would be a useful predictor of S. mansoni prevalence and/or intensity. Methodology Twelve villages, 6 villages that had showed the greatest decrease in S. mansoni prevalence (Responder villages) and 6 villages that showed relatively lower decrease (Hotspot villages) between the year 2011 and 2015 were randomly selected for this study. This was according to a previous Schistosomiasis Consortium for Operational Research and Elimination (SCORE) report from western Kenya. From each village, convenience sampling was used to identify 50 adults from 50 households for inclusion in this study. An interview with a questionnaire based upon MCA indicators was conducted. One stool sample from each of the 600 adults was examined based on four slides for S. mansoni eggs using Kato Katz technique. Mean Eggs per gram(EPG) was calculated by taking the average of the readings from the four slides. A log binomial regression model was used to identify the influence of the various age-groups(<30 years, 30-60 years and >60 years), household size, wealth class, occupation, education status, main water supply, sex and sub-county of residence on S. mansoni infection. EPG was then compared across variables that were significant based on multivariate log binomial model analysis using a mixed model. Principal findings Overall prevalence of S. mansoni was 41.3%. Significantly higher prevalence of S. mansoni were associated with males, those aged below 30 years, those who use unsafe water sources (unprotected wells, lakes and rivers), residents of Rachuonyo North, Hotspot villages and those earning livelihood from fishing. Only sex and household size were significant predictors in the multivariate model. Males were associated with significantly higher prevalence compared to the females (aPR = 1.37; 95% CI = 1.14-1.66). In addition, households with at least four persons had higher prevalence compared to those with less than four (aPR = 1.29; 95% CI = 1.03-1.61). However, there was no difference in prevalence between the wealth classes(broadly divided into poor and less poor categories). Intensity of infection (Mean EPG)was also significantly higher among males, younger age group, Rachuonyo North residents and Hotspot Villages. Conclusion Socioeconomic status based on an MCA model was not a contributing factor to S. mansoni prevalence and/or intensity possibly because the study populations were not sufficiently dissimilar. The use of convenience sampling to identify participants could also have contributed to the lack of significant findings.	[Omondi, Isaiah; Odiere, Maurice R.; Rawago, Fredrick; Mwinzi, Pauline N.; Musuva, Rosemary] Kenya Med Res Inst KEMRI, Ctr Global Hlth Res, Neglected Trop Dis Branch, Kisumu, Kenya; [Campbell, Carl] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Campbell, Carl] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Kenya Medical Research Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Omondi, I (corresponding author), Kenya Med Res Inst KEMRI, Ctr Global Hlth Res, Neglected Trop Dis Branch, Kisumu, Kenya.	iomondi19@gmail.com		OMONDI, ISAIAH/0000-0002-7688-3503	University of Georgia Research Foundation, Inc. by the Bill & Melinda Gates Foundation	University of Georgia Research Foundation, Inc. by the Bill & Melinda Gates Foundation	Financial support to conduct this study was received from University of Georgia Research Foundation, Inc. which was funded by the Bill & Melinda Gates Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adoka S O, 2014, East Afr Med J, V91, P232; Amek N, 2015, ACTA TROP, V144, P24, DOI 10.1016/j.actatropica.2015.01.006; Amollo D A, 2013, East Afr Med J, V90, P36; [Anonymous], 2008, ASSESSING ASSET INDI; Beal D. J., 2007, 15 ANN SE SAS US GRO; Berhe N, 2004, ACTA TROP, V92, P205, DOI 10.1016/j.actatropica.2004.06.011; Coutinho Leticia M S, 2008, Rev. Saúde Pública, V42, P992, DOI 10.1590/S0034-89102008000600003; Dawaki S, 2016, REV INST MED TROP SP, V58, DOI 10.1590/S1678-9946201658054; Deddens JA, 2008, OCCUP ENVIRON MED, V65, P501, DOI 10.1136/oem.2007.034777; Donohue RE, 2017, TROP MED INFECT DIS, V2, DOI 10.3390/tropicalmed2040061; Enk MJ, 2010, MEM I OSWALDO CRUZ, V105, P570, DOI 10.1590/S0074-02762010000400037; Gazzinelli A, 2006, ACTA TROP, V99, P260, DOI 10.1016/j.actatropica.2006.09.001; Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Houweling TAJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004546; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; Kittur N, 2020, AM J TROP MED HYG, V103, P24, DOI 10.4269/ajtmh.19-0815; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Kumar, 2012, J STAT APPL PROBABIL, V1, P1; Le Roux B., 2004, GEOMETRIC DATA ANAL, DOI DOI 10.1007/1-4020-2236-0; Mondiale de la Santu, 2017, WKLY EPIDEMIOL REC, V92, P749; Montresor A., 1998, WORLD HLTH ORG; Muhumuza S, 2009, TROP MED INT HEALTH, V14, P612, DOI 10.1111/j.1365-3156.2009.02273.x; Mwanga JR, 2015, KOREAN J PARASITOL, V53, P553, DOI 10.3347/kjp.2015.53.5.553; Nagi S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002991; Odiere MR, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-278; Opisa S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-226; Pritchett, 1998, 1994 WORLD BANK DEV, V1994; Sady H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002377; Salawu Oyetunde T, 2016, J Parasit Dis, V40, P93, DOI 10.1007/s12639-014-0454-2; Schistosomiasis W.H.O., 2018, FACTSHEET 115; Skov T, 1998, INT J EPIDEMIOL, V27, P91, DOI 10.1093/ije/27.1.91; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Westfall PH, 2011, MULTIPLE COMP MULTIP; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Wiegand RE, 2017, J INFECT DIS, V216, P1425, DOI 10.1093/infdis/jix496	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253041	10.1371/journal.pone.0253041	http://dx.doi.org/10.1371/journal.pone.0253041			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161354	Green Published, gold			2022-12-26	WOS:000671691900057
J	Guzman-Rivas, F; Quispe-Machaca, M; Queirolo, D; Ahumada, M; Urzua, A				Guzman-Rivas, Fabian; Quispe-Machaca, Marco; Queirolo, Dante; Ahumada, Mauricio; Urzua, Angel			Latitudinal changes in the lipid content and fatty acid profiles of juvenile female red squat lobsters (Pleuroncodes monodon) in breeding areas of the Humboldt Current System	PLOS ONE			English	Article							DECAPODA-ANOMURA-GALATHEIDAE; POPULATION GENETIC-STRUCTURE; SCYLLA-SERRATA CRUSTACEA; LIFE-HISTORY TRAITS; BIOCHEMICAL-COMPOSITION; CRANGON-CRANGON; REPRODUCTIVE-BIOLOGY; CONTINENTAL-SHELF; MUD CRAB; CHEMICAL-COMPOSITION	The red squat lobster Pleuroncodes monodon is a species of high commercial value that inhabits the Humboldt Current System. Along the Chilean coast, two populations are exploited by the fishing industry, one located off the coast of Coquimbo and the other off the coast of Concepcion. Yet, it is unknown whether there are differences in the "bioenergetic fuel" (measured as lipid content and fatty acid profile) of juvenile populations of these two fishing units and whether these bioenergetic compounds can be modulated by differences in the environmental parameters (such as temperature or chlorophyll-a) of their breeding areas. To shed some light on this, we measured the lipid content and fatty acid profiles of the viscera and muscle of juvenile female red squat lobsters from these two fishing units, specifically from breeding areas near long-exploited fishing grounds: a) the northern fishing unit (NFU, from 26 degrees S to 30 degrees S) and b) the southern fishing unit (SFU, from 32 degrees S to 37 degrees S). We found differences in the lipid content, fatty acid profiles, and ratios of saturated fatty acids (C16:0/C18:0) of juvenile females from these two locations. In addition, the essential fatty acids (DHA/EPA) found in the viscera versus the muscle of these lobsters varied significantly. Juvenile females from the SFU (i.e. Concepcion) showed a higher lipid content compared to the juvenile females from the NFU (i.e. Coquimbo). Consistently, individuals from the SFU had a higher content of fatty acids, which also proved to be richer in saturated and monounsaturated fatty acids compared to those from the NFU. Our results are important for the fisheries in both areas because these juvenile populations are the source of new recruits for the adult populations that are exploited by the fishing industry. Our study also aids in determining which populations are healthier or of better quality in bioenergetic terms. Furthermore, increasing the incorporation of bioenergetic parameters in fishery models is essential for the recruitment and stock assessment within an ecosystem approach, since it allows for the evaluation of the nutritional condition of different fishing populations.	[Guzman-Rivas, Fabian; Urzua, Angel] Univ Catolica Santisima Concepcion, Ctr Invest Biodiversidad & Ambientes Sustentables, Concepcion, Chile; [Guzman-Rivas, Fabian; Urzua, Angel] Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile; [Quispe-Machaca, Marco] Univ Catolica Santisima Concepcion, Fac Ciencias, Programa Doctorado Ciencias Con Menc Biodiversida, Concepcion, Chile; [Queirolo, Dante; Ahumada, Mauricio] Pontificia Univ Catolica Valparaiso, Lab Tecnol Pesquera, Escuela Ciencias Mar, Valparaiso, Chile	Universidad Catolica de la Santisima Concepcion; Universidad Catolica de la Santisima Concepcion; Universidad Catolica de la Santisima Concepcion; Pontificia Universidad Catolica de Valparaiso	Urzua, A (corresponding author), Univ Catolica Santisima Concepcion, Ctr Invest Biodiversidad & Ambientes Sustentables, Concepcion, Chile.; Urzua, A (corresponding author), Univ Catolica Santisima Concepcion, Fac Ciencias, Dept Ecol, Concepcion, Chile.	aurzua@ucsc.cl		Urzua, Angel/0000-0001-7706-5126; Guzman-Rivas, Fabian/0000-0002-8883-2324	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [11140213, 180034]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	Financial support was provided by Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) to A.U. (N degrees 11140213 and N degrees 180034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKMAN RG, 1967, COMP BIOCHEM PHYSIOL, V22, P907, DOI 10.1016/0010-406X(67)90781-5; Ahlgren G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P147, DOI 10.1007/978-0-387-89366-2_7; Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2; Azra MN, 2020, EGYPT J AQUATIC RES, V46, P97, DOI 10.1016/j.ejar.2019.11.006; Baeza, 2013, SEXUALITY EARLY DEV, V1, P1, DOI DOI 10.3354/SEDA000002; Baldanzi S, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3294-2; Balina S, 2018, BIOL BULL-US, V234, P139, DOI 10.1086/698266; Bascur M, 2018, J MAR BIOL ASSOC UK, V98, P1977, DOI 10.1017/S002531541700145X; Bascur M, 2017, MAR ECOL-EVOL PERSP, V38, DOI 10.1111/maec.12419; BAUER RT, 1992, INVERTEBR REPROD DEV, V22, P193, DOI 10.1080/07924259.1992.9672272; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; Berkenbusch K, 2000, MAR BIOL, V136, P497, DOI 10.1007/s002270050709; Berryman AA, 2002, OIKOS, V97, P439, DOI 10.1034/j.1600-0706.2002.970314.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bliss, 1983, BIOL CRUSTACEA, V5, P483; Bliss D.E., 1983, METABOLISM TRANSPORT, P263; Bravo C., 2020, PROGRAMA SEGUIMIENTO, DOI [10.5435/JAAOSGlobal-D-20-00098, DOI 10.5435/JAAOSGLOBAL-D-20-00098]; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; BREY T, 1993, ANTARCT SCI, V5, P253, DOI 10.1017/S0954102093000343; Buckup L, 2008, COMP BIOCHEM PHYS A, V149, P59, DOI 10.1016/j.cbpa.2007.10.008; Calado R, 2005, AQUAC RES, V36, P493, DOI 10.1111/j.1365-2109.2005.01235.x; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Cardillo M, 2002, J ANIM ECOL, V71, P79, DOI 10.1046/j.0021-8790.2001.00577.x; Cardoso RS, 2004, ESTUAR COAST SHELF S, V61, P559, DOI 10.1016/j.ecss.2004.06.021; Cartes JE, 1998, MAR ECOL PROG SER, V171, P233, DOI 10.3354/meps171233; Cequier-Sanchez E, 2008, J AGR FOOD CHEM, V56, P4297, DOI 10.1021/jf073471e; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; CLARKE A, 1987, MAR ECOL PROG SER, V38, P89, DOI 10.3354/meps038089; Colombo J, 2020, FISH RES, V226, DOI 10.1016/j.fishres.2020.105519; Colombo SM, 2017, ENVIRON REV, V25, P163, DOI 10.1139/er-2016-0062; Copeman LA, 2003, MAR BIOL, V143, P1213, DOI 10.1007/s00227-003-1156-y; Copeman L, 2014, AQUACULTURE, V424, P86, DOI 10.1016/j.aquaculture.2013.12.025; Costalago D, 2011, ESTUAR COAST SHELF S, V93, P350, DOI 10.1016/j.ecss.2011.05.005; DABRAMO LR, 1993, AQUACULTURE, V115, P63, DOI 10.1016/0044-8486(93)90359-7; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; Simith DDD, 2013, J EXP MAR BIOL ECOL, V440, P61, DOI 10.1016/j.jembe.2012.11.017; Defeo O, 2002, MAR ECOL PROG SER, V239, P169, DOI 10.3354/meps239169; Domingues P, 2012, AQUAC RES, V43, P167, DOI 10.1111/j.1365-2109.2011.02813.x; Ekau W, 2010, BIOGEOSCIENCES, V7, P1669, DOI 10.5194/bg-7-1669-2010; Ellis CD, 2017, MAR ECOL PROG SER, V563, P123, DOI 10.3354/meps11957; Espinoz C, 2016, INVERTEBR REPROD DEV, V60, P152, DOI 10.1080/07924259.2016.1174157; Espinoza-Fuenzalida NL, 2012, J CRUSTACEAN BIOL, V32, P565, DOI 10.1163/193724012X626601; FAGETTI E, 1971, MAR BIOL, V8, P70, DOI 10.1007/BF00349348; Figueroa D, 2000, GEOPHYS RES LETT, V27, P3905, DOI 10.1029/1999GL011302; Flores A, 2020, FISH RES, V225, DOI 10.1016/j.fishres.2020.105508; Floreto EAT, 2000, AQUACULTURE, V189, P211, DOI 10.1016/S0044-8486(00)00363-X; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIOVANNI, EARTH DAT 2019; Gladyshev MI, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P179, DOI 10.1007/978-0-387-89366-2_8; Gladyshev MI, 2013, PROSTAG OTH LIPID M, V107, P117, DOI 10.1016/j.prostaglandins.2013.03.002; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Gopurenko D, 2002, MAR FRESHWATER RES, V53, P849, DOI 10.1071/MF01225; Graeve M, 2001, POLAR BIOL, V24, P853; Graeve M, 2020, LIMNOL OCEANOGR-METH, V18, P196, DOI 10.1002/lom3.10360; Guijarro B, 2019, SCI MAR, V83, P57, DOI 10.3989/scimar.05012.04A; Guzman F, 2020, FISH RES, V221, DOI 10.1016/j.fishres.2019.105404; Guzman F, 2016, INVERTEBR REPROD DEV, V60, P137, DOI 10.1080/07924259.2016.1174155; HAIG JANET, 1955, LUNDS UNIV ARSSKR AVD 2, V51, P1; Hamdi SAH, 2011, AFR J PHARM PHARMACO, V5, P1589; Han T, 2015, CHIN J OCEANOL LIMN, V33, P957, DOI 10.1007/s00343-015-4262-z; Hansen A., 2011, Sources, sinks and sustainability, P339; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Haye PA, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1442-z; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Haye PA, 2010, EVOL DEV, V12, P628, DOI 10.1111/j.1525-142X.2010.00447.x; Hellessey N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62800-7; HINES AH, 1989, B MAR SCI, V45, P356; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Hollander J, 2008, EVOLUTION, V62, P1381, DOI 10.1111/j.1558-5646.2008.00365.x; Hollander J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-333; Hu SX, 2017, AQUAC RES, V48, P1291, DOI 10.1111/are.12971; Jungblut S, 2018, MAR ECOL PROG SER, V602, P169, DOI 10.3354/meps12712; KANAZAWA A, 1985, AQUACULTURE, V50, P39, DOI 10.1016/0044-8486(85)90151-6; Kattner G, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P257, DOI 10.1007/978-0-387-89366-2_11; Langer S., 2011, ADV J FOOD SCI TECHN, V3, P160; Lardies MA, 2001, MAR BIOL, V139, P1125; Latyshev NA, 2009, FOOD CHEM, V116, P657, DOI 10.1016/j.foodchem.2009.02.085; Limbourn AJ, 2009, COMP BIOCHEM PHYS B, V152, P292, DOI 10.1016/j.cbpb.2008.12.009; Lipcius RN, 1997, MAR FRESHWATER RES, V48, P807, DOI 10.1071/MF97194; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Lovrich GA, 2011, BIOLOGY OF SQUAT LOBSTERS, P183; Lucas A., 2002, BIOENERGETICS AQUATI; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Canales TM, 2015, FISH RES, V161, P261, DOI 10.1016/j.fishres.2014.08.006; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Martinez-Alarcon D, 2019, MAR ECOL PROG SER, V625, P41, DOI 10.3354/meps13046; Mika A, 2014, J MAR BIOL ASSOC UK, V94, P993, DOI 10.1017/S0025315414000162; Mili S, 2013, CAH BIOL MAR, V54, P271; Monaco CJ, 2010, AQUAT BIOL, V9, P23, DOI 10.3354/ab00223; Monroig O, 2018, FISHERIES SCI, V84, P911, DOI 10.1007/s12562-018-1254-x; Montecino V, 2009, PROG OCEANOGR, V83, P65, DOI 10.1016/j.pocean.2009.07.041; Pasquevich MY, 2011, COMP BIOCHEM PHYS B, V160, P201, DOI 10.1016/j.cbpb.2011.08.006; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; PRIMER-e, 2008, PRIM 6 PERM; PRUITT NL, 1990, J THERM BIOL, V15, P1, DOI 10.1016/0306-4565(90)90040-O; ROA R, 1995, MAR ECOL PROG SER, V116, P47, DOI 10.3354/meps116047; Roa R, 1998, MAR ECOL PROG SER, V167, P185, DOI 10.3354/meps167185; Romano N, 2014, MAR BIOL RES, V10, P460, DOI 10.1080/17451000.2013.819981; Rosa R, 2003, DEEP-SEA RES PT I, V50, P119, DOI 10.1016/S0967-0637(02)00147-4; Ruiz-Ruiz PA, 2021, J SEA RES, V167, DOI 10.1016/j.seares.2020.101984; SAETHER O, 1986, J LIPID RES, V27, P274; Schlechtriem C, 2006, LIPIDS, V41, P397, DOI 10.1007/s11745-006-5111-9; Seguel V, 2019, INVERTEBR REPROD DEV, V63, P282, DOI 10.1080/07924259.2019.1647471; Shishido CM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0124; Simon CJ, 2015, PHYSIOL BIOCHEM ZOOL, V88, P266, DOI 10.1086/681000; Smith MT, 2003, FISH RES, V65, P231, DOI 10.1016/j.fishres.2003.09.017; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Subramoniam T, 2017, SEXUAL BIOLOGY AND REPRODUCTION IN CRUSTACEANS, P1, DOI 10.1016/B978-0-12-809337-5.00001-0; Sun P, 2020, BRIT J NUTR, V123, P149, DOI 10.1017/S0007114519002563; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Thiel M, 2012, FISH RES, V129, P28, DOI 10.1016/j.fishres.2012.06.004; Timofeev SF, 2001, BIOL BULL+, V28, P646, DOI 10.1023/A:1012336823275; Torres P, 2008, ESTUAR COAST SHELF S, V80, P307, DOI 10.1016/j.ecss.2008.07.018; Tropea C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119468; Tulp I, 2016, ICES J MAR SCI, V73, P2539, DOI 10.1093/icesjms/fsw141; Urzua A, 2013, MAR FRESHW BEHAV PHY, V46, P381, DOI 10.1080/10236244.2013.857067; Urzua A, 2012, MAR BIOL, V159, P583, DOI 10.1007/s00227-011-1837-x; Urzua A, 2011, INVERTEBR REPROD DEV, V55, P236, DOI 10.1080/07924259.2011.576155; Wang GZ, 2007, J EXP MAR BIOL ECOL, V352, P129, DOI 10.1016/j.jembe.2007.07.017; Wehrtmann IS, 2011, BIOLOGY OF SQUAT LOBSTERS, P297; Wehrtmann IS, 1998, J CRUSTACEAN BIOL, V18, P413, DOI 10.2307/1549406; Whiteley NM, 1997, J THERM BIOL, V22, P419, DOI 10.1016/S0306-4565(97)00061-2; Wu XG, 2014, MAR FRESHWATER RES, V65, P228, DOI 10.1071/MF13078; Yannicelli B, 2012, PROG OCEANOGR, V92-95, P206, DOI 10.1016/j.pocean.2011.07.005; Zuur Alain F., 2009, P1	128	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253314	10.1371/journal.pone.0253314	http://dx.doi.org/10.1371/journal.pone.0253314			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157036	gold, Green Published			2022-12-26	WOS:000671691200010
J	Yoshizuka, H; Sato, T; Murakami, J; Mitsutake, T; Hiromatsu, M				Yoshizuka, Hisayoshi; Sato, Takanori; Murakami, Junya; Mitsutake, Tsubasa; Hiromatsu, Masao			Short-term changes in radiographic joint space width after jiggling exercise as conservative treatment for hip osteoarthritis: A retrospective case series of nine patients	PLOS ONE			English	Article							ASSOCIATION; PROGRESSION	Jiggling exercise is a conservative treatment for hip osteoarthritis, which involves continuous shaking of the foot and leg in small oscillations while seated. Previous studies have shown beneficial effects of jiggling exercises for outpatients with advanced- and terminal-stage hip osteoarthritis when performed for longer than 1 year, including increases in joint space width and remission of symptoms. We aimed to use the data from our own treatment to evaluate the short-term impact of intensive jiggling exercises on inpatients with hip osteoarthritis to further examine the clinical utility of this exercise. This retrospective case series study included nine patients (57 +/- 12 years) with nine hip joints with advanced- or terminal-stage hip osteoarthritis who performed continuous daily jiggling exercises, beginning from day of hospitalization to 6 months post-discharge. Jiggling exercise was performed seated, using the KENKO YUSURI(R) automated heel vibrating machine at 3.3-5.0 Hz. The patients were also instructed against weight-bearing during hospitalization. The values of radiographic joint space width and Japanese Orthopaedic Association hip score for pain at hospital admission, discharge, and at the 6-month post-discharge checkup were evaluated. Although the hospitalization period and daily time spent performing the jiggling exercise varied in each case (27-98 days and 2-6 hours, respectively), the joint space width increased in all patients and there was an improvement in the hip pain scores in eight patients. The mean values of the minimum joint space width and hip pain scores at discharge were the highest compared to those at hospital admission and 6 months post-discharge. Our results suggest that intensive jiggling exercise for inpatients with advanced- and terminal-stage hip osteoarthritis leads to earlier improvement in joint space width and pain. Daily jiggling exercise for an adequate duration or in combination with non-weight-bearing practices may be a feasible conservative treatment for hip osteoarthritis.	[Yoshizuka, Hisayoshi; Mitsutake, Tsubasa] Fukuoka Int Univ Hlth & Welf, Dept Phys Therapy, Fukuoka, Fukuoka, Japan; [Sato, Takanori; Murakami, Junya] Yanagawa Rehabil Hosp, Dept Rehabil Med, Yanagawa City, Fukuoka, Japan; [Hiromatsu, Masao] Yatsushiro Keijin Hosp, Dept Orthoped Surg, Yatsushiro City, Kumamoto, Japan	International University of Health & Welfare	Yoshizuka, H (corresponding author), Fukuoka Int Univ Hlth & Welf, Dept Phys Therapy, Fukuoka, Fukuoka, Japan.	yoshizukan@gmail.com		Yoshizuka, Hisayoshi/0000-0002-4979-7327; Mitsutake, Tsubasa/0000-0001-7515-6729	Japan Society for the Promotion of Science (JSPS) KAKENHI [20K23307]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 20K23307. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birrell F, 2005, RHEUMATOLOGY, V44, P337, DOI 10.1093/rheumatology/keh458; Block JA, 2014, NAT REV RHEUMATOL, V10, P324, DOI 10.1038/nrrheum.2014.61; CROFT P, 1990, AM J EPIDEMIOL, V132, P514, DOI 10.1093/oxfordjournals.aje.a115687; DELP SL, 1990, CLIN ORTHOP RELAT R, P189; Hiromatsu M, 2013, BONE JOINT NERVE, V3, P475; Hiromatsu M, 2014, HIP JOINT, V40, P70; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Ishibashi Y., 2019, HIP JOINT, V45, P649; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Jacobsen S, 2004, ACTA ORTHOP SCAND, V75, P713, DOI 10.1080/00016470410004085; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Jingushi S, 2011, J ORTHOP SCI, V16, P156, DOI 10.1007/s00776-011-0025-7; Kamaruzaman H, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1540-2; Kloppenburg M, 2020, OSTEOARTHR CARTILAGE, V28, P242, DOI 10.1016/j.joca.2020.01.002; Kuribayashi M, 2010, J ORTHOP SCI, V15, P452, DOI 10.1007/s00776-010-1490-0; Lane NE, 2004, ARTHRITIS RHEUM-US, V50, P1477, DOI 10.1002/art.20213; Maniwa S., 2017, HIP JOINT, V43, P998; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Rice D, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111769; SALTER RB, 1980, J BONE JOINT SURG AM, V62, P1232, DOI 10.2106/00004623-198062080-00002; Tateuchi H, 2017, OSTEOARTHR CARTILAGE, V25, P1291, DOI 10.1016/j.joca.2017.02.796; Teramoto Yohei, 2020, Case Rep Orthop, V2020, P2804193, DOI 10.1155/2020/2804193	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253643	10.1371/journal.pone.0253643	http://dx.doi.org/10.1371/journal.pone.0253643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157042	Green Published, gold			2022-12-26	WOS:000671691200032
J	Kovy, P; Orfi, Z; Bors, A; Kozma, A; Gopcsa, L; Dolgos, J; Lovas, N; Harasztdombi, J; Lakatos, V; Kiraly, A; Mikala, G; Valyi-Nagy, I; Remenyi, P; Andrikovics, H				Kovy, Petra; Orfi, Zoltan; Bors, Andras; Kozma, Andras; Gopcsa, Laszlo; Dolgos, Janos; Lovas, Nora; Harasztdombi, Jozsef; Lakatos, Viktor; Kiraly, Agnes; Mikala, Gabor; Valyi-Nagy, Istvan; Remenyi, Peter; Andrikovics, Hajnalka			Nucleophosmin1 and isocitrate dehydrogenase 1 and 2 as measurable residual disease markers in acute myeloid leukemia	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; STEM-CELL TRANSPLANTATION; CLONAL HEMATOPOIESIS; NPM1 MUTATIONS; CLINICAL CHARACTERISTICS; QUANTITATIVE ASSESSMENT; DNMT3A MUTATIONS; ADULT PATIENTS; MUTATED NPM1; DIGITAL PCR	Monitoring measurable residual disease (MRD) in acute myeloid leukemia (AML) plays an important role in predicting relapse and outcome. The applicability of the leukemia-initiating nucleophosmin1 (NPM1) gene mutations in MRD detection is well-established, while that of isocitrate dehydrogenase1/2 (IDH1/2) mutations are matter of debate. The aim of this study was to investigate the stability of NPM1 and IDH1/2 mutations at diagnosis and relapse retrospectively in 916 adult AML patients. The prognostic value of MRD was evaluated by droplet digital PCR on the DNA level in a selected subgroup of patients in remission. NPM1 re-emerged at relapse in 91% (72/79), while IDH1/2 in 87% (20/23) of mutation-positive cases at diagnosis. NPM1 mutation did not develop at relapse, on the contrary novel IDH1/2 mutations occurred in 3% (3/93) of previously mutation-negative cases. NPM1 MRD-positivity after induction (n = 116) proved to be an independent, adverse risk factor (MRDpos 24-month OS: 39.3 +/- 6.2% versus MRDneg: 58.5 +/- 7.5%, p = 0.029; HR: 2.16; 95%CI: 1.25-3.74, p = 0.006). In the favorable subgroup of mutated NPM1 without fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) or with low allelic ratio, NPM1 MRD provides a valuable prognostic biomarker (NPM1 MRDpos versus MRDneg 24-month OS: 42.9 +/- 6.7% versus 66.7 +/- 8.6%; p = 0.01). IDH1/2 MRD-positivity after induction (n = 62) was also associated with poor survival (MRDpos 24-month OS: 41.3 +/- 9.2% versus MRDneg: 62.5 +/- 9.0%, p = 0.003; HR 2.81 95%CI 1.09-7.23, p = 0.032). While NPM1 variant allele frequency decreased below 2.5% in remission in all patients, IDH1/2 mutations (typically IDH2 R140Q) persisted in 24% of cases. Our results support that NPM1 MRD even at DNA level is a reliable prognostic factor, while IDH1/2 mutations may represent pre-leukemic, founder or subclonal drivers.	[Kovy, Petra; Orfi, Zoltan; Bors, Andras; Kozma, Andras; Andrikovics, Hajnalka] Cent Hosp Southern Pest Natl Inst Hematol & Infec, Lab Mol Genet, Budapest, Hungary; [Kovy, Petra] Semmelweis Univ, Sch PhD Studies Racz Karoly, Budapest, Hungary; [Bors, Andras] Semmelweis Univ, Dept Transfusiol, Budapest, Hungary; [Gopcsa, Laszlo; Dolgos, Janos; Lovas, Nora; Harasztdombi, Jozsef; Lakatos, Viktor; Kiraly, Agnes; Mikala, Gabor; Valyi-Nagy, Istvan; Remenyi, Peter] Cent Hosp Southern Pest Natl Inst Hematol & Infec, Dept Hematol & Stem Cell Transplantat, Budapest, Hungary	Semmelweis University; Semmelweis University	Andrikovics, H (corresponding author), Cent Hosp Southern Pest Natl Inst Hematol & Infec, Lab Mol Genet, Budapest, Hungary.	andrikovics.hajnalka@dpckorhaz.hu	Kozma, András/HGA-9123-2022	Gopcsa, Laszlo/0000-0003-4930-7049; Kozma, Andras/0000-0001-5075-9953; Orfi, Zoltan/0000-0001-6099-2206; Valyi-Nagy, Istvan/0000-0003-3581-113X	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [BO/00809/18/8]; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund [UNKP-20-3-II-SE-79, UNKP-19-4-SE-83]; National Research, Development and Innovation Office [NVKP_16-1-2016-0005]; Development of a Translational Medicine Research Center and an Innovative Center for Cellular Therapy at the Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases [TKP2020-NKA-19]; Ministry of Human Capacities [EMMI IV/219-4/2021/EKF]	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); Development of a Translational Medicine Research Center and an Innovative Center for Cellular Therapy at the Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases; Ministry of Human Capacities	The study was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (AnB: BO/00809/18/8, https://mta.hu/bolyai-osztondij/bolyaijanoskutatasi-osztondij-105319), by the New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund (PK: UNKP-20-3-II-SE-79, AnB: UNKP-19-4-SE-83, http://www.unkp.gov.hu/unkp-rol), by grants from the National Research, Development and Innovation Office (PK, ZO, AnB, AK, LG, JD, NL, JH, GM, IV-N, PR, HA: NVKP_16-1-2016-0005, https://www.dpckorhaz.hu/informaciok/palyazatok/projektek/hazai-projektek/kiemelkedo-halalozasikockazattal-jaro-betegsegek-gyogyitasanak-eredmenyesseget-lenyegesen-javito-nemzetiprogram-nemzeti-innovacios-onkogenomikai-es-precizios-onkoterapias-program-elinditasa-eskapc/), by the Development of a Translational Medicine Research Center and an Innovative Center for Cellular Therapy at the Central Hospital of Southern Pest - National Institute of Hematology and Infectious Diseases (ZO, AnB, LG, JD, GM, IV-N, HA: TKP2020-NKA-19, https://nkfih.gov.hu/palyazoknak/tkp-2020) and by grants of Ministry of Human Capacities (AnB, HA: EMMI IV/219-4/2021/EKF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Alizadeh M, 2002, BLOOD, V99, P4618, DOI 10.1182/blood.V99.12.4618; Balsat M, 2017, J CLIN ONCOL, V35, P185, DOI 10.1200/JCO.2016.67.1875; Bataller A, 2020, BRIT J HAEMATOL, V191, P52, DOI 10.1111/bjh.16857; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Bill M, 2018, ANN HEMATOL, V97, P1757, DOI 10.1007/s00277-018-3373-y; Burchert A, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.03345; Chou WC, 2007, LEUKEMIA, V21, P998, DOI 10.1038/sj.leu.2404637; Chou WC, 2006, CANCER RES, V66, P3310, DOI 10.1158/0008-5472.CAN-05-4316; Chung HJ, 2020, ANN LAB MED, V40, P72, DOI 10.3343/alm.2020.40.1.72; Cocciardi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09745-2; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; Cross NCP, 2015, LEUKEMIA, V29, P999, DOI 10.1038/leu.2015.29; Debarri H, 2015, ONCOTARGET, V6, P42345, DOI 10.18632/oncotarget.5645; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; Dillon R, 2020, BLOOD, V135, P680, DOI 10.1182/blood.2019002959; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Dohner H, 2015, NEW ENGL J MED, V373, P1136, DOI 10.1056/NEJMra1406184; Eisfeld AK, 2020, LEUKEMIA, V34, P3215, DOI 10.1038/s41375-020-0872-3; Falini B, 2020, BLOOD, V136, P1707, DOI 10.1182/blood.2019004226; Ferret Y, 2018, HAEMATOLOGICA, V103, P822, DOI 10.3324/haematol.2017.183525; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Forghieri F., 2020, INT J MOL SCI, V21; Gaidzik VI, 2018, LEUKEMIA, V32, P30, DOI 10.1038/leu.2017.200; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gorello P, 2006, LEUKEMIA, V20, P1103, DOI 10.1038/sj.leu.2404149; Grimwade D, 2016, BLOOD, V127, P29, DOI 10.1182/blood-2015-07-604496; Hollein A, 2018, BLOOD ADV, V2, P3118, DOI 10.1182/bloodadvances.2018023432; Hourigan CS, 2020, J CLIN ONCOL, V38, P1273, DOI 10.1200/JCO.19.03011; Hubmann M, 2014, HAEMATOLOGICA, V99, P1317, DOI 10.3324/haematol.2014.104133; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Jain P, 2014, LEUKEMIA LYMPHOMA, V55, P1337, DOI 10.3109/10428194.2013.840776; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jongen-Lavrencic M, 2018, NEW ENGL J MED, V378, P1189, DOI 10.1056/NEJMoa1716863; Kapp-Schwoerer S, 2020, BLOOD, V136, P3041, DOI 10.1182/blood.2020005998; Karas M, 2016, ANTICANCER RES, V36, P5487, DOI 10.21873/anticanres.11130; Kayser S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.46; Klco JM, 2015, JAMA-J AM MED ASSOC, V314, P811, DOI 10.1001/jama.2015.9643; Koszarska M, 2013, LEUKEMIA LYMPHOMA, V54, P1028, DOI 10.3109/10428194.2012.736981; Kovy P., 2019, HEMATOLOGIA TRANSZFU HEMATOLOGIA TRANSZFU, V152, P142; Kronke J, 2013, BLOOD, V122, P100, DOI 10.1182/blood-2013-01-479188; Kronke J, 2011, J CLIN ONCOL, V29, P2709, DOI 10.1200/JCO.2011.35.0371; Lin CC, 2014, AM J HEMATOL, V89, P137, DOI 10.1002/ajh.23596; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Link-Lenczowska D, 2018, ANN HEMATOL, V97, P2299, DOI 10.1007/s00277-018-3451-1; Lussana F, 2019, CANCERS, V11, DOI 10.3390/cancers11101455; Maier J, 2019, J MOL DIAGN, V21, P27, DOI 10.1016/j.jmoldx.2018.08.012; Medeiros BC, 2017, LEUKEMIA, V31, P272, DOI 10.1038/leu.2016.275; Meloni G, 2009, HAEMATOL-HEMATOL J, V94, P298, DOI 10.3324/haematol.2008.000059; Mencia-Trinchant N, 2017, J MOL DIAGN, V19, P537, DOI 10.1016/j.jmoldx.2017.03.005; Ok CY, 2019, HAEMATOLOGICA, V104, P305, DOI 10.3324/haematol.2018.191148; Ommen HB, 2010, BLOOD, V115, P198, DOI 10.1182/blood-2009-04-212530; Papadaki C, 2009, BRIT J HAEMATOL, V144, P517, DOI 10.1111/j.1365-2141.2008.07488.x; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Platzbecker U, 2018, LANCET ONCOL, V19, P1668, DOI 10.1016/S1470-2045(18)30580-1; Ploen GG, 2014, BRIT J HAEMATOL, V167, P478, DOI 10.1111/bjh.13062; Schlenk RF, 2017, LEUKEMIA, V31, P1217, DOI 10.1038/leu.2017.22; Schnittger S, 2009, BLOOD, V114, P2220, DOI 10.1182/blood-2009-03-213389; Schuurhuis GJ, 2018, BLOOD, V131, P1275, DOI 10.1182/blood-2017-09-801498; Shayegi N, 2013, BLOOD, V122, P83, DOI 10.1182/blood-2012-10-461749; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Short NJ, 2020, JAMA ONCOL, V6, P1890, DOI 10.1001/jamaoncol.2020.4600; Stahl T, 2010, LEUKEMIA LYMPHOMA, V51, P1837, DOI 10.3109/10428194.2010.508822; STEIN E, 2020, BLOOD; Sun YJ, 2016, LEUKEMIA RES, V49, P102, DOI 10.1016/j.leukres.2016.09.001; Suzuki T, 2005, BLOOD, V106, P2854, DOI 10.1182/blood-2005-04-1733; Tefferi A, 2012, LEUKEMIA, V26, P475, DOI 10.1038/leu.2011.253; Tefferi A, 2010, LEUKEMIA, V24, P1302, DOI 10.1038/leu.2010.113; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; Topic E, 2015, CLIN CHEM LAB MED, V53, P1707, DOI 10.1515/cclm-2015-0869; Tuval A, 2019, HAEMATOLOGICA, V104, P872, DOI 10.3324/haematol.2018.195289; Wang WJ, 2018, EUR J HAEMATOL, V101, P291, DOI 10.1111/ejh.13084; Waterhouse M, 2019, CLIN CHEM LAB MED, V57, P641, DOI 10.1515/cclm-2018-0827; Waterhouse M, 2016, ANN HEMATOL, V95, P739, DOI 10.1007/s00277-016-2623-0; Wiseman DH, 2016, LEUKEMIA, V30, P1946, DOI 10.1038/leu.2016.93; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733	76	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253386	10.1371/journal.pone.0253386	http://dx.doi.org/10.1371/journal.pone.0253386			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153064	Green Accepted, gold, Green Published			2022-12-26	WOS:000671691000032
J	Ottina, E; Panova, V; Doglio, L; Kazachenka, A; Cornish, G; Kirkpatrick, J; Attig, J; Young, GR; Litchfield, K; Lesluyes, T; Van Loo, P; Swanton, C; MacRae, J; Tuting, T; Kassiotis, G				Ottina, Eleonora; Panova, Veera; Doglio, Laura; Kazachenka, Anastasiya; Cornish, Georgina; Kirkpatrick, Joanna; Attig, Jan; Young, George R.; Litchfield, Kevin; Lesluyes, Tom; Van Loo, Peter; Swanton, Charles; MacRae, James; Tuting, Thomas; Kassiotis, George			E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion	ONCOGENE			English	Article							CANCER; CELLS; CHECKPOINTS; PROMOTES; THERAPY; INNATE; IMPACT; GENES	The ubiquitin-proteasome system maintains protein homoeostasis, underpins the cell cycle, and is dysregulated in cancer. However, the role of individual E3 ubiquitin ligases, which mediate the final step in ubiquitin-mediated proteolysis, remains incompletely understood. Identified through screening for cancer-specific endogenous retroviral transcripts, we show that the little-studied E3 ubiquitin ligase HECTD2 exerts dominant control of tumour progression in melanoma. HECTD2 cell autonomously drives the proliferation of human and murine melanoma cells by accelerating the cell cycle. HECTD2 additionally regulates cancer cell production of immune mediators, initiating multiple immune suppressive pathways, which include the cyclooxygenase 2 (COX2) pathway. Accordingly, higher HECTD2 expression is associated with weaker anti-tumour immunity and unfavourable outcome of PD-1 blockade in human melanoma and counteracts immunity against a model tumour antigen in murine melanoma. This central, multifaceted role of HECTD2 in cancer cell-autonomous proliferation and in immune evasion may provide a single target for a multipronged therapy of melanoma.	[Ottina, Eleonora; Panova, Veera; Doglio, Laura; Kazachenka, Anastasiya; Cornish, Georgina; Attig, Jan; Kassiotis, George] Francis Crick Inst, Retroviral Immunol Lab, London, England; [Kirkpatrick, Joanna; MacRae, James] Francis Crick Inst, Prote STP, London, England; [Young, George R.] Francis Crick Inst, Retrovirus Host Interact Lab, London, England; [Litchfield, Kevin; Swanton, Charles] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England; [Lesluyes, Tom; Van Loo, Peter] Francis Crick Inst, Canc Genom Lab, London, England; [Tuting, Thomas] Univ Magdeburg, Dept Dermatol, Lab Expt Dermatol, Magdeburg, Germany; [Kassiotis, George] Imperial Coll London, Dept Infect Dis, Fac Med, London, England	Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Francis Crick Institute; Otto von Guericke University; Imperial College London	Kassiotis, G (corresponding author), Francis Crick Inst, Retroviral Immunol Lab, London, England.; Kassiotis, G (corresponding author), Imperial Coll London, Dept Infect Dis, Fac Med, London, England.	george.kassiotis@crick.ac.uk	Lesluyes, Tom/GSD-4621-2022; Lesluyes, Tom/AAB-6229-2019; Young, George/C-6733-2009	Lesluyes, Tom/0000-0003-2251-5884; Lesluyes, Tom/0000-0003-2251-5884; Young, George/0000-0002-1203-588X; Litchfield, Kevin/0000-0002-3725-0914; MacRae, James/0000-0002-1464-8583; Swanton, Charles/0000-0002-4299-3018; Ottina, Eleonora/0000-0002-9630-496X; Attig, Jan/0000-0002-2159-2880; Panova, Veera/0000-0001-8433-6430	Francis Crick Institute [FC001099, FC001169, FC001202]; Cancer Research UK (CRUK); UK Medical Research Council (MRC); Wellcome Trust; Wellcome Trust [FC001099, FC001169, FC001202, 102898/B/13/Z]; CRUK [C55533/A22158]	Francis Crick Institute; Cancer Research UK (CRUK)(Cancer Research UK); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK)	We are grateful for assistance from the Advanced Light Microscopy, Biological Research Facility, Cell Services, Flow Cytometry and Scientific Computing facilities at the Francis Crick Institute. The results shown here are in whole or part based upon data generated by the TCGA Research Network (http://cancergenome.nih.gov).This work benefited from data assembled by the CCLE consortium. This work was supported by the Francis Crick Institute (FC001099, FC001169, FC001202), which receives its core funding from Cancer Research UK (CRUK), the UK Medical Research Council (MRC), and the Wellcome Trust; and by the Wellcome Trust (102898/B/13/Z to GK) and CRUK (C55533/A22158 to GK). This research was funded in whole, or in part, by the Wellcome Trust (102898/B/13/Z; FC001099, FC001169, FC001202). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Attig J, 2019, GENOME RES, V29, P1578, DOI 10.1101/gr.248922.119; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bedognetti D, 2016, CURR OPIN IMMUNOL, V39, P150, DOI 10.1016/j.coi.2016.02.001; Coon TA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3881; Danelli L, 2021, CELL MOL IMMUNOL, V18, P1809, DOI 10.1038/s41423-020-0415-x; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gajewski TF, 2013, NAT IMMUNOL, V14, P1014, DOI 10.1038/ni.2703; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ishak CA, 2020, ANNU REV CANC BIOL, V4, P159, DOI 10.1146/annurev-cancerbio-030419-033525; Kassiotis G, 2016, NAT REV IMMUNOL, V16, P207, DOI 10.1038/nri.2016.27; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lau AN, 2020, ANNU REV CANC BIOL, V4, P17, DOI 10.1146/annurev-cancerbio-030419-033333; Lloyd SE, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-90; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; MacKie RM, 2009, ANN ONCOL, V20, P1, DOI 10.1093/annonc/mdp252; Ottina E, 2018, CANCER IMMUNOL RES, V6, P1292, DOI 10.1158/2326-6066.CIR-18-0038; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rossi M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09754-1; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117; Sun T, 2014, ONCOGENE, V33, P2790, DOI 10.1038/onc.2013.230; Suo C, 2018, BIOL DIRECT, V13, DOI 10.1186/s13062-018-0218-5; Takimoto CH, 2019, ANN ONCOL, V30, P486, DOI 10.1093/annonc/mdz006; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang YY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.228072; Wellenstein MD, 2018, IMMUNITY, V48, P399, DOI 10.1016/j.immuni.2018.03.004; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z; Zapparoli E, 2020, NUCLEIC ACIDS RES, V48, P9053, DOI 10.1093/nar/gkaa628; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015	42	2	2	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 16	2021	40	37					5567	5578		10.1038/s41388-021-01885-4	http://dx.doi.org/10.1038/s41388-021-01885-4		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	UR2PS	34145398	hybrid, Green Published			2022-12-26	WOS:000663295300001
J	Werdecker, L; Esch, T				Werdecker, Lena; Esch, Tobias			Burnout, satisfaction and happiness among German general practitioners (GPs): A cross-sectional survey on health resources and stressors	PLOS ONE			English	Article							JOB-SATISFACTION; ILLEGITIMATE TASKS; SUBJECTIVE HAPPINESS; WORK; CARE; PHYSICIANS; RECOVERY; DOCTORS; QUESTIONNAIRE; EXPERIENCES	Well-being is a major issue among health care professionals, especially physicians. Less job satisfaction and impaired health can have an impact on health care quality. Our aim was to examine the association of stressors (illegitimate tasks) and health related resources (work-related sense of coherence; recovery experience) with life satisfaction, happiness, job satisfaction and burnout among German general practitioners (GPs). We conducted a cross-sectional survey among general medical practices in Germany. Main outcome measures were life satisfaction, happiness (Subjective Happiness Scale), job satisfaction (Work Satisfaction Scale) and burnout (Copenhagen Burnout Inventory). 548 GPs from across Germany participated (53.6% males, 45.6% females; mostly representative of German GPs). One third (35.2%) of the participants reported a high prevalence of personal, and one quarter (26.5%) indicated a high prevalence of work-related burnout symptoms. Illegitimate tasks are negatively associated with life and job satisfaction and are positively associated with personal, work-related and patient-related burnout among GPs. Work-SoC and recovery experience are positively associated with life satisfaction, happiness, and job satisfaction and are negatively associated with personal, work-related and patient-related burnout. Female physicians have a higher job satisfaction than male physicians. Being female and working as an employed physician is associated with a higher prevalence of personal burnout symptoms. GPs working in a group practice are happier and more satisfied with their job than GPs in single practices. Personal, work-related and patient-related burnout symptoms are stronger in GPs working in a single practice than in GPs in group practices. Our results highlight that Work-SoC, recovery experience and illegitimate tasks are important for creating work-related well-being among GPs. Introducing health promotion activities which aim to strengthen recovery experience and Work-SoC, as well as interventions to restructure tasks, may increase life satisfaction, happiness, and job satisfaction and reduce burnout symptoms in this health care profession.	[Werdecker, Lena; Esch, Tobias] Witten Herdecke Univ, Fac Hlth, Sch Med, Inst Integrat Hlth Care & Hlth Promot, Witten, Germany		Werdecker, L (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Med, Inst Integrat Hlth Care & Hlth Promot, Witten, Germany.	lena.werdecker@uni-wh.de	Esch, Tobias/J-3812-2013	Esch, Tobias/0000-0001-5176-4367; Werdecker, Lena/0000-0003-4549-9880	Dr. Ausbuttel Co. GmbH	Dr. Ausbuttel Co. GmbH	The study was funded by Dr. Ausbuttel & Co. GmbH (https://www.drausbuettel.de/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AB, 2017, J OCCUP HEALTH PSYCH, V22, P273, DOI 10.1037/ocp0000056; Bauer GF, 2015, Z GESUNDHEITSPSYCHOL, V23, P20, DOI 10.1026/0943-8149/a000132; Beierlein C., 2015, KURZSKALA ERFASSUNG; Borritz M, 2006, SCAND J PUBLIC HEALT, V34, P49, DOI 10.1080/14034940510032275; Broetje S, 2020, HEALTH PROMOT INT, V35, P1168, DOI 10.1093/heapro/daz112; Chambers CNL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013947; Chesak SS, 2020, CURR CARDIOL REP, V22, DOI 10.1007/s11886-020-01300-6; Chou LP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004185; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohidon C, 2019, ANN FAM MED, V17, P510, DOI 10.1370/afm.2449; COOPER CL, 1989, BRIT MED J, V298, P366, DOI 10.1136/bmj.298.6670.366; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dewa CS, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015141; Dewa CS, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-325; Doring N., 2016, FORSCHUNGSMETHODEN E, V5; Dreher A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211223; Duffrin C, 2014, POSTGRAD MED J, V90, P377, DOI 10.1136/postgradmedj-2012-131512; Dyrbye LN, 2011, ARCH INTERN MED, V171, P1207, DOI 10.1001/archinternmed.2011.289; Dzau VJ, 2018, NEW ENGL J MED, V378, P312, DOI 10.1056/NEJMp1715127; Eatough EM, 2016, J ORGAN BEHAV, V37, P108, DOI 10.1002/job.2032; Eckleberry-Hunt J, 2016, SOUTH MED J, V109, P207, DOI 10.14423/SMJ.0000000000000437; Edwards N, 2002, BMJ-BRIT MED J, V324, P835, DOI 10.1136/bmj.324.7341.835; Edwards ST, 2018, J GEN INTERN MED, V33, P2138, DOI 10.1007/s11606-018-4679-0; Ejlertsson L, 2018, WORK, V59, P155, DOI 10.3233/WOR-172659; Field A., 2013, DISCOVERING STAT USI; Fila MJ, 2018, STRESS HEALTH, V34, P152, DOI 10.1002/smi.2768; Goetz K, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0747-0; Goetz K, 2016, FAM PRACT, V33, P498, DOI 10.1093/fampra/cmw047; Grodal K., 2019, SCAND J WORK ORGAN P, V4, P1, DOI [10.16993/sjwop.73, DOI 10.16993/SJWOP.73]; Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015; Hanebuth D., 2012, PSYCHOL EVERYDAY ACT, V5, P4; Heinke W, 2011, ANAESTHESIST, V60, P1109, DOI 10.1007/s00101-011-1947-3; Hirsch O, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102190; Iani L, 2014, SOC INDIC RES, V118, P953, DOI 10.1007/s11205-013-0468-7; Jenny GJ., 2017, HDB SALUTOGENESIS; Salvagioni DAJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185781; Kassam Aliya, 2015, J Grad Med Educ, V7, P70, DOI 10.4300/JGME-D-14-00022.1; KBV, 2021, KASS BUND IGES PRAXI; KBV KB, DIG PRAX; KBV KB., 2020, GES; Kinnunen U, 2013, STRESS HEALTH, V29, P369, DOI 10.1002/smi.2483; Kjeldmand D, 2008, ANN FAM MED, V6, P138, DOI 10.1370/afm.813; Klein J, 2010, INT J QUAL HEALTH C, V22, P525, DOI 10.1093/intqhc/mzq056; Kottwitz MU, 2019, IND HEALTH, V57, P637, DOI 10.2486/indhealth.2018-0008; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Leutgeb R, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0777-7; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Lopez-Lopez IM, 2019, INT J MENT HEALTH NU, V28, P1035, DOI 10.1111/inm.12606; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McEwen Bruce S, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017692328; Meier LL, 2018, EUR J WORK ORGAN PSY, V27, P764, DOI 10.1080/1359432X.2018.1526785; Messias E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023506; Milic J, 2019, INT REV PSYCHIATR, V31, P653, DOI 10.1080/09540261.2019.1594647; Misiak B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030755; Noroxe KB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030142; Noroxe KB, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0809-3; Nylenna M, 2005, SCAND J PRIM HEALTH, V23, P198, DOI 10.1080/02813430500311792; O'Dea B, 2017, IRISH J MED SCI, V186, P447, DOI 10.1007/s11845-016-1407-9; O'Dowd E, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3541-8; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Popa-Velea O, 2019, INT J OCCUP MED ENV, V32, P53, DOI 10.13075/ijomeh.1896.01302; Rosta J, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027891; Rotenstein LS, 2018, JAMA-J AM MED ASSOC, V320, P1131, DOI 10.1001/jama.2018.12777; Ruiz-Aranda D, 2014, J PSYCHIATR MENT HLT, V21, P106, DOI 10.1111/jpm.12052; Semmer N., 2007, OCCUPATIONAL STRESS, DOI [10.1007/s00586-006-0255-0, DOI 10.1007/S00586-006-0255-0]; Semmer NK, 2019, OCCUP HEALTH SCI, V3, P205, DOI 10.1007/s41542-019-00041-5; Semmer NK, 2015, WORK STRESS, V29, P32, DOI 10.1080/02678373.2014.1003996; Semmer NK, 2010, APPL PSYCHOL-INT REV, V59, P70, DOI 10.1111/j.1464-0597.2009.00416.x; Sexton JB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-022695; Silva RG, 2018, CURR PHARM TEACH LEA, V10, P903, DOI 10.1016/j.cptl.2018.04.002; Sinsky CA, 2013, ANN FAM MED, V11, P272, DOI 10.1370/afm.1531; Smith R, 2001, BMJ-BRIT MED J, V322, P1073, DOI 10.1136/bmj.322.7294.1073; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204; Sonnentag S, 2018, J OCCUP HEALTH PSYCH, V23, P248, DOI 10.1037/ocp0000077; Sonnentag S, 2015, J ORGAN BEHAV, V36, pS72, DOI 10.1002/job.1924; Spagnoli P, 2012, SOC INDIC RES, V105, P137, DOI 10.1007/s11205-010-9769-2; Swami V, 2009, SOC INDIC RES, V93, P393, DOI 10.1007/s11205-008-9331-7; Szecsenyi J, 2011, BMJ QUAL SAF, V20, P508, DOI 10.1136/bmjqs.2009.038166; Thrush CR, 2019, ACAD PSYCHIATR, V43, P361, DOI 10.1007/s40596-019-01043-9; Thun S, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3229-0; Viehmann A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176658; Voltmer E, 2012, INT ARCH OCC ENV HEA, V85, P819, DOI 10.1007/s00420-011-0725-5; Wagner A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3862-7; Wallace JE, 2009, LANCET, V374, P1714, DOI 10.1016/S0140-6736(09)61424-0; WARR P, 1979, J OCCUP PSYCHOL, V52, P129, DOI 10.1111/j.2044-8325.1979.tb00448.x; WHO-World Health Organization, 2019, BURN OUT OCC PHEN IN; Winwood P.C., 2004, INT J STRESS MANAGE, V11, P282, DOI [10.1037/1072-5245.11.3.282, DOI 10.1037/1072-5245.11.3.282]; WMA-The World Medical Association, 2018, WMA LEAD WARNS GLOB; Wolfshohl Jon A, 2019, J Clin Med Res, V11, P532, DOI 10.14740/jocmr3878; Wright JG, 2011, PAED CHILD HEALT-CAN, V16, P409, DOI 10.1093/pch/16.7.409; Zuger A, 2004, NEW ENGL J MED, V350, P69, DOI 10.1056/NEJMsr031703; Zwack J, 2013, ACAD MED, V88, P382, DOI 10.1097/ACM.0b013e318281696b	94	10	10	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253447	10.1371/journal.pone.0253447	http://dx.doi.org/10.1371/journal.pone.0253447			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BC	34143849	Green Published, gold			2022-12-26	WOS:000671690700068
J	Barcellos, S; Jacobson, M; Stone, AA				Barcellos, Silvia; Jacobson, Mireille; Stone, Arthur A.			Varied and unexpected changes in the well-being of seniors in the United States amid the COVID-19 pandemic	PLOS ONE			English	Article							MENTAL-HEALTH; LIFE	Recent evidence suggests that psychological health deteriorated during the COVID-19 pandemic but far less is known about changes in other measures of well-being. We examined changes in a broad set of measures of well-being among seniors just before and after the recognition of community spread of COVID-19 in the United States. We fielded two waves of a survey to a large, national online panel of adults ages 60 to 68 at wave 1. We measured depressive symptoms, negative affect, positive affect, pain, life satisfaction and self-rated health in each survey wave. 16,644 adults answered well-being questions in waves 1 and 2 of our survey (mean[SD]: age 64 [2.6]; 10,165 women [61%]; 15,161 [91%] white). We found large (20%; p<0.001) increases in the rate of depressive symptoms (1.4 percentage points; 95% CI, 0.97 to 1.86) and negative mood (0.225 scale points; 95% CI, 0.205 to 0.245) but no change in self-reported health and a decrease (12.5%; p<0.001) in the rate of self-reported pain (5 percentage points; 95% CI, -5.8 to -4.3). Depressive symptoms and negative affect increased more for women. Higher perceived risk of getting COVID-19 and of dying from the disease were associated with larger increases in the rate of depressive symptoms and negative affect and larger decreases in positive affect and life satsifaction. COVID-19 related job/income loss was the only pandemic-related factor predictive of the decline in pain. Although depressive symptoms and mood worsened during the COVID-19 pandemic, other measures of well-being were either not materially affected or even improved.	[Barcellos, Silvia; Stone, Arthur A.] Univ Southern Calif, Ctr Econ & Social Res CESR, Los Angeles, CA 90007 USA; [Barcellos, Silvia; Stone, Arthur A.] Univ Southern Calif, Dept Econ, Los Angeles, CA 90007 USA; [Jacobson, Mireille] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA 90007 USA; [Jacobson, Mireille; Stone, Arthur A.] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA; [Stone, Arthur A.] Univ Southern Calif, Dornsife Ctr Self Report Sci, Los Angeles, CA 90007 USA; [Stone, Arthur A.] Univ Southern Calif, Dept Psychol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Jacobson, M (corresponding author), Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA 90007 USA.; Jacobson, M (corresponding author), Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA.	mireillj@usc.edu	Jacobson, Mireille/AAD-1190-2022	Jacobson, Mireille/0000-0002-4977-8783	National Institutes on Aging [NIA K01AG050811-03S1, NIA K01AG050811-05S1]; Navigage Foundation	National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Navigage Foundation	1 SB received support from National Institutes on Aging grants NIA K01AG050811-03S1 and NIA K01AG050811-05S1 (https://www.nia.nih.gov/).MJ received support from Navigage Foundation (https://navigage.org/).	Alsan M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12403; [Anonymous], CDC COVID DATA TRACK; [Anonymous], 2021, DYNATA L DATA INSIGH; Case A, 2020, P NATL ACAD SCI USA, V117, P24785, DOI 10.1073/pnas.2012350117; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Daly M, 2021, J AFFECT DISORDERS, V278, P131, DOI 10.1016/j.jad.2020.09.065; Diener E, 2009, SOC INDIC RES SER, V39, P233, DOI 10.1007/978-90-481-2354-4_11; Ettman CK, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19686; Fitzpatrick KM, 2020, DEPRESS ANXIETY, V37, P957, DOI 10.1002/da.23080; Gallup, 2019, GALLUP; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Gupta S., 2020, TRACKING PUBLIC PRIV, Vw27027; Helliwell J. F., 2019, WORLD HAPPINESS REPO; Holingue C, 2020, AM J PUBLIC HEALTH, V110, P1628, DOI 10.2105/AJPH.2020.305857; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Klaiber P, 2021, J GERONTOL B-PSYCHOL, V76, pE30, DOI 10.1093/geronb/gbaa096; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lyall LM, 2018, J AFFECT DISORDERS, V229, P296, DOI 10.1016/j.jad.2017.12.106; McGinty EE, 2020, JAMA-J AM MED ASSOC, V324, P93, DOI 10.1001/jama.2020.9740; Moreland A., 2020, TIMING STATE TERRITO; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Pearman A, 2021, J GERONTOL B-PSYCHOL, V76, pE38, DOI 10.1093/geronb/gbaa120; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Stone AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242664; Stone AA, 2010, P NATL ACAD SCI USA, V107, P9985, DOI 10.1073/pnas.1003744107; Vahia IV, 2020, JAMA-J AM MED ASSOC, V324, P2253, DOI 10.1001/jama.2020.21753; van Tilburg TG, 2021, J GERONTOL B-PSYCHOL, V76, pE249, DOI 10.1093/geronb/gbaa111; Xie XY, 2020, JAMA PEDIATR, V174, P898, DOI 10.1001/jamapediatrics.2020.1619	29	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252962	10.1371/journal.pone.0252962	http://dx.doi.org/10.1371/journal.pone.0252962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138938	gold, Green Published			2022-12-26	WOS:000671690200099
J	Rahman, SMJ; Ahmed, NAMF; Abedin, MM; Ahammed, B; Ali, M; Rahman, MJ; Maniruzzaman, M				Rahman, S. M. Jubaidur; Ahmed, N. A. M. Faisal; Abedin, Md Menhazul; Ahammed, Benojir; Ali, Mohammad; Rahman, Md Jahanur; Maniruzzaman, Md			Investigate the risk factors of stunting, wasting, and underweight among under-five Bangladeshi children and its prediction based on machine learning approach	PLOS ONE			English	Article							UNDERNUTRITION; MALNUTRITION; NUTRITION; INCOME	Aims Malnutrition is a major health issue among Bangladeshi under-five (U5) children. Children are malnourished if the calories and proteins they take through their diet are not sufficient for their growth and maintenance. The goal of the research was to use machine learning (ML) algorithms to detect the risk factors of malnutrition (stunted, wasted, and underweight) as well as their prediction. Methods This work utilized malnutrition data that was derived from Bangladesh Demographic and Health Survey which was conducted in 2014. The selected dataset consisted of 7079 children with 13 factors. The potential risks of malnutrition have been identified by logistic regression (LR). Moreover, 3 ML classifiers (support vector machine (SVM), random forest (RF), and LR) have been implemented for predicting malnutrition and the performance of these ML algorithms were assessed on the basis of accuracy. Results The average prevalence of stunted, wasted, and underweight was 35.4%, 15.4%, and 32.8%, respectively. It was noted that LR identified five risk factors for stunting and underweight, as well as four factors for wasting. Results illustrated that RF can be accurately classified as stunted, wasted, and underweight children and obtained the highest accuracy of 88.3% for stunted, 87.7% for wasted, and 85.7% for underweight. Conclusion This research focused on the identification and prediction of major risk factors for stunting, wasting, and underweight using ML algorithms which will aid policymakers in reducing malnutrition among Bangladesh's U5 children.	[Rahman, S. M. Jubaidur; Ahmed, N. A. M. Faisal; Abedin, Md Menhazul; Ahammed, Benojir; Ali, Mohammad; Maniruzzaman, Md] Khulna Univ, Stat Discipline, Khulna, Bangladesh; [Rahman, Md Jahanur] Univ Rajshahi, Dept Stat, Rajshahi, Bangladesh	Khulna University; University of Rajshahi	Maniruzzaman, M (corresponding author), Khulna Univ, Stat Discipline, Khulna, Bangladesh.	monir.stat91@gmail.com	Maniruzzaman, Md/R-2123-2019	Maniruzzaman, Md/0000-0001-6151-8071				Akombi BJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9010044; Alves LC., 2020, ASSESSING PERFORMANC; [Anonymous], 2014, D770814 ASTM, DOI DOI 10.1520/D7708-14; Babatunde RO, 2010, FOOD POLICY, V35, P303, DOI 10.1016/j.foodpol.2010.01.006; Bampaire M., 2019, FACTORS ASS MALNUTRI; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Borson NS, 2020, PROCEEDINGS OF THE 2020 FOURTH WORLD CONFERENCE ON SMART TRENDS IN SYSTEMS, SECURITY AND SUSTAINABILITY (WORLDS4 2020), P169, DOI 10.1109/WorldS450073.2020.9210338; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Das S., 2017, BMC NUTR, V3, P1, DOI [10.1186/s40795-016-0122-2, DOI 10.1186/S40795-016-0122-2]; Eliyati Ning, 2019, Journal of Physics: Conference Series, V1282, DOI 10.1088/1742-6596/1282/1/012010; Fazle Rabbi A.M., 2014, ASIAN J MED SCI, V6, P85, DOI [10.3126/ajms.v6i2.10404, DOI 10.3126/AJMS.V6I2.10404]; Fiorentino M., 2015, MALNUTRITION SCH AGE; Habaasa G, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0448-y; Hange U, 2018, STUD COMPUT INTELL, V719, P109, DOI 10.1007/978-3-319-60170-0_8; Islam A., 2015, ADV PEDIAT RES, V2, P1; Islam MM, 2020, DIABETES METAB SYND, V14, P217, DOI 10.1016/j.dsx.2020.03.004; Islam MM., 2021, CURR WOMENS HLTH REV, V17, P1; Jaiswal Manish, 2019, Recent Trends in Communication, Computing, and Electronics. Select Proceedings of IC3E 2018. Lecture Notes in Electrical Engineering (LNEE 524), P463, DOI 10.1007/978-981-13-2685-1_44; Jaskari J, 2020, IEEE ACCESS, V8, P123347, DOI 10.1109/ACCESS.2020.3006710; Jesus TS, 2020, PHYSIOTHER CAN, V72, P122, DOI 10.3138/ptc-2018-0065; Khan GN, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0131-z; Kuttiyapillai D., 2014, IOSR J COMPUT ENG, V16, P86; Mahgoub SE., 2006, AFR J FOOD AGR NUTR, V6; Mani JJ., 2019, SOC NET FORENSICS CY, P9; Maniruzzaman M, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-019-0095-z; Mboya IB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040132; Mirelman A, 2012, GLOB HEART, V7, P61, DOI 10.1016/j.gheart.2012.01.006; Nure Alam S., 2011, INT J CURR RES, V3, P142; Olwedo MA, 2008, AFR HEALTH SCI, V8, P244; Pravana NK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017084; Rachmi CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154756; Rahman A., 2009, S ASIAN J POPUL HLTH, V2, P1; Rahman M, 2020, J BIOMOL STRUCT DYN, V38, P2093, DOI 10.1080/07391102.2019.1627248; Sanap SA, 2011, LECT NOTES COMPUT SC, V7077, P113, DOI 10.1007/978-3-642-27242-4_14; Sarkar D., 2014, SOCIOECONOMIC DETERM; Senthilkumar D, 2015, INT C IND ENG OP MAN, P186; Shahriar MM, 2019, 2019 IEEE INTERNATIONAL CONFERENCE ON INDUSTRY 4.0, ARTIFICIAL INTELLIGENCE, AND COMMUNICATIONS TECHNOLOGY (IAICT), P145, DOI 10.1109/ICIAICT.2019.8784823; Talukder A, 2020, NUTRITION, V78, DOI 10.1016/j.nut.2020.110861; Thangamani D., 2014, INT J ENG COMPUT SCI, V3; Dat TQ, 2018, AIMS PUBLIC HEALTH, V5, P203, DOI 10.3934/publichealth.2018.3.203; Vapnik V., 1998, STAT LEARNING THEORY; Webb P, 2004, ECON DEV CULT CHANGE, V52, P801, DOI 10.1086/420901; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; World Health Organization (WHO), 2006, WHO CHILD GROWTH STA, DOI DOI 10.4067/S0370-41062009000400012; Zarocostas J, 2006, BMJ-BRIT MED J, V333, P166	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253172	10.1371/journal.pone.0253172	http://dx.doi.org/10.1371/journal.pone.0253172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138925	gold, Green Published			2022-12-26	WOS:000671690200023
J	Stenning, FJ; Polglase, GR; Te Pas, AB; Crossley, KJ; Kluckow, M; Gill, AW; Wallace, EM; McGillick, EV; Binder, C; Blank, DA; Roberts, C; Hooper, SB				Stenning, Fiona J.; Polglase, Graeme R.; Te Pas, Arjan B.; Crossley, Kelly J.; Kluckow, Martin; Gill, Andrew W.; Wallace, Euan M.; McGillick, Erin, V; Binder, Corinna; Blank, Douglas A.; Roberts, Calum; Hooper, Stuart B.			Effect of maternal oxytocin on umbilical venous and arterial blood flows during physiological-based cord clamping in preterm lambs	PLOS ONE			English	Article							3RD STAGE; UTERINE; BIRTH	Background Delayed umbilical cord clamping (UCC) after birth is thought to cause placental to infant blood transfusion, but the mechanisms are unknown. It has been suggested that uterine contractions force blood out of the placenta and into the infant during delayed cord clamping. We have investigated the effect of uterine contractions, induced by maternal oxytocin administration, on umbilical artery (UA) and venous (UV) blood flows before and after ventilation onset to determine whether uterine contractions cause placental transfusion in preterm lambs. Methods and findings At similar to 128 days of gestation, UA and UV blood flows, pulmonary arterial blood flow (PBF) and carotid arterial (CA) pressures and blood flows were measured in three groups of fetal sheep during delayed UCC; maternal oxytocin following mifepristone, mifepristone alone, and saline controls. Each successive uterine contraction significantly (p<0.05) decreased UV (26.2 +/- 6.0 to 14.1 +/- 4.5 mL.min(-1).kg(-1)) and UA (41.2 +/- 6.3 to 20.7 +/- 4.0 mL.min(-1).kg(-1)) flows and increased CA pressure and flow (47.1 +/- 3.4 to 52.8 +/- 3.5 mmHg and 29.4 +/- 2.6 to 37.3 +/- 3.4 mL.min(-1).kg(-1)). These flows and pressures were partially restored between contractions, but did not return to pre-oxytocin administration levels. Ventilation onset during DCC increased the effects of uterine contractions on UA and UV flows, with retrograde UA flow (away from the placenta) commonly occurring during diastole. Conclusions We found no evidence that amplification of uterine contractions with oxytocin increase placental transfusion during DCC. Instead they decreased both UA and UV flow and caused a net loss of blood from the lamb. Uterine contractions did, however, have significant cardiovascular effects and reduced systemic and cerebral oxygenation.	[Stenning, Fiona J.; Polglase, Graeme R.; Crossley, Kelly J.; Wallace, Euan M.; McGillick, Erin, V; Binder, Corinna; Blank, Douglas A.; Roberts, Calum; Hooper, Stuart B.] Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia; [Stenning, Fiona J.; Polglase, Graeme R.; Crossley, Kelly J.; Wallace, Euan M.; McGillick, Erin, V; Hooper, Stuart B.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Te Pas, Arjan B.] Leiden Univ, Dept Paediat, Div Neonatol, Med Ctr, Leiden, Netherlands; [Kluckow, Martin] Royal North Shore Hosp, Dept Neonatal, Sydney, NSW, Australia; [Kluckow, Martin] Univ Sydney, Sydney, NSW, Australia; [Gill, Andrew W.] Univ Western Australia, Ctr Neonatal Res & Educ, Perth, WA, Australia; [Blank, Douglas A.] Royal Womens Hosp, Newborn Res, Melbourne, Vic, Australia; [Roberts, Calum] Monash Univ, Dept Paediat, Melbourne, Vic, Australia	Hudson Institute of Medical Research; Monash University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal North Shore Hospital; University of Sydney; University of Western Australia; Monash University	Hooper, SB (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic, Australia.; Hooper, SB (corresponding author), Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.	stuart.hooper@monash.edu	; Wallace, Euan/K-6774-2015	Polglase, Graeme/0000-0002-8906-614X; Wallace, Euan/0000-0002-4506-5233; Roberts, Calum/0000-0002-9111-5027; Hooper, Stuart/0000-0003-1676-4825	National Institute of Health [R01HD072848-01A1]; National Health and Medical Research Council (NHMRC) [606789]; NHMRC Research Fellowships [1173731, APP1058537]; Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; Veni-grant; Netherlands Organisation for Health Research and Development (ZonMw); Innovational Research Incentives Scheme Veni-Vidi-Vici	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L. Cooper Medical Research Foundation Fellowship; Financial Markets for Children Research Grant; Victorian Government's Operational Infrastructure Support Program; Veni-grant; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Innovational Research Incentives Scheme Veni-Vidi-Vici	This research was supported by National Institute of Health R01HD072848-01A1 (SH,GP), National Health and Medical Research Council (NHMRC) Program Grant (SH; 606789), NHMRC Research Fellowships (GRP: 1173731, and SBH: APP1058537), a Rebecca L. Cooper Medical Research Foundation Fellowship (GP), Financial Markets for Children Research Grant (GP) and the Victorian Government's Operational Infrastructure Support Program. ABtP is recipient of a Veni-grant, The Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme VeniVidi-Vici.	Begley CM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007412.pub3; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Blank DA, 2018, ARCH DIS CHILD-FETAL, V103, pF539, DOI 10.1136/archdischild-2017-314005; Bleul U, 2007, THERIOGENOLOGY, V67, P1123, DOI 10.1016/j.theriogenology.2006.12.007; Boere I, 2015, ARCH DIS CHILD-FETAL, V100, pF121, DOI 10.1136/archdischild-2014-307144; Crossley KJ, 2009, J PHYSIOL-LONDON, V587, P4695, DOI 10.1113/jphysiol.2009.174870; Fogarty M, 2018, AM J OBSTET GYNECOL, V218, P1, DOI 10.1016/j.ajog.2017.10.231; Hirst JJ, 2005, AM J OBSTET GYNECOL, V193, P256, DOI 10.1016/j.ajog.2004.11.009; Hooper SB, 2017, ARCH DIS CHILD-FETAL, V102, pF312, DOI 10.1136/archdischild-2016-311159; Hooper Stuart B, 2016, Matern Health Neonatol Perinatol, V2, P4, DOI 10.1186/s40748-016-0032-y; Hooper SB, 2015, ARCH DIS CHILD-FETAL, V100, pF355, DOI 10.1136/archdischild-2013-305703; Kluckow M, 2015, SEMIN FETAL NEONAT M, V20, P225, DOI 10.1016/j.siny.2015.03.002; Knol R, 2020, RESUSCITATION, V147, P26, DOI 10.1016/j.resuscitation.2019.12.007; Olofsson P, 1996, ULTRASOUND OBST GYN, V8, P247, DOI 10.1046/j.1469-0705.1996.08040247.x; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Polglase GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117504; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Rabe H, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003248.pub4, 10.1002/14651858.CD003248.pub3]; Roberts CL, 2008, INT J GYNECOL OBSTET, V103, P172, DOI 10.1016/j.ijgo.2008.05.025; RUDOLPH AM, 1979, ANNU REV PHYSIOL, V41, P383, DOI 10.1146/annurev.ph.41.030179.002123; Sakai M, 1997, INT J GYNECOL OBSTET, V59, P207, DOI 10.1016/S0020-7292(97)00129-X; Smit M, 2013, MIDWIFERY, V29, P859, DOI 10.1016/j.midw.2012.09.004; Sobotka KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112264; Soltani H, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006173.pub2; Tarnow-Mordi W, 2017, NEW ENGL J MED, V377, P2445, DOI 10.1056/NEJMoa1711281; Vain NE, 2020, ARCH DIS CHILD-FETAL, V105, pF14, DOI 10.1136/archdischild-2018-316649; WALLGREN G, 1960, Acta Paediatr, V49, P843, DOI 10.1111/j.1651-2227.1960.tb16094.x; Westgate JA, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.063; YAO AC, 1974, AM J DIS CHILD, V127, P128, DOI 10.1001/archpedi.1974.02110200130021; YAO AC, 1968, LANCET, V1, P380; YAO AC, 1969, LANCET, V2, P871; Yoo KY, 2006, ANESTH ANALG, V103, P443, DOI 10.1213/01.ane.0000236785.17606.58	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253306	10.1371/journal.pone.0253306	http://dx.doi.org/10.1371/journal.pone.0253306			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138957	Green Published, gold			2022-12-26	WOS:000671690200084
J	Lim, ES; Baek, SY; Oh, T; Koo, M; Lee, JY; Kim, HJ; Kim, JS				Lim, Eun Seob; Baek, Seung-Youb; Oh, Taeyoung; Koo, Minseon; Lee, Joo Young; Kim, Hyun Jung; Kim, Joo-Sung			Strain variation in Bacillus cereus biofilms and their susceptibility to extracellular matrix-degrading enzymes	PLOS ONE			English	Article							GENETIC DIVERSITY; DNA; FOOD; QUANTIFICATION; THURINGIENSIS; RESISTANCE	Bacillus cereus is a foodborne pathogen and can form biofilms on food contact surfaces, which causes food hygiene problems. While it is necessary to understand strain-dependent variation to effectively control these biofilms, strain-to-strain variation in the structure of B. cereus biofilms is poorly understood. In this study, B. cereus strains from tatsoi (BC4, BC10, and BC72) and the ATCC 10987 reference strain were incubated at 30 degrees C to form biofilms in the presence of the extracellular matrix-degrading enzymes DNase I, proteinase K, dispase II, cellulase, amyloglucosidase, and alpha-amylase to assess the susceptibility to these enzymes. The four strains exhibited four different patterns in terms of biofilm susceptibility to the enzymes as well as morphology of surface-attached biofilms or suspended cell aggregates. DNase I inhibited the biofilm formation of strains ATCC 10987 and BC4 but not of strains BC10 and BC72. This result suggests that some strains may not have extracellular DNA, or their extracellular DNA may be protected in their biofilms. In addition, the strains exhibited different patterns of susceptibility to protein- and carbohydrate-degrading enzymes. While other strains were resistant, strains ATCC 10987 and BC4 were susceptible to cellulase, suggesting that cellulose or its similar polysaccharides may exist and play an essential role in their biofilm formation. Our compositional and imaging analyses of strains ATCC 10987 and BC4 suggested that the physicochemical properties of their biofilms are distinct, as calculated by the carbohydrate to protein ratio. Taken together, our study suggests that the extracellular matrix of B. cereus biofilms may be highly diverse and provides insight into the diverse mechanisms of biofilm formation among B. cereus strains.	[Lim, Eun Seob; Koo, Minseon; Kim, Hyun Jung; Kim, Joo-Sung] Korea Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea; [Lim, Eun Seob; Baek, Seung-Youb; Oh, Taeyoung; Lee, Joo Young; Kim, Hyun Jung; Kim, Joo-Sung] Korea Food Res Inst, Res Div Strateg Food Technol, Res Grp Consumer Safety, Jeollabuk Do, South Korea; [Koo, Minseon] Korea Food Res Inst, Food Anal Ctr, Jeollabuk Do, South Korea; [Lee, Joo Young] Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon, South Korea	University of Science & Technology (UST); Korea Food Research Institute (KFRI); Korea Food Research Institute (KFRI); Sungkyunkwan University (SKKU)	Kim, HJ; Kim, JS (corresponding author), Korea Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea.; Kim, HJ; Kim, JS (corresponding author), Korea Food Res Inst, Res Div Strateg Food Technol, Res Grp Consumer Safety, Jeollabuk Do, South Korea.	hjkim@kfri.re.kr; jskim@kfri.re.kr	Kim, Joo-Sung/AAO-6846-2021	Kim, Joo-Sung/0000-0002-8173-9805	Main Research Program of the Korea Food Research Institute (KFRI) - Ministry of Science and ICT in South Korea [E0192101-02]	Main Research Program of the Korea Food Research Institute (KFRI) - Ministry of Science and ICT in South Korea	This research was supported by Main Research Program (E0192101-02) of the Korea Food Research Institute (KFRI) funded by the Ministry of Science and ICT in South Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Brown HL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00699; Combrouse T, 2013, J APPL MICROBIOL, V114, P1120, DOI 10.1111/jam.12127; Eboigbodin KE, 2008, BIOMACROMOLECULES, V9, P686, DOI 10.1021/bm701043c; Fish KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115824; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Galie S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00898; Gallo PM, 2015, IMMUNITY, V42, P1171, DOI 10.1016/j.immuni.2015.06.002; Gilan I, 2013, FEMS MICROBIOL LETT, V342, P18, DOI 10.1111/1574-6968.12114; Hayrapetyan H, 2015, INT J FOOD MICROBIOL, V200, P72, DOI 10.1016/j.ijfoodmicro.2015.02.005; Helgason E, 1998, CURR MICROBIOL, V37, P80, DOI 10.1007/s002849900343; Hobley L, 2015, FEMS MICROBIOL REV, V39, P649, DOI 10.1093/femsre/fuv015; Hoffmaster AR, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-191; Hussain MS, 2018, J MICROBIOL BIOTECHN, V28, P77, DOI 10.4014/jmb.1707.07023; Jakubovics NS, 2013, LETT APPL MICROBIOL, V57, P467, DOI 10.1111/lam.12134; Karunakaran E, 2011, APPL MICROBIOL BIOT, V89, P1161, DOI 10.1007/s00253-010-2919-2; Kim MJ, 2019, J FOOD PROTECT, V82, P605, DOI [10.4315/0362-028X.JFP-18-244, 10.4315/0362-028x.jfp-18-244]; Kwon M, 2017, FOOD SCI BIOTECHNOL, V26, P1103, DOI 10.1007/s10068-017-0129-8; Lee N, 2012, J FOOD PROTECT, V75, P225, DOI 10.4315/0362-028X.JFP-11-317; Lindback T, 2019, FOOD MICROBIOLOGY, 5 EDITION, P541, DOI 10.1128/9781555819972.ch20; Majed R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01054; Meireles A, 2016, FOOD RES INT, V86, P140, DOI 10.1016/j.foodres.2016.06.006; Oh Tae Young, 2016, Journal of Applied Biological Chemistry, V59, P63, DOI 10.3839/jabc.2016.012; Okshevsky M, 2015, CRIT REV MICROBIOL, V41, P341, DOI 10.3109/1040841X.2013.841639; Park KM, 2020, FOODS, V9, DOI 10.3390/foods9030249; Park KM, 2018, J FOOD PROTECT, V81, P1590, DOI 10.4315/0362-028X.JFP-18-205; Park KM, 2016, J FOOD PROTECT, V79, P605, DOI 10.4315/0362-028X.JFP-15-416; Ramirez MDF, 2015, INT J FOOD MICROBIOL, V207, P23, DOI 10.1016/j.ijfoodmicro.2015.04.030; Reda FM, 2019, FOOD SCI BIOTECHNOL, V28, P841, DOI 10.1007/s10068-018-0518-7; Serra DO, 2013, J BACTERIOL, V195, P5540, DOI 10.1128/JB.00946-13; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; Song H, 2019, FOOD SCI BIOTECHNOL, V28, P1265, DOI 10.1007/s10068-019-00570-3; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Sugimoto S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20485-z; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Waturangi DE., 2020, EMERGING CONCEPTS BA, P1; Whitfield GB, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008281; Wickstrom C, 2009, MICROBIOL-SGM, V155, P2866, DOI 10.1099/mic.0.030536-0; Wijman JGE, 2007, APPL ENVIRON MICROB, V73, P1481, DOI 10.1128/AEM.01781-06; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Zetzmann M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01428; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	43	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0245708	10.1371/journal.pone.0245708	http://dx.doi.org/10.1371/journal.pone.0245708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133441	Green Published, Green Submitted, gold			2022-12-26	WOS:000671682700046
J	Barrett, CT; Neal, HE; Edmonds, K; Moncman, CL; Thompson, R; Branttie, JM; Boggs, KB; Wu, CY; Leung, DW; Dutch, RE				Barrett, Chelsea T.; Neal, Hadley E.; Edmonds, Kearstin; Moncman, Carole L.; Thompson, Rachel; Branttie, Jean M.; Boggs, Kerri Beth; Wu, Cheng-Yu; Leung, Daisy W.; Dutch, Rebecca E.			Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; CATHEPSIN-L; ENTRY; ACTIVATION; INFLUENZA; PROTEASES; COV; MECHANISMS; INFECTION	The trimeric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) is the sole viral protein responsible for both viral binding to a host cell and the membrane fusion event needed for cell entry. In addition to facilitating fusion needed for viral entry, S can also drive cell-cell fusion, a pathogenic effect observed in the lungs of SARS-CoV-2-infected patients. While several studies have investigated S requirements involved in viral particle entry, examination of S stability and factors involved in S cell-cell fusion remain limited. A furin cleavage site at the border between the S1 and S2 subunits (S1/S2) has been identified, along with putative cathepsin L and transmembrane serine protease 2 cleavage sites within S2. We demonstrate that S must be processed at the S1/S2 border in order to mediate cell-cell fusion and that mutations at potential cleavage sites within the S2 subunit alter S processing at the S1/S2 border, thus preventing cell-cell fusion. We also identify residues within the internal fusion peptide and the cytoplasmic tail that modulate S-mediated cell-cell fusion. In addition, we examined S stability and protein cleavage kinetics in a variety of mammalian cell lines, including a bat cell line related to the likely reservoir species for SARS-CoV-2, and provide evidence that proteolytic processing alters the stability of the S trimer. This work therefore offers insight into S stability, proteolytic processing, and factors that mediate S cell-cell fusion, all of which help give a more comprehensive understanding of this high-profile therapeutic target.	[Barrett, Chelsea T.; Neal, Hadley E.; Edmonds, Kearstin; Moncman, Carole L.; Thompson, Rachel; Branttie, Jean M.; Boggs, Kerri Beth; Wu, Cheng-Yu; Dutch, Rebecca E.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Leung, Daisy W.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA	University of Kentucky; Washington University (WUSTL)	Dutch, RE (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	rdutc2@uky.edu		Wu, Cheng-Yu/0000-0003-4088-6347; Neal, Hadley/0000-0001-8433-593X	CCTS CURE Alliance pilot award from the University of Kentucky; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI051517]; National Institutes of Health [2P20 RR02017]	CCTS CURE Alliance pilot award from the University of Kentucky; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the CCTS CURE Alliance pilot award from the University of Kentucky, National Institute of Allergy and Infectious Diseases, National Institutes of Health grant R01AI051517, and National Institutes of Health grant 2P20 RR02017 to R. E. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Belouzard S, 2010, J BIOL CHEM, V285, P22756, DOI 10.1074/jbc.M110.103275; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Biswas NK, 2020, INDIAN J MED RES, V151, P450, DOI 10.4103/ijmr.IJMR_1125_20; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Branttie JM, 2020, J GEN VIROL, V101, P467, DOI 10.1099/jgv.0.001399; Braun E, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1073; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Buonvino S, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00372-1; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Caldas LA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73162-5; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Chan CM, 2008, EXP BIOL MED, V233, P1527, DOI 10.3181/0806-RM-197; Cheng YW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108254; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Davies J, 2020, MOL MED REP, V22, P4221, DOI 10.3892/mmr.2020.11510; El Najjar F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115736; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gong YQ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000771; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hornich B. F., 2020, SARS COV 2 SARS COV, DOI [10. 1101/2020.07.25.221135, DOI 10.1101/2020.07.25.221135]; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Hulswit RJG, 2016, ADV VIRUS RES, V96, P29, DOI 10.1016/bs.aivir.2016.08.004; Isabel S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70827-z; Islam OK, 2021, TRANSBOUND EMERG DIS, V68, P824, DOI 10.1111/tbed.13748; Izaguirre G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090837; Jiang XY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00392-4; Johnson Bryan A, 2020, bioRxiv, DOI 10.1101/2020.08.26.268854; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; Kawase M, 2019, J VIROL, V93, DOI 10.1128/JVI.00785-19; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Korber B, 2020, SPIKE MUTATION PIPEL; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Koyama T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050324; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Le Coupanec A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005261; Lemmin T, 2020, J STRUCT BIOL-X, V4, DOI 10.1016/j.yjsbx.2020.100038; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li W, 2020, BIOPHYS CHEM, V264, DOI 10.1016/j.bpc.2020.106420; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Luan JW, 2020, BIOCHEM BIOPH RES CO, V526, P165, DOI 10.1016/j.bbrc.2020.03.047; Mansbach Rachael A, 2020, bioRxiv, DOI 10.1101/2020.07.26.219741; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19; Mercatelli D., 2020, FRONT MICROBIOL, V11, P1, DOI [10.3389/fmicb.2020.01800, DOI 10.3389/fmicb.2020.01800]; Millet JK, 2018, VIROLOGY, V517, P3, DOI 10.1016/j.virol.2017.12.015; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Nguyen H. T., 2020, SPIKE GLYCOPROTEIN H, DOI 10.22.351569; Ogawa Junko, 2020, bioRxiv, DOI 10.1101/2020.07.21.214932; Oprinca GC, 2021, INT J LEGAL MED, V135, P329, DOI 10.1007/s00414-020-02406-w; Ou T., 2020, HYDROXYCHLOROQUINE M, DOI [10.1101/2020.07.22.216150, DOI 10.1101/2020.07.22.216150]; Papa G., 2020, FURIN CLEAVAGE SARS, DOI 10.1101/2020.08.13.243303; Plante Jessica A, 2020, bioRxiv, DOI 10.1101/2020.09.01.278689; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Slaughter KB, 2019, J VIROL, V93, DOI 10.1128/JVI.01069-19; Stadlmann S, 2020, J CLIN PATHOL, V73, P607, DOI 10.1136/jclinpath-2020-206657; Sun XJ, 2010, J VIROL, V84, P8683, DOI 10.1128/JVI.00797-10; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Webb S, 2017, J BIOL CHEM, V292, P5685, DOI 10.1074/jbc.M117.777235; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yurkovetskiy Leonid, 2020, Cell, V183, P739, DOI [10.1101/2020.07.04.187757, 10.1016/j.cell.2020.09.032]; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhou H, 2020, CURR BIOL, V30, P2196, DOI 10.1016/j.cub.2020.05.023; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu Y., 2020, COLD SPRING HARB SYM, DOI [10.1101/2020.08.25.266775, DOI 10.1101/2020.08.25.266775]	100	10	10	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100902	10.1016/j.jbc.2021.100902	http://dx.doi.org/10.1016/j.jbc.2021.100902			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157282	gold, Green Published			2022-12-26	WOS:000678068400091
J	Nassal, DM; Patel, NJ; Unudurthi, SD; Shaheen, R; Yu, J; Mohler, PJ; Hund, TJ				Nassal, Drew M.; Patel, Nehal J.; Unudurthi, Sathya D.; Shaheen, Rebecca; Yu, Jane; Mohler, Peter J.; Hund, Thomas J.			Ca2+/calmodulin kinase II-dependent regulation of beta(IV)-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; DILATED CARDIOMYOPATHY; HYPERTROPHY; CAMKII; CALCIUM; INHIBITION; CALMODULIN; PHOSPHORYLATION; SPECTRIN; FIBROSIS	Fibrosis is a pronounced feature of heart disease and the result of dysregulated activation of resident cardiac fibroblasts (CFs). Recent work identified stress-induced degradation of the cytoskeletal protein beta(IV)-spectrin as an important step in CF activation and cardiac fibrosis. Furthermore, loss of beta(IV)-spectrin was found to depend on Ca2+/calmodulin-dependent kinase II (CaMKII). Therefore, we sought to determine the mechanism for CaMKII-dependent regulation of beta(IV)-spectrin and CF activity. Computational screening and MS revealed a critical serine residue (S2250 in mouse and S2254 in human) in beta(IV)-spectrin phosphorylated by CaMKII. Disruption of beta(IV)-spectrin/CaMKII interaction or alanine substitution of beta(IV)-spectrin Ser2250 (beta(IV)-S2254A) prevented CaMKII-induced degradation, whereas a phosphomimetic construct (beta(IV)-spectrin with glutamic acid substitution at serine 2254 [beta(IV)-S2254E]) showed accelerated degradation in the absence of CaMKII. To assess the physiological significance of this phosphorylation event, we expressed exogenous beta(IV)-S2254A and beta(IV)-S2254E constructs in beta(IV)-spectrin-deficient CFs, which have increased proliferation and fibrotic gene expression compared with WT CFs. beta(IV)-S2254A but not beta(IV)-S2254E normalized CF proliferation, gene expression, and contractility. Pathophysiological targeting of beta(IV)-spectrin phosphorylation and subsequent degradation was identified in CFs activated with the profibrotic ligand angiotensin II, resulting in increased proliferation and signal transducer and activation of transcription 3 nuclear accumulation. While therapeutic delivery of exogenous WT beta(IV)-spectrin partially reversed these trends, beta(IV)-S2254A completely negated increased CF proliferation and signal transducer and activation of transcription 3 translocation. Moreover, we observed beta(IV)-spectrin phosphorylation and associated loss in total protein within human heart tissue following heart failure. Together, these data illustrate a considerable role for the beta(IV)-spectrin/CaMKII interaction in activating profibrotic signaling.	[Nassal, Drew M.; Patel, Nehal J.; Shaheen, Rebecca; Yu, Jane; Mohler, Peter J.; Hund, Thomas J.] Ohio State Univ, Wexner Med Ctr, Frick Ctr Heart Failure & Arrhythmia, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Nassal, Drew M.; Patel, Nehal J.; Unudurthi, Sathya D.; Shaheen, Rebecca; Yu, Jane; Hund, Thomas J.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH USA; [Mohler, Peter J.; Hund, Thomas J.] Ohio State Univ, Coll Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hund, TJ (corresponding author), Ohio State Univ, Wexner Med Ctr, Frick Ctr Heart Failure & Arrhythmia, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Hund, TJ (corresponding author), Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA.; Hund, TJ (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA.	thomas.hund@osumc.edu		Shaheen, Rebecca/0000-0002-5121-8558	National Institutes of Health [HL135096, HL156652, HL134824, HL135754]; Fondation Leducq [TNE 19CVD03]; American Heart Association Post-Doctoral Fellowship [18POST34030245]; Bob and Corrine Frick Center for Heart Failure and Arrhythmia; Dorothy M. Davis Heart and Lung Research Institute; NIH [1S10OD023436-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association Post-Doctoral Fellowship(American Heart Association); Bob and Corrine Frick Center for Heart Failure and Arrhythmia; Dorothy M. Davis Heart and Lung Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants HL135096 and HL156652 (T. J. H.), HL134824 (T. J. H. and P. J. M.), HL135754 (P. J. M.), the Fondation Leducq (TNE 19CVD03), the American Heart Association Post-Doctoral Fellowship (18POST34030245, D. M. N.), and funding from the Bob and Corrine Frick Center for Heart Failure and Arrhythmia and the Dorothy M. Davis Heart and Lung Research Institute. The MS Fusion Lumos instrument was purchased via an NIH shared instrument grant, 1S10OD023436-01 (Cleveland Clinic). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baba K, 2020, HISTOCHEM CELL BIOL, V153, P199, DOI 10.1007/s00418-019-01842-z; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Cao L, 2018, ACTA BIOCH BIOPH SIN, V50, P843, DOI 10.1093/abbs/gmy090; Chen Y, 2017, CARDIOVASC RES, V113, P310, DOI 10.1093/cvr/cvx004; Christensen MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000583; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fu X, 2018, J CLIN INVEST, V128, P2127, DOI 10.1172/JCI98215; Glynn P, 2015, CIRCULATION, V132, P567, DOI 10.1161/CIRCULATIONAHA.114.015218; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hashemi SM, 2009, J MOL CELL CARDIOL, V47, P203, DOI 10.1016/j.yjmcc.2009.04.010; Hegyi B, 2019, J MOL CELL CARDIOL, V127, P246, DOI 10.1016/j.yjmcc.2019.01.001; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Huang CYM, 2017, J NEUROSCI, V37, P11311, DOI 10.1523/JNEUROSCI.2112-17.2017; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Humeres C, 2019, JACC-BASIC TRANSL SC, V4, P449, DOI 10.1016/j.jacbts.2019.02.006; Hund TJ, 2014, CARDIOVASC RES, V102, P166, DOI 10.1093/cvr/cvu008; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kreusser MM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0581-2; Lafontant PJ, 2006, AM J PHYSIOL-CELL PH, V291, pC18, DOI 10.1152/ajpcell.00322.2005; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lubbers ER, 2019, J BIOL CHEM, V294, P9576, DOI 10.1074/jbc.RA119.007714; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Mattiazzi A, 2015, AM J PHYSIOL-HEART C, V308, pH1177, DOI 10.1152/ajpheart.00007.2015; Mattiazzi A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00005; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Mustroph J, 2017, PHARMACOL THERAPEUT, V176, P22, DOI 10.1016/j.pharmthera.2016.10.006; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Patel NJ, 2021, EXPERT OPIN THER TAR, V25, P63, DOI 10.1080/14728222.2021.1849145; Patel NJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131046; Peng JF, 2002, CIRC RES, V91, P1119, DOI 10.1161/01.RES.0000047090.08299.D5; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Schipper-Krom S, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00056; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stevenson MD, 2010, BIOPHYS J, V99, P19, DOI 10.1016/j.bpj.2010.03.041; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Unudurthi SD, 2018, J CLIN INVEST, V128, P5561, DOI 10.1172/JCI99245; Unudurthi SD, 2018, EXPERT REV CARDIOVAS, V16, P59, DOI 10.1080/14779072.2018.1418664; Unudurthi SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002865; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Westenbrink BD, 2013, EXPERT OPIN THER TAR, V17, P889, DOI 10.1517/14728222.2013.809064; Willeford A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97054; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang W, 2010, J CARDIOVASC PHARM, V55, P96, DOI 10.1097/FJC.0b013e3181c9548b; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688	63	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100893	10.1016/j.jbc.2021.100893	http://dx.doi.org/10.1016/j.jbc.2021.100893			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34153319	gold, Green Published			2022-12-26	WOS:000678068400087
J	Rentinck, MN; Kruger, R; Hoppe, PA; Humme, D; Niebank, M; Pokrywka, A; Stegemann, M; Kola, A; Hanitsch, LG; Leistner, R				Rentinck, Marc-Nicolas; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Niebank, Michaela; Pokrywka, Anna; Stegemann, Miriam; Kola, Axel; Hanitsch, Leif Gunnar; Leistner, Rasmus			Skin infections due to Panton-Valentine leukocidin (PVL)-producing S. aureus-Cost effectiveness of outpatient treatment	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MANAGEMENT; CARRIAGE; OUTBREAK; STRAINS	Introduction Skin and soft tissue infections (SSTI) caused by Panton-Valentine leukocidin (PVL)-producing strains of Staphylococcus aureus (PVL-SA) are associated with recurrent skin abscesses. Secondary prevention, in conjunction with primary treatment of the infection, focuses on topical decolonization. Topical decolonization is a standard procedure in cases of recurrent PVL-SA skin infections and is recommended in international guidelines. However, this outpatient treatment is often not fully reimbursed by health insurance providers, which may interfere with successful PVL-SA decolonization. Aim Our goal was to estimate the cost effectiveness of outpatient decolonization of patients with recurrent PVL-SA skin infections. We calculated the average cost of treatment for PVL-SA per outpatient decolonization procedure as well as per in-hospital stay. Methods The study was conducted between 2014 and 2018 at a German tertiary care university hospital. The cohort analyzed was obtained from the hospital's microbiology laboratory database. Data on medical costs, DRG-based diagnoses, and ICD-10 patient data was obtained from the hospital's financial controlling department. We calculated the average cost of treatment for patients admitted for treatment of PVL-SA induced skin infections. The cost of outpatient treatment is based on the German regulations of drug prices for prescription drugs. Results We analyzed a total of n = 466 swabs from n = 411 patients with recurrent skin infections suspected of carrying PVL-SA. PVL-SA was detected in 61.3% of all patients included in the study. Of those isolates, 80.6% were methicillin-susceptible, 19.4% methicillin-resistant. 89.8% of all patients were treated as outpatients. In 73.0% of inpatients colonized with PVL-SA the main diagnosis was SSTI. The median length of stay was 5.5 days for inpatients colonized with PVL-SA whose main diagnosis SSTI; the average cost was euro2,283. The estimated costs per decolonization procedure in outpatients ranged from euro50-euro110, depending on the products used. Conclusion Our data shows that outpatient decolonization offers a highly cost-effective secondary prevention strategy, which may prevent costly inpatient treatments. Therefore, health insurance companies should consider providing coverage of outpatient treatment of recurrent PVL-SA skin and soft tissue infections.	[Rentinck, Marc-Nicolas; Kola, Axel; Leistner, Rasmus] Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany; [Rentinck, Marc-Nicolas; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Niebank, Michaela; Pokrywka, Anna; Stegemann, Miriam; Kola, Axel; Hanitsch, Leif Gunnar; Leistner, Rasmus] Free Univ Berlin, Berlin, Germany; [Rentinck, Marc-Nicolas; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Niebank, Michaela; Pokrywka, Anna; Stegemann, Miriam; Kola, Axel; Hanitsch, Leif Gunnar; Leistner, Rasmus] Humboldt Univ, Berlin, Germany; [Rentinck, Marc-Nicolas; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Niebank, Michaela; Pokrywka, Anna; Stegemann, Miriam; Kola, Axel; Hanitsch, Leif Gunnar; Leistner, Rasmus] Berlin Inst Hlth, Berlin, Germany; [Rentinck, Marc-Nicolas; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Niebank, Michaela; Pokrywka, Anna; Stegemann, Miriam; Leistner, Rasmus] Charite Univ Med Berlin, Interdisciplinary Workgrp PVL Posit S Aureus, Berlin, Germany; [Krueger, Renate; Hoppe, Pia-Alice] Charite Univ Med Berlin, Div Pulmonol Immunol & Crit Care Med, Dept Pediat, Berlin, Germany; [Humme, Daniel; Pokrywka, Anna] Charite Univ Med Berlin, Dept Dermatol Venerol & Allergol, Berlin, Germany; [Niebank, Michaela; Stegemann, Miriam] Charite Univ Med Berlin, Dept Infect Dis & Resp Med, Berlin, Germany; [Hanitsch, Leif Gunnar] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Leistner, Rasmus] Charite Univ Med Berlin, Div Gastroenterol Infect Dis & Rheumatol Includin, Med Dept, Campus Benjamin Franklin, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rentinck, MN (corresponding author), Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany.; Rentinck, MN (corresponding author), Free Univ Berlin, Berlin, Germany.; Rentinck, MN (corresponding author), Humboldt Univ, Berlin, Germany.; Rentinck, MN (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Rentinck, MN (corresponding author), Charite Univ Med Berlin, Interdisciplinary Workgrp PVL Posit S Aureus, Berlin, Germany.	m.rent@fu-berlin.de		Rentinck, Marc-Nicolas/0000-0002-3009-4760; Stegemann, Miriam Songa/0000-0002-7968-0429; Leistner, Rasmus/0000-0002-1225-9023; Hanitsch, Leif G./0000-0002-8181-0093				Brown ML, 2012, J CLIN MICROBIOL, V50, P86, DOI 10.1128/JCM.05564-11; Bundesministerium fur Gesundheit, 2021, ARZN; Demir T, 2012, J ANTIMICROB CHEMOTH, V67, P837, DOI 10.1093/jac/dkr568; Gillet Y, 2011, INT J ANTIMICROB AG, V38, P457, DOI 10.1016/j.ijantimicag.2011.05.003; Hanitsch LG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231772; Ismail H, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05352-5; Kapadia S, 2018, J HOSP INFECT, V100, P359, DOI 10.1016/j.jhin.2018.03.021; Kazakova SV, 2005, NEW ENGL J MED, V352, P468, DOI 10.1056/NEJMoa042859; Klein S, 2019, INT J ANTIMICROB AG, V53, P261, DOI 10.1016/j.ijantimicag.2018.10.026; Kramer A, 2010, GMS HYG INFECT CONTR, V5, DOI 10.3205/dgkh000144; Landen MG, 2000, WESTERN J MED, V172, P235, DOI 10.1136/ewjm.172.4.235; Layer F, 2019, EPID B, V42, P43742, DOI [10.25646/6320.2, DOI 10.25646/6320.2]; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Mongkolrattanothai K, 2011, J MED MICROBIOL, V60, P317, DOI 10.1099/jmm.0.025841-0; Raupach-Rosin H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1503-5; Saeed K, 2018, INT J ANTIMICROB AG, V51, P16, DOI 10.1016/j.ijantimicag.2017.11.002; Septimus EJ, 2016, CLIN MICROBIOL REV, V29, P201, DOI 10.1128/CMR.00049-15; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Stoesser N, 2015, J CLIN MICROBIOL, V53, P2122, DOI 10.1128/JCM.00378-15; Sunderkotter C, 2019, J DTSCH DERMATOL GES, V17, P345, DOI 10.1111/ddg.13790; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wiese-Posselt M, 2007, CLIN INFECT DIS, V44, pE88, DOI 10.1086/517503	23	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253633	10.1371/journal.pone.0253633	http://dx.doi.org/10.1371/journal.pone.0253633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170945	Green Published, gold			2022-12-26	WOS:000671694400015
J	Shapira, S; Boustanai, I; Kazanov, D; Ben Shimon, M; Fokra, A; Arber, N				Shapira, Shiran; Boustanai, Ilana; Kazanov, Dina; Ben Shimon, Marina; Fokra, Ahmad; Arber, Nadir			Innovative dual system approach for selective eradication of cancer cells using viral-based delivery of natural bacterial toxin-antitoxin system	ONCOGENE			English	Article							MUTANT P53; GENE-THERAPY; MUTATIONS; DNA	The inactivation of p53, a tumor suppressor, and the activation of the RAS oncogene are the most frequent genetic alterations in cancer. We have shown that a unique E. coli MazF-MazE toxin-antitoxin (TA) system can be used for selective and effective eradication of RAS-mutated cancer cells. This out of the box strategy holds great promise for effective cancer treatment and management. We provide proof of concept for a novel platform to selectively eradicate cancer cells using an adenoviral delivery system based on the adjusted natural bacterial system. We generated adenoviral vectors carrying the mazF toxin (pAdEasy-Py4-SV40mP-mCherry-MazF) and the antitoxin mazE (pAdEasy-RGC-SV40mP-MazE-IRES-GFP) under the regulation of RAS and p53, resp. The control vector carries the toxin without the RAS-responsive element (pAdEasy-Delta Py4-SV40mP-mCherry-MazF). In vitro, the mazF-mazE TA system (Py4-SV40mP-mCherry-MazF+RGC-SV40mP-MazE-IRES-GFP) induced massive, dose-dependent cell death, at 69% compared to 19% for the control vector, in a co-infected HCT116 cell line. In vivo, the system caused significant tumor growth inhibition of HCT116 (KRAS(mut)/p53(mut)) tumors at 73 and 65% compared to PBS and Delta PY4 control groups, resp. In addition, we demonstrate 65% tumor growth inhibition in HCT116 (KRAS(mut)/p53(wt)) cells, compared to the other two control groups, indicating a contribution of the antitoxin in blocking system leakage in WT RAS cells. These data provide evidence of the feasibility of using mutations in the p53 and RAS pathway to efficiently kill cancer cells. The platform, through its combination of the antitoxin (mazE) with the toxin (mazF), provides effective protection of normal cells from basal low activity or leakage of mazF.	[Shapira, Shiran; Boustanai, Ilana; Kazanov, Dina; Ben Shimon, Marina; Fokra, Ahmad; Arber, Nadir] Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, Tel Aviv, Israel; [Shapira, Shiran; Boustanai, Ilana; Kazanov, Dina; Ben Shimon, Marina; Fokra, Ahmad; Arber, Nadir] Tel Aviv Sourasky Med Ctr, Hlth Promot Ctr, Tel Aviv, Israel; [Shapira, Shiran; Boustanai, Ilana; Fokra, Ahmad; Arber, Nadir] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Arber, N (corresponding author), Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, Tel Aviv, Israel.; Arber, N (corresponding author), Tel Aviv Sourasky Med Ctr, Hlth Promot Ctr, Tel Aviv, Israel.; Arber, N (corresponding author), Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel.	nadira@tlvmc.gov.il						Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; BARGONETTI J, 1992, GENE DEV, V6, P1886, DOI 10.1101/gad.6.10.1886; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bykov VJN, 2018, NAT REV CANCER, V18, P89, DOI 10.1038/nrc.2017.109; Crystal RG, 2014, HUM GENE THER, V25, P3, DOI 10.1089/hum.2013.2527; Davis TB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27584-x; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Duffy MJ, 2017, EUR J CANCER, V83, P258, DOI 10.1016/j.ejca.2017.06.023; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Dvory-Sobol H, 2005, BIOMED PHARMACOTHER, V59, pS370, DOI 10.1016/S0753-3322(05)80081-2; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jeng HH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2173; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kodaz H, 2017, EURASIAN J MED ONCOL, V1, P1, DOI 10.14744/ejmo.2017.22931; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Ledford H, 2015, NATURE, V528, P317, DOI 10.1038/528317a; Lee CS, 2017, GENES DIS, V4, P43, DOI 10.1016/j.gendis.2017.04.001; Lisiansky V, 2012, CANCER GENE THER, V19, P862, DOI 10.1038/cgt.2012.73; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Naumov I, 2012, EXP CELL RES, V318, P160, DOI 10.1016/j.yexcr.2011.09.015; Papke B, 2017, SCIENCE, V355, P1158, DOI 10.1126/science.aam7622; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shapira S, 2017, ONCOTARGET, V8, P38581, DOI 10.18632/oncotarget.16934; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Soussi T, 2015, CELL DEATH DIFFER, V22, P1239, DOI 10.1038/cdd.2015.53; Stites EC, 2018, CPT-PHARMACOMET SYST, V7, P342, DOI 10.1002/psp4.12291; Tomasini P, 2016, ONCOLOGIST, V21, P1450, DOI 10.1634/theoncologist.2015-0084; Witsch E, 2010, PHYSIOLOGY, V25, P85, DOI 10.1152/physiol.00045.2009; Yue XT, 2017, J MOL BIOL, V429, P1595, DOI 10.1016/j.jmb.2017.03.030; Zenonos K, 2013, WORLD J GASTRO ONCOL, V5, P97, DOI 10.4251/wjgo.v5.i5.97; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	32	1	1	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					4967	4979		10.1038/s41388-021-01792-8	http://dx.doi.org/10.1038/s41388-021-01792-8		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34172933	Green Published, hybrid			2022-12-26	WOS:000667360400001
J	Adatia, A; Wahab, M; Shahid, I; Moinuddin, A; Killian, KJ; Satia, I				Adatia, Adil; Wahab, Mustafaa; Shahid, Izza; Moinuddin, Ali; Killian, Kieran J.; Satia, Imran			Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects	PLOS ONE			English	Article							THORACIC SOCIETY; EX-SMOKERS; DISEASE; COPD; EXACERBATION; TRENDS; MORTALITY; IMPACT; HYPERSECRETION; SARCOPENIA	Background The effects of long-term cigarette smoke exposure on pulmonary physiology and how those effects lead to reduced exercise capacity are not well established. Methods We retrospectively analyzed the spirometry, single-breath gas transfer (DLCO), peripheral muscle strength, and maximum exercise capacity data in patients referred to McMaster University Medical Centre for cardiopulmonary exercise testing between 2000 and 2012. Results 29,441 subjects underwent CPET and had a recorded smoking history [58% male, mean age 51.1 years (S.D.+/- 19.6), BMI 27.4 kg/m(2)(+/- 5.8)]. 7081 (24%) were current or former smokers and were divided into 4 categories by packs years (mean +/- S.D.): <10 (5.8 +/- 3.3), 10-20 (17.1 +/- 2.9), 20-30 (27.1 +/- 2.8), 30-40 (37.3 +/- 2.8), and >40 (53.9 +/- 12.8). Patients with greater cigarette smoke exposure had lower expiratory flow rates (FEV1, FEF50, FEF75, PEFR), DLCO, and maximum power output (MPO) during exercise. There was no association between smoke exposure and muscle strength. Modeling MPO (kpm/min) output as a function of demographic and physiologic variables showed that the data are well explained by muscle strength (kg), FEV1 (L), and DLCO (mmHg/min/mL) in similar magnitude (MPO = 42.7*Quads(0.34)*FEV1(0.34) * DLCO0.43; r = 0.84). Conclusions Long-term cigarette smoke exposure is associated with small airway narrowing and impaired diffusion capacity but not with peripheral muscle weakness. The effects of smoking, age, and gender on maximum power output are mediated by reductions in FEV1, muscle strength and DLCO. Exercise capacity in smokers may benefit from therapies targeting all 3 variables.	[Adatia, Adil; Wahab, Mustafaa; Shahid, Izza; Moinuddin, Ali; Killian, Kieran J.; Satia, Imran] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Satia, Imran] St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON, Canada	McMaster University; McMaster University	Adatia, A (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	adatia4@mcmaster.ca	Satia, Imran/ABA-2872-2020; Moinuddin, Ali/GPW-8338-2022	Satia, Imran/0000-0003-4206-6000; Moinuddin, Ali/0000-0002-7720-0217; Adatia, Adil/0000-0002-7612-6529				Andersson F, 2002, RESP MED, V96, P700, DOI 10.1053/rmed.2002.1334; Anzueto A, 2020, RESP MED X, V2; Appleton S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001104.pub2; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bodduluri S, 2017, AM J RESP CRIT CARE, V196, P1404, DOI 10.1164/rccm.201705-0855OC; Brown DW, 2010, COPD, V7, P59, DOI 10.3109/15412550903499548; Burney PGJ, 2015, EUR RESPIR J, V45, P1239, DOI 10.1183/09031936.00142414; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calzetta L, 2017, RESP MED, V129, P189, DOI 10.1016/j.rmed.2017.06.020; Celli B, 2009, AM J RESP CRIT CARE, V180, P948, DOI 10.1164/rccm.200906-0876OC; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; Degens H, 2015, AM J RESP CRIT CARE, V191, P620, DOI 10.1164/rccm.201410-1830PP; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Frantz S, 2012, RESP MED, V106, P1116, DOI 10.1016/j.rmed.2012.04.010; GOLDSTEIN RS, 1994, LANCET, V344, P1394, DOI 10.1016/S0140-6736(94)90568-1; Graham BL, 2019, AM J RESP CRIT CARE, V200, pE70, DOI 10.1164/rccm.201908-1590ST; Graham BL, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00016-2016; Halpin DMG, 2012, INT J CHRONIC OBSTR, V7, P653, DOI 10.2147/COPD.S34186; Hopkinson NS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-25; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Isajevs S, 2009, EUR RESPIR J, V33, P61, DOI 10.1183/09031936.00145307; Johns DP, 2014, J THORAC DIS, V6, P1557, DOI 10.3978/j.issn.2072-1439.2014.08.18; Jones PW, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-161; Kirby M, 2013, THORAX, V68, P752, DOI 10.1136/thoraxjnl-2012-203108; Kok MO, 2012, EUR ADDICT RES, V18, P70, DOI 10.1159/000333600; Lipson DA., 2020, AM J RESP CRIT CARE; Lipson DA, 2018, NEW ENGL J MED, V378, P1671, DOI 10.1056/NEJMoa1713901; Lopez-Campos JL, 2014, LANCET RESP MED, V2, P54, DOI 10.1016/S2213-2600(13)70232-7; Macklem PT, 2010, EUR RESPIR J, V35, P676, DOI 10.1183/09031936.00120609; Maestrelli P, 2001, AM J RESP CRIT CARE, V164, pS76, DOI 10.1164/ajrccm.164.supplement_2.2106067; Maltais F, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1193-9; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Molinari N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0469-6; Molinari N, 2015, COPD, V12, P621, DOI 10.3109/15412555.2015.1007931; MULLEN JBM, 1987, THORAX, V42, P843, DOI 10.1136/thx.42.11.843; O'Donnell Denis E, 2007, COPD, V4, P225, DOI 10.1080/15412550701480455; O'Donnell DE, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01348-2016; Oba Y, 2016, THORAX, V71, P15, DOI 10.1136/thoraxjnl-2014-206732; ODONNELL DE, 1995, AM J RESP CRIT CARE, V152, P2005, DOI 10.1164/ajrccm.152.6.8520769; Oelsner EC, 2020, LANCET RESP MED, V8, P34, DOI 10.1016/S2213-2600(19)30276-0; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RIES AL, 1995, ANN INTERN MED, V122, P823, DOI 10.7326/0003-4819-122-11-199506010-00003; Rom O, 2012, ANN NY ACAD SCI, V1259, P47, DOI 10.1111/j.1749-6632.2012.06532.x; SANSORES RH, 1992, AM REV RESPIR DIS, V146, P959, DOI 10.1164/ajrccm/146.4.959; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Singh SJ, 2014, EUR RESPIR J, V44, P1447, DOI 10.1183/09031936.00150414; Steffl M, 2015, PHYSIOL RES, V64, P419, DOI 10.33549/physiolres.932802; Suissa S, 2008, EUR RESPIR J, V31, P927, DOI 10.1183/09031936.00098307; Thurlbeck WM, 1980, SMOKING AIRFLOW LIMI; Toy EL, 2010, COPD, V7, P214, DOI 10.3109/15412555.2010.481697; van den Borst B, 2011, THORAX, V66, P961, DOI 10.1136/thoraxjnl-2011-200010; Vestbo J, 2020, AM J RESP CRIT CARE; Vestbo J, 2016, LANCET, V387, P1817, DOI 10.1016/S0140-6736(16)30069-1; Wust RCI, 2008, APPL PHYSIOL NUTR ME, V33, P1240, DOI 10.1139/H08-116; Wust RCI., 2009, OXYGEN TRANSPORT TIS, V2009	55	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0250957	10.1371/journal.pone.0250957	http://dx.doi.org/10.1371/journal.pone.0250957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166381	gold, Green Published			2022-12-26	WOS:000671692800038
J	Sharmin, S; Lipka, U; Polle, A; Eckert, C				Sharmin, Shayla; Lipka, Ulrike; Polle, Andrea; Eckert, Christian			The influence of transpiration on foliar accumulation of salt and nutrients under salinity in poplar (Populus x canescens)	PLOS ONE			English	Article							XYLEM ABSCISIC-ACID; LEAF MESOPHYLL; TOLERANCE; GROWTH; POTASSIUM; CALCIUM; PLANTS; EXPRESSION; TRANSPORT; STRESS	Increasing salinity is one of the major drawbacks for plant growth. Besides the ion itself being toxic to plant cells, it greatly interferes with the supply of other macronutrients like potassium, calcium and magnesium. However, little is known about how sodium affects the translocation of these nutrients from the root to the shoot. The major driving force of this translocation process is thought to be the water flow through the xylem driven by transpiration. To dissect the effects of transpiration from those of salinity we compared salt stressed, ABA treated and combined salt- and ABA treated poplars with untreated controls. Salinity reduced the root content of major nutrients like K+, Ca2+ and Mg2+. Less Ca2+ and Mg2+ in the roots resulted in reduced leaf Ca2+ and leaf Mg2+ levels due to reduced stomatal conductance and reduced transpiration. Interestingly, leaf K+ levels were positively affected in leaves under salt stress although there was less K+ in the roots under salt. In response to ABA, transpiration was also decreased and Mg2+ and Ca2+ levels decreased comparably to the salt stress treatment, while K+ levels were not affected. Thus, our results suggest that loading and retention of leaf K+ is enhanced under salt stress compared to merely transpiration driven cation supply.	[Sharmin, Shayla; Lipka, Ulrike; Polle, Andrea; Eckert, Christian] Univ Gottingen, Forest Bot & Tree Physiol, Gottingen, Germany	University of Gottingen	Eckert, C (corresponding author), Univ Gottingen, Forest Bot & Tree Physiol, Gottingen, Germany.	eckert5@gwdg.de		Sharmin, Shayla/0000-0003-0481-7678	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Shayla Sharmin gratefully acknowledges the awarding of a doctoral scholarship of the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend M, 2009, PLANT PHYSIOL, V151, P2110, DOI 10.1104/pp.109.144956; BIDDULPH O, 1959, PLANT PHYSIOL, V34, P512, DOI 10.1104/pp.34.5.512; Centritto M, 2003, PLANT CELL ENVIRON, V26, P585, DOI 10.1046/j.1365-3040.2003.00993.x; Chen SL, 2003, ACTA BOT SIN, V45, P561; Chen SL, 2003, CAN J FOREST RES, V33, P967, DOI 10.1139/X03-066; Chen SL, 2002, J PLANT GROWTH REGUL, V21, P224, DOI 10.1007/s00344-002-1001-4; Chen SL, 2002, TREES-STRUCT FUNCT, V16, P16, DOI 10.1007/s00468-001-0138-2; Chen SL, 2001, TREES-STRUCT FUNCT, V15, P186, DOI 10.1007/s004680100091; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Daszkowska-Golec A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00138; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Erturk U, 2007, BIOL PLANTARUM, V51, P597, DOI 10.1007/s10535-007-0132-7; Escalante-Perez M, 2009, PLANTA, V229, P299, DOI 10.1007/s00425-008-0829-7; GRATTAN SR, 1992, AGR ECOSYST ENVIRON, V38, P275, DOI 10.1016/0167-8809(92)90151-Z; HANGER BC, 1979, COMMUN SOIL SCI PLAN, V10, P171, DOI 10.1080/00103627909366887; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hirsch RE, 1998, SCIENCE, V280, P918, DOI 10.1126/science.280.5365.918; Horie T, 2012, RICE, V5, DOI 10.1186/1939-8433-5-11; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; JEHL B, 1981, J MICROSC-OXFORD, V123, P307, DOI 10.1111/j.1365-2818.1981.tb02475.x; LAZAROFF N, 1966, AUST J BIOL SCI, V19, P991, DOI 10.1071/BI9660991; LEPLE JC, 1992, PLANT CELL REP, V11, P137, DOI 10.1007/BF00232166; Loupassaki MH, 2002, J PLANT NUTR, V25, P2457, DOI 10.1081/PLN-120014707; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Mian A, 2011, PLANT J, V68, P468, DOI 10.1111/j.1365-313X.2011.04701.x; Mickelbart MV, 2007, J PLANT NUTR, V30, P105, DOI 10.1080/01904160601055137; MITTELHEUSER CJ, 1969, NATURE, V221, P281, DOI 10.1038/221281a0; Muller A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00332; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Munns R, 2005, NEW PHYTOL, V167, P645, DOI 10.1111/j.1469-8137.2005.01487.x; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pantin F, 2013, NEW PHYTOL, V197, P65, DOI 10.1111/nph.12013; Percey WJ, 2016, PLANT PHYSIOL BIOCH, V109, P346, DOI 10.1016/j.plaphy.2016.10.011; PITMAN MG, 1965, AUST J BIOL SCI, V18, P987, DOI 10.1071/BI9650987; Polle A, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01875; Polle A, 2015, PLANT CELL ENVIRON, V38, P1794, DOI 10.1111/pce.12440; Popko J, 2010, PLANT BIOLOGY, V12, P242, DOI 10.1111/j.1438-8677.2009.00305.x; RICHARDS L. A., 1954, Diagnosis and Improvement of Saline and Alkali Soils.; Ruiz D, 1997, TREE PHYSIOL, V17, P141; Shahzad M, 2012, J AGRON CROP SCI, V198, P46, DOI 10.1111/j.1439-037X.2011.00487.x; Sharp RE, 2004, J EXP BOT, V55, P2343, DOI 10.1093/jxb/erh276; SMITH JAC, 1991, BOT ACTA, V104, P416, DOI 10.1111/j.1438-8677.1991.tb00252.x; Thu TTP, 2017, SOIL SCI PLANT NUTR, V63, P264, DOI 10.1080/00380768.2017.1323672; Wang M, 2013, INT J MOL SCI, V14, P7370, DOI 10.3390/ijms14047370; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wu HH, 2018, PLANT SOIL, V431, P1, DOI 10.1007/s11104-018-3770-y; Wu HHY, 2015, J INTEGR PLANT BIOL, V57, P171, DOI 10.1111/jipb.12238; Wu HH, 2013, PHYSIOL PLANTARUM, V149, P515, DOI 10.1111/ppl.12056; Yu DD, 2019, NEW PHYTOL, V223, P1192, DOI 10.1111/nph.15878; ZEKRI M, 1992, PLANT SOIL, V147, P171, DOI 10.1007/BF00029069	51	2	2	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253228	10.1371/journal.pone.0253228	http://dx.doi.org/10.1371/journal.pone.0253228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166404	gold, Green Published			2022-12-26	WOS:000671692800012
J	Parol-Kulczyk, M; Gzil, A; Maciejewska, J; Bodnar, M; Grzanka, D				Parol-Kulczyk, Martyna; Gzil, Arkadiusz; Maciejewska, Joanna; Bodnar, Magdalena; Grzanka, Dariusz			Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; BETA-CATENIN; TRANSCRIPTIONAL ACTIVATION; SOX4 EXPRESSION; CELL-MIGRATION; KEY CYTOKINE; STEM-CELLS; IN-VITRO	The chronic inflammation influences a microenvironment, where as a result of losing control over tissue homeostatic mechanisms, the carcinogenesis process may be induced. Inflammatory response cells can secrete a number of factors that support both initiation and progression of cancer and also they may consequently induct an epithelial-mesenchymal transition (EMT), the process responsible for development of distant metastasis. Macrophage migration inhibitory factor (MIF) acts as a pro-inflammatory cytokine that is considered as a link between chronic inflammation and tumor development. MIF can function as a modulator of important cancer-related genes expression, as well as an activator of signaling pathways that promotes the development of prostate cancer. The study was performed on FFPE tissues resected from patients who underwent radical prostatectomy. To investigate the relationship of studied proteins with involvement in tumor progression and initiation of epithelial-to-mesenchymal transition (EMT) process, we selected clinicopathological parameters related to tumor progression. Immunohistochemical analyses of MIF, SOX-4, beta-catenin and E-cadherin were performed on TMA slides. We found a statistically significant correlation of overall beta-catenin expression with the both lymph node metastasis (p<0.001) and presence of angioinvasion (p = 0.012). Membrane beta-catenin expression was associated with distant metastasis (p = 0.021). In turn, nuclear MIF was correlated with lymph node metastasis (p = 0.003). The positive protein-protein correlations have been shown between the total beta-catenin protein expression level with level of nuclear SOX-4 protein expression (r = 0.27; p<0.05) as well as negative correlation of beta-catenin expression with level of nuclear MIF protein expression (r = -0.23; p<0.05). Our results seem promising and strongly highlight the potential role of MIF in development of nodal metastases as well as may confirm an involvement of beta-catenin in disease spread in case of prostate cancer.	[Parol-Kulczyk, Martyna; Gzil, Arkadiusz; Maciejewska, Joanna; Bodnar, Magdalena; Grzanka, Dariusz] Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Fac Med, Dept Clin Pathomorphol, Torun, Poland	Nicolaus Copernicus University	Parol-Kulczyk, M (corresponding author), Nicolaus Copernicus Univ Torun, Coll Med Bydgoszcz, Fac Med, Dept Clin Pathomorphol, Torun, Poland.	mparol@cm.umk.pl	Bodnar, Magdalena/D-6131-2014	Bodnar, Magdalena/0000-0003-3748-1058; , Martyna/0000-0001-8130-4302				Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Amin MB, 2017, CA-CANCER J CLIN, V67, P93, DOI 10.3322/caac.21388; Bando H, 2002, JPN J CANCER RES, V93, P389, DOI 10.1111/j.1349-7006.2002.tb01269.x; Basu Sayon, 2016, F1000Res, V5, DOI 10.12688/f1000research.7579.1; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bilir B, 2016, CANCER RES, V76, P1112, DOI 10.1158/0008-5472.CAN-15-1868; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Charan M, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02992-y; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Cheng SP, 2015, ENDOCR-RELAT CANCER, V22, P179, DOI 10.1530/ERC-14-0269; Choudhary S, 2013, CARCINOGENESIS, V34, P2891, DOI 10.1093/carcin/bgt239; De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; del Vecchio MT, 2000, PROSTATE, V45, P51, DOI 10.1002/1097-0045(20000915)45:1<51::AID-PROS6>3.0.CO;2-9; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Fang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052804; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Funamizu N, 2013, INT J CANCER, V132, P785, DOI 10.1002/ijc.27736; Gordon-Weeks AN, 2015, CYTOKINE GROWTH F R, V26, P451, DOI 10.1016/j.cytogfr.2015.03.002; Graham JD, 1999, J MOL ENDOCRINOL, V22, P295, DOI 10.1677/jme.0.0220295; Grant CM, 2013, TRANSL ANDROL UROL, V2, P202, DOI 10.3978/j.issn.2223-4683.2013.09.04; Guda MR, 2019, AM J CANCER RES, V9, P2760; Guo F., 2017, INT J CLIN EXP PATHO, V13, P2916; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Hussain F, 2013, MOL CANCER THER, V12, P1223, DOI 10.1158/1535-7163.MCT-12-0988; Jafarnejad SM, 2010, AM J PATHOL, V177, P2741, DOI 10.2353/ajpath.2010.100377; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamimura A, 2000, CANCER, V89, P334, DOI 10.1002/1097-0142(20000715)89:2<334::AID-CNCR18>3.0.CO;2-N; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Lickert H, 2000, DEVELOPMENT, V127, P3805; Lin CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067128; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu YF, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694539; Mamoori A, 2019, GENE, V697, P165, DOI 10.1016/j.gene.2019.02.046; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mao QQ, 2010, CANCER INVEST, V28, P1013, DOI 10.3109/07357900802620844; Mawhinney L, 2014, MOL MED, V20, P729, DOI 10.2119/molmed.2014.00136; Meyer-Siegler KL, 2002, CANCER-AM CANCER SOC, V94, P1449, DOI 10.1002/cncr.10354; MeyerSiegler K, 1996, UROLOGY, V48, P448, DOI 10.1016/S0090-4295(96)00207-5; Moreno CS, 2010, AM J PATHOL, V176, P518, DOI 10.2353/ajpath.2010.090657; Mylavarapu S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00054; Nakamura M, 2011, J DERMATOL SCI, V61, P7, DOI 10.1016/j.jdermsci.2010.11.015; National Cancer Insitute, 2018, CANC STAT FACTS CANC; Ohkawara T, 2005, J GASTROENTEROL, V40, P117, DOI 10.1007/s00535-004-1526-3; Ohta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074315; Pei XJ, 2014, INT J MED SCI, V11, P106, DOI 10.7150/ijms.7264; Penticuff JC, 2019, NAT REV UROL, V16, P318, DOI 10.1038/s41585-019-0171-9; Presti M, 2018, ONCOL LETT, V16, P2881, DOI 10.3892/ol.2018.8990; Price N., 2004, 40 ANN M AM SOC CLIN, P9570; Putzke AP, 2011, AM J PATHOL, V179, P400, DOI 10.1016/j.ajpath.2011.03.028; Qin Y., 2019, CLINICOPATHOLOGICAL, V12, P10559; Rawla P, 2019, WORLD J ONCOL, V10, P63, DOI 10.14740/wjon1191; Ren Y, 2003, INT J CANCER, V107, P22, DOI 10.1002/ijc.11287; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Rubin MA, 2001, HUM PATHOL, V32, P690, DOI 10.1053/hupa.2001.25902; Saegusa M, 2012, LAB INVEST, V92, P511, DOI 10.1038/labinvest.2011.196; Saha B, 2008, PROSTATE, V68, P78, DOI 10.1002/pros.20670; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sanchez-Zamora YI, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/804519; Santos LL, 2009, CLIN CHIM ACTA, V399, P1, DOI 10.1016/j.cca.2008.09.014; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Schuijers J, 2014, EMBO J, V33, P146, DOI 10.1002/embj.201385358; Shi S, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/658141; Sinner D, 2007, MOL CELL BIOL, V27, P7802, DOI 10.1128/MCB.02179-06; Soumoy L, 2019, CANCERS, V11, DOI 10.3390/cancers11040529; Stark T, 2015, TRANSL ANDROL UROL, V4, P455, DOI 10.3978/j.issn.2223-4683.2015.04.12; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Vu T, 2017, CANCERS, V9, DOI 10.3390/cancers9120171; UMBAS R, 1992, CANCER RES, V52, P5104; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Verjans E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-230; Vervoort SJ, 2013, ONCOGENE, V32, P3397, DOI 10.1038/onc.2012.506; Wang L, 2013, PROSTATE CANCER P D, V16, P301, DOI 10.1038/pcan.2013.25; Weis WI, 2006, J BIOL CHEM, V281, P35593, DOI 10.1074/jbc.R600027200; Yao Y, 2016, STEM CELL REP, V7, P249, DOI 10.1016/j.stemcr.2016.07.003	85	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253112	10.1371/journal.pone.0253112	http://dx.doi.org/10.1371/journal.pone.0253112			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157052	gold, Green Published			2022-12-26	WOS:000671691200018
J	Yao, JP; Liu, WL; Liu, QB; Liu, YY; Chen, XD; Pan, M				Yao, Jianpeng; Liu, Wenling; Liu, Qingbin; Liu, Yuyang; Chen, Xiaodong; Pan, Mao			Optimized algorithm for multipoint geostatistical facies modeling based on a deep feedforward neural network	PLOS ONE			English	Article							IDENTIFICATION; CLASSIFICATION; LITHOFACIES; SIMULATION	Reservoir facies modeling is an important way to express the sedimentary characteristics of the target area. Conventional deterministic modeling, target-based stochastic simulation, and two-point geostatistical stochastic modeling methods are difficult to characterize the complex sedimentary microfacies structure. Multi-point geostatistics (MPG) method can learn a priori geological model and can realize multi-point correlation simulation in space, while deep neural network can express nonlinear relationship well. This article comprehensively utilizes the advantages of the two to try to optimize the multi-point geostatistical reservoir facies modeling algorithm based on the Deep Forward Neural Network (DFNN). Through the optimization design of the multi-grid training data organization form and repeated simulation of grid nodes, the simulation results of diverse modeling algorithm parameters, data conditions and deposition types of sedimentary microfacies models were compared. The results show that by optimizing the organization of multi-grid training data and repeated simulation of nodes, it is easier to obtain a random simulation close to the real target, and the simulation of sedimentary microfacies of different scales and different sedimentary types can be performed.	[Yao, Jianpeng; Liu, Qingbin; Liu, Yuyang; Pan, Mao] Peking Univ, Sch Earth & Space Sci, Key Lab Orogen Belts & Crustal Evolut, Beijing, Peoples R China; [Liu, Wenling; Liu, Yuyang] PetroChina, Res Inst Petr Explorat & Dev, Beijing, Peoples R China; [Liu, Qingbin] Sinopec, Petr Explorat & Prod Res Inst, Beijing, Peoples R China; [Chen, Xiaodong] Changqing Oilfield Branch Co Ltd, Explorat & Dev Res Inst, PetroChina, Xian, Peoples R China	Peking University; China National Petroleum Corporation; Sinopec; China National Petroleum Corporation; Sinopec	Yao, JP; Pan, M (corresponding author), Peking Univ, Sch Earth & Space Sci, Key Lab Orogen Belts & Crustal Evolut, Beijing, Peoples R China.	jpyao@pku.edu.cn; panmao@pku.edu.cn	Chen, Xiao/GQA-8928-2022; chen, xia/GYR-3948-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022	Chen, Xiao/0000-0002-9797-8384; 	Major National Science and Technology Projects of China [2017ZX05013-002-002, 2016ZX0510-001]	Major National Science and Technology Projects of China	This study was supported by the Major National Science and Technology Projects of China in the form of grants awarded to MP (2017ZX05013-002-002, 2016ZX0510-001), PetroChina in the form of salaries for WL, YL, and XC, and Sinopec in the form of a salary for QL. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mudhafar WJ, 2017, J PET EXPLOR PROD TE, V7, P1023, DOI 10.1007/s13202-017-0360-0; [安鹏 An Peng], 2018, [地球物理学进展, Progress in Geophysiscs], V33, P1029; [Anonymous], 2001, SPE ANN TECHN C EXH; Arpat G. B., 2005, SEQUENTIAL SIMULATIO; Avalos S, 2020, ARXIV PREPRINT ARXIV, P12190; Bhattacharya S, 2016, J NAT GAS SCI ENG, V33, P1119, DOI 10.1016/j.jngse.2016.04.055; Caers J., 2002, AAPG MEMOIR, V80, P383; Caers J., 1998, STOCHASTIC RESERVOIR; Chan H, 2017, ARXIV PREPRINT ARXIV; Chugunova TL, 2008, MATH GEOSCI, V40, P133, DOI 10.1007/s11004-007-9142-4; Feng Wenjie, 2014, Journal of Central South University (Science and Technology), V45, P1261; Hall Brendon, 2016, Leading Edge, V35, P906, DOI 10.1190/tle35100906.1; Honarkhah M, 2012, MATH GEOSCI, V44, P651, DOI 10.1007/s11004-012-9413-6; Journel A, 2006, MATH GEOL, V38, P591, DOI 10.1007/s11004-006-9031-2; Keuper J, 2017, COMPUTER VISION PATT; Laloy E, 2017, ARXIV170804975V2; [李国和 Li Guohe], 2018, [地球物理学进展, Progress in Geophysiscs], V33, P1660; Li GH, 2016, ADV INTEL SYS RES, V133, P354; Li JG., 2015, TECHNOLOGY INNOVATIO, V14, P21; Liang L., 2018, ARXIV PREPRINT ARXIV; Qin YB., 2017, COMPUTER SYSTEMS APP, V26, P273; Qiu YN., 2000, ACTA PETROLEI SINICA, V21, P125; Raeesi M, 2012, J PETROL SCI ENG, V82-83, P151, DOI 10.1016/j.petrol.2012.01.012; Ran QQ., 1995, PETROL EXPLOR DEV+, V22, P101; Ren MF, 2019, SYST SCI CONTROL ENG, V7, P158, DOI 10.1080/21642583.2019.1588804; [单敬福 Shan Jingfu], 2015, [地球物理学进展, Progress in Geophysiscs], V30, P1257; Shi SY., 2011, GEOLOGICAL SCI TECHN, V30, P138; Strebelle S, 2002, MATH GEOL, V34, P1, DOI 10.1023/A:1014009426274; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Torres A., 2013, P 2013 SEG ANN M; Wang H., 2017, FAULT BLOCK OIL GAS, V24, P490; Wang JH., 2013, J YANGTZE U NAT SCI, V10, P60; [王立鑫 Wang Lixin], 2019, [石油勘探与开发, Petroleum Exploration and Development], V46, P703; [王鸣川 Wang Mingchuan], 2018, [石油学报, Acta Petrolei Sinica], V39, P916; [吴胜和 Wu Qinghe], 2005, [古地理学报, Journal of palaeogeography], V7, P137; Wu SH., 2010, RESERVOIR CHARACTERI, P290; Xie YX, 2018, J PETROL SCI ENG, V160, P182, DOI 10.1016/j.petrol.2017.10.028; [喻思羽 Yu Siyu], 2017, [石油学报, Acta Petrolei Sinica], V38, P1425; Zhang CK, 2021, COMPUTAT GEOSCI, V25, P553, DOI 10.1007/s10596-020-10027-w; Zhang GY, 2018, GEOPHYS J INT, V215, P1368, DOI 10.1093/gji/ggy344; Zhang TF, 2019, PETROL SCI, V16, P541, DOI 10.1007/s12182-019-0328-4; Zhao T, 2014, SEG DENV 2014 ANN M SEG DENV 2014 ANN M; 范训礼, 1999, [测井技术, Well Logging Technology], V23, P50	43	1	1	17	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253174	10.1371/journal.pone.0253174	http://dx.doi.org/10.1371/journal.pone.0253174			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157029	Green Published, gold			2022-12-26	WOS:000671691200004
J	Liang, SK; Hsu, CC; Song, HL; Huang, YC; Kuo, CW; Yao, X; Li, CC; Yang, HC; Hung, YL; Chao, SY; Wu, SC; Tsai, FR; Chen, JK; Liao, WN; Cheng, SC; Tsou, TC; Wang, IC				Liang, Sheng-Kai; Hsu, Chia-Chan; Song, Hsiang-Lin; Huang, Yu-Chi; Kuo, Chun-Wei; Yao, Xiang; Li, Chien-Cheng; Yang, Hui-Chen; Hung, Yu-Ling; Chao, Sheng-Yang; Wu, Shun-Chi; Tsai, Feng-Ren; Chen, Jen-Kun; Liao, Wei-Neng; Cheng, Shin-Chin; Tsou, Tsui-Chun; Wang, I-Ching			FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis	ONCOGENE			English	Article							M1 TRANSCRIPTION FACTOR; PROGRESSION; EXPRESSION; BORTEZOMIB; INITIATION; INDUCTION; LANDSCAPE; SURVIVAL; TARGET; GENES	Small cell lung cancer (SCLC) continues to cause poor clinical outcomes due to limited advances in sustained treatments for rapid cancer cell proliferation and progression. The transcriptional factor Forkhead Box M1 (FOXM1) regulates cell proliferation, tumor initiation, and progression in multiple cancer types. However, its biological function and clinical significance in SCLC remain unestablished. Analysis of the Cancer Cell Line Encyclopedia and SCLC datasets in the present study disclosed significant upregulation of FOXM1 mRNA in SCLC cell lines and tissues. Gene set enrichment analysis (GSEA) revealed that FOXM1 is positively correlated with pathways regulating cell proliferation and DNA damage repair, as evident from sensitization of FOXM1-depleted SCLC cells to chemotherapy. Furthermore, Foxm1 knockout inhibited SCLC formation in the Rb1(fl/fl)Trp53(fl/fl)Myc(LSL/LSL) (RPM) mouse model associated with increased levels of neuroendocrine markers, Ascl1 and Cgrp, and decrease in Yap1. Consistently, FOXM1 depletion in NCI-H1688 SCLC cells reduced migration and enhanced apoptosis and sensitivity to cisplatin and etoposide. SCLC with high FOXM1 expression (N = 30, 57.7%) was significantly correlated with advanced clinical stage, extrathoracic metastases, and decrease in overall survival (OS), compared with the low-FOXM1 group (7.90 vs. 12.46 months). Moreover, the high-FOXM1 group showed shorter progression-free survival after standard chemotherapy, compared with the low-FOXM1 group (3.90 vs. 8.69 months). Our collective findings support the utility of FOXM1 as a prognostic biomarker and potential molecular target for SCLC.	[Liang, Sheng-Kai; Yang, Hui-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Hsinchu Branch, Hsinchu 300, Taiwan; [Liang, Sheng-Kai; Hsu, Chia-Chan; Huang, Yu-Chi; Yao, Xiang; Li, Chien-Cheng; Hung, Yu-Ling; Chao, Sheng-Yang; Wang, I-Ching] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan; [Song, Hsiang-Lin; Kuo, Chun-Wei] Natl Taiwan Univ Hosp, Dept Pathol, Hsinchu Branch, Hsinchu, Taiwan; [Huang, Yu-Chi; Hung, Yu-Ling; Wang, I-Ching] Natl Tsing Hua Univ, Train Res Ctr, Hsinchu 300, Taiwan; [Wu, Shun-Chi; Tsai, Feng-Ren] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 300, Taiwan; [Chen, Jen-Kun; Liao, Wei-Neng] Natl Hlth Res Inst, Inst Biomed Engn & Nanomed, Miaoli 350, Taiwan; [Cheng, Shin-Chin] Xiamen Univ, Sch Life Sci, Xiamen 361102, Fujian, Peoples R China; [Tsou, Tsui-Chun] Natl Hlth Res Inst, Natl Inst Environm Hlth Sci, Miaoli 350, Taiwan; [Wang, I-Ching] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan; Xiamen University; National Health Research Institutes - Taiwan; National Tsing Hua University	Wang, IC (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu 300, Taiwan.; Wang, IC (corresponding author), Natl Tsing Hua Univ, Train Res Ctr, Hsinchu 300, Taiwan.; Wang, IC (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan.	icwang@life.nthu.edu.tw	; CHENG, SHIH-CHIN/H-4567-2015	SONG, HSIANG-LIN/0000-0002-8720-6436; Wang, I-Ching/0000-0003-4398-2975; CHENG, SHIH-CHIN/0000-0003-1251-8774; LIANG, SHENG-KAI/0000-0003-3486-2293; Liao, WEI NENG/0000-0002-1857-741X	NHRI Laboratory Animal Center [LA-109-PP-01]; National Taiwan University Hospital Hsinchu Branch research grant [NTUH-HC 108-s267]; Ministry of Science and Technology of Taiwan grant [MOST105-2628-B-007-003-MY3, MOST109-2314-B-007-005-MY3]; National Tsing Hua University [108Q2502E1, 109Q2714E1, 110Q2501E1]; Brain Research Center under the Higher Education Sprout Project; Ministry of Education in Taiwan; Ministry of Science and Technology in Taiwan	NHRI Laboratory Animal Center; National Taiwan University Hospital Hsinchu Branch research grant; Ministry of Science and Technology of Taiwan grant; National Tsing Hua University; Brain Research Center under the Higher Education Sprout Project; Ministry of Education in Taiwan(Ministry of Education, Taiwan); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	We thank all study participants and staff at NTUH-HC for their contribution to this project, Feng-Yuan Tsai (NHRI), and NHRI Laboratory Animal Center (LA-109-PP-01), and I-BEN Service (TSSI-BN-31) for technical assistance, Stephen Elledge (Harvard Medical School) for kindly providing the pInducer10-mir-RUP-PheS plasmid, Pradip Raychaudhuri (UIC) and Vladimir Kalinichenko (CCHMC) for kindly providing the Foxm1fl/ fl mice. This work was supported by the National Taiwan University Hospital Hsinchu Branch research grant NTUH-HC 108-s267 (S-K L), the Ministry of Science and Technology of Taiwan grant MOST105-2628-B-007-003-MY3 and MOST109-2314-B-007-005-MY3 (I-C W), National Tsing Hua University grant 108Q2502E1, 109Q2714E1, 110Q2501E1 (I-C W), and by the Brain Research Center under the Higher Education Sprout Project, co-funded by the Ministry of Education and the Ministry of Science and Technology in Taiwan.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; BHAT UG, 2009, PLOS ONE, V4; Borromeo MD, 2016, CELL REP, V16, P1259, DOI 10.1016/j.celrep.2016.06.081; Byers LA, 2012, CANCER DISCOV, V2, P798, DOI 10.1158/2159-8290.CD-12-0112; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Dammert MA., 2019, NAT COMMUN, V10; Davies AM, 2007, CLIN CANCER RES, V13, p4647S, DOI 10.1158/1078-0432.CCR-07-0334; de Moraes GN, 2015, CELL SIGNAL, V27, P2496, DOI 10.1016/j.cellsig.2015.09.013; Fang PP, 2018, MOL CANCER RES, V16, P961, DOI 10.1158/1541-7786.MCR-17-0607; Gardner EE, 2017, CANCER CELL, V31, P286, DOI 10.1016/j.ccell.2017.01.006; Gartel AL, 2010, EXPERT OPIN INV DRUG, V19, P235, DOI 10.1517/13543780903563364; Gemenetzidis E, 2010, CANCER RES, V70, P9515, DOI 10.1158/0008-5472.CAN-10-2173; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Ireland AS, 2020, CANCER CELL, V38, P60, DOI 10.1016/j.ccell.2020.05.001; Jackman DM, 2005, LANCET, V366, P1385, DOI 10.1016/S0140-6736(05)67569-1; Jiang LY, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005895; Kalemkerian GP, 2013, J NATL COMPR CANC NE, V11, P78, DOI 10.6004/jnccn.2013.0011; Karachaliou N, 2013, TRANSL LUNG CANCER R, V2, P172, DOI 10.3978/j.issn.2218-6751.2013.01.01; KARIM S, 2012, ONCOL REV, V6; Keenan AB, 2019, NUCLEIC ACIDS RES, V47, pW212, DOI 10.1093/nar/gkz446; Kim SH, 2015, STEM CELL REP, V4, P226, DOI 10.1016/j.stemcr.2014.12.006; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Krupczak-Hollis K, 2004, DEV BIOL, V276, P74, DOI 10.1016/j.ydbio.2004.08.022; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; McColl K, 2017, ONCOTARGET, V8, P73745, DOI 10.18632/oncotarget.20572; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mok T, 2020, ANN ONCOL, V31, P1056, DOI 10.1016/j.annonc.2020.04.478; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Nicholson AG, 2016, J THORAC ONCOL, V11, P300, DOI 10.1016/j.jtho.2015.10.008; Okada K, 2013, ANN SURG ONCOL, V20, P1035, DOI 10.1245/s10434-012-2680-0; Pal S, 2018, CANCER RES, V78, P4007, DOI 10.1158/0008-5472.CAN-17-3691; PAN C, 2016, BMC CANCER, V16; Pandit B, 2009, CELL CYCLE, V8, P3425, DOI 10.4161/cc.8.20.9628; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Ramalingam SS, 2020, NEW ENGL J MED, V382, P41, DOI 10.1056/NEJMoa1913662; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Rotinen M, 2018, NAT MED, V24, P1887, DOI 10.1038/s41591-018-0241-1; Sato T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01911; Semenova EA, 2015, GENE DEV, V29, P1447, DOI 10.1101/gad.263145.115; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Stec DE, 1999, J BIOL CHEM, V274, P21285, DOI 10.1074/jbc.274.30.21285; Taromi S, 2017, ONCOTARGET, V8, P97061, DOI 10.18632/oncotarget.21221; Ustiyan V, 2012, DEV BIOL, V370, P198, DOI 10.1016/j.ydbio.2012.07.028; vanDiest PJ, 1997, J CLIN PATHOL, V50, P801, DOI 10.1136/jcp.50.10.801; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wang IC, 2008, ONCOGENE, V27, P4137, DOI 10.1038/onc.2008.60; Wang IC, 2014, ONCOGENE, V33, P5391, DOI 10.1038/onc.2013.475; Wang IC, 2008, J BIOL CHEM, V283, P20770, DOI 10.1074/jbc.M709892200; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang ZB, 2011, CANCER RES, V71, P4292, DOI 10.1158/0008-5472.CAN-10-4087; Wierstra I, 2006, FEBS J, V273, P4645, DOI 10.1111/j.1742-4658.2006.05468.x	57	7	7	1	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4847	4858		10.1038/s41388-021-01895-2	http://dx.doi.org/10.1038/s41388-021-01895-2		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34155349				2022-12-26	WOS:000664006700004
J	Almuhtaseb, MIA; Alby, F; Zucchermaglio, C; Fatigante, M				Almuhtaseb, Mona I. A.; Alby, Francesca; Zucchermaglio, Cristina; Fatigante, Marilena			Social support for breast cancer patients in the occupied Palestinian territory	PLOS ONE			English	Article							QUALITY-OF-LIFE; ASIAN-AMERICAN; WOMEN; EXPERIENCES; PERCEPTIONS; DEPRESSION; DIAGNOSIS; COUPLES	Previous research indicates that social support is beneficial to cancer patients in adjusting to the stress of the disease. Drawing on a qualitative content analysis of 36 semi-structured interviews, this article explores sources and types of social support in Arab-Palestinian women with breast cancer. Results show that members of the immediate family, husbands in particular, are reported to be the most supportive social sources. Given the limitations that characterize access to cancer care in the occupied Palestinian territory (OPT) and the collectivistic values of the society, women with breast cancer seem to rely mainly on their husbands to handle emotional, functional and informational needs. Emotional support includes the provision of care, trust, reassurance, and companionship. Functional support includes the practical assistance that the cancer patients receive in terms of financial support, attendance during treatment or help with domestic chores and childcare. Accessing appropriate informational support can be quite challenging in the OPT since available information is not always reliable. The family plays a key role in mediating communication with doctors. Contact with breast cancer patients and survivors is also a source of supporting information, with however a possible negative impact in terms of emotional coping. In this context, the immediate family becomes a fundamental resource for coping and a relational space that mediates connections with others, including doctors, acting as a "proxy" between the patient and the social environment. Findings are discussed in light of the historical and sociocultural context of the OPT.	[Almuhtaseb, Mona I. A.; Alby, Francesca; Zucchermaglio, Cristina; Fatigante, Marilena] Sapienza Univ Rome, Dept Social & Dev Psychol, Via Marsi, Rome, Italy	Sapienza University Rome	Alby, F (corresponding author), Sapienza Univ Rome, Dept Social & Dev Psychol, Via Marsi, Rome, Italy.	francesca.alby@uniroma1.it		Alby, Francesca/0000-0001-5126-5293	Sapienza University [RP118164126B8AD1]	Sapienza University	This work was supported by the Sapienza University's research grant 2018 n. RP118164126B8AD1, P.I.: Francesca Alby.	Al-Azri M, 2009, BREAST J, V15, P615, DOI 10.1111/j.1524-4741.2009.00812.x; Al-Azri MH, 2014, J HEALTH PSYCHOL, V19, P836, DOI 10.1177/1359105313479813; Alby F., 2019, GIORNALE ITALIANO PS, V1, P203, DOI DOI 10.1421/93788; Alby F., 2018, RASS PSICOL, V35, P32, DOI DOI 10.4458/0722-03; Alby F., 2019, SISTEMI INTELLIGENTI, V2, P365; Alby F, 2017, J CANCER EDUC, V32, P858, DOI 10.1007/s13187-016-1070-x; Alby F, 2014, HUM STUD, V37, P239, DOI 10.1007/s10746-013-9292-y; Almuhtaseb MIA, 2020, SAGE OPEN, V10, DOI 10.1177/2158244019898730; Anusasananun B, 2013, PAC RIM INT J NURS R, V17, P148; Ashing KT, 2003, PSYCHO-ONCOL, V12, P38, DOI 10.1002/pon.632; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P408, DOI 10.1002/pon.750; Azaiza F, 2008, PSYCHO-ONCOLOGY, V17, P34, DOI 10.1002/pon.1180; Azaiza F, 2011, BREAST CANCER RES TR, V128, P219, DOI 10.1007/s10549-010-1321-1; Bloom JR, 2001, SOC SCI MED, V53, P1513, DOI 10.1016/S0277-9536(00)00440-8; BUUNK BP, 1992, BRIT J CLIN PSYCHOL, V31, P445, DOI 10.1111/j.2044-8260.1992.tb01018.x; Carspecken P. F., 1996, CRITICAL ETHNOGRAPHY; Cebeci F, 2012, EUR J ONCOL NURS, V16, P406, DOI 10.1016/j.ejon.2011.09.003; COYNE JC, 1976, J ABNORM PSYCHOL, V85, P186, DOI 10.1037/0021-843X.85.2.186; Doumit MAA, 2010, EUR J ONCOL NURS, V14, P42, DOI 10.1016/j.ejon.2009.08.003; Drageset S, 2012, CANCER NURS, V35, pE39, DOI 10.1097/NCC.0b013e31823634aa; Drageset S, 2010, J ADV NURS, V66, P149, DOI 10.1111/j.1365-2648.2009.05210.x; Frank A.W., 1998, FAM SYST HEALTH, V16, P197, DOI [https://doi.org/10.1037/h0089849, DOI 10.1037/H0089849, 10.1037/h0089849]; Geertz Cl., 1973, INTERPRETATION CULTU; Gold M, 2004, INTERN MED J, V34, P578, DOI 10.1111/j.1445-5994.2004.00673.x; Goldblatt H, 2013, PSYCHO-ONCOLOGY, V22, P869, DOI 10.1002/pon.3078; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Hajian Sepideh, 2017, Asian Pac J Cancer Prev, V18, P215; Hammoudeh W, 2017, QUAL HEALTH RES, V27, P487, DOI 10.1177/1049732316628833; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hwang J.J., 2013, FACTORS INFLUENCING; Jassim GA, 2014, SOC SCI MED, V107, P189, DOI 10.1016/j.socscimed.2014.01.031; Joulaee A, 2012, INT NURS REV, V59, P362, DOI 10.1111/j.1466-7657.2012.00979.x; Kagawa-Singer M, 2003, PSYCHO-ONCOLOGY, V12, P24, DOI 10.1002/pon.619; Kavradim ST, 2013, J ADV NURS, V69, P1183, DOI 10.1111/j.1365-2648.2012.06110.x; Kayser K., 2007, FAM SYST HEALTH, V25, P404, DOI [DOI 10.1037/1091-7527.25.4.404, 10.1037/1091-7527.25.4.404]; Kayser K, 2014, J PSYCHOSOC ONCOL, V32, P264, DOI 10.1080/07347332.2014.897292; KLEINKE CL, 1991, REHABIL PSYCHOL, V36, P207, DOI 10.1037/0090-5550.36.4.207; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Lamyian M., 2007, Eastern Mediterranean Health Journal, V13, P1160; Landmark BT, 2002, SCAND J CARING SCI, V16, P216, DOI 10.1046/j.1471-6712.2002.00059.x; Mehrabi Esmat, 2016, J Caring Sci, V5, P43, DOI 10.15171/jcs.2016.005; Saca-Hazboun H, 2011, CLIN J ONCOL NURS, V15, P281, DOI 10.1188/11.CJON.281-286; Spiegel D, 2012, PSYCHO-ONCOLOGY, V21, P588, DOI 10.1002/pon.3067; Swindells S, 1999, INT J STD AIDS, V10, P383, DOI 10.1258/0956462991914302; Yusuf A, 2013, ASIAN PAC J CANCER P, V14, P3689, DOI 10.7314/APJCP.2013.14.6.3689; Zahedi F, 2011, J MED ETHICS HIST ME, V4; Zucchermaglio C, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017692015; Zucchermaglio C, 2016, TPM-TEST PSYCHOM MET, V23, P471, DOI 10.4473/TPM23.4.4; Zucchermaglio C, 2016, J WORKPLACE LEARN, V28, P174, DOI 10.1108/JWL-01-2016-0006	51	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252608	10.1371/journal.pone.0252608	http://dx.doi.org/10.1371/journal.pone.0252608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BC	34143797	Green Published, gold			2022-12-26	WOS:000671690700023
J	Feng, B; Li, SD; Wang, ZS; Cao, F; Wang, Z; Li, G; Liu, KC				Feng, Bo; Li, Shengdong; Wang, Zongshuai; Cao, Fang; Wang, Zheng; Li, Geng; Liu, Kaichang			Systematic analysis of lysine 2-hydroxyisobutyrylation posttranslational modification in wheat leaves	PLOS ONE			English	Article								Lysine 2-hydroxyisobutyrylation (Khib) is a recently discovered post-translational modification (PTM) showing diverse biological functions and effects in living organisms. However, the study of Khib in plant species is still relatively limited. Wheat (Triticum aestivum L.) is a global important cereal plant. In this study, the systematic Khib analysis was performed in wheat leave tissues. A total of 3004 Khib sites in 1104 proteins were repeatedly identified. Structure characterization of these Khib peptides revealed 12 conserved sequence motifs. Function classification and enrichment analysis indicated these Khib proteins showed a wide function and pathway distribution, of which ribosome activity, protein biosynthesis and photosynthesis were the preferred biological processes. Subcellular location predication indicated chloroplast was the dominant subcellular compartment where Khib was distributed. There may be some crosstalks among Khib, lysine acetylation and lysine succinylation modification because some proteins and sites were modified by all these three acylations. The present study demonstrated the critical role of Khib in wheat biological and physiology, which has expanded the scope of Khib in plant species. Our study is an available resource and reference of Khib function demonstration and structure characterization in cereal plant, as well as in plant kingdom.	[Feng, Bo; Li, Shengdong; Wang, Zongshuai; Cao, Fang; Wang, Zheng; Liu, Kaichang] Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China; [Li, Geng] Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong Agricultural University	Liu, KC (corresponding author), Shandong Acad Agr Sci, Crop Res Inst, Jinan, Shandong, Peoples R China.; Li, G (corresponding author), Shandong Agr Univ, Coll Agron, Tai An, Shandong, Peoples R China.	ligeng213@sina.com; liukc@saas.ac.cn		Feng, Bo/0000-0002-8691-9725	National Key Research and Development Program of China [2018YFD0300601, 2016YFD0300205]; Shandong Agricultural Science and technology Innovation Project [CXGC2016B04]; Shandong Agricultural Science and Technology Fund Program-Park Industry Upgrading Project [2019YQ001]	National Key Research and Development Program of China; Shandong Agricultural Science and technology Innovation Project; Shandong Agricultural Science and Technology Fund Program-Park Industry Upgrading Project	National Key Research and Development Program of China (2018YFD0300601, 2016YFD0300205), Shandong Agricultural Science and technology Innovation Project (CXGC2016B04), Shandong Agricultural Science and Technology Fund Program-Park Industry Upgrading Project (2019YQ001).	Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Cox N, 2020, ANNU REV BIOCHEM, V89, P795, DOI [10.1146/annurev-biochem-011520104801, 10.1146/annurev-biochem-011520-104801]; Crepin A, 2020, PLANT J, V102, P398, DOI 10.1111/tpj.14634; Csizmok V, 2018, CURR OPIN STRUC BIOL, V48, P58, DOI 10.1016/j.sbi.2017.10.013; Dai LZ, 2014, NAT CHEM BIOL, V10, P365, DOI [10.1038/NCHEMBIO.1497, 10.1038/nchembio.1497]; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Dong HY, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6703; Dong HY, 2018, MOL CELL PROTEOMICS, V17, P482, DOI 10.1074/mcp.RA117.000430; Fan J, 2015, ACS CHEM BIOL, V10, P95, DOI 10.1021/cb500846u; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H, 2018, CELL RES, V28, P111, DOI 10.1038/cr.2017.149; Huang J, 2017, P NATL ACAD SCI USA, V114, P8782, DOI 10.1073/pnas.1700796114; Hulsegge Ina, 2009, BMC Proc, V3 Suppl 4, pS10, DOI 10.1186/1753-6561-3-S4-S10; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ju Z, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107280; Ju Z, 2019, CHEMOMETR INTELL LAB, V191, P96, DOI 10.1016/j.chemolab.2019.06.009; Kage U, 2020, J EXP BOT, V71, P5323, DOI 10.1093/jxb/eraa227; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kumar P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35366-8; Lau PNI, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1247; Li QQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00143-6; M H-H., 2020, TRENDS BIOCHEM SCI, DOI [10.1016/j.tibs.2020.05.001, DOI 10.1016/J.TIBS.2020.05.001]; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Meng X., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Meng XX, 2019, MOL CELL PROTEOMICS, V18, P2359, DOI 10.1074/mcp.RA119.001426; Mishra A, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0896-z; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Ou M., 2019, SSRN, V3360100; Ries F, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9020214; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Suga M, 2020, CURR OPIN STRUC BIOL, V63, P10, DOI 10.1016/j.sbi.2020.02.005; Vu LD, 2018, TRENDS PLANT SCI, V23, P1068, DOI 10.1016/j.tplants.2018.09.004; Wang Y, 2019, SMALL METHODS, V3, DOI 10.1002/smtd.201900041; Wu Q, 2018, J PROTEOME RES, V17, P3176, DOI 10.1021/acs.jproteome.8b00289; Xue C, 2020, RICE, V13, DOI 10.1186/s12284-020-00389-1; Yin DQ, 2019, MOL CELL PROTEOMICS, V18, P2207, DOI 10.1074/mcp.RA119.001611; Yu ZM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15854-z; Zhang YM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3698-2; Zhang YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep21069; Zoschke R, 2018, PLANT CELL, V30, P745, DOI 10.1105/tpc.18.00016	43	2	2	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253325	10.1371/journal.pone.0253325	http://dx.doi.org/10.1371/journal.pone.0253325			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138952	gold, Green Published			2022-12-26	WOS:000671690200045
J	Giraudo, C; Librizzi, G; Fichera, G; Motta, R; Balestro, E; Calabrese, F; Carretta, G; Cattelan, AM; Navalesi, P; Pelloso, M; Plebani, M; Rea, F; Vettor, R; Vianello, A; Stramare, R				Giraudo, Chiara; Librizzi, Giovanni; Fichera, Giulia; Motta, Raffaella; Balestro, Elisabetta; Calabrese, Fiorella; Carretta, Giovanni; Cattelan, Anna Maria; Navalesi, Paolo; Pelloso, Michela; Plebani, Mario; Rea, Federico; Vettor, Roberto; Vianello, Andrea; Stramare, Roberto			Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; PARASPINAL MUSCLES; SARCOPENIA; PHYSIOTHERAPY; DENSITY	Purpose To evaluate if reduced muscle mass, assessed with Computed Tomography (CT), is a predictor of intensive care unit (ICU) hospitalization in COVID-19 patients. Methods In this Institution Review Board approved study, we retrospectively evaluated COVID-19 patients treated in our tertiary center from March to November 2020 who underwent an unenhanced chest CT scan within three weeks from hospitalization.We recorded the mean Hounsfield Unit (Hu) value of the right paravertebral muscle at the level of the 12(th) thoracic vertebra, the hospitalization unit (ICU and COVID-19 wards), clinical symptoms, Barthel Index, and laboratory findings.Logistic regression analysis was applied to assess if muscle loss (Hu<30) is a predictor of ICU admission and outcome.Fisher's exact and Student's tests were applied to evaluate if differences between patients with and without muscle loss occurred (p<0.05). Results One-hundred-fifty patients matched the inclusion criteria (46 females; mean age +/- SD 61.3 +/- 15 years-old), 36 treated in ICU. Patients in ICU showed significantly lower Hu values (29 +/- 24 vs 39.4 +/- 12, p = 0.001). Muscle loss was a predictor of ICU admission (p = 0.004).Patients with muscle loss were significantly older (73.4 +/- 10 vs 56.4 +/- 14 years), had lower Barthel Index scores (54.4 +/- 33 vs 85.1 +/- 26), red blood-cell count (3.9 +/- 1 vs 4.6 +/- 1x10(12)L(-1)), and Hb levels (11.5 +/- 2 vs 13.2 +/- 2g/l) as well as higher white blood-cell count (9.4 +/- 7 vs 7.2 +/- 4x10(9)L(-1)), C-reactive protein (71.5 +/- 71 vs 44 +/- 48U/L), and lactate dehydrogenase levels (335 +/- 163 vs 265.8 +/- 116U/L) (p<0.05, each). Conclusions Muscle loss seems to be a predictor of ICU hospitalization in COVID-19 patients and radiologists reporting chest CT at admission should note this finding in their reports.	[Giraudo, Chiara; Librizzi, Giovanni; Fichera, Giulia; Motta, Raffaella; Stramare, Roberto] Univ Padua, Dept Med DIMED, Padua, Italy; [Balestro, Elisabetta] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy; [Calabrese, Fiorella] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Pathol Anat Sect, Padua, Italy; [Carretta, Giovanni] Unita Locale Socio Sanitaria ULSS 3 Serenissima, Venice, Veneto Region, Italy; [Cattelan, Anna Maria] Padova Univ Hosp, Div Infect & Trop Dis, Padua, Italy; [Navalesi, Paolo] Univ Padua, Dept Med DIMED, Anesthesiol & Intens Care Unit, Padua, Italy; [Pelloso, Michela; Plebani, Mario] Univ Hosp Padova, Dept Lab Med, Padua, Italy; [Rea, Federico] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Thorac Surg, Padua, Italy; [Vettor, Roberto] Univ Padua, Dept Med DIMED, Internal Med, Padua, Italy; [Vianello, Andrea] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Pathophysiol Div, Padua, Italy	University of Padua; University of Padua; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; University of Padua; University of Padua	Giraudo, C (corresponding author), Univ Padua, Dept Med DIMED, Padua, Italy.	chiara.giraudo@unipd.it	Vianello, Andrea/AHD-3398-2022; VETTOR, ROBERTO/K-7121-2016; pelloso, michela/K-5615-2018; Navalesi, Paolo/F-9559-2010	Balestro, Elisabetta/0000-0003-1373-8197; Vianello, Andrea/0000-0002-8790-6029; MOTTA, RAFFAELLA/0000-0002-1886-9826; Librizzi, Giovanni/0000-0002-2409-457X; Pelloso, Michela/0000-0002-2853-4499; Giraudo, Chiara/0000-0003-0924-5883; Navalesi, Paolo/0000-0002-3733-3453				Aubrey J, 2014, ACTA PHYSIOL, V210, P489, DOI 10.1111/apha.12224; Barazzoni R, 2018, OBESITY FACTS, V11, P294, DOI 10.1159/000490361; Cacciatore F, 2015, BIOMARK MED, V9, P669, DOI [10.2217/BMM.15.28, 10.2217/bmm.15.28]; Cester G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9093042; Chargi N, 2019, EUR ARCH OTO-RHINO-L, V276, P1475, DOI 10.1007/s00405-019-05361-4; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Deng CY, 2018, AM J ROENTGENOL, V210, P526, DOI 10.2214/AJR.17.18020; Donini LM, 2020, CLIN NUTR, V39, P2368, DOI 10.1016/j.clnu.2019.11.024; Ekin EE, 2019, TURK J MED SCI, V49, P538, DOI 10.3906/sag-1809-48; Fintelmann FJ, 2018, ANN THORAC SURG, V105, P1507, DOI 10.1016/j.athoracsur.2018.01.013; Giraudo C, 2020, QUANT IMAG MED SURG, V10, P1602, DOI 10.21037/qims.2019.12.15; Goodpaster BH, 2000, ANN NY ACAD SCI, V904, P18; Hida T, 2018, NAGOYA J MED SCI, V80, P519, DOI 10.18999/nagjms.80.4.519; Ismail C, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00302; Kalichman L, 2010, EUR SPINE J, V19, P1136, DOI 10.1007/s00586-009-1257-5; Keller A, 2003, SPINE, V28, P1455, DOI 10.1097/00007632-200307010-00017; Khosla SG, 2020, J INVEST MED HIGH IM, V8, DOI 10.1177/2324709620984603; Kirwan R, 2020, GEROSCIENCE, V42, P1547, DOI 10.1007/s11357-020-00272-3; Lee S, 2005, J APPL PHYSIOL, V99, P1220, DOI 10.1152/japplphysiol.00053.2005; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Looijaard WGPM, 2018, CURR OPIN CRIT CARE, V24, P241, DOI 10.1097/MCC.0000000000000511; MAHONEY F I, 1965, Md State Med J, V14, P61; Martone AM, 2017, J CACHEXIA SARCOPENI, V8, P907, DOI 10.1002/jcsm.12224; Mitobe Yuta, 2019, J Clin Med Res, V11, P834, DOI 10.14740/jocmr4027; Moon SW, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1001-6; Morley JE, 2020, J CACHEXIA SARCOPENI, V11, P863, DOI 10.1002/jcsm.12589; Nemec U, 2017, ACAD RADIOL, V24, P1154, DOI 10.1016/j.acra.2017.02.008; Singh B, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.10686; Sommers J, 2015, CLIN REHABIL, V29, P1051, DOI 10.1177/0269215514567156; Stiller K, 2000, CHEST, V118, P1801, DOI 10.1378/chest.118.6.1801; Storheim K, 2003, J SPINAL DISORD TECH, V16, P271, DOI 10.1097/00024720-200306000-00008; Stramare R, 2020, RADIOL MED, V125, P691, DOI 10.1007/s11547-020-01231-w; Vellas B, 2018, J FRALITY AGING, V7, P2, DOI 10.14283/jfa.2017.30; Welch C, 2020, AGING DIS, V11, P1345, DOI 10.14336/AD.2020.1014; Welch C, 2018, AGING DIS, V9, P151, DOI 10.14336/AD.2017.0315; Williams GR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4783	37	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253433	10.1371/journal.pone.0253433	http://dx.doi.org/10.1371/journal.pone.0253433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138945	gold, Green Published			2022-12-26	WOS:000671690200064
J	Charniga, K; Cucunuba, ZM; Walteros, DM; Mercado, M; Prieto, F; Ospina, M; Nouvellet, P; Donnelly, CA				Charniga, Kelly; Cucunuba, Zulma M.; Walteros, Diana M.; Mercado, Marcela; Prieto, Franklyn; Ospina, Martha; Nouvellet, Pierre; Donnelly, Christl A.			Descriptive analysis of surveillance data for Zika virus disease and Zika virus-associated neurological complications in Colombia, 2015-2017	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; RIO-DE-JANEIRO; CASE DEFINITIONS; PREGNANCY OUTCOMES; INFECTION; TRANSMISSION; GUIDELINES; EPIDEMIOLOGY; ENCEPHALITIS; COLLECTION	Zika virus (ZIKV) is a mosquito-borne pathogen that recently caused a major epidemic in the Americas. Although the majority of ZIKV infections are asymptomatic, the virus has been associated with birth defects in fetuses and newborns of infected mothers as well as neurological complications in adults. We performed a descriptive analysis on approximately 106,000 suspected and laboratory-confirmed cases of Zika virus disease (ZVD) that were reported during the 2015-2017 epidemic in Colombia. We also analyzed a dataset containing patients with neurological complications and recent febrile illness compatible with ZVD. Females had higher cumulative incidence of ZVD than males. Compared to the general population, cases were more likely to be reported in young adults (20 to 39 years of age). We estimated the cumulative incidence of ZVD in pregnant females at 3,120 reported cases per 100,000 population (95% CI: 3,077-3,164), which was considerably higher than the incidence in both males and non-pregnant females. ZVD cases were reported in all 32 departments. Four-hundred and eighteen patients suffered from ZIKV-associated neurological complications, of which 85% were diagnosed with Guillain-Barre syndrome. The median age of ZIKV cases with neurological complications was 12 years older than that of ZVD cases. ZIKV-associated neurological complications increased with age, and the highest incidence was reported among individuals aged 75 and older. Even though neurological complications and deaths due to ZIKV were rare in this epidemic, better risk communication is needed for people living in or traveling to ZIKV-affected areas.	[Charniga, Kelly; Cucunuba, Zulma M.; Donnelly, Christl A.] Imperial Coll London, Med Res Council Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England; [Walteros, Diana M.; Mercado, Marcela; Prieto, Franklyn; Ospina, Martha] Inst Nacl Salud, Bogota, Colombia; [Nouvellet, Pierre] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England	Imperial College London; Instituto Nacional de Salud (Colombia); University of Sussex; University of Oxford	Charniga, K (corresponding author), Imperial Coll London, Med Res Council Ctr Global Infect Dis Anal, Dept Infect Dis Epidemiol, London, England.	Kelly.Charniga@gmail.com	Cucunuba, Zulma M/X-5670-2019	Cucunuba, Zulma M/0000-0002-8165-3198; PRIETO ALVARADO, FRANKLYN EDWIN/0000-0002-2079-7251; Charniga, Kelly/0000-0002-7648-7041; nouvellet, pierre/0000-0002-6094-5722	MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC) under the MRC/FCDO Concordat agreement [MR/R015600/1]; MRC Centre for Global Infectious Disease Analysis - UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement [MR/R015600/1]; European Union; Imperial College London's President's PhD Scholarship; Rutherford Fund [MR/R024855/1]	MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC) under the MRC/FCDO Concordat agreement; MRC Centre for Global Infectious Disease Analysis - UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Imperial College London's President's PhD Scholarship; Rutherford Fund	We acknowledge funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. KC is funded by Imperial College London's President's PhD Scholarship. ZMC is supported by a Fellowship through the Rutherford Fund (MR/R024855/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bersano A, 2006, J NEUROL, V253, P214, DOI 10.1007/s00415-005-0958-x; Bertolli J, 2020, AM J TROP MED HYG, V102, P955, DOI 10.4269/ajtmh.19-0961; Buckingham-Jeffery E, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4372-y; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023; Diarra I, 2020, EMERG INFECT DIS, V26, P945, DOI 10.3201/eid2605.191383; Dias J.C.P., 1997, CLIN TERAPEUTICA DOE, P33; Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gambhir M, 2013, CLIN INFECT DIS, V57, pS23, DOI 10.1093/cid/cit298; Gold CA, 2016, JAMA NEUROL, V73, P905, DOI 10.1001/jamaneurol.2016.1268; Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Humanitarian Data Exchange, IND COR COVID 19 SUB; Instituto Nacional de Salud, 2016, LESIONES CAUSAS EXTE; Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kohl KS, 2007, VACCINE, V25, P5671, DOI 10.1016/j.vaccine.2007.02.063; Leonhard SE, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008264; Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160; Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1; Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4; Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530; McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748; Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9; Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212; Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7; Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]; Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396; Ospina ML, 2020, NEW ENGL J MED, V383, P537, DOI 10.1056/NEJMoa1911023; Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1; Pacheco O., 2016, NEW ENGL J MED; Pacheco O, 2021, PAEDIATR PERINAT EP, V35, P92, DOI 10.1111/ppe.12690; Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112; Pan American Health Organization, 2017, HLTH AM 2017 ED SUMM; Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564; Pierson TC, 2020, NAT MICROBIOL, V5, P796, DOI 10.1038/s41564-020-0714-0; Poland GA, 2019, MAYO CLIN PROC, V94, P2572, DOI 10.1016/j.mayocp.2019.05.016; Raper J, 2021, TROP MED INFECT DIS, V6, DOI 10.3390/tropicalmed6010010; Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618; Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205; Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001; Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060; Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710; Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003; Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297; U.S. Centers for Disease Control and Prevention, REAL TIM RTPCR PAN D; U.S. Central Intelligence Agency, WORLD FACTB COL 2020; van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328; Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239; Walteros DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220049; Webb AJS, 2015, J NEUROL NEUROSUR PS, V86, P1196, DOI 10.1136/jnnp-2014-309056	61	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252236	10.1371/journal.pone.0252236	http://dx.doi.org/10.1371/journal.pone.0252236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133446	Green Accepted, Green Published, gold			2022-12-26	WOS:000671682700045
J	Light, TP; Gomez-Soler, M; Wang, ZC; Karl, K; Zapata-Mercado, E; Gehring, MP; Lechtenberg, BC; Pogorelov, TV; Hristova, K; Pasquale, EB				Light, Taylor P.; Gomez-Soler, Maricel; Wang, Zichen; Karl, Kelly; Zapata-Mercado, Elmer; Gehring, Marina P.; Lechtenberg, Bernhard C.; Pogorelov, Taras, V; Hristova, Kalina; Pasquale, Elena B.			A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; FGFR1 AMPLIFICATION; MOLECULAR-DYNAMICS; RECEPTOR DIMERS; PROSTATE-CANCER; DIMERIZATION; EXPRESSION; MIGRATION; DISTINCT; EPHRINS	The Eph receptor tyrosine kinases and their ephrin ligands regulate many physiological and pathological processes. EphA4 plays important roles in nervous system development and adult homeostasis, while aberrant EphA4 signaling has been implicated in neurodegeneration. EphA4 may also affect cancer malignancy, but the regulation and effects of EphA4 signaling in cancer are poorly understood. A correlation between decreased patient survival and high EphA4mRNAexpression inmelanoma tumors that also highly express ephrinAligands suggests that enhancedEphA4 signaling may contribute to melanoma progression. A search for EphA4 gain-of-function mutations in melanoma uncovered a mutation of the highly conserved leucine 920 in the EphA4 sterile alpha motif (SAM) domain. We found that mutation of L920 to phenylalanine (L920F) potentiates EphA4 autophosphorylation and signaling, making it the first documented EphA4 cancer mutation that increases kinase activity. Quantitative Foster resonance energy transfer and fluorescence intensity fluctuation (FIF) analyses revealed that the L920F mutation induces a switch in EphA4 oligomer size, from a dimer to a trimer. We propose this switch in oligomer size as a novel mechanism underlying EphA4-linked tumorigenesis. Molecular dynamics simulations suggest that the L920F mutation alters EphA4 SAM domain conformation, leading to the formation of EphA4 trimers that assemble through two aberrant SAM domain interfaces. Accordingly, EphA4wild-type and the L920Fmutant are affected differently by the SAMdomain and are differentially regulated by ephrin ligand stimulation. The increased EphA4 activation induced by the L920F mutation, through the novel mechanism we uncovered, supports a functional role for EphA4 in promoting pathogenesis.	[Light, Taylor P.; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Gomez-Soler, Maricel; Gehring, Marina P.; Lechtenberg, Bernhard C.; Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, Canc Ctr, La Jolla, CA 92037 USA; [Wang, Zichen; Pogorelov, Taras, V] Univ Illinois, Sch Chem Sci, Beckman Inst Adv Sci & Technol, Dept Chem,Ctr Biophys & Quantitat Biol, Urbana, IL USA; [Wang, Zichen; Pogorelov, Taras, V] Univ Illinois, Sch Chem Sci, Natl Ctr Supercomp Applicat, Urbana, IL USA; [Karl, Kelly; Zapata-Mercado, Elmer; Hristova, Kalina] Johns Hopkins Univ, Inst NanoBioTechnol, Program Mol Biophys, Baltimore, MD 21205 USA; [Lechtenberg, Bernhard C.] Walter & Eliza Hall Inst Med Res, Ubiquitin Signalling Div, Parkville, Vic 3052, Australia; [Lechtenberg, Bernhard C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Walter & Eliza Hall Institute; University of Melbourne	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Inst NanoBioTechnol, Baltimore, MD 21218 USA.; Pasquale, EB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Canc Ctr, La Jolla, CA 92037 USA.; Hristova, K (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Program Mol Biophys, Baltimore, MD 21205 USA.	kalina.hristova@jhu.edu; elenap@sbpdiscovery.org		Wang, Zichen/0000-0003-4759-3053; Karl, Kelly/0000-0002-7810-3179; Zapata-Mercado, Elmer/0000-0002-9766-8124; Pogorelov, Taras/0000-0001-5851-7721	NIH [NS087070, AG062617, GM068619]; NSF [MCB 1712740]; NIH Director's Transformative Research Award [R01 GM123455]; Department of Chemistry; Office of the Vice-Chancellor for Research (RSOCR Award) [4703]; School of Chemical Sciences, University of Illinois at UrbanaChampaign; Extreme Science and Engineering Discovery Environment (XSEDE) - National Science Foundation [TG-MCB130112, ACI-1053575]; Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH Director's Transformative Research Award; Department of Chemistry; Office of the Vice-Chancellor for Research (RSOCR Award); School of Chemical Sciences, University of Illinois at UrbanaChampaign; Extreme Science and Engineering Discovery Environment (XSEDE) - National Science Foundation; Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign	This work was supported by NIH grants NS087070 and AG062617 (to E. B. P.) as well as NIH GM068619 and NSF MCB 1712740 (to K. H.). In addition, T. V. P. is grateful for support from a NIH Director's Transformative Research Award (R01 GM123455), the Department of Chemistry, the Office of the Vice-Chancellor for Research (RSOCR Award 4703), School of Chemical Sciences, University of Illinois at UrbanaChampaign, and the Extreme Science and Engineering Discovery Environment (XSEDE, Grant TG-MCB130112), which is supported by National Science Foundation Grant ACI-1053575. Z. W. acknowledges support from the Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign. Part of this research was conducted using computational resources at the Maryland Advanced Research Computing Center (MARCC). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed F, 2021, BIOPHYS J, V120, P55, DOI 10.1016/j.bpj.2020.11.2262; Ahmed F, 2018, BIOCHEM J, V475, P3669, DOI 10.1042/BCJ20180637; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Batson J, 2014, BIOL OPEN, V3, P453, DOI 10.1242/bio.20146601; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bisson N, 2007, MOL BIOL CELL, V18, P1030, DOI 10.1091/mbc.E06-04-0294; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Byrne PO, 2020, J BIOL CHEM, V295, P13353, DOI 10.1074/jbc.RA120.012852; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; de Marcondes PG, 2017, J CELL BIOCHEM, V118, P442, DOI 10.1002/jcb.25738; Desta IT, 2020, STRUCTURE, V28, P1071, DOI 10.1016/j.str.2020.06.006; Ding LL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694298; Dionne U, 2018, MOL CELL, V70, P995, DOI 10.1016/j.molcel.2018.05.013; Dong YL, 2018, MOL CELL BIOCHEM, V439, P95, DOI 10.1007/s11010-017-3139-1; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez-Soler M, 2019, J BIOL CHEM, V294, P8791, DOI 10.1074/jbc.RA119.008213; Hachim IY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14549-9; Hua KT, 2018, CANCER RES, V78, P216, DOI 10.1158/0008-5472.CAN-17-1933; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang YC, 2016, BLOOD, V128, P1578, DOI 10.1182/blood-2016-02-702530; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Jing XF, 2016, CANCER MED-US, V5, P1214, DOI 10.1002/cam4.670; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; King C, 2017, J BIOL CHEM, V292, P5291, DOI 10.1074/jbc.M116.764282; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin CY, 2017, J CANCER, V8, P1089, DOI 10.7150/jca.17471; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu CL, 2014, ONCOL LETT, V7, P2165, DOI 10.3892/ol.2014.2011; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Park EK, 2004, MOL BIOL CELL, V15, P1647, DOI 10.1091/mbc.E03-09-0674; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Paul MD, 2019, CYTOKINE GROWTH F R, V49, P23, DOI 10.1016/j.cytogfr.2019.10.004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saintigny P, 2012, MOL CANCER THER, V11, P2021, DOI 10.1158/1535-7163.MCT-12-0030; Sarabipour S, 2016, J MOL BIOL, V428, P3903, DOI 10.1016/j.jmb.2016.08.026; Sarabipour S, 2016, BBA-BIOMEMBRANES, V1858, P1436, DOI 10.1016/j.bbamem.2016.03.027; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Sarabipour S, 2014, ANAL BIOCHEM, V449, P155, DOI 10.1016/j.ab.2013.12.027; Schaupp A, 2014, J CELL BIOL, V204, P409, DOI 10.1083/jcb.201305037; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shi XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45084; Singh DR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0017-7; Singh DR, 2017, J MOL BIOL, V429, P2231, DOI 10.1016/j.jmb.2017.05.020; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stoneman MR, 2019, NAT METHODS, V16, P493, DOI 10.1038/s41592-019-0408-9; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Vincenzi M, 2020, CURR MED CHEM, V27, P450, DOI 10.2174/0929867325666181009114445; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Xia JF, 2014, MOL CANCER THER, V13, P1918, DOI 10.1158/1535-7163.MCT-13-0804; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003	92	5	5	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100876	10.1016/j.jbc.2021.100876	http://dx.doi.org/10.1016/j.jbc.2021.100876			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139238	Green Published, gold			2022-12-26	WOS:000678068400076
J	Soni, H; Kumar, R; Kanthakumar, P; Adebiyi, A				Soni, Hitesh; Kumar, Ravi; Kanthakumar, Praghalathan; Adebiyi, Adebowale			Interleukin 1 beta-induced calcium signaling via TRPA1 channels promotes mitogen-activated protein kinase-dependent mesangial cell proliferation	FASEB JOURNAL			English	Article						calcium entry; interleukin 1 beta; mesangial cell proliferation; mitogen-activated protein kinase; TRPA1 channels	MAJOR SOURCE; A1 TRPA1; RECEPTOR; CA2+; IL-1-BETA; ALPHA; GLOMERULONEPHRITIS; FIBRONECTIN; EXPRESSION; MACROPHAGES	Glomerular mesangial cell (GMC)-derived pleiotropic cytokine, interleukin-1 (IL-1), contributes to hypercellularity in human and experimental proliferative glomerulonephritis. IL-1 promotes mesangial proliferation and may stimulate extracellular matrix accumulation, mechanisms of which are unclear. The present study shows that the beta isoform of IL-1 (IL-1 beta) is a potent inducer of IL-1 type I receptor-dependent Ca2+ entry in mouse GMCs. We also demonstrate that the transient receptor potential ankyrin 1 (TRPA1) is an intracellular store-independent diacylglycerol-sensitive Ca2+ channel in the cells. IL-1 beta-induced Ca2+ and Ba2+ influxes in the cells were negated by pharmacological inhibition and siRNA-mediated knockdown of TRPA1 channels. IL-1 beta did not stimulate fibronectin production in cultured mouse GMCs and glomerular explants but promoted Ca2+-dependent cell proliferation. IL-1 beta also stimulated TRPA1-dependent ERK mitogen-activated protein kinase (MAPK) phosphorylation in the cells. Concomitantly, IL-1 beta-induced GMC proliferation was attenuated by TRPA1 and RAF1/ MEK/ERK inhibitors. These findings suggest that IL-1 beta-induced Ca2+ entry via TRPA1 channels engenders MAPK-dependent mesangial cell proliferation. Hence, TRPA1-mediated Ca2+ signaling could be of pathological significance in proliferative glomerulonephritis.	[Soni, Hitesh; Kumar, Ravi; Kanthakumar, Praghalathan; Adebiyi, Adebowale] Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Adebiyi, A (corresponding author), Univ Tennessee, Coll Med, Dept Physiol, Hlth Sci Ctr, Memphis, TN 38163 USA.	aadebiyi@uthsc.edu		Kanthakumar, Praghalathan/0000-0002-7610-8945; Kumar, Ravi/0000-0002-2514-257X; Adebiyi, Adebowale/0000-0002-7033-1871	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01 HL151735]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01 HL151735	Abraham ST, 1997, CIRC RES, V81, P575, DOI 10.1161/01.RES.81.4.575; Adebiyi A, 2014, EXP CELL RES, V324, P92, DOI 10.1016/j.yexcr.2014.03.011; Adebiyi A, 2014, J CELL PHYSIOL, V229, P502, DOI 10.1002/jcp.24470; Afsar B, 2018, DRUGS, V78, P1073, DOI 10.1007/s40265-018-0942-2; Agell N, 2002, CELL SIGNAL, V14, P649, DOI 10.1016/S0898-6568(02)00007-4; ALLISON MEM, 1974, J CLIN INVEST, V53, P1402, DOI 10.1172/JCI107689; Anders HJ, 2016, J AM SOC NEPHROL, V27, P2564, DOI 10.1681/ASN.2016020177; Atoyan R, 2009, J INVEST DERMATOL, V129, P2312, DOI 10.1038/jid.2009.58; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; BHASIN HK, 1978, LAB INVEST, V39, P21; BRADFIELD JWB, 1977, LAB INVEST, V36, P481; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Chuderland Dana, 2008, Commun Integr Biol, V1, P4; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 2018, IMMUNOL REV, V281, P8, DOI 10.1111/imr.12621; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Enslen H, 1996, P NATL ACAD SCI USA, V93, P10803, DOI 10.1073/pnas.93.20.10803; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guimaraes Marilia Z. P., 2007, P151; Humeau J, 2018, CELL CALCIUM, V70, P3, DOI 10.1016/j.ceca.2017.07.006; IKEDA M, 1991, CLIN EXP IMMUNOL, V83, P149; Illario M, 2003, J BIOL CHEM, V278, P45101, DOI 10.1074/jbc.M305355200; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; Ma R, 2006, EXP BIOL MED, V231, P145; Ma ST, 2021, AM J HYPERTENS, V34, P110, DOI 10.1093/ajh/hpaa162; Ma ST, 2019, AM J PHYSIOL-RENAL, V317, pE623, DOI 10.1152/ajprenal.00069.2019; MARTIN J, 1986, J IMMUNOL, V137, P525; Masola V, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1770-1; MATSUMOTO K, 1988, AM J NEPHROL, V8, P463, DOI 10.1159/000167656; Morrison DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011254; MOSQUERA JA, 1993, LAB INVEST, V68, P406; Niemir ZI, 1997, KIDNEY INT, V52, P393, DOI 10.1038/ki.1997.346; NORONHA IL, 1993, KIDNEY INT, V43, P682, DOI 10.1038/ki.1993.98; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pawluczyk IZA, 1998, KIDNEY INT, V54, P62, DOI 10.1046/j.1523-1755.1998.00965.x; Pohoczky K, 2016, J MOL ENDOCRINOL, V56, P135, DOI 10.1530/JME-15-0184; Prandini P, 2016, AM J RESP CELL MOL, V55, P645, DOI 10.1165/rcmb.2016-0089OC; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Radeke H H, 1991, Eur Cytokine Netw, V2, P51; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rush BM, 2018, JOVE-J VIS EXP, DOI 10.3791/58162; Sachdeva R, 2019, CELL CALCIUM, V78, P66, DOI 10.1016/j.ceca.2019.01.002; Salmon MD, 2011, INT IMMUNOPHARMACOL, V11, P145, DOI 10.1016/j.intimp.2010.11.006; SEDOR JR, 1992, KIDNEY INT, V41, P595, DOI 10.1038/ki.1992.89; Silverman HA., 822734 BIORXIV; Soni H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18143-x; STAHL RAK, 1990, AM J PHYSIOL, V259, pF419, DOI 10.1152/ajprenal.1990.259.3.F419; Stockand JD, 1998, PHYSIOL REV, V78, P723, DOI 10.1152/physrev.1998.78.3.723; TANG WW, 1994, J CLIN INVEST, V93, P273, DOI 10.1172/JCI116956; Tesch GH, 1997, NEPHROL DIAL TRANSPL, V12, P1109, DOI 10.1093/ndt/12.6.1109; Tesch GH, 1997, AM J PATHOL, V151, P141; Timoshanko JR, 2004, J AM SOC NEPHROL, V15, P910, DOI 10.1097/01.ASN.0000115704.86897.F4; Venkatachalam K, 2001, J BIOL CHEM, V276, P33980, DOI 10.1074/jbc.C100321200; Vesey DA, 2002, KIDNEY INT, V62, P31, DOI 10.1046/j.1523-1755.2002.00401.x; Wang R, 2007, LIFE SCI, V80, P2481, DOI 10.1016/j.lfs.2007.04.010; Wang Z, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/5179468; Wu CK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073415; Wu CK, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22052309; Wu CK., 2019, J CLIN MED, V8; Yin SJ, 2018, J INFLAMM-LOND, V15, DOI 10.1186/s12950-018-0204-9; Yoshiki S, 2010, MOL BIOL CELL, V21, P1088, DOI 10.1091/mbc.E09-06-0455; Zhai WW, 2004, BRIT J PHARMACOL, V143, P1042, DOI 10.1038/sj.bjp.0705971	67	4	4	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21729	10.1096/fj.202100367R	http://dx.doi.org/10.1096/fj.202100367R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143493	Green Accepted			2022-12-26	WOS:000667814100063
J	Larabi-Marie-Sainte, S; Jan, R; Al-Matouq, A; Alabduhadi, S				Larabi-Marie-Sainte, Souad; Jan, Roohi; Al-Matouq, Ali; Alabduhadi, Sara			The impact of timetable on student's absences and performance	PLOS ONE			English	Article							ATTENDANCE	Student's academic performance is the point of interest for both the student and the academic institution in higher education. This performance can be affected by several factors and one of them is student absences. This is mainly due to the missed lectures and other class activities. Studies related to university timetabling investigate the different techniques and algorithms to design course timetables without analyzing the relationship between student attendance behavior and timetable design. This article first aimed at demonstrating the impact of absences and timetabling design on student's academic performance. Secondly, this study showed that the number of absences can be caused by three main timetable design factors: namely, (1) the number of courses per semester, (2) the average number of lectures per day and (3) the average number of free timeslots per day. This was demonstrated using Educational Data Mining on a large dataset collected from Prince Sultan University. The results showed a high prediction performance reaching 92% when predicting student's GPA based on absences and the factors related to timetabling design. High prediction performance reaching 87% was also obtained when predicting student absences based on the three timetable factors mentioned above. The results demonstrated the importance of designing course timetables in view of student absence behavior. Some suggestions were reported such as limiting the number of enrolled courses based on student's GPA, avoiding busy and almost free days and using automated timetabling to minimize the number of predicted absences. This in turn will help in generating balanced student timetables, and thus improving student academic performance.	[Larabi-Marie-Sainte, Souad; Jan, Roohi; Alabduhadi, Sara] Prince Sultan Univ, Coll Comp & Informat Sci, Comp Sci Dept, Riyadh, Saudi Arabia; [Al-Matouq, Ali] Prince Sultan Univ, Coll Engn, Prod & Manufacture Dept, Riyadh, Saudi Arabia	Prince Sultan University; Prince Sultan University	Larabi-Marie-Sainte, S (corresponding author), Prince Sultan Univ, Coll Comp & Informat Sci, Comp Sci Dept, Riyadh, Saudi Arabia.	slarabi@psu.edu.sa	Marie-Sainte, Souad Larabi/T-9005-2018; AlMatouq, Ali/G-4099-2019	AlMatouq, Ali/0000-0002-4588-4431	Advance Operations and Analytical Research Group (AOARG), Prince Sultan University	Advance Operations and Analytical Research Group (AOARG), Prince Sultan University	This document is the results of the research project funded by the Advance Operations and Analytical Research Group (AOARG), Prince Sultan University.	Al-Matouq AA, 2020, IEEE ACCESS, V8, P167475, DOI 10.1109/ACCESS.2020.3019598; Algarni A, 2016, INT J ADV COMPUT SC, V7, P456; ALTMAN NS, 1992, AM STAT, V46, P175, DOI 10.2307/2685209; [Anonymous], 2014, J APPL SCI, DOI DOI 10.3923/jas.2014.171.176; [Anonymous], 2015, INDIAN J SCI TECHNOL; Asirvadam V.S, 2004, IEEE INT C CONTR APP; Bashiri M, 2011, SCI IRAN, V18, P1600, DOI 10.1016/j.scient.2011.08.031; Chan JYK, 2014, J CHEM EDUC, V91, P1417, DOI 10.1021/ed500170x; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Crede M, 2010, REV EDUC RES, V80, P272, DOI 10.3102/0034654310362998; Dokuka S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236737; Dutti A, 2017, IEEE ACCESS, V5, P15991, DOI 10.1109/ACCESS.2017.2654247; Fernandez-Hilario A., 2018, LEARNING IMBALANCED; Guodong Z, 2018, ARXIV181012281; Gupta A, 1998, ANN OPER RES, V78, P165, DOI 10.1023/A:1018945915940; Haseena S., 2017, INT J ADV RES TRENDS, V4; Kabakchieva D, 2013, CYBERN INF TECHNOL, V13, P61, DOI 10.2478/cait-2013-0006; Kassarnig V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187078; Kaur K, 2015, 2015 1ST INTERNATIONAL CONFERENCE ON NEXT GENERATION COMPUTING TECHNOLOGIES (NGCT), P756, DOI 10.1109/NGCT.2015.7375222; Kiran Kumar .M, 2019, INT J ENG ADV TECHNO, V8; Krawczyk B, 2016, PROG ARTIF INTELL, V5, P221, DOI 10.1007/s13748-016-0094-0; Lunardon N, 2014, R J, V6, P79; Lunt M, 2015, RHEUMATOLOGY, V54, P1137, DOI 10.1093/rheumatology/ket146; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02478259; Ocak G., 2017, EUROPEAN J ED STUDIE, V3; Pardos ZA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233207; Pavithra A., 2018, INT J SCI RES COMPUT, V7; Rahman A. U., 2018, J 8EORETICAL APPL IN, V96, P4417; Rudova H, 2011, J SCHEDULING, V14, P187, DOI 10.1007/s10951-010-0171-3; Samsudin NA., 2020, J AM ACAD RES, V8, P49, DOI [10.1111/j.1540-4609.2010.00294.x, DOI 10.1111/J.1540-4609.2010.00294.X]; Sengar NS., 2019, INT J ADV RES IDEAS, V5, P818; Sharabiani A, 2014, IEEE GLOB ENG EDUC C, P832, DOI 10.1109/EDUCON.2014.6826192; Siddiqui MA, 2013, IEEE INT CONF ADV LE, P224, DOI 10.1109/ICALT.2013.70; Tomar A., 2016, INT J ENG TRENDS TEC, V38, P326, DOI [10.14445/22315381/IJETT-V38P260, DOI 10.14445/22315381/IJETT-V38P260]; Verma A., 2017, INT J COMPUTER SCI I, V9, P15, DOI [10.5121/ijcsit.2017.9502, DOI 10.5121/IJCSIT.2017.9502]; Westerman JW, 2011, DECIS SCI-J INNOV ED, V9, P49, DOI 10.1111/j.1540-4609.2010.00294.x	36	0	1	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253256	10.1371/journal.pone.0253256	http://dx.doi.org/10.1371/journal.pone.0253256			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170914	Green Published, gold			2022-12-26	WOS:000671694400050
J	Smith, JL; Mumbengegwi, D; Haindongo, E; Cueto, C; Roberts, KW; Gosling, R; Uusiku, P; Kleinschmidt, I; Bennett, A; Sturrock, HJ				Smith, Jennifer L.; Mumbengegwi, Davis; Haindongo, Erastus; Cueto, Carmen; Roberts, Kathryn W.; Gosling, Roly; Uusiku, Petrina; Kleinschmidt, Immo; Bennett, Adam; Sturrock, Hugh J.			Malaria risk factors in northern Namibia: The importance of occupation, age and mobility in characterizing high-risk populations	PLOS ONE			English	Article							AGRICULTURAL PRACTICES; ELIMINATION; TRANSMISSION; MOSQUITOS; DISTRICT; CHILDREN; PROGRAMS; ETHIOPIA; AFRICA; REGION	In areas of low and unstable transmission, malaria cases occur in populations with lower access to malaria services and interventions, and in groups with specific malaria risk exposures often away from the household. In support of the Namibian National Vector Borne Disease Program's drive to better target interventions based upon risk, we implemented a health facility-based case control study aimed to identify risk factors for symptomatic malaria in Zambezi Region, northern Namibia. A total of 770 febrile individuals reporting to 6 health facilities and testing positive by rapid diagnostic test (RDT) between February 2015 and April 2016 were recruited as cases; 641 febrile individuals testing negative by RDT at the same health facilities through June 2016 were recruited as controls. Data on socio-demographics, housing construction, overnight travel, use of malaria prevention and outdoor behaviors at night were collected through interview and recorded on a tablet-based questionnaire. Remotely-sensed environmental data were extracted for geo-located village residence locations. Multivariable logistic regression was conducted to identify risk factors and latent class analyses (LCA) used to identify and characterize high-risk subgroups. The majority of participants (87% of cases and 69% of controls) were recruited during the 2016 transmission season, an outbreak year in Southern Africa. After adjustment, cases were more likely to be cattle herders (Adjusted Odds Ratio (aOR): 4.46 95%CI 1.05-18.96), members of the police or other security personnel (aOR: 4.60 95%CI: 1.16-18.16), and pensioners/unemployed persons (aOR: 2.25 95%CI 1.24-4.08), compared to agricultural workers (most common category). Children (aOR 2.28 95%CI 1.13-4.59) and self-identified students were at higher risk of malaria (aOR: 4.32 95%CI 2.31-8.10). Other actionable risk factors for malaria included housing and behavioral characteristics, including traditional home construction and sleeping in an open structure (versus modern structure: aOR: 2.01 95%CI 1.45-2.79 and aOR: 4.76 95%CI: 2.14-10.57); cross border travel in the prior 30 days (aOR: 10.55 95%CI 2.94-37.84); and outdoor agricultural work at night (aOR: 2.09 95%CI 1.12-3.87). Malaria preventive activities were all protective and included personal use of an insecticide treated net (ITN) (aOR: 0.61 95%CI 0.42-0.87), adequate household ITN coverage (aOR: 0.63 95%CI 0.42-0.94), and household indoor residual spraying (IRS) in the past year (versus never sprayed: (aOR: 0.63 95%CI 0.44-0.90). A number of environmental factors were associated with increased risk of malaria, including lower temperatures, higher rainfall and increased vegetation for the 30 days prior to diagnosis and residing more than 5 minutes from a health facility. LCA identified six classes of cases, with class membership strongly correlated with occupation, age and select behavioral risk factors. Use of ITNs and IRS coverage was similarly low across classes. For malaria elimination these high-risk groups will need targeted and tailored intervention strategies, for example, by implementing alternative delivery methods of interventions through schools and worksites, as well as the use of specific interventions that address outdoor transmission.	[Smith, Jennifer L.; Cueto, Carmen; Roberts, Kathryn W.; Gosling, Roly; Bennett, Adam; Sturrock, Hugh J.] Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA; [Mumbengegwi, Davis] Univ Namibia, Multidisciplinary Res Ctr, Windhoek, Namibia; [Haindongo, Erastus] Univ Namibia, Fac Hlth Sci, Sch Med, Windhoek, Namibia; [Uusiku, Petrina] Natl Minist Hlth & Social Serv, Windhoek, Namibia; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Kleinschmidt, Immo] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England	University of California System; University of California San Francisco; University of Namibia; University of Namibia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Smith, JL (corresponding author), Univ Calif San Francisco, Global Hlth Grp, Malaria Eliminat Initiat, San Francisco, CA 94143 USA.	Jennifer.smith@ucsf.edu		Roberts, Kathryn W./0000-0002-3558-7644; Haindongo, Erastus/0000-0002-7094-6569	Bill & Melinda Gates Foundation [OPP1160129]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This work was supported by a grant from the Bill & Melinda Gates Foundation to the Malaria Elimination Initiative at UCSF (OPP1160129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agegnehu F, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5370-4; Alegana VA, 2013, SPAT SPATIO-TEMPORAL, V7, P25, DOI 10.1016/j.sste.2013.09.001; Alegana VA, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-6; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Cahyaningrum Pratiwi, 2018, J Prev Med Public Health, V51, P148, DOI 10.3961/jpmph.18.036; Chanda E, 2018, T ROY SOC TROP MED H, V112, P546, DOI 10.1093/trstmh/try097; Chritz S, MALARIA CONTROL MIGR MALARIA CONTROL MIGR; Clementi E, 2020, INT J INFECT DIS, V100, P27, DOI 10.1016/j.ijid.2020.08.035; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Cohee LM, 2018, AM J TROP MED HYG, V98, P95, DOI 10.4269/ajtmh.17-0590; Cohee LM., LANCET GLOB HEALTH, DOI [10.1016/S2214-109X%2820%2930325-9, DOI 10.1016/S2214-109X%2820%2930325-9]; Cohen JM, 2018, PERSONAL COMMUNICATI; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Essendi WM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2845-4; Global Malaria Programme, 2006, IND RES SPRAYING US IND RES SPRAYING US; Gottert A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25518; Grigg MJ, 2017, LANCET PLANET HEALTH, V1, pE97, DOI [10.1016/S2542-5196(17)30031-1, 10.1016/s2542-5196(17)30031-1]; Gueye CS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1190; Haiyambo DH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007290; Hsiang MS, 2020, LANCET, V395, P1361, DOI 10.1016/S0140-6736(20)30470-0; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Ijumba JN, 2001, MED VET ENTOMOL, V15, P1, DOI 10.1046/j.1365-2915.2001.00279.x; Ijumba JN, 2002, MED VET ENTOMOL, V16, P28, DOI 10.1046/j.0269-283x.2002.00337.x; Ijumba JN, 2002, T ROY SOC TROP MED H, V96, P476, DOI 10.1016/S0035-9203(02)90408-6; Jacobson JO, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2807-x; Jacobson JO, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1679-1; Janko MM, 2018, LANCET PLANET HEALTH, V2, pE74, DOI 10.1016/S2542-5196(18)30009-3; Khadka A, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2368-4; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kureya T, 2017, IRAN J PARASITOL, V12, P423; Lalji S, 2016, GLOB HEALTH-SCI PRAC, V4, P251, DOI 10.9745/GHSP-D-16-00040; Lemma W, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8415-4; Lengeler C, 2004, Cochrane Database Syst Rev, pCD000363; Liu JX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087358; Makadzange K, 2018, PUBLIC HEALTH ACTION, V8, pS29, DOI 10.5588/pha.17.0016; Manning JE, 2014, TRENDS PARASITOL, V30, P571, DOI 10.1016/j.pt.2014.10.002; McCreesh P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2626-5; Medzihradsky Oliver F, 2018, BMJ Open, V8, pe019294, DOI 10.1136/bmjopen-2017-019294; Merzouki A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25615; Messina JP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-161; Midekisa A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0954-7; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Mordecai EA, 2019, ECOL LETT, V22, P1690, DOI 10.1111/ele.13335; Mphwatiwa T, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1964-z; Namibia Statistics Agency, 2014, 2011 POP HOUS CENS R 2011 POP HOUS CENS R; Nankabirwa J, 2014, TROP MED INT HEALTH, V19, P1294, DOI 10.1111/tmi.12374; National Vector-borne Disease Control Program NMoHaSS, ENT SURV WORK GROUP ENT SURV WORK GROUP; Nghipumbwa MH, 2018, PUBLIC HEALTH ACTION, V8, pS18, DOI 10.5588/pha.17.0076; Pinchoff J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156717; Programme GotRoNNV-bDC, 2015, MAL ANN REP 2014 201 MAL ANN REP 2014 201; Raman J, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03227-3; Raykov T, 2016, STRUCT EQU MODELING, V23, P726, DOI 10.1080/10705511.2015.1103193; Rehman AM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2954-0; Ren ZP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116932; Schicker RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143829; Smith JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180845; Smith JL, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1719-x; Sturrock HJW, 2015, AM J TROP MED HYG, V93, P139, DOI 10.4269/ajtmh.14-0256; Sturrock HJW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063830; Teboh-Ewungkem MI, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-428; Tejedor-Garavito N, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2004-8; Tesfahunegn A, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2992-7; Tesfahunegn A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6798-x; Tesfay K, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4680-7; Tessema S, 2019, ELIFE, V8, DOI 10.7554/eLife.43510; Tusting LS, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003055; Tusting LS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002234; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; Walldorf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134061; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; Workineh B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4315-z	71	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252690	10.1371/journal.pone.0252690	http://dx.doi.org/10.1371/journal.pone.0252690			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170917	Green Published, gold			2022-12-26	WOS:000671694400023
J	Martino, NA; Vicenti, R; Macciocca, M; Seracchioli, R; Marzano, G; Mastrorocco, A; Lacalandra, GM; Tomaiuolo, M; Marchesani, G; Chiaravalle, EA; Klinger, FG; Marcozzi, S; Fabbri, R; Dell'Aquila, ME				Martino, Nicola Antonio; Vicenti, Rossella; Macciocca, Maria; Seracchioli, Renato; Marzano, Giuseppina; Mastrorocco, Antonella; Lacalandra, Giovanni Michele; Tomaiuolo, Michele; Marchesani, Giuliana; Chiaravalle, Eugenio Antonio; Klinger, Francesca Gioia; Marcozzi, Serena; Fabbri, Raffaella; Dell'Aquila, Maria Elena			Effects of low-dose X-ray medical diagnostics on female gonads: Insights from large animal oocytes and human ovaries as complementary models	PLOS ONE			English	Article							INDUCED CHROMOSOME-ABERRATIONS; IN-VITRO MATURATION; IONIZING-RADIATION; DEVELOPMENTAL COMPETENCE; FOLLICLE DEVELOPMENT; OXIDATIVE STRESS; MATURE OOCYTES; APOPTOSIS; CELLS; IRRADIATION	Diagnostic imaging has significantly grown over the last thirty years as indispensable support for diagnostic, prognostic, therapeutic and monitoring procedures of human diseases. This study explored the effects of low-dose X-ray medical diagnostics exposure on female fertility. To aim this, cumulus-oocyte complexes (COCs) recovered from the ovaries of juvenile sheep and human ovaries were used as complementary models for in vitro studies. In the sheep model, the effects of low-dose X-rays on oocyte viability and developmental competence were evaluated. In human ovaries originated from two age group (21-25 and 33-36 years old) subjects with gender dysphoria, X-rays effects on tissue morphology, follicular density and expression of apoptosis-related (NOXA, PUMA, Bcl2, Bak, gamma H2AX) and cell cycle-related genes (p21 and ki67) were investigated. It was noted that in sheep, the minimum dose of 10 mGy did not influence most of examined parameters at oocyte and embryo levels, whereas 50 and 100 mGy X-ray exposure reduced oocyte bioenergetic/oxidative activity but without any visible effects on oocyte and embryo development. In addition, blastocyst bioenergetic/oxidative status was reduced with all used doses. Overall data on human ovaries showed that low-dose X-rays, similarly as in sheep, did not alter any of examined parameters. However, in women belonging to the 33-36 year group, significantly reduced follicular density was observed after exposure to 50 and 100 mGy, and increased NOXA and Bax expression after exposure at 50 mGy. In conclusion, used low-doses of X-ray exposure, which resemble doses used in medical diagnostics, produce weak damaging effects on female fertility with increased susceptibility in advanced age.	[Martino, Nicola Antonio; Marzano, Giuseppina; Mastrorocco, Antonella; Dell'Aquila, Maria Elena] Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Vicenti, Rossella; Macciocca, Maria; Seracchioli, Renato; Fabbri, Raffaella] Univ Bologna, Dept Med & Surg Sci, Gynecol & Physiopathol Human Reprod Unit, S Orsola Malpighi Hosp Bologna, Bologna, Italy; [Lacalandra, Giovanni Michele] Univ Bari Aldo Moro, Dept Vet Med, Bari, Italy; [Tomaiuolo, Michele; Marchesani, Giuliana; Chiaravalle, Eugenio Antonio] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Klinger, Francesca Gioia; Marcozzi, Serena] Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Histol & Embryol, Rome, Italy; [Martino, Nicola Antonio] Univ Turin, Dept Vet Sci, Turin, Italy	Universita degli Studi di Bari Aldo Moro; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Universita degli Studi di Bari Aldo Moro; IZS Puglia e Basilicata; University of Rome Tor Vergata; University of Turin	Martino, NA (corresponding author), Univ Bari Aldo Moro, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy.; Martino, NA (corresponding author), Univ Turin, Dept Vet Sci, Turin, Italy.	nicolaantonio.martino@unito.it	LACALANDRA, Giovanni Michele/P-4661-2014; Marcozzi, Serena/GRS-0237-2022; Martino, Nicola Antonio/N-4096-2014; Seracchioli, Renato/Q-6101-2016	Marcozzi, Serena/0000-0001-5873-5753; Mastrorocco, Antonella/0000-0001-7136-4029; Dell'Aquila, Maria Elena/0000-0003-3629-7005; Martino, Nicola Antonio/0000-0001-6853-2757; Seracchioli, Renato/0000-0001-7487-1333	Ministry of Health [GR-2011-02351396]	Ministry of Health	This study was supported by the project GR-2011-02351396 (Ministry of Health, Young Researchers Grant 2011/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens I, 2009, HUM REPROD UPDATE, V15, P359, DOI 10.1093/humupd/dmn063; Albamonte M., 2012, J MED RES SCI, V2, P134; Alessio N, 2015, ONCOTARGET, V6, P8155, DOI 10.18632/oncotarget.2692; Anderson RA, 2014, HUM REPROD, V29, P97, DOI 10.1093/humrep/det388; [Anonymous], RAD EXPOSURE XRAY EX; BAIRD DT, 1983, J REPROD FERTIL, V69, P343, DOI 10.1530/jrf.0.0690343; Bianchi M., 1983, OVARY CYTOTOXIC INSU; Campbell BK, 2003, REPRODUCTION, P429; Chandrashekhar Y, 2015, JACC-CARDIOVASC IMAG, V8, P885, DOI 10.1016/j.jcmg.2015.05.004; Cotterill M, 2013, MOL HUM REPROD, V19, P444, DOI 10.1093/molehr/gat013; Dayal D, 2008, BIOCHEM J, V413, P185, DOI 10.1042/BJ20071643; De Roo C, 2017, REPROD BIOMED ONLINE, V34, P557, DOI 10.1016/j.rbmo.2017.03.008; Dell'Aquila ME, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/878062; Dell'Aquila ME, 2009, FERTIL STERIL, V91, P249, DOI 10.1016/j.fertnstert.2007.10.042; Dumesic DA, 2015, FERTIL STERIL, V103, P303, DOI 10.1016/j.fertnstert.2014.11.015; Duncan FE, 2016, FUTURE ONCOL, V12, P1687, DOI 10.2217/fon-2016-0121; Fabbri R, 2016, HUM REPROD, V31, P1838, DOI 10.1093/humrep/dew134; Fabbri R, 2010, REPROD BIOMED ONLINE, V21, P819, DOI 10.1016/j.rbmo.2010.07.008; FRITZNIGGLI H, 1991, INT J RADIAT BIOL, V59, P175, DOI 10.1080/09553009114550161; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Hamatani K, 2008, CANCER RES, V68, P7176, DOI 10.1158/0008-5472.CAN-08-0293; Hanoux V, 2007, CELL DEATH DIFFER, V14, P671, DOI 10.1038/sj.cdd.4402052; Harris SE, 2010, HUM REPROD, V25, P2305, DOI 10.1093/humrep/deq181; Heng BC, 2006, J BIOMED SCI, V13, P433, DOI 10.1007/s11373-005-9051-9; Huda W, 2007, AM J ROENTGENOL, V188, P540, DOI 10.2214/AJR.06.0101; Albamonte MI, 2013, HUM REPROD, V28, P698, DOI 10.1093/humrep/des453; Jacquet P, 2001, MUTAT RES-FUND MOL M, V473, P249, DOI 10.1016/S0027-5107(00)00153-6; Jin XD, 2018, BIOCHEM BIOPH RES CO, V500, P958, DOI 10.1016/j.bbrc.2018.04.214; KAMIGUCHI Y, 1982, MUTAT RES, V103, P33, DOI 10.1016/0165-7992(82)90083-5; Kanagaraj K, 2015, MUTAT RES-GEN TOX EN, V789, P1, DOI 10.1016/j.mrgentox.2015.05.008; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Latini G, 2012, CURR MED CHEM, V19, P6171, DOI 10.2174/0929867311209066171; Ledda S, 1997, J REPROD FERTIL, V109, P73, DOI 10.1530/jrf.0.1090073; Leoni GG, 2007, MOL REPROD DEV, V74, P249, DOI 10.1002/mrd.20442; Leoni GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124911; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Lundy T, 1999, J REPROD FERTIL, V115, P251, DOI 10.1530/jrf.0.1150251; Marcozzi S, 2018, MINERVA GINECOL, V70, P549, DOI 10.23736/S0026-4784.18.04274-0; Martino NA, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-99; Martino NA, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-27; Martino NA, 2016, REPROD TOXICOL, V65, P204, DOI 10.1016/j.reprotox.2016.08.004; Martino NA, 2012, FERTIL STERIL, V97, P720, DOI 10.1016/j.fertnstert.2011.12.014; Mastrorocco A, 2019, MOL REPROD DEV, V86, P1430, DOI 10.1002/mrd.23256; MATSUDA Y, 1985, MUTAT RES, V151, P275; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; McLaughlin M, 2017, HUM REPROD, V32, P165, DOI 10.1093/humrep/dew260; McLaughlin M, 2014, MOL HUM REPROD, V20, P736, DOI 10.1093/molehr/gau037; Meirow D, 2010, CLIN OBSTET GYNECOL, V53, P727, DOI 10.1097/GRF.0b013e3181f96b54; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2020, RADIOLOGY, V295, P418, DOI 10.1148/radiol.2020192256; Moravek MB, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa014; Nitta Y, 2003, INT J RADIAT BIOL, V79, P241, DOI 10.1080/0955300031000096315; OGILVYSTUART AL, 1993, ENVIRON HEALTH PERSP, V101, P109, DOI 10.2307/3431383; Osipov AN, 2015, ONCOTARGET, V6, P27275, DOI 10.18632/oncotarget.4739; Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023; Peng L, 2008, CRYOBIOLOGY, V57, P175, DOI 10.1016/j.cryobiol.2008.06.005; Pesty A, 2010, REPROD TOXICOL, V29, P93, DOI 10.1016/j.reprotox.2009.10.007; Nguyen QN, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0633-7; Salvat F, 2015, ANN NUCL ENERGY, V82, P98, DOI 10.1016/j.anucene.2014.08.007; Sanders JE, 1996, BLOOD, V87, P3045, DOI 10.1182/blood.V87.7.3045.bloodjournal8773045; Sapmaz-Metin M, 2014, ACTA BIOL HUNG, V65, P27, DOI 10.1556/ABiol.65.2014.1.3; Somoskoi B, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0018-z; Spitz DR, 2004, CANCER METAST REV, V23, P311, DOI 10.1023/B:CANC.0000031769.14728.bc; Steele Joseph R, 2016, J Adv Pract Oncol, V7, P310; TEASE C, 1986, MUTAT RES, V173, P211, DOI 10.1016/0165-7992(86)90038-2; Thompson JG, 2016, REPROD FERT DEVELOP, V28, P41, DOI 10.1071/RD15340; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; Walker SK, 1996, BIOL REPROD, V55, P703, DOI 10.1095/biolreprod55.3.703; Wallace W H, 1989, Clin Oncol (R Coll Radiol), V1, P75, DOI 10.1016/S0936-6555(89)80039-1; Wallace WHB, 2011, CANCER-AM CANCER SOC, V117, P2301, DOI 10.1002/cncr.26045; Wallace WHB, 2005, INT J RADIAT ONCOL, V62, P738, DOI 10.1016/j.ijrobp.2004.11.038; Wallace WHB, 2003, HUM REPROD, V18, P117, DOI 10.1093/humrep/deg016; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Yang WL, 2003, INT J CANCER, V103, P360, DOI 10.1002/ijc.10822; Zhao H, 2019, ONCOL LETT, V17, P42, DOI 10.3892/ol.2018.9566	77	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253536	10.1371/journal.pone.0253536	http://dx.doi.org/10.1371/journal.pone.0253536			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166427	Green Published, gold			2022-12-26	WOS:000671692800074
J	Takashima, Y; Kawaguchi, A; Fukai, J; Iwadate, Y; Kajiwara, K; Hondoh, H; Yamanaka, R				Takashima, Yasuo; Kawaguchi, Atsushi; Fukai, Junya; Iwadate, Yasuo; Kajiwara, Koji; Hondoh, Hiroaki; Yamanaka, Ryuya			Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma	PLOS ONE			English	Article							PI3K/AKT/MTOR; CYTOSKELETON; SELECTION; INVASION; TUMORS	Dysregulation of cell morphology and cell-cell interaction results in cancer cell growth, migration, invasion, and metastasis. Besides, a balance between the extracellular matrix (ECM) and matrix metalloprotease (MMP) is required for cancer cell morphology and angiogenesis. Here, we determined gene signatures associated with the morphology and microenvironment of primary central nervous system lymphoma (PCNSL) to enable prognosis prediction. Next-generation sequencing (NGS) on 31 PCNSL samples revealed gene signatures as follows: ACTA2, ACTR10, CAPG, CORO1C, KRT17, and PALLD in cytoskeleton, CDH5, CLSTN1, ITGA10, ITGAX, ITGB7, ITGA8, FAT4, ITGAE, CDH10, ITGAM, ITGB6, and CDH18 in adhesion, COL8A2, FBN1, LAMB3, and LAMA2 in ECM, ADAM22, ADAM28, MMP11, and MMP24 in MMP. Prognosis prediction formulas with the gene expression values and the Cox regression model clearly divided survival curves of the subgroups in each status. Furthermore, collagen genes contributed to gene network formation in glasso, suggesting that the ECM balance controls the PCNSL microenvironment. Finally, the comprehensive balance of morphology and microenvironment enabled prognosis prediction by a combinatorial expression of 8 representative genes, including KRT17, CDH10, CDH18, COL8A2, ADAM22, ADAM28, MMP11, and MMP24. Besides, these genes could also diagnose PCNSL cell types with MTX resistances in vitro. These results would not only facilitate the understanding of biology of PCNSL but also consider targeting pathways for anti-cancer treatment in personalized precision medicine in PCNSL.	[Takashima, Yasuo; Yamanaka, Ryuya] Iseikai Holon Grp, Osaka Iseikai Clin Canc Therapy, Osaka, Japan; [Takashima, Yasuo; Yamanaka, Ryuya] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan; [Kawaguchi, Atsushi] Saga Univ, Fac Med, Ctr Comprehens Community Med, Saga, Japan; [Fukai, Junya] Wakayama Med Univ, Dept Neurol Surg, Sch Med, Wakayama, Japan; [Iwadate, Yasuo] Chiba Univ, Grad Sch Med Sci, Dept Neurosurg, Chiba, Japan; [Kajiwara, Koji] Yamaguchi Univ, Grad Sch Med Sci, Dept Neurosurg, Ube, Yamaguchi, Japan; [Hondoh, Hiroaki] Toyama Prefectural Cent Hosp, Dept Neurosurg, Toyama, Japan	Kyoto Prefectural University of Medicine; Saga University; Wakayama Medical University; Chiba University; Yamaguchi University	Yamanaka, R (corresponding author), Iseikai Holon Grp, Osaka Iseikai Clin Canc Therapy, Osaka, Japan.; Yamanaka, R (corresponding author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Lab Mol Target Therapy Canc, Kyoto, Japan.	ryaman@koto.kpu-m.ac.jp		Takashima, Yasuo/0000-0001-8876-6673; Yamanaka, Ryuya/0000-0003-2941-7996	MEXT KAKENHI [16H05441, 18K09001]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the MEXT KAKENHI Grant Numbers 16H05441 and 18K09001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO R, 1993, ACTA NEUROPATHOL, V86, P71, DOI 10.1007/BF00454901; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bethge N, 2014, EPIGENETICS-US, V9, P428, DOI 10.4161/epi.27554; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Bui TM, 2020, J LEUKOCYTE BIOL, V108, P787, DOI 10.1002/JLB.2MR0220-549R; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Carey VJ, 2005, BIOINFORMATICS, V21, P135, DOI 10.1093/bioinformatics/bth458; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Hayano A, 2019, INT J CLIN ONCOL, V24, P1020, DOI 10.1007/s10147-019-01451-9; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JELLINGER KA, 1995, J NEURO-ONCOL, V24, P33, DOI 10.1007/BF01052655; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kasenda B, 2015, ANN ONCOL, V26, P1305, DOI 10.1093/annonc/mdv076; Kawaguchi A, 2012, CLIN CANCER RES, V18, P5672, DOI 10.1158/1078-0432.CCR-12-0596; LEBLANC M, 1993, J AM STAT ASSOC, V88, P457, DOI 10.2307/2290325; Lemma SA, 2017, CARCINOGENESIS, V38, P812, DOI 10.1093/carcin/bgx061; Li SZ, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0622-8; Li XC, 2020, INT J BIOL SCI, V16, P2014, DOI 10.7150/ijbs.44943; Lim DH, 2015, ANTICANCER RES, V35, P3333; Lossos IS, 2004, NEW ENGL J MED, V350, P1828, DOI 10.1056/NEJMoa032520; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Parascandolo A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41416; Reni M, 1999, BRIT J CANCER, V79, P530, DOI 10.1038/sj.bjc.6690083; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Takashima Y, 2020, CLIN CANCER RES, V26, P2754, DOI 10.1158/1078-0432.CCR-18-3851; Takashima Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65463-6; Takashima Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229577; Takashima Y, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6129-8; Takashima Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46473-5; Takashima Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210400; Takashima Yasuo, 2018, Oncotarget, V9, P27471, DOI 10.18632/oncotarget.25463; Takashima Yasuo, 2018, Oncotarget, V9, P19065, DOI 10.18632/oncotarget.24897; Tun HW, 2008, BLOOD, V111, P3200, DOI 10.1182/blood-2007-10-119099; Weaver BAA, 2005, CANCER CELL, V8, P7, DOI 10.1016/j.ccr.2005.06.011; Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6; YAMADA KM, 1976, P NATL ACAD SCI USA, V73, P1217, DOI 10.1073/pnas.73.4.1217; Yamanaka R, 2003, INT J ONCOL, V23, P913; Yang GH, 2019, NATURE, V565, P192, DOI 10.1038/s41586-018-0813-8; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang YQ, 2017, CANCER CELL, V31, P820, DOI 10.1016/j.ccell.2017.04.013	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0251272	10.1371/journal.pone.0251272	http://dx.doi.org/10.1371/journal.pone.0251272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166375	Green Published, gold			2022-12-26	WOS:000671692800019
J	Perlstein, SG; Verboord, M				Perlstein, Sara Gron; Verboord, Marc			Lockdowns, lethality, and laissez-faire politics. Public discourses on political authorities in high-trust countries during the COVID-19 pandemic	PLOS ONE			English	Article							SOCIAL MEDIA; SENTIMENT ANALYSIS; EBOLA-VIRUS; CRISIS; TWITTER; COMMUNICATION; GOVERNMENT; HEALTH; EVENT	This study looks at population response to government containment strategies during initial stages of the COVID-19 pandemic in four high-trust Northern European countries-Denmark, Germany, the Netherlands, and Sweden-with special emphasis on expressions of governmental trust. Sentiment analysis and topic modeling analysis were performed using Twitter data from three phases during the initial European lockdown, and results were compared over time and between countries. Findings show that, in line with existing theory, assertive crisis responses and proactive communication were generally well-received, whereas tentative crisis responses or indications by the authorities that the crisis was manageable were generally met with suspicion. In addition, while government support was high in all countries during the height of the crisis, messages critical of the government as well as conspiracy theories were nevertheless widely circulated. Importantly, countries with the least assertive strategies, rather than clear negative responses, saw heightened polarization of sentiment in the population. Furthermore, in the case of Sweden, a laissez-faire strategy was generally accepted by the population, despite strong criticism from other countries, until mortality rates started to rise. Possible explanations for these findings are discussed with an emphasis of prior trust as a potential explanatory factor. Future research should seek to replicate these findings in other countries with different levels of prior governmental trust or with a different severity of the COVID-19 outbreak than the countries in this study as well as triangulate the findings of this study using alternative methods.	[Perlstein, Sara Gron; Verboord, Marc] Erasmus Univ, Erasmus Sch Hist Culture & Commun, Rotterdam, Netherlands; [Perlstein, Sara Gron] Leiden Univ, Fac Governance & Global Affairs, Inst Secur & Global Affairs, The Hague, Netherlands	Erasmus University Rotterdam; Leiden University; Leiden University - Excl LUMC	Verboord, M (corresponding author), Erasmus Univ, Erasmus Sch Hist Culture & Commun, Rotterdam, Netherlands.	verboord@eshcc.eur.nl	Verboord, Marc/AAP-4499-2020; Perlstein, Sara/AAE-7944-2022	Verboord, Marc/0000-0002-6098-3075; Perlstein, Sara/0000-0001-5301-2409				Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3; Amt Auswartiges., 2020, DEUTSCHL EUR COR HIL; Andersson S., 2020, VARLDEN IDAG 0319; [Anonymous], 2015, METHODS CRITICAL DIS; [Anonymous], 2018, SHAR PEOPL WHO TRUST; Baars C., 2020, TAGESSCHAU 0417; Bacsu JD, 2021, J MED INTERNET RES, V23, DOI 10.2196/26254; Banai IP., 2020, BELIEFS COVID 19 CON; Benoit W. L., 2018, J INT CRISIS RISK CO, V1, DOI [10.30658/jicrcr.1.1.2, 10.30658/jicrcr, DOI 10.30658/JICRCR.1.1.2]; Berschens R., 2020, HANDELSBATT 0327; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Boin A., 2017, POLITICS CRISIS MANA, V2nd; Bouzzine YD., 2020, MANAGEMENT STUDIES, V10, P64; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Brainard J, 2020, SIMUL-T SOC MOD SIM, V96, P365, DOI 10.1177/0037549719885021; Bull, 2020, BEATING COVID 19 PRO; Bursztyn Leonardo, 2020, MISINFORMATION PANDE; CBS News, 2020, CBS NEW 0430; Ceron A, 2014, NEW MEDIA SOC, V16, P340, DOI 10.1177/1461444813480466; Chamlee-Wright E, 2010, PUBLIC CHOICE, V144, P253, DOI 10.1007/s11127-009-9516-x; Chatagnier JT, 2012, J PEACE RES, V49, P631, DOI 10.1177/0022343312440808; Cornelson Kirsten, 2020, POLITICAL POLARIZATI; D'heer E, 2014, EUR J COMMUN, V29, P720, DOI 10.1177/0267323114544866; Dahal B, 2019, SOC NETW ANAL MIN, V9, DOI 10.1007/s13278-019-0568-8; Diesner J., 2020, GOOGLE DOCS; Diesner J., 2014, C INT COMM ASS ICA M; Dodds W., 2019, WORLDS WORST PROBLEM, P31, DOI DOI 10.1007/978-3-030-30410-2_4; Donner W., 2018, HDB DISASTER RES PP, P289, DOI [10.1007/978-3-319-63254-4_15, DOI 10.1007/978-3-319-63254-4_15]; Engelbart T., 2020, DAGELIJKSE STAN 0305; ETIENNE J., 2010, REV FRANCAISE SCI PO, V60, P493, DOI [10.3917/rfspe.602.0139, DOI 10.3917/RFSPE.602.0139]; Eurostat, DAT EUR; Farzanegan MR, 2021, J RISK FINANC MANAG, V14, DOI 10.3390/jrfm14030105; Folkhalsomyndigheten, 2020, HAR ANSV ATT FORH SM; Franchini Antonia Francesca, 2020, Acta Biomed, V91, P245, DOI 10.23750/abm.v91i2.9625; Fukuyama F., 1996, TRUST SOCIAL VIRTUES; Ge Song, 2014, Journal of Multimedia, V9, P635, DOI 10.4304/jmm.9.5.635-643; Gentili D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030911; Gonzalez-Bailon S, 2014, SOC INTERNET NETWORK, P209; Gruzd A, 2020, BIG DATA SOC, V7, DOI 10.1177/2053951720938405; Gupta M, 2020, DERMATOL THER, V33, DOI 10.1111/dth.13329; Hansen SS., 2020, ALTINGET 0420; Helsloot I., 2004, J CONTING CRISIS MAN, V12, P98, DOI [10.1111/j.0966-0879.2004.00440.x, DOI 10.1111/J.0966-0879.2004.00440.X]; Henrique J., 2018, GETOLDTWEETS PYTHON; Hetherington MJ, 2003, PS-POLIT SCI POLIT, V36, P37; Holdert M., 2020, NOS; Hong L., 2010, P 1 WORKSH SOC MED A, P80, DOI DOI 10.1145/1964858.1964870; Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092; Howard A, 2017, INT J DISAST RISK RE, V22, P139, DOI 10.1016/j.ijdrr.2017.03.002; Hugelius Karin, 2017, PLoS Curr, V9, DOI 10.1371/currents.dis.f4a444e1f182776bdf567893761f86b8; Ilyas Sardar Haider Waseem, 2020, dg.o '20: The 21st Annual International Conference on Digital Government Research, DOI 10.1145/3396956.3396973; Kim EHJ, 2016, J INF SCI, V42, P763, DOI 10.1177/0165551515608733; Lachlan KA, 2014, COMMUN STUD, V65, P500, DOI 10.1080/10510974.2014.956941; Lachlan KA, 2014, COMMUN STUD, V65, P519, DOI 10.1080/10510974.2014.956940; Larsson Y., 2020, SVT NYHETER 0417; Lauritzen DB., 2020, ALTINGET 0408; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Leetaru K, 2013, 1 MONDAY, V18, DOI DOI 10.5210/FM.V18I5.4366; LePan N., 2020, VISUALISING HIST PAN; Li CL, 2017, ACM T INFORM SYST, V36, DOI 10.1145/3091108; Li SY, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2019.102177; Li XM, 2018, INFORM SCIENCES, V456, P83, DOI 10.1016/j.ins.2018.04.071; Lindberg M., 2020, GOTEBORGS POSTE 0428; Lu X, 2021, BUILD SIMUL-CHINA, V14, P25, DOI 10.1007/s12273-020-0637-y; Malmqvist MA., 2020, AFTONBLADET; Maor M., 2019, INT REV PUBLIC POLIC, V1, P46, DOI [10.4000/irpp.277, DOI 10.4000/IRPP.277]; Maor M., 2020, MODERN GUIDE PUBLIC, P93; Marien S, 2011, EUR J POLIT RES, V50, P267, DOI 10.1111/j.1475-6765.2010.01930.x; Mckee M, 2020, NAT MED, V26, P640, DOI 10.1038/s41591-020-0863-y; Moreno MA, 2013, CYBERPSYCH BEH SOC N, V16, P708, DOI 10.1089/cyber.2012.0334; Mungiu-Pippidi A., 2015, PUBLIC INTEGRITY TRU; Murphy P, 2020, COVID 19 PROPORTIONA, DOI [10.1007/978-981-15-7514-3, DOI 10.1007/978-981-15-7514-3]; Newman DJ, 2006, J AM SOC INF SCI TEC, V57, P753, DOI 10.1002/asi.20342; Norris P, 2011, DEMOCRATIC DEFICIT: CRITICAL CITIZENS REVISITED, P1, DOI 10.1017/CBO9780511973383; NOS Nieuws, 2020, NOS NIEUWS 0309; OECD, 2018, HLTH CAR RES; OECD, 2020, HOWS LIFE 2020 MEASU, DOI [10.1787/23089679, DOI 10.1787/23089679]; Olson RS, 2010, INT STUD PERSPECT, V11, P205, DOI 10.1111/j.1528-3585.2010.00404.x; Osterholm MT., 2020, WASH POST; Pastore y Piontti A., 2019, CHARTING NEXT PANDEM, P11, DOI [10.1007/978-3-319-93290-3, DOI 10.1007/978-3-319-93290-3]; Politiken, 2020, POLITIKEN 0424; Poorolajal J, 2021, J RES HEALTH SCI, V21, DOI 10.34172/jrhs.2021.40; Porter JE., 2009, ETHICS INTERNET RES, P1; Pradana A. W., 2019, KINETIK GAME TECHNOL, P375, DOI [10.22219/kinetik.v4i4.912, DOI 10.22219/KINETIK.V4I4.912]; Pruss D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216922; Ramage D., 2009, NIPS 2009 WORKSH APP, V5, P1; Regeringen, 2020, STRAT MED ANL DET NY; Ritzau, 2020, JYDSKEVESTKYSTE 0321; Rodriguez H., 2007, HDB DISASTER RES, P551; Rodriguez H., 2007, P3, DOI 10.1111/geoa.12072; Ruiz Estrada MA, 2020, SSRN, DOI [10.2139/ssrn.3560681, DOI 10.2139/SSRN.3560681]; Savigny Heather., 2002, POLITICS, V22, P1, DOI [10.1111/1467-9256.00152, DOI 10.1111/1467-9256.00152]; Scheufele DA., 2004, PUBLIC OPINION POLLI, P26; SCHNEIDER SK, 1992, PUBLIC ADMIN REV, V52, P135, DOI 10.2307/976467; Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944; Spence PR, 2016, COMPUT HUM BEHAV, V54, P667, DOI 10.1016/j.chb.2015.08.045; Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178; Starbird K., 2014, ICONFERENCE 2014 P, P654, DOI [DOI 10.9776/14308, 10.9776/14308]; Statista, 2020, STATISTA 0605; Su Y, 2020, J INF TECHNOL POLITI, V17, P357, DOI 10.1080/19331681.2020.1756553; Sundhedsstyrelsen, 2020, SPORGSM SVAR NY COR; Surian D, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6045; Talbot CV, 2020, COMPUT HUM BEHAV, V102, P112, DOI 10.1016/j.chb.2019.08.005; Tampere P, 2016, CORP COMMUN, V21, P414, DOI 10.1108/CCIJ-08-2015-0049; Tang JT, 2020, FRONT ARTIF INTEL AP, V329, P74, DOI 10.3233/FAIA200642; Taylor-Clark K, 2005, BIOSECUR BIOTERROR, V3, P138, DOI 10.1089/bsp.2005.3.138; The World Bank, 2020, WORLD EC FOR GLOB CO; Tirkkonen P, 2011, PUBLIC RELAT REV, V37, P172, DOI 10.1016/j.pubrev.2011.01.004; Trouw. Een 'intelligente lockdown', 2020, TROUW 0323; van Wijk J, 2017, POLICY SCI, V50, P469, DOI 10.1007/s11077-016-9262-0; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Wallace C., 2016, SOCIAL MEDIA RES GUI, V1, P16; Weston S, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00203-20; Wicke P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240010; Winter LD., 2020, TELEGRAAF 0304; Wissenschaft Spiegel., 2020, SPIEGEL; Wolf LJ, 2020, BRIT J SOC PSYCHOL, V59, P618, DOI 10.1111/bjso.12401; World Health Organisation, 2020, WHO CHARACTERIZES CO; World Health Organization, 2017, 650 000 PEOPL DIE RE; Wray R., 2006, INT J MASS EMERGENCI, V24, P45; Wu DD., 2020, PANDEMIC RISK MANAGE, DOI [10.1007/978-3-030-52197-4, DOI 10.1007/978-3-030-52197-4]; Xue J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239441	121	3	3	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253175	10.1371/journal.pone.0253175	http://dx.doi.org/10.1371/journal.pone.0253175			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161377	gold, Green Published			2022-12-26	WOS:000671691900040
J	O'Connor, MJ; Thakar, T; Nicolae, CM; Moldovan, GL				O'Connor, Michael J.; Thakar, Tanay; Nicolae, Claudia M.; Moldovan, George-Lucian			PARP14 regulates cyclin D1 expression to promote cell-cycle progression	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; FAMILY; CANCER; GENE; P21; P53; PROLIFERATION; INHIBITION; DYNAMICS; PARP-14	Cyclin D1 is an essential regulator of the G1-S cell-cycle transition and is overexpressed in many cancers. Expression of cyclin D1 is under tight cellular regulation that is controlled by many signaling pathways. Here we report that PARP14, a member of the poly(ADP-ribose) polymerase (PARP) family, is a regulator of cyclin D1 expression. Depletion of PARP14 leads to decreased cyclin D1 protein levels. In cells with a functional retinoblastoma (RB) protein pathway, this results in G1 cell-cycle arrest and reduced proliferation. Mechanistically, we found that PARP14 controls cyclin D1 mRNA levels. Using luciferase assays, we show that PARP14 specifically regulates cyclin D1 3 ' UTR mRNA stability. Finally, we also provide evidence that G1 arrest in PARP14-depleted cells is dependent on an intact p53-p21 pathway. Our work uncovers a new role for PARP14 in promoting cell-cycle progression through both cyclin D1 and the p53 pathway.	[O'Connor, Michael J.; Thakar, Tanay; Nicolae, Claudia M.; Moldovan, George-Lucian] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Moldovan, GL (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	glm29@psu.edu	Thakar, Tanay/AGX-3854-2022	Nicolae, Claudia/0000-0003-4933-5496; Thakar, Tanay/0000-0001-5261-458X	NIH [R01ES026184]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Drs James Broach, Gregory Yochum, Lisa Shantz, Hein Te Riele, Titia de Lange, Nicholas Dyson, Hong-Gang Wang, Raymond Hohl, Myriam Gorospe, Khandan Keyomarsi, and Peter Sicinski for materials and advice, as well as the Penn State College of Medicine Flow Cytometry core for their assistance with flow cytometry experiments. This work was supported by NIH R01ES026184 (to G-LM).	Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Barbarulo A, 2013, ONCOGENE, V32, P4231, DOI 10.1038/onc.2012.448; Benedict B, 2018, ELIFE, V7, DOI 10.7554/eLife.37868; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carbone M, 2008, ONCOGENE, V27, P6083, DOI 10.1038/onc.2008.221; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Cho SH, 2009, BLOOD, V113, P2416, DOI 10.1182/blood-2008-03-144121; DeFilippis RA, 2003, J VIROL, V77, P1551, DOI 10.1128/JVI.77.2.1551-1563.2003; Dyson NJ, 2016, GENE DEV, V30, P1492, DOI 10.1101/gad.282145.116; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Farkas T, 2002, J BIOL CHEM, V277, P26741, DOI 10.1074/jbc.M200381200; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Goenka S, 2006, P NATL ACAD SCI USA, V103, P4210, DOI 10.1073/pnas.0506981103; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Guiley KZ, 2019, SCIENCE, V366, P1330, DOI 10.1126/science.aaw2106; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hydbring P, 2017, CANCER CELL, V31, P576, DOI 10.1016/j.ccell.2017.03.004; Iansante V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8882; Im SA, 2019, NEW ENGL J MED, V381, P307, DOI 10.1056/NEJMoa1903765; Iqbal MB, 2014, BLOOD, V124, P3646, DOI 10.1182/blood-2014-07-588046; Kettner NM, 2019, CLIN CANCER RES, V25, P3996, DOI 10.1158/1078-0432.CCR-18-3274; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lee MS, 2016, ONCOTARGET, V7, P39595, DOI 10.18632/oncotarget.9153; Mayr C, 2017, ANNU REV GENET, V51, P171, DOI 10.1146/annurev-genet-120116-024704; Milek M, 2017, GENOME RES, V27, P1344, DOI 10.1101/gr.218438.116; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; Nicolae CM, 2018, ONCOGENE, V37, P3647, DOI 10.1038/s41388-018-0219-y; Nicolae CM, 2015, NUCLEIC ACIDS RES, V43, P3143, DOI 10.1093/nar/gkv147; Nicolae CM, 2014, J BIOL CHEM, V289, P13627, DOI 10.1074/jbc.M114.556340; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Riley JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083127; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; Stengel KR, 2009, J BIOL CHEM, V284, P19265, DOI 10.1074/jbc.M808740200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Velez-Cruz R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081776; Viatour P, 2011, DIS MODEL MECH, V4, P581, DOI 10.1242/dmm.008060; Vyas S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5426; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wells J, 2002, P NATL ACAD SCI USA, V99, P3890, DOI 10.1073/pnas.062047499; Yang Z, 2017, MOL CANCER RES, V15, P1579, DOI 10.1158/1541-7786.MCR-17-0084; Yao N, 2019, MOL CARCINOGEN, V58, P1291, DOI 10.1002/mc.23011; Zhang JF, 2016, MOL CELL, V62, P929, DOI 10.1016/j.molcel.2016.04.023	47	8	8	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4872	4883		10.1038/s41388-021-01881-8	http://dx.doi.org/10.1038/s41388-021-01881-8		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34158578	Green Accepted			2022-12-26	WOS:000664429900001
J	Cherkasova, V; Iben, JR; Pridham, KJ; Kessler, AC; Maraia, RJ				Cherkasova, Vera; Iben, James R.; Pridham, Kevin J.; Kessler, Alan C.; Maraia, Richard J.			The leucine-NH4(+) uptake regulator Any1 limits growth as part of a general amino acid control response to loss of La protein by fission yeast	PLOS ONE			English	Article							RNA-POLYMERASE III; COUPLING GCN4 EXPRESSION; SCHIZOSACCHAROMYCES-POMBE; QUALITY-CONTROL; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; STRESS-RESPONSE; NUCLEAR EXPORT; EXOSOME; DEGRADATION	The sla1(+) gene of Schizosachharoymces pombe encodes La protein which promotes proper processing of precursor-tRNAs. Deletion of sla1 (sla1 Delta) leads to disrupted tRNA processing and sensitivity to target of rapamycin (TOR) inhibition. Consistent with this, media containing NH4(+) inhibits leucine uptake and growth of sla1 Delta cells. Here, transcriptome analysis reveals that genes upregulated in sla1 Delta cells exhibit highly significant overalp with general amino acid control (GAAC) genes in relevant transcriptomes from other studies. Growth in NH4(+) media leads to additional induced genes that are part of a core environmental stress response (CESR). The sla1 Delta GAAC response adds to evidence linking tRNA homeostasis and broad signaling in S. pombe. We provide evidence that deletion of the Rrp6 subunit of the nuclear exosome selectively dampens a subset of GAAC genes in sla1 Delta cells suggesting that nuclear surveillance-mediated signaling occurs in S. pombe. To study the NH4(+)-effects, we isolated sla1 Delta spontaneous revertants (SSR) of the slow growth phenotype and found that GAAC gene expression and rapamycin hypersensitivity were also reversed. Genome sequencing identified a F32V substitution in Any1, a known negative regulator of NH4(+)-sensitive leucine uptake linked to TOR. We show that H-3-leucine uptake by SSR-any1-F32V cells in NH4(+)-media is more robust than by sla1 Delta cells. Moreover, F32V may alter any1(+) function in sla1 Delta vs. sla1(+) cells in a distinctive way. Thus deletion of La, a tRNA processing factor leads to a GAAC response involving reprogramming of amino acid metabolism, and isolation of the any1-F32V rescuing mutant provides an additional specific link.	[Cherkasova, Vera] NIH, Kelly DeWitt Inc, Natl Lib Med, Bethesda, MD USA; [Iben, James R.] Eunice Kennedy Shriver NICHHD, Mol Genom Core, Div Intramural Res, NIH, Bethesda, MD USA; [Pridham, Kevin J.] Virginia Tech, Fralin Biomed Res Inst, Roanoke, VA USA; [Kessler, Alan C.; Maraia, Richard J.] Eunice Kennedy Shriver NICHHD, Sect Mol & Cell Biol, Div Intramural Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Maraia, RJ (corresponding author), Eunice Kennedy Shriver NICHHD, Sect Mol & Cell Biol, Div Intramural Res, NIH, Bethesda, MD 20892 USA.	maraiar@nih.gov	Maraia, Richard/ABC-1442-2020	Iben, James/0000-0002-1130-7660; Pridham, Kevin/0000-0002-2636-9688	Division of Intramural Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health [HD000412-31 PGD]	Division of Intramural Research of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health	I would like to note that this work was supported by the Division of Intramural Research (HD000412-31 PGD) of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection, interpretation, or decision to submit for publication.	ABASTADO JP, 1991, MOL CELL BIOL, V11, P486, DOI 10.1128/MCB.11.1.486; Anda S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182143; Anderson J, 1998, GENE DEV, V12, P3650, DOI 10.1101/gad.12.23.3650; Arimbasseri AG, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005671; Bayfield MA, 2009, NAT STRUCT MOL BIOL, V16, P430, DOI 10.1038/nsmb.1573; Bicho CC, 2010, MOL CELL PROTEOMICS, V9, P1567, DOI 10.1074/mcp.M110.000208; Blewett NH, 2018, BBA-GENE REGUL MECH, V1861, P361, DOI 10.1016/j.bbagrm.2018.01.013; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Bruch A, 2020, NUCLEIC ACIDS RES, V48, P7307, DOI 10.1093/nar/gkaa455; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Calvo O, 1999, MOL CELL BIOL, V19, P4167; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cherkasova V, 2012, MOL BIOL CELL, V23, P480, DOI 10.1091/mbc.E11-08-0732; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Copela LA, 2006, RNA, V12, P644, DOI 10.1261/rna.2307206; Copela LA, 2008, RNA, V14, P1214, DOI 10.1261/rna.1050408; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; De Zoysa T, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008893; Delan-Forino C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16965-4; Doi A, 2015, GENES CELLS, V20, P292, DOI 10.1111/gtc.12223; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Duncan CDS, 2018, P NATL ACAD SCI USA, V115, pE1829, DOI 10.1073/pnas.1713991115; Ekwall K, 1999, GENETICS, V153, P1153; Fang F, 2004, MOL CELL BIOL, V24, P10766, DOI 10.1128/MCB.24.24.10766-10776.2004; Foretek D, 2016, RNA, V22, P339, DOI 10.1261/rna.054973.115; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Grewal SIS, 1997, GENETICS, V146, P1221; Gudipati RK, 2012, MOL CELL, V48, P409, DOI 10.1016/j.molcel.2012.08.018; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Huang Hsiao-Yun, 2016, Life-Basel, V6, P16, DOI 10.3390/life6020016; Huang Y, 2006, NAT STRUCT MOL BIOL, V13, P611, DOI 10.1038/nsmb1110; Iben JR, 2011, NUCLEIC ACIDS RES, V39, P4728, DOI 10.1093/nar/gkr066; Intine RV, 2002, MOL CELL, V9, P1113, DOI 10.1016/S1097-2765(02)00533-6; Intine RVA, 2000, MOL CELL, V6, P339, DOI 10.1016/S1097-2765(00)00034-4; Irvine DV, 2009, GENOME RES, V19, P1077, DOI 10.1101/gr.089318.108; Jacobs JZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6344; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Karagiannis J, 1999, CURR GENET, V35, P593, DOI 10.1007/s002940050457; Karkusiewicz I, 2011, J BIOL CHEM, V286, P39478, DOI 10.1074/jbc.M111.253310; KEENEY JB, 1994, GENETICS, V136, P849; Kufel J, 2003, RNA, V9, P202, DOI 10.1261/rna.2145103; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lamichhane TN, 2016, RNA, V22, P583, DOI 10.1261/rna.054064.115; Lamichhane TN, 2013, MOL CELL BIOL, V33, P2918, DOI 10.1128/MCB.00278-13; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Lemay JF, 2010, MOL CELL, V37, P34, DOI 10.1016/j.molcel.2009.12.019; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2015, RNA BIOL, V12, P525, DOI 10.1080/15476286.2015.1022704; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Liu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139045; Lock A, 2019, NUCLEIC ACIDS RES, V47, pD821, DOI 10.1093/nar/gky961; Lorenz DR, 2014, ELIFE, V3, DOI 10.7554/eLife.04506; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Marsikova J, 2020, P NATL ACAD SCI USA, V117, P15123, DOI 10.1073/pnas.1922076117; Martin R, 2013, J CELL SCI, V126, P3010, DOI 10.1242/jcs.118067; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Mohler K, 2018, RNA BIOL, V15, P594, DOI 10.1080/15476286.2017.1379635; Moir RD, 2013, BBA-GENE REGUL MECH, V1829, P361, DOI 10.1016/j.bbagrm.2012.11.001; Mukherjee K, 2016, RNA, V22, P1311, DOI 10.1261/rna.051490.115; Nakase Y, 2018, J CELL SCI, V131, DOI 10.1242/jcs.221457; Nakase Y, 2013, J CELL SCI, V126, P3972, DOI 10.1242/jcs.128355; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Navarro FJ, 2017, J CELL SCI, V130, P4144, DOI 10.1242/jcs.208066; Nemoto N, 2010, J MOL BIOL, V404, P183, DOI 10.1016/j.jmb.2010.09.016; NIEDERBERGER P, 1981, MOL CELL BIOL, V1, P584, DOI 10.1128/MCB.1.7.584; Ogami Koichi, 2018, Non-Coding RNA, V4, P8, DOI 10.3390/ncrna4010008; Otsubo Y, 2020, GENES-BASEL, V11, DOI 10.3390/genes11090956; Otsubo Y, 2018, EMBO REP, V19, DOI 10.15252/embr.201744867; Palkova Z, 2000, J CELL SCI, V113, P1923; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Petersen Janni, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top079764; Qiu HF, 2000, MOL CELL BIOL, V20, P2505, DOI 10.1128/MCB.20.7.2505-2516.2000; Rawal Y, 2018, MOL CELL, V70, P297, DOI 10.1016/j.molcel.2018.03.007; Rodriguez-Lopez M, 2020, CELL REP, V30, P3240, DOI 10.1016/j.celrep.2020.02.058; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Shichino Y, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008598; Sloan KE, 2012, BIOCHEM SOC T, V40, P850, DOI 10.1042/BST20120061; Thodberg M, 2019, NUCLEIC ACIDS RES, V47, P1671, DOI 10.1093/nar/gky1227; Turowski TW, 2016, GENOME RES, V26, P933, DOI 10.1101/gr.205492.116; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Vakiloroayaei A, 2017, NUCLEIC ACIDS RES, V45, P11341, DOI 10.1093/nar/gkx764; Van Horn DJ, 1997, RNA, V3, P1434; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vazquez De Aldana Carlos R., 1994, Molecular and Cellular Biology, V14, P7920; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK RC, 1990, MOL CELL BIOL, V10, P2820, DOI 10.1128/MCB.10.6.2820; Wilkinson D, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/4932905; Willis IM, 2018, ANNU REV BIOCHEM, V87, P75, DOI 10.1146/annurev-biochem-062917-012624; Wlotzka W, 2011, EMBO J, V30, P1790, DOI 10.1038/emboj.2011.97; Wolin SL, 2019, SCIENCE, V366, P822, DOI 10.1126/science.aax2957; Wolin SL, 2002, ANNU REV BIOCHEM, V71, P375, DOI 10.1146/annurev.biochem.71.090501.150003; Yoo CJ, 1997, CELL, V89, P393, DOI 10.1016/S0092-8674(00)80220-2; Zhu SH, 1996, J BIOL CHEM, V271, P24989, DOI 10.1074/jbc.271.40.24989; Zinshteyn B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003675	106	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253494	10.1371/journal.pone.0253494	http://dx.doi.org/10.1371/journal.pone.0253494			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153074	Green Published, gold			2022-12-26	WOS:000671691000012
J	Fay, M; Salazar, JK; Ramachandran, P; Stewart, D				Fay, Megan; Salazar, Joelle K.; Ramachandran, Padmini; Stewart, Diana			Microbiomes of commercially-available pine nuts and sesame seeds	PLOS ONE			English	Article							SP NOV.; GEN. NOV.; STREPTOCOCCUS-THERMOPHILUS; CLOACIBACTERIUM-NORMANENSE; RALSTONIA-SOLANACEARUM; CHEMICAL-COMPOSITION; WATER; FOOD; PSEUDOMONAS; BACTERIAL	Metagenomic analysis of food is becoming more routine and can provide important information pertaining to the shelf life potential and the safety of these products. However, less information is available on the microbiomes associated with low water activity foods. Pine nuts and sesame seeds, and food products which contain these ingredients, have been associated with recalls due to contamination with bacterial foodborne pathogens. The objective of this study was to identify the microbial community of pine nuts and sesame seeds using targeted 16S rRNA sequencing technology. Ten different brands of each seed type were assessed, and core microbiomes were determined. A total of 21 and 16 unique taxa with proportional abundances >1% in at least one brand were identified in the pine nuts and sesame seeds, respectively. Members of the core pine nut microbiome included the genera Alishewanella, Aminivibrio, Mycoplasma, Streptococcus, and unassigned OTUs in the families of Desulfobacteraceae and Xanthomonadaceae. For sesame seeds, the core microbiome included Aminivibrio, Chryseolina, Okibacterium, and unassigned OTUs in the family Flavobacteriaceae. The microbiomes of these seeds revealed that these products are dominated by environmental bacterial genera commonly isolated from soil, water, and plants; bacterial genera containing species known as commensal organisms were also identified. Understanding these microbiomes can aid in the risk assessment of these products by identifying food spoilage potential and community members which may co-enrich with foodborne bacterial pathogens.	[Fay, Megan; Salazar, Joelle K.; Stewart, Diana] US FDA, Div Food Proc Sci & Technol, Bedford Pk, IL 60501 USA; [Ramachandran, Padmini] US FDA, Div Microbiol, College Pk, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Salazar, JK (corresponding author), US FDA, Div Food Proc Sci & Technol, Bedford Pk, IL 60501 USA.	Joelle.Salazar@fda.hhs.gov		Salazar, Joelle/0000-0002-3587-7588	Oak Ridge Institute for Science and Education (ORISE) Research Participation Program	Oak Ridge Institute for Science and Education (ORISE) Research Participation Program	Megan Fay was supported by the Oak Ridge Institute for Science and Education (ORISE) Research Participation Program through an interagency agreement between the U.S.Department of Energy and the U.S. Food and Drug Administration. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Al-Zeyara SA, 2011, INT J FOOD MICROBIOL, V145, P98, DOI 10.1016/j.ijfoodmicro.2010.11.036; Allen TD, 2006, INT J SYST EVOL MICR, V56, P1311, DOI 10.1099/ijs.0.64218-0; Antwi P, 2017, BIORESOURCE TECHNOL, V235, P348, DOI 10.1016/j.biortech.2017.03.141; Blackwell Reginald, 2012, Morbidity and Mortality Weekly Report, V61, P944; Brenner DJ., 2015, BERGEYS MANUAL SYSTE; Brzoska RM, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01701-18; Buckova Maria, 2018, Int J Food Microbiol, V266, P42, DOI 10.1016/j.ijfoodmicro.2017.11.010; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; CDC, NAT OUTBR REP SYST N; CDC, 2019, OUTBR SALM INF LINK; CDC, MULT OUTBR HUM SALM; CDC (Center for Disease Control and Prevention), 2013, MULT OUTBR SALM MONT; Cho SH, 2010, SYST APPL MICROBIOL, V33, P122, DOI 10.1016/j.syapm.2009.12.004; Choi JY, 2013, INT J SYST EVOL MICR, V63, P4402, DOI 10.1099/ijs.0.047969-0; Chun BH, 2017, INT J SYST EVOL MICR, V67, P1688, DOI 10.1099/ijsem.0.001841; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; CTV, SES SEEDS HELLOFRESH; CULLEN GA, 1969, VET REC, V85, P115, DOI 10.1136/vr.85.5.115; De Filippis F, 2018, ANNU REV FOOD SCI T, V9, P589, DOI 10.1146/annurev-food-030117-012312; Denny TP, 2000, TRENDS MICROBIOL, V8, P486, DOI 10.1016/S0966-842X(00)01860-6; El Demerdash Hasson A., 2006, Biotechnology Journal, V1, P398, DOI 10.1002/biot.200600018; Escobar-Zepeda A, 2016, FOOD MICROBIOL, V57, P116, DOI 10.1016/j.fm.2016.02.004; Evtushenko LI, 2002, INT J SYST EVOL MICR, V52, P987, DOI 10.1099/00207713-52-3-987; Falkenstein D, 2010, LIAN BRAND SESAME SE; FDA, HOUS THALL REC SEL P; FDA. Brodt Zenatti Holding LLC, REC KAR BRAND TAH SO; FDA FDA. Superior Nut & Candy Co. Inc, REC PIN NUTS POSS HL; Federico B, 2015, INT J FOOD MICROBIOL, V215, P179, DOI 10.1016/j.ijfoodmicro.2015.09.017; Fiorillo L, 2019, DENT J-BASEL, V7, DOI 10.3390/dj7040114; FSN, WAYM FARMS REC RAW P; FSN, SALM RISK SPURS SES; Fukunaga Y, 2009, J GEN APPL MICROBIOL, V55, P267, DOI 10.2323/jgam.55.267; Gram L, 2002, INT J FOOD MICROBIOL, V78, P79, DOI 10.1016/S0168-1605(02)00233-7; Haggag WM, 2007, AFR J BIOTECHNOL, V6, P1568; Harb M, 2015, ENVIRON SCI-WAT RES, V1, P800, DOI [10.1039/c5ew00162e, 10.1039/C5EW00162E]; Heini N, 2018, INT J FOOD MICROBIOL, V283, P59, DOI 10.1016/j.ijfoodmicro.2018.06.019; Hempel PP, 2020, MICROBIOL RESOUR ANN, V9, DOI 10.1128/MRA.00352-20; Honda T, 2013, INT J SYST EVOL MICR, V63, P3679, DOI 10.1099/ijs.0.052225-0; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; Jarvis KG, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02540; Kampfer P, 2017, INT J SYST EVOL MICR, V67, P4956, DOI 10.1099/ijsem.0.002357; Ker K, 2012, BIOMASS BIOENERG, V47, P295, DOI 10.1016/j.biombioe.2012.09.031; Kim BC, 2009, J MICROBIOL, V47, P699, DOI 10.1007/s12275-009-0343-z; Kim MS, 2009, INT J SYST EVOL MICR, V59, P2313, DOI 10.1099/ijs.0.007260-0; KING AD, 1970, APPL MICROBIOL, V20, P208, DOI 10.1128/AEM.20.2.208-214.1970; Kramer J. M., 1989, Foodborne bacterial pathogens., P21; Krizova L, 2015, INT J SYST EVOL MICR, V65, P3905, DOI 10.1099/ijsem.0.000511; Leal SM, 2016, J CLIN MICROBIOL, V54, P2928, DOI 10.1128/JCM.01393-16; Lee DG, 2013, INT J SYST EVOL MICR, V63, P3180, DOI 10.1099/ijs.0.047639-0; Lee HJ, 2020, ANTON LEEUW INT J G, V113, P155, DOI 10.1007/s10482-019-01325-0; Lopes LD, 2018, ENVIRON MICROBIOL, V20, P62, DOI 10.1111/1462-2920.13957; Lopez-Velasco G, 2011, J APPL MICROBIOL, V110, P1203, DOI 10.1111/j.1365-2672.2011.04969.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104; Lutz M, 2017, CYTA-J FOOD, V15, P284, DOI 10.1080/19476337.2016.1250109; Martinez, 2020, PAIRWISEADONIS PAIRW; Mellor GE, 2011, FOOD MICROBIOL, V28, P1101, DOI 10.1016/j.fm.2011.02.003; Mercado-Blanco J, 2007, ANTON LEEUW INT J G, V92, P367, DOI 10.1007/s10482-007-9167-1; Michaylova M, 2007, FEMS MICROBIOL LETT, V269, P160, DOI 10.1111/j.1574-6968.2007.00631.x; Nouha K, 2016, BIORESOURCE TECHNOL, V212, P120, DOI 10.1016/j.biortech.2016.04.021; Oksanen J, 2019, **DATA OBJECT**; Ottesen A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0894-1; Park SK, 2011, INT J SYST EVOL MICR, V61, P1118, DOI 10.1099/ijs.0.022517-0; Pettengill James B, 2012, BMC Res Notes, V5, P378, DOI 10.1186/1756-0500-5-378; Qu JiangQi, 2015, International Proceedings of Chemical, Biological and Environmental Engineering (IPCBEE), V87, P67; RAZIN S, 1992, J GEN MICROBIOL, V138, P407, DOI 10.1099/00221287-138-3-407; Reetha BMA, 2018, J ASIA-PAC ENTOMOL, V21, P937, DOI 10.1016/j.aspen.2018.07.005; Salah ZB, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01447-16; Salazar JK, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1323-4; Schubert K, 1996, INT J SYST BACTERIOL, V46, P81, DOI 10.1099/00207713-46-1-81; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shi SB, 2019, INT J SYST EVOL MICR, V69, P1411, DOI 10.1099/ijsem.0.003328; Singh D, 2014, CURR MICROBIOL, V69, P127, DOI 10.1007/s00284-014-0566-z; Singh H, 2016, INT J SYST EVOL MICR, V66, P189, DOI 10.1099/ijsem.0.000696; Stelzmueller I, 2006, CLIN MICROBIOL INFEC, V12, P99, DOI 10.1111/j.1469-0691.2005.01309.x; TERNSTROM A, 1993, J APPL BACTERIOL, V75, P25, DOI 10.1111/j.1365-2672.1993.tb03403.x; Vidic J, 2020, BIOSENSORS-BASEL, V10, DOI 10.3390/bios10030015; Wang HF, 2015, ANTON LEEUW INT J G, V107, P835, DOI 10.1007/s10482-014-0376-0; Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0; Xia X, 2016, STAND GENOMIC SCI, V11, DOI 10.1186/s40793-016-0169-3; Yuki M., 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00210-14 24652984, DOI 10.1128/GENOMEA.00210-1424652984]; Zheng JF, 2017, APPL SOIL ECOL, V111, P94, DOI 10.1016/j.apsoil.2016.11.017; Zheng XF, 2020, CURR MICROBIOL, V77, P2049, DOI 10.1007/s00284-020-02014-2; Zuleta A, 2018, ITAL J FOOD SCI, V30, P170, DOI 10.14674/IJFS-996	85	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252605	10.1371/journal.pone.0252605	http://dx.doi.org/10.1371/journal.pone.0252605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153055	Green Published, gold			2022-12-26	WOS:000671691000028
J	Toosty, NT; Hagishima, A; Tanaka, KI				Toosty, Nishat Tasnim; Hagishima, Aya; Tanaka, Ken-Ichi			Heat health risk assessment analysing heatstroke patients in Fukuoka City, Japan	PLOS ONE			English	Article							MORTALITY-RATES; AIR-TEMPERATURE; CLIMATE; STROKE; IMPACT; VULNERABILITY; POPULATIONS; MODELS; CITIES; COLD	Background Climate change, as a defining issue of the current time, is causing severe heat-related illness in the context of extremely hot weather conditions. In Japan, the remarkable temperature increase in summer caused by an urban heat island and climate change has become a threat to public health in recent years. Methods This study aimed to determine the potential risk factors for heatstroke by analysing data extracted from the records of emergency transport to the hospital due to heatstroke in Fukuoka City, Japan. In this regard, a negative binomial regression model was used to account for overdispersion in the data. Age-structure analyses of heatstroke patients were also embodied to identify the sub-population of Fukuoka City with the highest susceptibility. Results The daily maximum temperature and wet-bulb globe temperature (WBGT), along with differences in both the mean temperature and time-weighted temperature from those of the consecutive past days were detected as significant risk factors for heatstroke. Results indicated that there was a positive association between the resulting risk factors and the probability of heatstroke occurrence. The elderly of Fukuoka City aged 70 years or older were found to be the most vulnerable to heatstroke. Most of the aforementioned risk factors also encountered significant and positive associations with the risk of heatstroke occurrence for the group with highest susceptibility. Conclusion These results can provide insights for health professionals and stakeholders in designing their strategies to reduce heatstroke patients and to secure the emergency transport systems in summer.	[Toosty, Nishat Tasnim; Hagishima, Aya] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Energy & Environm Engn, Kasuga, Fukuoka, Japan; [Toosty, Nishat Tasnim] Univ Dhaka, Dept Stat, Dhaka, Bangladesh; [Hagishima, Aya] Kyushu Univ, Fac Engn Sci, Kasuga, Fukuoka, Japan; [Tanaka, Ken-Ichi] Kyushu Environm Evaluat Assoc, Fukuoka, Japan	Kyushu University; University of Dhaka; Kyushu University	Toosty, NT (corresponding author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Energy & Environm Engn, Kasuga, Fukuoka, Japan.; Toosty, NT (corresponding author), Univ Dhaka, Dept Stat, Dhaka, Bangladesh.	toosty.stat@gmail.com	Hagishima, Aya/GRE-6546-2022	Hagishima, Aya/0000-0002-8342-6570; Toosty, Nishat Tasnim/0000-0003-4605-8745	national project "Regional Adaptation Consortium" under the Ministry of the Environment, Japan; Ministry of Environment, Japan	national project "Regional Adaptation Consortium" under the Ministry of the Environment, Japan; Ministry of Environment, Japan(Ministry of the Environment, Japan)	This study was financially supported by the national project "Regional Adaptation Consortium" under the Ministry of the Environment, Japan. Funder: Ministry of Environment, Japan. Award Number: Not available Grant Recipient: Hagishima A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA; Akatsuka S., 2016, ADV METEOROL, V2016; Allison P. D., 1999, MULTIPLE REGRESSION; An Q, 2016, PLOS ONE, V11, P1; Anchordoqui L.A., 2020, SCI MED J, V2, P68, DOI [10.28991/SciMedJ-2020-02-SI-5, DOI 10.28991/SCIMEDJ-2020-02-SI-5]; Anchordoqui LA, 2020, SCIMEDICINE J, V2, P83; ANDERSON RK, 1987, J APPL PHYSIOL, V63, P1089, DOI 10.1152/jappl.1987.63.3.1089; [Anonymous], 2015, AUST J EMERG MANAG, V30, P9; [Anonymous], 2000, 549942000 BRIT STAND; [Anonymous], 2019, EMERG SCI J; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; ASHRAE A., 2017, 552017 ASHRAE, V2017; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Basu R, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-40; Benmarhnia T, 2015, EPIDEMIOLOGY, V26, P781, DOI 10.1097/EDE.0000000000000375; Brode P, 2012, INT J BIOMETEOROL, V56, P481, DOI 10.1007/s00484-011-0454-1; Budd GM, 2008, J SCI MED SPORT, V11, P20, DOI 10.1016/j.jsams.2007.07.003; Ng CFS, 2014, INT J BIOMETEOROL, V58, P941, DOI 10.1007/s00484-013-0677-4; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; El-Zein A, 2004, SCI TOTAL ENVIRON, V330, P71, DOI 10.1016/j.scitotenv.2004.02.027; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Engel J., 1984, STAT NEERL, V38, P159, DOI [10.1111/j.1467-9574.1984.tb01107.x, DOI 10.1111/J.1467-9574.1984.TB01107.X]; Fahrmeir L., LUDWIG FAHRMEIR; Feulner G, 2017, GLOB CHALL, V1, P5, DOI 10.1002/gch2.1003; FROME EL, 1973, J AM STAT ASSOC, V68, P935, DOI 10.2307/2284525; Ha J, 2011, SCI TOTAL ENVIRON, V409, P3274, DOI 10.1016/j.scitotenv.2011.05.034; HABERMAN SJ, 1973, ANN STAT, V1, P617, DOI 10.1214/aos/1176342458; Hanna EG, 2015, INT J ENV RES PUB HE, V12, P8034, DOI 10.3390/ijerph120708034; Hayashida K, 2019, ACUTE MED SURG, V6, P206, DOI 10.1002/ams2.387; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; IPCC, 2014, CLIM CHAN 2014 IMP A, P1133; KALKSTEIN LS, 1993, EXPERIENTIA, V49, P969, DOI 10.1007/BF02125644; Kayaba M., 2013, JPN J HEALTH HUM ECO, V79, P47, DOI [10.3861/jshhe.79.47, DOI 10.3861/JSHHE.79.47]; Kenney W. L., 1997, American Journal of Physiology, V272, pH1609; Kodera S, 2019, ENVIRON INT, V130, DOI 10.1016/j.envint.2019.104907; Kondo M, 2013, ENVIRON HEALTH PREV, V18, P251, DOI 10.1007/s12199-012-0313-7; Kotani K, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1437882; LAWLESS JF, 1987, CAN J STAT, V15, P209, DOI 10.2307/3314912; Leon LR, 2006, J THERM BIOL, V31, P67, DOI 10.1016/j.jtherbio.2005.11.023; Li CX, 2020, CLIN CHIM ACTA, V510, P35, DOI 10.1016/j.cca.2020.06.045; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; MANTON KG, 1981, BIOMETRICS, V37, P259, DOI 10.2307/2530416; Miyake Y., 2013, JMAJ - Japan Medical Association Journal, V56, P167; Miyatake Nobuyuki, 2012, Environmental Health and Preventive Medicine, V17, P77, DOI 10.1007/s12199-011-0221-2; Montazami A, 2017, BUILD ENVIRON, V122, P422, DOI 10.1016/j.buildenv.2017.06.002; Nakamura S., 2013, JMAJ - Japan Medical Association Journal, V56, P162; Oku A, 2017, DISCUSS PAP SER, V17A; Ono T., 2017, P ANN C ARCH I JAP 2, P783; Onozuka D, 2015, ENVIRON RES, V140, P177, DOI 10.1016/j.envres.2015.03.031; Periard JD, 2015, SCAND J MED SCI SPOR, V25, P20, DOI 10.1111/sms.12408; Plavcova E, 2010, INT J BIOMETEOROL, V54, P539, DOI 10.1007/s00484-010-0303-7; Ragettli MS, 2017, ENVIRON RES, V158, P703, DOI 10.1016/j.envres.2017.07.021; Sato R., 2018, 25 NAT C HEAT ISL I; Seposo XT, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1368969; Seposo XT, 2015, INT J ENV RES PUB HE, V12, P6842, DOI 10.3390/ijerph120606842; Stapleton JM, 2014, APPL PHYSIOL NUTR ME, V39, P292, DOI 10.1139/apnm-2013-0317; Stocker T.F., 2013, PHYS SCI BASIS, P1535, DOI [10.1017/CBO9781107415324, DOI 10.1017/CB09781107415324, DOI 10.1017/CBO9781107415324]; Sun XM, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-76; Takahashi N, 2015, INT J ENV RES PUB HE, V12, P3188, DOI 10.3390/ijerph120303188; Tamura K., 1995, J BIOMETEOROL, V32, P111; Tanigawa K, 2006, RESUSCITATION, V69, P365, DOI 10.1016/j.resuscitation.2006.04.001; Tewari P, 2019, ENERG BUILDINGS, V199, P145, DOI 10.1016/j.enbuild.2019.06.049; The Bureau of Statistics of the Ministry of Internal Affairs and Communications Japan, NAT POP CENS 2015; Xiang JJ, 2014, IND HEALTH, V52, P91, DOI 10.2486/indhealth.2012-0145; Yang J, 2016, ENVIRON INT, V92-93, P232, DOI 10.1016/j.envint.2016.04.001; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]	67	7	7	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253011	10.1371/journal.pone.0253011	http://dx.doi.org/10.1371/journal.pone.0253011			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153053	Green Published, gold			2022-12-26	WOS:000671691000009
J	Flores, SRL; Nelson, S; Woloshun, RR; Wang, XY; Ha, JH; Lee, JK; Yu, Y; Merlin, D; Collins, JF				Flores, Shireen R. L.; Nelson, Savannah; Woloshun, Regina R.; Wang, Xiaoyu; Ha, Jung-Heun; Lee, Jennifer K.; Yu, Yang; Merlin, Didier; Collins, James F.			Intestinal iron absorption is appropriately modulated to match physiological demand for iron in wild-type and iron-loaded Hamp (hepcidin) knockout rats during acute colitis	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; HEREDITARY HEMOCHROMATOSIS; MURINE MODEL; EXPRESSION; ANEMIA; PATHOGENESIS; FERROPORTIN; DEFICIENCY; GENE; PREVALENCE	Mucosal damage, barrier breach, inflammation, and iron-deficiency anemia (IDA) typify ulcerative colitis (UC) in humans. The anemia in UC appears to mainly relate to systemic inflammation. The pathogenesis of this 'anemia of inflammation' (AI) involves cytokine-mediated transactivation of hepatic Hamp (encoding the iron-regulatory hormone, hepcidin). In AI, high hepcidin represses iron absorption (and iron release from stores), thus lowering serum iron, and restricting iron for erythropoiesis (causing anemia). In less-severe disease states, inflammation may be limited to the intestine, but whether this perturbs iron homeostasis is uncertain. We hypothesized that localized gut inflammation will increase overall iron demand (to support the immune response and tissue repair), and that hepatic Hamp expression will decrease in response, thus derepressing (i.e., enhancing) iron absorption. Accordingly, we developed a rat model of mild, acute colitis, and studied iron absorption and homeostasis. Rats exposed (orally) to DSS (4%) for 7 days had intestinal (but not systemic) inflammation, and biomarker analyses demonstrated that iron utilization was elevated. Iron absorption was enhanced (by 2-3-fold) in DSS-treated, WT rats of both sexes, but unexpectedly, hepatic Hamp expression was not suppressed. Therefore, to gain a better understanding of regulation of iron absorption during acute colitis, Hamp KO rats were used for further experimentation. The severity of DSS-colitis was similar in Hamp KOs as in WT controls. In the KOs, increased iron requirements associated with the physiological response to colitis were satisfied by mobilizing hepatic storage iron, rather than by increasing absorption of enteral iron (as occurred in WT rats). In conclusion then, in both sexes and genotypes of rats, iron absorption was appropriately modulated to match physiological demand for dietary iron during acute intestinal inflammation, but regulatory mechanisms may not involve hepcidin.	[Flores, Shireen R. L.; Nelson, Savannah; Woloshun, Regina R.; Wang, Xiaoyu; Ha, Jung-Heun; Lee, Jennifer K.; Yu, Yang; Collins, James F.] Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA; [Merlin, Didier] Georgia State Univ, Ctr Diagnost & Therapeut, Inst Biomed Sci, Atlanta, GA 30303 USA; [Merlin, Didier] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Wang, Xiaoyu] China Agr Univ, Coll Food Sci & Nutr Engn, Key Lab Precis Nutr & Food Qual, Beijing, Peoples R China; [Ha, Jung-Heun] Dankook Univ, Dept Food Sci & Nutr, Cheonan, South Korea; [Ha, Jung-Heun] Dankook Univ, Res Ctr Industrializat Nat Nutraceut, Cheonan, South Korea	State University System of Florida; University of Florida; University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; China Agricultural University; Dankook University; Dankook University	Collins, JF (corresponding author), Univ Florida, Food Sci & Human Nutr Dept, Gainesville, FL 32611 USA.	jfcollons@ufl.edu		Collins, James Forrest/0000-0002-8765-0297; Yu, Yang/0000-0002-7956-9245	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK074867]; NIDDK [R01 DK109717]; Office of Dietary Supplements	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This investigation was funded by grants R01 DK074867 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (JFC), and R01 DK109717 from NIDDK and the Office of Dietary Supplements (JFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bessman NJ, 2020, SCIENCE, V368, P186, DOI 10.1126/science.aau6481; BOTHWELL TH, 1958, J LAB CLIN MED, V51, P24; Brissot P, 2019, TRANSFUS CLIN BIOL, V26, P80, DOI 10.1016/j.tracli.2018.08.006; Bryda Elizabeth C, 2013, Mo Med, V110, P207; Cao C, 2014, J NUTR, V144, P1710, DOI 10.3945/jn.114.197939; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; CONRAD ME, 1962, BLOOD, V20, P173, DOI 10.1182/blood.V20.2.173.173; Deugnier Y, 2007, WORLD J GASTROENTERO, V13, P4755, DOI 10.3748/wjg.v13.i35.4755; Doguer C, 2017, BLOOD ADV, V1, P1335, DOI 10.1182/bloodadvances.2017008359; Dudkowiak R, 2013, ADV CLIN EXP MED, V22, P585; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Ellenbroek B, 2016, DIS MODEL MECH, V9, P1079, DOI 10.1242/dmm.026120; Fillebeen C, 2015, HAEMATOLOGICA, V100, pE334, DOI 10.3324/haematol.2015.126870; Filmann N, 2014, INFLAMM BOWEL DIS, V20, P936, DOI 10.1097/01.MIB.0000442728.74340.fd; FINCH C, 1994, BLOOD, V84, P1697; Fleming RE, 2005, SEMIN LIVER DIS, V25, P411, DOI 10.1055/s-2005-923313; Fleming RE, 1999, P NATL ACAD SCI USA, V96, P3143, DOI 10.1073/pnas.96.6.3143; Frazer DM, 2017, CELL MOL GASTROENTER, V3, P410, DOI 10.1016/j.jcmgh.2016.12.002; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Ganz T, 2009, SEMIN HEMATOL, V46, P387, DOI 10.1053/j.seminhematol.2009.06.001; Gulec S, 2014, J NUTR, V144, P12, DOI 10.3945/jn.113.183160; Gutschow P, 2015, HAEMATOLOGICA, V100, P167, DOI 10.3324/haematol.2014.116723; Kautz L, 2014, NAT GENET, V46, P678, DOI 10.1038/ng.2996; Klopfleisch R, 2012, J COMP PATHOL, V147, P460, DOI 10.1016/j.jcpa.2012.09.001; Knutson MD, 2000, J NUTR, V130, P621, DOI 10.1093/jn/130.3.621; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Koutroubakis IE, 2016, J CLIN GASTROENTEROL, V50, P638, DOI 10.1097/MCG.0000000000000417; Lomer MCE, 2012, BRIT J NUTR, V107, P1806, DOI 10.1017/S0007114511004971; Mathies F, 2018, J IMMUNOL, V201, P3558, DOI 10.4049/jimmunol.1800711; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; PIRZIOBIROLI G, 1960, J LAB CLIN MED, V55, P216; Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002; RAMSAY WNM, 1957, CLIN CHIM ACTA, V2, P214, DOI 10.1016/0009-8981(57)90105-5; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Sangkhae V, 2017, ADV NUTR, V8, P126, DOI 10.3945/an.116.013961; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; TORRANCE J D, 1968, South African Journal of Medical Sciences, V33, P9; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; Wang LJ, 2012, INFLAMM BOWEL DIS, V18, P112, DOI 10.1002/ibd.21675; Wang XY, 2019, MOL THER, V27, P493, DOI 10.1016/j.ymthe.2019.01.003; WEINTRAUB LR, 1965, BRIT J HAEMATOL, V11, P432, DOI 10.1111/j.1365-2141.1965.tb06605.x; Weiss G, 2019, BLOOD, V133, P40, DOI 10.1182/blood-2018-06-856500; Weiss G, 2010, HAEMATOL-HEMATOL J, V95, P175, DOI 10.3324/haematol.2009.017046; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Zhou XY, 1998, P NATL ACAD SCI USA, V95, P2492, DOI 10.1073/pnas.95.5.2492; Zoller H, 1999, LANCET, V353, P2120, DOI 10.1016/S0140-6736(98)11179-0; Zoller H, 2001, GASTROENTEROLOGY, V120, P1412, DOI 10.1053/gast.2001.24033; Zumerle S, 2014, BLOOD, V123, P3646, DOI 10.1182/blood-2014-01-550467	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252998	10.1371/journal.pone.0252998	http://dx.doi.org/10.1371/journal.pone.0252998			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143808	Green Published, gold			2022-12-26	WOS:000671690700066
J	Weli, SC; Tartor, H; Spilsberg, B; Dale, OB; Lillehaug, A				Weli, Simon Chioma; Tartor, Haitham; Spilsberg, Bjorn; Dale, Ole Bendik; Lillehaug, Atle			Short communication: Evaluation of charged membrane filters and buffers for concentration and recovery of infectious salmon anaemia virus in seawater	PLOS ONE			English	Article							DROPLET DIGITAL PCR; ATLANTIC SALMON; LARGE VOLUMES; QUANTITATIVE DETECTION; RAPID CONCENTRATION; ENTERIC VIRUSES; COPY NUMBER; RT-PCR; ISAV; WATER	Infectious salmon anaemia virus (ISAV) is the cause of an important waterborne disease of farmed Atlantic salmon. Detection of virus in water samples may constitute an alternative method to sacrificing fish for surveillance of fish populations for the presence of ISA-virus. We aimed to evaluate different membrane filters and buffers for concentration and recovery of ISAV in seawater, prior to molecular detection. One litre each of artificial and natural seawater was spiked with ISAV, followed by concentration with different filters and subsequent elution with different buffers. The negatively charged MF hydrophilic membrane filter, combined with NucliSENS(R) lysis buffer, presented the highest ISAV recovery percentages with 12.5 +/- 1.3% by RT-qPCR and 31.7 +/- 10.7% by RT-ddPCR. For the positively charged 1 MDS Zeta Plus(R) Virosorb(R) membrane filter, combined with NucliSENS(R) lysis buffer, the ISAV recovery percentages were 3.4 +/- 0.1% by RT-qPCR and 10.8 +/- 14.2% by RT-ddPCR. The limits of quantification (LOQ) were estimated to be 2.2 x 10(3) ISAV copies/L of natural seawater for both RT-qPCR and RT-ddPCR. The ISAV concentration method was more efficient in natural seawater.	[Weli, Simon Chioma; Tartor, Haitham; Spilsberg, Bjorn; Dale, Ole Bendik; Lillehaug, Atle] Norwegian Vet Inst, Oslo, Norway	Norwegian Veterinary Institute	Weli, SC (corresponding author), Norwegian Vet Inst, Oslo, Norway.	Simon.Weli@vetinst.no	Dale, Ole Bendik/ABB-6276-2021	tartor, Haitham muhammed/0000-0003-3913-7410	Fiskeri - Og Havbruksnaeringens Forskningsfond [267411]; Norwegian Fishery Ministry grant: Biosecurity in Aquaculture [13055]	Fiskeri - Og Havbruksnaeringens Forskningsfond; Norwegian Fishery Ministry grant: Biosecurity in Aquaculture	This research work was funded by grants from the Fiskeri - Og Havbruksnaeringens Forskningsfond, 267411, and the Norwegian Fishery Ministry grant: Biosecurity in Aquaculture (13055).	Aamelfot M, 2014, J FISH DIS, V37, P291, DOI 10.1111/jfd.12225; ABBASZADEGAN M, 1993, APPL ENVIRON MICROB, V59, P1318, DOI 10.1128/AEM.59.5.1318-1324.1993; Aldrin M, 2011, J R SOC INTERFACE, V8, P1346, DOI 10.1098/rsif.2010.0737; Aspehaug V, 2005, J VIROL, V79, P12544, DOI 10.1128/JVI.79.19.12544-12553.2005; Bernhardt LV, 2021, DIS AQUAT ORGAN, V144, P61, DOI 10.3354/dao03572; Biering E, 2002, DIS AQUAT ORGAN, V49, P117, DOI 10.3354/dao049117; Burns MJ, 2010, EUR FOOD RES TECHNOL, V231, P353, DOI 10.1007/s00217-010-1277-8; Cao Y, 2012, J APPL MICROBIOL, V113, P66, DOI 10.1111/j.1365-2672.2012.05305.x; Christensen E, 2017, J WATER HEALTH, V15, P695, DOI 10.2166/wh.2017.055; Damira FU, 2016, ANAL CHEM, V88, P812, DOI 10.1021/acs.analchem.5b03238; DANNEVIG BH, 1995, VET RES, V26, P438; Devold M, 2000, DIS AQUAT ORGAN, V40, P9, DOI 10.3354/dao040009; Falk K, 2004, J VIROL, V78, P3063, DOI 10.1128/JVI.78.6.3063-3071.2004; Fong TT, 2005, MICROBIOL MOL BIOL R, V69, P357, DOI 10.1128/MMBR.69.2.357-371.2005; Grgicak CM, 2010, J FORENSIC SCI, V55, P1331, DOI 10.1111/j.1556-4029.2010.01460.x; Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12; Katayama H, 2002, APPL ENVIRON MICROB, V68, P1033, DOI 10.1128/AEM.68.3.1033-1039.2002; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; Krossoy B, 2001, J GEN VIROL, V82, P1757, DOI 10.1099/0022-1317-82-7-1757; LOGAN KB, 1981, J VIROL METHODS, V3, P241, DOI 10.1016/0166-0934(81)90074-4; LOGAN KB, 1980, J VIROL METHODS, V1, P87, DOI 10.1016/0166-0934(80)90017-8; Lui YLE, 2014, J VIROL METHODS, V207, P200, DOI 10.1016/j.jviromet.2014.07.014; Lukasik J, 2000, APPL ENVIRON MICROB, V66, P2914, DOI 10.1128/AEM.66.7.2914-2920.2000; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Mardones FO, 2014, PREV VET MED, V114, P37, DOI 10.1016/j.prevetmed.2014.01.012; Mardones FO, 2009, DIS AQUAT ORGAN, V84, P105, DOI 10.3354/dao02040; McClure CA, 2005, PREV VET MED, V72, P263, DOI 10.1016/j.prevetmed.2005.07.010; Miotke L, 2014, ANAL CHEM, V86, P2618, DOI 10.1021/ac403843j; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Mu D, 2015, BIOTECHNOL LETT, V37, P2063, DOI 10.1007/s10529-015-1890-5; NUPEN EM, 1985, WATER SCI TECHNOL, V17, P63, DOI 10.2166/wst.1985.0096; NYLUND A, 1994, DIS AQUAT ORGAN, V19, P95, DOI 10.3354/dao019095; Racki N, 2014, ANAL BIOANAL CHEM, V406, P661, DOI 10.1007/s00216-013-7476-y; Rimstad E, 2002, APMIS, V110, P273, DOI 10.1034/j.1600-0463.2002.100401.x; Rusch JC, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2916-3; Snow M, 2006, DEV BIOLOGICALS, V126, P133; Sobsey M. D., 1995, MALE SPECIFIC COLIPH; SOBSEY MD, 1973, APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; SOBSEY MD, 1985, WATER SCI TECHNOL, V17, P23, DOI 10.2166/wst.1985.0092; Strand DA, 2019, J APPL ECOL, V56, P1661, DOI 10.1111/1365-2664.13404; Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005; Te SH, 2015, APPL ENVIRON MICROB, V81, P5203, DOI 10.1128/AEM.00931-15; Totland GK, 1996, DIS AQUAT ORGAN, V26, P25, DOI 10.3354/dao026025; UKWIR, 2000, METH DET EN PATH BIO; Weerakoon KG, 2016, J MICROBIOL METH, V125, P19, DOI 10.1016/j.mimet.2016.03.012; Weli SC, 2021, J VIROL METHODS, V287, DOI 10.1016/j.jviromet.2020.113990; Whale AS, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks203; Wyn-Jones AP, 2001, J APPL MICROBIOL, V91, P945, DOI 10.1046/j.1365-2672.2001.01470.x	48	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253297	10.1371/journal.pone.0253297	http://dx.doi.org/10.1371/journal.pone.0253297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133472	gold, Green Published			2022-12-26	WOS:000671682700027
J	Aragon-Herrera, A; Feijoo-Bandin, S; Morana-Fernandez, S; Anido-Varela, L; Rosello-Lleti, E; Portoles, M; Tarazon, E; Lage, R; Moscoso, I; Barral, L; Bani, D; Bigazzi, M; Gualillo, O; Gonzalez-Juanatey, JR; Lago, F				Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania; Lage, Ricardo; Moscoso, Isabel; Barral, Luis; Bani, Daniele; Bigazzi, Mario; Gualillo, Oreste; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca			Relaxin has beneficial effects on liver lipidome and metabolic enzymes	FASEB JOURNAL			English	Article						desaturases; liver; lysoglycerophospholipids; metabolomics; relaxin	FATTY LIVER; FIBROSIS; PHOSPHATIDYLCHOLINE; DISEASE; AXIS; LIPOTOXICITY; DECREASES; INSULIN; DELTA-5; AKT	Relaxin is an insulin-like hormone with pleiotropic protective effects in several organs, including the liver. We aimed to characterize its role in the control of hepatic metabolism in healthy rats. Sprague-Dawley rats were treated with human recombinant relaxin-2 for 2 weeks. The hepatic metabolic profile was analyzed using UHPLC-MS platforms. Hepatic gene expression of key enzymes of desaturation (Fads1/Fads2) of n-6 and n-3 polyunsaturated fatty acids (PUFAs), of phosphatidylethanolamine (PE) N-methyltransferase (Pemt), of fatty acid translocase Cd36, and of glucose-6-phosphate isomerase (Gpi) were quantified by Real Time-PCR. Activation of 5 ' AMP-activated protein kinase (AMPK) was analyzed by Western Blot. Relaxin-2 significantly modified the hepatic levels of 19 glycerophospholipids, 2 saturated (SFA) and 1 monounsaturated (MUFA) fatty acids (FA), 3 diglycerides, 1 sphingomyelin, 2 aminoacids, 5 nucleosides, 2 nucleotides, 1 carboxylic acid, 1 redox electron carrier, and 1 vitamin. The most noteworthy changes corresponded to the substantially decreased lysoglycerophospholipids, and to the clearly increased FA (16:1n-7/16:0) and MUFA + PUFA/SFA ratios, suggesting enhanced desaturase activity. Hepatic gene expression of Fads1, Fads2, and Pemt, which mediates lipid balance and liver health, was increased by relaxin-2, while mRNA levels of the main regulator of hepatic FA uptake Cd36, and of the essential glycolysis enzyme Gpi, were decreased. Relaxin-2 augmented the hepatic activation of the hepatoprotector and master regulator of energy homeostasis AMPK. Relaxin-2 treatment also rised FADS1, FADS2, and PEMT gene expression in cultured Hep G2 cells. Our results bring to light the hepatic metabolic features stimulated by relaxin, a promising hepatoprotective molecule.	[Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Biomed Res Santiago de Compostela IDIS SERGA, Cellular & Mol Cardiol Unit, Santiago De Compostela, Spain; [Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Morana-Fernandez, Sandra; Anido-Varela, Laura; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Biomed Res Santiago de Compostela IDIS SERGA, Dept Cardiol, Santiago De Compostela, Spain; [Aragon-Herrera, Alana; Feijoo-Bandin, Sandra; Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania; Lage, Ricardo; Moscoso, Isabel; Ramon Gonzalez-Juanatey, Jose; Lago, Francisca] Inst Hlth Carlos III, CIBERCV, Madrid, Spain; [Morana-Fernandez, Sandra; Lage, Ricardo; Moscoso, Isabel] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain; [Morana-Fernandez, Sandra; Lage, Ricardo; Moscoso, Isabel] Univ Clin Hosp Santiago de Compostela, Hlth Res Inst, Santiago De Compostela, Spain; [Rosello-Lleti, Esther; Portoles, Manuel; Tarazon, Estefania] La Fe Univ Hosp IIS La Fe, Cardiocirculatory Unit, Hlth Inst, Valencia, Spain; [Barral, Luis] Univ A Coruna, Polytech Univ, Dept Phys & Earth Sci, Polymers Res Grp,Sch Serantes, Ferrol, Spain; [Bani, Daniele] Univ Florence, Dept Expt & Clin Med, Res Unit Histol & Embryol, Florence, Italy; [Bigazzi, Mario] Prosperius Inst, Endocrine Sect, Florence, Italy; [Gualillo, Oreste] Santiago Univ Clin Hosp, SERGAS Serv Galego Saude, NEIRID Lab Neuroendocrine Interact Rheumatol & In, Res Lab 9, Santiago De Compostela, Spain; [Gualillo, Oreste] Santiago Univ Clin Hosp, IDIS Inst Invest Sanitaria Santiago, NEIRID Lab Neuroendocrine Interact Rheumatol & In, Res Lab 9, Santiago De Compostela, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade da Coruna; Universidad Politecnica de Madrid; University of Florence; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Feijoo-Bandin, S (corresponding author), Hosp Clin Univ Santiago de Compostela, Unidad Invest Cardiol Celular & Mol 7, Inst Invest Sanitarias Santiago de Compostela IDI, Planta 2,Edificio Consultas Externas, Santiago De Compostela 15706, Spain.	Sandra.Feijoo.Bandin@sergas.es	Moscoso, Isabel/GXZ-9513-2022; Tarazón, Estefanía/D-6950-2017; Roselló Lletí, Esther/ABG-8503-2020; Aragon Herrera, Alana/GRE-9069-2022; PORTOLES, MANUEL/B-4789-2009; barral, luis/L-8737-2015	Moscoso, Isabel/0000-0002-6078-4666; Tarazón, Estefanía/0000-0003-3466-2558; Roselló Lletí, Esther/0000-0003-2627-6104; PORTOLES, MANUEL/0000-0002-4415-7160; barral, luis/0000-0002-3421-0239; Feijoo-Bandin, Sandra/0000-0002-3739-5806; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Aragon Herrera, Alana/0000-0003-3089-0684	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III [PI15/00681, PI17/00409, PI18/00821]; RETICS Programme [RD16/0012/0014]; CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme [734899]; GAIN-Xunta de Galicia; FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain)	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS Programme; CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme; GAIN-Xunta de Galicia; FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain)	Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Fondo de Investigaciones Sanitarias. Instituto de Salud Carlos III, Grant/Award Number: PI15/00681, PI17/00409, PI18/00821, RETICS Programme RD16/0012/0014 and CIBERCV; EC | European Regional Development Fund (ERDF); European Union Framework MSCA-RISE-H2020 Programme, Grant/Award Number: Project number 734899; Predoctoral research grants from GAIN-Xunta de Galicia and FPU Program of the Spanish Ministry of Science, Innovation and Universities (Spain); Predoctoral research grant from Spanish PFIS Program of the Instituto de Salud Carlos III (ISCIII) (Spain); Predoctoral research grant from GAIN-Xunta de Galicia	Ahmad N, 2012, MOL CELL ENDOCRINOL, V363, P46, DOI 10.1016/j.mce.2012.07.006; Akazawa Y, 2018, J GASTROENTEROL, V53, P893, DOI 10.1007/s00535-018-1451-5; Aragon-Herrera A, 2018, ENDOCRINE, V60, P103, DOI 10.1007/s12020-018-1534-3; Aragon-Herrera A, 2019, PHARMACOL RES, V144, P51, DOI 10.1016/j.phrs.2019.04.009; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Arendt BM, 2013, APPL PHYSIOL NUTR ME, V38, P334, DOI 10.1139/apnm-2012-0261; Bani D, 2001, HORM METAB RES, V33, P175, DOI 10.1055/s-2001-14935; Bani D, 2020, DRUG DISCOV TODAY, V25, P1239, DOI 10.1016/j.drudis.2020.04.014; Bani D, 2012, CURR DIABETES REV, V8, P329, DOI 10.2174/157339912802083487; Barr J, 2012, J PROTEOME RES, V11, P2521, DOI 10.1021/pr201223p; Bartrons R, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00331; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Bennett RG, 2014, LIVER INT, V34, P416, DOI 10.1111/liv.12247; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Chiappini F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46658; Chiurchiu V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00038; Clarke JD, 2014, DIGEST DIS SCI, V59, P365, DOI 10.1007/s10620-013-2873-9; Coliva G, 2020, MOLECULES, V25, DOI 10.3390/molecules25081925; Delgado GE, 2017, J CLIN LIPIDOL, V11, P126, DOI 10.1016/j.jacl.2016.10.015; Eslam M, 2020, J HEPATOL, V73, P202, DOI 10.1016/j.jhep.2020.03.039; Miquilena-Colina ME, 2011, GUT, V60, P1394, DOI 10.1136/gut.2010.222844; Fallowfield JA, 2014, HEPATOLOGY, V59, P1492, DOI 10.1002/hep.26627; Fausther M, 2018, AM J PHYSIOL-GASTR L, V315, pG12, DOI 10.1152/ajpgi.00006.2018; Feijoo-Bandin S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00599; Fondevila MF, 2021, HEPATOLOGY, V73, P606, DOI 10.1002/hep.31290; Greenhill C, 2015, NAT REV ENDOCRINOL, V13, P249, DOI [10.1038/nrendo.2017.38, 10.1038/nrendo.2015.40]; Gromovsky AD, 2018, ARTERIOSCL THROM VAS, V38, P218, DOI 10.1161/ATVBAHA.117.309660; Halls ML, 2007, BRIT J PHARMACOL, V150, P677, DOI 10.1038/sj.bjp.0707140; Han MS, 2008, J LIPID RES, V49, P84, DOI 10.1194/jlr.M700184-JLR200; Hirsova P, 2016, J LIPID RES, V57, P1758, DOI 10.1194/jlr.R066357; Hu MY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10893-8; Huang X, 2019, AUTOPHAGY, V15, P1258, DOI 10.1080/15548627.2019.1580105; Ichiba M, 2003, LIVER INT, V23, P338, DOI 10.1034/j.1478-3231.2003.00868.x; Jiang S, 2017, AGEING RES REV, V38, P18, DOI 10.1016/j.arr.2017.07.001; Jimenez-Castro MB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071785; Ju CH, 2019, BIOCHEM BIOPH RES CO, V511, P531, DOI 10.1016/j.bbrc.2019.02.091; Key CCC, 2020, J LIPID RES, V61, P1075, DOI 10.1194/jlr.RA120000760; Ko SH, 2014, BIOCHEM BIOPH RES CO, V443, P610, DOI 10.1016/j.bbrc.2013.12.018; Lee KC, 2019, LAB INVEST, V99, P1203, DOI 10.1038/s41374-019-0240-y; Li Lei O, 2010, Mol Endocrinol, V24, P657, DOI 10.1210/me.2009-0152; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lin HY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101298; Marra F, 2018, J HEPATOL, V68, P280, DOI 10.1016/j.jhep.2017.11.014; Marra F, 2009, HEPATOLOGY, V50, P957, DOI 10.1002/hep.23046; Martinez-Arranz I, 2015, J PROTEOMICS, V127, P275, DOI 10.1016/j.jprot.2015.01.019; Mukhopadhyay P, 2014, HEPATOLOGY, V59, P1998, DOI 10.1002/hep.26763; Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Nazeer SS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29370-1; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Patel DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177953; Qi SW, 2017, CLIN CHIM ACTA, V473, P89, DOI 10.1016/j.cca.2017.08.022; Rey E, 2020, LIVER INT, V40, P2553, DOI 10.1111/liv.14519; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Seibold JR, 2000, ANN INTERN MED, V132, P871, DOI 10.7326/0003-4819-132-11-200006060-00004; Simon J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010040; Summers RJ, 2017, BRIT J PHARMACOL, V174, P915, DOI 10.1111/bph.13778; Svegliati-Baroni G, 2019, FREE RADICAL BIO MED, V144, P293, DOI 10.1016/j.freeradbiomed.2019.05.029; Tessari P, 2010, CURR OPIN CLIN NUTR, V13, P81, DOI 10.1097/MCO.0b013e32833383af; Unemori E, 2017, BRIT J PHARMACOL, V174, P921, DOI 10.1111/bph.13695; van der Veen JN, 2017, BBA-BIOMEMBRANES, V1859, P1558, DOI 10.1016/j.bbamem.2017.04.006; Wan S, 2019, FASEB J, V33, P10986, DOI 10.1096/fj.201900679R; Williams EJ, 2001, GUT, V49, P577, DOI 10.1136/gut.49.4.577; Wilson CG, 2016, ENDOCRINOLOGY, V157, P570, DOI 10.1210/en.2015-1866; Zdralevic M, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00313; Zhang Y, 2019, BIOANALYSIS, V11, P1003, DOI 10.4155/bio-2018-0319; Zhao P, 2020, SCIENCE, V367, P652, DOI 10.1126/science.aay0542	67	0	0	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21737	10.1096/fj.202002620RR	http://dx.doi.org/10.1096/fj.202002620RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143495				2022-12-26	WOS:000667814100087
J	Yang, YH; Wang, CJ; Li, RF; Yi, YJ; Zeng, L; Yang, H; Zhang, CF; Song, KY; Guo, SJ				Yang, Yan Hui; Wang, Chao Jie; Li, Rui Fang; Yi, Yan Jie; Zeng, Lei; Yang, Heng; Zhang, Chang Fu; Song, Kai Yi; Guo, Si Jiao			Transcriptome-based identification and expression characterization of RgABCC transporters in Rehmannia glutinosa	PLOS ONE			English	Article							ATP-BINDING CASSETTE; PLANT ABC TRANSPORTERS; ARABIDOPSIS-THALIANA; VACUOLAR TRANSPORT; PROTEIN; FAMILY; RESISTANCE; CADMIUM; ACCUMULATION; TOLERANCE	ABCC multidrug resistance-associated proteins (ABCCs/MRPs), a subfamily of ABC transporters, are involved in multiple physiological processes. Although these proteins have been characterized in some plants, limited efforts have been made to address their possible roles in Rehmannia glutinosa, a medicinal plant. Here, we scanned R. glutinosa transcriptome sequences and identified 18 RgABCC genes by in silico analysis. Sequence alignment revealed that the RgABCCs were closely phylogenetically related and highly conserved with other plant ABCCs/MRPs. Subcellular localization revealed that most of the RgABCCs were deposited in vacuoles and a few in plasma membranes. Tissue-specific expression of the RgABCCs indicated significant specific accumulation patterns, implicating their roles in the respective tissues. Differential temporal expression patterns of the RgABCCs exhibited their potential roles during root development. Various abiotic stress and hormone treatment experiments indicated that some RgABCCs could be transcriptionally regulated in roots. Furthermore, the transcription of several RgABCCs in roots was strongly activated by cadmium (Cd), suggesting possible roles under heavy metal stresses. Functional analysis of RgABCC1 heterologous expression revealed that it may increase the tolerance to Cd in yeast, implying its Cd transport activity. Our study provides a detailed inventory and molecular characterization of the RgABCCs and valuable information for exploring their functions in R. glutinosa.	[Yang, Yan Hui; Wang, Chao Jie; Li, Rui Fang; Yi, Yan Jie; Zeng, Lei; Yang, Heng; Zhang, Chang Fu; Song, Kai Yi; Guo, Si Jiao] Henan Univ Technol, Coll Bioengn, Zhengzhou High Technol Zero, Zhengzhou 450001, Henan, Peoples R China	Henan University of Technology	Yang, YH (corresponding author), Henan Univ Technol, Coll Bioengn, Zhengzhou High Technol Zero, Zhengzhou 450001, Henan, Peoples R China.	yyhui2004@126.com	yi, yiyanjie/AAC-2854-2022	, Yanhui/0000-0003-3896-916X; Yang, Heng/0000-0001-8603-3847	National Natural Science Foundation of China [81973417]; Science Foundation of Henan University of Technology [2017RCJH05]; Program for Innovative Research Team (in Science and Technology) of the University of Henan Province [19IRTSTHN008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Henan University of Technology; Program for Innovative Research Team (in Science and Technology) of the University of Henan Province	This research was supported by grants from the National Natural Science Foundation of China (No. 81973417), the Science Foundation of Henan University of Technology (No. 2017RCJH05) and the Program for Innovative Research Team (in Science and Technology) of the University of Henan Province (No. 19IRTSTHN008).	Behrens CE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37504-8; Bhati KK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00488; Brunetti P, 2015, J EXP BOT, V66, P3815, DOI 10.1093/jxb/erv185; Burla B, 2013, PLANT PHYSIOL, V163, P1446, DOI 10.1104/pp.113.222547; Cakir B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078860; Chen PJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02150; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Demurtas OC, 2019, PLANT CELL, V31, P2789, DOI 10.1105/tpc.19.00193; El Guizani T, 2014, BIOL PLANTARUM, V58, P231, DOI 10.1007/s10535-013-0387-0; Feng TY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78018-6; Francisco RM, 2013, PLANT CELL, V25, P1840, DOI 10.1105/tpc.112.102152; Gaillard S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-22; Gattiker Alexandre, 2002, Appl Bioinformatics, V1, P107; Ghosh M, 1999, P NATL ACAD SCI USA, V96, P5001, DOI 10.1073/pnas.96.9.5001; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hu WH, 2009, PLANT SCI, V176, P583, DOI 10.1016/j.plantsci.2009.01.016; Hwang JU, 2016, MOL PLANT, V9, P338, DOI 10.1016/j.molp.2016.02.003; Ibraheem O, 2010, COMPUT BIOL CHEM, V34, P268, DOI 10.1016/j.compbiolchem.2010.09.003; Jasinski M, 2003, PLANT PHYSIOL, V131, P1169, DOI 10.1104/pp.102.014720; Klein M, 2004, PLANT J, V39, P219, DOI 10.1111/j.1365-313X.2004.02125.x; Klein M, 2006, FEBS LETT, V580, P1112, DOI 10.1016/j.febslet.2005.11.056; Kolukisaoglu HU, 2002, PLANTA, V216, P107, DOI 10.1007/s00425-002-0890-6; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1060-0; Li MJ, 2015, J EXP BOT, V66, P5837, DOI 10.1093/jxb/erv288; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Ortiz C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215901; MARTINOIA E, 1993, NATURE, V364, P247, DOI 10.1038/364247a0; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; Mishra AK, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8150523; Ofori PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200854; Pang KY, 2013, GENE, V526, P411, DOI 10.1016/j.gene.2013.05.051; Panzeri D, 2011, NEW PHYTOL, V191, P70, DOI 10.1111/j.1469-8137.2011.03666.x; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; Petrovic S, 2000, YEAST, V16, P561, DOI 10.1002/(SICI)1097-0061(200004)16:6<561::AID-YEA551>3.0.CO;2-L; Raichaudhuri A, 2009, J BIOL CHEM, V284, P8449, DOI 10.1074/jbc.M808632200; Rea PA, 1999, J EXP BOT, V50, P895, DOI 10.1093/jexbot/50.suppl_1.895; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Shi MY, 2020, SCI HORTIC-AMSTERDAM, V271, DOI 10.1016/j.scienta.2020.109464; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Song WY, 2014, P NATL ACAD SCI USA, V111, P15699, DOI 10.1073/pnas.1414968111; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Sun L., 2018, BIOCHEM BIOPH RES CO, V497, P997, DOI [10.1016/j.bbrc.2018.02.133, DOI 10.1016/j.bbrc.2018.02.133]; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Tommasini R, 1998, PLANT J, V13, P773, DOI 10.1046/j.1365-313X.1998.00076.x; Nguyen VNT, 2014, J PLANT PHYSIOL, V171, P1276, DOI 10.1016/j.jplph.2014.05.006; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Wang TL, 2006, PLANT CELL ENVIRON, V29, P1901, DOI 10.1111/j.1365-3040.2006.01566.x; Wanke D, 2010, PLANT BIOLOGY, V12, P15, DOI 10.1111/j.1438-8677.2010.00380.x; Wheeler DL, 2002, NUCLEIC ACIDS RES, V30, P13, DOI 10.1093/nar/30.1.13; Wilkins MR, 1999, METH MOL B, V112, P531; Wise AA, 2006, METH MOL B, V343, P43; Yan C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00349; Yang Mingzhang, 2020, Curr Protoc Bioinformatics, V69, pe90, DOI 10.1002/cpbi.90; Yang YH, 2015, GENET MOL RES, V14, P13022, DOI 10.4238/2015.October.21.23; Yang YH, 2014, MOL BREEDING, V34, P905, DOI 10.1007/s11032-014-0084-5; Zhang XD, 2018, GENE, V664, P139, DOI 10.1016/j.gene.2018.04.060; Zhu Y, 2018, PLANT BIOLOGY, V20, P365, DOI 10.1111/plb.12666	65	1	1	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253188	10.1371/journal.pone.0253188	http://dx.doi.org/10.1371/journal.pone.0253188			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170906	Green Published, gold			2022-12-26	WOS:000671694400022
J	Jing, DJ; Meng, XX; Ge, SC; Zhang, T; Ma, MX; Tong, LQ				Jing, Deji; Meng, Xiangxi; Ge, Shaocheng; Zhang, Tian; Ma, Mingxing; Tong, Linquan			Reconstruction and seepage simulation of a coal pore-fracture network based on CT technology	PLOS ONE			English	Article							RAY MU-CT; PERMEABILITY EVOLUTION; MICRO-TOMOGRAPHY; GAS-ADSORPTION; SEAM GAS; WATER; SEM	The distribution of multiscale pores and fractures in coal and rock is an important basis for reflecting the capacity of fluid flow in coal seam seepage passages. Accurate extraction and qualitative and quantitative analysis of pore-fracture structures are helpful in revealing the flow characteristics of fluid in seepage channels. The relationship between pore and fracture connectivity can provide a scientific reference for optimizing coal seam water injection parameters. Therefore, to analyse the change in permeability caused by the variability in the coal pore-fracture network structure, a CT scanning technique was used to scan coal samples from the Leijia District, Fuxin. A total of 720 sets of original images were collected, a median filter was used to filter out the noise in the obtained images, and to form the basis of a model, the reconstruction and analysis of the three-dimensional pore-fracture morphology of coal samples were carried out. A pore-fracture network model of the coal body was extracted at different scales. Using the maximum sphere algorithm combined with the coordination number, the effect of different quantitative relationships between pore size and pore throat channel permeability was studied. Avizo software was used to simulate the flow path of fluid in the seepage channels. The change trend of the fluid velocity between different seepage channels was discussed. The results of the pore-fracture network models at different scales show that the pore-fracture structure is nonuniform and vertically connected, and the pores are connected at connecting points. The pore size distribution ranges from 104 mu m to 9425 mu m. The pore throat channel length distribution ranges from 4206 mu m to 48073 mu m. The size of the coordination number determines the connectivity and thus the porosity of the coal seam. The more connected pore channels there are, the larger the pore diameters and the stronger the percolation ability. During flow in the seepage channels of the coal, the velocity range is divided into a low-speed region, medium-speed region and high-speed region. The fluid seepage in the coal seam is driven by the following factors: pore connectivity > pore and pore throat dimensions > pore and pore throat structure distribution. Ultimately, the pore radius and pore connectivity directly affect the permeability of the coal seam.	[Jing, Deji; Meng, Xiangxi; Zhang, Tian; Ma, Mingxing] Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Peoples R China; [Jing, Deji; Meng, Xiangxi; Zhang, Tian; Ma, Mingxing] Minist Educ, Key Lab Mine Thermodynam Disaster & Control, Fuxing, Peoples R China; [Ge, Shaocheng] Coll Safety & Emergency Management Engn, Taiyuan, Peoples R China; [Tong, Linquan] NHC, Natl Ctr Occupat Safety & Hlth, Beijing, Peoples R China	Liaoning Technical University	Meng, XX (corresponding author), Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Peoples R China.; Meng, XX (corresponding author), Minist Educ, Key Lab Mine Thermodynam Disaster & Control, Fuxing, Peoples R China.	455062996@qq.com		Meng, Xiangxi/0000-0002-5570-0288	National Natural Science Foundation of China [51704146]; discipline innovation team of Liaoning Technical University [LNTU20TD-18]; Natural Science Foundation of Liaoning Province of China [2020-MS-304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); discipline innovation team of Liaoning Technical University; Natural Science Foundation of Liaoning Province of China(Natural Science Foundation of Liaoning Province)	The National Natural Science Foundation of China (51704146) Project supported by discipline innovation team of Liaoning Technical University (LNTU20TD-18) the Natural Science Foundation of Liaoning Province of China (2020-MS-304).	Balucan RD, 2018, J NAT GAS SCI ENG, V55, P206, DOI 10.1016/j.jngse.2018.05.007; Cai YD, 2014, INT J COAL GEOL, V122, P91, DOI 10.1016/j.coal.2013.12.012; Cai YD, 2013, FUEL, V103, P258, DOI 10.1016/j.fuel.2012.06.055; Cheng W., 2017, ARAB J SCI ENG, V42, P1; Clarkson CR, 2013, FUEL, V103, P606, DOI 10.1016/j.fuel.2012.06.119; Fredrich J.T., 1996, INT J ROCK MECH MIN, V33; Graham-Brown MPM, 2016, KIDNEY INT, V90, P835, DOI 10.1016/j.kint.2016.07.014; Hamawand I, 2013, RENEW SUST ENERG REV, V22, P550, DOI 10.1016/j.rser.2013.02.030; Icardi M, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.013032; Jiao YY, 2015, INT J NUMER ANAL MET, V39, P457, DOI 10.1002/nag.2314; Jing DJ, 2021, POWDER TECHNOL, V388, P554, DOI 10.1016/j.powtec.2021.04.067; Jovin TG, 2017, INT J STROKE, V12, P641, DOI 10.1177/1747493017710341; Kelly S, 2016, ADV WATER RESOUR, V95, P302, DOI 10.1016/j.advwatres.2015.06.010; Li S, 2012, COMPUT GEOSCI-UK, V48, P220, DOI 10.1016/j.cageo.2012.01.004; Li X, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215961; Li ZT, 2017, FUEL, V209, P43, DOI 10.1016/j.fuel.2017.07.088; Liu MJ, 2015, J NAT GAS SCI ENG, V22, P182, DOI 10.1016/j.jngse.2014.11.027; MIKHAIL RS, 1968, J COLLOID INTERF SCI, V26, P45, DOI 10.1016/0021-9797(68)90270-1; Nie BS, 2015, FUEL, V158, P908, DOI 10.1016/j.fuel.2015.06.050; Nie BS, 2014, ENG FAIL ANAL, V41, P81, DOI 10.1016/j.engfailanal.2013.10.007; Okabe H, 2005, J PETROL SCI ENG, V46, P121, DOI 10.1016/j.petrol.2004.08.002; Nunes JPP, 2016, J GEOPHYS RES-SOL EA, V121, P558, DOI 10.1002/2015JB012117; Qin L, 2018, ENG GEOL, V233, P1, DOI 10.1016/j.enggeo.2017.11.019; QU Xiaoyang, 2019, J CHINA COAL SOC, V44, P950; Rabbani A, 2014, J PETROL SCI ENG, V123, P164, DOI 10.1016/j.petrol.2014.08.020; Rathi B, 2017, WATER RESOUR RES, V53, P10779, DOI 10.1002/2017WR021240; Roslin A, 2019, FUEL, V254, DOI 10.1016/j.fuel.2019.05.162; Saif T, 2017, APPL ENERG, V202, P628, DOI 10.1016/j.apenergy.2017.05.039; Shahsavandi S, 2015, ADV VIROL, V2015, P1, DOI 10.1155/2015/675921; Song WH, 2017, J NAT GAS SCI ENG, V48, P111, DOI 10.1016/j.jngse.2016.12.041; Sun YF, 2018, MICROPOR MESOPOR MAT, V258, P8, DOI 10.1016/j.micromeso.2017.08.049; Wang DK, 2021, J PETROL SCI ENG, V196, DOI 10.1016/j.petrol.2020.108051; Wang YK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227957; Xie XH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239662; Yang YF, 2018, ENERGIES, V11, DOI 10.3390/en11082145; Yin GZ, 2018, POWDER TECHNOL, V325, P234, DOI 10.1016/j.powtec.2017.10.058; Zhang HT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232182; Zhang L, 2020, FUEL, V262, DOI 10.1016/j.fuel.2019.116635; Zhao YX, 2018, FUEL, V215, P102, DOI 10.1016/j.fuel.2017.11.014; Zhou HW, 2018, INT J COAL GEOL, V189, P35, DOI 10.1016/j.coal.2018.02.007; Zhou SD, 2016, FUEL, V181, P218, DOI 10.1016/j.fuel.2016.04.119	41	6	6	22	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252277	10.1371/journal.pone.0252277	http://dx.doi.org/10.1371/journal.pone.0252277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166372	Green Published, gold			2022-12-26	WOS:000671692800094
J	Pan, SW; Su, WJ; Chan, YJ; Chuang, FY; Feng, JY; Chen, YM				Pan, Sheng-Wei; Su, Wei-Juin; Chan, Yu-Jiun; Chuang, Fan-Yi; Feng, Jia-Yih; Chen, Yuh-Min			Mycobacterium tuberculosis-derived circulating cell-free DNA in patients with pulmonary tuberculosis and persons with latent tuberculosis infection	PLOS ONE			English	Article							PCR	Objectives The timely diagnosis of pulmonary tuberculosis (PTB) is challenging. Although pathogen-derived circulating cell-free DNA (cfDNA) has been detected in humans, the significance of Mycobacterium tuberculosis (MTB)-cfDNA detection in patients with PTB remains unclear. Methods This study enrolled patients with PTB and persons with latent tuberculosis infection (LTBI) as the study and control groups, respectively, from 2018 to 2020. We measured interferon-gamma levels and calculated blood monocyte-to-lymphocyte ratio (MLR). We conducted plasma cfDNA extraction, quantitative polymerase chain reaction (qPCR), and droplet digital PCR targeting the IS6110 gene of MTB. We calculated the sensitivity and specificity of using MTB-cfDNA to identify PTB and analyzed the factors associated with PTB diagnosis and MTB-cfDNA positivity. Results We enrolled 24 patients with PTB and 57 LTBI controls. The sensitivity of using MTB-cfDNA to identify PTB was 54.2%(13/24) in total and 46.2%(6/13) in smear-negative cases. Two LTBI controls (3.5%) tested positive for MTB-cfDNA, indicating a specificity of 96.5%(55/57). By using MTB-cfDNA positivity and an MLR >= 0.42 to identify PTB, sensitivity increased to 79.2%(19/24). Among patients with PTB, MTB-specific interferon-gamma levels were higher in MTB-cfDNA positive participants than in those who tested negative (7.0 +/- 2.7 vs 2.7 +/- 3.0 IU/mL, p<0.001). MTB-cfDNA levels declined after 2 months of anti-tuberculosis therapy (p<0.001). Conclusion The sensitivity of using MTB-cfDNA to identify PTB in participants was 54.2%, which increased to 79.2% after incorporating an MLR >= 0.42 into the analysis. MTB-cfDNA positivity was associated with MTB-specific immune response, and MTB-cfDNA levels declined after treatment. The clinical value of MTB-cfDNA in PTB management necessitates further investigation.	[Pan, Sheng-Wei; Su, Wei-Juin; Chuang, Fan-Yi; Feng, Jia-Yih; Chen, Yuh-Min] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Pan, Sheng-Wei; Su, Wei-Juin; Chuang, Fan-Yi; Feng, Jia-Yih; Chen, Yuh-Min] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan; [Pan, Sheng-Wei; Chan, Yu-Jiun] Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan; [Chan, Yu-Jiun] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Chan, Yu-Jiun] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Div Microbiol, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Pan, SW; Feng, JY (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Pan, SW; Feng, JY (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan.; Pan, SW (corresponding author), Natl Yang Ming Chiao Tung Univ, Inst Publ Hlth, Taipei, Taiwan.	sanweipan@gmail.com; peterofeng@gmail.com		Pan, Sheng-Wei/0000-0002-7400-6996; Su, Wei-Juin/0000-0001-9581-6472	Taipei Veterans General Hospital [V110C-045]; Ministry of Science and Technology in Taiwan [107-2314-B075-057, 108-2314-B-075-001, 109-2314-B075 -094]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	SWP received the following grants from Taipei Veterans General Hospital [V108B-039, V109C-053 and V110C-042] and the Ministry of Science and Technology in Taiwan [107-2314-B075-057, 108-2314-B-075-001, and 109-2314-B075 -094]. JYF received the grant from Taipei Veterans General Hospital [V110C-045]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020 EDITION GLOBAL; Click ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17683-6; Ramirez JD, 2019, INT J INFECT DIS, V79, P1, DOI 10.1016/j.ijid.2018.10.029; Drain PK, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00021-18; Feng JY, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00664-18; Fernandez-Carballo BL, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01234-18; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; La Manna MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171358; Lyu LN, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05375-y; Mayito Jonathan, 2020, AAS Open Res, V3, P34, DOI 10.12688/aasopenres.13108.1; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mojtabanezhad Shariatpanahi Afsaneh, 2018, BMC Res Notes, V11, P757, DOI 10.1186/s13104-018-3866-8; Nomura J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4001-8; Pan SW, 2016, J MICROBIOL IMMUNOL, V49, P575, DOI 10.1016/j.jmii.2015.10.005; Pan SY, 2013, J THORAC DIS, V5, P251, DOI 10.3978/j.issn.2072-1439.2013.05.08; Rasool G, 2019, INT J IMMUNOPATH PH, V33, DOI 10.1177/2058738419827174; Ryu YJ, 2015, TUBERC RESPIR DIS, V78, P64, DOI 10.4046/trd.2015.78.2.64; Sakhno LV, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/793292; Song N, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0076-3; Ushio R, 2016, TUBERCULOSIS, V99, P47, DOI 10.1016/j.tube.2016.04.004; Yang JR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00369; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0	22	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253879	10.1371/journal.pone.0253879	http://dx.doi.org/10.1371/journal.pone.0253879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166477	gold, Green Published			2022-12-26	WOS:000671692800083
J	Chen, TL; Liu, HD; Liu, ZL; Li, KS; Qin, RX; Wang, Y; Liu, JL; Li, ZP; Gao, QL; Pan, C; Yang, F; Zhao, W; Zhang, ZL; Xu, YF				Chen, Tianli; Liu, Hongda; Liu, Zengli; Li, Kangshuai; Qin, Ruixi; Wang, Yue; Liu, Jialiang; Li, Zhipeng; Gao, Qinglun; Pan, Chang; Yang, Fan; Zhao, Wei; Zhang, Zongli; Xu, Yunfei			FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis	ONCOGENE			English	Article							FACTOR RECEPTOR 4; GROWTH-FACTOR 19; BILE-ACIDS; CANCER; IDENTIFICATION; MUTATIONS; METABOLISM; RESISTANCE; PROGNOSIS	Treatment options for gallbladder carcinoma (GBC) are limited and GBC prognosis remains poor. There is no well-accepted targeted therapy to date, so effective biomarkers of GBC are urgently needed. Here we investigated the expression and correlations of fibroblast growth factor receptors (FGFR1-4) and 18 fibroblast growth factors (FGFs) in two independent patient cohorts and evaluated their prognostic significance. Consequently, we demonstrated that both FGF19 and FGFR4 were unfavorable prognostic biomarkers, and their co-expression was a more sensitive predictor. By analyzing the correlations between all 18 FGFs and FGFR4, we showed that FGF19 expression was significantly associated with FGFR4 and promoted GBC progression via stimulating FGFR4. With experiments using GBC cells, GPBAR1(-/-) mice models, and human subjects, we demonstrated that elevated bile acids (BAs) could increase the transcription and expression of FGF19 and FGFR4 by activating GPBAR1-cAMP-EGR1 pathway. FGF19 secreted from GBC cells promoted GBC progression by stimulating FGFR4 and downstream ERK in an autocrine manner with bile as a potential carrier. Patients with GBC had significantly higher FGF19 in serum and bile, compared to patients with cholelithiasis. BLU9931 inhibited FGFR4 and attenuated its oncogenic effects in GBC cell line. In conclusion, upregulation of BAs elevated co-expression of FGF19 and FGFR4 by activating GPBAR1-cAMP-EGR1 pathway. Co-expression of FGF19 and FGFR4 was a sensitive and unfavorable prognostic marker. GBC cells secreted FGF19 and facilitated progression by activating FGFR4 with bile as a potential carrier in an autocrine pathway.	[Chen, Tianli; Liu, Zengli; Li, Kangshuai; Wang, Yue; Liu, Jialiang; Li, Zhipeng; Zhao, Wei; Zhang, Zongli; Xu, Yunfei] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Peoples R China; [Liu, Hongda] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China; [Qin, Ruixi] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Peoples R China; [Li, Zhipeng] Shandong Univ, Shandong Prov ENT Hosp, Dept Gen Surg, Jinan, Peoples R China; [Gao, Qinglun] Shandong Prov Third Hosp, Dept Hepatobiliary Surg, Jinan, Peoples R China; [Pan, Chang] Shandong Univ, Qilu Hosp, Dept Emergency, Jinan, Peoples R China; [Yang, Fan] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan, Peoples R China; [Yang, Fan] Shandong Univ, Sch Med, Dept Biochem & Mol Biol, Jinan, Peoples R China	Shandong University; Nanjing Medical University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Zhang, ZL; Xu, YF (corresponding author), Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Peoples R China.	zzlzzl1900@163.com; xuyunfei1988@126.com		Liu, Hongda/0000-0002-5977-9130; Chen, Tianli/0000-0003-3706-0712	National Natural Science Foundation of China [82072676]; China Postdoctoral Science Foundation [2020M682190]; Shandong University Multidisciplinary Research and Innovation Team of Young Scholars [2020QNQT002]; Shandong Province Major Research and Design Program [2018GSF118169]; Natural Science Foundation of Shandong Province [ZR2019MH008]; Jinan City Science and Technology Development Program [201805017, 201805013]; Major Project of Shandong University Clinical Study [2020SDUCRCA018]; Project of Clinical New Techniques of Qilu Hospital affiliated to Shandong Universtiy, Clinical Research Innovation Fund Project [CXPJJH11800001-2018240]; Hengrui Hepatobiliary and Pancreatic Foundation [Y-2017-144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shandong University Multidisciplinary Research and Innovation Team of Young Scholars; Shandong Province Major Research and Design Program; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Jinan City Science and Technology Development Program; Major Project of Shandong University Clinical Study; Project of Clinical New Techniques of Qilu Hospital affiliated to Shandong Universtiy, Clinical Research Innovation Fund Project; Hengrui Hepatobiliary and Pancreatic Foundation	Our study was supported by the National Natural Science Foundation of China (Grant No. 82072676), the China Postdoctoral Science Foundation (Grant No. 2020M682190), Shandong University Multidisciplinary Research and Innovation Team of Young Scholars (Grant No. 2020QNQT002), Shandong Province Major Research and Design Program (Grant No. 2018GSF118169), Natural Science Foundation of Shandong Province (ZR2019MH008), Jinan City Science and Technology Development Program (Grant No. 201805017, 201805013), the Major Project of Shandong University Clinical Study (Grant No. 2020SDUCRCA018), the Project of Clinical New Techniques of Qilu Hospital affiliated to Shandong Universtiy, Clinical Research Innovation Fund Project (CXPJJH11800001-2018240) and Hengrui Hepatobiliary and Pancreatic Foundation (Grant No.Y-2017-144).	Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Camilleri M, 2017, GASTROENTEROLOGY, V152, P1656, DOI 10.1053/j.gastro.2016.12.052; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Elzi David J, 2016, Genes Cancer, V7, P125, DOI 10.18632/genesandcancer.101; Gao LX, 2019, ONCOGENE, V38, P2394, DOI 10.1038/s41388-018-0591-7; Ge HF, 2014, J BIOL CHEM, V289, P30470, DOI 10.1074/jbc.M114.592022; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Goyal L, 2017, CANCER DISCOV, V7, P252, DOI 10.1158/2159-8290.CD-16-1000; Hagel M, 2015, CANCER DISCOV, V5, P424, DOI 10.1158/2159-8290.CD-14-1029; Heinzle C, 2014, CURR PHARM DESIGN, V20, P2881, DOI 10.2174/13816128113199990594; Henley SJ, 2015, CANCER EPIDEM BIOMAR, V24, P1319, DOI 10.1158/1055-9965.EPI-15-0199; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Javle M, 2016, CANCER-AM CANCER SOC, V122, P3838, DOI 10.1002/cncr.30254; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Keitel V, 2019, HANDB EXP PHARMACOL, V256, P19, DOI 10.1007/164_2019_230; Keitel V, 2013, CURR OPIN GASTROEN, V29, P299, DOI 10.1097/MOG.0b013e32835f3f14; Li F, 2020, ONCOGENE, V39, P3507, DOI 10.1038/s41388-020-1227-2; Li JN, 2019, BBA-MOL BASIS DIS, V1865, P895, DOI 10.1016/j.bbadis.2018.05.011; Li ML, 2014, NAT GENET, V46, P872, DOI 10.1038/ng.3030; Li Tiangang, 2015, Adv Pharmacol, V74, P263, DOI 10.1016/bs.apha.2015.04.003; Mhatre S, 2017, LANCET ONCOL, V18, P535, DOI 10.1016/S1470-2045(17)30167-5; Mitin T, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw324; Nakamura H, 2015, NAT GENET, V47, P1003, DOI 10.1038/ng.3375; PLEVRIS JN, 1995, GUT, V37, P127, DOI 10.1136/gut.37.1.127; Qiu B, 2019, EBIOMEDICINE, V50, P166, DOI 10.1016/j.ebiom.2019.11.021; Reue K, 2014, CURR OPIN LIPIDOL, V25, P140, DOI 10.1097/MOL.0000000000000060; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Song KH, 2009, HEPATOLOGY, V49, P297, DOI 10.1002/hep.22627; Sonne DP, 2016, J CLIN ENDOCR METAB, V101, P3002, DOI 10.1210/jc.2016-1607; Sugiyama N, 2010, CANCER RES, V70, P7851, DOI 10.1158/0008-5472.CAN-10-1223; Sun RQ, 2019, EBIOMEDICINE, V47, P142, DOI 10.1016/j.ebiom.2019.08.062; Taylor JG, 2009, J CLIN INVEST, V119, P3395, DOI 10.1172/JCI39703; Tiong KH, 2016, ONCOTARGET, V7, P57633, DOI 10.18632/oncotarget.9328; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Valle JW, 2021, LANCET, V397, P428, DOI 10.1016/S0140-6736(21)00153-7; Valle JW, 2017, CANCER DISCOV, V7, P943, DOI 10.1158/2159-8290.CD-17-0245; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Wu XL, 2011, EXPERT OPIN THER TAR, V15, P1307, DOI 10.1517/14728222.2011.624514; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu YF, 2019, ONCOGENE, V38, P868, DOI 10.1038/s41388-018-0485-8; Xu YF, 2014, BIOCHEM BIOPH RES CO, V446, P54, DOI 10.1016/j.bbrc.2014.02.050; Xu YF, 2017, ONCOTARGET, V8, P4888, DOI 10.18632/oncotarget.13982; Yang F, 2020, NATURE, V587, P499, DOI 10.1038/s41586-020-2569-1; Ye YW, 2011, CANCER-AM CANCER SOC, V117, P5304, DOI 10.1002/cncr.26207; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482; Zhou M, 2014, CANCER RES, V74, P3306, DOI 10.1158/0008-5472.CAN-14-0208; Zweers SJLB, 2012, HEPATOLOGY, V55, P575, DOI 10.1002/hep.24702	48	26	25	4	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4941	4953		10.1038/s41388-021-01850-1	http://dx.doi.org/10.1038/s41388-021-01850-1		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163030				2022-12-26	WOS:000664853000003
J	Du, EL; Ji, M				Du, ErLe; Ji, Meng			Analyzing the regional economic changes in a high-tech industrial development zone using machine learning algorithms	PLOS ONE			English	Article							EFFICIENCY; MODEL	The aims are to improve the efficiency in analyzing the regional economic changes in China's high-tech industrial development zones (IDZs), ensure the industrial structural integrity, and comprehensively understand the roles of capital, technology, and talents in regional economic structural changes. According to previous works, the economic efficiency and impact mechanism of China's high-tech IDZ are analyzed profoundly. The machine learning (ML)-based Data Envelopment Analysis (DEA) and Malmquist index measurement algorithms are adopted to analyze the dynamic and static characteristics of high-tech IDZ's economic data from 2009 to 2019. Furthermore, a high-tech IDZ economic efficiency influencing factor model is built. Based on the detailed data of a high-tech IDZ, the regional economic changes are analyzed from the following dimensions: economic environment, economic structure, number of talents, capital investment, and high-tech IDZ's regional scale, which verifies the effectiveness of the proposed model further. Results demonstrate that the comprehensive economic efficiency of all national high-tech IDZs in China is relatively high. However, there are huge differences among different regions. The economic efficiency of the eastern region is significantly lower than the national average. The economic structure, number of talents, capital investment, and economic efficiency of the high-tech IDZs show a significant positive correlation. The economic changes in high-tech IDZs can be improved through the secondary industry, employee value, and funding input. The ML technology applied can make data processing more efficient, providing proper suggestions for developing China's high-tech industrial parks.	[Du, ErLe; Ji, Meng] Harbin Bank, Dept Strateg Dev, Harbin, Peoples R China		Du, EL (corresponding author), Harbin Bank, Dept Strateg Dev, Harbin, Peoples R China.	duerle@163.com		Du, Erle/0000-0002-2260-5890	Special Fund for Postdoctoral of HeiLongJiang Province	Special Fund for Postdoctoral of HeiLongJiang Province	This work was supported in part by the Special Fund for Postdoctoral of HeiLongJiang Province, China.LBH-Z20027. The Harbin Bank provided support in the form of salaries for authors ErLe Du and Meng Ji, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Carboni OA, 2018, APPL ECON, V50, P335, DOI 10.1080/00036846.2017.1313954; Dheskali E, 2020, BIOCHEM ENG J, V154, DOI 10.1016/j.bej.2019.107462; Ding S, 2019, COMPUT IND ENG, V127, P749, DOI 10.1016/j.cie.2018.11.016; Du J, 2018, EUR J OPER RES, V269, P171, DOI 10.1016/j.ejor.2017.01.006; Farokhzadian J, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01260-5; Gerbec M, 2017, SAFETY SCI, V100, P225, DOI 10.1016/j.ssci.2016.07.006; Ghoddusi H, 2019, ENERG ECON, V81, P709, DOI 10.1016/j.eneco.2019.05.006; Huang X., 2020, COMPLEXITY, P356; Jatoth C, 2017, SOFT COMPUT, V21, P7221, DOI 10.1007/s00500-016-2267-y; Li CX, 2020, ENVIRON SCI POLLUT R, V27, P36621, DOI 10.1007/s11356-020-09536-z; Li YC, 2019, GROWTH CHANGE, V50, P114, DOI 10.1111/grow.12270; Lin RY, 2018, INFOR, V56, P265, DOI 10.1080/03155986.2017.1279898; Lin SF, 2021, SOCIO-ECON PLAN SCI, V74, DOI 10.1016/j.seps.2020.100939; Medvedev Dmitry, 2016, Russian Journal of Economics, V2, P327; Nosratabadi S, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8101799; Peykani P, 2019, EXPERT SYST APPL, V136, P439, DOI 10.1016/j.eswa.2019.06.039; Rao N, 2017, J MED TOXICOL, V13, P227, DOI 10.1007/s13181-017-0623-7; Storm H, 2020, EUR REV AGRIC ECON, V47, P849, DOI 10.1093/erae/jbz033; Vilar L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161344; Wang DD, 2019, COMPUT ENVIRON URBAN, V77, DOI 10.1016/j.compenvurbsys.2019.101365; Wei GW, 2017, EXPERT SYST APPL, V81, P28, DOI 10.1016/j.eswa.2017.03.043; Wu HT, 2020, ENERG ECON, V91, DOI 10.1016/j.eneco.2020.104880; Wu TW, 2019, GEOSCI MODEL DEV, V12, P1573, DOI 10.5194/gmd-12-1573-2019; Xie KF, 2018, TECHNOL FORECAST SOC, V135, P156, DOI 10.1016/j.techfore.2018.01.021; Yang ZS, 2020, CITIES, V98, DOI 10.1016/j.cities.2019.102577; Yu Z, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5258; Zhuo CF, 2020, SCI TOTAL ENVIRON, V707, DOI 10.1016/j.scitotenv.2019.135939	27	0	0	13	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0250802	10.1371/journal.pone.0250802	http://dx.doi.org/10.1371/journal.pone.0250802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157015	Green Published, gold			2022-12-26	WOS:000671691200023
J	Khatun, M; Monir, MM; Xu, T; Xu, HM; Zhu, J				Khatun, Mita; Monir, Md Mamun; Xu, Ting; Xu, Haiming; Zhu, Jun			Genome-wide conditional association study reveals the influences of lifestyle cofactors on genetic regulation of body surface area in MESA population	PLOS ONE			English	Article							COMPLEX TRAITS; SLEEP DURATION; NORMAL-WEIGHT; OBESITY; OVERWEIGHT; MASS; ARCHITECTURE; SURVIVAL; CLUSTER; ADULTS	Body surface area (BSA) is an important trait used for many clinical purposes. People's BSA may vary due to genetic background, race, and different lifestyle factors (such as walking, exercise, reading, smoking, transportation, etc.). GWAS of BSA was conducted on 5,324 subjects of four ethnic populations of European-American, African-American, Hispanic-American, and Chinese-American from the Multi-Ethnic Study of Atherocloris (MESA) data using unconditional and conditional full genetic models. In this study, fifteen SNPs were identified (Experiment-wise P-EW < 1x10(-5)) using unconditional full genetic model, of which thirteen SNPs had individual genetic effects and seven SNPs were involved in four pairs of epistasis interactions. Seven single SNPs and eight pairs of epistasis SNPs were additionally identified using exercise, smoking, and transportation cofactor-conditional models. By comparing association analysis results from unconditional and cofactor conditional models, we observed three different scenarios: (i) genetic effects of several SNPs did not affected by cofactors, e.g., additive effect of gene CREB5 (a estimates -0.013 for T/T and 0.013 for G/G, -Log(10) P-EW = 8.240) did not change in the cofactor models; (ii) genetic effects of several SNPs affected by cofactors, e.g., the genetic additive effect (a estimates 0.012 for A/A and -0.012 for G/G, -Log(10) P-EW = 7.185) of SNP of the gene GRIN2A was not significant in transportation cofactor model; and (iii) genetic effects of several SNPs suppressed by cofactors, e.g., additive (a estimates -0.018 for G/G and 0.018 for C/C, -Log(10) P-EW = 19.737) and dominance (d estimates -0.038 for G/C, -Log(10) P-EW = 27.734) effects of SNP of gene ERBB4 was identified using only transportation cofactor model. Gene ontology analysis showed that several genes are related to the metabolic pathway of calcium compounds, coronary artery disease, type-2 Diabetes, Alzheimer disease, childhood obesity, sleeping duration, Parkinson disease, and cancer. This study revealed that lifestyle cofactors could contribute, suppress, increase or decrease the genetic effects of BSA associated genes.	[Khatun, Mita; Monir, Md Mamun; Xu, Haiming; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou, Peoples R China; [Xu, Ting] Zhejiang Univ, Dept Math, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Xu, HM; Zhu, J (corresponding author), Zhejiang Univ, Inst Bioinformat, Hangzhou, Peoples R China.	hmxu@zju.edu.cn; jzhu@zju.edu.cn		Xu, Haiming/0000-0002-0675-4087	National Science Foundation of China [2016YFC1303301, 31371250]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported in part by grants from the National Science Foundation of China (2016YFC1303301, 31371250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan MA, 2019, DNA RES, V26, P119, DOI 10.1093/dnares/dsy043; Anderson M., 2010, RACE ETHNICITY CANC; Bell AC, 2002, OBES RES, V10, P277, DOI 10.1038/oby.2002.38; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bornhorst C, 2012, EUR J PEDIATR, V171, P1029, DOI 10.1007/s00431-011-1670-8; Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Bryan MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105062; Chuang JC, 2017, J THORAC ONCOL, V12, P833, DOI 10.1016/j.jtho.2017.01.023; Clair C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-23; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Cornelis MC, 2012, AM J EPIDEMIOL, V175, P191, DOI 10.1093/aje/kwr368; COSOLO WC, 1994, ANTI-CANCER DRUG, V5, P293, DOI 10.1097/00001813-199406000-00005; Gustafson D, 2003, ARCH INTERN MED, V163, P1524, DOI 10.1001/archinte.163.13.1524; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hwang Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002893; Jakicic JM, 1999, JAMA-J AM MED ASSOC, V282, P1554, DOI 10.1001/jama.282.16.1554; Kudo K, 2015, CANCER CHEMOTH PHARM, V76, P251, DOI 10.1007/s00280-015-2789-5; Law AJ, 2007, HUM MOL GENET, V16, P129, DOI 10.1093/hmg/ddl449; Liu WB, 2019, COMPUT BIOL CHEM, V78, P497, DOI 10.1016/j.compbiolchem.2018.11.010; Livingston EH, 2001, AM J PHYSIOL-ENDOC M, V281, pE586, DOI 10.1152/ajpendo.2001.281.3.E586; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luo X, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00015; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Monir MM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00627; Monir MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep38600; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; Osada Y, 2005, J BIOL CHEM, V280, P8596, DOI 10.1074/jbc.M413340200; Qi L, 2014, SCI CHINA LIFE SCI, V57, P526, DOI 10.1007/s11427-014-4650-1; Qi T, 2014, HEREDITY, V113, P224, DOI 10.1038/hdy.2014.17; Roy SK, 2012, CORONARY ARTERY DIS, V23, P113, DOI 10.1097/MCA.0b013e32834f1b72; Sacco JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008933; Sallinen R, 2010, ANN MED, V42, P296, DOI 10.3109/07853891003777109; Schaub J, 2011, NUTR CLIN PRACT, V26, P553, DOI 10.1177/0884533611416820; Searle SR., 2009, VARIANCE COMPONENTS; Shabestari AA, 2013, IRAN RED CRESCENT ME, V15, DOI 10.5812/ircmj.16616; Sparreboom A, 2003, J CLIN ONCOL, V21, P2803, DOI 10.1200/JCO.2003.99.038; Theorell-Haglow J, 2016, CURR OBES REP, V5, P333, DOI 10.1007/s13679-016-0225-8; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Verbraecken J, 2006, METABOLISM, V55, P515, DOI 10.1016/j.metabol.2005.11.004; Yang J, 2005, THEOR APPL GENET, V110, P1268, DOI 10.1007/s00122-005-1963-2; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Zhang FT, 2015, SCI REP-UK, V5, DOI 10.1038/srep10298; Zhang WG, 2016, SCI REP-UK, V6, DOI 10.1038/srep38073; Zuliani R, 2011, PSYCHIAT RES-NEUROIM, V191, P133, DOI 10.1016/j.pscychresns.2010.11.001	46	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253167	10.1371/journal.pone.0253167	http://dx.doi.org/10.1371/journal.pone.0253167			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143809	Green Submitted, Green Published, gold			2022-12-26	WOS:000671690700076
J	Veres, G; Vas, NF; Lassen, ML; Beresova, M; Krizsan, AK; Forgacs, A; Berenyi, E; Balkay, L				Veres, Gergo; Vas, Norman Felix; Lassen, Martin Lyngby; Beresova, Monika; Krizsan, Aron K.; Forgacs, Attila; Berenyi, Ervin; Balkay, Laszlo			Effect of grey-level discretization on texture feature on different weighted MRI images of diverse disease groups	PLOS ONE			English	Article							LUNG-CANCER; RADIOMICS; REPEATABILITY; ACQUISITION; DIAGNOSIS	Purpose Many studies of MRI radiomics do not include the discretization method used for the analyses, which might indicate that the discretization methods used are considered irrelevant. Our goals were to compare three frequently used discretization methods (lesion relative resampling (LRR), lesion absolute resampling (LAR) and absolute resampling (AR)) applied to the same data set, along with two different lesion segmentation approaches. Methods We analyzed the effects of altering bin widths or bin numbers for the three different sampling methods using 40 texture indices (TIs). The impact was evaluated on brain MRI studies obtained for 71 patients divided into three different disease groups: multiple sclerosis (MS, N = 22), ischemic stroke (IS, N = 22), cancer patients (N = 27). Two different MRI acquisition protocols were considered for all patients, a T2- and a post-contrast 3D T1-weighted MRI sequence. Elliptical and manually drawn VOIs were employed for both imaging series. Three different types of gray-level discretization methods were used: LRR, LAR and AR. Hypothesis tests were done among all diseased and control areas to compare the TI values in these areas. We also did correlation analyses between TI values and lesion volumes. Results In general, no significant differences were reported in the results when employing the AR and LAR discretization methods. It was found that employing 38 TIs introduced variation in the results when the number of bin parameters was altered, suggesting that both the degree and direction of monotonicity between each TI value and binning parameters were characteristic for each TI. Furthermore, while TIs were changing with altering binning values, no changes correlated to neither disease nor the MRI sequence. We found that most indices correlated weakly with the volume, while the correlation coefficients were independent of both diseases analyzed and MR contrast. Several cooccurrence-matrix based texture parameters show a definite higher correlation when employing the LRR discretization method However, with the best correlations obtained for the manually drawn VOI. Hypothesis tests among all disease and control areas (co-lateral hemisphere) revealed that the AR or LAR discretization techniques provide more suitable texture features than LRR. In addition, the manually drawn segmentation gave fewer significantly different TIs than the ellipsoid segmentations. In addition, the amount of TIs with significant differences was increasing with increasing the number of bins, or decreasing bin widths. Conclusion Our findings indicate that the AR discretization method may offer the best texture analysis in MR image assessments. Employing too many bins or too large bin widths might reduce the selection of TIs that can be used for differential diagnosis. In general, more statistically different TIs were observed for elliptical segmentations when compared to the manually drawn VOIs. In the texture analysis of MR studies, studies and publications should report on all important parameters and methods related to data collection, corrections, normalization, discretization, and segmentation.	[Veres, Gergo; Beresova, Monika; Berenyi, Ervin] Univ Debrecen, Fac Med, Dept Med Imaging, Div Radiol & Imaging Sci, Debrecen, Hungary; [Vas, Norman Felix; Balkay, Laszlo] Univ Debrecen, Fac Med, Dept Med Imaging, Div Nucl Med & Translat Imaging, Debrecen, Hungary; [Lassen, Martin Lyngby] Cedars Sinai Med Ctr, AIM Grp, Los Angeles, CA 90048 USA; [Lassen, Martin Lyngby] Univ Copenhagen, Dept Clin Physiol Nucl Med & PET & Cluster Mol Im, Copenhagen, Denmark; [Krizsan, Aron K.; Forgacs, Attila] Scanomed Nucl Med Ctr, Debrecen, Hungary	University of Debrecen; University of Debrecen; Cedars Sinai Medical Center; University of Copenhagen; Scanomed	Veres, G (corresponding author), Univ Debrecen, Fac Med, Dept Med Imaging, Div Radiol & Imaging Sci, Debrecen, Hungary.	veres.gergo@med.unideb.hu		Beresova, Monika/0000-0001-8610-3788	Thematic Excellence Programme of the Ministry for Innovation and Technology in Hungary [TKP2020-NKA-04]	Thematic Excellence Programme of the Ministry for Innovation and Technology in Hungary	The research was supported by the Thematic Excellence Programme (TKP2020-NKA-04) of the Ministry for Innovation and Technology in Hungary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Berenguer R, 2018, RADIOLOGY, V288, P407, DOI 10.1148/radiol.2018172361; Bianchini L, 2021, MAGN RESON MED, V85, P1713, DOI 10.1002/mrm.28521; Carre A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69298-z; Chen JJ, 2016, CLIN RADIOL, V71, P815, DOI 10.1016/j.crad.2016.05.010; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; Dastmalchian S, 2021, EUR J NUCL MED MOL I, V48, P683, DOI 10.1007/s00259-020-05037-w; Desseroit MC, 2017, J NUCL MED, V58, P406, DOI 10.2967/jnumed.116.180919; Duron L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213459; El-Koussy M, 2014, EUR NEUROL, V72, P309, DOI 10.1159/000362719; Fiset S, 2019, RADIOTHER ONCOL, V135, P107, DOI 10.1016/j.radonc.2019.03.001; Forgacs A, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab2328; Forgacs A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164113; Geraldes R, 2018, NAT REV NEUROL, V14, P199, DOI 10.1038/nrneurol.2018.14; Gevaert O, 2014, RADIOLOGY, V273, P168, DOI 10.1148/radiol.14131731; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goya-Outi J, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aabd21; Gugliandolo SG, 2021, EUR RADIOL, V31, P716, DOI 10.1007/s00330-020-07105-z; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Kickingereder P, 2018, NEURO-ONCOLOGY, V20, P848, DOI 10.1093/neuonc/nox188; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larroza A., 2016, ASSESSMENT CELLULAR, P75, DOI [10.5772/64641, DOI 10.5772/64641]; Loizou C.P., 2009, P 2009 9 INT C INF T, P1, DOI [10.1109/ITAB.2009.5394331, DOI 10.1109/ITAB.2009.5394331]; Machado LF, 2020, COMPUT BIOL MED, V124, DOI 10.1016/j.compbiomed.2020.103966; Mayerhoefer ME, 2020, J NUCL MED, V61, P488, DOI 10.2967/jnumed.118.222893; Molina D, 2016, COMPUT BIOL MED, V78, P49, DOI 10.1016/j.compbiomed.2016.09.011; Nael K, 2016, MAGN RESON IMAGING C, V24, P293, DOI 10.1016/j.mric.2015.11.002; Nael K, 2014, STROKE, V45, P1985, DOI 10.1161/STROKEAHA.114.005305; Orlhac F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145063; Park YW, 2021, NEURORADIOLOGY, V63, P343, DOI 10.1007/s00234-020-02529-2; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Reig B, 2020, J MAGN RESON IMAGING, V52, P998, DOI 10.1002/jmri.26852; Rizzo Stefania, 2018, Eur Radiol Exp, V2, P36, DOI 10.1186/s41747-018-0068-z; Sahraian MA, 2010, CLIN NEUROL NEUROSUR, V112, P609, DOI 10.1016/j.clineuro.2010.03.022; Scalco E, 2020, MED PHYS, V47, P1680, DOI 10.1002/mp.14038; Schick U, 2020, CANCER RADIOTHER, V24, P755, DOI 10.1016/j.canrad.2020.07.005; Schick U, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190105; Schwier M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45766-z; Shafiq-ul-Hassan M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28895-9; Shen WC, 2017, EUR J NUCL MED MOL I, V44, P1721, DOI 10.1007/s00259-017-3697-1; Song LR, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01364; Thawani R, 2018, LUNG CANCER, V115, P34, DOI 10.1016/j.lungcan.2017.10.015; Tian ZR, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00876; Wang HX, 2020, J MAGN RESON IMAGING, V52, P873, DOI 10.1002/jmri.27111; Xiao DD, 2018, CLIN NEUROL NEUROSUR, V173, P84, DOI 10.1016/j.clineuro.2018.08.004; Yang F, 2018, PHYS MEDICA, V50, P26, DOI 10.1016/j.ejmp.2018.05.017; Zhang X, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0276-7; Zhong X, 2020, BMC MED IMAGING, V20, DOI 10.1186/s12880-020-00502-2; Zwanenburg A, 2018, RADIOTHER ONCOL, V127, pS543, DOI 10.1016/S0167-8140(18)31291-X; Zwanenburg A, 2019, EUR J NUCL MED MOL I, V46, P2638, DOI 10.1007/s00259-019-04391-8	51	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253419	10.1371/journal.pone.0253419	http://dx.doi.org/10.1371/journal.pone.0253419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143830	Green Published, gold			2022-12-26	WOS:000671690700024
J	Pan, XB; Huang, ST; Qu, S; Chen, KH; Jiang, YM; Zhu, XD				Pan, Xin-Bin; Huang, Shi-Ting; Qu, Song; Chen, Kai-Hua; Jiang, Yan-Ming; Zhu, Xiao-Dong			Retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; 7TH EDITION; PROGNOSTIC VALUE; SYSTEM; PATTERNS; CANCER	Purposes To evaluate retropharyngeal lymph node metastasis on N stage of nasopharyngeal carcinoma (NPC). Methods NPC patients were extracted from the Surveillance, Epidemiology, and End Results database between 2004 and 2016. Pathologically confirmed patients with complete data of retropharyngeal lymph node metastasis were investigated. The included patients were divided into N1a and N1b groups. Overall survival (OS) and cancer-specific survival (CSS) were assessed using the Kaplan-Meier method and propensity score matching (PSM) analyses. Results This retrospective cohort study examined 759 patients: 70 who were stage N1a and 689 who were stage N1b. Before PSM, N1a group was associated with similar 5-year OS (77.7% vs. 72.4%; P = 0.15) and CSS (85.6% vs. 79.9%; P = 0.09) compared to N1b group. After PSM, a similar OS (75.0% vs. 60.7%; P = 0.12) was found between the radiotherapy and chemoradiotherapy groups. However, N1a group showed a better 5-year CSS (83.8% vs. 71.1%; P = 0.04) compared to N1b group. Stage N1b was an independent risk prognostic factor for CSS (hazard ratio = 2.54, 95% confidence interval: 1.02-6.34; P = 0.04). Conclusions OS was not different between N1a and N1b groups. Retropharyngeal lymph node metastasis defined as stage N1 of the 8(th) edition American Joint Committee on Cancer staging system is reasonable.	[Pan, Xin-Bin; Huang, Shi-Ting; Qu, Song; Chen, Kai-Hua; Jiang, Yan-Ming; Zhu, Xiao-Dong] Guangxi Med Univ, Canc Hosp, Dept Radiat Oncol, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Zhu, XD (corresponding author), Guangxi Med Univ, Canc Hosp, Dept Radiat Oncol, Nanning, Guangxi, Peoples R China.	zhuxiaodonggx@163.com			Research and Development Project of Guangxi [1598012-22, AB18221007]; Guangxi Medical University [GXMUYSF201521]; Department of Education of Guangxi Zhuang Autonomous Region [KY2016LX029]	Research and Development Project of Guangxi; Guangxi Medical University; Department of Education of Guangxi Zhuang Autonomous Region	This study was supported by the grant of Research and Development Project of Guangxi (no. 1598012-22 and no. AB18221007), Guangxi Medical University (no. GXMUYSF201521), and Department of Education of Guangxi Zhuang Autonomous Region (no. KY2016LX029).	Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; King AD, 2000, HEAD NECK-J SCI SPEC, V22, P275; Liao XB, 2008, INT J RADIAT ONCOL, V72, P1368, DOI 10.1016/j.ijrobp.2008.03.017; Ma J, 2007, CLIN CANCER RES, V13, P1445, DOI 10.1158/1078-0432.CCR-06-2059; Marta GN, 2014, RADIOTHER ONCOL, V110, P9, DOI 10.1016/j.radonc.2013.11.010; Ng SH, 2004, EUR J NUCL MED MOL I, V31, P1073, DOI 10.1007/s00259-004-1498-9; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Pan JJ, 2015, AM J CLIN ONCOL-CANC, V38, P189, DOI 10.1097/COC.0b013e31828f5c96; Pan XB, 2017, ONCOTARGET, V8, P102573, DOI 10.18632/oncotarget.21751; Peng G, 2012, RADIOTHER ONCOL, V104, P286, DOI 10.1016/j.radonc.2012.08.013; SHAM JST, 1990, INT J RADIAT ONCOL, V19, P929, DOI 10.1016/0360-3016(90)90014-B; Tang LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108375; Tang LL, 2008, CANCER, V113, P347, DOI 10.1002/cncr.23555; Tang LL, 2009, CANCER-AM CANCER SOC, V115, P680, DOI 10.1002/cncr.24049; Zhang BL, 2015, ORAL ONCOL, V51, P1041, DOI 10.1016/j.oraloncology.2015.08.005; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006; Zong JF, 2015, ORAL ONCOL, V51, P254, DOI 10.1016/j.oraloncology.2014.10.012	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253424	10.1371/journal.pone.0253424	http://dx.doi.org/10.1371/journal.pone.0253424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138943	gold, Green Published			2022-12-26	WOS:000671690200086
J	Sokolova, M; Thompson, F; Mariani, P; Krag, LA				Sokolova, Maria; Thompson, Fletcher; Mariani, Patrizio; Krag, Ludvig Ahm			Towards sustainable demersal fisheries: NepCon image acquisition system for automatic Nephrops norvegicus detection	PLOS ONE			English	Article							FISH	Underwater video monitoring systems are being widely used in fisheries to investigate fish behavior in relation to fishing gear and fishing gear performance during fishing. Such systems can be useful to evaluate the catch composition as well. In demersal trawl fisheries, however, their applicability can be challenged by low light conditions, mobilized sediment and scattering in murky waters. In this study, we introduce a novel observation system (called NepCon) which aims at reducing current limitations by combining an optimized image acquisition setup and tailored image analyses software. The NepCon system includes a high-contrast background to enhance the visibility of the target objects, a compact camera and an artificial light source. The image analysis software includes a machine learning algorithm which is evaluated here to test automatic detection and count of Norway lobster (Nephrops norvegicus). NepCon is specifically designed for applications in demersal trawls and this first phase aims at increasing the accuracy of N. norvegicus detection at the data acquisition level. To find the best contrasting background for the purpose we compared the output of four image segmentation methods applied to static images of N. norvegicus fixed in front of four test background colors. The background color with the best performance was then used to evaluate computer vision and deep learning approaches for automatic detection, tracking and counting of N. norvegicus in the videos. In this initial phase we tested the system in an experimental setting to understand the feasibility of the system for future implementation in real demersal fishing conditions. The N. norvegicus directed trawl fishery typically has no assistance from underwater observation technology and therefore are largely conducted blindly. The demonstrated perception system achieves 76% accuracy (F-score) in automatic detection and count of N. norvegicus, which provides a significant elevation of the current benchmark.	[Sokolova, Maria; Krag, Ludvig Ahm] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Fisheries Technol, Hirtshals, Denmark; [Thompson, Fletcher; Mariani, Patrizio] Tech Univ Denmark, Natl Inst Aquat Resources, Sect Oceans & Arctic, Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Sokolova, M (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Sect Fisheries Technol, Hirtshals, Denmark.	msok@aqua.dtu.dk	Mariani, Patrizio/AAP-2007-2021	Mariani, Patrizio/0000-0002-8015-1583; Sokolova, Maria/0000-0002-6380-4052; Thompson, Fletcher/0000-0002-0639-9871; Krag, Ludvig Ahm/0000-0002-1531-1499	European Union [7553521]; European Maritime and Fisheries Fund; Danish Fisheries Agency [33112-I-19-076]	European Union(European Commission); European Maritime and Fisheries Fund; Danish Fisheries Agency	Krag L.A. received European Union's Horizon 2020 research and innovation programme under grant agreement No 7553521 (SMARTFISH) http://smartfishh2020.eu/Krag L.A. received European Maritime and Fisheries Fund and the Danish Fisheries Agency, grant No 33112-I-19-076 (AutoCatch) https://ec.europa.eu/fisheries/cfp/emff_en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla W., 2017, MASK R CNN OBJECT DE, DOI DOI 10.1109/CVPR.2017.106; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Allken V, 2021, GEOSCI DATA J, V8, P199, DOI 10.1002/gdj3.114; Alvarez-Ellacuria A, 2020, ICES J MAR SCI, V77, P1330, DOI 10.1093/icesjms/fsz216; Garcia JA, 2016, FRONT ARTIF INTEL AP, V288, P9, DOI 10.3233/978-1-61499-696-5-9; Burger W., 2016, DIGITAL IMAGE PROCES; Campbell N, 2009, ICES J MAR SCI, V66, P2052, DOI 10.1093/icesjms/fsp176; Catchpole TL, 2008, REV FISH BIOL FISHER, V18, P17, DOI 10.1007/s11160-007-9061-y; DeCelles GR, 2017, T AM FISH SOC, V146, P462, DOI 10.1080/00028487.2017.1282888; Ditria EM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00429; EU-European Union, 2019, OFFICIAL J EUROPEAN; Fairchild M.D., 2013, COLOUR APPEARANCE MO, DOI DOI 10.1002/9781118653128; Farmer ASD., 1975, SYNOPSIS BIOL DATA N; Fernandes PG, 2011, ICES J MAR SCI, V68, P1734, DOI 10.1093/icesjms/fsr131; Garcia R, 2020, ICES J MAR SCI, V77, P1354, DOI 10.1093/icesjms/fsz186; GOODWIN TW, 1949, BIOCHEM J, V45, P268, DOI 10.1042/bj0450268; He K., 2017, P IEEE INT C COMPUTE, P2961, DOI [DOI 10.1109/ICCV.2017.322, 10.1109/ICCV.2017.322]; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jain Ramesh, 1995, MACHINE VISION; Kang Myounghee, 2011, Fisheries and Aquatic Sciences, V14, P218; KINNEY JAS, 1967, J OPT SOC AM, V57, P802, DOI 10.1364/JOSA.57.000802; Krag LA, 2016, AQUAT LIVING RESOUR, V29, DOI 10.1051/alr/2016028; Krag LA, 2009, FISH RES, V98, P62, DOI 10.1016/j.fishres.2009.03.012; Krag LA, 2008, FISH RES, V91, P175, DOI 10.1016/j.fishres.2007.11.022; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kulkarni N., 2012, INT J IMAG GRAPH SIG, V4, P28, DOI [DOI 10.5815/IJIGSP.2012.01.04, 10.5815/ijigsp.2012.01.04]; Lin T., 2014, EUROPEAN C COMPUTER, P740; Mariani P, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11010162; Martignac F, 2015, FISH FISH, V16, P486, DOI 10.1111/faf.12071; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; OMahony N, 2019, DEEP LEARNING VS TRA; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rosen S, 2013, FISH RES, V148, P64, DOI 10.1016/j.fishres.2013.08.002; Santos J, 2018, FISHERIES MANAG ECOL, V25, P464, DOI 10.1111/fme.12323; Savina E, 2019, FISH RES, V219, DOI 10.1016/j.fishres.2019.105311; Schroff F, 2008, P BRIT MACH VIS C 20; Sherlock M., 2016, VESSEL TOWED PLATFOR; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Sonka M., 2014, J ELECTRON IMAGING, Vxix; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; Szeliski R, 2011, TEXTS COMPUT SCI, P1, DOI 10.1007/978-1-84882-935-0; THOMSEN B, 1993, ICES MAR SC, V196, P161; Torrey L., 2010, HDB RES MACHINE LEAR, P242, DOI DOI 10.4018/978-1-60566-766-9.CH011; Tremeau A, 2000, IEEE T IMAGE PROCESS, V9, P735, DOI 10.1109/83.841950; Tseng CH, 2020, ICES J MAR SCI, V77, P1367, DOI 10.1093/icesjms/fsaa076; Ungfors A, 2013, ADV MAR BIOL, V64, P247, DOI 10.1016/B978-0-12-410466-2.00007-8; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; White DJ, 2006, FISH RES, V80, P203, DOI 10.1016/j.fishres.2006.04.009; Xin Li, 2010, Proceedings of the 2010 International Conference on Information and Automation (ICIA 2010), P1862, DOI 10.1109/ICINFA.2010.5512258; Yu Chuang, 2020, Information Processing in Agriculture, V7, P523, DOI 10.1016/j.inpa.2020.01.002; Zhang D, 2016, BIOSYST ENG, V145, P65, DOI 10.1016/j.biosystemseng.2016.02.013	52	5	5	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252824	10.1371/journal.pone.0252824	http://dx.doi.org/10.1371/journal.pone.0252824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133448	Green Published, gold			2022-12-26	WOS:000671682700038
J	Lian, CL; Huang, QZ; Zhong, XY; He, ZY; Liu, BY; Zeng, HJ; Xu, NB; Yang, Z; Liao, CX; Fu, Z; Guo, HB				Lian, Changlin; Huang, Qiongzhen; Zhong, Xiangyang; He, Zhenyan; Liu, Boyang; Zeng, Huijun; Xu, Ningbo; Yang, Zhao; Liao, Chenxin; Fu, Zhao; Guo, Hongbo			Pentraxin 3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis	FASEB JOURNAL			English	Article						apoptosis; dopaminergic neuron; human adipose-derived mesenchymal stem cells; Parkinson's disease; pentraxin 3	CONDITIONED MEDIUM; MODEL; INJURY; PTX3; NEUROGENESIS; RECEPTORS; PROTECTS; DEATH	Although adipose-derived human mesenchymal stem cell (hADSC) transplantation has recently emerged as a promising therapeutic modality for Parkinson's disease (PD), its underlying mechanism of action has not been fully elucidated. This study evaluated the therapeutic effects of stereotaxic injection of hADSCs in the striatum of the 6-OHDA-induced mouse model. Furthermore, an in vitro PD model was constructed using tissue-organized brain slices. The therapeutic effect was also evaluated using a co-culture of the hADSCs and 6-OHDA-treated brain slice. The analysis of hADSC exocrine proteins using RNA-sequencing, human protein cytokine arrays, and label-free quantitative proteomics identified key extracellular factors in the hADSC secretion environment. The degeneration and apoptosis of the dopaminergic neurons were measured in the PD samples in vivo and in vitro, and the beneficial effects were evaluated using quantitative reverse transcription-polymerase chain reaction, western blotting, Fluoro-Jade C, TUNEL assay, and immunofluorescence analysis. This study found that hADSCs protected the dopaminergic neurons in the in vivo and vitro models. We identified Pentraxin 3 (PTX3) as a key extracellular factor in the hADSC secretion environment. Moreover, we found that human recombinant PTX3 (rhPTX3) treatment could rescue the pathophysiological behavior of the PD mice in vivo, prevent dopaminergic neuronal death, and increase neuronal terminals in the ventral tegmental area + substantia nigra pars compacta and striatum in the PD brain slices in vitro. Furthermore, testing of the pro-apoptotic markers in the PD mouse brain following rhPTX3 treatment revealed that rhPTX3 can prevent apoptosis and degeneration of the dopaminergic neurons. This study discovered that PTX3, a hADSC-secreted protein, potentially protected the dopaminergic neurons against apoptosis and degeneration during PD progression and improved motor performance in PD mice, indicating the possible mechanism of action of hADSC replacement therapy for PD. Thus, our study discovered potential translational implications for the development of PTX3-based therapeutics for PD.	[Lian, Changlin; Huang, Qiongzhen; Zhong, Xiangyang; Liu, Boyang; Zeng, Huijun; Xu, Ningbo; Yang, Zhao; Liao, Chenxin; Fu, Zhao; Guo, Hongbo] Southern Med Univ, Zhujiang Hosp,Guangdong Prov Key Lab Brain Funct, Neurosurg Inst Guangdong Prov,Minist China Diag &, Neurosurg Ctr,Natl Key Clin Specialty,Engn Techno, 253 Gongye Middle Ave, Guangzhou 510280, Guangdong, Peoples R China; [He, Zhenyan] Zhengzhou Univ, Affiliated Tumor Hosp, Dept Neurosurg, Zhengzhou, Peoples R China	Southern Medical University - China; Zhengzhou University	Guo, HB (corresponding author), Southern Med Univ, Zhujiang Hosp,Guangdong Prov Key Lab Brain Funct, Neurosurg Inst Guangdong Prov,Minist China Diag &, Neurosurg Ctr,Natl Key Clin Specialty,Engn Techno, 253 Gongye Middle Ave, Guangzhou 510280, Guangdong, Peoples R China.	guohongbo911@126.com	Xu, Ningbo/Q-3820-2017	Xu, Ningbo/0000-0001-9055-3597	Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project [2017A030308001]; National Natural Science Foundation of China [81874079, 81672477]; Guangdong Province Science and Technology Innovation Strategy Special Fund [2018A030310422]; Guangdong Medical Science and Technology Research Fund [A2018542]; Key development and promotion project of Henan province [212102310662]	Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Innovation Strategy Special Fund; Guangdong Medical Science and Technology Research Fund; Key development and promotion project of Henan province	This study was supported by the Natural Science Foundation of Guangdong Province-Major Basic Cultivation Project (Grant/Award Numbers: 2017A030308001), the National Natural Science Foundation of China, (Grant/Award Numbers: 81874079, 81672477), Guangdong Province Science and Technology Innovation Strategy Special Fund (2018A030310422), Guangdong Medical Science and Technology Research Fund (A2018542), and Key development and promotion project of Henan province (No. 212102310662)	Aebersold R, 2016, NATURE, V537, P347, DOI 10.1038/nature19949; Armstrong MJ, 2020, JAMA-J AM MED ASSOC, V323, P548, DOI 10.1001/jama.2019.22360; Bacakova L, 2018, BIOTECHNOL ADV, V36, P1111, DOI 10.1016/j.biotechadv.2018.03.011; Balestrino R, 2020, EUR J NEUROL, V27, P27; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bonavita E, 2015, CELL, V160, P700, DOI 10.1016/j.cell.2015.01.004; Cai Y, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01831-3; Cappuzzello C, 2016, J INVEST DERMATOL, V136, P293, DOI 10.1038/JID.2015.346; Cavaliere F, 2010, J NEUROSCI METH, V188, P205, DOI 10.1016/j.jneumeth.2010.02.008; Croft CL, 2019, J EXP MED, V216, P539, DOI 10.1084/jem.20182184; Fang B, 2019, J CELL MOL MED, V23, P4244, DOI 10.1111/jcmm.14314; Garlanda C, 2018, PHYSIOL REV, V98, P623, DOI 10.1152/physrev.00016.2017; Glavaski-Joksimovic A, 2013, EXP NEUROL, V247, P25, DOI 10.1016/j.expneurol.2013.03.016; Hartmann A, 2002, NEUROLOGY, V58, P308, DOI 10.1212/WNL.58.2.308; Hernandez-Baltazar D, 2017, NEUROLOGIA, V32, P533, DOI 10.1016/j.nrl.2015.06.011; Humpel Christian, 2018, Curr Protoc Immunol, V123, pe59, DOI 10.1002/cpim.59; Kress GJ, 2005, NEUROBIOL DIS, V20, P639, DOI 10.1016/j.nbd.2005.04.019; Lee HW, 2011, MOVEMENT DISORD, V26, P2364, DOI 10.1002/mds.23871; Lee HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195758; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Nakhaeifard M, 2018, CELL J, V20, P348, DOI 10.22074/cellj.2018.5343; Palomares T, 2018, MOL NEUROBIOL, V55, P13, DOI 10.1007/s12035-017-0714-0; Pan Q, 2015, J KOREAN NEUROSURG S, V57, P82, DOI 10.3340/jkns.2015.57.2.82; Park HJ, 2016, ACTA NEUROPATHOL, V132, P685, DOI 10.1007/s00401-016-1605-6; Park HJ, 2014, NEUROBIOL AGING, V35, P1920, DOI 10.1016/j.neurobiolaging.2014.01.028; Park HW, 2015, J NEUROSCI RES, V93, P1814, DOI 10.1002/jnr.23616; Pires AO, 2017, PROG NEUROBIOL, V156, P69, DOI 10.1016/j.pneurobio.2017.04.006; Pu CM, 2017, J INVEST DERMATOL, V137, P1353, DOI 10.1016/j.jid.2016.12.030; Rafat A, 2019, CELL J, V20, P450, DOI 10.22074/cellj.2019.5507; Rajkovic I, 2018, J MOL MED, V96, P1319, DOI 10.1007/s00109-018-1698-6; Schneider-Brachert W, 2013, INT J MOL SCI, V14, P14475, DOI 10.3390/ijms140714475; Schulze WX, 2010, ANNU REV PLANT BIOL, V61, P491, DOI 10.1146/annurev-arplant-042809-112132; Schwerk A, 2015, CYTOTHERAPY, V17, P199, DOI 10.1016/j.jcyt.2014.09.005; Singh S, 2007, BRAIN RES REV, V54, P233, DOI 10.1016/j.brainresrev.2007.02.001; Tran C, 2015, ADV DRUG DELIVER REV, V82-83, P1, DOI 10.1016/j.addr.2014.10.007; Tysnes OB, 2017, J NEURAL TRANSM, V124, P901, DOI 10.1007/s00702-017-1686-y; Venderova K, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009365; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015; Xue JH, 2019, MAT SCI ENG C-MATER, V100, P584, DOI 10.1016/j.msec.2019.03.024; Zhang C, 2017, REDOX BIOL, V11, P1, DOI 10.1016/j.redox.2016.10.019; Zhou C, 2020, NEURAL REGEN RES, V15, P2318, DOI 10.4103/1673-5374.285001	42	4	4	3	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21748	10.1096/fj.202100408RR	http://dx.doi.org/10.1096/fj.202100408RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34152016	hybrid			2022-12-26	WOS:000667814100023
J	Bauer, J; Cuvelier, N; Ragab, N; Simon-Keller, K; Nitzki, F; Geyer, N; Botermann, DS; Elmer, DP; Rosenberger, A; Rando, TA; Biressi, S; Fagin, JA; Saur, D; Dullin, C; Schildhaus, HU; Schulz-Schaeffer, W; Aberger, F; Uhmann, A; Hahn, H				Bauer, Julia; Cuvelier, Nicole; Ragab, Nada; Simon-Keller, Katja; Nitzki, Frauke; Geyer, Natalie; Botermann, Dominik S.; Elmer, Dominik P.; Rosenberger, Albert; Rando, Thomas A.; Biressi, Stefano; Fagin, James A.; Saur, Dieter; Dullin, Christian; Schildhaus, Hans-Ulrich; Schulz-Schaeffer, Walter; Aberger, Fritz; Uhmann, Anja; Hahn, Heidi			Context-dependent modulation of aggressiveness of pediatric tumors by individual oncogenic RAS isoforms	ONCOGENE			English	Article							EMBRYONAL RHABDOMYOSARCOMA; K-RAS; SIGNALING PATHWAY; CELL-SURVIVAL; N-RAS; CANCER; HEDGEHOG; ACTIVATION; GENE; EXPRESSION	A prototypic pediatric cancer that frequently shows activation of RAS signaling is embryonal rhabdomyosarcoma (ERMS). ERMS also show aberrant Hedgehog (HH)/GLI signaling activity and can be driven by germline mutations in this pathway. We show, that in ERMS cell lines derived from sporadic tumors i.e. from tumors not caused by an inherited genetic variant, HH/GLI signaling plays a subordinate role, because oncogenic mutations in HRAS, KRAS, or NRAS (collectively named oncRAS) inhibit the main HH target GLI1 via the MEK/ERK-axis, but simultaneously increase proliferation and tumorigenicity. oncRAS also modulate expression of stem cell markers in an isoform- and context-dependent manner. In Hh-driven murine ERMS that are caused by a Patched mutation, oncHRAS and mainly oncKRAS accelerate tumor development, whereas oncNRAS induces a more differentiated phenotype. These features occur when the oncRAS mutations are induced at the ERMS precursor stage, but not when induced in already established tumors. Moreover, in contrast to what is seen in human cell lines, oncRAS mutations do not alter Hh signaling activity and marginally affect expression of stem cell markers. Together, all three oncRAS mutations seem to be advantageous for ERMS cell lines despite inhibition of HH signaling and isoform-specific modulation of stem cell markers. In contrast, oncRAS mutations do not inhibit Hh-signaling in Hh-driven ERMS. In this model, oncRAS mutations seem to be advantageous for specific ERMS populations that occur within a specific time window during ERMS development. In addition, this window may be different for individual oncRAS isoforms, at least in the mouse.	[Bauer, Julia; Cuvelier, Nicole; Ragab, Nada; Nitzki, Frauke; Geyer, Natalie; Botermann, Dominik S.; Uhmann, Anja; Hahn, Heidi] Univ Med Ctr Goettingen, Dept Human Genet, Gottingen, Germany; [Simon-Keller, Katja] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Elmer, Dominik P.; Aberger, Fritz] Paris Lodron Univ Salzburg, Dept Biosci, Canc Cluster Salzburg, Salzburg, Austria; [Rosenberger, Albert] Univ Med Ctr Goettingen, Dept Genet Epidemiol, Gottingen, Germany; [Rando, Thomas A.; Biressi, Stefano] Stanford Univ, Paul Glenn Ctr Biol Aging, Sch Med, Stanford, CA USA; [Rando, Thomas A.; Biressi, Stefano] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA USA; [Biressi, Stefano] Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA USA; [Biressi, Stefano] Univ Trento, Dept Cellular Computat & Integrat Biol CIBIO, Povo, Italy; [Biressi, Stefano] Univ Trento, Dulbecco Telethon Inst, Povo, Italy; [Fagin, James A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Saur, Dieter] Klin & Poliklin Innere Med II, Klinikum Rechts Isar TUM, Munich, Germany; [Dullin, Christian] Univ Med Ctr Goettingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Schildhaus, Hans-Ulrich] Univ Med Ctr Essen, Inst Pathol, Essen, Germany; [Schulz-Schaeffer, Walter] Saarland Univ, Dept Neuropathol, Med Ctr, Homburg, Germany	University of Gottingen; Ruprecht Karls University Heidelberg; Salzburg University; University of Gottingen; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Trento; Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Trento; Memorial Sloan Kettering Cancer Center; Technical University of Munich; University of Gottingen; University of Duisburg Essen; Universitatsklinikum des Saarlandes	Hahn, H (corresponding author), Univ Med Ctr Goettingen, Dept Human Genet, Gottingen, Germany.	hhahn@gwdg.de	Saur, Dieter/O-8355-2015	Saur, Dieter/0000-0001-5874-0210; Dullin, Christian/0000-0003-4297-8077; Rosenberger, Albert/0000-0001-7848-1332; Botermann, Dominik Simon/0000-0001-7747-7147; Aberger, Fritz/0000-0003-2009-6305; Bauer, Julia/0000-0001-5390-1855; Biressi, Stefano Augusto Maria/0000-0001-8631-3419	German Research Foundation [HA 2197/9-1, HA 2197/9-2]; Wilhelm Sander foundation [2017.110.1]; Austrian Science Fund (FWF) [P25629, W1213]; Projekt DEAL	German Research Foundation(German Research Foundation (DFG)); Wilhelm Sander foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Projekt DEAL	This work was supported by grants HA 2197/9-1 and HA 2197/9-2 from the German Research Foundation to HH, by grant 2017.110.1 of the Wilhelm Sander foundation to HH. and KSK. and by grants P25629 and W1213 of the Austrian Science Fund (FWF) to FA. Open Access funding enabled and organized by Projekt DEAL.	Aberger F, 2012, VITAM HORM, V88, P25, DOI 10.1016/B978-0-12-394622-5.00002-X; Almazan-Moga A, 2017, BRIT J CANCER, V117, P1314, DOI 10.1038/bjc.2017.305; Ashford AL, 2016, CELL MOL LIFE SCI, V73, P883, DOI 10.1007/s00018-015-2032-x; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biressi S, 2013, DEV BIOL, V379, P195, DOI 10.1016/j.ydbio.2013.04.021; CHARDIN P, 1985, INT J CANCER, V35, P647, DOI 10.1002/ijc.2910350513; Chen L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005075; Chen X, 2013, CANCER CELL, V24, P710, DOI 10.1016/j.ccr.2013.11.002; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Dasgupta R, 2016, SEMIN PEDIATR SURG, V25, P276, DOI 10.1053/j.sempedsurg.2016.09.011; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Genadry KC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00475; Geyer N, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00396; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hahn H, 2000, J BIOL CHEM, V275, P28341, DOI 10.1074/jbc.C000352200; Hahn H, 1998, NAT MED, V4, P619, DOI 10.1038/nm0598-619; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hettmer S, 2015, J PEDIAT HEMATOL ONC, V37, P147, DOI 10.1097/MPH.0000000000000115; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Jongmans MCJ, 2010, GENE CHROMOSOME CANC, V49, P635, DOI 10.1002/gcc.20773; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Kratz CP, 2011, AM J MED GENET C, V157C, P83, DOI 10.1002/ajmg.c.30300; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Martinez-Cruzado L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27878; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; MOON B, 2014, JNCI-J NATL CANCER I, V106; Nakahata K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125454; Nitzki F, 2011, ONCOGENE, V30, P4428, DOI 10.1038/onc.2011.157; Paulson V, 2011, GENE CHROMOSOME CANC, V50, P397, DOI 10.1002/gcc.20864; Pietrobono S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00556; Pressey JG, 2011, PEDIATR BLOOD CANCER, V57, P930, DOI 10.1002/pbc.23174; Ridzewski R, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00130; Robbins KM, 2016, AM J MED GENET A, V170, P3197, DOI 10.1002/ajmg.a.37949; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; SCRABLE H, 1989, P NATL ACAD SCI USA, V86, P7480, DOI 10.1073/pnas.86.19.7480; Sesillo FB, 2019, CELL REP, V26, P689, DOI 10.1016/j.celrep.2018.12.089; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Sieber OM, 2005, NAT REV CANCER, V5, P649, DOI 10.1038/nrc1674; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soleimani VD, 2011, CANCER CELL, V19, P157, DOI 10.1016/j.ccr.2011.01.044; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tostar Ulrica, 2010, Genes Cancer, V1, P941, DOI 10.1177/1947601910385449; Tsumura H, 2006, ONCOGENE, V25, P7673, DOI 10.1038/sj.onc.1209749; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Yohe ME, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4470; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; ZHAN SL, 1994, J CLIN INVEST, V94, P445, DOI 10.1172/JCI117344; Zhao XS, 2015, CANCER RES, V75, P3623, DOI 10.1158/0008-5472.CAN-14-2999-T; Zibat A, 2010, ONCOGENE, V29, P6323, DOI 10.1038/onc.2010.368; Zibat A, 2009, CARCINOGENESIS, V30, P918, DOI 10.1093/carcin/bgp068	54	2	2	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					4955	4966		10.1038/s41388-021-01904-4	http://dx.doi.org/10.1038/s41388-021-01904-4		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34172934	hybrid, Green Published			2022-12-26	WOS:000667016100003
J	Paliwal, M; Weber, KA; Smith, AC; Elliott, JM; Muhammad, F; Dahdaleh, NS; Bodurka, J; Dhaher, Y; Parrish, TB; Mackey, S; Smith, ZA				Paliwal, Monica; Weber, Kenneth A.; Smith, Andrew C.; Elliott, James M.; Muhammad, Fauziyya; Dahdaleh, Nader S.; Bodurka, Jerzy; Dhaher, Yasin; Parrish, Todd B.; Mackey, Sean; Smith, Zachary A.			Fatty infiltration in cervical flexors and extensors in patients with degenerative cervical myelopathy using a multi-muscle segmentation model	PLOS ONE			English	Article							SPONDYLOTIC MYELOPATHY; SKELETAL-MUSCLE; LONGUS-COLLI; ALIGNMENT; WHIPLASH; IMPACT; ASSOCIATION; PREVALENCE; DISABILITY; MANAGEMENT	Background In patients with degenerative cervical myelopathy (DCM) that have spinal cord compression and sensorimotor deficits, surgical decompression is often performed. However, there is heterogeneity in clinical presentation and post-surgical functional recovery. Objectives Primary: a) to assess differences in muscle fat infiltration (MFI) in patients with DCM versus controls, b) to assess association between MFI and clinical disability. Secondary: to assess association between MFI pre-surgery and post-surgical functional recovery. Study design Cross-sectional case control study. Methods Eighteen patients with DCM (58.6 +/- 14.2 years, 10 M/8F) and 25 controls (52.6 +/- 11.8 years, 13M/12 F) underwent 3D Dixon fat-water imaging. A convolutional neural network (CNN) was used to segment cervical muscles (MFSS- multifidus and semispinalis cervicis, LC- longus capitis/colli) and quantify MFI. Modified Japanese Orthopedic Association (mJOA) and Nurick were collected. Results Patients with DCM had significantly higher MFI in MFSS (20.63 +/- 5.43 vs 17.04 +/- 5.24, p = 0.043) and LC (18.74 +/- 6.7 vs 13.66 +/- 4.91, p = 0.021) than controls. Patients with increased MFI in LC and MFSS had higher disability (LC: Nurick (Spearman's rho = 0.436, p = 0.003) and mJOA (rho = -0.399, p = 0.008)). Increased MFI in LC pre-surgery was associated with post-surgical improvement in Nurick (rho = -0.664, p = 0.026) and mJOA (rho = -0.603, p = 0.049). Conclusion In DCM, increased muscle adiposity is significantly associated with sensorimotor deficits, clinical disability, and functional recovery after surgery. Accurate and time efficient evaluation of fat infiltration in cervical muscles may be conducted through implementation of CNN models.	[Paliwal, Monica; Muhammad, Fauziyya; Smith, Zachary A.] Univ Oklahoma, Dept Neurosurg, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Weber, Kenneth A.; Mackey, Sean] Stanford Univ, Dept Anesthesiol, Syst Neurosci & Pain Lab, Perioperat & Pain Med, Palo Alto, CA USA; [Smith, Andrew C.] Sch Med, Dept Phys Med & Rehabil, Phys Therapy Program, Aurora, CO USA; [Elliott, James M.] Northwestern Univ, Feinberg Sch Med, Dept Phys Therapy & Human Movement Sci, Chicago, IL USA; [Elliott, James M.] Univ Sydney, Fac Med & Hlth, Kolling Inst Med Res, St Leonards, NSW, Australia; [Dahdaleh, Nader S.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL USA; [Bodurka, Jerzy] Laureate Inst Brain Res, Tulsa, OK USA; [Bodurka, Jerzy] Univ Oklahoma, Stephenson Sch Biomed Engn, Norman, OK USA; [Dhaher, Yasin] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX USA; [Parrish, Todd B.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University; Northwestern University; Feinberg School of Medicine; University of Sydney; Kolling Institute of Medical Research; Northwestern University; Feinberg School of Medicine; Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma - Norman; University of Texas System; University of Texas Southwestern Medical Center Dallas; Northwestern University; Feinberg School of Medicine	Paliwal, M (corresponding author), Univ Oklahoma, Dept Neurosurg, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.	monicapaliwal1@gmail.com		Smith, Andrew/0000-0001-5020-8094; Parrish, Todd/0000-0002-1184-1572; Mackey, Sean/0000-0001-7744-5348; Weber, Kenneth/0000-0002-0916-9174; Paliwal, Monica/0000-0001-9022-8399	National Institute on Neurological Disorders and Stroke [K23NS104211]; National Institute of Neurological Disorders and Stroke; National Institute of Child Health and Human Development [K23NS104211, L30NS108301, R03HD094577, R01HD079076-01]; National Institute of Drug Abuse [K24DA029262]	National Institute on Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	Zachary A. Smith received funding from the National Institute on Neurological Disorders and Stroke (grant K23NS104211). Kenneth A. Weber II received funding from National Institute of Neurological Disorders and Stroke and National Institute of Child Health and Human Development (grants K23NS104211, L30NS108301 and R03HD094577). Andrew C. Smith received funding from National Institute of Child Health and Human Development (grant R03HD094577). Sean Mackey received funding from National Institute of Drug Abuse (grant K24DA029262). James M. Elliott received funding from National Institute of Child Health and Human Development (grants R01HD079076-01 and R03HD094577). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames CP, 2013, SPINE, V38, pS149, DOI 10.1097/BRS.0b013e3182a7f449; Azimi P, 2020, ASIAN SPINE J, V14, P543, DOI 10.31616/asj.2020.0147; Bakhsheshian J, 2017, GLOB SPINE J, V7, P572, DOI 10.1177/2192568217699208; Banaszek D, 2020, J NEUROTRAUM, V37, P839, DOI 10.1089/neu.2019.6581; Blomgren J, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2324-z; Bodine SC, 2013, INT J BIOCHEM CELL B, V45, P2200, DOI 10.1016/j.biocel.2013.06.011; Boyd-Clark LC, 2002, SPINE, V27, P694, DOI 10.1097/00007632-200204010-00005; Cloney M, 2018, J CLIN NEUROSCI, V57, P208, DOI 10.1016/j.jocn.2018.03.028; Cloney MB, 2018, SPINE, V43, P675, DOI 10.1097/BRS.0000000000002470; Colakoglu B, 2019, J INT MED RES, V47, P3590, DOI 10.1177/0300060519853430; Dulor JP, 1998, FEBS LETT, V439, P89, DOI 10.1016/S0014-5793(98)01216-2; Elliott J, 2006, SPINE, V31, pE847, DOI 10.1097/01.brs.0000240841.07050.34; Elliott JM, 2020, AM J EMERG MED, V38, P869, DOI 10.1016/j.ajem.2019.06.052; Elliott JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234061; Elliott JM, 2010, SPINE, V35, P948, DOI 10.1097/BRS.0b013e3181bb0e55; FLECKENSTEIN JL, 1993, RADIOLOGY, V187, P213, DOI 10.1148/radiology.187.1.8451416; Flexman AM, 2016, SPINE J, V16, P1315, DOI 10.1016/j.spinee.2016.06.017; FORBES GB, 1970, METABOLIS, V19, P653, DOI 10.1016/0026-0495(70)90062-4; Fortin M, 2016, EUR SPINE J, V25, P1452, DOI 10.1007/s00586-016-4503-7; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Gibson E, 2018, IEEE T MED IMAGING, V37, P1822, DOI 10.1109/TMI.2018.2806309; Gibson E, 2018, COMPUT METH PROG BIO, V158, P113, DOI 10.1016/j.cmpb.2018.01.025; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Hodges P, 2006, SPINE, V31, P2926, DOI 10.1097/01.brs.0000248453.51165.0b; Hopkins BS, 2019, WORLD NEUROSURG, V127, pE436, DOI 10.1016/j.wneu.2019.03.165; Hopkins BS, 2018, SPINE, V43, pE1204, DOI 10.1097/BRS.0000000000002667; Ichihara K, 2003, J NEUROSURG, V99, P278, DOI 10.3171/spi.2003.99.3.0278; Inose Hiroyuki, 2018, Osteoporos Sarcopenia, V4, P33, DOI 10.1016/j.afos.2018.02.003; Iyer S, 2016, SPINE, V41, P371, DOI 10.1097/BRS.0000000000001221; Kadanka Z, 2011, EUR SPINE J, V20, P1533, DOI 10.1007/s00586-011-1811-9; Kalsi-Ryan S, 2013, NEUROSCIENTIST, V19, P409, DOI 10.1177/1073858412467377; Karadimas SK, 2015, EUR SPINE J, V24, pS132, DOI 10.1007/s00586-014-3264-4; Khayatzadeh S, 2017, PHYS THER, V97, P756, DOI 10.1093/ptj/pzx040; Kong LD, 2013, EXP THER MED, V6, P852, DOI 10.3892/etm.2013.1224; Lansdown DA, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117718537; Liu HW, 2017, NEUROLOGY, V89, P602, DOI 10.1212/WNL.0000000000004197; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; MAYOUXBENHAMOU MA, 1994, SURG RADIOL ANAT, V16, P367, DOI 10.1007/BF01627655; Melis B, 2009, ORTHOP TRAUMATOL-SUR, V95, P319, DOI 10.1016/j.otsr.2009.05.001; Mohanty C, 2015, SPINE, V40, P11, DOI 10.1097/BRS.0000000000000670; Morley JE, 2016, WIEN KLIN WOCHENSCHR, V128, P439, DOI 10.1007/s00508-016-1087-5; Nagata K, 2014, SPINE J, V14, P2811, DOI 10.1016/j.spinee.2014.03.051; Nouri A, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.3.FOCUS1667; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; NURICK S, 1972, BRAIN, V95, P87; O'leary S, 2015, MUSCLE NERVE, V52, P772, DOI 10.1002/mus.24612; Paliwal M, 2020, WORLD NEUROSURG, V144, pE939, DOI 10.1016/j.wneu.2020.09.148; Park S, 2016, BONE JOINT J, V98B, P1093, DOI 10.1302/0301-620X.98B8.37623; Patil PG, 2005, NEUROSURGERY, V57, P753, DOI 10.1227/01.NEU.0000175729.79119.1d; Rhee J, 2017, GLOB SPINE J, V7, p35S, DOI 10.1177/2192568217703083; Shiban Ehab, 2014, Neurol Clin Pract, V4, P296, DOI 10.1212/CPJ.0000000000000050; Smith AC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68452-x; Smith Andrew C, 2015, Spinal Cord Ser Cases, V1; Smith ZA, 2020, WORLD NEUROSURG, V134, pE497, DOI 10.1016/j.wneu.2019.10.109; Storheim K, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1505-5; Suleiman LI, 2018, J CLIN NEUROSCI, V51, P57, DOI 10.1016/j.jocn.2018.02.023; Suvarnnato T, 2019, J PAIN RES, V12, P915, DOI 10.2147/JPR.S190125; Tetreault L, 2017, EUR SPINE J, V26, P78, DOI 10.1007/s00586-016-4660-8; Thakar S, 2019, ACTA NEUROCHIR, V161, P2201, DOI 10.1007/s00701-019-03972-8; Urrutia J, 2018, SKELETAL RADIOL, V47, P955, DOI 10.1007/s00256-018-2880-1; Valencia AP, 2018, AM J SPORT MED, V46, P2161, DOI 10.1177/0363546518769267; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Walton DM, 2018, J HAND THER, V31, P179, DOI 10.1016/j.jht.2017.12.008; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Weber KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44416-8; Wen CY, 2014, SPINE J, V14, P1493, DOI 10.1016/j.spinee.2013.08.052; Wilson JRF, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113491; Zhang JT, 2016, SPINAL CORD, V54, P1127, DOI 10.1038/sc.2016.64	70	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253863	10.1371/journal.pone.0253863	http://dx.doi.org/10.1371/journal.pone.0253863			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170961	Green Published, gold			2022-12-26	WOS:000671694400033
J	Lim, YJ; Lee, HN				Lim, Yu Jin; Lee, Han Na			Optimal use of radiotherapy in the definitive treatment of non-bulky IB-IIA cervical cancer: A population-based long-term survival analysis	PLOS ONE			English	Article							RADICAL HYSTERECTOMY; STAGE-IB; OUTCOMES; SURGERY; THERAPY; CARCINOMA; INCOME	Purpose Although current clinical guidelines recommend surgery or radiotherapy for non-bulky IB-IIA cervical cancer, clinical data supporting the curative role of radiotherapy in the early-stage disease are insufficient. We evaluated the prognostic implications of definitive radiotherapy and determined its optimal use in clinical practice. Methods Patients with non-bulky (<4 cm) IB-IIA cervical cancer who underwent hysterectomy or primary radiotherapy between 1988 and 2015 were identified from the Surveillance, Epidemiology, and End Results database. Based on the use of brachytherapy and/or chemotherapy, the primary radiotherapy group was classified into three cohorts: hysterectomy vs. radiotherapy overall, with/without brachytherapy and/or chemotherapy (cohort A); radiotherapy and brachytherapy with/without chemotherapy (patients with external beam radiation alone were excluded, cohort B); radiotherapy with brachytherapy and chemotherapy (patients who did not receive chemotherapy were additionally excluded, cohort C). Disease-specific survival (DSS) after hysterectomy was compared to that after primary radiotherapy in each cohort. Results Among the 9,391 initially identified patients, 1,762, 1,244, and 750 patients were classified into cohorts A, B, and C, respectively, after propensity score matching. In cohort A, DSS after primary radiotherapy was inferior to that after hysterectomy (P = 0.001). In cohort B, a trend toward differential survival in favor of hysterectomy was observed with marginal significance (P = 0.061). However, in cohort C, DSS after primary radiotherapy was not significantly different to that after hysterectomy (P = 0.127). According to hazard rate function plots, patients receiving external beam radiation alone had an increased short-term risk of disease-specific mortality, whereas patients without evidence of chemotherapy had a distinct late risk surge at approximately 15 years of follow-up. Conclusion Optimizing radiotherapy methods with brachytherapy and the use of chemotherapy should be considered for the long-term curative efficacy of primary radiotherapy for non-bulky IB-IIA cervical cancer. Further studies are warranted to corroborate our results.	[Lim, Yu Jin] Kyung Hee Univ, Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Lee, Han Na] Kyung Hee Univ, Kyung Hee Univ Hosp Gangdong, Dept Radiol, Coll Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital	Lim, YJ (corresponding author), Kyung Hee Univ, Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	yujindw@gmail.com			National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, Information and Communications Technology & Future Planning) [2021R1C1C1005297]	National Research Foundation of Korea (NRF) - Korean government (Ministry of Science, Information and Communications Technology & Future Planning)(National Research Foundation of Korea)	YJL received a National Research Foundation of Korea (NRF) grant funded by the Korean government (Ministry of Science, Information and Communications Technology & Future Planning) (2021R1C1C1005297). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque K, 2020, INT J RADIAT ONCOL, V106, P464, DOI 10.1016/j.ijrobp.2019.10.042; American Cancer Society, 2020, AM CANC SOC CANC FAC; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Bansal N, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.015; Brewster WR, 2001, OBSTET GYNECOL, V97, P248, DOI 10.1016/S0029-7844(00)01117-0; Canfell K, 2020, LANCET, V395, P591, DOI 10.1016/S0140-6736(20)30157-4; Doll KM, 2018, JAMA SURG, V153, P588, DOI 10.1001/jamasurg.2018.0501; Han K, 2013, INT J RADIAT ONCOL, V87, P111, DOI 10.1016/j.ijrobp.2013.05.033; International Agency for Research on Cancer, 2020, CANC FACT SHEETS WOR; Kagei K, 2003, INT J RADIAT ONCOL, V55, P1265, DOI 10.1016/S0360-3016(02)04075-0; Kim WY, 2011, GYNECOL OBSTET INVES, V71, P19, DOI 10.1159/000320722; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Landoni F, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e34; LaVigne AW, 2017, GYNECOL ONCOL REP, V22, P16, DOI 10.1016/j.gore.2017.08.004; Liu P, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6651-8; Mahmoud O, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.102; Mazzola R, 2017, TECHNOL CANCER RES T, V16, P310, DOI 10.1177/1533034616655055; National Cancer Institute, 2021, SAMPL SEER RES DAT U; National Cancer Institute, 2021, SEER STAT SOFTW; National Cancer Institute, 2021, DOC SEER DAT; National Comprehensive Cancer Network`, 2021, NCCN CLIN PRACTICE G, DOI 10.6004/jnccn.2009.0057; Park JY, 2012, J GYNECOL ONCOL, V23, P226, DOI 10.3802/jgo.2012.23.4.226; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tewari KS, 2019, J CLIN ONCOL, V37, P2472, DOI 10.1200/JCO.18.02303; Wu SG, 2017, CANCER MANAG RES, V9, P813, DOI 10.2147/CMAR.S145926; Yamashita H, 2005, GYNECOL ONCOL, V97, P834, DOI 10.1016/j.ygyno.2005.03.017; Yan RN, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018738	28	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253649	10.1371/journal.pone.0253649	http://dx.doi.org/10.1371/journal.pone.0253649			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166433	Green Published, gold			2022-12-26	WOS:000671692800069
J	Gopichandran, V; Sakthivel, K				Gopichandran, Vijayaprasad; Sakthivel, Kalirajan			Doctor-patient communication and trust in doctors during COVID 19 times-A cross sectional study in Chennai, India	PLOS ONE			English	Article								Background The COVID 19 pandemic created a global public health crisis. Physical distancing, masks, personal protective equipment worn by the doctors created difficulties in effective doctor-patient communication. Objectives This study was conducted to assess the difficulties faced by patients in communicating with their doctors due to the COVID 19 preventive measures, and its impact on the trust on their doctors. Methods A cross sectional study of 359 persons attending a tertiary care center in Chennai, sampled in a non-probabilistic manner selected from the outpatient department, wards, and isolation facilities, was conducted using a questionnaire containing items covering three dimensions namely difficulties faced in accessing the health facility, difficulties in doctor-patient communication and trust in the doctors. The data were collected using Google Forms and analyzed using GNU PSPP open-source statistical software version 1.4.0. Results More than 60% of the participants complained of difficulty in accessing the health facility. More than 60% had difficulties in communicating with the doctors. There was a high level of trust in doctors among more than 80% of the participants. Comparison of the mean scores revealed that accessibility was a problem across ages, sexes, education and occupation groups. Communication barriers decreased with age and increased with education, but trust increased with age, but reduced with increasing education. Multivariable linear regression analysis revealed that difficulties in communication had a negative impact on trust (beta = -0.63, p<0.001) and increasing education had a negative impact on trust (beta = -0.42, p = 0.034). Conclusions The COVID 19 pandemic and the preventive strategies such as lock-down, physical distancing, face mask and personal protective equipment created barriers to effective doctor patient communication and led to some compromise in trust in doctors during this time.	[Gopichandran, Vijayaprasad] ESIC Med Coll & PGIMSR, Dept Community Med, Chennai, Tamil Nadu, India; [Sakthivel, Kalirajan] ESIC Med Coll & PGIMSR, Chennai, Tamil Nadu, India		Gopichandran, V (corresponding author), ESIC Med Coll & PGIMSR, Dept Community Med, Chennai, Tamil Nadu, India.	vijay.gopichandran@gmail.com		Gopichandran, Vijayaprasad/0000-0003-2635-9583				Baidya M, 2014, J POSTGRAD MED, V60, P21, DOI 10.4103/0022-3859.128802; Fayehun F., 2020, COVID 19 LOCKDOWNS A; Free Software Foundation, 2020, GNU PSPP; Gopichandran Vijayaprasad, 2020, Indian J Med Ethics, VV, P1, DOI [10.20529/IJME.2020.77, 10.20529/IJME.2020.053, 10.20529/IJME.2020.026]; Gopichandran V, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004115; Gopichandran V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069170; Karlsson U, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3944; Khullar D, 2020, JAMA-J AM MED ASSOC, V324, P2359, DOI 10.1001/jama.2020.12938; Kumar A, 2020, ADV INTELL SYST COMP, V1069, P1, DOI [10.1007/978-3-030-32520-6_1, 10.1016/j.puhip.2020.100009]; Ministry of Health and Family Welfare, 2020, NOV COR DIS 2019 COV, DOI [10.1111/cup.13867, DOI 10.1111/CUP.13867]; Montgomery T, 2020, JAMA-J AM MED ASSOC, V324, P2365, DOI 10.1001/jama.2020.18368; Nwoga H.O., 2020, INT J COMMUNITY MED, V7, P4690, DOI [10.18203/2394-6040.ijcmph20205136, DOI 10.18203/2394-6040.IJCMPH20205136]; Philip M, 2021, J HUM DEV CAPABIL, V22, P27, DOI 10.1080/19452829.2020.1863026; Pollard CA, 2020, PHYSIOL GENOMICS, V52, P549, DOI 10.1152/physiolgenomics.00089.2020; Prinja Shankar, 2012, Indian J Community Med, V37, P142, DOI 10.4103/0970-0218.99907; Ruckmini S., 2020, THE GUARDIAN; Samarasekara K, 2021, POSTGRAD MED J, V97, P406, DOI 10.1136/postgradmedj-2020-138444; Sturmey G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1814; WHO Headquarters, 2020, PULS SURV CONT ESS H; Worldometers, 2021, COR CAS IND; Yadav UN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00508	21	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253497	10.1371/journal.pone.0253497	http://dx.doi.org/10.1371/journal.pone.0253497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161383	Green Published, gold			2022-12-26	WOS:000671691900046
J	Maroko, AR; Hopper, K; Gruer, C; Jaffe, M; Zhen, E; Sommer, M				Maroko, Andrew R.; Hopper, Kim; Gruer, Caitlin; Jaffe, Maayan; Zhen, Erica; Sommer, Marni			Public restrooms, periods, and people experiencing homelessness: An assessment of public toilets in high needs areas of Manhattan, New York	PLOS ONE			English	Article							ENVIRONMENTAL JUSTICE; ACCESS; MANAGEMENT; HYGIENE; PARKS; CARE	Access to safe, clean water and sanitation is globally recognized as essential for public health. Public toilets should be accessible to all members of a society, without social or physical barriers preventing usage. A public toilet facility's design and upkeep should offer privacy and safety, ensure cleanliness, provide required sanitation-related resources, and be gender equitable, including enabling comfortable and safe management of menstruation. Menstrual hygiene management (MHM) refers to the need to ensure that girls, women and all people who menstruate have access to clean menstrual products, privacy to change the materials as often as needed, soap and water for washing the body as required, and access to facilities to dispose of used materials. Challenges around menstruation faced by people experiencing homelessness, which tend to be greater than those facing the general population, include inadequate toilet and bathing facilities, affordability issues around menstrual products, and menstrual stigma. Public toilets are a vital resource for managing menstruation, particularly for vulnerable populations without reliable access to private, safe, and clean spaces and menstrual products. This mixed-methods study sought to: 1) understand the lived experiences of MHM among people experiencing homelessness in New York City with respect to public toilets; 2) describe general and MHM-related characteristics of public toilets in high need areas of Manhattan and analyze their interrelationships; and 3) examine the associations among neighborhood-level demographics and the public toilet characteristics in those areas. Qualitative methods included key informant interviews (n = 15) and in-depth interviews (n = 22) with people with experience living on the street or in shelters, which were analyzed using Malterud's 'systematic text condensation' for thematic cross-case analysis. Quantitative methods included audits and analyses of public toilet facilities (n = 25) using traditional statistics (e.g., Spearman's correlations) and spatial analyses (e.g., proximity buffers). Qualitative findings suggest cleanliness, access to restrooms, and availability of resources are critical issues for the participants or prospective users. Quantitative analyses revealed insufficiently provided, maintained, and resourced public toilets for managing menstruation in high-needs areas. Findings also suggest that toilets with more MHM-related resource availability, such as menstrual products and toilet stall disposal bins, were more difficult to access. Neighborhood-level characteristics showed a potential environmental injustice, as areas characterized by higher socioeconomic status are associated with more access to MHM-specific resources in public restrooms, as well as better overall quality.	[Maroko, Andrew R.; Zhen, Erica] CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Environm Occupat & Geospatial Hlth Sci, New York, NY 10021 USA; [Hopper, Kim; Gruer, Caitlin; Jaffe, Maayan; Sommer, Marni] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA	City University of New York (CUNY) System; Columbia University	Maroko, AR (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, Dept Environm Occupat & Geospatial Hlth Sci, New York, NY 10021 USA.	andrew.maroko@sph.cuny.edu		Maroko, Andrew/0000-0002-9398-2386	Sid and Helaine Lerner MHM Faculty Support Fund	Sid and Helaine Lerner MHM Faculty Support Fund	MS is supported by "The Sid and Helaine Lerner MHM Faculty Support Fund." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie LC, 2008, AM J PREV MED, V34, P9, DOI 10.1016/j.amepre.2007.09.030; Anguelovski I, 2019, P NATL ACAD SCI USA, V116, P26139, DOI 10.1073/pnas.1920490117; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Capone D, 2020, AM J PUBLIC HEALTH, V110, P1567, DOI 10.2105/AJPH.2020.305833; Coalition for the Homeless, 2019, FACTS HOM FACTS HOM; Cowan J., 2019, NEW YORK TIMES; Durfor, 2015, PERSONAL HYGIENE SEL; Eicher C. L., 2001, CARTOGR GEOGR INF SC, V28, P125, DOI [10.1559/152304001782173727, DOI 10.1559/152304001782173727]; Ensign J, 2008, WOMEN HLTH, P0242; Garvin E, 2013, J URBAN HEALTH, V90, P412, DOI 10.1007/s11524-012-9782-7; Ginsburg ZA., 2018, J COMMUNITY HLTH; Girod C, 2017, J URBAN HEALTH, V94, P835, DOI 10.1007/s11524-017-0189-3; Greed C, 2016, TOWN PLAN REV, V87, P505, DOI 10.3828/tpr.2016.35; Hajat A, 2013, ENVIRON HEALTH PERSP, V121, P1325, DOI 10.1289/ehp.1206337; Houston Avril M, 2006, J Pediatr Adolesc Gynecol, V19, P271, DOI 10.1016/j.jpag.2006.05.002; Hutton G., 2017, WATER SUPPLY SANITAT; Johnston-Robledo I, 2013, SEX ROLES, V68, P9, DOI 10.1007/s11199-011-0052-z; Kuhlmann AS, 2019, OBSTET GYNECOL, V133, P238, DOI 10.1097/AOG.0000000000003060; Levit R., 2017, WAITING MENSTRUATION; Littke H., 2016, J URBANISM INT RES P, V9, P353; Lucan SC, 2015, APPETITE, V90, P23, DOI 10.1016/j.appet.2015.02.034; Maantay JA, 2013, CITIES ENV CATE, V1; Maantay J, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/115003; Maroko A., 2019, PAP APPL GEOGR, P1; Maroko AR, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.180344; Maroko AR, 2012, APPL GEOGR, V34, P533, DOI 10.1016/j.apgeog.2012.02.005; McLaughlin CG, 2002, HEALTH SERV RES, V37, P1441, DOI 10.1111/1475-6773.12171; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; McNamara N, 2019, PATCH; Mennis J, 2003, PROF GEOGR, V55, P31; Mennis J., 2006, CARTOGR GEOGR INF SC, V33, P179, DOI [10.1559/152304006779077309, DOI 10.1559/152304006779077309]; Morello-Frosch R, 2001, URBAN AFF REV, V36, P551, DOI 10.1177/10780870122184993; Newman A., 2019, NEW YORK TIMES; NYC Department of Homeless Services, 2019, STATS REP STATS REP; NYC Department of Homeless Services, HOPE 2020 HOPE 2020; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Rigolon A, 2016, LANDSCAPE URBAN PLAN, V153, P160, DOI 10.1016/j.landurbplan.2016.05.017; Ruggles S., 2019, DATABASE; Schmitt ML, 2018, WATER-SUI, V10, DOI 10.3390/w10091193; Schoep ME, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026186; Sommer M, 2020, HEALTH PLACE, V66, DOI 10.1016/j.healthplace.2020.102431; Sommer M, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0379-8; Sommer M, 2013, AM J PUBLIC HEALTH, V103, P1556, DOI 10.2105/AJPH.2013.301374; Stanwell-Smith R, 2010, PUBLIC HEALTH, V124, P613, DOI 10.1016/j.puhe.2010.07.002; Starfield B, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-15; Street P, 2019, P AHFE 2019 INT C HU, V966, P87; UNICEF, 2018, FAST FACTS 9 THINGS; UNICEF WaterAid and WSUP., 2018, FEM FRIENDL PUBL COM; van Doorslaer E, 2000, J HEALTH ECON, V19, P553, DOI 10.1016/S0167-6296(00)00050-3; Venkatapuram Sridhar, 2010, Health Hum Rights, V12, P3; Viola D, 2013, J PUBLIC HEALTH POL, V34, P424, DOI 10.1057/jphp.2013.19	52	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252946	10.1371/journal.pone.0252946	http://dx.doi.org/10.1371/journal.pone.0252946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161351	Green Published, gold			2022-12-26	WOS:000671691900049
J	Al Awaji, NN; Almudaiheem, AA; Mortada, EM				Al Awaji, Nisreen Naser; Almudaiheem, Alanoud A.; Mortada, Eman M.			Assessment of caregivers' perspectives regarding speech-language services in Saudi Arabia during COVID-19	PLOS ONE			English	Article							TELEHEALTH; CHILDREN; CHALLENGES; THERAPY; PATHOLOGISTS; TECHNOLOGY; DISORDERS; BARRIERS	Background As a consequence of stay-at-home and other lockdown measures, such as social distancing, all health care service provisions during the COVID-19 pandemic have been affected, including the provision of speech therapy. Telehealth services can play a major role in maintaining access to health care, help speech and language pathologists (SLPs) overcome physical barriers by providing patients and caregivers with access to health care, and limit the discontinuity of patient care. To have a better understanding of the changes that have occurred in these services during COVID-19, this research was conducted to explore the nature and current situation of speech-language services in Saudi Arabia based on caregivers' perspectives. It also investigated whether changes have occurred in these services during the COVID-19 lockdown. The study also determined the perception of caregivers in delivering SLS sessions remotely. Method A cross-sectional study was conducted with 385 caregivers in Saudi Arabia. An online survey asked whether children were experiencing any SLS problems and if they had received any intervention. The survey also assessed the perception of changes in service during the COVID-19 lockdown and the perceptions, acceptance, and willingness of the caregivers to deliver telehealth speech services in Saudi Arabia. Results About 50% of the respondents had or were suspected to have a child with SLS problems, and just over half of them had accessed SLS services. Most of the respondents reported suspension of therapy sessions as a response to the COVID-19 pandemic. While the respondents had little experience using telehealth prior to the pandemic, they generally showed a willingness to use telehealth in therapy sessions, expressing a preference for video calls over other options. Conclusion The study revealed that SLS services in Saudi Arabia are limited and that accessing these services is challenging. Alternative service delivery using remote services could help caregivers overcome such challenges. When telehealth was introduced as an option for service delivery, the caregivers showed welcoming responses, particularly with video calls.	[Al Awaji, Nisreen Naser] Princess Nourah Bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Dept Hlth Commun Sci, Riyadh, Saudi Arabia; [Almudaiheem, Alanoud A.] King Abdullah Specialized Children Hosp King Abdu, Riyadh, Saudi Arabia; [Mortada, Eman M.] Princess Nourah Bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Hlth Sci Dept, Riyadh, Saudi Arabia; [Mortada, Eman M.] Zagazig Univ, Fac Med, Community Environm & Occupat Med Dept, Zagazig, Egypt	Princess Nourah bint Abdulrahman University; Princess Nourah bint Abdulrahman University; Egyptian Knowledge Bank (EKB); Zagazig University	Al Awaji, NN (corresponding author), Princess Nourah Bint Abdulrahman Univ, Coll Hlth & Rehabil Sci, Dept Hlth Commun Sci, Riyadh, Saudi Arabia.	Nnalawaji@pnu.edu.sa	Awaji, Nisreen Al/ADA-1296-2022; Mortada, Eman/AAP-4354-2020	Mortada, Eman/0000-0002-8660-4299; Al Awaji, Nisreen/0000-0002-1853-0398				Alaboudi A, 2016, J INFECT PUBLIC HEAL, V9, P725, DOI 10.1016/j.jiph.2016.09.001; Alanazi AA, 2017, INT J HEALTH SCI-IJH, V11, P43; Alquraini T, 2010, INT J SPEC EDUC, V25, P139; Alshahrani A, 2019, INT J MED INFORM, V128, P7, DOI 10.1016/j.ijmedinf.2019.05.007; American Speech-Language-Hearing Association, 2008, SPEECH LANGUAGE DISO; American Speech-Language-Hearing Association, 2005, ASHA SPEECH LANG PAT ASHA SPEECH LANG PAT; Ashburner J, 2016, RES AUTISM SPECT DIS, V23, P1, DOI 10.1016/j.rasd.2015.11.011; Baker E, 2011, LANG SPEECH HEAR SER, V42, P140, DOI 10.1044/0161-1461(2010/10-0023); Bashshur R, 2020, TELEMED E-HEALTH, V26, P571, DOI 10.1089/tmj.2020.29040.rb; Brobst JB, 2009, FOCUS AUTISM DEV DIS, V24, P38, DOI 10.1177/1088357608323699; Cole B, 2019, INT J TELEREHABILITA, V11, P33, DOI 10.5195/ijt.2019.6273; Cole B, 2016, INT J TELEREHABILITA, V8, P77, DOI 10.5195/ijt.2016.6206; Crowe Hall B.J., 1991, LANG SPEECH HEAR SER, V22, P334, DOI DOI 10.1044/0161-1461.2201.334; Demiris G, 2005, INT J MED INFORM, V74, P851, DOI 10.1016/j.ijmedinf.2005.03.018; Dew A, 2013, DISABIL REHABIL, V35, P1564, DOI 10.3109/09638288.2012.720346; Dunkley C, 2010, INT J SPEECH-LANG PA, V12, P333, DOI 10.3109/17549500903456607; Fairweather GC, 2016, INT J SPEECH-LANG PA, V18, P592, DOI 10.3109/17549507.2016.1143973; General Authority for Statistics, 2016, DEM SURV 2016, P207; Hill A, 2002, J TELEMED TELECARE, V8, P187, DOI 10.1258/135763302320272158; Hines M, 2015, J TELEMED TELECARE, V21, P469, DOI 10.1177/1357633X15604555; Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1106; Jazieh A.R, 2020, FRONT MED, V7, P1, DOI [10.1007/s11684-013-0241-y, DOI 10.1007/S11684-013-0241-Y]; Keck CS, 2014, TELEMED E-HEALTH, V20, P653, DOI 10.1089/tmj.2013.0295; Khoja MA, 2018, INT J SPEECH-LANG PA, V20, P103, DOI 10.1080/17549507.2018.1428686; Law J, 2000, BRIT MED J, V321, P908, DOI 10.1136/bmj.321.7266.908; Law J, 2004, J SPEECH LANG HEAR R, V47, P924, DOI 10.1044/1092-4388(2004/069); Law J, 1998, Int J Lang Commun Disord, V33 Suppl, P21; Mashima Pauline A, 2008, Telemed J E Health, V14, P1101, DOI 10.1089/tmj.2008.0080; May J., 2014, J CLIN PRACT SPEECH, V16, P147; McLeod S, 2009, J SPEECH LANG HEAR R, V52, P1213, DOI 10.1044/1092-4388(2009/08-0085); Milaat WA, 2001, DISABIL REHABIL, V23, P199; of Education U. D, 2004, INDIVIDUALS DISABILI; Persson M, 2015, ORTHOD CRANIOFAC RES, V18, P1, DOI 10.1111/ocr.12104; Pettinari CJ, 2001, J ADV NURS, V36, P668, DOI 10.1046/j.1365-2648.2001.02031.x; Rashid Hassan, 2020, TELEMEDICINE RISE SA; Review B, 2008, BERCOW REV DCSF, V2008; Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001; Wainer AL, 2015, J AUTISM DEV DISORD, V45, P3877, DOI 10.1007/s10803-014-2186-7; Wallisch A, 2019, INT J TELEREHABILITA, V11, P15, DOI 10.5195/ijt.2019.6274; Yang Y, 2020, CLIN ORAL INVEST, V24, P1861, DOI 10.1007/s00784-020-03267-8	40	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253441	10.1371/journal.pone.0253441	http://dx.doi.org/10.1371/journal.pone.0253441			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157033	Green Published, gold			2022-12-26	WOS:000671691200027
J	Ito, M; Yamaguchi, M; Katsuno, T; Nobata, H; Iwagaitsu, S; Sugiyama, H; Kinashi, H; Banno, S; Ando, M; Kubo, Y; Ishimoto, T; Ito, Y				Ito, Mayumi; Yamaguchi, Makoto; Katsuno, Takayuki; Nobata, Hironobu; Iwagaitsu, Shiho; Sugiyama, Hirokazu; Kinashi, Hiroshi; Banno, Shogo; Ando, Masahiko; Kubo, Yoko; Ishimoto, Takuji; Ito, Yasuhiko			Association between serum magnesium levels and abdominal aorta calcification in patients with pre-dialysis chronic kidney disease stage 5	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; VASCULAR CALCIFICATION; ARTERIAL CALCIFICATION; CARDIOVASCULAR-DISEASE; RENAL-DISEASE; MORTALITY; CALCIUM; QUANTIFICATION; HYPOMAGNESEMIA; PREDICTOR	Background Several studies have revealed the relationship between serum magnesium levels and vascular calcification in chronic kidney disease patients. Despite excellent predictability of abdominal aorta calcification for cardiovascular disease events, the relationship between serum magnesium levels and abdominal aorta calcification, as evaluated by quantitative methods, in pre-dialysis patients remains unclear. This study aimed to determine the abdominal aorta calcification volume using computerized tomography and its association with serum magnesium levels in pre-dialysis chronic kidney disease stage 5 patients. Methods This single-center cross-sectional study included 100 consecutive patients with pre-dialysis chronic kidney disease stage 5 between January 2016 and May 2020 at Aichi Medical University Hospital, Japan. The relationships between serum magnesium levels and the abdominal aorta calcification volume were assessed using multiple linear regression models after adjusting for clinically relevant factors. We also assessed clinical factors that affect serum magnesium levels. Results The mean serum magnesium level was 2.0 mg/dL (interquartile range, 1.8 to 2.3). Multivariate analyses revealed that a higher serum magnesium level (stand. beta = -0.245, p = 0.010) was significantly associated with a reduced abdominal aorta calcification volume, and that a history of cardiovascular disease (stand. beta = 0.3792, p < 0.001) and older age (stand. beta = 0.278, p = 0.007) were significantly associated with an increased abdominal aorta calcification volume. Moreover, multivariate analysis showed that the use of proton pump inhibitor or potassium-competitive acid blocker was significantly associated with lower serum magnesium levels (stand. beta = -0.246, p = 0.019). Conclusions The present study revealed that the higher Mg level was significantly associated with lower volume of abdominal aorta calcification in pre-dialysis chronic kidney disease stage 5 patients. Further studies should be undertaken to determine the appropriate magnesium level to suppress vascular calcification.	[Ito, Mayumi; Yamaguchi, Makoto; Katsuno, Takayuki; Nobata, Hironobu; Iwagaitsu, Shiho; Sugiyama, Hirokazu; Kinashi, Hiroshi; Banno, Shogo; Ito, Yasuhiko] Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Data Coordinating Ctr, Dept Adv Med, Nagoya, Aichi, Japan; [Kubo, Yoko] Nagoya Univ, Dept Prevent Med, Grad Sch Med, Nagoya, Aichi, Japan; [Ishimoto, Takuji] Nagoya Univ, Dept Nephrol & Renal Replacement Therapy, Grad Sch Med, Nagoya, Aichi, Japan	Aichi Medical University; Nagoya University; Nagoya University; Nagoya University	Ito, Y (corresponding author), Aichi Med Univ, Dept Nephrol & Rheumatol, Nagakute, Aichi, Japan.	yasuito@aichi-med-u.ac.jp	Ishimoto, Takuji/M-4873-2014	Ishimoto, Takuji/0000-0002-9861-5331; ito, mayumi/0000-0002-2966-157X				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alexopoulos N, 2009, NAT REV CARDIOL, V6, P681, DOI 10.1038/nrcardio.2009.165; An C, 2014, EUR RADIOL, V24, P2491, DOI 10.1007/s00330-014-3298-3; Bai YL, 2015, BIOMED REP, V3, P593, DOI 10.3892/br.2015.473; Budoff MJ, 2011, ATHEROSCLEROSIS, V215, P196, DOI 10.1016/j.atherosclerosis.2010.11.017; Chang JR, 2020, PEPTIDES, V123, DOI 10.1016/j.peptides.2019.170181; Cunningham J, 2012, CLIN KIDNEY J, V5, P39, DOI 10.1093/ndtplus/sfr166; de Weert TT, 2009, AM J NEURORADIOL, V30, P177, DOI 10.3174/ajnr.A1301; Disthabanchong S, 2018, INT J NEPHROL, V2018, DOI 10.1155/2018/3162806; Fein Paula, 2014, Adv Perit Dial, V30, P90; Floege J, 2020, J NEPHROL, V33, P497, DOI 10.1007/s40620-019-00689-w; Foley RN, 1998, J NEPHROL, V11, P239; Forbang NI, 2016, ATHEROSCLEROSIS, V255, P54, DOI 10.1016/j.atherosclerosis.2016.10.036; Golledge J, 2014, CURR PHARM DESIGN, V20, P5834, DOI 10.2174/1381612820666140212195309; Horl WH., 2008, CLIN J AM SOC NEPHRO, V3, P1599, DOI [10.2215/CJN.02120508, DOI 10.2215/CJN.02120508]; Isaka Y, 2021, J AM SOC NEPHROL, V32, P723, DOI 10.1681/ASN.2020050598; Ishimura E, 2007, CLIN NEPHROL, V68, P222; Ishimura E, 2007, MAGNESIUM RES, V20, P237, DOI 10.1684/mrh.2007.0116; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kircelli F, 2012, NEPHROL DIAL TRANSPL, V27, P514, DOI 10.1093/ndt/gfr321; Lacson E, 2015, AM J KIDNEY DIS, V66, P1056, DOI 10.1053/j.ajkd.2015.06.014; Leow K, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.017205; Li L, 2015, AM J KIDNEY DIS, V66, P1047, DOI 10.1053/j.ajkd.2015.05.024; Li XJ, 2021, J CARDIOVASC TRANSL, V14, P525, DOI 10.1007/s12265-020-10081-w; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Louvet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115342; Louvet L, 2013, NEPHROL DIAL TRANSPL, V28, P869, DOI 10.1093/ndt/gfs520; Mikolasevic I, 2016, EUR J INTERN MED, V30, P99, DOI 10.1016/j.ejim.2016.01.026; Mokas S, 2016, KIDNEY INT, V90, P598, DOI 10.1016/j.kint.2016.05.020; Molnar AO, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0549-y; de Oca AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089525; Montezano AC, 2010, HYPERTENSION, V56, P453, DOI 10.1161/HYPERTENSIONAHA.110.152058; Mori S, 2015, ATHEROSCLEROSIS, V239, P622, DOI 10.1016/j.atherosclerosis.2014.12.041; Nakashima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143656; NasrAllah MM, 2016, INT J CARDIOL, V220, P884, DOI 10.1016/j.ijcard.2016.06.064; Nitta K, 2015, CONTRIB NEPHROL, V185, P156, DOI 10.1159/000380980; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rocha-Singh KJ, 2014, CATHETER CARDIO INTE, V83, pE212, DOI 10.1002/ccd.25387; Sakaguchi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163673; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Tatami Y, 2015, ATHEROSCLEROSIS, V243, P349, DOI 10.1016/j.atherosclerosis.2015.10.016; ter Braake AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20241-3; ter Braake AD, 2017, ARTERIOSCL THROM VAS, V37, P1431, DOI 10.1161/ATVBAHA.117.309182; Vervloet M, 2017, KIDNEY INT, V91, P808, DOI 10.1016/j.kint.2016.09.024; Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529; Xu JS, 2015, EXP THER MED, V9, P1028, DOI 10.3892/etm.2015.2215	48	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253592	10.1371/journal.pone.0253592	http://dx.doi.org/10.1371/journal.pone.0253592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143857	Green Published, gold			2022-12-26	WOS:000671690700008
J	Joannes, C; Castagne, R; Lepage, B; Delpierre, C; Kelly-Irving, M				Joannes, Camille; Castagne, Raphaele; Lepage, Benoit; Delpierre, Cyrille; Kelly-Irving, Michelle			Could teacher-perceived parental interest be an important factor in understanding how education relates to later physiological health? A life course approach	PLOS ONE			English	Article							ALLOSTATIC LOAD; SOCIOECONOMIC POSITION; ACADEMIC-ACHIEVEMENT; MIDLIFE FINDINGS; INVOLVEMENT; CHILDHOOD; RISK; MECHANISMS; MAGNITUDE; MACARTHUR	Education is associated with later health, and notably with an indicator of physiological health measuring the cost of adapting to stressful conditions, named allostatic load. Education is itself the result of a number of upstream variables. We examined the origins of educational attainment through the lens of interactions between families and school i.e. parents' interest in their child's education as perceived by teachers. This study aims to examine whether parental interest during a child's educational trajectory is associated with subsequent allostatic load, and whether education or other pathways mediate this relationship. We used data from 9 377 women and men born in 1958 in Great Britain and included in the National Child Development Study to conduct secondary data analyses. Parental interest was measured from questionnaire responses by teachers collected at age 7, 11 and 16. Allostatic load was defined using 14 biomarkers assayed in blood from a biosample collected at 44 years of age. Linear regression analyses were carried out on a sample of 8 113 participants with complete data for allostatic load, missing data were imputed. Participants whose parents were considered to be uninterested in their education by their teacher had a higher allostatic load on average in midlife in both men (beta = 0,41 [0,29; 0,54]) and women (beta = 0,69 [0,54; 0,83]). We examined the role of the educational and other pathways including psychosocial, material/financial, and behavioral variables, as potential mediators in the relationship between parental interest and allostatic load. The direct link between parental interest and allostatic load was completely mediated in men, but only partially mediated in women. This work provides evidence that parents' interest in their child's education as perceived by teachers is associated with subsequent physiological health in mid-life and may highlight a form of cultural dissonance between family and educational spheres.	[Joannes, Camille; Castagne, Raphaele; Lepage, Benoit; Delpierre, Cyrille; Kelly-Irving, Michelle] Univ Toulouse, Univ Paul Sabatier, INSERM, Equ Res Team,CERPOP, Toulouse, France; [Lepage, Benoit] CHU Toulouse, Dept Epidemiol, Toulouse, France; [Kelly-Irving, Michelle] Univ Toulouse III Paul Sabatier, Interdisciplinary Fed Res Inst Hlth & Soc IFERISS, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Joannes, C (corresponding author), Univ Toulouse, Univ Paul Sabatier, INSERM, Equ Res Team,CERPOP, Toulouse, France.	camille.joannes@univ-tlse3.fr	Lepage, Benoit/AAD-6193-2021; Kelly Irving, Michelle/AAA-5052-2022	Kelly Irving, Michelle/0000-0001-5749-4791; Joannes, Camille/0000-0002-7077-9035; delpierre, cyrille/0000-0002-0831-080X	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [856478]; Institut National du Cancer & the Institut de recherche en sante publique is [INCA-CA-2019-204]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Institut National du Cancer & the Institut de recherche en sante publique is	MKI received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. [856478]). CJ received funding from the Institut National du Cancer & the Institut de recherche en sante publique is (grant No. INCA-CA-2019-204).	Abel T, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.066159; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Solis CB, 2016, SOC SCI MED, V165, P19, DOI 10.1016/j.socscimed.2016.07.031; Bernard L., 1995, TABLEAUX FAMILLES HE; Bourdieu P, 2001, SOCIOLOGY OF ECONOMIC LIFE, SECOND EDITION, P96; Bourdieu P., 1964, HERITIERS ETUD CULT, P9; Bourdieu P., 1979, INHERITORS FRENCH ST; Breinholt A, 2020, BRIT J SOCIOL, V71, P28, DOI 10.1111/1468-4446.12711; Brunner E., 1999, SOCIAL DETERMINANTS, P17; Castagne R, 2018, EUR J EPIDEMIOL, V33, P441, DOI 10.1007/s10654-018-0364-1; Causadias J., 2018, HDB CULTURE BIOL, DOI [10.1002/9781119181361, DOI 10.1002/9781119181361]; Collins P.H., 2000, BLACK FEMINIST THOUG, DOI DOI 10.4324/9780429500480-5; Delpierre C, 2016, LONGITUD LIFE COURSE, V7, P79, DOI 10.14301/llcs.v7i1.325; Doane LD., 2017, HDB CULT BIOL INTERP, P227, DOI [10.1002/9781119181361.ch10, DOI 10.1002/9781119181361.CH10]; Dumais SA, 2006, POETICS, V34, P83, DOI 10.1016/j.poetic.2005.09.003; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Fan XT, 2001, EDUC PSYCHOL REV, V13, P1, DOI 10.1023/A:1009048817385; Flouri E, 2006, BRIT J EDUC PSYCHOL, V76, P41, DOI 10.1348/000709905X52508; Flouri E, 2004, BRIT J EDUC PSYCHOL, V74, P141, DOI 10.1348/000709904773839806; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Gruenewald TL, 2012, SOC SCI MED, V74, P75, DOI 10.1016/j.socscimed.2011.09.037; Hamdi NR, 2016, BRAIN BEHAV IMMUN, V56, P221, DOI 10.1016/j.bbi.2016.01.014; Hango D, 2007, SOC SCI RES, V36, P1371, DOI 10.1016/j.ssresearch.2007.01.005; Hertzman C, 2001, SOC SCI MED, V53, P1575, DOI 10.1016/S0277-9536(00)00437-8; Hill NE, 2009, DEV PSYCHOL, V45, P740, DOI 10.1037/a0015362; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Krieger N, 2005, J EPIDEMIOL COMMUN H, V59, P350, DOI 10.1136/jech.2004.024562; Krieger N, 2020, ANNU REV PUBL HEALTH, V41, P37, DOI 10.1146/annurev-publhealth-040119-094017; Kubzansky LD, 1999, ANN BEHAV MED, V21, P330, DOI 10.1007/BF02895966; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lareau A., HOME ADVANTAGE SOCIA, P1989; Mackenbach JP, 2017, HEALTH PLACE, V47, P44, DOI 10.1016/j.healthplace.2017.07.005; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Meloni M, 2017, PALGRAVE HDB BIOL SO, P519, DOI [DOI 10.1057/978-1-137-52879-7_22, 10.1057/978-1-137-52879-7_22]; Mensah FK, 2008, J EPIDEMIOL COMMUN H, V62, P599, DOI 10.1136/jech.2007.065706; Mirowsky J, 1998, RES AGING, V20, P415, DOI 10.1177/0164027598204003; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C., 1999, DEV HLTH WEALTH NATI, P47; Robertson T, 2015, BRAIN BEHAV IMMUN, V45, P41, DOI 10.1016/j.bbi.2014.10.005; Robertson T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-184; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Sacker A, 2002, SOC SCI MED, V55, P863, DOI 10.1016/S0277-9536(01)00228-3; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Serre D., 2012, ACTES RECHERCHE SCI, V191-192, P4, DOI [DOI 10.3917/ARSS.191.0004, 10.3917/arss.191.0004]; Solis CB, 2016, PSYCHONEUROENDOCRINO, V74, P24, DOI 10.1016/j.psyneuen.2016.08.018; Sterling P, 2012, PHYSIOL BEHAV, V106, P5, DOI 10.1016/j.physbeh.2011.06.004; SuiChu EH, 1996, SOCIOL EDUC, V69, P126, DOI 10.2307/2112802; Thin D., 2006, REV BRAS EDUC; Thomas C, 2008, PEDIATRICS, V121, pE1240, DOI 10.1542/peds.2007-2403; VanderWeele TJ, 2009, STAT INTERFACE, V2, P457; Westerlund H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1977-x; Westerlund H, 2013, J EPIDEMIOL COMMUN H, V67, P508, DOI 10.1136/jech-2012-202052	54	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252518	10.1371/journal.pone.0252518	http://dx.doi.org/10.1371/journal.pone.0252518			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138891	Green Published, gold			2022-12-26	WOS:000671690200020
J	Soria-Oliver, M; Lopez, JS; Torrano, F; Garcia-Gonzalez, G				Soria-Oliver, Maria; Lopez, Jorge S.; Torrano, Fermin; Garcia-Gonzalez, Guillermo			Do psychosocial factors mediate the appearance of musculoskeletal symptoms? Evidence of an empirical study about the role of mental workload in computer workers	PLOS ONE			English	Article							RISK-FACTORS; OFFICE WORKERS; MUSCLE-ACTIVITY; JOB STRAIN; NECK PAIN; DISORDERS; PREVALENCE; USERS; DISCOMFORT; SHOULDER	The emergence of musculoskeletal symptoms (MSSs) in computer workers is a relevant occupational health problem. This study tests a multilevel model of analysis of risk factors in the appearance of musculoskeletal pain and discomfort in computer workers that integrates indicators from different areas: temporal usage patterns, ergonomic factors, psychosocial factors, and individual variables, specifically testing the possible mediating role of the mental workload. A cross-sectional study was performed through online registration with a non-probabilistic sample of 1198 workers from Spanish organizations. The results show that mental workload has a higher association than the rest of the factors with the onset of pain and discomfort in various body areas: neck in men, neck, shoulders and upper back in women. They also support the mediation role of mental workload in the relationship between usage patterns and the appearance of musculoskeletal symptoms. The use of multilevel theoretical models that adequately consider the complexity of the relationships between the different risk factors is necessary for a better understanding and intervention on MSSs in computer workers.	[Soria-Oliver, Maria; Lopez, Jorge S.] Univ Publ Navarra, Fac Ciencias Salud, Navarra, Spain; [Lopez, Jorge S.] IdiSNA Inst Invest Sanitarias Navarra, Pamplona, Spain; [Torrano, Fermin; Garcia-Gonzalez, Guillermo] UNIR Univ Int Rioja, Logrono, La Rioja, Spain	Universidad Publica de Navarra; Universidad Internacional de La Rioja (UNIR)	Soria-Oliver, M; Lopez, JS (corresponding author), Univ Publ Navarra, Fac Ciencias Salud, Navarra, Spain.; Lopez, JS (corresponding author), IdiSNA Inst Invest Sanitarias Navarra, Pamplona, Spain.	maria.soria@unavarra.es; Jorge.lopez@unavarra.es	Torrano, Fermin/F-9468-2016; Torrano, Fermin/AAQ-2813-2020; López, Jorge S./ABB-7254-2020; Lopez, Jorge Santiago/B-8313-2011; Garcia Gonzalez, Guillermo/F-1646-2019	Torrano, Fermin/0000-0002-0624-2145; Torrano, Fermin/0000-0002-0624-2145; Lopez, Jorge Santiago/0000-0002-3465-0787; Garcia Gonzalez, Guillermo/0000-0002-5927-4124				Andersen JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019691; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Baron S, 1996, AM J IND MED, V29, P609; Bongers PM, 2002, AM J IND MED, V41, P315, DOI 10.1002/ajim.10050; Brewer S, 2006, J OCCUP REHABIL, V16, P325, DOI 10.1007/s10926-006-9031-6; Carayon P, 2007, SCAND J WORK ENV HEA, P10; Cho CY, 2012, J MANIP PHYSIOL THER, V35, P534, DOI 10.1016/j.jmpt.2012.07.004; Coenen P, 2019, OCCUP ENVIRON MED, V76, P502, DOI 10.1136/oemed-2018-105553; Crawford JO, 2020, BEST PRACT RES CL RH, V34, DOI 10.1016/j.berh.2020.101558; Dalmau I., 2004, ANUARIO PSICOLOGIA, V35, P521; Delp L, 2013, AM J IND MED, V56, P1072, DOI 10.1002/ajim.22222; Díaz Ramiro Eva, 2010, Rev. psicol. trab. organ., V26, P191; Eijckelhof BHW, 2013, EUR J APPL PHYSIOL, V113, P2897, DOI 10.1007/s00421-013-2602-2; El-Bestar SF, 2011, INT J OCCUP SAF ERGO, V17, P195; European Agency for Safety and Health at Work, 2019, 3 EUROPEAN SURVEY EN; European Agency for Safety and Health at Work (EU-OSHA), 2020, WORK REL MUSC DIS RE; Fogleman M, 2002, INT J IND ERGONOM, V29, P311, DOI 10.1016/S0169-8141(01)00071-3; Gerr F, 2004, J ELECTROMYOGR KINES, V14, P25, DOI 10.1016/j.jelekin.2003.09.014; Goode N, 2019, SAFETY SCI, V120, P146, DOI 10.1016/j.ssci.2019.05.037; Griffiths KL, 2007, J OCCUP REHABIL, V17, P743, DOI 10.1007/s10926-007-9108-x; Griffiths KL, 2012, WORK, V42, P533, DOI 10.3233/WOR-2012-1396; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hayes Andrew F, 2017, Behav Res Ther, V98, P39, DOI 10.1016/j.brat.2016.11.001; Hayes AF, 2013, QUANT METH EDUC BEHA, P219; Heinrich J, 2004, OCCUP ENVIRON MED, V61, P1027, DOI 10.1136/oem.2004.013219; HernuYndez-Fernaud, 2009, REV PSICOL TRAB ORG, V5, P29; Homan MM, 2003, AIHA J-J SCI OCCUP E, V64, P48, DOI 10.1080/15428110308984784; Huang GD, 2002, AM J IND MED, V41, P298, DOI 10.1002/ajim.10045; IJmker S, 2007, OCCUP ENVIRON MED, V64, P211, DOI 10.1136/oem.2006.026468; Instituto Nacional de Estadistica (INE), 2020, HOMBR MUJ ESP; Jensen C, 2002, INT J IND ERGONOM, V30, P265, DOI 10.1016/S0169-8141(02)00130-0; Kelson DM, 2019, APPL ERGON, V81, DOI 10.1016/j.apergo.2019.102908; Lapointe J, 2009, SCAND J WORK ENV HEA, V35, P134, DOI 10.5271/sjweh.1312; Lloret-Segura S, 2014, AN PSICOL-SPAIN, V30, P1151, DOI 10.6018/analesps.30.3.199361; Magnavita N, 2015, INT ARCH OCC ENV HEA, V88, P185, DOI 10.1007/s00420-014-0952-7; Maume DJ, 2007, RES SOCIOL WORK, V17, P251, DOI 10.1016/S0277-2833(07)17008-4; Memon M.A., 2018, J APPL STRUCTURAL EQ, V2, pi, DOI [10.47263/jasem.2(1)01, DOI 10.47263/JASEM.2(1)01]; Meroni M, 2010, MED LAV, V101, P276; Meshkati, 1998, HUMAN MENTAL WORKLOA; Molina Aragonés Josep Maria, 2017, Med. segur. trab., V63, P167; Nakazawa T, 2002, AM J IND MED, V42, P421, DOI 10.1002/ajim.10133; Nasrull, 2018, INT J ENG TECNOLOG, V7, P30, DOI [10.14419/ijet.v7i3.20.18726, DOI 10.14419/IJET.V7I3.20.18726]; National Information Society Agency (NIA), 2013, YB INF SOC STAT; Oha Kristel, 2014, BMC Musculoskelet Disord, V15, P181, DOI 10.1186/1471-2474-15-181; Ortego G, 2016, J PSYCHOSOM RES, V90, P70, DOI 10.1016/j.jpsychores.2016.09.006; Paksaichol A, 2012, OCCUP ENVIRON MED, V69, P610, DOI 10.1136/oemed-2011-100459; Piranveyseh P, 2016, INT J OCCUP SAF ERGO, V22, P267, DOI 10.1080/10803548.2015.1135568; Prodanovska-Stojcevska V, 2016, PROC CBU, V4, P669, DOI 10.12955/cbup.v4.830; Robertson MM, 2016, INT ARCH OCC ENV HEA, V89, P7, DOI 10.1007/s00420-015-1046-x; Salvendy G., 2021, HDB HUMAN FACTORS ER, DOI [10.1002/9781119636113, DOI 10.1002/9781119636113]; Sasikumar V, 2020, INT J OCCUP SAF ERGO, V26, P384, DOI 10.1080/10803548.2018.1480583; Sauter SL, 1996, BEYOND BIOMECHANICS, P3; Soria-Oliver M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173166; Soriano JB, 2018, MED CLIN-BARCELONA, V151, P171, DOI 10.1016/j.medcli.2018.05.011; Stanam A, 2019, J ENVIRON HEALTH, V81, P14; Stock SR, 2018, SCAND J WORK ENV HEA, V44, P113, DOI 10.5271/sjweh.3696; Szeto GPY, 2005, MANUAL THER, V10, P270, DOI 10.1016/j.math.2005.01.004; Taib MFM, 2016, WORK, V54, P543, DOI 10.3233/WOR-162334; Village J., 2005, Occupational Ergonomics, V5, P205; Waersted Morten, 2010, BMC Musculoskelet Disord, V11, P79, DOI 10.1186/1471-2474-11-79; Wahlstrom J, 2005, OCCUP MED-OXFORD, V55, P168, DOI 10.1093/occmed/kqi083; Wahlstrom J, 2004, OCCUP ENVIRON MED, V61, P523, DOI 10.1136/oem.2003.009563; Waongenngarm P, 2018, APPL ERGON, V68, P230, DOI 10.1016/j.apergo.2017.12.003; Woo EHC, 2016, MANUAL THER, V26, P47, DOI 10.1016/j.math.2016.07.004; Wu SS, 2012, J OCCUP HEALTH, V54, P34, DOI 10.1539/joh.11-0119-OA; Xie YF, 2017, APPL ERGON, V59, P132, DOI 10.1016/j.apergo.2016.08.020; Ye SY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014914	67	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252179	10.1371/journal.pone.0252179	http://dx.doi.org/10.1371/journal.pone.0252179			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138890	gold, Green Published			2022-12-26	WOS:000671690200095
J	Zhang, J; Chen, Q; Shi, MH; Zhou, HP; Xu, LY				Zhang, Jian; Chen, Qing; Shi, Minghong; Zhou, Hongping; Xu, Linyun			Interaction and influence of a flow field and particleboard particles in an airflow forming machine with a coupled Euler-DPM model	PLOS ONE			English	Article							RICE STRAW; SIMULATION	Particleboards are widely used in the artificial board market, which can be constructed from a variety of raw materials and require small amounts of energy to be produced. In the particleboard production process, forming machines play an important role as the key equipment for achieving continuous production. In recent years, airflow forming machines have received increasing attention in particleboard production lines because of their strong separation ability and low price. However, the internal flow field is complex and difficult to control, which affects the surface quality and strength of the particleboard. The most pressing technical difficulty is controlling the flow field characteristics of the airflow paver. At present, the research on this subject is conducted primarily through repeated experiments, which entail long research periods and high processing costs. To reduce human and financial costs, in this study, Computational Fluid Dynamics (CFD) is employed to investigate the flow field and the gas-solid two-phase flow field coupled with particle movement of an airflow forming machine. The accuracy of the calculation model is verified by comparing characteristic point velocities obtained from experimental analysis and a simulation. The simulation results show that in practical production, the frequency of a negative pressure fan should be greater than 27 Hz. It is necessary to set the shoulder properly, and the slab smoothness can be improved by moving the shoulder back on the premise of meeting the strength requirements of the box. The distance between the shoulders of the box body should be less than 2570 mm, and particles with uniform diameter should be added to the paving box to reduce the turbulence effect, improve the quality of particle forming and provide actual particleboard production with a solid theoretical foundation.	[Zhang, Jian; Chen, Qing; Shi, Minghong; Zhou, Hongping; Xu, Linyun] Nanjing Forestry Univ, Coll Mech & Elect Engn, Nanjing, Peoples R China	Nanjing Forestry University	Chen, Q (corresponding author), Nanjing Forestry Univ, Coll Mech & Elect Engn, Nanjing, Peoples R China.	qchen@njfu.edu.cn		Zhang, Jian/0000-0003-4255-8603	National Natural Science Foundation of China [51906111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Qing Chen is supported by the National Natural Science Foundation of China (No. 51906111). He plays a role in study design, decision to publish and preparation of the manuscript.	Ahn N, 2020, ENERGIES, V13, DOI 10.3390/en13226050; Bacigalupe A, 2021, J POLYM ENVIRON, V29, P2033, DOI 10.1007/s10924-020-02036-8; Buyuksari U, 2010, BIORESOURCE TECHNOL, V101, P255, DOI 10.1016/j.biortech.2009.08.038; Ferziger J. H., 2001, COMPUTATIONAL METHOD; Huang Xiao, 2019, Journal of Nanjing Forestry University (Natural Sciences Edition), V43, P107; Kurz D, 2013, PROG COMPUT FLUID DY, V13, P322, DOI 10.1504/PCFD.2013.055060; Lamaming J, 2020, COMPOS PART B-ENG, V183, DOI 10.1016/j.compositesb.2019.107731; Le KH, 2018, DRY TECHNOL, V36, P1866, DOI 10.1080/07373937.2018.1444633; Leban JM, 2005, SCAND J FOREST RES, V20, P534, DOI 10.1080/02827580500432305; Li GF, 2019, CLUSTER COMPUT, V22, pS2719, DOI 10.1007/s10586-017-1435-x; Lin QJ, 2012, INT J ADHES ADHES, V34, P11, DOI 10.1016/j.ijadhadh.2012.01.005; Liu XG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231316; Moslemi A, 2020, INT J ADHES ADHES, V99, DOI 10.1016/j.ijadhadh.2020.102582; Najafi SK, 2007, J MATER SCI, V42, P789, DOI 10.1007/s10853-006-1454-0; Nasif G, 2019, INT J NUMER METHOD H, V29, P2277, DOI 10.1108/HFF-10-2018-0553; Qi YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140893; Rajika JKAT, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2817-x; Schubert M, 2020, WOOD SCI TECHNOL, V54, P703, DOI 10.1007/s00226-020-01184-3; Sudbrock F, 2015, DRY TECHNOL, V33, P1808, DOI 10.1080/07373937.2015.1026982; Versteeg H.K., 2007, INTRO COMPUTATIONAL; Wang KL, 2018, POLYM COMPOSITE, V39, P119, DOI 10.1002/pc.23912; Xiong JJ, 2011, CHINA WOOD BASED PAN, V18, P22; Xiong XQ, 2020, SCI ADV MATER, V12, P795, DOI 10.1166/sam.2020.3741	23	4	4	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253311	10.1371/journal.pone.0253311	http://dx.doi.org/10.1371/journal.pone.0253311			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138940	Green Published, gold			2022-12-26	WOS:000671690200073
J	Zuniga, MA; Rubio-Palis, Y; Brochero, H				Zuniga, Miguel A.; Rubio-Palis, Yasmin; Brochero, Helena			Updating the bionomy and geographical distribution of Anopheles (Nyssorhynchus) albitarsis F: A vector of malaria parasites in northern South America	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; ENTOMOLOGICAL INOCULATION RATES; MOSQUITOS DIPTERA-CULICIDAE; GOLD-MINING AREAS; CAURA-RIVER-BASIN; MITOCHONDRIAL-DNA; BOLIVAR-STATE; NATURAL INFECTIVITY; SPECIES COMPOSITION; GUAYANA HIGHLANDS	Anopheles albitarsis F is a putative species belonging to the Albitarsis Complex, recognized by rDNA, mtDNA, partial white gene, and microsatellites sequences. It has been reported from the island of Trinidad, Venezuela and Colombia, and incriminated as a vector of malaria parasites in the latter. This study examined mitochondrially encoded cytochrome c oxidase I (MT-CO1) sequences of An. albitarsis F from malaria-endemic areas in Colombia and Venezuela to understand its relations with other members of the Complex, revised and update the geographical distribution and bionomics of An. albitarsis F and explore hypotheses to explain its phylogenetic relationships and geographical expansion. Forty-five MT-CO1 sequences obtained in this study were analyzed to estimate genetic diversity and possible evolutionary relationships. Sequences generated 37 haplotypes clustered in a group where the genetic divergence of Venezuelan populations did not exceed 1.6% with respect to Colombian samples. Anopheles albitarsis F (pi = 0.013) represented the most recent cluster located closer to An. albitarsis I (pi = 0.009). Barcode gap was detected according to Albitarsis Complex lineages previously reported (threshold 0.014-0.021). Anopheles albitarsis F has a wide distribution in northern South America and might play an important role in the transmission dynamics of malaria due to its high expansion capacity. Future studies are required to establish the southern distribution of An. albitarsis F in Venezuela, and its occurrence in Guyana and Ecuador.	[Zuniga, Miguel A.] Univ Nacl Autonoma Honduras, Fac Ciencias, Dept Francisco Morazan, Escuela Microbiol, Tegucigalpa, Honduras; [Rubio-Palis, Yasmin] Univ Carabobo, Fac Ciencias Salud, Dept Clin Integral, Sede Aragua, Maracay, Estado Aragua, Venezuela; [Rubio-Palis, Yasmin] Serv Autonomo Inst Altos Estudios Dr Arnoldo Gaba, Ctr Estudios Enfermedades Endem & Salud Ambiental, Maracay, Estado Aragua, Venezuela; [Brochero, Helena] Univ Nacl Colombia, Fac Ciencias Agr, Dept Agron, Bogota, DC, Colombia	Universidad Nacional Autonoma de Honduras; Universidad Nacional de Colombia	Rubio-Palis, Y (corresponding author), Univ Carabobo, Fac Ciencias Salud, Dept Clin Integral, Sede Aragua, Maracay, Estado Aragua, Venezuela.; Rubio-Palis, Y (corresponding author), Serv Autonomo Inst Altos Estudios Dr Arnoldo Gaba, Ctr Estudios Enfermedades Endem & Salud Ambiental, Maracay, Estado Aragua, Venezuela.	rubiopalis@gmail.com		Zuniga, Miguel Angel/0000-0003-0263-5723; RUBIO-PALIS, YASMIN/0000-0003-0056-2540	Red de Macro Universidades Publicas de America Latina y el Caribe; Universidad Nacional de Colombia	Red de Macro Universidades Publicas de America Latina y el Caribe; Universidad Nacional de Colombia	MAZ was funded by Red de Macro Universidades Publicas de America Latina y el Caribe to visit the Entomology Laboratory, Facultad de Ciencias Agrarias, Universidad Nacional de Colombia. YRP received no specific funding for this work. HB was funded by Universidad Nacional de Colombia.	Abou Orm S, 2017, B MALARIOL SALUD AMB, V57, P15; Ahrens D, 2016, SYST BIOL, V65, P478, DOI 10.1093/sysbio/syw002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1999, SED BAS WOR; [Anonymous], 1987, COLOMB MED; Arnett JR, 1947, JNY ENTOMOL SOC, V4, P185; Berry P. E., 2005, Plant diversity and complexity patterns: local, regional and global dimensions. Proceedings of an International Symposium held at the Royal Danish Academy of Sciences and Letters in Copenhagen, Denmark, 25-28 May, 2003, P145; Berti J, 2016, B MALARIOL SALUD AMB, V56, P78; Berti J, 2011, B MALARIOL SALUD AMB, V51, P59; BLANTON FRANKLIN S., 1956, MOSQUITO NEWS, V16, P22; Brochero H, 2010, AM J TROP MED HYG, V83, P585, DOI 10.4269/ajtmh.2010.09-0482; Brochero HHL, 2007, AM J TROP MED HYG, V76, P1113, DOI 10.4269/ajtmh.2007.76.1113; Brochero HL, 2005, J AM MOSQUITO CONTR, V21, P182, DOI 10.2987/8756-971X(2005)21[182:BAABSO]2.0.CO;2; Brochero HL, 2006, THESIS PONTIFICIA U; BURKE K, 1988, ANNU REV EARTH PL SC, V16, P201, DOI 10.1146/annurev.ea.16.050188.001221; Carmen EPG, 2006, REV COLOMB ENTOMOL, V32, P49; Carrejo, 2009, CLAVES NOTAS DISTRIB; Chadee DD, 2006, J AM MOSQUITO CONTR, V22, P22, DOI 10.2987/8756-971X(2006)22[22:EOTMVA]2.0.CO;2; CHADEE DD, 1992, J MED ENTOMOL, V29, P567, DOI 10.1093/jmedent/29.3.567; CHADEE DD, 1992, ANN TROP MED PARASIT, V86, P583, DOI 10.1080/00034983.1992.11812713; Clement M., 2002, P 16 INT PARALLEL DI, P7; COLLINS WE, 1985, J PARASITOL, V71, P771, DOI 10.2307/3281711; Conn JE, 2007, HEREDITY, V99, P245, DOI 10.1038/sj.hdy.6801002; CRD, 2009, CRDS GUIDANCE UNDERT; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; da Silva-Vasconcelos A, 2002, MEM I OSWALDO CRUZ, V97, P151, DOI 10.1590/S0074-02762002000200002; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Santi VP, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1088-x; DeSalle R, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00302; Dos Santos RL, 2009, REV SAUDE PUBL, V43, P859, DOI 10.1590/S0034-89102009000500016; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Duran JS, 2014, THESIS U NACL COLOMB; Dusfour I, 2012, J AM MOSQUITO CONTR, V28, P309, DOI 10.2987/12-6248R.1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Foley DH, 2014, J VECTOR ECOL, V39, P168, DOI 10.1111/j.1948-7134.2014.12084.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GABALDON A, 1983, AM J TROP MED HYG, V32, P203, DOI 10.4269/ajtmh.1983.32.203; Galardo AKR, 2009, MED VET ENTOMOL, V23, P335, DOI 10.1111/j.1365-2915.2009.00839.x; GIGLIOLI G., 1959, Rivista di Parassitologia, V20, P279; Gomez G, 2013, MOL ECOL RESOUR, V13, P1082, DOI 10.1111/1755-0998.12126; Gomez GF, 2017, INFECT GENET EVOL, V54, P379, DOI 10.1016/j.meegid.2017.07.028; GonzuYlez, 1997, B DIR MALARIOL SAN A, V37, P35; Gutierrez LA, 2008, ACTA TROP, V107, P99, DOI 10.1016/j.actatropica.2008.04.019; Gutierrez LA, 2010, MEM I OSWALDO CRUZ, V105, P1019, DOI 10.1590/S0074-02762010000800011; Gutierrez LA, 2009, MEM I OSWALDO CRUZ, V104, P1117, DOI 10.1590/S0074-02762009000800008; GuzmuYn H, 2018, B MALARIOL SALUD AMB, V58, P17; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HEDGES SB, 2001, BIOGEOGRAPHY W INDIE, P15, DOI DOI 10.1201/9781420039481.CH2; Hernandez-Valencia JC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240207; HUBER O, 1988, TAXON, V37, P595, DOI 10.2307/1221102; Huber O., 1987, PANTEPUI, V2, P2; Huber O., 1995, SCI GUAIANAE, V5, P37; HUDSON JE, 1984, B ENTOMOL RES, V74, P129, DOI 10.1017/S0007485300010002; Jimenez IP, 2014, J AM MOSQUITO CONTR, V30, P91, DOI 10.2987/13-6382.1; Jimenez P, 2012, BIOMEDICA, V32, P13, DOI 10.1590/S0120-41572012000500003; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KITZMILLER J B, 1977, Mosquito Systematics, V9, P112; KREUTZER R D, 1976, Acta Amazonica, V6, P473; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laporta GZ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1038-4; Lehr MA, 2005, ANN ENTOMOL SOC AM, V98, P908, DOI 10.1603/0013-8746(2005)098[0908:CSITAN]2.0.CO;2; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; LINTHICUM K J, 1988, Mosquito Systematics, V20, P98; Loaiza JR, 2008, J MED ENTOMOL, V45, P841, DOI 10.1603/0022-2585(2008)45[841:SCADOA]2.0.CO;2; Marinotti O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-142; Martinez-Villegas L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219523; Mayr E., 1967, Bulletin of the American Museum of Natural History, V136, P269; McDiarmid RW, 2005, Ecology & Evolution in the Tropics: A Herpetological Perspective, P461; McKeon SN, 2013, AM J TROP MED HYG, V88, P1079, DOI 10.4269/ajtmh.12-0203; McKeon SN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-271; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Montoya C, 2017, BIOMEDICA, V37; Moreno JE, 2007, MED VET ENTOMOL, V21, P339, DOI 10.1111/j.1365-2915.2007.00704.x; Moreno JE, 2005, MED VET ENTOMOL, V19, P329, DOI 10.1111/j.1365-2915.2005.00572.x; Moreno Jorge, 2000, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V40, P21; Moreno Jorge, 2002, Entomotropica, V17, P157; Moreno JE, 2015, B MALARIOL SALUD AMB, V55, P117; Moreno JE, 2015, B MALARIOL SALUD AMB, V55, P52; Moreno JE, 2009, MEM I OSWALDO CRUZ, V104, P764, DOI 10.1590/S0074-02762009000500017; Motoki MT, 2021, J MED ENTOMOL, V58, P599, DOI 10.1093/jme/tjaa211; Motoki MT, 2009, MEM I OSWALDO CRUZ, V104, P823, DOI 10.1590/S0074-02762009000600004; NARANG SK, 1993, BIOCHEM GENET, V31, P97, DOI 10.1007/BF02399823; Naranjo-Diaz N, 2019, ACTA TROP, V190, P13, DOI 10.1016/j.actatropica.2018.10.011; Naranjo-Diaz N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-61; Navarro E, 2015, B MALARIOL SALUD AMB, V55, P194; Navarro JC, 2007, ZOOTAXA, P1; Orjuela LI, 2013, BIOMEDICA, V33, P42, DOI [10.7705/biomedica.v33i1.619, 10.1590/S0120-41572013000100006]; Osborn Frances R., 2004, Boletin de Malariologia y Salud Ambiental, V44, P77; Pacheco-Gómez Miguel Alfonso, 2018, rev.fac.med., V66, P201, DOI 10.15446/revfacmed.v66n2.61071; PAHO/WHO, PROF MAL CHAMP AM 20; Pedro PM, 2010, J HERED, V101, P618, DOI 10.1093/jhered/esq054; Phillips JD, 2019, ECOL EVOL, V9, P2996, DOI 10.1002/ece3.4757; Povoa MM, 2006, MEM I OSWALDO CRUZ, V101, P163, DOI 10.1590/S0074-02762006000200008; Purez E, 2007, SALUD DESARROLLO SOC, V28, P108; QGIS Development Team, 2018, QGIS GEOGR INF SYST; Rafael MS, 2005, GENET MOL RES, V4, P684; RAMBAJAN I, 1984, TROP GEOGR MED, V36, P61; Rambaut A., 2012, FIGTREE VERSION 1 4; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reidenbach Kyanne R., 2009, BMC Evolutionary Biology, V9, DOI 10.1186/1471-2148-9-298; ROSAFREITAS MG, 1990, MEM I OSWALDO CRUZ, V85, P275, DOI 10.1590/S0074-02761990000300004; Rossetti DD, 2005, QUATERNARY RES, V63, P78, DOI 10.1016/j.yqres.2004.10.001; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rubio-Palis Y., 2019, Boletin de Malariologia y Salud Ambiental, V59, P98; Rubio-Palis Y, 2003, J AM MOSQUITO CONTR, V19, P107; Rubio-Palis Y., 2000, ANOPHELES NYSSORHYNC; Rubio-Palis Yasmin, 2005, ENTOMOTROPICA, V20, P29; Rubio-Palis Y, 2014, B MALARIOL SALUD AMB, V54, P186; Rubio-Palis Y, 2014, B MALARIOL SALUD AMB, V54, P100; Rubio-Palis Y, 2013, B MALARIOL SALUD AMB, V53, P68; Rubio-Palis Y, 2013, MEM I OSWALDO CRUZ, V108, P220, DOI 10.1590/0074-0276108022013015; Rubio-Palis Y, 2012, MEM I OSWALDO CRUZ, V107, P546, DOI 10.1590/S0074-02762012000400017; RubioPalis Y, 1997, J MED ENTOMOL, V34, P499, DOI 10.1093/jmedent/34.5.499; RUBIOPALIS Y, 1994, AM J TROP MED HYG, V50, P420, DOI 10.4269/ajtmh.1994.50.420; RUBIOPALIS Y, 1992, J AM MOSQUITO CONTR, V8, P261; RUBIOPALIS Y, 1992, ACTA TROP, V52, P167, DOI 10.1016/0001-706X(92)90033-T; RUBIOPALIS Y, 1994, MED VET ENTOMOL, V8, P275, DOI 10.1111/j.1365-2915.1994.tb00509.x; RUBIOPALIS Y, 1992, MED VET ENTOMOL, V6, P325, DOI 10.1111/j.1365-2915.1992.tb00628.x; Ruiz-Lopez F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-44; Rull V, 2005, J BIOGEOGR, V32, P921, DOI 10.1111/j.1365-2699.2005.01252.x; Rull V, 2004, EARTH-SCI REV, V67, P125, DOI 10.1016/j.earscirev.2004.02.004; Rull V, 2004, GLOBAL ECOL BIOGEOGR, V13, P141, DOI 10.1111/j.1466-882X.2004.00073.x; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rull V, 2019, BIODIVERSITY OF PANTEPUI: THE PRISTINE LOST WORLD OF THE NEOTROPICAL GUIANA HIGHLANDS, P33, DOI 10.1016/B978-0-12-815591-2.00002-1; Rull V, 2011, SCIENCE, V331, P398, DOI 10.1126/science.331.6016.398-c; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santorelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20596-7; SCHUBERT C, 1994, QUATERN INT, V21, P81, DOI DOI 10.1016/1040-6182%2894%2990022-1; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; Steiner W.W.M., 1982, P523; Buitrago LS, 2013, MEM I OSWALDO CRUZ, V108, P1045, DOI 10.1590/0074-0276130217; Steyermark J. A., 1979, TROPICAL BOT, P185; Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016; Sutil Oramas E., 1980, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V20, P1; TAJIMA F, 1983, GENETICS, V105, P437; Tami A., 2020, MALARIA SO VENEZUELA, DOI [10.1101/2020.03.13.990457, DOI 10.1101/2020.03.13.990457]; Teletchea F, 2010, MITOCHONDR DNA, V21, P206, DOI 10.3109/19401736.2010.532212; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Der Kuyp E, 1985, MED B, V9, P108; Wilkerson RC, 1995, MEM I OSWALDO CRUZ, V90, P721, DOI 10.1590/S0074-02761995000600013; WILKERSON RC, 1995, J MED ENTOMOL, V32, P697, DOI 10.1093/jmedent/32.5.697; XIA X, 2018, PEERJ, V6, DOI DOI 10.7717/PEERJ.5321; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zetek J, 1944, J TROP MED HYG, V21, P105, DOI [10.4269/ajtmh.1944.s1-24.105, DOI 10.4269/AJTMH.1944.S1-24.105]; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	151	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253230	10.1371/journal.pone.0253230	http://dx.doi.org/10.1371/journal.pone.0253230			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138918	gold, Green Published			2022-12-26	WOS:000671690200005
J	Du, GK; Huang, HR; Zhu, QW; Ying, L				Du, Guankui; Huang, Hairong; Zhu, Qiwei; Ying, Li			Effects of cat ownership on the gut microbiota of owners	PLOS ONE			English	Article							PET OWNERSHIP; CHILDHOOD; ASTHMA	Pet ownership is an essential environmental exposure that might influence the health of the owner. This study's primary objectives were to explore the effects of cat ownership on the gut microbial diversity and composition of owners. Raw data from the American Gut Project were obtained from the SRA database. A total of 214 Caucasian individuals (111 female) with cats and 214 individuals (111 female) without cats were used in the following analysis. OTU number showed significant alteration in the Cat group and Female_cat group, compared with that of the no cat (NC) group and Female_ NC group, respectively. Compared with the NC group, the microbial phylum Proteobacteria was significantly decreased in the Cat group. The microbial families Alcaligenaceae and Pasteurellaceae were significantly reduced, while Enterobacteriaceae and Pseudomonadaceae were significantly increased in the Cat group. Fifty metabolic pathways were predicted to be significantly changed in the Cat group. Twenty-one and 13 metabolic pathways were predicted to be significantly changed in the female_cat and male_cat groups, respectively. Moreover, the microbial phylum Cyanobacteria was significantly decreased, while the families Alcaligenaceae, Pseudomonadaceae and Enterobacteriaceae were significantly changed in the normal weight cat group. In addition, 41 and 7 metabolic pathways were predicted to be significantly changed in the normal-weight cat and overweight cat groups, respectively. Therefore, this study demonstrated that cat ownership could influence owners' gut microbiota composition and function, especially in the female group and normal-weight group.	[Du, Guankui] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China; [Du, Guankui; Zhu, Qiwei] Hainan Med Univ, Key Lab Mol Biol, Haikou, Hainan, Peoples R China; [Huang, Hairong] Hainan Med Univ, Sch Publ Hlth, Haikou, Hainan, Peoples R China; [Ying, Li] Haikou Customs, Haikou, Hainan, Peoples R China	Hainan Medical University; Hainan Medical University; Hainan Medical University	Du, GK (corresponding author), Hainan Med Univ, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China.; Du, GK (corresponding author), Hainan Med Univ, Key Lab Mol Biol, Haikou, Hainan, Peoples R China.; Ying, L (corresponding author), Haikou Customs, Haikou, Hainan, Peoples R China.	duguankui@163.com; yingli@customs.gov.cn	Du, Guankui/AAG-7628-2019	Du, Guankui/0000-0002-1117-8299	National Natural Science Foundation of China [81960672]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China (No. 81960672) (Guankui Du) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermingham EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080992; Beukema M, 2020, EXP MOL MED, V52, P1364, DOI 10.1038/s12276-020-0449-2; Brandt N, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13881; Butowski CF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216072; Cani PD, 2014, DIABETES METAB, V40, P246, DOI 10.1016/j.diabet.2014.02.004; Catoi AF, 2019, CURR PHARM DESIGN, V25, P2038, DOI 10.2174/1381612825666190708190437; CAUGANT DA, 1984, J HYG-CAMBRIDGE, V92, P377, DOI 10.1017/S0022172400064597; Chiodini RJ, 2016, MICROBIOL-SGM, V162, P1608, DOI 10.1099/mic.0.000336; Chng KR, 2016, EBIOMEDICINE, V8, P195, DOI 10.1016/j.ebiom.2016.04.034; Conteh AR, 2020, TOXICOL RES-UK, V9, P569, DOI 10.1093/toxres/tfaa065; Douglas GM, 2018, METHODS MOL BIOL, V1849, P169, DOI 10.1007/978-1-4939-8728-3_11; Exner C, 1997, ZBL HYG UMWELTMED, V199, P497; Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9; Gan GZH, 2020, AGING MENT HEALTH, V24, P1605, DOI 10.1080/13607863.2019.1633620; Gray PB, 2015, ANTHROZOOS, V28, P673, DOI 10.1080/08927936.2015.1064216; Gulick EE, 2012, J PSYCHOSOC NURS MEN, V50, P30, DOI 10.3928/02793695-20121003-01; Ihuoma H, 2018, J ALLERGY CLIN IMMUN, V141, P820, DOI 10.1016/j.jaci.2017.09.030; Johnson CC, 2017, TRANSL RES, V179, P60, DOI 10.1016/j.trsl.2016.06.010; Kates AE, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00073; Lamprecht P, 2019, J AUTOIMMUN, V97, P29, DOI 10.1016/j.jaut.2018.10.005; Lazar V, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00021; Levin AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31775; Ma X, 2020, J PSYCHIATR RES, V123, P136, DOI 10.1016/j.jpsychires.2020.02.005; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; Miyake K, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103498; Moyaert H, 2006, RES VET SCI, V81, P1, DOI 10.1016/j.rvsc.2005.10.004; Palomaki J, 2019, SCHIZOPHR RES, V206, P444, DOI 10.1016/j.schres.2018.12.020; Pan LB, 2020, ACTA PHARMACOL SIN B, V10, P249, DOI 10.1016/j.apsb.2019.10.007; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Ramon ME, 2008, PREV VET MED, V85, P23, DOI 10.1016/j.prevetmed.2007.12.017; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Sitarik AR, 2018, INDOOR AIR, V28, P539, DOI 10.1111/ina.12456; Smirnova E, 2020, HEPATOLOGY, V72, P271, DOI 10.1002/hep.31178; Smith BP, 2017, HUM NATURE-INT BIOS, V28, P255, DOI 10.1007/s12110-017-9290-2; Taniguchi Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54955-9; Thakur MK., 2018, VOICE INTELLECTUAL M, V8, P101; Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510; Tun HM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0254-x; Valdes AM, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2179; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Wang ZN, 2019, EUR HEART J, V40, P583, DOI [10.1093/eurheartj/ehy799, 10.109]; Wen L, 2017, J NUTR, V147, p1468S, DOI 10.3945/jn.116.240754; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; Wu CST, 2018, ANTHROZOOS, V31, P577, DOI 10.1080/08927936.2018.1505269; Yang L, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00375; Yoshii K, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00048; ZASLOFF RL, 1994, PSYCHOL REP, V75, P747, DOI 10.2466/pr0.1994.75.2.747	48	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253133	10.1371/journal.pone.0253133	http://dx.doi.org/10.1371/journal.pone.0253133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133453	gold, Green Published			2022-12-26	WOS:000671682700028
J	Cardenas, A; Papadogiannis, A; Dimitrov, E				Cardenas, Andrea; Papadogiannis, Alexander; Dimitrov, Eugene			The role of medial prefrontal cortex projections to locus ceruleus in mediating the sex differences in behavior in mice with inflammatory pain	FASEB JOURNAL			English	Article						locus ceruleus; medial prefrontal cortex; pain; sex difference	NORADRENERGIC NEURONS; MEMORY PERFORMANCE; NEUROPATHIC PAIN; COERULEUS; RAT; NOREPINEPHRINE; ORGANIZATION; RESPONSES; SYSTEM; MODEL	We tested the hypothesis that the cognitive impairment associated with inflammatory pain may result from dysregulation of the top-down control of locus ceruleus's (LC) activity by the medial prefrontal cortex (mPFC). Injection of complete Freund's adjuvant (CFA) served as a model for inflammatory pain. The CFA injection decreased the thermal thresholds in both sexes but only the male mice showed increased anxiety-like behavior and diminished cognition, while the females were not affected. Increased calcium fluorescence, a marker for neuronal activity, was detected by photometry in the mPFC of males but not in females with CFA. Next, while chemogenetic inhibition of the projections from the mPFC to the LC improved the object recognition memory of males with pain, the inhibition of the mPFC to LC pathway in female mice produced anxiolysis and spatial memory deficits. The behavior results prompted us to compare the reciprocal innervation of mPFC and LC between the sexes. We used an anterograde transsynaptic tagging technique, which relies on postsynaptic cre transfer, to assess the innervation of LC by mPFC efferents. The males showed a higher rate of postsynaptic cre transfer into LC neurons from mPFC efferents than the females. And vice versa, a retrograde tracing experiment demonstrated that LC to mPFC projection neurons were more numerous in females when compared to males. In conclusion, we provide evidence that subtle differences in the reciprocal neuronal circuit between the LC and mPFC may contribute to sex differences associated with the adverse cognitive effects of inflammatory pain.	[Cardenas, Andrea; Dimitrov, Eugene] Rosalind Franklin Univ Med & Sci, Ctr Neurobiol Stress Resilience & Psychiat Disord, 3333 Green Bay Rd, N Chicago, IL 60064 USA; [Papadogiannis, Alexander] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, N Chicago, IL 60064 USA	Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science	Dimitrov, E (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Neurobiol Stress Resilience & Psychiat Disord, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	eugene.dimitrov@rosalindfranklin.edu			NIH [R01MH105528]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by NIH grant R01MH105528 to ED	Alba-Delgado C, 2013, BIOL PSYCHIAT, V73, P54, DOI 10.1016/j.biopsych.2012.06.033; Andreoli M, 2017, EXP NEUROL, V298, P1, DOI 10.1016/j.expneurol.2017.08.010; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Bangasser DA, 2019, NEUROPSYCHOPHARMACOL, V44, P129, DOI 10.1038/s41386-018-0137-2; Bangasser DA, 2016, BRAIN RES, V1641, P177, DOI 10.1016/j.brainres.2015.11.021; Bangasser DA, 2011, PHYSIOL BEHAV, V103, P342, DOI 10.1016/j.physbeh.2011.02.037; Ben Abdallah NMB, 2011, EXP NEUROL, V227, P42, DOI 10.1016/j.expneurol.2010.09.008; Berridge CW, 2016, BRAIN RES, V1641, P189, DOI 10.1016/j.brainres.2015.11.024; Cardenas A, 2020, PAIN, V161, P1861, DOI 10.1097/j.pain.0000000000001875; Cardoso-Cruz H, 2019, PAIN, V160, P805, DOI 10.1097/j.pain.0000000000001457; Cardoso-Cruz H, 2013, J NEUROSCI, V33, P2465, DOI 10.1523/JNEUROSCI.5197-12.2013; Chandler DJ, 2019, J NEUROSCI, V39, P8239, DOI 10.1523/JNEUROSCI.1164-19.2019; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Clewett DV, 2018, J NEUROSCI, V38, P1558, DOI 10.1523/JNEUROSCI.2097-17.2017; Drake RAR, 2021, ELIFE, V10, DOI 10.7554/eLife.65156; Euston DR, 2012, NEURON, V76, P1057, DOI 10.1016/j.neuron.2012.12.002; Fan XC, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00085; Fehrenbacher JC., 2012, CURR PROTOC PHARM CH, V56, P5; Franowicz JS, 2002, J NEUROSCI, V22, P8771; Guettier JM, 2009, P NATL ACAD SCI USA, V106, P19197, DOI 10.1073/pnas.0906593106; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hayashida K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040822; Hayashida K, 2018, ADV EXP MED BIOL, V1099, P93, DOI 10.1007/978-981-13-1756-9_8; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; Howorth PW, 2009, J COMP NEUROL, V512, P141, DOI 10.1002/cne.21879; Huang JT, 2019, NAT NEUROSCI, V22, P1659, DOI 10.1038/s41593-019-0481-5; Hughes SW, 2013, PAIN, V154, P1680, DOI 10.1016/j.pain.2013.05.010; Jett JD, 2013, NEUROPSYCHOPHARMACOL, V38, P585, DOI 10.1038/npp.2012.216; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kim Myung-A., 2003, Korean Journal of Biological Sciences, V7, P49; Kummer KK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103440; Llorca-Torralba M, 2016, NEUROSCIENCE, V338, P93, DOI 10.1016/j.neuroscience.2016.05.057; Loyd DR, 2006, J COMP NEUROL, V496, P723, DOI 10.1002/cne.20962; LUQUE JM, 1992, DEV BRAIN RES, V67, P211, DOI 10.1016/0165-3806(92)90221-H; Matos SC, 2018, BRAIN STRUCT FUNCT, V223, P1149, DOI 10.1007/s00429-017-1543-7; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Moriarty O, 2016, SCAND J PAIN, V10, P61, DOI 10.1016/j.sjpain.2015.09.008; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; Moriya S, 2019, IBRO REP, V7, P1, DOI 10.1016/j.ibror.2019.05.005; Mulvey B, 2018, CELL REP, V23, P2225, DOI 10.1016/j.celrep.2018.04.054; Ohtani S, 2018, J PHARMACOL SCI, V138, P76, DOI 10.1016/j.jphs.2018.09.005; Ong WY, 2019, MOL NEUROBIOL, V56, P1137, DOI 10.1007/s12035-018-1130-9; Ossipov MH, 2014, CURR OPIN SUPPORT PA, V8, P143, DOI 10.1097/SPC.0000000000000055; Parent AJ, 2016, NEUROSCIENCE, V315, P70, DOI 10.1016/j.neuroscience.2015.11.065; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; Radley JJ, 2008, J NEUROSCI, V28, P5806, DOI 10.1523/JNEUROSCI.0552-08.2008; Reyes BAS, 2014, LIFE SCI, V112, P2, DOI 10.1016/j.lfs.2014.07.017; Sales AC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006267; SARA SJ, 1995, P NATL ACAD SCI USA, V92, P6032, DOI 10.1073/pnas.92.13.6032; Saunders A., 2015, CURR PROTOC NEUROSCI, V72, P1; Shah AA, 2003, BRAIN RES, V969, P183, DOI 10.1016/S0006-8993(03)02299-6; Shepard R, 2017, DEV COGN NEUROS-NETH, V28, P29, DOI 10.1016/j.dcn.2017.10.009; Stone LS, 1997, J NEUROSCI, V17, P7157; Suto T, 2014, PAIN, V155, P1935, DOI 10.1016/j.pain.2014.05.014; Tuscher JJ, 2018, NEUROBIOL LEARN MEM, V156, P103, DOI 10.1016/j.nlm.2018.11.002; Tuttle AH, 2018, NAT METHODS, V15, P994, DOI 10.1038/s41592-018-0224-7; Uematsu A, 2017, NAT NEUROSCI, V20, P1602, DOI 10.1038/nn.4642; Uematsu A, 2015, LEARN MEMORY, V22, P444, DOI 10.1101/lm.037283.114; Usdin TB, 2016, NEUROSCIENTIST, V22, P521, DOI 10.1177/1073858416633104; van Eden CG, 2000, PROG BRAIN RES, V126, P49; Wagner M, 2016, NEUROSCIENCE, V324, P420, DOI 10.1016/j.neuroscience.2016.03.038; Wang GQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8660; Wu XB, 2016, NEUROSCI LETT, V611, P40, DOI 10.1016/j.neulet.2015.11.030; Zhang ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066122; Zingg B, 2020, J NEUROSCI, V40, P3250, DOI 10.1523/JNEUROSCI.2158-19.2020; Zingg B, 2017, NEURON, V93, P33, DOI 10.1016/j.neuron.2016.11.045	68	3	3	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21747	10.1096/fj.202100319RR	http://dx.doi.org/10.1096/fj.202100319RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151467	Green Accepted			2022-12-26	WOS:000667814100010
J	Corgiat, EB; List, SM; Rounds, JC; Corbett, AH; Moberg, KH				Corgiat, Edwin B.; List, Sara M.; Rounds, J. Christopher; Corbett, Anita H.; Moberg, Kenneth H.			The RNA-binding protein Nab2 regulates the proteome of the developing Drosophila brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; MUSHROOM BODIES; ZC3H14; LOCALIZATION; GENERATION; EXPRESSION; NEURONS; PATHWAY; AXONS	The human ZC3H14 gene, which encodes a ubiquitously expressed polyadenosine zinc finger RNA-binding protein, is mutated in an inherited form of autosomal recessive, non-syndromic intellectual disability. To gain insight into neurological functions of ZC3H14, we previously developed a Drosophila melanogaster model of ZC3H14 loss by deleting the fly ortholog, Nab2. Studies in this invertebrate model revealed that Nab2 controls final patterns of neuron projection within fully developed adult brains, but the role of Nab2 during development of the Drosophila brain is not known. Here, we identify roles for Nab2 in controlling the dynamic growth of axons in the developing brain mushroom bodies, which support olfactory learning and memory, and regulating abundance of a small fraction of the total brain proteome. The group of Nab2-regulated brain proteins, identified by quantitative proteomic analysis, includes the microtubule-binding protein Futsch, the neuronal Ig-family transmembrane protein turtle, the glial:neuron adhesion protein contactin, the Rac GTPase-activating protein tumbleweed, and the planar cell polarity factor Van Gogh, which collectively link Nab2 to the processes of brain morphogenesis, neuroblast proliferation, circadian sleep/wake cycles, and synaptic development. Overall, these data indicate that Nab2 controls the abundance of a subset of brain proteins during the active process of wiring the pupal brain mushroom body and thus provide a window into potentially conserved functions of the Nab2/ZC3H14 RNA-binding proteins in neurodevelopment.	[Corgiat, Edwin B.; Rounds, J. Christopher; Moberg, Kenneth H.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Corgiat, Edwin B.; Rounds, J. Christopher] Emory Univ, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Corgiat, Edwin B.; Rounds, J. Christopher; Corbett, Anita H.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [List, Sara M.] Emory Univ, Grad Program Neurosci, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Moberg, KH (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.; Corbett, AH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	acorbe2@emory.edu; kmoberg@emory.edu		Moberg, Kenneth/0000-0002-9820-5543; Rounds, J. Christopher/0000-0001-5287-8454; Corbett, Anita/0000-0002-0461-6895	Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health [5P30NS055077];  [5F31NS110312-02];  [5F31HD088043-03];  [5R01MH10730505]	Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health; ; ; 	Research reported in this publication was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant, 5P30NS055077. Financial support is as follows: 5F31NS110312-02, 5F31HD088043-03, and 5R01MH10730505. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal S., 2019, SCI REP-UK, P1; Aibara S, 2017, NUCLEIC ACIDS RES, V45, P1529, DOI 10.1093/nar/gkw1224; Alboukadel K., 2018, GGPUBR GGPLOT2 BASED; Alpert T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108324; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Axelrod JD, 2002, NAT CELL BIOL, V4, pE6, DOI 10.1038/ncb0102-e6; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Becker R, 1988, COMPUTER SCI SERIES; Bienkowski RS, 2017, CELL REP, V20, P1372, DOI 10.1016/j.celrep.2017.07.038; Butler MT, 2017, NAT REV MOL CELL BIO, V18, P375, DOI 10.1038/nrm.2017.11; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chambers JM., 1992, STAT MODELS S; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Edens BM, 2015, BBA-MOL BASIS DIS, V1852, P685, DOI 10.1016/j.bbadis.2014.07.024; Fasken MB, 2019, PROTEIN SCI, V28, P513, DOI 10.1002/pro.3565; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fox J., 2019, R COMPANION APPL REG, V.; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hakanen J, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00244; He CW, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180116; Hornberg H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00081; Holt CE, 2019, NAT STRUCT MOL BIOL, V26, P557, DOI 10.1038/s41594-019-0263-5; Jalloh B., 2020, NAB2 RNA BINDING PRO; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Jones S. K., 2020, POLYADENOSINE RNA BI, DOI 10.08.331827; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kang HX, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0472-1; Kelly S. M., 2012, RNA BIOL, V6286, P159; Kelly SM, 2016, DEV NEUROBIOL, V76, P93, DOI 10.1002/dneu.22301; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Kuleshov MV, 2019, NUCLEIC ACIDS RES, V47, pW183, DOI 10.1093/nar/gkz347; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunz T, 2012, DEVELOPMENT, V139, P2510, DOI 10.1242/dev.077883; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee WH, 2020, G3-GENES GENOM GENET, V10, P3575, DOI 10.1534/g3.120.401637; Lepelletier L, 2017, J NEUROSCI, V37, P1685, DOI 10.1523/JNEUROSCI.3016-16.2016; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maechler M., 2016, CLUSTER CLUSTERANALY; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morris KJ, 2018, NUCLEIC ACIDS RES, V46, P6561, DOI 10.1093/nar/gky446; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Preitner N, 2016, DEVELOPMENT, V143, P2753, DOI 10.1242/dev.128348; R Core Team, 2020, R LANG ENV STAT COMP; Rha J, 2017, HUM MOL GENET, V26, P3663, DOI 10.1093/hmg/ddx248; Rounds J. C., 2021, DIS ASS PROTEINS DRO, DOI [10.1101/2021.03.01.433469, DOI 10.1101/2021.03.01.433469]; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shimizu K, 2011, J NEUROSCI, V31, P4944, DOI 10.1523/JNEUROSCI.0154-11.2011; Soucek S, 2016, MOL CELL BIOL, V36, P2697, DOI 10.1128/MCB.00402-16; Stoeckli ET, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151415; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Taylor J, 1998, GENETICS, V150, P199; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Venables WN., 2002, MODERN APPL STAT S 4; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang YS, 2010, DEVELOPMENT, V137, P4091, DOI 10.1242/dev.057455; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Wigington CP, 2016, J BIOL CHEM, V291, P22442, DOI 10.1074/jbc.M116.754069; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Zou YM, 2012, CURR TOP DEV BIOL, V101, P141, DOI 10.1016/B978-0-12-394592-1.00009-0; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	77	2	2	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100877	10.1016/j.jbc.2021.100877	http://dx.doi.org/10.1016/j.jbc.2021.100877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139237	Green Submitted, Green Published, gold			2022-12-26	WOS:000678068400077
J	Selen, ES; Wolfgang, MJ				Selen, Ebru S.; Wolfgang, Michael J.			mTORC1 activation is not sufficient to suppress hepatic PPAR alpha signaling or ketogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LIPID-METABOLISM; INSULIN-RESISTANCE; FUEL METABOLISM	The mechanistic target of rapamycin (mTOR) is often referred to as a master regulator of the cellular metabolism that can integrate the growth factor and nutrient signaling. Fasting suppresses hepatic mTORC1 activity via the activity of the tuberous sclerosis complex (TSC), a negative regulator of mTORC1, to suppress anabolic metabolism. The loss of TSC1 in the liver locks the liver in a constitutively anabolic state even during fasting, which was suggested to regulate peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling and ketogenesis, but the molecular determinants of this regulation are unknown. Here, we examined if the activation of the mTORC1 complex in mice by the liver-specific deletion of TSC1 (TSC1(L-/-)) is sufficient to suppress PPAR alpha signaling and therefore ketogenesis in the fasted state. We found that the activation of mTORC1 in the fasted state is not sufficient to repress PPAR alpha-responsive genes or ketogenesis. Furthermore, we examined whether the activation of the anabolic program mediated by mTORC1 complex activation in the fasted state could suppress the robust catabolic programming and enhanced PPAR alpha transcriptional response of mice with a liver-specific defect in mitochondrial long-chain fatty acid oxidation using carnitine palmitoyltransferase 2 (Cpt2(L-/-)) mice. We generated Cpt2(L-/-); Tsc1(L-/-) double-KO mice and showed that the activation of mTORC1 by deletion of TSC1 could not suppress the catabolic PPAR alpha-mediated phenotype of Cpt2(L-/-) mice. These data demonstrate that the activation of mTORC1 by the deletion of TSC1 is not sufficient to suppress a PPAR alpha transcriptional program or ketogenesis after fasting.	[Selen, Ebru S.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.; Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu			National Institutes of Health [R01DK120530, R01DK116746]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01DK120530 and R01DK116746 to M. J. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bowman CE, 2019, CELL REP, V29, P1299, DOI 10.1016/j.celrep.2019.09.053; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cappel DA, 2019, CELL METAB, V29, P1291, DOI 10.1016/j.cmet.2019.03.014; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Kim K, 2012, HEPATOLOGY, V55, P1727, DOI 10.1002/hep.25537; Kucejova B, 2016, CELL REP, V16, P508, DOI 10.1016/j.celrep.2016.06.006; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee J, 2017, CELL REP, V20, P655, DOI 10.1016/j.celrep.2017.06.080; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Quinn WJ, 2017, J CLIN INVEST, V127, P4207, DOI 10.1172/JCI96036; Selen ES, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.135626; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	26	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100884	10.1016/j.jbc.2021.100884	http://dx.doi.org/10.1016/j.jbc.2021.100884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146544	Green Published, gold			2022-12-26	WOS:000678068400083
J	Krueger, J; Santinon, F; Kazanova, A; Issa, ME; Larrivee, B; Kremer, R; Milhalcioiu, C; Rudd, CE				Krueger, Janna; Santinon, Francois; Kazanova, Alexandra; Issa, Mark E.; Larrivee, Bruno; Kremer, Richard; Milhalcioiu, Catalin; Rudd, Christopher E.			Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy	PLOS ONE			English	Article							REACTIVE T-CELLS; DOWN-REGULATION; ALPHA-BETA; CD8; CHLOROQUINE; AUTOPHAGY; AZITHROMYCIN; CANCER; TUMORIGENESIS; RECEPTORS	Immunotherapy using checkpoint blockade (ICB) with antibodies such as anti-PD-1 has revolutionised the treatment of many cancers. Despite its use to treat COVID-19 patients and autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, the effect of hydroxychloroquine (HCQ) on cancer immunotherapy has not been examined. In this study, remarkably, we find that HCQ alone, or in combination with azithromycin (AZ), at doses used to treat patients, decreased the therapeutic benefit of anti-PD-1 in cancer immunotherapy. No deleterious effect was seen on untreated tumors. Mechanistically, HCQ and HCQ/AZ inhibited PD-L1 expression on tumor cells, while specifically targeting the anti-PD-1 induced increase in progenitor CD8(+)CD44(+)PD-1(+)TCF1(+) tumor infiltrating T cells (TILs) and the generation of CD8(+)CD44(+)PD-1(+) effectors. Surprisingly, it also impaired the appearance of a subset of terminally exhausted CD8(+) TILs. No effect was seen on the presence of CD4(+) T cells, FoxP3(+) regulatory T cells (Tregs), thymic subsets, B cells, antibody production, myeloid cells, or the vasculature of mice. This study indicates for the first time that HCQ and HCQ/AZ negatively impact the ability of anti-PD-1 checkpoint blockade to promote tumor rejection.	[Krueger, Janna; Santinon, Francois; Kazanova, Alexandra; Issa, Mark E.; Rudd, Christopher E.] Rosemont Hosp CR HMR Montreal, Div Immunooncol, Res Ctr Maisonneuve, Montreal, PQ, Canada; [Krueger, Janna; Santinon, Francois; Kazanova, Alexandra; Issa, Mark E.; Rudd, Christopher E.] Univ Montreal, Dept Microbiol Infect & Immunol, Montreal, PQ, Canada; [Larrivee, Bruno] Univ Montreal, Dept Ophthalmol, Montreal, PQ, Canada; [Kremer, Richard; Rudd, Christopher E.] McGill Univ, Dept Med, Div Expt Med, Hlth Ctr, Montreal, PQ, Canada; [Milhalcioiu, Catalin] McGill Univ, Dept Med, Div Med Oncol, Hlth Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; McGill University	Rudd, CE (corresponding author), Rosemont Hosp CR HMR Montreal, Div Immunooncol, Res Ctr Maisonneuve, Montreal, PQ, Canada.; Rudd, CE (corresponding author), Univ Montreal, Dept Microbiol Infect & Immunol, Montreal, PQ, Canada.; Rudd, CE (corresponding author), McGill Univ, Dept Med, Div Expt Med, Hlth Ctr, Montreal, PQ, Canada.	christopher.e.rudd@umontreal.ca	Rudd, Christopher E/ABF-7259-2021; Rudd, Christopher E/GOH-2021-2022	Rudd, Christopher E/0000-0001-5295-9019; Kazanova, Alexandra/0000-0003-4850-9845; Larrivee, Bruno/0000-0003-1388-3108; Issa, Mark/0000-0002-0854-4147	Canadian Institutes of Health Foundation [159912]	Canadian Institutes of Health Foundation(Canadian Institutes of Health Research (CIHR))	The project was funded by Canadian Institutes of Health Foundation grant (159912).	Accapezzato D, 2005, J EXP MED, V202, P817, DOI 10.1084/jem.20051106; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Andreani J, 2020, MICROB PATHOGENESIS, V145, DOI 10.1016/j.micpath.2020.104228; [Anonymous], FDA APPR VEN CLL SLL; Arshad S, 2020, INT J INFECT DIS, V97, P396, DOI 10.1016/j.ijid.2020.06.099; Baaten BJG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00023; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BARBER EK, 1989, P NATL ACAD SCI USA, V86, P3277, DOI 10.1073/pnas.86.9.3277; Bonam SR, 2020, AUTOPHAGY, V16, P2260, DOI 10.1080/15548627.2020.1779467; Catteau L, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.106144; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03; Cianfanelli V, 2015, NAT CELL BIOL, V17, P20, DOI 10.1038/ncb3072; Cicchini M, 2014, AUTOPHAGY, V10, P2036, DOI 10.4161/auto.34398; COVID-19 RISK and Treatments (CORIST) Collaboration, 2020, Eur J Intern Med, V82, P38, DOI 10.1016/j.ejim.2020.08.019; Devaux CA, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105938; Fernandez AD, 2004, J INFECT DIS, V190, P1762, DOI 10.1086/425038; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Gesbert F, 2005, INT IMMUNOL, V17, P1093, DOI 10.1093/intimm/dxh289; Giudicessi JR, 2020, MAYO CLIN PROC, V95, P1213, DOI 10.1016/j.mayocp.2020.03.024; Grisotto MG, 2001, IMMUNOLOGY, V102, P209, DOI 10.1046/j.1365-2567.2001.01170.x; HAUGHN L, 1992, NATURE, V358, P328, DOI 10.1038/358328a0; Horby P, 2020, NEW ENGL J MED, V383, P2030, DOI 10.1056/NEJMoa2022926; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Karsli-Uzunbas G, 2014, CANCER DISCOV, V4, P914, DOI 10.1158/2159-8290.CD-14-0363; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412; Lenzer J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1335; Li Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0938-5; Liu J, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-0156-0; Magagnoli J, 2020, MED-CAMBRIDGE, V1, P114, DOI [10.1016/j.medj.2020.06.001, 10.1101/2020.04.16.20065920]; Mahevas M, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m2328, 10.1136/bmj.m1844]; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Molina JM, 2020, MED MALADIES INFECT, V50, P384, DOI 10.1016/j.medmal.2020.03.006; Nina PB, 2020, INDIAN J PUBLIC HLTH, V64, P125, DOI 10.4103/ijph.IJPH_496_20; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Patel S, 2016, ONCOTARGET, V7, P59087, DOI 10.18632/oncotarget.10824; Poschet Jens F, 2020, bioRxiv, DOI 10.1101/2020.03.29.008631; Raghu D, 2019, TRENDS IMMUNOL, V40, P1149, DOI 10.1016/j.it.2019.10.006; Roldan EQ, 2020, PHARMACOL RES, V158, DOI 10.1016/j.phrs.2020.104904; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Rudd CE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01638; Rudd CE, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz8128; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; Sharma G, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133225; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Smith GA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan4931; Strauss L, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay1863; Tang W, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1849; Thome R, 2014, IMMUNOL CELL BIOL, V92, P124, DOI 10.1038/icb.2013.73; Thome R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065913; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69; WALKER PR, 1995, J IMMUNOL, V155, P3443; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilkinson B, 2004, IMMUNOLOGY, V111, P368, DOI 10.1111/j.0019-2805.2004.01832.x; Wong YK, 2020, LANCET RHEUMATOL, V2, pE255, DOI 10.1016/S2665-9913(20)30093-X; Wozniacka A, 2008, BRIT J DERMATOL, V159, P1124, DOI 10.1111/j.1365-2133.2008.08804.x; Wu SF, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1393-y; Yamamoto K, 2020, NATURE, V581, P100, DOI 10.1038/s41586-020-2229-5; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yu B, 2020, SCI CHINA LIFE SCI, V63, P1515, DOI 10.1007/s11427-020-1732-2; Zhang, 2020, EFFICACY HYDROXYCHLO, P7, DOI [10.1101/.20040758, 10.1101/2020.03.22.20040758, DOI 10.1101/2020.03.22.20040758]; ZHANG L, 1995, J IMMUNOL, V155, P3464; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	76	4	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0251731	10.1371/journal.pone.0251731	http://dx.doi.org/10.1371/journal.pone.0251731			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181666	gold, Green Published			2022-12-26	WOS:000671695800014
J	Coratti, G; Pane, M; Brogna, C; Ricotti, V; Messina, S; D'Amico, A; Bruno, C; Vita, G; Berardinelli, A; Mazzone, E; Magri, F; Ricci, F; Mongini, T; Battini, R; Bello, L; Pegoraro, E; Baranello, G; Previtali, SC; Politano, L; Comi, GP; Sansone, VA; Donati, A; Hogrel, JY; Straub, V; De Lucia, S; Niks, E; Servais, L; De Groot, I; Chesshyre, M; Bertini, E; Goemans, N; Muntoni, F; Mercuri, E				Coratti, Giorgia; Pane, Marika; Brogna, Claudia; Ricotti, Valeria; Messina, Sonia; D'Amico, Adele; Bruno, Claudio; Vita, Gianluca; Berardinelli, Angela; Mazzone, Elena; Magri, Francesca; Ricci, Federica; Mongini, Tiziana; Battini, Roberta; Bello, Luca; Pegoraro, Elena; Baranello, Giovanni; Previtali, Stefano C.; Politano, Luisa; Comi, Giacomo P.; Sansone, Valeria A.; Donati, Alice; Hogrel, Jean Yves; Straub, Volker; De Lucia, Silvana; Niks, Erik; Servais, Laurent; De Groot, Imelda; Chesshyre, Mary; Bertini, Enrico; Goemans, Nathalie; Muntoni, Francesco; Mercuri, Eugenio		Int DMD Grp; iMDEX Consortium	North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up	PLOS ONE			English	Article								Introduction The aim of this study was to report 36-month longitudinal changes using the North Star Ambulatory Assessment (NSAA) in ambulant patients affected by Duchenne muscular dystrophy amenable to skip exons 44, 45, 51 or 53. Materials and methods We included 101 patients, 34 had deletions amenable to skip exon 44, 25 exon 45, 19 exon 51, and 28 exon 53, not recruited in any ongoing clinical trials. Five patients were counted to skip exon 51 and 53 since they had a single deletion of exon 52. Results The difference between subgroups (skip 44, 45, 51 and 53) was significant at 12 (p = 0.043), 24 (p = 0.005) and 36 months (p <= 0.001). Discussion Mutations amenable to skip exons 53 and 51 had lower baseline values and more negative changes than the other subgroups while those amenable to skip exon 44 had higher scores both at baseline and at follow up. Conclusion Our results confirm different progression of disease in subgroups of patients with deletions amenable to skip different exons. This information is relevant as current long term clinical trials are using the NSAA in these subgroups of mutations.	[Coratti, Giorgia; Pane, Marika; Brogna, Claudia; Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Dept Woman & Child Hlth & Publ Hlth, Child Hlth Area, Pediat Neurol, Rome, Italy; [Coratti, Giorgia; Pane, Marika; Brogna, Claudia; Mazzone, Elena; Mercuri, Eugenio] Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Clin Nemo, Rome, Italy; [Ricotti, Valeria; Baranello, Giovanni; Chesshyre, Mary; Muntoni, Francesco] UCL, Dubowitz Neuromuscular Ctr, London, England; [Ricotti, Valeria; Baranello, Giovanni; Chesshyre, Mary; Muntoni, Francesco] Great Ormond St Hosp Sick Children, London, England; [Ricotti, Valeria; Chesshyre, Mary; Muntoni, Francesco] NIHR Great Ormond St Hosp Biomed Res Ctr, London, England; [Messina, Sonia] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Messina, Sonia; Vita, Gianluca] Univ Hosp G Martino, Nemo SUD Clin Ctr, Messina, Italy; [D'Amico, Adele; Bertini, Enrico] Bambino Gesu Pediat Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Bruno, Claudio] IRCCS Ist Giannina Gaslini, Ctr Translat & Expt Myol, Genoa, Italy; [Berardinelli, Angela] IRCCS Mondino Fdn, Pavia, Italy; [Magri, Francesca; Comi, Giacomo P.] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy; [Ricci, Federica; Mongini, Tiziana] Univ Turin, Neuromuscular Ctr, AOU Citta Salute & Sci, Turin, Italy; [Battini, Roberta] Stella Maris Inst, Dept Dev Neurosci, Pisa, Italy; [Battini, Roberta] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Bello, Luca; Pegoraro, Elena] Univ Padua, Dept Neurosci, Padua, Italy; [Baranello, Giovanni] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy; [Previtali, Stefano C.] IRCCS San Raffaele Sci Inst, Div Neurosci, Milan, Italy; [Politano, Luisa] Univ Campania Luigi Vanvitelli, Cardiomyol & Med Genet, Naples, Italy; [Sansone, Valeria A.] Univ Milan, ASST Niguarda Hosp, NEMO Ctr Milan, Neurorehabil Unit, Milan, Italy; [Donati, Alice] Metab Unit, Florence, Italy; [Hogrel, Jean Yves; De Lucia, Silvana] Hop Armand Trousseau, Inst Myol, Inst Mot 1, Paris, France; [Straub, Volker] Newcastle Univ, John Walton Muscular Dystrophy Res Ctr, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Straub, Volker] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Niks, Erik] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Servais, Laurent] CHU Liege, Ctr Reference Malad Neuromusculaires, Liege, Belgium; [Servais, Laurent] Univ Oxford, MDUK Neuromuscular Ctr, Dept Paediat, Oxford, England; [De Groot, Imelda] Radboud Univ Nijmegen, Donders Ctr Med Neurosci, Dept Rehabil, Med Ctr, Nijmegen, Netherlands; [Goemans, Nathalie] Univ Hosp Leuven, Dept Child Neurol, Leuven, Belgium	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Messina; AOU Policlinico Gaetano Martino; IRCCS Bambino Gesu; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Fondazione Casimiro Mondino; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Fondazione Stella Maris; University of Pisa; University of Padua; IRCCS Istituto Neurologico Besta; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Campania Vanvitelli; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Liege; University of Oxford; Radboud University Nijmegen; KU Leuven; University Hospital Leuven	Mercuri, E (corresponding author), Univ Cattolica Sacro Cuore, Dept Woman & Child Hlth & Publ Hlth, Child Hlth Area, Pediat Neurol, Rome, Italy.; Mercuri, E (corresponding author), Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Clin Nemo, Rome, Italy.	eugeniomaria.mercuri@unicatt.it	Comi, Giacomo P/K-5702-2016; Coratti, Giorgia/AAV-3224-2021; Ricci, Federica/AAY-9172-2021; Coratti, Giorgia/Y-6292-2019; POLITANO, LUISA/AAK-6885-2020; battini, roberta/P-9095-2017; BROGNA, Claudia/K-9759-2016	Comi, Giacomo P/0000-0002-1383-5248; Coratti, Giorgia/0000-0001-6666-5628; Coratti, Giorgia/0000-0001-6666-5628; battini, roberta/0000-0002-7889-1355; BROGNA, Claudia/0000-0002-9526-6367; Pane, Marika/0000-0002-4851-6124; Straub, Volker/0000-0001-9046-3540; Vita, Gianluca/0000-0003-4190-8042; Hogrel, Jean-Yves/0000-0003-0045-7505	Association Francaise contre les Myopathies (AFM) [IMDEX/NCT02780492]; UCL MRC Neuromuscular Biobank; Muscular Dystrophy UK; NIHR Great Ormond Street Hospital Biomedical Research Centre; Telethon [GUP 15011]; NIHR Newcastle BRC; NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London; Great Ormond Street Hospital Trust, London	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); UCL MRC Neuromuscular Biobank; Muscular Dystrophy UK; NIHR Great Ormond Street Hospital Biomedical Research Centre; Telethon(Fondazione Telethon); NIHR Newcastle BRC; NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London; Great Ormond Street Hospital Trust, London	The study was partially founded by the Italian Telethon (GUP 15011) to EM and partially funded by the Association Francaise contre les Myopathies (AFM) for the collection and analysis of the data from the patients recruited in iMDEX natural history study (IMDEX/NCT02780492). We are grateful for the support of the UCL MRC Neuromuscular Biobank and the Muscular Dystrophy UK for the support given to the Dubowitz Neuromuscular Centre. This research was also supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre. FM and TV are supported by the NIHR Great Ormond Street Hospital Biomedical Research Centre, Great Ormond Street Institute of Child Health, University College London, & Great Ormond Street Hospital Trust, London. VS is supported by the NIHR Newcastle BRC. Several members of the iMDEX consortium and of the International DMD group are members of the European Reference Network for Neuromuscular Diseases (EURO-NMD). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano LN, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000015858; Anthony K, 2014, JAMA NEUROL, V71, P32, DOI 10.1001/jamaneurol.2013.4908; Bello L, 2016, NEUROLOGY, V87, P401, DOI 10.1212/WNL.0000000000002891; Brogna C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218683; Goemans N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164684; Mazzone ES, 2009, NEUROMUSCULAR DISORD, V19, P458, DOI 10.1016/j.nmd.2009.06.368; Mazzone E, 2010, NEUROMUSCULAR DISORD, V20, P712, DOI 10.1016/j.nmd.2010.06.014; Mazzone ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151445; Mazzone ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052512; Mendell JR, 2016, ANN NEUROL, V79, P257, DOI 10.1002/ana.24555; Pane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108205; Pane M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083400, 10.1371/journal.pone.0108205]; Ricotti V, 2016, J NEUROL NEUROSUR PS, V87, P149, DOI 10.1136/jnnp-2014-309405; Ricotti V, 2013, J NEUROL NEUROSUR PS, V84, P698, DOI 10.1136/jnnp-2012-303902; Scott E, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.520; Servais Laurent, 2015, J Neuromuscul Dis, V2, P269; van Vliet L, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-105	17	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253882	10.1371/journal.pone.0253882	http://dx.doi.org/10.1371/journal.pone.0253882			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170974	Green Published, gold			2022-12-26	WOS:000671694400070
J	Frank, MO; Blachere, NE; Parveen, S; Hacisuleyman, E; Fak, J; Luna, JM; Michailidis, E; Wright, S; Stark, P; Campbell, A; Foo, A; Sakmar, TP; Huffman, V; Bergh, M; Goldfarb, A; Mansisidor, A; Patriotis, AL; Palmquist, KH; Poulton, N; Leicher, R; Vargas, CDM; Duba, I; Hurley, A; Colagreco, J; Pagane, N; Orange, DE; Mora, K; Rakeman, JL; Fowler, RC; Fernandes, H; Lamendola-Essel, MF; Didkovsky, N; Silvera, L; Masci, J; Allen, M; Rice, CM; Darnell, RB				Frank, Mayu O.; Blachere, Nathalie E.; Parveen, Salina; Hacisuleyman, Ezgi; Fak, John; Luna, Joseph M.; Michailidis, Eleftherios; Wright, Samara; Stark, Pamela; Campbell, Ann; Foo, Ashley; Sakmar, Thomas P.; Huffman, Virginia; Bergh, Marissa; Goldfarb, Audrey; Mansisidor, Andres; Patriotis, Agata L.; Palmquist, Karl H.; Poulton, Nicolas; Leicher, Rachel; Vargas, Cesar D. M.; Duba, Irene; Hurley, Arlene; Colagreco, Joseph; Pagane, Nicole; Orange, Dana E.; Mora, Kevin; Rakeman, Jennifer L.; Fowler, Randal C.; Fernandes, Helen; Lamendola-Essel, Michelle F.; Didkovsky, Nicholas; Silvera, Leopolda; Masci, Joseph; Allen, Machelle; Rice, Charles M.; Darnell, Robert B.			DRUL for school: Opening Pre-K with safe, simple, sensitive saliva testing for SARS-CoV-2	PLOS ONE			English	Article								To address the need for simple, safe, sensitive, and scalable SARS-CoV-2 tests, we validated and implemented a PCR test that uses a saliva collection kit use at home. Individuals self-collected 300 mu l saliva in vials containing Darnell Rockefeller University Laboratory (DRUL) buffer and extracted RNA was assayed by RT-PCR (the DRUL saliva assay). The limit of detection was confirmed to be 1 viral copy/mu l in 20 of 20 replicate extractions. Viral RNA was stable in DRUL buffer at room temperature up to seven days after sample collection, and safety studies demonstrated that DRUL buffer immediately inactivated virus at concentrations up to 2.75x10(6) PFU/ml. Results from SARS-CoV-2 positive nasopharyngeal (NP) swab samples collected in viral transport media and assayed with a standard FDA Emergency Use Authorization (EUA) test were highly correlated with samples placed in DRUL buffer. Direct comparison of results from 162 individuals tested by FDA EUA oropharyngeal (OP) or NP swabs with co-collected saliva samples identified four otherwise unidentified positive cases in DRUL buffer. Over six months, we collected 3,724 samples from individuals ranging from 3 months to 92 years of age. This included collecting weekly samples over 10 weeks from teachers, children, and parents from a pre-school program, which allowed its safe reopening while at-risk pods were quarantined. In sum, we validated a simple, sensitive, stable, and safe PCR-based test using a self-collected saliva sample as a valuable tool for clinical diagnosis and screening at workplaces and schools.	[Frank, Mayu O.; Blachere, Nathalie E.; Parveen, Salina; Hacisuleyman, Ezgi; Fak, John; Luna, Joseph M.; Bergh, Marissa; Orange, Dana E.; Mora, Kevin; Fernandes, Helen; Lamendola-Essel, Michelle F.; Didkovsky, Nicholas; Darnell, Robert B.] Rockefeller Univ, Lab Mol Neurooncol, 1230 York Ave, New York, NY 10021 USA; [Blachere, Nathalie E.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Luna, Joseph M.; Michailidis, Eleftherios; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, 1230 York Ave, New York, NY 10021 USA; [Wright, Samara; Stark, Pamela] Rockefeller Univ, Child & Family Ctr, 1230 York Ave, New York, NY 10021 USA; [Campbell, Ann; Foo, Ashley] Rockefeller Univ, Occupat Hlth Serv, 1230 York Ave, New York, NY 10021 USA; [Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [Huffman, Virginia] Rockefeller Univ, Human Resources, 1230 York Ave, New York, NY 10021 USA; [Goldfarb, Audrey] Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10021 USA; [Mansisidor, Andres; Duba, Irene; Pagane, Nicole] Rockefeller Univ, Lab Genome Architecture & Dynam, 1230 York Ave, New York, NY 10021 USA; [Patriotis, Agata L.] Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10021 USA; [Palmquist, Karl H.] Rockefeller Univ, Lab Morphogenesis, 1230 York Ave, New York, NY 10021 USA; [Poulton, Nicolas] Rockefeller Univ, Lab Host Pathogen Biol, 1230 York Ave, New York, NY 10021 USA; [Leicher, Rachel] Rockefeller Univ, Lab Nanoscale Biophys & Biochem, 1230 York Ave, New York, NY 10021 USA; [Vargas, Cesar D. M.] Rockefeller Univ, Lab Neurogenet Language, 1230 York Ave, New York, NY 10021 USA; [Hurley, Arlene] Rockefeller Univ, Rockefeller Univ Hosp, 1230 York Ave, New York, NY 10021 USA; [Colagreco, Joseph] Rockefeller Univ, Leonard Wagner Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10021 USA; [Orange, Dana E.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Rakeman, Jennifer L.; Fowler, Randal C.] New York City Dept Hlth & Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA; [Fernandes, Helen] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Lamendola-Essel, Michelle F.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Silvera, Leopolda; Masci, Joseph; Allen, Machelle] New York City Hlth & Hosp, Elmhurst Hosp Ctr, Elmhurst, NY USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Rockefeller University; Columbia University; Memorial Sloan Kettering Cancer Center	Darnell, RB (corresponding author), Rockefeller Univ, Lab Mol Neurooncol, 1230 York Ave, New York, NY 10021 USA.; Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	darnelr@rockefeller.edu		Lamendola-Essel, Michelle/0000-0002-4379-4694; Palmquist, Karl/0000-0002-2749-1458; Frank, Mayu/0000-0002-5597-4828; Michailidis, Eleftherios/0000-0002-9907-4346	G. Harold and Leila Y. Mathers Charitable Foundation; BAWD Foundation; Rockefeller University	G. Harold and Leila Y. Mathers Charitable Foundation; BAWD Foundation; Rockefeller University	C.M.R acknowledges the generous support of the G. Harold and Leila Y. Mathers Charitable Foundation, the BAWD Foundation, and The Rockefeller University. R.B.D. wishes to disclose that he receives consulting fees as a Senior Visiting Fellow at MITRE Corporation, has started a charitable LLC, D4S Testing, to offer free DRUL saliva testing to NYC school children, and is an Investigator of the Howard Hughes Medical Institute.	Akst J., 2020, RNA EXTRACTION KITS; Baird RP, 2020, NEW YORKER; Bateman Nicole., 2020, WHY HAS COVID 19 BEE; CDC, 2019, CDC 2019 NOV COR 201; CDC, 2020, OV TEST SARS COV 2 C; CDC, 2020, COVID 19 CAS DEATHS; CDC, 2021, GUIDANCE OPERATING C; CDC, 2021, OP STRAT K 12 SCH OP STRAT K 12 SCH; Cepheid, 2021, XPERT XPRESS SARS CO; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Esbin MN, 2020, RNA, V26, P771, DOI 10.1261/rna.076232.120; Institute for Health Metrics and Evaluation, COVID 19 PROJ; Kaiser J, 2014, SCIENCE, V345, P1112, DOI 10.1126/science.345.6201.1112; Spectrum Solutions, EM US AUTH EUA SUMM EM US AUTH EUA SUMM	14	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252949	10.1371/journal.pone.0252949	http://dx.doi.org/10.1371/journal.pone.0252949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170927	Green Submitted, gold, Green Published			2022-12-26	WOS:000671694400053
J	Lee, H; Lee, HK; Lee, K				Lee, Hoseon; Lee, Hye-Kyung; Lee, Kounseok			Is personality linked to season of birth?	PLOS ONE			English	Article							TEMPERAMENT; ASSOCIATION; TRAITS; POLYMORPHISMS; SCHIZOPHRENIA; ADOLESCENTS; DIMENSIONS; MELATONIN; CHILDREN; SEEKING	The environment is a very significant factor in early childhood development. Season of birth (SOB) is a proxy viable for the environment to which the babies are exposed, thus also significant in early development. This study investigates the association between SOB and personality. A total 2,962 college students were included as study participants. The participants were classified into four seasonal groups based on their birth month and underwent a personality assessment using the Temperament and Character Inventory (TCI). Statistical analysis was performed using one-way analysis of variance (ANOVA) and multinomial logistic regression analysis. The male participants born in autumn scored high on the Disorderliness (NS4) subscale (beta = 0.055, P = 0.042) and the male participants born in summer and winter scored high on the Extravagance (NS3) subscale (summer: beta = 0.072, P = 0.01, winter: beta = 0.078, P = 0.003). The difference observed indicates a relationship between the SOB and temperament, especially NS. Our findings suggest that environmental factors may affect temperament in early development, although further research is likely needed to clarify the causality between them.	[Lee, Hoseon] Seodaemoonbom Psychiat Clin, Seoul, South Korea; [Lee, Hoseon; Lee, Kounseok] Hanyang Univ, Coll Med, Dept Psychiat, Seoul, South Korea; [Lee, Hye-Kyung] Kongju Natl Univ, Coll Nursing & Hlth, Dept Nursing, Gongju, South Korea	Hanyang University; Kongju National University	Lee, K (corresponding author), Hanyang Univ, Coll Med, Dept Psychiat, Seoul, South Korea.	dual@hanyang.ac.kr		Lee, Kounseok/0000-0002-6084-5043; Lee, Hoseon/0000-0002-4513-4833	National Research Foundation of Korea (NRF) - Ministry of Education [NRF2018R1D1A1B07050245]; Ministry of Trade, Industry and Energy (MOTIE, Korea) [20012931]	National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Trade, Industry and Energy (MOTIE, Korea)	YES -This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF2018R1D1A1B07050245), and the Technology Innovation Program (20012931) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea). This funding source played no role in the study design, collection, analysis, and interpretation of data, the writing of the manuscript,	[Anonymous], 2010, ANXIETY MOOD; Asberg M, 1997, ANN NY ACAD SCI, V836, P158, DOI 10.1111/j.1749-6632.1997.tb52359.x; BERMAN SM, 1995, BEHAV GENET, V25, P45, DOI 10.1007/BF02197241; Brenner AV, 2004, NEUROLOGY, V63, P276, DOI 10.1212/01.WNL.0000129984.01327.9D; Caci H, 2004, EUR PSYCHIAT, V19, P79, DOI 10.1016/j.eurpsy.2003.09.007; Chotai J, 2003, PERS INDIV DIFFER, V35, P897, DOI 10.1016/S0191-8869(02)00306-9; Chotai J, 2002, EUR ARCH PSY CLIN N, V252, P130, DOI 10.1007/s00406-002-0372-7; Chotai J, 2002, PSYCHIAT RES, V111, P45, DOI 10.1016/S0165-1781(02)00107-5; Chotai J, 2002, J AFFECT DISORDERS, V69, P69, DOI 10.1016/S0165-0327(00)00379-7; Chotai J, 1999, NEUROPSYCHOBIOLOGY, V39, P57, DOI 10.1159/000026561; Chotai J, 2001, NEUROPSYCHOBIOLOGY, V44, P19, DOI 10.1159/000054909; Chotai J., 2005, NEUROPSYCHOBIOLOGY, V39, P57; Chotai J, 2006, PSYCHIAT RES, V145, P189, DOI 10.1016/j.psychres.2005.11.008; Chotai J, 2009, COMPR PSYCHIAT, V50, P562, DOI 10.1016/j.comppsych.2008.11.010; Cloninger CR, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0621-4; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; Comings DE, 2000, CLIN GENET, V58, P375, DOI 10.1034/j.1399-0004.2000.580508.x; Currie J, 2009, J HEALTH ECON, V28, P688, DOI 10.1016/j.jhealeco.2009.02.001; Davis FC, 1997, J BIOL RHYTHM, V12, P498, DOI 10.1177/074873049701200603; Ebstein RP, 2000, EUR J PHARMACOL, V410, P205, DOI 10.1016/S0014-2999(00)00852-9; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Flouris AD, 2009, AM J HUM BIOL, V21, P214, DOI 10.1002/ajhb.20818; Gerra G, 2000, PSYCHONEUROENDOCRINO, V25, P479, DOI 10.1016/S0306-4530(00)00004-4; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Golimbet V E, 2007, Neurosci Behav Physiol, V37, P601, DOI 10.1007/s11055-007-0058-8; GUPTA S, 1992, PERS INDIV DIFFER, V13, P631, DOI 10.1016/0191-8869(92)90206-5; HOFMAN MA, 1995, BRAIN RES, V671, P254, DOI 10.1016/0006-8993(94)01339-J; Joinson C, 2005, PERS INDIV DIFFER, V38, P859, DOI 10.1016/j.paid.2004.06.010; Kamata M, 2009, EUR PSYCHIAT, V24, P86, DOI 10.1016/j.eurpsy.2008.10.006; Kim S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073339; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lachman HM, 1998, AM J PSYCHIAT, V155, P835; Lee HJ, 2003, AM J MED GENET B, V121B, P44, DOI 10.1002/ajmg.b.20054; Mann JJ, 1998, NAT MED, V4, P25, DOI 10.1038/nm0198-025; Miettunen J, 2007, COMPR PSYCHIAT, V48, P161, DOI 10.1016/j.comppsych.2006.10.007; Mimarakis D, 2018, EUR PSYCHIAT, V47, P9, DOI 10.1016/j.eurpsy.2017.07.014; Min B., 2007, MANUAL TEMPERAMENT C, P15; Natale V, 2002, NEUROPSYCHOBIOLOGY, V46, P209, DOI 10.1159/000067803; Noble EP, 1998, AM J MED GENET, V81, P257, DOI 10.1002/(SICI)1096-8628(19980508)81:3<257::AID-AJMG10>3.0.CO;2-E; NOBLE EP, 1994, AM J HUM GENET, V54, P658; Pivac N, 2009, CROAT MED J, V50, P43, DOI 10.3325/cmj.2009.50.43; Schwartz PJ, 2011, MED HYPOTHESES, V76, P785, DOI 10.1016/j.mehy.2011.02.019; Strous RD, 1997, PSYCHIAT RES, V69, P71, DOI 10.1016/S0165-1781(96)03111-3; Tavassoli E, 2013, INT J DEV NEUROSCI, V31, P790, DOI 10.1016/j.ijdevneu.2013.09.010; Tochigi M., 2004, NEUROSCI, VLett, P120; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	48	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253815	10.1371/journal.pone.0253815	http://dx.doi.org/10.1371/journal.pone.0253815			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170954	Green Published, gold			2022-12-26	WOS:000671694400019
J	Qiu, YF; Yang, Y; Yang, RY; Liu, CX; Hsu, JM; Jiang, Z; Sun, LL; Wei, YK; Li, CW; Yu, DH; Zhang, J; Hung, MC				Qiu, Yufan; Yang, Yi; Yang, Riyao; Liu, Chunxiao; Hsu, Jung-Mao; Jiang, Zhou; Sun, Linlin; Wei, Yongkun; Li, Chia-Wei; Yu, Dihua; Zhang, Jin; Hung, Mien-Chie			Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer	ONCOGENE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; EXTRACELLULAR VESICLES; EXPRESSION; BIOLOGY	Programmed cell death 1 (PD-1) is widely expressed in tumor-infiltrating lymphocytes (TILs) of triple-negative breast cancer (TNBC). As a dominant inhibitory immune checkpoint (ICP) receptor, cell surface PD-1 is well-known to transduce negative signaling of effector T cell activity during cell-cell contact. However, despite its well-documented inhibitory effects, higher PD-1 expression in TILs is significantly associated with longer survival in TNBC patients. This phenomenon raises an interesting question whether PD-1 harbors positive activity to enhance anti-tumor immunity. Here, we show that PD-1 is secreted in an exosomal form by activated T cells and can remotely interact with either cell surface or exosomal programmed death-ligand 1 (PD-L1), induce PD-L1 internalization via clathrin-mediated endocytosis, and thereby prevent subsequent cellular PD-L1: PD-1 interaction, restoring tumor surveillance through attenuating PD-L1-induced suppression of tumor-specific cytotoxic T cell activity. Our results, through revealing an anti-PD-L1 function of exosomal PD-1, provide a positive role to enhance cytotoxic T cell activity and a potential therapeutic strategy of modifying the exosome surface with membrane-bound inhibitory ICP receptors to attenuate the suppressive tumor immune microenvironment.	[Qiu, Yufan; Zhang, Jin] Tianjin Med Univ Canc Inst & Hosp, Treatment & Res Ctr, Dept Breast Canc Prevent 3, Tianjin, Peoples R China; [Qiu, Yufan; Zhang, Jin] Tianjin Med Univ Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Qiu, Yufan; Zhang, Jin] Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China; [Qiu, Yufan; Zhang, Jin] Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China; [Qiu, Yufan; Zhang, Jin] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China; [Qiu, Yufan; Yang, Yi; Yang, Riyao; Liu, Chunxiao; Hsu, Jung-Mao; Jiang, Zhou; Sun, Linlin; Wei, Yongkun; Li, Chia-Wei; Yu, Dihua; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Qiu, Yufan; Zhang, Jin] Tianjin Med Univ, Tianjin, Peoples R China; [Yang, Yi] Third Mil Med Univ, Southwest Hosp, Inst Pathol & Southwest Canc Ctr, Army Med Univ, Chongqing, Peoples R China; [Hsu, Jung-Mao; Hung, Mien-Chie] China Med Univ, Grad Inst Biomed Sci & Res Ctr Mol Med, Taichung 406, Taiwan; [Sun, Linlin] Tianjin Med Univ Gen Hosp, Lung Canc Inst, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Tianjin, Peoples R China; [Li, Chia-Wei] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; Army Medical University; China Medical University Taiwan; Tianjin Medical University; Academia Sinica - Taiwan; Asia University Taiwan	Zhang, J (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Treatment & Res Ctr, Dept Breast Canc Prevent 3, Tianjin, Peoples R China.; Zhang, J (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Minist Educ, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China.; Zhang, J (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.; Zhang, J (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.; Zhang, J (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Tianjin, Peoples R China.; Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Zhang, J (corresponding author), Tianjin Med Univ, Tianjin, Peoples R China.; Hung, MC (corresponding author), China Med Univ, Grad Inst Biomed Sci & Res Ctr Mol Med, Taichung 406, Taiwan.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung 413, Taiwan.	zhangjin@tjmuch.com; mhung@cmu.edu.tw	Jiang, Zhou/ABF-2435-2021; Hung, Mien-Chie/ABD-5911-2021; Hsu, Jung-Mao/AAC-9527-2019; Li, Chia-Wei/AAC-8660-2019; Yang, Riyao/R-7593-2019	Jiang, Zhou/0000-0003-4247-2949; Hung, Mien-Chie/0000-0003-4317-4740; Li, Chia-Wei/0000-0002-2531-2866; Yang, Riyao/0000-0002-0278-4385; Qiu, Yufan/0000-0002-6791-9957	National Institutes of Health CCSG [CA016672]; Cancer Prevention and Research Institute of Texas [RP160710]; MD Anderson-China Medical University Sister Institution Fund; Ministry of Science and Technology in Taiwan [MOST 109-2327-B-039-003, MOST 109-2314-B-001-008]; Patel Memorial Breast Cancer Endowment Fund; National Natural Science Foundation of China [81672623]; Science and Technology Support Program of Tianjin, China [19YFZCSY0030]; China Scholarship Council [201906940042]	National Institutes of Health CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; MD Anderson-China Medical University Sister Institution Fund; Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan); Patel Memorial Breast Cancer Endowment Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Program of Tianjin, China; China Scholarship Council(China Scholarship Council)	This work was funded in part by the following: grants from the National Institutes of Health CCSG CA016672; Cancer Prevention and Research Institute of Texas (RP160710); The MD Anderson-China Medical University Sister Institution Fund; Ministry of Science and Technology in Taiwan (MOST 109-2327-B-039-003 to MCH, MOST 109-2314-B-001-008 to CWL); Patel Memorial Breast Cancer Endowment Fund; The National Natural Science Foundation of China (No. 81672623); The Science and Technology Support Program of Tianjin, China (No. 19YFZCSY0030); The China Scholarship Council Award to YQ (No. 201906940042). We would like to thank the scientific editors in the Research Medical Library at MD Anderson Cancer Center for editorial assistance.	Bastos N, 2018, SEMIN CELL DEV BIOL, V78, P13, DOI 10.1016/j.semcdb.2017.08.009; Beit-Yannai E, 2018, J CELL MOL MED, V22, P2001, DOI 10.1111/jcmm.13479; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Burugu S, 2017, ANN ONCOL, V28, P2977, DOI 10.1093/annonc/mdx557; Burugu S, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1502128; Calvo V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072631; Chen L, 2019, MED SCI MONITOR, V25, P4877, DOI 10.12659/MSM.917058; Datar I, 2019, CLIN CANCER RES, V25, P4663, DOI 10.1158/1078-0432.CCR-18-4142; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fernandez-Poma SM, 2017, CANCER RES, V77, P3672, DOI 10.1158/0008-5472.CAN-17-0236; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Gutierrez-Vazquez C, 2013, IMMUNOL REV, V251, P125, DOI 10.1111/imr.12013; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Harano K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204513; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Latchman YE, 2004, P NATL ACAD SCI USA, V101, P10691, DOI 10.1073/pnas.0307252101; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12574; Liu CX, 2021, J HEPATOL, V74, P907, DOI 10.1016/j.jhep.2020.09.030; Loi S, 2014, ANN ONCOL, V25, P1544, DOI 10.1093/annonc/mdu112; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Lu J, 2018, IMMUNOL RES, V66, P313, DOI 10.1007/s12026-018-9000-0; Luan X, 2017, ACTA PHARMACOL SIN, V38, P754, DOI 10.1038/aps.2017.12; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Pardoll D, 2015, SEMIN ONCOL, V42, P523, DOI 10.1053/j.seminoncol.2015.05.003; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Pruneri G, 2016, ANN ONCOL, V27, P249, DOI 10.1093/annonc/mdv571; Ren XY, 2018, CANCER BIOL THER, V19, P373, DOI 10.1080/15384047.2018.1423919; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Seo N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02865-1; Sharma P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-56542-4; Theodoraki MN, 2018, CLIN CANCER RES, V24, P896, DOI 10.1158/1078-0432.CCR-17-2664; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tucci M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1387706; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; Ventimiglia LN, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00084; Wang JL, 2014, MOL MED REP, V9, P125, DOI 10.3892/mmr.2013.1759; Wang XC, 2019, J MED GENET, V56, P29, DOI 10.1136/jmedgenet-2018-105439; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Xie FT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1074-3; Yang JT, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6387924; Yang RY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21099-2; Yeong J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0499-y	48	30	31	9	28	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					4992	5001		10.1038/s41388-021-01896-1	http://dx.doi.org/10.1038/s41388-021-01896-1		JUN 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34172932	hybrid, Green Published			2022-12-26	WOS:000667016100002
J	Deol, AK; Scarponi, D; Beckwith, P; Yates, TA; Karat, AS; Yan, AWC; Baisley, KS; Grant, AD; White, RG; McCreesh, N				Deol, Arminder K.; Scarponi, Danny; Beckwith, Peter; Yates, Tom A.; Karat, Aaron S.; Yan, Ada W. C.; Baisley, Kathy S.; Grant, Alison D.; White, Richard G.; McCreesh, Nicky			Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens	PLOS ONE			English	Article							TUBERCULOSIS; INFECTION	Background In light of the role that airborne transmission plays in the spread of SARS-CoV-2, as well as the ongoing high global mortality from well-known airborne diseases such as tuberculosis and measles, there is an urgent need for practical ways of identifying congregate spaces where low ventilation levels contribute to high transmission risk. Poorly ventilated clinic spaces in particular may be high risk, due to the presence of both infectious and susceptible people. While relatively simple approaches to estimating ventilation rates exist, the approaches most frequently used in epidemiology cannot be used where occupancy varies, and so cannot be reliably applied in many of the types of spaces where they are most needed. Methods The aim of this study was to demonstrate the use of a non-steady state method to estimate the absolute ventilation rate, which can be applied in rooms where occupancy levels vary. We used data from a room in a primary healthcare clinic in a high TB and HIV prevalence setting, comprising indoor and outdoor carbon dioxide measurements and head counts (by age), taken over time. Two approaches were compared: approach 1 using a simple linear regression model and approach 2 using an ordinary differential equation model. Results The absolute ventilation rate, Q, using approach 1 was 2407 l/s [95% CI: 1632-3181] and Q from approach 2 was 2743 l/s [95% CI: 2139-4429]. Conclusions We demonstrate two methods that can be used to estimate ventilation rate in busy congregate settings, such as clinic waiting rooms. Both approaches produced comparable results, however the simple linear regression method has the advantage of not requiring room volume measurements. These methods can be used to identify poorly-ventilated spaces, allowing measures to be taken to reduce the airborne transmission of pathogens such as Mycobacterium tuberculosis, measles, and SARS-CoV-2.	[Deol, Arminder K.; Scarponi, Danny; Karat, Aaron S.; Grant, Alison D.; White, Richard G.; McCreesh, Nicky] London Sch Hyg & Trop Med, TB Ctr, Dept Infect Dis Epidemiol, London, England; [Beckwith, Peter] Univ Cape Town, Dept Med, Cape Town, South Africa; [Beckwith, Peter; Karat, Aaron S.] Queen Margaret Univ, Inst Global Hlth & Dev, Edinburgh, Midlothian, Scotland; [Yates, Tom A.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England; [Yan, Ada W. C.] Imperial Coll London, Dept Infect Dis, Sect Immunol Infect, London, England; [Baisley, Kathy S.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Grant, Alison D.] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Africa Hlth Res Inst, Durban, South Africa; [Grant, Alison D.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Queen Margaret University; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Africa Health Research Institute; University of Kwazulu Natal; University of Witwatersrand	Deol, AK (corresponding author), London Sch Hyg & Trop Med, TB Ctr, Dept Infect Dis Epidemiol, London, England.	arminder.deol@lshtm.ac.uk	White, Richard G/D-5407-2009; Yan, Ada/AGW-5338-2022	White, Richard G/0000-0003-4410-6635; Yan, Ada/0000-0001-7456-339X; Karat, Aaron/0000-0001-9643-664X; McCreesh, Nicky/0000-0003-1409-8531; Beckwith, Peter/0000-0003-3206-5696; Deol, Arminder/0000-0002-7154-5505	Economic and Social Research Council (ESRC); Antimicrobial Resistance Cross Council Initiative; GCRF [ES/P008011/1]; Bloomsbury SET (Research England) [CCF17-7779]; Wellcome Trust [103865Z/14/Z, 218261/Z/19/Z]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; European Union [MR/P002404/1]; Bill and Melinda Gates Foundation [OPP1084276, OPP1135288, OPP1137034, OPP1151915, OPP1160830, OPP1212544_2019]; UNITAID [PO 8477-0-600]; ESRC [ES/P008011/1]; NIHR Academic Clinical Fellowship [ACF-2018-21-007]; NIHR Imperial Biomedical Research Centre (BRC); US National Institutes of Allergy and Infectious Diseases [1R01A1147321-01]	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Antimicrobial Resistance Cross Council Initiative; GCRF; Bloomsbury SET (Research England); Wellcome Trust(Wellcome Trust); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UNITAID; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIHR Academic Clinical Fellowship; NIHR Imperial Biomedical Research Centre (BRC); US National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The support of the Economic and Social Research Council (ESRC) is gratefully acknowledged. The project is partly funded by the Antimicrobial Resistance Cross Council Initiative supported by the seven research councils in partnership with other funders including support from the GCRF, Grant reference: ES/P008011/1. ASK is funded by The Bloomsbury SET (Research England), grant ref CCF17-7779, AWCY is funded by a Wellcome Trust Investigator Award to Becca Asquith (103865Z/14/Z), AD, NM and RGW are funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement that is also part of the EDCTP2 programme supported by the European Union MR/P002404/1. RGW is additionally supported by the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276/OPP1135288, CORTIS: OPP1137034/OPP1151915, Vaccines: OPP1160830), UNITAID (4214-LSHTM-Sept15; PO 8477-0-600), and ESRC (ES/P008011/1). TAY is funded by an NIHR Academic Clinical Fellowship (ACF-2018-21-007) and acknowledges support from the NIHR Imperial Biomedical Research Centre (BRC). ADG is supported by ESRC (ES/P008011/1), the Bill and Melinda Gates Foundation (OPP1212544_2019) and the US National Institutes of Allergy and Infectious Diseases (1R01A1147321-01). NM and DS are supported by the Wellcome Trust grant number 218261/Z/19/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Cox H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029589; Escombe AR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3717-9; Escombe AR, 2007, PLOS MED, V4, P309, DOI 10.1371/journal.pmed.0040068; Gandhi NR., 2012, NOSOCOMIAL TRANSMISS; Gelmanova IY, 2007, B WORLD HEALTH ORGAN, V85, P703, DOI 10.2471/BLT.06.038331; Hamner L, 2020, MMWR-MORBID MORTAL W, V69, P606, DOI 10.15585/mmwr.mm6919e6; Kielmann K, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00667-6; McCarthy KM, 2015, INT J TUBERC LUNG D, V19, P647, DOI 10.5588/ijtld.14.0759; MENZIES R, 1995, AM J RESP CRIT CARE, V152, P1992, DOI 10.1164/ajrccm.152.6.8520767; Nardell E.A., 2016, MYCOBACT DIS, V6, DOI DOI 10.4172/2161-1068.1000231; Persily A, 2017, INDOOR AIR, V27, P868, DOI 10.1111/ina.12383; RILEY EC, 1978, AM J EPIDEMIOL, V107, P421, DOI 10.1093/oxfordjournals.aje.a112560; Rudnick SN, 2003, INDOOR AIR, V13, P237, DOI 10.1034/j.1600-0668.2003.00189.x; Taylor JG, 2016, INT J TUBERC LUNG D, V20, P1155, DOI 10.5588/ijtld.16.0085; WHO, 2020, 174 WHO; World Health Organization, 2020, ADV PUBL; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2019, MAT MORT 2000 2017 I, P1; Xiao S., 2020, EVIDENCE PROBABLE AE, DOI 10.1101/2020.04.16.20067728v1; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5	21	3	3	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253096	10.1371/journal.pone.0253096	http://dx.doi.org/10.1371/journal.pone.0253096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166388	Green Accepted, Green Published, gold			2022-12-26	WOS:000671692800072
J	Almatroudi, A; Mousa, AM; Vinnakota, D; Abalkhail, A; Alwashmi, ASS; Almatroodi, SA; Alhumaydhi, FA; Kabir, R; Mahmud, I				Almatroudi, Ahmad; Mousa, Ayman M.; Vinnakota, Divya; Abalkhail, Adil; Alwashmi, Ameen S. S.; Almatroodi, Saleh A.; Alhumaydhi, Fahad A.; Kabir, Russell; Mahmud, Ilias			Prevalence and associated factors of respiratory allergies in the Kingdom of Saudi Arabia: A cross-sectional investigation, September-December 2020	PLOS ONE			English	Article							EDUCATIONAL-LEVEL; RISK-FACTORS; ASTHMA; URBAN; SYMPTOMS; RHINITIS; DISEASE; CITY	Background Prevalence of different respiratory allergies is increasing in the Kingdom of Saudi Arabia (KSA). Environmental risk factors of respiratory allergy vary regionally, hence the prevalence. This necessitates the needs for regional studies. This article reports prevalence and symptoms of respiratory allergies in the Qassim region, and the factors associated with the prevalence. Methods Eight hundred and fifty individuals aged >= 18 years and were living in the Qassim region filled up our structured online questionnaire between September and December 2020. We estimated the prevalence of different respiratory allergies with 95% confidence intervals. Multi-variable logistic regression analyses were performed to investigate the risk factors of respiratory allergies. Findings The prevalence of any respiratory allergy in the Qassim region was 28.8%. Most families (58.1%) had at least one member with respiratory allergy. The prevalence of allergic rhinitis and bronchial asthma were 13.5% and 11.2% 4.1% respectively. The reported symptoms included runny nose (13.6%), red, watery, and itchy eyes (10.4%), difficulty sleeping at night (10.2%), difficulty breathing in cold weather (9.2%), noisy breathing (8.5%), sneezing (8%), repeated coughing (7.5%) and shortness of breath (6.4%). Individuals with a family history were more likely to report any respiratory allergy (OR: 7.8), bronchial asthma (OR: 4.2) and allergic rhinitis (OR: 8.1) compared to the individuals without such family history. Odds of respiratory allergies was higher among males (OR: 1.5). Saudi nationals were less likely to report allergic rhinitis than the non-Saudis (OR: 0.4). Among those who reported a respiratory allergy, most (73.5%) received treatment and majority (61.7%) demonstrated compliance to the treatment, 8.8% needed hospitalization, and 23.1% needed emergency nebulization. Conclusions Prevalence reported in our study is different than that reported in other regions. Variability in the environmental exposures might explain this. We recommend a meta-analysis to estimate the national prevalence of respiratory allergies.	[Almatroudi, Ahmad; Alwashmi, Ameen S. S.; Almatroodi, Saleh A.; Alhumaydhi, Fahad A.] Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah, Saudi Arabia; [Mousa, Ayman M.] Qassim Univ, Coll Appl Med Sci, Dept Basic Hlth Sci, Buraydah, Saudi Arabia; [Mousa, Ayman M.] Benha Univ, Fac Med, Dept Histol & Cell Biol, Banha, Egypt; [Vinnakota, Divya; Kabir, Russell] Anglia Ruskin Univ, Fac Hlth Educ Med & Social Care, Sch Allied Hlth, Chelmsford, Essex, England; [Abalkhail, Adil; Mahmud, Ilias] Qassim Univ, Coll Publ Hlth & Hlth Informat, Dept Publ Hlth, Al Bukairiyah, Saudi Arabia	Qassim University; Qassim University; Egyptian Knowledge Bank (EKB); Benha University; Anglia Ruskin University; Qassim University	Alhumaydhi, FA (corresponding author), Qassim Univ, Coll Appl Med Sci, Dept Med Labs, Buraydah, Saudi Arabia.; Mahmud, I (corresponding author), Qassim Univ, Coll Publ Hlth & Hlth Informat, Dept Publ Hlth, Al Bukairiyah, Saudi Arabia.	f.alhumaydhi@qu.edu.sa; i.emdadulhaque@qu.edu.sa	Vinnakota, Dr Divya/AAR-1301-2021; Kabir, Russell/H-9715-2019; Mousa, Ayman/AAQ-1031-2021; Mahmud, Ilias/N-5085-2017; Alhumaydhi, Fahad/Z-3879-2019	Vinnakota, Dr Divya/0000-0002-9707-1491; Kabir, Russell/0000-0001-9257-2775; Mousa, Ayman/0000-0001-5541-7928; Mahmud, Ilias/0000-0003-1330-7813; Alhumaydhi, Fahad/0000-0002-0151-8309; Abalkhail, Adil/0000-0002-2294-9837	Deanship of Scientific Research, Qassim University	Deanship of Scientific Research, Qassim University	Authors would like to thank the Deanship of Scientific Research, Qassim University for funding the publication of this research. The funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AM, 2020, SMALL RUMINANT RES, V188, DOI 10.1016/j.smallrumres.2020.106098; Al Frayh AR, 2001, ANN ALLERG ASTHMA IM, V86, P292, DOI 10.1016/S1081-1206(10)63301-7; Al Ghobain MO, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-239; Al-Dawood K, 2000, CROAT MED J, V41, P437; Alamoudi O.S., 2006, ANN THORAC MED, V1, P76, DOI [10.4103/1817-1737.27106, DOI 10.4103/1817-1737.27106]; Almehizia AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217182; Alruwaili Mohammed Farhan, 2018, Electron Physician, V10, P6920, DOI 10.19082/6920; Alshehri MA, 2000, SAUDI MED J, V21, P1048; Bacon SL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-125; BAKKE PS, 1995, AM J EPIDEMIOL, V141, P1080, DOI 10.1093/oxfordjournals.aje.a117373; Calderon MA, 2015, J ALLERGY CLIN IMMUN, V136, P38, DOI 10.1016/j.jaci.2014.10.012; D'Amato G, 2010, J INVEST ALLERG CLIN, V20, P95; Dave ND, 2011, IMMUNOL ALLERGY CLIN, V31, P55, DOI 10.1016/j.iac.2010.09.009; Demoly P, 2020, NPJ PRIM CARE RESP M, V30, DOI 10.1038/s41533-020-00195-8; Eagan TML, 2004, RESP MED, V98, P730, DOI 10.1016/j.rmed.2004.02.008; Heck S, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0026-x; Hijazi N, 1998, EUR RESPIR J, V12, P41, DOI 10.1183/09031936.98.12010041; Hussain SM, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8102527; Hyrkas H, 2014, RESP MED, V108, P63, DOI 10.1016/j.rmed.2013.10.019; Ibrahim NK, 2019, PAK J MED SCI, V35, P1060, DOI 10.12669/pjms.35.4.1281; Juniper EF, 2005, RESP MED, V99, P553, DOI 10.1016/j.rmed.2004.10.008; Moradi-Lakeh M, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0080-5; Musharrafieh Umayya, 2020, Asthma Res Pract, V6, P3, DOI 10.1186/s40733-020-00056-8; Navarro AM, 2017, CLIN TRANSL ALLERGY, V7, DOI 10.1186/s13601-017-0150-2; Pawankar R, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-12; Pawankar R, 2008, WORLD ALLERGY ORGAN, V1, pS4, DOI [10.1097/WOX.0b013e31817ff995, 10.1097/1939-4551-1-S1-S1]; Prescott E, 1999, EUR RESPIR J, V13, P1109, DOI 10.1034/j.1399-3003.1999.13e28.x; Sinha B, 2015, J POSTGRAD MED, V61, P169, DOI 10.4103/0022-3859.159418; Stewart WF, 2003, J OCCUP ENVIRON MED, V45, P1234, DOI 10.1097/01.jom.0000099999.27348.78; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; Thomas WR, 2010, TRENDS MOL MED, V16, P321, DOI 10.1016/j.molmed.2010.04.008; Valerio MA, 2010, CLIN PEDIATR, V49, P535, DOI 10.1177/0009922809356465; Wheatley LM, 2015, NEW ENGL J MED, V372, P456, DOI 10.1056/NEJMcp1412282; World Health Organization, 2021, ASTHMA	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253558	10.1371/journal.pone.0253558	http://dx.doi.org/10.1371/journal.pone.0253558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161374	gold, Green Published, Green Accepted			2022-12-26	WOS:000671691900011
J	Christner, N; Essler, S; Hazzam, A; Paulus, M				Christner, Natalie; Essler, Samuel; Hazzam, Astrid; Paulus, Markus			Children's psychological well-being and problem behavior during the COVID-19 pandemic: An online study during the lockdown period in Germany	PLOS ONE			English	Article							PARENTING STRESS; MENTAL-HEALTH; EXTERNALIZING BEHAVIOR; EARLY-CHILDHOOD; PSYCHOPATHOLOGY; DISORDERS; DIVORCE	As COVID-19 dramatically changes human social life, restrictive lockdown periods to slow the spread of the virus have been suggested to particularly affect the psychological well-being of children and their families. To capture lockdown-related effects on a large scale, the present study used an online questionnaire completed by parents of 3-10-year-olds during the most restrictive lockdown period in Germany thus far (N = 2,672). Parents reported their stress level, their child's well-being, and their child's problem behaviors among others. Results showed that most parents and children experienced lockdown-related stress. Concerning children, not being able to meet with friends and family members outside the household emerged as the primary challenge. Older children (7-10 years) evidenced more emotional symptoms as well as less conduct problems and hyperactivity than younger children (3-6 years). Children's own and their parents' stress level, the degree to which children missed other children, and children's age all showed to be negatively related to children's general life satisfaction. Single parenthood and being an only child were associated with higher levels of child problems. Taken together, these findings shed light on the psychological well-being of children and their families during governmental lockdown measures, as well as on relations between children's coping and demographic background. They have implications for possible avenues for interventions, inter alia by encouraging policies that facilitate the maintenance of social relationships and focus particularly on children from single parent families, on only children as well as on families in challenging housing situations.	[Christner, Natalie; Essler, Samuel; Hazzam, Astrid; Paulus, Markus] Ludwig Maximilians Univ Munchen, Dept Psychol, Munich, Germany	University of Munich	Christner, N (corresponding author), Ludwig Maximilians Univ Munchen, Dept Psychol, Munich, Germany.	natalie.christner@psy.lmu.de		Christner, Natalie/0000-0002-5751-8324	Claussen-Simon-Stiftung	Claussen-Simon-Stiftung	This study was supported by a scholarship of the Claussen-Simon-Stiftung to SE.	AMATO PR, 1991, PSYCHOL BULL, V110, P26, DOI 10.1037/0033-2909.110.1.26; BARNARD CP, 1994, AM J FAM THER, V22, P135, DOI 10.1080/01926189408251307; Beauchaine TP, 2019, DEV PSYCHOPATHOL, V31, P799, DOI 10.1017/S0954579419000671; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Boe T, 2014, J ABNORM CHILD PSYCH, V42, P705, DOI 10.1007/s10802-013-9818-9; Bojanowski S, 2014, Z KINDER JUG-PSYCH, V42, P223, DOI 10.1024/1422-4917/a000295; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Bronfenbrenner U, 2007, HDB CHILD PSYCHOL, P793, DOI DOI 10.1002/9780470147658.CHPSY0114; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; CHIN MEEJUNG, 2020, Family and Environment Research, V58, P447, DOI 10.6115/fer.2020.032; CICCHETTI D, 1995, DEV PSYCHOPATHOL, V7, P1, DOI 10.1017/S0954579400006301; Coley RL, 2013, DEV PSYCHOL, V49, P1775, DOI 10.1037/a0031033; Costa NM, 2006, J PSYCHOPATHOL BEHAV, V28, P113, DOI 10.1007/s10862-006-7489-3; de Miranda DM, 2020, INT J DISAST RISK RE, V51, DOI 10.1016/j.ijdrr.2020.101845; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; Evans GW, 2003, J SOC ISSUES, V59, P475, DOI 10.1111/1540-4560.00074; Fabes RA, 1992, NEW DIR CHILD ADOLES; FALBO T, 1986, PSYCHOL BULL, V100, P176, DOI 10.1037/0033-2909.100.2.176; Feldman D.H., 2012, HDB PSYCHOL, P197, DOI [10.1002/9781118133880.hop206008, DOI 10.1002/9781118133880.HOP206008]; Flavell JH, 1999, ANNU REV PSYCHOL, V50, P21, DOI 10.1146/annurev.psych.50.1.21; FURMAN W, 1983, CHILD DEV, V54, P549, DOI 10.1111/j.1467-8624.1983.tb00479.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Granic I, 2006, PSYCHOL REV, V113, P101, DOI 10.1037/0033-295X.113.1.101; Grant KE, 2003, PSYCHOL BULL, V129, P447, DOI 10.1037/0033-2909.129.3.447; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; GRINGLAS M, 1995, J FAM ISSUES, V16, P29, DOI 10.1177/019251395016001003; Hay DF, 2004, J CHILD PSYCHOL PSYC, V45, P84, DOI 10.1046/j.0021-9630.2003.00308.x; Janitza S, 2020, EUR CHILD ADOLES PSY, V29, P123, DOI 10.1007/s00787-019-01337-1; Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013; Klein AM, 2013, EUR J PSYCHOL ASSESS, V29, P96, DOI 10.1027/1015-5759/a000129; Lampert T., 2018, J HLTH MONIT, V3, P114, DOI [10.17886/RKI-GBE-2018-016, DOI 10.17886/RKI-GBE-2018-016]; Lansford JE, 2019, INT J BEHAV DEV, V43, P74, DOI 10.1177/0165025418783272; Laursen Brett, 2002, New Dir Child Adolesc Dev, P27; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Mackler JS, 2015, J MARRIAGE FAM, V77, P388, DOI 10.1111/jomf.12163; Masarik AS, 2017, CURR OPIN PSYCHOL, V13, P85, DOI 10.1016/j.copsyc.2016.05.008; Masten Ann S, 2020, Advers Resil Sci, V1, P95, DOI 10.1007/s42844-020-00010-w; Mieloo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036805; NEWCOMB AF, 1995, PSYCHOL BULL, V117, P306, DOI 10.1037/0033-2909.117.2.306; Paulus M, 2014, DEV PSYCHOL, V50, P914, DOI 10.1037/a0034169; Prime H, 2020, AM PSYCHOL, V75, P631, DOI 10.1037/amp0000660; Rapee R. M., 2001, DEV PSYCHOPATHOL, DOI [10.1093/med:psych/9780195123630.003.0021, DOI 10.1093/MED:PSYCH/9780195123630.003.0021]; Rask CU, 2012, PSYCHOSOMATICS, V53, P58, DOI 10.1016/j.psym.2011.05.006; Ravens-Sieberer U, 2006, KIDSCREEN QUESTIONNA; Remmerswaal D, 2011, J ANXIETY DISORD, V25, P444, DOI 10.1016/j.janxdis.2010.11.008; Romero E, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196975; Rubin KH., 2005, DEV SCI ADV TXB, P469, DOI DOI 10.1093/OXFORDHB/9780199958474.013.0011; Spinelli M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01713; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; Stone LL, 2016, J PSYCHOPATHOL BEHAV, V38, P76, DOI 10.1007/s10862-015-9500-3; Tandon M, 2009, CHILD ADOL PSYCH CL, V18, P593, DOI 10.1016/j.chc.2009.03.004; Thompson RA, 2000, CHILD DEV, V71, P145, DOI 10.1111/1467-8624.00128; Ungar M, 2013, J CHILD PSYCHOL PSYC, V54, P348, DOI 10.1111/jcpp.12025; Williford AP, 2007, J ABNORM CHILD PSYCH, V35, P251, DOI 10.1007/s10802-006-9082-3; Woerner W, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-2002-6; Wood JJ, 2004, CHILD PSYCHIAT HUM D, V35, P121, DOI 10.1007/s10578-004-1881-6; Wright Kristi D., 2003, Cognitive Behaviour Therapy, V32, P194, DOI 10.1080/16506070310014691; Yeasmin S, 2020, CHILD YOUTH SERV REV, V117, DOI 10.1016/j.childyouth.2020.105277; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	59	24	24	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253473	10.1371/journal.pone.0253473	http://dx.doi.org/10.1371/journal.pone.0253473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161376	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000671691900005
J	Gui, T; Yao, CH; Jia, BH; Shen, K				Gui, Ting; Yao, Chenhe; Jia, Binghan; Shen, Keng			Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods	PLOS ONE			English	Article							SISTER-CHROMATID COHESION; CYCLE-ASSOCIATED 5; EXPRESSION OMNIBUS; BLADDER-CANCER; CELL-CYCLE; GENOME; PROLIFERATION; PROGNOSIS; PATHWAY; CDCA5	Background Though considerable efforts have been made to improve the treatment of epithelial ovarian cancer (EOC), the prognosis of patients has remained poor. Identifying differentially expressed genes (DEGs) involved in EOC progression and exploiting them as novel biomarkers or therapeutic targets is of great value. Methods Overlapping DEGs were screened out from three independent gene expression omnibus (GEO) datasets and were subjected to Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analyses. The protein-protein interactions (PPI) network of DEGs was constructed based on the STRING database. The expression of hub genes was validated in GEPIA and GEO. The relationship of hub genes expression with tumor stage and overall survival and progression-free survival of EOC patients was investigated using the cancer genome atlas data. Results A total of 306 DEGs were identified, including 265 up-regulated and 41 down-regulated. Through PPI network analysis, the top 20 genes were screened out, among which 4 hub genes, which were not researched in depth so far, were selected after literature retrieval, including CDC45, CDCA5, KIF4A, ESPL1. The four genes were up-regulated in EOC tissues compared with normal tissues, but their expression decreased gradually with the continuous progression of EOC. Survival curves illustrated that patients with a lower level of CDCA5 and ESPL1 had better overall survival and progression-free survival statistically. Conclusion Two hub genes, CDCA5 and ESPL1, identified as probably playing tumor-promotive roles, have great potential to be utilized as novel therapeutic targets for EOC treatment.	[Gui, Ting; Shen, Keng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Obstet & Gynecol, Beijing, Peoples R China; [Yao, Chenhe; Jia, Binghan] Beijing Zhicheng Biomed Technol Co Ltd, Dept R&D Technol Ctr, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Shen, K (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Peking Union Med Coll, Dept Obstet & Gynecol, Beijing, Peoples R China.	sk_shenkeng@sina.com			Beijing Zhicheng Biomedical Technology Co, Ltd.; National Natural Science Foundation of China [81572576]	Beijing Zhicheng Biomedical Technology Co, Ltd.; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Beijing Zhicheng Biomedical Technology Co, Ltd. The funding organization played a role in data curation and resources. This study was also financially supported by National Natural Science Foundation of China (No. 81572576).	Bai LM, 2020, J COMPUT BIOL, V27, P965, DOI 10.1089/cmb.2019.0254; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Borton MT, 2016, J CELL BIOCHEM, V117, P351, DOI 10.1002/jcb.25277; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chang IW, 2015, AM J TRANSL RES, V7, P710; Chen H, 2019, J CANCER, V10, P1846, DOI 10.7150/jca.28809; Chen JL, 2017, J CANCER RES THER, V13, P651, DOI 10.4103/jcrt.JCRT_491_17; Chen QK, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3917982; Chen X, 2018, BIOINFORMATICS, V34, P3178, DOI 10.1093/bioinformatics/bty333; Cheng E, 2012, GENETICS, V192, P147, DOI 10.1534/genetics.112.141051; Cohen Y, 2014, HEMATOLOGY, V19, P286, DOI 10.1179/1607845413Y.0000000125; Ding YG, 2020, AM J OTOLARYNG, V41, DOI 10.1016/j.amjoto.2020.102434; Fan XH, 2010, CLIN CANCER RES, V16, P629, DOI 10.1158/1078-0432.CCR-09-1815; Feng H, 2019, J OVARIAN RES, V12, DOI 10.1186/s13048-019-0508-2; Finetti P, 2014, BREAST CANCER RES TR, V147, P51, DOI 10.1007/s10549-014-3070-z; Fu GH, 2020, J CANCER, V11, P2408, DOI 10.7150/jca.35372; Gao J, 2011, TUMOR BIOL, V32, P53, DOI 10.1007/s13277-010-0090-0; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Hou GJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04176-9; Hu Y, 2019, ONCOTARGETS THER, V12, P11609, DOI 10.2147/OTT.S231941; Huang ZM, 2016, ONCOTARGET, V7, P39872, DOI 10.18632/oncotarget.9524; Kumar R, 2017, J CELL BIOCHEM, V118, P1283, DOI 10.1002/jcb.25835; Li GL, 2019, J CELL PHYSIOL, V234, P22071, DOI 10.1002/jcp.28770; Li XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087767; Lin JD, 2017, MED ONCOL, V34, DOI 10.1007/s12032-016-0858-1; Liu L, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00373; Lou WY, 2019, AGING-US, V11, P11416, DOI 10.18632/aging.102538; MacAlpine DM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010207; Magdalou I, 2014, SEMIN CELL DEV BIOL, V30, P154, DOI 10.1016/j.semcdb.2014.04.035; Milanese JS, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0100-7; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Mukherjee M, 2014, ONCOGENE, V33, P5511, DOI 10.1038/onc.2013.493; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Nguyen MH, 2010, CANCER RES, V70, P5337, DOI 10.1158/0008-5472.CAN-09-4372; Nguyen PA, 2018, MOL BIOL CELL, V29, P304, DOI 10.1091/mbc.E17-09-0540; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Qadir F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6059-5; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng L, 2018, GENE, V678, P90, DOI 10.1016/j.gene.2018.08.005; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Subramanyam S, 2013, NUCLEIC ACIDS RES, V41, P9020, DOI 10.1093/nar/gkt691; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Tian YH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5072-4; Tokuzen N, 2016, ONCOTARGET, V7, P2343, DOI 10.18632/oncotarget.6148; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wan Z, 2019, GENET TEST MOL BIOMA, V23, P766, DOI 10.1089/gtmb.2019.0063; Wang DY, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0811-1; Wang JL, 2018, ONCOL REP, V40, P1875, DOI 10.3892/or.2018.6579; Wei JC, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00176; Wen DY, 2018, MED SCI MONITOR, V24, P2786, DOI 10.12659/MSM.907389; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Wu MJ, 2020, PEERJ, V8, DOI 10.7717/peerj.8961; Wu Q, 2019, ONCOTARGETS THER, V12, P3545, DOI 10.2147/OTT.S198621; Xu J, 2019, EBIOMEDICINE, V46, P54, DOI 10.1016/j.ebiom.2019.07.030; Yang X, 2018, ONCOTARGETS THER, V11, P1457, DOI 10.2147/OTT.S152238; Yi M, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4169691; Zhang J, 2020, BRIEF BIOINFORM, V21, P1080, DOI 10.1093/bib/bbz040; Zhang JJ, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007435; Zhang L, 2017, ONCOTARGET, V8, P19684, DOI 10.18632/oncotarget.14962; Zhang XZ, 2020, J CELL BIOCHEM, V121, P4741, DOI 10.1002/jcb.29689; Zhang YX, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/3186051; Zhao L, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20202911; Zhou Q, 2019, J CANCER RES CLIN, V145, P2383, DOI 10.1007/s00432-019-02974-4; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	68	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253136	10.1371/journal.pone.0253136	http://dx.doi.org/10.1371/journal.pone.0253136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143800	Green Submitted, Green Published, gold			2022-12-26	WOS:000671690700055
J	Tsakanova, G; Stepanyan, A; Arakelova, E; Ayvazyan, V; Tonoyan, V; Arakelyan, A; Hildebrandt, G; Schultke, E				Tsakanova, Gohar; Stepanyan, Ani; Arakelova, Elina; Ayvazyan, Violetta; Tonoyan, Vahan; Arakelyan, Arsen; Hildebrandt, Guido; Schueltke, Elisabeth			The radioenhancement potential of Schiff base derived copper (II) compounds against lung carcinoma in vitro	PLOS ONE			English	Article							CU-64-LABELED TRIPHENYLPHOSPHONIUM; ANTICANCER ACTIVITY; RADIATION-THERAPY; TARGETING COPPER; TUMOR-CELLS; COMPLEXES; CYTOTOXICITY; MECHANISMS; CATIONS; DNA	For the last years, copper complexes have been intensively implicated in biomedical research as components of cancer treatment. Herewith, we provide highlights of the synthesis, physical measurements, structural characterization of the newly developed Cu(II) chelates of Schiff Bases, Cu(Picolinyl-L-Tryptopahanate)(2), Cu(Picolinyl-L-Tyrosinate)(2), Cu(Isonicotinyl-L-Tyrosinate)(2), Cu(Picolinyl-L-Phenylalaninate)(2), Cu(Nicotinyl-L-Phenylalaninate)(2), Cu(Isonicotinyl-L-Phenylalaninate)(2), and their radioenhancement capacity at kV and MV ranges of irradiation of human lung carcinoma epithelial cells in vitro. The methods of cell growth, viability and proliferation were used. All compounds exerted very potent radioenhancer capacities in the irradiated lung carcinoma cells at both kV and MV ranges in a 100 mu M concentration. At a concentration of 10 mu M, only Cu(Picolinyl-L-Tyrosinate)(2), Cu(Isonicotinyl-L-Tyrosinate)(2), Cu(Picolinyl-L-Phenylalaninate)(2) possessed radioenhancer properties at kV and MV ranges. Cu(Picolinyl-L-Tryptophanate)(2) showed radioenhancer properties only at kV range. Cu(Nicotinyl-L-Phenylalaninate)(2) and Cu(Isonicotinyl-L-Phenylalaninate)(2) showed remarkable radioenhancer activity only at MV range. All compounds acted in dose-dependent manner at both tested energy ranges. These copper (II) compounds, in combination with 1 Gy irradiation at either 120 kV or 6 MV, are more efficient at delaying cell growth of lung cancer cells and at reducing cell viability in vitro than the irradiation administered alone. Thus, we have demonstrated that the studied copper compounds have a good potential for radioenhancement.	[Tsakanova, Gohar; Stepanyan, Ani; Arakelova, Elina; Ayvazyan, Violetta; Tonoyan, Vahan; Arakelyan, Arsen] Inst Mol Biol NAS RA, Yerevan, Armenia; [Tsakanova, Gohar] CANDLE Synchrotron Res Inst, Yerevan, Armenia; [Hildebrandt, Guido; Schueltke, Elisabeth] Rostock Univ, Dept Radiooncol, Med Ctr, Rostock, Germany	National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; University of Rostock	Tsakanova, G (corresponding author), Inst Mol Biol NAS RA, Yerevan, Armenia.; Tsakanova, G (corresponding author), CANDLE Synchrotron Res Inst, Yerevan, Armenia.	g_tsakanova@mb.sci.am		Tsakanova, Gohar/0000-0003-2072-6397; Stepanyan, Ani/0000-0001-8564-8532	German Federal Ministry of Education and Research and State Committee of Science of the Ministry of Education and Science of the Republic of Armenia [16GE-040, 19YR-1F045, 20TTCG-1F003]	German Federal Ministry of Education and Research and State Committee of Science of the Ministry of Education and Science of the Republic of Armenia	This work was supported by the German Federal Ministry of Education and Research and State Committee of Science of the Ministry of Education and Science of the Republic of Armenia and in the frames of 16GE-040, 19YR-1F045 and 20TTCG-1F003 research projects.	Abu-Dief Ahmed M, 2015, Beni Suef Univ J Basic Appl Sci, V4, P119, DOI 10.1016/j.bjbas.2015.05.004; Adsule S, 2006, J MED CHEM, V49, P7242, DOI 10.1021/jm060712l; Al Zoubi W., 2013, INT J ORG CHEM, V3, P73; Arns A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187710; Arulmurugan S., 2010, RAS YAN J CHEM, V3, P385; Baskar Rajamanickam, 2014, Front Mol Biosci, V1, P24, DOI 10.3389/fmolb.2014.00024; Bonvalot S, 2017, CLIN CANCER RES, V23, P908, DOI 10.1158/1078-0432.CCR-16-1297; Boyajyan A., 2013, NATO SCI PEACE SEC B; Bulatov E, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0120-z; Cater MA, 2013, ACS CHEM BIOL, V8, P1621, DOI 10.1021/cb400198p; Chaiswing Luksana, 2018, Critical Reviews in Oncogenesis, V23, P39, DOI 10.1615/CritRevOncog.2018025946; Chakraborty A, 2010, EUR J PHARMACOL, V647, P1, DOI 10.1016/j.ejphar.2010.08.003; Cheriyan VT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093711; da Silveira VC, 2008, J INORG BIOCHEM, V102, P1090, DOI 10.1016/j.jinorgbio.2007.12.033; Datta R, 2012, MAPANA J SCI MJS, V11, P57; Denoyer D, 2015, METALLOMICS, V7, P1459, DOI 10.1039/c5mt00149h; DHAR DN, 1982, J SCI IND RES INDIA, V41, P501; Gandin V, 2015, METALLOMICS, V7, P1497, DOI 10.1039/c5mt00163c; Guo YN, 2019, RSC ADV, V9, P41737, DOI 10.1039/c9ra07298e; Herman B., 2015, MOLVIEW; Howard M, 2017, J RADIAT RES, V58, P608, DOI 10.1093/jrr/rrx018; Hussain A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41063-x; International Association for the study of Lung Cancer, 2017, LUNG CANC FACTS STAT; Jopp M, 2017, EUR J MED CHEM, V132, P274, DOI 10.1016/j.ejmech.2017.03.019; Kajal A., 2013, J CATAL, V2013, P1, DOI [DOI 10.1155/2013/893512, 10.1155/2013/893512]; Karapetyan NH, 2016, J BIOMOL STRUCT DYN, V34, P177, DOI 10.1080/07391102.2015.1020876; Kim YS, 2008, J MED CHEM, V51, P2971, DOI 10.1021/jm7015045; Lim SN, 2015, J RADIAT RES, V56, P77, DOI 10.1093/jrr/rru084; Mahendiran D, 2018, RSC ADV, V8, P16973, DOI 10.1039/c8ra00954f; Majumder A, 2006, POLYHEDRON, V25, P1753, DOI 10.1016/j.poly.2005.11.029; Malakyan M., 2012, 1 INT C RAD DOS VAR, P166; Malakyan Margarita, 2016, F1000Res, V5, P1921, DOI 10.12688/f1000research.9226.1; Marthinsen ABL, 2010, ACTA ONCOL, V49, P1261, DOI 10.3109/0284186X.2010.504226; Marzano C., 2019, COPPER I CHEM PHOSPH, P83, DOI DOI 10.1016/B978-0-12-815052-8.00004-X; Marzano C, 2009, ANTI-CANCER AGENT ME, V9, P185, DOI 10.2174/187152009787313837; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Molinaro C, 2020, CANCERS, V12, DOI 10.3390/cancers12102863; More MS, 2019, MATER TODAY CHEM, V14, DOI 10.1016/j.mtchem.2019.100195; Mundt AJ, 2003, HOLLAND FREI CANC ME; Palanimuthu D, 2013, J MED CHEM, V56, P722, DOI 10.1021/jm300938r; Park KC, 2016, METALLOMICS, V8, P874, DOI [10.1039/c6mt00105j, 10.1039/C6MT00105J]; Paul P, 2002, P INDIAN AS-CHEM SCI, V114, P269; Pottier A, 2014, ANTICANCER RES, V34, P443; Pui A, 2007, INORG CHIM ACTA, V360, P2139, DOI 10.1016/j.ica.2006.10.040; Qi JX, 2020, J COORD CHEM, V73, P1208, DOI 10.1080/00958972.2020.1768378; Rey NA, 2009, J INORG BIOCHEM, V103, P1323, DOI 10.1016/j.jinorgbio.2009.05.008; Risteski Milan, 2013, Pril (Makedon Akad Nauk Umet Odd Med Nauki), V34, P49; Santini C, 2014, CHEM REV, V114, P815, DOI 10.1021/cr400135x; Sheikhshoaie I, 2010, ARAB J SCI ENG, V35, P53; SMITH TJ, 1995, J MOL GRAPHICS, V13, P122, DOI 10.1016/0263-7855(94)00019-O; Tadele KT, 2019, ANTI-CANCER AGENT ME, V19, P1786, DOI 10.2174/1871520619666190227171716; Tang L, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0758-7; Tardito S, 2012, J MED CHEM, V55, P10448, DOI 10.1021/jm301053a; The National Toxicology Program (NTP), 2003, INT CTR EV ALT TOX M; U.S. National Institute Of Health National Cancer Institute, SEER CANC STAT REV 1; Vanco J, 2008, J INORG BIOCHEM, V102, P595, DOI 10.1016/j.jinorgbio.2007.10.003; Varkey J.T., 2016, RES REV J CHEM, V5, P37; Walter C, 2007, RADIOTHER ONCOL, V85, P418, DOI 10.1016/j.radonc.2007.10.014; Wang JJ, 2007, J MED CHEM, V50, P5057, DOI 10.1021/jm0704088; World Health Organization, 2018, CANC FACT SHEET, DOI [10.1136/bmjoq-2018-000437, DOI 10.1136/BMJOQ-2018-000437]; Yamoah K, 2015, INT J RADIAT ONCOL, V93, P737, DOI 10.1016/j.ijrobp.2015.07.2284; Zhamharyan LG., 2012, 1 INT C RAD DOS VAR, P165; Zhang Z, 2012, J BIOL INORG CHEM, V17, P1257, DOI 10.1007/s00775-012-0940-x; Zhou W, 2014, CHEM SCI, V5, P2761, DOI 10.1039/c4sc00384e	64	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253553	10.1371/journal.pone.0253553	http://dx.doi.org/10.1371/journal.pone.0253553			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143847	gold, Green Published			2022-12-26	WOS:000671690700021
J	Akalu, Y; Yeshaw, Y; Tesema, GA; Demissie, GD; Molla, MD; Muche, A; Diress, M; Tiruneh, SA				Akalu, Yonas; Yeshaw, Yigizie; Tesema, Getayeneh Antehunegn; Demissie, Getu Debalkie; Molla, Meseret Derbew; Muche, Abebe; Diress, Mengistie; Tiruneh, Sofonyas Abebaw			Iron-rich food consumption and associated factors among children aged 6-23 months in sub-Saharan Africa: A multilevel analysis of Demographic and Health Surveys	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; DEFICIENCY ANEMIA; YOUNG-CHILDREN; MASS-MEDIA; INFANTS; DETERMINANTS; PREVALENCE; INTERVENTIONS; PATTERNS	Introduction Anemia remains a major public health problem for children in sub-Saharan Africa (SSA). Iron-rich foods consumption has a determinant role on the anemia status. Hence, this study aimed to determine the prevalence of good consumption of iron-rich foods and its associated factors among children aged 6-23 months in SSA. Materials and methods The recent Demographic and Health Survey data sets of thirty-five SSA countries were used. Data were analyzed using STATA/MP version 16.0 and all statistical analyses were done after weighting the data. A generalized linear mixed model using Poisson regression with robust error variance was used to determine factors associated with good consumption of iron-rich food. Association of variables was declared at a p-value of <= 0.05 and adjusted prevalence ratio (aPR) ratio with its 95% confidence interval (CI) was calculated for each variable. Results The total weighted samples of 77,001 children aged 6-23 months were included. The prevalence of consumption of iron rich foods was 42.1% (95% CI: 41.78-42.48). Children with age of 12-17 (adjusted prevalence ratio (aPR) = 1.96, 95% CI: 1.89-2.04) and 18-23 months (aPR = 2.05, 95% CI: 1.97-2.14), who took drugs for intestinal parasites (aPR = 1.30, 95% CI: 1.26-1.34), with postnatal check within 2 months (aPR = 1.09, 95% CI: 1.06-1.13), and children from women with ANC visit of 1-3 (aPR = 1.31, 95% CI: 1.24-1.37) and >= 4 (aPR = 1.41, 95% CI: 1.34-1.48) had higher prevalence of good consumption of iron rich foods. Moreover, the prevalence of consumptions of iron rich foods was higher among children from; family with rich (aPR = 1.36, 95%CI: 1.30-1.42) and middle (aPR = 1.14 95% CI: 1.09-1.19) wealth index, and mother with media exposure (aPR = 1.26, 95%CI: 1.22-1.31). Conclusion The prevalence of good consumption of iron-rich foods among children aged 6-23 months in SSA countries is low. Child factors, family factors, and community-level factors were significantly associated with consumption of iron rich foods. Strategies to increase the consumption of iron-rich foods during this critical stage of growth and development should be designed in SSA.	[Akalu, Yonas; Yeshaw, Yigizie; Diress, Mengistie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia; [Yeshaw, Yigizie; Tesema, Getayeneh Antehunegn] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Demissie, Getu Debalkie] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Molla, Meseret Derbew] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Biochem, Gondar, Ethiopia; [Muche, Abebe] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia; [Tiruneh, Sofonyas Abebaw] Debre Tabor Univ, Coll Hlth Sci, Dept Publ Hlth, Debre Tabor, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Akalu, Y (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia.	yonasakalu21@gmail.com	Yeshaw, Yigizie/L-6336-2019	Yeshaw, Yigizie/0000-0003-4587-7925; Diress, Mengistie/0000-0003-4186-4991; Abebaw Tiruneh, Sofonyas/0000-0001-5867-5105; Akalu, Yonas/0000-0002-0914-7768; Molla, Meseret Derbew/0000-0002-2622-522X				Adekanmbi AF, 2007, J TROP PEDIATRICS, V53, P103, DOI 10.1093/tropej/fml064; Ai YX, 2012, PEDIATR INT, V54, P669, DOI 10.1111/j.1442-200X.2012.03648.x; [Anonymous], 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1208-6; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Baek Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213610; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Berhanu Z, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1523-6; Carvalho AGC, 2010, REV SAUDE PUBL, V44, P513, DOI 10.1590/S0034-89102010000300015; Croft TN, 2018, GUIDE DHS STAT; de la Cruz-Gongora V, 2018, SALUD PUBLICA MEXICO, V60, P291, DOI 10.21149/8824; Dee DL, 2008, PEDIATRICS, V122, pS98, DOI 10.1542/peds.2008-1315m; Diouf S, 2015, ARCH PEDIATRIE, V22, P1188, DOI 10.1016/j.arcped.2015.08.015; Gewa CA, 2015, J HEALTH POPUL NUTR, V34, DOI 10.1186/s41043-015-0008-y; Graziose MM, 2018, PUBLIC HEALTH NUTR, V21, P273, DOI [10.1017/S1368980017002786, 10.1017/s1368980017002786]; Haileselassie M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0225707; Hannah R, 2017, OUR WORLD DATA; Ickes Scott, 2017, BMC Nutr, V3, DOI 10.1186/s40795-017-0140-8; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Kabir I, 2012, MATERN CHILD NUTR, V8, P11, DOI 10.1111/j.1740-8709.2011.00379.x; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Kehoe L, 2017, J HUM NUTR DIET, V30, P405, DOI 10.1111/jhn.12449; Kim SS, 2020, CURR DEV NUTR, V4, DOI 10.1093/cdn/nzz140; Kim SS, 2019, J NUTR, V149, P1470, DOI 10.1093/jn/nxz087; Locks LM, 2015, MATERN CHILD NUTR, V11, P882, DOI 10.1111/mcn.12032; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Marinda PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204009; Mashreky SR., 2015, S E ASIA J PUBLIC HE, V5, P18; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; McCann JC, 2007, AM J CLIN NUTR, V85, P931, DOI 10.1093/ajcn/85.4.931; McCarthy EK, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12320; Menon P, 2016, J NUTR, V146, P2075, DOI 10.3945/jn.116.232314; Milford AB, 2019, APPETITE, V141, DOI 10.1016/j.appet.2019.06.005; Mokori A, 2017, S AFR J CLIN NUTR, V30, P7, DOI 10.1080/16070658.2016.1225887; Muriuki JM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-1502-7; Mya KS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209044; Na MZ, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12564; Radlowski EC, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00585; Rakotomanana H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4835-1; Rodriguez-Ramirez S, 2016, J NUTR, V146, P1916, DOI 10.3945/jn.115.220145; Sanchez-Pimienta TG, 2016, J NUTR, V146, P1874, DOI 10.3945/jn.115.227074; Scott JA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020181; Scott SP, 2014, NUTRIENTS, V6, P5915, DOI 10.3390/nu6125915; Senarath U, 2012, MATERN CHILD NUTR, V8, P89, DOI 10.1111/j.1740-8709.2011.00370.x; Siega-Riz AM, 2010, J AM DIET ASSOC, V110, pS38, DOI 10.1016/j.jada.2010.09.001; Smith L. C., 2006, Research Report - International Food Policy Research Institute; Solomon D, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0680-1; Sungkar Saleha, 2017, J Parasitol Res, V2017, P5476739, DOI 10.1155/2017/5476739; Tiruneh SA, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00635-8; UNICEF, 2019, STATE WORLDS CHILDRE, DOI DOI 10.18356/A4D964A5-EN; Venegas-Aviles Y, 2020, NUTR J, V19, DOI 10.1186/s12937-020-00567-3; Victor R, 2014, MATERN CHILD NUTR, V10, P545, DOI 10.1111/j.1740-8709.2012.00435.x; Vos T, 2017, LANCET, V390, P1211, DOI 10.1016/S0140-6736(17)32154-2; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; White JM, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12505; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, DAIL IR SUPPL CHILDR; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Worwood M., 2007, ASSESSING IRON STATU; Yu P, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30289; Ziegler EE, 2011, NUTR REV, V69, pS37, DOI 10.1111/j.1753-4887.2011.00431.x	61	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253221	10.1371/journal.pone.0253221	http://dx.doi.org/10.1371/journal.pone.0253221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138916	gold, Green Published			2022-12-26	WOS:000671690200013
J	Ansari, E; Loganathan, D				Ansari, Ejaz; Loganathan, Deva			12-month clinical outcomes of combined phacoemulsification and ab interno trabeculectomy for open-angle glaucoma in the United Kingdom	PLOS ONE			English	Article							KAHOOK DUAL BLADE; EXCISIONAL GONIOTOMY; INTRAOCULAR-PRESSURE; SURGICAL OUTCOMES; PREVALENCE; DEVICE	Background/Objectives To describe intraocular pressure (IOP) and ocular hypotensive medication outcomes of combined phacoemulsification and ab interno trabeculectomy with the Kahook Dual Blade (KDB; New World Medical, Inc, Rancho Cucamonga, CA) in adults with cataract and open-angle glaucoma (OAG). Subjects/Methods Retrospective chart review of existing medical records. Data collected included intraocular pressure (IOP) and IOP-lowering medication use preoperatively and through up to 24 months postoperatively. Paired t-tests were utilized to compare preoperative to postoperative mean IOP and mean medications used. Results Data from 32 eyes of 26 subjects were analyzed. Subjects were predominantly Caucasian (25/26) had mean (standard error) age of 79.3 (1.2) years, and eyes had moderate-advanced OAG (mean visual field mean deviation -8.3 [1.3] dB). Mean IOP was 19.8 (0.8) mmHg at baseline and 15.5 (0.6) mmHg (p<0.0001) after mean follow-up of 11.5 (1.0) months; IOP reductions of >= 20% were achieved in 20/32 eyes (62.5%). Mean medication use declined from 2.4 (0.2) medications per eye at baseline to 0.5 (0.2) at last follow-up (p<0.0001); 23/32 eyes (71.9%) were medication-free at last follow-up. No vision-threatening complications were observed. Conclusions Combined phacoemulsification and ab interno trabeculectomy with the KDB safely provided mean IOP reductions of 21.7% and mean IOP medication reductions of 83% after mean follow-up of 12 months in eyes with moderate to advanced OAG. This procedure provides medication-independence in most eyes with statistically and clinically significant IOP reductions.	[Ansari, Ejaz] Maidstone & Tunbridge Wells NHS Trust, Canterbury, Kent, England; [Ansari, Ejaz] Univ Kent, Canterbury, Kent, England; [Loganathan, Deva] Maidstone & Tunbridge Wells NHS Trust, Maidstone, Kent, England	University of Kent	Ansari, E (corresponding author), Maidstone & Tunbridge Wells NHS Trust, Canterbury, Kent, England.; Ansari, E (corresponding author), Univ Kent, Canterbury, Kent, England.	e.ansari@nhs.net			New World Medical	New World Medical	Assistance with manuscript preparation was provided by Tony Realini, MD, MPH, with support from New World Medical.	Agrawal P, 2018, OPHTHALMOL THER, V7, P49, DOI 10.1007/s40123-018-0131-0; Ansari E, 2017, OPHTHALMOL THER, V6, P233, DOI 10.1007/s40123-017-0098-2; Armstrong James J, 2017, J Glaucoma, V26, P511, DOI 10.1097/IJG.0000000000000643; Bamashmus MA, 2004, EYE, V18, P257, DOI 10.1038/sj.eye.6700606; Barry M, 2020, CUREUS, V12, DOI 10.7759/cureus.6682; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bourne RRA., 2017, LANCET GLOB HEALTH, DOI [10.1016/S2214-109X%2817%2930393-5, DOI 10.1016/S2214-109X%2817%2930393-5]; Chan MPY, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3889; Dick HB, 2019, OPHTHALMOL THER, V8, P19, DOI 10.1007/s40123-019-0161-2; Dorairaj SK, 2018, ADV THER, V35, P1460, DOI 10.1007/s12325-018-0755-4; Dorairaj SK, 2018, CLIN OPHTHALMOL, V12, P791, DOI 10.2147/OPTH.S158403; ElMallah MK, 2019, ADV THER, V36, P2515, DOI 10.1007/s12325-019-01025-1; Fechtner RD, 2010, CORNEA, V29, P618, DOI 10.1097/ICO.0b013e3181c325b2; Gazzard G, 2019, LANCET, V393, P1505, DOI 10.1016/S0140-6736(18)32213-X; Greenwood MD, 2017, J CATARACT REFR SURG, V43, P1197, DOI 10.1016/j.jcrs.2017.06.046; Hirabayashi MT, 2019, CLIN OPHTHALMOL, V13, P2017, DOI 10.2147/OPTH.S208468; Hirabayashi MT, 2019, CLIN OPHTHALMOL, V13, P715, DOI 10.2147/OPTH.S196105; Kornmann HL, 2019, CLIN OPHTHALMOL, V13, P2369, DOI 10.2147/OPTH.S224643; Lavia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183142; Le C, 2019, J GLAUCOMA, V28, P411, DOI 10.1097/IJG.0000000000001143; Lee D, 2019, CLIN OPHTHALMOL, V13, P2097, DOI 10.2147/OPTH.S224109; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; McCann P., 2020, BRIT J OPHTHALMOL; Minassian DC, 2000, BRIT J OPHTHALMOL, V84, P1159, DOI 10.1136/bjo.84.10.1159; Pezzullo L, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2836-0; Pillunat LE, 2017, CLIN OPHTHALMOL, V11, P1583, DOI 10.2147/OPTH.S135316; Quartilho A, 2016, EYE, V30, P602, DOI 10.1038/eye.2015.288; Richter GM, 2016, CLIN OPHTHALMOL, V10, P189, DOI 10.2147/OPTH.S80490; Saheb H, 2012, CURR OPIN OPHTHALMOL, V23, P96, DOI 10.1097/ICU.0b013e32834ff1e7; Salinas L, 2018, J GLAUCOMA, V27, P849, DOI 10.1097/IJG.0000000000001019; Seibold LK, 2013, AM J OPHTHALMOL, V155, P524, DOI 10.1016/j.ajo.2012.09.023; Shah M, 2019, EYE VISION, V6, DOI 10.1186/s40662-019-0154-1; Sieck EG, 2019, EYE VISION, V6, DOI 10.1186/s40662-019-0153-2; Sieck EG, 2018, OPHTHALMOL GLAUCOMA, V1, P75, DOI 10.1016/j.ogla.2018.06.006	34	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252826	10.1371/journal.pone.0252826	http://dx.doi.org/10.1371/journal.pone.0252826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138879	gold, Green Published			2022-12-26	WOS:000671690200105
J	Lim, HJ; Kang, ER; Park, MY; Kim, BK; Kim, MJ; Jung, S; Roh, KH; Sung, N; Yang, JH; Lee, MW; Lee, SH; Yang, YJ				Lim, Ho Jae; Kang, Eun-Rim; Park, Min Young; Kim, Bo Kyung; Kim, Min Jin; Jung, Sunkyung; Roh, Kyoung Ho; Sung, Nackmoon; Yang, Jae-Hyun; Lee, Min-Woo; Lee, Sun-Hwa; Yang, Yong-Jin			Development of a multiplex real-time PCR assay for the simultaneous detection of four bacterial pathogens causing pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RAPID DETECTION; RESISTANCE; SPUTUM; GENES	Classification of clinical symptoms and diagnostic microbiology are essential to effectively employ antimicrobial therapy for lower respiratory tract infections (LRTIs) in a timely manner. Empirical antibiotic treatment without microbial identification hinders the selective use of narrow-spectrum antibiotics and effective patient treatment. Thus, the development of rapid and accurate diagnostic procedures that can be readily adopted by the clinic is necessary to minimize non-essential or excessive use of antibiotics and accelerate patient recovery from LRTI-induced damage. We developed and validated a multiplex real-time polymerase chain reaction (mRT-PCR) assay with good analytical performance and high specificity to simultaneously detect four bacterial pathogens causing pneumonia: Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and Moraxella catarrhalis. The analytical performance of mRT-PCR against target pathogens was evaluated by the limit of detection (LOD), specificity, and repeatability. Two hundred and ten clinical specimens from pneumonia patients were processed using an automatic nucleic acid extraction system for the "respiratory bacteria four" (RB4) mRT-PCR assay, and the results were directly compared to references from bacterial culture and/or Sanger sequencing. The RB4 mRT-PCR assay detected all target pathogens from sputum specimens with a coefficient of variation ranging from 0.29 to 1.71 and conservative LOD of DNA corresponding to 5 x 10(2) copies/reaction. The concordance of the assay with reference-positive specimens was 100%, and additional bacterial infections were detected from reference-negative specimens. Overall, the RB4 mRT-PCR assay showed a more rapid turnaround time and higher performance that those of reference assays. The RB4 mRT-PCR assay is a high-throughput and reliable tool that assists decision-making assessment and outperforms other standard methods. This tool supports patient management by considerably reducing the inappropriate use of antibiotics.	[Lim, Ho Jae; Kang, Eun-Rim; Park, Min Young; Jung, Sunkyung; Lee, Sun-Hwa; Yang, Yong-Jin] Seegene Med Fdn, Dept Mol Diagnost, Seoul, South Korea; [Lim, Ho Jae] Chosun Univ, Dept Integrat Biol Sci, Gwangju, South Korea; [Kim, Bo Kyung; Kim, Min Jin; Lee, Sun-Hwa] Seegene Med Fdn, Dept Lab Med, Seoul, South Korea; [Roh, Kyoung Ho] Ilsan Hosp, Dept Lab Med, Natl Hlth Insurance Serv, Goyang, Gyeonggi, South Korea; [Sung, Nackmoon] Seegene Med Fdn, Clin Res Inst, Seoul, South Korea; [Yang, Jae-Hyun] Harvard Med Sch, Dept Genet, Blavatnik Inst, Paul F Glenn Ctr Biol Aging Res, Boston, MA USA; [Lee, Min-Woo] Soonchunhyang Univ, Soonchunhyang Inst Medi Bio Sci SIMS, Cheonan Si, South Korea; [Lee, Min-Woo] Soonchunhyang Univ, Dept Integrated Biomed Sci, Cheonan Si, South Korea	Chosun University; National Health Insurance Service; NHIS Ilsan Hospital; Harvard University; Harvard Medical School; Soonchunhyang University; Soonchunhyang University	Yang, YJ (corresponding author), Seegene Med Fdn, Dept Mol Diagnost, Seoul, South Korea.	yjyang@mf.seegene.com	Kim, Mi Jin/GXH-9639-2022; Yang, Jae-Hyun/GWQ-6204-2022	Lim, Ho Jae/0000-0003-0115-5170; Yang, Yong-Jin/0000-0002-6153-9646				Baldassarri RJ, 2019, ARCH PATHOL LAB MED, V143, P683, DOI 10.5858/arpa.2017-0573-RA; Chen J, 2019, INFECT DRUG RESIST, V12, P2335, DOI 10.2147/IDR.S213296; Chun JY, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm051; Creer DD, 2006, THORAX, V61, P75, DOI 10.1136/thx.2004.027441; Etoh Kohju, 2008, Kurume Medical Journal, V55, P55, DOI 10.2739/kurumemedj.55.55; Gadsby NJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.004; Garza-Ramos U, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0396-6; Gomez LF, 2018, AM J TROP MED HYG, V98, P1303, DOI 10.4269/ajtmh.17-0214; Guo Y, 2010, ACTA PHARMACOL SIN, V31, P1487, DOI 10.1038/aps.2010.115; Hsu SF, 2012, J MICROBIOL IMMUNOL, V45, P134, DOI 10.1016/j.jmii.2011.09.004; Hu XM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00382; Huh HJ, 2017, J CLIN MICROBIOL, V55, P479, DOI [10.1128/jcm.02045-16, 10.1128/JCM.02045-16]; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Kara S, 2019, TUBERK TORAK, V67, P108, DOI 10.5578/tt.68421; Kim YJ, 2017, J KOREAN MED SCI, V32, P1642, DOI 10.3346/jkms.2017.32.10.1642; Lee S, 2018, CLIN EXP VACCINE RES, V7, P111, DOI 10.7774/cevr.2018.7.2.111; Lee SH, 2019, J MICROBIOL IMMUNOL, V52, P920, DOI 10.1016/j.jmii.2019.10.009; Lee YJ, 2015, J KOREAN MED SCI, V30, P733, DOI 10.3346/jkms.2015.30.6.733; Lyu JF, 2019, J MED MICROBIOL, V68, P368, DOI 10.1099/jmm.0.000917; Montazeri EA, 2015, BURNS, V41, P590, DOI 10.1016/j.burns.2014.08.018; Ruhanya V, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110324; Shannon KE, 2007, SCI TOTAL ENVIRON, V382, P121, DOI 10.1016/j.scitotenv.2007.02.039; Song JH, 2016, SEMIN RESP CRIT CARE, V37, P839, DOI 10.1055/s-0036-1592075; Takahashi H, 2017, INT J FOOD MICROBIOL, V246, P92, DOI 10.1016/j.ijfoodmicro.2016.12.015; Tchatchouang S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4834396; Wang HY, 2014, J CLIN MICROBIOL, V52, P1911, DOI 10.1128/JCM.00389-14; Wongsurakiat P, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0944-1; Yoo IY, 2020, INT J INFECT DIS, V95, P326, DOI 10.1016/j.ijid.2020.03.024	28	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253402	10.1371/journal.pone.0253402	http://dx.doi.org/10.1371/journal.pone.0253402			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138947	Green Published, gold			2022-12-26	WOS:000671690200115
J	Wulff, JP; Segura, DF; Devescovi, F; Muntaabski, I; Milla, FH; Scannapieco, AC; Cladera, JL; Lanzavecchia, SB				Wulff, Juan P.; Segura, Diego F.; Devescovi, Francisco; Muntaabski, Irina; Milla, Fabian H.; Scannapieco, Alejandra C.; Cladera, Jorge L.; Lanzavecchia, Silvia B.			Identification and characterization of soluble binding proteins associated with host foraging in the parasitoid wasp Diachasmimorpha longicaudata	PLOS ONE			English	Article							PHEROMONE-BINDING; ANTENNAL TRANSCRIPTOME; RAPID EVOLUTION; GYPSY-MOTH; HONEY-BEE; EXPRESSION; GENES; BRACONIDAE; DIPTERA; RNA	The communication and reproduction of insects are driven by chemical sensing. During this process, chemical compounds are transported across the sensillum lymph to the sensory neurons assisted by different types of soluble binding proteins: odorant-binding proteins (OBPs); chemosensory proteins (CSPs); some members of ML-family proteins (MD-2 (myeloid differentiation factor-2)-related Lipid-recognition), also known as NPC2-like proteins. Potential transcripts involved in chemosensing were identified by an in silico analysis of whole-body female and male transcriptomes of the parasitic wasp Diachasmimorpha longicaudata. This analysis facilitated the characterization of fourteen OBPs (all belonging to the Classic type), seven CSPs (and two possible isoforms), and four NPC2-like proteins. A differential expression analysis by qPCR showed that eleven of these proteins (CSPs 2 and 8, OBPs 2, 3, 4, 5, 6, 9, 10, and 11, and NPC2b) were over-expressed in female antenna and two (CSP 1 and OBP 12) in the body without antennae. Foraging behavior trials (linked to RNA interference) suggest that OBPs 9, 10, and 11 are potentially involved in the female orientation to chemical cues associated with the host. OBP 12 seems to be related to physiological processes of female longevity regulation. In addition, transcriptional silencing of CSP 3 showed that this protein is potentially associated with the regulation of foraging behavior. This study supports the hypothesis that soluble binding proteins are potentially linked to fundamental physiological processes and behaviors in D. longicaudata. The results obtained here contribute useful information to increase the parasitoid performance as a biological control agent of fruit fly pest species.	[Wulff, Juan P.; Segura, Diego F.; Devescovi, Francisco; Muntaabski, Irina; Milla, Fabian H.; Scannapieco, Alejandra C.; Cladera, Jorge L.; Lanzavecchia, Silvia B.] Inst Genet Ewald A Favret INTA Gv IABIMO CONICET, Lab Insectos Importancia Agron, Buenos Aires, DF, Argentina		Wulff, JP (corresponding author), Inst Genet Ewald A Favret INTA Gv IABIMO CONICET, Lab Insectos Importancia Agron, Buenos Aires, DF, Argentina.	wulff.juan@inta.gob.ar		Muntaabski, Irina/0000-0002-0631-791X; Lanzavecchia, Silvia/0000-0001-5965-4082; wulff, juan pedro/0000-0002-5773-4684	National Institute of Agricultural Technology (INTA) [INTA-I116, INTA I079]; National Scientific and Technological Promotion Agency (ANPCyT) [PICT-2017-0402, PICT-2017-0239, PICT-2018-01778]	National Institute of Agricultural Technology (INTA); National Scientific and Technological Promotion Agency (ANPCyT)(ANPCyT)	This work was financially supported by the National Institute of Agricultural Technology (INTA, https://www.argentina.gob.ar/inta) through the project INTA I079 (INTA-I116 activity interaction D. longicaudata: fruit fly, IR: S.B.L) and the National Scientific and Technological Promotion Agency (ANPCyT, https://www.argentina.gob.ar/ciencia/agencia) through the projects: PICT-2017-0402 (IR: S.B.L), PICT-2017-0239 (IR: D.F.S) and PICT-2018-01778 (IR:J.P.W). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1908, BIOMETRIKA, V6, P1; [Anonymous], 2004, AZ QUANT PCR; Brand P, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0451-9; Chen AE, 2015, ECOTOXICOLOGY, V24, P595, DOI 10.1007/s10646-014-1407-3; Colazza S, 2010, PROG BIOL CONTROL, V9, P97, DOI 10.1007/978-1-4020-9110-0_4; Mannino MC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2759-2; Dall KB, 2019, GENES NUTR, V14, DOI 10.1186/s12263-019-0650-x; Danneels EL, 2010, TOXINS, V2, P494, DOI 10.3390/toxins2040494; Devescovi F., 2015, ESTUDIOS SUPERPARASI; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ehrenberg S, 2019, J INSECT PHYSIOL, V113, P1, DOI 10.1016/j.jinsphys.2018.12.008; Findlay GD, 2008, PLOS BIOL, V6, P1417, DOI 10.1371/journal.pbio.0060178; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fluegel ML, 2006, GENETICS, V172, P185, DOI 10.1534/genetics.105.046565; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Glatz R, 2015, PROG MOL BIOL TRANSL, V130, P1; Goelen T, 2018, J PEST SCI, V91, P351, DOI 10.1007/s10340-017-0907-3; Gong Y, 2009, CHEM BIOL, V16, P162, DOI 10.1016/j.chembiol.2009.01.005; Gu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042871; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hausser J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07391-8; He P, 2019, PEST MANAG SCI, V75, P1606, DOI 10.1002/ps.5277; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang X, 2005, DEVELOPMENT, V132, P5115, DOI 10.1242/dev.02079; Iovinella I, 2011, J PROTEOME RES, V10, P3439, DOI 10.1021/pr2000754; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051779; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Johnson AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13048; Josek T, 2018, TICKS TICK-BORNE DIS, V9, P1317, DOI 10.1016/j.ttbdis.2018.05.013; Kowcun A, 2001, J BIOL CHEM, V276, P44770, DOI 10.1074/jbc.M104688200; Lapierre LR, 2011, CURR BIOL, V21, P1507, DOI 10.1016/j.cub.2011.07.042; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal W, 2014, AM ENTOMOL, P60; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li KM, 2012, J CHEM ECOL, V38, P287, DOI 10.1007/s10886-012-0085-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maleszka J, 2007, DEV GENES EVOL, V217, P189, DOI 10.1007/s00427-006-0127-y; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Matsuo T, 2008, GENETICS, V178, P1061, DOI 10.1534/genetics.107.079046; Maung K., 2019, STRUCTURAL CHARACTER, V7, P296; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; Miller M.A., 2010, P GAT COMP ENV WORKS; Montoya P, 2000, ANN ENTOMOL SOC AM, V93, P47, DOI 10.1603/0013-8746(2000)093[0047:FRASBD]2.0.CO;2; Oliveira DS, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01175; Onchuru TO, 2019, ECOL EVOL, V9, P8187, DOI 10.1002/ece3.5387; Ovruski Sergio M., 2003, Rev. Soc. Entomol. Argent., V62, P49; Ovruski SM, 2011, FLA ENTOMOL, V94, P195, DOI 10.1653/024.094.0211; Parmakelis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008885; Pelosi P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00320; Peng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180775; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Scheuermann EA, 2019, GENETICS, V213, P897, DOI 10.1534/genetics.119.302629; Schroeder EA, 2015, TRENDS ENDOCRIN MET, V26, P589, DOI 10.1016/j.tem.2015.08.007; Segura DF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152222; Segura DF, 2012, ENTOMOL EXP APPL, V143, P164, DOI 10.1111/j.1570-7458.2012.01246.x; Shen J., 2019, PEST MANAG SCI, P75, DOI [10.1002/ps.5498 31140683, DOI 10.1002/PS.549831140683]; Shi XZ, 2012, INSECT BIOCHEM MOLEC, V42, P545, DOI 10.1016/j.ibmb.2012.04.002; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Steel M, 2001, MATH BIOSCI, V170, P91, DOI 10.1016/S0025-5564(00)00061-4; Sun JS, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180208; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tang LD, 2020, GENES-BASEL, V11, DOI 10.3390/genes11020144; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Tvedte ES, 2019, GENOME BIOL EVOL, V11, P2767, DOI 10.1093/gbe/evz205; Venthur H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01163; Viscarret MM, 2006, BIOL CONTROL, V36, P147, DOI 10.1016/j.biocontrol.2005.08.009; Vogt R.G., 1987, P385; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Wagner A, 2005, MOL BIOL EVOL, V22, P1365, DOI 10.1093/molbev/msi126; Wallberg A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5642-0; Wang GY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31294-9; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Wang SN, 2015, INT J BIOL SCI, V11, P737, DOI 10.7150/ijbs.11786; Wang SX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18472-x; Wang YL, 2017, INSECT BIOCHEM MOLEC, V89, P58, DOI 10.1016/j.ibmb.2017.09.001; Wang ZZ, 2019, J INTEGR AGR, V18, P705, DOI 10.1016/S2095-3119(18)62078-7; Wicher D., 2019, FRONTIERS MEDIA SA; Xiao SK, 2019, ELIFE, V8, DOI 10.7554/eLife.51040; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xiu CL, 2019, COMP BIOCHEM PHYS D, V29, P320, DOI 10.1016/j.cbd.2019.01.004; Yi SY, 2018, INT J BIOL MACROMOL, V107, P2667, DOI 10.1016/j.ijbiomac.2017.10.149; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhao YN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148159; Zheng Y, 2018, INSECT SCI, V25, P765, DOI 10.1111/1744-7917.12473; Zhou CX, 2015, COMP BIOCHEM PHYS D, V16, P10, DOI 10.1016/j.cbd.2015.06.003; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou X-H., 2012, BIOL CHEM, P394; Zhu J., 2019, CHEMOSENSORY PROTEIN, V2, P147, DOI [10.1007/978-3-030-05165-5_6, DOI 10.1007/978-3-030-05165-5_6]; Zhu J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00052	94	1	1	10	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252765	10.1371/journal.pone.0252765	http://dx.doi.org/10.1371/journal.pone.0252765			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138896	Green Published, gold			2022-12-26	WOS:000671690200026
J	Norgaard, HW; Pernicka, E; Vandkilde, H				Norgaard, Heide W.; Pernicka, Ernst; Vandkilde, Helle			Shifting networks and mixing metals: Changing metal trade routes to Scandinavia correlate with Neolithic and Bronze Age transformations	PLOS ONE			English	Article							COLLECTOR ICP-MS; LEAD-ISOTOPE; SOUTHEASTERN ALPS; COPPER PRODUCTION; ARTIFACTS; TRENTINO; DEPOSITS; BRITAIN; RATIOS; GREECE	Based on 550 metal analyses, this study sheds decisive light on how the Nordic Bronze Age was founded on metal imports from shifting ore sources associated with altered trade routes. On-and-off presence of copper characterised the Neolithic. At 2100-2000 BC, a continuous rise in the flow of metals to southern Scandinavia begins. First to arrive via the central German unetician hubs was high-impurity metal from the Austrian Inn Valley and Slovakia; this was complemented by high-tin British metal, enabling early local production of tin bronzes. Increased metal use locally fuelled the leadership competitions visible in the metal-led material culture. The unetice downfall c.1600 BC resulted for a short period in a raw materials shortage, visible in the reuse of existing stocks, but stimulated direct Nordic access to the Carpathian basin. This new access expedited innovations in metalwork with reliance on chalcopyrite from Slovakia, as well as opening new sources in the eastern Alps, along an eastern route that also conveyed Baltic amber as far as the Aegean. British metal plays a central role during this period. Finally, from c.1500 BC, when British copper imports ceased, the predominance of novel northern Italian copper coincides with the full establishment of the NBA and highlights a western route, connecting the NBA with the southern German Tumulus culture and the first transalpine amber traffic.	[Norgaard, Heide W.] Moesgaard Museum, Dept Archaeol, Aarhus, Denmark; [Norgaard, Heide W.; Vandkilde, Helle] Aarhus Univ, Sch Culture & Soc, Dept Archaeol & Heritage Studies, Aarhus, Denmark; [Pernicka, Ernst] Curt Engelhorn Ctr Archaeometry, Mannheim, Germany	Aarhus University	Norgaard, HW (corresponding author), Moesgaard Museum, Dept Archaeol, Aarhus, Denmark.; Norgaard, HW; Vandkilde, H (corresponding author), Aarhus Univ, Sch Culture & Soc, Dept Archaeol & Heritage Studies, Aarhus, Denmark.; Pernicka, E (corresponding author), Curt Engelhorn Ctr Archaeometry, Mannheim, Germany.	hn@moesgaardmuseum.dk; ernst.pemicka@ceza.de; farkhv@cas.au.dk		Vandkilde, Helle/0000-0001-9326-7633; Norgaard, Heide Wrobel/0000-0002-9349-7516	Independent Research Fund Denmark [DFF - 610700030]; Research Fund Sapere Aude program [DFF - IP 6107-00030B]; Cultural Ministry of Denmark [FORM.2020-0009]; Aarhus University Material Culture and Heritage Programme (MCH-Grant) [2019-F]	Independent Research Fund Denmark; Research Fund Sapere Aude program; Cultural Ministry of Denmark; Aarhus University Material Culture and Heritage Programme (MCH-Grant)	This research has been made possible by the support of the Independent Research Fund Denmark under grant agreement DFF - 610700030, the Research Fund Sapere Aude program (DFF - IP 6107-00030B) and the Cultural Ministry of Denmark (FORM.2020-0009), all three to HWN. The research and archaeological study of the shafthole axes was further supported by the Aarhus University Material Culture and Heritage Programme (MCH-Grant 2019-F) to HV and HWN.	Addis A, 2017, ARCHAEOL ANTHROP SCI, V9, P985, DOI 10.1007/s12520-016-0462-5; Addis A, 2016, ARCHAEOMETRY, V58, P96, DOI 10.1111/arcm.12160; Addis A, 2013, LATE BRONZE AGE META; Aner E, 2008, FUNDE ALTEREN BRONZE; Aner E, 1979, FUNDE ALTEREN BRONZE; Aner E, 1977, FUNDE ALTEREN BRONZE; Aner E., 2014, FUNDE ALTEREN BRONZE, DOI [10.1111/pme.12557, DOI 10.1111/PME.12557]; Aner E., 1984, FUNDE ALTEREN BRONZE, DOI [10.1302/0301-620X.66B3.6725339, DOI 10.1302/0301-620X.66B3.6725339]; Aner E, 1976, FUNDE ALTEREN BRONZE; Aner E, 1981, FUNDE ALTEREN BRONZE; Aner E, 2001, FUNDE ALTEREN BRONZE; Aner E., 2005, FUNDE ALTEREN BRONZE; Aner E., 2011, FUNDE ALTEREN BRONZE; Aner E, 1990, FUNDE ALTEREN BRONZE; Aner E, 1986, FUNDE ALTEREN BRONZE; Aner E, 1993, FUNDE ALTEREN BRONZE; Aner E, 1991, FUNDE ALTEREN BRONZE; Aner E., 1973, FUNDE ALTEREN BRONZE; Aner E., 1995, FUNDE ALTEREN BRONZE, DOI [10.1016/s0194-5998%2895%2970240-7, DOI 10.1016/S0194-5998%2895%2970240-7]; Aner E, 1978, FUNDE ALTEREN BRONZE; Antonovic D, 2006, METALL MATER ENG, V12, P85; Artioli G, 2020, ARCHAEOMETRY, V62, P53, DOI 10.1111/arcm.12542; Artioli G, 2016, J ARCHAEOL SCI, V75, P27, DOI 10.1016/j.jas.2016.09.005; Basu A, 1996, EARTH PROCESSES READ, V95, P429, DOI DOI 10.1029/GM095P0429; Bergerbrant S., 2007, BRONZE AGE IDENTITIE; Bray P, 2015, J ARCHAEOL SCI, V56, P202, DOI 10.1016/j.jas.2014.12.013; Broholm HC, 1952, DANSKE OLDSAGER 3 AE; Brondsted J., 1931, ACTA ARCHAEOL-DEN, VII, P111; Brugmann G., 2018, ARCHAOMETRIE DENKMAL, P64; Brun E., 1984, SCHWEIZ, V8 1, P7; Brunn WAv, 1959, HORTFUNDE FRUHEN BRO; Bunnefeld J.-H., 2016, ALTERBRONZEZEITLICHE; Bunnefeld J.-H., 2015, BAR INT SER, V2771, P57; Bunnefeld JH, 2011, PRAEHIST Z, V86, P207, DOI 10.1515/PZ.2011.012; Canovaro C, 2016, THESIS U STUDI PADOV; Cattin F, 2007, 2 INT C ARCH EUR 200, P1; Cattin F, 2011, J ARCHAEOL SCI, V38, P1221, DOI 10.1016/j.jas.2010.12.016; Christensen K., 2007, GERMANIA, V85, P35; Christensen K., 2006, ACTA ARCHAEOL-DEN, V77, P164; Cierny J., 2008, PRAHISTORISCHE KUPFE; Cullberg C, 1968, ARTIFACT ANAL STUDY; Czajlik Z., 2012, BRONZ AG CRAFTS CRAF, P167, DOI [10.1007/s12104-011-9321-6, DOI 10.1007/S12104-011-9321-6]; David W, 2002, STUDIEN ORNAMENTIK D; Doonan R., 1996, OLD FLAMES SLA UNPUB; DUNSTAN LP, 1980, J RES NAT BUR STAND, V85, P1, DOI 10.6028/jres.085.001; Earle T., 2015, PARADIGM FOUND ARCHA, P234; Ernee M., 2012, GERMANIA, V87, P355; Ernee M, 2013, 1600 KULTURELLER UMB, P453; FLETCHER CJN, 1993, J GEOL SOC LONDON, V150, P77, DOI 10.1144/gsjgs.150.1.0076; Forssander J. E., 1936, OSTSKANDINAVISCHE NO; Frank C., 2010, LAK DWELL R MUNR P M, P113; Frei KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219850; Frost L., 2011, AARBOGER NORDISK OLD, V2008, P7; Frotzscher M., 2009, THESIS U HALLE WITTE, V3, P4; Galer S.J.G., 1998, MINERAL MAG, V62A, P491, DOI [DOI 10.1180/minmag.1998.62A.1.260, 10.1180/minmag.1998.62A.1.260, DOI 10.1180/MINMAG.1998.62A.1.260]; Gebauer AB, 2021, EUR J ARCHAEOL, V24, P27, DOI 10.1017/eaa.2019.73; Goldenberg G., 2004, ALPENKUPFER RAME S17, P165; Guglielmino R., 2006, ACCORDIA RES PAPERS, V10, P87; Harbison P., 1968, PALAEOHISTORIA, V14, P175; Herdits H., 2004, ANSCHNITT, P177; Hermann F., 1947, ANTIMONERZVORKOMMEN, P5; Hirata T, 1996, ANALYST, V121, P1407, DOI 10.1039/an9962101407; Hodos T., 2017, ROUTLEDGE HDB ARCHAE, P509; Holst MK., 2015, SKELHOJ BRONZE AGE B, VII; Hoppner B, 2005, ARCHAEOMETRY, V47, P293, DOI 10.1111/j.1475-4754.2005.00203.x; Hornstrup K.M., 2012, ACTA ARCHAEOL, V83, P9, DOI [10.1163/16000390-08301001, DOI 10.1111/j.1600-0390.2012.00513.x, 10.1111/j.1600-0390.2012.00513.x]; Iacono F, 2015, EUR J ARCHAEOL, V18, P259, DOI 10.1179/1461957114Y.0000000074; Joel E.C., 1997, OXBOW MONOGRAPH, V64, P129; Jung R., 2011, PREHIST MONOGR, V29, P231; Jung R, 2013, ARCHAOL KORRESPONDEN, V43, P175; Junghans S., 1974, KUPFER BRONZE FRUHEN; Junghans S., 1968, METALLGRUPPEN BEIM S; Junghans S., 1960, STUDIEN ANFANGEN MET; Karo G, 1933, SCHACHTGRABER MYKENA; Kaul F, 2013, ANTIQUITY, V87, P461, DOI 10.1017/S0003598X00049061; Klassen L., 2004, JADE KUPFER UNTERSUC; Klassen L., 2000, FRUHES KUPFER NORDEN, V36; Klassen L, 2001, PRAEHISTORICHE Z, V76, P55; Kneisel J., 2011, ANTHROPOGENIC PRESSU, V8, P49; Kneisel J., 2013, STUDIEN ARCHAOLOGIE, P95; Kolcze Z., 2014, JUTLAND ARCHAEOLOGIC, V83, P77; Kraus S, 2014, ARCHAOMETALLURGISCHE; Krause R., 1998, AT BRONZ EUR 20 VLL, VII, P219; Kristiansen K., 1998, EUROPE HIST; Kristiansen K., 2005, RISE BRONZE AGE SOC; Kristiansen K., 1998, MENSCH UMWELT BRONZE, P281; Kunze R., 2020, PREHISTORIC MINING M, P391; LING J, 2012, J ARCHAEOL SCI, P1; Ling J, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.05.002; Ling J, 2014, J ARCHAEOL SCI, V41, P106, DOI 10.1016/j.jas.2013.07.018; Lomborg E., 1966, ACTA ARCHAEOL-DEN, V36, P223, DOI [10.1002/1097-0142(19940615)73:123.0.co;2-e, DOI 10.1002/1097-0142(19940615)73:123.0.CO;2-E]; Lomborg E., 1960, ACTA ARCHAEOL-DEN, V30, P51; Lutz J., 1996, ARCHAEOMETRY, V38, P313, DOI [10.1111/j.1475-4754.1996.tb00779.x, DOI 10.1111/J.1475-4754.1996.TB00779.X]; Malmer MP., 1989, REG FORH NORD BRONZ, P19; Mar an J., 2020, OBJECTS IDEAS TRAVEL, V350, P31; Maran J., 2013, MOBILITY MEANING TRA, P147; Maran J, 2014, AM J ARCHAEOL, V118, P529; Melheim AL, 2015, BRIT ARCHAEOLOGICAL; Melheim L, 2018, J ARCHAEOL SCI, V96, P85, DOI 10.1016/j.jas.2018.04.003; Metten B., 2003, BEITRAG SPATBRONZEZE; Modarressi-Tehrani D., 2016, BRIGHT ORES SHINY ME, P109; Modlinger M, 2020, J ARCHAEOL SCI-REP, V33, DOI 10.1016/j.jasrep.2020.102476; Moesta H., 1989, ARCHAOMETALLURGIE S7, P141, DOI [10.1016/0269-7491%2889%2990021-3, DOI 10.1016/0269-7491%2889%2990021-3]; Muller J, 2012, PRAEHIST Z, V87, P44; Muller J, 2010, BRUSZCZEWO 2 AUSGRAB; Needham S., 1998, CIRCULATION METAL BR; Niederschlag E, 2003, ARCHAEOMETRY, V45, P61, DOI 10.1111/1475-4754.00097; Nimis P, 2012, EUR J MINERAL, V24, P23, DOI 10.1127/0935-1221/2012/0024-2163; Norgaard H.W., 2018, BRONZE AGE METALWORK; Norgaard HW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227504; Norgaard HW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219574; Norgaard HW, 2018, PRAEHIST Z, V93, P89, DOI 10.1515/pz-2017-0015; Norgaard HW, 2011, HALSKRAGEN BRONZEZEI; Norgaard HW., 2017, DANSK KEMI, V5, P32; Northover JP., 1991, BRIT MUSEUM OCCASION, P63; O'Brien W., 2015, PREHISTORIC COPPER M; Obereder J., 1993, ARCHAOLOGIE OSTERREI, V4/2, P5; Oldeberg A., 1974, ALTERE METALLZEIT SC; Olsen J, 2011, RADIOCARBON, V53, P261, DOI 10.1017/S0033822200056538; Pernicka E., 1990, ZENTRALMUSEUMS MAI 1, V37, P21; Pernicka E, 2017, SPANGENBARRENHORT OB, P168; Pernicka E., 1997, EURASIA ANTIQUA, V3, P41; Pernicka E., 1993, PRAEHIST Z, V68, P1, DOI DOI 10.1515/PRHZ.1993.68.1.1; Pernicka E., 2010, GRIFF NACH STERNEN E, P719; Pernicka E, 2016, ARCHAEOL AUSTRIACA, P57, DOI 10.1553/archaeologia100s57; Pernicka E, 2016, ARCHAEOL AUSTRIACA, P19, DOI 10.1553/archaeologia100s19; Piel M., 1992, FESTSCHRIFT ZUM 50JA, P463; Pollard AM, 2018, PROVENANCE NEW APPRO; Pre&beta;linger H., 1989, ANSCHNITT BEIHEFT, V7, P235; Radivojevic M, 2019, J ARCHAEOL RES, V27, P131, DOI 10.1007/s10814-018-9123-9; Randsborg K., 2006, ACTA ARCHAEOL-DEN, V77, P1; Rasmussen Marianne, 2013, SKELHJ BRONZE AGE BA, V1; Rassmann C., 2013, THESIS AARHUS U HOJB; Rehkamper M, 1998, INT J MASS SPECTROM, V181, P123, DOI 10.1016/S1387-3806(98)14170-2; Rehkamper M, 2000, J ANAL ATOM SPECTROM, V15, P1451, DOI 10.1039/b005262k; Rehren T, 2012, J ARCHAEOL SCI, V39, P1717, DOI 10.1016/j.jas.2012.01.009; Reiter S., 2014, BEING DOING SE UNPUB; Reiter SS, 2019, EUR J ARCHAEOL, V22, P454, DOI 10.1017/eaa.2019.35; Reiter SS., 2019, DANISH J ARCHAEOLOGY, P8, DOI 10.7146/dja.v8i0.114995; Risch R., 2013, 1600 KULTURELLER UMB, P597; Roberts B, 2013, OXFORD HDB ONLINE, P1, DOI DOI 10.1093/OXFORDHB/9780199545841.013.037; Rohl B., 1996, ARCHAEOMETRY, V38, P165, DOI DOI 10.1111/J.1475-4754.1996.TB00769.X; Schreiner M., 2007, ERZLAGERSTATTEN HRON; Schubert M, 2013, CUPRUM TYROLENSE 555, P123; Silvestri E., 2015, BERGAUF BERGAB 1000, P201; Simonsen J, 2017, DAILY LIFE TURN NEOL; Smith AD, 2011, J ARCHAEOL SCI, V38, P3029, DOI 10.1016/j.jas.2011.06.036; Sorensen TF., 2012, DAN J ARCHAEOL, V1, P45, DOI [10.1080/21662282.2012.750446, DOI 10.1080/21662282.2012.750446]; Stos-Gale Z, 2017, METAL HOARD PILE SCA, P201; Stos-Gale ZA, 1998, ARCHAEOMETRY, V40, P217, DOI 10.1111/j.1475-4754.1998.tb00834.x; Suchowska-Ducke P., 2015, FORGING IDENTITIES M, V2, P257; Thirlwall MF, 2000, CHEM GEOL, V163, P299, DOI 10.1016/S0009-2541(99)00135-7; Thornton CP, 2009, J WORLD PREHIST, V22, P301, DOI 10.1007/s10963-009-9019-1; Timberlake S., 2014, HIST METALL, V47, P75; Timberlake S, 2013, MIN EUR HIST IMP ENV, P59; Timberlake S, 2013, CHUNGARA, V45, P33, DOI 10.4067/S0717-73562013000100002; Turck R., 2010, METALLE Z JUNGNEOLIT; Vandkilde H., 2017, PLACE THINGS TIME ME; Vandkilde H, 1996, ABSOLUTE CHRONOLOGY, P183; Vandkilde H., 1996, METALWORK LATE NEOLI; Vandkilde H., 2004, OFFA, V61/62, P75; Vandkilde H., 1998, ATELIER BRONZIER EUR, P119; Vandkilde H., 2019, P PREHIST SOC, V85, P1, DOI [10.1017/ppr.2019.7, DOI 10.1017/PPR.2019.7]; Vandkilde H, 2016, PRAEHIST Z, V91, P103, DOI 10.1515/pz-2016-0005; Vandkilde H, 2014, EUR J ARCHAEOL, V17, P602, DOI 10.1179/1461957114Y.0000000064; Weisgerber G, 2004, ALPENKUPFER RAME ALP; White WM, 2000, CHEM GEOL, V167, P257, DOI 10.1016/S0009-2541(99)00182-5; Williams R.A, 2014, HIST METALL, V47, P93; Williams RA, 2019, ANTIQUITY, V93, P1178, DOI 10.15184/aqy.2019.130; Williams RA, 2018, THESIS U LIVERPOOL; Woltermann G., 2016, PRAHISTORISCHEN BERN	171	11	11	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252376	10.1371/journal.pone.0252376	http://dx.doi.org/10.1371/journal.pone.0252376			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133451	gold, Green Published			2022-12-26	WOS:000671682700026
J	Kortenoeven, MLA; Esteva-Font, C; Dimke, H; Poulsen, SB; Murali, SK; Fenton, RA				Kortenoeven, Marleen L. A.; Esteva-Font, Cristina; Dimke, Henrik; Poulsen, Soren B.; Murali, Sathish K.; Fenton, Robert A.			High dietary potassium causes ubiquitin-dependent degradation of the kidney sodium-chloride cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CL-COTRANSPORTER; SENSITIVE NACL COTRANSPORTER; FUNCTIONAL EXPRESSION; URINARY SODIUM; BLOOD-PRESSURE; IN-VIVO; PROTEIN; PHOSPHORYLATION; HSP70; HYPERTENSION	The thiazide-sensitive sodium-chloride cotransporter (NCC) in the renal distal convoluted tubule (DCT) plays a critical role in regulating blood pressure (BP) and K+ homeostasis. During hyperkalemia, reduced NCC phosphorylation and total NCC abundance facilitate downstream electrogenic K+ secretion and BP reduction. However, the mechanism for the K+-dependent reduction in total NCC levels is unknown. Here, we show that NCC levels were reduced in ex vivo renal tubules incubated in a high-K+ medium for 24-48 h. This reduction was independent of NCC transcription, but was prevented using inhibitors of the proteasome (MG132) or lysosome (chloroquine). Ex vivo, high K+ increased NCC ubiquitylation, but inhibition of the ubiquitin conjugation pathway prevented the high K+-mediated reduction in NCC protein. In tubules incubated in high K+ media ex vivo or in the renal cortex of mice fed a high K+ diet for 4 days, the abundance and phosphorylation of heat shock protein 70 (Hsp70), a key regulator of ubiquitin-dependent protein degradation and protein folding, were decreased. Conversely, in similar samples the expression of PP1 alpha, known to dephosphorylate Hsp70, was also increased. NCC coimmunoprecipitated with Hsp70 and PP1 alpha, and inhibiting their actions prevented the high K+-mediated reduction in total NCC levels. In conclusion, we show that hyperkalemia drives NCC ubiquitylation and degradation via a PP1 alpha-dependent process facilitated by Hsp70. This mechanism facilitates K+-dependent reductions in NCC to protect plasma K+ homeostasis and potentially reduces BP.	[Kortenoeven, Marleen L. A.; Esteva-Font, Cristina; Poulsen, Soren B.; Murali, Sathish K.; Fenton, Robert A.] Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark; [Kortenoeven, Marleen L. A.; Dimke, Henrik] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Dimke, Henrik] Odense Univ Hosp, Dept Nephrol, Odense, Denmark	Aarhus University; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kortenoeven, MLA; Fenton, RA (corresponding author), Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark.; Kortenoeven, MLA (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark.	kortenoeven@health.sdu.dk; Robert.a.fenton@biomed.au.dk	Fenton, Robert/AFR-6983-2022; Kortenoeven, Marleen/B-8565-2014; Fenton, Robert A/ABD-9824-2021; Dimke, Henrik/G-7970-2011	Fenton, Robert/0000-0003-1623-199X; Kortenoeven, Marleen/0000-0001-9962-8276; Poulsen, Soren Brandt/0000-0002-0082-3934; Dimke, Henrik/0000-0002-9170-2168; Murali, Sathish K/0000-0002-7056-9839	Independent Research Fund Denmark [1333-00279, 1331-00738B]; Aarhus University Research Foundation; Helen & Ejnar Bjornows Foundation; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Mindelegat); Lundbeck Foundation; Independent Research Fund Denmark; Leducq Foundation	Independent Research Fund Denmark; Aarhus University Research Foundation; Helen & Ejnar Bjornows Foundation; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Mindelegat); Lundbeck Foundation(Lundbeckfonden); Independent Research Fund Denmark; Leducq Foundation(Leducq Foundation)	M. L. K. A. is supported by the Independent Research Fund Denmark (Project No. 1333-00279 and 1331-00738B) and grants from Aarhus University Research Foundation and Helen & Ejnar Bjornows Foundation. The project is further funded by the Leducq Foundation, the Novo Nordisk Foundation (incl. Fabrikant Vilhelm Pedersen og Hustrus Mindelegat), the Lundbeck Foundation and the Independent Research Fund Denmark.	Akita S, 2003, HYPERTENSION, V42, P8, DOI 10.1161/01.HYP.0000074668.08704.6E; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Cuevas CA, 2017, J AM SOC NEPHROL, V28, P1814, DOI 10.1681/ASN.2016090935; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Edkins Adrienne L, 2015, Subcell Biochem, V78, P219, DOI 10.1007/978-3-319-11731-7_11; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Ferdaus MZ, 2019, AM J PHYSIOL-RENAL, V317, pF825, DOI 10.1152/ajprenal.00216.2019; Flores-Delgado G, 2007, J PROTEOME RES, V6, P1165, DOI 10.1021/pr060504h; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; Frische S, 2018, AM J PHYSIOL-RENAL, V315, pF429, DOI 10.1152/ajprenal.00539.2017; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hoorn EJ, 2020, PHYSIOL REV, V100, P321, DOI 10.1152/physrev.00044.2018; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kortenoeven MLA, 2021, AM J PHYSIOL-RENAL, V320, pF908, DOI 10.1152/ajprenal.00064.2021; Marion S, 2014, J BIOL CHEM, V289, P11715, DOI 10.1074/jbc.M113.544312; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Penton D, 2019, J AM SOC NEPHROL, V30, P737, DOI 10.1681/ASN.2018050540; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Picard N, 2014, J AM SOC NEPHROL, V25, P511, DOI 10.1681/ASN.2012121202; PolanowskaGrabowska R, 1997, BLOOD, V90, P1516, DOI 10.1182/blood.V90.4.1516.1516_1516_1526; Rosenbaek LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12819-0; Rosenbaek LL, 2017, AM J PHYSIOL-RENAL, V313, pF495, DOI 10.1152/ajprenal.00088.2017; Rosenbaek LL, 2014, J BIOL CHEM, V289, P13347, DOI 10.1074/jbc.M113.543710; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Shoda W, 2017, KIDNEY INT, V91, P402, DOI 10.1016/j.kint.2016.09.001; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Sorensen MV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126910; Su XT, 2020, AM J PHYSIOL-RENAL, V319, pF534, DOI 10.1152/ajprenal.00284.2020; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Thomson MN, 2020, AM J PHYSIOL-RENAL, V318, pF216, DOI 10.1152/ajprenal.00232.2019; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu P, 2019, J AM SOC NEPHROL, V30, P1424, DOI 10.1681/ASN.2019010025; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568	51	7	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100915	10.1016/j.jbc.2021.100915	http://dx.doi.org/10.1016/j.jbc.2021.100915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174287	gold, Green Published			2022-12-26	WOS:000690879300006
J	Bhat, OM; Yuan, XX; Kukreja, RC; Li, PL				Bhat, Owais M.; Yuan, Xinxu; Kukreja, Rakesh C.; Li, Pin-Lan			Regulatory role of mammalian target of rapamycin signaling in exosome secretion and osteogenic changes in smooth muscle cells lacking acid ceramidase gene	FASEB JOURNAL			English	Article						arterial stiffness; exosome; mTOR; sphingolipids; vascular calcification	ARTERIAL MEDIAL CALCIFICATION; VASCULAR CALCIFICATION; OSTEOBLASTIC DIFFERENTIATION; UP-REGULATION; CD38 GENE; SPHINGOMYELINASE; INHIBITION; EXPRESSION; DEGRADATION; TRANSITION	Acid ceramidase (murine gene code: Asah1) (50 kDa) belongs to N-terminal nucleophile hydrolase family. This enzyme is located in the lysosome, which mediates conversion of ceramide (CER) into sphingosine and free fatty acids at acidic pH. CER plays an important role in intracellular sphingolipid metabolism and its increase causes inflammation. The mammalian target of rapamycin complex 1 (mTORC1) signaling on late endosomes (LEs)/lysosomes may control cargo selection, membrane biogenesis, and exosome secretion, which may be fine controlled by lysosomal sphingolipids such as CER. This lysosomal-CER-mTOR signaling may be a crucial molecular mechanism responsible for development of arterial medial calcification (AMC). Torin-1 (5 mg/kg/day), an mTOR inhibitor, significantly decreased aortic medial calcification accompanied with decreased expression of osteogenic markers like osteopontin (OSP) and runt-related transcription factor 2 (RUNX2) and upregulation of smooth muscle 22 alpha (SM22-alpha) in mice receiving high dose of Vitamin D (500 000 IU/kg/day). Asah1(fl/fl)/SMCre mice had markedly increased co-localization of mTORC1 with lysosome-associated membrane protein-1 (Lamp-1) (lysosome marker) and decreased co-localization of vacuolar protein sorting-associated protein 16 (VPS16) (a multivesicular bodies [MVBs] marker) with Lamp-1, suggesting mTOR activation caused reduced MVBs interaction with lysosomes. Torin-1 significantly reduced the co-localization of mTOR vs Lamp-1, increased lysosome-MVB interaction which was associated with reduced accumulation of CD63 and annexin 2 (exosome markers) in the coronary arterial wall of mice. Using coronary artery smooth muscle cells (CASMCs), P-i-stimulation significantly increased p-mTOR expression in Asah1(fl/fl)/SMCre CASMCs as compared to WT/WT cells associated with increased calcium deposition and mineralization. Torin-1 blocked P-i-induced calcium deposition and mineralization. siRNA mTOR and Torin-1 significantly reduce co-localization of mTORC1 with Lamp-1, increased VPS16 vs Lamp-1 co-localization in P-i-stimulated CASMCs, associated with decreased exosome release. Functionally, Torin-1 significantly reduces arterial stiffening as shown by restoration from increased pulse wave velocity and decreased elastin breaks. These results suggest that lysosomal CER-mTOR signaling may play a critical role for the control of lysosome-MVB interaction, exosome secretion and arterial stiffening during AMC.	[Bhat, Owais M.; Yuan, Xinxu; Li, Pin-Lan] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; [Kukreja, Rakesh C.] Virginia Commonwealth Univ, VCU Pauley Heart Ctr, Div Cardiol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Li, PL (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Med Coll, Virginia Campus, Richmond, VA 23298 USA.	pin-lan.li@vcuhealth.org			National Institutes of Health [HL122937, HL057244, HL075316]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: HL122937, HL057244 and HL075316	Bao JX, 2017, FRONT BIOSCI-LANDMRK, V22, P558, DOI 10.2741/4502; Bao JX, 2017, CELL PHYSIOL BIOCHEM, V41, P555, DOI 10.1159/000457877; Bhat O, 2020, J CELL MOL MED, V24, P539, DOI 10.1111/jcmm.14761; Bhat OM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58568-5; Bhat OM, 2015, J CARDIOL, V66, P28, DOI 10.1016/j.jjcc.2014.10.012; Bianco F, 2009, EMBO J, V28, P1043, DOI 10.1038/emboj.2009.45; Boini KM, 2012, J CELL MOL MED, V16, P1674, DOI 10.1111/j.1582-4934.2011.01462.x; Cai YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17540-6; Cao JM, 2017, MOL MED REP, V16, P1911, DOI 10.3892/mmr.2017.6844; Chandrika G, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695921; Chatterjee S, 2014, CIRCULATION, V129, P2403, DOI 10.1161/CIRCULATIONAHA.113.007559; Chong ZZ, 2011, TRENDS CARDIOVAS MED, V21, P151, DOI 10.1016/j.tcm.2012.04.005; Ding M, 2011, ARTERIOSCL THROM VAS, V31, P1403, DOI 10.1161/ATVBAHA.110.216804; El-Abbadi MM, 2009, KIDNEY INT, V75, P1297, DOI 10.1038/ki.2009.83; GIACHELLI CM, 1995, ANN NY ACAD SCI, V760, P109, DOI 10.1111/j.1749-6632.1995.tb44624.x; Goettsch C, 2016, J CLIN INVEST, V126, P1323, DOI 10.1172/JCI80851; Guo Y, 2019, FUNCT INTEGR GENOMIC, V19, P633, DOI 10.1007/s10142-019-00669-0; Gurley JM, 2016, DIABETES, V65, P2911, DOI 10.2337/db16-0305; Hartley CJ, 1997, AM J PHYSIOL-HEART C, V273, pH494, DOI 10.1152/ajpheart.1997.273.1.H494; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Hoenderop JGJ, 2004, KIDNEY INT, V66, P1082, DOI 10.1111/j.1523-1755.2004.00858.x; Huber LA, 2016, CURR OPIN CELL BIOL, V39, P8, DOI 10.1016/j.ceb.2016.01.006; Iijima Katsuya, 2011, Clin Calcium, V21, P53, DOI CliCa111218031810; Jiao Y, 2017, ARTERIOSCL THROM VAS, V37, P1657, DOI 10.1161/ATVBAHA.117.309653; Kapustin AN, 2016, J PHYSIOL-LONDON, V594, P2905, DOI 10.1113/JP271340; Kapustin AN, 2017, ARTERIOSCL THROM VAS, V37, pE22, DOI 10.1161/ATVBAHA.116.308886; Kapustin AN, 2015, CIRC RES, V116, P1312, DOI 10.1161/CIRCRESAHA.116.305012; Kapustin AN, 2012, TRENDS CARDIOVAS MED, V22, P133, DOI 10.1016/j.tcm.2012.07.009; Krohn JB, 2016, J PHYSIOL-LONDON, V594, P2895, DOI 10.1113/JP271338; Krohn JB, 2016, ARTERIOSCL THROM VAS, V36, P525, DOI 10.1161/ATVBAHA.115.307009; Kurdi A, 2016, BRIT J CLIN PHARMACO, V82, P1267, DOI 10.1111/bcp.12820; Lesniewski LA, 2017, AGING CELL, V16, P17, DOI 10.1111/acel.12524; Li ST, 2018, INT J MOL MED, V42, P1517, DOI 10.3892/ijmm.2018.3699; Li X, 2014, J MOL MED, V92, P473, DOI 10.1007/s00109-014-1120-y; Liao LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082379; Lin ME, 2015, AM J PATHOL, V185, P1958, DOI 10.1016/j.ajpath.2015.03.020; Lin X, 2019, LIFE SCI, V232, DOI 10.1016/j.lfs.2019.116582; Lu QB, 2018, BBA-MOL BASIS DIS, V1864, P2154, DOI 10.1016/j.bbadis.2018.04.002; Luong TTD, 2021, CLIN SCI, V135, P515, DOI 10.1042/CS20201122; Mackey RH, 2007, ADV CARDIOL, V44, P234, DOI 10.1159/000096744; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Mondal RK, 2009, INDIAN PEDIATR, V46, P175; Nakahara T, 2017, JACC-CARDIOVASC IMAG, V10, P582, DOI 10.1016/j.jcmg.2017.03.005; Nakano-Kurimoto R, 2009, AM J PHYSIOL-HEART C, V297, pH1673, DOI 10.1152/ajpheart.00455.2009; Ode T, 2017, EXP CELL RES, V350, P103, DOI 10.1016/j.yexcr.2016.11.011; Pai A, 2011, AM J PATHOL, V178, P764, DOI 10.1016/j.ajpath.2010.10.006; Pan SL, 2017, AM J TRANSL RES, V9, P1307; Price PA, 2001, J NUTR, V131, P2910, DOI 10.1093/jn/131.11.2910; Qin JD, 2012, J BIOL CHEM, V287, P13620, DOI 10.1074/jbc.M111.304857; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Quinn U, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012024; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Rzucidlo EM, 2009, VASCULAR, V17, pS15, DOI 10.2310/6670.2008.00089; Schieder M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pl3; Serban KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31596; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shroff RC, 2007, SEMIN DIALYSIS, V20, P103, DOI 10.1111/j.1525-139X.2007.00255.x; Shroff RC, 2010, J AM SOC NEPHROL, V21, P103, DOI 10.1681/ASN.2009060640; Smith ER, 2016, METHODS MOL BIOL, V1397, P175, DOI 10.1007/978-1-4939-3353-2_13; Song Y, 2017, EUR J PHARMACOL, V794, P45, DOI 10.1016/j.ejphar.2016.11.029; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; SUGITA M, 1972, SCIENCE, V178, P1100, DOI 10.1126/science.178.4065.1100; Taniguchi M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.416552; TANIMURA A, 1983, P SOC EXP BIOL MED, V172, P173; Tassew NG, 2017, CELL REP, V20, P99, DOI 10.1016/j.celrep.2017.06.009; Tong XY, 2016, J MOL CELL CARDIOL, V92, P30, DOI 10.1016/j.yjmcc.2016.01.020; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vogel KR, 2015, ANN CLIN TRANSL NEUR, V2, P699, DOI 10.1002/acn3.200; Wang Y, 2018, Zhonghua Yi Xue Za Zhi, V98, P1446, DOI 10.3760/cma.j.issn.0376-2491.2018.18.016; Xu TH, 2019, J CELL PHYSIOL, V234, P14306, DOI 10.1002/jcp.28130; Xu Z, 2017, EUR J PHARMACOL, V813, P1, DOI 10.1016/j.ejphar.2017.06.038; Yuan XX, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158532; Yuan XX, 2019, AM J PHYSIOL-HEART C, V316, pH345, DOI 10.1152/ajpheart.00342.2018; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhan JK, 2015, INT J CARDIOL, V189, P188, DOI 10.1016/j.ijcard.2015.04.086; Zhan JK, 2014, EXP CELL RES, V323, P352, DOI 10.1016/j.yexcr.2014.02.016; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhang MH, 2020, HISTOCHEM CELL BIOL, V153, P357, DOI 10.1007/s00418-020-01847-z; Zhang WY, 2019, INT J CLIN EXP PATHO, V12, P2474; Zhang Y, 2014, CARDIOVASC RES, V102, P68, DOI 10.1093/cvr/cvu011; Zhao J, 2019, MOL MED REP, V20, P5197, DOI 10.3892/mmr.2019.10747; Zhao Y, 2015, KIDNEY INT, V88, P711, DOI 10.1038/ki.2015.160; Zhou KC, 2018, ACS CENTRAL SCI, V4, P548, DOI 10.1021/acscentsci.7b00582; Zhu DX, 2015, J CELL MOL MED, V19, P165, DOI 10.1111/jcmm.12373	85	3	3	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21732	10.1096/fj.202100385R	http://dx.doi.org/10.1096/fj.202100385R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143450	Green Accepted			2022-12-26	WOS:000667814100074
J	Liu, LF; Ge, W; Zhang, ZW; Li, Y; Xie, MX; Zhao, CH; Yao, CL; Luo, C; Wu, ZJ; Wang, WB; Zhao, D; Zhang, J; Qiu, W; Wang, YW				Liu, Longfei; Ge, Wen; Zhang, Zhiwei; Li, Ya; Xie, Mengxiao; Zhao, Chenhui; Yao, Chunlei; Luo, Can; Wu, Zhijiao; Wang, Wenbo; Zhao, Dan; Zhang, Jing; Qiu, Wen; Wang, Yingwei			Sublytic C5b-9 triggers glomerular mesangial cell proliferation via enhancing FGF1 and PDGF alpha gene transcription mediated by GCN5-dependent SOX9 acetylation in rat Thy-1 nephritis	FASEB JOURNAL			English	Article						acetylation; GCN5; SOX9; sublytic C5b-9; Thy-1 nephritis	LYSINE ACETYLTRANSFERASE GCN5; DNA-BINDING; C/EBP-BETA; COMPLEMENT; EXPRESSION; COMPLEXES; APOPTOSIS; ACTIVATION; CANCER; THROMBOSPONDIN-1	Rat Thy-1 nephritis (Thy-1N) is an animal model of human mesangioproliferative glomerulonephritis (MsPGN), accompanied by glomerular mesangial cell (GMC) proliferation and extracellular matrix (ECM) deposition. Although sublytic C5b-9 formed on GMC membrane could induce cell proliferation, the mechanism is still unclear. In this study, we first demonstrated that the level of SRY related HMG-BOX gene 9 (SOX9), general control nonderepressible 5 (GCN5), fibroblast growth factor 1 (FGF1) and platelet-derived growth factor alpha (PDGF alpha) was all elevated both in the renal tissues of Thy-1N rats (in vivo) and in the GMCs (in vitro) with sublytic C5b-9 stimulation. Then, we not only discovered that sublytic C5b-9 caused GMC proliferation through increasing SOX9, GCN5, FGF1 and PDGF alpha expression, but also proved that SOX9 and GCN5 formed a complex and combined with FGF1 and PDGF alpha promoters, leading to FGF1 and PDGF alpha gene transcription. More importantly, GCN5 could mediate SOX9 acetylation at lysine 62 (K62) to enhance SOX9 binding to FGF1 or PDGF alpha promoter and promote FGF1 or PDGF alpha synthesis and GMC proliferation. Besides, the experiments in vivo also showed that FGF1 and PDGF alpha expression, GMC proliferation and urinary protein secretion in Thy-1N rats were greatly reduced by silencing renal SOX9, GCN5, FGF1 or PDGF alpha gene. Furthermore, the renal tissues of MsPGN patients also exhibited positive expression of these genes mentioned above. Collectively, our findings indicate that GCN5, SOX9 and FGF1/PDGF alpha can form an axis and play an essential role in sublytic C5b-9-triggered GMC proliferation, which might provide a novel insight into the pathogenesis of Thy-1N and MsPGN.	[Liu, Longfei; Ge, Wen; Zhang, Zhiwei; Li, Ya; Luo, Can; Wu, Zhijiao; Wang, Wenbo; Zhao, Dan; Zhang, Jing; Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Dept Immunol, Key Lab Immunol Environm & Dis, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China; [Liu, Longfei] Nanjing Med Univ, Affiliated Huaian 1 Peoples Hosp, Dept Cent Lab, Huaian, Peoples R China; [Xie, Mengxiao] Nanjing Med Univ, Dept Lab Med, Affiliated Hosp 1, Nanjing, Peoples R China; [Zhao, Chenhui] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing, Peoples R China; [Yao, Chunlei] Nanjing Med Univ, Dept Nephrol, Affiliated Hosp 1, Nanjing, Peoples R China; [Qiu, Wen; Wang, Yingwei] Nanjing Med Univ, Key Lab Antibody Technol, Minist Hlth, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Qiu, W; Wang, YW (corresponding author), Nanjing Med Univ, Dept Immunol, Key Lab Immunol Environm & Dis, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China.	qiuwen@njmu.edu.cn; wangyw1508@njmu.edu.cn			National Natural Science Foundations of China [31770934, 31470853, 81971468, NMUB2020138]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundations of China, Grant/Award Number: 31770934, 31470853 and 81971468 Nanjing Medical University Science and Technology Development Fund: Grant/Award Number: NMUB2020138	Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181; Bai JX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01982; Borkham-Kamphorst E, 2016, CYTOKINE GROWTH F R, V28, P53, DOI 10.1016/j.cytogfr.2015.10.002; Cai CM, 2013, J CLIN INVEST, V123, P1109, DOI 10.1172/JCI66666; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen L, 2013, J BIOL CHEM, V288, P14510, DOI 10.1074/jbc.M113.458737; Cheng PF, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0594-4; Couser WG, 2001, KIDNEY INT, V59, P905, DOI 10.1046/j.1523-1755.2001.059003905.x; Dutta R, 2016, MOL GENET METAB, V119, P37, DOI 10.1016/j.ymgme.2016.06.013; Fan L, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.01478; Fosbrink M, 2005, IMMUNOL RES, V31, P37, DOI 10.1385/IR:31:1:37; Gao L, 2006, CLIN EXP IMMUNOL, V144, P326, DOI 10.1111/j.1365-2249.2006.03069.x; Gao L, 2009, CELL PROLIFERAT, V42, P83, DOI 10.1111/j.1365-2184.2008.00575.x; Guo L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00834-8; Haseeb A, 2019, NUCLEIC ACIDS RES, V47, P6917, DOI 10.1093/nar/gkz523; He FX, 2016, J MOL CELL BIOL, V8, P477, DOI 10.1093/jmcb/mjw021; Holmlund T, 2013, LEUKEMIA, V27, P578, DOI 10.1038/leu.2012.265; Jana S, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2019.113789; Kang HM, 2016, CELL REP, V14, P861, DOI 10.1016/j.celrep.2015.12.071; Li TT, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0877-2; Liang G, 2018, KIDNEY INT, V93, P95, DOI 10.1016/j.kint.2017.05.013; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Liu K, 2015, INT J MOL SCI, V16, P21897, DOI 10.3390/ijms160921897; Liu LS, 2012, J BIOL CHEM, V287, P16410, DOI 10.1074/jbc.M111.319566; Lu Y, 2019, CELL MOL IMMUNOL, V16, P735, DOI 10.1038/s41423-018-0020-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; Maillard N, 2015, J AM SOC NEPHROL, V26, P1503, DOI 10.1681/ASN.2014101000; Mustachio LM, 2019, AM J CANCER RES, V9, P1830; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Qiao LJ, 2018, J CELL MOL MED, V22, P5333, DOI 10.1111/jcmm.13806; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Qiu W, 2012, J PATHOL, V226, P619, DOI 10.1002/path.3011; Qiu W, 2009, EUR J IMMUNOL, V39, P3251, DOI 10.1002/eji.200939264; Rivera-Gonzalez GC, 2016, CELL STEM CELL, V19, P738, DOI 10.1016/j.stem.2016.09.002; Santos JC, 2016, CANCER RES, V76, P6735, DOI 10.1158/0008-5472.CAN-16-1120; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; Stangou M, 2008, SCAND J UROL NEPHROL, V42, P373, DOI 10.1080/00365590801943241; Sumi E, 2007, AM J PATHOL, V170, P1854, DOI 10.2353/ajpath.2007.060899; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Ud-Din AIMS, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071018; Vainer R, 2016, J MOL BIOL, V428, P3013, DOI 10.1016/j.jmb.2016.06.009; Wang LH, 2020, CANCER LETT, V468, P14, DOI 10.1016/j.canlet.2019.10.004; Wang YJ, 2017, CELL REP, V20, P600, DOI 10.1016/j.celrep.2017.06.065; Wang YW, 2006, LIFE SCI, V79, P182, DOI 10.1016/j.lfs.2005.12.053; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wu WF, 2020, PHYTOMEDICINE, V69, DOI 10.1016/j.phymed.2020.153202; Xu JH, 2006, CELL TISSUE RES, V326, P159, DOI 10.1007/s00441-006-0214-4; Yu TY, 2020, INT J BIOL SCI, V16, P2340, DOI 10.7150/ijbs.46573; Yu TY, 2019, J CELL MOL MED, V23, P5654, DOI 10.1111/jcmm.14473; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Yunus MA, 2010, J VIROL METHODS, V169, P112, DOI 10.1016/j.jviromet.2010.07.006; Zakrzewska M, 2008, CRIT REV CL LAB SCI, V45, P91, DOI 10.1080/10408360701713120 ; Zhang J, 2018, J IMMUNOL, V201, P3184, DOI 10.4049/jimmunol.1800719; Zhang J, 2014, FASEB J, V28, P1511, DOI 10.1096/fj.13-242693; Zhang W, 2019, MOL ONCOL, V13, P2194, DOI 10.1002/1878-0261.12560; Zhao CH, 2018, ONCOGENE, V37, P4821, DOI 10.1038/s41388-018-0298-9; Zhu GQ, 2017, J IMMUNOL, V198, P1104, DOI 10.4049/jimmunol.1600403	61	2	2	2	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21751	10.1096/fj.202002814RR	http://dx.doi.org/10.1096/fj.202002814RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34156114				2022-12-26	WOS:000667814100032
J	Johnson, MS; Skjerdingstad, N; Ebrahimi, OV; Hoffart, A; Johnson, SU				Johnson, Miriam S.; Skjerdingstad, Nora; Ebrahimi, Omid, V; Hoffart, Asle; Johnson, Sverre Urnes			Mechanisms of parental distress during and after the first COVID-19 lockdown phase: A two-wave longitudinal study	PLOS ONE			English	Article							CHILD-BEHAVIOR PROBLEMS; PERCEIVED CONTROL; STRESS; HEALTH; DEPRESSION; ANXIETY; INFLEXIBILITY; ASSOCIATIONS; RESILIENCE; ADJUSTMENT	Background In these unpredictable times of the global coronavirus disease 2019 (COVID-19) pandemic, parents worldwide are affected by the stress and strain caused by the physical distancing protocols that have been put in place. Objective In a two-wave longitudinal survey, we investigated the levels of parental stress and symptoms of anxiety and depression in a sample of parents at two time points; during the implementation of the strictest physical distancing protocols following the onset of the COVID-19 pandemic (T1, N = 2,868) and three months after the discontinuation of the protocols (T2, N = 1,489). Further, we investigated the relationships between parental stress and anxiety and depression relative to relationship quality and anger toward their children at the two aforementioned time points, including subgroups based on age, parental role, cultural background, relationship status, education level, number of children, employment status and pre-existing psychiatric diagnosis. Methods and findings Parents were asked to fill out a set of validated questionnaires on the two measurement points. Parental stress significantly decreased from T1 to T2, indicating that the cumulative stress that parents experienced during the implementation of the distancing protocols declined when the protocols were phased out. The decrease of perceived parental stress was accompanied by a significant decrease in the symptoms of both depression and anxiety among the participating parents. Symptoms meeting the clinical cut-offs for depression (23.0%) and generalized anxiety disorder (23.3%) were reported among participating parents at T1, compared to 16.8% and 13.8% at T2, respectively. The reduction in depression and anger toward their child(ren) from T1 to T2 was associated with a reduction of parental stress. Relationship quality and anger toward their child(ren) at T1 further predicted a change in the level of parental stress from T1 to T2. Conclusions The study underlines the negative psychological impacts of the implementation of the distancing protocols on parents' health and well-being. Uncovering the nature of how these constructs are associated with parents and families facing a social crisis such as the ongoing pandemic may contribute to the design of relevant interventions to reduce parental distress and strengthen parental coping and resilience.	[Johnson, Miriam S.] Oslo Metropolitan Univ, Oslo, Norway; [Skjerdingstad, Nora; Ebrahimi, Omid, V; Hoffart, Asle; Johnson, Sverre Urnes] Univ Oslo, Dept Psychol, Oslo, Norway; [Ebrahimi, Omid, V; Hoffart, Asle; Johnson, Sverre Urnes] Modum Bad Psychiat Hosp, Vikersund, Norway	Oslo Metropolitan University (OsloMet); University of Oslo	Johnson, MS (corresponding author), Oslo Metropolitan Univ, Oslo, Norway.	mirsin@oslomet.no		Ebrahimi, Omid V./0000-0002-8335-2217				ABIDIN RR, 1992, J CLIN CHILD PSYCHOL, V21, P407, DOI 10.1207/s15374424jccp2104_12; Ballash NG, 2006, J ANXIETY DISORD, V20, P486, DOI 10.1016/j.janxdis.2005.05.002; Beckerman M, 2017, CHILD ABUSE NEGLECT, V64, P109, DOI 10.1016/j.chiabu.2016.12.015; Bradbury-Jones C, 2020, J CLIN NURS, V29, P2047, DOI 10.1111/jocn.15296; Brooks S.K., 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8,10227, 10.1016/S0140-6736]; Brown SM, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104699; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Campbell A.M., 2020, FORENSIC SCI INT REP, V2, DOI [10.1016/j.fsir.2020.100089, DOI 10.1016/J.FSIR.2020.100089]; Chan KL, 2011, VIOLENCE VICTIMS, V26, P364, DOI 10.1891/0886-6708.26.3.364; COMPAS BE, 1991, J SOC ISSUES, V47, P23, DOI 10.1111/j.1540-4560.1991.tb01832.x; Crasta D, 2020, J CONTEXT BEHAV SCI, V18, P117, DOI 10.1016/j.jcbs.2020.09.003; Deater-Deckard K D, 2004, PARENTING STRESS; Dijkstra MTM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01415; Ebrahimi OV, 2021, CLIN PSYCHOL SCI, V9, P489, DOI 10.1177/2167702621994545; Falconier MK, 2015, CLIN PSYCHOL REV, V42, P28, DOI 10.1016/j.cpr.2015.07.002; Folkman S, 2010, PSYCHO-ONCOLOGY, V19, P901, DOI 10.1002/pon.1836; Fredman SJ, 2010, J TRAUMA STRESS, V23, P446, DOI 10.1002/jts.20555; Gassman-Pines A, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-007294; Griffith AK, 2021, LANCET CHILD ADOLESC, V5, P322, DOI 10.1007/s10896-020-00172-2; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Hjemdal O, 2006, CLIN PSYCHOL PSYCHOT, V13, P194, DOI 10.1002/cpp.488; Hoffart Asle, 2020, Front Psychiatry, V11, P589127, DOI 10.3389/fpsyt.2020.589127; Horesh D, 2020, PSYCHOL TRAUMA-US, V12, P331, DOI 10.1037/tra0000592; Mondragon NI, 2021, PSYCHOL HEALTH, V36, P179, DOI 10.1080/08870446.2020.1804570; Jiao WY, 2020, J PEDIATR-US, V221, P264, DOI 10.1016/j.jpeds.2020.03.013; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kazdin AE, 2003, J CONSULT CLIN PSYCH, V71, P504, DOI 10.1037/0022-006X.71.3.504; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lam D., 1999, CHILD FAMILY SOCIAL, V4, P337, DOI [10.1046/j.1365-2206.1999.00133.x, DOI 10.1046/J.1365-2206.1999.00133.X]; Lazarus R.S., 1984, EMOTION ADAPTATION; Le YY, 2017, J FAM PSYCHOL, V31, P679, DOI 10.1037/fam0000315; Marchetti D, 2020, J PEDIATR PSYCHOL, V45, P1114, DOI 10.1093/jpepsy/jsaa093; Marshall EM, 2017, CURR OPIN PSYCHOL, V13, P54, DOI 10.1016/j.copsyc.2016.04.013; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Masten AS, 2008, ECOL SOC, V13; Mousavi SF, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.553880; Neece CL, 2012, AJIDD-AM J INTELLECT, V117, P48, DOI 10.1352/1944-7558-117.1.48; Norwegian Institute of Public Health, 2016, PUBL HLTH REP HLTH S; O'Connell Nathaniel S, 2017, J Biom Biostat, V8, P1, DOI 10.4172/2155-6180.1000334; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Peltz JS, 2020, J CONTEXT BEHAV SCI, V17, P168, DOI 10.1016/j.jcbs.2020.07.001; Pietromonaco PR, 2021, AM PSYCHOL, V76, P438, DOI 10.1037/amp0000714; Pontoppidan M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205662; Prime H, 2020, AM PSYCHOL, V75, P631, DOI 10.1037/amp0000660; Rodriguez CM, 2007, CHILD MALTREATMENT, V12, P325, DOI 10.1177/1077559507305993; Rodriguez CM, 1997, CHILD ABUSE NEGLECT, V21, P367, DOI 10.1016/S0145-2134(96)00177-9; Russell BS, 2020, CHILD PSYCHIAT HUM D, V51, P671, DOI 10.1007/s10578-020-01037-x; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Sharpley CF, 1997, J INTELLECT DEV DIS, V22, P19, DOI 10.1080/13668259700033261; Smith M., 2004, CHILD FAMILY SOCIAL, V9, P3, DOI [DOI 10.1111/J.1365-2206.2004.00312.X, https://doi.org/10.1111/j.1365-2206.2004.00312.x, 10.1111/j.1365-2206.2004.00312.x]; Spinelli M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01713; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sprang G, 2013, DISASTER MED PUBLIC, V7, P105, DOI 10.1017/dmp.2013.22; Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872; Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van der Noordt M, 2014, OCCUP ENVIRON MED, V71, P730, DOI 10.1136/oemed-2013-101891; Vinkers CH, 2020, EUR NEUROPSYCHOPHARM, V35, P12, DOI 10.1016/j.euroneuro.2020.05.003; WEBSTERSTRATTON C, 1988, J ABNORM CHILD PSYCH, V16, P299, DOI 10.1007/BF00913802; WHIPPLE EE, 1991, CHILD ABUSE NEGLECT, V15, P279, DOI 10.1016/0145-2134(91)90072-L; Williford AP, 2007, J ABNORM CHILD PSYCH, V35, P251, DOI 10.1007/s10802-006-9082-3	62	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253087	10.1371/journal.pone.0253087	http://dx.doi.org/10.1371/journal.pone.0253087			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166429	Green Published, gold			2022-12-26	WOS:000671692800088
J	Yang, QH; Gruenbacher, DM; Brase, GL; Stamm, JLH; DeLoach, SA; Scoglio, CM				Yang, Qihui; Gruenbacher, Don M.; Brase, Gary L.; Stamm, Jessica L. Heier; DeLoach, Scott A.; Scoglio, Caterina M.			Simulating human behavioral changes in livestock production systems during an epidemic: The case of the US beef cattle industry	PLOS ONE			English	Article							MOUTH-DISEASE; MODEL; VACCINATION; STRATEGIES; OUTBREAK; SPREAD	Human behavioral change around biosecurity in response to increased awareness of disease risks is a critical factor in modeling animal disease dynamics. Here, biosecurity is referred to as implementing control measures to decrease the chance of animal disease spreading. However, social dynamics are largely ignored in traditional livestock disease models. Not accounting for these dynamics may lead to substantial bias in the predicted epidemic trajectory. In this research, an agent-based model is developed by integrating the human decision-making process into epidemiological processes. We simulate human behavioral change on biosecurity practices following an increase in the regional disease incidence. We apply the model to beef cattle production systems in southwest Kansas, United States, to examine the impact of human behavior factors on a hypothetical foot-and-mouth disease outbreak. The simulation results indicate that heterogeneity of individuals regarding risk attitudes significantly affects the epidemic dynamics, and human-behavior factors need to be considered for improved epidemic forecasting. With the same initial biosecurity status, increasing the percentage of risk-averse producers in the total population using a targeted strategy can more effectively reduce the number of infected producer locations and cattle losses compared to a random strategy. In addition, the reduction in epidemic size caused by the shifting of producers' risk attitudes towards risk-aversion is heavily dependent on the initial biosecurity level. A comprehensive investigation of the initial biosecurity status is recommended to inform risk communication strategy design.	[Yang, Qihui; Gruenbacher, Don M.; Scoglio, Caterina M.] Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA; [Brase, Gary L.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA; [Stamm, Jessica L. Heier] Kansas State Univ, Dept Ind & Mfg Syst Engn, Manhattan, KS 66506 USA; [DeLoach, Scott A.] Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University; Kansas State University	Yang, QH (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, Manhattan, KS 66506 USA.	qihui@ksu.edu			United States National Science Foundation [CMMI-1744812]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by United States National Science Foundation under Grant Award CMMI-1744812. https://www.nsf.gov/awardsearch/showAward?AWD_ID=1744812 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulkareem SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226483; Aktipis CA, 2011, HUM ECOL, V39, P131, DOI 10.1007/s10745-010-9364-9; Bates TW, 2003, AM J VET RES, V64, P195, DOI 10.2460/ajvr.2003.64.195; Bertram MR, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00174; Boklund A, 2013, PREV VET MED, V111, P206, DOI 10.1016/j.prevetmed.2013.05.008; Bucini G, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00196; Chan HF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76763-2; Dion E, 2011, ECOL MODEL, V222, P2059, DOI 10.1016/j.ecolmodel.2011.03.026; Drouillard JS, 2018, ASIAN AUSTRAL J ANIM, V31, P1007, DOI 10.5713/ajas.18.0428; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Gortazar C, 2020, PREV VET MED, V180, DOI 10.1016/j.prevetmed.2020.105030; Gozzi N, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007879; Granell C, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.128701; Hashem NM, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.582528; Hidano A, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00137; Jablonski KE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194450; Kim H, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.3064; Kinsley AC, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00596; Liu H, 2012, PROCEDIA COMPUT SCI, V9, P857, DOI 10.1016/j.procs.2012.04.092; Mankad A, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0375-9; Marchant-Forde JN, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.625372; Marvuglia A, 2017, J CLEAN PROD, V142, P1539, DOI 10.1016/j.jclepro.2016.11.150; Mendes AJ, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.558409; Moustakas A, 2015, STOCH ENV RES RISK A, V29, P623, DOI 10.1007/s00477-014-1016-y; Peel D., 2020, EC DAMAGES US BEEF C; Rasch S, 2016, ENVIRON MODELL SOFTW, V75, P402, DOI 10.1016/j.envsoft.2014.12.008; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; Rossi G., 2017, SCI REP UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/s41598-016-0028-x]; Sahneh FD, 2014, MATH MODEL NAT PHENO, V9, P136, DOI 10.1051/mmnp/20149209; Schemann K, 2011, PREV VET MED, V102, P304, DOI 10.1016/j.prevetmed.2011.08.002; Seedorf J, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00358; Sok J, 2020, EUR REV AGRIC ECON, V47, P1201, DOI 10.1093/erae/jbz041; Tago D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157450; Tomczyk S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01821; Walz E, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00501; Wiltshire SW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194013; Yadav S, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00263; Yang QH, 2021, PHYSICA A, V563, DOI 10.1016/j.physa.2020.125466; Yang QH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240819; Yang Qihui, 2020, Infect Dis Model, V5, P563, DOI 10.1016/j.idm.2020.08.001; Yang QH, 2019, PHYSICA A, V526, DOI 10.1016/j.physa.2019.04.092; Ye Y, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.042314	42	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253498	10.1371/journal.pone.0253498	http://dx.doi.org/10.1371/journal.pone.0253498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166451	gold, Green Published			2022-12-26	WOS:000671692800081
J	Etterson, M; Schumaker, N; Garber, K; Lennartz, S; Kanarek, A; Connolly, J				Etterson, Matthew; Schumaker, Nathan; Garber, Kristina; Lennartz, Steven; Kanarek, Andrew; Connolly, Jennifer			A spatially explicit model for estimating risks of pesticide exposure to bird populations	PLOS ONE			English	Article							FECUNDITY; TOXICITY	Pesticides are used widely in agriculture and have the potential to affect non-target organisms, including birds. We developed an integrated modeling system to allow for spatially-explicit evaluation of potential impacts to bird populations following exposures to pesticides. Our novel methodology builds upon three existing models: the Terrestrial Investigation Model (TIM), the Markov Chain Nest Productivity Model (MCnest), and HexSim to simulate population dynamics. We parameterized the integrated modeling system using information required under the Federal Insecticide, Fungicide, and Rodenticide Act, together with species habitat and life history data available from the scientific literature as well as landcover data representing agricultural areas and species habitat. Our case study of the federally threatened California Gnatcatcher (Polioptila californica) illustrates how the integrated modeling system can estimate the population-scale consequences of pesticide applications. We simulated impacts from two insecticides applied to wheat: one causing mortality (survival stressor), and the other causing reproductive failure (reproductive stressor). We observed declines in simulated gnatcatcher abundance and changes in the species' distribution following applications of each pesticide; however, the impacts of the two pesticides were different. Our methodology attempts to strike a balance between biological realism and model complexity and should be applicable to a wide array of species, systems, and stressors.	[Etterson, Matthew] US EPA, Off Res & Dev, Ctr Computat Toxicol & Exposure, Great Lakes Toxicol & Ecol Div, Duluth, MN 55804 USA; [Schumaker, Nathan] US EPA, Off Res & Dev, Ctr Publ Hlth & Environm Assessment, Pacific Ecol Syst Div, Corvallis, OR USA; [Garber, Kristina; Lennartz, Steven; Kanarek, Andrew; Connolly, Jennifer] US EPA, Off Pesticide Programs, Environm Fate & Effects Div, Washington, DC 20460 USA; [Lennartz, Steven] US EPA, Off Informat Technol Operat, Enterprise Hosting Div, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency; United States Environmental Protection Agency	Etterson, M (corresponding author), US EPA, Off Res & Dev, Ctr Computat Toxicol & Exposure, Great Lakes Toxicol & Ecol Div, Duluth, MN 55804 USA.	etterson.matthew@epa.gov		Schumaker, Nathan/0000-0002-4331-825X				Akcakaya HR, 1997, CONSERV BIOL, V11, P422, DOI 10.1046/j.1523-1739.1997.96164.x; [Anonymous], 2016, BIOL EV CHAPT CHLORP; Atwood D., 2017, PESTICIDES IND SALES; Atwood J. L., 2001, BIRDS N AM, DOI [10.2173/bna.574, DOI 10.2173/BNA.574]; Bennett RS, 2007, INTEGR ENVIRON ASSES, V3, P498, DOI 10.1897/IEAM_2007-029.1; Bennett RS, 2006, HUM ECOL RISK ASSESS, V12, P762, DOI 10.1080/10807030500531489; Bennett RS, 2013, INTEGR ENVIRON ASSES, V9, P600, DOI 10.1002/ieam.1478; Bennett RS., 2013, EPA600R13033 US ENV EPA600R13033 US ENV; Bennett RS., 2013, EPA600R13034 US ENV EPA600R13034 US ENV; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Bright J.A., 2008, 28 RSPB CTR CONS SCI; Caswell, 2000, MATRIX POPULATION MO; ECOFRAM, 1999, ECOFRAM TERR DRAFT R ECOFRAM TERR DRAFT R; ESRI, 2015, ARCGIS DESKT REL 10; Etterson M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176998; Etterson MA, 2013, INTEGR ENVIRON ASSES, V9, P590, DOI 10.1002/ieam.1450; Etterson MA, 2011, ECOL MODEL, V222, P2178, DOI 10.1016/j.ecolmodel.2010.10.013; Etterson MA, 2009, ECOL APPL, V19, P622, DOI 10.1890/08-0499.1; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Gleason TR, 2001, HUM ECOL RISK ASSESS, V7, P1027, DOI 10.1080/20018091094835; Hallmann CA, 2014, NATURE, V511, P341, DOI 10.1038/nature13531; Marovich RA., 1997, SPECIES COMMODITY CO; Mathworks, 2016, MATLAB R2016B; Mineau P, 1996, REGUL TOXICOL PHARM, V24, P24, DOI 10.1006/rtph.1996.0061; Mineau P, 2006, ENVIRON TOXICOL CHEM, V25, P1214, DOI 10.1897/05-035R.1; Moore DRJ, 2017, INTEGR ENVIRON ASSES, V13, P542, DOI 10.1002/ieam.1890; Nagy LR, 2005, ECOLOGY, V86, P675, DOI 10.1890/04-0155; National Research Council, 2013, ASS RISKS END THREAT, DOI 10.17226/18344; Pastorok R. A., 2001, ECOLOGICAL MODELING; Preston Kristine L., 1998, Western Birds, V29, P242; Rosenberg K. V., 2016, PARTNERS FLIGHT LAND; Schumaker NH, 2018, LANDSCAPE ECOL, V33, P197, DOI 10.1007/s10980-017-0605-9; Teske ME, 2001, 0102 CONT DYN 0102 CONT DYN; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; USEPA, 2015, TECHNICAL DESCRIPTIO; *USEPA, 2004, OV EC RISK ASS PROC; [USEPA] US Environmental Protection Agency, 2012, US GUID T REX VERS 1; USFWS, ECOS ENV CONS ONL SY ECOS ENV CONS ONL SY; USFWS, 2010, COAST CAL GNATC POL COAST CAL GNATC POL; USGS, GAP AN PROGR GAP GAP AN PROGR GAP; Winchell CS, 2008, J WILDLIFE MANAGE, V72, P1322, DOI 10.2193/2006-356	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252545	10.1371/journal.pone.0252545	http://dx.doi.org/10.1371/journal.pone.0252545			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161343	Green Published, gold			2022-12-26	WOS:000671691900015
J	Hagiwara, M; Fushimi, A; Yamashita, N; Bhattacharya, A; Rajabi, H; Long, MD; Yasumizu, Y; Oya, M; Liu, S; Kufe, D				Hagiwara, Masayuki; Fushimi, Atsushi; Yamashita, Nami; Bhattacharya, Atrayee; Rajabi, Hasan; Long, Mark D.; Yasumizu, Yota; Oya, Mototsugu; Liu, Song; Kufe, Donald			MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells	ONCOGENE			English	Article							TRANSCRIPTIONAL REPRESSION; PLURIPOTENCY; EXPRESSION; SUBUNIT; BAF180; STRESS; REPAIR; GENES; NANOG	The polybromo-associated PBAF (SWI/SNF) chromatin remodeling complex, which includes PBRM1, ARID2, and BRD7, regulates cell differentiation and genomic integrity. MUC1-C is an oncogenic protein that drives lineage plasticity in prostate cancer (PC) progression. The present work demonstrates that MUC1-C induces PBRM1, ARID2, and BRD7 expression by the previously unrecognized E2F1-mediated activation of their respective promoters. The functional significance of the MUC1-C -> PBAF pathway is supported by demonstrating involvement of MUC1-C in associating with nuclear PBAF and driving the NRF2 antioxidant gene transcriptome in PC cells. Mechanistically, MUC1-C forms a complex with NRF2 and PBRM1 on the NRF2 target SLC7A11 gene that encodes the xCT cystine-glutamate antiporter, increases chromatin accessibility and induces SLC7A11/xCT expression. We also show that MUC1-C and PBRM1 are necessary for induction of other NRF2 target genes, including G6PD and PGD that regulate the pentose phosphate pathway. Our results further demonstrate that MUC1-C integrates activation of PBRM1 with the regulation of antioxidant genes, ROS levels, pluripotency factor expression and the cancer stem cell (CSC) state. These findings reveal a role for MUC1-C in regulating PBAF, redox balance and lineage plasticity of PC CSC progression. Our findings also uncover involvement of MUC1-C in integrating the PBAF and BAF pathways in cancer.	[Hagiwara, Masayuki; Fushimi, Atsushi; Yamashita, Nami; Bhattacharya, Atrayee; Rajabi, Hasan; Kufe, Donald] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA; [Long, Mark D.; Liu, Song] Roswell Park Comprehens Canc Ctr, Dept Biostat & Bioinformat, Buffalo, NY USA; [Yasumizu, Yota; Oya, Mototsugu] Keio Univ, Sch Med, Dept Urol, Tokyo, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Keio University	Kufe, D (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA.	donald_kufe@dfci.harvard.edu	Bhattacharya, Atrayee/AAJ-9314-2021	Bhattacharya, Atrayee/0000-0002-3322-6175; Long, Mark/0000-0003-1120-8176	National Cancer Institute of the National Institutes of Health [CA97098, CA166480, CA233084, CA232979]	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under grant numbers CA97098, CA166480 and CA233084 awarded to DK and CA232979 awarded to SL.	Ahmad R, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0608-9; Brownlee PM, 2014, CELL REP, V6, P973, DOI 10.1016/j.celrep.2014.02.012; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; de la Vega MR, 2018, CANCER CELL, V34, P21, DOI 10.1016/j.ccell.2018.03.022; Guerrero-Martinez JA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20217-3; Hagiwara M, 2021, CANCER RES, V81, P1111, DOI 10.1158/0008-5472.CAN-20-2588; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Hasegawa M, 2015, CLIN CANCER RES, V21, P2338, DOI 10.1158/1078-0432.CCR-14-3000; Hata T, 2019, CANCER RES, V79, P5711, DOI 10.1158/0008-5472.CAN-19-1034; Hata T, 2019, MOL CANCER THER, V18, P1744, DOI 10.1158/1535-7163.MCT-19-0156; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Hiraki M, 2017, ONCOGENE, V36, P2791, DOI 10.1038/onc.2016.439; Hodges C, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026930; Hopson S, 2017, ACS CHEM BIOL, V12, P2482, DOI 10.1021/acschembio.7b00541; Huang Lei, 2010, Genes Cancer, V1, P239; Jeter CR, 2015, STEM CELLS, V33, P2381, DOI 10.1002/stem.2007; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; Kent LN, 2019, NAT REV CANCER, V19, P326, DOI 10.1038/s41568-019-0143-7; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; King HW, 2017, ELIFE, V6, DOI 10.7554/eLife.22631; Kufe DW, 2020, CARCINOGENESIS, V41, P1173, DOI 10.1093/carcin/bgaa082; Li W, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137112; Lim JKM, 2019, P NATL ACAD SCI USA, V116, P9433, DOI 10.1073/pnas.1821323116; Liu XD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15959-6; Lu X, 2014, ONCOGENE, V33, P2655, DOI 10.1038/onc.2013.209; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Pan J, 2019, NAT GENET, V51, P618, DOI 10.1038/s41588-019-0363-5; Papamichos-Chronakis M, 2013, NAT REV GENET, V14, P62, DOI 10.1038/nrg3345; Porter EG, 2019, ISCIENCE, V15, P196, DOI 10.1016/j.isci.2019.04.027; Rajabi H, 2018, ONCOGENE, V37, P2079, DOI 10.1038/s41388-017-0096-9; Rajabi H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07850-0; Schick S, 2019, NAT GENET, V51, P1399, DOI 10.1038/s41588-019-0477-9; Somyajit K, 2017, SCIENCE, V358, P797, DOI 10.1126/science.aao3172; Tanabe A, 2020, CANCERS, V12, DOI 10.3390/cancers12102780; Vitale I, 2017, MOL CELL, V66, P306, DOI 10.1016/j.molcel.2017.04.006; Wu Q, 2017, EPIGENOMICS-UK, V9, P919, DOI 10.2217/epi-2017-0034; Yamamoto M, 2019, CANCER RES, V79, P2031, DOI 10.1158/0008-5472.CAN-18-3259; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yasumizu Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14219-6; Yin L, 2012, BLOOD, V119, P810, DOI 10.1182/blood-2011-07-369686; Zhang XL, 2014, STEM CELL REP, V3, P460, DOI 10.1016/j.stemcr.2014.07.004	44	11	11	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4930	4940		10.1038/s41388-021-01899-y	http://dx.doi.org/10.1038/s41388-021-01899-y		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163028	hybrid, Green Published			2022-12-26	WOS:000664853000006
J	Lin, IH; Chien, CC; Chen, YH; Pao, SI; Chen, JT; Chen, CL				Lin, I-Hung; Chien, Chien-Cheng; Chen, Yi-Hao; Pao, Shu-, I; Chen, Jiann-Torng; Chen, Ching-Long			Ultra-widefield retinal imaging for adjunctive resident training in retinal break detection	PLOS ONE			English	Article							INDIRECT OPHTHALMOSCOPY; SCLERAL DEPRESSION	We evaluated the clinical utility of ultra-widefield imaging as an adjunctive tool for training resident ophthalmologists in the detection of retinal breaks. This was a prospective study conducted at a secondary health care center (Tri-Service General Hospital) in Taiwan. Participants were 44 patients (53 eyes) who were referred to our hospital after being diagnosed with retinal breaks. Patients first underwent an indirect ophthalmoscopy examination of the total fundus without scleral depression by our junior (first and second year) or senior (third and fourth year) resident ophthalmologist and then underwent an ultra-widefield imaging examination with a central image and four gaze-steered (up, down, nasal, and temporal) images to determine the number of retinal breaks in the total fundus and the four quadrants. Of the total 53 eyes, 31 were examined by junior residents and 22 were examined by senior residents. In the group of junior residents, ultra-widefield imaging was significantly better at detecting retinal breaks of the total fundus (49 vs. 33 retinal breaks, p < 0.001) and the temporal quadrant (17 vs. 10 retinal breaks, p = 0.018) than indirect ophthalmoscopy. In the group of senior residents, there was no significant difference in the ability to detect retinal breaks in the total fundus or each of the four quadrants with ultra-widefield imaging or indirect ophthalmoscopy. Our results indicate that, compared to indirect ophthalmoscopy, ultra-widefield imaging with a central image and four gaze-steered images has a better performance and is a useful adjunct tool for the detection of retinal breaks in junior resident training. Additionally, it could be a useful method for teaching indirect ophthalmoscopy examination to junior residents.	[Lin, I-Hung; Chien, Chien-Cheng; Chen, Yi-Hao; Pao, Shu-, I; Chen, Jiann-Torng; Chen, Ching-Long] Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital	Chen, CL (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Ophthalmol, Taipei, Taiwan.	doc30881@mail.ndmctsgh.edu.tw		Lin, I-Hung/0000-0003-4268-2540	TriService General Hospital [TSGH-D-110173, TSGH-D-110109, TSGH-D-110112]; Ministry of Science and Technology, Taiwan [MOST 107-2314-B-016 -031 -MY3]	TriService General Hospital; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the TriService General Hospital TSGH-D-110173 to IHL, TSGH-D-110109 to JTC, TSGH-D-110112 to CLC, and the Ministry of Science and Technology, Taiwan, MOST 107-2314-B-016 -031 -MY3 to JTC.	Ajlan Radwan, 2017, Int J Retina Vitreous, V3, P47, DOI 10.1186/s40942-017-0100-0; Dunphy RW, 2008, OPHTHAL SURG LAS IM, V39, P160, DOI 10.3928/15428877-20080301-07; Elfervig L S, 1998, Insight, V23, P66, DOI 10.1016/S1060-135X(98)90029-X; Garoon RB, 2018, GRAEF ARCH CLIN EXP, V256, P1053, DOI 10.1007/s00417-018-3950-8; HAVENER WH, 1958, AM J OPHTHALMOL, V45, P915, DOI 10.1016/0002-9394(58)90408-2; ING EB, 1992, CAN J OPHTHALMOL, V27, P166; Kiss S., 2018, NEW CAPABILITIES MAK; Kornberg DL, 2016, SEMIN OPHTHALMOL, V31, P505, DOI 10.3109/08820538.2014.981551; KRAUSHAR MF, 1979, AM J OPHTHALMOL, V87, P97, DOI 10.1016/0002-9394(79)90200-9; LINDER B, 1966, ACTA OPHTHALMOL, VS, P7; Natkunarajah M, 2003, EYE, V17, P607, DOI 10.1038/sj.eye.6700456; Nguyen NV, 2019, INT J RETINA VITR, V5, DOI 10.1186/s40942-019-0201-z; Panwar N, 2016, TELEMED E-HEALTH, V22, P198, DOI 10.1089/tmj.2015.0068; Patel SN, 2020, THER ADV OPHTHALMOL, V12, DOI 10.1177/2515841419899495; Rai AS, 2017, CAN J OPHTHALMOL, V52, P430, DOI 10.1016/j.jcjo.2017.02.015; Shukla SY, 2015, OPHTHALMOLOGY, V122, P2360, DOI 10.1016/j.ophtha.2015.05.007; STRAATSMA BR, 1968, ARCH OPHTHALMOL-CHIC, V80, P3; Witmer MT, 2013, SURV OPHTHALMOL, V58, P143, DOI 10.1016/j.survophthal.2012.07.003	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253227	10.1371/journal.pone.0253227	http://dx.doi.org/10.1371/journal.pone.0253227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161357	Green Published, gold			2022-12-26	WOS:000671691900028
J	Zhang, JG; Guan, WC; Xu, XL; Wang, FC; Li, X; Xu, GX				Zhang, Jinguo; Guan, Wencai; Xu, Xiaolin; Wang, Fanchen; Li, Xin; Xu, Guoxiong			A novel homeostatic loop of sorcin drives paclitaxel-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human ovarian cancer	ONCOGENE			English	Article							CALCIUM-BINDING PROTEIN; MULTIDRUG-RESISTANCE; MESENCHYMAL TRANSITION; COLORECTAL-CANCER; UP-REGULATION; TGF-BETA; OVEREXPRESSION; MICRORNA; CELLS; EMT	The primary chemotherapy of ovarian cancer (OC) often acquires chemoresistance. Sorcin (SRI), a soluble resistance-related calcium-binding protein, has been reported to be an oncogenic protein in cancer. However, the molecular mechanisms of SRI regulation and the role and aberrant expression of SRI in chemoresistant OC remain unclear. Here, we identified SRI as a key driver of paclitaxel (PTX)-resistance and explored its regulatory mechanism. Using transcriptome profiles, qRT-PCR, proteomics, Western blot, immunohistochemistry, and bioinformatics analyses, we found that SRI was overexpressed in PTX-resistant OC cells and the overexpression of SRI was related to the poor prognosis of patients. SRI was a key molecule required for growth, migration, and PTX-resistance in vitro and in vivo and was involved in epithelial-mesenchymal transition (EMT) and stemness. Mechanistic studies showed that miR-142-5p directly bound to the 3MODIFIER LETTER PRIME-UTR of SRI to suppress its expression, whereas a transcription factor zinc-finger E-box binding homeobox 1 (ZEB1) inhibited the transcription of miR-142-5p by directly binding to the E-box fragment in the miR-142 promoter region. Furthermore, ZEB1 was negatively regulated by SRI which physically interacted with Smad4 to block its translocation from the cytosol to the nucleus. Taken together, our findings unveil a novel homeostatic loop of SRI that drives the PTX-resistance and malignant progression via Smad4/ZEB1/miR-142-5p in human OC. Targeting this SRI/Smad4/ZEB1/miR-142-5p loop may reverse the PTX-resistance.	[Zhang, Jinguo; Guan, Wencai; Xu, Xiaolin; Wang, Fanchen; Li, Xin; Xu, Guoxiong] Fudan Univ, Jinshan Hosp, Res Ctr Clin Med, Shanghai 201508, Peoples R China; [Zhang, Jinguo; Xu, Xiaolin; Wang, Fanchen; Li, Xin; Xu, Guoxiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Xu, Guoxiong] Fudan Univ, Jinshan Hosp, Ctr Tumor Diag & Therapy, Shanghai 201508, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, GX (corresponding author), Fudan Univ, Jinshan Hosp, Res Ctr Clin Med, Shanghai 201508, Peoples R China.; Xu, GX (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.; Xu, GX (corresponding author), Fudan Univ, Jinshan Hosp, Ctr Tumor Diag & Therapy, Shanghai 201508, Peoples R China.	guoxiong.xu@fudan.edu.cn		Zhang, Jinguo/0000-0001-9952-9307; wencai, guan/0000-0001-8168-0711	National Natural Science Foundation of China [81872121]; Natural Science Foundation of Shanghai [17ZR1404100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai)	We are thankful for all research participants and technical assistants involved in this research project. This work was supported by grants from the National Natural Science Foundation of China (grant no. 81872121) and the Natural Science Foundation of Shanghai (grant no. 17ZR1404100) to GX.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Baird RD, 2010, NAT REV CLIN ONCOL, V7, P575, DOI 10.1038/nrclinonc.2010.120; Battista T, 2020, CANCERS, V12, DOI 10.3390/cancers12040887; Bushweller JH, 2019, NAT REV CANCER, V19, P611, DOI 10.1038/s41568-019-0196-7; Caramel J, 2018, CANCER RES, V78, P30, DOI 10.1158/0008-5472.CAN-17-2476; Colotti G, 2014, MOLECULES, V19, P13976, DOI 10.3390/molecules190913976; Dabaghi M, 2016, GENET TEST MOL BIOMA, V20, P516, DOI 10.1089/gtmb.2016.0031; Deng LM, 2019, INT J ONCOL, V55, P451, DOI 10.3892/ijo.2019.4831; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gao YY, 2015, MOL MED REP, V11, P2118, DOI 10.3892/mmr.2014.2936; Genovese I, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.342; Gong ZH, 2014, ONCOL LETT, V8, P2393, DOI 10.3892/ol.2014.2543; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; He QC, 2011, ONCOL REP, V25, P237, DOI 10.3892/or_00001066; Hu H, 2020, ANTI-CANCER DRUG, V31, P483, DOI 10.1097/CAD.0000000000000894; Hu YH, 2014, BREAST CANCER RES TR, V143, P287, DOI 10.1007/s10549-013-2809-2; Ilari A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16828; Islam F, 2018, EXP MOL PATHOL, V104, P98, DOI 10.1016/j.yexmp.2018.01.006; Jolly MK, 2019, PHARMACOL THERAPEUT, V194, P161, DOI 10.1016/j.pharmthera.2018.09.007; Katsuno Y, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau8544; Kim JJ, 2013, J CELL BIOCHEM, V114, P1286, DOI 10.1002/jcb.24464; Koti M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-549; Lloyd KL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1101-8; Long L, 2019, EXP MOL PATHOL, V106, P116, DOI 10.1016/j.yexmp.2019.01.001; Madany Mecca, 2018, Discoveries (Craiova), V6, pe86, DOI 10.15190/d.2018.7; Maddalena F, 2011, CANCER RES, V71, P7659, DOI 10.1158/0008-5472.CAN-11-2172; Marmugi A, 2016, DIABETES, V65, P1009, DOI 10.2337/db15-1334; Mladinich Megan, 2016, Stem Cells Int, V2016, P5285892; Mohammad RM, 2015, SEMIN CANCER BIOL, V35, pS78, DOI 10.1016/j.semcancer.2015.03.001; Monk BJ, 2016, CURR PHARM DESIGN, V22, P4717, DOI 10.2174/1381612822666160505114326; NOMAN M, 2018, ONCOIMMUNOLOGY, V7; Orellana-Serradell O, 2019, ASIAN J ANDROL, V21, P460, DOI 10.4103/aja.aja_1_19; Papageorgis P, 2011, CANCER RES, V71, P998, DOI 10.1158/0008-5472.CAN-09-3269; Parekh HK, 2002, BIOCHEM PHARMACOL, V63, P1149, DOI 10.1016/S0006-2952(02)00850-X; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Shibue T, 2017, NAT REV CLIN ONCOL, V14, P611, DOI 10.1038/nrclinonc.2017.44; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Suarez J, 2013, AM J PHYSIOL-CELL PH, V304, pC248, DOI 10.1152/ajpcell.00039.2012; Sun YT, 2018, J CELL PHYSIOL, V233, P3066, DOI 10.1002/jcp.26087; Torre LA, 2018, CA-CANCER J CLIN, V68, P284, DOI 10.3322/caac.21456; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wang FC, 2020, AGING-US, V12, P11042, DOI 10.18632/aging.103317; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xie N, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0015-6; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yoshida T., 2016, PLOS ONE, V11, P0147344; Yu WX, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819892264; Zhang LY, 2016, CURR CANCER DRUG TAR, V16, P429, DOI 10.2174/1568009616666160404121105; Zhang XC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0176-3; Zhou DB, 2017, CELL SIGNAL, V35, P197, DOI 10.1016/j.cellsig.2017.04.009; Zhu W, 2020, EUR REV MED PHARMACO, V24, P4306, DOI 10.26355/eurrev_202004_21011	53	9	9	3	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4906	4918		10.1038/s41388-021-01891-6	http://dx.doi.org/10.1038/s41388-021-01891-6		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163033	Green Published, hybrid			2022-12-26	WOS:000664853000002
J	Li, XY; Wu, ZM; He, J; Jin, YT; Chu, CY; Cao, Y; Gu, F; Wang, HY; Hou, CJ; Liu, XP; Zou, Q				Li, Xiaoyan; Wu, Zhengming; He, Jing; Jin, Yiting; Chu, Chengyu; Cao, Yun; Gu, Fei; Wang, Hongying; Hou, Chenjian; Liu, Xiuping; Zou, Qiang			OGT regulated O-GlcNAcylation promotes papillary thyroid cancer malignancy via activating YAP	ONCOGENE			English	Article							HIPPO PATHWAY; GLCNAC; TRANSFERASE; PHOSPHORYLATION; PROLIFERATION; MECHANISMS; NUCLEAR	The incidence of thyroid cancer is growing rapidly during the past decades worldwide. Although most thyroid tumors are curable, some patients diagnosed with distant metastases are associated with poor prognosis. The molecular mechanisms underlying these cases are still largely unknown. Here we found that the upregulated O-Linked N-Acetylglucosamine Transferase (OGT) expression and O-GlcNAcylation (O-GlcNAc) modification in papillary thyroid cancer (PTC) were essential in tumor growth and metastasis. Mass spectrometry analysis showed that YAP was the effector protein modified by OGT. In details, YAP Ser109 O-GlcNAcylation promoted the malignant phenotypes in PTC cells by inducing YAP Ser127 dephosphorylation and activation. Our work clearly showed the critical role of OGT and YAP played in PTC tumors and made it possible for us to seek the clinical potential of manipulating OGT/YAP activity in PTC targeted therapies. These findings also confirmed OGT worked in collaboration with classical Hippo pathway kinases as an upstream regulator of YAP in PTC tumors.	[Li, Xiaoyan; He, Jing; Jin, Yiting; Chu, Chengyu; Cao, Yun; Gu, Fei; Wang, Hongying; Zou, Qiang] Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China; [Wu, Zhengming] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wu, Zhengming] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Hou, Chenjian; Liu, Xiuping] Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai, Peoples R China; [Liu, Xiuping] Fudan Univ, Shanghai Peoples Hosp 5, Dept Pathol, Shanghai, Peoples R China	Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Fudan University; Fudan University	Zou, Q (corresponding author), Fudan Univ, Huashan Hosp, Dept Gen Surg, Shanghai 200040, Peoples R China.; Liu, XP (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Pathol, Shanghai, Peoples R China.; Liu, XP (corresponding author), Fudan Univ, Shanghai Peoples Hosp 5, Dept Pathol, Shanghai, Peoples R China.	xpliu1228@fudan.edu.cn; zouqiang_hs@163.com		Li, Xiaoyan/0000-0002-1243-3845	National Nature Science Foundation of China and Science and Technology Commission of Shanghai Municipality [81602326];  [15411952503]	National Nature Science Foundation of China and Science and Technology Commission of Shanghai Municipality; 	This work was supported by grant no. 81602326 from the National Nature Science Foundation of China and Science and Technology Commission of Shanghai Municipality (No. 15411952503).	Akella NM, 2020, MOL CANCER RES, V18, P585, DOI 10.1158/1541-7786.MCR-19-0732; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Cao BJ, 2019, J CELL MOL MED, V23, P2384, DOI 10.1111/jcmm.14043; Carling T, 2014, ANNU REV MED, V65, P125, DOI 10.1146/annurev-med-061512-105739; Chen R, 2019, NAT CELL BIOL, V21, P1565, DOI 10.1038/s41556-019-0426-y; Cheng Y, 2016, ONCOL LETT, V12, P572, DOI 10.3892/ol.2016.4647; Coca-Pelaz A, 2020, ADV THER, V37, P3112, DOI 10.1007/s12325-020-01391-1; Di Domenico F, 2019, EXPERT REV NEUROTHER, V19, P1, DOI 10.1080/14737175.2019.1540932; DONG DLY, 1994, J BIOL CHEM, V269, P19321; Duan FF, 2018, J HEPATOL, V68, P1191, DOI 10.1016/j.jhep.2018.02.003; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Ferrer CM, 2017, ONCOGENE, V36, P559, DOI 10.1038/onc.2016.228; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Gonzalez-Gonzalez Rogelio, 2011, ISRN Oncol, V2011, P915925, DOI 10.5402/2011/915925; HALTIWANGER RS, 1990, J BIOL CHEM, V265, P2563; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Itkonen HM, 2020, MOL CANCER RES, V18, P1512, DOI 10.1158/1541-7786.MCR-20-0339; Itkonen HM, 2019, THERANOSTICS, V9, P2183, DOI 10.7150/thno.30834; Jiang MZ, 2019, ONCOGENE, V38, P301, DOI 10.1038/s41388-018-0435-5; Jin L, 2020, CELL MOL BIOL LETT, V25, DOI 10.1186/s11658-020-00208-x; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim SH, 2017, BIOCHEM BIOPH RES CO, V483, P793, DOI 10.1016/j.bbrc.2016.10.156; Lim H, 2017, JAMA-J AM MED ASSOC, V317, P1338, DOI 10.1001/jama.2017.2719; Lin Yi-Cheng, 2018, Oncotarget, V9, P31032, DOI 10.18632/oncotarget.25772; Liu ZM, 2019, APPL IMMUNOHISTO M M, V27, P59, DOI 10.1097/PAI.0000000000000544; Liu ZM, 2017, AM J TRANSL RES, V9, P3212; Lu H, 2020, GLYCOBIOLOGY; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Makwana V, 2019, BBA-GEN SUBJECTS, V1863, P1302, DOI 10.1016/j.bbagen.2019.04.002; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Moon S, 2017, EMBO REP, V18, P61, DOI 10.15252/embr.201642683; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nagashima S, 2017, CURR DRUG TARGETS, V18, P447, DOI 10.2174/1389450117666160112115641; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Peng CM, 2017, MOL CELL, V68, P591, DOI 10.1016/j.molcel.2017.10.010; Pepe F, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.35; Pobbati AV, 2015, STRUCTURE, V23, P2076, DOI 10.1016/j.str.2015.09.009; Saiselet Manuel, 2012, Front Endocrinol (Lausanne), V3, P133, DOI 10.3389/fendo.2012.00133; Seo HG, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02999-5; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Singh JP, 2015, CANCER LETT, V356, P244, DOI 10.1016/j.canlet.2014.04.014; Wang LS, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5033-y; Wu ZM, 2021, TRENDS BIOCHEM SCI, V46, P51, DOI 10.1016/j.tibs.2020.08.008; Xing MZ, 2013, NAT REV CANCER, V13, P184, DOI 10.1038/nrc3431; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Zeidan Q, 2010, J CELL SCI, V123, P13, DOI 10.1242/jcs.053678; Zhang P, 2015, ONCOTARGETS THER, V8, P3305, DOI 10.2147/OTT.S82845; Zhang X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15280; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng W, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1110-9; Zhu GZ, 2016, GLYCOBIOLOGY, V26, P820, DOI 10.1093/glycob/cww025	53	8	8	4	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4859	4871		10.1038/s41388-021-01901-7	http://dx.doi.org/10.1038/s41388-021-01901-7		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34155345				2022-12-26	WOS:000664006700001
J	Li, BR; Pei, GS; Yao, J; Ding, QQ; Jia, PL; Zhao, ZM				Li, Bingrui; Pei, Guangsheng; Yao, Jun; Ding, Qingqing; Jia, Peilin; Zhao, Zhongming			Cell-type deconvolution analysis identifies cancer-associated myofibroblast component as a poor prognostic factor in multiple cancer types	ONCOGENE			English	Article							STROMAL CELLS; TUMOR-CELLS; MITOMYCIN-C; FIBROBLASTS; FIBROSIS	Cancer-associated fibroblasts (CAFs) constitute a prominent component of the tumor microenvironment and play critical roles in cancer progression and drug resistance. Although recent studies indicate CAFs may consist of several CAF subtypes, the breadth of CAF heterogeneity and functional roles of CAF subtypes in cancer progression remain unclear. In this study, we implemented a cell-type deconvolutional approach to comprehensively characterize cell-type alternations across 18 cancer types from The Cancer Genome Atlas (TCGA). Pan-cancer survival analysis using deconvoluted CAF subtypes revealed myofibroblastic CAF (myCAF) composition as a poor prognostic factor in nine cancer types. Patients with higher myCAF compositions tend to have worse response to six antineoplastic drugs predicted by a lncRNA-based Elastic Net prediction model (LENP). In addition, integrative mutational analysis identified 14 and 413 genes associated with the differentiation degree of myCAF and inflammatory CAF (iCAF), respectively, with significant enrichment of genes involved in fibroblast and extracellular matrix (ECM)-related pathways. In summary, our findings systematically illustrated the complex roles of CAF subtypes in patient prognosis and drug response, and identified putative driver genes in CAF-subtype differentiation. These results provided novel therapeutic perspectives for targeting CAF subtypes in tumor microenvironment and arranging treatment scheme based on the CAF compositions in different cancer types.	[Li, Bingrui; Pei, Guangsheng; Jia, Peilin; Zhao, Zhongming] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA; [Yao, Jun] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ding, Qingqing] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhao, Zhongming] Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA; [Zhao, Zhongming] MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; UTMD Anderson Cancer Center	Jia, PL; Zhao, ZM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Ctr Precis Hlth, Houston, TX 77030 USA.; Zhao, ZM (corresponding author), Univ Texas Hlth Sci Ctr, Sch Publ Hlth, Ctr Human Genet, Houston, TX 77030 USA.; Zhao, ZM (corresponding author), MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	peilin.jia@gmail.com; zhongming.zhao@uth.tmc.edu		Li, Bingrui/0000-0002-4807-1452; Pei, Guangsheng/0000-0003-1804-7598	National Institutes of Health [R01LM012806]; Cancer Prevention and Research Institute of Texas grant (CPRIT) [RP180734, RP170668]; CPRIT [RP180734]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas grant (CPRIT); CPRIT	This work was partially supported by National Institutes of Health grant (R01LM012806) and the Cancer Prevention and Research Institute of Texas grant (CPRIT RP180734 and RP170668). Publication charges for this article have been funded by CPRIT RP180734.	Aboussekhra A, 2011, INT J DEV BIOL, V55, P841, DOI 10.1387/ijdb.113362aa; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cho JG, 2018, EUR ARCH OTO-RHINO-L, V275, P2355, DOI 10.1007/s00405-018-5061-x; COBOS FA, 2020, NAT COMMUN, V11; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elenbaas B, 2001, EXP CELL RES, V264, P169, DOI 10.1006/excr.2000.5133; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fox NG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09989-y; Glastonbury CA, 2019, AM J HUM GENET, V104, P1013, DOI 10.1016/j.ajhg.2019.03.025; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Kadel D, 2019, CELL BIOL TOXICOL, V35, P407, DOI 10.1007/s10565-019-09461-z; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Kobayashi H, 2019, NAT REV GASTRO HEPAT, V16, P282, DOI 10.1038/s41575-019-0115-0; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Mukaida N, 2016, WORLD J GASTROENTERO, V22, P5301, DOI 10.3748/wjg.v22.i23.5301; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Pei GS, 2021, GENOME RES, V31, P146, DOI 10.1101/gr.265769.120; Pei GS, 2019, BIOINFORMATICS, V35, P3842, DOI 10.1093/bioinformatics/btz138; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; SAPPINO AP, 1988, INT J CANCER, V41, P707, DOI 10.1002/ijc.2910410512; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Singh M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11049-4; Stunnenberg HG, 2016, CELL, V167, P1897, DOI 10.1016/j.cell.2016.12.002; Sturm G, 2019, BIOINFORMATICS, V35, pI436, DOI 10.1093/bioinformatics/btz363; Su SC, 2018, CELL, V172, P841, DOI 10.1016/j.cell.2018.01.009; Sun Y, 2015, EUR J PHARMACOL, V765, P198, DOI 10.1016/j.ejphar.2015.08.002; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang X, 1999, BRIT J CANCER, V80, P1223, DOI 10.1038/sj.bjc.6690489; Wang YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02951-4; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zheng J, 2019, QUANT BIOL, V7, P247, DOI 10.1007/s40484-019-0189-2	44	8	8	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4686	4694		10.1038/s41388-021-01870-x	http://dx.doi.org/10.1038/s41388-021-01870-x		JUN 2021	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34140640				2022-12-26	WOS:000662838900002
J	Seguya, A; Bajunirwe, F; Kakande, E; Nakku, D				Seguya, Amina; Bajunirwe, Francis; Kakande, Elijah; Nakku, Doreen			Feasibility of establishing an infant hearing screening program and measuring hearing loss among infants at a regional referral hospital in south western Uganda	PLOS ONE			English	Article							RISK-FACTORS; HEALTH-CARE; OTOACOUSTIC EMISSIONS; IDENTIFYING INFANTS; UNITED-STATES; PREVALENCE; CHILDREN; AFRICA; INTERVENTION; PRINCIPLES	Introduction Despite the high burden of hearing loss (HL) globaly, most countries in resource limited settings lack infant hearing screening programs(IHS) for early HL detection. We examined the feasibility of establishing an IHS program in this setting, and in this pilot program measured the prevalence of infant hearing loss (IHL) and described the characteristics of the infants with HL. Methods We assessed feasibility of establishing an IHS program at a regional referral hospital in south-western Uganda. We recruited infants aged 1 day to 3 months and performed a three-staged screening. At stage 1, we used Transient Evoked Oto-acoustic Emissions (TEOAEs), at stage 2 we repeated TEOAEs for infants who failed TEOAEs at stage 1 and at stage 3, we conducted Automated brainstem responses(ABRs) for those who failed stage 2. IHL was present if they failed an ABR at 35dBHL. Results We screened 401 infants, mean age was 7.2 days (SD = 7.1). 74.6% (299 of 401) passed stage 1, the rest (25.4% or 102 of 401) were referred for stage 2. Of those referred (n = 102), only 34.3% (35 of 102) returned for stage 2 screening. About 14.3% (5/35) failed the repeat TEOAEs in at least one ear. At stage 3, 80% (4 of 5) failed the ABR screening in at least one ear, while 25% (n = 1) failed the test bilaterally. Among the 334 infants that completed the staged screening, the prevalence of IHL was 4/334 or 12 per 1000. Risk factors to IHL were Newborn Special Care Unit (NSCU) admission, gentamycin or oxygen therapy and prematurity. Conclusions IHS program establishment in a resource limited setting is feasible. Preliminary data indicate a high prevalence of IHL. Targeted screening of infants at high risk may be a more realistic and sustainable initial step towards establishing IHS program s in a developing country like Uganda.	[Seguya, Amina] Mulago Natl Referral Hosp, Dept Ear Nose & Throat Surg, Kampala, Uganda; [Bajunirwe, Francis] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Kakande, Elijah] Infect Dis Res Collaborat, Kampala, Uganda; [Nakku, Doreen] Mbarara Univ Sci & Technol, Dept Ear Nose & Throat Surg, Mbarara, Uganda	Mulago National Referral Hospital; Mbarara University of Science & Technology; Mbarara University of Science & Technology	Seguya, A (corresponding author), Mulago Natl Referral Hosp, Dept Ear Nose & Throat Surg, Kampala, Uganda.	seguya.amina@gmail.com		Seguya, Amina/0000-0003-0499-0227	Brigham and Women's Hospital, Department of Otolaryngology, Harvard medical School to the Department of ENT surgery at Mbarara University of Science and Technology	Brigham and Women's Hospital, Department of Otolaryngology, Harvard medical School to the Department of ENT surgery at Mbarara University of Science and Technology	This research was funded by a small grant from the Brigham and Women's Hospital, Department of Otolaryngology, Harvard medical School to the Department of ENT surgery at Mbarara University of Science and Technology to support postgraduate research for AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attias J, 2006, INT J AUDIOL, V45, P528, DOI 10.1080/14992020600810039; Augustine AM, 2014, INDIAN PEDIATR, V51, P179, DOI 10.1007/s13312-014-0380-5; Bezuidenhout JK, 2018, S AFR J CHILD HEALTH, V12, P159, DOI [10.7196/SAJCH.2018.v12i4.1522, 10.7196/sajch.2018.v12i4.1522]; Bielecki I, 2011, INT J PEDIATR OTORHI, V75, P925, DOI 10.1016/j.ijporl.2011.04.007; Bouillot L, 2019, INT J PEDIATR OTORHI, V117, P30, DOI 10.1016/j.ijporl.2018.11.011; Brough H., 2017, INT J NEONAT SCREEN, V3, P33; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Busse AM, 2020, INT J PEDIATR OTORHI, V134, DOI 10.1016/j.ijporl.2020.110039; Butcher E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219600; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Das S, 2020, J OTOL, V15, P174, DOI 10.1016/j.joto.2020.05.001; Davis AC, 2019, B WORLD HEALTH ORGAN, V97, P646, DOI 10.2471/BLT.19.224683; de Garcia BG, 2011, REV PANAM SALUD PUBL, V29, P145; Fakhim SA, 2010, J INT ADV OTOL, V6, P365; Gaffney M., 2010, Morbidity and Mortality Weekly Report, V59, P220; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Huang LH, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-97; Kamenov K, 2021, DEV MED CHILD NEUROL, V63, P16, DOI 10.1111/dmcn.14694; Kanji A, 2021, J MATERN-FETAL NEO M, V34, P2107, DOI 10.1080/14767058.2019.1658732; KISH L, 1965, AM SOCIOL REV, V30, P564, DOI 10.2307/2091346; Kumar A, 2017, INDIAN J OTOLARYNGOL, V69, P296, DOI 10.1007/s12070-017-1081-x; Kushalnagar P, 2010, J CLIN ETHIC, V21, P143; Lin HC, 2005, LARYNGOSCOPE, V115, P1957, DOI 10.1097/01.mlg.0000178323.06183.3e; McPherson B, 2012, INDIAN J MED RES, V135, P152; Meyer ME, 2012, INT J PEDIATR OTORHI, V76, P698, DOI 10.1016/j.ijporl.2012.02.023; Mumtaz N, 2020, PAK J MED SCI, V36, P1036, DOI 10.12669/pjms.36.5.1965; Neumann K., 2020, J EARLY HEAR DETECT, V5, P63; Neumann K, 2019, INT J NEONAT SCREEN, V5, DOI 10.3390/ijns5010007; Olusanya BO, 2008, B WORLD HEALTH ORGAN, V86, P956, DOI 10.2471/BLT.07.050005; Olusanya BO, 2006, INT J PEDIATR OTORHI, V70, P619, DOI 10.1016/j.ijporl.2005.08.004; Olusanya BO, 2006, PAEDIATR PERINAT EP, V20, P366, DOI 10.1111/j.1365-3016.2006.00733.x; Olusanya BO, 2011, INT J PEDIATR OTORHI, V75, P316, DOI 10.1016/j.ijporl.2010.12.002; Olusanya BO, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-66; Organization W.H., 2018, ADDR RIS PREV HEAR L ADDR RIS PREV HEAR L; Petrocchi-Bartal L, 2016, S AFR J CHILD HEALTH, V10, P139, DOI [10.7196/sajch.2016.v10i2.1114, 10.7196/SAJCH.2016.v10i2.1114]; Pourarian Shahnaz, 2012, Iran J Otorhinolaryngol, V24, P129; Rissmann A, 2018, INT J PEDIATR OTORHI, V107, P110, DOI 10.1016/j.ijporl.2018.01.035; Stevens JP, 2003, ARCH DIS CHILD-FETAL, V88, P179; Swanepoel D, 2013, INT J PEDIATR OTORHI, V77, P394, DOI 10.1016/j.ijporl.2012.11.034; Tanon-Anoh MJ, 2010, INT J PEDIATR OTORHI, V74, P188, DOI 10.1016/j.ijporl.2009.11.008; Thangavelu K, 2019, ACTA PAEDIATR, V108, P1972, DOI 10.1111/apa.14837; WHO, 2021, WHO WORLD HEAR DAY 2 WHO WORLD HEAR DAY 2; Williams TR, 2015, MMWR-MORBID MORTAL W, V64, P351; World Health Organization, WHO DEAFN HEAR LOSS; Wroblewska-Seniuk K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184359; Wroblewska-Seniuk KE, 2017, PEDIATR RES, V81, P415, DOI 10.1038/pr.2016.250; Yoshinaga-Itano C, 2014, J DEAF STUD DEAF EDU, V19, P143, DOI 10.1093/deafed/ent043	47	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253305	10.1371/journal.pone.0253305	http://dx.doi.org/10.1371/journal.pone.0253305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138954	gold, Green Published			2022-12-26	WOS:000671690200083
J	Pang, NN; Alimu, XRGL; Chen, R; Muhashi, M; Ma, JJ; Chen, G; Zhao, F; Wang, L; Qu, JH; Ding, JB				Pang, Nannan; Alimu, Xierenguli; Chen, Rong; Muhashi, Maliya; Ma, Jiajia; Chen, Gang; Zhao, Fang; Wang, Lei; Qu, Jianhua; Ding, Jianbing			Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia	FASEB JOURNAL			English	Article						chronic lymphocytic leukemia (CLL); CD4(+) T cell subset; Tim-3; Galectin-9 signal pathway	REGULATORY T-CELLS; TIM-3; EXPRESSION; PLASTICITY; RESISTANCE; THERAPY; BALANCE	Tim-3 is a negative immunoregulator in anti-tumor response, but its mechanism in chronic lymphocytic leukemia (CLL) is not yet clear. The aim of this study was to understand the role of Galectin-9/Tim-3 signaling pathway in the regulation of CD4(+) T cell subsets in CLL patients. Flow cytometry results showed that the number of Treg cells obviously increased, and there was a significant Treg/Th17 imbalance in CLL patients. In addition, Tim-3 overexpressed on the surface of Th1 and Treg cells in CLL patients. The levels of Galectin-9 and IL-10 were significantly elevated in patients of CLL, especially in stages of Binet B, and C. However, IFN-gamma decreased. Moreover, Galectin-9 in CLL patients was positively correlated with the number of Tim-3(+) Treg cells and the level of IL-10. Interestingly, when the Tim-3/Galectin-9 pathway was blocked in vitro, the level of IL-10 in the culture supernatant of CD4(+) T was significantly reduced, while the levels of IFN-gamma and TNF-alpha were increased. After co-culture with activated Th1 cells, the apoptosis of CLL cells was significantly increased, and this effect was reversed after treatment with Tim-3(+) Tregs. In summary, Galectin-9/Tim-3 are elevated in CLL and associated with disease progression. By the negative regulation of CD4(+) T cells, activated Galectin-9/Tim-3 suppresses Th1 effector function and also promotes Treg to be involved in immune escape of CLL. This pathway might become the potential target of immunotherapy in CLL patients.	[Pang, Nannan; Alimu, Xierenguli; Chen, Rong; Muhashi, Maliya; Ma, Jiajia; Chen, Gang; Zhao, Fang; Wang, Lei; Qu, Jianhua] Xinjiang Med Univ, Affiliated Hosp 1, Hematol Inst Xinjiang Uygur Autonomous Reg, Ctr Hematol, 1 Liyu Shan Rd, Urumqi 830054, Xinjiang, Peoples R China; [Pang, Nannan] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Pathogenesis Prevent & Treatment Hi, Urumqi, Peoples R China; [Ding, Jianbing] Xinjiang Med Univ, Basic Med Coll, 393 Xinyi Rd, Urumqi 830054, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Qu, JH (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Hematol Inst Xinjiang Uygur Autonomous Reg, Ctr Hematol, 1 Liyu Shan Rd, Urumqi 830054, Xinjiang, Peoples R China.; Ding, JB (corresponding author), Xinjiang Med Univ, Basic Med Coll, 393 Xinyi Rd, Urumqi 830054, Xinjiang, Peoples R China.	jhuaqu@163.com; 1601379937@qq.com		Ding, Jianbing/0000-0001-5506-7665	National Natural Science Foundation of China [81860033, 81960039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81860033 and 81960039	Allahmoradi E, 2017, IRAN J IMMUNOL, V14, P257, DOI IJIv14i4A1; Asadzadeh Z, 2017, CELL IMMUNOL, V322, P15, DOI 10.1016/j.cellimm.2017.10.015; Audino AN, 2019, RESIST TARGET ANTI-C, V21, P155, DOI 10.1007/978-3-030-24424-8_7; Aue G, 2018, J IMMUNOL, V201, P1967, DOI 10.4049/jimmunol.1800570; Beyer M, 2005, BLOOD, V106, P2018, DOI 10.1182/blood-2005-02-0642; Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; De Matteis S, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1545-0; Duffield AS, 2017, BLOOD ADV, V1, P1324, DOI 10.1182/bloodadvances.2017007260; Gao JW, 2018, BIOCHEM BIOPH RES CO, V498, P409, DOI 10.1016/j.bbrc.2018.02.114; Giannoni P, 2017, CURR MOL MED, V17, P24, DOI 10.2174/1566524017666170220095838; Gomes AL, 2016, CANCER CELL, V30, P161, DOI 10.1016/j.ccell.2016.05.020; Granier C, 2017, CANCER RES, V77, P1075, DOI 10.1158/0008-5472.CAN-16-0274; Ha D, 2019, P NATL ACAD SCI USA, V116, P609, DOI 10.1073/pnas.1812186116; Hastings WD, 2009, EUR J IMMUNOL, V39, P2492, DOI 10.1002/eji.200939274; Hematology Committee of Chinese Medical Association, 2018, Zhonghua Xue Ye Xue Za Zhi, V39, P353, DOI 10.3760/cma.j.issn.0253-2727.2018.05.001; Idler I, 2010, BRIT J HAEMATOL, V148, P948, DOI 10.1111/j.1365-2141.2009.08014.x; Karmali R, 2013, J LEUKOCYTE BIOL, V93, P161, DOI 10.1189/jlb.0612301; Knochelmann HM, 2018, CELL MOL IMMUNOL, V15, P458, DOI 10.1038/s41423-018-0004-4; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Lad DP, 2015, LEUKEMIA LYMPHOMA, V56, P2424, DOI 10.3109/10428194.2014.986479; Liu FF, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0667-4; Liu Y, 2015, AM J TRANSPLANT, V15, P954, DOI 10.1111/ajt.13067; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Mulvey JJ, 2016, AM J DERMATOPATH, V38, P492, DOI 10.1097/DAD.0000000000000441; Oomizu S, 2012, CLIN IMMUNOL, V143, P51, DOI 10.1016/j.clim.2012.01.004; Pang NN, 2016, INT IMMUNOPHARMACOL, V40, P57, DOI 10.1016/j.intimp.2016.07.008; Qorraj M, 2017, LEUKEMIA, V31, P470, DOI 10.1038/leu.2016.214; Sheng CC, 2019, NEOPLASMA, V66, P167, DOI 10.4149/neo_2018_180610N385; Shi HB, 2020, ADV EXP MED BIOL, V1248, P83, DOI 10.1007/978-981-15-3266-5_5; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Taghiloo Saeid, 2017, Asian Pac J Cancer Prev, V18, P2269; Ueno A, 2018, J AUTOIMMUN, V87, P38, DOI 10.1016/j.jaut.2017.12.004; Wang JY, 2019, SCAND J IMMUNOL, V89, DOI 10.1111/sji.12755; Wu C, 2014, IMMUNITY, V41, P270, DOI 10.1016/j.immuni.2014.06.011; Yousefi M, 2015, FUTURE ONCOL, V11, P1567, DOI 10.2217/fon.14.298; Yu JT, 2019, ONCOL LETT, V17, P1461, DOI 10.3892/ol.2018.9743; Zhao MG, 2018, CLIN EXP PHARMACOL P, V45, P1206, DOI 10.1111/1440-1681.13007	38	6	7	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21556	10.1096/fj.202100013R	http://dx.doi.org/10.1096/fj.202100013R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34137463	hybrid			2022-12-26	WOS:000667814100028
J	Alissa, NA				Alissa, Nawal A.			Knowledge and intentions regarding the Pap smear test among Saudi Arabian women	PLOS ONE			English	Article							CERVICAL-CANCER	Background The knowledge of Pap smear and uptake of preventive behaviors to prevent cervical cancer are the most important contributors to the advanced stage of the disease. Knowledge is one of the most leading factors to predict the health behaviors and a helpful factor in performing screening procedures. This study aimed to investigate Saudi Arabian women knowledge of Pap testing in relation to their intention to undergo the test. Methods An online survey including demographic characteristics (3 questions), knowledge (13 questions), and intentions (3 questions) towards Pap smear was completed by 467 Saudi Arabian women. Data were analyzed through SPSS version 22, using descriptive statistics and correlation to measure the relationship between knowledge, demographic factors, and intention. Results The study found that average level of knowledge was 1.3 which is between high and moderate knowledge, and the average score for the intention was 2.88, to indicate that the intentions to uptake Pap smear among the participants were above the average. The study revealed a significant correlation between demographic factors and intention (p<0.01). Conclusion Findings from the current study can inform health care providers about Saudi Arabian women knowledge of Pap smear and the intention to uptake the test. Strategies to motivate women to undergo Pap screening should be introduced.	[Alissa, Nawal A.] King Saud Univ, Coll Appl Med Sci, Dept Community Hlth Sci, Riyadh, Saudi Arabia	King Saud University	Alissa, NA (corresponding author), King Saud Univ, Coll Appl Med Sci, Dept Community Hlth Sci, Riyadh, Saudi Arabia.	nalissa@ksu.edu.sa	Alissa, Nawal/GZA-8336-2022		"Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University	"Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University(King Saud University)	This research project was supported by a grant from the "Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University.	AL-Hammadi Fatima Ahmed, 2017, Asian Pac J Cancer Prev, V18, P3379, DOI 10.22034/APJCP.2017.18.12.3379; Al-Mandeel HM, 2016, ANN SAUDI MED, V36, P313, DOI 10.5144/0256-4947.2016.313; Al-Shaikh GK, 2014, SAUDI MED J, V35, P1223; Alwahaibi NY, 2017, ANN TROP MED PUBLIC, V10, P396, DOI 10.4103/1755-6783.208731; Ashtarian Hossein PhD, 2017, Int J Community Based Nurs Midwifery, V5, P188; Bazarbashi Shouki, 2017, Asian Pac J Cancer Prev, V18, P2437, DOI 10.22034/APJCP.2017.18.9.2437; Harsha KHN, 2014, ANN MED HEALTH SCI R, V4, P751, DOI 10.4103/2141-9248.141547; HPV Information Centre, 2018, SAUD AR HUM PAP REL; Jassim G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5023-7; Kim HW, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-100; Moyer VA, 2012, ANN INTERN MED, V156, P880, DOI 10.7326/0003-4819-156-12-201206190-00424; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rezaie-Chamani S., 2012, Journal of Family and Reproductive Health, V6, P177; Rise J, 2008, BRIT J HEALTH PSYCH, V13, P291, DOI 10.1348/135910707X187245; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; WHO, 2018, CERV CANC	16	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253850	10.1371/journal.pone.0253850	http://dx.doi.org/10.1371/journal.pone.0253850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166452	Green Published, Green Submitted, gold			2022-12-26	WOS:000671692800026
J	Choi, JH; Han, HS; Park, YJ; Koo, S; Lee, T; Lee, KM				Choi, Ji Hye; Han, Hee Soo; Park, Young Jin; Koo, Seungbum; Lee, Taeyong; Lee, Kyoung Min			Relationship between ankle varus moment during gait and radiographic measurements in patients with medial ankle osteoarthritis	PLOS ONE			English	Article							SUPRAMALLEOLAR OSTEOTOMY; ARTHROPLASTY; BIOMECHANICS; KNEE	Background Kinetic data obtained during gait can be used to clarify the biomechanical pathogenesis of osteoarthritis of the lower extremity. This study aimed to investigate the difference in ankle varus moment between the varus angulation and medial translation types of medial ankle osteoarthritis, and to identify the radiographic measurements associated with ankle varus moment. Methods Twenty-four consecutive patients [mean age 65.8 (SD) 8.0 years; 9 men and 15 women] with medial ankle osteoarthritis were included. Fourteen and 10 patients had the varus angulation (tibiotalar tilt angle >= 3 degrees) and medial translation (tibiotalar tilt angle<3 degrees) types, respectively. All patients underwent three-dimensional gait analysis, and the maximum varus moment of the ankle was recorded. Radiographic measurement included tibial plafond inclination, tibiotalar tilt angle, talar dome inclination, and lateral talo-first metatarsal angle. Comparison between the two types of medial ankle osteoarthritis and the relationship between the maximum ankle varus moment and radiographic measurements were analyzed. Results The mean tibial plafond inclination, tibiotalar tilt angle, talar dome inclination, lateral talo-first metatarsal angle, and maximum ankle varus moment were 6.4 degrees (SD 3.3 degrees), 5.0 degrees (SD 4.6 degrees), 11.4 degrees (SD 5.2 degrees), -6.5 degrees (SD 11.7 degrees), and 0.185 (SD 0.082) Nm/kg, respectively. The varus angulation type showed a greater maximum ankle varus moment than the medial translation type (p = .005). The lateral talo-first metatarsal angle was significantly associated with the maximum ankle varus moment (p = .041) in the multiple regression analysis. Conclusion The varus angulation type of medial ankle osteoarthritis is considered to be more imbalanced biomechanically than the medial displacement type. The lateral talo-first metatarsal angle, being significantly associated with the ankle varus moment, should be considered for correction during motion-preserving surgeries for medial ankle osteoarthritis to restore the biomechanical balance of the ankle.	[Choi, Ji Hye; Han, Hee Soo; Park, Young Jin; Lee, Kyoung Min] Seoul Natl Univ, Dept Orthopaed Surg, Bundang Hosp, Seongnam Si, South Korea; [Koo, Seungbum] Korea Adv Inst Sci & Technol, Dept Mech Engn, Daejon, South Korea; [Lee, Taeyong] Ewha Womans Univ, Coll Engn, Div Mech & Biomed Engn, Seoul, South Korea	Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University	Lee, KM (corresponding author), Seoul Natl Univ, Dept Orthopaed Surg, Bundang Hosp, Seongnam Si, South Korea.	oasis100@empal.com		Koo, Seungbum/0000-0002-4843-1083; Lee, Kyoung Min/0000-0002-2372-7339	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT [NRF2017M3A9D8064200]	Bio & Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science ICT	This study was funded by Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT (NRF2017M3A9D8064200).	Barg A, 2019, FOOT ANKLE CLIN, V24, P239, DOI 10.1016/j.fcl.2019.02.004; Coetzee JC, 2004, CLIN ORTHOP RELAT R, P27, DOI 10.1097/01.blo.0000132180.69464.84; COLEMAN SS, 1977, CLIN ORTHOP RELAT R, P60; Deleu PA, 2020, CLIN BIOMECH, V73, P213, DOI 10.1016/j.clinbiomech.2020.01.015; Doets HC, 2006, J BONE JOINT SURG AM, V88A, P1272, DOI 10.2106/JBJS.E.00414; Haraguchi N, 2015, J BONE JOINT SURG AM, V97A, P333, DOI 10.2106/JBJS.M.01327; Haskell A, 2004, CLIN ORTHOP RELAT R, P98, DOI 10.1097/01.blo.0000132248.64290.52; Kobayashi H, 2016, J FOOT ANKLE SURG, V55, P60, DOI 10.1053/j.jfas.2015.06.011; Krahenbuhl N, 2019, FOOT ANKLE CLIN, V24, P173, DOI 10.1016/j.fcl.2019.02.001; Lee O-Sung, 2018, Knee Surg Relat Res, V30, P311, DOI 10.5792/ksrr.18.035; Lee WC, 2011, J BONE JOINT SURG AM, V93A, P1243, DOI 10.2106/JBJS.J.00249; Maskill MP, 2010, FOOT ANKLE INT, V31, P1057, DOI 10.3113/FAI.2010.1057; Murray C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193662; Queen R, 2017, J ORTHOP RES, V35, P2345, DOI 10.1002/jor.23609; Saltzman CL, 2006, J BONE JOINT SURG AM, V88A, P2366, DOI 10.2106/JBJS.F.00295; Schmitt D, 2015, GAIT POSTURE, V42, P373, DOI 10.1016/j.gaitpost.2015.07.005; Szczerbik E, 2011, ACTA BIOENG BIOMECH, V13, P43; Valderrabano V, 2007, CLIN BIOMECH, V22, P894, DOI 10.1016/j.clinbiomech.2007.05.003; Wood PLR, 2009, J BONE JOINT SURG BR, V91B, P69, DOI 10.1302/0301-620X.91B1.21346; Xie K, 2018, J ARTHROPLASTY, V33, P3694, DOI 10.1016/j.arth.2018.08.015	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253570	10.1371/journal.pone.0253570	http://dx.doi.org/10.1371/journal.pone.0253570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166436	Green Published, gold			2022-12-26	WOS:000671692800021
J	Shi, ZY; Xu, DH; Xu, LD				Shi, Zhangyu; Xu, Dehong; Xu, Lidi			Spatiotemporal characteristics and impact mechanism of high-quality development of cultural tourism in the Yangtze River Delta urban agglomeration	PLOS ONE			English	Article							PERCEPTIONS; RESIDENTS	The Yangtze River Delta urban agglomeration is the leading and demonstration area for the high-quality development of culture tourism (HDCT) in China. It is of great significance to study the spatiotemporal characteristics and impact mechanism of the HDCT for revealing the internal law of HDCT and promoting the collaborative innovation of culture tourism among cities. Based on the scientific construction of the evaluation system of HDCT, this paper made a quantitative analysis of 26 cities' HDCT by using coupling coordination degree model, Lisa spatiotemporal transition and spatial Durbin model (SDM). The results show that: The overall level of 26 cities' HDCT shows a fluctuating upward trend, and presents a "Z" pattern in space. More than 80% of the cities are at the medium and high level. Shanghai has obvious advantages in the primacy degree. There is a significant positive spatial autocorrelation among cities with high-quality of culture tourism development. The spatial clustering and proximity of the same kind are increasing, and the radiation effect is gradually obvious. The local spatial association patterns are mainly HH and LL agglomeration, and the characteristics of polarization are gradually prominent. The local spatial correlation structure of HDCT has strong stability, the transfer inertia between types is prominent, and the overall spatial evolution is lack of integration with obvious path dependence and lock-in effect. The spatiotemporal evolution of the HDCT is a complex process under the interaction of multiple factors, and there is a significant spatial spillover effect (0.256). The level of economic development, technological innovation, professional talent allocation are the three main factors. According to the dominant factor, it can be divided into economy stabilizing type, industry optimizing type, innovation driving type and traffic impacting type. These findings have implications for local governments and tourism management departments to achieve high-quality innovative development of cultural tourism.	[Shi, Zhangyu] Zhejiang Gongshang Univ, Hangzhou Coll Commerce, Hangzhou, Peoples R China; [Shi, Zhangyu] Zhejiang Gongshang Univ, Sch Tourism & Urban Rural Planning, Hangzhou, Peoples R China; [Shi, Zhangyu] Zhejiang Gongshang Univ, Rural Cultural Tourism Promot Ctr, Hangzhou Coll Commerce, Hangzhou, Peoples R China; [Xu, Dehong; Xu, Lidi] Hangzhou Polytech, Sch Tourism Management, Hangzhou, Peoples R China	Zhejiang Gongshang University; Zhejiang Gongshang University; Zhejiang Gongshang University	Shi, ZY (corresponding author), Zhejiang Gongshang Univ, Hangzhou Coll Commerce, Hangzhou, Peoples R China.; Shi, ZY (corresponding author), Zhejiang Gongshang Univ, Sch Tourism & Urban Rural Planning, Hangzhou, Peoples R China.; Shi, ZY (corresponding author), Zhejiang Gongshang Univ, Rural Cultural Tourism Promot Ctr, Hangzhou Coll Commerce, Hangzhou, Peoples R China.	shizhangyu2002@163.com	shi, zhangyu/GQH-3864-2022		Philosophy and Social Science Foundation of Zhejiang Province [19NDJC405YBM]	Philosophy and Social Science Foundation of Zhejiang Province	This study was supported by the Philosophy and Social Science Foundation of Zhejiang Province in the form of a grant awarded to LX (19NDJC405YBM).	Alipour H, 2005, TOURISM MANAGE, V26, P79, DOI 10.1016/j.tourman.2003.08.017; Attallah NF, 2015, TOUR HOSP RES, V15, P149, DOI 10.1177/1467358414567916; Bing H., 2015, ECON GEOGR, V35, P211; Castellani V, 2010, TOURISM MANAGE, V31, P871, DOI 10.1016/j.tourman.2009.10.001; Chen H, 2018, TOUR MANAG PERSPECT, V26, P153, DOI 10.1016/j.tmp.2017.10.006; Chen X.Q, 2006, TOURISM TRIBUNE, V21, P59; [程晓丽 Cheng Xiaoli], 2012, [地理研究, Geographical Research], V31, P169; Fan QY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16244936; Gao Nan, 2013, Tourism Tribune, V28, P62; Han H, 2020, ASIA PAC J TOUR RES, V25, P424, DOI 10.1080/10941665.2020.1737551; He J.M., 2018, TOUR TRIB, V33, P9; Hou B, 2016, WORLD REGIONAL STUDI, V25, P166; Hou Bing, 2013, Tourism Tribune, V28, P102; Hughes HL, 1996, ANN TOURISM RES, V23, P707, DOI 10.1016/0160-7383(95)00099-2; [纪小美 Ji Xiaomei], 2016, [地理研究, Geographical Research], V35, P363; [江金波 Jiang Jinbo], 2018, [地理研究, Geographical Research], V37, P1751; Jin SH, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104070; Khan M, 2003, ANN TOURISM RES, V30, P109, DOI 10.1016/S0160-7383(02)00032-4; Kim C, 1998, ANN TOURISM RES, V25, P202; Kim W, 2013, ASIA PAC J TOUR RES, V18, P534, DOI 10.1080/10941665.2012.695285; Li CX, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7547-4; Li CX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051446; Li M, 2019, SCI DEV, P83; Li P., 2020, SUSTAINABILITY-BASEL, V12, P3390, DOI [https://doi.org/10.3390/su12083390, DOI 10.3390/SU12083390]; Li ZG., 2008, TOURISM SCI, P27; Liu GF, 2015, ASIA PAC J TOUR RES, V20, P500, DOI 10.1080/10941665.2014.904805; Liu YingJi, 2020, Tourism Tribune, V35, P28; Campa JL, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205845; [马慧强 Ma Huiqiang], 2018, [经济地理, Economic Geography], V38, P190; Ma Y, 2011, WORLD REGIONAL STUDI, V20, P143; Mao XR., 2016, AREAL RES DEV, P91; Mira MD, 2019, J QUAL ASSUR HOSP TO, V20, P273, DOI 10.1080/1528008X.2018.1530164; Nelson V, 2015, TOURISM GEOGR, V17, P192, DOI 10.1080/14616688.2014.986751; Norberg-Bohm V, 1999, POLICY SCI, V32, P13, DOI 10.1023/A:1004384913598; Rey SJ, 2011, LETT SPAT RESOUR SCI, V4, P81, DOI 10.1007/s12076-010-0048-2; Richards Greg, 2007, CULTURAL TOURISM GLO; Ruan WQ, 2019, TOURISM MANAGE, V75, P609, DOI 10.1016/j.tourman.2019.06.021; Russo AP, 2002, TOURISM MANAGE, V23, P631, DOI 10.1016/S0261-5177(02)00027-4; Sari FO, 2016, INT J HOSP MANAG, V54, P95, DOI 10.1016/j.ijhm.2016.02.004; Sheng Y. C., 2009, TOURISM TRIBUNE, V24, P23, DOI CNKI:SUN:LYXK.0.2009-08-011; Sheng YC., 2014, HUMAN GEOGRAPHY, P113; Shin Y, 2010, ASIA PAC J TOUR RES, V15, P405, DOI 10.1080/10941665.2010.520944; Song H., 2010, TOURISM SCI, V24, P71; [孙剑锋 Sun Jianfeng], 2019, [经济地理, Economic Geography], V39, P207; Tokarchuk O, 2017, TOURISM ECON, V23, P343, DOI 10.1177/1354816616656272; Vergori AS, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104058; Wang K., 2013, ECON GEOGR, V33, P161; Weng G., 2016, ECON GEOGR, V36, P178; [肖妮 Xiao Ni], 2019, [地理科学, Scientia Geographica Sinica], V39, P978; [徐冬 Xu Dong], 2019, [地理学报, Acta Geographica Sinica], V74, P814; Xu D, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11030822; Yang J, 2021, J HOSP TOUR MANAG, V47, P35, DOI 10.1016/j.jhtm.2021.02.008; Zhang AP., 2015, CHINA SCIENTIA GEOGR, V35, P283; Zhang HC, 2019, CONT EC MANAGEMENT, V41, P60; Zhang H, 2011, TOURISM MANAGE, V32, P443, DOI 10.1016/j.tourman.2010.02.007; Zhong S., 2014, HUMAN GEOGRAPHY, V29, P125; Zhu T.X, 2005, TOURISM TRIBUNE, V20, P82	57	5	5	55	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0252842	10.1371/journal.pone.0252842	http://dx.doi.org/10.1371/journal.pone.0252842			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BH	34157034	Green Published, gold			2022-12-26	WOS:000671691200011
J	Ogawa, C; Tsuchiya, K; Tomosugi, N; Maeda, K				Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Maeda, Kunimi			Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa	PLOS ONE			English	Article							REGULATES HEPCIDIN; IRON-DEFICIENCY; HEMODIALYSIS; INFLAMMATION; ANEMIA; EXPRESSION; INCREASE; GENE	Background Hypoxia-inducible factor (HIF) prolyl hydroxylase domain inhibitors, which have recently become clinically available for treating renal anemia, are attracting attention for their novel mechanisms of action. Methods Relationships of reticulocyte hemoglobin content (CHr), which reflects recent Hb synthesis, with serum ferritin (s-ft) and transferrin saturation (TSAT) were examined in 30 patients on hemodialysis after switching from darbepoetin alfa (DA) to roxadustat (Rox). Iron deficiency was defined as CHr < 32.0 pg. Cutoff values of s-ft and TSAT were determined using receiver operating characteristic curves for the endpoint CHr >= 32.0 pg. Logistic analysis was performed with the reference group having s-ft or TSAT below the corresponding cutoff value (low vs high). Results With the endpoint CHr >= 32.0 pg on Day 0, cutoff values for s-ft and TSAT were respectively 49.7 ng/mL and 21.6% on Day 0 and 35.5 ng/mL and 16.2% on Day 28. With the endpoint CHr >= 32.0 pg on Day 28, cutoff values for s-ft and TSAT on Day 0 were 81.6 ng/mL and 23.9%, respectively. According to multivariable logistic analysis, the odds ratios of CHr >= 32.0 pg on Day 0 were significantly higher for high TSAT on Day 0 [34.7 (95% CI 2.42-131.0), p<0.003] and Day 28 [24.8 (95% CI 2.75-224.0), p = 0.004]. There were no significant differences by s-ft. Odd ratios of CHr >= 32.0 pg on Day 28 were also significantly higher for high s-ft on Day 0 [16.0 (95% CI 1.57-163.0), p = 0.019] and high TSAT on Day 0 [13.5 (95% CI 1.24-147.0), pConclusions Our results suggest Hb synthesis was maintained with lower TSAT and s-ft during Rox therapy compared with DA therapy. To avoid iron deficiency during the 4 weeks after switching DA to Rox, ideal s-ft and TSAT levels before the switch are 81.6 ng/mL and 23.9%, respectively.	[Ogawa, Chie; Maeda, Kunimi] Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan; [Ogawa, Chie; Tsuchiya, Ken; Tomosugi, Naohisa; Maeda, Kunimi] Biomarker Soc Inc, Kawasaki, Kanagawa, Japan; [Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Div Syst Biosci, Med Res Inst, Drug Discovery Project Res Ctr, Kanazawa, Ishikawa, Japan	Tokyo Women's Medical University; Kanazawa Medical University	Ogawa, C (corresponding author), Maeda Inst Renal Res, Kawasaki, Kanagawa, Japan.; Ogawa, C (corresponding author), Biomarker Soc Inc, Kawasaki, Kanagawa, Japan.	tato.ogawa@gmail.com						Akizawa T, 2020, J AM SOC NEPHROL, V31, P1628, DOI 10.1681/ASN.2019060623; Chen N, 2019, NEW ENGL J MED, V381, P1011, DOI 10.1056/NEJMoa1901713; El Sewefy DA, 2019, INT UROL NEPHROL, V51, P325, DOI 10.1007/s11255-018-2062-z; Fishbane S, 2001, KIDNEY INT, V60, P2406, DOI 10.1046/j.1523-1755.2001.00077.x; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Lok CN, 1999, J BIOL CHEM, V274, P24147, DOI 10.1074/jbc.274.34.24147; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; Mitsuiki Koji, 2003, Clin Exp Nephrol, V7, P52; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Ogawa C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197153; Ogawa C, 2020, HEMATOLOGY, V25, P71, DOI 10.1080/16078454.2020.1720103; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rattanasompattikul M, 2013, NEPHROL DIAL TRANSPL, V28, P1936, DOI 10.1093/ndt/gfs368; Rolfs A, 1997, J BIOL CHEM, V272, P20055, DOI 10.1074/jbc.272.32.20055; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Shah YM, 2009, CELL METAB, V9, P152, DOI 10.1016/j.cmet.2008.12.012; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tessitore N, 2001, NEPHROL DIAL TRANSPL, V16, P1416, DOI 10.1093/ndt/16.7.1416; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252439	10.1371/journal.pone.0252439	http://dx.doi.org/10.1371/journal.pone.0252439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143801	gold, Green Published			2022-12-26	WOS:000671690700042
J	Vyleta, NP; Snyder, JS				Vyleta, Nicholas P.; Snyder, Jason S.			Prolonged development of long-term potentiation at lateral entorhinal cortex synapses onto adult-born neurons	PLOS ONE			English	Article							ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; GRANULE CELLS; CRITICAL PERIOD; PERIRHINAL CORTEX; COGNITIVE DECLINE; EXPERIENCE; MEMORY; RAT	Critical period plasticity at adult-born neuron synapses is widely believed to contribute to the learning and memory functions of the hippocampus. Experience regulates circuit integration and for a transient interval, until cells are similar to 6 weeks old, new neurons display enhanced long-term potentiation (LTP) at afferent and efferent synapses. Since neurogenesis declines substantially with age, this raises questions about the extent of lasting plasticity offered by adult-born neurons. Notably, however, the hippocampus receives sensory information from two major cortical pathways. Broadly speaking, the medial entorhinal cortex conveys spatial information to the hippocampus via the medial perforant path (MPP), and the lateral entorhinal cortex, via the lateral perforant path (LPP), codes for the cues and items that make experiences unique. While enhanced critical period plasticity at MPP synapses is relatively well characterized, no studies have examined long-term plasticity at LPP synapses onto adult-born neurons, even though the lateral entorhinal cortex is uniquely vulnerable to aging and Alzheimer's pathology. We therefore investigated LTP at LPP inputs both within (4-6 weeks) and beyond (8(+) weeks) the traditional critical period. At immature stages, adult-born neurons did not undergo significant LTP at LPP synapses, and often displayed long-term depression after theta burst stimulation. However, over the course of 3-4 months, adult-born neurons displayed increasingly greater amounts of LTP. Analyses of short-term plasticity point towards a presynaptic mechanism, where transmitter release probability declines as cells mature, providing a greater dynamic range for strengthening synapses. Collectively, our findings identify a novel form of new neuron plasticity that develops over an extended interval, and may therefore be relevant for maintaining cognitive function in aging.	[Vyleta, Nicholas P.; Snyder, Jason S.] Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Psychol, Vancouver, BC, Canada	University of British Columbia	Snyder, JS (corresponding author), Univ British Columbia, Djavad Mowafaghian Ctr Brain Hlth, Dept Psychol, Vancouver, BC, Canada.	jasonsnyder@psych.ubc.ca		Snyder, Jason/0000-0002-5509-0272	Canadian Foundation for Innovation; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Foundation for Innovation (JSS), the Canadian Institutes of Health Research (JSS) and the Michael Smith Foundation for Health Research (JSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez DD, 2016, SCIENCE, V354, P459, DOI 10.1126/science.aaf2156; Amani M, 2021, J NEUROSCI, V41, P2301, DOI 10.1523/JNEUROSCI.2376-20.2021; Anacker C, 2018, NATURE, V559, P98, DOI 10.1038/s41586-018-0262-4; Anderson ML, 2011, EUR J NEUROSCI, V33, P175, DOI 10.1111/j.1460-9568.2010.07486.x; Araque A, 2017, NEUROPHARMACOLOGY, V124, P13, DOI 10.1016/j.neuropharm.2017.06.017; BARNES CA, 1980, J PHYSIOL-LONDON, V309, P473, DOI 10.1113/jphysiol.1980.sp013521; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bekinschtein P, 2014, HIPPOCAMPUS, V24, P905, DOI 10.1002/hipo.22304; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bergami M, 2015, NEURON, V85, P710, DOI 10.1016/j.neuron.2015.01.001; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Bota M, 2015, P NATL ACAD SCI USA, V112, pE2093, DOI 10.1073/pnas.1504394112; Bottes S, 2021, NAT NEUROSCI, V24, P225, DOI 10.1038/s41593-020-00759-4; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cahill SP, 2017, HIPPOCAMPUS, V27, P1155, DOI 10.1002/hipo.22760; Cameron HA, 2015, ANNU REV PSYCHOL, V66, P53, DOI 10.1146/annurev-psych-010814-015006; Chamberland S, 2017, J NEUROSCI, V37, P4913, DOI 10.1523/JNEUROSCI.0159-17.2017; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; CHRISTIE BR, 1994, NEUROREPORT, V5, P385, DOI 10.1097/00001756-199401120-00003; Ciric T, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1435; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Cole JD, 2020, J NEUROSCI, V40, P5740, DOI 10.1523/JNEUROSCI.1665-19.2020; Cui YH, 2016, ELIFE, V5, DOI 10.7554/eLife.13185; Cushman JD, 2021, PROG NEUROBIOL, V199, DOI 10.1016/j.pneurobio.2020.101961; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Denny CA, 2012, HIPPOCAMPUS, V22, P1188, DOI 10.1002/hipo.20964; Deshmukh SS, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00069; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Fernandez-Ruiz A, 2021, SCIENCE, V372, P50, DOI 10.1126/science.abf3119; Fidalgo CO, 2016, HIPPOCAMPUS, V26, P1579, DOI 10.1002/hipo.22658; Froc DJ, 2003, J NEUROPHYSIOL, V90, P32, DOI 10.1152/jn.00105.2003; Fukaya R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016754118; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gil-Mohapel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075125; Glover LR, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001154; Goncalves JT, 2016, NAT NEUROSCI, V19, P788, DOI 10.1038/nn.4301; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Huckleberry KA, 2021, HIPPOCAMPUS, V31, P543, DOI 10.1002/hipo.23318; Hunsaker MR, 2013, HIPPOCAMPUS, V23, P380, DOI 10.1002/hipo.22097; HYMAN BT, 1986, ANN NEUROL, V20, P472, DOI 10.1002/ana.410200406; Jackman SL, 2017, NEURON, V94, P447, DOI 10.1016/j.neuron.2017.02.047; Jahn HM, 2018, CELL TISSUE RES, V371, P23, DOI 10.1007/s00441-017-2677-x; Johnson SA, 2017, HIPPOCAMPUS, V27, P759, DOI 10.1002/hipo.22729; Khan UA, 2014, NAT NEUROSCI, V17, P304, DOI 10.1038/nn.3606; Kheirbek MA, 2012, J NEUROSCI, V32, P8696, DOI 10.1523/JNEUROSCI.1692-12.2012; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kim S, 2018, ELIFE, V7, DOI 10.7554/eLife.35269; Kim YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.06414; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Leitner FC, 2016, NAT NEUROSCI, V19, P935, DOI 10.1038/nn.4303; Leuner B, 2007, P NATL ACAD SCI USA, V104, P17169, DOI 10.1073/pnas.0708228104; Liu XS, 2000, BRAIN RES, V856, P202, DOI 10.1016/S0006-8993(99)02421-X; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Maurer AP, 2017, FRONT SYST NEUROSCI, V11, DOI 10.3389/fnsys.2017.00049; Meunier M, 2006, J NEUROSCI, V26, P7718, DOI 10.1523/JNEUROSCI.1949-06.2006; Miller SM, 2019, NAT NEUROSCI, V22, P1565, DOI 10.1038/s41593-019-0484-2; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; Morrissey MD, 2014, NEUROBIOL LEARN MEM, V115, P95, DOI 10.1016/j.nlm.2014.08.006; Olsen RK, 2017, NEUROBIOL AGING, V57, P195, DOI 10.1016/j.neurobiolaging.2017.04.025; Petersen RP, 2013, NEUROSCIENCE, V252, P154, DOI 10.1016/j.neuroscience.2013.07.063; Pilz GA, 2018, SCIENCE, V359, P658, DOI 10.1126/science.aao5056; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Reagh ZM, 2018, NEURON, V97, P1187, DOI 10.1016/j.neuron.2018.01.039; Reagh ZM, 2016, HIPPOCAMPUS, V26, P417, DOI 10.1002/hipo.22562; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seib DR, 2020, BEHAV NEUROSCI, V134, P283, DOI 10.1037/bne0000370; Seib DR, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.0197869, 10.1371/Journal.pone.0197869]; Snyder JS, 2019, TRENDS NEUROSCI, V42, P164, DOI 10.1016/j.tins.2018.12.001; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; STEWARD O, 1976, J COMP NEUROL, V167, P285, DOI 10.1002/cne.901670303; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Van Cauter T, 2013, CEREB CORTEX, V23, P451, DOI 10.1093/cercor/bhs033; Vandael D, 2020, NEURON, V107, P509, DOI 10.1016/j.neuron.2020.05.013; Vandrey B, 2020, CURR BIOL, V30, P169, DOI 10.1016/j.cub.2019.11.027; Vivar C, 2016, NEUROIMAGE, V131, P29, DOI 10.1016/j.neuroimage.2015.11.031; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Vyleta NP, 2014, SCIENCE, V343, P665, DOI 10.1126/science.1244811; Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.3.CO;2-A; Wang WS, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0160-16.2016; Wilson DIG, 2013, HIPPOCAMPUS, V23, P1280, DOI 10.1002/hipo.22165; Woods NI, 2020, NEURON, V107, P173, DOI 10.1016/j.neuron.2020.04.002; Woods NI, 2018, J NEUROSCI, V38, P5843, DOI 10.1523/JNEUROSCI.1737-17.2018; Yang SM, 2015, J NEUROSCI, V35, P15379, DOI 10.1523/JNEUROSCI.2345-15.2015; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Yeung LK, 2017, J NEUROSCI, V37, P5527, DOI 10.1523/JNEUROSCI.3664-16.2017	99	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253642	10.1371/journal.pone.0253642	http://dx.doi.org/10.1371/journal.pone.0253642			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143843	Green Published, Green Submitted, gold			2022-12-26	WOS:000671690700070
J	Dunn, L; Lang, C; Marilleau, N; Terrat, S; Biju-Duval, L; Lelievre, M; Perrin, S; Prevost-Boure, NC				Dunn, Laurie; Lang, Christophe; Marilleau, Nicolas; Terrat, Sebastien; Biju-Duval, Luc; Lelievre, Melanie; Perrin, Solene; Prevost-Boure, Nicolas Chemidlin			Soil microbial communities in the face of changing farming practices: A case study in an agricultural landscape in France	PLOS ONE			English	Article							LAND-USE; ORGANIC-CARBON; BACTERIAL; IMPACT; DIVERSITY; TILLAGE; BIOMASS; CROP; PESTICIDES; MICROORGANISMS	According to biogeography studies, the abundance and richness of soil microorganisms vary across multiple spatial scales according to soil properties and farming practices. However, soil microorganisms also exhibit poorly understood temporal variations. This study aimed at better understanding how soil microbial communities respond to changes in farming practices at a landscape scale over time. A regular grid of 269 sites was set up across a 1,200 ha farming landscape, and soil samples were characterized for their molecular microbial biomass and bacterial richness at two dates (2011 and 2016). A mapping approach highlighted that spatial microbial patterns were stable over time, while abundance and richness levels were modified. The drivers of these changes were investigated though a PLS-PM (partial least square path-modeling) approach. Soil properties were stable over time, but farming practices changed. Molecular microbial biomass was mainly driven by soil resources, whereas bacterial richness depended on both farming practices and ecological parameters. Previous-crop and management effects and a temporal dependence of the microbial community on the historical farming management were also highlighted.	[Dunn, Laurie; Terrat, Sebastien; Biju-Duval, Luc; Prevost-Boure, Nicolas Chemidlin] Univ Bourgogne Franche Comte, AgrosupDijon, INRAE, UMR Agroecol 1347, Dijon, France; [Lang, Christophe] Univ Bourgogne Franche Comte, CNRS, Inst Rech Femto ST, Besancon, France; [Marilleau, Nicolas] Sorbonne Univ, IRD, UMI UMMISCO 209, Bondy, France; [Lelievre, Melanie; Perrin, Solene] INRAE, Plateforme GenoSol, UMR Agroecol 1347, Dijon, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Technologie de Belfort-Montbeliard (UTBM); UDICE-French Research Universities; Sorbonne Universite; Cadi Ayyad University of Marrakech; Hanoi University of Science & Technology; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; University of Yaounde I; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Dunn, L (corresponding author), Univ Bourgogne Franche Comte, AgrosupDijon, INRAE, UMR Agroecol 1347, Dijon, France.	laurie.dunn@inrae.fr	Prévost-Bouré, Nicolas Chemidlin/U-7714-2017	Prévost-Bouré, Nicolas Chemidlin/0000-0002-8575-4295; DUNN, Laurie/0000-0001-7063-5982				Alhameid A, 2019, SOIL SCI SOC AM J, V83, P1431, DOI 10.2136/sssaj2018.03.0125; [Anonymous], 2015, STAT WORLDS SOIL RES; Ashworth AJ, 2017, SOIL BIOL BIOCHEM, V114, P210, DOI 10.1016/j.soilbio.2017.07.019; Bahram M, 2018, NATURE, V560, P233, DOI 10.1038/s41586-018-0386-6; Benitez J, 2020, INFORM MANAGE-AMSTER, V57, DOI 10.1016/j.im.2019.05.003; Benitez ME, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02903-w; Berard A, 2015, CLIM RES, V66, P243, DOI 10.3354/cr01343; Bickel S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13966-w; Billen G, 2014, GLOB FOOD SECUR-AGR, V3, P209, DOI 10.1016/j.gfs.2014.08.003; Blazewicz SJ, 2014, ECOLOGY, V95, P1162, DOI 10.1890/13-1031.1; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Bu RY, 2020, AGR ECOSYST ENVIRON, V287, DOI 10.1016/j.agee.2019.106681; Buscardo E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22380-z; Carini P, 2020, MBIO, V11, DOI 10.1128/mBio.02776-19; Chavarria DN, 2018, AGR ECOSYST ENVIRON, V264, P1, DOI 10.1016/j.agee.2018.05.008; Chen C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09258-y; Choisnel C, 1995, METEOROLOGIE, V8, P29, DOI [10.4267/2042/51939, DOI 10.4267/2042/51939]; Chowdhury A, 2008, INDIAN J MICROBIOL, V48, P114, DOI 10.1007/s12088-008-0011-8; Chu HY, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00803-19; Clivot H, 2019, ENVIRON MODELL SOFTW, V118, P99, DOI 10.1016/j.envsoft.2019.04.004; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Constancias F, 2015, MICROBIOLOGYOPEN, V4, P518, DOI 10.1002/mbo3.256; Constancias F, 2015, MICROBIOLOGYOPEN, V4, P505, DOI 10.1002/mbo3.255; DeAngelis KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00104; Delgado-Baquerizo M, 2019, ECOSYSTEMS, V22, P1220, DOI 10.1007/s10021-018-0333-2; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; Delgado-Baquerizo M, 2017, ENVIRON MICROBIOL, V19, P1176, DOI 10.1111/1462-2920.13642; Dequiedt S, 2011, GLOBAL ECOL BIOGEOGR, V20, P641, DOI 10.1111/j.1466-8238.2010.00628.x; Diggle J, GEOR PACKAGE GEOSTAT; DJEMIEL C, 2020, ZENODO, DOI DOI 10.1186/S12859-020-03829-3; Drenovsky RE, 2010, GLOBAL ECOL BIOGEOGR, V19, P27, DOI 10.1111/j.1466-8238.2009.00486.x; Elsgaard L, 2001, ENVIRON TOXICOL CHEM, V20, P1656, DOI [10.1897/1551-5028(2001)020&lt;1656:EARAOL&gt;2.0.CO;2, 10.1002/etc.5620200806]; Fanelli RM, 2020, ENVIRONMENTS, V7, DOI 10.3390/environments7040033; de Souza TAF, 2018, SUSTAIN AGR REV, V28, P211, DOI 10.1007/978-3-319-90309-5_7; Fernandes A., 2019, WIT T ECOL ENV, V239, P145, DOI [10.2495/WS190131, DOI 10.2495/WS190131]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2017, NAT REV MICROBIOL, V15, P579, DOI 10.1038/nrmicro.2017.87; Furtak K., 2018, SUSTAINABILITY AGROE, P45, DOI [10.5772/intechopen.72966, DOI 10.5772/INTECHOPEN.72966]; Geisseler D, 2016, APPL SOIL ECOL, V106, P1, DOI 10.1016/j.apsoil.2016.04.015; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; Glodowska M., 2019, Agricultural Sciences, V10, P330, DOI 10.4236/as.2019.103028; Griffiths RI, 2016, APPL SOIL ECOL, V97, P61, DOI 10.1016/j.apsoil.2015.06.018; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; Hamer U, 2021, BASIC APPL ECOL, V53, P143, DOI 10.1016/j.baae.2021.03.014; Hannula SE, 2019, MBIO, V10, DOI 10.1128/mBio.02635-19; Hilton S, 2018, APPL SOIL ECOL, V126, P34, DOI 10.1016/j.apsoil.2018.02.007; Horrigue W, 2016, ECOL INDIC, V64, P203, DOI 10.1016/j.ecolind.2015.12.004; Huang FY, 2019, EUR J SOIL BIOL, V92, P8, DOI 10.1016/j.ejsobi.2019.04.001; Hussain M-AH., EFFECTS SOIL TEXTURE, P7, DOI [10.1016/j.medengphy.2012.09.006, DOI 10.1016/J.MEDENGPHY.2012.09.006]; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jawinska E, 2010, CHANGES SOIL MICROBI, P11; Joimel S, 2016, SCI TOTAL ENVIRON, V545, P40, DOI 10.1016/j.scitotenv.2015.12.035; Karas PA, 2018, SCI TOTAL ENVIRON, V637, P636, DOI 10.1016/j.scitotenv.2018.05.073; Karimi B, 2020, GLOBAL ECOL BIOGEOGR, V29, P1399, DOI 10.1111/geb.13118; Karimi B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40422-y; Kraut-Cohen J, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135791; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lavigne C., 2019, PAYSAGE BIODIVERSITE; Le Guillou C, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.676; Leloup J, 2018, GEODERMA, V317, P1, DOI 10.1016/j.geoderma.2017.12.018; Li JW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58217-x; Li JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18486-5; Liddle K, 2020, SOIL SYST, V4, DOI 10.3390/soilsystems4030041; Liu D, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02456; Louis BP, 2016, ENVIRON CHEM LETT, V14, P331, DOI 10.1007/s10311-016-0571-5; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Maharjan GR, 2018, SOIL TILL RES, V180, P210, DOI 10.1016/j.still.2018.03.009; Malard LA, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz128; Marty JR., 1969, THESIS U TOULOUSE; Mori A, 1977, B TECHNIQUE INFORM; Naylor D, 2018, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02223; Negreiros J., 2010, Journal of Applied Sciences, V10, P852, DOI 10.3923/jas.2010.852.867; Nivelle E, 2016, APPL SOIL ECOL, V108, P147, DOI 10.1016/j.apsoil.2016.08.004; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Piotrowska-Dlugosz A, 2019, J SOIL SEDIMENT, V19, P345, DOI 10.1007/s11368-018-2022-3; Pires LF, 2017, SOIL TILL RES, V165, P66, DOI 10.1016/j.still.2016.07.010; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Ramakrishnan B, 2019, SCI TOTAL ENVIRON, V654, P177, DOI 10.1016/j.scitotenv.2018.11.041; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Reis F, 2019, APPL SOIL ECOL, V143, P89, DOI 10.1016/j.apsoil.2019.05.031; Romdhane S, 2019, SCI TOTAL ENVIRON, V651, P241, DOI 10.1016/j.scitotenv.2018.09.159; RStudio Team, 2020, R STUDIO INTEGRATED; Russolillo G, 2019, PLSPM TOOLS PARTIAL; Sahu PK, 2019, ECOL INDIC, V105, P601, DOI 10.1016/j.ecolind.2018.05.084; Sanchez G., 2013, PLS PATH MODELING R; Seaton FM, 2020, SOIL BIOL BIOCHEM, V144, DOI 10.1016/j.soilbio.2020.107766; Serrano E, 2014, EPIDEMIOL INFECT, V142, P530, DOI 10.1017/S0950268813001295; Siebers M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200160; Singh JS, 2018, SCI TOTAL ENVIRON, V634, P497, DOI 10.1016/j.scitotenv.2018.03.373; Sinkeviciene A., 2009, Agronomy Research, V7, P485; Sun BJ, 2020, EUR J SOIL BIOL, V97, DOI 10.1016/j.ejsobi.2020.103155; Tardy V, 2014, ENV MICROBIOL REP, V6, P173, DOI 10.1111/1758-2229.12126; Terrat S, 2020, METHODS ECOL EVOL, V11, P168, DOI 10.1111/2041-210X.13316; Terrat S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186766; Tripathi BM, 2018, ISME J, V12, P1072, DOI 10.1038/s41396-018-0082-4; Upton RN, 2019, SOIL BIOL BIOCHEM, V132, P58, DOI 10.1016/j.soilbio.2019.01.016; van Leeuwen JP, 2017, EUR J SOIL BIOL, V79, P14, DOI 10.1016/j.ejsobi.2017.02.001; Venter ZS, 2016, PEDOBIOLOGIA, V59, P215, DOI 10.1016/j.pedobi.2016.04.001; Wallenius K, 2011, SOIL BIOL BIOCHEM, V43, P1464, DOI 10.1016/j.soilbio.2011.03.018; Wang FM, 2017, FUNCT ECOL, V31, P2344, DOI 10.1111/1365-2435.12925; Widmer F, 2006, APPL SOIL ECOL, V33, P294, DOI 10.1016/j.apsoil.2005.09.007; Wolejko E, 2020, APPL SOIL ECOL, V147, DOI 10.1016/j.apsoil.2019.09.006; Wolinska A, 2017, INT AGROPHYS, V31, P259, DOI 10.1515/intag-2016-0040; Wu JG, 2020, SOIL SCI PLANT NUTR, V66, P177, DOI 10.1080/00380768.2019.1705181; Yang Wang, 2017, arXiv; Yuan M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76837-1; Yvoz S, 2020, EUR J AGRON, V115, DOI 10.1016/j.eja.2020.126009; Zhang B, 2019, SOIL TILL RES, V195, DOI 10.1016/j.still.2019.104376; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001	109	5	5	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252216	10.1371/journal.pone.0252216	http://dx.doi.org/10.1371/journal.pone.0252216			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138883	Green Published, gold			2022-12-26	WOS:000671690200088
J	Lee, HJ; Kim, HK; Kim, BS; Han, KD; Park, JB; Lee, H; Lee, SP; Kim, YJ				Lee, Hyun-Jung; Kim, Hyung-Kwan; Kim, Bong-Sung; Han, Kyung-Do; Park, Jun-Bean; Lee, Heesun; Lee, Seung-Pyo; Kim, Yong-Jin			Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; DABIGATRAN ETEXILATE; SAFETY; PHARMACOKINETICS; WARFARIN; PHARMACODYNAMICS; PREVENTION; APIXABAN; STROKE; TRACT	Background Proton pump inhibitors (PPIs) are known to reduce the risk of upper gastrointestinal bleeding in patients on oral anticoagulants, and patients are increasingly on oral anticoagulants and PPI co-therapy. However, evidence is lacking on the safety and effectiveness of oral anticoagulants when co-administered with PPIs. Methods Among patients initiating oral anticoagulants (warfarin and non-vitamin K antagonist oral anticoagulants [NOACs], i.e. rivaroxaban, dabigatran, apixaban, and edoxaban) during 2013-2017, those concomitantly prescribed PPIs were identified (n = 19,851). The primary endpoint was hospitalization for major upper gastrointestinal bleeding, and secondary endpoints were death and ischemic stroke. Results During a mean 1.4 years of follow-up, the primary endpoint occurred in 512 (2.58%) patients. Overall, NOACs were associated with lower upper gastrointestinal bleeding risk after adjustment for age, sex, comorbidities and concomitant medications (adjusted hazard ratio 0.78, 95% confidence interval 0.65-0.94), compared to warfarin. There was no significant difference in upper gastrointestinal bleeding risk among the individual NOACs. This trend of reduced risk for upper gastrointestinal bleeding in NOACs compared to warfarin was consistent for both regular and reduced doses, throughout bleeding risk groups, and other subgroup analyses. NOACs were also associated with lower risk of death compared to warfarin. The risk for ischemic stroke was not significantly different among the oral anticoagulants in patients with atrial fibrillation. Conclusion In patients on oral anticoagulant and PPI co-therapy, NOACs were associated with lower risk of upper gastrointestinal bleeding and mortality compared to warfarin, while there was no difference among the oral anticoagulants for stroke prevention. In patients on PPI therapy, NOACs may preferred over warfarin for decreasing risk of upper gastrointestinal bleeding and mortality.	[Lee, Hyun-Jung; Kim, Hyung-Kwan; Park, Jun-Bean; Lee, Heesun; Lee, Seung-Pyo; Kim, Yong-Jin] Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea; [Kim, Bong-Sung; Han, Kyung-Do] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Soongsil University	Kim, HK (corresponding author), Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Div Cardiol, Seoul, South Korea.	cardiman73@gmail.com		Lee, Hyun-Jung/0000-0002-7498-0705; Kim, Hyung-Kwan/0000-0001-7950-2131	Ildong research fund [0620201160]	Ildong research fund	This study was supported by the Ildong research fund [grant number 0620201160 to HKK].	Abraham NS, 2017, GASTROENTEROLOGY, V152, P1014, DOI 10.1053/j.gastro.2016.12.018; Agewall S, 2013, EUR HEART J, V34, P1708, DOI 10.1093/eurheartj/eht042; Aronow Wilbert S, 2009, J Atr Fibrillation, V1, P154, DOI 10.4022/jafib.154; Bhatt DL, 2008, J AM COLL CARDIOL, V52, P1502, DOI 10.1016/j.jacc.2008.08.002; Chan EW, 2015, GASTROENTEROLOGY, V149, P586, DOI 10.1053/j.gastro.2015.05.002; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cox R, 2016, INTERN MED J, V46, P1456, DOI 10.1111/imj.13275; Gelosa P, 2018, PHARMACOL RES, V135, P60, DOI 10.1016/j.phrs.2018.07.016; Greenwald DA, 2004, AM J MED, V117, p8S, DOI 10.1016/j.amjmed.2004.07.019; Henriksen DP, 2015, PHARMACOEPIDEM DR S, V24, P1337, DOI 10.1002/pds.3881; JULKUNEN RJK, 1976, MED BIOL, V54, P260; Kuwayama T, 2017, J ARRYTHM, V33, P619, DOI 10.1016/j.joa.2017.07.013; Lee HJ, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012771; Lee HJ, 2019, STROKE, V50, P2582, DOI 10.1161/STROKEAHA.119.026048; Lee SR, 2019, J AM COLL CARDIOL, V73, P3295, DOI 10.1016/j.jacc.2019.04.052; Lee SR, 2019, STROKE, V50, P2245, DOI 10.1161/STROKEAHA.119.025536; Liesenfeld KH, 2011, J THROMB HAEMOST, V9, P2168, DOI 10.1111/j.1538-7836.2011.04498.x; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Matsuura H, 2018, EUR HEART J, V39, P3400, DOI 10.1093/eurheartj/ehy538; Mentias A, 2020, STROKE, V51, P2076, DOI 10.1161/STROKEAHA.120.029541; Miller CS, 2017, CLIN GASTROENTEROL H, V15, P1674, DOI 10.1016/j.cgh.2017.04.031; Moayyedi P, 2019, GASTROENTEROLOGY, V157, P403, DOI 10.1053/j.gastro.2019.04.041; Moore KT, 2011, J CARDIOVASC PHARM, V58, P581, DOI 10.1097/FJC.0b013e31822f6c2b; Paneni F, 2017, J AM COLL CARDIOL, V69, P1952, DOI 10.1016/j.jacc.2017.01.064; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Ray WA, 2018, JAMA-J AM MED ASSOC, V320, P2221, DOI 10.1001/jama.2018.17242; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Rutherford OCW, 2020, EUR HEART J-CARD PHA, V6, P75, DOI 10.1093/ehjcvp/pvz086; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Stangier J, 2005, J CLIN PHARMACOL, V45, P555, DOI 10.1177/0091270005274550; Stangier J, 2008, CLIN PHARMACOKINET, V47, P47, DOI 10.2165/00003088-200847010-00005; Teichert M, 2011, BRIT J HAEMATOL, V153, P379, DOI 10.1111/j.1365-2141.2011.08633.x; Toya Y, 2016, J GASTROEN HEPATOL, V31, P610, DOI 10.1111/jgh.13024; Upreti VV, 2013, CLIN PHARMACOL-ADV A, V5, P59, DOI 10.2147/CPAA.S41999; Wang KL, 2015, STROKE, V46, P2555, DOI 10.1161/STROKEAHA.115.009947; Wu Alan Hb, 2011, Clin Proteomics, V8, P12, DOI 10.1186/1559-0275-8-12	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253310	10.1371/journal.pone.0253310	http://dx.doi.org/10.1371/journal.pone.0253310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138972	Green Published, Green Accepted, gold			2022-12-26	WOS:000671690200069
J	Tunggal, HC; Munson, PV; O'Connor, MA; Hajari, N; Dross, SE; Bratt, D; Fuller, JT; Bagley, K; Fuller, DH				Tunggal, Hillary Claire; Munson, Paul Veness; O'Connor, Megan Ashley; Hajari, Nika; Dross, Sandra Elizabeth; Bratt, Debra; Fuller, James Thomas; Bagley, Kenneth; Fuller, Deborah Heydenburg			Effects of therapeutic vaccination on the control of SIV in rhesus macaques with variable responsiveness to antiretroviral drugs	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; HEAT-LABILE ENTEROTOXIN; PRIMARY HIV-1 INFECTION; DNA VACCINE; IMMUNE-RESPONSES; MOLECULAR ADJUVANT; CHOLERA-TOXIN; DEPLETION; REPLICATION	A therapeutic vaccine that induces lasting control of HIV infection could eliminate the need for lifelong adherence to antiretroviral therapy. This study investigated a therapeutic DNA vaccine delivered with a single adjuvant or a novel combination of adjuvants to augment T cell immunity in the blood and gut-associated lymphoid tissue in SIV-infected rhesus macaques. Animals that received DNA vaccines expressing SIV proteins, combined with plasmids expressing adjuvants designed to increase peripheral and mucosal T cell responses, including the catalytic subunit of the E. coli heat-labile enterotoxin, IL-12, IL-33, retinaldehyde dehydrogenase 2, soluble PD-1 and soluble CD80, were compared to mock-vaccinated controls. Following treatment interruption, macaques exhibited variable levels of viral rebound, with four animals from the vaccinated groups and one animal from the control group controlling virus at median levels of 10(3) RNA copies/ml or lower (controllers) and nine animals, among all groups, exhibiting immediate viral rebound and median viral loads greater than 10(3) RNA copies/ml (non-controllers). Although there was no significant difference between the vaccinated and control groups in protection from viral rebound, the variable virological outcomes during treatment interruption enabled an examination of immune correlates of viral replication in controllers versus non-controllers regardless of vaccination status. Lower viral burden in controllers correlated with increased polyfunctional SIV-specific CD8(+) T cells in mesenteric lymph nodes and blood prior to and during treatment interruption. Notably, higher frequencies of colonic CD4(+) T cells and lower Th17/Treg ratios prior to infection in controllers correlated with improved responses to ART and control of viral rebound. These results indicate that mucosal immune responses, present prior to infection, can influence efficacy of antiretroviral therapy and the outcome of immunotherapeutic vaccination, suggesting that therapies capable of modulating host mucosal responses may be needed to achieve HIV cure.	[Tunggal, Hillary Claire; Munson, Paul Veness; O'Connor, Megan Ashley; Dross, Sandra Elizabeth; Fuller, James Thomas; Fuller, Deborah Heydenburg] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Tunggal, Hillary Claire; Munson, Paul Veness; O'Connor, Megan Ashley; Hajari, Nika; Dross, Sandra Elizabeth; Bratt, Debra; Fuller, Deborah Heydenburg] Washington Natl Primate Res Ctr, Seattle, WA 98121 USA; [Bagley, Kenneth] Profectus Biosci, Baltimore, MD USA; [Munson, Paul Veness] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Bratt, Debra] Univ Georgia, Athens, GA 30602 USA; [Bagley, Kenneth] Orlance Inc, Baltimore, MD USA	University of Washington; University of Washington Seattle; University System of Georgia; University of Georgia	Fuller, DH (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.; Fuller, DH (corresponding author), Washington Natl Primate Res Ctr, Seattle, WA 98121 USA.	fullerdh@uw.edu		O'Connor, Megan/0000-0003-2127-5073; Fuller, Deborah/0000-0001-7315-2441	National Institutes of Health [T32-AI007140]; National Institute of Allergy and Infectious Diseases [R44AI110315, R01 AI104679]; Office of Research Infrastructure Programs [P51OD010425]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Research Infrastructure Programs	This work was supported with federal funds from the National Institutes of Health (www.nih.gov, T32-AI007140 to M.A.O.), the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov, R44AI110315 to K.B. and R01 AI104679 to D.H.F.), and the Office of Research Infrastructure Programs (orip.nih.gov, P51OD010425 to D.H.F.). During this study, K. B. was a paid employee of Profectus Biosciences and assisted in study design and participated in the review and editing of this manuscript. Apart from these specific roles, Profectus Biosciences did not have any additional role in the data collection, data analysis or decision to publish the manuscript. K.B. is currently a paid employee of Orlance Incorporation. Orlance did not provide any support for this study and was not involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other funders of this study provided support in the form of salaries for authors H.C.T., P.V.M., M.A.O., N.H., S.E.D., J.T.F., D.B., and D.H.F., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Bagley KC, 2002, INFECT IMMUN, V70, P5533, DOI 10.1128/IAI.70.10.5533-5539.2002; Bagley K, 2015, HUM VACC IMMUNOTHER, V11, P2228, DOI 10.1080/21645515.2015.1026498; Blasi M, 2020, NPJ VACCINES, V5, DOI 10.1038/s41541-020-0186-5; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Borducchi EN, 2016, NATURE, V540, P284, DOI 10.1038/nature20583; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buggert M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4526; Cassani B, 2012, MOL ASPECTS MED, V33, P63, DOI 10.1016/j.mam.2011.11.001; Cecchinato V, 2008, MUCOSAL IMMUNOL, V1, P279, DOI 10.1038/mi.2008.14; Chevalier MF, 2013, BLOOD, V121, P29, DOI 10.1182/blood-2012-07-409755; Douek Daniel, 2007, Top HIV Med, V15, P114; Ensoli B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00417; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Frater J, 2014, AIDS, V28, P699, DOI 10.1097/QAD.0000000000000130; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Fuller DH, 2006, VIROLOGY, V348, P200, DOI 10.1016/j.virol.2005.12.008; Fuller DH, 2002, J VIROL, V76, P3309, DOI 10.1128/JVI.76.7.3309-3317.2002; Garcia F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004682; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Holechek SA, 2016, VACCINE, V34, P5629, DOI 10.1016/j.vaccine.2016.09.013; Hong JJ, 2017, AIDS, V31, P1819, DOI 10.1097/QAD.0000000000001576; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Jalah R, 2012, HUM VACC IMMUNOTHER, V8, P1620, DOI 10.4161/hv.21407; Kalams SA, 2013, J INFECT DIS, V208, P818, DOI 10.1093/infdis/jit236; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Larijani MS, 2019, CURR HIV RES, V17, P75, DOI 10.2174/1570162X17666190618160608; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Lewis MG, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-21; Lim SY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000997; Lim SY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000738; Loffredo JT, 2007, J VIROL, V81, P8827, DOI 10.1128/JVI.00895-07; Loret EP, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0251-3; Makedonas G, 2006, SPRINGER SEMIN IMMUN, V28, P209, DOI 10.1007/s00281-006-0025-4; McBrien JB, 2018, EUR J IMMUNOL, V48, P898, DOI 10.1002/eji.201747172; McLaren JE, 2019, J IMMUNOL, V202, P943, DOI 10.4049/jimmunol.1701757; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mothe BR, 2003, J VIROL, V77, P2736, DOI 10.1128/JVI.77.4.2736-2740.2003; Munson P, 2018, HUM VACC IMMUNOTHER, V14, P1820, DOI 10.1080/21645515.2018.1448328; Nakamura-Hoshi M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68267-w; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; O'Connor MA, 2019, AIDS RES HUM RETROV, V35, P295, DOI [10.1089/aid.2018.0184, 10.1089/AID.2018.0184]; Pallikkuth S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003471; Pau AK, 2014, INFECT DIS CLIN N AM, V28, P371, DOI 10.1016/j.idc.2014.06.001; Peterson CW, 2013, J MED PRIMATOL, V42, P237, DOI 10.1111/jmp.12060; Pollard RB, 2014, LANCET INFECT DIS, V14, P291, DOI 10.1016/S1473-3099(13)70343-8; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Seddiki N, 2018, CURR OPIN HIV AIDS, V13, P119, DOI [10.1097/COH.0000000000000444, 10.1097/coh.0000000000000444]; Sneller MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8848; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Starke CE, 2020, J CLIN INVEST, V130, P789, DOI 10.1172/JCI129161; Strongin Z, 2020, J VIROL, V94, DOI 10.1128/JVI.00338-20; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Tung FY, 2016, VACCINE, V34, P2225, DOI 10.1016/j.vaccine.2016.03.021; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Villarreal DO, 2015, VACCINE, V33, P4313, DOI 10.1016/j.vaccine.2015.03.086; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Winstone N, 2011, J VIROL, V85, P9578, DOI 10.1128/JVI.05060-11; Yang QT, 2011, EUR J IMMUNOL, V41, P3351, DOI 10.1002/eji.201141629; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; Ziani W, 2021, J VIROL, V95, DOI 10.1128/JVI.02064-20; Zicari S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030200; zur Megede J, 2008, AIDS RES HUM RETROV, V24, P1103, DOI 10.1089/aid.2008.0055	73	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253265	10.1371/journal.pone.0253265	http://dx.doi.org/10.1371/journal.pone.0253265			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138927	Green Published, gold			2022-12-26	WOS:000671690200079
J	Zhu, HQ; Li, Q; Zhao, YL; Peng, H; Guo, LY; Zhu, J; Jiang, Z; Zeng, ZX; Xu, B; Chen, SS				Zhu, Hengqing; Li, Qing; Zhao, Yulan; Peng, Hong; Guo, Liangyun; Zhu, Jing; Jiang, Zi; Zeng, Zhaoxia; Xu, Bin; Chen, Sisi			Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation	ONCOGENE			English	Article							POLO-LIKE KINASES; VRK2; IDENTIFICATION; STABILIZATION; EPIDEMIOLOGY; ACCUMULATION; EXPRESSION; STABILITY; LIGASE; AURORA	As a key cell cycle regulator, polo-like kinase 1 (Plk1) has been recognized as a crucial factor involved in the progression of pancreatic cancer (PC). However, its regulatory mechanism is poorly understood. Here, we present evidence that Plk1 is a novel substrate of vaccinia-related kinase 2 (VRK2), a serine-threonine kinase that is highly expressed and predicts poor prognosis in PC. VRK2 phosphorylates Plk1 at threonine 210 and protects it from ubiquitin-dependent proteasomal degradation. We showed that mechanistically complement factor H-related protein (CFHR), as a major E3 ligase, promotes Plk1 degradation by ubiquitinating it at lysine 209. Phosphorylation of Plk1 at threonine 210 by VRK2 interferes with the interaction of Chfr with Plk1 and antagonizes Plk1 ubiquitination, thereby stabilizing the Plk1 protein. Taken together, our data reveal a mechanism of Plk1 overexpression in PC and provide evidence for targeting VRK2 as a potential therapeutic strategy.	[Zhu, Hengqing] Nanchang Univ, Dept Gen Surg, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Zhu, Hengqing] Zhejiang Univ, Dept Thyroid Surg, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China; [Li, Qing] Nanchang Univ, Dept Pathol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Zhao, Yulan] Zhejiang Univ, Dept Ultrasound Med, Affiliated Hosp 2, Sch Med, Hangzhou, Peoples R China; [Peng, Hong] 908th Hosp Chinese Peoples Liberat Army Joint, Dept Colorectal Surg, Nanchang, Jiangxi, Peoples R China; [Guo, Liangyun] Nanchang Univ, Dept Ultrasound, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Zhu, Jing; Jiang, Zi] Nanchang Univ, Dept Pharm, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Zeng, Zhaoxia] Nanchang Univ, Dept Radiol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China; [Xu, Bin] Nanchang Univ, Dept Burns, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Chen, Sisi] Nanchang Univ, Dept Neurol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China	Nanchang University; Zhejiang University; Nanchang University; Zhejiang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University; Nanchang University	Xu, B (corresponding author), Nanchang Univ, Dept Burns, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.; Chen, SS (corresponding author), Nanchang Univ, Dept Neurol, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China.	bxu1990@126.com; Cheinsee@163.com		Chen, Sisi/0000-0002-1908-5054	Scientific research and cultivation project of talents in the First Affiliated Hospital of Nanchang University [YFYPY202015]	Scientific research and cultivation project of talents in the First Affiliated Hospital of Nanchang University	This study was supported by the Scientific research and cultivation project of talents in the First Affiliated Hospital of Nanchang University (YFYPY202015).	Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Chen B, 2018, MOL MED REP, V18, P105, DOI 10.3892/mmr.2018.8941; de Carcer G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05429-5; Eckerdt F, 2005, J BIOL CHEM, V280, P36575, DOI 10.1074/jbc.M504548200; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Golsteyn R M, 1996, Prog Cell Cycle Res, V2, P107; Grimont A, 2015, GUT, V64, P1790, DOI 10.1136/gutjnl-2014-307075; Ilic M, 2016, WORLD J GASTROENTERO, V22, P9694, DOI 10.3748/wjg.v22.i44.9694; Jeong YH, 2018, J NEUROCHEM, V147, P609, DOI 10.1111/jnc.14562; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Kim JS, 2011, J BIOL CHEM, V286, P30615, DOI 10.1074/jbc.M111.231803; Kim S, 2015, MOL CELL BIOL, V35, P1754, DOI 10.1128/MCB.01325-14; Kim S, 2014, MOL CELL BIOL, V34, P643, DOI 10.1128/MCB.00756-13; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li J, 2016, CELL CYCLE, V15, P711, DOI 10.1080/15384101.2016.1148838; Lin QJ, 2015, WORLD J GASTROENTERO, V21, P7988, DOI 10.3748/wjg.v21.i26.7988; Liu ZX, 2017, TRANSL ONCOL, V10, P22, DOI 10.1016/j.tranon.2016.10.003; Mahajan UM, 2016, GUT, V65, P1838, DOI 10.1136/gutjnl-2016-311393; Mai J, 2019, THERANOSTICS, V9, P3541, DOI 10.7150/thno.32908; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; McGuigan A, 2018, WORLD J GASTROENTERO, V24, P4846, DOI 10.3748/wjg.v24.i43.4846; Monsalve DM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.40; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Shin CH, 2017, CELL DEATH DIFFER, V24, P1861, DOI 10.1038/cdd.2017.106; Shin SB, 2020, ONCOGENE, V39, P767, DOI 10.1038/s41388-019-1023-z; Song B, 2013, MOL CANCER THER, V12, P58, DOI 10.1158/1535-7163.MCT-12-0632; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tesli M, 2016, BRIT J PSYCHIAT, V209, P114, DOI 10.1192/bjp.bp.115.161950; Vazquez-Cedeira M, 2012, J BIOL CHEM, V287, P42739, DOI 10.1074/jbc.M112.404285; Wen DH, 2017, CELL REP, V21, P2147, DOI 10.1016/j.celrep.2017.10.085; Xiao DB, 2016, MOL CELL, V64, P493, DOI 10.1016/j.molcel.2016.09.016; Xin XF, 2019, ACS APPL MATER INTER, V11, P14647, DOI 10.1021/acsami.9b02756; Yabar CS, 2016, GASTROENTEROL CLIN N, V45, P429, DOI 10.1016/j.gtc.2016.04.003	39	4	4	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4663	4674		10.1038/s41388-021-01893-4	http://dx.doi.org/10.1038/s41388-021-01893-4		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34140642				2022-12-26	WOS:000662838900003
J	Sherman, J; Verstandig, G; Brumer, Y				Sherman, Jeff; Verstandig, Grant; Brumer, Yisroel			Application of machine learning to large in-vitro databases to identify cancer cell characteristics: telomerase reverse transcriptase (TERT) expression	ONCOGENE			English	Article								Advances in biotechnology and machine learning have created an enhanced environment for unearthing and exploiting previously unrecognized relationships between genomic and epigenetic data with potential therapeutic implications. We applied advanced algorithms to data from the Cancer Dependency Map to uncover increasingly complex relationships. Specifically, we investigate characteristics of tumor cell lines with varying levels of telomerase reverse transcriptase (TERT) expression in liver cancer. The findings indicate that the effect of CRISPR knockout of Histone Deacetylase 1 (HDAC1) and numerous individual respiratory complex I genes is strongly related to the level of TERT expression, with knockout being particularly efficacious at killing or inhibiting growth of tumor cells with low levels of TERT expression for HDAC1 and high levels for Complex I genes. These findings suggest key biomarkers for therapeutic efficacy and yield novel potential pathways for drug development and provide further proof of principle for the potential of artificial intelligence in oncology.	[Sherman, Jeff; Verstandig, Grant; Brumer, Yisroel] Zephyr AI, Washington, DC 20006 USA; [Sherman, Jeff; Verstandig, Grant; Brumer, Yisroel] Red Cell Partners, Washington, DC 20011 USA		Sherman, J (corresponding author), Zephyr AI, Washington, DC 20006 USA.; Sherman, J (corresponding author), Red Cell Partners, Washington, DC 20011 USA.	sherman@redcellpartners.com		Sherman, Jeff/0000-0003-1377-0357; Brumer, Yisroel/0000-0002-7046-0198				Amisaki M, 2019, CANCER SCI, V110, P550, DOI 10.1111/cas.13884; Bazaga A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67846-1; DepMap Broad, 2020, DEPMAP 21Q1 PUBL FIG, DOI [10.6084/m9.figshare.13681534.v1, DOI 10.6084/M9.FIGSHARE.13681534.V1]; Dezso Z, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3442-9; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Indran IR, 2011, CANCER RES, V71, P266, DOI 10.1158/0008-5472.CAN-10-1588; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Koh CM, 2015, J CLIN INVEST, V125, P2109, DOI 10.1172/JCI79134; Liu TT, 2016, GENES-BASEL, V7, DOI 10.3390/genes7070038; Madhukar NS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12928-6; Rosen J, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101543; Saretzki G, 2014, CURR PHARM DESIGN, V20, P6386, DOI 10.2174/1381612820666140630095606; Seynnaeve B, 2017, SCI REP-UK, V7, DOI 10.1038/srep45704; Sherman J, 2021, ONCOGENE, V40, P3766, DOI 10.1038/s41388-021-01807-4; Shimada K, 2019, TOOL BROWSING CANC D, DOI 10.1101/2019.12.13.874776v1; Travis J, 2015, SCIENCE, V350, P1456, DOI 10.1126/science.350.6267.1456; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Urra FA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00118; Yuan XT, 2019, ONCOGENE, V38, P6172, DOI 10.1038/s41388-019-0872-9; Yuan XT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133338	20	2	2	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					5038	5041		10.1038/s41388-021-01894-3	http://dx.doi.org/10.1038/s41388-021-01894-3		JUN 2021	4	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34135463				2022-12-26	WOS:000662140500001
J	Frost, J; Rocha, S; Ciulli, A				Frost, Julianty; Rocha, Sonia; Ciulli, Alessio			Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; HIF-ALPHA; HYPOXIA; GENE; EXPRESSION; COMPLEX; OPTIMIZATION; DEGRADATION; THERAPY; PRODUCT	Von Hippel-Lindau (VHL) disease is characterized by frequent mutation of VHL protein, a tumor suppressor that functions as the substrate recognition subunit of a Cullin2 RING E3 ligase complex (CRL2(VHL)). CRL2(VHL) plays important roles in oxygen sensing by targeting hypoxia-inducible factor-alpha (HIF-alpha) subunits for ubiquitination and degradation. VHL is also commonly hijacked by bifunctional molecules such as proteolysis-targeting chimeras to induce degradation of target molecules. We previously reported the design and characterization of VHL inhibitors VH032 and VH298 that block the VHL:HIF-alpha interaction, activate the HIF transcription factor, and induce a hypoxic response, which can be beneficial to treat anemia and mitochondrial diseases. How these compounds affect the global cellular proteome remains unknown. Here, we use unbiased quantitative MS to identify the proteomic changes elicited by the VHL inhibitor compared with hypoxia or the broad-spectrum prolyl-hydroxylase domain enzyme inhibitor IOX2. Our results demonstrate that VHL inhibitors selectively activate the HIF response similar to the changes induced in hypoxia and IOX2 treatment. Interestingly, VHL inhibitors were found to specifically upregulate VHL itself. Our analysis revealed that this occurs via protein stabilization of VHL isoforms and not via changes in transcript levels. Increased VHL levels upon VH298 treatment resulted in turn in reduced levels of HIF-1 alpha protein. This work demon-strates the specificity of VHL inhibitors and reveals different antagonistic effects upon their acute versus prolonged treatment in cells. These findings suggest that therapeutic use of VHL inhibitors may not produce overt side effects from HIF stabilization as previously thought.	[Frost, Julianty; Ciulli, Alessio] Div Biol Chem & Drug Discovery, Dundee, Scotland; [Frost, Julianty; Rocha, Sonia] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland; [Frost, Julianty; Rocha, Sonia] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol Physiol & Cell Signalling, Liverpool, Merseyside, England	University of Dundee; University of Liverpool	Ciulli, A (corresponding author), Div Biol Chem & Drug Discovery, Dundee, Scotland.; Rocha, S (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.; Rocha, S (corresponding author), Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol Physiol & Cell Signalling, Liverpool, Merseyside, England.	srocha@liverpool.ac.uk; a.ciulli@dundee.ac.uk	Ciulli, Alessio/A-6279-2011	Ciulli, Alessio/0000-0002-8654-1670; Frost, Julianty/0000-0001-8209-2575	Wellcome Trust [102398]; European Research Council [ERC-2012-StG-311460]; Cancer Research UK [C99667/A12918]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by the Wellcome Trust through a PhD Studentship to J. F. (102398), the European Research Council through a Starting Grant to A. C. (ERC-2012-StG-311460 DrugE3CRLs), and Cancer Research UK through a Senior Fellowship to S. R. (C99667/A12918).	Batie M, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020047; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; BORST P, 1991, ACTA ONCOL, V30, P87, DOI 10.3109/02841869109091819; Cardote TAF, 2017, STRUCTURE, V25, P901, DOI 10.1016/j.str.2017.04.009; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Frost Julianty, 2019, Wellcome Open Res, V4, P17, DOI 10.12688/wellcomeopenres.15044.1; Frost J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13312; Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/NCHEMBIO.2329, 10.1038/nchembio.2329]; Galdeano C, 2014, J MED CHEM, V57, P8657, DOI 10.1021/jm5011258; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Girardini M, 2019, BIOORGAN MED CHEM, V27, P2466, DOI 10.1016/j.bmc.2019.02.048; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; Hasanov E, 2017, ONCOGENE, V36, P3450, DOI 10.1038/onc.2016.495; Hasegawa S, 2018, CURR OPIN NEPHROL HY, V27, P331, DOI 10.1097/MNH.0000000000000431; Hsu T, 2012, ONCOGENE, V31, P2247, DOI 10.1038/onc.2011.442; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Khan S, 2019, NAT MED, V25, P1938, DOI 10.1038/s41591-019-0668-z; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Labrousse-Arias D, 2017, J CELL BIOL, V216, P835, DOI 10.1083/jcb.201608024; Lai YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016975; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maniaci C, 2019, CURR OPIN CHEM BIOL, V52, P145, DOI 10.1016/j.cbpa.2019.07.003; Maniaci C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00954-1; Mayer-Kuckuk P, 2002, P NATL ACAD SCI USA, V99, P3400, DOI 10.1073/pnas.062036899; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Pettersson Mariell, 2019, Drug Discov Today Technol, V31, P15, DOI 10.1016/j.ddtec.2019.01.002; Qiu S, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/1897174; Qiu S, 2018, BIOCHEM BIOPH RES CO, V505, P1063, DOI 10.1016/j.bbrc.2018.09.172; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Rubio S, 2014, J PLANT PHYSIOL, V171, P373, DOI 10.1016/j.jplph.2013.11.009; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Shenoy N, 2016, ANN ONCOL, V27, P1685, DOI 10.1093/annonc/mdw241; Soares P, 2018, J MED CHEM, V61, P599, DOI 10.1021/acs.jmedchem.7b00675; Tovell H, 2019, ACS CHEM BIOL, V14, P2024, DOI 10.1021/acschembio.9b00505; Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015; Varshney N, 2017, J KIDNEY CANCER VHL, V4, P20, DOI 10.15586/jkcvhl.2017.88; Verma R, 2020, MOL CELL, V77, P446, DOI 10.1016/j.molcel.2020.01.010; Wang YX, 2016, CANCER LETT, V383, P1, DOI 10.1016/j.canlet.2016.09.009; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang J, 2018, SCIENCE, V361, P290, DOI 10.1126/science.aap8411; Zhang J, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010035	51	2	2	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100910	10.1016/j.jbc.2021.100910	http://dx.doi.org/10.1016/j.jbc.2021.100910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34174286	gold, Green Published			2022-12-26	WOS:000690873500007
J	Parrot, C; Moulinier, L; Bernard, F; Hashem, Y; Dupuy, D; Sissler, M				Parrot, Camila; Moulinier, Luc; Bernard, Florian; Hashem, Yaser; Dupuy, Denis; Sissler, Marie			Peculiarities of aminoacyl-tRNA synthetases from trypanosomatids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; SEQUENCE; BINDING; BRUCEI; DOMAIN; ATP	Trypanosomatid parasites are responsible for various human diseases, such as sleeping sickness, animal trypanosomiasis, or cutaneous and visceral leishmaniases. The few available drugs to fight related parasitic infections are often toxic and present poor efficiency and specificity, and thus, finding new molecular targets is imperative. Aminoacyl-tRNA synthetases (aaRSs) are essential components of the translational machinery as they catalyze the specific attachment of an amino acid onto cognate tRNA(s). In trypanosomatids, one gene encodes both cytosolicand mitochondrial-targeted aaRSs, with only three exceptions. We identify here a unique specific feature of aaRSs from trypanosomatids, which is that most of them harbor distinct insertion and/or extension sequences. Among the 26 identified aaRSs in the trypanosome Leishmania tarentolae, 14 contain an additional domain or a terminal extension, confirmed in mature mRNAs by direct cDNA nanopore sequencing. Moreover, these RNA-Seq data led us to address the question of aaRS dual localization and to determine splice-site locations and the 50-UTR lengths for each mature aaRS-encoding mRNA. Altogether, our results provided evidence for at least one specific mechanism responsible for mitochondrial addressing of some L. tarentolae aaRSs. We propose that these newly identified features of trypanosomatid aaRSs could be developed as relevant drug targets to combat the diseases caused by these parasites.	[Parrot, Camila; Bernard, Florian; Hashem, Yaser; Dupuy, Denis; Sissler, Marie] Univ Bordeaux, IECB, U1212 INSERM, ARNA,UMR5320,CNRS, Pessac, France; [Moulinier, Luc] Univ Strasbourg, CNRS, ICube Lab, CSTB Complex Syst & Translat Bioinformat, Strasbourg, France; [Moulinier, Luc] Univ Strasbourg, CNRS, Strasbourg Federat Translat Med FMTS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sissler, M (corresponding author), Univ Bordeaux, IECB, U1212 INSERM, ARNA,UMR5320,CNRS, Pessac, France.	m.sissler@iecb.u-bordeaux.fr		SISSLER, Marie/0000-0001-8594-5238; Bernard, Florian/0000-0003-2691-3871; Parrot, Camila/0000-0002-9495-2015	University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux	University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux	C. P. was supported by the University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BEDOUELLE H, 1993, BIOCHIMIE, V75, P1099, DOI 10.1016/0300-9084(93)90009-H; Bullwinkle TJ, 2014, TOP CURR CHEM, V344, P43, DOI 10.1007/128_2013_423; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Chadha S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006575; Chung S, 2020, MOL CELLS, V43, P350, DOI 10.14348/molcells.2020.2287; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frechin M, 2009, RNA BIOL, V6, P31, DOI 10.4161/rna.6.1.7564; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Gianchecchi E, 2020, EXPERT REV ANTI-INFE, V18, P563, DOI 10.1080/14787210.2020.1751611; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Hamilton V, 2014, EUKARYOT CELL, V13, P539, DOI 10.1128/EC.00312-13; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; Kaser S, 2018, MOL BIOCHEM PARASIT, V221, P52, DOI 10.1016/j.molbiopara.2018.03.004; Kalidas S, 2014, EUKARYOT CELL, V13, P504, DOI 10.1128/EC.00017-14; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kelly P, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007983; Kim HS, 2014, FEBS LETT, V588, P2328, DOI 10.1016/j.febslet.2014.05.027; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Koh CY, 2015, ACTA CRYSTALLOGR D, V71, P1684, DOI 10.1107/S1399004715007683; Kwon NH, 2019, NAT REV DRUG DISCOV, V18, P629, DOI 10.1038/s41573-019-0026-3; Larson ET, 2011, J MOL BIOL, V409, P159, DOI 10.1016/j.jmb.2011.03.026; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; McLachlan G., 2000, WILEY SER PROB STAT; Mekonnen G, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006790; Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277; Ognjenovic J, 2016, NUCLEIC ACIDS RES, V44, P3420, DOI 10.1093/nar/gkw082; Park JS, 2018, INT J BIOL MACROMOL, V120, P835, DOI 10.1016/j.ijbiomac.2018.08.171; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Simpson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003841; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Torres-Larios A, 2003, J MOL BIOL, V331, P201, DOI 10.1016/S0022-2836(03)00719-8; Torrie LS, 2020, ACS INFECT DIS, V6, P1044, DOI 10.1021/acsinfecdis.9b00453; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wicker N, 2002, NUCLEIC ACIDS RES, V30, P3992, DOI 10.1093/nar/gkf511; Xu XL, 2018, RNA BIOL, V15, P649, DOI 10.1080/15476286.2017.1377868; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Zhang ZS, 2020, RSC MED CHEM, V11, P885, DOI 10.1039/d0md00057d; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; 2006, P NATL ACAD SCI USA, V103, P6847	62	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100913	10.1016/j.jbc.2021.100913	http://dx.doi.org/10.1016/j.jbc.2021.100913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34175310	Green Published, gold			2022-12-26	WOS:000690879300014
J	Chan, KHK; Hsu, YH; Yang, X; Goto, A; Chen, BH				Chan, Kei Hang Katie; Hsu, Yi-Hsiang; Yang, Xia; Goto, Atsushi; Chen, Brian H.			The 2020 FASEB virtual Catalyst Conference on Integrative Approach for Complex Diseases Prevention and Management and Beyond, December 16, 2020	FASEB JOURNAL			English	Editorial Material									[Chan, Kei Hang Katie] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Chan, Kei Hang Katie] City Univ Hong Kong, Dept Elect Engn, Hong Kong, Peoples R China; [Chan, Kei Hang Katie] Brown Univ, Ctr Global Cardiometabol Hlth, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Chan, Kei Hang Katie] Brown Univ, Warren Alpert Sch Med, Dept Med, Providence, RI 02912 USA; [Chan, Kei Hang Katie] Brown Univ, Warren Alpert Sch Med, Dept Surg, Providence, RI 02912 USA; [Hsu, Yi-Hsiang] Inst Aging Res, Hebrew SeniorLife, Boston, MA USA; [Hsu, Yi-Hsiang] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Yang, Xia] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Goto, Atsushi] Yokohama City Univ, Grad Sch Data Sci, Dept Hlth Data Sci, Yokohama, Japan; [Goto, Atsushi] Natl Canc Ctr, Ctr Publ Hlth Sci, Epidemiol & Prevent Grp, Tokyo, Japan; [Chen, Brian H.] Univ Calif San Diego, Herbert Wertheim Sch Publ Hlth & Human Longevher, La Jolla, CA 92093 USA; [Chen, Brian H.] FOXO Technol Inc, Minneapolis, MN USA	City University of Hong Kong; City University of Hong Kong; Brown University; Brown University; Brown University; Harvard University; Hebrew SeniorLife; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles; Yokohama City University; National Cancer Center - Japan; University of California System; University of California San Diego	Chan, KHK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, TYB-1A-315,3-F,Yuen Bldg,31 To Yuen St,Kowloon, Hong Kong, Peoples R China.	kkhchan@cityu.edu.hk	Goto, Atsushi/AAE-4863-2022	Goto, Atsushi/0000-0003-0669-654X; Chan, Kei Hang Katie/0000-0001-9070-5394	City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC); Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China)	City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC)(City University of Hong Kong); Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China)	Special thanks to all the speakers, the FASEB team (Dr. Hannah V. Carey, Ms. Andrea Bauerfeind, Ms. Ying Zhu, and their team members), and to all attendees for their genuine support throughout the organization and duration of the CC. K.K.C. is supported by grants from City University of Hong Kong (Hong Kong SAR, China) New Research Initiatives/Infrastructure Support from Central (APRC) and Hong Kong Innovation and Technology Fund (ITF) (Hong Kong SAR, China). B.H.C. is an employee of FOXO Technologies, Inc. (Minneapolis, MN, USA).		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21500	10.1096/fj.202100317	http://dx.doi.org/10.1096/fj.202100317			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165815				2022-12-26	WOS:000667814100003
J	Guerrero-Santoro, J; Khor, JM; Acikbas, AH; Jaynes, JB; Ettensohn, CA				Guerrero-Santoro, Jennifer; Khor, Jian Ming; Acikbas, Ayse Haruka; Jaynes, James B.; Ettensohn, Charles A.			Analysis of the DNA-binding properties of Alx1, an evolutionarily conserved regulator of skeletogenesis in echinoderms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS HOMEODOMAIN PROTEINS; PAIRED-LIKE HOMEOPROTEIN; GENETIC INTERACTIONS; FUNCTIONAL DOMAINS; TRANSCRIPTION; CART1; NETWORK; DIMERIZATION; SPECIFICITY; MUTANT	Alx1, a homeodomain-containing transcription factor, is a highly conserved regulator of skeletogenesis in echinoderms. In sea urchins, Alx1 plays a central role in the differentiation of embryonic primary mesenchyme cells (PMCs) and positively regulates the transcription of most biomineralization genes expressed by these cells. The alx1 gene arose via duplication and acquired a skeletogenic function distinct from its paralog (alx4) through the exonization of a 41-amino acid motif (the D2 domain). Alx1 and Alx4 contain glutamine-50 paired-type homeodomains, which interact preferentially with palindromic binding sites in vitro. Chromatin immunoprecipitation sequencing (ChIP-seq) studies have shown, however, that Alx1 binds both to palindromic and half sites in vivo. To address this apparent discrepancy and explore the function of the D2 domain, we used an endogenous cis-regulatory module associated with Sp-mtmmpb, a gene that encodes a PMC-specific metalloprotease, to analyze the DNA-binding properties of Alx1. We find that Alx1 forms dimeric complexes on TAAT-containing half sites by a mechanism distinct from the well-known mechanism of dimerization on palindromic sites. We used transgenic reporter assays to analyze the functional roles of half sites in vivo and demonstrate that two sites with partially redundant functions are essential for the PMC-specific activity of the Sp-mtmmpb cis-regulatory module. Finally, we show that the D2 domain influences the DNA-binding properties of Alx1 in vitro, suggesting that the exonization of this motif may have facilitated the acquisition of new transcriptional targets and consequently a novel developmental function.	[Guerrero-Santoro, Jennifer; Khor, Jian Ming; Acikbas, Ayse Haruka; Ettensohn, Charles A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Jaynes, James B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Carnegie Mellon University; Jefferson University	Ettensohn, CA (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	jsantoro@andrew.cmu.edu; ettensohn@cmu.edu		Khor, Jian Ming/0000-0002-1428-6770; Oshima Acikbas, Ayse Haruka/0000-0001-9581-4506	National Science Foundation [IOS-1354973]; National Institutes of Health [R24-OD023046, R01-GM117458]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Science Foundation (IOS-1354973, to C. A. E.) and the National Institutes of Health (R24-OD023046 to C. A. E. and R01-GM117458 to J. B. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschuler Sarah E, 2013, J Nucleic Acids Investig, V4, P19; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bertola DR, 2013, AM J MED GENET A, V161A, P600, DOI 10.1002/ajmg.a.35762; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bobola N, 2017, CURR OPIN GENET DEV, V43, P1, DOI 10.1016/j.gde.2016.09.008; Cai RL, 1998, BIOCHEM BIOPH RES CO, V250, P305, DOI 10.1006/bbrc.1998.9257; Capellini TD, 2010, DEVELOPMENT, V137, P2559, DOI 10.1242/dev.048819; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Czarkwiani A, 2013, GENE EXPR PATTERNS, V13, P464, DOI 10.1016/j.gep.2013.09.002; Dee CT, 2013, HUM MOL GENET, V22, P239, DOI 10.1093/hmg/dds423; El-Ruby M, 2018, AM J MED GENET A, V176, P1190, DOI 10.1002/ajmg.a.38655; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Erkenbrack EM, 2015, P NATL ACAD SCI USA, V112, pE4075, DOI 10.1073/pnas.1509845112; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Farley EK, 2016, P NATL ACAD SCI USA, V113, P6508, DOI 10.1073/pnas.1605085113; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Gao F, 2015, DEV BIOL, V400, P148, DOI 10.1016/j.ydbio.2015.01.017; Hughes AEO, 2018, GENOME RES, V28, P1520, DOI 10.1101/gr.231886.117; Iioka T, 2003, J BONE MINER RES, V18, P1419, DOI 10.1359/jbmr.2003.18.8.1419; Khor JM, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.569314; Khor JM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.180653; Khor JM, 2017, ELIFE, V6, DOI 10.7554/eLife.32728; Koga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149067; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Matsumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068774; McCauley BS, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-17; Merabet S, 2016, TRENDS GENET, V32, P334, DOI 10.1016/j.tig.2016.03.004; Mirasierra M, 2006, MOL ENDOCRINOL, V20, P2876, DOI 10.1210/me.2005-0472; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; Qu SM, 1999, DEVELOPMENT, V126, P359; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; Shashikant T, 2018, GENESIS, V56, DOI 10.1002/dvg.23253; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Ullah A, 2017, CLIN GENET, V91, P494, DOI 10.1111/cge.12822; Uz E, 2010, AM J HUM GENET, V86, P789, DOI 10.1016/j.ajhg.2010.04.002; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275	45	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100901	10.1016/j.jbc.2021.100901	http://dx.doi.org/10.1016/j.jbc.2021.100901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157281	Green Published, gold			2022-12-26	WOS:000678068400090
J	Harwood, SL; Nielsen, NS; Diep, K; Jensen, KT; Nielsen, PK; Yamamoto, K; Enghild, JJ				Harwood, Seandean Lykke; Nielsen, Nadia Sukusu; Diep, Khang; Jensen, Kathrine Tejlgard; Nielsen, Peter Kresten; Yamamoto, Kazuhiro; Enghild, Jan J.			Development of selective protease inhibitors via engineering of the bait region of human alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; HUMAN ALPHA-2-MACROGLOBULIN; STRUCTURAL BASIS; PROTEOLYTIC ACTIVITIES; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; CLEAVAGE SITES; COMPONENT C4; HUMAN PLASMA; FAST FORMS	Human alpha(2)-macroglobulin (A2M) is an abundant protease inhibitor in plasma, which regulates many proteolytic processes and is involved in innate immunity. A2M's unique protease-trapping mechanism of inhibition is initiated when a protease cleaves within the exposed and highly susceptible "bait region." As the wild-type bait region is permissive to cleavage by most human proteases, A2M is accordingly a broad-spectrum protease inhibitor. In this study, we extensively modified the bait region in order to identify any potential functionally important elements in the bait region sequence and to engineer A2M proteins with restrictive bait regions, which more selectively inhibit a target protease. A2M in which the bait region was entirely replaced by glycine-serine repeats remained fully functional and was not cleaved by any tested protease. Therefore, this bait region was designated as the "tabula rasa" bait region and used as the starting point for further bait region engineering. Cleavage of the tabula rasa bait region by specific proteases was conveyed by the insertion of appropriate substrate sequences, e.g., basic residues for trypsin. Screening and optimization of tabula rasa bait regions incorporating matrix metalloprotease 2 (MMP2) substrate sequences produced an A2M that was specifically cleaved by MMPs and inhibited MMP2 cleavage activity as efficiently as wild-type A2M. We propose that this approach can be used to develop A2M-based protease inhibitors, which selectively inhibit target proteases, which might be applied toward the clinical inhibition of dys-regulated proteolysis as occurs in arthritis and many types of cancer.	[Harwood, Seandean Lykke; Nielsen, Nadia Sukusu; Diep, Khang; Jensen, Kathrine Tejlgard; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Harwood, Seandean Lykke; Nielsen, Peter Kresten] Novo Nordisk AS, Global Res Technol, Malov, Denmark; [Yamamoto, Kazuhiro] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England	Aarhus University; Novo Nordisk; University of Liverpool	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	jje@mbg.au.dk		Enghild, Jan Johannes/0000-0001-9292-9172; Harwood, Seandean Lykke/0000-0003-4654-8832	Velux Fonden [00014557]; Danish Council for Independent Research-Medical Science [DFF-4004-00471]; LEO Foundation; Novo Nordisk Foundation (BIO-MS); Versus Arthritis Career Development Fellowship [21447]	Velux Fonden(Velux Fonden); Danish Council for Independent Research-Medical Science(Det Frie Forskningsrad (DFF)); LEO Foundation(LEO Pharma); Novo Nordisk Foundation (BIO-MS); Versus Arthritis Career Development Fellowship	J. J. E. is supported by the Velux Fonden (00014557), the Danish Council for Independent Research-Medical Science (DFF-4004-00471), the LEO Foundation, and the Novo Nordisk Foundation (BIO-MS). K. Y. is supported by Versus Arthritis Career Development Fellowship (Grant 21447).	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arbelaez LF, 1997, ARCH BIOCHEM BIOPHYS, V347, P62, DOI 10.1006/abbi.1997.0309; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BOISSET N, 1993, J MOL BIOL, V232, P522, DOI 10.1006/jmbi.1993.1408; Bond JS, 2019, J BIOL CHEM, V294, P1643, DOI 10.1074/jbc.TM118.004156; BORTH W, 1994, ANN NY ACAD SCI, V737, P267, DOI 10.1111/j.1749-6632.1994.tb44317.x; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; BRETAUDIERE JP, 1988, P NATL ACAD SCI USA, V85, P1437, DOI 10.1073/pnas.85.5.1437; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; CHRISTENSEN U, 1984, BIOCHEMISTRY-US, V23, P6619, DOI 10.1021/bi00321a052; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; ELLIS V, 1982, BIOCHIM BIOPHYS ACTA, V701, P24; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ENGHILD JJ, 1989, J BIOL CHEM, V264, P8779; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; GETTINS P, 1986, BIOCHEMISTRY-US, V25, P5011, DOI 10.1021/bi00366a007; Gron H, 1997, J PERIODONTAL RES, V32, P61, DOI 10.1111/j.1600-0765.1997.tb01383.x; HALL PK, 1981, BIOCHEM BIOPH RES CO, V100, P8, DOI 10.1016/S0006-291X(81)80055-1; HARPEL PC, 1970, J EXP MED, V132, P329, DOI 10.1084/jem.132.2.329; Harwood SL, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100090; Harwood SL, 2020, BIOCHEMISTRY-US, V59, P4799, DOI 10.1021/acs.biochem.0c00803; Harwood SL, 2020, J BIOL CHEM, V295, P16732, DOI 10.1074/jbc.RA120.015694; HOWELL JB, 1983, ARCH BIOCHEM BIOPHYS, V221, P261, DOI 10.1016/0003-9861(83)90143-1; Ikai A, 1999, CYTOTECHNOLOGY, V31, P53, DOI 10.1023/A:1008011919876; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Keil B., 1971, ENZYMES, V3, P249, DOI [10.1016/S1874-6047(08)60399-6., 10.1021/bi00843a047, DOI 10.1021/BI00843A047]; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Laronha H, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050717; Levin M, 2017, BBA-MOL CELL RES, V1864, P1927, DOI 10.1016/j.bbamcr.2017.06.009; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; MEIER UC, 1991, BIOL CHEM H-S, V372, P1051, DOI 10.1515/bchm3.1991.372.2.1051; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; NAGASE H, 1983, J BIOL CHEM, V258, P7490; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Raymond WW, 2009, J IMMUNOL, V182, P5770, DOI 10.4049/jimmunol.0900127; Razai AS, 2020, J BIOL CHEM, V295, P2464, DOI 10.1074/jbc.RA119.011712; ROCHE PA, 1987, BIOCHEMISTRY-US, V26, P486, DOI 10.1021/bi00376a021; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; SALVESEN G, 1993, METHOD ENZYMOL, V223, P121; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SOTTRUPJENSEN L, 1983, ANN NY ACAD SCI, V421, P188, DOI 10.1111/j.1749-6632.1983.tb18109.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; VANLEUVEN F, 1988, J BIOL CHEM, V263, P468; VANROMPAEY L, 1995, BIOCHEM J, V312, P191, DOI 10.1042/bj3120191; VanRompaey L, 1997, BIOCHEM J, V326, P507; VIRCA GD, 1984, J BIOL CHEM, V259, P8870; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zhang Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1363-4	68	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100879	10.1016/j.jbc.2021.100879	http://dx.doi.org/10.1016/j.jbc.2021.100879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139236	gold, Green Published			2022-12-26	WOS:000678068400078
J	Combs, IR; Studivan, MS; Eckert, RJ; Voss, JD				Combs, Ian R.; Studivan, Michael S.; Eckert, Ryan J.; Voss, Joshua D.			Quantifying impacts of stony coral tissue loss disease on corals in Southeast Florida through surveys and 3D photogrammetry	PLOS ONE			English	Article							BLACK BAND DISEASE; REEF FISH; OUTBREAK; MORTALITY; DYNAMICS; DRIVERS; METRICS; AREA	Since 2014, stony coral tissue loss disease (SCTLD) has contributed to substantial declines of reef-building corals in Florida. The emergence of this disease, which impacts over 20 scleractinian coral species, has generated a need for widespread reef monitoring and the implementation of novel survey and disease mitigation strategies. This study paired SCTLD prevalence assessments with colony-level monitoring to help improve understanding of disease dynamics on both individual coral colonies and at reef-wide scales. Benthic surveys were conducted throughout the northern Florida Reef Tract to monitor the presence/absence of disease, disease prevalence, and coral species affected by SCTLD. Observed SCTLD prevalence was lower in Jupiter and Palm Beach than in Lauderdale-by-the-Sea or St. Lucie Reef, but there were no significant changes in prevalence over time. To assess colony-level impacts of the disease, we optimized a low-cost, rapid 3D photogrammetry technique to fate-track infected Montastraea cavernosa coral colonies over four time points spanning nearly four months. Total colony area and healthy tissue area on fate-tracked colonies decreased significantly over time. However disease lesion area did not decrease over time and was not correlated with total colony area. Taken together these results suggest that targeted intervention efforts on larger colonies may maximize preservation of coral cover. Traditional coral surveys combined with 3D photogrammetry can provide greater insights into the spatiotemporal dynamics and impacts of coral diseases on individual colonies and coral communities than surveys or visual estimates of disease progression alone.	[Combs, Ian R.; Studivan, Michael S.; Eckert, Ryan J.; Voss, Joshua D.] Florida Atlantic Univ, Oceanog Inst, Harbor Branch, Dept Biol Sci, Ft Pierce, FL 34946 USA; [Combs, Ian R.] Mote Marine Lab, Elizabeth Moore Int Ctr Coral Reef Res & Restorat, Sarasota, FL 34236 USA; [Studivan, Michael S.] Univ Miami, Cooperat Inst Marine & Atmospher Studies, Miami, FL USA	Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; Mote Marine Laboratory & Aquarium; University of Miami	Combs, IR (corresponding author), Florida Atlantic Univ, Oceanog Inst, Harbor Branch, Dept Biol Sci, Ft Pierce, FL 34946 USA.; Combs, IR (corresponding author), Mote Marine Lab, Elizabeth Moore Int Ctr Coral Reef Res & Restorat, Sarasota, FL 34236 USA.	combsi9892@gmail.com	Eckert, Ryan J/R-5600-2018	Eckert, Ryan J/0000-0002-3010-9395; Studivan, Michael/0000-0002-3771-0415; Combs, Ian/0000-0002-6765-0011	Florida Department of Environmental Protection [B430E1, B55008]; Environmental Protection Agency (South Florida Geographic Initiative award) [X7 00D667-17]; NOAA Coral Reef Conservation Program [NA16NOS4820052]; Harbor Branch Oceanographic Institute Foundation through the Indian River Lagoon Graduate Research Fellowship	Florida Department of Environmental Protection; Environmental Protection Agency (South Florida Geographic Initiative award); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Harbor Branch Oceanographic Institute Foundation through the Indian River Lagoon Graduate Research Fellowship	Funding for this research was awarded to Dr. Joshua D Voss from the Florida Department of Environmental Protection (awards B430E1 and B55008), the Environmental Protection Agency (South Florida Geographic Initiative award X7 00D667-17. Mr. Jeff Beal co-PI), and the NOAA Coral Reef Conservation Program (award NA16NOS4820052). Additional funding was awarded to Mr. Ian R Combs by the Harbor Branch Oceanographic Institute Foundation through the Indian River Lagoon Graduate Research Fellowship.	Aeby GS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00678; Alvarez-Filip L, 2019, PEERJ, V7, DOI 10.7717/peerj.8069; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; Beal J., 2012, T911 USFWS; Brandt ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057164; BROWN DC, 1971, PHOTOGRAMM ENG, V37, P855; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Burns JHR, 2015, INT ARCH PHOTOGRAMM, V45, P61, DOI 10.5194/isprsarchives-XL-5-W5-61-2015; Bythell JC, 2001, CORAL REEFS, V20, P193; Cocito S, 2003, J EXP MAR BIOL ECOL, V297, P57, DOI 10.1016/S0022-0981(03)00369-1; Combs IR., 2021, ICOMBS2017 ANAL 3D M, DOI [10.5281/zenodo.4728238, DOI 10.5281/ZENODO.4728238]; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; Cunning R, 2019, MAR POLLUT BULL, V145, P185, DOI 10.1016/j.marpolbul.2019.05.027; Dalton SJ, 2006, CORAL REEFS, V25, P37, DOI 10.1007/s00338-005-0039-8; Ferrari R., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Figueira W, 2015, REMOTE SENS-BASEL, V7, P16883, DOI 10.3390/rs71215859; Frias-Lopez J, 2003, APPL ENVIRON MICROB, V69, P2409, DOI 10.1128/AEM.69.4.2409-2413.2003; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gilliam DS, 2015, RM085 FLOR DEP, P43; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gutierrez-Heredia L, 2015, LIMNOL OCEANOGR-METH, V13, P178, DOI 10.1002/lom3.10017; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Jones NP., 2018, SPATIOTEMPORAL CHANG, P1; Landsberg JH, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.576013; Lange ID, 2020, METHODS ECOL EVOL, V11, P714, DOI 10.1111/2041-210X.13388; Lavy A, 2015, METHODS ECOL EVOL, V6, P521, DOI 10.1111/2041-210X.12331; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; Martinez, 2020, PAIRWISEADONIS PAIRW; McClanahan TR, 1998, ENVIRON CONSERV, V25, P122, DOI 10.1017/S0376892998000174; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Meiling S, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.597643; Meyer JL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02244; Miller AW, 2015, MAR ECOL-EVOL PERSP, V36, P278, DOI 10.1111/maec.12142; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Muller EM., 2020, FRONT MICROBIOL, V11, P1, DOI [10.3389/fmicb.2020.00001, DOI 10.3389/FMICB.2020.00001]; Muller EM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00163; Muller EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110759; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Neely K., 2018, FY 2018 INSITU DIS I; Neely K., 2020, 20192020 FY; Neely K., 2018, EXSITU DIS TREATMENT; NOAA, 2018, FLOR KEYS NATL MAR S; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Oksanen A.J., 2012, COMMUNITY ECOLOGY PA, V263; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Pohlert T., 2020, PMCMRPLUS CALCULATE, DOI [10.1007/s11356-019-07314-0, DOI 10.1007/S11356-019-07314-0]; Pohlert T., 2014, PAIRWISE MULTIPLE CO; Precht WF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31374; R Core Team, 2020, R LANG ENV STAT COMP; Richardson LL, 1998, REV BIOL TROP, V46, P187; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Roberts KE, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007185; Roth L., 2020, CARIBBEAN SCTLD DASH; Ruiz-Morenol D, 2012, DIS AQUAT ORGAN, V100, P249, DOI 10.3354/dao02488; Selig ER., 2011, ANAL RELATIONSHIP OC, P111, DOI [10.1029/61ce07, DOI 10.1029/61CE07]; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; SMITH SV, 1978, NATURE, V273, P225, DOI 10.1038/273225a0; Voss JD, 2006, DIS AQUAT ORGAN, V69, P33, DOI 10.3354/dao069033; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Walker B.K., 2018, SE FLORIDA REEF WIDE; Walker BK., 2018, SE FLORIDA LARGE 2 M; Walton CJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00323; Weil E, 2009, DIS AQUAT ORGAN, V87, P45, DOI 10.3354/dao02103; Westoby MJ, 2012, GEOMORPHOLOGY, V179, P300, DOI 10.1016/j.geomorph.2012.08.021; YAMAMURO M, 1995, LIMNOL OCEANOGR, V40, P617, DOI 10.4319/lo.1995.40.3.0617; Young GC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201847	68	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252593	10.1371/journal.pone.0252593	http://dx.doi.org/10.1371/journal.pone.0252593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170916	Green Published, gold			2022-12-26	WOS:000671694400059
J	Pilusa, S; Myezwa, H; Potterton, J				Pilusa, Sonti; Myezwa, Hellen; Potterton, Joanne			Environmental factors influencing the prevention of secondary health conditions among people with spinal cord injury, South Africa	PLOS ONE			English	Article							CARE; PARTICIPATION; INDIVIDUALS; ACCESS	Background The environment where people live, work or play can influence health and disability outcomes. People with spinal cord injury are at risk for secondary health conditions, with this increasing readmission rates and decreasing quality of life. Studies on preventative care for secondary health conditions and factors influencing the prevention of secondary health conditions are scarce in low to middle-income countries. Aim To explore environmental factors influencing the prevention of secondary health conditions in people with spinal cord injury. Setting This study was based at a public rehabilitation hospital, South Africa. Methods Explorative qualitative design was used. Semi-structured interviews were conducted with 21 therapists, 17 people with a spinal cord injury and six caregivers. The interviews were transcribed verbatim. Analysis was conducted using content analysis. Results The categories that emerged included the impact of social support, inaccessible built environment and transport system, and an inefficient health care system. Sub-categories for the inefficient health care systems were: Shortage of resources, health workers lack of knowledge on prevention of secondary health conditions and inadequate patient care approach. Conclusion Environmental factors influencing the prevention of secondary health conditions are complex and multifactorial. When developing rehabilitation and prevention programmes, environmental factors must be considered.	[Pilusa, Sonti; Myezwa, Hellen; Potterton, Joanne] Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Physiotherapy, Johannesburg, South Africa	University of Witwatersrand	Pilusa, S (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Therapeut Sci, Dept Physiotherapy, Johannesburg, South Africa.	Sonti.pilusa@wits.ac.za	Fazli, Ghazal/AAE-8320-2022	PILUSA, sonti/0000-0003-0606-9669	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York [G-1957145]; Sida [54100113]; Uppsala Monitoring Centre; DELTAS Africa Initiative [107768/Z/15/Z]; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK); UK government; Thuthuka	Consortium for Advanced Research Training in Africa (CARTA); Carnegie Corporation of New York; Sida; Uppsala Monitoring Centre; DELTAS Africa Initiative; New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust (UK)(Wellcome Trust); UK government; Thuthuka	SP was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No-G-1957145), Sida (Grant No:54100113), Uppsala Monitoring Centre and the DELTAS Africa Initiative (Grant No: 107768/Z/15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the Fellow. Thuthuka grant also supported this research.	Adriaansen JJE, 2016, J REHABIL MED, V48, P853, DOI 10.2340/16501977-2166; Adriaansen JJE, 2013, J REHABIL MED, V45, P1016, DOI 10.2340/16501977-1207; DeJong G, 2015, J SPINAL CORD MED, V38, P696, DOI 10.1080/10790268.2015.1101917; Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001; Fuseini A.-G., 2018, NURS PRACT TOD-IRAN, V5, P335; Graham L., 2014, POVERTY DISABILITY S; Guilcher SJT, 2013, DISABIL REHABIL, V35, P894, DOI 10.3109/09638288.2012.721048; Guilcher SJT, 2012, J SPINAL CORD MED, V35, P330, DOI 10.1179/2045772312Y.0000000035; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hanass-Hancock J, 2017, AFR J DISABIL, V6, DOI 10.4102/ajod.v6i0.280; Jensen MP, 2012, SPINAL CORD, V50, P373, DOI 10.1038/sc.2011.150; Joseph C, 2016, SPINAL CORD, V54, P535, DOI 10.1038/sc.2015.189; Joseph C, 2016, PHYS THER, V96, P1372, DOI 10.2522/ptj.20150258; Maart S, 2014, DISABIL REHABIL, V36, P1489, DOI 10.3109/09638288.2013.807883; Madasa V, 2020, SPINAL CORD SER CASE, V6, DOI 10.1038/s41394-020-00334-w; Mashola MK, 2019, SAMJ S AFR MED J, V109, P107, DOI [10.7196/samj.2019.v109i2.13344, 10.7196/SAMJ.2019.v109i2.13344]; Matter RA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3605-9; Mayosi BM, 2014, NEW ENGL J MED, V371, P1344, DOI 10.1056/NEJMsr1405012; Modisakeng C, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05080-1; Morris LD, 2021, DISABIL REHABIL, V43, P877, DOI 10.1080/09638288.2019.1641851; Munce SEP, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-48; National Institute for Health and Care Excellence, 2015, TYP 1 DIAB AD DIAGN, DOI DOI 10.1016/J.ANNEMERGMED.2013.12.004; Oderud T, 2014, AFR J DISABIL, V3, DOI 10.4102/ajod.v3i2.80; Pilusa S, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4202-7; Sherry K., 2015, S AFRICAN HLTH REV, V201, P89; Statistics South Africa, 2014, PROF PERS DIS S AFR; Statistics South Africa, 2018, POV MAPP S AFR; United Nations, 2019, STESASERA423 DEP EC, P1; United Nations (UN) General Assembly, 2007, CONV RIGHTS PERS DIS; van Loo MA, 2010, SPINAL CORD, V48, P423, DOI 10.1038/sc.2009.142; Venter CJ, 2003, TRANSPORT RES REC, P79; Vergunst R, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2674-5; Visagie S, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.63; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2002, COMMON LANGUAGE FUNC; Zanini C, 2020, SPINAL CORD, V58, P882, DOI 10.1038/s41393-020-0444-4; Zanini C, 2020, J SPINAL CORD MED, V43, P247, DOI 10.1080/10790268.2018.1543094	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252280	10.1371/journal.pone.0252280	http://dx.doi.org/10.1371/journal.pone.0252280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170928	Green Published, gold			2022-12-26	WOS:000671694400039
J	Zhang, XH; Liu, HJ; Mao, CY; Shi, JQ; Meng, GL; Wu, JH; Pan, YR				Zhang, Xinhuan; Liu, Hongjie; Mao, Chengyuan; Shi, Junqing; Meng, Guolian; Wu, Jinhong; Pan, Yuran			The intelligent engine start-stop trigger system based on the actual road running status	PLOS ONE			English	Article							RECOGNITION	With the rapid development of urbanization and the popularization of the vehicle, the frequent occurrence of traffic jams results in idling fuel waste, environmental pollution, and other issues. In order to alleviate these problems, engine start-stop technology has been widely used in different types of vehicles in recent years. However, current start-stop trigger technology has many deficiencies, such as mistaken triggering and frequent engine start-stop, which greatly reduces user driving experience, causing most of them to deactivate this system. The intelligent engine start-stop trigger (IEST) system based on the actual road running status was established by building the image recognition model and the digital traffic analysis model in order to solve this problem. A system test shows that IEST can avoid frequently engine starting and stopping. The results show that IEST could effectively improve the driving experience and reduce engine fuel consumption, and it promotes conventional engine start-stop technology.	[Zhang, Xinhuan; Mao, Chengyuan; Shi, Junqing; Meng, Guolian; Wu, Jinhong; Pan, Yuran] Zhejiang Normal Univ, Inst Rd & Traff Engn, Jinhua, Zhejiang, Peoples R China; [Liu, Hongjie] Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China	Zhejiang Normal University; Xi'an Jiaotong University	Zhang, XH (corresponding author), Zhejiang Normal Univ, Inst Rd & Traff Engn, Jinhua, Zhejiang, Peoples R China.; Liu, HJ (corresponding author), Xi An Jiao Tong Univ, Sch Elect & Informat Engn, Xian, Shaanxi, Peoples R China.	zxh@zjnu.cn; hj_popel@stu.xjtu.edu	zhang, xinhuan/AHE-1003-2022	zhang, xinhuan/0000-0002-2156-7538	Zhejiang Provincial Natural Science Foundation of China (General program) [LY18G010009, LY18G030021]; Zhejiang Provincial Educational Committee; Scientific Research Foundation for the Returned Scholars, Ministry of Education of China [ZC304012027]	Zhejiang Provincial Natural Science Foundation of China (General program); Zhejiang Provincial Educational Committee; Scientific Research Foundation for the Returned Scholars, Ministry of Education of China	This research was supported by Zhejiang Provincial Natural Science Foundation of China (General program) (Grant NO. LY18G010009 and LY18G030021), Zhejiang Provincial Educational Committee(Grant NO.Y201738488), the Scientific Research Foundation for the Returned Scholars, Ministry of Education of China(Grant NO. ZC304012027).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambellouis S., 1996, Symposium on Robotics and Cybernetics. CESA '96 IMACS Multiconference. Computational Engineering in Systems Applications, P328; [Anonymous], 2015, AUTOMOBILE ELECT, P15; Bowman ET, 2001, GEOTECHNIQUE, V51, P545, DOI 10.1680/geot.51.6.545.40465; Buluswar SD, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P171, DOI 10.1109/ICCV.1998.710715; Chen KB, 2015, J POWER SOURCES, V278, P411, DOI 10.1016/j.jpowsour.2014.12.051; Cheng EJ, 2019, PATTERN RECOGN LETT, V125, P71, DOI 10.1016/j.patrec.2019.03.006; de la Escalera A, 2003, IMAGE VISION COMPUT, V21, P247, DOI 10.1016/S0262-8856(02)00156-7; delaEscalera A, 1997, IEEE T IND ELECTRON, V44, P848, DOI 10.1109/41.649946; Deng JK, 2019, PROC CVPR IEEE, P4685, DOI 10.1109/CVPR.2019.00482; Fonseca N, 2011, TRANSPORT RES D-TR E, V16, P194, DOI 10.1016/j.trd.2010.10.001; Gadekallu TR, 2021, J REAL-TIME IMAGE PR, V18, P1383, DOI 10.1007/s11554-020-00987-8; Grisan E, 2008, IEEE T MED IMAGING, V27, P310, DOI 10.1109/TMI.2007.904657; Guan H., 2017, ELECT IMAGING, P3, DOI [10.2352/ISSN.2470-1173.2017, DOI 10.2352/ISSN.2470-1173.2017]; Hirabayashi M, 2019, ROBOT AUTON SYST, V111, P62, DOI 10.1016/j.robot.2018.10.004; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Ibarra D, 2015, APPL ACOUST, V100, P55, DOI 10.1016/j.apacoust.2015.07.003; Javed AR, 2021, IEEE T NETW SCI ENG, V8, P1456, DOI 10.1109/TNSE.2021.3059881; Javed AR, 2021, IEEE T INTELL TRANSP, V22, P4291, DOI 10.1109/TITS.2020.3025875; Kim S.-K., 1997, 30th International Symposium on Automotive Technology and Automation. Robotics, Motion and Machine Vision in the Automotive Industries, P171; Lekshmi S, 2003, ASTRON ASTROPHYS, V405, P1163, DOI 10.1051/0004-6361:20030541; Liang XY, 2019, IEEE T VEH TECHNOL, V68, P1243, DOI 10.1109/TVT.2018.2890726; Ouyang ZC, 2020, IEEE T MOBILE COMPUT, V19, P300, DOI 10.1109/TMC.2019.2892451; Overton K. J., 1979, Proceedings of the 1979 IEEE Computer Society Conference on Pattern Recognition and Image Processing, P498; Possatti LC, 2019, IEEE IJCNN; Reddy GT, 2020, IEEE ACCESS, V8, P54776, DOI 10.1109/ACCESS.2020.2980942; Maddikunta PKR, 2020, IET INTELL TRANSP SY, V14, P1388, DOI 10.1049/iet-its.2020.0009; Russell JC, 2009, ECOLOGY, V90, P2007, DOI 10.1890/08-1069.1; Sheridan ThomasB., 1992, TELEROBOTICS AUTOMAT, V8, P301; Wu T, 2020, IEEE T VEH TECHNOL, V69, P8243, DOI 10.1109/TVT.2020.2997896; Xiao Xiao., 2018, MECH METHOD ENGINE S, P108; Yang H, 2019, PATTERN RECOGN, V85, P1, DOI 10.1016/j.patcog.2018.07.028; Zadeh MM, 1998, P SOC PHOTO-OPT INS, V3207, P272, DOI 10.1117/12.300865; Zhen J., 2014, BREAKTHROUGH NEEDED, P33	33	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253201	10.1371/journal.pone.0253201	http://dx.doi.org/10.1371/journal.pone.0253201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170905	gold, Green Published			2022-12-26	WOS:000671694400071
J	Gibbs, DA; West, JM; Bradley, P				Gibbs, David A.; West, Jordan M.; Bradley, Patricia			Incorporating adaptation and resilience into an integrated watershed and coral reef management plan	PLOS ONE			English	Article							RUNOFF; SCALE	Changing environmental conditions are forcing natural resource managers and communities to adapt their strategies to account for global shifts in precipitation, temperature, sea level and more, all of which are occurring in addition to local human impacts. Adapting to threats from climate change requires a fundamental shift in the practice of natural resource management through the development of forward-looking "climate-smart" goals and strategies. Here we present a proof-of-concept application of a decision-support tool to help design climate-smart management actions for the watershed and coral reef management plan for Guanica Bay watershed in southwest Puerto Rico. We also explore the connection between adaptation planning and coral reef resilience, using a recently developed Puerto Rico-wide reef resilience assessment. In the first phase of the study, we used the publicly available Adaptation Design Tool to draft initial climate-smart versions of twelve proposed management actions. In the second phase, two actions (dirt road management on steep slopes, and coral reef restoration) were further refined through consultations with local experts to make more detailed design adjustments; this included the option to use information from the coral reef resilience assessment to inform design improvements. The first phase resulted in moderately detailed assessments that broadly accounted for anticipated direct and indirect effects of climate change on the planned management actions. The second phase resulted in more site-specific technical assessments and additional important design details. The expert panel charged with discussing climate-smart reef restoration around Guanica used the reef resilience assessment to guide discussion of reef restoration, highlighting the importance of having such information available for adaptation planning. This study demonstrates how climate change impacts can be effectively incorporated into a management plan at the most granular level of planning and how a structured, formalized process can be as valuable as the resulting adaptation information.	[Gibbs, David A.] US EPA, Washington, DC 20460 USA; [West, Jordan M.] US EPA, Off Res & Dev, Washington, DC 20460 USA; [Bradley, Patricia] Tetra Tech Inc, Owings Mills, MD USA; [Gibbs, David A.] World Resources Inst, Washington, DC 20006 USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Gibbs, DA (corresponding author), US EPA, Washington, DC 20460 USA.; Gibbs, DA (corresponding author), World Resources Inst, Washington, DC 20006 USA.	david.gibbs@wri.org		Gibbs, David/0000-0001-7389-8569	U.S. Environmental Protection Agency (EPA) [EP-C-12-060, EP-C-17-031]; Oak Ridge Institute for Science and Education (ORISE) fellowship	U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Oak Ridge Institute for Science and Education (ORISE) fellowship	This study was funded by U.S. Environmental Protection Agency (EPA) Contracts EP-C-12-060 and EP-C-17-031, with support to DAG from an Oak Ridge Institute for Science and Education (ORISE) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NAT CONSERV; Bauer L.J., 2012, 155 NOAA NOS NCCOS, V155, P37; Bousquin J., 2014, BAYESIAN BELIEF NETW; Bradley MP., 2014, CORAL REEF COASTAL E; Bradley MP, 2015, EPA600R15248 NAT HLT EPA600R15248 NAT HLT; Carriger JF, 2013, COAST MANAGE, V41, P19, DOI 10.1080/08920753.2012.747814; CWP C for WP, 2008, GUAN BAY WAT MAN PLA GUAN BAY WAT MAN PLA; Donovan MK, 2020, P NATL ACAD SCI USA, V117, P5351, DOI 10.1073/pnas.1915395117; Eslinger D.L., 2012, OPENNSPECT OPEN SOUR; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Garcia JR, 2003, LATIN AMERICAN CORAL REEFS, P111, DOI 10.1016/B978-044451388-5/50006-0; Garcia-Sais Jorge, 2005, NOAA Technical Memorandum NOS NCCOS, V11, P91; Garcia-Sais JR., 2005, MONITORING COR UNPUB MONITORING COR UNPUB, P131; Gibbs DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224360; Gross J., 2014, UNDERSTANDING CLIMAT, P87; Grossarth SK, 2007, ECOL ENG, V30, P1, DOI 10.1016/j.ecoleng.2006.09.011; Hernandez-Delgado E.A., 2014, NATURAL RESOUR, V2014, P538, DOI DOI 10.4236/NR.2014.510049; Julius SH, 2008, REPORT US CLIMATE CH, P873; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lipton D., 2018, IMPACTS RISKS ADAPTA, VII, P268, DOI [DOI 10.7930/NCA4.2018.CH7, 10.7930/NCA4.2018.CH7]; Maynard J., 2017, GUIDE ASSESSING CORA; Maynard JA., 2014, ASSESSING RELATIVE R; Maynard JA, 2015, BIOL CONSERV, V192, P109, DOI 10.1016/j.biocon.2015.09.001; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McKay L, 2012, NHDPLUS VERSION 2 US; Miller GL, 2009, IITFGTR35 USDA FOR S, P437; Morelock J, 2001, CARIBBEAN J SCI SPEC, V4, P57; NMFS NMFS, 2015, REC PLAN ELKH ACR PA REC PLAN ELKH ACR PA; Obura D.O., 2009, RESILIENCE ASSESSMEN, P70; Oliver LM, 2014, MAR ENVIRON RES, V99, P95, DOI 10.1016/j.marenvres.2014.04.005; Otero E, 2009, CARIBB J SCI, V45, P168; Ramos-Scharron CE, 2017, LAND DEGRAD DEV, V28, P936, DOI 10.1002/ldr.2567; Ramos-Scharron CE., 2009, EFFECTS LAND D UNPUB EFFECTS LAND D UNPUB, P94; Ramos-Scharron CE, 2007, P 7 CAR ISL WAT RES P 7 CAR ISL WAT RES, P26; Riniwati H, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070107; Sayre NF, 2005, PROG HUM GEOG, V29, P276, DOI 10.1191/0309132505ph546oa; Scharron CER, 2010, CATENA, V82, P146, DOI 10.1016/j.catena.2010.06.001; Shivlani M., 2011, SPATIAL CHARACTERIZA, P61; Smith A, 2017, ECOL INDIC, V74, P371, DOI 10.1016/j.ecolind.2016.11.036; Stein B.A., 2014, CLIMATE SMART CONSER; Sturm P., 2012, 12 INT COR REEF S CA; The Puerto Rico Climate Change Council (PRCCC), 2013, PUERT RIC STAT CLIM; Torres JL, 2001, B MAR SCI, V69, P631; Turner MG, 1989, LANDSCAPE ECOL, V3, P245, DOI 10.1007/BF00131542; U.S. Coral Triangle Initiative Support Program, CLIMATE CHANGE ADAPT; USCRTF, 2000, COR REEF PROT AR GUI COR REEF PROT AR GUI, P14; Velazco-Dominguez A, 2003, CLIMATE CHANGE CORAL; Viqueira Rios RA, 2018, 20122017 PROT CUENC 20122017 PROT CUENC; Wagner D., 2016, MARINE SANCTUARIES C; West JM, 2018, ENVIRON MANAGE, V62, P644, DOI 10.1007/s00267-018-1065-y; West JM, 2017, ENVIRON MANAGE, V59, P102, DOI 10.1007/s00267-016-0774-3; Whitall D, 2013, 176 NOAA NOS NCCOS C, P169; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilkinson C., 2004, STATUS CORAL REEFS W	54	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253343	10.1371/journal.pone.0253343	http://dx.doi.org/10.1371/journal.pone.0253343			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166409	Green Published, gold			2022-12-26	WOS:000671692800017
J	Portela-Pino, I; Valverde-Esteve, T; Martinez-Patino, MJ				Portela-Pino, Iago; Valverde-Esteve, Teresa; Jose Martinez-Patino, Maria			Age as a determining variable in the practice or abandonment of physical exercise among young people	PLOS ONE			English	Article							ADULT LIFE; BARRIERS; ADOLESCENTS; CHILDHOOD; EDUCATION; SPORTS; GENDER; HEALTH; SCHOOL; TIME	Background Numerous studies have reported a gradual decline in the practice of physical exercise with age, confirming high dropout rates in the adolescent period. The aim of this study was to investigate the motivation or barriers that lead to greater or lesser adherence to physical exercise among children and adolescents. Methods In this study, 1,081 individuals volunteered to participate [239 children (age: 10.89 +/- .66 years) and 842 adolescents (age: 14.9 +/- 1.75 years)]. For this purpose, we used the Self-Report on Motivation for Exercising (AMPEF) and Self-Report on Barriers to Exercising (ABPEF) questionnaires. Results The most significant motivational factors in the practice of physical exercise (in both children and adolescents) are competition, social recognition and challenge (t = -16.02, p < .001), prevention and positive health (t = 5.24, p < .001) and affiliation, fun and well-being (t = -19.54, p < .001), while the barriers focus on fatigue and laziness (t = -13.20, p < .001) and body image and physical-social anxiety (t = -5.71, p < .001). It is also observed that adolescents showed significantly higher motivation than children and greater presence of barriers in the practice of physical exercise. Conclusions The age is a determining variable to include in preventive and intervention programs for the practice of physical exercise.	[Portela-Pino, Iago] Univ Isabel I, Dept Hlth Sci, Burgos, Spain; [Valverde-Esteve, Teresa] Univ Valencia, Dept Didact Mus Visual & Body Express, Valencia, Spain; [Jose Martinez-Patino, Maria] Univ Vigo, Dept Specif Didact, Vigo, Spain	University of Valencia; Universidade de Vigo	Valverde-Esteve, T (corresponding author), Univ Valencia, Dept Didact Mus Visual & Body Express, Valencia, Spain.	Teresa.valverde@uv.es	Pino, Iago/AAD-8309-2022; Valverde, Teresa/ADU-0934-2022	Valverde, Teresa/0000-0002-8712-9872; , IIS Galicia Sur/0000-0003-3812-7413	Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital (Generalitat Valenciana) [Best/2019/110]; Fulbright Comission; University of Valencia	Conselleria de Innovacion, Universidades, Ciencia y Sociedad Digital (Generalitat Valenciana); Fulbright Comission; University of Valencia	TVE: Conselleria de Inno-vacio ' n, Universidades, Ciencia y Sociedad Digital Generalitat Valenciana, Best/2019/110), Fulbright Comission and University of Valencia grants.	Almagro BJ, 2011, RICYDE-REV INT CIENC, V7, P250, DOI 10.5232/ricyde2011.02501; Sanchez-Ojeda MA, 2015, NUTR HOSP, V31, P1910, DOI 10.3305/nh.2015.31.5.8608; Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511; Baena-Morales S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18042129; Biddle SJH, 2005, J PHYS ACT HEALTH, V2, P423, DOI [DOI 10.1123/JPAH.2.4.423, 10.1123/jpah.2.4.423]; Bowman, 2018, DISABIL REHABIL, V10, P1, DOI DOI 10.1080/09638288.2018.1432702; Brown WJ, 2015, BRIT J SPORT MED, V49, P1069, DOI 10.1136/bjsports-2013-093090; Cairney J, 2014, MED SCI SPORT EXER, V46, P730, DOI 10.1249/MSS.0000000000000168; Calero Morales Santiago, 2016, Rev Cubana Invest Bioméd, P366; Castro-Sanchez M, 2016, RICYDE-REV INT CIENC, V12, P262, DOI 10.5232/ricyde2016.04504; Chillon P, 2009, EUR J PUBLIC HEALTH, V19, P470, DOI 10.1093/eurpub/ckp048; Cox A., 2018, CHILD YOUTH ENV, V28, P232, DOI [10.7721/chilyoutenvi.28.2.0232, DOI 10.7721/CHILYOUTENVI.28.2.0232]; Dai JH, 2020, RISK MANAG HEALTHC P, V13, P1419, DOI 10.2147/RMHP.S257844; Darnell S.C., 2017, 3 WORLD THEMAT TWQ J, V2, P23, DOI [10.1080/23802014.2017.1314772, DOI 10.1080/23802014.2017.1314772]; Deci EL, 2002, HDB SELF DETERMINATI; Diaz M.J.A., 2018, SALUD MOVIMIENTO, V8, P25; Dominguez-Alonso J, 2018, REV INT MED CIENC AC, V18, P753, DOI 10.15366/rimcafd2018.72.010; Dominguez-Alonso J., 2018, RETOS, P273; Dominguez-Gonzalez F., 2018, Cuadernos de Psicologia del Deporte, V18, P33; Eyre ELJ, 2015, J CHILD HEALTH CARE, V19, P345, DOI 10.1177/1367493513508845; Fernandes Débora Cecilio, 2012, Psico-USF, V17, P447; Ghorbani M.H., 2020, SPORT MANAGEMENT STU, V12, P83; Giulianotti R, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072241; Goni E, 2010, EUR J EDUC PSYCHOL, V3, P199, DOI 10.30552/ejep.v3i2.52; Gonzalez N., 2018, REV COLOMB CARDIOL, V25, P125, DOI [10.1016/J.RCCAR.2017.12.008, DOI 10.1016/J.RCCAR.2017.12.008]; Herranz Aguayo Inmaculada, 2013, Escritos de Psicología, V6, P13, DOI 10.5231/psy.writ.2013.1906; Hoare E, 2017, SPORTS, V5, DOI 10.3390/sports5030047; James M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5274-3; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Kozatek A., 2020, Journal of Physical Education and Sport, V20, P403, DOI 10.7752/jpes.2020.s1057; Kwan MY, 2011, AM J HLTH STUD, V26, P87; Larouche R, 2012, J PHYS ACT HEALTH, V9, P516, DOI 10.1123/jpah.9.4.516; Lee ST, 2016, ASIA-PAC J PUBLIC HE, V28, p21S, DOI 10.1177/1010539516638155; Lemke W., 2016, UN CHRONICLE, V53, P6, DOI [DOI 10.18356/cb2782b5-fr, DOI 10.18356/7260830A-EN]; Levine MP, 2016, EAT DISORD, V24, P39, DOI 10.1080/10640266.2015.1113826; Lindsey I., 2017, ENHANCING CONTRIBUTI; Lindsey I, 2019, INT REV SOCIOL SPORT, V54, P793, DOI 10.1177/1012690217752651; Ll Capdevila., 2004, REV PSICOL DEPORTE, V13, P55; Lores A. P, 2008, REV PSICOL DEPORTE, V17, P7; Manohar J., 2017, J PHARM SCI RES, V9, P194; Salazar-Ayala CM, 2020, RETOS-NUEV TEND EDUC, P838; Markland D, 1997, BRIT J HEALTH PSYCH, V2, P361, DOI 10.1111/j.2044-8287.1997.tb00549.x; Martínez Baena Alejandro César, 2012, CPD, V12, P45, DOI 10.4321/s1578-84232012000100005; Martins J, 2015, HEALTH EDUC RES, V30, P742, DOI 10.1093/her/cyv042; Maturo CC, 2013, AM J PUBLIC HEALTH, V103, pE23, DOI 10.2105/AJPH.2013.301366; Moreno-Murcia J. A., 2006, CUAD PSICOL DEPORT, V6, P39; Ninerola J., 2017, REV PSICOLOGIA DEPOR REV PSICOLOGIA DEPOR, V15, P53; Owens S, 2017, AM J LIFESTYLE MED, V11, P96, DOI 10.1177/1559827615594585; Parshikova N.V., 2017, THEORY PRACTICE PHYS, V7, P32; Pino I., 2017, REV GALEGO PORTUGUES, V14, P174; Portela Pino I., 2021, PERSPECTIVES HLTH AN, P209; Reichert FF, 2007, AM J PUBLIC HEALTH, V97, P515, DOI 10.2105/AJPH.2005.070144; Revuelta L., 2018, Cuadernos de Psicologia del Deporte, V18, P228; Rice ME, 2005, LAW HUMAN BEHAV, V29, P615, DOI 10.1007/s10979-005-6832-7; Rodriguez-Romo G, 2009, REV PANAM SALUD PUBL, V26, P244, DOI 10.1590/S1020-49892009000900009; Smith MA, 2009, PHYS EDUC-US, V66, P209; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; Stamatakis E, 2011, J AM COLL CARDIOL, V57, P292, DOI 10.1016/j.jacc.2010.05.065; Thompson CM., INT YB RES ARTS ED 3, V2015, P293; Warburton DER, 2016, CAN J CARDIOL, V32, P495, DOI 10.1016/j.cjca.2016.01.024	60	1	1	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253750	10.1371/journal.pone.0253750	http://dx.doi.org/10.1371/journal.pone.0253750			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166459	gold, Green Published			2022-12-26	WOS:000671692800010
J	Wang, L; Luo, JL; Liu, YX				Wang, Lu; Luo, Jianli; Liu, Yuxia			Agricultural cooperatives participating in vegetable supply chain integration: A case study of a trinity cooperative in China	PLOS ONE			English	Article							PRODUCT DEVELOPMENT; PERFORMANCE; INNOVATION; MANAGEMENT; NETWORK; EXPERIENCES; PLANT; RISK	Supply chain integration plays an important role in the development of the vegetable industry in terms of vegetable quality, vegetable safety, and vegetable security in rural China. This paper explores how agricultural cooperatives integrate the vegetable supply chain by taking a trinity cooperative as an example in China. It explains the translation concatenation of supply chain integration for this cooperative by constructing actor networks in four development stages, including the seed stage, start-up stage, development stage, and mature stage. The findings show that supply chain integration in production cooperation, supply & sales cooperation, and credit cooperation is a useful trinity cooperative model of supply chain integration for investigating vegetable supply chain integration through internal integration and external integration. This paper suggests that cooperatives in the vegetable supply chain should facilitate close coordination among different shareholders and further improve the efficiency of supply chain integration. The government should provide training opportunities and funding to encourage cooperatives to participate in supply chain integration within the vegetable industry.	[Wang, Lu; Luo, Jianli] Wenzhou Univ, Sch Business, Wenzhou, Zhejiang, Peoples R China; [Liu, Yuxia] Wenzhounese Econ Res Inst, Wenzhou, Zhejiang, Peoples R China	Wenzhou University	Luo, JL (corresponding author), Wenzhou Univ, Sch Business, Wenzhou, Zhejiang, Peoples R China.; Liu, YX (corresponding author), Wenzhounese Econ Res Inst, Wenzhou, Zhejiang, Peoples R China.	luolinjian@gmail.com; 61386800@gq.com		Liu, Yuxia/0000-0002-1422-9020	Qianjiang Talents Plan [QJC1902001]; National Social Science Foundation of China [17BGL132]; Zhejiang Provincial Social Science Planning [21NDJC318YBM]	Qianjiang Talents Plan; National Social Science Foundation of China; Zhejiang Provincial Social Science Planning	We acknowledge the financial support of the financial support of Qianjiang Talents Plan (type C)(Grant NO. QJC1902001), National Social Science Foundation of China (Grand No. 17BGL132), Zhejiang Provincial Social Science Planning (Grand No. 21NDJC318YBM).	Ajates R, 2020, ORGANIZATION, V27, P337, DOI 10.1177/1350508419888900; Aka KG, 2019, J CLEAN PROD, V225, P524, DOI 10.1016/j.jclepro.2019.03.351; Baranyai Z, 2012, ACTUAL PROBL ECON, P301; Brian, 2005, TOURISM MANAGE, V32, P641; CALLON M, 1986, SOCIOL RE MONOGR, P196, DOI 10.1111/j.1467-954X.1984.tb00113.x; Chen, 2018, RURAL EC, V4, P126; Chen IJ, 2004, INT J PROD RES, V42, P131, DOI 10.1080/00207540310001602865; Cheng Y, 2016, SUPPLY CHAIN MANAG, V21, P550, DOI 10.1108/SCM-10-2015-0391; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Eksoz C, 2019, OMEGA-INT J MANAGE S, V87, P20, DOI 10.1016/j.omega.2018.11.007; ForguYcs, 2008, J RURAL COOPERATION, V36, P57; Francis, 2009, CRIT PERSPECT, V21, P243; Gao, 2012, CHINA RURAL EC, P4; Hamprecht E, 2005, SUPPLY CHAIN MANAG, V10, P7, DOI 10.1108/13598540510578315; Han JQ, 2011, INT J PROD ECON, V134, P312, DOI 10.1016/j.ijpe.2009.11.005; Hansen M. H., 2002, INT FOOD AGRIBUS MAN, V5, P41, DOI [10.1016/s1096-7508(02)00069-1, DOI 10.1016/S1096-7508(02)00069-1]; Hillebrand B, 2004, J PROD INNOVAT MANAG, V21, P110, DOI 10.1111/j.0737-6782.2004.00061.x; [霍宝锋 Huo Baofeng], 2016, [系统工程理论与实践, Systems Engineering-Theory & Practice], V36, P363; Idris N, 2011, ACTA HORTIC, V895, P137; Jajja MSS, 2018, INT J PROD ECON, V205, P118, DOI 10.1016/j.ijpe.2018.08.032; Jajja MSS, 2017, INT J OPER PROD MAN, V37, P1054, DOI 10.1108/IJOPM-09-2014-0424; Jia XP, 2012, CHINA ECON REV, V23, P665, DOI 10.1016/j.chieco.2010.07.001; Lau AKW, 2010, J PROD INNOVAT MANAG, V27, P761, DOI 10.1111/j.1540-5885.2010.00749.x; Lee CW, 2007, SUPPLY CHAIN MANAG, V12, P444, DOI 10.1108/13598540710826371; Lee H, 2006, J STRATEGIC INF SYST, V15, P177, DOI 10.1016/j.jsis.2005.10.002; Liu, 2012, SCI SCI MANAGEMENT S, V33, P158; Luo JL, 2017, FOOD POLICY, V73, P19, DOI 10.1016/j.foodpol.2017.09.001; Ma W., 2020, CHINA ECON REV, V62, P1; Ma WL, 2018, AM J AGR ECON, V100, P502, DOI 10.1093/ajae/aax079; Mikulcak F, 2015, LAND USE POLICY, V43, P248, DOI 10.1016/j.landusepol.2014.10.024; Narkhede B., 2019, OPERATION RES PERSPE, P1; Neszmulyi, 2017, TAIWANESE AGR EC REV, V23, P131; Pal R., 2021, INT J PROD ECON, V231, P1; Ragatz GL, 2002, J BUS RES, V55, P389, DOI 10.1016/S0148-2963(00)00158-2; Schoenherr T, 2012, J OPER MANAG, V30, P99, DOI 10.1016/j.jom.2011.09.001; Sousa R, 2017, INT J OPER PROD MAN, V37, P444, DOI 10.1108/IJOPM-11-2015-0696; Swink M, 2007, J OPER MANAG, V25, P148, DOI 10.1016/j.jom.2006.02.006; Tessarolo P, 2007, J PROD INNOVAT MANAG, V24, P69, DOI 10.1111/j.1540-5885.2006.00233.x; Tsou HT, 2015, MANAGE DECIS, V53, P2107, DOI 10.1108/MD-01-2015-0014; Tuna E, 2021, J CO-OP ORGAN MANAG, V9, DOI 10.1016/j.jcom.2021.100134; Vasa L, 2014, J INT FOOD AGRIBUS M, V26, P286, DOI 10.1080/08974438.2013.833567; Vedula CE, 2014, MICCAI WORKSH M2CAI, V3, P3, DOI DOI 10.1109/MWSYM.2014.6848587; Wang, 2012, PROGR SCI TECHNOLOGY, V29, P52; Wang L, 2019, INT FOOD AGRIBUS MAN, V22, P767, DOI 10.22434/IFAMR2019.0023; Wiengarten F, 2016, INT J PROD ECON, V171, P361, DOI 10.1016/j.ijpe.2015.03.020; Wong CWY, 2013, INT J PROD ECON, V146, P566, DOI 10.1016/j.ijpe.2013.08.004; Wong CWY, 2011, J MANAGE INFORM SYST, V28, P161, DOI 10.2753/MIS0742-1222280305; Wu IL, 2014, INT J PROD ECON, V148, P122, DOI 10.1016/j.ijpe.2013.09.016; Yin R. K., 2003, CASE STUDY RES DESIG, V5; [詹爱岚 Zhan Ailan], 2011, [科学学研究, Studies in Science of Science], V29, P56; Zhao, 2012, NEW COOPERATIVE DEV; Zhao XD, 2011, J OPER MANAG, V29, P17, DOI 10.1016/j.jom.2010.04.004; Zhuo N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183241	53	2	2	22	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253668	10.1371/journal.pone.0253668	http://dx.doi.org/10.1371/journal.pone.0253668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166454	Green Published, gold			2022-12-26	WOS:000671692800058
J	He, R; Yang, Y; Hu, ZZ; Xue, R; Hu, YJ				He, Rui; Yang, Ye; Hu, Zhizhong; Xue, Ru; Hu, Yajuan			Resistance mechanisms and fitness of pyraclostrobin-resistant isolates of Lasiodiplodia theobromae from mango orchards	PLOS ONE			English	Article							BENZIMIDAZOLE-RESISTANCE; BOTRYTIS-CINEREA; BIOCHEMICAL-CHARACTERIZATION; STROBILURIN FUNGICIDES; LABORATORY MUTANTS; SENSITIVITY; MUTATIONS; DISEASE	Background Stem-end rot, caused by Lasiodiplodia theobromae (Pat.) Griffon & Maubl is a serious postharvest disease in mango. In China, a high prevalence of the QoI fungicides resistance has been reported in the last decade. The study aimed to discuss factors determining rapid development of pyraclostrobin-resistance and its resistance mechanisms. Methods To determine the resistance stability and fitness of pyraclostrobin resistance in L. theobromae, three phenotypes of pyraclostrobin resistance were compared and analyzed for the EC50 values, mycelial growth, virulence and temperature sensitivity and osmotic stress sensitivity. The relative conductivity and enzyme activities of different phenotypes were compared under fungicide stress to explore possible biochemical mechanisms of pyraclostrobin resistance in L. theobromae. The Cytb gene sequences of different phenotypes were analysed. Results All isolates retained their original resistance phenotypes during the 10 subcultures on a fungicide-free PDA, factor of sensitivity change (FSC) was approximately equal to 1. The resistance-pyraclostrobin of the field isolates should be relatively stable. Two pyraclostrobin-resistant phenotypes shared similar mycelial growth, virulence and temperature sensitivity with pyraclostrobin-sensitive phenotype. After treated by pyraclostrobin, the relative conductivity of the sensitive phenotype was significantly increased. The time of Pyr-R and Pyr-HR reached the most conductivity was about 8-10 times than that of Pyr-S, the time for the maximum value appearance showed significant differences between sensitive and resistant phenotypes. The activities of Glutathione S-transferase (GST), catalase (CAT) and peroxidase (POD) of Pyr-HR were 1.78, 5.45 and 1.65 times respectively, significantly higher than that of Pyr-S after treated by 200 mg/l pyraclostrobin. Conclusion The results showed that the pyraclostrobin-resistant phenotypes displayed high fitness and high-risk. The nucleotide sequences were identical among all pyraclostrobin-resistant and -sensitive isolates. The pyraclostrobin resistance was not attributable to Cytb gene alterations, there may be some of other resistance mechanisms. Differential response of enzyme activity and cell membrane permeability were observed in resistant- and sensitive-isolates suggesting a mechanism of metabolic resistance.	[He, Rui; Hu, Zhizhong; Xue, Ru; Hu, Yajuan] Hainan Univ, Inst Plant Protect, Haikou, Hainan, Peoples R China; [He, Rui] Hainan Med Univ, Haikou, Hainan, Peoples R China; [Yang, Ye] Hainan Univ, Inst Plant Protect, Key Lab Green Prevent & Control Trop Plant Dis &, Haikou, Hainan, Peoples R China	Hainan University; Hainan Medical University; Hainan University	Yang, Y (corresponding author), Hainan Univ, Inst Plant Protect, Key Lab Green Prevent & Control Trop Plant Dis &, Haikou, Hainan, Peoples R China.	991003@hainu.edu.cn		Yang, Ye/0000-0003-0191-2485	National Natural Science Foundation of China [31560521]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (31560521).	BARAK E, 1984, PESTIC BIOCHEM PHYS, V21, P412, DOI 10.1016/0048-3575(84)90110-X; Brent K.J., 2007, FRAC MONOGRAPH, V2; Cai M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16881; Chen FP, 2020, PESTIC BIOCHEM PHYS, V162, P60, DOI 10.1016/j.pestbp.2019.08.008; Chen X.L., 2015, CHINA J FRUIT SCI, V32, P481; Duan YB, 2014, J PEST SCI, V87, P221, DOI 10.1007/s10340-013-0526-6; Fernandez-Ortuno D, 2010, FUNGICIDES, P203; Fujimura M, 2000, PESTIC BIOCHEM PHYS, V67, P125, DOI 10.1006/pest.2000.2479; Gisi U, 2002, PEST MANAG SCI, V58, P859, DOI 10.1002/ps.565; Grasso V, 2006, PEST MANAG SCI, V62, P465, DOI 10.1002/ps.1236; [贺瑞 He Rui], 2018, [植物保护, Plant Protection], V44, P188; Holliday P., 1980, FUNGUS DIS TROPICAL, P42, DOI [10.1007/BF03213662, DOI 10.1007/BF03213662]; Hu MeiJiao, 2012, Journal of Fruit Science, V29, P105; Hu MeiJiao, 2009, Journal of Fruit Science, V26, P671; Johnson G., 1992, ACTA HORTICULTURAE, V341, P329, DOI [10.17660/ActaHortic.1993.341.36, DOI 10.17660/ACTAHORTIC.1993.341.36]; Kim YK, 2011, PHYTOPATHOLOGY, V101, P1385, DOI 10.1094/PHYTO-04-11-0123; Li JL, 2017, PESTIC BIOCHEM PHYS, V138, P15, DOI 10.1016/j.pestbp.2017.02.001; Ma ZH, 2003, APPL ENVIRON MICROB, V69, P7145, DOI 10.1128/AEM.69.12.7145-7152.2003; Mabbett T., 2014, INT PEST CONTROL, V56, P104; Malandrakis AA, 2013, INT J FOOD MICROBIOL, V162, P237, DOI 10.1016/j.ijfoodmicro.2013.01.014; Markoglou AN, 2006, EUR J PLANT PATHOL, V115, P149, DOI 10.1007/s10658-006-0008-2; Nottensteiner M, 2019, GESUNDE PFLANZ, V71, P155, DOI 10.1007/s10343-019-00475-5; Pavlidi N, 2018, CURR OPIN INSECT SCI, V27, P97, DOI 10.1016/j.cois.2018.04.007; Ren L, 2020, J PLANT DIS PROTECT, V127, P657, DOI 10.1007/s41348-020-00316-y; Sevastos A, 2017, PESTIC BIOCHEM PHYS, V141, P23, DOI 10.1016/j.pestbp.2016.11.002; Shin JH, 2003, J MICROBIOL, V41, P219; Sierotzki H, 2000, PESTIC BIOCHEM PHYS, V68, P107, DOI 10.1006/pest.2000.2506; Sierotzki H, 2007, PEST MANAG SCI, V63, P225, DOI 10.1002/ps.1330; Song TT, 2012, J APPL MICROBIOL, V112, P175, DOI 10.1111/j.1365-2672.2011.05188.x; Trkulja N, 2013, EUR J PLANT PATHOL, V135, P889, DOI 10.1007/s10658-012-0135-x; Twumasi P., 2014, African Journal of Agricultural Research, V9, P613; Walker AS, 2009, PEST MANAG SCI, V65, P906, DOI 10.1002/ps.1772; Xu CY, 2014, PESTIC BIOCHEM PHYS, V115, P32, DOI 10.1016/j.pestbp.2014.08.001; Yang Y, 2019, PLANT DIS, V103, P2076, DOI 10.1094/PDIS-01-19-0148-RE; Zhang CQ, 2012, CROP PROT, V42, P256, DOI 10.1016/j.cropro.2012.07.018; Zhao L., 2017, CHINESE J PESTIC SCI, V19, P1	36	2	2	11	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253659	10.1371/journal.pone.0253659	http://dx.doi.org/10.1371/journal.pone.0253659			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161390	Green Published, gold			2022-12-26	WOS:000671691900023
J	Almeida, N; Ramos, JA; Rodrigues, I; dos Santos, I; Pereira, JM; Matos, DM; Araujo, PM; Geraldes, P; Melo, T; Paiva, VH				Almeida, Nathalie; Ramos, Jaime A.; Rodrigues, Isabel; dos Santos, Ivo; Pereira, Jorge M.; Matos, Diana M.; Araujo, Pedro M.; Geraldes, Pedro; Melo, Tommy; Paiva, Vitor H.			Year-round at-sea distribution and trophic resources partitioning between two sympatric Sulids in the tropical Atlantic	PLOS ONE			English	Article							FORAGING BEHAVIOR; SEXUAL SEGREGATION; COMPETITIVE-EXCLUSION; STABLE-ISOTOPES; WANDERING ALBATROSSES; SMOOTHING PARAMETER; SEABIRD COMMUNITY; PELAGIC SEABIRD; NORTH PACIFIC; BROWN BOOBIES	In the oligotrophic tropical marine environment resources are usually more patchily distributed and less abundant to top predators. Thus, spatial and trophic competition can emerge, especially between related seabird species belonging to the same ecological guild. Here we studied the foraging ecology of two sympatric species-brown booby (BRBO) Sula leucogaster (breeding) and red-footed boobies (RFBO) Sula sula (non-breeding)-at Raso islet (Cabo Verde), across different seasons. Sexual segregation was only observed during Jun-Oct, when RFBO were present, with larger females BRBO remaining closer to the colonies, while males and RFBO travelled further and exploited different habitats. Overall, species appeared to prefer areas with specific oceanic features, particularly those related with oceanic currents and responsible for enhancing primary productivity in tropical oceanic areas (e.g. Sea Surface Height and Ocean Mixed Layer Thickness). Female BRBOs showed high foraging-site fidelity during the period of sympatry, while exploiting the same prey species as the other birds. However, during the months of co-existence (Jun.-Oct.), isotopic mixing models suggested that female BRBO would consume a higher proportion of epipelagic fish, whereas female RFBO would consume more squid compared to the other birds, possibly due to habitat-specific prey availability and breeding energy-constraints for BRBO. We conclude that divergent parental roles, environmental conditions, habitat preference and competition could be mechanisms simultaneously underlying sexual segregation for BRBO during a period of co-existence, while inter-specific foraging differences appear to be more affected by habitat preference and different breeding stages. These results support previous statements that BRBO can adapt their foraging ecology to different circumstances of environmental conditions and competition, and that marine physical features play an important role in foraging decisions of boobies.	[Almeida, Nathalie; Ramos, Jaime A.; dos Santos, Ivo; Pereira, Jorge M.; Matos, Diana M.; Araujo, Pedro M.; Paiva, Vitor H.] Univ Coimbra, MARE Marine & Environm Sci Ctr, Dept Life Sci, Coimbra, Portugal; [Almeida, Nathalie; Rodrigues, Isabel; Melo, Tommy] Biosfera Cabo Verde, Sao Vicente, Cape Verde; [Araujo, Pedro M.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Campus Agrario Vairao, Vairao, Portugal; [Geraldes, Pedro] SPEASoc Portuguesa Estudo Aves, Lisbon, Portugal	Universidade de Coimbra; Universidade do Porto	Almeida, N (corresponding author), Univ Coimbra, MARE Marine & Environm Sci Ctr, Dept Life Sci, Coimbra, Portugal.	mellonaty@hotmail.com	Ramos, Jaime/B-6616-2018; Pereira, Jorge Miguel/I-5814-2016; Macedo Matos, Diana/B-4056-2019; Paiva, Vitor/J-1092-2019	Ramos, Jaime/0000-0002-9533-987X; Pereira, Jorge Miguel/0000-0002-7594-3535; Macedo Matos, Diana/0000-0001-8078-456X; Paiva, Vitor/0000-0001-6368-9579; dos Santos, Ivo/0000-0001-8415-1700; Almeida, Nathalie/0000-0002-1302-3944	project Alcyon -Conservation of seabirds from Cabo Verde; BirdLife International; MAVA foundation [MAVA17022]; strategic program of MARE - FCT [UID/MAR/04292/2020]	project Alcyon -Conservation of seabirds from Cabo Verde; BirdLife International; MAVA foundation; strategic program of MARE - FCT	This work received financial and logistic support (for fieldwork campaigns, GPS tracking devices and laboratory analysis) from the project Alcyon -Conservation of seabirds from Cabo Verde, coordinated by BirdLife International and funded by the MAVA foundation (MAVA17022; http://en.mava-foundation.org), through its strategic plan for West Africa (2017-2022). NA is also most thankful to MAVA foundation for the granted PhD fellowship which allowed to develop this work. This study also benefitted from funding by the strategic program of MARE, financed by FCT (UID/MAR/04292/2020), through national funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli C., 2017, R PACKAGE CIRCULAR C; Ainley DG, 2004, ECOL MONOGR, V74, P159, DOI 10.1890/02-4073; Castillo-Guerrero JA, 2011, J ORNITHOL, V152, P269, DOI 10.1007/s10336-010-0575-z; Ancona S, 2012, MAR ECOL PROG SER, V462, P261, DOI 10.3354/meps09851; Aristegui J, 2009, PROG OCEANOGR, V83, P33, DOI 10.1016/j.pocean.2009.07.031; Arkhipkin AI, 2015, REV FISH SCI AQUAC, V23, P92, DOI 10.1080/23308249.2015.1026226; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Bakun A, 2006, SCI MAR, V70, P105, DOI 10.3989/scimar.2006.70s2105; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Ballance LT., 2001, ENCY OCEAN SCI, V5, P2636, DOI [10.1006/rwos.2001.0233, DOI 10.1006/RWOS.2001.0233]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BIRT VL, 1987, MAR ECOL PROG SER, V40, P205, DOI 10.3354/meps040205; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Brown Margaret E., 1996, Current Ornithology, V13, P67; Bugge J, 2011, J ORNITHOL, V152, P253, DOI 10.1007/s10336-010-0578-9; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carboneras C., 1992, P312; Cardoso C., 2017, THESIS U ALGARVE; Carroll G, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0788; Castillo-Guerrero JA, 2016, ARDEA, V104, P33, DOI 10.5253/arde.v104i1.a3; Catry T, 2009, MAR ECOL PROG SER, V391, P231, DOI 10.3354/meps07717; Cerveira LR, 2020, MAR ENVIRON RES, V162, DOI 10.1016/j.marenvres.2020.105165; CHASTEL O, 1995, ECOLOGY, V76, P2240, DOI 10.2307/1941698; Cherel Y, 2008, MAR ECOL PROG SER, V366, P281, DOI 10.3354/meps07587; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Ciancio JE, 2016, RAPID COMMUN MASS SP, V30, P1865, DOI 10.1002/rcm.7661; CLARKE A, 1980, IBIS, V122, P488, DOI 10.1111/j.1474-919X.1980.tb00903.x; Claster W, 2016, AEDFORECASTING CHANG; Clay TA, 2016, SCI REP-UK, V6, DOI 10.1038/srep29932; Cleasby IR, 2015, MAR ECOL PROG SER, V518, P1, DOI 10.3354/meps11112; Connan M, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3201-2; Courbin N, 2020, ANIM BEHAV, V166, P95, DOI 10.1016/j.anbehav.2020.06.012; de Grissac S, 2017, ECOL EVOL, V7, P6766, DOI 10.1002/ece3.3210; Donahue SE, 2021, AQUAT CONSERV, V31, P324, DOI 10.1002/aqc.3470; Dufois F, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600282; Eeden RVan., 2016, FINE SCALE FORAGING, DOI [10.3354/meps11557, DOI 10.3354/MEPS11557]; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; FRANCE R, 1995, CAN J FISH AQUAT SCI, V52, P651, DOI 10.1139/f95-065; Freitas R., 2015, NATURAL HIST DESERTA, P14; Garriga J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151984; Gause G.F, 1973, STRUGGLE EXISTENCE; GILARDI JD, 1992, COLON WATERBIRD, V15, P148, DOI 10.2307/1521367; Gonzalez-Solis J, 2000, OIKOS, V90, P390, DOI 10.1034/j.1600-0706.2000.900220.x; Grecian WJ, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0084; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hazevoet C., 2015, NATURAL HIST DESERTA, P208; Hijmans RJ, RASTER GEOGRAPHIC DA; Huffaker C., 1966, J CHEM INF MODEL, V37, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Ichii T, 2004, FISH OCEANOGR, V13, P295, DOI 10.1111/j.1365-2419.2004.00293.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JAEGER RG, 1974, BIOSCIENCE, V24, P33, DOI 10.2307/1296657; Jaquemet S, 2005, MAR BIOL, V147, P573, DOI 10.1007/s00227-005-1610-0; Jenkins E, 2020, PHYSIOL BIOCHEM ZOOL, V93, P296, DOI 10.1086/709460; Kappes MA, 2011, MAR ECOL PROG SER, V441, P281, DOI 10.3354/meps09376; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lerma M, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-02921-1; Lerma Miriam, 2020, Marine Biology (Berlin), V167, P1; Lewis S, 2005, IBIS, V147, P408, DOI 10.1111/j.1474-919x.2005.00428.x; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Longhrust AR., 1987, ECOLOGY TROPICAL OCE; Louzao M, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-8; Mendez L., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Mendez L, 2017, MAR ECOL PROG SER, V568, P217, DOI 10.3354/meps12052; Mendez L, 2016, ACTA OECOL, V72, P87, DOI 10.1016/j.actao.2015.10.017; Meunier T, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC007905; Miller MGR, 2018, J ORNITHOL, V159, P425, DOI 10.1007/s10336-017-1512-1; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Oppel S, 2015, BEHAV ECOL SOCIOBIOL, V69, P915, DOI 10.1007/s00265-015-1903-3; Paiva VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139390; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Passadore C, 2018, ECOL EVOL, V8, P242, DOI 10.1002/ece3.3674; Pearcy WG, 1996, FISH OCEANOGR, V5, P1, DOI 10.1111/j.1365-2419.1996.tb00013.x; Pelegri JL, 2005, J MARINE SYST, V54, P3, DOI 10.1016/j.jmarsys.2004.07.003; Pelletier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031768; Pena-Izquierdo J, 2012, SCI MAR, V76, P65, DOI 10.3989/scimar.03607.18C; Pereira JM, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3316-0; Pettex E, 2010, J EXP BIOL, V213, P2365, DOI 10.1242/jeb.042267; Pettex E, 2019, J AVIAN BIOL, V50, DOI 10.1111/jav.01935; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Phillips RA, 2011, MAR BIOL, V158, P2199, DOI 10.1007/s00227-011-1725-4; Poli CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178318; Ponton-Cevallos J, 2017, EMU, V117, P31, DOI 10.1080/01584197.2016.1265431; Potier S, 2015, ANIM BEHAV, V103, P83, DOI 10.1016/j.anbehav.2015.02.008; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Ramos JA, 2018, CONDOR, V120, P283, DOI 10.1650/CONDOR-17-220.1; Scales KL, 2014, J APPL ECOL, V51, P1575, DOI 10.1111/1365-2664.12330; Schneider D.C., 1990, Polar Research, V8, P17, DOI 10.1111/j.1751-8369.1990.tb00370.x; Semedo G, 2021, BIRD CONSERV INT, V31, P53, DOI 10.1017/S0959270920000428; Shaffer SA, 2001, FUNCT ECOL, V15, P203, DOI 10.1046/j.1365-2435.2001.00514.x; Simmr Parnell A., STABLE ISOTOPE MIXIN; Spear LB, 2001, MAR ECOL PROG SER, V219, P275, DOI 10.3354/meps219275; Stoffel MA, 2017, METHODS ECOL EVOL, V8, P1639, DOI 10.1111/2041-210X.12797; Surman CA, 2003, J ZOOL, V259, P219, DOI 10.1017/S0952836902003047; Thaxter CB, 2009, J AVIAN BIOL, V40, P75, DOI 10.1111/j.1600-048X.2008.04507.x; Thiebault A, 2019, J AVIAN BIOL, V50, DOI 10.1111/jav.02032; Thiebault A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30972; Thomas AC, 2001, GEOPHYS RES LETT, V28, P3421, DOI 10.1029/2001GL013368; Traisnel G, 2019, MAR ECOL PROG SER, V608, P279, DOI 10.3354/meps12827; Votier SC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1068; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Wakefield ED, 2015, ECOLOGY, V96, P3058, DOI 10.1890/14-1300.1; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; Weimerskirch H, 2006, OECOLOGIA, V146, P681, DOI 10.1007/s00442-005-0226-x; Weimerskirch H, 2004, MAR ECOL PROG SER, V275, P297, DOI 10.3354/meps275297; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2010, PROG OCEANOGR, V86, P204, DOI 10.1016/j.pocean.2010.04.003; Weimerskirch H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009928; Weimerskirch H, 2009, MAR ECOL PROG SER, V391, P267, DOI 10.3354/meps07981; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; Wilkinson BP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231654; Wojczulanis K, 2006, J ORNITHOL, V147, P543, DOI 10.1007/s10336-006-0077-1; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2016, J AM STAT ASSOC, V111, P1548, DOI 10.1080/01621459.2016.1180986; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Xavier J. C, 2009, CEPHALOPOD BEAK GUID; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x; Young HS, 2010, MAR ECOL PROG SER, V416, P285, DOI 10.3354/meps08756; Young HS, 2010, MAR ECOL PROG SER, V403, P291, DOI 10.3354/meps08478; Zavalaga CB, 2010, MAR ECOL PROG SER, V404, P259, DOI 10.3354/meps08490	126	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253095	10.1371/journal.pone.0253095	http://dx.doi.org/10.1371/journal.pone.0253095			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153067	Green Published, gold			2022-12-26	WOS:000671691000013
J	Chen, YD; Bi, FG; Sun, ZX				Chen, Yangdi; Bi, Fanggang; Sun, Zixue			A network pharmacology approach to determine the underlying mechanisms of action of Yishen Tongluo formula for the treatment of oligoasthenozoospermia	PLOS ONE			English	Article							POTENTIAL TARGETS; SPERM MOTILITY; PREDICTION; PEROXIDATION; ASSOCIATION; APOPTOSIS; CYTOKINES; EXPOSURE; ESTROGEN; GENOMES	Oligoasthenozoospermia is a complex disease caused by a variety of factors, and its incidence is increasing yearly worldwide. Yishen Tongluo formula (YSTLF), created by Professor Sun Zixue, has been used to treat oligoasthenozoospermia in clinical practice for several decades with a good therapeutic effect. However, the chemical and pharmacological profiles of YSTLF remain unclear and need to be elucidated. In this study, a network pharmacology approach was applied to explore the potential mechanisms of YSTLF in oligoasthenozoospermia treatment. All of the compounds in YSTLF were retrieved from the corresponding databases, and the bioactive ingredients were screened according to their oral bioavailability (OB) and drug-likeness (DL). The potential proteins of YSTLF were obtained from the traditional Chinese medicine systems pharmacology (TCMSP) database and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM) database, while the potential genes of oligoasthenozoospermia were obtained from the GeneCards database and the DisGeNET database. The STRING database was used to construct an interaction network according to the common targets identified by the online tool Venny for YSTLF and oligoasthenozoospermia. The topological characteristics of nodes were visualized and analyzed through Cytoscape. Biological functions and significant pathways were determined and analyzed using the Gene Ontology (GO) knowledgebase, the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Metascape. Finally, the disease-formula-compound-target-pathway network was constructed by Cytoscape. A total of 106 bioactive ingredients and 134 potential targets from YSTLF were associated with oligoasthenozoospermia or considered to be therapeutically relevant. Pathway analysis indicated that the PI3K/Akt, MAPK and apoptosis signaling pathways were significant pathways involved in oligoasthenozoospermia. In conclusion, the current study expounded the pharmacological actions and molecular mechanisms of YSTLF in treating oligoasthenozoospermia from a holistic viewpoint. The potential molecular mechanisms were closely related to antioxidative stress, antiapoptosis and anti-inflammation, with TNF, CCND1, ESR1, NFKBIA, NR3C1, MAPK8, and IL6 being possible targets. This network pharmacology prediction may offer a helpful tool to illustrate the molecular mechanisms of the Chinese herbal compound YSTLF in oligoasthenozoospermia treatment.	[Chen, Yangdi] Henan Univ Chinese Med, Zhengzhou, Henan, Peoples R China; [Bi, Fanggang] Zhengzhou Univ, Dept Orthoped Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Sun, Zixue] Henan Univ Chinese Med, Dept Reprod Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Zhengzhou, Henan, Peoples R China	Henan University of Traditional Chinese Medicine; Zhengzhou University; Henan University of Traditional Chinese Medicine	Sun, ZX (corresponding author), Henan Univ Chinese Med, Dept Reprod Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Zhengzhou, Henan, Peoples R China.	sunhhzx@163.com			National Natural Science Foundation of China (NSFC) [81974573]; Central Plains Thousand Talents Program of Henan Province-Central Plains Famous Doctors Project [ZYMY201809]; Major Special Project of Henan Province for Chinese Medical Researches [2018ZYZD10]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Central Plains Thousand Talents Program of Henan Province-Central Plains Famous Doctors Project; Major Special Project of Henan Province for Chinese Medical Researches	This study was funded by the National Natural Science Foundation of China (NSFC) (81974573), Central Plains Thousand Talents Program of Henan Province (ZYMY201809)-Central Plains Famous Doctors Project and Major Special Project of Henan Province for Chinese Medical Researches (2018ZYZD10).	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1; Bai X, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80780-6; Cemeli E, 2004, ENVIRON MOL MUTAGEN, V44, P420, DOI 10.1002/em.20071; Chen Xiang, 2020, Zhonghua Nan Ke Xue, V26, P341; Cooke PS, 2017, PHYSIOL REV, V97, P995, DOI 10.1152/physrev.00018.2016; Deng C., 2020, K AKT MTOR SIGNALLIN, DOI [10.2174/1566524020666201203164910, DOI 10.2174/1566524020666201203164910]; Diao RY, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13155; Dyer S, 2016, HUM REPROD, V31, P1588, DOI 10.1093/humrep/dew082; Fraczek M, 2008, J ANDROL, V29, P85, DOI 10.2164/jandrol.107.003319; Fraczek M, 2013, J REPROD IMMUNOL, V100, P76, DOI 10.1016/j.jri.2013.09.005; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hu PD, 2017, CELL CYCLE, V16, P2290, DOI 10.1080/15384101.2017.1380130; Huang WY, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113317; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kumar Naina, 2015, J Hum Reprod Sci, V8, P191, DOI 10.4103/0974-1208.170370; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Liu ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep21146; Lu HC, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1108-3; Lu J, 2020, BIOMED PHARMACOTHER, V122, DOI 10.1016/j.biopha.2019.109777; Lu T., 2020, EFFECT NANOTITANIUM, DOI [10.1007/s12011-020-02404-4, DOI 10.1007/S12011-020-02404-4]; Luo TT, 2020, CHIN J INTEGR MED, V26, P72, DOI 10.1007/s11655-019-3064-0; Martinez P, 2007, ASIAN J ANDROL, V9, P102, DOI 10.1111/j.1745-7262.2007.00238.x; MEN Bo., 2017, CHINESE MED MODERN D, V15, P84; Min KB, 2017, ENVIRON POLLUT, V226, P118, DOI 10.1016/j.envpol.2017.03.069; Nordkap L, 2017, ANDROLOGY-US, V5, P1105, DOI 10.1111/andr.12418; Perdichizzi A, 2007, J CLIN IMMUNOL, V27, P152, DOI 10.1007/s10875-007-9071-5; Nueno VIP, 2016, CURR PHARM DESIGN, V22, P6881, DOI 10.2174/138161282246170124192058; Pinero J, 2017, NUCLEIC ACIDS RES, V45, pD833, DOI 10.1093/nar/gkw943; Politch JA, 2007, HUM REPROD, V22, P2928, DOI 10.1093/humrep/dem281; Potnuri AG, 2018, BIOMED PHARMACOTHER, V101, P174, DOI 10.1016/j.biopha.2018.02.068; Primmer CR, 2013, MOL ECOL, V22, P3216, DOI 10.1111/mec.12309; Rakha B., 2020, GALLUS GALLUS MURGHI, V18, P311, DOI [10.1089/bio.2020.0007, DOI 10.1089/BIO.2020.0007]; Rashid HO, 2015, AUTOPHAGY, V11, P1956, DOI 10.1080/15548627.2015.1091141; Ru JL, 2014, J CHEMINFORMATICS, V6, DOI 10.1186/1758-2946-6-13; Sapozhkova Z., 2020, DIAGNOSTIKA, V65, P106, DOI [10.18821/0869-2084-2020-65-2-106-110, DOI 10.51620/0869-2084]; Saraswat S, 2020, REPROD DOMEST ANIM, V55, P1080, DOI 10.1111/rda.13746; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen XY, 2018, INT J MOL MED, V42, P2819, DOI 10.3892/ijmm.2018.3825; Silva EJR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17944-4; Stelzer G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2722-2; Sun W, 2014, J ASSIST REPROD GEN, V31, P541, DOI 10.1007/s10815-014-0177-4; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tao WY, 2013, J ETHNOPHARMACOL, V145, P1, DOI 10.1016/j.jep.2012.09.051; Wang HY, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0248-1; Wang J, 2010, LUPUS, V19, P734, DOI 10.1177/0961203309359517; Wang Y, 2021, J ADV RES, V28, P231, DOI 10.1016/j.jare.2020.07.007; Xu WM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00007; Xu X, 2012, INT J MOL SCI, V13, P6964, DOI 10.3390/ijms13066964; Yahyazadeh A, 2019, BIOTECH HISTOCHEM, V94, P298, DOI 10.1080/10520295.2019.1566568; Yang Z, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/7628125; Ye RJ, 2020, FITOTERAPIA, V147, DOI 10.1016/j.fitote.2020.104756; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu LS, 2019, OPEN BIOL, V9, pCP6, DOI 10.1098/rsob.180091; Zhang J, 2020, EXP CELL RES, V394, DOI 10.1016/j.yexcr.2020.112151; Zhang SN, 2017, J ETHNOPHARMACOL, V198, P131, DOI 10.1016/j.jep.2017.01.002; Zhang YH, 2015, TOXICOL REP, V2, P664, DOI 10.1016/j.toxrep.2015.04.007; Zhang ZY, 2020, J ETHNOPHARMACOL, V249, DOI 10.1016/j.jep.2019.112371; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhu Q, 2019, ARTIF CELL NANOMED B, V47, P2010, DOI 10.1080/21691401.2019.1608217	59	2	3	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252906	10.1371/journal.pone.0252906	http://dx.doi.org/10.1371/journal.pone.0252906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153045	gold, Green Published			2022-12-26	WOS:000671691000024
J	Mohidem, NA; Osman, M; Hashim, Z; Muharam, FM; Elias, SM; Shaharudin, R				Mohidem, Nur Adibah; Osman, Malina; Hashim, Zailina; Muharam, Farrah Melissa; Elias, Saliza Mohd; Shaharudin, Rafiza			Association of sociodemographic and environmental factors with spatial distribution of tuberculosis cases in Gombak, Selangor, Malaysia	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; TREATMENT OUTCOMES; AIR-POLLUTION; PULMONARY TUBERCULOSIS; DIESEL EXHAUST; RISK-FACTORS; TRANSMISSION; DETERMINANTS; CLUSTERS; DISEASE	Tuberculosis (TB) cases have increased drastically over the last two decades and it remains as one of the deadliest infectious diseases in Malaysia. This cross-sectional study aimed to establish the spatial distribution of TB cases and its association with the sociodemographic and environmental factors in the Gombak district. The sociodemographic data of 3325 TB cases such as age, gender, race, nationality, country of origin, educational level, employment status, health care worker status, income status, residency, and smoking status from 1st January 2013 to 31st December 2017 in Gombak district were collected from the MyTB web and Tuberculosis Information System (TBIS) database at the Gombak District Health Office and Rawang Health Clinic. Environmental data consisting of air pollution such as air quality index (AQI), carbon monoxide (CO), nitrogen dioxide (NO2), sulphur dioxide (SO2), and particulate matter 10 (PM10,) were obtained from the Department of Environment Malaysia from 1st July 2012 to 31st December 2017; whereas weather data such as rainfall were obtained from the Department of Irrigation and Drainage Malaysia and relative humidity, temperature, wind speed, and atmospheric pressure were obtained from the Malaysia Meteorological Department in the same period. Global Moran's I, kernel density estimation, Getis-Ord Gi* statistics, and heat maps were applied to identify the spatial pattern of TB cases. Ordinary least squares (OLS) and geographically weighted regression (GWR) models were used to determine the spatial association of sociodemographic and environmental factors with the TB cases. Spatial autocorrelation analysis indicated that the cases was clustered (p<0.05) over the five-year period and year 2016 and 2017 while random pattern (p>0.05) was observed from year 2013 to 2015. Kernel density estimation identified the high-density regions while Getis-Ord Gi* statistics observed hotspot locations, whereby consistently located in the southwestern part of the study area. This could be attributed to the overcrowding of inmates in the Sungai Buloh prison located there. Sociodemographic factors such as gender, nationality, employment status, health care worker status, income status, residency, and smoking status as well as; environmental factors such as AQI (lag 1), CO (lag 2), NO2 (lag 2), SO2 (lag 1), PM10 (lag 5), rainfall (lag 2), relative humidity (lag 4), temperature (lag 2), wind speed (lag 4), and atmospheric pressure (lag 6) were associated with TB cases (p<0.05). The GWR model based on the environmental factors i.e. GWR2 was the best model to determine the spatial distribution of TB cases based on the highest R-2 value i.e. 0.98. The maps of estimated local coefficients in GWR models confirmed that the effects of sociodemographic and environmental factors on TB cases spatially varied. This study highlighted the importance of spatial analysis to identify areas with a high TB burden based on its associated factors, which further helps in improving targeted surveillance.	[Mohidem, Nur Adibah; Hashim, Zailina; Elias, Saliza Mohd] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Environm & Occupat Hlth, Serdang, Selangor, Malaysia; [Osman, Malina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol, Serdang, Selangor, Malaysia; [Muharam, Farrah Melissa] Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor, Malaysia; [Shaharudin, Rafiza] Natl Inst Hlth, Inst Med Res, Shah Alam, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Kementerian Kesihatan Malaysia	Muharam, FM (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Agr Technol, Serdang, Selangor, Malaysia.	farrahm@upm.edu.my	Shaharudin, Rafiza/CAF-2155-2022	Shaharudin, Rafiza/0000-0002-8811-5843; Mohidem, Nur Adibah/0000-0002-4523-2302				Abascal E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59373-w; Abdul IW, 2020, SCI AFR, V7, DOI 10.1016/j.sciaf.2020.e00307; Adeniji SE, 2020, J KING SAUD UNIV SCI, V32, P575, DOI 10.1016/j.jksus.2018.08.010; Alipour Fayez Elham, 2020, J Immunoassay Immunochem, V41, P885, DOI 10.1080/15321819.2020.1806075; Alves LS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4263-1; Amsalu E, 2019, ARCH GERONTOL GERIAT, V83, P328, DOI 10.1016/j.archger.2019.05.011; An SJ, 2020, J THORAC DIS, V12, P375, DOI 10.21037/jtd.2020.01.38; [Anonymous], 2019, DIS CONTR DIV; Asgharinia S, 2020, GROUNDWATER SUST DEV, V10, DOI 10.1016/j.gsd.2019.100294; Asnawi NH, 2016, SAINS MALAYS, V45, P1869, DOI 10.17576/jsm-2016-4512-11; Beiranvand R, 2016, IRAN J PUBLIC HEALTH, V45, P86; Ben Jmaa Maissa, 2020, Tunis Med, V98, P232; Bhembe NL, 2020, INFECT GENET EVOL, V80, DOI 10.1016/j.meegid.2020.104182; Blanco-Guillot F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193911; de Almeida CPB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25409-5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campelo TA, 2020, REV INST MED TROP SP, V62, DOI [10.1590/S1678-9946202062004, 10.1590/s1678-9946202062004]; Cao K, 2019, ANN AM ASSOC GEOGR, V109, P173, DOI 10.1080/24694452.2018.1470925; Cao K, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13050469; Carvalho Marilia Sá, 2005, Cad. Saúde Pública, V21, P361, DOI 10.1590/S0102-311X2005000200003; Census, 2018, POPULATION DISTRIBUT; Cheng H, 2019, INT J BIOMETEOROL, V63, P1437, DOI 10.1007/s00484-019-01766-2; Cheng J, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1477-1; Chia SZG, 2020, AM J INFECT CONTROL, V48, P650, DOI 10.1016/j.ajic.2019.10.014; Click ES, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104232; Commiesie E, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.86; Ding ZQ, 2020, MATH BIOSCI ENG, V17, P4317, DOI 10.3934/mbe.2020238; Erawati M, 2020, J MULTIDISCIP HEALTH, V13, P197, DOI 10.2147/JMDH.S241972; ESRI, 2016, ARCV GIS GEO INF SYS; Esri, COMM REGR PROBL CONS; Fotheringham AS, 1998, ENVIRON PLANN A, V30, P1905, DOI 10.1068/a301905; Fotheringham AS, 1999, GEOGR ANAL, V31, P340; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Ghadimi-Moghadam A, 2020, ACTA MEDICA MEDITERR, V36, P557, DOI 10.19193/0393-6384_2020_1_88; Goroh MMD, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5030124; Guo C, 2017, EPIDEMIOL INFECT, V145, P2510, DOI 10.1017/S0950268817001133; Guthmann JP, 2020, EUROSURVEILLANCE, V25, P17, DOI 10.2807/1560-7917.ES.2020.25.4.1900191; Haddad MB, 2020, AM J PREV MED, V58, P858, DOI 10.1016/j.amepre.2019.12.010; Han M., 2014, NITROGEN DIOXIDE INH; Hassim M., 2020, IOP Conference Series: Earth and Environmental Science, V479, DOI 10.1088/1755-1315/479/1/012018; Hella J, 2017, J INFECTION, V75, P191, DOI 10.1016/j.jinf.2017.06.009; Hertz D, 2019, SEMIN IMMUNOPATHOL, V41, P225, DOI 10.1007/s00281-018-0725-6; Huang J, 2018, ENVIRON INT, V113, P42, DOI 10.1016/j.envint.2018.01.022; Huang K, 2020, ENVIRON RES, V189, DOI 10.1016/j.envres.2020.109900; Huang K, 2020, ENVIRON RES, V184, DOI 10.1016/j.envres.2020.109343; Huang SQ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051522; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Jiandong Y., 2020, CHINA INT J INFECT D; Jin Y, 2018, BIOMED ENVIRON SCI, V31, P448, DOI 10.3967/bes2018.058; Khalique F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113763; Khan AH, 2019, INFECT DIS CLIN PRAC, V27, P148, DOI 10.1097/IPC.0000000000000719; Kim K, 2018, TUBERCULOSIS, V111, P127, DOI 10.1016/j.tube.2018.06.003; Kolifarhood G, 2015, J EPIDEMIOL GLOB HEA, V5, P221, DOI 10.1016/j.jegh.2014.11.001; Krige DG., 1966, J S AFR I MIN MET, V66, P13; Kuddus MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49135-8; Kuhnert D, 2018, EPIDEMICS-NETH, V25, P47, DOI 10.1016/j.epidem.2018.05.004; Lai TC, 2016, OCCUP ENVIRON MED, V73, P56, DOI 10.1136/oemed-2015-102995; Lee A, 2015, ANN GLOB HEALTH, V81, P368, DOI 10.1016/j.aogh.2015.08.006; Leung CC, 2005, INT J EPIDEMIOL, V34, P924, DOI 10.1093/ije/dyi080; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Li QH, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103949; Li XZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068102, 10.1371/journal.pone.0067744]; Li ZQ, 2019, INT J INFECT DIS, V87, P177, DOI 10.1016/j.ijid.2019.07.027; Liew SM, 2019, ASIA-PAC J PUBLIC HE, V31, P61, DOI 10.1177/1010539518817980; Liu M Y, 2018, Zhonghua Liu Xing Bing Xue Za Zhi, V39, P1565, DOI 10.3760/cma.j.issn.0254-6450.2018.12.006; Malaysian Meteorological Department, 2018, GEN CLIM MAL; McMillen DP, 2004, AM J AGR ECON, V86, P554, DOI 10.1111/j.0002-9092.2004.600_2.x; Ministry of Health Malaysia. Academy of Medicine Malaysia & Malaysian Thoracic Society, CLIN PRACTICE GUIDEL, V12; Ministry of Health of Malaysia, 2019, ANN REP 2018 TB CONT; Mohidem NA, 2018, REV ENVIRON HEALTH, V33, P407, DOI 10.1515/reveh-2018-0026; Mollel EW, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00212-z; Murakami R, 2019, INT J TUBERC LUNG D, V23, P181, DOI 10.5588/ijtld.18.0369; Palanisamy GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026254; PATTERSON HD, 1981, BIOMETRICS, V37, P862, DOI 10.2307/2530185; Petersen WF., 1942, ANN M AM COLL CHE PH; Pica N, 2012, CURR OPIN VIROL, V2, P90, DOI 10.1016/j.coviro.2011.12.003; Pinto CT, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv152; Puente C.E., 1986, MATH GEOL, V18, P287, DOI DOI 10.1007/BF00898033; Readhead A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09523-6; Saito Y, 2002, EXP LUNG RES, V28, P493, DOI 10.1080/01902140290096764; Saito Y, 2002, EXP LUNG RES, V28, P201, DOI 10.1080/019021402753570509; Sana A., 2018, SEASONALITY PULMONAR, V97, P808; Schroeder L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103718; Singh H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228712; Smid JH, 2010, INT J FOOD MICROBIOL, V139, pS57, DOI 10.1016/j.ijfoodmicro.2009.12.015; Sohn M, 2019, INT J ENVIRON HEAL R, V29, P657, DOI 10.1080/09603123.2019.1566522; Sopori ML, 1998, PSYCHONEUROENDOCRINO, V23, P189, DOI 10.1016/S0306-4530(97)00076-0; Stang, 2020, ENFERM CLIN, V30, P383, DOI 10.1016/j.enfcli.2019.10.105; Stanikzai MH, 2019, J CLIN DIAGN RES, V13, DOI 10.7860/JCDR/2019/42689.13249; Sultana S, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10051511; Sweeney S, 2020, PHARMACOECONOMICS, V38, P619, DOI 10.1007/s40273-020-00898-3; Taherian A, 2020, INT J HEALTH PROMOT, V58, P83, DOI 10.1080/14635240.2019.1678396; Thai L T, 2020, Med J Malaysia, V75, P204; Tok PSK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231986; Uden L, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx137; van de Schoot R, 2014, CHILD DEV, V85, P842, DOI 10.1111/cdev.12169; Wah W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1121; Wang JF., 2017, ACTA GEOGRAPHICA SIN, V27, P116; Wang JJ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000485; Wang P, 2004, ARTIF INTELL, V158, P97, DOI 10.1016/j.artint.2003.09.003; Wang W, 2016, J THORAC DIS, V8, pE57, DOI 10.3978/j.issn.2072-1439.2015.12.64; Wang Y S, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P526, DOI 10.3760/cma.j.cn112338-20190614-00441; Wardani DWSR, 2020, INDIAN J COMMUN MED, V45, P43, DOI 10.4103/ijcm.IJCM_182_19; WHO, 2017, GLOB TUB REP; Xia LJ, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-6698-6; Xue R., 2020, ECOLOGICA SINICA, V40; Yang S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16224395; You SM, 2016, ENVIRON POLLUT, V218, P1170, DOI 10.1016/j.envpol.2016.08.071; Zdaniuk B., 2014, ENCY QUALITY LIFE WE, DOI [10.1007/978-94-007-0753-5_2008, DOI 10.1007/978-94-007-0753-5_2008]	109	3	4	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252146	10.1371/journal.pone.0252146	http://dx.doi.org/10.1371/journal.pone.0252146			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138899	Green Published, gold			2022-12-26	WOS:000671690200009
J	Obembe, OS; Hendricks, NP; Tack, J				Obembe, Oladipo S.; Hendricks, Nathan P.; Tack, Jesse			Decreased wheat production in the USA from climate change driven by yield losses rather than crop abandonment	PLOS ONE			English	Article							WINTER-WHEAT; EXTREME HEAT; TEMPERATURE; DROUGHT; WEATHER; STRESS; GROWTH; IMPACT; FROST	An increase in global average surface temperature over the 21st century will affect food production. There is still uncertainty if the source of the production losses caused by climate change could be driven either by lower yield or reduced area harvested. We use county-level production data on winter wheat coupled with fine-scale weather outcomes between 1981-2007 to examine the impact of climate change on winter wheat production in Kansas. We decompose the total impact of weather variables through both the yield and harvested acreage channels. We find that an insignificant portion-both in terms of magnitude and statistical significance-of the production losses are due to reduced harvested acres (i.e., crop abandonment). The proportion harvested only account for 14.88% and 21.71% of the total damages under RCPs 4.5 and 8.5 and neither effect is statistically significant. An implication of this result implies that studies that only examine climate impacts on harvested yields are not significantly underestimating the climate change impacts on production.	[Obembe, Oladipo S.] Arkansas State Univ, Coll Agr, Jonesboro, AR 72401 USA; [Hendricks, Nathan P.; Tack, Jesse] Kansas State Univ, Dept Agr Econ, Manhattan, KS 66506 USA	Arkansas State University; Kansas State University	Obembe, OS (corresponding author), Arkansas State Univ, Coll Agr, Jonesboro, AR 72401 USA.	oobembe@astate.edu						Acevedo E., 2009, BREAD WHEAT IMPROVEM, P39; Asseng S, 2015, NAT CLIM CHANGE, V5, P143, DOI [10.1038/nclimate2470, 10.1038/NCLIMATE2470]; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; Barlow KM, 2015, FIELD CROP RES, V171, P109, DOI 10.1016/j.fcr.2014.11.010; Bond J, 2015, USDA EC RES SERVICE; Bunting A, 1982, FOOD NUTR CLIMATE FOOD NUTR CLIMATE; Cameron AC, 2008, REV ECON STAT, V90, P414, DOI 10.1162/rest.90.3.414; Cameron AC, 2015, J HUM RESOUR, V50, P317, DOI 10.3368/jhr.50.2.317; CHAMBERLAIN G, 1980, REV ECON STUD, V47, P225, DOI 10.2307/2297110; Cromey MG, 1998, NEW ZEAL J CROP HORT, V26, P279, DOI 10.1080/01140671.1998.9514065; Cui XM, 2020, J ASSOC ENVIRON RESO, V7, P901, DOI 10.1086/709859; Eitzinger J, 2003, AGR WATER MANAGE, V61, P195, DOI 10.1016/S0378-3774(03)00024-6; Fuglie, 2007, EC BRIEF NUMBER 9; Gammans M, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa6b0c; Hawkins E, 2013, AGR FOREST METEOROL, V170, P19, DOI 10.1016/j.agrformet.2012.04.007; Hendricks NP, 2018, J ASSOC ENVIRON RESO, V5, P545, DOI 10.1086/697305; Herbek J., 2009, COMPREHENSIVE GUIDE; Herrero M., 2019, IPCC SPECIAL REPORT; Hubert B, 2010, CROP SCI, V50, pS33, DOI 10.2135/cropsci2009.09.0530; Ihsan MZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00795; Iizumi T, 2018, INT J CLIMATOL, V38, P5405, DOI 10.1002/joc.5818; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Kang YH, 2009, PROG NAT SCI-MATER, V19, P1665, DOI 10.1016/j.pnsc.2009.08.001; Kukal MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21848-2; Li XN, 2015, PLANT GROWTH REGUL, V77, P11, DOI 10.1007/s10725-015-0029-y; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Maunder WJ, 2012, DICT GLOBAL CLIMATE; Mendelsohn R, 2007, CLIMATIC CHANGE, V81, P61, DOI 10.1007/s10584-005-9009-y; Miao RQ, 2016, AM J AGR ECON, V98, P191, DOI 10.1093/ajae/aav025; MUNDLAK Y, 1978, ECONOMETRICA, V46, P69, DOI 10.2307/1913646; O'Leary GJ, 2015, GLOBAL CHANGE BIOL, V21, P2670, DOI 10.1111/gcb.12830; Ortiz-Bobea A, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab1e75; Ortiz-Bobea A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4343; Paulsen GM, 1997, PUBLICATION KANSAS C PUBLICATION KANSAS C, V529; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Ray DK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217148; Robertson LD, 2004, U IDAHO COLL AGR LIF, V827, P12; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Shroyer J., 1995, SPRING FREEZE INJURY; Stuecker MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201426; Tack J, 2011, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8d27; Tack J, 2015, P NATL ACAD SCI USA, V112, P6931, DOI 10.1073/pnas.1415181112; Wang S.L., 2015, US AGR PRODUCTIVITY; Warrick B. E., 1999, FREEZE INJURY WHEAT; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Xu H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156083; Yu HQ, 2018, INT J DISAST RISK SC, V9, P376, DOI 10.1007/s13753-018-0187-4	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252067	10.1371/journal.pone.0252067	http://dx.doi.org/10.1371/journal.pone.0252067			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138898	Green Published, gold			2022-12-26	WOS:000671690200066
J	Park, SJ; Ahmad, F; Bahde, RJ; Philp, A; Kim, J; Huang, TJ; Kim, MK; Trenkle, WC; Chung, JH				Park, Sung-Jun; Ahmad, Faiyaz; Bahde, Robert J.; Philp, Andrew; Kim, Jeonghan; Huang, Tianjiao; Kim, Myung K.; Trenkle, William C.; Chung, Jay H.			Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis	PLOS ONE			English	Article							PROTEIN-KINASE AMPK; PHOSPHODIESTERASE-4 INHIBITOR; SKELETAL-MUSCLE; ROFLUMILAST; PHOSPHORYLATION; METABOLISM; HYPERTROPHY; BENEFITS; ROLIPRAM; TARGET	AMP-activated protein kinase (AMPK) is an evolutionarily conserved energy sensor. Activation of AMPK leads to a number of metabolic benefits, including improved mitochondrial function in skeletal muscle and lowering of serum glucose levels in type-2 diabetes models. However, direct activation of AMPK leads to cardiac enlargement, and an alternative strategy that activates AMPK without affecting the heart is needed. Inhibition of phosphodiesterase 4 (PDE4), which is poorly expressed in the human heart, activates AMPK in other tissues. In a screen to identify novel PDE4 inhibitors, we discovered compound CBU91, which is 5-10 fold more potent than rolipram, the best characterized PDE4 inhibitor. CBU91, like rolipram, is able to activate AMPK and Sirt1 and increase mitochondrial function in myotubes. These findings suggest that activation of AMPK in myotubes is a general property of PDE4 inhibition and that PDE4 inhibition may activate AMPK in metabolically relevant tissues without affecting the heart.	[Park, Sung-Jun; Kim, Jeonghan; Huang, Tianjiao; Kim, Myung K.; Chung, Jay H.] NHLBI, Lab Obes & Aging Res, Cardiovasc Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Ahmad, Faiyaz] Sidra Med & Res Ctr, Dept Pediat Med, Div Endocrinol, Doha, Qatar; [Bahde, Robert J.; Trenkle, William C.] NIDDK, Lab Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Philp, Andrew] Garvan Inst Med Res, Diabet & Metab Div, Mitochondrial Metab & Ageing Lab, Darlinghurst, NSW, Australia; [Bahde, Robert J.] US FDA, Silver Spring, MD USA; [Trenkle, William C.] USDA, Washington, DC 20250 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Sidra Medical & Research Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Garvan Institute of Medical Research; US Food & Drug Administration (FDA); United States Department of Agriculture (USDA)	Park, SJ; Chung, JH (corresponding author), NHLBI, Lab Obes & Aging Res, Cardiovasc Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	parksj2@nhlbi.nih.gov; chungj@nhlbi.nih.gov	Khan, Faiyaz Ahmad/AAW-7944-2021	Philp, Andrew/0000-0003-3860-4136; Kim, Jeonghan/0000-0003-1695-9630; Ahmad Khan, Faiyaz/0000-0003-4242-2941	National Institutes of Health (NIH) [JC HL006119]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JC HL006119 National Institutes of Health (NIH).	Berdeaux R, 2012, AM J PHYSIOL-ENDOC M, V303, pE1, DOI 10.1152/ajpendo.00555.2011; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cauthron RD, 1998, MOL CELL BIOL, V18, P1416, DOI 10.1128/MCB.18.3.1416; Chung JH, 2012, ADIPOCYTE, V1, P256, DOI 10.4161/adip.21158; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Field SK, 2011, CLIN MED INSIGHTS-CI, V5, P57, DOI 10.4137/CCRPM.S7049; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gancedo JM, 2013, BIOL REV, V88, P645, DOI 10.1111/brv.12020; Gavalda A, 2013, EXPERT OPIN THER PAT, V23, P997, DOI 10.1517/13543776.2013.794789; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensterle M, 2014, J CLIN ENDOCR METAB, V99, pE1476, DOI 10.1210/jc.2014-1430; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Korhonen R, 2013, BRIT J PHARMACOL, V169, P1525, DOI 10.1111/bph.12189; Li YF, 2009, NEUROPSYCHOPHARMACOL, V34, P2404, DOI 10.1038/npp.2009.66; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Pages L, 2009, EXPERT OPIN THER PAT, V19, P1501, DOI 10.1517/13543770903313753; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Patel VA, 2015, J BIOL CHEM, V290, P22352, DOI 10.1074/jbc.M115.667345; Richter W, 2013, EXPERT OPIN THER TAR, V17, P1011, DOI 10.1517/14728222.2013.818656; Shinkre BA, 2010, BIOORG MED CHEM LETT, V20, P5690, DOI 10.1016/j.bmcl.2010.08.021; Tikoo K, 2014, BIOCHEM BIOPH RES CO, V450, P1581, DOI 10.1016/j.bbrc.2014.07.039; Vollert S, 2012, DIABETOLOGIA, V55, P2779, DOI 10.1007/s00125-012-2632-z; Wang R, 2019, ADV EXP MED BIOL, V1206, P421, DOI 10.1007/978-981-15-0602-4_19; Wouters EFM, 2012, J CLIN ENDOCR METAB, V97, pE1720, DOI 10.1210/jc.2011-2886; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang KQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02455-z	28	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253269	10.1371/journal.pone.0253269	http://dx.doi.org/10.1371/journal.pone.0253269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138962	Green Published, gold			2022-12-26	WOS:000671690200093
J	Romanchek, GR; Abbaszadeh, S				Romanchek, Gregory R.; Abbaszadeh, Shiva			Stopping criteria for ending autonomous, single detector radiological source searches	PLOS ONE			English	Article							SOURCE LOCALIZATION	While the localization of radiological sources has traditionally been handled with statistical algorithms, such a task can be augmented with advanced machine learning methodologies. The combination of deep and reinforcement learning has provided learning-based navigation to autonomous, single-detector, mobile systems. However, these approaches lacked the capacity to terminate a surveying/search task without outside influence of an operator or perfect knowledge of source location (defeating the purpose of such a system). Two stopping criteria are investigated in this work for a machine learning navigated system: one based upon Bayesian and maximum likelihood estimation (MLE) strategies commonly used in source localization, and a second providing the navigational machine learning network with a "stop search" action. A convolutional neural network was trained via reinforcement learning in a 10 m x 10 m simulated environment to navigate a randomly placed detector-agent to a randomly placed source of varied strength (stopping with perfect knowledge during training). The network agent could move in one of four directions (up, down, left, right) after taking a 1 s count measurement at the current location. During testing, the stopping criteria for this navigational algorithm was based upon a Bayesian likelihood estimation technique of source presence, updating this likelihood after each step, and terminating once the confidence of the source being in a single location exceeded 0.9. A second network was trained and tested with similar architecture as the previous but which contained a fifth action: for self-stopping. The accuracy and speed of localization with set detector and source initializations were compared over 50 trials of MLE-Bayesian approach and 1000 trials of the CNN with self-stopping. The statistical stopping condition yielded a median localization error of similar to 1.41 m and median localization speed of 12 steps. The machine learning stopping condition yielded a median localization error of 0 m and median localization speed of 17 steps. This work demonstrated two stopping criteria available to a machine learning guided, source localization system.	[Romanchek, Gregory R.; Abbaszadeh, Shiva] Univ Illinois, Grainger Coll Engn, Dept Nucl, Plasma,Radiol Engn, Urbana, IL 61801 USA; [Abbaszadeh, Shiva] Univ Calif Santa Cruz, Jack Baskin Sch Engn, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Santa Cruz	Romanchek, GR (corresponding author), Univ Illinois, Grainger Coll Engn, Dept Nucl, Plasma,Radiol Engn, Urbana, IL 61801 USA.	romanch2@illinois.edu		Romanchek, Gregory/0000-0002-4775-2176	Department of Energy National Nuclear Security Administration through the Consortium for Nonproliferation Enabling Capabilities [DE-NA0002576]	Department of Energy National Nuclear Security Administration through the Consortium for Nonproliferation Enabling Capabilities	This work is based upon work supported by the Department of Energy National Nuclear Security Administration under Award Number(s) DE-NA0002576 through the Consortium for Nonproliferation Enabling Capabilities to GR (https://cnec.ncsu.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R. B., 2019, 2019 IEEE 15 INT C A; [Anonymous], D3S ID GAMM NEUTR DE D3S ID GAMM NEUTR DE; Bai EW, 2015, IEEE T NUCL SCI, V62, P3274, DOI 10.1109/TNS.2015.2497327; Deb B, 2013, IEEE T NUCL SCI, V60, P1315, DOI 10.1109/TNS.2013.2247060; Duisterhof B.P., 2021, ARXIV190911236 ARXIV190911236; Gong P, 2019, APPL RADIAT ISOTOPES, V150, P1, DOI 10.1016/j.apradiso.2019.04.037; Gunatilaka B.Ristic, 2007, 2007 INFORM DECISION; Hellfeld D, 2019, IEEE T NUCL SCI, V66, P2088, DOI 10.1109/TNS.2019.2930294; Hite J, 2019, RADIAT PHYS CHEM, V155, P271, DOI 10.1016/j.radphyschem.2018.06.024; Liu Z, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19040960; Liu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205092; Miles PR, 2021, NUCL TECHNOL, V207, P37, DOI 10.1080/00295450.2020.1738796; Miller EA, 2015, NUCL INSTRUM METH A, V784, P332, DOI 10.1016/j.nima.2015.01.038; Moreland M., 2007, 2007 10 INT C INF FU 2007 10 INT C INF FU; Morelande MR, 2009, IEEE T SIGNAL PROCES, V57, P4220, DOI 10.1109/TSP.2009.2026618; Newaz AA, 2016, ROBOT AUTON SYST, V85, P12, DOI 10.1016/j.robot.2016.08.002; Romanchek GR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228048; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Vavrek J.R., 2020, IEEE T NUCL SCI	19	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253211	10.1371/journal.pone.0253211	http://dx.doi.org/10.1371/journal.pone.0253211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138929	gold, Green Published			2022-12-26	WOS:000671690200031
J	Shook, J; Gangopadhyay, T; Wu, LJ; Ganapathysubramanian, B; Sarkar, S; Singh, AK				Shook, Johnathon; Gangopadhyay, Tryambak; Wu, Linjiang; Ganapathysubramanian, Baskar; Sarkar, Soumik; Singh, Asheesh K.			Crop yield prediction integrating genotype and weather variables using deep learning	PLOS ONE			English	Article							TEMPERATURE; SYSTEM	Accurate prediction of crop yield supported by scientific and domain-relevant insights, is useful to improve agricultural breeding, provide monitoring across diverse climatic conditions and thereby protect against climatic challenges to crop production. We used performance records from Uniform Soybean Tests (UST) in North America to build a Long Short Term Memory (LSTM)-Recurrent Neural Network based model that leveraged pedigree relatedness measures along with weekly weather parameters to dissect and predict genotype response in multiple-environments. Our proposed models outperformed other competing machine learning models such as Support Vector Regression with Radial Basis Function kernel (SVR-RBF), least absolute shrinkage and selection operator (LASSO) regression and the data-driven USDA model for yield prediction. Additionally, for providing interpretability of the important time-windows in the growing season, we developed a temporal attention mechanism for LSTM models. The outputs of such interpretable models could provide valuable insights to plant breeders.	[Shook, Johnathon; Singh, Asheesh K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Gangopadhyay, Tryambak; Wu, Linjiang; Ganapathysubramanian, Baskar; Sarkar, Soumik] Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA	Iowa State University; Iowa State University	Singh, AK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.; Sarkar, S (corresponding author), Iowa State Univ, Dept Mech Engn, Ames, IA 50011 USA.	Soumiks@iastate.edu; Singhak@iastate.edu	SARKAR, SOUMIK/T-9707-2018		Iowa Soybean Association; Monsanto Chair in Soybean Breeding; RF Baker Center for Plant Breeding; Plant Sciences Institute; USDA; NSF NRT; ISU's Presidential Interdisciplinary Research Initiative [378]	Iowa Soybean Association; Monsanto Chair in Soybean Breeding; RF Baker Center for Plant Breeding; Plant Sciences Institute; USDA(United States Department of Agriculture (USDA)); NSF NRT(National Science Foundation (NSF)NSF - Office of the Director (OD)); ISU's Presidential Interdisciplinary Research Initiative	Funding for this project was provided by Iowa Soybean Association (AKS), Monsanto Chair in Soybean Breeding (AKS), RF Baker Center for Plant Breeding (AKS), Plant Sciences Institute (SS, BG and AKS), USDA (SS, BG, AKS), NSF NRT (graduate fellowship to JS) and ISU's Presidential Interdisciplinary Research Initiative (AKS, BG, 378 SS).	Abadi M, 2016, PROCEEDINGS OF OSDI'16: 12TH USENIX SYMPOSIUM ON OPERATING SYSTEMS DESIGN AND IMPLEMENTATION, P265; Arunkumar N, 2019, SOFT COMPUT, V23, P9083, DOI 10.1007/s00500-018-3618-7; Bahdanau D., 2015, P INT C REPR LEARN; BENGIO Y, 1994, IEEE T NEURAL NETWOR, V5, P157, DOI 10.1109/72.279181; Bishop KA, 2014, FOOD ENERGY SECUR, V3, P33, DOI 10.1002/fes3.44; Blanc E, 2017, AGR FOREST METEOROL, V236, P145, DOI 10.1016/j.agrformet.2016.12.022; Chen C, 2018, ARXIV PREPRINT ARXIV; Cho K., 2014, EMNLP, DOI 10.3115/v1/w14-4012; Choi E, 2016, ADV NEUR IN, V29; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Doetseh P, 2014, INT CONF FRONT HAND, P279, DOI 10.1109/ICFHR.2014.54; Dorffner G., 1996, Neural Network World, V6, P447; Durrell J, 2017, PATHWAYS IMPACT BUIL; Falk KG, 2020, PLANT PHENOMICS, V2020, DOI 10.34133/2020/1925495; Gangopadhyay Tryambak, 2020, Dynamic Data Driven Application Systems. Third International Conference, DDDAS 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12312), P93, DOI 10.1007/978-3-030-61725-7_13; Gangopadhyay T, 2020, ARXIV PREPRINT ARXIV; Gangopadhyay T, 2018, NEURIPS 2018 WORKSH; Gangopadhyay T., 2019, DEEP LEARNING MONITO; Gangopadhyay T., 2020, DYNAMICS CONTROL ENE, P283; Gao TS, 2018, ROBOTICS, V7, DOI 10.3390/robotics7040061; Gers FA, 1999, IEE CONF PUBL, P850, DOI [10.1162/089976600300015015, 10.1049/cp:19991218]; Ghosal S, 2018, P NATL ACAD SCI USA, V115, P4613, DOI 10.1073/pnas.1716999115; Gibson LR, 1996, CROP SCI, V36, P98, DOI 10.2135/cropsci1996.0011183X003600060034x; Gillen A.M., 2018, UNIFORM SOYBEAN TEST; Greff K, 2017, IEEE T NEUR NET LEAR, V28, P2222, DOI 10.1109/TNNLS.2016.2582924; Hickey LT, 2019, NAT BIOTECHNOL, V37, P744, DOI 10.1038/s41587-019-0152-9; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; HYMOWITZ T, 1983, ECON BOT, V37, P371, DOI 10.1007/BF02904196; Jagtap SS, 2002, AGR ECOSYST ENVIRON, V93, P73, DOI 10.1016/S0167-8809(01)00358-9; Jiang H, 2020, GLOBAL CHANGE BIOL, V26, P1754, DOI 10.1111/gcb.14885; Jiang Z, 2018, ARXIV PREPRINT ARXIV; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Khaki S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00621; Kim J, 2017, IEEE I CONF COMP VIS, P2961, DOI 10.1109/ICCV.2017.320; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Lenaerts B, 2019, PLANT SCI, V287, DOI 10.1016/j.plantsci.2019.110207; Lin T, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab66cb; Liu YQ, 2020, EXPERT SYST APPL, V143, DOI 10.1016/j.eswa.2019.113082; Malhotra P, 2015, PROCEEDINGS, P89; Melillo TTCR, 2014, CLIMATE CHANGE IMPAC; Nowling G, 2018, UNIFORM SOYBEAN TEST; Parmley K, 2019, PLANT PHENOMICS, V2019, DOI 10.34133/2019/5809404; Parmley KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53451-4; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Petrica AC., 2016, THEORETICAL APPL EC, V23; Puteh A. B., 2013, Australian Journal of Crop Science, V7, P1472; Qin Y, 2017, ARXIV PREPRINT ARXIV; Roberts MJ, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa7f33; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Shakeel PM, 2018, HEALTH INF SCI SYST, V6, DOI 10.1007/s13755-018-0054-0; Shook JM., 2018, INTEGRATING GENOTYPE, P331561; Singh A, 2016, TRENDS PLANT SCI, V21, P110, DOI 10.1016/j.tplants.2015.10.015; Singh AK, 2018, TRENDS PLANT SCI, V23, P883, DOI 10.1016/j.tplants.2018.07.004; Singh R, 2017, ADV NEUR IN, V30; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Syakur MA, 2018, IOP CONF SER-MAT SCI, V336, DOI 10.1088/1757-899X/336/1/012017; Tracy SR, 2020, TRENDS PLANT SCI, V25, P105, DOI 10.1016/j.tplants.2019.10.015; Vaswani A, 2017, ADV NEUR IN, V30; Vogel E, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/ab154b; Westcott PC., 2013, WEATHER EFFECTS EXPE; WESTGATE ME, 1993, J EXP BOT, V44, P109, DOI 10.1093/jxb/44.1.109; Wu T, 2017, ARXIV PREPRINT ARXIV, V2; You JX, 2017, AAAI CONF ARTIF INTE, P4559; Zhang LX, 2016, CROP J, V4, P139, DOI 10.1016/j.cj.2015.12.003; Zhang QS, 2018, FRONT INFORM TECH EL, V19, P27, DOI 10.1631/FITEE.1700808; Zhang QS, 2018, PROC CVPR IEEE, P8827, DOI 10.1109/CVPR.2018.00920; Zisserman Andrew, 2014, WORKSH TRACK P INT C, DOI DOI 10.48550/ARXIV.1312.6034	68	19	20	10	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252402	10.1371/journal.pone.0252402	http://dx.doi.org/10.1371/journal.pone.0252402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138872	Green Published, gold, Green Submitted			2022-12-26	WOS:000671690200027
J	Goudswaard, LJ; Harrison, S; Van de Klee, D; Chaturvedi, N; Lawlor, DA; Smith, GD; Hughes, AD; Howe, LD				Goudswaard, Lucy J.; Harrison, Sean; Van de Klee, Daniel; Chaturvedi, Nishi; Lawlor, Debbie A.; Smith, George Davey; Hughes, Alun D.; Howe, Laura D.			Blood pressure variability and night-time dipping assessed by 24-hour ambulatory monitoring: Cross-sectional association with cardiac structure in adolescents	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; EUROPEAN-SOCIETY; ORGAN DAMAGE; INDEX; RISK; CHILDREN; HEALTH; ADULTS	Greater blood pressure (BP) is associated with greater left ventricular mass indexed to height(2.7) (LVMi(2.7)) in adolescents. This study examined whether greater BP variability and reduced night-time dipping are associated with cardiac remodeling in a general population of adolescents. A cross-sectional analysis was undertaken in 587 UK adolescents (mean age 17.7 years; 43.1% male). BP was measured in a research clinic and using 24-hour ambulatory monitoring. We examined associations (for both systolic and diastolic BP) of: 1) clinic and 24-hour mean BP; 2) measures of 24-hour BP variability: standard deviation weighted for day/night (SDdn), variability independent of the mean (VIM) and average real variability (ARV); and 3) night-time dipping with cardiac structures. Cardiac structures were assessed by echocardiography: 1) LVMi(2.7); 2) relative wall thickness (RWT); 3) left atrial diameter indexed to height (LADi) and 4) left ventricular internal diameter in diastole (LVIDD). Higher systolic BP was associated with greater LVMi(2.7). Systolic and diastolic BP were associated with greater RWT. Associations were inconsistent for LADi and LVIDD. There was evidence for associations between both greater SDdn and ARV and higher RWT (per 1 SD higher diastolic ARV, mean difference in RWT was 0.13 SDs, 95% CI 0.045 to 0.21); these associations with RWT remained after adjustment for mean BP. There was no consistent evidence of associations between night-time dipping and cardiac structure. Measurement of BP variability, even in adolescents with blood pressure in the physiologic range, might benefit risk of cardiovascular remodeling assessment.	[Goudswaard, Lucy J.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England; [Goudswaard, Lucy J.; Harrison, Sean; Lawlor, Debbie A.; Smith, George Davey; Howe, Laura D.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Goudswaard, Lucy J.; Harrison, Sean; Lawlor, Debbie A.; Smith, George Davey; Howe, Laura D.] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Van de Klee, Daniel] BrisDoc Healthcare Serv, Acute GP Team, Bristol, Avon, England; [Chaturvedi, Nishi; Hughes, Alun D.] UCL, Inst Cardiovasc Sci, London, England	University of Bristol; University of Bristol; University of Bristol; University of London; University College London	Goudswaard, LJ (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Bristol, Avon, England.; Goudswaard, LJ (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England.; Goudswaard, LJ (corresponding author), Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.	lg14289@bristol.ac.uk	Hughes, Alun David/N-3781-2013; Davey Smith, George/A-7407-2013	Hughes, Alun David/0000-0001-5432-5271; Davey Smith, George/0000-0002-1407-8314; Harrison, Sean/0000-0002-7966-0700; Goudswaard, Lucy/0000-0003-1481-6871; Lawlor, Debbie A/0000-0002-6793-2262	Wellcome [102215/2/13/2]; University of Bristol as part of the British Heart Foundation; UK Medical Research Council [MR/M020894/1, MC_UU_00011/1, MC_UU_00011/6-7]; University of Bristol; British Heart Foundation	Wellcome; University of Bristol as part of the British Heart Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; British Heart Foundation(British Heart Foundation)	The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. LJG is funded by a University of Bristol alumni PhD studentship as part of the British Heart Foundation 4-year Integrative Cardiovascular Science programme. LDH is funded by a Career Development Award from the UK Medical Research Council (MR/M020894/1). LDH, SH, DAL and GDS work in a unit that receives funding from the University of Bristol and the UK Medical Research Council (MC_UU_00011/1 and MC_UU_00011/6-7). This work was supported by a grant from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.	Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Anstey DE, 2018, HYPERTENSION, V72, P1200, DOI 10.1161/HYPERTENSIONAHA.118.11319; Armstrong AC, 2014, EUR HEART J-CARD IMG, V15, P893, DOI 10.1093/ehjci/jeu018; Banegas JR, 2018, NEW ENGL J MED, V378, P1509, DOI 10.1056/NEJMoa1712231; Bello NA, 2020, J HYPERTENS, V38, P102, DOI 10.1097/HJH.0000000000002221; Belsha CW, 1998, AM J HYPERTENS, V11, P410, DOI 10.1016/S0895-7061(98)00014-4; Bilo G, 2007, J HYPERTENS, V25, P2058, DOI 10.1097/HJH.0b013e32829c6a60; Bjelakovic B, 2013, J CLIN HYPERTENS, V15, P905, DOI 10.1111/jch.12206; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Chen W, 2011, AM J HYPERTENS, V24, P77, DOI 10.1038/ajh.2010.176; Cikes M, 2016, EUR HEART J, V37, P1642, DOI 10.1093/eurheartj/ehv510; Cuspidi C, 2018, INT J CARDIOL, V270, P302, DOI 10.1016/j.ijcard.2018.06.031; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DESWIET M, 1992, BRIT MED J, V304, P23, DOI 10.1136/bmj.304.6818.23; Di Tullio MR, 2003, STROKE, V34, P2380, DOI 10.1161/01.STR.0000089680.77236.60; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gaasch WH, 2011, J AM COLL CARDIOL, V58, P1733, DOI 10.1016/j.jacc.2011.07.022; Hansen TW, 2011, HYPERTENSION, V57, P3, DOI 10.1161/HYPERTENSIONAHA.109.133900; Hara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103169; Harrington D, 2019, NEW ENGL J MED, V381, P285, DOI 10.1056/NEJMe1906559; Harville EW, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16010015; Henskens LHG, 2011, J HYPERTENS, V29, P242, DOI 10.1097/HJH.0b013e32834192d5; Howe LD, 2013, J EPIDEMIOL COMMUN H, V67, P358, DOI 10.1136/jech-2012-201892; Hutcheon JA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2289; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Laitinen TT, 2017, JAMA PEDIATR, V171, P781, DOI 10.1001/jamapediatrics.2017.1085; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee Heirim, 2015, Clin Hypertens, V21, P21, DOI 10.1186/s40885-015-0031-8; Leisman D, 2014, J CLIN HYPERTENS, V16, P437, DOI 10.1111/jch.12322; Leoncini G, 2013, J HUM HYPERTENS, V27, P663, DOI 10.1038/jhh.2013.45; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mancia G, 2000, J CARDIOVASC PHARM, V35, pS15, DOI 10.1097/00005344-200000004-00003; Mancusi C, 2018, INT J CARDIOL, V265, P229, DOI 10.1016/j.ijcard.2018.03.120; McCarron P, 2000, LANCET, V355, P1430, DOI 10.1016/S0140-6736(00)02146-2; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Picone DS, 2017, J AM COLL CARDIOL, V70, P572, DOI 10.1016/j.jacc.2017.05.064; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Salles GF, 2016, HYPERTENSION, V67, P693, DOI 10.1161/HYPERTENSIONAHA.115.06981; Seeman T, 2016, EUR J PEDIATR, V175, P1091, DOI 10.1007/s00431-016-2749-z; Sega R, 2002, HYPERTENSION, V39, P710, DOI 10.1161/hy0202.104376; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; Stevens SL, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4098; Urbina EM, 2011, J CLIN HYPERTENS, V13, P332, DOI 10.1111/j.1751-7176.2011.00471.x; Wade KH, 2018, CIRCULATION, V138, P2187, DOI 10.1161/CIRCULATIONAHA.117.033278; Wang JQ, 2017, J HYPERTENS, V35, P10, DOI 10.1097/HJH.0000000000001159; Wang SX, 2014, HYPERTENS RES, V37, P870, DOI 10.1038/hr.2014.88; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Woodiwiss AJ, 2018, AM J HYPERTENS, V31, P1002, DOI 10.1093/ajh/hpy075; Yano Y, 2012, HYPERTENS RES, V35, P695, DOI 10.1038/hr.2012.26; ZIMPFER M, 1981, J CLIN INVEST, V67, P430, DOI 10.1172/JCI110051	53	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253196	10.1371/journal.pone.0253196	http://dx.doi.org/10.1371/journal.pone.0253196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133455	Green Published, gold			2022-12-26	WOS:000671682700003
J	Hou, SR; Lee, JM; Myint, W; Matsuo, H; Yilmaz, NK; Schiffer, CA				Hou, Shurong; Lee, Jeong Min; Myint, Wazo; Matsuo, Hiroshi; Yilmaz, Nese Kurt; Schiffer, Celia A.			Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; CRISPR-CAS9 NUCLEASES; CYTOSINE DEAMINATION; DRUG-RESISTANCE; DNA; BINDING; MUTAGENESIS; DETERMINANTS; RESTRICTION	The human cytidine deaminase family of APOBEC3s (A3s) plays critical roles in both innate immunity and the development of cancers. A3s comprise seven functionally overlapping but distinct members that can be exploited as nucleotide base editors for treating genetic diseases. Although overall structurally similar, A3s have vastly varying deamination activity and substrate preferences. Recent crystal structures of ssDNAbound A3s together with experimental studies have provided some insights into distinct substrate specificities among the family members. However, the molecular interactions responsible for their distinct biological functions and how structure regulates substrate specificity are not clear. In this study, we identified the structural basis of substrate specificities in three catalytically active A3 domains whose crystal structures have been previously characterized: A3A, A3B- CTD, and A3GCTD. Through molecular modeling and dynamic simulations, we found an interdependency between ssDNA substrate binding conformation and nucleotide sequence specificity. In addition to the U-shaped conformation seen in the crystal structure with the CTC0 motif, A3A can accommodate the CCC0 motif when ssDNA is in a more linear (L) conformation. A3B can also bind both U- and L-shaped ssDNA, unlike A3G, which can stably recognize only linear ssDNA. These varied conformations are stabilized by sequence-specific interactions with active site loops 1 and 7, which are highly variable among A3s. Our results explain the molecular basis of previously observed substrate specificities in A3s and have implications for designing A3-specific inhibitors for cancer therapy as well as engineering base-editing systems for gene therapy.	[Hou, Shurong; Lee, Jeong Min; Yilmaz, Nese Kurt; Schiffer, Celia A.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Myint, Wazo; Matsuo, Hiroshi] Frederick Natl Lab Canc Res, Basic Res Lab, Frederick, MD USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yilmaz, NK; Schiffer, CA (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Nese.KurtYilmaz@umassmed.edu; Celia.Schiffer@umassmed.edu		Myint, Wazo/0000-0002-2055-5180; Schiffer, Celia/0000-0003-2270-6613	NIH office of intramural training and education's Intramural AIDS Research Fellowship; National Cancer Institute, National Institutes of Health [HHSN26120080001E]	NIH office of intramural training and education's Intramural AIDS Research Fellowship; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W. M. is supported in part by the NIH office of intramural training and education's Intramural AIDS Research Fellowship. For W. M. and H.M., this project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does it mention of trade names,commercial products, or organizations imply endorsement by the US Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Autore F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011515; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Byeon IJL, 2016, BIOCHEMISTRY-US, V55, P2944, DOI 10.1021/acs.biochem.6b00382; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; CACCIAMANI T, 1991, ARCH BIOCHEM BIOPHYS, V290, P285, DOI 10.1016/0003-9861(91)90543-R; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cortez LM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008545; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Henes M, 2019, ACS CHEM BIOL, V14, P2441, DOI 10.1021/acschembio.9b00370; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hou SR, 2019, J CHEM THEORY COMPUT, V15, P637, DOI 10.1021/acs.jctc.8b00545; Ito F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21955-0; Ito F, 2017, J MOL BIOL, V429, P1787, DOI 10.1016/j.jmb.2017.04.021; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Maiti A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04872-8; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Matsumoto T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44407-9; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Ng JCF, 2020, CURR RES STRUCT BIOL, V2, P130, DOI 10.1016/j.crstbi.2020.07.001; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ozen A, 2014, P NATL ACAD SCI USA, V111, P15993, DOI 10.1073/pnas.1414063111; Paulsen JL, 2017, J CHEM THEORY COMPUT, V13, P2300, DOI 10.1021/acs.jctc.6b01262; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2014, VIROLOGY, V471, P105, DOI 10.1016/j.virol.2014.09.023; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2020, FASEB BIOADV, V2, P49, DOI 10.1096/fba.2019-00068; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17694-3; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shi K, 2015, J BIOL CHEM, V290, P28120, DOI 10.1074/jbc.M115.679951; Silvas TV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25881-z; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Solomon WC, 2019, NUCLEIC ACIDS RES, V47, P7676, DOI 10.1093/nar/gkz550; Soumana DI, 2016, J AM CHEM SOC, V138, P11850, DOI 10.1021/jacs.6b06454; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Wagner JR, 2019, J CHEM INF MODEL, V59, P2264, DOI 10.1021/acs.jcim.8b00427; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Xiao X, 2017, NUCLEIC ACIDS RES, V45, P7494, DOI 10.1093/nar/gkx362; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	79	3	3	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100909	10.1016/j.jbc.2021.100909	http://dx.doi.org/10.1016/j.jbc.2021.100909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34171358	Green Published, gold			2022-12-26	WOS:000690873500002
J	Adam, G; Shiomi, T; Monica, G; Jarrod, S; Vincent, A; Becky, M; Tina, Z; Jeanine, D				Adam, Gerber; Shiomi, Takayuki; Monica, Goldklang; Jarrod, Sonett; Vincent, Anguiano; Becky, Mercer; Tina, Zelonina; Jeanine, D'Armiento			Suppression of cigarette smoke induced MMP1 expression by selective serotonin re-uptake inhibitors	FASEB JOURNAL			English	Article							MATRIX METALLOPROTEINASE-1; PULMONARY; EMPHYSEMA; INFLAMMATION; APOPTOSIS; STATINS; CELLS; COPD	Globally, COPD remains a major cause of disability and death. In the United States alone, it is estimated that approximately 14 million people suffer from the disease. Given the high disease burden and requirement for chronic, long-term medical care associated with COPD, it is essential that new disease modifying agents are developed to complement the symptomatic therapeutics currently available. In the present report, we have identified a potentially novel therapeutic agent through the use of a high throughput screen based on the knowledge that cigarette smoke induces the proteolytic enzyme MMP1 leading to destruction of the lung in COPD. A construct utilizing the cigarette responsive promoter element of MMP-1 was conjugated to a luciferase reporter and utilized in an in vitro assay to screen the NIH Molecular Libraries Small Molecule Repository to identify putative targets that suppressed luciferase expression in response to cigarette smoke extract (CSE). Selective serotonin reuptake inhibitors potently inhibited luciferase expression and were further validated. SSRI treatment suppressed MMP-1 production in small airway epithelial cells exposed to (CSE) in vitro as well as in smoke exposed rabbits. In addition, SSRI treatment inhibited inflammatory cytokine production while rescuing cigarette smoke induced downregulation in vivo of the anti-inflammatory lipid transporter ABCA1, previously shown by our laboratory to be lung protective. Importantly, SSRI treatment prevented lung destruction in smoke exposed rabbits as measured by morphometry. These studies support further investigation into SSRIs as a novel therapeutic for COPD may be warranted.	[Adam, Gerber; Monica, Goldklang; Jarrod, Sonett; Tina, Zelonina; Jeanine, D'Armiento] Columbia Univ, Coll Phys & Surg, Dept Med Anesthesiol Physiol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA; [Shiomi, Takayuki] Int Univ Hlth & Welf, Ctr Basic Med Sci, Grad Sch, Chiba, Japan; [Vincent, Anguiano] Mt Sinai Hosp, Icahn Sch Med, Dept Oncol Sci, New York, NY 10029 USA; [Becky, Mercer] Palm Beach State Coll, Off Acad Affairs, Lake Worth, FL USA	Columbia University; NewYork-Presbyterian Hospital; International University of Health & Welfare; Icahn School of Medicine at Mount Sinai	Jeanine, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med Anesthesiol Physiol & Cell Biol, Irving Med Ctr, New York, NY 10027 USA.	jmd12@cumc.columbia.edu	Shiomi, Takayuki/A-2228-2014	Shiomi, Takayuki/0000-0002-4250-1204	NHLBI [R01 HL086936]	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NHLBI, Grant/Award Number: R01 HL086936	Caiaffo V, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.231; Centers for Disease C, 2003, MMWR MORB MORTAL WKL, V52, P303; Chai AB, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0526-9; Chen HP, 2019, INT J CHRONIC OBSTR, V14, P1009, DOI 10.2147/COPD.S196210; Criner GJ, 2014, NEW ENGL J MED, V370, P2201, DOI 10.1056/NEJMoa1403086; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Durairaj H, 2015, INT IMMUNOPHARMACOL, V25, P485, DOI 10.1016/j.intimp.2015.02.029; Fessler MB, 2018, PHARMACOL THERAPEUT, V181, P1, DOI 10.1016/j.pharmthera.2017.07.010; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Geraghty P, 2011, J BIOL CHEM, V286, P30211, DOI 10.1074/jbc.M111.238824; Goldklang MP, 2016, AM J RESP CELL MOL, V55, P848, DOI 10.1165/rcmb.2015-0407OC; Gu HF, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00165; Habib M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120559; Hamsanathan S, 2019, AM J RESP CELL MOL, V61, P21, DOI 10.1165/rcmb.2018-0410TR; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194; Kiecolt-Glaser JK, 2015, AM J PSYCHIAT, V172, P1075, DOI 10.1176/appi.ajp.2015.15020152; Knadler MP, 2011, CLIN PHARMACOKINET, V50, P281, DOI 10.2165/11539240-000000000-00000; Kohler CA, 2018, MOL NEUROBIOL, V55, P4195, DOI 10.1007/s12035-017-0632-1; Lareau Suzanne C, 2010, Int J Chron Obstruct Pulmon Dis, V5, P401, DOI 10.2147/COPD.S14715; LAURENT P, 1983, CHEST, V83, pS63, DOI 10.1378/chest.83.5.63S; Liu FY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1388-x; Mercer BA, 2004, J BIOL CHEM, V279, P17690, DOI 10.1074/jbc.M313842200; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Michaeloudes C, 2020, J INNATE IMMUN, V12, P31, DOI 10.1159/000504344; Rawdin BJ, 2013, BRAIN BEHAV IMMUN, V31, P143, DOI 10.1016/j.bbi.2012.11.011; Sanja M, 2018, SCAND J CLIN LAB INV, V78, P533, DOI 10.1080/00365513.2018.1514464; Seagrave J, 2004, EXP LUNG RES, V30, P1, DOI 10.1080/01902140490252858; Sekine T, 2019, J APPL TOXICOL, V39, P717, DOI 10.1002/jat.3761; SNIDER GL, 1992, AM REV RESPIR DIS, V146, P1615, DOI 10.1164/ajrccm/146.6.1615; Sonett J, 2018, FASEB J, V32, P6724, DOI 10.1096/fj.201701381; Vozoris NT, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00475-2018; Waiskopf N, 2014, J MOL NEUROSCI, V53, P306, DOI 10.1007/s12031-013-0174-6; Wallace AM, 2014, LUNG, V192, P467, DOI 10.1007/s00408-014-9585-6; Wallace AM, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-79; Wang LN, 2019, BRAIN BEHAV IMMUN, V79, P24, DOI 10.1016/j.bbi.2019.02.021; Yeo J, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0603-y; Zhang W, 2017, CHEST, V152, P1159, DOI 10.1016/j.chest.2017.08.015	39	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21519	10.1096/fj.202001966RR	http://dx.doi.org/10.1096/fj.202001966RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34137477	Green Published, hybrid			2022-12-26	WOS:000667814100042
J	Liu, LR; Liu, F; Guan, YJ; Zou, JA; Zhang, CY; Xiong, CX; Zhao, TC; Bayliss, G; Li, XG; Zhuang, SG				Liu, Lirong; Liu, Feng; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Zhao, Ting C.; Bayliss, George; Li, Xiaogang; Zhuang, Shougang			Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis	FASEB JOURNAL			English	Article						proliferation; renal interstitial fibroblasts; Smad3; SMYD2; TGF-beta 1; unilateral ureteral obstruction	TO-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; INTERSTITIAL FIBROSIS; EMERGING ROLES; METHYLATION; INHIBITION; CANCER; PROGRESSION; GENE; MECHANISMS	SET and MYND domain protein 2 (SMYD2) is a lysine methyltransferase that mediates histone H3 lysine 36 trimethylation (H3K36me3) and acts as a regulator of tumorgenesis and cystic growth. However, its role in renal fibrosis remains unknown. In this study, we found that SMYD2 was highly expressed in the murine kidney of renal fibrosis induced by unilateral ureteral obstruction, and primarily located in interstitial fibroblasts and renal tubular epithelial cells. Pharmacological inhibition of SMYD2 with AZ505, a highly selective inhibitor of SMYD2, protected against renal fibrosis and inhibited activation/proliferation of renal interstitial fibroblasts and conversion of epithelial cells to a profibrotic phenotype in this model. In cultured renal interstitial fibroblasts, treatment with AZ505 or silencing of SMYD2 by specific siRNA also inhibited serum- or TGF-beta 1-induced activation and proliferation of renal interstitial fibroblasts. Mechanistic studies showed that SMYD2 inhibition reduced phosphorylation of several profibrotic signaling molecules, including Smad3, extracellular signal-regulated kinase 1/2, AKT, signal transducer and activator of transcription-3 and nuclear factor-kappa B in both injured kidney and cultured renal fibroblasts. AZ505 was also effective in suppressing renal expression of Snail and Twist, two transcriptional factors that mediate renal partial epithelial-mesenchymal transition and fibrosis. Conversely, AZ505 treatment prevented downregulation of Smad7, a renoprotective factor in vivo and in vitro. These results indicate that SMYD2 plays a critical role in mediating conversion of epithelial cells to a profibrotic phenotype, renal fibroblast activation and renal fibrogenesis, and suggest that SMYD2 may be a potential target for the treatment of chronic fibrosis in kidney disease.	[Liu, Lirong; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Bayliss, George; Zhuang, Shougang] Brown Univ, Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Liu, Lirong; Guan, Yingjie; Zou, Jianan; Zhang, Chunyun; Xiong, Chongxiang; Bayliss, George; Zhuang, Shougang] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Liu, Lirong] Guizhou Med Univ, Affiliated Hosp, Ctr Clin Labs, Guiyang, Peoples R China; [Liu, Lirong] Guizhou Med Univ, Sch Clin Lab Sci, Guiyang, Peoples R China; [Liu, Feng; Zhuang, Shougang] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China; [Zhao, Ting C.] Rhode Isl Hosp, Dept Surg, Providence, RI USA; [Li, Xiaogang] Mayo Clin, Dept Med, Rochester, MN USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Guizhou Medical University; Guizhou Medical University; Tongji University; Lifespan Health Rhode Island; Rhode Island Hospital; Mayo Clinic	Zhuang, SG (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Nephrol, Shanghai, Peoples R China.	szhuang@lifespan.org			National Natural Science Foundation of China [81670623, 81830021]; National key R&D Program of China [2018YFA0108802]; US National Institutes of Health [2R01DK08506505A1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National key R&D Program of China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Natural Science Foundation of China grants (81670623 and 81830021 to SZ), National key R&D Program of China (2018YFA0108802 to SZ), and US National Institutes of Health (2R01DK08506505A1 to SZ).	Andrikopoulos P, 2019, J AM SOC NEPHROL, V30, P33, DOI 10.1681/ASN.2018020209; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Chung ACK, 2013, MOL THER, V21, P388, DOI 10.1038/mt.2012.251; El-Deiry WS, 2016, CANCER RES, V76, P5189, DOI 10.1158/0008-5472.CAN-16-2055; Ferguson AD, 2011, STRUCTURE, V19, P1262, DOI 10.1016/j.str.2011.06.011; Hu LP, 2009, CANCER RES, V69, P4067, DOI 10.1158/0008-5472.CAN-08-4097; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Komatsu S, 2009, CARCINOGENESIS, V30, P1139, DOI 10.1093/carcin/bgp116; Lan AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105451; Li B, 2018, FUTURE ONCOL, V14, P1825, DOI 10.2217/fon-2017-0682; Li LDXY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0347-x; Li LX, 2017, J CLIN INVEST, V127, P2751, DOI 10.1172/JCI90921; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu N, 2011, J AM SOC NEPHROL, V22, P1064, DOI 10.1681/ASN.2010090956; Lovisa S, 2016, TRENDS ENDOCRIN MET, V27, P681, DOI 10.1016/j.tem.2016.06.004; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Nakakido M, 2015, NEOPLASIA, V17, P367, DOI 10.1016/j.neo.2015.03.002; Nguyen H, 2015, J BIOL CHEM, V290, P13641, DOI 10.1074/jbc.M114.626861; Pace J, 2019, AM J PHYSIOL-RENAL, V316, pF1151, DOI 10.1152/ajprenal.00034.2019; Pang MY, 2010, KIDNEY INT, V78, P257, DOI 10.1038/ki.2010.154; Parmar N, 2020, J IMMUNOL, V204, P2762, DOI 10.4049/jimmunol.1900251; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Qie S, 2016, J MOL MED, V94, P1313, DOI 10.1007/s00109-016-1475-3; Santos F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040891; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Stenvinkel P, 2018, NAT REV NEPHROL, V14, P265, DOI 10.1038/nrneph.2017.169; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tang PMK, 2019, NAT REV NEPHROL, V15, P144, DOI 10.1038/s41581-019-0110-2; Grande MT, 2015, NAT MED, V21, P989, DOI 10.1038/nm.3901; Sakamoto LHT, 2014, LEUKEMIA RES, V38, P496, DOI 10.1016/j.leukres.2014.01.013; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Wang Y, 2019, ONCOGENE, V38, P4948, DOI 10.1038/s41388-019-0766-x; Wanner N, 2017, CELL TISSUE RES, V369, P75, DOI 10.1007/s00441-017-2588-x; Yan LB, 2019, THERANOSTICS, V9, P8377, DOI 10.7150/thno.37628; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yi X, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0711-4; Zhang HS, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0056-4; Zhang X, 2015, CELL MOL LIFE SCI, V72, P4257, DOI 10.1007/s00018-015-2001-4; Zhou XX, 2016, J AM SOC NEPHROL, V27, P2092, DOI 10.1681/ASN.2015040457; Zoccali C, 2017, NAT REV NEPHROL, V13, DOI 10.1038/nrneph.2017.52	43	7	8	4	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21715	10.1096/fj.202000554RRR	http://dx.doi.org/10.1096/fj.202000554RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143514	Green Accepted			2022-12-26	WOS:000667814100045
J	Shi, XZ; Li, JH; Min, BY; Yang, RJ; He, CX; Yang, YL				Shi, Xiangzhou; Li, Jinghua; Min, Binying; Yang, Ruijing; He, Chunxiang; Yang, Yilin			Application of ultrasound elastography for monitoring the effects of T beta R1 shRNA therapy on hepatic fibrosis in a rat model	PLOS ONE			English	Article							LIVER FIBROSIS; MARKERS	Background To investigate the application of ultrasound elastography in monitoring the effects of the transforming growth factor (TGF)-beta 1 signaling pathway-targeted combination therapy for hepatic fibrosis. Methods 1. Short hairpin RNA (shRNA) constructs targeted towards T beta R1 were designed, synthesized, and packaged using an adeno-associated virus (AAV), and the effective target shRNA was selected based on transfection results. 2. Fifty rats were randomly allocated (n = 10 per group) to the (A) control group, (B) model group, (C) 0-week therapy group, (D) 4-week therapy group, and (E) combination therapy group. At weeks 2, 4, 6, 8, 10, and 12, acoustic radiation force impulse (ARFI) elastography was used to measure the liver stiffness, inner diameter of the portal vein diameter, and blood velocity; radio frequency ultrasound imaging was used to measure the abdominal aortic elasticity parameter and pulse wave velocity (PWV) of the rats. 3. At week 12, portal vein puncture was performed to measure the portal venous pressure, and rat liver specimens were obtained for the pathological measurement of the degree of hepatic fibrosis. Results 1. An shRNA interference sequence targeted towards T beta R1 was successfully designed, screened, and packaged using an AAV, and small-animal imaging results indicated expression of the specific shRNA in the liver. 2. At week 12, the ultrasound elastography results were significantly different between the experimental groups and the control group (p < 0.01); among the experimental groups, differences were significant between the therapy groups and the model group (p < 0.01). For groups C and E, the therapeutic effects on hepatic fibrosis in rats were significant, with the pathological results indicating a significant reduction in the degree of hepatic fibrosis (p < 0.01). The therapeutic effectiveness of group D was less than that of group C (p < 0.05). Significant differences existed between the portal venous pressure of the experimental groups and of the control group (p < 0.01). For the abdominal aortic elasticity parameter measured by radio frequency ultrasound imaging, differences existed between the values obtained from the experimental groups and from that of the control group (p < 0.05), while statistically significant differences were not found among the various experimental groups. 3. Continuous ultrasound examination results indicated that the elasticity value of group A was significantly different from those of the other groups after 2 weeks of model establishment (p < 0.01); after 6 weeks, the elasticity values of groups C and E were significantly different compared with those of groups B and D (p < 0.01). For the abdominal aortic elasticity parameter and pulse wave velocity (PWV), there were no significant differences among the various groups (p > 0.05). Conclusion CCl4-induced hepatic fibrosis can be treated through shRNA silencing of T beta R1. Ultrasound ARFI elastography is superior to external force-assisted elastography as it can reflect the degree of fibrosis in moderate to severe hepatic fibrosis and the variations in the degree of fibrosis after treatment. Portal venous pressure was positively correlated with the degree of fibrosis; with early combination therapy, both the degree of fibrosis and portal venous pressure could be effectively reduced.	[Shi, Xiangzhou; Li, Jinghua; Min, Binying; Yang, Ruijing; He, Chunxiang; Yang, Yilin] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diag, Xian, Peoples R China	Air Force Military Medical University	Yang, YL (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diag, Xian, Peoples R China.	yangyl66@126.com			National Natural Science Foundation of China [81371566]; Fourth Military Medical University [2019xc070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fourth Military Medical University	This work was supported by a grant from the National Natural Science Foundation of China (no. 81371566) and Fourth Military Medical University (CN) (no.2019xc070). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2018, ABDOM RADIOL, V43, P800, DOI 10.1007/s00261-017-1375-1; Baues M, 2017, ADV DRUG DELIVER REV, V121, P9, DOI 10.1016/j.addr.2017.10.013; Enomoto H, 2015, WORLD J GASTROENTERO, V21, P7427, DOI 10.3748/wjg.v21.i24.7427; Ferraioli G, 2015, ULTRASOUND MED BIOL, V41, P1161, DOI 10.1016/j.ultrasmedbio.2015.03.007; Frulio N, 2013, Diagn Interv Imaging, V94, P515, DOI 10.1016/j.diii.2013.02.005; Jiang HY, 2017, ABDOM RADIOL, V42, P490, DOI 10.1007/s00261-016-0913-6; Jiang K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239624; Kennedy P, 2018, RADIOLOGY, V286, P738, DOI 10.1148/radiol.2018170601; Khimji A, 2011, PHARMACOL RES, V63, P512, DOI 10.1016/j.phrs.2011.03.005; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; McCuskey RS, 2000, LIVER, V20, P3, DOI 10.1034/j.1600-0676.2000.020001003.x; Pavlov CS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010542.pub2; Shrestha N, 2016, FOOD CHEM TOXICOL, V93, P129, DOI 10.1016/j.fct.2016.04.024; Surendran SP, 2017, INT J NANOMED, V12, P6997, DOI 10.2147/IJN.S145951; Svegliati-Baroni G, 2005, HEPATOLOGY, V42, P343, DOI 10.1002/hep.20798; Tannapfel A, 2012, DTSCH ARZTEBL INT, V109, P477, DOI 10.3238/arztebl.2012.0477; Tapper EB, 2017, NEW ENGL J MED, V377, P756, DOI 10.1056/NEJMra1610570; Wang XP, 2020, QUANT IMAG MED SURG, V10, P1208, DOI 10.21037/qims-19-849; Zhang L, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-39	19	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253150	10.1371/journal.pone.0253150	http://dx.doi.org/10.1371/journal.pone.0253150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181670	Green Submitted, Green Published, gold			2022-12-26	WOS:000671695800012
J	Dadi, BR; Solomon, Z; Tesfaye, M				Dadi, Belayneh Regasa; Solomon, Zerihun; Tesfaye, Mheret			Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; PEDIATRIC-PATIENTS; CLINICAL-SAMPLES; COLONIZATION; PREVALENCE; EPIDEMIOLOGY	Background The emergence of vancomycin resistant Enterococci (VRE) has alarmed the global community due to its tendency for colonization of the gastrointestinal tract. Human Immunodeficiency Virus (HIV) patients are colonized by vancomycin resistant Enterococci than other groups. The aim of this study was to determine the incidence of vancomycin resistant Enterococci and its associated factors among HIV infected patients on Anti-Retroviral Therapy (ART). Methods Institution based cross sectional study was conducted among HIV infected patients on ART at from June 1 to August 30, 2020. Socio-demographic and clinical data were collected by pre-tested structured questionnaire. Stool sample was collected and processed by standard microbiological techniques. Kirby Bauer Disc diffusion method was used to perform antimicrobial susceptibility testing. Data were entered by Epi data version 4.6.0.2 and analyzed by SPSS version 25. Bivariable and multivariable logistic regression model was used to analyze the association between dependent and independent variables. P-values in the multivariable analysis, adjusted odds ratio (AOR) and 95% confidence interval (CI) were used to determine the strength of association. P-value <= 0.05 was considered as significant. Results Enterococci spp was isolated on 123/200 (61.50%) patients. Among these isolates, the incidence of vancomycin resistant Enterococci was 11.4% [95% CI: (6.0-17.0)]. Antimicrobial susceptibility patterns against Enterococci showed highest rate of resistance to ampicillin (69.9%). Multidrug resistances were observed in 49.59% of Enterococci isolates. Study participants who had prior antibioticexposurer more than two weeks [AOR = 7.35; 95% CI: (1.2144.64)] and hospitalization for the last six months [AOR = 5.68; 95% CI: (1.09 29.74)] were significantly associated with vancomycin resistant Enterococci. Conclusions In our study high incidence of vancomycin resistant Enterococci was found. Previous exposure to antibiotics for more than two weeks and hospitalization for more than six months were significantly associated with vancomycin resistant Enterococci. The isolated Enterococci had variable degrees of resistance to commonly prescribed antibiotics. Therefore, periodic surveillance on antimicrobial resistance pattern, adhering to rational use of antibiotics and implementing infection prevention protocols may reduce colonization by VRE.	[Dadi, Belayneh Regasa; Solomon, Zerihun; Tesfaye, Mheret] Arba Minch Univ, Dept Med Microbiol, Arba Minch, Ethiopia	Arba Minch University	Dadi, BR (corresponding author), Arba Minch Univ, Dept Med Microbiol, Arba Minch, Ethiopia.	belayjanimen@gmail.com	Dadi, Belayneh Regasa/GPF-8125-2022	Regasa Dadi, Belayneh/0000-0002-7653-3685				Abamecha Abdulhakim, 2015, BMC Res Notes, V8, P213, DOI 10.1186/s13104-015-1200-2; Abebe W, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-185; Achenbach C, 2006, INFECT CONT HOSP EP, V27, P102, DOI 10.1086/499391; Agegne M, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/7510157; Al-Dahmoshi HOM, 2019, J PURE APPL MICROBIO, V13, P531, DOI 10.22207/JPAM.13.1.59; Alevizakos M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw246; Ali S, 2018, INT J MICROBIOL, V2018, DOI 10.1155/2018/4753460; Alotaibi FE, 2017, CHINESE MED J-PEKING, V130, P340, DOI 10.4103/0366-6999.198923; Amberpet R, 2018, J LAB PHYS, V10, P89, DOI 10.4103/JLP.JLP_32_17; Anvarinejad M, 2017, ARCH PEDIATR INFECT, V5, DOI 10.5812/pedinfect.37680; Axelrad JE, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0259-4; Buetti N, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0466-x; Carroll KC, 2016, JAWETZ MELNICK ADELB, V27th; Cattoir V, 2013, J ANTIMICROB CHEMOTH, V68, P731, DOI 10.1093/jac/dks469; Census, 2007, SO PEOPL NAT NAT REG; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V28th, DOI DOI 10.1108/08876049410065598; Batistao DWD, 2012, MEM I OSWALDO CRUZ, V107, P57, DOI 10.1590/S0074-02762012000100008; Deshpande VR, 2013, J INFECT DEV COUNTR, V7, P155, DOI 10.3855/jidc.3018; Ekuma Agantem Emmanuel, 2016, Afr J Infect Dis, V10, P121, DOI 10.21010/ajid.v10i2.8; Emaneini M, 2016, EUR J CLIN MICROBIOL, V35, P1387, DOI 10.1007/s10096-016-2702-0; Faron ML, 2016, J CLIN MICROBIOL, V54, P2436, DOI 10.1128/JCM.00211-16; Ferede Zelalem Tena, 2018, BMC Res Notes, V11, P793, DOI 10.1186/s13104-018-3898-0; Flokas ME, 2017, INT J ANTIMICROB AG, V49, P565, DOI 10.1016/j.ijantimicag.2017.01.008; Foka FET, 2018, S AFR J SCI, V114, P20, DOI 10.17159/sajs.2018/4508; Kateete DP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4136-7; Kee SY, 2012, JPN J INFECT DIS, V65, P57; Kwobah C., 2015, J DIS GLOB HLTH, V3, P73; Markwart R, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0594-3; Moemen D, 2015, BRAZ J MICROBIOL, V46, P777, DOI 10.1590/S1517-838246320140403; Murray PR, 2016, MED MICROBIOLOGY; Naing L, 2006, ARCH OROFAC SCI, V1, P9; Nilsson Oskar, 2012, Infect Ecol Epidemiol, V2, DOI 10.3402/iee.v2i0.16959; O'Driscoll T, 2015, INFECT DRUG RESIST, V8, P217, DOI 10.2147/IDR.S54125; Orsi G B, 2013, Ann Ig, V25, P485, DOI 10.7416/ai.2013.1948; Rameshkumar MR., 2018, INTECH OPEN, V98, DOI [10.1016/j.jgar.2018.10.019, DOI 10.1016/J.JGAR.2018.10.019]; Remschmidt C, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0353-x; Sood S, 2008, INDIAN J MED RES, V128, P111; Susan L., 2018, MEDSCAPE, V97, P223; Swathirajan CR, 2020, J INFECT PUBLIC HEAL, V13, P75, DOI 10.1016/j.jiph.2019.06.015; Toru Milkiyas, 2018, BMC Res Notes, V11, P281, DOI 10.1186/s13104-018-3382-x; Ventola C Lee, 2015, P T, V40, P277; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Yilema A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2363-3	43	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0251727	10.1371/journal.pone.0251727	http://dx.doi.org/10.1371/journal.pone.0251727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166383	Green Published, gold			2022-12-26	WOS:000671692800001
J	Meagher, P; Civitarese, R; Lee, X; Gordon, M; Bugyei-Twum, A; Desjardins, JF; Kabir, G; Zhang, YL; Kosanam, H; Visram, A; Leong-Poi, H; Advani, A; Connelly, KA				Meagher, Patrick; Civitarese, Robert; Lee, Xavier; Gordon, Mark; Bugyei-Twum, Antoinette; Desjardins, Jean-Francois; Kabir, Golam; Zhang, Yanling; Kosanam, Hari; Visram, Aylin; Leong-Poi, Howard; Advani, Andrew; Connelly, Kim A.			The Goto Kakizaki rat: Impact of age upon changes in cardiac and renal structure, function	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; HEART-FAILURE; CARDIOVASCULAR OUTCOMES; STATISTICAL-MODEL; DIABETIC HEART; MORTALITY; DAPAGLIFLOZIN; INHIBITION; ACTIVATION; MORBIDITY	Background Patients with diabetes are at a high risk for developing cardiac dysfunction in the absence of coronary artery disease or hypertension, a condition known as diabetic cardiomyopathy. Contributing to heart failure is the presence of diabetic kidney disease. The Goto-Kakizaki (GK) rat is a non-obese, non-hypertensive model of type 2 diabetes that, like humans, shares a susceptibility locus on chromosome 10. Herein, we perform a detailed analysis of cardio-renal remodeling and response to renin angiotensin system blockade in GK rats to ascertain the validity of this model for further insights into disease pathogenesis. Methods Study 1: Male GK rats along with age matched Wistar control animals underwent longitudinal assessment of cardiac and renal function for 32 weeks (total age 48 weeks). Animals underwent regular echocardiography every 4 weeks and at sacrifice, early (similar to 24 weeks) and late (similar to 48 weeks) timepoints, along with pressure volume loop analysis. Histological and molecular characteristics were determined using standard techniques. Study 2: the effect of renin angiotensin system (RAS) blockade upon cardiac and renal function was assessed in GK rats. Finally, proteomic studies were conducted in vivo and in vitro to identify novel pathways involved in remodeling responses. Results GK rats developed hyperglycaemia by 12 weeks of age (p<0.01 c/w Wistar controls). Echocardiographic assessment of cardiac function demonstrated preserved systolic function by 48 weeks of age. Invasive studies demonstrated left ventricular hypertrophy, pulmonary congestion and impaired diastolic function. Renal function was preserved with evidence of hyperfiltration. Cardiac histological analysis demonstrated myocyte hypertrophy (p<0.05) with evidence of significant interstitial fibrosis (p<0.05). RT qPCR demonstrated activation of the fetal gene program, consistent with cellular hypertrophy. RAS blockade resulted in a reduction blood pressure(P<0.05) cardiac interstitial fibrosis (p<0.05) and activation of fetal gene program. No significant change on either systolic or diastolic function was observed, along with minimal impact upon renal structure or function. Proteomic studies demonstrated significant changes in proteins involved in oxidative phosp4horylation, mitochondrial dysfunction, beta-oxidation, and PI3K/Akt signalling (all p<0.05). Further, similar changes were observed in both LV samples from GK rats and H9C2 cells incubated in high glucose media. Conclusion By 48 weeks of age, the diabetic GK rat demonstrates evidence of preserved systolic function and impaired relaxation, along with cardiac hypertrophy, in the presence of hyperfiltration and elevated protein excretion. These findings suggest the GK rat demonstrates some, but not all features of diabetes induced "cardiorenal" syndrome. This has implications for the use of this model to assess preclinical strategies to treat cardiorenal disease.	[Meagher, Patrick; Civitarese, Robert; Lee, Xavier; Gordon, Mark; Bugyei-Twum, Antoinette; Desjardins, Jean-Francois; Kabir, Golam; Zhang, Yanling; Kosanam, Hari; Visram, Aylin; Leong-Poi, Howard; Advani, Andrew; Connelly, Kim A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Meagher, Patrick; Lee, Xavier; Bugyei-Twum, Antoinette; Visram, Aylin; Connelly, Kim A.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Leong-Poi, Howard; Advani, Andrew; Connelly, Kim A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto	Connelly, KA (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada.; Connelly, KA (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.; Connelly, KA (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	ConnellyK@smh.ca		Meagher, Patrick/0000-0002-0221-3806; Lee, Xavier/0000-0002-8158-6183	Heart and Stroke Foundation of Canada [G-15-0009282]; St. Michael's Hospital Foundation "SCAR WARS" program; Department of Medicine, University of Toronto	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); St. Michael's Hospital Foundation "SCAR WARS" program; Department of Medicine, University of Toronto(University of Toronto)	This study was funded in part by the Heart and Stroke Foundation of Canada in the form of a grant (G-15-0009282) and by St. Michael's Hospital Foundation "SCAR WARS" program in the form of funds, both to KAC. The Department of Medicine, University of Toronto also provided support in the form of a Merit Award for KAC. The specific roles of these authors are articulated in the `author contributions' section.	Al Kury L, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/2974304; Al-Bazz DY, 2020, FUTUR CARDIOL, V16, P77, DOI 10.2217/fca-2019-0065; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Bugyei-Twum A, 2018, CARDIOVASC RES, V114, P1629, DOI 10.1093/cvr/cvy131; Bugyei-Twum A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39551; Chamnan P, 2011, DIABETES CARE, V34, P950, DOI 10.2337/dc09-2326; Chan YK, 2016, MOL CELL ENDOCRINOL, V430, P68, DOI 10.1016/j.mce.2016.04.006; Connelly KA, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0741-9; Connelly KA, 2009, CIRC-HEART FAIL, V2, P129, DOI 10.1161/CIRCHEARTFAILURE.108.765750; Dunlay SM, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.65; Fan WJ, 2017, CARDIOVASC ENDOCRINO, V6, P8, DOI 10.1097/XCE.0000000000000116; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gribble FM, 2010, NEW ENGL J MED, V362, P361, DOI 10.1056/NEJMcibr0911499; Gronholm T, 2005, EUR J PHARMACOL, V519, P267, DOI 10.1016/j.ejphar.2005.07.015; Guest PC, 2019, METHODS MOL BIOL, V1916, P203, DOI 10.1007/978-1-4939-8994-2_19; Guthrie R, 2018, POSTGRAD MED, V130, P149, DOI 10.1080/00325481.2018.1423852; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Holscher ME, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122136; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Ingelfinger JR, 2016, NEW ENGL J MED, V375, P380, DOI 10.1056/NEJMe1607413; ISHIBASHI S, 1994, J CLIN INVEST, V93, P1885, DOI 10.1172/JCI117179; Jiang SN, 1999, J BIOL CHEM, V274, P29905, DOI 10.1074/jbc.274.42.29905; Kai H, 1998, CIRC RES, V83, P594, DOI 10.1161/01.RES.83.6.594; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kojima N, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S9-005; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuliszewski M, 2011, CAN J CARDIOL, V27, pS328, DOI 10.1016/j.cjca.2011.07.598; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; Lindman BR, 2017, CIRCULATION, V135, P736, DOI 10.1161/CIRCULATIONAHA.116.025957; Mancini GBJ, 2017, CAN J CARDIOL, V33, P366, DOI 10.1016/j.cjca.2016.07.512; Marso SP, 2016, NEW ENGL J MED, V375, P1834, DOI 10.1056/NEJMoa1607141; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Meagher P, 2018, CAN J CARDIOL, V34, P632, DOI 10.1016/j.cjca.2018.02.026; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Palygin O, 2019, AM J PHYSIOL-RENAL, V317, pF1450, DOI 10.1152/ajprenal.00246.2019; Park JJ, 2020, CLIN RES CARDIOL, V109, P225, DOI 10.1007/s00392-019-01505-y; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Roy A, 2020, DIABETES THER, V11, P2791, DOI 10.1007/s13300-020-00921-y; Ruggenenti P, 2010, NAT REV NEPHROL, V6, P319, DOI 10.1038/nrneph.2010.58; Sandu OA, 2000, DIABETES, V49, P2178, DOI 10.2337/diabetes.49.12.2178; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Siddiqi FS, 2015, ENDOCRINOLOGY, V156, P1121, DOI 10.1210/en.2014-1650; van Heerebeek L, 2008, CIRCULATION, V117, P43, DOI 10.1161/CIRCULATIONAHA.107.728550; Verma S, 2019, CIRCULATION, V140, P1693, DOI 10.1161/CIRCULATIONAHA.119.042375; Wang GY, 2017, INT J MED SCI, V14, P698, DOI 10.7150/ijms.19800; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Wheeler DC, 2020, NEPHROL DIAL TRANSPL, V35, P1700, DOI 10.1093/ndt/gfaa234; Woo V, 2019, CURR MED RES OPIN, V35, P1283, DOI 10.1080/03007995.2019.1576479; Xu GF, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k1497; Yuen DA, 2013, STEM CELLS, V31, P2408, DOI 10.1002/stem.1502; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	55	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252711	10.1371/journal.pone.0252711	http://dx.doi.org/10.1371/journal.pone.0252711			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166385	Green Published, gold			2022-12-26	WOS:000671692800089
J	Xi, DD; Li, XF; Gao, L; Zhang, ZH; Zhu, YY; Zhu, HF				Xi, Dandan; Li, Xiaofeng; Gao, Lu; Zhang, Zhaohui; Zhu, Yuying; Zhu, Hongfang			Application of exogenous salicylic acid reduces disease severity of Plasmodiophora brassicae in pakchoi (Brassica campestris ssp. chinensis Makino)	PLOS ONE			English	Article							GENE-EXPRESSION; OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; TOLERANCE; PATHWAYS; CLUBROOT; PLANTS	Clubroot is one of the most serious diseases affecting Brassicaceae plants worldwide. However, there is no effective control method for clubroot. Salicylic acid (SA) is a plant hormone that plays a critical role in plant defense. In our study, we found the disease severity of a clubroot-sensitive cultivar of pakchoi, Xinxiaqing, was reduced with 0.6mM exogenous SA after the infection of P. brassicae. To investigate the mechanism of SA-reduced disease severity against clubroot, then we analyzed the plant growth, alteration of antioxidant enzyme system, and related gene expression of Xinxiaqing. Results showed that the clubroot incidence rate and disease index were decreased after being treated with 0.6 mM exogenous SA. Furthermore, plant growth, reactive oxygen species (ROS) contents, and membrane lipid peroxidation were changed. The activities of antioxidant enzymes, including superoxide dismutase (SOD), ascorbic acid-peroxidase (APX), catalase (CAT), and glutathione reductase (GR), were increased. Additionally, the production rates of malondialdehyde (MDA), hydrogen peroxide (H2O2), and superoxide anion (O-2(center dot-)) were also inhibited. The expression levels of genes, encoding SOD, APX, CAT, and GR, were increased. By summering all results, we conclude that 0.6 mM SA contributes to the reduction of disease severity to clubroot by increasing the activities of antioxidant enzymes, abilities of osmotic regulation, and ROS scavenging to reduce the clubroot-induced damage in pakchoi.	[Xi, Dandan; Li, Xiaofeng; Gao, Lu; Zhang, Zhaohui; Zhu, Yuying; Zhu, Hongfang] Shanghai Acad Agr Sci, Hort Res Inst, Shanghai, Peoples R China; [Xi, Dandan; Li, Xiaofeng; Gao, Lu; Zhang, Zhaohui; Zhu, Yuying; Zhu, Hongfang] Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China; [Zhang, Zhaohui] Shanghai Acad Agr Sci, Zhuanghang Comprehens Expt Stn, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences; Shanghai Academy of Agricultural Sciences	Zhu, HF (corresponding author), Shanghai Acad Agr Sci, Hort Res Inst, Shanghai, Peoples R China.; Zhu, HF (corresponding author), Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.	zhuhongfang@saas.sh.cn	zhang, zh/GWV-4677-2022; li, xiaofeng/GXF-9442-2022		Agriculture Research System of Shanghai, China [202002]; National Key R&D Program of China [2017YFD0101803]	Agriculture Research System of Shanghai, China; National Key R&D Program of China	Hongfang Zhu received the Agriculture Research System of Shanghai, China (Grant No. 202002) and the National Key R&D Program of China (Grant No.2017YFD0101803) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, FUNCT PLANT BIOL, V38, P462, DOI 10.1071/FP11026; ALLEN RD, 1995, PLANT PHYSIOL, V107, P1049, DOI 10.1104/pp.107.4.1049; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Chu MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1166; Deenamo N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071883; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Howard RJ, 2010, CAN J PLANT PATHOL, V32, P43, DOI 10.1080/07060661003621761; [黄蓉 Huang Rong], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P252; INGRAM DS, 1972, PROC R SOC SER B-BIO, V180, P103, DOI 10.1098/rspb.1972.0008; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Lemarie S, 2015, PLANT CELL PHYSIOL, V56, P2158, DOI 10.1093/pcp/pcv127; Li T, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1784-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovelock DA, 2013, AUSTRALAS PLANT PATH, V42, P141, DOI 10.1007/s13313-012-0167-x; Lowe-Power TM, 2016, MBIO, V7, DOI 10.1128/mBio.00656-16; Ludwig-Muller J, 2015, MOL PLANT PATHOL, V16, P349, DOI 10.1111/mpp.12185; Ludwig-Muller J., 2014, PLANT SIGNAL BAHAV PLANT SIGNAL BAHAV, V9, P4; Mabood F., 2007, Salicylic acid: a plant hormone, P151, DOI 10.1007/1-4020-5184-0_6; Mahesh HM, 2017, PLANT PHYSIOL BIOCH, V117, P12, DOI 10.1016/j.plaphy.2017.05.012; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Pasquer F, 2005, PLANT MOL BIOL, V57, P693, DOI 10.1007/s11103-005-1728-y; Prerostova S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124024; Spormann S, 2019, J ENVIRON MANAGE, V241, P226, DOI 10.1016/j.jenvman.2019.04.035; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang LJ, 2006, PLANT SCI, V170, P685, DOI 10.1016/j.plantsci.2005.09.005; Zhu HF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44724-z; Zhu HongFang, 2017, Acta Botanica Boreali-Occidentalia Sinica, V37, P297	36	6	6	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0248648	10.1371/journal.pone.0248648	http://dx.doi.org/10.1371/journal.pone.0248648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166377	Green Published, gold			2022-12-26	WOS:000671692800055
J	Kathamuthu, GR; Moideen, K; Sridhar, R; Baskaran, D; Babu, S				Kathamuthu, Gokul Raj; Moideen, Kadar; Sridhar, Rathinam; Baskaran, Dhanaraj; Babu, Subash			Reduced neutrophil granular proteins and post-treatment modulation in tuberculous lymphadenitis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EXTRACELLULAR TRAPS; HOST-DEFENSE; INNATE; MYELOPEROXIDASE; INFLAMMATION; ACTIVATION; NECROSIS; CELLS; LIFE	Background Neutrophils are important for host innate immune defense and mediate inflammatory responses. Pulmonary tuberculosis (PTB) is associated with increased neutrophil granular protein (NGP) levels in the circulation. However, the systemic levels of neutrophil granular proteins were not examined in tuberculous lymphadenitis (TBL) disease. Methods We measured the systemic levels of NGP (myeloperoxidase [MPO], elastase and proteinase 3 [PRTN3]) in TBL and compared them to latent tuberculosis (LTB) and healthy control (HC) individuals. We also measured the pre-treatment (Pre-T) and post-treatment (Post-T) systemic levels of neutrophil granular proteins in TBL individuals upon anti-tuberculosis treatment (ATT) completion. In addition, we studied the correlation and discriminatory ability of NGPs using receiver operating characteristic (ROC) analysis. Results Our data suggests that systemic levels of NGPs (MPO, PRTN3, elastase) were significantly reduced in TBL individuals compared to LTB and HC individuals. Similarly, after ATT, the plasma levels of MPO and elastase but not PRTN3 were significantly elevated compared to pre-treatment levels. NGPs (except PRTN3) were positively correlated with absolute neutrophil count of TBL, LTB and HC individuals. Further, NGPs were able to significantly discriminate TBL from LTB and HC individuals. Conclusion Hence, we conclude reduced neutrophil granular protein levels might be associated with disease pathogenesis in TBL.	[Kathamuthu, Gokul Raj; Moideen, Kadar; Babu, Subash] NIRT, Natl Inst Hlth, Int Ctr Excellence Res, Chennai, Tamil Nadu, India; [Kathamuthu, Gokul Raj; Baskaran, Dhanaraj] Natl Inst Res TB NIRT, Chennai, Tamil Nadu, India; [Sridhar, Rathinam] Govt Stanley Med Hosp, Chennai, Tamil Nadu, India; [Babu, Subash] NIAID, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kathamuthu, GR (corresponding author), NIRT, Natl Inst Hlth, Int Ctr Excellence Res, Chennai, Tamil Nadu, India.; Kathamuthu, GR (corresponding author), Natl Inst Res TB NIRT, Chennai, Tamil Nadu, India.	gokul.r@nirt.res.in	Babu, Subash/GXG-4746-2022		Division of Intramural Research, NIAID, NIH	Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research, NIAID, NIH.	Aratani Y, 2018, ARCH BIOCHEM BIOPHYS, V640, P47, DOI 10.1016/j.abb.2018.01.004; Arora V K, 2007, Indian J Tuberc, V54, P165; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blok DC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0833-z; Blomgran R, 2011, J IMMUNOL, V186, P7110, DOI 10.4049/jimmunol.1100001; Borkute RR, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094801; Borregaard N, 2010, IMMUNITY, V33, P657, DOI 10.1016/j.immuni.2010.11.011; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Catano JC, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0008-2016; Cassatella MA, 2019, TRENDS IMMUNOL, V40, P648, DOI 10.1016/j.it.2019.05.003; Corleis B, 2012, CELL MICROBIOL, V14, P1109, DOI 10.1111/j.1462-5822.2012.01783.x; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; Dallenga T, 2018, INT J MED MICROBIOL, V308, P142, DOI 10.1016/j.ijmm.2017.10.001; Dallenga T, 2017, CELL HOST MICROBE, V22, P519, DOI 10.1016/j.chom.2017.09.003; Denholm Justin T, 2010, Infect Drug Resist, V3, P63; Dorhoi A, 2015, EUR J IMMUNOL, V45, P2191, DOI 10.1002/eji.201545493; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fontanilla JM, 2011, CLIN INFECT DIS, V53, P555, DOI 10.1093/cid/cir454; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; Holden IK, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz388; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; Kathamuthu GR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233426; Kathamuthu GR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207404; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lerner TR, 2015, CELL MICROBIOL, V17, P1277, DOI 10.1111/cmi.12480; Liu CH, 2017, CELL MOL IMMUNOL, V14, P963, DOI 10.1038/cmi.2017.88; Lowe DM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00903; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Mattila JT, 2015, CELL MICROBIOL, V17, P1085, DOI 10.1111/cmi.12428; Menzies D, 2018, NEW ENGL J MED, V379, P440, DOI 10.1056/NEJMoa1714283; Moideen K, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00008-18, 10.1128/iai.00008-18]; Niazi MKK, 2015, DIS MODEL MECH, V8, P1141, DOI 10.1242/dmm.020867; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Popa C, 2007, J LIPID RES, V48, P751, DOI 10.1194/jlr.R600021-JLR200; Ren K, 2009, BRAIN RES REV, V60, P57, DOI 10.1016/j.brainresrev.2008.12.020; Scapini P, 2014, BLOOD, V124, P710, DOI 10.1182/blood-2014-03-453217; Soehnlein O, 2017, NAT REV IMMUNOL, V17, P248, DOI 10.1038/nri.2017.10; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Sorensen OE, 2016, J CLIN INVEST, V126, P1612, DOI 10.1172/JCI84538; Witko-Sarsat V, 1999, BLOOD, V94, P2487, DOI 10.1182/blood.V94.7.2487.419k07_2487_2496; World Health Organization, 2021, 10 THREATS GLOB HLTH; Yang CT, 2012, CELL HOST MICROBE, V12, P301, DOI 10.1016/j.chom.2012.07.009; Yipp BG, 2013, BLOOD, V122, P2784, DOI 10.1182/blood-2013-04-457671	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253534	10.1371/journal.pone.0253534	http://dx.doi.org/10.1371/journal.pone.0253534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153068	Green Published, gold, Green Accepted			2022-12-26	WOS:000671691000019
J	Scheerer, NE; Birmingham, E; Boucher, TQ; Iarocci, G				Scheerer, Nichole E.; Birmingham, Elina; Boucher, Troy Q.; Iarocci, Grace			Attention capture by trains and faces in children with and without autism spectrum disorder	PLOS ONE			English	Article							CIRCUMSCRIBED ATTENTION; WILLIAMS-SYNDROME; VISUAL-ATTENTION; INDIVIDUALS; EXPERTISE; PERCEPTION; AMYGDALA; STIMULI; PARTS; AREA	This study examined involuntary capture of attention, overt attention, and stimulus valence and arousal ratings, all factors that can contribute to potential attentional biases to face and train objects in children with and without autism spectrum disorder (ASD). In the visual domain, faces are particularly captivating, and are thought to have a 'special status' in the attentional system. Research suggests that similar attentional biases may exist for other objects of expertise (e.g. birds for bird experts), providing support for the role of exposure in attention prioritization. Autistic individuals often have circumscribed interests around certain classes of objects, such as trains, that are related to vehicles and mechanical systems. This research aimed to determine whether this propensity in autistic individuals leads to stronger attention capture by trains, and perhaps weaker attention capture by faces, than what would be expected in non-autistic children. In Experiment 1, autistic children (6-14 years old) and age- and IQ-matched non-autistic children performed a visual search task where they manually indicated whether a target butterfly appeared amongst an array of face, train, and neutral distractors while their eye-movements were tracked. Autistic children were no less susceptible to attention capture by faces than non-autistic children. Overall, for both groups, trains captured attention more strongly than face stimuli and, trains had a larger effect on overt attention to the target stimuli, relative to face distractors. In Experiment 2, a new group of children (autistic and non-autistic) rated train stimuli as more interesting and exciting than the face stimuli, with no differences between groups. These results suggest that: (1) other objects (trains) can capture attention in a similar manner as faces, in both autistic and non-autistic children (2) attention capture is driven partly by voluntary attentional processes related to personal interest or affective responses to the stimuli.	[Scheerer, Nichole E.] Western Univ, Brain & Mind Inst, London, ON, Canada; [Scheerer, Nichole E.; Boucher, Troy Q.; Iarocci, Grace] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Birmingham, Elina] Simon Fraser Univ, Fac Educ, Burnaby, BC, Canada	Western University (University of Western Ontario); Simon Fraser University; Simon Fraser University	Iarocci, G (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada.	grace_iarocci@sfu.ca		Boucher, Troy/0000-0002-0648-1752; Scheerer, Nichole/0000-0003-0070-6559	Natural Science and Engineering Research Council (NSERC) of Canada [408052-2013]; BrainsCAN Postdoctoral Fellowship at Western University - Canada First Research Excellence Fund (CFREF)	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); BrainsCAN Postdoctoral Fellowship at Western University - Canada First Research Excellence Fund (CFREF)	The work was supported by a grant from the Natural Science and Engineering Research Council (NSERC, https://www.nserc-crsng.gc.ca) of Canada (grant #408052-2013) awarded to senior author, GI, and a BrainsCAN Postdoctoral Fellowship (https://brainscan.uwo.ca) at Western University, funded by the Canada First Research Excellence Fund (CFREF) that was granted to NS.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwood T, 2003, LEARNING AND BEHAVIOR PROBLEMS IN ASPERGER SYNDROME, P126; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 1999, BRIT J PSYCHIAT, V175, P484, DOI 10.1192/bjp.175.5.484; Bindemann M, 2005, PSYCHON B REV, V12, P1048, DOI 10.3758/BF03206442; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; Burack JA, 2016, J COGN DEV, V17, P553, DOI 10.1080/15248372.2016.1197226; Busey TA, 2005, VISION RES, V45, P431, DOI 10.1016/j.visres.2004.08.021; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Critchley HD, 2000, BRAIN, V123, P2203, DOI 10.1093/brain/123.11.2203; Devue C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034598; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; ENNS JT, 1989, J EXP CHILD PSYCHOL, V48, P171, DOI 10.1016/0022-0965(89)90001-5; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Foss-Feig JH, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9149-6; Gauthier I, 1997, VISION RES, V37, P1673, DOI 10.1016/S0042-6989(96)00286-6; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Hirai M, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9172-7; Iarocci G, 2009, DEVELOPMENTAL SCI, V12, P715, DOI 10.1111/j.1467-7687.2009.00810.x; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2007, RES PRACT PERS SEV D, V32, P89, DOI 10.2511/rpsd.32.2.89; Langton SRH, 2008, COGNITION, V107, P330, DOI 10.1016/j.cognition.2007.07.012; Leder H, 2000, Q J EXP PSYCHOL-A, V53, P513, DOI 10.1080/027249800390583; Lewis MB, 2003, PERCEPTION, V32, P903, DOI 10.1068/p5007; McGugin RW, 2011, ATTEN PERCEPT PSYCHO, V73, P309, DOI 10.3758/s13414-010-0006-5; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Parsons OE, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0132-1; PEARSON DA, 1990, CHILD DEV, V61, P1779, DOI 10.1111/j.1467-8624.1990.tb03565.x; Pereira E. J, 2019, PSYCHOL RES-PSYCH FO, P1, DOI [10.1007/s10633-019-09682-x, DOI 10.1007/S10633-019-09682-X]; Pereira Effie J, 2019, Vision (Basel), V3, DOI 10.3390/vision3020029; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2012, J AUTISM DEV DISORD, V42, P634, DOI 10.1007/s10803-011-1266-1; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; Richler JJ, 2008, J EXP PSYCHOL LEARN, V34, P1356, DOI 10.1037/a0013080; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Sasson NJ, 2006, J AUTISM DEV DISORD, V36, P381, DOI 10.1007/s10803-006-0076-3; Sasson NJ, 2014, J AUTISM DEV DISORD, V44, P584, DOI 10.1007/s10803-013-1910-z; Sasson NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042457; Sasson NJ, 2011, J AUTISM DEV DISORD, V41, P242, DOI 10.1007/s10803-010-1038-3; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Schwarzer G, 2000, CHILD DEV, V71, P391, DOI 10.1111/1467-8624.00152; South M, 2005, J AUTISM DEV DISORD, V35, P145, DOI 10.1007/s10803-004-1992-8; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Theeuwes J, 2006, VIS COGN, V13, P657, DOI 10.1080/13506280500410949; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Unruh KE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00586; Walther D., 2005, SALIENCY TOOLBOX VER; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Wechsler D., 2011, WECHSLER ABBREVIATED; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671; Wong ACN, 2009, PSYCHOL SCI, V20, P1108, DOI 10.1111/j.1467-9280.2009.02430.x; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006	62	0	0	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0250763	10.1371/journal.pone.0250763	http://dx.doi.org/10.1371/journal.pone.0250763			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143788	gold, Green Published			2022-12-26	WOS:000671690700012
J	Skals, R; Krogager, ML; Appel, EVR; Schnurr, TM; Have, CT; Gislason, G; Poulsen, HE; Kober, L; Engstrom, T; Stender, S; Hansen, T; Grarup, N; Lee, CJY; Andersson, C; Torp-Pedersen, C; Weeke, PE				Skals, Regitze; Krogager, Maria Lukacs; Appel, Emil Vincent R.; Schnurr, Theresia M.; Have, Christian Theil; Gislason, Gunnar; Poulsen, Henrik Enghusen; Kober, Lars; Engstrom, Thomas; Stender, Steen; Hansen, Torben; Grarup, Niels; Lee, Christina Ji-Young; Andersson, Charlotte; Torp-Pedersen, Christian; Weeke, Peter E.			Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiography	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; GLYCEMIC TRAITS; IDENTIFY	Aims Insulin resistance associates with development of metabolic syndrome and risk of cardiovascular disease. The link between insulin resistance and cardiovascular disease is complex and multifactorial. Confirming the genetic link between insulin resistance, type 2 diabetes, and coronary artery disease, as well as the extent of coronary artery disease, is important and may provide better risk stratification for patients at risk. We investigated whether a genetic risk score of 53 single nucleotide polymorphisms known to be associated with insulin resistance phenotypes was associated with diabetes and burden of coronary artery disease. Methods and results We genotyped patients with a coronary angiography performed in the capital region of Denmark from 2010-2014 and constructed a genetic risk score of the 53 single nucleotide polymorphisms. Logistic regression using quartiles of the genetic risk score was performed to determine associations with diabetes and coronary artery disease. Associations with the extent of coronary artery disease, defined as one-, two- or three-vessel coronary artery disease, was determined by multinomial logistic regression. We identified 4,963 patients, of which 17% had diabetes and 55% had significant coronary artery disease. Of the latter, 27%, 14% and 14% had one, two or three-vessel coronary artery disease, respectively. No significant increased risk of diabetes was identified comparing the highest genetic risk score quartile with the lowest. An increased risk of coronary artery disease was found for patients with the highest genetic risk score quartile in both unadjusted and adjusted analyses, OR 1.21 (95% CI: 1.03, 1.42, p = 0.02) and 1.25 (95% CI 1.06, 1.48, p<0.01), respectively. In the adjusted multinomial logistic regression, patients in the highest genetic risk score quartile were more likely to develop three-vessel coronary artery disease compared with patients in the lowest genetic risk score quartile, OR 1.41 (95% CI: 1.10, 1.82, p<0.01). Conclusions Among patients referred for coronary angiography, only a strong genetic predisposition to insulin resistance was associated with risk of coronary artery disease and with a greater disease burden.	[Skals, Regitze; Lee, Christina Ji-Young] Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark; [Krogager, Maria Lukacs; Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Appel, Emil Vincent R.; Schnurr, Theresia M.; Have, Christian Theil; Hansen, Torben; Grarup, Niels] Univ Copenhagen, Novo Nordisk Fdn, Fac Hlth & Med Sci, Ctr Basic Metab Res, Copenhagen, Denmark; [Gislason, Gunnar; Andersson, Charlotte] Univ Copenhagen, Dept Cardiol, Hosp Gentofte, Hellerup, Denmark; [Poulsen, Henrik Enghusen] Univ Copenhagen, Bispebjerg & Frederiksberg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Kober, Lars; Engstrom, Thomas] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark; [Stender, Steen] Univ Copenhagen, Dept Clin Biochem, Hosp Gentofte, Copenhagen, Denmark; [Weeke, Peter E.] Bispebjerg & Frederiksberg Hosp, Dept Cardiol, Copenhagen, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Skals, R (corresponding author), Aalborg Univ Hosp, Unit Clin Biostat, Aalborg, Denmark.	r.skals@rn.dk	Gislason, Gunnar/B-7561-2009; Grarup, Niels/K-2807-2015	Gislason, Gunnar/0000-0002-0548-402X; Grarup, Niels/0000-0001-5526-1070; Skals, Regitze/0000-0003-2560-4487; Hansen, Torben/0000-0001-8748-3831; Kober, Lars/0000-0002-6635-1466; Krogager, Maria/0000-0001-9285-6903; stender, steen/0000-0003-1037-1158; Schnurr, Theresia/0000-0002-6573-4959	Danish Heart Foundation [15-R99-A5858-22910]; Novo Nordisk Foundation supports research activities in the Novo Nordisk Research Foundation Center for Basic Metabolic Research, University of Copenhagen [NNF15OC0016544]	Danish Heart Foundation; Novo Nordisk Foundation supports research activities in the Novo Nordisk Research Foundation Center for Basic Metabolic Research, University of Copenhagen	This work was supported by The Danish Heart Foundation [grant number 15-R99-A5858-22910] (https://hjerteforeningen.dk/).The Novo Nordisk Foundation [grant number NNF15OC0016544] supports research activities in the Novo Nordisk Research Foundation Center for Basic Metabolic Research, University of Copenhagen (http://metabol.ku.dk/).	Banasik K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-10; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Gast KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052036; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Justesen JM, 2015, CIRC-CARDIOVASC GENE, V8, P465, DOI 10.1161/CIRCGENETICS.114.000637; Knowles JW, 2015, J CLIN INVEST, V125, P1739, DOI [10.1172/JCI74692, 10.1172/JCI74592]; Koskinas KC, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003255; Krarup NT, 2015, ATHEROSCLEROSIS, V240, P305, DOI 10.1016/j.atherosclerosis.2015.03.022; Lotta LA, 2017, NAT GENET, V49, P17, DOI 10.1038/ng.3714; Luthra S, 2015, ANN THORAC SURG, V100, P2383, DOI 10.1016/j.athoracsur.2015.07.005; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; R Core Team, 2020, R LANG ENV STAT COMP; Reaven G, 2012, ARTERIOSCL THROM VAS, V32, P1754, DOI 10.1161/ATVBAHA.111.241885; Salazar MR, 2013, DIABETES VASC DIS RE, V10, P346, DOI 10.1177/1479164113479809; Scott RA, 2014, DIABETES, V63, P4378, DOI 10.2337/db14-0319; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; van Domburg RT, 2009, EUR HEART J, V30, P453, DOI 10.1093/eurheartj/ehn530; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Waziri H, 2016, EUROINTERVENTION, V12, P441, DOI 10.4244/EIJY15M09_04; Xue A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04951-w; Yaghootkar H, 2014, DIABETES, V63, P4369, DOI 10.2337/db14-0318	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252855	10.1371/journal.pone.0252855	http://dx.doi.org/10.1371/journal.pone.0252855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143812	gold, Green Published			2022-12-26	WOS:000671690700029
J	Khan, F; Ali, S; Saeed, A; Kumar, R; Khan, AW				Khan, Firdos; Ali, Shaukat; Saeed, Alia; Kumar, Ramesh; Khan, Abdul Wali			Forecasting daily new infections, deaths and recovery cases due to COVID-19 in Pakistan by using Bayesian Dynamic Linear Models	PLOS ONE			English	Article							TIME-SERIES	The COVID-19 has caused the deadliest pandemic around the globe, emerged from the city of Wuhan, China by the end of 2019 and affected all continents of the world, with severe health implications and as well as financial-damage. Pakistan is also amongst the top badly effected countries in terms of casualties and financial loss due to COVID-19. By 20(th) March, 2021, Pakistan reported 623,135 total confirmed cases and 13,799 deaths. A state space model called 'Bayesian Dynamic Linear Model' (BDLM) was used for the forecast of daily new infections, deaths and recover cases regarding COVID-19. For the estimation of states of the models and forecasting new observations, the recursive Kalman filter was used. Twenty days ahead forecast show that the maximum number of new infections are 4,031 per day with 95% prediction interval (3,319-4,743). Death forecast shows that the maximum number of the deaths with 95% prediction interval are 81 and (67-93), respectively. Maximum daily recoveries are 3,464 with 95% prediction interval (2,887-5,423) in the next 20 days. The average number of new infections, deaths and recover cases are 3,282, 52 and 1,840, respectively, in the upcoming 20 days. As the data generation processes based on the latest data has been identified, therefore it can be updated with the availability of new data to provide latest forecast.	[Khan, Firdos] Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad, Pakistan; [Ali, Shaukat] Minist Climate Change, Global Change Impact Studies Ctr GCISC, Islamabad, Pakistan; [Saeed, Alia; Kumar, Ramesh] Hlth Serv Acad, Islamabad, Pakistan; [Saeed, Alia] ClimatExperts, Islamabad, Pakistan; [Khan, Abdul Wali] Minist Natl Hlth Serv, Regulat & Coordinat Islamabad, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan; Health Services Academy	Khan, F (corresponding author), Natl Univ Sci & Technol NUST, Sch Nat Sci SNS, Islamabad, Pakistan.	kfyousafzai@gmail.com	Khan, Firdos/AAE-7252-2019	Khan, Firdos/0000-0002-0869-943X				Ali M, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0242762, 10.1371/journal.pone.02427620]; Aslam M, 2020, DATA BRIEF, V31, DOI 10.1016/j.dib.2020.105854; Barber D., 2011, BAYESIAN TIME SERIES; Bloom DA., 2018, INT MONETARY FUND IM, V55; Boccaletti S, 2020, CHAOS SOLITON FRACT, V135, DOI 10.1016/j.chaos.2020.109794; Box G.E.P., 2015, TIME SERIES ANAL FOR; Castillo O, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110242; Chatfield C., 1978, APPL STAT, V27, P264, DOI [10.2307/2347162, DOI 10.2307/2347162]; Chaurasia Vikas, 2022, Research on Biomedical Engineering, V38, P35, DOI 10.1007/s42600-020-00105-4; De Livera AM, 2011, J AM STAT ASSOC, V106, P1513, DOI 10.1198/jasa.2011.tm09771; Douc R., 2014, NONLINEAR TIME SERIE, DOI [10.1016/j.jhealeco.2013.10.010, DOI 10.1016/J.JHEALECO.2013.10.010]; Enders W., 2010, APPL ECONOMETRIC TIM, V3rd; Girum T, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00285-w; Hu Z, 2020, J MED INTERNET RES, V22, DOI 10.2196/21176; Johnson M, 2019, J AGR BIOL ENVIR ST, V24, P1, DOI 10.1007/s13253-018-00338-y; Kalman R-E., 1960, T ASME J BASIC ENG, P35; Khan F., 2018, International Journal of Water, V12, P1, DOI 10.1504/IJW.2018.090184; Khan F, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110189; Kunsch H., 2001, COMPLEX STOCHASTIC S, P109; Ma TY, 2019, J ADV TRANSPORT, DOI 10.1155/2019/5314520; Madhav N., 2017, DIS CONTROL PRIORITI, V9, P315, DOI [10.1596/978-1-4648-0527-1_ch17, DOI 10.1596/978-1-4648-0527-1]; Mahrouf M, 2021, AXIOMS, V10, DOI 10.3390/axioms10010018; Martinez-Valero C, 2020, MED CLIN-BARCELONA, V155, P459, DOI 10.1016/j.medcli.2020.07.007; Mathevet T, 2004, HYDROL EARTH SYST SC, V8, P1051, DOI 10.5194/hess-8-1051-2004; Melin P, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020181; Meo SA, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00456-9; Migon HS, 2005, HANDB STAT, V25, P553, DOI 10.1016/S0169-7161(05)25019-8; Momeni-Boroujeni A, 2021, INFECT DIS REP, V13, P239, DOI 10.3390/idr13010027; Nouvellet P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21358-2; Oreshkin BN, 2019, ARXIV190510437; Papastefanopoulos V, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10113880; Petris G, 2009, USE R, P31, DOI 10.1007/b135794_2; Petris G, 2010, J STAT SOFTW, V36, P1; Pole A., 1994, APPL BAYESIAN FORECA; Salinas D, 2020, INT J FORECASTING, V36, P1181, DOI 10.1016/j.ijforecast.2019.07.001; Sarkar K, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110049; Sun TZ, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109949; Taylor SJ, 2018, AM STAT, V72, P37, DOI 10.1080/00031305.2017.1380080; West M., 1997, BAYESIAN FORECASTING, V2nd edition; Yousaf M, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109926; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116; Zhao B., 2020, ANN MATH PHYS, V3, P023, DOI [10.17352/amp.000014, DOI 10.17352/AMP.000014]	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253367	10.1371/journal.pone.0253367	http://dx.doi.org/10.1371/journal.pone.0253367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138956	gold, Green Published			2022-12-26	WOS:000671690200117
J	Hoang, DK; Doan, MC; Mai, LD; Ho-Le, TP; Ho-Pham, LT				Hoang, Duy K.; Doan, Minh C.; Mai, Linh D.; Ho-Le, Thao P.; Ho-Pham, Lan T.			Burden of osteoporosis in Vietnam: An analysis of population risk	PLOS ONE			English	Article							FRACTURE RISK; MORTALITY; WOMEN; PREVENTION; NOMOGRAM; FRAX; MEN	Purpose To estimate the proportion of men and women aged 50 years and older who would be classified as "high risk" for fracture and eligible for anti-fracture treatment. Methods The study involved 1421 women and 652 men aged 50 years and older, who were recruited from the general population in Ho Chi Minh City, Vietnam. Fracture history was ascertained from each individual. Bone mineral density (BMD) was measured at the lumbar spine and femoral neck by DXA (Hologic Horizon). The diagnosis of osteoporosis was based on the T-scores <= -2.50 derived from either femoral neck or lumbar spine BMD. The 10-year risks of major fractureand hip fracture were estimated from FRAX version for Thai population. The criteria for recommended treatment were based on the US National Osteoporosis Foundation (NOF). Results The average age of women and men was similar to 60 yr (SD 7.8). Approximately 11% (n = 152) of women and 14% (n = 92) of men had a prior fracture. The prevalence of osteoporosis was 27% (n = 381; 95% CI, 25 to 29%) in women and 13% (n = 87; 95% CI, 11 to 16%) in men. Only 1% (n = 11) of women and 0.1% (n = 1) of men had 10-year risk of major fracture >= 20%. However, 23% (n = 327) of women and 9.5% (n = 62) of men had 10-year risk of hip fracture >= 3%. Using the NOF recommended criteria, 49% (n = 702; 95% CI, 47 to 52%) of women and 35% (n = 228; 95% CI, 31 to 39%) of men would be eligible for therapy. Conclusion Almost half of women and just over one-third of men aged 50 years and older in Vietnam meet the NOF criteria for osteoporosis treatment. This finding can help develop guidelines for osteoporosis treatment in Vietnam.	[Hoang, Duy K.; Doan, Minh C.; Mai, Linh D.; Ho-Pham, Lan T.] Ton Duc Thang Univ, Bone & Muscle Res Grp, Ho Chi Minh City, Vietnam; [Hoang, Duy K.; Doan, Minh C.; Mai, Linh D.; Ho-Pham, Lan T.] Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam; [Doan, Minh C.; Mai, Linh D.; Ho-Pham, Lan T.] Pham Ngoc Thach Univ Med, Dept Internal Med, Ho Chi Minh City, Vietnam; [Ho-Le, Thao P.] Garvan Inst Med Res, Sydney, NSW, Australia; [Ho-Le, Thao P.] Hatinh Univ, Fac Engn & Informat Technol, Ha Tinh, Vietnam	Ton Duc Thang University; Ton Duc Thang University; Garvan Institute of Medical Research	Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Bone & Muscle Res Grp, Ho Chi Minh City, Vietnam.; Ho-Pham, LT (corresponding author), Ton Duc Thang Univ, Fac Appl Sci, Ho Chi Minh City, Vietnam.; Ho-Pham, LT (corresponding author), Pham Ngoc Thach Univ Med, Dept Internal Med, Ho Chi Minh City, Vietnam.	hophamthuclan@tdtu.edu.vn		Hoang, Khuong-Duy/0000-0002-5621-5583; Ho-Pham, Lan T/0000-0001-8382-5080; Doan, Minh C./0000-0001-7314-0387	Foundation for Science and Technology Development of Ton Duc Thang University (FOSTECT) [FOSTECT.2014.BR.09]; Department of Science and Technology of Ho Chi Minh City	Foundation for Science and Technology Development of Ton Duc Thang University (FOSTECT); Department of Science and Technology of Ho Chi Minh City	This research is partly funded by the Foundation for Science and Technology Development of Ton Duc Thang University (FOSTECT, https://fostect.tdtu.edu.vn/), Grant number FOSTECT.2014.BR.09, and a grant from the Department of Science and Technology of Ho Chi Minh City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Blume SW, 2011, OSTEOPOROSIS INT, V22, P1835, DOI 10.1007/s00198-010-1419-7; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1174, DOI 10.1210/jc.2009-0852; Center JR, 2011, J CLIN ENDOCR METAB, V96, P1006, DOI 10.1210/jc.2010-2730; Chen P, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3712-7; Cole TJ, 2008, AM J CLIN NUTR, V87, P1959, DOI 10.1093/ajcn/87.6.1959; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Dagan N, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6755; Donaldson MG, 2009, J BONE MINER RES, V24, P675, DOI [10.1359/jbmr.081203, 10.1359/JBMR.081203]; Gallagher JC, 2018, MENOPAUSE, V25, P1403, DOI 10.1097/GME.0000000000001263; Ho-Pham Lan T, 2017, Osteoporos Sarcopenia, V3, P90, DOI 10.1016/j.afos.2017.06.001; Ho-Pham LT, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-182; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Pluskiewicz W, 2014, AGING MALE, V17, P174, DOI 10.3109/13685538.2013.875991; R Development Core Team, 2006, LANG ENV STAT COMP; Reid IR, 2018, NEW ENGL J MED, V379, P2407, DOI 10.1056/NEJMoa1808082; Schnell S, 2010, GERIATR ORTHOP SURG, V1, P6, DOI 10.1177/2151458510378105; van den Bergh Joop P W, 2010, Curr Osteoporos Rep, V8, P131, DOI 10.1007/s11914-010-0022-3; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269	23	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252592	10.1371/journal.pone.0252592	http://dx.doi.org/10.1371/journal.pone.0252592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133437	Green Published, gold			2022-12-26	WOS:000671682700042
J	Solano, T; Mittal, R; Shoele, K				Solano, Tomas; Mittal, Rajat; Shoele, Kourosh			One size fits all?: A simulation framework for face-mask fit on population-based faces	PLOS ONE			English	Article							VIRUS TRANSMISSION; LEAK SITES; RESPIRATOR; SPREAD	The use of face masks by the general population during viral outbreaks such as the COVID-19 pandemic, although at times controversial, has been effective in slowing down the spread of the virus. The extent to which face masks mitigate the transmission is highly dependent on how well the mask fits each individual. The fit of simple cloth masks on the face, as well as the resulting perimeter leakage and face mask efficacy, are expected to be highly dependent on the type of mask and facial topology. However, this effect has, to date, not been adequately examined and quantified. Here, we propose a framework to study the efficacy of different mask designs based on a quasi-static mechanical model of the deployment of face masks onto a wide range of faces. To illustrate the capabilities of the proposed framework, we explore a simple rectangular cloth mask on a large virtual population of subjects generated from a 3D morphable face model. The effect of weight, age, gender, and height on the mask fit is studied. The Centers for Disease Control and Prevention (CDC) recommended homemade cloth mask design was used as a basis for comparison and was found not to be the most effective design for all subjects. We highlight the importance of designing masks accounting for the widely varying population of faces. Metrics based on aerodynamic principles were used to determine that thin, feminine, and young faces were shown to benefit from mask sizes smaller than that recommended by the CDC. Besides mask size, side-edge tuck-in, or pleating, of the masks as a design parameter was also studied and found to have the potential to cause a larger localized gap opening.	[Solano, Tomas; Shoele, Kourosh] Florida State Univ, Florida A&M Univ, Joint Coll Engn, Dept Mech Engn, Tallahassee, FL 32306 USA; [Mittal, Rajat] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Mittal, Rajat] Johns Hopkins Univ, Sch Med, Baltimore, MD USA	State University System of Florida; Florida A&M University; Florida State University; Johns Hopkins University; Johns Hopkins University	Shoele, K (corresponding author), Florida State Univ, Florida A&M Univ, Joint Coll Engn, Dept Mech Engn, Tallahassee, FL 32306 USA.	kshoele@eng.famu.fsu.edu			National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems [CBET-2034992, CBET-2034983]	National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems(National Science Foundation (NSF))	Award Number: CBET-2034992 | Recipient: Kourosh Shoele National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems https://www.nsf.gov/.Award Number: CBET-2034983 | Recipient: Rajat Mittal National Science Foundation, Division of Chemical, Bioengineering, Environmental, and Transport Systems https://www.nsf.gov/.	Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Bouaziz S, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601116; Brienen NCJ, 2010, RISK ANAL, V30, P1210, DOI 10.1111/j.1539-6924.2010.01428.x; CDC, 2020, COR DIS 2019 COVID 1; Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071; D'Amico B, 2016, ENG STRUCT, V117, P518, DOI 10.1016/j.engstruct.2016.03.034; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Duck FA, 2013, PHYS PROPERTIES TISS; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Fung Y.C., 2013, BIOMECHANICS MECH PR; GALOWIN LS, 1974, AIAA J, V12, P1585, DOI 10.2514/3.49549; Gralton J, 2013, J MED VIROL, V85, P2151, DOI 10.1002/jmv.23698; Lee SA, 2005, ANN OCCUP HYG, V49, P245, DOI 10.1093/annhyg/meh097; Lei ZP, 2013, ANN OCCUP HYG, V57, P493, DOI 10.1093/annhyg/mes085; Lei ZP, 2012, J OCCUP ENVIRON HYG, V9, P46, DOI 10.1080/15459624.2011.635130; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Mittal R, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0025476; Morawska L, 2020, CLIN INFECT DIS, V71, P2311, DOI 10.1093/cid/ciaa939; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P1; Ngonghala CN, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108364; O'Kelly E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245688; Oestenstad RK, 2010, J OCCUP ENVIRON HYG, V7, P332, DOI 10.1080/15459621003729909; OESTENSTAD RK, 1990, AM IND HYG ASSOC J, V51, P285, DOI 10.1202/0002-8894(1990)051<0285:DOFLSO>2.0.CO;2; Paysan P, 2009, AVSS: 2009 6TH IEEE INTERNATIONAL CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P296, DOI 10.1109/AVSS.2009.58; Penava Z, 2014, FIBRES TEXT EAST EUR, V22, P57; RODDEMAN DG, 1987, J APPL MECH-T ASME, V54, P888, DOI 10.1115/1.3173134; Song Y, 2010, CHEM ENG COMMUN, V197, P551, DOI 10.1080/00986440903245971; Stockwell RE, 2018, AM J RESP CRIT CARE, V198, P1339, DOI 10.1164/rccm.201805-0823LE; Tang JW, 2009, J R SOC INTERFACE, V6, pS727, DOI 10.1098/rsif.2009.0295.focus; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618; Vanden Driessche K, 2015, AM J RESP CRIT CARE, V192, P897, DOI 10.1164/rccm.201503-0481LE; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Viola IM, 2021, IEEE OPEN J ENG MED, V2, P26, DOI 10.1109/OJEMB.2021.3053215; Wells WF, 1934, AM J HYG, V20, P611, DOI 10.1093/oxfordjournals.aje.a118097; White FM., 1979, FLUID MECH-SOV RES	38	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252143	10.1371/journal.pone.0252143	http://dx.doi.org/10.1371/journal.pone.0252143			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133436	Green Submitted, gold, Green Published			2022-12-26	WOS:000671682700002
J	Holmberg, R; Gustavsson, J; Bonander, C				Holmberg, Robin; Gustavsson, Johanna; Bonander, Carl			Evaluation of the design and implementation of municipal ice cleat distribution programs for the prevention of ice-related fall injuries among older adults in Sweden	PLOS ONE			English	Article							ANTI-SLIP DEVICES; BEHAVIOR-CHANGE; MAINTENANCE; SURFACES; WALKING; HEALTH	Introduction The risk for outdoor falls tends to increase during winter due to icy road conditions. Several Swedish municipalities have introduced programs that provide their senior citizens with a pair of ice cleats in an attempt to tackle this problem. In this paper, we perform a process evaluation to identify potential barriers to the success of these programs and analyze the logic of their design. Methods We sent a survey to all 290 Swedish municipalities to collect data on the characteristics of ice cleat distribution programs. We also performed focus-group interviews with older adults to gain insight into their thoughts about ice cleat programs. We synthesized our data with existing literature on ice cleats and behavior change theory to populate a logic model to identify and analyze hidden assumptions and potential flaws using program theory analysis. Results On average, about 40% of the eligible population living in the intervention municipalities collected a pair of ice cleats. While we identified some other, but mostly minor, barriers to implementation, the main barrier appears to be a lack of scale (i.e., insufficient procurement and distribution of ice cleats), as 90% of all purchased ice cleats were eventually distributed. While previous research suggests that ice cleats can decrease injury risks if worn, we find that there is limited evidence on the effects of distribution on ice cleat use. Our interviewees emphasized the potential utility of ice cleats for staying safe and active during winter but stressed that ice cleats need to be user-friendly and of high-quality to increase the likelihood that a distribution program encourages behavior change. Conclusion Existing ice cleat distribution programs appear to have reached a meaningful share of the targeted population. Additional research is required to assess their effects on ice cleat use and injury rates.	[Holmberg, Robin; Gustavsson, Johanna] Karlstad Univ, Dept Polit Hist Religious & Cultural Studies, Karlstad, Sweden; [Holmberg, Robin; Gustavsson, Johanna; Bonander, Carl] Karlstad Univ, Ctr Societal Risk Res, Karlstad, Sweden; [Bonander, Carl] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Inst Med, Gothenburg, Sweden	Karlstad University; Karlstad University; University of Gothenburg	Holmberg, R (corresponding author), Karlstad Univ, Dept Polit Hist Religious & Cultural Studies, Karlstad, Sweden.; Holmberg, R (corresponding author), Karlstad Univ, Ctr Societal Risk Res, Karlstad, Sweden.	robin.holmberg@kau.se		Holmberg, Robin/0000-0001-5637-0359; Bonander, Carl/0000-0002-1189-9950	Kamprad Family Foundation for Entrepreneurship, Research Charity [20180067]	Kamprad Family Foundation for Entrepreneurship, Research Charity	This work was supported by a research grant from The Kamprad Family Foundation for Entrepreneurship, Research & Charity (grant number 20180067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoory L, 2005, INJURY PREV, V11, P260, DOI 10.1136/ip.2004.007104; [Anonymous], 2017, KOMMUNALLAG, P725; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bengtsson M., 2016, NURS OPEN, V2, P8, DOI [10.1016/j.npls.2016.01.001, DOI 10.1016/J.NPLS.2016.01.001]; Berggard G, 2010, ACCIDENT ANAL PREV, V42, P1199, DOI 10.1016/j.aap.2010.01.011; Berntman M., 2015, BULLETIN I TEKNIK SA BULLETIN I TEKNIK SA, V295; Bjornstig U, 1997, ACCIDENT ANAL PREV, V29, P211, DOI 10.1016/S0001-4575(96)00074-7; Bonander C, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.105282; BRUCE M, 1986, J OCCUP ACCID, V7, P273, DOI 10.1016/0376-6349(86)90018-0; Champion LV., 2008, RES PRACTICE, V4th ed, P45; Coryn CLS, 2011, AM J EVAL, V32, P199, DOI 10.1177/1098214010389321; Creswell J.W., 2009, RES DESIGN QUALITATI, DOI DOI 10.1007/S11252-005-3264-6; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; Faskunger J., 2007, BYGGD MILJO FYSISK A; Gard G, 2006, APPL ERGON, V37, P177, DOI 10.1016/j.apergo.2005.04.004; Gard G, 2001, ACCIDENT ANAL PREV, V33, P1, DOI 10.1016/S0001-4575(00)00002-6; Gard G, 2000, ACCIDENT ANAL PREV, V32, P455, DOI 10.1016/S0001-4575(99)00070-6; Gielen AC, 2003, EPIDEMIOL REV, V25, P65, DOI 10.1093/epirev/mxg004; Gustavsson J, 2020, J TRANSP HEALTH, V17, DOI 10.1016/j.jth.2020.100865; Gyllencreutz L, 2015, SCAND J CARING SCI, V29, P225, DOI 10.1111/scs.12153; Kerr J, 2012, J PLAN LIT, V27, P43, DOI 10.1177/0885412211415283; Kwasnicka D, 2016, HEALTH PSYCHOL REV, V10, P277, DOI 10.1080/17437199.2016.1151372; Larsson A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142451; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; MCAULEY E, 1993, J BEHAV MED, V16, P103, DOI 10.1007/BF00844757; McKiernan FE, 2005, J AM GERIATR SOC, V53, P943, DOI 10.1111/j.1532-5415.2005.53302.x; MERRILD U, 1983, ACCIDENT ANAL PREV, V15, P41, DOI 10.1016/0001-4575(83)90005-2; MSB, 2010, PE MED STOR SNOM VIN PE MED STOR SNOM VIN; Rossi HP., 2019, EVALUATION SYSTEMATI, V8th ed; Saunders RP, 2005, HEALTH PROMOT PRACT, V6, P134, DOI 10.1177/1524839904273387; Schepers P, 2017, J SAFETY RES, V62, P227, DOI 10.1016/j.jsr.2017.06.020; Weiss C. H., 1998, EVALUATION METHODS S; Weiss CH, 1997, EVALUATION REV, V21, P501, DOI 10.1177/0193841X9702100405; Wibeck V., 2010, FOKUSGRUPPER FOKUSER	34	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253054	10.1371/journal.pone.0253054	http://dx.doi.org/10.1371/journal.pone.0253054			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170912	Green Published, gold			2022-12-26	WOS:000671694400038
J	Lee, G; Jang, GH; Kang, HY; Song, G				Lee, Gwangho; Jang, Gun Hyuk; Kang, Ho Young; Song, Giltae			Predicting aptamer sequences that interact with target proteins using an aptamer-protein interaction classifier and a Monte Carlo tree search approach	PLOS ONE			English	Article							IN-VITRO; SELECTION; DOCKING; SERVER	Oligonucleotide-based aptamers, which have a three-dimensional structure with a single-stranded fragment, feature various characteristics with respect to size, toxicity, and permeability. Accordingly, aptamers are advantageous in terms of diagnosis and treatment and are materials that can be produced through relatively simple experiments. Systematic evolution of ligands by exponential enrichment (SELEX) is one of the most widely used experimental methods for generating aptamers; however, it is highly expensive and time-consuming. To reduce the related costs, recent studies have used in silico approaches, such as aptamer-protein interaction (API) classifiers that use sequence patterns to determine the binding affinity between RNA aptamers and proteins. Some of these methods generate candidate RNA aptamer sequences that bind to a target protein, but they are limited to producing candidates of a specific size. In this study, we present a machine learning approach for selecting candidate sequences of various sizes that have a high binding affinity for a specific sequence of a target protein. We applied the Monte Carlo tree search (MCTS) algorithm for generating the candidate sequences using a score function based on an API classifier. The tree structure that we designed with MCTS enables nucleotide sequence sampling, and the obtained sequences are potential aptamer candidates. We performed a quality assessment using the scores of docking simulations. Our validation datasets revealed that our model showed similar or better docking scores in ZDOCK docking simulations than the known aptamers. We expect that our method, which is size-independent and easy to use, can provide insights into searching for an appropriate aptamer sequence for a target protein during the simulation step of SELEX.	[Lee, Gwangho; Song, Giltae] Pusan Natl Univ, Sch Comp Sci & Engn, Busan, South Korea; [Jang, Gun Hyuk; Kang, Ho Young] NuclixBio, Res & Dev, Seoul, South Korea	Pusan National University	Song, G (corresponding author), Pusan Natl Univ, Sch Comp Sci & Engn, Busan, South Korea.	gsong@pusan.ac.kr		Lee, Gwangho/0000-0001-6304-1932; Song, Giltae/0000-0001-8796-4678	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT) [2020-0-01450]; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2021R1A2C2010775]	Institute of Information & Communications Technology Planning & Evaluation (IITP) - Korea government (MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work was supported by an Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korea government (MSIT) (No. 2020-0- 01450, Artificial Intelligence Convergence Research Center [Pusan National University]) and by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1A2C2010775) to GS. NuclixBio provided support in the form of salaries for authors [G.H.J. and H.Y.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `Author Contributions' section.	Ahirwar R, 2016, SCI REP-UK, V6, DOI 10.1038/srep21285; AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Alam KK, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.4; Alshaer W, 2018, ADV DRUG DELIVER REV, V134, P122, DOI 10.1016/j.addr.2018.09.011; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bang I, 2015, MOL CELLS, V38, P105, DOI 10.14348/molcells.2015.2301; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bojar Ondrej, 2014, P 9 WORKSH STAT MACH, P12, DOI DOI 10.3115/V1/W14-3302; Boniecki MJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1479; Boughorbel S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177678; Breiman L., 2001, MACH LEARN, V45, P5; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chaslot GMJB, 2008, NEW MATH NAT COMPUT, V4, P343, DOI 10.1142/S1793005708001094; Chen W, 2014, ANAL BIOCHEM, V456, P53, DOI 10.1016/j.ab.2014.04.001; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choi SH, 2012, STRUCTURE, V20, P340, DOI 10.1016/j.str.2011.12.011; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chushak Y, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp408; Cruz-Migoni A, 2019, P NATL ACAD SCI USA, V116, P2545, DOI 10.1073/pnas.1811360116; Cruz-Toledo J, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas006; Dong J, 2018, J CHEMINFORMATICS, V10, DOI 10.1186/s13321-018-0270-2; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Govindan G, 2011, ANNU IEEE IND CONF; Gunaratne R, 2018, NAT BIOTECHNOL, V36, P606, DOI 10.1038/nbt.4153; Hamada M, 2018, BIOCHIMIE, V145, P8, DOI 10.1016/j.biochi.2017.10.005; Hoinka J, 2014, LECT N BIOINFORMAT, V8394, P115, DOI 10.1007/978-3-319-05269-4_9; Joseph DF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211756; Kahsai AW, 2016, NAT CHEM BIOL, V12, P709, DOI 10.1038/nchembio.2126; Kocsis L, 2006, LECT NOTES COMPUT SC, V4212, P282, DOI 10.1007/11871842_29; Lee W, 2019, IEEE ACM T COMPUTATI; Lennarz S, 2015, ACS CHEM BIOL, V10, P320, DOI 10.1021/cb5005756; Li BQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086729; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Negandary M, 2020, BIOSENS BIOELECTRON, V152, DOI 10.1016/j.bios.2020.112018; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Peng C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051070; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Scornet E, 2016, IEEE T INFORM THEORY, V62, P1485, DOI 10.1109/TIT.2016.2514489; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wu Y., 2016, ARXIV; Xiong HJ, 2019, INT J BIOL MACROMOL, V132, P190, DOI 10.1016/j.ijbiomac.2019.03.165; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; Zhang LN, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1087-5; Zhu J, 2014, THERANOSTICS, V4, P931, DOI 10.7150/thno.9663	52	5	5	12	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253760	10.1371/journal.pone.0253760	http://dx.doi.org/10.1371/journal.pone.0253760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170922	Green Published, gold			2022-12-26	WOS:000671694400061
J	Li, JJ; Liu, G; Ma, ZH				Li, Jingjing; Liu, Gang; Ma, Zihan			RD internationalization, domestic technology alliance, and innovation in emerging market	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; FOREIGN DIRECT-INVESTMENT; KNOWLEDGE-BASED THEORY; ABSORPTIVE-CAPACITY; COMBINATIVE CAPABILITIES; DEVELOPMENT COOPERATION; COGNITIVE DISTANCE; EMPIRICAL-EVIDENCE; GROWTH EVIDENCE; HOST-COUNTRY	Although R&D internationalization plays an important role in enterprises' globalization, few studies explore the mechanism of R&D internationalization and emerging market companies' innovation, or the relationship between R&D internationalization, domestic technology alliances and absorptive capacity. How does the R&D internationalization of emerging market enterprises affect the innovation of those enterprises? Under fierce market competition, do absorption capacity and domestic technology alliances have a significant impact on enterprise innovation? From the perspective of the knowledge-based view, this paper studies 185 enterprises undergoing R&D internationalization in China from 2012 to 2017, using high-dimensional Poisson fixed effects model, we use instrumental (HDFE IV) estimation to explain the impact of R&D internationalization on the innovation of the parent company and the mechanism behind it. The study finds that R&D internationalization positively promotes the parent company's innovation, and domestic technology alliances and absorptive capacity play a partial mediator role in R&D internationalization. In the face of fierce market competition, domestic technical alliances play a significant role in promoting enterprise innovation, while absorptive capacity plays a negative role in promoting enterprise innovation with the moderating effect of market competition.	[Li, Jingjing; Ma, Zihan] Wuhan Univ, Sch Econ & Management, Wuhan, Hubei, Peoples R China; [Liu, Gang] Hubei Univ Econ, Sch Business Adm, Wuhan, Hubei, Peoples R China	Wuhan University; Hubei University of Economics	Ma, ZH (corresponding author), Wuhan Univ, Sch Econ & Management, Wuhan, Hubei, Peoples R China.; Liu, G (corresponding author), Hubei Univ Econ, Sch Business Adm, Wuhan, Hubei, Peoples R China.	liugang20201016@163.com; mazihan20201016@163.com		, jingjing/0000-0001-5542-6410	National key Social Science Foundation [12AZD034]; National key social science foundation of China [18VDL016]	National key Social Science Foundation; National key social science foundation of China	This study was supported by the project of the National key Social Science Foundation, "Research on the Main Influencing factors and Operation Promotion Mechanism of Creative Asset-seeking Transnational Mergers and Acquisitions" (Grant No.12AZD034), National key social science foundation of China named "research on political risks, economic risks, security risks, operational risks and countermeasures for the construction of `One Belt and One Road'". (Grant No. 18VDL016)." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2011, INT J OPER PROD MAN, V31, P1164, DOI 10.1108/01443571111178484; Alcacer J, 2007, MANAGE SCI, V53, P760, DOI 10.1287/mnsc.1060.0637; Almeida P, 2002, ORGAN SCI, V13, P147, DOI 10.1287/orsc.13.2.147.534; Almeida P, 2004, STRATEGIC MANAGE J, V25, P847, DOI 10.1002/smj.388; Ambos B, 2005, RES POLICY, V34, P395, DOI 10.1016/j.respol.2005.01.016; [Anonymous], 2008, J KNOWL MANAGE; ARORA A, 1994, J ECON BEHAV ORGAN, V24, P91, DOI 10.1016/0167-2681(94)90055-8; Asakawa K, 2001, RES POLICY, V30, P735, DOI 10.1016/S0048-7333(00)00103-7; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; BAUM JAC, 1991, ADMIN SCI QUART, V36, P187, DOI 10.2307/2393353; Belderbos R, 2015, J INT BUS STUD, V46, P491, DOI 10.1057/jibs.2014.63; Belderbos R, 2013, J INT BUS STUD, V44, P765, DOI 10.1057/jibs.2013.33; Bertrand O, 2013, STRATEGIC MANAGE J, V34, P751, DOI 10.1002/smj.2034; Bhagat RS, 2002, ACAD MANAGE REV, V27, P204, DOI 10.5465/AMR.2002.6588000; Buckley P. J., 1976, FUTURE MULTINATIONAL, DOI DOI 10.1007/978-1-349-02899-3_3; Buckley PJ, 2007, J INT BUS STUD, V38, P447, DOI 10.1057/palgrave.jibs.8400274; Butler C, 2008, MANAGE DECIS, V46, P330, DOI 10.1108/00251740810854186; Cantwell J, 2005, STRATEGIC MANAGE J, V26, P1109, DOI 10.1002/smj.497; Cantwell J., 2006, ASIAN BUS MANAG, V5, P249; Chen CJ, 2012, RES POLICY, V41, P1544, DOI 10.1016/j.respol.2012.06.008; CHESBROUGH H, 2006, OPEN INNOVATION RES; Child J., 2005, MANAGE ORGAN REV, V1, P381, DOI [10.1111/j.1740-8784.2005.0020a.x, DOI 10.1111/J.1740-8784.2005.0020A.X]; COHEN WM, 1990, ADMIN SCI QUART, V35, P128, DOI 10.2307/2393553; Correia S., 2019, ECONOMICS, V1, P1; CRAVENS D., 1993, J STRATEGIC MARKETIN, V1, P55, DOI DOI 10.1080/09652549300000005; Cyert R. M., 1963, BEHAV THEORY FIRM; De Marchi V, 2012, RES POLICY, V41, P614, DOI 10.1016/j.respol.2011.10.002; Driffield N, 2010, J INT BUS STUD, V41, P350, DOI 10.1057/jibs.2009.57; Dunning J.H., 1995, INT STUDIES MANAGEME, V25, P39, DOI DOI 10.1080/00208825.1995.11656651; DUNNING JH, 1988, J INT BUS STUD, V19, P1, DOI 10.1057/palgrave.jibs.8490372; Dussauge P, 2000, STRATEGIC MANAGE J, V21, P99, DOI 10.1002/(SICI)1097-0266(200002)21:2<99::AID-SMJ80>3.3.CO;2-7; Duysters G, 2003, R&D MANAGE, V33, P49, DOI 10.1111/1467-9310.00281; Elango B, 2011, MANAGE INT REV, V51, P461, DOI 10.1007/s11575-011-0085-0; Faems D, 2005, J PROD INNOVAT MANAG, V22, P238, DOI 10.1111/j.0737-6782.2005.00120.x; Fan G., 2018, NERI INDEX MARKETIZA; Field LC, 2017, J FINANC ECON, V123, P488, DOI 10.1016/j.jfineco.2016.12.001; Frost TS, 2001, STRATEGIC MANAGE J, V22, P101, DOI 10.1002/1097-0266(200101)22:2<101::AID-SMJ155>3.0.CO;2-G; Gao T, 2004, REG SCI URBAN ECON, V34, P101, DOI 10.1016/S0166-0462(03)00023-1; Garcia R, 2002, J PROD INNOVAT MANAG, V19, P110, DOI 10.1016/S0737-6782(01)00132-1; Gassmann O, 1999, RES POLICY, V28, P231, DOI 10.1016/S0048-7333(98)00114-0; Gassmann O, 2004, R&D MANAGE, V34, P423, DOI 10.1111/j.1467-9310.2004.00350.x; GLAESER EL, 1992, J POLIT ECON, V100, P1126, DOI 10.1086/261856; GOURIEROUX C, 1984, ECONOMETRICA, V52, P681, DOI 10.2307/1913471; GRANT RM, 1995, BEST PAP PROC, P17; Grant RM, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/smj.4250171110; HAGEDOORN J, 1994, STRATEGIC MANAGE J, V15, P291, DOI 10.1002/smj.4250150404; Hakanson L, 2010, IND CORP CHANGE, V19, P1801, DOI 10.1093/icc/dtq052; HAMEL G, 1991, STRATEGIC MANAGE J, V12, P83, DOI 10.1002/smj.4250120908; Hammervoll T, 2009, EUR J MARKETING, V43, P630, DOI 10.1108/03090560910946963; Hao JJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12156155; Helfat CE, 1997, STRATEGIC MANAGE J, V18, P339, DOI 10.1002/(SICI)1097-0266(199705)18:5<339::AID-SMJ883>3.0.CO;2-7; Henderson R, 1996, RAND J ECON, V27, P32, DOI 10.2307/2555791; Henderson R, 2005, AM ECON REV, V95, P461, DOI 10.1257/0002828053828644; Hesselborn P. O., 1977, INT ALLOCATION EC AC, P395, DOI DOI 10.1007/978-1-349-03196-2_38; HEWITT G, 1980, KYKLOS, V33, P308, DOI 10.1111/j.1467-6435.1980.tb02637.x; Hitt MA, 2004, ORGAN SCI, V15, P173, DOI 10.1287/orsc.1030.0045; Hsu CW, 2015, INT BUS REV, V24, P187, DOI 10.1016/j.ibusrev.2014.07.007; Huergo E, 2004, SMALL BUS ECON, V22, P193, DOI 10.1023/B:SBEJ.0000022220.07366.b5; Hymer S. H, 1976, INT OPERATIONS NATL; Inkpen AC, 2005, ACAD MANAGE REV, V30, P146, DOI [10.5465/AMR.2005.15281445, 10.2307/20159100]; Iwasa T, 2004, RES POLICY, V33, P807, DOI 10.1016/j.respol.2004.01.002; Kafouros MI, 2008, TECHNOVATION, V28, P63, DOI 10.1016/j.technovation.2007.07.009; Kim J, 2009, BRIT J MANAGE, V20, P363, DOI 10.1111/j.1467-8551.2008.00580.x; KODAMA F, 1992, HARVARD BUS REV, V70, P70; KOGUT B, 1992, ORGAN SCI, V3, P383, DOI 10.1287/orsc.3.3.383; Kotabe M, 2011, J WORLD BUS, V46, P166, DOI 10.1016/j.jwb.2010.05.005; Kothari T, 2013, J INT MANAG, V19, P276, DOI 10.1016/j.intman.2013.03.007; Kuemmerle W, 1997, HARVARD BUS REV, V75, P61; Kuo CC, 2008, CHINA ECON REV, V19, P594, DOI 10.1016/j.chieco.2008.06.004; Lai MY, 2006, CHINA ECON REV, V17, P300, DOI 10.1016/j.chieco.2006.04.005; Lall S., 1983, NEW MULTINATIONALS S; Lambe CJ, 1997, J PROD INNOVAT MANAG, V14, P102, DOI 10.1016/S0737-6782(96)00077-X; LECRAW DJ, 1993, J INT BUS STUD, V24, P589, DOI 10.1057/palgrave.jibs.8490247; Lehrer M, 2002, J WORLD BUS, V37, P297, DOI 10.1016/S1090-9516(02)00096-2; LEVINTHAL DA, 1993, STRATEGIC MANAGE J, V14, P95, DOI 10.1002/smj.4250141009; Lhuillery S, 2009, RES POLICY, V38, P45, DOI 10.1016/j.respol.2008.09.002; Li CL, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12072587; LI J, 2003, MANAGERIAL DECISION, V24, P101; LIEBERMAN MB, 1988, STRATEGIC MANAGE J, V9, P41, DOI 10.1002/smj.4250090706; Lin HL, 2010, SOUTH ECON J, V77, P434, DOI 10.4284/sej.2010.77.2.434; Luo YD, 2007, J INT BUS STUD, V38, P481, DOI 10.1057/palgrave.jibs.8400275; Luo YD, 2010, J WORLD BUS, V45, P68, DOI 10.1016/j.jwb.2009.04.003; Ma LF., 2015, CHINA IND EC, V7, P5; Makino S, 2002, J INT BUS STUD, V33, P403, DOI 10.1057/palgrave.jibs.8491024; Malmberg A, 2006, GROWTH CHANGE, V37, P1, DOI 10.1111/j.1468-2257.2006.00302.x; March JG., 1958, ORGANIZATIONS; Mariyakhan K, 2020, ENERGIES, V13, DOI 10.3390/en13020407; Mathews J. A., 2006, Asia Pacific Journal of Management, V23, P5, DOI 10.1007/s10490-006-6113-0; Mathews JA, 1999, J WORLD BUS, V34, P139, DOI 10.1016/S1090-9516(99)00013-9; Meng MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238030; Mention AL., 2012, INT J INNOV MANAG, V3, P124; Mockler RJ, 2009, MANAGE DECIS, V39, P980; Muller D, 2005, J PERS SOC PSYCHOL, V89, P852, DOI 10.1037/0022-3514.89.6.852; Munoz-Pascual L, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12103966; Nelson R., 1982, EVOL THEOR; Nesta L, 2005, J IND ECON, V53, P123, DOI 10.1111/j.0022-1821.2005.00248.x; Nieto MJ, 2007, TECHNOVATION, V27, P367, DOI 10.1016/j.technovation.2006.10.001; NOHRIA N, 1991, STRATEGIC MANAGE J, V12, P105, DOI 10.1002/smj.4250120909; Nonaka I., 1995, KNOWLEDGE CREATION C; Nooteboom B, 2007, RES POLICY, V36, P1016, DOI 10.1016/j.respol.2007.04.003; Ocasio W, 1997, STRATEGIC MANAGE J, V18, P187, DOI 10.1002/(SICI)1097-0266(199707)18:1+<187::AID-SMJ936>3.3.CO;2-B; Papanastassiou M, 2020, J INT BUS STUD, V51, P623, DOI 10.1057/s41267-019-00258-0; Peng M., 2006, GLOBAL STRATEGY; Peng MW, 2008, J INT BUS STUD, V39, P920, DOI 10.1057/palgrave.jibs.8400377; Peng ZY, 2017, THUNDERBIRD INT BUS, V59, P349, DOI 10.1002/tie.21845; Penner-Hahn J, 2005, STRATEGIC MANAGE J, V26, P121, DOI 10.1002/smj.436; PFEFFER J, 1976, ADMIN SCI QUART, V21, P398, DOI 10.2307/2391851; Pfeffer J, 1978, EXTERNAL CONTROL ORG; Phene A, 2008, J INT BUS STUD, V39, P901, DOI 10.1057/palgrave.jibs.8400383; Ritala P, 2013, J PROD INNOVAT MANAG, V30, P154, DOI 10.1111/j.1540-5885.2012.00956.x; Ruckman K, 2009, J STRATEGY MANAG, V2, P56, DOI 10.1108/17554250910948703; Rugman AM, 2014, INT J EMERG MARK, V9, P205, DOI 10.1108/IJoEM-08-2013-0127; Rui HC, 2008, J WORLD BUS, V43, P213, DOI 10.1016/j.jwb.2007.11.006; Sanna-Randaccio F, 2007, J INT BUS STUD, V38, P47, DOI 10.1057/palgrave.jibs.8400249; Scherer F.M., 1990, IND MARKET STRUCTURE; Schumpeter J. A., 1943, CAPITALISM SOCIALISM, DOI DOI 10.1007/s11135-015-0230-0; Shankar V, 2006, MANAGE SCI, V52, P276, DOI 10.1287/mnsc.1050.0443; SINGH H, 1987, STRATEGIC MANAGE J, V8, P377, DOI 10.1002/smj.4250080407; Singh J, 2008, RES POLICY, V37, P77, DOI 10.1016/j.respol.2007.09.004; Song J, 2011, RES POLICY, V40, P380, DOI 10.1016/j.respol.2011.01.002; Srivastava MK, 2011, ACAD MANAGE J, V54, P797, DOI 10.5465/AMJ.2011.64870140; Stock J.H, 2005, ESSAYS HONOR T ROTHE, V80, P1; Sullivan BN, 2010, ORGAN SCI, V21, P432, DOI 10.1287/orsc.1090.0436; Teece DJ, 1997, STRATEGIC MANAGE J, V18, P509, DOI 10.1002/(SICI)1097-0266(199708)18:7<509::AID-SMJ882>3.0.CO;2-Z; Tobin J., 1969, J MONEY CREDIT BANK, V1, P15, DOI DOI 10.2307/1991374; Todo Y, 2008, J IND ECON, V56, P752, DOI 10.1111/j.1467-6451.2008.00363.x; Trajtenberg, 2002, PATENTS CITATIONS IN, DOI 10.7551/mitpress/5263.001.0001; TUSHMAN ML, 1986, ADMIN SCI QUART, V31, P439, DOI 10.2307/2392832; van Pottelsberghe B, 2001, REV ECON STAT, V83, P490; Walcott SM, 2002, PROF GEOGR, V54, P349, DOI 10.1111/0033-0124.00335; Walker R.D., 1995, PATENTS SCI TECHNICA; Wang CQ, 2012, J INT BUS STUD, V43, P655, DOI 10.1057/jibs.2012.18; Wang P, 2007, J FINANC RES, V4, P171; Wiersema MF, 2008, STRATEGIC MANAGE J, V29, P115, DOI 10.1002/smj.653; Winter S.G., 1987, KNOWLEDGE COMPETENCE; Wu J, 2016, J WORLD BUS, V51, P251, DOI 10.1016/j.jwb.2015.09.002; Xia TJ, 2008, TECHNOVATION, V28, P776, DOI 10.1016/j.technovation.2008.03.007; Yiu DW, 2007, J INT BUS STUD, V38, P519, DOI 10.1057/palgrave.jibs.8400278; Yli-Renko H, 2001, J BUS VENTURING, V16, P529, DOI 10.1016/S0883-9026(99)00062-2; Yuan J., 2015, MANAGE WORLD, V1, P139; Zahra SA, 2002, ACAD MANAGE REV, V27, P185, DOI 10.2307/4134351; Zahra SA, 2008, J BUS VENTURING, V23, P195, DOI 10.1016/j.jbusvent.2007.01.001; Zhang JF, 2009, IND MARKET MANAG, V38, P207, DOI 10.1016/j.indmarman.2008.12.007; Zhang X, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11247225; Zhao HX, 2004, J INT BUS STUD, V35, P524, DOI 10.1057/palgrave.jibs.8400106; Zhou KZ, 2005, J MARKETING, V69, P42, DOI 10.1509/jmkg.69.2.42.60756	147	1	1	8	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252669	10.1371/journal.pone.0252669	http://dx.doi.org/10.1371/journal.pone.0252669			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170909	gold, Green Published			2022-12-26	WOS:000671694400057
J	Rastogi, A; Chauhan, S; Ramalingam, A; Verma, M; Babu, S; Ahwal, S; Bansal, A				Rastogi, Aayushi; Chauhan, Sapna; Ramalingam, Archana; Verma, Madhavi; Babu, Seena; Ahwal, Sarita; Bansal, Akanksha			Capacity building of healthcare workers: Key step towards elimination of viral hepatitis in developing countries	PLOS ONE			English	Article							SAFETY; KNOWLEDGE; INJURIES; EXPOSURE; RISKS; BLOOD	Background Lack of awareness about viral hepatitis (VH) potentially predisposes the healthcare workers (HCWs) to a higher risk of infection and may in turn increase the risk of transmission of the infection to their families and in the community. Thus, combating VH, requires adequate and updated training to the HCWs. With this objective, Project PRAKASH designed a meticulously planned training program, aimed to assess the effect of a one-day training on VH among in-service nurses. Methods and material The content and schedule of scientific sessions of the training program were decided by subject experts to improve knowledge, attitude and practice(KAP) related to VH among in-service nurses. A 54-item questionnaire divided into four domains: Transmission and Risk Factors; Prevention; Treatment; Pathophysiology and Disease Progression were used to assess the KAP related to VH. The questionnaire consisted of four sections: demographic details, knowledge(30-items), attitude(12-items) and practice(12-itmes) with a total score of 30, 60 and 24 respectively in each section. The pre-post knowledge assessment was done and impact assessment survey was undertaken among the participants who completed six months post-training period. Paired-t-test was used to assess the effect of training on knowledge using SPSSv-22. Results A total of 5253 HCWs were trained through 32 one-day trainings, however data for 4474 HCWs was included in final pre-post knowledge analysis after removing the missing/incomplete data. Mean age of participants was 33.7 +/- 8.4 with median experience of 8(IQR: 3-13). Mean improvement in knowledge score was found to be significant (p<0.001) with mean knowledge score of 19.3 +/- 4.4 in pre-test and 25.7 +/- 3.9 in the post-test out of 30. Impact assessment survey suggested change in attitude and practice of HCWs. Conclusion The one-day training programs helped the in-service nurses to enhance their knowledge related to viral hepatitis. The study provided a roadmap to combating viral hepatitis through health education among HCWs about viral hepatitis.	[Rastogi, Aayushi; Ramalingam, Archana] Inst Liver & Biliary Sci, Dept Epidemiol, Delhi, India; [Chauhan, Sapna; Bansal, Akanksha] Inst Liver & Biliary Sci, Project ECHO & PRAKASH, Delhi, India; [Verma, Madhavi; Ahwal, Sarita] Inst Liver & Biliary Sci, Coll Nursing, Delhi, India; [Babu, Seena] Inst Liver & Biliary Sci, Delhi, India	Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS); Institute of Liver & Biliary Sciences (ILBS)	Bansal, A (corresponding author), Inst Liver & Biliary Sci, Project ECHO & PRAKASH, Delhi, India.	akankshambansal@gmail.com	Rastogi, Aayushi/AAD-9006-2021	Rastogi, Aayushi/0000-0001-6823-1874; Ramalingam, Archana/0000-0003-0011-7017	CIPLA foundation [CSR/HO/412/2017-2018]	CIPLA foundation	The present work was undertaken by the project PRAKASH, Institute of Liver and Biliary Sciences which was supported by grant received by CIPLA foundation via grant number CSR/HO/412/2017-2018 under its corporate social responsibility policy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron D, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2893-8; Wahed WYA, 2020, J COMMUN HEALTH, V45, P1242, DOI 10.1007/s10900-020-00882-0; Adam A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231930; Akazong WE, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-031075; Anjum BF, 2016, INT J MED RES HEALTH, V5, P115; [Anonymous], 2003, B WORLD HEALTH ORGAN, V81; Ansa V O, 2002, East Afr Med J, V79, P254; Batham A, 2007, INDIAN PEDIATR, V44, P663; Batra V, 2015, ANN GASTROENTEROL, V28, P276; Bergold M, 2013, Z EVIDENZ FORTBILD Q, V107, P36, DOI 10.1016/j.zefq.2012.11.018; Berhea TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202542; Bhardwaj T., 2019, J GLOBAL ORAL HLTH, V2, P36; Bisworanjan Dash, 2013, International Journal of Medicine and Public Health, V3, P119; Board S, 2001, NEW ENGL J MED, V345; Chavan Girish M, 2015, J Family Med Prim Care, V4, P439, DOI 10.4103/2249-4863.161349; Clarke SP, 2002, AM J INFECT CONTROL, V30, P207, DOI 10.1067/mic.2002.123392; Dement JM, 2004, AM J IND MED, V46, P637, DOI 10.1002/ajim.20106; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Hebo HJ, 2019, SCI WORLD J, V2019; HOWARD GS, 1980, EVALUATION REV, V4, P93, DOI 10.1177/0193841X8000400105; Jha AK, 2012, HEPAT RES TREAT, V2012; Joukar Farahnaz, 2017, Open Nurs J, V11, P34, DOI 10.2174/1874434601711010034; Kar SS, 2016, S E ASIAN J MED ED, V10, P69; Kermode M, 2004, INT J INFECT DIS, V8, P325, DOI 10.1016/j.ijid.2004.03.005; Keshan P., 2020, J ADV MED MED RES, P364; Keshan P, 2021, INDAN J COMMUNITY HE, V33, P212, DOI [10.47203/IJCH.2020.v33i01.031, 10.47203/IJCH.2021.v33i01.031]; Liu K, 2012, J CLIN NURS, V21, P1476, DOI 10.1111/j.1365-2702.2011.03991.x; McHugh MD, 2010, RES NURS HEALTH, V33, P276, DOI 10.1002/nur.20388; Miller LMS, 2009, PSYCHOL AGING, V24, P63, DOI 10.1037/a0014586; Muralidhar S, 2010, INDIAN J MED RES, V131, P405; Patel DA, 2012, J GLOB INFECT DIS, V4, P55, DOI 10.4103/0974-777X.93762; Pham TTH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223733; Rapiti E., 2005, SHARPS INJURIES GLOB; Sannathimmappa Mohan B, 2019, Avicenna J Med, V9, P43, DOI 10.4103/ajm.AJM_164_18; Seetharam S., 2009, INDIAN J MED ETHICS, DOI [10.20529/IJME.2009.042, DOI 10.20529/IJME.2009.042]; Sharma B, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29553; Shindano TA, 2017, AM J TROP MED HYG, V96, P400, DOI 10.4269/ajtmh.16-0287; Singhal V., 2011, VACCINES VACCIN, V2, P4; Siraj F., 2016, INT J REPROD CONTRAC, V5, P58; Sukriti, 2008, J GASTROEN HEPATOL, V23, P1710, DOI 10.1111/j.1440-1746.2008.05483.x; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; Tufon Kukwah Anthony, 2019, Oman Med J, V34, P313, DOI 10.5001/omj.2019.62; ul Haq N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-692; Van der Scheun FC, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4606-z; Wegman DH, 2004, HLTH SAFETY NEEDS OL; Yasobant Sandul, 2017, J Family Med Prim Care, V6, P589, DOI 10.4103/2249-4863.222009	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253539	10.1371/journal.pone.0253539	http://dx.doi.org/10.1371/journal.pone.0253539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166449	gold, Green Published			2022-12-26	WOS:000671692800056
J	Tai, HM; You, MF; Lin, CH; Tsai, TY; Pan, CY; Chen, JY				Tai, Hsueh-Ming; You, Ming-Feng; Lin, Chia-Hua; Tsai, Tsung-Yu; Pan, Chieh-Yu; Chen, Jyh-Yih			Scale-up production of and dietary supplementation with the recombinant antimicrobial peptide tilapia piscidin 4 to improve growth performance in Gallus gallus domesticus	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; MICROBIAL DIVERSITY; EXPRESSION; PURIFICATION; ANTIBIOTICS; ARGININE	Antimicrobial peptides (AMPs) are short and positively charged peptides with broad-spectrum antimicrobial activities. AMPs have been investigated as potential antibiotic alternatives to improve growth performance and prevent pathogen infection in the poultry industry. The antimicrobial peptide tilapia piscidin 4 (TP4) was derived from Oreochromis niloticus, possesses antimicrobial activities and immunomodulatory properties, promotes intestinal health, and protects against pathogen infection. The codon-optimized sequence of TP4 was introduced into the pPICZ alpha A vector and transformed into Pichia pastoris. Large-scale expression was induced following culture with methanol in a 500-liter fermenter. Freeze drying of fermented rTP4 broth and then rTP4 evaluation as a feed additive for Gallus gallus domesticus were performed. The in vitro antimicrobial activity of recombinant TP4 (rTP4) against gram-positive and gram-negative pathogens was evaluated. Evaluation of the effect of temperature on the antimicrobial activity of rTP4 showed its high stability at high temperatures. rTP4 significantly enhanced the phagocytic activity of macrophage cells, indicating that rTP4 has a remarkable ability to stimulate macrophages. rTP4 was used as a dietary supplement at 0.75, 1.5, 3.0, 6.0 and 12% in G. g. domesticus for five weeks, and growth performance, gut microbiota composition, and histology were assessed. The 3.0% rTP4 supplement group showed a significant increase in weight gain ratio and feed efficiency compared to those of the basal broiler diet group. Crude rTP4 was expressed by yeast to significantly promote growth efficiency and resistance against pathogens in G. g. domesticus, which could indicate its use as a suitable alternative to antibiotics as feed additives in the poultry industry.	[Tai, Hsueh-Ming; You, Ming-Feng; Lin, Chia-Hua; Tsai, Tsung-Yu; Chen, Jyh-Yih] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan; [Pan, Chieh-Yu] Natl Kaohsiung Univ Sci & Technol, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan	Academia Sinica - Taiwan; National Kaohsiung University of Science & Technology	Chen, JY (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Jiaushi, Ilan, Taiwan.; Pan, CY (corresponding author), Natl Kaohsiung Univ Sci & Technol, Dept & Grad Inst Aquaculture, Kaohsiung, Taiwan.	panjade@nkust.edu.tw; zoocjy@gate.sinica.edu.tw	Chen, Jyh-Yih/F-3412-2014	Chen, Jyh-Yih/0000-0001-7858-8236	Marine Research Station in the Institute of Cellular and Organismic Biology at Academia Sinica, Taiwan; Council of Agriculture, Executive Yuan, Taiwan (R.O.C.) [107AS-22.1.4-LI-L1, 1072101011805-220104L1]	Marine Research Station in the Institute of Cellular and Organismic Biology at Academia Sinica, Taiwan; Council of Agriculture, Executive Yuan, Taiwan (R.O.C.)	Research funding for this study was partly from the Marine Research Station in the Institute of Cellular and Organismic Biology at Academia Sinica, Taiwan. Research money to Mr. Jyh-Yih Chen from the Council of Agriculture, Executive Yuan, Taiwan (R.O.C.), supported the study from Jan 2018 to Dec 2021 (The Application of Antimicrobial Peptides as Feed Additives for Fowls, 107AS-22.1.4-LI-L1, 1072101011805-220104L1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharudin MMA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251514; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chattopadhyay MK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00334; Chen W, 2014, PROTEIN EXPRES PURIF, V102, P63, DOI 10.1016/j.pep.2014.08.001; Chen WF, 2015, BIOMATERIALS, V53, P1, DOI 10.1016/j.biomaterials.2015.02.069; Colorni A, 2008, J FISH DIS, V31, P423, DOI 10.1111/j.1365-2761.2008.00922.x; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Cutrona KJ, 2015, FEBS LETT, V589, P3915, DOI 10.1016/j.febslet.2015.11.002; Daneshmand A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50511-7; Dathe M, 2001, FEBS LETT, V501, P146, DOI 10.1016/S0014-5793(01)02648-5; Diarra MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00282; Gupta A, 2014, APPL BIOCHEM BIOTECH, V172, P3354, DOI 10.1007/s12010-014-0775-8; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Javadpour MM, 1996, J MED CHEM, V39, P3107, DOI 10.1021/jm9509410; Jia X, 2000, APPL ENVIRON MICROB, V66, P1928, DOI 10.1128/AEM.66.5.1928-1932.2000; Li S.Y., 2017, AMB EXPRESS, P7, DOI [10.1186/s13568-016-0306-9, DOI 10.1186/S13568-016-0306-9]; Li YF, 2011, PROTEIN EXPRES PURIF, V80, P260, DOI 10.1016/j.pep.2011.08.001; MALOY WL, 1995, BIOPOLYMERS, V37, P105, DOI 10.1002/bip.360370206; Mehdi Y, 2018, ANIM NUTR, V4, P170, DOI 10.1016/j.aninu.2018.03.002; Meng DM, 2019, PROTEIN EXPRES PURIF, V160, P19, DOI 10.1016/j.pep.2019.03.007; Mihailescu M, 2019, J AM CHEM SOC, V141, P9837, DOI 10.1021/jacs.9b00440; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Moon WJ, 2007, PROTEIN EXPRES PURIF, V51, P141, DOI 10.1016/j.pep.2006.07.010; Narayana JL, 2015, ONCOTARGET, V6, P12936; Pan CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169678; Pan Y, 2019, DEV COMP IMMUNOL, V92, P43, DOI 10.1016/j.dci.2018.10.008; Peng KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050263; Peng ZX, 2014, APPL MICROBIOL BIOT, V98, P5487, DOI 10.1007/s00253-014-5560-7; Tanoira RP, 2014, INFECTION, V42, P597, DOI 10.1007/s15010-014-0621-5; Proano-Bolanos C, 2016, J PROTEOMICS, V146, P1, DOI 10.1016/j.jprot.2016.06.017; Salger SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159423; Sang M, 2017, PROTEIN EXPRES PURIF, V140, P44, DOI 10.1016/j.pep.2017.08.001; Singh P, 2013, POULTRY SCI, V92, P272, DOI 10.3382/ps.2012-02603; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Stensvag K, 2008, DEV COMP IMMUNOL, V32, P275, DOI 10.1016/j.dci.2007.06.002; Sun DD, 2012, J ANTIBIOT, V65, P117, DOI 10.1038/ja.2011.120; Ting CH, 2019, CANCERS, V11, DOI 10.3390/cancers11010107; Ting CH, 2016, ONCOTARGET, V7, P40329, DOI 10.18632/oncotarget.9612; Wang SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216946; Wang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050603; Xia LJ, 2013, EXP THER MED, V5, P1745, DOI 10.3892/etm.2013.1056; Yasir M, 2018, MATERIALS, V11, DOI 10.3390/ma11122468; Yoon JH, 2013, J SCI FOOD AGR, V93, P587, DOI 10.1002/jsfa.5840; Zahran E., 2019, AQUACULTURE, P513; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang XL, 2018, APPL MICROBIOL BIOT, V102, P4817, DOI 10.1007/s00253-018-8982-9; Zhu CH, 2020, POULTRY SCI, V99, P1096, DOI 10.1016/j.psj.2019.12.030	47	2	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253661	10.1371/journal.pone.0253661	http://dx.doi.org/10.1371/journal.pone.0253661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166442	Green Published, gold			2022-12-26	WOS:000671692800057
J	Falvo, I; Zufferey, MC; Albanese, E; Fadda, M				Falvo, Ilaria; Zufferey, Maria Caiata; Albanese, Emiliano; Fadda, Marta			Lived experiences of older adults during the first COVID-19 lockdown: A qualitative study	PLOS ONE			English	Article							HEALTH; VULNERABILITY; INTERVIEWS; TELEPHONE	Background and aim Public health measures used to mitigate the COVID-19 epidemic may have unintended, detrimental consequences particularly on older adults, whose voices and perspectives are often silent or silenced. The aim of this study was to explore the lived experiences of individuals aged 64 or older during the first COVID-19 lockdown. Methods We conducted a qualitative study in a convenience sample of 19 older adults (aged 64+) living at home in the Italian-speaking region of Switzerland during the first COVID-19 lockdown, between April and May 2020. Participants varied in terms of gender, education, age, nationality, and socio-economic status. We conducted semi-structured phone interviews to elicit emotions, expectations and hopes in relation to the present situation, and the post-pandemic world. We inquired about opinions on the enforced public health measures, including those specifically targeting older adults, and on the societal portrayal of older adults. Findings We found that the epidemic and the public health response to it had both generated a variety of resentments and a high degree of ambivalence at the individual, micro-, meso- and macro-social levels. We also found that labelling older adults as an at-risk sub-population inevitably contributed to public and self-stigmatization. Discussion We conducted an in-depth qualitative investigation of lived experiences of older adults during the first wave of the COVID-19 pandemic in one of the most gravely hit region in Europe. Our findings on the complexity of unintended, detrimental consequences of outbreak responses on older adults have relevant implications for local adaptions of public health measures, and suggest that public health authorities should engage vulnerable sub-populations and promote bi-directional communication to inform and support communities.	[Falvo, Ilaria; Albanese, Emiliano; Fadda, Marta] Univ Svizzera Italiana, Fac Biomed Sci, Inst Publ Hlth, Lugano, Switzerland; [Zufferey, Maria Caiata] Univ Appl Sci & Arts Southern Switzerland, Dept Business Econ Hlth & Social Care, Manno, Switzerland	Universita della Svizzera Italiana	Fadda, M (corresponding author), Univ Svizzera Italiana, Fac Biomed Sci, Inst Publ Hlth, Lugano, Switzerland.	marta.fadda@usi.ch		Falvo, Ilaria/0000-0002-1701-7656; Fadda, Marta/0000-0003-3537-0346				[Anonymous], 2018, NVIVO QUAL DAT AN SO; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brooks J, 2022, J MATERN-FETAL NEO M, V35, P3519, DOI 10.1080/14767058.2020.1827384; CDC, COR DIS 2019 COVID 1; Chee SY, 2020, MILLENN ASIA, V11, P299, DOI 10.1177/0976399620958326; Dalton L, 2020, LANCET CHILD ADOLESC, V4, P346, DOI 10.1016/S2352-4642(20)30097-3; El Hayek S, 2020, AM J GERIAT PSYCHIAT, V28, P1058, DOI 10.1016/j.jagp.2020.05.009; Fang XY, 2020, AGING-US, V12, P12493, DOI 10.18632/aging.103579; Fenton-OCreevy M., NEED CONSTRUCTIVE AM; FOPH, NEW COR SIT SWITZ NEW COR SIT SWITZ; GEDC, COVID 19 OLD AD KEY COVID 19 OLD AD KEY; Gilligan M, 2020, J FAM THEOR REV, V12, P431, DOI 10.1111/jftr.12397; Goethals L, 2020, JMIR AGING, V3, DOI 10.2196/19007; Hamm ME, 2020, AM J GERIAT PSYCHIAT, V28, P924, DOI 10.1016/j.jagp.2020.06.013; Hua CL, 2020, J MARRIAGE FAM, DOI 10.1111/jomf.12716; Hurst SA, 2008, BIOETHICS, V22, P191, DOI 10.1111/j.1467-8519.2008.00631.x; Jesmi Ali-Asghar, 2021, Med Glas (Zenica), V18, P18, DOI 10.17392/1247-21; Kang SJ, 2020, INFECT CHEMOTHER, V52, P154, DOI 10.3947/ic.2020.52.2.154; Klein EG, 2020, SUBST USE MISUSE, V56, P437, DOI 10.1080/10826084.2020.1869264; Klein G., 2007, P 8 INT NDM C PAC GR; Lee YJ, 2020, J GERONTOL SOC WORK, V63, P559, DOI 10.1080/01634372.2020.1777240; Liu Q, 2020, LANCET GLOB HEALTH, V8, pE790, DOI 10.1016/S2214-109X(20)30204-7; Luna F, 2014, PUBLIC HEALTH ETH-UK, V7, P180, DOI 10.1093/phe/phu012; Margraf J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243523; Monahan C, 2020, AM PSYCHOL, V75, P887, DOI 10.1037/amp0000699; Nanda A, 2020, AGING CLIN EXP RES, V32, P1199, DOI 10.1007/s40520-020-01581-5; Novick G, 2008, RES NURS HEALTH, V31, P391, DOI 10.1002/nur.20259; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Ortenzi F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249488; Pelicioni PHS, 2020, BRAZ J PHYS THER, V24, P293, DOI 10.1016/j.bjpt.2020.04.005; Repubblica e Cantone Ticino, COVID 19; Rothman NB, 2017, ACAD MANAG ANN, V11, P33, DOI 10.5465/annals.2014.0066; Schroder-Butterfill E, 2006, AGEING SOC, V26, P9, DOI 10.1017/S0144686X05004423; Sun NN, 2020, AM J INFECT CONTROL, V48, P592, DOI 10.1016/j.ajic.2020.03.018; SUPSI, INV STUD POP ANZ TIC INV STUD POP ANZ TIC; Swiss Federal Statistical Office, 2020, PERM RES POP AG CANT PERM RES POP AG CANT; Szolnoki G., 2013, WINE EC POLICY, V2, P57, DOI DOI 10.1016/J.WEP.2013.10.001; Teti M, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406920920962; Tyrrell CJ, 2020, PSYCHOL TRAUMA-US, V12, pS214, DOI 10.1037/tra0000845; van Gaalen RI, 2010, J AGING STUD, V24, P105, DOI 10.1016/j.jaging.2008.10.006; Van Orden KA, 2021, AM J GERIAT PSYCHIAT, V29, P816, DOI 10.1016/j.jagp.2020.05.004; Vasileiou K, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0594-7; Verhage M, 2021, J GERONTOL B-PSYCHOL, V76, pE290, DOI 10.1093/geronb/gbab008; Vogl S, 2013, SOCIOL METHODOL, V43, P133, DOI 10.1177/0081175012465967; Whitehead BR, 2021, GERONTOLOGIST, V61, P36, DOI 10.1093/geront/gnaa126; WHO, 2020, COORD GLOB RES ROADM; WHPO, COVID 19 STRAT UPD 1 COVID 19 STRAT UPD 1; World Health Organization, OLD PEOPL COVID 19; Yin Y, 2021, BMC FAM PRACT, V22, DOI 10.1186/s12875-020-01364-x	49	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252101	10.1371/journal.pone.0252101	http://dx.doi.org/10.1371/journal.pone.0252101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161334	gold, Green Published			2022-12-26	WOS:000671691900016
J	Toro, DM; Ramasawmy, R; Neto, PVS; Pereira, GL; Sarmento, PS; Dray, HLSN; Sousa, KS; Affonso, JS; Silva, JA; Garcia, NP; Barbieri, MV; Victoria, FS; Donadi, EA; Costa, AG; Ogusku, MM; Sadahiro, A; Tarrago, AM; Malheiro, A				Toro, Diana Mota; Ramasawmy, Rajendranath; Silva Neto, Pedro Vieira; Pereira, Grenda Leite; Sarmento, Priscila Santos; Silva Negreiros Dray, Hanna Lara; Sousa, Keyla Santos; Affonso, Juliana Santos; Silva, Jessica Albuquerque; Garcia, Nadja Pinto; Barbieri, Marilu Victoria; Victoria, Flamir Silva; Donadi, Eduardo Antonio; Costa, Allyson Guimaraes; Ogusku, Mauricio Morishi; Sadahiro, Aya; Tarrago, Andrea Monteiro; Malheiro, Adriana			Inflammasome genes polymorphisms may influence the development of hepatitis C in the Amazonas, Brazil	PLOS ONE			English	Article							PLASMA INTERLEUKIN-18 LEVELS; NLRP3 INFLAMMASOME; STELLATE CELLS; LIVER FIBROSIS; HCV PATIENTS; B-VIRUS; ACTIVATION; IL-1-BETA; GROWTH; BETA	Hepatitis C is considered a major public health problem caused by the hepatitis C virus (HCV). Viral infections are known to induce production of IL1 beta through the signaling pathway of inflammasomes. Emerging evidences suggest that Inflammasome genes may influence the immune response against HCV as the host genetic background may contribute to the balance between acute and chronic inflammation. We investigated in 151 patients with chronic hepatitis C and 206 healthy blood donors' individuals (HD). Polymorphisms in the IL1B and IL18 genes were genotyped by PCR-RFLP, while NLRP3, CARD8, CTSB and AIM2 by RT- PCR. Serum assay of IL-1 beta cytokine was performed by ELISA. 84 patients presented mild fibrosis (<F2) and 67 advanced fibrosis (>= F2). Among the HD individuals the NLRP3-rs10754558 C/C genotype correlated with higher IL-1 beta levels compared to the G/G genotype. Similar pattern was observed in patients with hepatitis C, mean circulating IL-1 beta levels were 21,96 +/- 4.5 and 10,62 +/- 3.3pg/mL among the C/C and G/G genotypes, respectively. This pattern holds even after stratification of the patients into mild fibrosis and advanced fibrosis, demonstrating that the NLRP3-rs10754558 or another polymorphism in linkage disequilibrium with it possibly has an influence on the processing of pro-IL-1 beta. Notably, higher levels of IL-1 beta (Mann-Whitney test, p<0.0001) were observed among patients (mean +/- SEM: 19,24 +/- 3.pg/mL) when compared with controls (mean +/- SEM: 11,80 +/- 1.0pg/mL). Gene-gene interaction showed that individuals heterogyzotes for both CARD8-rs2009373 and IL1B-rs16944 are less prone to hepatitis C development (p(adj) = 0.039). Similarly, herozygote carriers for CTSB-rs1692816 and AIM2-rs1103577 (p(adj) = 0.008) or for IL18-rs187238 and NLRP3-rs10754558 (p(adj) = 0.005), have less chances to the development of hepatitis C. However, between subgroups of <F2 and >= F2, individuals homozygous for the T allele of CARD8-rs2009373 and heterozygous for IL18-rs187238 (p(adj) = 0.028), have mild form of fibrosis.	[Toro, Diana Mota; Ramasawmy, Rajendranath; Silva Neto, Pedro Vieira; Pereira, Grenda Leite; Sarmento, Priscila Santos; Costa, Allyson Guimaraes; Ogusku, Mauricio Morishi; Sadahiro, Aya; Tarrago, Andrea Monteiro; Malheiro, Adriana] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Barbieri, Marilu Victoria; Victoria, Flamir Silva; Costa, Allyson Guimaraes; Malheiro, Adriana] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Barbieri, Marilu Victoria; Victoria, Flamir Silva; Costa, Allyson Guimaraes] Fundacao Med Trop Dr Heitor Vieira Dourado, Inst Pesquisa Clin Carlos Borborema, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Univ Hilton Lins, Fac Med, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath; Costa, Allyson Guimaraes; Ogusku, Mauricio Morishi; Sadahiro, Aya; Tarrago, Andrea Monteiro; Malheiro, Adriana] Genom Hlth Surveilance Network Optimizat Assistan, Manaus, Amazonas, Brazil; [Silva Negreiros Dray, Hanna Lara; Sousa, Keyla Santos; Affonso, Juliana Santos; Silva, Jessica Albuquerque; Garcia, Nadja Pinto; Costa, Allyson Guimaraes; Tarrago, Andrea Monteiro; Malheiro, Adriana] Fundacao Hosp Hematol & Hemoterapia Amazonas, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil; [Sousa, Keyla Santos; Affonso, Juliana Santos; Costa, Allyson Guimaraes; Tarrago, Andrea Monteiro; Malheiro, Adriana] Univ Estado Amazonas, Programa Posgrad Ciencias Aplicadas Hematol, Manaus, Amazonas, Brazil; [Donadi, Eduardo Antonio] Univ Sao Paulo, Fac Med, Programa Posgrad Imunol Basica & Aplicada, Ribeirao Preto, SP, Brazil; [Costa, Allyson Guimaraes] Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil; [Ogusku, Mauricio Morishi] Inst Nacl de Pesquisas da Amazonia, Lab Micobacteriol, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Universidade do Estado do Amazonas; Universidade do Estado do Amazonas; Universidade de Sao Paulo; Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia	Costa, AG; Malheiro, A (corresponding author), Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.; Costa, AG; Malheiro, A (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.; Costa, AG (corresponding author), Fundacao Med Trop Dr Heitor Vieira Dourado, Inst Pesquisa Clin Carlos Borborema, Manaus, Amazonas, Brazil.; Costa, AG; Malheiro, A (corresponding author), Genom Hlth Surveilance Network Optimizat Assistan, Manaus, Amazonas, Brazil.; Costa, AG; Malheiro, A (corresponding author), Fundacao Hosp Hematol & Hemoterapia Amazonas, Diretoria Ensino & Pesquisa, Manaus, Amazonas, Brazil.; Costa, AG; Malheiro, A (corresponding author), Univ Estado Amazonas, Programa Posgrad Ciencias Aplicadas Hematol, Manaus, Amazonas, Brazil.; Costa, AG (corresponding author), Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil.	allyson.gui.costa@gmail.com; malhiiroadriana@yahoo.com.br	Costa, Allyson Guimarães/AAD-3923-2021	Costa, Allyson Guimarães/0000-0002-7312-6822; Mota toro, Diana/0000-0002-1003-3848	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (Pro-Estado Program) [002/2008, 007/2018, 005/2019]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PAMEQ Program) [004/2019]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PAPAC Program) [005/2019]; Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PECTI-AM/SAUDE Program) [004/2020]; Rede Genomica de Vigilancia em Saude do Estado do Amazonas (REGESAM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407818/2016]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Ministry of Health	Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (Pro-Estado Program); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PAMEQ Program); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PAPAC Program); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (PECTI-AM/SAUDE Program); Rede Genomica de Vigilancia em Saude do Estado do Amazonas (REGESAM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Ministry of Health	This work was funded by Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM) (Pro-Estado Program -#002/2008, #007/2018 and #005/2019, PAMEQ Program #004/2019, PAPAC Program -#005/2019 and PECTI-AM/SAUDE Program #004/2020), Rede Genomica de Vigilancia em Saude do Estado do Amazonas (REGESAM), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Universal Program -#407818/2016), Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior (CAPES) and Brazilian Ministry of Health.	Amir M, 2018, HEPATOLOGY, V67, P479, DOI 10.1002/hep.29491; Amirpour-Rostami S, 2019, VIRAL IMMUNOL, V32, P208, DOI 10.1089/vim.2018.0155; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Borelli V, 2015, INFECT AGENTS CANCER, V10, DOI 10.1186/s13027-015-0022-0; Burdette D, 2012, J GEN VIROL, V93, P235, DOI 10.1099/vir.0.034033-0; CDC . Centers for Disease Control and Prevention, 2015, VIR HEP DIV VIR HEP; Chattergoon MA, 2011, J INFECT DIS, V204, P1730, DOI 10.1093/infdis/jir642; Chen W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084953; de Souza-Cruz S, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0610-6; Eklund D, 2014, J INFECT DIS, V209, P749, DOI 10.1093/infdis/jit572; Estfanous SZK, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/3273645; Fibbi G, 2001, GROWTH FACTORS, V19, P87, DOI 10.3109/08977190109001078; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Health BM of, 2018, PROT CLIN DIR TER HE; Heim MH, 2014, J HEPATOL, V61, pS14, DOI 10.1016/j.jhep.2014.06.035; Hirankarn N, 2006, WORLD J GASTROENTERO, V12, P776, DOI 10.3748/wjg.v12.i5.776; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Ito S, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4483; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95; Kajdaniuk D, 2013, ENDOKRYNOL POL, V64, P384, DOI 10.5603/EP.2013.0022; Kamada AJ., 2014, MEM I OSWALDO CRUZ, V109; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lapinski TW, 2001, ARCH IMMUNOL THER EX, V49, P311; Mian SA, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.1659.1659; Mirza S, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-71; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pontillo A, 2010, JAIDS-J ACQ IMM DEF, V54, P236, DOI 10.1097/QAI.0b013e3181dd17d4; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; QIAGEN, 2016, SCREEN TB CONF; Qiu B, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0288-3; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Tarrago AM, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155052; Tian ZG, 2000, J IMMUNOL, V165, P3959, DOI 10.4049/jimmunol.165.7.3959; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; Tsutsui H, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/641865; Vecchiet J, 2005, ANN CLIN LAB SCI, V35, P415; Wells RG, 2004, FEBS LETT, V559, P107, DOI 10.1016/S0014-5793(04)00037-7; Zhou D, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3185397	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253470	10.1371/journal.pone.0253470	http://dx.doi.org/10.1371/journal.pone.0253470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161370	Green Published, gold			2022-12-26	WOS:000671691900008
J	Coradi, PC; Martens, S; Rodrigues, HE; Leal, AF; da Costa, DR; Saath, R; Borem, FM				Coradi, Paulo Carteri; Martens, Samuel; Rodrigues, Henrique Eguilhor; Leal, Andressa Fernandes; da Costa, Douglas Romeu; Saath, Reni; Borem, Flavio Meira			Development and validation of a heated drying air diffusion system to optimize rotary dryers and final coffee quality	PLOS ONE			English	Article							MATHEMATICAL-MODEL; FLOW; MICROWAVE; KINETICS; SIMULATION; TEMPERATURE; PARTICLES; LEAVES	The final quality of pre-processed coffees is influenced by the applied drying technology. Thus, the aim of the study was to develop and validate a heated air flow diffusion system to optimize and reduce the drying time of rotary dryers and improve the final quality of coffee. Computational fluid dynamics was used for the simulation of the air fluid dynamics in the combustion chamber of the heat generator. It was observed that the energy losses in the upper and lower walls of the heat generator chamber were higher with an increase in the convective heat transfer coefficient. It was found that the rate of fluid flow presented a fully developed profile, in which the higher speed value was found in the central region of the outlet. The reduction in moisture content during coffee drying was directly proportional to the increase in temperature. The Midilli model shows the best fit to describe the drying curves of the coffee. The effective diffusion coefficient increases with increasing temperature of the drying air. It was observed that the adjustments of the fluid dynamics in the burning of gas and the adaptation of the diffuser system significantly influenced the drying time and final quality of naturally processed and pulped coffees. In conclusion, the adapted technological set, a rotary dryer with gas heating and diffusion of heated air, had a high performance in the final quality of the coffee, and for this reason it is recommended to producers and the industry.	[Coradi, Paulo Carteri] Univ Fed Santa Maria, Campus Cachoeira do Sul, Cachoeira Do Sul, RS, Brazil; [Coradi, Paulo Carteri; Martens, Samuel; Rodrigues, Henrique Eguilhor; Leal, Andressa Fernandes] Univ Fed Santa Maria, Dept Agr Engn, Santa Maria, RS, Brazil; [da Costa, Douglas Romeu] Univ Fed Sergipe, Dept Agr Engn, Sao Cristovao, SE, Brazil; [Saath, Reni] Sate Univ Maringa, Dept Agron, Maringa, Parana, Brazil; [Borem, Flavio Meira] Univ Fed Lavras, Dept Agr Engn, Lavras, MG, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Sergipe; Universidade Federal de Lavras	Coradi, PC (corresponding author), Univ Fed Santa Maria, Campus Cachoeira do Sul, Cachoeira Do Sul, RS, Brazil.; Coradi, PC (corresponding author), Univ Fed Santa Maria, Dept Agr Engn, Santa Maria, RS, Brazil.	paulo.coradi@ufsm.br	Coradi, Paulo Carteri/G-8007-2015	Coradi, Paulo Carteri/0000-0001-9150-2169	CAPES (Coordination for the Improvement of Higher Education Personnel) [001]; CNPq (National Council for Scientific and Technological Development); FAPERGS-RS (Research Support Foundation of the State of Rio Grande do Sul)	CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS-RS (Research Support Foundation of the State of Rio Grande do Sul)	The authors would like to thank CAPES (Coordination for the Improvement of Higher Education Personnel)-Financial Code 001, CNPq (National Council for Scientific and Technological Development), FAPERGS-RS (Research Support Foundation of the State of Rio Grande do Sul), for contributions to financial research projects, and scholarships for carrying out the experiments.	Aidani E, 2017, FOOD SCI NUTR, V5, P596, DOI 10.1002/fsn3.435; Alves GE, 2017, ACTA SCI-AGRON, V39, P225, DOI 10.4025/actasciagron.v39i2.31065; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; ASAE Stardands, 2003, 3521 ASAE; Atungulu GG, 2018, DRY TECHNOL, V36, P383, DOI 10.1080/07373937.2017.1335751; Babalis SJ, 2004, J FOOD ENG, V65, P449, DOI 10.1016/j.jfoodeng.2004.02.005; Baker CGJ, 2010, DRY TECHNOL, V28, P730, DOI 10.1080/07373931003799368; Bakhtavar MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207569; Borem F. M., 2018, Coffee Science, V13, P159, DOI 10.25186/cs.v13i2.1410; Borem FM, 2020, J SENS STUD, V35, DOI 10.1111/joss.12552; Borem FM, 2008, CIENC AGROTEC, V32, P1609, DOI 10.1590/S1413-70542008000500038; Brooker D.B., 1992, DRYING STORAGE GRAIN, V4th; BSCA, 2015, BRAZIL SPECIALTY COF; Burmester K, 2010, J FOOD ENG, V99, P430, DOI 10.1016/j.jfoodeng.2009.12.021; Campos AT, 1999, BRAZ J STORAGE, V24, P37; Chen YQ, COMMUN NONLIN SCI NU, V64, P213; Compaore A, 2017, DRY TECHNOL, V35, P500, DOI 10.1080/07373937.2016.1192189; Coradi PC, 2022, DRY TECHNOL, V40, P1369, DOI 10.1080/07373937.2020.1870040; Coradi PC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78914-x; Coradi PC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242522; Coradi PC, 2020, J FOOD PROCESS PRES, V44, DOI 10.1111/jfpp.14961; Coradi PC, 2020, J STORED PROD RES, V87, DOI 10.1016/j.jspr.2020.101624; Coradi PC, 2018, DRY TECHNOL, V36, P545, DOI 10.1080/07373937.2017.1347943; Coradi PC, 2014, DRY TECHNOL, V32, P969, DOI 10.1080/07373937.2013.879593; Correa PC, 2010, INT J FOOD SCI TECH, V45, P2016, DOI 10.1111/j.1365-2621.2010.02373.x; Defendi RO, 2016, DRY TECHNOL, V34, P360, DOI 10.1080/07373937.2015.1055496; Dewitt DP., 2003, FUNDAMENTALS HEAT TR, p494P; do Livramento KG, 2017, FOOD CHEM, V221, P1874, DOI 10.1016/j.foodchem.2016.10.069; Doymaz I, 2004, J FOOD ENG, V64, P465, DOI 10.1016/j.jfoodeng.2003.11.013; Elrayes SF, 2011, J AGR RES, V89, P615; Gao XY, 2016, DRY TECHNOL, V34, P437, DOI 10.1080/07373937.2015.1060491; Ghazanfari A, 2006, DRY TECHNOL, V24, P1637, DOI 10.1080/07373930601031463; Hashemi G, 2009, J FOOD ENG, V92, P331, DOI 10.1016/j.jfoodeng.2008.12.004; Hemis M, 2012, BIOSYST ENG, V112, P202, DOI 10.1016/j.biosystemseng.2012.04.002; Henning AA., 1991, INFORM ABRATES, V1, P15; Isquierdo EP, 2013, T ASABE, V56, P1003; Jamaleddine TJ, 2010, DRY TECHNOL, V28, P120, DOI 10.1080/07373930903517458; Janas S, 2010, J FOOD ENG, V100, P527, DOI 10.1016/j.jfoodeng.2010.05.001; Kashaninejad M, 2007, J FOOD ENG, V78, P98, DOI 10.1016/j.jfoodeng.2005.09.007; Khanali M, 2014, J FOOD ENG, V137, P64, DOI 10.1016/j.jfoodeng.2014.03.020; Khanali M, 2013, DRY TECHNOL, V31, P414, DOI 10.1080/07373937.2012.738751; Khatchatourian OA, 2012, BIOSYST ENG, V113, P54, DOI 10.1016/j.biosystemseng.2012.06.006; Khomwachirakul P, 2016, DRY TECHNOL, V34, P403, DOI 10.1080/07373937.2015.1081930; Leobet EL, 2020, DRY TECHNOL, V38, P1421, DOI 10.1080/07373937.2019.1644347; Lopes DD, 2014, BIOSYST ENG, V118, P105, DOI 10.1016/j.biosystemseng.2013.11.011; Madamba PS, 1996, J FOOD ENG, V29, P75, DOI 10.1016/0260-8774(95)00062-3; Mari J, 2018, J FOOD PROCESS ENG, V41, DOI 10.1111/jfpe.12821; Mohapatra D, 2005, J FOOD ENG, V66, P513, DOI 10.1016/j.jfoodeng.2004.04.023; Nuthong P, 2011, J FOOD ENG, V102, P233, DOI 10.1016/j.jfoodeng.2010.08.024; Oliveira JA, 2008, BRAZ J AGR ENV ENG, V12, P181, DOI [10.1590/S1415-43662008000200011, DOI 10.1590/S1415-43662008000200011]; Ozbek B, 2007, J FOOD ENG, V83, P541, DOI 10.1016/j.jfoodeng.2007.04.004; Pereira RGFA, 2003, BRAZ J STORAGE, V27, P3; Phitakwinai S, 2019, FOOD SCI NUTR, V7, P2921, DOI 10.1002/fsn3.1144; Ranjbaran M, 2012, DRY TECHNOL, V30, P362, DOI 10.1080/07373937.2011.642913; Rodriguez J, 2014, DRY TECHNOL, V32, P1931, DOI 10.1080/07373937.2014.917094; Saath R, 2010, CIENC AGROTEC, V34, P196, DOI 10.1590/S1413-70542010000100025; Sanjinez-Argandona EJ, 2011, CIENCIA TECNOL ALIME, V31, P308, DOI 10.1590/S0101-20612011000200005; Sivakumar R, 2016, RENEW SUST ENERG REV, V61, P280, DOI 10.1016/j.rser.2016.04.014; Soysal Y, 2006, BIOSYST ENG, V93, P403, DOI 10.1016/j.biosystemseng.2006.01.017; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062868; Zhang G, 2000, J AGR ENG RES, V76, P141, DOI 10.1006/jaer.2000.0538	61	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0251312	10.1371/journal.pone.0251312	http://dx.doi.org/10.1371/journal.pone.0251312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157022	Green Published, gold			2022-12-26	WOS:000671691200009
J	Nik-Azis, NM; Mohd, N; Fadzilah, FM; Haflah, NHM; Said, MSM; Baharin, B				Nik-Azis, Nik-Madihah; Mohd, Nurulhuda; Fadzilah, Fazalina Mohd; Haflah, Nor Hazla Mohamed; Said, Mohd Shahrir Mohamed; Baharin, Badiah			Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study	PLOS ONE			English	Article							AMERICAN-COLLEGE; CLASSIFICATION; CRITERIA; OSTEOARTHRITIS; ASSOCIATION; HEALTH; POPULATION; SELECTION; IMPACT	Patients with rheumatoid arthritis (RA) experience a higher prevalence of periodontitis. This study aimed to examine the variation of periodontitis experienced with different serotypes suffered by RA patients and to examine the relationship between the different medications taken for RA that may influence this relationship. Two hundred and sixty RA and control participants underwent standardized periodontal examinations. Medical, serological and radiological (Sharp/van der Heijde) records were assessed. Functional status was assessed using the administered Health Assessment Questionnaire. Moreover, disease parameters, including disease activity (DAS28-ESR) and anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) seropositivity were evaluated. Periodontitis was higher in RA (71.54%) compared with controls (54.62%). The stage of periodontitis experienced by ACPA-positive participants were higher than APCA-negative participants. The probing pocket depth and recession experienced by RF-positive participants were higher than those who were RF-negative. RA participants on methotrexate had lower clinical attachment loss and lower periodontal probing depth compared with participants on a combination methotrexate and other disease-modifying antirheumatic drugs. Participants taking corticosteroids had lower gingival index scores. The association between seropositivity and the type of medications taken with periodontal health parameters in this group of patients suggests that both seropositivity and medications taken are important modifiers in the relationship between periodontitis and RA.	[Nik-Azis, Nik-Madihah; Mohd, Nurulhuda; Baharin, Badiah] Univ Kebangsaaan Malaysia, Fac Dent, Dept Restorat Dent, Unit Periodontol, Kuala Lumpur, Malaysia; [Fadzilah, Fazalina Mohd] Sunway Med Ctr, Radiol Dept, Bandar Sunway, Selangor, Malaysia; [Haflah, Nor Hazla Mohamed; Said, Mohd Shahrir Mohamed] Hosp Univ Kebangsaan Malaysia, Fac Med, Bandar Tun Razak, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Nik-Azis, NM; Mohd, N (corresponding author), Univ Kebangsaaan Malaysia, Fac Dent, Dept Restorat Dent, Unit Periodontol, Kuala Lumpur, Malaysia.	nikmadiah@ukm.edu.my; nurulhuda.mohd@ukm.edu.my	Haflah, Nor Hazla Mohamed/AAZ-9759-2020; Azis, Madihah/AAJ-7422-2021; MOHAMED SAID, PROF DR MOHD SHAHRIR/J-5065-2014	Haflah, Nor Hazla Mohamed/0000-0002-5408-3943; MOHAMED SAID, PROF DR MOHD SHAHRIR/0000-0003-1459-1844				AINAMO J, 1975, INT DENT J, V25, P229; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Ayravainen L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011916; Choi IA, 2016, KOREAN J INTERN MED, V31, P977, DOI 10.3904/kjim.2015.202; Dissick A, 2010, J PERIODONTOL, V81, P223, DOI 10.1902/jop.2009.090309; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Eriksson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155956; Fuggle NR, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00080; GARGIULO AV, 1982, J PERIODONTOL, V53, P568, DOI 10.1902/jop.1982.53.9.568; Gibofsky A, 2006, CURR MED RES OPIN, V22, P169, DOI 10.1185/030079906X80341; Gonzalez-Febles J, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-2121-6; Harrold LR, 2012, ARTHRITIS RHEUM-US, V64, P630, DOI 10.1002/art.33380; Hussein H, 2008, INT J RHEUM DIS, V11, P237, DOI 10.1111/j.1756-185X.2008.00384.x; Ivanova M, 2020, RHEUMATOL BULGARIA, V28, P11, DOI [10.35465/28.4.2020.pp3-18, DOI 10.35465/28.4.2020.PP3-18, 10.35465/28.4.2020]; Jung GU, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1465402; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Karapetsa D, 2022, ORAL DIS, V28, P1715, DOI 10.1111/odi.13842; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Landewe R, 2005, CLIN EXP RHEUMATOL, V23, pS63; Li RB, 2017, INT J RHEUM DIS, V20, P1887, DOI 10.1111/1756-185X.13240; Lopez R, 2007, EUR J ORAL SCI, V115, P339, DOI 10.1111/j.1600-0722.2007.00476.x; MARKITZIU A, 1990, J CLIN PERIODONTOL, V17, P228, DOI 10.1111/j.1600-051X.1990.tb00018.x; Md Redzuan A, 2018, ASIAN J PHARM CLIN R, V11; Mikuls TR, 2014, ARTHRITIS RHEUMATOL, V66, P1090, DOI 10.1002/art.38348; Mohamed AS, 2016, INT J PHARM PHARM SC, V8, P317; Mohd-Dom T., 2013, MALAYSIAN J PUBLIC H, V13, P38; Nguyen V, 2020, ACTA ODONTOL SCAND, V78, P522, DOI 10.1080/00016357.2020.1747635; Nik-Madihahnik-Azis, 2019, SAINS MALAYS, V48, P645, DOI 10.17576/jsm-2019-4803-18; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Papapanou PN, 2018, J CLIN PERIODONTOL, V45, pS162, DOI 10.1111/jcpe.12946; Payne Jeffrey B, 2015, Curr Oral Health Rep, V2, P20; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Rahajoe PS, 2020, J CLIN PERIODONTOL, V47, P552, DOI 10.1111/jcpe.13277; Renvert S, 2020, BMC RHEUMATOL, V4, DOI 10.1186/s41927-020-00129-4; Rodriguez-Lozano B, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1808-z; Romero-Sanchez C, 2017, CURR RHEUMATOL REV, V13, P139, DOI 10.2174/1573397113666170407161520; Sakthiswary R, 2019, MED HEALTH-KUALA LUM, V14, P203, DOI 10.17576/MH.2019.1402.18; Savioli C, 2012, JCR-J CLIN RHEUMATOL, V18, P180, DOI 10.1097/RHU.0b013e31825828be; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Svard A, 2020, CLIN EXP RHEUMATOL, V38, P699; Terao C, 2015, J AUTOIMMUN, V59, P85, DOI 10.1016/j.jaut.2015.03.002; The J, 1996, Oral Dis, V2, P253; THE J, 1991, J CLIN IMMUNOL, V11, P132, DOI 10.1007/BF00918681; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, P456, DOI 10.1111/jcpe.12732; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252859	10.1371/journal.pone.0252859	http://dx.doi.org/10.1371/journal.pone.0252859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153036	Green Published, gold			2022-12-26	WOS:000671691000004
J	Cheng, B; Htoo, SN; Mhote, NPP; Davison, CM				Cheng, Breagh; Htoo, Saw Nay; Mhote, Naw Pue Pue; Davison, Colleen M.			Association between biological sex and insecticide-treated net use among household members in ethnic minority and internally displaced populations in eastern Myanmar	PLOS ONE			English	Article							BED NETS	Malaria prevalence in Myanmar is highest among remote and ethnic minority populations living near forest fringes along the country's international borders. Insecticide-treated nets (ITNs) are a key intervention used to prevent malaria transmission, but insufficient ITN availability and low use can hinder effectiveness. This study assessed age and sex disparities in ITN possession, access, and use among household members of ethnic minority and internally displaced populations in eastern Myanmar. Cross-sectional data from the 2013 Eastern Burma Retrospective Mortality Survey were used to describe prevalence of ITN possession, access, and use. The association between a household member's biological sex and their ITN use was assessed using multilevel log binomial regression. Age and household ITN supply were tested as potential effect modifiers. Of 37927 household members, 89.8% (95% CI: 89.5, 90.1) of people lived in households with at least one ITN. Approximately half belonged to households with sufficient ITN supply and used an ITN. Pregnant women and children under five had the highest proportion of ITN use regardless of sufficient household ITN status. Female adults aged 15 to 49 years old (Risk ratio or RR: 1.4, 95% CI: 1.29, 1.52) were more likely to use ITNs. This relationship did not differ by sufficient household ITN status. The findings suggest that among ethnic minority populations in areas where ITN use is indicated, many households do not have adequate ITN supply, and many individuals are not using ITNs. Children under five and pregnant women appear to be prioritized for ITN use and overall, women are slightly more likely to use ITNs than men. This study's findings can support efforts ensuring that all household members belonging to ethnic minority and displaced populations in Eastern Myanmar benefit from sufficient ITN access and use for malaria prevention.	[Cheng, Breagh; Davison, Colleen M.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada; [Htoo, Saw Nay] Burma Med Assoc, Mae Sot, Thailand; [Mhote, Naw Pue Pue] Hlth Informat Syst Working Grp, Mae Sot, Thailand	Queens University - Canada	Davison, CM (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.	davisonc@queensu.ca	Davison, Colleen M/L-3157-2016	Davison, Colleen M/0000-0002-0410-3352	Frederick Banting and Charles Best Canada Graduate Scholarship; Michael Smith Foreign Study Supplement provided through the Canadian Institutes of Health Research (CIHR); Queen Elizabeth Scholars Advanced Scholars Fund	Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Michael Smith Foreign Study Supplement provided through the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth Scholars Advanced Scholars Fund	Funding for this study was provided by a Frederick Banting and Charles Best Canada Graduate Scholarship and a Michael Smith Foreign Study Supplement provided through the Canadian Institutes of Health Research (CIHR) and a Research Assistant stipend through a Queen Elizabeth Scholars Advanced Scholars Fund (Davison CM, co-PI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, NETW PROJ VECT CONTR; [Anonymous], 2020, PRES MAL IN BURM MAL; Aung T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162292; Beyrer Chris, 2008, Confl Health, V2, P2, DOI 10.1186/1752-1505-2-2; Bhumiratana A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/363417; Cuddy A, 2021, BBC NEWS; Demographic Health Survey Program, 2001, HOUS POP HOUS CHAR I; Drake TL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0886-x; Fokam EB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4155-5; Galbraith S, 2010, J NEUROSCI, V30, P10601, DOI 10.1523/JNEUROSCI.0362-10.2010; Garley AE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-119; Geng JT, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2924-6; Ghinai I, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1651-5; Graves P, 2019, MYANMAR MALARIA BURD; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Gryseels C, 2019, AM J TROP MED HYG, V100, P1424, DOI 10.4269/ajtmh.18-0730; Health System Information Working Group, 2015, LONG ROAD REC ETHN C; Hill J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001488; Krezanoski PJ, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010411; Lee CI, 2009, GLOB PUBLIC HEALTH, V4, P229, DOI 10.1080/17441690802676360; Li NN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-361; Linn SY, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2800-4; Liu H, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0727-y; Lwin MM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-5; Maung TM, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0111-z; Maung TM, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0399-2; McNeish D, 2019, PSYCHOL METHODS, V24, P20, DOI 10.1037/met0000182; Min KT, 2020, MALARIA J, V19, DOI 10.1186/s12936-019-3088-0; Mu TT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1567-0; Naing C, 2020, J INFECT DIS, V222, pS717, DOI 10.1093/infdis/jiaa335; Nuwaha F, 2001, AM J TROP MED HYG, V65, P877, DOI 10.4269/ajtmh.2001.65.877; Nyunt MH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-211; Ohnmar, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-309; Olapeju B, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2575-z; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0921-y; Ricotta E, 2014, GLOB HEALTH-SCI PRAC, V2, P165, DOI 10.9745/GHSP-D-14-00021; Roll Back Malaria, 2009, GUID COR POP BAS IND; Roll Back Malaria, 2013, HOUS SURV IND MAL CO; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-364; Streiner DL, 2011, CHEST, V140, P16, DOI 10.1378/chest.11-0523; Tang K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017770; Than WP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0353-8; The Border Consortium, 2017, REF IDP CAMP POP DEC; The Border Consortium, 2013, POV DISPL LOC GOV SE; United Nations High Commissioner for Refugees (UNCHR), 2020, THAIL MYANM BORD REF; WHO, 2011, WORLD MALARIA REPORT 2011, P1; World Health Organization, 2016, EXT EV NAT MAL CONTR; Zhao Y, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2398-y; Zhou GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1512-2	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252896	10.1371/journal.pone.0252896	http://dx.doi.org/10.1371/journal.pone.0252896			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143807	Green Published, gold			2022-12-26	WOS:000671690700031
J	Du Truong, C; Craig, TA; Cui, GF; Botuyan, MV; Serkasevich, RA; Chan, KY; Mer, G; Chiu, PL; Kumar, R				Du Truong, Chloe; Craig, Theodore A.; Cui, Gaofeng; Botuyan, Maria Victoria; Serkasevich, Rachel A.; Chan, Ka-Yi; Mer, Georges; Chiu, Po-Lin; Kumar, Rajiv			Cryo-EM reveals conformational flexibility in apo DNA polymerase zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST REV1; TRANSLESION SYNTHESIS; COMPLEX-FORMATION; STATISTICAL-MODEL; PROTEIN-KINASE; SUBUNIT; BYPASS; DELTA; VISUALIZATION; MUTAGENESIS	The translesion synthesis (TLS) DNA polymerases Rev1 and Pol zeta function together in DNA lesion bypass during DNA replication, acting as nucleotide inserter and extender polymerases, respectively. While the structural characterization of the Saccharomyces cerevisiae Pol zeta in its DNA-bound state has illuminated how this enzyme synthesizes DNA, a mechanistic understanding of TLS also requires probing conformational changes associated with DNA-and Rev1 binding. Here, we used single-particle cryo-electron microscopy to determine the structure of the apo Pol zeta holoenzyme. We show that compared with its DNA-bound state, apo Pol zeta displays enhanced flexibility that correlates with concerted motions associated with expansion of the Pol zeta DNA-binding channel upon DNA binding. We also identified a lysine residue that obstructs the DNA-binding channel in apo Pol zeta, suggesting a gating mechanism. The Pol zeta subunit Rev7 is a hub protein that directly binds Rev1 and is a component of several other protein complexes such as the shieldin DNA double-strand break repair complex. We analyzed the molecular interactions of budding yeast Rev7 in the context of Pol zeta and those of human Rev7 in the context of shieldin using a crystal structure of Rev7 bound to a fragment of the shieldin-3 protein. Overall, our study provides new insights into Pol zeta mechanism of action and the manner in which Rev7 recognizes partner proteins.	[Du Truong, Chloe; Chan, Ka-Yi; Chiu, Po-Lin] Arizona State Univ, Biodesign Inst, Sch Mol Sci, Tempe, AZ 85281 USA; [Craig, Theodore A.; Serkasevich, Rachel A.; Kumar, Rajiv] Mayo Clin, Dept Med, Div Hypertens & Nephrol, Nephrol & Hypertens Res, Rochester, MN 55901 USA; [Cui, Gaofeng; Botuyan, Maria Victoria; Mer, Georges; Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA; [Mer, Georges] Mayo Clin, Dept Canc Biol, Rochester, MN 55901 USA; [Chiu, Po-Lin] Arizona State Univ, Biodesign Ctr Struct Appl Discovery, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic; Mayo Clinic; Arizona State University; Arizona State University-Tempe	Chiu, PL (corresponding author), Arizona State Univ, Biodesign Inst, Sch Mol Sci, Tempe, AZ 85281 USA.; Kumar, R (corresponding author), Mayo Clin, Dept Med, Div Hypertens & Nephrol, Nephrol & Hypertens Res, Rochester, MN 55901 USA.; Mer, G; Kumar, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA.; Mer, G (corresponding author), Mayo Clin, Dept Canc Biol, Rochester, MN 55901 USA.; Chiu, PL (corresponding author), Arizona State Univ, Biodesign Ctr Struct Appl Discovery, Tempe, AZ 85281 USA.	mer.georges@mayo.edu; plchiu@asu.edu; rkumar@mayo.edu	Chiu, Po-Lin/ABB-7848-2021; Chiu, Po-Lin/GWV-6758-2022; Mer, Georges/AAT-4946-2021	Chiu, Po-Lin/0000-0001-8608-7650; Chiu, Po-Lin/0000-0001-8608-7650; Mer, Georges/0000-0002-1900-1578; Botuyan, Maria Victoria/0000-0002-6466-7432	Arizona State University (ASU); NVIDIA GPU Grant Program	Arizona State University (ASU); NVIDIA GPU Grant Program	This research was also supported by Arizona State University (ASU) startup funds to P.-L. C. We thank the GPU device support by the NVIDIA GPU Grant Program to P.-L. C.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baynton K, 2000, TRENDS BIOCHEM SCI, V25, P74, DOI 10.1016/S0968-0004(99)01524-8; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Bezalel-Buch R, 2020, NUCLEIC ACIDS RES, V48, P8461, DOI 10.1093/nar/gkaa580; Brandao LN, 2014, GENETICS, V197, P1111, DOI 10.1534/genetics.114.165308; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chatterjee N, 2020, P NATL ACAD SCI USA, V117, P28918, DOI 10.1073/pnas.2016064117; Cheng AC, 2018, J STRUCT BIOL, V204, P270, DOI 10.1016/j.jsb.2018.07.015; Chiu PL, 2015, J STRUCT BIOL, V192, P163, DOI 10.1016/j.jsb.2015.08.015; Cui GF, 2018, J MOL BIOL, V430, P2042, DOI 10.1016/j.jmb.2018.05.017; Dai YX, 2020, J BIOL CHEM, V295, P250, DOI 10.1074/jbc.RA119.011464; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fattah FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004419; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gomez-Llorente Y, 2013, CELL REP, V5, P79, DOI 10.1016/j.celrep.2013.08.046; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2004, NUCLEIC ACIDS RES, V32, P1122, DOI 10.1093/nar/gkh279; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Jain R, 2019, NAT STRUCT MOL BIOL, V26, P955, DOI 10.1038/s41594-019-0305-z; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LEMONTT JF, 1971, GENETICS, V68, P21; Leung W, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010010; Liang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15879-5; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Malik R, 2020, NAT STRUCT MOL BIOL, V27, P913, DOI 10.1038/s41594-020-0476-7; Marians KJ, 2018, ANNU REV BIOCHEM, V87, P217, DOI 10.1146/annurev-biochem-062917-011921; Martin SK, 2019, NUCLEIC ACIDS RES, V47, P8348, DOI 10.1093/nar/gkz705; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Miniowitz-Shemtov S, 2015, P NATL ACAD SCI USA, V112, P11536, DOI 10.1073/pnas.1515358112; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rizzo AA, 2019, ENZYMES, V45, P139, DOI 10.1016/bs.enz.2019.07.001; Rizzo AA, 2018, P NATL ACAD SCI USA, V115, pEB191, DOI 10.1073/pnas.1801149115; Rosenberg SC, 2015, J CELL BIOL, V211, P745, DOI 10.1083/jcb.201509076; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Taniguchi T, 2019, MOL CELL, V75, P419, DOI 10.1016/j.molcel.2019.07.012; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wojtaszek JL, 2019, CELL, V178, P152, DOI 10.1016/j.cell.2019.05.028; Xie W, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024512118; Yamanaka K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006842; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	73	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100912	10.1016/j.jbc.2021.100912	http://dx.doi.org/10.1016/j.jbc.2021.100912			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174285	Green Published, gold			2022-12-26	WOS:000690879300013
J	Sridhar, A; Lummis, SCR; Pasini, D; Mehregan, A; Brams, M; Kambara, K; Bertrand, D; Lindahl, E; Howard, RJ; Ulens, C				Sridhar, Akshay; Lummis, Sarah C. R.; Pasini, Diletta; Mehregan, Aujan; Brams, Marijke; Kambara, Kumiko; Bertrand, Daniel; Lindahl, Erik; Howard, Rebecca J.; Ulens, Chris			Regulation of a pentameric ligand-gated ion channel by a semiconserved cationic lipid-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; PROTEIN INTERACTIONS; GENERAL-ANESTHETICS; STRUCTURAL BASIS; SOFTWARE NEWS; K+ CHANNEL; RECEPTOR; DYNAMICS; ACTIVATION; MECHANISM	Pentameric ligand-gated ion channels (pLGICs) are crucial mediators of electrochemical signal transduction in various organisms from bacteria to humans. Lipids play an important role in regulating pLGIC function, yet the structural bases for specific pLGIC-lipid interactions remain poorly understood. The bacterial channel ELIC recapitulates several properties of eukaryotic pLGICs, including activation by the neurotransmitter GABA and binding and modulation by lipids, offering a simplified model system for structure-function relationship studies. In this study, functional effects of noncanonical amino acid substitution of a potential lipid-interacting residue (W206) at the top of the M1-helix, combined with detergent interactions observed in recent X-ray structures, are consistent with this region being the location of a lipid-binding site on the outward face of the ELIC transmembrane domain. Coarse grained and atomistic molecular dynamics simulations revealed preferential binding of lipids containing a positive charge, particularly involving interactions with residue W206, consistent with cation-pi binding. Polar contacts from other regions of the protein, particularly M3 residue Q264, further support lipid binding via headgroup ester linkages. Aromatic residues were identified at analogous sites in a handful of eukaryotic family members, including the human GABA(A) receptor epsilon subunit, suggesting conservation of relevant interactions in other evolutionary branches. Further mutagenesis experiments indicated that mutations at this site in epsilon-containing GABA(A) receptors can change the apparent affinity of the agonist response to GAB(A), suggesting a potential role of this site in channel gating. In conclusion, this work details type-specific lipid interactions, which adds to our growing understanding of how lipids modulate pLGICs.	[Sridhar, Akshay; Lindahl, Erik] KTH Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Solna, Sweden; [Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge, England; [Pasini, Diletta; Mehregan, Aujan; Brams, Marijke; Ulens, Chris] Katholieke Univ Leuven, Lab Struct Neurobiol, Dept Cellular & Mol Med, Fac Med, Leuven, Belgium; [Kambara, Kumiko; Bertrand, Daniel] HiQScreen Sarl, Geneva, Switzerland; [Lindahl, Erik; Howard, Rebecca J.] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden	Royal Institute of Technology; University of Cambridge; KU Leuven; Stockholm University	Ulens, C (corresponding author), Katholieke Univ Leuven, Lab Struct Neurobiol, Dept Cellular & Mol Med, Fac Med, Leuven, Belgium.; Howard, RJ (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden.	ecca.noward@scilifelab.se; chris.ulens@kuleuven.be		Ulens, Chris/0000-0002-8202-5281	Marie Sklodowska-Curie grant [898762]; Swedish Research Council [2017-04641, 2019-02433]; Swedish e-Science Research Center; MRC [MR/L021676]; FWO-Vlaanderen [G0C9717N, G0C1319N]; KU Leuven [C3/19/023, C14/17/093]	Marie Sklodowska-Curie grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish e-Science Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FWO-Vlaanderen(FWO); KU Leuven(KU Leuven)	A. S. was supported by Marie Sklodowska-Curie grant 898762, and E. L./R. J. H. by grants from the Swedish Research Council (2017-04641, 2019-02433) and Swedish e-Science Research Center. S. C. R. L. was supported by the MRC grant MR/L021676. C. U. was supported by grants from FWO-Vlaanderen (G0C9717N, G0C1319N) and KU Leuven (C3/19/023, C14/17/093).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Arcario MJ, 2017, J BIOL CHEM, V292, P9480, DOI 10.1074/jbc.M117.780197; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06361-4; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Dumas F, 1999, FEBS LETT, V458, P271, DOI 10.1016/S0014-5793(99)01148-5; Duncan AL, 2020, ANNU REV PHARMACOL, V60, P31, DOI 10.1146/annurev-pharmtox-010919-023411; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henault CM, 2019, NAT CHEM BIOL, V15, P1156, DOI 10.1038/s41589-019-0369-4; Henault CM, 2015, J BIOL CHEM, V290, P25118, DOI 10.1074/jbc.M115.676833; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Khan HM, 2020, J CHEM THEORY COMPUT, V16, P2550, DOI 10.1021/acs.jctc.9b01194; Khan HM, 2019, J CHEM THEORY COMPUT, V15, P7, DOI 10.1021/acs.jctc.8b00839; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim JJ, 2020, NATURE, V585, P303, DOI 10.1038/s41586-020-2654-5; Knoflach F, 2018, JOVE-J VIS EXP, DOI 10.3791/57842; Lacin E, 2017, J GEN PHYSIOL, V149, P799, DOI 10.1085/jgp.201711801; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Martens C, 2016, NAT STRUCT MOL BIOL, V23, P744, DOI 10.1038/nsmb.3262; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; Muller MP, 2019, CHEM REV, V119, P6086, DOI 10.1021/acs.chemrev.8b00608; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Polovinkin L, 2018, NATURE, V563, P275, DOI 10.1038/s41586-018-0672-3; Price KL, 2005, J NEUROSCI METH, V149, P172, DOI 10.1016/j.jneumeth.2005.05.014; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rahman MM, 2020, NEURON, V106, P952, DOI 10.1016/j.neuron.2020.03.012; Robinson CV, 2019, TRENDS BIOCHEM SCI, V44, P795, DOI 10.1016/j.tibs.2019.04.001; Rupakheti CR, 2018, THEOR CHEM ACC, V137, DOI 10.1007/s00214-018-2376-z; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tong AL, 2019, ELIFE, V8, DOI 10.7554/eLife.50766; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	72	8	8	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100899	10.1016/j.jbc.2021.100899	http://dx.doi.org/10.1016/j.jbc.2021.100899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34157288	Green Published, gold			2022-12-26	WOS:000690873500003
J	Li, Y; Jiang, YD; Zhang, L; Qian, W; Hou, XH; Lin, R				Li, Ying; Jiang, Yudong; Zhang, Lei; Qian, Wei; Hou, Xiaohua; Lin, Rong			Exogenous l-fucose protects the intestinal mucosal barrier depending on upregulation of FUT2-mediated fucosylation of intestinal epithelial cells	FASEB JOURNAL			English	Article						fucosylation; FUT2; inflammatory bowel disease; intestinal barrier; l-fucose	EXCLUSIVE ENTERAL NUTRITION; INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; CROHNS-DISEASE; TRANSFERASE 2; ASSOCIATION	FUT2, a protein that uses l-fucose to mediate fucosylation of intestinal epithelial cells, is one of the detected gene variants in IBD patients. We aimed to investigate whether exogenous l-fucose could be an enteral nutritional supplement to protect intestinal barrier function. The effect of l-fucose on the restoration of epithelial barrier function in both the DSS-induced colitis mouse model and LPS-stimulated Caco-2 cells was investigated, and the impact on fucosylation of epithelial cells was examined. The severity of DSS-induced colitis was significantly reduced by l-fucose. Restoration of epithelial barrier function by l-fucose was detected. Direct l-fucose-mediated protection of tight junctions was observed in Caco-2 cells. Moreover, exogenous l-fucose promoted the exogenous metabolic pathway of l-fucose, and fucosylation of epithelial cells both in vivo and in vitro. Moreover, knockout of the FUT2 gene restrained fucosylation and the protective effect of l-fucose on barrier function. The severity of colitis was not improved by l-fucose in Fut2 knockout mice. Therefore we conclude that exogenous l-fucose protects intestinal barrier function and relieves intestinal inflammation via upregulation of FUT2-mediated fucosylation of intestinal epithelial cells.	[Li, Ying; Jiang, Yudong; Zhang, Lei; Qian, Wei; Hou, Xiaohua; Lin, Rong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Hou, XH; Lin, R (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Div Gastroenterol, Wuhan 430022, Peoples R China.	houxh@hust.edu.cn; selinalin35@hotmail.com		Jiang, Yudong/0000-0001-5783-539X; lin, rong/0000-0001-9463-8942	National Natural Science Foundation of China (NSFC) [81330014]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81330014	Aheman A, 2012, WORLD J GASTROENTERO, V18, P4758, DOI 10.3748/wjg.v18.i34.4758; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Citkowska A, 2019, MAR DRUGS, V17, DOI 10.3390/md17080458; Cott C, 2016, BBA-MOL CELL RES, V1863, P1106, DOI 10.1016/j.bbamcr.2016.02.004; de Bie C, 2013, J CROHNS COLITIS, V7, P263, DOI 10.1016/j.crohns.2012.07.001; Dias CC, 2019, DIGEST LIVER DIS, V51, P952, DOI 10.1016/j.dld.2019.01.016; Gerasimidis K, 2013, INFLAMM BOWEL DIS, V19, P2411, DOI 10.1097/MIB.0b013e31829ed855; Goto Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep15918; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Guo Z, 2013, NUTR CLIN PRACT, V28, P499, DOI 10.1177/0884533613487218; Huoponen S., 2015, PLOS ONE, V10; Jones Jennifer L, 2019, J Can Assoc Gastroenterol, V2, pS42, DOI 10.1093/jcag/gwy048; Maroni L, 2015, CLIN REV ALLERG IMMU, V48, P182, DOI 10.1007/s12016-014-8423-1; NAKAJIMA H, 1995, J GASTROENTEROL, V30, P115; Parmar AS, 2012, TISSUE ANTIGENS, V80, P488, DOI 10.1111/tan.12016; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pillai N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185500; Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050; Rausch P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00991; Rolandsdotter H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020414; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Terahara K, 2011, BIOCHEM BIOPH RES CO, V404, P822, DOI 10.1016/j.bbrc.2010.12.067; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; Wang YW, 2017, GASTROENTEROLOGY, V152, P193, DOI 10.1053/j.gastro.2016.09.004; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wu H, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/4148651	28	4	4	7	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21699	10.1096/fj.202002446RRRR	http://dx.doi.org/10.1096/fj.202002446RRRR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151459				2022-12-26	WOS:000667814100073
J	Nunez, JJ; Nguyen, TT; Zhou, YH; Cao, B; Ng, RT; Chen, J; Frey, BN; Milev, R; Muller, DJ; Rotzinger, S; Soares, CN; Uher, R; Kennedy, SH; Lam, RW				Nunez, John-Jose; Nguyen, Teyden T.; Zhou, Yihan; Cao, Bo; Ng, Raymond T.; Chen, Jun; Frey, Benicio N.; Milev, Roumen; Muller, Daniel J.; Rotzinger, Susan; Soares, Claudio N.; Uher, Rudolf; Kennedy, Sidney H.; Lam, Raymond W.			Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1	PLOS ONE			English	Article							IMPAIRMENT; SCALE; REPRODUCIBILITY; QUESTIONNAIRE; PRODUCTIVITY; VARIABLES; EFFICACY; MODEL; WORK	Objectives Antidepressants are first-line treatments for major depressive disorder (MDD), but 40-60% of patients will not respond, hence, predicting response would be a major clinical advance. Machine learning algorithms hold promise to predict treatment outcomes based on clinical symptoms and episode features. We sought to independently replicate recent machine learning methodology predicting antidepressant outcomes using the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) dataset, and then externally validate these methods to train models using data from the Canadian Biomarker Integration Network in Depression (CAN-BIND-1) dataset. Methods We replicated methodology from Nie et al (2018) using common algorithms based on linear regressions and decision trees to predict treatment-resistant depression (TRD, defined as failing to respond to 2 or more antidepressants) in the STAR*D dataset. We then trained and externally validated models using the clinical features found in both datasets to predict response (>= 50% reduction on the Quick Inventory for Depressive Symptomatology, Self-Rated [QIDS-SR]) and remission (endpoint QIDS-SR score <= 5) in the CAN-BIND-1 dataset. We evaluated additional models to investigate how different outcomes and features may affect prediction performance. Results Our replicated models predicted TRD in the STAR*D dataset with slightly better balanced accuracy than Nie et al (70%-73% versus 64%-71%, respectively). Prediction performance on our external methodology validation on the CAN-BIND-1 dataset varied depending on outcome; performance was worse for response (best balanced accuracy 65%) compared to remission (77%). Using the smaller set of features found in both datasets generally improved prediction performance when evaluated on the STAR*D dataset. Conclusion We successfully replicated prior work predicting antidepressant treatment outcomes using machine learning methods and clinical data. We found similar prediction performance using these methods on an external database, although prediction of remission was better than prediction of response. Future work is needed to improve prediction performance to be clinically useful.	[Nunez, John-Jose; Lam, Raymond W.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Nunez, John-Jose; Nguyen, Teyden T.; Zhou, Yihan; Ng, Raymond T.] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Cao, Bo] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada; [Chen, Jun] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China; [Frey, Benicio N.; Soares, Claudio N.] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Milev, Roumen] Queens Univ, Dept Psychiat, Kingston, ON, Canada; [Milev, Roumen] Queens Univ, Dept Psychol, Kingston, ON, Canada; [Muller, Daniel J.; Rotzinger, Susan; Kennedy, Sidney H.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Uher, Rudolf] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada	University of British Columbia; University of British Columbia; University of Alberta; McMaster University; Queens University - Canada; Queens University - Canada; University of Toronto; Dalhousie University	Lam, RW (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada.	r.lam@ubc.ca	Uher, Rudolf/A-5477-2008; Milev, Roumen/F-4521-2012; Frey, Benicio/AAJ-8212-2021; Soares, Claudio/AAC-9335-2022; Mueller, Daniel Josef/GVT-7899-2022	Uher, Rudolf/0000-0002-2998-0546; Milev, Roumen/0000-0001-6884-171X; Mueller, Daniel Josef/0000-0003-4978-4400; Nunez, John-Jose/0000-0002-1602-6382	Ontario Brain Institute; Ontario government; Canadian Institutes of Health Research (CIHR); Lundbeck; Bristol-Myers Squibb; Pfizer; Servier; CIHR Team Grant: GACD Mental Health [GAC-154985]	Ontario Brain Institute; Ontario government; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lundbeck(Lundbeck Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Servier(Servier); CIHR Team Grant: GACD Mental Health(Canadian Institutes of Health Research (CIHR))	CAN-BIND is an Integrated Discovery Program carried out in partnership with, and financial support from, the Ontario Brain Institute, an independent non-profit corporation, funded partially by the Ontario government. The opinions, results and conclusions are those of the authors and no endorsement by the Ontario Brain Institute is intended or should be inferred. Additional funding was provided by the Canadian Institutes of Health Research (CIHR), Lundbeck, Bristol-Myers Squibb, Pfizer, and Servier. Funding and/or in kind support is also provided by the investigators' universities and academic institutions. All study medications are independently purchased at wholesale market values. JJN is partially supported by CIHR Team Grant: GACD Mental Health, GAC154985. CIHR: https://cihr-irsc.gc.ca/e/193.html Lundbeck: https://www.lundbeck.com/ca/en Bristol-Myers Squibb: https://www.bms.com/Pfizer: https://www.pfizer.ca/Servier: https://servier.com/en/.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; [Anonymous], DEPRESSION TREATMENT; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Berman RM, 2007, J CLIN PSYCHIAT, V68, P843, DOI 10.4088/JCP.v68n0604; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Buhlmann P, 2013, J STAT PLAN INFER, V143, P1835, DOI 10.1016/j.jspi.2013.05.019; Camerer CF., 2018, NAT HUM BEHAV, V2, P637, DOI [DOI 10.1038/s41562-018-0399-z, 10.1038/s41562-018-0399-z]; Chekroud AM, 2017, JAMA PSYCHIAT, V74, P370, DOI 10.1001/jamapsychiatry.2017.0025; Chekroud AM, 2016, LANCET PSYCHIAT, V3, P243, DOI 10.1016/S2215-0366(15)00471-X; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Coiera E, 2018, J AM MED INFORM ASSN, V25, P963, DOI 10.1093/jamia/ocy028; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Dwyer DB, 2018, ANNU REV CLIN PSYCHO, V14, P91, DOI [10.1146/annurev-clinpsy-032816045037, 10.1146/annurev-clinpsy-032816-045037]; Ferrari AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069637; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Gillett G, 2020, PHARMACOL THERAPEUT, V212, DOI 10.1016/j.pharmthera.2020.107557; Hieronymus F, 2016, MOL PSYCHIATR, V21, P523, DOI 10.1038/mp.2015.53; Hutson M, 2018, SCIENCE, V359, P725, DOI 10.1126/science.359.6377.725; Iniesta R, 2016, J PSYCHIATR RES, V78, P94, DOI 10.1016/j.jpsychires.2016.03.016; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Kautzky A, 2017, J CLIN PSYCHIAT, V78, P215, DOI 10.4088/JCP.15m10381; Kennedy SH, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.18m12202; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Lam RW, 2014, VALUE HEALTH, V17, pA195, DOI 10.1016/j.jval.2014.03.1137; Lam RW., 2016, BMC PSYCHIATRY, P16, DOI [10.1186/s12888-016-0718-8, DOI 10.1186/S12888-016-0718-8]; Lee Y, 2018, J AFFECT DISORDERS, V241, P519, DOI 10.1016/j.jad.2018.08.073; LEON AC, 1992, SOC PSYCH PSYCH EPID, V27, P78, DOI 10.1007/BF00788510; Lin EGN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030969; McKinney W., PANDAS FDN PYTHON LI, P9; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Mundt JC, 2002, BRIT J PSYCHIAT, V180, P461, DOI 10.1192/bjp.180.5.461; Nie Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197268; Nunez J-J, 2018, NIMH DATA ARCHIVE, DOI [10.15154/1503299, DOI 10.15154/1503299]; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Serretti A, 2007, J AFFECT DISORDERS, V98, P239, DOI 10.1016/j.jad.2006.08.008; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Steger MF, 2009, J COUNS PSYCHOL, V56, P289, DOI 10.1037/a0015416; Stevanovic D, 2011, J PSYCHIATR MENT HLT, V18, P744, DOI 10.1111/j.1365-2850.2011.01735.x; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Zimmerman M, 2001, COMPR PSYCHIAT, V42, P175, DOI 10.1053/comp.2001.23126	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253023	10.1371/journal.pone.0253023	http://dx.doi.org/10.1371/journal.pone.0253023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9DB	34181661	gold, Green Published			2022-12-26	WOS:000671695800034
J	Hassan, RM; Salem, ST; Hassan, SIM; Hegab, AS; Elkholy, YS				Hassan, Reem M.; Salem, Sherifa T.; Hassan, Saly Ismail Mostafa; Hegab, Asmaa Sayed; Elkholy, Yasmine S.			Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients	PLOS ONE			English	Article							METALLO-BETA-LACTAMASES; MULTIPLEX PCR; RAPID DETECTION; GENES; MECHANISMS; PLASTICITY; EMERGENCE; REGION; ISABA1	Acinetobacter baumannii (A. baumannii) represents a global threat owing to its ability to resist most of the currently available antimicrobial agents. Moreover, emergence of carbapenem resistant A. baumannii (CR-AB) isolates limits the available treatment options. Enzymatic degradation by variety of ss-lactamases, have been identified as the most common mechanism of carbapenem resistance in A. baumannii. The alarming increase in the prevalence of CR-AB necessitates continuous screening and molecular characterization to appreciate the problem. The present study was performed to assess the prevalence and characterize carbapenemases among 206 CR-AB isolated from various clinical specimens collected from different intensive care units at Kasr Al-Aini Hospital. All isolates were confirmed to be A. baumannii by detection of the blaOXA-51-like gene. Molecular screening of 13 common Ambler class bla carbapenemases genes in addition to insertion sequence (IS-1) upstream OXA-23 were performed by using four sets of multiplex PCR, followed by identification using gene sequencing technology. Among the investigated genes, the prevalence of blaOXA-23, and blaOXA-58 were 77.7%, and 1.9%, respectively. The ISAba1 was detected in 10% of the blaOXA-23 positive isolates. The prevalence of metallo-beta-lactamases (MBLs) studied; blaNDM-1, blaSPM, blaVIM, blaSIM-1 were 11.7%, 6.3%, 0.5%, and 0.5% respectively. One of class A; bla KPC was detected in 10.7% of the investigated isolates. blaOXA-24/40, blaIMP, blaGES, blaVEB and blaGIM were not detected in any of the studied isolates. Moreover, 18.4% of the isolates have shown to harbor two or more of the screened bla genes. We concluded that the most prevalent type of ss-lactamases genes among CR-AB isolates collected from Egyptian patients were blaOXA-23 followed by blaNDM-1 and blaKPC.	[Hassan, Reem M.; Salem, Sherifa T.] Cairo Univ, Fac Med, Dept Clin & Chem Pathol, Cairo, Egypt; [Hassan, Saly Ismail Mostafa] Beni Suef Univ, Fac Med, Dept Clin Pathol, Bani Suwayf, Egypt; [Hegab, Asmaa Sayed; Elkholy, Yasmine S.] Cairo Univ, Fac Med, Dept Med Microbiol & Immunol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Cairo University	Hegab, AS (corresponding author), Cairo Univ, Fac Med, Dept Med Microbiol & Immunol, Cairo, Egypt.	asmahgab@kasralainy.edu.eg	Salem, Sherifa T./S-2744-2017	Salem, Sherifa T./0000-0003-2303-0619; Hassan, Reem/0000-0002-7032-4735; Hegab, Asmaa/0000-0002-6304-652X				Abbott I, 2013, EXPERT REV ANTI-INFE, V11, P395, DOI [10.1586/ERI.13.21, 10.1586/eri.13.21]; Abouelfetouh A, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0611-6; Al-Agamy MH, 2014, INT J INFECT DIS, V22, P49, DOI [10.1016/j.ijid.2013.12.004, 10.10]; Al-Hassan L, 2013, CLIN MICROBIOL INFEC, V19, P1082, DOI 10.1111/1469-0691.12143; Alkasaby NM, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/3925868; Almasaudi SB, 2018, SAUDI J BIOL SCI, V25, P586, DOI 10.1016/j.sjbs.2016.02.009; Benmahmod AB, 2019, MICROB DRUG RESIST, V25, P480, DOI 10.1089/mdr.2018.0141; Bonnin RA, 2012, CLIN MICROBIOL INFEC, V18, pE362, DOI 10.1111/j.1469-0691.2012.03928.x; Bonnin RA, 2011, ANTIMICROB AGENTS CH, V55, P2424, DOI 10.1128/AAC.01795-10; Cai Y, 2012, J ANTIMICROB CHEMOTH, V67, P1607, DOI 10.1093/jac/dks084; Clinical and Laboratory Standards Institute Guidelines, 2018, M100S28 CLIN LAB ST; CONSTANTINIU S, 2004, J PREV MED, V12, P35; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; El-Mahdy TS, 2017, MICROB DRUG RESIST, V23, P115, DOI 10.1089/mdr.2015.0304; Espinal P, 2013, J ANTIMICROB CHEMOTH, V68, P1928, DOI 10.1093/jac/dkt109; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fattouh M., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P732; Handal R, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/8012104; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P4174, DOI 10.1128/AAC.49.10.4174-4179.2005; Hrabak J, 2012, EUROSURVEILLANCE, V17, P9; Huang XZ, 2012, J MED MICROBIOL, V61, P1532, DOI 10.1099/jmm.0.045823-0; Kaase M, 2011, J ANTIMICROB CHEMOTH, V66, P1260, DOI 10.1093/jac/dkr135; Kamel NA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202119; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Mohamed N. M., 2011, Research Journal of Microbiology, V6, P750, DOI 10.3923/jm.2011.750.760; Mugnier PD, 2009, J BACTERIOL, V191, P2414, DOI 10.1128/JB.01258-08; Paton R, 1993, Int J Antimicrob Agents, V2, P81, DOI 10.1016/0924-8579(93)90045-7; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Pogue JM, 2013, EXPERT REV ANTI-INFE, V11, P383, DOI [10.1586/ERI.13.14, 10.1586/eri.13.14]; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Ramadan RA, 2018, INFECT DRUG RESIST, V11, P1261, DOI 10.2147/IDR.S170233; Rossi F, 2009, J MED MICROBIOL, V58, P1522, DOI 10.1099/jmm.0.011080-0; SCAIFE W, 1995, J ANTIMICROB CHEMOTH, V36, P585, DOI 10.1093/jac/36.3.585; Touati M, 2012, INT J ANTIMICROB AG, V40, P89, DOI 10.1016/j.ijantimicag.2012.03.017; Turton JF, 2006, J CLIN MICROBIOL, V44, P2974, DOI 10.1128/JCM.01021-06; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Vandecraen J, 2017, CRIT REV MICROBIOL, V43, P709, DOI 10.1080/1040841X.2017.1303661; Voets GM, 2011, INT J ANTIMICROB AG, V37, P356, DOI 10.1016/j.ijantimicag.2011.01.005; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	42	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0251508	10.1371/journal.pone.0251508	http://dx.doi.org/10.1371/journal.pone.0251508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166384	Green Submitted, Green Published, gold			2022-12-26	WOS:000671692800066
J	Li, XH; Ke, HY; Ouyang, CA; Yu, XL; Liu, YM; Wang, F; Li, WW				Li, Xiaohong; Ke, Hongyang; Ouyang, Chuan; Yu, Xiaoli; Liu, Yumei; Wang, Fei; Li, Wanwei			Investigation of the indoor Rn-222 and Rn-220 levels in the residential environment and estimation of the annual effective radiation dose for ordinary residents	PLOS ONE			English	Article							LUNG-CANCER; RADON; THORON; PROGENY; CHINA; RISK	To evaluate the health risk of radon and its progeny, a large amount of accurate monitoring data is needed according to the theory and practice of health risk assessment. However, the indoor radon levels in different regions in China and worldwide reveal temporal and spatial variations. In addition, the residents living in different areas follow distinct living modes. Therefore, it is recommended and accepted by many researchers to detect the radon level in local areas and subsequently conduct health risk assessments based on local detection data. In this study, 21 bedrooms of households in Weifang city were selected, and the indoor Rn-222 and Rn-220 levels were detected with RAD7 radon detector in winter, while the annual effective radiation dose was calculated for ordinary residents in Weifang city. Our investigation showed that the 24- and 12-hour average levels of Rn-222 were 35.7 +/- 15.2 Bq/m(3) and 36.2 +/- 15.8 Bq/m(3), respectively. The 24- and 12-hour average levels of Rn-220 were 30.4 +/- 12.3 Bq/m(3) and 22.4 +/- 11.6 Bq/m(3), respectively. There were significant differences in the average levels of Rn-222 and Rn-220 between floors. The estimated annual effective radiation dose received by ordinary residents in Weifang city was 1.7193 mSv, of which 0.9479 mSv originated from Rn-222 and its progeny and 0.7714 mSv originated from Rn-220 and its progeny, accounting for 55.1% and 44.9%, respectively, of the total dose. Our findings suggest that Rn-220 should not be ignored by local residents in Weifang city, and more attention should be paid to Rn-220 in future research.	[Li, Xiaohong; Ke, Hongyang; Ouyang, Chuan; Yu, Xiaoli; Li, Wanwei] Weifang Med Univ, Sch Publ Hlth, Weifang, Shandong, Peoples R China; [Li, Xiaohong; Ke, Hongyang; Ouyang, Chuan; Yu, Xiaoli; Li, Wanwei] Weifang Med Univ, Publ Hlth Testing Ctr, Sch Publ Hlth & Management, Weifang, Shandong, Peoples R China; [Li, Xiaohong; Ke, Hongyang; Ouyang, Chuan; Yu, Xiaoli; Li, Wanwei] Weifang Key Lab Hlth Inspect & Quarantine, Weifang, Shandong, Peoples R China; [Liu, Yumei; Wang, Fei] Weifang Med Univ, Expt Demonstrat Teaching Ctr Publ Hlth, Sch Publ Hlth, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University	Li, WW (corresponding author), Weifang Med Univ, Sch Publ Hlth, Weifang, Shandong, Peoples R China.; Li, WW (corresponding author), Weifang Med Univ, Publ Hlth Testing Ctr, Sch Publ Hlth & Management, Weifang, Shandong, Peoples R China.; Li, WW (corresponding author), Weifang Key Lab Hlth Inspect & Quarantine, Weifang, Shandong, Peoples R China.	lilili127@163.com		Wanwei, Li/0000-0001-6475-6948	Natural Science Foundation of Shandong Province [ZR2015HL099]; Shandong Medical and Health Science and Technology Development Plan Project [2019WS592]; Science and Technology Development Foundation of Weifang [2019GX027]; Natural Science Foundation of Shandong [ZR2020MH336]; Shandong Traditional Chinese Medicine Science Technology Project [2020M077]; Shandong Sino US sports economy and Health Engineering Cooperation Research Center Project [sdca20191017]; Weifang Medical University	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Medical and Health Science and Technology Development Plan Project; Science and Technology Development Foundation of Weifang; Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Shandong Traditional Chinese Medicine Science Technology Project; Shandong Sino US sports economy and Health Engineering Cooperation Research Center Project; Weifang Medical University	This work was supported by the Natural Science Foundation of Shandong Province (ZR2015HL099)?Shandong Medical and Health Science and Technology Development Plan Project (2019WS592), Science and Technology Development Foundation of Weifang (2019GX027), Natural Science Foundation of Shandong (ZR2020MH336), Shandong Traditional Chinese Medicine Science Technology Project (2020M077) and Shandong Sino US sports economy and Health Engineering Cooperation Research Center Project (sdca20191017) and doctoral research initiation fund of Weifang Medical University.	Afolabi Olusegun Temitope, 2015, BMC Res Notes, V8, P677, DOI 10.1186/s13104-015-1447-7; Boice JD, 1997, RADIAT RES, V147, P135, DOI 10.2307/3579413; Cheng JP, 2002, J NUCL SCI TECHNOL, V39, P695, DOI 10.3327/jnst.39.695; CLARKE RH, 1989, NATURE, V338, P197, DOI 10.1038/338197a0; Curguz Z, 2015, J ENVIRON RADIOACTIV, V148, P163, DOI 10.1016/j.jenvrad.2015.06.026; Guo QJ, 2005, J NUCL SCI TECHNOL, V42, P588, DOI 10.3327/jnst.42.588; Guo QJ, 2001, J NUCL SCI TECHNOL, V38, P799, DOI 10.3327/jnst.38.799; Krewski D, 2005, EPIDEMIOLOGY, V16, P137, DOI 10.1097/01.ede.0000152522.80261.e3; Li XH, 2020, J RADIOANAL NUCL CH, V324, P561, DOI 10.1007/s10967-020-07082-z; LUBIN JH, 1989, HEALTH PHYS, V57, P417, DOI 10.1097/00004032-198909000-00008; Lubin JH, 2004, INT J CANCER, V109, P132, DOI 10.1002/ijc.11683; Lubin JH, 1997, RADIAT RES, V147, P126, DOI 10.2307/3579412; Park TH, 2018, ENVIRON SCI POLLUT R, V25, P12678, DOI 10.1007/s11356-018-1531-3; Rubin D.B, 2009, J MARKET RES, V137, P180; Shang B, 2008, RADIAT ENVIRON BIOPH, V47, P367, DOI 10.1007/s00411-008-0163-2; Suzuki G, 2010, J RADIAT RES, V51, P683, DOI 10.1269/jrr.10083; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, UNSCEAR 2000 REPORT; United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2000, ANN B EXP NAT RAD SO; Yonehara H, 2005, INT CONGR SER, V1276, P58, DOI 10.1016/j.ics.2004.10.014; Zhang L, 2008, J RADIOL PROT, V28, P603, DOI 10.1088/0952-4746/28/4/N02; Zhao GZ, 2008, RADIAT MEAS, V43, pS479, DOI 10.1016/j.radmeas.2008.03.012	21	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253463	10.1371/journal.pone.0253463	http://dx.doi.org/10.1371/journal.pone.0253463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166418	gold, Green Published			2022-12-26	WOS:000671692800011
J	Hsu, SN; Hui, EWE; Liu, MZ; Wu, D; Hughes, TA; Smith, J				Hsu, Sharon Nienyun; Hui, Erika Wong En; Liu, Mengzhen; Wu, Di; Hughes, Thomas A.; Smith, James			Revealing nuclear receptor hub modules from Basal-like breast cancer expression networks	PLOS ONE			English	Article							MOLECULAR PORTRAITS; RESPONSE GENES; FOS FAMILY; C-FOS; HETEROGENEITY; SUBTYPES; STAT1; CLASSIFICATION; CARCINOMAS; ACTIVATION	Nuclear receptors are a class of transcriptional factors. Together with their co-regulators, they regulate development, homeostasis, and metabolism in a ligand-dependent manner. Their ability to respond to environmental stimuli rapidly makes them versatile cellular components. Their coordinated activities regulate essential pathways in normal physiology and in disease. Due to their complexity, the challenge remains in understanding their direct associations in cancer development. Basal-like breast cancer is an aggressive form of breast cancer that often lacks ER, PR and Her2. The absence of these receptors limits the treatment for patients to the non-selective cytotoxic and cytostatic drugs. To identify potential drug targets it is essential to identify the most important nuclear receptor association network motifs in Basal-like subtype progression. This research aimed to reveal the transcriptional network patterns, in the hope to capture the underlying molecular state driving Basal-like oncogenesis. In this work, we illustrate a multidisciplinary approach of integrating an unsupervised machine learning clustering method with network modelling to reveal unique transcriptional patterns (network motifs) underlying Basal-like breast cancer. The unsupervised clustering method provides a natural stratification of breast cancer patients, revealing the underlying heterogeneity in Basal-like. Identification of gene correlation networks (GCNs) from Basal-like patients in both the TCGA and METABRIC databases revealed three critical transcriptional regulatory constellations that are enriched in Basal-like. These represent critical NR components implicated in Basal-like breast cancer transcription. This approach is easily adaptable and applicable to reveal critical signalling relationships in other diseases.	[Hsu, Sharon Nienyun; Hui, Erika Wong En; Liu, Mengzhen; Wu, Di; Smith, James] Univ Leeds, Fac Environm, Sch Food Sci & Nutr, Leeds, W Yorkshire, England; [Hsu, Sharon Nienyun] Univ Leeds, Fac Biol Sci, Astbury Ctr, Leeds, W Yorkshire, England; [Hughes, Thomas A.] Univ Leeds, Sch Med, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Smith, J (corresponding author), Univ Leeds, Fac Environm, Sch Food Sci & Nutr, Leeds, W Yorkshire, England.	J.Smith252@leeds.ac.uk	Hughes, Thomas A/O-8031-2015; Smith, James/AAV-3824-2021	Hughes, Thomas A/0000-0003-1169-3386; Smith, James/0000-0002-7465-6067; Hsu, Sharon Nienyun/0000-0003-2356-9155				Abduljabbar R, 2015, BREAST CANCER RES TR, V150, P511, DOI 10.1007/s10549-015-3348-9; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BLAND KI, 1995, ANN SURG, V221, P706, DOI 10.1097/00000658-199506000-00010; Butts CT, 2019, **DATA OBJECT**; Chiu AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29992-5; Conzen SD, 2008, MOL ENDOCRINOL, V22, P2215, DOI 10.1210/me.2007-0421; Cooke E, 2020, BHC BAYESIAN HIERARC; Csardi G, TRIAD CENSUS TRIAD C; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Dai XF, 2015, AM J CANCER RES, V5, P2929; Davis J. A., 1972, SOCIOLOGICAL THEORIE, V2, P218; Dhiman VK, 2018, NAT REV GENET, V19, P160, DOI 10.1038/nrg.2017.102; Doan TB, 2017, J MOL ENDOCRINOL, V58, pR169, DOI 10.1530/JME-16-0082; Erler JT, 2012, CELL, V149, P731, DOI 10.1016/j.cell.2012.04.014; Furlong LI, 2013, TRENDS GENET, V29, P150, DOI 10.1016/j.tig.2012.11.004; Garrido-Castro AC, 2019, CANCER DISCOV, V9, P176, DOI 10.1158/2159-8290.CD-18-1177; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Holding AN, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1698-z; Hsu KS, 2017, J BIOL CHEM, V292, P10048, DOI 10.1074/jbc.M116.771071; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang AN, 2005, CIRC RES, V96, P164, DOI 10.1161/01.RES.0000153669.24827.DF; Huang R, 2017, CELL PHYSIOL BIOCHEM, V43, P2212, DOI 10.1159/000484300; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koedoot E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11020-3; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langer S, 2006, EUR J GYNAECOL ONCOL, V27, P345; Lin ML, 2015, ONCOTARGET, V6, P21685, DOI 10.18632/oncotarget.3942; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Llopis S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-139; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Mehraj V, 2013, J INFECT DIS, V208, P942, DOI 10.1093/infdis/jit266; Meissl K, 2017, CYTOKINE, V89, P12, DOI 10.1016/j.cyto.2015.11.011; Mikula M, 2003, ONCOGENE, V22, P6725, DOI 10.1038/sj.onc.1206781; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Muscat GEO, 2013, MOL ENDOCRINOL, V27, P350, DOI 10.1210/me.2012-1265; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Opgen-Rhein R., 2006, REVSTAT-STAT J, V4, P53; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pascual-Garcia M, 2013, J IMMUNOL, V190, P6520, DOI 10.4049/jimmunol.1201393; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sabatier R, 2011, BREAST CANCER RES TR, V126, P407, DOI 10.1007/s10549-010-0897-9; Savage RS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-242; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Shimizu S, 2008, INT J BIOCHEM CELL B, V40, P755, DOI 10.1016/j.biocel.2007.10.011; Sirinukunwattana K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075748; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Tatebe K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-170; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Toft DJ, 2011, MOL ENDOCRINOL, V25, P199, DOI 10.1210/me.2010-0164; Tullai JW, 2007, J BIOL CHEM, V282, P23981, DOI 10.1074/jbc.M702044200; Yang Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4231	67	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252901	10.1371/journal.pone.0252901	http://dx.doi.org/10.1371/journal.pone.0252901			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161324	Green Published, gold			2022-12-26	WOS:000671691900051
J	Oyama, Y; Shigeta, S; Tokunaga, H; Tsuji, K; Ishibashi, M; Shibuya, Y; Shimada, M; Yasuda, J; Yaegashi, N				Oyama, Yoshiko; Shigeta, Shogo; Tokunaga, Hideki; Tsuji, Keita; Ishibashi, Masumi; Shibuya, Yusuke; Shimada, Muneaki; Yasuda, Jun; Yaegashi, Nobuo			CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; MOLECULAR-MECHANISMS; CLINICAL-TRIAL; DNA-REPAIR; CISPLATIN; RESISTANCE; CARCINOMA; COMPLEX; P21; SUPPRESSION	Platinum sensitivity is an important prognostic factor in patients with ovarian cancer. Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a core member of the nucleosome remodeling and deacetylase complex, which functions as a chromatin remodeler. Emerging evidence indicates that CHD4 could be a potential therapeutic target for cancer therapy. The purpose of this study was to clarify the role of CHD4 in ovarian cancer and investigate its therapeutic potential focusing on platinum sensitivity. In an analysis of the Cancer Genome Atlas ovarian cancer dataset, CHD4 gene amplification was associated with worse overall survival. CHD4 mRNA expression was significantly higher in platinum-resistant samples in a subsequent clinical sample analysis, suggesting that CHD4 overexpression conferred platinum resistance to ovarian cancer cells, resulting in poor patient survival. In concordance with these findings, CHD4 knockdown enhanced the induction of apoptosis mediated by cisplatin in ovarian cancer cells TOV21G and increased cisplatin sensitivity in multiple ovarian cancer cells derived from different subtypes. However, CHD4 knockdown did not affect the expression of RAD51 or p21, the known targets of CHD4 in other cancer types that can modulate platinum sensitivity. Knockdown and overexpression assays revealed that CHD4 positively regulated the expression of multi-drug transporter MDR1 and its coding protein p-glycoprotein. In addition, a first-in-class CHD4/SMARCA5 inhibitor ED2-AD101 showed synergistic interactions with cisplatin. Our findings suggest that CHD4 mediates platinum sensitivity by modulating MDR1 expression in ovarian cancer. Further, CHD4 suppression has a potential to be a novel therapeutic strategy in combination with platinum agents.	[Oyama, Yoshiko; Shigeta, Shogo; Tokunaga, Hideki; Tsuji, Keita; Ishibashi, Masumi; Shibuya, Yusuke; Shimada, Muneaki; Yaegashi, Nobuo] Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan; [Yasuda, Jun] Miyagi Canc Ctr, Div Mol & Cellular Oncol, Res Inst, Natori, Miyagi, Japan	Tohoku University; Miyagi Cancer Center	Tokunaga, H (corresponding author), Tohoku Univ, Dept Obstet & Gynecol, Grad Sch Med, Sendai, Miyagi, Japan.	hideki.tokunaga.a1@tohoku.ac.jp			JSPS KAKENHI [19H03795, 19K09747, 19K23904, 20K18211]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the JSPS KAKENHI Grants (19H03795 to NY, 19K09747 to KT, 19K23904, and 20K18211 to SS). https://www.jsps.go.jp/english/e-grants/index.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Amable L, 2016, PHARMACOL RES, V106, P27, DOI 10.1016/j.phrs.2016.01.001; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Banerjee S, 2013, CLIN CANCER RES, V19, P961, DOI 10.1158/1078-0432.CCR-12-2243; Basta J, 2015, TRANSL RES, V165, P36, DOI 10.1016/j.trsl.2014.05.003; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Beaufort CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103988; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Bouazoune K, 2002, EMBO J, V21, P2430, DOI 10.1093/emboj/21.10.2430; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang SJ, 2013, GYNECOL ONCOL, V130, P493, DOI 10.1016/j.ygyno.2013.05.040; D'Alesio C, 2019, BIOL OPEN, V8, DOI 10.1242/bio.038323; D'Alesio C, 2016, ONCOTARGET, V7, P80901, DOI 10.18632/oncotarget.12646; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Domcke S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3126; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Enomoto T, 2019, INT J GYNECOL CANCER, V29, P1043, DOI 10.1136/ijgc-2019-000384; FAGAN KJ, 1990, NEUROLOGY, V40, P1689, DOI 10.1212/WNL.40.11.1689; Fardel O, 1996, GEN PHARMACOL, V27, P1283, DOI 10.1016/S0306-3623(96)00081-X; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Ghosh S, 2019, BIOORG CHEM, V88, DOI 10.1016/j.bioorg.2019.102925; Gomez-del Arco P, 2016, CELL METAB, V23, P881, DOI 10.1016/j.cmet.2016.04.008; Gourley C, 2019, J CLIN ONCOL, V37, P2257, DOI 10.1200/JCO.18.02050; Guillemette S, 2015, GENE DEV, V29, P489, DOI 10.1101/gad.256214.114; Heintz APM, 2003, INT J GYNECOL OBSTET, V83, P135, DOI 10.1016/S0020-7292(03)90118-4; Heshmati Y, 2018, HAEMATOLOGICA, V103, P1169, DOI 10.3324/haematol.2017.183970; Hoffmeister H, 2017, NUCLEIC ACIDS RES, V45, P10534, DOI 10.1093/nar/gkx711; Hou MF, 2017, EXP CELL RES, V359, P458, DOI 10.1016/j.yexcr.2017.08.029; Kathawala RJ, 2015, DRUG RESIST UPDATE, V18, P1, DOI 10.1016/j.drup.2014.11.002; Kishtagari A, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-119311; Konstantinopoulos PA, 2015, CANCER DISCOV, V5, P1137, DOI 10.1158/2159-8290.CD-15-0714; Larsen DH, 2010, J CELL BIOL, V190, P731, DOI 10.1083/jcb.200912135; Li W, 2016, DRUG RESIST UPDATE, V27, P14, DOI 10.1016/j.drup.2016.05.001; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Li Y, 2018, AM J CANCER RES, V8, P903; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Lu H, 2016, ONCOL RES, V23, P119, DOI 10.3727/096504015X14496932933656; Luo CW, 2018, EXP CELL RES, V363, P65, DOI 10.1016/j.yexcr.2017.12.032; Markman M, 2004, J CLIN ONCOL, V22, P3120, DOI 10.1200/JCO.2004.05.195; Marques JG, 2020, ELIFE, V9, DOI 10.7554/eLife.54993; Mayes K, 2014, ADV CANCER RES, V121, P183, DOI 10.1016/B978-0-12-800249-0.00005-6; McKenzie LD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40327-w; Moschetta M, 2016, ANN ONCOL, V27, P1449, DOI 10.1093/annonc/mdw142; Nitta M, 2001, GYNECOL ONCOL, V81, P10, DOI 10.1006/gyno.2000.6084; O'Shaughnessy A, 2013, BIOCHEM SOC T, V41, P777, DOI 10.1042/BST20130027; OMURA G, 1986, CANCER, V57, P1725, DOI 10.1002/1097-0142(19860501)57:9<1725::AID-CNCR2820570903>3.0.CO;2-J; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Peng G, 2011, WORLD J CLIN ONCOL, V2, P73, DOI 10.5306/wjco.v2.i2.73; Pokhriyal Ruchika, 2019, Biomark Cancer, V11, p1179299X19860815, DOI 10.1177/1179299X19860815; Rocha CRR, 2018, CLINICS, V73, DOI 10.6061/clinics/2018/e478s; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shibuya Y, 2018, GENE CHROMOSOME CANC, V57, P51, DOI 10.1002/gcc.22507; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smith R, 2018, NUCLEIC ACIDS RES, V46, P6087, DOI 10.1093/nar/gky334; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang HC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174087; Wang YM, 2012, CANCER RES, V72, P4037, DOI 10.1158/0008-5472.CAN-12-0103; Xia LM, 2017, CANCER CELL, V31, P653, DOI 10.1016/j.ccell.2017.04.005; Xia X, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-399; Zhang Jing, 2019, J Cancer Res Cell Ther, V3	62	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0251079	10.1371/journal.pone.0251079	http://dx.doi.org/10.1371/journal.pone.0251079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161330	gold, Green Published			2022-12-26	WOS:000671691900047
J	Preusting, LC; Raadsen, MP; Abourashed, A; Voeten, HACM; Wagener, MN; de Wit, E; van Gorp, ECM; Doornekamp, L				Preusting, L. C.; Raadsen, M. P.; Abourashed, A.; Voeten, H. A. C. M.; Wagener, M. N.; de Wit, E.; van Gorp, E. C. M.; Doornekamp, L.			COVID-19 related stigma and health-protective behaviours among adolescents in the Netherlands: An explorative study	PLOS ONE			English	Article							CHINESE COMMUNITIES; PERCEIVED THREAT; RISK PERCEPTION; UNITED-KINGDOM; SARS; FEAR; INFORMATION; PREVENTION; EFFICACY; OPTIMISM	The COVID-19 pandemic has forced many governments to impose social distancing measures upon its citizens, including in the Netherlands. Motivating adolescents to adhere to measures such as social distancing can be challenging, since adolescents are relatively more affected by them, while experiencing virtually no personal health benefit. In addition, the COVID-19 pandemic seems to impact the social environment of adolescents in schools, as some media sources have reported bullying and stigmatisation of students with an Asian appearance. This study aims to explore the experiences of adolescents regarding their Health-Protective Behaviour (HPB), as well as the prevalence and expression of stigma towards ethnic minorities within the context of the first wave of COVID-19 pandemic. We performed a cross-sectional mixed-methods study, including two independent online questionnaires. An adapted version of the "HPB" questionnaire (n = 528) and the "Measure of Disease-Related Stigma (MDRS)" questionnaire (n = 380), were administered to Dutch adolescents of 10-16 years old, attending primary or secondary school. Furthermore, 15 interviews were held with eight male and seven female adolescents. All data collection took place between March 17 and April 20, 2020. Results show that adolescents perceive COVID-19 as a threat to other peoples' health, rather than their own, and report adherence to public health measures in the interest of older and more vulnerable members of their community. We found no convincing evidence for widespread misinformation or stigmatising of certain ethnic groups among adolescents related to COVID-19 during this study. Participants acknowledged such behaviour happened in the early stages of the pandemic, before this study was initiated. Adolescents are a vital group for public health researchers to engage with during a pandemic, even when reaching them can be challenging.	[Preusting, L. C.; Raadsen, M. P.; Abourashed, A.; van Gorp, E. C. M.; Doornekamp, L.] Univ Med Ctr Rotterdam, Dept Virosci, Erasmus MC, Rotterdam, Netherlands; [Preusting, L. C.] Vrije Univ Amsterdam, Fac Sci, Amsterdam, Netherlands; [Voeten, H. A. C. M.] Municipal Publ Hlth Serv Rotterdam Rijnmond, Rotterdam, Netherlands; [Voeten, H. A. C. M.] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands; [Wagener, M. N.] Rotterdam Univ Appl Sci, Ctr Expertise Innovat Care, Rotterdam, Netherlands; [de Wit, E.] Vrije Univ Amsterdam, Athena Inst Res Commun & Innovat Life & Hlth Sci, Amsterdam, Netherlands; [van Gorp, E. C. M.] Univ Med Ctr Rotterdam, Dept Internal Med Infect Dis, Erasmus MC, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Preusting, LC (corresponding author), Univ Med Ctr Rotterdam, Dept Virosci, Erasmus MC, Rotterdam, Netherlands.; Preusting, LC (corresponding author), Vrije Univ Amsterdam, Fac Sci, Amsterdam, Netherlands.	lisennepreusting@gmail.com		Abourashed, Ayat/0000-0002-0438-1600; Preusting, Lisanne/0000-0002-0059-3518; de wit, emmy/0000-0002-4047-0555; Voeten, Helene/0000-0003-1358-6752				[Anonymous], 2020, KIND ZIJN ONZ SLACHT; [Anonymous], 2020, NOS 0313; [Anonymous], 2020, SOC STIGM ASS COVID; [Anonymous], 2020, ADOLESCENT HEALTH; [Anonymous], 2020, OMG MET GEV COR IK V; [Anonymous], YOUR RES IS IT SUBJE; [Anonymous], 2019, CBS 1202; [Anonymous], 2020, GEDR OND COVID 19 BE; [Anonymous], 2020, NUFFIC; Arnett JJ, 2000, ADDICT BEHAV, V25, P625, DOI 10.1016/S0306-4603(99)00072-6; Banker S, 2020, JUDGM DECIS MAK, V15, P1037; Barattucci M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.554561; Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986; Brug J, 2004, EMERG INFECT DIS, V10, P1486, DOI 10.3201/eid1008.040283; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Campos-Mercade P, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2021.104367; Chesney MA, 1999, AM BEHAV SCI, V42, P1162, DOI 10.1177/00027649921954822; Conner M, 2005, PREDICTING HLTH BEHA; de Zwart O, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-114; de Zwart O, 2009, INT J BEHAV MED, V16, P30, DOI 10.1007/s12529-008-9008-2; Doornekamp L, 2017, AM J TROP MED HYG, V97, P97, DOI 10.4269/ajtmh.16-0661; Field A., 2013, DISCOVERING STAT USI; HARRIS DM, 1979, J HEALTH SOC BEHAV, V20, P17, DOI 10.2307/2136475; HEINE SJ, 1995, J PERS SOC PSYCHOL, V68, P595, DOI 10.1037/0022-3514.68.4.595; Hofland T., 2020, ERASMUS MAGAZIN 0211; Jiang XY, 2009, INT J BEHAV MED, V16, P58, DOI 10.1007/s12529-008-9005-5; Jolley D, 2021, BRIT J DEV PSYCHOL, V39, P499, DOI 10.1111/bjdp.12368; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Karamouzian M, 2015, INT J HEALTH POLICY, V4, P55, DOI 10.15171/ijhpm.2014.128; Lee PI, 2020, J MICROBIOL IMMUNOL, V53, P371, DOI 10.1016/j.jmii.2020.02.011; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1088, DOI 10.1111/apa.15270; Lunn PD, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113478; MADDUX JE, 1983, J EXP SOC PSYCHOL, V19, P469, DOI 10.1016/0022-1031(83)90023-9; Mak WWS, 2006, SOC SCI MED, V63, P1912, DOI 10.1016/j.socscimed.2006.04.016; Moreno MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2592; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Qiu HY, 2020, LANCET INFECT DIS, V20, P689, DOI 10.1016/S1473-3099(20)30198-5; Rademaker G., 2020, EENVANDAAG AVRO 0213; Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112; Sharot T, 2011, CURR BIOL, V21, pR941, DOI 10.1016/j.cub.2011.10.030; Strauss A., 1990, BASICS QUALITATIVE R; Stump T.K., 2016, STIGMA HEALTH, V1, P87, DOI [https://doi.org/10.1037/sah0000012, DOI 10.1037/SAH0000012]; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Wolfers M, 2011, AIDS PATIENT CARE ST, V25, P311, DOI 10.1089/apc.2010.0186	48	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253342	10.1371/journal.pone.0253342	http://dx.doi.org/10.1371/journal.pone.0253342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157046	Green Published, gold			2022-12-26	WOS:000671691200025
J	Boone, MA; Taslim, C; Crow, JC; Selich-Anderson, J; Byrum, AK; Showpnil, IA; Sunkel, BD; Wang, M; Stanton, BZ; Theisen, ER; Lessnick, SL				Boone, Megann A.; Taslim, Cenny; Crow, Jesse C.; Selich-Anderson, Julia; Byrum, Andrea K.; Showpnil, Iftekhar A.; Sunkel, Benjamin D.; Wang, Meng; Stanton, Benjamin Z.; Theisen, Emily R.; Lessnick, Stephen L.			The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma	ONCOGENE			English	Article							FUSION PROTEIN; DOMAIN; TRANSLOCATION; EWS; TRANSFORMATION; PARTNERSHIPS; EXPRESSION; GENERATION; LANDSCAPE; CHROMATIN	Ewing sarcoma is an aggressive bone cancer of children and young adults defined by the presence of a chromosomal translocation: t(11;22)(q24;q12). The encoded protein, EWS/FLI, fuses the amino-terminal domain of EWS to the carboxyl-terminus of FLI. The EWS portion is an intrinsically disordered transcriptional regulatory domain, while the FLI portion contains an ETS DNA-binding domain and two flanking regions of unknown function. Early studies using non-Ewing sarcoma models provided conflicting information on the roles of each domain of FLI in EWS/FLI oncogenic function. We therefore sought to define the specific contributions of each FLI domain to EWS/FLI activity in a well-validated Ewing sarcoma model and, in doing so, to better understand Ewing sarcoma development mediated by the fusion protein. We analyzed a series of engineered EWS/FLI mutants with alterations in the FLI portion using a variety of assays. Fluorescence anisotropy, CUT&RUN, and ATAC-sequencing experiments revealed that the isolated ETS domain is sufficient to maintain the normal DNA-binding and chromatin accessibility function of EWS/FLI. In contrast, RNA-sequencing and soft agar colony formation assays revealed that the ETS domain alone was insufficient for transcriptional regulatory and oncogenic transformation functions of the fusion protein. We found that an additional alpha-helix immediately downstream of the ETS domain is required for full transcriptional regulation and EWS/FLI-mediated oncogenesis. These data demonstrate a previously unknown role for FLI in transcriptional regulation that is distinct from its DNA-binding activity. This activity is critical for the cancer-causing function of EWS/FLI and may lead to novel therapeutic approaches.	[Boone, Megann A.; Stanton, Benjamin Z.; Theisen, Emily R.; Lessnick, Stephen L.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Boone, Megann A.; Taslim, Cenny; Crow, Jesse C.; Selich-Anderson, Julia; Byrum, Andrea K.; Showpnil, Iftekhar A.; Sunkel, Benjamin D.; Wang, Meng; Stanton, Benjamin Z.; Theisen, Emily R.; Lessnick, Stephen L.] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43210 USA; [Showpnil, Iftekhar A.; Stanton, Benjamin Z.; Theisen, Emily R.; Lessnick, Stephen L.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Stanton, Benjamin Z.; Theisen, Emily R.; Lessnick, Stephen L.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Lessnick, SL (corresponding author), Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Childhood Canc & Blood Dis, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA.; Lessnick, SL (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.	stephen.lessnick@nationwidechildrens.org		Sunkel, Benjamin/0000-0003-1376-9567; Theisen, Emily/0000-0003-2923-1198; Boone, Megann/0000-0002-7806-8027; Stanton, Benjamin/0000-0002-2613-2955	National Institute of Health [T32 GM068412, U54 CA231641]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the National Institute of Health award T32 GM068412 to MAB, and U54 CA231641 to SLL. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SLL declares a competing interest as a member of the advisory board for Salarius Pharmaceuticals. SLL is also a listed inventor on United States Patent No. US 7,939,253 B2, "Methods and compositions for the diagnosis and treatment of Ewing's sarcoma," and United States Patent No. US 8,557,532, "Diagnosis and treatment of drug-resistant Ewing's sarcoma." This does not alter our adherence to Oncogene policies on sharing data and materials.	Arvand A, 2001, CANCER RES, V61, P5311; AURIAS A, 1983, CR ACAD SCI III-VIE, V296, P1105; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Erkizan HV, 2010, CLIN CANCER RES, V16, P4077, DOI 10.1158/1078-0432.CCR-09-2261; Gangwal K, 2008, CELL CYCLE, V7, P3127, DOI 10.4161/cc.7.20.6892; Gangwal Kunal, 2010, Genes Cancer, V1, P177; Gu ZG, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4625-x; Hodges HC, 2018, NAT STRUCT MOL BIOL, V25, P61, DOI 10.1038/s41594-017-0007-3; Hou CX, 2015, BIOCHEMISTRY-US, V54, P7365, DOI 10.1021/acs.biochem.5b01121; Johnson KM, 2017, P NATL ACAD SCI USA, V114, P9870, DOI 10.1073/pnas.1701872114; Kim S, 2006, MOL CELL BIOL, V26, P2467, DOI 10.1128/MCB.26.7.2467-2478.2006; Kovar Heinrich, 2011, Sarcoma, V2011, P1, DOI 10.1155/2011/837474; Laudet V, 1999, ONCOGENE, V18, P1351, DOI 10.1038/sj.onc.1202444; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; LESSNICK SL, 1995, ONCOGENE, V10, P423; LIANG H, 1994, P NATL ACAD SCI USA, V91, P11655, DOI 10.1073/pnas.91.24.11655; Longhi A, 2012, CANCER-AM CANCER SOC, V118, P5050, DOI 10.1002/cncr.27493; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maag Jesper L V, 2018, F1000Res, V7, P1576, DOI 10.12688/f1000research.16409.2; MAO XH, 1994, J BIOL CHEM, V269, P18216; Martinez-Ramirez A, 2003, CANCER GENET CYTOGEN, V141, P138, DOI 10.1016/S0165-4608(02)00670-2; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Mendiola M, 2006, INT J CANCER, V118, P1381, DOI 10.1002/ijc.21578; Pishas KI, 2018, MOL CANCER THER, V17, P1902, DOI 10.1158/1535-7163.MCT-18-0373; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Regan MC, 2013, P NATL ACAD SCI USA, V110, P13374, DOI 10.1073/pnas.1301726110; Riggi N, 2014, CANCER CELL, V26, P668, DOI 10.1016/j.ccell.2014.10.004; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar S, 2014, CLIN CANCER RES, V20, P4584, DOI 10.1158/1078-0432.CCR-14-0072; Sankar S, 2011, CANCER GENET-NY, V204, P351, DOI 10.1016/j.cancergen.2011.07.008; Sizemore GM, 2017, NAT REV CANCER, V17, P337, DOI 10.1038/nrc.2017.20; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Spahn L, 2003, ONCOGENE, V22, P6819, DOI 10.1038/sj.onc.1206810; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Theisen Emily R, 2019, Genes Cancer, V10, P21, DOI 10.18632/genesandcancer.188; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; ZUCMAN J, 1993, EMBO J, V12, P4481, DOI 10.1002/j.1460-2075.1993.tb06137.x	48	7	7	0	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4759	4769		10.1038/s41388-021-01876-5	http://dx.doi.org/10.1038/s41388-021-01876-5		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34145397	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000663295300003
J	Park, KY; Seo, S; Han, J; Park, JY				Park, Kyu Young; Seo, Sumin; Han, Junhee; Park, Ji Young			Respiratory virus surveillance in Canada during the COVID-19 pandemic: An epidemiological analysis of the effectiveness of pandemic-related public health measures in reducing seasonal respiratory viruses test positivity	PLOS ONE			English	Article								Background Various public health measures have been implemented globally to counter the coronavirus disease 2019 (COVID-19) pandemic. The purpose of this study was to evaluate respiratory virus surveillance data to determine the effectiveness of such interventions in reducing transmission of seasonal respiratory viruses. Method We retrospectively analysed data from the Respiratory Virus Detection Surveillance System in Canada, before and during the COVID-19 pandemic, by interrupted time series regression. Results The national level of infection with seasonal respiratory viruses, which generally does not necessitate quarantine or contact screening, was greatly reduced after Canada imposed physical distancing and other quarantine measures. The 2019-2020 influenza season ended earlier than it did in the previous year. The influenza virus was replaced by rhinovirus/enterovirus or parainfluenza virus in the previous year, with the overall test positivity remaining at approximately 35%. However, during the 2019-2020 post-influenza period, the overall test positivity of respiratory viruses during the COVID-19 was still low (7.2%). Moreover, the 2020-2021 influenza season had not occurred by the end of February 2021. Conclusion Respiratory virus surveillance data may provide real-world evidence of the effectiveness of implemented public health interventions during the current and future pandemics.	[Park, Kyu Young] Univ British Columbia, Fac Dent, Vancouver, BC, Canada; [Seo, Sumin] Hallym Univ, Hallym Inst Clin Med, Div Biostat, Med Ctr, Anyang, South Korea; [Han, Junhee] Hallym Univ, Dept Stat, Chunchon, South Korea; [Park, Ji Young] Hallym Univ, Sacred Heart Hosp, Dept Pulm Allergy & Crit Care Med, Anyang, South Korea	University of British Columbia; Hallym University; Hallym University; Hallym University	Park, JY (corresponding author), Hallym Univ, Sacred Heart Hosp, Dept Pulm Allergy & Crit Care Med, Anyang, South Korea.	evan007@naver.com		Park, Ji Young/0000-0002-6533-4656				Al-Rifai RH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246903; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], CBC NEW; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Centre for Immunization and Respiratory Infectious Diseases Public Health Agency of Canada, RESP VIR DET CAN; Chan CP, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa087; Fisman D, 2012, CLIN MICROBIOL INFEC, V18, P946, DOI 10.1111/j.1469-0691.2012.03968.x; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Government of Canada, COR DIS COVID 19 OUT; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Hale T, OXFORD COVID 19 GOVT; Harris K., 2020, CBC NEWS; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lee H, 2021, CLIN INFECT DIS, V73, pE132, DOI 10.1093/cid/ciaa672; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Moriyama M, 2020, ANNU REV VIROL, V7, P83, DOI 10.1146/annurev-virology-012420-022445; Nickbakhsh S, 2019, P NATL ACAD SCI USA, V116, P27142, DOI 10.1073/pnas.1911083116; Public Health Agency of Canada, INFL SURV RES 2021; Public Health Ontario, ONT RESP PATH B 2021; Satia I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228544; Scally G, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1932; Song SK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e269; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Stafford N, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1395; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; World Health Organization, COR DIS COVID 2019 S; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4	28	17	17	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253451	10.1371/journal.pone.0253451	http://dx.doi.org/10.1371/journal.pone.0253451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143839	gold, Green Published			2022-12-26	WOS:000671690700046
J	van der Bolt, B; van Nes, EH				van der Bolt, Bregje; van Nes, Egbert H.			Understanding the critical rate of environmental change for ecosystems, cyanobacteria as an example	PLOS ONE			English	Article							SAFE OPERATING SPACE; EVOLUTIONARY RESCUE; CLIMATE-CHANGE; ADAPTATION; PHOTOINHIBITION; BIFURCATION; EXTINCTION; SYSTEMS; LIGHT	Recently it has been show that in some ecosystems fast rates of change of environmental drivers may trigger a critical transition, whereas change of the same magnitude but at slower rates would not. So far, few studies describe this phenomenon of rate-induced tipping, while it is important to understand this phenomenon in the light of the ongoing rapid environmental change. Here, we demonstrate rate-induced tipping in a simple model of cyanobacteria with realistic parameter settings. We explain graphically that there is a range of initial conditions at which a gradual increase in environmental conditions can cause a collapse of the population, but only if the change is fast enough. In addition, we show that a pulse in the environmental conditions can cause a temporary collapse, but that is dependent on both the rate and the duration of the pulse. Furthermore, we study whether the autocorrelation of stochastic environmental conditions can influence the probability of inducing rate-tipping. As both the rate of environmental change, and autocorrelation of the environmental variability are increasing in parts of the climate, the probability for rate-induced tipping to occur is likely to increase. Our results imply that, even though the identification of rate sensitive ecosystems in the real world will be challenging, we should incorporate critical rates of change in our ecosystem assessments and management.	[van der Bolt, Bregje; van Nes, Egbert H.] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands	Wageningen University & Research	van der Bolt, B (corresponding author), Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands.	bregje.vanderbolt@wur.nl		van der Bolt, Bregje/0000-0002-5601-8475	Ministry of Education, Culture and Science (OCW); European Union's Horizon 2020 research and innovation Programme under the Marie Sklodowska-Curie grant	Ministry of Education, Culture and Science (OCW)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Union's Horizon 2020 research and innovation Programme under the Marie Sklodowska-Curie grant	BvdB and EvN carried out this work under the programme of the Netherlands Earth System Science Centre (NESSC), financially supported by the Ministry of Education, Culture and Science (OCW). In addition, EvB received funding from the European Union's Horizon 2020 research and innovation Programme under the Marie Sklodowska-Curie grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwin P, 2017, NONLINEARITY, V30, DOI 10.1088/1361-6544/aa675b; Ashwin P, 2012, PHILOS T R SOC A, V370, P1166, DOI 10.1098/rsta.2011.0306; Bathiany S, 2016, CRYOSPHERE, V10, P1631, DOI 10.5194/tc-10-1631-2016; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Bestelmeyer BT, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00216.1; Boulton CA, 2015, P NATL ACAD SCI USA, V112, P11496, DOI 10.1073/pnas.1501781112; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Collins S, 2009, EVOLUTION, V63, P2952, DOI 10.1111/j.1558-5646.2009.00770.x; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dakos V, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0263; Dhooge A, 2003, ACM T MATH SOFTWARE, V29, P141, DOI 10.1145/779359.779362; Faassen EJ., 2015, OIKOS; Gerla DJ, 2011, OIKOS, V120, P359, DOI 10.1111/j.1600-0706.2010.18573.x; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; HOLT RD, 1990, TRENDS ECOL EVOL, V5, P311, DOI 10.1016/0169-5347(90)90088-U; Huisman J, 2018, NAT REV MICROBIOL, V16, P471, DOI 10.1038/s41579-018-0040-1; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Liautaud K, 2019, ECOL LETT, V22, P1243, DOI 10.1111/ele.13289; Lindsey HA, 2013, NATURE, V494, P463, DOI 10.1038/nature11879; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Luke CM, 2011, EUR J SOIL SCI, V62, P5, DOI 10.1111/j.1365-2389.2010.01312.x; MEGARD RO, 1980, LIMNOL OCEANOGR, V25, P373, DOI 10.4319/lo.1980.25.2.0373; O'Keeffe PE, 2019, ARXIV190201796 ARXIV190201796; PEETERS J C H, 1978, Hydrobiological Bulletin, V12, P134, DOI 10.1007/BF02260714; Perron GG, 2008, J EVOLUTION BIOL, V21, P1724, DOI 10.1111/j.1420-9101.2008.01596.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Siteur K, 2016, OIKOS, V125, P1689, DOI 10.1111/oik.03112; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; van der Bolt B, 2018, NAT CLIM CHANGE, V8, P478, DOI 10.1038/s41558-018-0160-7; van Nes EH, 2016, TRENDS ECOL EVOL, V31, P902, DOI 10.1016/j.tree.2016.09.011; Vanselow A, 2019, J THEOR BIOL, V479, P64, DOI 10.1016/j.jtbi.2019.07.008; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Wagner TJW, 2015, GEOPHYS RES LETT, V42, P10333, DOI 10.1002/2015GL066297; Wieczorek S, 2011, P ROY SOC A-MATH PHY, V467, P1243, DOI 10.1098/rspa.2010.0485	39	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253003	10.1371/journal.pone.0253003	http://dx.doi.org/10.1371/journal.pone.0253003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143824	Green Published, gold			2022-12-26	WOS:000671690700077
J	Ding, XF; Qu, Q; Wang, XY				Ding, Xianfeng; Qu, Quan; Wang, Xinyi			A modified filter nonmonotone adaptive retrospective trust region method	PLOS ONE			English	Article							LINE SEARCH TECHNIQUE; CONVERGENCE	In this paper, aiming at the unconstrained optimization problem, a new nonmonotone adaptive retrospective trust region line search method is presented, which takes advantages of multidimensional filter technique to increase the acceptance probability of the trial step. The new nonmonotone trust region ratio is presented, which based on the convex combination of nonmonotone trust region ratio and retrospective ratio. The global convergence and the superlinear convergence of the algorithm are shown in the right circumstances. Comparative numerical experiments show the better effective and robustness.	[Ding, Xianfeng; Qu, Quan; Wang, Xinyi] Southwest Petr Univ, Sch Sci, Chengdu, Peoples R China; [Ding, Xianfeng] Southwest Petr Univ, Sch Artificial Intelligence, Chengdu, Peoples R China	Southwest Petroleum University; Southwest Petroleum University	Qu, Q (corresponding author), Southwest Petr Univ, Sch Sci, Chengdu, Peoples R China.	545434091@qq.com			International Cooperation Program of Chengdu City [2020-GH02-00023HZ]	International Cooperation Program of Chengdu City	International Cooperation Program of Chengdu City, Project number: 2020-GH02-00023HZ.	Ahookhosh M, 2012, APPL MATH MODEL, V36, P478, DOI 10.1016/j.apm.2011.07.021; Amini K, 2016, 4OR-Q J OPER RES, V14, P133, DOI 10.1007/s10288-016-0305-3; Andrei N., 2008, ADV MODEL OPTIM, V10, P147; CHAMBERLAIN RM, 1982, MATH PROGRAM STUD, V16, P1; Conn A. R., 2000, MPS SIAM SERIES OPTI; Cui ZC, 2012, COMPUT OPTIM APPL, V53, P795, DOI 10.1007/s10589-012-9460-4; DENG NY, 1993, J OPTIMIZ THEORY APP, V76, P259, DOI 10.1007/BF00939608; Dolan ED, 2002, MATH PROGRAM, V91, P201, DOI 10.1007/s101070100263; Fletcher R, 2002, MATH PROGRAM, V91, P239, DOI 10.1007/s101070100244; Gould NIM, 2005, SIAM J OPTIMIZ, V16, P341, DOI 10.1137/040603851; GRIPPO L, 1986, SIAM J NUMER ANAL, V23, P707, DOI 10.1137/0723046; Gu NZ, 2008, COMPUT MATH APPL, V55, P2158, DOI 10.1016/j.camwa.2007.08.038; Kimiaei M, 2017, CALCOLO, V54, P769, DOI 10.1007/s10092-016-0208-x; Li DH, 2001, J COMPUT APPL MATH, V129, P15, DOI 10.1016/S0377-0427(00)00540-9; Nocedal J., 1998, ADV NONLINEAR PROGRA, P153, DOI [10.1007/978-1-4613-3335-7_7, DOI 10.1007/978-1-4613-3335-7]; Qu Q, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12040656; Sheng Z, 2018, ACTA MATH SCI, V38, P479, DOI 10.1016/S0252-9602(18)30762-8; Wachter A, 2005, SIAM J OPTIMIZ, V16, P1, DOI 10.1137/S1052623403426556; Wei ZX, 2006, APPL MATH COMPUT, V175, P1156, DOI 10.1016/j.amc.2005.08.027; Yuan GL, 2010, COMPUT OPTIM APPL, V47, P237, DOI 10.1007/s10589-008-9219-0; Zhang HC, 2004, SIAM J OPTIMIZ, V14, P1043, DOI 10.1137/S1052623403428208; Zhang JL, 2003, MATH METHOD OPER RES, V58, P283, DOI 10.1007/s001860300302; Zhang XS, 2002, SCI CHINA SER A, V45, P620	23	1	1	8	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253016	10.1371/journal.pone.0253016	http://dx.doi.org/10.1371/journal.pone.0253016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138939	Green Published, gold			2022-12-26	WOS:000671690200102
J	Ferreira, CD; Dufloth, R; de Carvalho, AC; Reis, RM; Santana, I; Carvalho, RS; Gama, RR				Ferreira, Chrystiano de C.; Dufloth, Rozany; de Carvalho, Ana C.; Reis, Rui M.; Santana, Iara; Carvalho, Raiany S.; Gama, Ricardo R.			Correlation of p16 immunohistochemistry with clinical and epidemiological features in oropharyngeal squamous-cell carcinoma	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; NECK-CANCER; RISK-FACTORS; ORAL-CAVITY; HPV STATUS; HEAD; PREVALENCE; SMOKING; VALIDATION; REGION	Background Oropharyngeal cancer is an important public health problem. The aim of our study was to correlatep16 immunohistochemistry in oropharynx squamous cell carcinomas(OPSCC) with clinical and epidemiological features. Material and methods We conducted across-sectional study on patients with OPSCC treated at a single institution from 2014 to 2019. Epidemiological and clinical-pathological data were collected from medical records and a questionnaire was applied to determine alcohol consumption, smoking, and sexual behavior. The HPV status was determined by p16 immunohistochemistry. Results A total of 252 patients participated in the study, of these 221 (87.7%) were male. There were 81 (32.14%) p16 positive cases and 171 (67.85%) p16 negative cases. The p16positive group was significantly associated with younger patients (50-59 years), higher education level, lower clinical stage and patients who never drank or smoked. Through univariate logistic regression, we observed that female sex (OR, 3.47; 95% CI, 1.60-7.51) and higher education level (OR, 9.39; 95% CI, 2, 81-31,38) were significantly more likely to be p16 positive. Early clinical stage (AJCC8ed) was more associated with p16 positivity both in univariate (OR, 0.14; 95% CI, 0.07-0.26, p<0.001) and multivariate analysis (OR, 0.18; 95% CI, 0.06-0.49, p = 0.001). Conclusion This study showed that drinkers and current smokers were less likely to be p16+. Female sex, higher education level and younger age at diagnosis were associated with a higher probability of being p16+. Additionally, there was a higher proportion of patients with early clinical stage (I or II) in the p16 positive group when compared to the p16 negative group.	[Ferreira, Chrystiano de C.; Carvalho, Raiany S.; Gama, Ricardo R.] Barretos Canc Hosp, Dept Head & Neck Surg, Barretos, SP, Brazil; [Ferreira, Chrystiano de C.] Fed Univ Rondonia, Dept Med, Rondonia, Brazil; [Dufloth, Rozany] Rede DOr Sao Luiz Hosp Network, Inst Anat Pathol, Sao Paulo, Brazil; [Dufloth, Rozany] Ctr Univ Sao Camilo, Dept Med, Sao Paulo, Brazil; [de Carvalho, Ana C.; Reis, Rui M.] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, SP, Brazil; [Reis, Rui M.] Univ Minho, Med Sch, Life & Hlth Sci Res Inst, Braga, Portugal; [Santana, Iara] Barretos Canc Hosp, Dept Pathol, Barretos, Brazil	Hospital de Cancer de Barretos; Universidade Federal de Rondonia; Centro Universitario Sao Camilo; Hospital de Cancer de Barretos; Universidade do Minho; Hospital de Cancer de Barretos	Ferreira, CD (corresponding author), Barretos Canc Hosp, Dept Head & Neck Surg, Barretos, SP, Brazil.; Ferreira, CD (corresponding author), Fed Univ Rondonia, Dept Med, Rondonia, Brazil.	chrystiano_campos@yahoo.com.br	Gama, Ricardo/AGJ-7649-2022; Reis, Rui Manuel/B-1744-2018; Reis, Rui Manuel/AAD-6470-2020; de Carvalho, Ana Carolina/Q-4055-2019	Gama, Ricardo/0000-0003-4406-8958; Reis, Rui Manuel/0000-0002-9639-7940; Reis, Rui Manuel/0000-0002-9639-7940; de Carvalho, Ana Carolina/0000-0002-0114-7659				Anantharaman D, 2017, INT J CANCER, V140, P1968, DOI 10.1002/ijc.30608; Bahl A, 2014, HEAD NECK-J SCI SPEC, V36, P505, DOI 10.1002/hed.23317; Baumeister P, 2014, J CANCER RES CLIN, V140, P1011, DOI 10.1007/s00432-014-1631-5; Betiol JC, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0067-8; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caley A, 2015, HEAD NECK-J SCI SPEC, V37, P202, DOI 10.1002/hed.23584; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; D'Souza G, 2009, J INFECT DIS, V199, P1263, DOI 10.1086/597755; Dahlstrom KR, 2015, ORAL ONCOL, V51, P832, DOI 10.1016/j.oraloncology.2015.06.005; Dahlstrom KR, 2011, HEAD NECK-J SCI SPEC, V33, P847, DOI 10.1002/hed.21550; De Cicco R, 2020, HEAD NECK-J SCI SPEC, V42, P93, DOI 10.1002/hed.25985; Du E, 2019, LARYNGOSCOPE, V129, P2506, DOI 10.1002/lary.27807; Edge SB., 2017, AJCC CANC STAGING MA, P113; Fakhry C, 2018, J CLIN ONCOL, V36, P3152, DOI 10.1200/JCO.18.00684; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Gorphe P, 2019, HEAD NECK-J SCI SPEC, V41, P1039, DOI 10.1002/hed.25523; Instituto Nacional de Cancer Jose Alencar Gomes da Silva (BR), 2019, EST 2020 INC CANC BR; Jordan RC, 2012, AM J SURG PATHOL, V36, P945, DOI 10.1097/PAS.0b013e318253a2d1; Larsen CG, 2014, BRIT J CANCER, V110, P1587, DOI 10.1038/bjc.2014.42; Lewis JS, 2018, ARCH PATHOL LAB MED, V142, P559, DOI 10.5858/arpa.2017-0286-CP; Lydiatt W., 2017, OROPHARYNX P16 HYPOP, P123; Mehanna H, 2016, HEAD NECK-J SCI SPEC, V38, pE1863, DOI 10.1002/hed.24336; Mehanna H, 2013, HEAD NECK-J SCI SPEC, V35, P747, DOI 10.1002/hed.22015; Lopez RVM, 2014, CANCER CAUSE CONTROL, V25, P461, DOI 10.1007/s10552-014-0348-8; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; National Comprehensive Cancer Network, 2020, HEAD NECK CANC VERSI; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Petito G, 2017, BRAZ J OTORHINOLAR, V83, P38, DOI 10.1016/j.bjorl.2016.01.004; Posner MR, 2011, ANN ONCOL, V22, P1071, DOI 10.1093/annonc/mdr006; Possati-Resende JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134445; Read TRH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049324; Ribeiro KB, 2011, INT J EPIDEMIOL, V40, P489, DOI 10.1093/ije/dyq249; Robinson M, 2012, HEAD NECK PATHOL, V6, pS83, DOI 10.1007/s12105-012-0370-7; Smith EM, 1998, LARYNGOSCOPE, V108, P1098, DOI 10.1097/00005537-199807000-00027; Talamini R, 2000, BRIT J CANCER, V83, P1238, DOI 10.1054/bjoc.2000.1398; Vokes EE, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv344; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253418	10.1371/journal.pone.0253418	http://dx.doi.org/10.1371/journal.pone.0253418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138935	gold, Green Published			2022-12-26	WOS:000671690200078
J	Pro, G; Gilbert, PA; Baldwin, JA; Brown, CC; Young, S; Zaller, N				Pro, George; Gilbert, Paul A.; Baldwin, Julie A.; Brown, Clare C.; Young, Sean; Zaller, Nickolas			Multilevel modeling of county-level excessive alcohol use, rurality, and COVID-19 case fatality rates in the US	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; URBAN DISPARITIES; CONSUMPTION	Objective Reports of disparities in COVID-19 mortality rates are emerging in the public health literature as the pandemic continues to unfold. Alcohol misuse varies across the US and is related to poorer health and comorbidities that likely affect the severity of COVID-19 infection. High levels of pre-pandemic alcohol misuse in some counties may have set the stage for worse COVID-19 outcomes. Furthermore, this relationship may depend on how rural a county is, as access to healthcare in rural communities has lagged behind more urban areas. The objective of this study was to test for associations between county-level COVID-19 mortality, pre-pandemic county-level excessive drinking, and county rurality. Method We used national COVID-19 data from the New York Times to calculate county-level case fatality rates (n = 3,039 counties and county equivalents; October 1 -December 31, 2020) and other external county-level data sources for indicators of rurality and health. We used beta regression to model case fatality rates, adjusted for several county-level population characteristics. We included a multilevel component to our model and defined state as a random intercept. Our focal predictor was a single variable representing nine possible combinations of low/mid/high alcohol misuse and low/mid/high rurality. Results The median county-level COVID-19 case fatality rate was 1.57%. Compared to counties with low alcohol misuse and low rurality (referent), counties with high levels of alcohol and mid (beta = -0.17, p = 0.008) or high levels of rurality (beta = -0.24, p<0.001) demonstrated significantly lower case fatality rates. Conclusions Our findings highlight the intersecting roles of county-level alcohol consumption, rurality, and COVID-19 mortality.	[Pro, George; Zaller, Nickolas] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA; [Gilbert, Paul A.] Univ Iowa, Dept Community & Behav Hlth, Coll Publ Hlth, Iowa City, IA USA; [Baldwin, Julie A.] No Arizona Univ, Ctr Hlth Equ Res, Flagstaff, AZ 86011 USA; [Brown, Clare C.] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Policy & Management, Little Rock, AR 72205 USA; [Young, Sean] Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Environm & Occupat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Iowa; Northern Arizona University; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Pro, G (corresponding author), Univ Arkansas Med Sci, Fay W Boozman Coll Publ Hlth, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA.	gcpro@uams.edu	Young, Sean G/H-6469-2014	Young, Sean G/0000-0002-0054-0627				Ahmed R, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030330; [Anonymous], 2020, MMWR Morb Mortal Wkly Rep, V69, P1753, DOI 10.15585/mmwr.mm6946a6; Borders TF, 2007, J RURAL HEALTH, V23, P314, DOI 10.1111/j.1748-0361.2007.00109.x; Census Bureau U.S, 2020, RUR AM US CENS BUR H; Centers for Disease Control and Prevention, 2021, MORT US 2019, DOI [10.1002/art.41632, DOI 10.1002/ART.41632]; Centers for Disease Control and Prevention, 2020, PREV DAT ANAL TOOLS; Cheng KJG, 2020, J RURAL HEALTH, V36, P602, DOI 10.1111/jrh.12511; Cressie N, 1991, STAT SPATIAL DATA; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; Douthit N, 2015, PUBLIC HEALTH, V129, P611, DOI 10.1016/j.puhe.2015.04.001; Ene M., 2015, P GLIMMIX; Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Henning-Smith C, 2020, J AGING SOC POLICY, V32, P396, DOI 10.1080/08959420.2020.1770036; Kerr WC, 2010, INT J ENV RES PUB HE, V7, P269, DOI 10.3390/ijerph7010269; Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0; Melvin SC, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200256; Pasala S, 2015, ALCOHOL RES-CURR REV, V37, P185; Pro G, 2020, RURAL REMOTE HEALTH, V20, DOI 10.22605/RRH6074; Rehm J, 2011, ALCOHOL RES HEALTH, V34, P135; Robert Wood Johnson Foundation, 2020, COU HLTH RANK ROADM; Sarkar D, 2015, ALCOHOL RES-CURR REV, V37, P153; Shah P, 2020, ANN MED, V52, P354, DOI 10.1080/07853890.2020.1791356; Singh GK, 2014, J URBAN HEALTH, V91, P272, DOI 10.1007/s11524-013-9847-2; Singh GK, 2014, AM J PREV MED, V46, pE19, DOI 10.1016/j.amepre.2013.10.017; Waldorf BS, 2015, WORKSH RAT RUR AR CL; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Yang JC, 2021, IEEE T INTELL TRANSP, V22, P3742, DOI 10.1109/TITS.2020.3023788	28	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253466	10.1371/journal.pone.0253466	http://dx.doi.org/10.1371/journal.pone.0253466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138950	gold, Green Published			2022-12-26	WOS:000671690200016
J	McGlashan, EM; Poudel, GR; Jamadar, SD; Phillips, AJK; Cain, SW				McGlashan, Elise M.; Poudel, Govinda R.; Jamadar, Sharna D.; Phillips, Andrew J. K.; Cain, Sean W.			Afraid of the dark: Light acutely suppresses activity in the human amygdala	PLOS ONE			English	Article							PREFRONTAL CORTEX; LATERAL HABENULA; EMOTIONAL BRAIN; GANGLION-CELLS; MELANOPSIN; ORGANIZATION; THERAPY; FEAR; SENSITIVITY; PROJECTIONS	Light improves mood. The amygdala plays a critical role in regulating emotion, including fear-related responses. In rodents the amygdala receives direct light input from the retina, and light may play a role in fear-related learning. A direct effect of light on the amygdala represents a plausible mechanism of action for light's mood-elevating effects in humans. However, the effect of light on activity in the amygdala in humans is not well understood. We examined the effect of passive dim-to-moderate white light exposure on activation of the amygdala in healthy young adults using the BOLD fMRI response (3T Siemens scanner; n = 23). Participants were exposed to alternating 30s blocks of light (10 lux or 100 lux) and dark (<1 lux), with each light intensity being presented separately. Light, compared with dark, suppressed activity in the amygdala. Moderate light exposure resulted in greater suppression of amygdala activity than dim light. Furthermore, functional connectivity between the amygdala and ventro-medial prefrontal cortex was enhanced during light relative to dark. These effects may contribute to light's mood-elevating effects, via a reduction in negative, fear-related affect and enhanced processing of negative emotion.	[McGlashan, Elise M.; Jamadar, Sharna D.; Phillips, Andrew J. K.; Cain, Sean W.] Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia; [McGlashan, Elise M.; Jamadar, Sharna D.; Phillips, Andrew J. K.; Cain, Sean W.] Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia; [Poudel, Govinda R.] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia	Monash University; Monash University; Australian Catholic University	Cain, SW (corresponding author), Monash Univ, Sch Psychol Sci, Melbourne, Vic, Australia.; Cain, SW (corresponding author), Monash Univ, Turner Inst Brain & Mental Hlth, Melbourne, Vic, Australia.	Sean.Cain@monash.edu		Phillips, Andrew/0000-0003-1156-7056; McGlashan, Elise/0000-0002-3864-7198	Turner Institute Strategic Project Grant; Medicine Nursing and Health Sciences Platform Access Grant; ACURF Program Grant; Australian National Health and Medical Research Council Fellowship [APP1174164]	Turner Institute Strategic Project Grant; Medicine Nursing and Health Sciences Platform Access Grant; ACURF Program Grant; Australian National Health and Medical Research Council Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by a Turner Institute Strategic Project Grant awarded to SWC, SDJ, EMM and AJKP and a Medicine Nursing and Health Sciences Platform Access Grant awarded to SWC and GRP. GRP is supported by an ACURF Program Grant. SDJ is supported by an Australian National Health and Medical Research Council Fellowship (APP1174164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; Commission Internationale de l'Eclairage [CIE], 2018, 026E2018 CIE; Fernandez DC, 2018, CELL, V175, P71, DOI 10.1016/j.cell.2018.08.004; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Gooley JJ, 2012, J NEUROSCI, V32, P14242, DOI 10.1523/JNEUROSCI.1321-12.2012; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kaiser C, 2019, NEUROIMAGE, V189, P581, DOI 10.1016/j.neuroimage.2019.01.064; Kim MJ, 2011, CEREB CORTEX, V21, P1667, DOI 10.1093/cercor/bhq237; Lam RW, 2016, JAMA PSYCHIAT, V73, P56, DOI 10.1001/jamapsychiatry.2015.2235; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; LeGates TA, 2012, NATURE, V491, P594, DOI 10.1038/nature11673; LEWY AJ, 1985, AM J PSYCHIAT, V142, P725; Marek R, 2013, J PHYSIOL-LONDON, V591, P2381, DOI 10.1113/jphysiol.2012.248575; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; McGlashan EM, 2019, J AFFECT DISORDERS, V256, P386, DOI 10.1016/j.jad.2019.05.076; McGlashan EM, 2018, PSYCHOPHARMACOLOGY, V235, P3201, DOI 10.1007/s00213-018-5019-0; McGlashan EM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01022; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Motzkin JC, 2015, BIOL PSYCHIAT, V77, P276, DOI 10.1016/j.biopsych.2014.02.014; Mure LS, 2019, SCIENCE, V366, P1251, DOI 10.1126/science.aaz0898; Pail G, 2011, NEUROPSYCHOBIOLOGY, V64, P152, DOI 10.1159/000328950; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Phillips AJK, 2019, P NATL ACAD SCI USA, V116, P12019, DOI 10.1073/pnas.1901824116; PITTENDRIGH CS, 1964, AM NAT, V98, P261, DOI 10.1086/282327; Prayag AS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00126; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Roecklein K, 2013, PSYCHIAT RES, V210, P150, DOI 10.1016/j.psychres.2013.05.023; Sonoda T, 2020, SCIENCE, V368, P527, DOI 10.1126/science.aay3152; Terman M, 2005, CNS SPECTRUMS, V10, P647, DOI 10.1017/S1092852900019611; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Vandewalle G, 2011, BIOL PSYCHIAT, V70, P954, DOI 10.1016/j.biopsych.2011.06.022; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108; Watson LA, 2018, J PHYSIOL-LONDON, V596, P6249, DOI 10.1113/JP275917; Wirz-Justice A, 2005, PSYCHOL MED, V35, P939, DOI 10.1017/S003329170500437X; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	47	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252350	10.1371/journal.pone.0252350	http://dx.doi.org/10.1371/journal.pone.0252350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133439	Green Published, gold			2022-12-26	WOS:000671682700040
J	Pallone, LV; Navarra, LC; Goncalves, GA; de Jesus, FA; Melo, DG; Ferreira, RA; Germano, CMR				Pallone, Leticia Valerio; Navarra, Laura Carvalho; Goncalves, Gleice Aline; de Jesus, Felipe Alves; Melo, Debora Gusmao; Ferreira, Rodrigo Alves; Ramos Germano, Carla Maria			Neonatal thyrotropin levels and auditory neural maturation in full-term newborns	PLOS ONE			English	Article							CONGENITAL HYPOTHYROIDISM; CHILDREN; MILD; T-3	Objective This study aimed to look for a possible relationship between thyrotropin (TSH) values from neonatal bloodspot screening testing and newborn lower auditory pathway myelinization evaluated using the brainstem evoked response audiometry (ABR) test. Methods Sixty-two healthy full-term newborns without perinatal problems were enrolled in the study. TSH results were collected from neonatal bloodspot screening data and were below the test cut-off level (15 mu UI/mL). The TSH test was performed between three and seven days, and the ABR test was performed in the first 28 days of life. The newborns were divided into two groups: Group 1 (n = 35), TSH between 0 and 5 mu UI/mL, and group 2 (n = 27), TSH between 5 and 15 mu UI/mL. Data are presented as mean +/- SD, median, or percentage, depending on the variable. Results Wave latency and interpeak interval values for Groups 1 and 2 were as follows: Wave I: 1.8 +/- 0.1 and 1.7 +/- 0.1; Wave III: 4.4 +/- 0.1 and 4.4 +/- 0.1; Wave V: 6.9 +/- 0.1 and 6.9 +/- 0.1; interval I-III: 2.6 +/- 0.1 and 2.6 +/- 0.1; interval I-V: 5.1 +/- 0.1 and 5.1 +/- 0.1; interval III-V: 2.4 +/- 0.1 and 2.4 +/- 0.1. There were no significant differences in ABR parameters between groups 1 and 2 (p > 0.05). Multiple regression analysis showed a slight significant negative correlation between TSH and wave I values (standardized beta = -0.267; p = 0.036), without observing any relationship with the other ABR waves recorded. Conclusions This study investigated the relationship of TSH and auditory myelinization evaluated by ABR. It did not show a significant change in lower auditory pathway myelinization according to TSH levels in newborns with TSH screening levels lower than 15 mu UI/mL.	[Pallone, Leticia Valerio; Navarra, Laura Carvalho; Goncalves, Gleice Aline; de Jesus, Felipe Alves; Melo, Debora Gusmao; Ferreira, Rodrigo Alves; Ramos Germano, Carla Maria] Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil	Universidade Federal de Sao Carlos	Germano, CMR (corresponding author), Univ Fed Sao Carlos, Dept Med, Sao Paulo, Brazil.	cgermano@ufscar.br	GERMANO, CARLA MARIA RAMOS/S-5312-2019; Melo, Débora Gusmão/E-3677-2012	GERMANO, CARLA MARIA RAMOS/0000-0001-5030-7164; Melo, Débora Gusmão/0000-0001-7005-3544	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP) [2015/15471-4]	Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	CMRG received a grant [grant number 2015/15471-4] from Sao Paulo Research Foundation (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, FAPESP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi S, 2016, IRAN J MED SCI, V41, P415; Altincik A, 2015, J CLIN RES PEDIATR E, V7, P211, DOI 10.4274/jcrpe.1985; Atli SK, 2019, J PEDIATR ENDOCR MET, V32, P689, DOI 10.1515/jpem-2018-0463; Bakhos D, 2017, EUR ANN OTORHINOLARY, V134, P325, DOI 10.1016/j.anorl.2017.02.011; Bruno R, 2015, HEARING RES, V327, P43, DOI 10.1016/j.heares.2015.04.018; Casali RL, 2010, BRAZ J OTORHINOLAR, V76, P729, DOI 10.1590/S1808-86942010000600011; Christensen-Adad FC, 2017, J PEDIAT-BRAZIL, V93, P649, DOI 10.1016/j.jped.2017.05.003; Rosa LAC, 2014, CODAS, V26, P117, DOI 10.1590/2317-1782/2014469IN; El-Hattab AW, 2018, PEDIATR CLIN N AM, V65, P389, DOI 10.1016/j.pcl.2017.11.013; Ferreira Ligia Oliva, 2011, Rev. soc. bras. fonoaudiol., V16, P317, DOI 10.1590/S1516-80342011000300013; Frezzato RC, 2017, CODAS, V29, DOI 10.1590/2317-1782/20172016064; Gupta S, 2017, J CLIN DIAGN RES, V11, pCC13, DOI 10.7860/JCDR/2017/25604.9989; Kilberg MJ, 2018, J PEDIATR-US, V192, P204, DOI 10.1016/j.jpeds.2017.09.003; Lain S, 2017, EUR J ENDOCRINOL, V177, pD1, DOI 10.1530/EJE-17-0107; Mendoza A, 2017, PHARMACOL THERAPEUT, V173, P135, DOI 10.1016/j.pharmthera.2017.02.012; Ministry of Health, 2015, 1161 SASMS MIN HLTH; Ng L, 2013, NAT REV ENDOCRINOL, V9, P296, DOI 10.1038/nrendo.2013.58; Nunez A, 2017, REV MED CHILE, V145, P1579, DOI 10.4067/s0034-98872017001201579; de Andrade CLO, 2019, REV PAUL PEDIATR, V37, P82, DOI [10.1590/1984-0462/;2019;37;1;00014, 10.1590/1984-0462/2019;37;1;00014]; Oliveira HB., 2013, J MED BIOL SCI, V12, P486, DOI [10.9771/cmbio.v12i4.9198, DOI 10.9771/CMBIO.V12I4.9198]; Paladugu Sridevi, 2015, Indian J Endocrinol Metab, V19, P829, DOI 10.4103/2230-8210.167547; Pallone LV, 2020, J PEDIAT-BRAZIL, V96, P202, DOI 10.1016/j.jped.2018.08.007; Campos MLP, 2017, ARCH ARGENT PEDIATR, V115, P12, DOI [10.5546/aap.2017.12, 10.5546/aap.2017.eng.12]; Pollitt RJ, 2016, ARCH DIS CHILD, V101, P120, DOI 10.1136/archdischild-2015-309546; Prezioso G, 2018, HORM RES PAEDIAT, V90, P73, DOI 10.1159/000492129; Richter CP, 2011, CELL PHYSIOL BIOCHEM, V28, P997, DOI 10.1159/000335812; Salazar P, 2019, MOL NEUROBIOL, V56, P2952, DOI 10.1007/s12035-018-1270-y; Sharlin DS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22553-w; Silvestrin SM, 2017, J PEDIAT-BRAZIL, V93, P274, DOI 10.1016/j.jped.2016.07.006; Thornton ARD, 2008, CLIN NEUROPHYSIOL, V119, P786, DOI 10.1016/j.clinph.2007.12.008; van Trotsenburg P, 2021, THYROID, V31, P387, DOI 10.1089/thy.2020.0333	31	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253229	10.1371/journal.pone.0253229	http://dx.doi.org/10.1371/journal.pone.0253229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133461	Green Published, gold			2022-12-26	WOS:000671682700019
J	Tibbe, D; Pan, YE; Reissner, C; Harms, FL; Kreienkamp, HJ				Tibbe, Debora; Pan, Yingzhou Edward; Reissner, Carsten; Harms, Frederike L.; Kreienkamp, Hans-Juergen			Functional analysis of CASK transcript variants expressed in human brain	PLOS ONE			English	Article							SYNAPTIC DEVELOPMENT; LIPRIN-ALPHA; PROTEIN; COMPLEX; SAP97; MUTATIONS; ORGANIZATION; MECHANISMS; NEUREXINS; DELETION	The calcium-/calmodulin dependent serine protein kinase (CASK) belongs to the membrane-associated guanylate kinases (MAGUK) family of proteins. It fulfils several different cellular functions, ranging from acting as a scaffold protein to transcription control, as well as regulation of receptor sorting. CASK functions depend on the interaction with a variety of partners, for example neurexin, liprin-alpha, Tbr1 and SAP97. So far, it is uncertain how these seemingly unrelated interactions and resulting functions of CASK are regulated. Here, we show that alternative splicing of CASK can guide the binding affinity of CASK isoforms to distinct interaction partners. We report seven different variants of CASK expressed in the fetal human brain. Four out of these variants are not present in the NCBI GenBank database as known human variants. Functional analyses showed that alternative splicing affected the affinities of CASK variants for several of the tested interaction partners. Thus, we observed a clear correlation of the presence of one splice insert with poor binding of CASK to SAP97, supported by molecular modelling. The alternative splicing and distinct properties of CASK variants in terms of protein-protein interaction should be taken into consideration for future studies.	[Tibbe, Debora; Pan, Yingzhou Edward; Harms, Frederike L.; Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Reissner, Carsten] Westfalische Wilhelms Univ Munster, Inst Anat & Mol Neurobiol, Munster, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Kreienkamp, HJ (corresponding author), Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany.	kreienkamp@uke.de		Harms, Frederike Leonie/0000-0003-2610-0600; Kreienkamp, Hans-Jurgen/0000-0002-8871-9970	Deutsche Forschungsgemeinschaft [KU 1240/101]; Research Promotion Fund of the Faculty of Medicine (FFM) of the University Medical Center Hamburg-Eppendorf	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Promotion Fund of the Faculty of Medicine (FFM) of the University Medical Center Hamburg-Eppendorf	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (Kr 1321/7-1, to H.-J.K.). F.L.H. was supported by the Research Promotion Fund of the Faculty of Medicine (FFM) of the University Medical Center Hamburg-Eppendorf and by a grant from the Deutsche Forschungsgemeinschaft (KU 1240/101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Borg JP, 1999, J NEUROSCI, V19, P1307; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Dembowski JA, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/816237; Dillman AA, 2013, NAT NEUROSCI, V16, P499, DOI 10.1038/nn.3332; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Furlanis E, 2018, ANNU REV CELL DEV BI, V34, P451, DOI 10.1146/annurev-cellbio-100617-062826; Hackett A, 2010, EUR J HUM GENET, V18, P544, DOI 10.1038/ejhg.2009.220; Hata Y, 1996, J NEUROSCI, V16, P2488; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; LaConte LEW, 2016, CELL MOL LIFE SCI, V73, P3599, DOI 10.1007/s00018-016-2183-4; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Li YJ, 2014, P NATL ACAD SCI USA, V111, P17444, DOI 10.1073/pnas.1416515111; Lin CW, 2006, J COMP NEUROL, V494, P606, DOI 10.1002/cne.20825; Lin EI, 2013, J NEUROSCI, V33, P12067, DOI 10.1523/JNEUROSCI.0816-13.2013; Marcheva B, 2020, GENE DEV, V34, P1089, DOI 10.1101/gad.338178.120; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017; Pan LF, 2011, J BIOL CHEM, V286, P40069, DOI 10.1074/jbc.C111.293084; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pan YZE, 2021, J NEUROCHEM, V157, P1331, DOI 10.1111/jnc.15215; Porter AP, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230086; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; Reissner C, 2014, P NATL ACAD SCI USA, V111, P17350, DOI 10.1073/pnas.1420387111; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schreiner D, 2014, NEURON, V84, P386, DOI 10.1016/j.neuron.2014.09.011; Shin H, 2003, J BIOL CHEM, V278, P11393, DOI 10.1074/jbc.M211874200; Spangler SA, 2013, J CELL BIOL, V201, P915, DOI 10.1083/jcb.201301011; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Tabuchi K, 2002, J NEUROSCI, V22, P4264, DOI 10.1523/JNEUROSCI.22-11-04264.2002; Tully MD, 2012, BIOCHEMISTRY-US, V51, P899, DOI 10.1021/bi201178v; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Valayannopoulos V, 2012, BRAIN, V135, DOI 10.1093/brain/awr108; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wei ZY, 2011, MOL CELL, V43, P586, DOI 10.1016/j.molcel.2011.07.021; Ye F, 2018, CURR OPIN STRUC BIOL, V48, P6, DOI 10.1016/j.sbi.2017.08.006; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zhu JW, 2016, NAT REV NEUROSCI, V17, P209, DOI 10.1038/nrn.2016.18	48	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253223	10.1371/journal.pone.0253223	http://dx.doi.org/10.1371/journal.pone.0253223			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133460	Green Published, gold			2022-12-26	WOS:000671682700023
J	Kowarschik, S; Schollkopf, J; Muller, T; Tian, SH; Knerr, J; Bakker, H; Rein, S; Dong, M; Weber, S; Grosse, R; Schmidt, G				Kowarschik, Stefanie; Schoellkopf, Julian; Mueller, Thomas; Tian, Songhai; Knerr, Julian; Bakker, Hans; Rein, Stephan; Dong, Min; Weber, Stefan; Grosse, Robert; Schmidt, Gudula			Yersinia pseudotuberculosis cytotoxic necrotizing factor interacts with glycosaminoglycans	FASEB JOURNAL			English	Article						cytotoxic necrotizing factor; glycosamioglycan; receptor; toxin; Yersinia	RHO; PEPTIDE	The Cytotoxic Necrotizing Factor Y (CNFY) is produced by the gram-negative, enteric pathogen Yersinia pseudotuberculosis. The bacterial toxin belongs to a family of deamidases, which constitutively activate Rho GTPases, thereby balancing inflammatory processes. We identified heparan sulfate proteoglycans as essential host cell factors for intoxication with CNFY. Using flow cytometry, microscopy, knockout cell lines, pulsed electron-electron double resonance, and bio-layer interferometry, we studied the role of glucosaminoglycans in the intoxication process of CNFY. Especially the C-terminal part of CNFY, which encompasses the catalytic activity, binds with high affinity to heparan sulfates. CNFY binding with the N-terminal domain to a hypothetical protein receptor may support the interaction between the C-terminal domain and heparan sulfates, which seems sterically hindered in the full toxin. A second conformational change occurs by acidification of the endosome, probably allowing insertion of the hydrophobic regions of the toxin into the endosomal membrane. Our findings suggest that heparan sulfates play a major role for intoxication within the endosome, rather than being relevant for an interaction at the cell surface.	[Kowarschik, Stefanie; Schoellkopf, Julian; Mueller, Thomas; Knerr, Julian; Grosse, Robert; Schmidt, Gudula] Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany; [Tian, Songhai; Dong, Min] Boston Childrens Hosp, Dept Urol, Boston, MA USA; [Tian, Songhai; Dong, Min] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Bakker, Hans] Hannover Med Sch, Inst Clin Biochem, Hannover, Germany; [Rein, Stephan; Weber, Stefan] Univ Freiburg, Inst Phys Chem, Freiburg, Germany	University of Freiburg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Hannover Medical School; University of Freiburg	Schmidt, G (corresponding author), Univ Freiburg, Fac Med, Inst Expt & Clin Pharmacol & Toxicol, Albert Str 25, D-79104 Freiburg, Germany.	Gudula.Schmidt@pharmakol.uni-freiburg.de	Bakker, Hans/A-1787-2017	Bakker, Hans/0000-0002-1364-9154; Knerr, Julian/0000-0002-2614-6185	Deutsche Forschungsgemeinschaft (DFG) [SFB850]; SIBW	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); SIBW	Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: SFB850 (C2) and SIBW	Akhtar J, 2009, FEBS J, V276, P7228, DOI 10.1111/j.1742-4658.2009.07402.x; Blumenthal B, 2007, INFECT IMMUN, V75, P3344, DOI 10.1128/IAI.01937-06; Burger S, 2003, BIOCHEM BIOPH RES CO, V307, P584, DOI 10.1016/S0006-291X(03)01234-8; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Collins LE, 2019, J LEUKOCYTE BIOL, V105, P81, DOI 10.1002/JLB.3RU0618-246R; Elgundi Z, 2020, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01482; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Garcia J, 2019, ANN BIOMED ENG, V47, P1078, DOI 10.1007/s10439-019-02202-7; GREVE H, 1988, J BIOL CHEM, V263, P12886; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoffmann C, 2004, J BIOL CHEM, V279, P16026, DOI 10.1074/jbc.M313556200; Hoffmann C, 2005, REV PHYSIOL BIOCH P, V152, P49, DOI 10.1007/s10254-004-0026-4; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2016, EMAGRES, V5, P1459, DOI 10.1002/9780470034590.emrstm1518; Jewell SA, 2015, SOFT MATTER, V11, P7748, DOI 10.1039/c5sm00876j; Kim JS, 2016, J CONTROL RELEASE, V235, P165, DOI 10.1016/j.jconrel.2016.05.066; Knust Z, 2009, INFECT IMMUN, V77, P1835, DOI 10.1128/IAI.01145-08; Mani K, 2004, GLYCOBIOLOGY, V14, P599, DOI 10.1093/glycob/cwh067; Monnappa AK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32530-y; Nollmann M, 2004, BIOPHYS J, V86, P3141, DOI 10.1016/S0006-3495(04)74362-3; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Piteau M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003884; Rein S, 2018, J MAGN RESON, V295, P17, DOI 10.1016/j.jmr.2018.07.015; Reppin F, 2018, TOXINS, V10, DOI 10.3390/toxins10010003; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Schweer J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003746; SOBEL M, 1992, J BIOL CHEM, V267, P8857; Tao L, 2019, NAT MICROBIOL, V4, P1760, DOI 10.1038/s41564-019-0464-z; Wilson IBH, 2004, CELL MOL LIFE SCI, V61, P794, DOI 10.1007/s00018-003-3278-2; Wuyts W, 1998, AM J HUM GENET, V62, P346, DOI 10.1086/301726; Xie M, 2019, CELL SIGNAL, V54, P115, DOI 10.1016/j.cellsig.2018.11.022	34	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21647	10.1096/fj.202001630R	http://dx.doi.org/10.1096/fj.202001630R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165206	hybrid			2022-12-26	WOS:000667814100059
J	Shim, JY				Shim, Joong-Youn			Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; FORCE-FIELD; MOLECULAR-DYNAMICS; IDENTIFICATION; AGONIST; SIMULATION; ANANDAMIDE; CHARMM	Delta(9)-tetrahydrocannabinol (Delta(9)-THC), the main active ingredient of Cannabis sativa (marijuana), interacts with the human brain cannabinoid (CB1) receptor and mimics pharmacological effects of endocannabinoids (eCBs) like N-arachidonylethanolamide (AEA). Due to its flexible nature of AEA structure with more than 15 rotatable bonds, establishing its binding mode to the CB1 receptor is elusive. The aim of the present study was to explore possible binding conformations of AEA within the binding pocket of the CB1 receptor confirmed in the recently available X-ray crystal structures of the CB1 receptor and predict essential AEA binding domains. We performed long time molecular dynamics (MD) simulations of plausible AEA docking poses until its receptor binding interactions became optimally established. Our simulation results revealed that AEA favors to bind to the hydrophobic channel (HC) of the CB1 receptor, suggesting that HC holds essential significance in AEA binding to the CB1 receptor. Our results also suggest that the Helix 2 (H2)/H3 region of the CB1 receptor is an AEA binding subsite privileged over the H7 region.	[Shim, Joong-Youn] Dalton State Coll, Sch Arts & Sci, Dept Phys Sci, Dalton, GA 30720 USA	University System of Georgia; Dalton State College	Shim, JY (corresponding author), Dalton State Coll, Sch Arts & Sci, Dept Phys Sci, Dalton, GA 30720 USA.	jshim@daltonstate.edu			NVIDIA	NVIDIA	I gratefully acknowledge Dr. Randall Griffus for his generous support for securing Hewlett Packard Z440 workstations with NVIDIA Tesla K40 GPUs and a Hewlett Packard Z4 G4 workstation with NVIDIA GP100 GPUs. I thank Mr. Alvaro Cortez, Ms. Arianna Fisher and Ms. Nashely Hernandez for their critical reading and comments on the manuscript.	ADAMS IB, 1995, J PHARMACOL EXP THER, V273, P1172; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; COMPTON DR, 1993, J PHARMACOL EXP THER, V265, P218; Conner SN, 2016, OBSTET GYNECOL, V128, P713, DOI 10.1097/AOG.0000000000001649; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Glass M, 1999, MOL PHARMACOL, V56, P1362, DOI 10.1124/mol.56.6.1362; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hua T, 2017, NATURE, V547, P468, DOI 10.1038/nature23272; Hua T, 2016, CELL, V167, P750, DOI 10.1016/j.cell.2016.10.004; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ignatowska-Jankowska BM, 2015, NEUROPSYCHOPHARMACOL, V40, P2948, DOI 10.1038/npp.2015.148; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Konig B, 1997, LANGMUIR, V13, P525, DOI 10.1021/la960571y; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; MACKIE K, 1993, MOL PHARMACOL, V44, P498; McAllister SD, 2004, J BIOL CHEM, V279, P48024, DOI 10.1074/jbc.M406648200; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murphy JW, 2003, BIOCHEM PHARMACOL, V65, P1623, DOI 10.1016/S0006-2952(03)00155-2; Pamplona FA, 2012, P NATL ACAD SCI USA, V109, P21134, DOI 10.1073/pnas.1202906109; Pertwee RG, 2008, BRIT J PHARMACOL, V153, P199, DOI 10.1038/sj.bjp.0707442; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shao ZH, 2019, NAT CHEM BIOL, V15, P1199, DOI 10.1038/s41589-019-0387-2; Shao ZH, 2016, NATURE, V540, P602, DOI 10.1038/nature20613; Shim JY, 2013, J BIOL CHEM, V288, P32449, DOI 10.1074/jbc.M113.489153; Shim JY, 2011, J BIOL CHEM, V286, P33422, DOI 10.1074/jbc.M111.261651; Slivicki RA, 2018, BIOL PSYCHIAT, V84, P722, DOI 10.1016/j.biopsych.2017.06.032; Song ZH, 1996, MOL PHARMACOL, V49, P891; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309; Yang JF, 2020, ACS CHEM NEUROSCI, V11, P3455, DOI 10.1021/acschemneuro.0c00551; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	46	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0229879	10.1371/journal.pone.0229879	http://dx.doi.org/10.1371/journal.pone.0229879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181638	Green Submitted, gold, Green Published			2022-12-26	WOS:000671695800007
J	Liu, GY; Xia, JF; Zheng, K; Cheng, J; Du, J; Li, D				Liu, Guoyang; Xia, Junfang; Zheng, Kan; Cheng, Jian; Du, Jun; Li, Dong			Effects of moisture content and tillage methods on creep properties of paddy soil	PLOS ONE			English	Article							DISCRETE ELEMENT METHOD; STRIP-TILLAGE; NO-TILLAGE; MODEL; DEM; STRESS; COMPRESSIBILITY; CALIBRATION; SIMULATION; COMPACTION	The rheological properties parameters of paddy soil affect the interaction between the tillage tools and soil, thus influencing the operation quality and power consumption. In order to study the effects of tillage methods and moisture content on the rheological properties parameters of paddy soil in the middle and lower reaches of the Yangtze River, uniaxial compression creep tests of paddy soils with four moisture contents under no tillage (moisture contents: 26.71%, 24.52%, 23.26%, 21.28%) and plough tillage (moisture contents: 26.77%, 25.55%, 23.40%, 20.56%) were carried out using a TMS-PRO texture analyzer. The creep properties curves obtained from the tests, and the rheological constitutive equation of paddy soil under compression was established by Burgers viscoelastic model. Respectively, the quantitative change rules of creep properties of paddy soil with different moisture contents under different tillage methods and the correlation between these parameters were explored. The results showed that the moisture content under the three-year plough tillage and no tillage methods had significant influence on the rheological properties parameters of paddy soil (P < 0.05). The instantaneous elastic modulus, delay elastic modulus, and viscosity coefficient of the two paddy soils (no tillage and plough tillage soils) decreased with the increase of moisture content. However, the variation rules of relaxation time and delay viscosity coefficient with moisture content differed between these two paddy soils. Specifically, the strain rate of the two paddy soils decreased as moisture content decreased, where the total strain combines elastic strain, viscous strain, and viscoelastic strain. The initial strain rate and steady strain rate of the plough tillage paddy soils were lower than that of the no tillage paddy soils. The established creep model equation could be used to obtain viscoelastic rheological parameters of paddy soil in a wide range. The fitting equations between rheological parameters and moisture content were introduced into Burgers model, and the coupling equations between creep deformation and moisture content and time were derived, which could be used to predict the creep properties and deformation behavior of paddy soil in a certain range of no tillage and ploughed field. Overall, this study has a certain theoretical significance for the development and improvement of paddy soil rheology theory, and can also provide theoretical basis and technical support for the research of agricultural machinery design optimization, field water, soil conservation, soil tillage and compaction related simulation analysis in the middle and lower reaches of the Yangtze River.	[Liu, Guoyang; Xia, Junfang; Zheng, Kan; Cheng, Jian; Du, Jun; Li, Dong] Huazhong Agr Univ, Coll Engn, Wuhan, Peoples R China	Huazhong Agricultural University	Zheng, K (corresponding author), Huazhong Agr Univ, Coll Engn, Wuhan, Peoples R China.	zhengkan@mail.hzau.edu.cn			program of China's National Natural Science Foundation Project [31901412]; Natural Science Foundation Project of Hubei Province [2019CFB130]; Special Fund Project of Basic Scientific Research Business Cost of Central University [2662018QD033]	program of China's National Natural Science Foundation Project(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Hubei Province; Special Fund Project of Basic Scientific Research Business Cost of Central University	This study was financially supported by a program of China's National Natural Science Foundation Project (Grant No. 31901412), Natural Science Foundation Project of Hubei Province (Grant No. 2019CFB130) and Special Fund Project of Basic Scientific Research Business Cost of Central University (2662018QD033).	Abbaspour-Gilandeh Y, 2015, J TERRAMECHANICS, V57, P61, DOI 10.1016/j.jterra.2014.12.002; Ahmadi E, 2016, COMPUT ELECTRON AGR, V121, P1, DOI 10.1016/j.compag.2015.11.017; Assmann JM, 2014, AGR ECOSYST ENVIRON, V190, P52, DOI 10.1016/j.agee.2013.12.003; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; BURMAN BC, 1980, GEOTECHNIQUE, V30, P331; Coetzee CJ, 2016, POWDER TECHNOL, V297, P50, DOI 10.1016/j.powtec.2016.04.003; Deng YF, 2018, APPL CLAY SCI, V166, P299, DOI 10.1016/j.clay.2018.09.027; Duong TV, 2013, SOILS FOUND, V53, P868, DOI 10.1016/j.sandf.2013.10.006; Engelund ET, 2012, HOLZFORSCHUNG, V66, P959, DOI 10.1515/hf-2011-0172; Gadi Vinay Kumar, 2016, Rhizosphere, V1, P58, DOI 10.1016/j.rhisph.2016.07.003; Gao WD, 2016, SOIL TILL RES, V155, P190, DOI 10.1016/j.still.2015.08.004; Hassani MM, 2015, COMPUT METHOD APPL M, V283, P1032, DOI 10.1016/j.cma.2014.10.031; Higashimori M, 2010, IEEE INT CONF ROBOT, P5120, DOI 10.1109/ROBOT.2010.5509462; Holthusen D., 2020, SOIL TILL RES, V203; Hu W, 2020, AUTOMAT CONSTR, V113, DOI 10.1016/j.autcon.2020.103141; Janda A, 2016, POWDER TECHNOL, V293, P60, DOI 10.1016/j.powtec.2015.05.034; Kuncoro PH, 2014, SOIL TILL RES, V143, P172, DOI 10.1016/j.still.2014.02.006; Li B, 2016, SOIL TILL RES, V158, P177, DOI 10.1016/j.still.2015.12.010; Li DW, 2017, COLD REG SCI TECHNOL, V141, P163, DOI 10.1016/j.coldregions.2017.06.009; Li ST, 2018, J CLEAN PROD, V179, P55, DOI 10.1016/j.jclepro.2017.12.228; Ma RuiJun, 2018, Transactions of the Chinese Society of Agricultural Engineering, V34, P43; Ma S, 2020, J SCI FOOD AGR, V100, P177, DOI 10.1002/jsfa.10012; Matin MA, 2016, SOIL TILL RES, V155, P271, DOI 10.1016/j.still.2015.08.016; Md-Tahir H, 2019, BIOSYST ENG, V188, P14, DOI 10.1016/j.biosystemseng.2019.10.001; Okuka AS, 2020, APPL MATH MODEL, V77, P1894, DOI 10.1016/j.apm.2019.09.035; Or D, 2002, SOIL TILL RES, V64, P41, DOI 10.1016/S0167-1987(01)00256-2; PARKER JC, 1987, WATER RESOUR RES, V23, P618, DOI 10.1029/WR023i004p00618; Qiu Shujin, 2019, Transactions of the Chinese Society of Agricultural Engineering, V35, P322, DOI 10.11975/j.issn.1002-6819.2019.24.038; Reichert JM, 2018, CATENA, V165, P345, DOI 10.1016/j.catena.2018.02.014; Roessler T, 2019, POWDER TECHNOL, V343, P803, DOI 10.1016/j.powtec.2018.11.034; Schmalz HJ, 2013, RANGELAND ECOL MANAG, V66, P445, DOI 10.2111/REM-D-12-00040.1; Shen JP, 2010, APPL SOIL ECOL, V46, P119, DOI 10.1016/j.apsoil.2010.06.015; Singh HV, 2016, GEODERMA, V262, P165, DOI 10.1016/j.geoderma.2015.08.011; Smith CW, 1997, GEODERMA, V78, P93, DOI 10.1016/S0016-7061(97)00029-3; Tabatabaeefar A., 2003, International Agrophysics, V17, P207; Tang D, 2017, SOILS FOUND, V57, P892, DOI 10.1016/j.sandf.2017.08.020; Thakur SC, 2014, GRANUL MATTER, V16, P383, DOI 10.1007/s10035-014-0506-4; Ucgul M, 2015, BIOSYST ENG, V129, P298, DOI 10.1016/j.biosystemseng.2014.11.006; Ucgul M, 2014, SOIL TILL RES, V144, P220, DOI 10.1016/j.still.2013.10.003; Vaitauskiene K, 2017, SOIL TILL RES, V174, P139, DOI 10.1016/j.still.2017.07.006; Veenstra J. J., 2006, California Agriculture, V60, P146, DOI 10.3733/ca.v060n03p146; Vernon-Carter EJ, 2016, J FOOD ENG, V169, P18, DOI 10.1016/j.jfoodeng.2015.08.005; Wang XZ, 2019, BIOSYST ENG, V182, P138, DOI 10.1016/j.biosystemseng.2019.04.005; Yin T, 2018, J INTEGR AGR, V17, P2546, DOI 10.1016/S2095-3119(18)61925-2; Zeng ZW, 2017, COMPUT ELECTRON AGR, V143, P130, DOI 10.1016/j.compag.2017.10.005; [张春岭 Zhang Chunling], 2019, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V50, P25; Zhang JH, 2022, INT J PAVEMENT ENG, V23, P673, DOI 10.1080/10298436.2020.1765244; Zhang YJ, 2017, FIELD CROP RES, V209, P151, DOI 10.1016/j.fcr.2017.05.002; Zhao ShuHong, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P32; [祝英豪 Zhu Yinghao], 2019, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V50, P49	50	5	5	8	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253623	10.1371/journal.pone.0253623	http://dx.doi.org/10.1371/journal.pone.0253623			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166431	Green Published, gold			2022-12-26	WOS:000671692800016
J	Gededzha, MP; Mampeule, N; Jugwanth, S; Zwane, N; David, A; Burgers, WA; Blackburn, JM; Grove, JS; George, JA; Sanne, I; Scott, L; Stevens, W; Mayne, ES				Gededzha, Maemu P.; Mampeule, Nakampe; Jugwanth, Sarika; Zwane, Nontobeko; David, Anura; Burgers, Wendy A.; Blackburn, Jonathan M.; Grove, Jurette S.; George, Jaya A.; Sanne, Ian; Scott, Lesley; Stevens, Wendy; Mayne, Elizabeth S.			Performance of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies in South Africa	PLOS ONE			English	Article							SARS-COV-2; COVID-19	Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) has been identified as the causative agent for causing the clinical syndrome of COVID -19. Accurate detection of SARS-CoV-2 infection is not only important for management of infected individuals but also to break the chain of transmission. South Africa is the current epicenter of SARS-CoV-2 infection in Africa. To optimize the diagnostic algorithm for SARS-CoV-2 in the South African setting, the study aims to evaluate the diagnostic performance of the EUROIMMUN Anti-SARS-CoV-2 assays. This study reported the performance of EUROIMMUN enzyme-linked immunosorbent assay (ELISA) for semi-quantitative detection of IgA and IgG antibodies in serum and plasma samples targeting the recombinant S1 domain of the SARS-CoV-2 spike protein as antigen. Samples were collected from 391 individuals who had tested positive for SARS-CoV-2 and 139 SARS CoV-2 negative controls. Samples were stratified by number of days' post-PCR diagnosis and symptoms. The sensitivity of EUROIMMUN IgG was 64.1% (95% CI: 59.1-69.0%) and 74.3% (95% CI: 69.6-78.6%) for IgA and the specificity was lower for IgA [84.2% (95% CI: 77-89.2%)] than IgG [95.2% (95% CI: 90.8-98.4%)]. The EUROIMMUN Anti-SARS-CoV-2 ELISA Assay sensitivity was higher for IgA but low for IgG and improved for both assays in symptomatic individuals and at later timepoints post PCR diagnosis.	[Gededzha, Maemu P.; Mampeule, Nakampe; Jugwanth, Sarika; Zwane, Nontobeko; Mayne, Elizabeth S.] Univ Witwatersrand, Fac Hlth Sci, Dept Immunol, Johannesburg, South Africa; [Gededzha, Maemu P.; Mampeule, Nakampe; Jugwanth, Sarika; Grove, Jurette S.; George, Jaya A.; Scott, Lesley; Stevens, Wendy; Mayne, Elizabeth S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [David, Anura; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Dept Mol Med & Haematol, Johannesburg, South Africa; [Burgers, Wendy A.] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Burgers, Wendy A.] Wellcome Ctr Infect Dis Res Africa, Cape Town, South Africa; [Burgers, Wendy A.; Blackburn, Jonathan M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Blackburn, Jonathan M.] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Div Chem, Cape Town, South Africa; [Blackburn, Jonathan M.] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Div Syst Biol, Cape Town, South Africa; [Grove, Jurette S.; George, Jaya A.] Univ Witwatersrand, Fac Hlth Sci, Dept Chem Pathol, Johannesburg, South Africa; [Sanne, Ian] Univ Witwatersrand, Fac Hlth Sci, Dept Med, Clin HIV Res Unit, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand; University of Cape Town; University of Cape Town; University of Cape Town; University of Cape Town; University of Witwatersrand; University of Witwatersrand	Gededzha, MP (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Dept Immunol, Johannesburg, South Africa.; Gededzha, MP (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	Maemu.gededzha@nhls.ac.za	Gededzha, Maemu/AGU-4446-2022	Burgers, Wendy/0000-0003-3396-9398; Scott, Lesley/0000-0001-6573-9525; Blackburn, Jonathan/0000-0001-8988-9595; Gededzha, Maemu/0000-0003-0686-1293; Mayne, Elizabeth/0000-0002-6360-3488; George, Jaya/0000-0001-8769-3505	Bill Melinda Gates [OPP1171455]	Bill Melinda Gates(Bill & Melinda Gates Foundation)	WS, OPP1171455, Bill & Melinda Gates, https://www.gatesfoundation.org/Foundation, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Beavis KG, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104468; Beeton-Kempen N, 2014, INT J CANCER, V135, P1842, DOI 10.1002/ijc.28832; Ben-Shmuel A, 2020, CLIN MICROBIOL INFEC, V26, P1658, DOI 10.1016/j.cmi.2020.09.004; Blackburn JM, 2012, METHODS MOL BIOL, V800, P133, DOI 10.1007/978-1-61779-349-3_10; Bond K, 2020, J INFECT DIS, V222, P1280, DOI 10.1093/infdis/jiaa467; Brochot E, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.584251; Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Fang FC, 2020, CLIN INFECT DIS, V71, P2996, DOI 10.1093/cid/ciaa742; Fenwick C, 2021, J VIROL, V95, DOI 10.1128/JVI.01828-20; GeurtsvanKessel CH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17317-y; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Hartenian E, 2020, J BIOL CHEM, V295, P12910, DOI 10.1074/jbc.REV120.013930; Harvala H, 2021, TRANSFUSION MED, V31, P167, DOI 10.1111/tme.12746; Hinton DM, 2020, US FOOD DRUG ADM, V564, P1; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hong KH, 2020, ANN LAB MED, V40, P351, DOI 10.3343/alm.2020.40.5.351; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Katz AP, 2020, HEAD NECK-J SCI SPEC, V42, P1621, DOI 10.1002/hed.26317; Kohmer N, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104480; Kohmer N, 2020, J MED VIROL, V92, P2243, DOI 10.1002/jmv.26145; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li Y, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2032057; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1156, DOI 10.1515/cclm-2020-0473; Liu L, 2020, EMERG MICROBES INFEC, V9, P1664, DOI 10.1080/22221751.2020.1791738; Ma H, 2020, CELL MOL IMMUNOL, V17, P773, DOI 10.1038/s41423-020-0474-z; Makatsa MS, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.589940; Mayne ES, 2020, SAMJ S AFR MED J, V110, P842, DOI 10.7196/SAMJ.2020.v110i9.15098; Montesinos Isabel, 2020, J Clin Virol, V128, P104413, DOI 10.1016/j.jcv.2020.104413; Ni L, 2020, IMMUNITY, V52, P971, DOI 10.1016/j.immuni.2020.04.023; Nicol T, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104511; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Padoan A, 2020, CLIN CHIM ACTA, V507, P164, DOI 10.1016/j.cca.2020.04.026; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Smith M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050786; Stadlbauer Daniel, 2020, Curr Protoc Microbiol, V57, pe100, DOI 10.1002/cpmc.100; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Stites EC, 2020, MED-CAMBRIDGE, V1, P78, DOI 10.1016/j.medj.2020.08.001; Streeck H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19509-y; Tang MS, 2020, CLIN CHEM, V66, P1055, DOI 10.1093/clinchem/hvaa120; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; Tehrani ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237828; Theel ES, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01243-20; Traugott M, 2020, J INFECT DIS, V222, P362, DOI 10.1093/infdis/jiaa305; Tuaillon E, 2020, J INFECTION, V81, pE39, DOI 10.1016/j.jinf.2020.05.077; U.S. Food and Drug Administration, 2020, PFIZ BIONTECH COVID, V564, P1; Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, P1082, DOI 10.1016/j.cmi.2020.05.023; Varnaite R, 2020, J IMMUNOL, V205, P2437, DOI 10.4049/jimmunol.2000717; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Wang ZJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1555; Wernike K, 2021, TRANSBOUND EMERG DIS, V68, P253, DOI 10.1111/tbed.13684; WHO) WHO, 2020, MOD TRANSM VIR CAUS, P19; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001; Wu F, 2020, JAMA INTERN MED, V180, P1356, DOI 10.1001/jamainternmed.2020.4616; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Yu HQ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01526-2020; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	66	6	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252317	10.1371/journal.pone.0252317	http://dx.doi.org/10.1371/journal.pone.0252317			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161348	Green Published, gold			2022-12-26	WOS:000671691900033
J	Horiuchi, T; Mihashi, T; Hoshi, S; Okamoto, F; Oshika, T				Horiuchi, Tetsuya; Mihashi, Toshifumi; Hoshi, Sujin; Okamoto, Fumiki; Oshika, Tetsuro			Artificial accommodating intraocular lens powered by an ion polymer-metal composite actuator	PLOS ONE			English	Article							FOCUS	The current method of controlling the focus of an accommodating intraocular lens is based on ciliary muscle contraction and cannot be used in older patients with presbyopia. We aimed to develop a dynamically accommodating intraocular lens powered by a membrane-shaped ion polymer metal composite actuator that is thin enough to be inserted in the eye. This study addresses two key problems identified in our previous accommodating intraocular lens prototype: the lack of repeatability due to the use of swine lenses instead of artificial lenses and the occurrence of a sixth order aberration. Thus, we present a new accommodating intraocular lens design and a method to transfer energy to actuators. To accommodate lens deformation and depth of focus, we used a membrane-shaped ion polymer metal composite actuator, thin enough to be inserted in the eye, and used an artificial silicone lens. To prevent the sixth order aberration, we included a ring between the ion polymer metal composite actuator and the lens. Different voltage patterns were applied to the IPMC actuator and changes in focus were observed. We were able to obtain repeatability and prevent the sixth order aberration. The dioptric power changed to +/- 0.23 D when +/- 1.5 V was used; however, at >1.5 V, a large accommodating range occurred, in addition to astigmatic vision. Thus, we have developed a novel prototype that is completely artificial, allowing reproducible and repeatable results. Visual accommodative demands were successfully met; however, although astigmatic vision was lessened, it was not completely eradicated.	[Horiuchi, Tetsuya] Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Ikeda, Osaka, Japan; [Mihashi, Toshifumi; Hoshi, Sujin; Okamoto, Fumiki; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki, Japan; [Mihashi, Toshifumi] Teikyo Univ, Fac Med Technol, Dept Orthopt, Itabashi Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Teikyo University	Horiuchi, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Nanomat Res Inst, Ikeda, Osaka, Japan.	tetsu-horiuchi@aist.go.jp			JSPS KAKENHI [JP18H05470, 18K18411]; T-CReDO, Tsukuba Clinical Research & Development Organization [A17-83]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); T-CReDO, Tsukuba Clinical Research & Development Organization	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research in Innovative Areas "Science of Soft Robot" project (grant numbers JP18H05470 and 18K18411) and T-CReDO, Tsukuba Clinical Research & Development Organization (grant number A17-83).	Alio JL, 2009, J CATARACT REFR SURG, V35, P1671, DOI 10.1016/j.jcrs.2009.04.043; Atchison DA, 1997, OPTOMETRY VISION SCI, V74, P511, DOI 10.1097/00006324-199707000-00019; Bhatt UK, 2013, J CATARACT REFR SURG, V39, P36, DOI 10.1016/j.jcrs.2012.08.052; Carpi F, 2011, ADV FUNCT MATER, V21, P4152, DOI 10.1002/adfm.201101253; DeBoer CMT, 2016, IEEE T BIO-MED ENG, V63, P1129, DOI 10.1109/TBME.2015.2484379; Hasan N, 2016, OPT EXPRESS, V24, P13334, DOI 10.1364/OE.24.013334; Hoffer KJ, 2014, ESSENT OPHTHALMOL, P5, DOI 10.1007/978-3-319-09219-5_2; Horiuchi T, 2017, SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa61e8; Horiuchi T, 2016, OPT EXPRESS, V24, P23280, DOI 10.1364/OE.24.023280; Maffli L, 2015, ADV FUNCT MATER, V25, P1656, DOI 10.1002/adfm.201403942; McCafferty SJ, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.17; Peng RL, 2014, APPL OPTICS, V53, P249, DOI 10.1364/AO.53.000249; Pepose PS, 2009, CATARACT REFRACT SUR, V9, P39; Shimizu Ippei, 2009, 2009 ICROS-SICE International Joint Conference. ICCAS-SICE 2009, P4752; Vdovin G, 2003, OPT EXPRESS, V11, P810, DOI 10.1364/OE.11.000810; Wei K, 2014, OPT LETT, V39, P1318, DOI 10.1364/OL.39.001318; World Health Organisation, 2020, BLINDN VIS IMP; Yamagishi K, 2019, BIOMATER SCI-UK, V7, P520, DOI 10.1039/c8bm01290c	18	0	0	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252986	10.1371/journal.pone.0252986	http://dx.doi.org/10.1371/journal.pone.0252986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161344	Green Published, gold			2022-12-26	WOS:000671691900012
J	Shitu, S; Adugna, G; Abebe, H				Shitu, Solomon; Adugna, Getachew; Abebe, Haimanot			Occupational exposure to blood/body fluid splash and its predictors among midwives working in public health institutions at Addis Ababa city Ethiopia, 2020. Institution-based cross-sectional study	PLOS ONE			English	Article							NEEDLESTICK INJURIES; CARE WORKERS	Background Blood/body fluid splash are hazards to health care professionals in their working area. Around twenty bloodborne pathogens are known to be transmitted through these occupational injuries. This problem alters the health status of health care professionals in different ways, including physically, mentally, and psychologically. Even though health professionals especially midwives who are working in delivery rooms are highly affected, little is known about the exposure. So, this study was aimed to assess the prevalence of exposure to blood/body fluid splash and its predictors among midwives working in public health institutions of Addis Ababa city. Methods Institution based cross-sectional study was conducted among 438 study participants in public health institutions in Addis Ababa. Data was collected from March 1-20, 2020 by a self-administered questionnaire. The data were entered into Epi data version 3.1 and then exported to SPSS version 24 for analysis. All variables with PResults In this study, a total of 424 respondents respond yielding a response rate of 97%. The prevalence of blood and body fluid splashes (BBFs) was 198 (46.7%). Not training on infection prevention, working in two shifts (> 12 hours), not regularly apply universal precautions, job-related stress, an average monthly salary of 5001-8000 were independent predictors of blood and body fluid splashes. Conclusion The study revealed that nearly half of midwives were exposed to BBFS. This highlights the need for key stakeholders such as policymakers and service providers to design appropriate policies to avert this magnitude and making the environment enabling to comply with standard precautions. We recommend that this study may be done by including rural setting institutions and by including other health professionals that are susceptible to BBFS at work. Formal training on infection prevention and safety practice to apply universal precautions will be needed from the concerned bodies to prevent exposures to blood/body fluid splash.	[Shitu, Solomon] Wolkite Univ, Coll Hlth & Med Sci, Dept Midwifery, Wolkite, Ethiopia; [Adugna, Getachew] Addis Ababa City Hlth Dept, City Hlth Off, Addis Ababa, Ethiopia; [Abebe, Haimanot] Wolkite Univ, Coll Hlth & Med Sci, Dept Publ Hlth, Wolkite, Ethiopia		Shitu, S (corresponding author), Wolkite Univ, Coll Hlth & Med Sci, Dept Midwifery, Wolkite, Ethiopia.	solomonsht7@gmail.com			Addis Ababa University, College of Health Sciences of the School of Public Health	Addis Ababa University, College of Health Sciences of the School of Public Health	Special acknowledgment goes to the Addis Ababa University, College of Health Sciences of the School of Public Health for the support provided to undertake this study. Our deepest gratitude goes to the Addis Ababa city health bureau and selected health institutions.	Alemayehu T, 2016, INT J OCCUP ENV MED, V7, P172, DOI 10.15171/ijoem.2016.714; Alonso A., 2014, J NURSING CARE, V03; [Anonymous], 2009, ENV ENG ENV HLTH SAF; [Anonymous], 2008, WORKB DES IMPL EV SH; Awases M., 2004, MIGRATION HLTH PROFE; Barry S.Levy., 2017, OCCUPATIONAL ENV HLT, Vseventh; Bekele T, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0085-2; Bi P, 2008, ASIA-PAC J PUBLIC HE, V20, P139, DOI 10.1177/1010539507312235; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed, DOI [10.1097/01.ede.0000229155.05644.43, DOI 10.1097/01.EDE.0000229155.05644.43]; Central Statistical Agency Addis Ababa E, 2016, ETH DEM HLTH SURV; Cheng HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034911; Dejene H., 2002, HOUSING I HLTH ENV H, DOI [10.1002/jmv.10164, DOI 10.1002/JMV.10164]; Dilie A, 2017, J ENVIRON PUBLIC HEA, V2017, DOI 10.1155/2017/2438713; Elizabetta R., 2005, ENV BURDEN DISEASE S, V11; Fishman S., 2012, Reducing Risks, Promoting Healthy Life, V33, P72; Gessessew Amanuel, 2009, Ethiop Med J, V47, P213; Goel Varun, 2017, J Lab Physicians, V9, P20, DOI 10.4103/0974-2727.187917; International Labor Organization, ILO COD PRACT HIV AI, P200; Jahangiri M, 2016, SAF HEALTH WORK-KR, V7, P72, DOI 10.1016/j.shaw.2015.07.006; Kakizaki M., 2011, BMC RES NOTES, V4; Kaweti G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2642-0; Kelebore WG., 2016, SCI J PUBLIC HLTH, V4, P463; Lee JM., 2005, AAOHN J; Lily P., 2002, ENV HLTH HYGIENE, V2nd, P140; Mbaisi EM, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.10.1373; Mengesha HB., 2014, OCCUP MED HLTH AFF, P1; Motaarefi H, 2016, J CLIN DIAGN RES, V10, pIE1, DOI 10.7860/JCDR/2016/17973.8221; Norsayani MY, 2003, J OCCUP HEALTH, V45, P172, DOI 10.1539/joh.45.172; Nouetchognou JS., 2016, BMC RES NOTES, V9; Nwankwo TO, 2011, NIGER J CLIN PRACT, V14, P34, DOI 10.4103/1119-3077.79237; Oluwatosin O. A., 2016, International Journal of Medicine and Public Health, V6, P31, DOI 10.4103/2230-8598.179757; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Reda AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014420; Schoenbach V.J., 2000, UNDERSTANDING FUNDAM; Seng M, 2016, EPIDEMIOL INFECT, V144, P2546, DOI 10.1017/S0950268816000893; Sharew NT, 2017, ANN OCCUP ENVIRON ME, V29, DOI 10.1186/s40557-017-0163-2; Tadesse M., 2016, MED SAFETY GLOBAL HL, V05; Tadesse M, 2010, TROP DOCT, V40, P111, DOI 10.1258/td.2009.090191; Tesafa Bamlie JB., 2015, J NURSING CARE, V04; Walle L., 2013, INT J INFECT CONTROL, V9; Wicker S, 2008, INT ARCH OCC ENV HEA, V81, P347, DOI 10.1007/s00420-007-0219-7; Yimechew Z., 2013, OCCUPATIONAL EXPOSUR, V8	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0251815	10.1371/journal.pone.0251815	http://dx.doi.org/10.1371/journal.pone.0251815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143794	Green Published, gold			2022-12-26	WOS:000671690700059
J	Desai, HS; Chauhan, BS				Desai, Het Samir; Chauhan, Bhagirath Singh			Differential germination characteristics of glyphosate-resistant and glyphosate-susceptible Chloris virgata populations under different temperature and moisture stress regimes	PLOS ONE			English	Article							SEED-GERMINATION; HAIRY FLEABANE; ECOLOGY	Thorough knowledge of the germination behavior of weed species could aid in the development of effective weed control practices, especially when glyphosate resistance is involved. A study was conducted using two glyphosate-resistant (GR) (SGW2 and CP2) and two glyphosate-susceptible (GS) (Ch and SGM2) populations of Chloris virgata, an emerging and troublesome weed species of Australian farming systems, to evaluate their germination response to different alternating temperature (15/5, 25/15 and 35/25 degrees C with 12 h/12 h light/dark photoperiod) and moisture stress regimes (0, -0.1, -0.2, -0.4, -0.8 and -1.6 MPa). These temperature regimes represent temperatures occurring throughout the year in the eastern grain region of Australia. Seeds germinated in all the temperature regimes with no clear indication of optimum thermal conditions for the GR and GS populations. All populations exhibited considerable germination at the lowest alternating temperature regime 15/5 degrees C (61%, 87%, 49%, and 47% for Ch, SGM2, SGW2, and CP2, respectively), demonstrating the ability of C. virgata to germinate in winter months despite being a summer annual. Seed germination of all populations was inhibited at -0.8 and -1.6 MPa osmotic potential at two alternating temperature regimes (15/5 and 35/25 degrees C); however, some seeds germinated at 25/15 degrees C at -0.8 MPa osmotic potential, indicating the ability of C. virgata to germinate in arid regions and drought conditions. Three biological parameters (T10: incubation period required to reach 10% germination; T50: incubation period required to reach 50% germination; and T90: incubation period required to reach 90% germination) suggested late water imbibition with increasing moisture stress levels. The GR population SGW2 exhibited a distinctive pattern in T10, T50, and T90, possessing delayed germination behaviour and thus demonstrating an escape mechanism against pre-plating weed management practices. Knowledge gained from this study will help in developing site-specific and multi-tactic weed control protocols.	[Desai, Het Samir; Chauhan, Bhagirath Singh] Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Australia; [Desai, Het Samir; Chauhan, Bhagirath Singh] Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Australia	University of Queensland; University of Queensland	Chauhan, BS (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat QAAFI, Gatton, Australia.; Chauhan, BS (corresponding author), Univ Queensland, Sch Agr & Food Sci SAFS, Gatton, Australia.	b.chauhan@uq.edu.au		Desai, Het/0000-0003-2900-8658				ANDERSON D E, 1974, Brigham Young University Science Bulletin Biological Series, V19, P1; Baskin CC, 1998, SEEDS, P1, DOI 10.1016/B978-012080260-9/50001-4; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199949; Choi B, 2019, PLANT SPEC BIOL, V34, P5, DOI 10.1111/1442-1984.12227; da Silva LJ, 2019, J SEED SCI, V41, P250, DOI 10.1590/2317-1545v42n2217267; Desai HS, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091266; DORTENZIO WA, 1980, WEED SCI, V28, P534, DOI 10.1017/S0043174500061178; Fernando N, 2016, WEED SCI, V64, P605, DOI 10.1614/WS-D-15-00212.1; Govaerts B, 2009, CRIT REV PLANT SCI, V28, P97, DOI 10.1080/07352680902776358; Hawkes JR, 2005, AUST J AGR RES, V56, P257, DOI 10.1071/AR04259; Kumar V, 2018, WEED SCI, V66, P721, DOI 10.1017/wsc.2018.54; Kumar V, 2017, WEED SCI, V65, P361, DOI 10.1017/wsc.2016.26; Kumar V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161533; Llewellyn Rick., 2016, IMPACT WEEDS AUSTR G; Loura D, 2020, WEED SCI, V68, P411, DOI 10.1017/wsc.2020.28; Mahajan G, 2018, WEED SCI, V66, P752, DOI 10.1017/wsc.2018.55; Manalil S, 2020, CROP PASTURE SCI, V71, P916, DOI 10.1071/CP20092; Manalil S, 2018, CROP PASTURE SCI, V69, P926, DOI 10.1071/CP18059; MICHEL BE, 1995, AGRON J, V87, P126, DOI 10.2134/agronj1995.00021962008700010022x; Mollaee M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57307-9; Ngo TD, 2017, WEED SCI, V65, P413, DOI 10.1017/wsc.2016.33; Norsworthy JK, 2008, CROP PROT, V27, P151, DOI 10.1016/j.cropro.2007.04.019; OSTEN V, 2012, FEATHERTOP RHODES GR; Owen MDK, 2008, PEST MANAG SCI, V64, P377, DOI 10.1002/ps.1539; Travlos IS, 2013, J PEST SCI, V86, P345, DOI 10.1007/s10340-012-0446-x; Zhang H, 2012, S AFR J BOT, V78, P203, DOI 10.1016/j.sajb.2011.08.008	27	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253346	10.1371/journal.pone.0253346	http://dx.doi.org/10.1371/journal.pone.0253346			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138963	Green Published, gold			2022-12-26	WOS:000671690200017
J	Godtman, RA; Persson, E; Cazzaniga, W; Sandin, F; Carlsson, S; Ahlgren, G; Johansson, E; Robinsson, D; Hugosson, J; Stattin, P				Godtman, Rebecka Arnsrud; Persson, Erik; Cazzaniga, Walter; Sandin, Fredrik; Carlsson, Stefan; Ahlgren, Goran; Johansson, Eva; Robinsson, David; Hugosson, Jonas; Stattin, Par			Association of surgeon and hospital volume with short-term outcomes after robot-assisted radical prostatectomy: Nationwide, population-based study	PLOS ONE			English	Article							POSITIVE SURGICAL MARGINS; CANCER REGISTER; COHORT PROFILE; MORBIDITY; QUALITY; SWEDEN	Background and objective Few studies have investigated the association between surgical volume and outcome of robot-assisted radical prostatectomy (RARP) in an unselected cohort. We sought to investigate the association between surgical volume with peri-operative and short-term outcomes in a nation-wide, population-based study group. Methods 9,810 RARP's registered in the National Prostate Cancer Register of Sweden (2015-2018) were included. Associations between outcome and volume were analyzed with multivariable logistic regression including age, PSA-density, number of positive biopsy cores, cT stage, Gleason score, and extent of lymph node dissection. Results Surgeons and hospitals in the highest volume group compared to lowest group had shorter operative time; surgeon (OR 9.20, 95% CI 7.11-11.91), hospital (OR 2.16, 95% CI 1.53-3.06), less blood loss; surgeon (OR 2.58. 95% CI 2.07-3.21) hospital (no difference), more often nerve sparing intention; surgeon (OR 2.89, 95% CI 2.34-3.57), hospital (OR 2.02, 95% CI 1.66-2.44), negative margins; surgeon (OR 1.90, 95% CI 1.54-2.35), hospital (OR 1.28, 95% CI 1.07-1.53). There was wide range in outcome between hospitals and surgeons with similar volume that remained after adjustment. Conclusions High surgeon and hospital volume were associated with better outcomes. The range in outcome was wide in all volume groups, which indicates that factors besides volume are of importance. Registration of surgical performance is essential for quality control and improvement.	[Godtman, Rebecka Arnsrud; Hugosson, Jonas] Univ Goteborg, Sahlgrenska Univ Hosp, Inst Clin Sci, Sahlgrenska Acad,Dept Urol, Gothenburg, Sweden; [Persson, Erik; Sandin, Fredrik] Reg Canc Ctr Uppsala Orebro, Uppsala, Sweden; [Cazzaniga, Walter] Univ Vita Salute San Raffaele, Unit Urol URI, IRCCS Osped San Raffaele, Div Expt Oncol, Milan, Italy; [Cazzaniga, Walter; Johansson, Eva; Stattin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Carlsson, Stefan] Karolinska Univ Hosp, Div Urol, Stockholm, Sweden; [Carlsson, Stefan] Karolinska Inst, Dept Mol Med & Surg MMK, Stockholm, Sweden; [Ahlgren, Goran] Lund Univ, Skane Univ Hosp, Dept Urol, Lund, Sweden; [Robinsson, David] Hogland Hosp, Dept Urol, Eksjo, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Lund University; Skane University Hospital	Godtman, RA (corresponding author), Univ Goteborg, Sahlgrenska Univ Hosp, Inst Clin Sci, Sahlgrenska Acad,Dept Urol, Gothenburg, Sweden.	r.godtman@gmail.com	Cazzaniga, Walter/AFZ-0495-2022	Cazzaniga, Walter/0000-0002-0372-5694; Robinson, David/0000-0002-3433-8873; Arnsrud Godtman, Rebecka/0000-0003-2061-6550	Swedish Research Council [2017 00847]; Swedish Cancer Society [2016 0700]; Uppsala County Council; ALF-agreement [75480]; Swedish government	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Uppsala County Council; ALF-agreement; Swedish government	PS: Swedish Research Council (2017 00847, https://www.vr.se/english.html); The Swedish Cancer Society (2016 0700, https://www.cancerfonden.se/om-oss/about); Uppsala County Council (https://regionuppsala.se/) RAG: the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (75480, website N/A) These grants were unconditional and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bianco FJ, 2010, J UROLOGY, V183, P977, DOI 10.1016/j.juro.2009.11.015; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Birkmeyer JD, 2013, NEW ENGL J MED, V369, P1434, DOI 10.1056/NEJMsa1300625; Budaus L, 2010, J UROLOGY, V184, P2285, DOI 10.1016/j.juro.2010.08.024; Carlsson S, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-25; Carter SC, 2014, BJU INT, V113, pE112, DOI 10.1111/bju.12451; Cathcart P, 2015, EUR UROL, V68, P22, DOI 10.1016/j.eururo.2015.02.028; Cazzaniga W, 2019, J SURG ONCOL, V120, P803, DOI 10.1002/jso.25643; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Evans SM, 2014, BJU INT, V114, P680, DOI 10.1111/bju.12509; Frioriksson JO, 2014, J UROLOGY, V192, P112, DOI 10.1016/j.juro.2014.01.109; Gershman B, 2017, J UROLOGY, V198, P92, DOI 10.1016/j.juro.2017.01.067; Groeben C, 2017, WORLD J UROL, V35, P1045, DOI 10.1007/s00345-016-1982-4; Leow JJ, 2018, EUR UROL FOCUS, V4, P775, DOI 10.1016/j.euf.2017.03.008; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Morche J, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0376-4; National Institute for Health and Care Excellence, PROST CANC DIAGN MAN; Nyberg M, 2021, BJU INT, V127, P361, DOI 10.1111/bju.15238; Trinh QD, 2013, EUR UROL, V64, P786, DOI 10.1016/j.eururo.2013.04.012; Regionala cancercentrum i samverkan RCC, NAT VARDPR PROST VER NAT VARDPR PROST VER; Rubin DB., 1987, IMPUTATION FO NONRES; Sooriakumaran P, 2016, J SURG ONCOL, V113, P310, DOI 10.1002/jso.24109; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Steinsvik EAS, 2013, SCAND J UROL, V47, P92, DOI 10.3109/00365599.2012.707684; Tomic K, 2015, EUR J CANCER, V51, P101, DOI 10.1016/j.ejca.2014.10.025; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; Van Hemelrijck M, 2016, INT J EPIDEMIOL, V45, P73, DOI 10.1093/ije/dyv305; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; Xia LL, 2020, J UROLOGY, V203, P926, DOI 10.1097/JU.0000000000000698	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253081	10.1371/journal.pone.0253081	http://dx.doi.org/10.1371/journal.pone.0253081			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138904	gold, Green Published			2022-12-26	WOS:000671690200108
J	Kajikawa, O; Herrero, R; Chow, YH; Hung, CF; Matute-Bello, G				Kajikawa, Osamu; Herrero, Raquel; Chow, Yu-Hua; Hung, Chi F.; Matute-Bello, Gustavo			The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; EPITHELIAL-CELL APOPTOSIS; ACUTE LUNG INJURY; FAS/FASL SYSTEM; DOWN-REGULATION; ACTIVATION; INFLAMMATION; OUTCOMES; IDENTIFICATION; EXPRESSION	We have previously reported that the 26-amino acid N-terminus stalk region of soluble Fas ligand (sFasL), which is separate from its binding site, is required for its biological function. Here we investigate the mechanisms that link the structure of the sFasL stalk region with its function. Using site-directed mutagenesis we cloned a mutant form of sFasL in which all the charged amino acids of the stalk region were changed to neutral alanines (mut-sFasL). We used the Fas-sensitive Jurkat T-cell line and mouse and human alveolar epithelial cells to test the bioactivity of sFasL complexes, using caspase-3 activity and Annexin-V externalization as readouts. Finally, we tested the effects of mut-sFasL on lipopolysaccharide-induced lung injury in mice. We found that mutation of all the 8 charged amino acids of the stalk region into the non-charged amino acid alanine (mut-sFasL) resulted in reduced apoptotic activity compared to wild type sFasL (WT-sFasL). The mut-sFasL attenuated WT-sFasL function on the Fas-sensitive human T-cell line Jurkat and on primary human small airway epithelial cells. The inhibitory mechanism was associated with the formation of complexes of mut-sFasL with the WT protein. Intratracheal administration of the mut-sFasL to mice 24 hours after intratracheal Escherichia coli lipopolysaccharide resulted in attenuation of the inflammatory response 24 hours later. Therefore, the stalk region of sFasL has a critical role on bioactivity, and changes in the structure of the stalk region can result in mutant variants that interfere with the wild type protein function in vitro and in vivo.	[Kajikawa, Osamu; Chow, Yu-Hua; Hung, Chi F.; Matute-Bello, Gustavo] Univ Washington, Dept Med, Ctr Lung Biol, Div Pulm & Crit Care Med, Seattle, WA 98195 USA; [Kajikawa, Osamu; Matute-Bello, Gustavo] VA Puget Sound Healthcare Syst, Med Res Serv, Seattle, WA 98108 USA; [Herrero, Raquel] Hosp Univ Getafe, Inst Salud Carlos III, Madrid, Spain; [Herrero, Raquel] CIBER Enfermedades Resp, Madrid, Spain	University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Hospital Universitario de Getafe; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Matute-Bello, G (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.; Matute-Bello, G (corresponding author), VA Puget Sound Healthcare Syst, Med Res Serv, Seattle, WA 98108 USA.	matuteb@uw.edu			U.S. Department of Veterans Affairs [i01 BX002914]; Washington Research Foundation; National Institutes of Health [HL127075-05]; Instituto de Salud Carlos III [PI19/01091, PI15/00482]; Comunidad de Madrid [S2017/BMD-3727]	U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Washington Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid)	This study was supported by the U.S. Department of Veterans Affairs in the form of a grant awarded to GM-B (i01 BX002914), the Washington Research Foundation in the form of a grant awarded to GM-B, the National Institutes of Health in the form of a grant awarded to CFH (HL127075-05), Instituto de Salud Carlos III in the form of grants awarded to RH (PI19/01091, PI15/00482), and Comunidad de Madrid in the form of a grant awarded to RH (S2017/BMD-3727-EXOHEPCM).	Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Bem RA, 2008, AM J PHYSIOL-LUNG C, V295, pL314, DOI 10.1152/ajplung.00210.2007; Berg D, 2007, CELL DEATH DIFFER, V14, P2021, DOI 10.1038/sj.cdd.4402213; BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Del Sorbo L, 2016, CRIT CARE MED, V44, pE604, DOI 10.1097/CCM.0000000000001601; Farnand AW, 2011, AM J RESP CELL MOL, V45, P650, DOI 10.1165/rcmb.2010-0153OC; Fudala R, 2010, CLIN SCI, V118, P519, DOI 10.1042/CS20090422; Gil S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-91; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Herrero R, 2019, THORAX, V74, P69, DOI 10.1136/thoraxjnl-2018-211535; Herrero R, 2013, AM J PHYSIOL-LUNG C, V305, pL377, DOI 10.1152/ajplung.00271.2012; Herrero R, 2011, J CLIN INVEST, V121, P1174, DOI 10.1172/JCI43004; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Krupa A, 2007, AM J RESP CELL MOL, V37, P532, DOI 10.1165/rcmb.2006-0395OC; Li GX, 2011, AM J RESP CRIT CARE, V183, P59, DOI 10.1164/rccm.201003-0436OC; Matsumoto N, 2007, FEBS J, V274, P2376, DOI 10.1111/j.1742-4658.2007.05772.x; Matute-Bello G, 2005, J INFECT DIS, V191, P596, DOI 10.1086/427261; Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069; Matute-Bello G, 2004, CLIN DIAGN LAB IMMUN, V11, P358, DOI 10.1128/CDLI.11.2.358-361.2004; Matute-Bello G, 1999, J IMMUNOL, V163, P2217; Matute-Bello G, 2001, AM J PHYSIOL-LUNG C, V281, pL328, DOI 10.1152/ajplung.2001.281.2.L328; Matute-Bello G, 2001, AM J PATHOL, V158, P153, DOI 10.1016/S0002-9440(10)63953-3; Matute-Bello G, 2007, AM J RESP CELL MOL, V37, P210, DOI 10.1165/rcmb.2006-0471OC; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Perl M, 2005, AM J PATHOL, V167, P1545, DOI 10.1016/S0002-9440(10)61240-0; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rieux-Laucat F, 2018, J CLIN IMMUNOL, V38, P558, DOI 10.1007/s10875-018-0523-x; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Schneider P, 1997, J BIOL CHEM, V272, P18827, DOI 10.1074/jbc.272.30.18827; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Shudo K, 2001, EUR J IMMUNOL, V31, P2504, DOI 10.1002/1521-4141(200108)31:8<2504::AID-IMMU2504>3.0.CO;2-C; STONER GD, 1975, CANCER RES, V35, P2177; Suda T, 1996, J IMMUNOL, V157, P3918; Suda T, 1997, J EXP MED, V186, P2045, DOI 10.1084/jem.186.12.2045; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; van den Berg E, 2011, AM J PHYSIOL-LUNG C, V301, pL451, DOI 10.1152/ajplung.00368.2010; Vargo-Gogola T, 2002, ARCH BIOCHEM BIOPHYS, V408, P155, DOI 10.1016/S0003-9861(02)00525-8; Wadsworth SJ, 2010, J ALLERGY CLIN IMMUN, V126, P366, DOI 10.1016/j.jaci.2010.05.015; Weckbach S, 2013, J TRAUMA ACUTE CARE, V74, P792, DOI 10.1097/TA.0b013e31827a3655	45	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253260	10.1371/journal.pone.0253260	http://dx.doi.org/10.1371/journal.pone.0253260			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138914	gold, Green Published			2022-12-26	WOS:000671690200081
J	Romani-Perez, M; Lopez-Almela, I; Bullich-Vilarrubias, C; Rueda-Ruzafa, L; Del Pulgar, EMG; Benitez-Paez, A; Liebisch, G; Lamas, JA; Sanz, Y				Romani-Perez, Marina; Lopez-Almela, Inmaculada; Bullich-Vilarrubias, Clara; Rueda-Ruzafa, Lola; Gomez Del Pulgar, Eva M.; Benitez-Paez, Alfonso; Liebisch, Gerhard; Antonio Lamas, Jose; Sanz, Yolanda			Holdemanella biformis improves glucose tolerance and regulates GLP-1 signaling in obese mice	FASEB JOURNAL			English	Article						glucagon-like peptide 1; gut microbiota; Holdemanella biformis; obesity; type 2 diabetes; vagal afferent neurons	CHAIN FATTY-ACIDS; PEPTIDE-1 SECRETION; GUT-MICROBIOME; DIET; RECEPTORS; IMMUNE	Impaired glucose homeostasis in obesity is mitigated by enhancing the glucoregulatory actions of glucagon-like peptide 1 (GLP-1), and thus, strategies that improve GLP-1 sensitivity and secretion have therapeutic potential for the treatment of type 2 diabetes. This study shows that Holdemanella biformis, isolated from the feces of a metabolically healthy volunteer, ameliorates hyperglycemia, improves oral glucose tolerance and restores gluconeogenesis and insulin signaling in the liver of obese mice. These effects were associated with the ability of H. biformis to restore GLP-1 levels, enhancing GLP-1 neural signaling in the proximal and distal small intestine and GLP-1 sensitivity of vagal sensory neurons, and to modify the cecal abundance of unsaturated fatty acids and the bacterial species associated with metabolic health. Our findings overall suggest the potential use of H biformis in the management of type 2 diabetes in obesity to optimize the sensitivity and function of the GLP-1 system, through direct and indirect mechanisms.	[Romani-Perez, Marina; Lopez-Almela, Inmaculada; Bullich-Vilarrubias, Clara; Gomez Del Pulgar, Eva M.; Benitez-Paez, Alfonso; Sanz, Yolanda] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia 46980, Spain; [Rueda-Ruzafa, Lola; Antonio Lamas, Jose] Univ Vigo, Biomed Res Ctr CINBIO, Lab Neurosci, Vigo, Spain; [Liebisch, Gerhard] Univ Regensburg, Inst Clin Chem & Lab Med, Regensburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidade de Vigo; CINBIO; University of Regensburg	Romani-Perez, M (corresponding author), Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Unit, Valencia 46980, Spain.	marina.romani@iata.csic.es	Benítez-Páez, Alfonso/AAY-7143-2020; Rueda, Lola/AGQ-6540-2022; Liebisch, Gerhard/G-6130-2010; Sanz, Yolanda/H-5498-2012; Romani Perez, Marina/K-4124-2017; Lamas, J Antonio/O-1434-2019	Benítez-Páez, Alfonso/0000-0001-5707-4340; Liebisch, Gerhard/0000-0003-4886-0811; Sanz, Yolanda/0000-0002-1615-1976; Lopez Almela, Inmaculada/0000-0001-9886-8622; , Lola/0000-0002-0151-8018; , IIS Galicia Sur/0000-0003-3812-7413; Gomez del Pulgar Villanueva, Eva Maria/0000-0002-4509-1044; Romani Perez, Marina/0000-0002-1009-0156; Lamas, J Antonio/0000-0002-4453-4595	European Union Horizon 2020 research and innovation program [797297]; Spanish Ministry of Science and Innovation [AGL2017-88801-P]; European Union 7th Framework Program [613979]	European Union Horizon 2020 research and innovation program; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union 7th Framework Program(European Commission)	European Union Horizon 2020 research and innovation program, Grant/Award Number: 797297; European Union 7th Framework Program, Grant/Award Number: 613979; Spanish Ministry of Science and Innovation, Grant/Award Number: AGL2017-88801-P	Bauer PV, 2018, CELL METAB, V27, P572, DOI 10.1016/j.cmet.2018.01.013; Boets E, 2017, J PHYSIOL-LONDON, V595, P541, DOI 10.1113/JP272613; Breton J, 2016, CELL METAB, V23, P324, DOI 10.1016/j.cmet.2015.10.017; Brubaker PL, 2018, COMPR PHYSIOL, V8, P1185, DOI 10.1002/cphy.c170055; Cadaveira-Mosquera A, 2012, J MOL NEUROSCI, V48, P86, DOI 10.1007/s12031-012-9780-y; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Cheng YH, 2015, J BIOL CHEM, V290, P14302, DOI 10.1074/jbc.M115.655662; Chimerel C, 2014, CELL REP, V9, P1202, DOI 10.1016/j.celrep.2014.10.032; Christ A, 2019, IMMUNITY, V51, P794, DOI 10.1016/j.immuni.2019.09.020; Claus SP, 2017, CELL METAB, V26, P6, DOI 10.1016/j.cmet.2017.06.009; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Maesschalck C, 2014, INT J SYST EVOL MICR, V64, P3877, DOI 10.1099/ijs.0.064626-0; Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2; Drucker DJ, 2018, CELL METAB, V27, P740, DOI 10.1016/j.cmet.2018.03.001; Duca FA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21235-y; Duca FA, 2013, J NUTR BIOCHEM, V24, P1663, DOI 10.1016/j.jnutbio.2013.05.005; Ecker J, 2012, J CHROMATOGR B, V897, P98, DOI 10.1016/j.jchromb.2012.04.015; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fung TC, 2017, NAT NEUROSCI, V20, P145, DOI 10.1038/nn.4476; Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001; Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079; Grasset E, 2017, CELL METAB, V25, P1075, DOI 10.1016/j.cmet.2017.04.013; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Krieger JP, 2016, DIABETES, V65, P34, DOI 10.2337/db15-0973; Lauffer LM, 2009, DIABETES, V58, P1058, DOI 10.2337/db08-1237; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lewis JE, 2020, DIABETOLOGIA, V63, P1396, DOI 10.1007/s00125-020-05149-w; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liebisch G, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9040121; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin CR, 2018, CELL MOL GASTROENTER, V6, P133, DOI 10.1016/j.jcmgh.2018.04.003; Modasia A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.575595; Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001; O'Toole PW, 2017, MICROB BIOTECHNOL, V10, P1066, DOI 10.1111/1751-7915.12752; Plovier H, 2017, NAT MED, V23, P107, DOI 10.1038/nm.4236; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Pujo J, 2021, GUT, V70, P1088, DOI 10.1136/gutjnl-2020-321173; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rastelli M, 2019, ENDOCR REV, V40, P1271, DOI 10.1210/er.2018-00280; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rocca AS, 2001, ENDOCRINOLOGY, V142, P1148, DOI 10.1210/en.142.3.1148; Romani-Perez M, 2017, CURR OPIN CLIN NUTR, V20, P484, DOI 10.1097/MCO.0000000000000419; Sandoval D, 2015, MOL CELL ENDOCRINOL, V418, P27, DOI 10.1016/j.mce.2015.02.017; Sandoval DA, 2008, DIABETES, V57, P2046, DOI 10.2337/db07-1824; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tsai YL, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-018-0493-6; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wollam J, 2019, DIABETES, V68, P1415, DOI 10.2337/db18-1307; Yang ML, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.28; Zagato E, 2020, NAT MICROBIOL, V5, P511, DOI 10.1038/s41564-019-0649-5	60	7	7	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21734	10.1096/fj.202100126R	http://dx.doi.org/10.1096/fj.202100126R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143451	Green Published			2022-12-26	WOS:000667814100083
J	Zhang, BC; Lapenta, K; Wang, Q; Nam, JH; Chung, DJ; Robert, ME; Nathanson, MH; Yang, XY				Zhang, Bichen; Lapenta, Kalina; Wang, Qi; Nam, Jin Hyun; Chung, Dongjun; Robert, Marie E.; Nathanson, Michael H.; Yang, Xiaoyong			Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; LIVER; EXPRESSION; MOUSE; ACID; IDENTIFICATION; PROLIFERATION; PEPTIDES; FIBROSIS; CANCER	Liver fibrosis is a common characteristic of chronic liver diseases. The activation of hepatic stellate cells (HSCs) plays a key role in fibrogenesis in response to liver injury, yet the mechanism by which damaged hepatocytes modulate the activation of HSCs is poorly understood. Our previous studies have established that liver-specific deletion of O-GlcNAc transferase (OGT)leads to hepatocyte necroptosis and spontaneous fibrosis. Here, we report that OGT-deficient hepatocytes secrete trefoil factor 2 (TFF2) that activates HSCs and contributes to the fibrogenic process. The expression and secretion of TFF2 are induced in OGT-deficient hepatocytes but not in WT hepatocytes. TFF2 activates the platelet-derived growth factor receptor beta signaling pathway that promotes the proliferation and migration of primary HSCs. TFF2 protein expression is elevated in mice with carbon tetrachloride-induced liver injury. These findings identify TFF2 as a novel factor that mediates intercellular signaling between hepatocytes and HSCs and suggest a role of the hepatic OGT-TFF2 axis in the process of fibrogenesis.	[Zhang, Bichen; Wang, Qi; Yang, Xiaoyong] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Lapenta, Kalina; Yang, Xiaoyong] Yale Univ, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA; [Nam, Jin Hyun] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Chung, Dongjun] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH USA; [Robert, Marie E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, Sch Med, New Haven, CT USA	Yale University; Yale University; Medical University of South Carolina; University System of Ohio; Ohio State University; Yale University; Yale University	Yang, XY (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.; Yang, XY (corresponding author), Yale Univ, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA.	xiaoyong.yang@yale.edu		Yang, Xiaoyong/0000-0002-5315-7285; Nam, Jin Hyun/0000-0003-2165-5287; Robert, Marie/0000-0002-6385-4578; Chung, Dongjun/0000-0002-8072-5671; Nathanson, Michael/0000-0001-9964-0160	National Institutes of Health [R01DK089098, R01DK102648, P01DK57751]; Yale Liver Center [P30DK34989]; American Diabetes Association [1-19-IBS-119]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center; American Diabetes Association(American Diabetes Association)	This work was supported by the National Institutes of Health (R01DK089098, R01DK102648), Yale Liver Center (P30DK34989), and American Diabetes Association (1-19-IBS-119) to X. Y., the National Institutes of Health (P01DK57751) to M. E. R., M. H. N., and X. Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aihara E, 2017, ANNU REV PHYSIOL, V79, P357, DOI 10.1146/annurev-physiol-021115-105447; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Baldini SF, 2016, J MOL BIOL, V428, P3295, DOI 10.1016/j.jmb.2016.04.035; Bujak M, 2018, CELL PHYSIOL BIOCHEM, V47, P827, DOI 10.1159/000490039; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dhar DK, 2003, LAB INVEST, V83, P1343, DOI 10.1097/01.LAB.0000085190.99749.15; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Emidio NB, 2019, TRENDS BIOCHEM SCI, V44, P387, DOI 10.1016/j.tibs.2019.01.004; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hagerstrand D, 2006, ONCOGENE, V25, P4913, DOI 10.1038/sj.onc.1209497; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Hayashi Y, 2018, BIOCHEM BIOPH RES CO, V506, P12, DOI 10.1016/j.bbrc.2018.10.023; Hertel SC, 2004, PEPTIDES, V25, P755, DOI 10.1016/j.peptides.2003.11.021; Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007; Hoffmann W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124535; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Huang H, 2021, J CELL PHYSIOL, V236, P7491, DOI 10.1002/jcp.30385; Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Khoury Thaer, 2005, Int J Gastrointest Cancer, V35, P171, DOI 10.1385/IJGC:35:3:171; Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; O'Rourke JM, 2018, WORLD J GASTROENTERO, V24, P4436, DOI 10.3748/wjg.v24.i39.4436; Ochiai Y, 2020, HEPATOLOGY, V72, P503, DOI 10.1002/hep.31039; Ong QX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00599; Orime K, 2013, ENDOCRINOLOGY, V154, P54, DOI 10.1210/en.2012-1814; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sasaki M, 2003, LAB INVEST, V83, P1403, DOI 10.1097/01.LAB.0000092230.59485.9E; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Wake K, 2006, P JPN ACAD B-PHYS, V82, P155, DOI 10.2183/pjab.82.155; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wei W, 2021, NAT CHEM BIOL, V17, P326, DOI 10.1038/s41589-020-00698-y; Wu XJ, 2019, AM J PHYSIOL-ENDOC M, V317, pE436, DOI 10.1152/ajpendo.00454.2018; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zhang BC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127709; Zhao M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708736; Zhu Y, 2017, DIABETES, V66, P2789, DOI 10.2337/db17-0323	54	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100887	10.1016/j.jbc.2021.100887	http://dx.doi.org/10.1016/j.jbc.2021.100887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146542	Green Published, gold			2022-12-26	WOS:000678068400085
J	Rahim, SA; Kodandaramaiah, U; Kulkarni, A; Barua, D				Rahim, Sumayya Abdul; Kodandaramaiah, Ullasa; Kulkarni, Aboli; Barua, Deepak			Striking between-population floral divergences in a habitat specialized plant	PLOS ONE			English	Article							POLLINATOR-MEDIATED SELECTION; CRITICALLY ENDANGERED BALSAM; WESTERN-GHATS; FLOWER COLOR; ISLAND POPULATIONS; GENETIC-DIVERGENCE; SPATIAL VARIATION; LOCAL ADAPTATION; HONEY-BEES; DIFFERENTIATION	When the habitat occupied by a specialist species is patchily distributed, limited gene flow between the fragmented populations may allow population differentiation and eventual speciation. 'Sky islands'-montane habitats that form terrestrial islands-have been shown to promote diversification in many taxa through this mechanism. We investigate floral variation in Impatiens lawii, a plant specialized on laterite rich rocky plateaus that form sky islands in the northern Western Ghats mountains of India. We focus on three plateaus separated from each other by ca. 7 to 17 km, and show that floral traits have diverged strongly between these populations. In contrast, floral traits have not diverged in the congeneric I. oppositifolia, which co-occurs with I. lawii in the plateaus, but is a habitat generalist that is also found in the intervening valleys. We conducted common garden experiments to test whether the differences in I. lawii are due to genetic differentiation or phenotypic plasticity. There were strong differences in floral morphology between experimental plants sourced from the three populations, and the relative divergences between population pairs mirrored that seen in the wild, indicating that the populations are genetically differentiated. Common garden experiments confirmed that there was no differentiation in I. oppositifolia. Field floral visitation surveys indicated that the observed differences in floral traits have consequences for I. lawii populations, by reducing the number of visitors and changing the relative abundance of different floral visitor groups. Our results highlight the role of habitat specialization in diversification, and corroborates the importance of sky islands as centres of diversification.	[Rahim, Sumayya Abdul; Kodandaramaiah, Ullasa] Indian Inst Sci Educ & Res Thiruvananthapuram, IISER TVM Ctr Res & Educ Ecol & Evolut ICREEE, Thiruvananthapuram, Kerala, India; [Kulkarni, Aboli; Barua, Deepak] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Kulkarni, Aboli] Agharkar Res Inst, Biodivers & Paleobiol Grp, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram; Indian Institute of Science Education & Research (IISER) Pune; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Kodandaramaiah, U (corresponding author), Indian Inst Sci Educ & Res Thiruvananthapuram, IISER TVM Ctr Res & Educ Ecol & Evolut ICREEE, Thiruvananthapuram, Kerala, India.	ullasa@iisertvm.ac.in		Kodandaramaiah, Ullasa/0000-0002-1564-1738	Indian Institute of Science Education and Research Thiruvananthapuram; Department of Biotechnology [BT/PR27535/NDB/39/600/2018]; Indian Institute of Science Education and Research Pune	Indian Institute of Science Education and Research Thiruvananthapuram; Department of Biotechnology; Indian Institute of Science Education and Research Pune	The work was funded by intra-mural grants from Indian Institute of Science Education and Research Thiruvananthapuram and Indian Institute of Science Education and Research Pune, as well as a grant from the Department of Biotechnology to UK and DB (BT/PR27535/NDB/39/600/2018).	Alexandersson R, 2002, P ROY SOC B-BIOL SCI, V269, P631, DOI 10.1098/rspb.2001.1928; Anderson B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1420; ANTONOVICS J., 1971, Advances in Ecological Research, V7, P1, DOI 10.1016/S0065-2504(08)60202-0; Arigela RK, 2019, KEW BULL, V74, DOI 10.1007/s12225-019-9831-4; Arista M, 2013, J ECOL, V101, P1613, DOI 10.1111/1365-2745.12151; Armbruster WS, 2009, EVOL ECOL, V23, P159, DOI 10.1007/s10682-008-9259-z; Aslan CE, 2016, NAT AREA J, V36, P478, DOI 10.3375/043.036.0413; Balachandran C, 2014, CURR SCI INDIA, V106, P1379; Barbara T, 2008, HEREDITY, V101, P285, DOI 10.1038/hdy.2008.65; BHASKAR V, 1974, CURR SCI INDIA, V43, P626; Bhaskar V, 2012, TAXONOMIC MONOGRAPH; Bischoff A, 2010, RESTOR ECOL, V18, P338, DOI 10.1111/j.1526-100X.2008.00454.x; Brunet J, 2009, ANN BOT-LONDON, V103, P1567, DOI 10.1093/aob/mcp096; Cadena CD, 2007, MOL PHYLOGENET EVOL, V44, P993, DOI 10.1016/j.ympev.2006.12.012; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Caris PL, 2006, AM J BOT, V93, P1, DOI 10.3732/ajb.93.1.1; Cosacov A, 2014, ANN BOT-LONDON, V113, P251, DOI 10.1093/aob/mct239; Cox SC, 2014, MOL ECOL, V23, P4103, DOI 10.1111/mec.12840; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Cruz-Lustre G, 2020, PLANT SYST EVOL, V306, DOI 10.1007/s00606-020-01634-2; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; Deng JY, 2020, MOL ECOL, V29, P762, DOI 10.1111/mec.15353; Dessai Jyosna R. N., 2011, Rheedea, V21, P23; Edh K, 2007, MOL ECOL, V16, P4972, DOI 10.1111/j.1365-294X.2007.03585.x; EPLING C, 1960, EVOLUTION, V14, P238, DOI 10.2307/2405830; Epling C, 1942, GENETICS, V27, P0317; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Forister ML, 2012, ECOLOGY, V93, P981, DOI 10.1890/11-0650.1; Galen C, 1999, BIOSCIENCE, V49, P631, DOI 10.2307/1313439; GALEN C, 1989, EVOLUTION, V43, P882, DOI 10.1111/j.1558-5646.1989.tb05185.x; Gamba D, 2020, MOL ECOL, V29, P3413, DOI 10.1111/mec.15575; GRANT V, 1994, P NATL ACAD SCI USA, V91, P3, DOI 10.1073/pnas.91.1.3; GREY-WILSON C, 1980, Kew Bulletin, V34, P689, DOI 10.2307/4119063; Hall MC, 2006, EVOLUTION, V60, P2466, DOI 10.1554/05-688.1; Hareesh VS, 2020, PHYTOTAXA, V437, P291, DOI 10.11646/phytotaxa.437.5.3; Hattori M, 2016, J PLANT INTERACT, V11, P152, DOI 10.1080/17429145.2016.1226437; Heald W.F., 1951, NAT HIST, V60, P95; Hernandez-Villa V, 2020, FLORA, V262, DOI 10.1016/j.flora.2019.151505; Hladun KR, 2011, ENVIRON EXP BOT, V74, P90, DOI 10.1016/j.envexpbot.2011.05.003; Holycross AT, 2007, BIOL CONSERV, V134, P142, DOI 10.1016/j.biocon.2006.07.020; Hothorn T., 2008, R PACKAGE VERSION, P0; Husson F., 2016, MULTIVARIATE EXPLORA, V96, P698; Jackman S., 2015, R PACKAGE VERSION, V1; Janz N, 2011, ANNU REV ECOL EVOL S, V42, P71, DOI 10.1146/annurev-ecolsys-102710-145024; KASSAMBARA A, 2017, EXTRACT VISUALIZE RE, P76; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kay KM, 2019, ANN BOT-LONDON, V123, P405, DOI 10.1093/aob/mcy143; Kay KM, 2009, ANNU REV ECOL EVOL S, V40, P637, DOI 10.1146/annurev.ecolsys.110308.120310; Koski MH, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0635; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lekhak M. M., 2012, Rheedea, V22, P39; Lenth RV., 2021, EMMEANS ESTIMATED MA; Mabberley D.J., 2017, MABBERLEYS PLANT BOO, DOI [10.1017/9781316335581, DOI 10.1017/9781316335581]; Medel R, 2003, ECOLOGY, V84, P1721, DOI 10.1890/01-0688; Meindl GA, 2013, OECOLOGIA, V173, P1355, DOI 10.1007/s00442-013-2711-y; Munoz-Fuentes V, 2009, J BIOGEOGR, V36, P1516, DOI 10.1111/j.1365-2699.2008.02067.x; Murren CJ, 2006, ECOLOGY, V87, P2591, DOI 10.1890/0012-9658(2006)87[2591:IACEOM]2.0.CO;2; Narayanan MKR, 2013, PHYTOTAXA, V83, P54; Pan T, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-018-1333-8; Price MV, 2005, ECOLOGY, V86, P2106, DOI 10.1890/04-1274; R Core Team, 2020, R LANG ENV STAT COMP; Ramasubbu R, 2011, CURR SCI INDIA, V100, P1550; Richards CL, 2010, ESTUAR COAST, V33, P840, DOI 10.1007/s12237-009-9186-4; Ripley B., 2013, PACKAGE MASS, V538, P113, DOI DOI 10.1038/S41467-021-21898-7; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Robin VV, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0861; Ruchisansakun S, 2016, BOT J LINN SOC, V181, P651, DOI 10.1111/boj.12427; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Leal BSS, 2019, ANN BOT-LONDON, V124, P499, DOI 10.1093/aob/mcz105; Schemske DW, 2007, EVOLUTION, V61, P2528, DOI 10.1111/j.1558-5646.2007.00219.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sekar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071573; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; Sreekala AK, 2008, CURR SCI INDIA, V95, P386; Sreekala AK, 2016, ADV POLLEN SPORE RES, V34, P1; Tennessen JA, 2008, COPEIA, P558, DOI 10.1643/CG-06-038; Tian JP, 2004, ANN BOT-LONDON, V93, P167, DOI 10.1093/aob/mch013; Vamosi JC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2004; Vishnu M, 2020, TAIWANIA, V65, P187, DOI 10.6165/tai.2020.65.187; Wang H, 2016, ANN BOT-LONDON, V117, P995, DOI 10.1093/aob/mcw036; Wang Q, 2013, PLANT SYST EVOL, V299, P1263, DOI 10.1007/s00606-013-0794-x; WASER NM, 1985, AM J BOT, V72, P1726, DOI 10.2307/2443730; Watve A., 2008, SPEC HABITATS THREAT, V11, P147; Watve Aparna, 2003, Geobios (Jodhpur), V30, P41; Watve Aparna, 2013, Journal of Threatened Taxa, V5, P3935, DOI 10.11609/JoTT.o3372.3935-62; Widdowson M, 1996, EARTH PLANET SC LETT, V137, P57, DOI 10.1016/0012-821X(95)00211-T; Wright S, 1943, GENETICS, V28, P114; Wright S, 1943, GENETICS, V28, P139; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhao ZG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118299	91	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253038	10.1371/journal.pone.0253038	http://dx.doi.org/10.1371/journal.pone.0253038			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181672	gold, Green Published			2022-12-26	WOS:000671695800019
J	Yao, HX; Abban, OJ; Boadi, AD				Yao Hongxing; Abban, Olivier Joseph; Boadi, Alex Dankyi			Foreign aid and economic growth: Do energy consumption, trade openness and CO2 emissions matter? A DSUR heterogeneous evidence from Africa's trading blocs	PLOS ONE			English	Article							CROSS-SECTIONAL DEPENDENCE; LAGRANGE MULTIPLIER TEST; DIRECT-INVESTMENT; FINANCIAL DEVELOPMENT; PANEL-DATA; ELECTRICITY CONSUMPTION; FRESH-EVIDENCE; NEXUS; URBANIZATION; IMPACT	The paramount vision of every country or sub-regions is to attain economic growth and sustainable economic growth. The paradigm drift of studies into foreign aid and sustainable economic growth has shown conflicting results that play on researchers to fill the gap of knowledge void. The plurality of studies looked at economic growth and foreign aid in single countries. However, one of the major determinants of sustainable growth such as CO2 emissions and trade goes beyond the boundaries of a country. Deductively, grouped countries or sub-regional studies are needed to ascertain the heterogeneous relationship and cross-sectional dependency among panels grouping. We fill these gaps with the recent empirical methodology to unveil the impact of foreign aid, CO2 emissions, trade openness, and energy consumption on economic growth. Thus a percentage rise in foreign aid corresponds to different significant weights in all panel groupings with exception of Southern African Development Community, which unveiled a non-significant estimate. Whereas trade openness in all panel grouping indicated a significant weight on economic growth. An increase in CO2 emissions has a significant material effect on economic growth in Common Market for Eastern and Southern Africa, Economic Community of West African States, and Community of Sahel-Saharan States. The impact of energy consumption on economic growth across the panel groupings was statistically significant with Common Market for Eastern and Southern Africa having the highest weight impact. These results obtained in this study indicate that foreign aid, energy consumption, trade openness, and CO2 emissions are positively correlated with economic growth. Based on the finding, the significant of the policy implications suggested. (a) The need for a paradigm shift from fossil fuel sources to renewables is encouraged in the various trading blocs (b) The need to embrace carbon storage and capturing techniques to decouple pollutant emissions from economic growth on the continent's growth trajectory.	[Yao Hongxing; Abban, Olivier Joseph] Jiangsu Univ, Sch Math Sci, Inst Appl Syst & Anal IASA, Zhenjiang, Jiangsu, Peoples R China; [Yao Hongxing] Jiangsu Univ, Sch Finance & Econ, Zhenjiang, Jiangsu, Peoples R China; [Boadi, Alex Dankyi] Univ Cape Coast Directorate Res, Innovat & Consultancy, Cape Coast, Ghana	Jiangsu University; Jiangsu University	Yao, HX; Abban, OJ (corresponding author), Jiangsu Univ, Sch Math Sci, Inst Appl Syst & Anal IASA, Zhenjiang, Jiangsu, Peoples R China.; Yao, HX (corresponding author), Jiangsu Univ, Sch Finance & Econ, Zhenjiang, Jiangsu, Peoples R China.	hxyao@ujs.edu.cn; oliverjosephs@yahoo.com	Dankyi, Alex Boadi/AAV-4772-2021; Abban, Olivier Joseph/ABD-9323-2021	Dankyi, Alex Boadi/0000-0002-1601-9377; Abban, Olivier/0000-0001-9968-6361	National Natural Science Foundation of China [71701082]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with Grant No. 71701082 supported this work. The funding was received by Professor Yao Hongxing.	Abban OJ, 2021, ENVIRON SCI POLLUT R, V28, P27778, DOI 10.1007/s11356-020-12222-9; Abban OJ, 2020, ENVIRON SCI POLLUT R, V27, P11387, DOI 10.1007/s11356-020-07685-9; Abdouli M, 2018, J APPL ANIMAL NUTR, P1, DOI [10.1007/s13132-018-0546-9, DOI 10.1017/JAN.2018.1, 10.1017/JAN.2018.1, DOI 10.1007/S13132-018-0546-9]; Acaravci A, 2010, ENERG ECON, V32, P604, DOI 10.1016/j.eneco.2009.10.016; Adams J, 2020, WORLD J ENTREP MANAG, V16, P249, DOI 10.1108/WJEMSD-01-2020-0003; Ahmad M, 2018, ENVIRON SCI POLLUT R, V25, P30617, DOI 10.1007/s11356-018-3054-3; Akintande OJ, 2020, ENERGY, V206, DOI 10.1016/j.energy.2020.117992; Alam K., 2020, INT J EC FINANCIAL I, V10, P118, DOI [10.32479/ijefi.8657, DOI 10.32479/IJEFI.8657]; Alemzero DA, 2021, ENVIRON SCI POLLUT R, V28, P2158, DOI 10.1007/s11356-020-10554-0; Ali M, 2020, LEADERSHIP ORG DEV J, V41, P349, DOI 10.1108/LODJ-05-2019-0230; Asamoah LA, 2019, TRANSNATL CORP REV, V11, P65, DOI 10.1080/19186444.2019.1578156; Asongu SA, 2020, TELECOMMUN POLICY, V44, DOI 10.1016/j.telpol.2019.101838; Aydin M, 2020, ENVIRON SCI POLLUT R, V27, P43233, DOI 10.1007/s11356-020-10238-9; Bakirtas T, 2018, ENERGY, V147, P110, DOI 10.1016/j.energy.2018.01.011; Baltagi BH, 2012, J ECONOMETRICS, V170, P164, DOI 10.1016/j.jeconom.2012.04.004; Carbonell JB, 2018, ECON GEOGR, V94, P425; Bird G, 2020, REV DEV ECON, V24, P1, DOI 10.1111/rode.12630; Breitung J, 2005, STAT NEERL, V59, P414, DOI 10.1111/j.1467-9574.2005.00299.x; BREUSCH TS, 1980, REV ECON STUD, V47, P239, DOI 10.2307/2297111; Cai YF, 2018, J CLEAN PROD, V182, P1001, DOI 10.1016/j.jclepro.2018.02.035; Cetin M, 2018, ENVIRON SCI POLLUT R, V25, P36589, DOI 10.1007/s11356-018-3526-5; Destek MA, 2020, J CLEAN PROD, V242, DOI 10.1016/j.jclepro.2019.118537; Dong KY, 2018, ENERG ECON, V75, P180, DOI 10.1016/j.eneco.2018.08.017; Dumitrescu EI, 2012, ECON MODEL, V29, P1450, DOI 10.1016/j.econmod.2012.02.014; Fan WY, 2020, RENEW ENERG, V146, P598, DOI 10.1016/j.renene.2019.06.170; Fashina O. A., 2018, J INT STUDIES, V11, P104, DOI [10.14254/2071-8330.2018/11-2/8, DOI 10.14254/2071-8330.2018/11-2/8]; Gherghina SC, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11195421; Gorus MS, 2019, ENERGY, V168, P815, DOI 10.1016/j.energy.2018.11.139; Hanif I, 2019, ENERGY, V171, P493, DOI 10.1016/j.energy.2019.01.011; Harb N, 2019, Q REV ECON FINANC, V73, P192, DOI 10.1016/j.qref.2018.12.002; Haseeb A, 2018, ENVIRON SCI POLLUT R, V25, P31283, DOI 10.1007/s11356-018-3034-7; Huang BN, 2008, ECOL ECON, V67, P41, DOI 10.1016/j.ecolecon.2007.11.006; Huchet-Bourdon M, 2018, WORLD ECON, V41, P59, DOI 10.1111/twec.12586; Ibrahim M, 2018, J POLICY MODEL, V40, P1104, DOI 10.1016/j.jpolmod.2018.08.001; Ilesanmi KD, 2017, OPEC ENERGY REV, V41, P55, DOI 10.1111/opec.12094; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; Jena NR, 2020, AFR J ECON MANAG STU, V11, P147, DOI 10.1108/AJEMS-08-2019-0305; Kong QX, 2021, FINANC RES LETT, V38, DOI 10.1016/j.frl.2020.101488; Mahembe E, 2019, COGENT ECON FINANC, V7, DOI 10.1080/23322039.2019.1626321; Maji IK, 2019, ENERGY REP, V5, P384, DOI 10.1016/j.egyr.2019.03.005; Mark NC, 2005, REV ECON STUD, V72, P797, DOI 10.1111/j.1467-937X.2005.00352.x; Maruta AA, 2020, ECON MODEL, V89, P444, DOI 10.1016/j.econmod.2019.11.008; Mikayilov JI, 2018, J CLEAN PROD, V197, P1558, DOI 10.1016/j.jclepro.2018.06.269; Muhammad B, 2019, ENERGY, V179, P232, DOI 10.1016/j.energy.2019.03.126; Munir K, 2018, MANAG ENVIRON QUAL, V29, P1123, DOI 10.1108/MEQ-05-2018-0087; Munir Q, 2020, ENERG ECON, V85, DOI 10.1016/j.eneco.2019.104571; Mustafa ME., 2019, J EC COOPERATION DEV, V40; Nathaniel SP, 2020, GEOJOURNAL, V85, P1499, DOI 10.1007/s10708-019-10034-0; Naz S, 2019, ENVIRON SCI POLLUT R, V26, P2806, DOI 10.1007/s11356-018-3837-6; Ouyang YF, 2018, ENERG ECON, V71, P238, DOI 10.1016/j.eneco.2018.02.015; Ozcan B, 2020, ECON MODEL, V84, P203, DOI 10.1016/j.econmod.2019.04.010; Park Y, 2018, ENVIRON SCI POLLUT R, V25, P30708, DOI 10.1007/s11356-018-3108-6; Pedroni P, 2004, ECONOMET THEOR, V20, P597, DOI 10.1017/S0266466604203073; Pesaran MH, 2008, J ECONOMETRICS, V142, P50, DOI 10.1016/j.jeconom.2007.05.010; Pesaran MH, 2007, J APPL ECONOMET, V22, P265, DOI 10.1002/jae.951; Pesaran MH, 2021, EMPIR ECON, V60, P13, DOI 10.1007/s00181-020-01875-7; Pesaran MH, 2015, ECONOMET REV, V34, P1088, DOI 10.1080/07474938.2014.956623; Raghutla C, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2081; Rani R, 2019, GLOB BUS REV, V20, P795, DOI 10.1177/0972150919837079; Rao DT, 2020, GLOB BUS REV, DOI 10.1177/0972150919890957; Saidi Kais, 2021, Environment Systems & Decisions, V41, DOI 10.1007/s10669-020-09762-3; Saidi K, 2017, SUSTAIN CITIES SOC, V33, P45, DOI 10.1016/j.scs.2017.05.013; Salahuddin M, 2018, RENEW SUST ENERG REV, V81, P2002, DOI 10.1016/j.rser.2017.06.009; Saud S, 2019, ENVIRON SCI POLLUT R, V26, P2253, DOI 10.1007/s11356-018-3688-1; Shahbaz M, 2018, ENERG ECON, V71, P282, DOI 10.1016/j.eneco.2018.02.023; Sirag A, 2018, INT J SOC ECON, V45, P1236, DOI 10.1108/IJSE-10-2017-0476; Sobiech I, 2019, WORLD DEV, V113, P44, DOI 10.1016/j.worlddev.2018.08.016; Sokhanvar A, 2019, TOUR MANAG PERSPECT, V29, P86, DOI 10.1016/j.tmp.2018.10.005; Solarin SA, 2018, ENVIRON SCI POLLUT R, V25, P22641, DOI 10.1007/s11356-018-2392-5; Sothan S, 2018, J INT TRADE ECON DEV, V27, P168, DOI 10.1080/09638199.2017.1349167; Stamatiou P, 2019, INT J COMPUT ECON EC, V9, P268, DOI 10.1504/IJCEE.2019.102509; Vojtovic S., 2019, LINKAGES EC GROWTH F; Wang Q, 2019, J CLEAN PROD, V225, P1017, DOI 10.1016/j.jclepro.2019.04.008; Westerlund J, 2007, ECON LETT, V97, P185, DOI 10.1016/j.econlet.2007.03.003; Wu JY, 2021, ENERGY ECOL ENVIRON, V6, P213, DOI 10.1007/s40974-020-00176-0; Yazgan S, 2018, REV ECON PERSPECT, V18, P3, DOI 10.1515/revecp-2018-0001	76	8	8	11	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253457	10.1371/journal.pone.0253457	http://dx.doi.org/10.1371/journal.pone.0253457			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9CN	34170949	gold, Green Published			2022-12-26	WOS:000671694400044
J	Chan, CEZ; Seah, SGK; Chye, D; Massey, S; Torres, M; Lim, APC; Wong, SKK; Neo, JJY; San Wong, P; Lim, JH; Loh, GSL; Wang, DL; Boyd-Kirkup, JD; Guan, SY; Thakkar, D; Teo, GH; Purushotorman, K; Hutchinson, PE; Young, BE; Low, JG; MacAry, PA; Hentze, H; Prativadibhayankara, VS; Ethirajulu, K; Comer, JE; Tseng, CT; Barrett, ADT; Ingram, PJ; Brasel, T; Hanson, BJ				Chan, Conrad E. Z.; Seah, Shirley G. K.; Chye, De Hoe; Massey, Shane; Torres, Maricela; Lim, Angeline P. C.; Wong, Steven K. K.; Neo, Jacklyn J. Y.; San Wong, Pui; Lim, Jie Hui; Loh, Gary S. L.; Wang, Dongling; Boyd-Kirkup, Jerome D.; Guan, Siyu; Thakkar, Dipti; Teo, Guo Hui; Purushotorman, Kiren; Hutchinson, Paul E.; Young, Barnaby E.; Low, Jenny G.; MacAry, Paul A.; Hentze, Hannes; Prativadibhayankara, Venkateshan S.; Ethirajulu, Kantharaj; Comer, Jason E.; Tseng, Chien-Te K.; Barrett, Alan D. T.; Ingram, Piers J.; Brasel, Trevor; Hanson, Brendon John			The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; HUMAN MONOCLONAL-ANTIBODIES; INFECTION; MACAQUES; CELLS	Although SARS-CoV-2-neutralizing antibodies are promising therapeutics against COVID-19, little is known about their mechanism(s) of action or effective dosing windows. We report the generation and development of SC31, a potent SARS-CoV-2 neutralizing antibody, isolated from a convalescent patient. Antibody-mediated neutralization occurs via an epitope within the receptor-binding domain of the SARS-CoV-2 Spike protein. SC31 exhibited potent anti-SARS-CoV-2 activities in multiple animal models. In SARS-CoV-2 infected K18-human ACE2 transgenic mice, treatment with SC31 greatly reduced viral loads and attenuated pro-inflammatory responses linked to the severity of COVID-19. Importantly, a comparison of the efficacies of SC31 and its Fc-null LALA variant revealed that the optimal therapeutic efficacy of SC31 requires Fc-mediated effector functions that promote IFN gamma-driven anti-viral immune responses, in addition to its neutralization ability. A dose-dependent efficacy of SC31 was observed down to 5mg/kg when administered before viral-induced lung inflammatory responses. In addition, antibody-dependent enhancement was not observed even when infected mice were treated with SC31 at sub-therapeutic doses. In SARS-CoV-2-infected hamsters, SC31 treatment significantly prevented weight loss, reduced viral loads, and attenuated the histopathology of the lungs. In rhesus macaques, the therapeutic potential of SC31 was evidenced through the reduction of viral loads in both upper and lower respiratory tracts to undetectable levels. Together, the results of our preclinical studies demonstrated the therapeutic efficacy of SC31 in three different models and its potential as a COVID-19 therapeutic candidate.	[Chan, Conrad E. Z.; Seah, Shirley G. K.; Chye, De Hoe; Lim, Angeline P. C.; Wong, Steven K. K.; Neo, Jacklyn J. Y.; San Wong, Pui; Lim, Jie Hui; Loh, Gary S. L.; Wang, Dongling; Hanson, Brendon John] DSO Natl Labs, Biol Def Programme, Singapore, Singapore; [Massey, Shane; Torres, Maricela; Comer, Jason E.; Tseng, Chien-Te K.; Brasel, Trevor] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Massey, Shane; Torres, Maricela; Comer, Jason E.; Brasel, Trevor] Univ Texas Med Branch, Off Regulated Nonclin Studies, Galveston, TX 77555 USA; [Boyd-Kirkup, Jerome D.; Guan, Siyu; Thakkar, Dipti; Ingram, Piers J.] Hummingbird Biosci, Singapore, Singapore; [Teo, Guo Hui; Purushotorman, Kiren; Hutchinson, Paul E.] Natl Univ Singapore, Life Sci Inst, Singapore, Singapore; [Young, Barnaby E.] Natl Ctr Infect Dis, Singapore, Singapore; [Low, Jenny G.] Singapore Gen Hosp, Singapore, Singapore; [Low, Jenny G.] Duke Natl Univ, Programme Emerging Infect Dis, Singapore Med Sch, Singapore, Singapore; [MacAry, Paul A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Hentze, Hannes; Prativadibhayankara, Venkateshan S.; Ethirajulu, Kantharaj] A Star Res Ent ARES, Expt Drug Dev Ctr, Therapeut Dev, Singapore, Singapore; [Tseng, Chien-Te K.] Univ Texas Med Branch, Ctr Biodef & Emerging Dis, Galveston, TX 77555 USA; [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; National University of Singapore; National Centre for Infectious Diseases Singapore; Singapore General Hospital; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hanson, BJ (corresponding author), DSO Natl Labs, Biol Def Programme, Singapore, Singapore.; Brasel, T (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Brasel, T (corresponding author), Univ Texas Med Branch, Off Regulated Nonclin Studies, Galveston, TX 77555 USA.; Ingram, PJ (corresponding author), Hummingbird Biosci, Singapore, Singapore.	cenzou@dso.org.sg; p.ingram@hummingbirdbio.com; trbrasel@utmb.edu; hbrendon@dso.org.sg	Young, Barnaby/GVR-9935-2022	Young, Barnaby/0000-0003-1010-2230	Ministry of Defence, Singapore	Ministry of Defence, Singapore(Ministry of Defence, Singapore)	This study was supported by the Ministry of Defence, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Atwal G.S., 2020, REGN COV2 ANTIBODY C, DOI 10.1101/2020.08.02.233320; Bao LN, 2020, NATURE, V583, P830, DOI 10.1038/s41586-020-2312-y; Brining DL, 2010, COMPARATIVE MED, V60, P389; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Du S, 2020, CELL, V183, P1013, DOI 10.1016/j.cell.2020.09.035; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Fukushi S, 2005, J GEN VIROL, V86, P2269, DOI 10.1099/vir.0.80955-0; Golden JW, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.142032; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Hoepel W., 2020, IMMUNOLOGY, DOI [10.1101/2020.07.13.190140, DOI 10.1101/2020.07.13.190140]; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Jones Bryan E, 2020, bioRxiv, DOI 10.1101/2020.09.30.318972; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Klein Sabra, 2020, medRxiv, DOI [10.1172/JCI142004, 10.1101/2020.06.26.20139063]; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lee WS, 2020, NAT MICROBIOL, V5, P1185, DOI 10.1038/s41564-020-00789-5; Liang WH, 2020, NEW ENGL J MED, V382, P1708, DOI DOI 10.1038/s41586-020-2349-y; Lim APC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-130; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Moreno-Eutimio MA, 2020, MICROBES INFECT, V22, P226, DOI 10.1016/j.micinf.2020.04.009; Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Munster VJ, 2020, NATURE, V585, P268, DOI [10.1038/s41586-020-2324-7, 10.1101/2020.03.21.001628]; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Schafer Alexandra, 2020, bioRxiv, DOI 10.1101/2020.09.15.298067; Shan C, 2020, CELL RES, V30, P670, DOI 10.1038/s41422-020-0364-z; Shete-Aich A, 2020, INDIAN J MED RES, DOI [10.4103/ijmr.IJMR_4431_20 33361645, DOI 10.4103/IJMR.IJMR_4431_2033361645]; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Singh DK, 2021, NAT MICROBIOL, V6, P73, DOI 10.1038/s41564-020-00841-4; Tang YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01708; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; van Doremalen N, 2020, NATURE, V586, P578, DOI [10.1101/2020.05.13.093195, 10.1038/s41586-020-2608-y]; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090; Wang YQ, 2020, J CLIN INVEST, V130, P5235, DOI [10.1172/JCI138759., 10.1172/JCI138759]; Winkler ES, 2020, NAT IMMUNOL, V21, P1327, DOI 10.1038/s41590-020-0778-2; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14; Yip MS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-82; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	57	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253487	10.1371/journal.pone.0253487	http://dx.doi.org/10.1371/journal.pone.0253487			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161386	Green Submitted, gold, Green Published			2022-12-26	WOS:000671691900065
J	Baek, IC; Choi, EJ; Shin, DH; Kim, HJ; Choi, H; Kim, TG				Baek, In-Cheol; Choi, Eun-Jeong; Shin, Dong-Hwan; Kim, Hyoung-Jae; Choi, Haeyoun; Kim, Tai-Gyu			Allele and haplotype frequencies of human leukocyte antigen-A, -B, -C,-DRB1,-DRB3/4/5,-DQA1,-DQB1,-DPA1, and-DPB1 by next generation sequencing-based typing in Koreans in South Korea	PLOS ONE			English	Article							11 HLA LOCI; CLASS-II ALLELE; HIGH-RESOLUTION; HIGH-THROUGHPUT; MAXIMUM-LIKELIHOOD; HLA-DRB1; HISTOCOMPATIBILITY; POPULATION; DIVERSITY; UPDATE	Allele frequencies and haplotype frequencies of HLA-A, -B, -C, -DRB1, -DRB3/4/5, -DQA1, -DQB1, -DPA1, and -DPB1 have been rarely reported in South Koreans using unambiguous, phase-resolved next generation DNA sequencing. In this study, HLA typing of 11 loci in 173 healthy South Koreans were performed using next generation DNA sequencing with long-range PCR, TruSight HLA v2 kit, Illumina MiSeqDx platform system, and Assign((TM)) for TruSight((TM)) HLA software. Haplotype frequencies were calculated using the PyPop software. Direct counting methods were used to investigate the association with DRB1 for samples with only one copy of a particular secondary DRB locus. We compared these allele types with the ambiguous allele combinations of the IPD-IMGT/HLA database. We identified 20, 40, 26, 31, 19, 16, 4, and 16 alleles of HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1, and HLA-DPB1, respectively. The number of HLA-DRB3/4/5 alleles was 4, 5, and 3, respectively. The haplotype frequencies of most common haplotypes were as follows: A*33:03:01-B*44:03:01-C*14:03-DRB1*13:02:01-DQB1*06:04:01-DPB1*04:01:01 (2.89%), A*33:03:01-B*44:03:01-C*14:03 (4.91%), DRB1*08:03:02-DQA1*01:03:01-DQB1*06:01:01-DPA1*02:02:02-DPB1*05:01:01 (5.41%), DRB1*04:05:01-DRB4*01:03:01 (12.72%), DQA1*01:03:01-DQB1*06:01:01 (13.01%), and DPA1*02:02:02-DPB1*05:01:01 (30.83%). In samples with only one copy of a specific secondary DRB locus, we examined its association with DRB1. We, thus, resolved 10 allele ambiguities in HLA-B, -C (each exon 2+3), -DRB1, -DQB1, -DQA1, and -DPB1 (each exon 2) of the IPD-IMGT/HLA database. Korean population was geographically close to Japanese and Han Chinese populations in the genetic distances by multidimensional scaling (MDS) plots. The information obtained by HLA typing of the 11 extended loci by next generation sequencing may be useful for more exact diagnostic tests on various transplantations and the genetic population relationship studies in South Koreans.	[Baek, In-Cheol; Choi, Eun-Jeong; Shin, Dong-Hwan; Kim, Hyoung-Jae; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea; [Choi, Haeyoun; Kim, Tai-Gyu] Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Hematopoiet Stem Cell Bank, Seoul, South Korea.; Kim, TG (corresponding author), Catholic Univ Korea, Coll Med, Dept Microbiol, Seoul, South Korea.	kimtg@catholic.ac.kr		Baek, In-Cheol/0000-0003-3630-3364; Kim, Tai-Gyu/0000-0002-2226-2138	Korean Health Technology R&D Project,Ministry for Health &Welfare, Republic of Korea [HI14C3417]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2019R1I1A1A01064049]	Korean Health Technology R&D Project,Ministry for Health &Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by a grant of the Korean Health Technology R&D Project,Ministry for Health &Welfare, Republic of Korea (HI14C3417) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2019R1I1A1A01064049).	Ahn Stephen, 2011, Immune Netw, V11, P324, DOI 10.4110/in.2011.11.6.324; ANDERSSON G, 1987, J BIOL CHEM, V262, P8748; Baek IC, 2021, HLA, V97, P112, DOI 10.1111/tan.14134; Begovich AB, 2001, TISSUE ANTIGENS, V57, P424, DOI 10.1034/j.1399-0039.2001.057005424.x; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Cecka JM, 2015, AM J TRANSPLANT, V15, P855, DOI 10.1111/ajt.13169; Danzer M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-221; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Do MD, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00383; Duquesnoy RJ, 2015, AM J TRANSPLANT, V15, P923, DOI 10.1111/ajt.13167; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Geretz A, 2020, HUM IMMUNOL, V81, P437, DOI 10.1016/j.humimm.2020.06.010; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Guerra SG, 2020, HUM IMMUNOL, V81, P269, DOI 10.1016/j.humimm.2020.04.001; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hong SB, 2015, FORENSIC SCI INT-GEN, V17, P99, DOI 10.1016/j.fsigen.2015.03.017; Hou LH, 2019, HLA, V93, P474, DOI 10.1111/tan.13535; Hurley CK, 2020, HLA, V95, P516, DOI 10.1111/tan.13811; In JW, 2015, ANN LAB MED, V35, P429, DOI 10.3343/alm.2015.35.4.429; Johansson A, 2008, EUR J HUM GENET, V16, P1341, DOI 10.1038/ejhg.2008.88; Kuranov AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115265; Kwok J, 2020, HUM IMMUNOL, V81, P577, DOI 10.1016/j.humimm.2020.08.005; Lan JH, 2015, CURR OPIN ORGAN TRAN, V20, P461, DOI 10.1097/MOT.0000000000000217; Lancaster AK, 2007, TISSUE ANTIGENS, V69, P192, DOI 10.1111/j.1399-0039.2006.00769.x; Lange V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-63; Lee KW, 2005, TISSUE ANTIGENS, V65, P437, DOI 10.1111/j.1399-0039.2005.00386.x; Lee KW, 1999, HUM IMMUNOL, V60, P731, DOI 10.1016/S0198-8859(99)00031-2; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Lind C, 2010, HUM IMMUNOL, V71, P1033, DOI 10.1016/j.humimm.2010.06.016; Liu C, 2021, HUM IMMUNOL, V82, P488, DOI 10.1016/j.humimm.2020.04.009; Mack SJ, 2013, TISSUE ANTIGENS, V81, P194, DOI 10.1111/tan.12093; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Mosbruger TL, 2020, HUM IMMUNOL, V81, P413, DOI 10.1016/j.humimm.2020.06.004; Ozaki Y, 2014, TISSUE ANTIGENS, V83, P10, DOI 10.1111/tan.12258; Ozaki Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1514-4; Park H, 2016, INT J IMMUNOGENET, V43, P287, DOI 10.1111/iji.12288; Petersdorf EW, 2004, BLOOD, V104, P2976, DOI 10.1182/blood-2004-04-1674; Robinson J, 2020, NUCLEIC ACIDS RES, V48, pD948, DOI 10.1093/nar/gkz950; Saito S, 2013, TISSUE ANTIGENS, V82, P82, DOI 10.1111/tan.12142; Shiina T, 2012, TISSUE ANTIGENS, V80, P305, DOI 10.1111/j.1399-0039.2012.01941.x; Shin DH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216941; Smith AG, 2019, HLA, V94, P296, DOI 10.1111/tan.13619; Song EY, 2004, HUM IMMUNOL, V65, P270, DOI 10.1016/j.humimm.2003.12.005; Song EY, 2002, TISSUE ANTIGENS, V59, P475, DOI 10.1034/j.1399-0039.2002.590604.x; SUTTON VR, 1989, IMMUNOGENETICS, V29, P317, DOI 10.1007/BF00352841; Wang CL, 2012, P NATL ACAD SCI USA, V109, P8676, DOI 10.1073/pnas.1206614109; Zhao LP, 2016, DIABETES, V65, P710, DOI 10.2337/db15-1115; Zhou XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139485	48	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253619	10.1371/journal.pone.0253619	http://dx.doi.org/10.1371/journal.pone.0253619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153078	gold, Green Published			2022-12-26	WOS:000671691000026
J	Sun, Y; Zhao, HX; Liang, J; Ma, XJ				Sun, Yan; Zhao, Haixing; Liang, Jing; Ma, Xiujuan			Eigenvalue-based entropy in directed complex networks	PLOS ONE			English	Article							GRAPHS; INFORMATION; ENERGY; DYNAMICS; INDEX	Entropy is an important index for describing the structure, function, and evolution of network. The existing research on entropy is primarily applied to undirected networks. Compared with an undirected network, a directed network involves a special asymmetric transfer. The research on the entropy of directed networks is very significant to effectively quantify the structural information of the whole network. Typical complex network models include nearest-neighbour coupling network, small-world network, scale-free network, and random network. These network models are abstracted as undirected graphs without considering the direction of node connection. For complex networks, modeling through the direction of network nodes is extremely challenging. In this paper, based on these typical models of complex network, a directed network model considering node connection in-direction is proposed, and the eigenvalue entropies of three matrices in the directed network is defined and studied, where the three matrices are adjacency matrix, in-degree Laplacian matrix and in-degree signless Laplacian matrix. The eigenvalue-based entropies of three matrices are calculated in directed nearest-neighbor coupling, directed small world, directed scale-free and directed random networks. Through the simulation experiment on the real directed network, the result shows that the eigenvalue entropy of the real directed network is between the eigenvalue entropy of directed scale-free network and directed small-world network.	[Sun, Yan; Zhao, Haixing; Liang, Jing; Ma, Xiujuan] Qinghai Normal Univ, Sch Comp, Xining, Peoples R China; [Sun, Yan] Qinghai Nationality Univ, Sch Comp, Xining, Peoples R China; [Sun, Yan; Zhao, Haixing; Liang, Jing; Ma, Xiujuan] State Key Lab Tibetan Intelligent Informat Proc &, Xining, Peoples R China	Qinghai Normal University; Qinghai Nationalities University	Zhao, HX (corresponding author), Qinghai Normal Univ, Sch Comp, Xining, Peoples R China.; Zhao, HX (corresponding author), State Key Lab Tibetan Intelligent Informat Proc &, Xining, Peoples R China.	h.x.zhao@163.com			National Natural Science Foundation of China [11661069, 61663041]; Science and Technology Plan of Qinghai Province, China [2019-ZJ-7012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Qinghai Province, China	Project supported by the National Natural Science Foundation of China (Grant Nos.11661069,61663041), the Science and Technology Plan of Qinghai Province, China(Grant No.2019-ZJ-7012).	[Anonymous], 2003, J NINGBO U NAT SCI E, V3, P228; Ayyaswamy SK, 2011, APPL ANAL DISCR MATH, V5, P37, DOI 10.2298/AADM101121030A; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Belkin M, 2002, ADV NEUR IN, V14, P585; BONCHEV D, 1977, J CHEM PHYS, V67, P4517, DOI 10.1063/1.434593; Broder A, 2000, COMPUT NETW, V33, P309, DOI 10.1016/S1389-1286(00)00083-9; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Chung F, 2005, ANN COMB, V9, P1, DOI 10.1007/s00026-005-0237-z; Cvetkovic D., 1980, SPECTRA GRAPHS THEOR; Dehmer M, 2012, MATCH-COMMUN MATH CO, V67, P147; Ebel H, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.035103; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Farkas IJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026704; Hansen K, 2009, J CHEM INF MODEL, V49, P2077, DOI 10.1021/ci900161g; IVANCIUC O, 1993, J MATH CHEM, V14, P21, DOI 10.1007/BF01164452; Ivanciuc O, 2001, J CHEM INF COMP SCI, V41, P536, DOI 10.1021/ci000086f; Ivanciuc O., 1999, ROUM CHEM Q REV, V7, P41; JUHASZ F, 1982, COMBINATORICA, V2, P153, DOI 10.1007/BF02579314; Klebanov L, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-9; Konstantinova EV, 1990, VYCHISL SISTEMY, V136, P38; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Li X., 2016, MATH FDN APPL GRAPH, P133; Mehta ML., 2001, REV RANDOM MATRICES; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P175, DOI 10.1007/BF02476948; MOWSHOWITZ A, 1968, B MATH BIOPHYS, V30, P225, DOI 10.1007/BF02476692; Murai T, 2003, SPECTRAL ANAL DIRECT; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Rada J, 2012, LINEAR MULTILINEAR A, V60, P323, DOI 10.1080/03081087.2011.596539; Radicchi F, 2012, UNDERST COMPLEX SYST, P233, DOI 10.1007/978-3-642-23068-4_7; Ramezanpour A, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036128; Randic M, 1997, J CHEM INF COMP SCI, V37, P1072, DOI 10.1021/ci970242r; Randic M., 2001, CHEMINFORM, V32, P147; RASHEVSKY N., 1955, BULL MATH BIOPHYS, V17, P229, DOI 10.1007/BF02477860; SABIDUSSI G, 1959, DUKE MATH J, V26, P693, DOI 10.1215/S0012-7094-59-02667-5; Schwartz N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.015104; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stanford, DAT SET EUR E MAIL N; Tadic B, 2001, PHYSICA A, V293, P273, DOI 10.1016/S0378-4371(01)00014-0; TRUCCO ERNESTO, 1956, BULL MATH BIOPHYS, V18, P129, DOI 10.1007/BF02477836; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhou DL, 2004, J PHYS CHEM A, V108, P4239, DOI 10.1021/jp037917f	41	2	2	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0251993	10.1371/journal.pone.0251993	http://dx.doi.org/10.1371/journal.pone.0251993			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153043	gold, Green Published			2022-12-26	WOS:000671691000023
J	Zebire, D; Menkir, A; Adetimirin, V; Mengesha, W; Meseka, S; Gedil, M				Zebire, Degife; Menkir, Abebe; Adetimirin, Victor; Mengesha, Wende; Meseka, Silvestro; Gedil, Melaku			Identifying suitable tester for evaluating Striga resistant lines using DArTseq markers and agronomic traits	PLOS ONE			English	Article							MAIZE INBRED LINES; GENETIC-DIVERSITY; COMBINING ABILITY; HERMONTHICA; SOFTWARE; POPULATIONS; PERFORMANCE; YIELD	A desirable tester that elicits greater genetic difference in Striga resistance among test crosses in a breeding program has not been reported. Therefore, this study was conducted to characterize 30 Striga resistant yellow endosperm maize inbred lines and three testers with varying resistance levels to Striga using DArTseq SNP markers and agronomic traits to identify a suitable tester for resistance hybrid breeding. Marker-based and agronomic trait-based genetic distances were estimated for yellow endosperm maize inbred lines and testers with varying resistance levels to Striga. The Marker-based cluster analysis separated the Striga resistant lines and testers into two distinct groups. Although the susceptible tester (T3) was the most distantly related to the 30 Striga resistant inbred lines, it exhibited a narrower range in genetic distance estimates and poor agronomic performance under Striga infestation in crosses with the resistant lines. In contrast, the resistant tester (T2) showed a broader range in genetic distance estimates in pairs with the 30 resistant lines. Also, it formed many high yielding hybrids with desirable traits under parasite pressure. Furthermore, the most significant positive association between agronomic trait-based and marker-based distance estimates (r = 0.389, P = 0.01) was observed when T2 has paired with the Striga resistant maize inbred lines. It thus appears that T2 may be used as a suitable tester to determine the breeding value of lines in hybrid maize resistance breeding programs. T2 was the most suitable tester, with a tolerant tester (T1) as an alternative tester to characterize the combining ability of Striga resistant maize inbred lines. This result can also encourage other breeders to investigate testers relative discriminating ability with varying levels of resistance in hybrid breeding for resistance to diseases, pests, and other parasitic plants.	[Zebire, Degife; Menkir, Abebe; Mengesha, Wende; Meseka, Silvestro; Gedil, Melaku] Int Inst Trop Agr IITA, Ibadan, Nigeria; [Zebire, Degife] Univ Ibadan, Pan Africa Univ Life & Earth Sci Inst, Ibadan, Nigeria; [Zebire, Degife] Arba Minch Univ, Coll Agr Sci, Dept Plant Sci, Arba Minch, Ethiopia; [Adetimirin, Victor] Univ Ibadan, Dept Agron, Ibadan, Nigeria	CGIAR; International Institute of Tropical Agriculture (IITA); University of Ibadan; Arba Minch University; University of Ibadan	Menkir, A (corresponding author), Int Inst Trop Agr IITA, Ibadan, Nigeria.	a.menkir@cgiar.org	Meseka, Silvestro/AAV-6090-2021		African Union; Bill and Malinda Gates Foundation [OPP1134248]	African Union; Bill and Malinda Gates Foundation	This report was part of PhD research of the first author, funded by African Union and the Bill and Malinda Gates Foundation (Grant number: OPP1134248), under the framework of Pan African University and the Stress Tolerant Maize for Africa (STMA), respectively.	Aci MM, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0655-2; Adu GB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214810; Ahuja SL, 2007, EUPHYTICA, V153, P87, DOI 10.1007/s10681-006-9244-y; Badu-Apraku B, 2013, CROP SCI, V53, P9, DOI 10.2135/cropsci2012.06.0381; Barrett BA, 1998, CROP SCI, V38, P1261, DOI 10.2135/cropsci1998.0011183X003800050025x; Betra FJ, 2003, GENETIC DIVERSITY SP; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cairns JE, 2012, ADV AGRON, V114, P1, DOI 10.1016/B978-0-12-394275-3.00006-7; Ceyhan E, 2008, AFR J BIOTECHNOL, V7, P2810; Dao A., 2014, GENETIC DIVERSITY IN, P1; Ertiro BT, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4173-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gichuru LN, 2013, BREEDING INVESTIGATI; GUTIERREZGAITAN MA, 1986, CROP SCI, V26, P99, DOI 10.2135/cropsci1986.0011183X002600010024x; Hallauer AR, 2010, HANDB PLANT BREED, V6, P383, DOI 10.1007/978-1-4419-0766-0_8; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Kim SK., 1991, COMBAT STRIGA AFRICA; Kling JG., 2000, BREEDING STRIGA RESI, P103; Li M. S., 2007, COMP 4 TESTERS EVALU; Linehan V, 2013, GLOBAL FOOD PRODUCTI; Liu K MS., 2005, POWERMARKER 3 25 STA; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Macauley H., 2015, FEED AFR, P36; Makumbi D, 2011, EUPHYTICA, V180, P143, DOI 10.1007/s10681-010-0334-5; Marone D, 2012, MOL GENET GENOMICS, V287, P741, DOI 10.1007/s00438-012-0714-8; Mengesha WA, 2017, PLANT BREEDING, V136, P338, DOI 10.1111/pbr.12479; Menkir A, 2006, PLANT BREEDING, V125, P131, DOI 10.1111/j.1439-0523.2006.01175.x; Menkir A, 2004, THEOR APPL GENET, V108, P1582, DOI 10.1007/s00122-004-1585-0; Menkir A, 2019, CROP SCI, V59, P2484, DOI 10.2135/cropsci2018.12.0749; Menkir A, 2010, CROP SCI, V50, P602, DOI 10.2135/cropsci2009.05.0247; Guimaraes LJM, 2012, CIENC RURAL, V42, P770, DOI 10.1590/S0103-84782012000500002; Mwimali M, 2016, EUPHYTICA, V208, P323, DOI 10.1007/s10681-015-1602-1; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira HS, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-018-2324-y; Pinto LR, 2003, EUPHYTICA, V134, P277, DOI 10.1023/B:EUPH.0000004946.15260.4a; Pritchard JK, 2000, GENETICS, V155, P945; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Rashid M, 2007, LINE X TESTER ANAL B; RUSSELL W. A., 1961, CROP SCI, V1, P393, DOI 10.2135/cropsci1961.0011183X000100060004x; SAS I, 2013, SAS USERS GUIDE VERS; Semagn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-113; Sharma J.R., 2006, STAT BIOMETRICAL TEC; Smale M., 2013, AFRICAN GREEN REVOLU, P165; SMITH JSC, 1992, ADV AGRON, V47, P85, DOI 10.1016/S0065-2113(08)60489-7; SMITH OS, 1986, CROP SCI, V26, P540, DOI 10.2135/cropsci1986.0011183X002600030023x; Spallek T, 2013, MOL PLANT PATHOL, V14, P861, DOI 10.1111/mpp.12058; Sprague G. F., 1942, JOUR AMER SOC AGRON, V34, P923; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tandon JP., 1967, EUPHYTICA, V16, P370; Vasal SK, 1992, HETEROTIC PATTERNS 9; Warburton ML, 2005, EUPHYTICA, V142, P97, DOI 10.1007/s10681-005-0817-y; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wende A, 2013, EUPHYTICA, V191, P269, DOI 10.1007/s10681-012-0826-6; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Xie Y, 2006, J INTEGR PLANT BIOL, V48, P1069, DOI 10.1111/j.1744-7909.2006.00298.x; Yang SY, 2006, THEOR APPL GENET, V113, P585, DOI 10.1007/s00122-006-0317-z; Yoseph B., 2014, AFR J BIOTECHNOL, V4, P596; Zebire D, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10091276	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253481	10.1371/journal.pone.0253481	http://dx.doi.org/10.1371/journal.pone.0253481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143833	gold, Green Published			2022-12-26	WOS:000671690700064
J	Karthigesu, K; Sandrasegarampillai, B; Arasaratnam, V				Karthigesu, Kandeepan; Sandrasegarampillai, Balakumar; Arasaratnam, Vasanthy			Factors influencing the iodine status of children aged 12 to 59 months from Jaffna District, Sri Lanka in the post-iodization era; a descriptive, cross-sectional study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ENDEMIC GOITER; DEFICIENCY; SUPPLEMENTATION; GROWTH; REGION; SALT; EPIDEMIOLOGY; DISORDERS; EXCRETION	Background Iodine status, including Iodine Deficiency (ID) of the children aged 12-59 months of Jaffna District, Sri Lanka, have never been studied. This study thus aimed to assess ID among children aged 12-59 months by monitoring the Urinary Iodine Concentrations (UIC), the prevalence of goitre, and the factors causing ID. Method A cross-sectional study was conducted among 846 children aged 12-59 months in Jaffna District, Sri Lanka. Sociodemographic characteristics and other factors were collected using an interviewer-administered questionnaire. Dietary pattern of children was obtained using semi-quantitative food frequency questionnaire. We performed urinary iodine estimation and physical examinations to detect the goitre, according to the World Health Organization criteria. A multivariate logistic linear regression model was used to identify the factors that causing ID. Result The median UIC was 146.4 mu g/L (interquartile range = 112.6-185.3 mu g/L). Based on the UIC (<100 mu g/L), 17.8% had ID, of which 15.7% and 2.1% had mild and moderate ID. The mean consumption of iodine from food was 128.7 (+/- 20.2) mu g/day. Gender variation had no influence on ID (p>0.05). Median UIC was significantly associated with living area, wealth status, type of drinking water, and method of iodized salt usage. A higher percentage of ID was significantly associated with younger age [AOR 2.32 (95% CI: 1.31-4.10)], urban area [AOR 1.94 (95% CI 1.27-2.96)], inland regions [AOR 3.20 (95% CI 1.85-5.55)], improper method of iodized salt usage [AOR 3.63 (95% CI: 1.38-9.56)], and low consumption of iodine-containing foods. The neck palpation revealed that only three children had goitre (0.4%). Conclusion This study revealed that high ID among the children in Jaffna children was due to improper usage of iodized salt, even though the iodized salt is freely available in the region, living area, and age, while the prevalence of goitre was not significantly identified as a public health problem.	[Karthigesu, Kandeepan; Sandrasegarampillai, Balakumar; Arasaratnam, Vasanthy] Univ Jaffna, Dept Biochem, Fac Med, Jaffna, Sri Lanka	University Jaffna	Karthigesu, K (corresponding author), Univ Jaffna, Dept Biochem, Fac Med, Jaffna, Sri Lanka.	kkandeepan@univ.jfn.ac.lk	Karthigesu, Kandeepan/AAE-6388-2022	Karthigesu, Kandeepan/0000-0002-2893-7888	National Research Council, Sri Lanka, a government organization [NRC-13-121]	National Research Council, Sri Lanka, a government organization	K.K, S.B, and V.A received the fund from National Research Council, Sri Lanka, a government organization. The principal investigator is V.A. The Grant number is NRC-13-121. The URL is https://www.nrc.gov.lk/.The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Z, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3914-z; Abeysuriya V, 2012, CEYLON MED J, V57, P69, DOI 10.4038/cmj.v57i2.4459; Ahmed M, 2014, J FAM COMMUNITY MED, V21, P48, DOI 10.4103/2230-8229.128783; Als C, 2000, EUR J ENDOCRINOL, V143, P629, DOI 10.1530/eje.0.1430629; Andersson M, 2012, J NUTR, V142, P744, DOI 10.3945/jn.111.149393; Angermayr L, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003819.pub3; [Anonymous], 2014, VIT MIN NUTR INF SYS; [Anonymous], 2020, EC SOC STAT SRI LANK EC SOC STAT SRI LANK; [Anonymous], 2001, FOOD NUTR BOARD I ME, P258, DOI [10.17226/10026, DOI 10.17226/10026]; [Anonymous], 2007, ASS IOD DEF DIS MON; Asfaw A, 2020, BMC NUTR, V6, DOI 10.1186/s40795-020-00345-8; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Biban B G, 2017, Curr Health Sci J, V43, P103, DOI 10.12865/CHSJ.43.02.01; Caylan N., 2019, HDB FAMINE STARVATIO, P1809, DOI [10.1007/978-3-319-55387-0_46, DOI 10.1007/978-3-319-55387-0_46]; Chandrasinghe P., 2015, WORLD J ENDOC SURG, V7, P55; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166681; de Benoistde Benoist B, 2004, IODINE STATUS WORLDW; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Diosady L. L., 1997, Food and Nutrition Bulletin, V18, P388; Eastman CJ., 2000, ENDOTEXT; Fernando M A, 1989, Asia Pac J Public Health, V3, P11, DOI 10.1177/101053958900300103; Fernando R, 2015, CEYLON MED J, V60, P41, DOI 10.4038/cmj.v60i2.8150; Fernando R., 2012, INT J INTERN MED, V1, P17; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Fleury Y, 2001, J CLIN ENDOCR METAB, V86, P750, DOI 10.1210/jc.86.2.750; Fordyce FM, 2000, SCI TOTAL ENVIRON, V263, P127, DOI 10.1016/S0048-9697(00)00684-7; Ghirri P, 2014, NUTRIENTS, V6, P382, DOI 10.3390/nu6010382; Gopalakrishnan T, 2020, POPUL ENVIRON, V42, P129, DOI 10.1007/s11111-020-00350-w; Gordon RC, 2009, AM J CLIN NUTR, V90, P1264, DOI 10.3945/ajcn.2009.28145; Habyarimana J. B., 2015, Sustainable Agriculture Research, V4, P78; Hailu S, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0158-4; Hassen HY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221106; Hernando V., 2015, IODINE DEFICIENCY DI, V4, P1, DOI [10.4172/2167-7948.100017, DOI 10.4172/2167-7948.100017]; Hettiarachchi M, 2010, BRIT J NUTR, V103, P1015, DOI 10.1017/S0007114509992728; Household Income and Expenditure Survey of Sri Lanka, 2016, HOUS INC EXP SURV SR HOUS INC EXP SURV SR; Jayatisa R, 2013, SRI LANKA J DIABETES, V3, P4, DOI [10.4038/sjdem.v3i1.5469, DOI 10.4038/SJDEM.V3I1.5469]; Jayatissa R., 2005, CEYLON MEDICAL JOURNAL, V50, P144; Jayatissa R., 2012, 3 NATL SURVEY IODINE; Jayatissa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041109; Jayatissa R, 2019, ANN NY ACAD SCI, V1446, P139, DOI 10.1111/nyas.13987; Jayawardena R, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-63; Kandeepan K., 2017, BREASTFEEDING PRACTI, V54, P172, DOI [10.21048/ijnd.2017.54.2.14899, DOI 10.21048/IJND.2017.54.2.14899]; Kandeepan K, 2016, PROC FOOD SCI, V6, P220, DOI 10.1016/j.profoo.2016.02.016; Kapil U, 2014, ASIA PAC J CLIN NUTR, V23, P278, DOI [10.6133/apjcn.2014.23.2.03, 10.6133/apjcn.2013.23.2.03]; Kibatu G, 2014, ETHIOP J HEALTH SCI, V24, P109, DOI 10.4314/ejhs.v24i2.2; Kim JY, 2000, YONSEI MED J, V41, P22, DOI 10.3349/ymj.2000.41.1.22; Konrade I, 2014, MED LITH, V50, P124, DOI 10.1016/j.medici.2014.06.003; Lazarus JH, 2015, ENVIRON GEOCHEM HLTH, V37, P605, DOI 10.1007/s10653-015-9681-4; Ma ZF, 2016, J CLIN ENDOCR METAB, V101, P1737, DOI 10.1210/jc.2015-3591; Macedo MD, 2012, CAD SAUDE PUBLICA, V28, P346, DOI 10.1590/S0102-311X2012000200013; Mahagamage M. G. Y. L., 2019, Journal of Water and Land Development, P3; Mardani M., 2015, J HLTH SCI SURVEIL S, V3, P71; Matthys B, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-50; Mezgebu Y, 2012, ETHIOP J HEALTH SCI, V22, P196; Moghames P, 2016, NUTR J, V15, DOI 10.1186/s12937-015-0121-1; Morales-Suarez-Varela M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10121884; NATH SK, 1992, INT J VITAM NUTR RES, V62, P66; Nutrition Landscape Information System (NLiS) Worls Health Organization, HOUS CONS AD IOD SAL HOUS CONS AD IOD SAL; Pino S, 1996, CLIN CHEM, V42, P239; Rana R, 2013, J FOOD SCI TECH MYS, V50, P1212, DOI 10.1007/s13197-011-0436-7; Rossi R, 1998, J ENDOCRINOL, V159, P373, DOI 10.1677/joe.0.1590373; Sandell E. B., 1937, MICROCHIM ACTA, V1, P9, DOI [10.1007/BF01476194, DOI 10.1007/BF01476194]; Shim JS, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014009; Sikdar KY., 2017, J PHARM SCI-US, V15, P161, DOI [10.3329/dujps.v15i2.30931, DOI 10.3329/DUJPS.V15I2.30931]; Smith TJ., 1990, CLIN METHODS HIST PH, V3rd edition; Smyth PPA, 2011, ENVIRON GEOCHEM HLTH, V33, P389, DOI 10.1007/s10653-011-9384-4; Soldin OP, 2002, CLIN BIOCHEM, V35, P575, DOI 10.1016/S0009-9120(02)00406-X; Tenpenny KE, 2009, ENDOCR PRACT, V15, P298, DOI 10.4158/EP08330.ORR1; Volzke H, 2013, THYROID, V23, P346, DOI 10.1089/thy.2012.0416; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wah-Yun Low, 2002, Asia Pac J Public Health, V14, P110, DOI 10.1177/101053950201400210; Wang YL, 2009, INDIAN J MED RES, V130, P413; Wang ZF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020206; Wayne EJ, 1964, CLIN ASPECTS IODINE; Wolff J, 1998, PHARMACOL REV, V50, P89; World Health Organization, 2002, GLOB STRAT INF YOUNG; Yoganathan Thirunavukkarasu, 2015, Indian J Endocrinol Metab, V19, P817, DOI 10.4103/2230-8210.167563; Zimmermann M, 2000, AM J CLIN NUTR, V71, P88; Zimmermann MB, 2008, LANCET, V372, P1251, DOI 10.1016/S0140-6736(08)61005-3; Zou Y, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005484; Zoysa GED., 2015, GALL MED J, V20, P10, DOI [10.4038/gmj.v20i1.7921, DOI 10.4038/GMJ.V20I1.7921]	81	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252548	10.1371/journal.pone.0252548	http://dx.doi.org/10.1371/journal.pone.0252548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138886	Green Published, gold			2022-12-26	WOS:000671690200106
J	Amendola, C; Lacerenza, M; Pirovano, I; Contini, D; Spinelli, L; Cubeddu, R; Torricelli, A; Re, R				Amendola, Caterina; Lacerenza, Michele; Pirovano, Ileana; Contini, Davide; Spinelli, Lorenzo; Cubeddu, Rinaldo; Torricelli, Alessandro; Re, Rebecca			Optical characterization of 3D printed PLA and ABS filaments for diffuse optics applications	PLOS ONE			English	Article							INFRARED SPECTROSCOPY SYSTEM; BLOOD-FLOW; SENSITIVITY; TISSUE; BRAIN	The interest for Fused Deposition Modelling (FDM) in the field of Diffuse Optics (DO) is rapidly increasing. The most widespread FDM materials are polylactic acid (PLA) and acrylonitrile butadiene styrene (ABS), thanks to their low cost and easiness-to-print. This is why, in this study, 3D printed samples of PLA and ABS materials were optically characterized in the range from the UV up to the IR wavelengths, in order to test their possible employment for probe construction in DO applications. To this purpose, measurements with Near Infrared Spectroscopy and Diffuse Correlation Spectroscopy techniques were considered. The results obtained show how the material employed for probe construction can negatively affect the quality of DO measurements.	[Amendola, Caterina; Lacerenza, Michele; Pirovano, Ileana; Contini, Davide; Cubeddu, Rinaldo; Torricelli, Alessandro; Re, Rebecca] Politecn Milan, Dipartimento Fis, Milan, Italy; [Spinelli, Lorenzo; Cubeddu, Rinaldo; Torricelli, Alessandro; Re, Rebecca] CNR, Ist Foton & Nanotecnol IFN, Milan, Italy	Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fotonica e Nanotecnologie (IFN-CNR)	Amendola, C (corresponding author), Politecn Milan, Dipartimento Fis, Milan, Italy.	caterina.amendola@polimi.it	Pirovano, Ileana/AEY-7428-2022	PIROVANO, Ileana/0000-0003-4905-3990; amendola, caterina/0000-0002-6738-9589; Re, Rebecca/0000-0002-9521-8066	European Union [101016087]	European Union(European Commission)	This study was partially supported by the European Union's Horizon 2020 research and innovation programme, grant agreement number 101016087.The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.There was no additional external funding received for this study.	Adams M.E., 1993, ACRYLONITRILE BUTADI, V6; BAKR NA, 1995, J MATER RES, V10, P2653, DOI 10.1557/JMR.1995.2653; Bangalore-Yogananda CG, 2018, BIOMED OPT EXPRESS, V9, P131, DOI 10.1364/BOE.9.000131; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Durduran T, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/7/076701; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Feng J, 2020, ACS APPL MATER INTER, V12, P20287, DOI 10.1021/acsami.0c03903; Hutchinson MH, 2006, J POLYM ENVIRON, V14, P119, DOI 10.1007/s10924-006-0001-z; Jeong HY, 2020, NANOPHOTONICS-BERLIN, V9, P1139, DOI 10.1515/nanoph-2019-0483; Johansson J, 2002, APPL SPECTROSC, V56, P725, DOI 10.1366/000370202760077676; Lacerenza M, 2020, BIOMED OPT EXPRESS, V11, P5934, DOI 10.1364/BOE.403327; Martelli F., 2010, LIGHT PROPAGATION OT; Milej D, 2016, BIOMED OPT EXPRESS, V7, P4514, DOI 10.1364/BOE.7.004514; Neher B., 2018, MAT SCI APPL, V9, P246; Phan P, 2016, BIOMED OPT EXPRESS, V7, P4424, DOI 10.1364/BOE.7.004424; Pirovano I, 2020, BIOMED OPT EXPRESS, V11, P240, DOI 10.1364/BOE.380996; Re R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18010264; SEARLE ND, 1989, J POLYM SCI POL CHEM, V27, P1341, DOI 10.1002/pola.1989.080270418; Solomon IJ, 2021, MATER TODAY-PROC, V37, P509, DOI 10.1016/j.matpr.2020.05.484; Torricelli A, 2015, CHEM ENGINEER TRANS, V44, P43, DOI 10.3303/CET1544008; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Vyavahare S, 2020, RAPID PROTOTYPING J, V26, P176, DOI 10.1108/RPJ-04-2019-0106; Wittbrodt B, 2015, ADDIT MANUF, V8, P110, DOI 10.1016/j.addma.2015.09.006; Zhang HC, 2015, RSC ADV, V5, P4639, DOI 10.1039/c4ra14538k	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253181	10.1371/journal.pone.0253181	http://dx.doi.org/10.1371/journal.pone.0253181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133454	Green Published, gold			2022-12-26	WOS:000671682700017
J	Broughton, RK; Bullock, JM; George, C; Hill, RA; Hinsley, SA; Maziarz, M; Melin, M; Mountford, JO; Sparks, TH; Pywell, RF				Broughton, Richard K.; Bullock, James M.; George, Charles; Hill, Ross A.; Hinsley, Shelley A.; Maziarz, Marta; Melin, Markus; Mountford, J. Owen; Sparks, Tim H.; Pywell, Richard F.			Long-term woodland restoration on lowland farmland through passive rewilding	PLOS ONE			English	Article							ABANDONED FARMLAND; AGRICULTURAL LAND; BIRD COMMUNITIES; SEED DISPERSERS; MARSH TIT; HABITAT; BIODIVERSITY; CHRONOSEQUENCES; CONSEQUENCES; CONSERVATION	Natural succession of vegetation on abandoned farmland provides opportunities for passive rewilding to re-establish native woodlands, but in Western Europe the patterns and outcomes of vegetation colonisation are poorly known. We combine time series of field surveys and remote sensing (lidar and photogrammetry) to study woodland development on two farmland fields in England over 24 and 59 years respectively: the New Wilderness (2.1 ha) abandoned in 1996, and the Old Wilderness (3.9 ha) abandoned in 1961, both adjacent to ancient woodland. Woody vegetation colonisation of the New Wilderness was rapid, with 86% vegetation cover averaging 2.9 m tall after 23 years post-abandonment. The Old Wilderness had 100% woody cover averaging 13.1 m tall after 53 years, with an overstorey tree-canopy (>= 8 m tall) covering 91%. By this stage, the structural characteristics of the Old Wilderness were approaching those of neighbouring ancient woodlands. The woody species composition of both Wildernesses differed from ancient woodland, being dominated by animal-dispersed pedunculate oak Quercus robur and berry-bearing shrubs. Tree colonisation was spatially clustered, with wind-dispersed common ash Fraxinus excelsior mostly occurring near seed sources in adjacent woodland and hedgerows, and clusters of oaks probably resulting from acorn hoarding by birds and rodents. After 24 years the density of live trees in the New Wilderness was 132/ha (57% oak), with 390/ha (52% oak) in the Old Wilderness after 59 years; deadwood accounted for 8% of tree stems in the former and 14% in the latter. Passive rewilding of these 'Wilderness' sites shows that closed-canopy woodland readily re-established on abandoned farmland close to existing woodland, it was resilient to the presence of herbivores and variable weather, and approached the height structure of older woods within approximately 50 years. This study provides valuable long-term reference data in temperate Europe, helping to inform predictions of the potential outcomes of widespread abandonment of agricultural land in this region.	[Broughton, Richard K.; Bullock, James M.; George, Charles; Hinsley, Shelley A.; Mountford, J. Owen; Pywell, Richard F.] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Hill, Ross A.] Bournemouth Univ, Dept Life & Environm Sci, Talbot Campus, Poole, Dorset, England; [Maziarz, Marta] Polish Acad Sci, Museum & Inst Zool, Warsaw, Poland; [Melin, Markus] Nat Resources Inst Finland, Joensuu, Finland; [Sparks, Tim H.] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Sparks, Tim H.] Univ Cambridge, Museum Zool, Cambridge, England	UK Centre for Ecology & Hydrology (UKCEH); Bournemouth University; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; Natural Resources Institute Finland (Luke); Poznan University of Life Sciences; University of Cambridge	Broughton, RK (corresponding author), UK Ctr Ecol & Hydrol, Wallingford, Oxon, England.	rbrou@ceh.ac.uk	Bullock, James M/F-9997-2011; Pywell, Richard F/E-8738-2010; Hill, Ross A/B-3871-2009; Melin, Markus/H-6112-2017	Pywell, Richard F/0000-0001-6431-9959; Melin, Markus/0000-0001-7290-9203; Broughton, Richard/0000-0002-6838-9628; Maziarz, Marta/0000-0002-2921-5713	Natural Environment Research Council (NERC); Biotechnology and Biological Sciences Research Council (BBSRC) [NE/N018125/1]	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RKB, CG and RFP were funded by the Natural Environment Research Council (NERC) and the Biotechnology and Biological Sciences Research Council (BBSRC) under research programme NE/N018125/1 LTS-M ASSIST Achieving Sustainable Agricultural Systems www.assist.ceh.ac.uk.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold Henry, 2005, English Nature Research Reports, V613, P86; Ashwood F, 2019, RESTOR ECOL, V27, P1381, DOI 10.1111/rec.13003; Axelsson P., 2000, INT ARCH PHOTOGRAMM, V33, P110, DOI DOI 10.1016/J.ISPRSJPRS.2005.10.005; Bellamy PE, 2009, BIRD STUDY, V56, P338, DOI 10.1080/00063650902806914; Benayas JMR, 2008, FRONT ECOL ENVIRON, V6, P329, DOI 10.1890/070057; Benjamin K, 2005, LANDSCAPE ECOL, V20, P627, DOI 10.1007/s10980-005-0068-2; Betts MG, 2017, NATURE, V547, P441, DOI 10.1038/nature23285; Broughton RK, 2020, BIRD STUDY, V67, P269, DOI 10.1080/00063657.2020.1863333; Broughton RK, 2020, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-020-02906-0; Broughton RK, 2014, BIRD STUDY, V61, P404, DOI 10.1080/00063657.2014.934193; Broughton RK, 2013, ECOL INFORM, V14, P25, DOI 10.1016/j.ecoinf.2012.11.012; Broughton RK, 2012, CONDOR, V114, P812, DOI 10.1525/cond.2012.110171; Broughton RK, 2011, BIRD STUDY, V58, P229, DOI 10.1080/00063657.2011.582641; Broughton RK, 2021, TREE SHRUB VEGETATIO, DOI [10.5285/65-db979-eebd-4331-94f6-52f0844fb3cb, DOI 10.5285/65-DB979-EEBD-4331-94F6-52F0844FB3CB]; Browne SJ, 2004, BIRD STUDY, V51, P1, DOI 10.1080/00063650409461326; Burton V, 2018, FOREST ECOL MANAG, V430, P366, DOI 10.1016/j.foreco.2018.08.003; Casey Dorothy, 2020, British Wildlife, V31, P179; Cerqueira Y., 2015, REWILDING EUROPEAN L, DOI [10.1007/978-3-319-12039-3_3, DOI 10.1007/978-3-319-12039-3_3]; Cook-Patton SC, 2020, NATURE, V585, P545, DOI 10.1038/s41586-020-2686-x; Cooke A, 2019, MUNTJAC WATER DEER N; Corlett RT, 2016, TRENDS ECOL EVOL, V31, P453, DOI 10.1016/j.tree.2016.02.017; Cramer V. A., 2007, OLD FIELDS DYNAMICS; den Ouden Jan, 2005, P223, DOI 10.1079/9780851998060.0223; Fitzgibbon CD, 1997, J APPL ECOL, V34, P530, DOI 10.2307/2404895; Fuentes-Montemayor E, 2012, BIOL CONSERV, V153, P265, DOI 10.1016/j.biocon.2012.04.019; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gibbs JP, 1998, LANDSCAPE ECOL, V13, P263, DOI 10.1023/A:1008056424692; Graham L., 2019, ECOLOGY HEDGEROWS FI, P72; Gregg R, 2021, NERR094 NAT ENGL RES NERR094 NAT ENGL RES, Vsecond; Grime J. P., 2014, COMP PLANT ECOLOGY F; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harmer R, 2001, BIOL CONSERV, V101, P291, DOI 10.1016/S0006-3207(01)00072-6; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Hermy M, 2007, ECOL RES, V22, P361, DOI 10.1007/s11284-007-0354-3; Heywood L., 2005, 10 YEARS CHANGE WOOD, P44; Hill M.O., 2004, PLANTATT ATTRIBUTES; Hill RA, 2010, APPL VEG SCI, V13, P86, DOI 10.1111/j.1654-109X.2009.01053.x; Hill RA, 2009, ISPRS J PHOTOGRAMM, V64, P223, DOI 10.1016/j.isprsjprs.2008.12.004; Hinsley Shelley A., 2005, English Nature Research Reports, V613, P75; HM Government, 2018, GREEN FUT OUR 25 YEA; Hodge SJ, 1998, FORESTRY, V71, P99, DOI 10.1093/forestry/71.2.99; Holt CA, 2012, BIRD STUDY, V59, P416, DOI 10.1080/00063657.2012.722191; Jackman S, 2020, PSCL CLASSES METHODS; JENSEN TS, 1986, OECOLOGIA, V70, P214, DOI 10.1007/BF00379242; Jogiste K., 2015, RESTORATION BOREAL T, P187; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Kirby K, 2020, Q J FOREST, V114, P230; Kirby K., 2005, 10 YEARS CHANGE WOOD, P27; Kirby KJ, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P46, DOI 10.1079/9781780643373.0046; Kollmann J, 1996, VEGETATIO, V125, P193, DOI 10.1007/BF00044651; Kopecky M, 2009, APPL VEG SCI, V12, P251, DOI 10.1111/j.1654-109X.2009.01023.x; Lewandowski P, 2021, FOREST ECOL MANAG, V481, DOI 10.1016/j.foreco.2020.118693; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Maltamo M, 2014, MANAG FOR ECOSYST, V27, P1, DOI 10.1007/978-94-017-8663-8; Martinez D, 2017, ECOSYSTEMS, V20, P616, DOI 10.1007/s10021-016-0043-6; McRoberts RE, 2007, REMOTE SENS ENVIRON, V110, P412, DOI 10.1016/j.rse.2006.09.034; Meli P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171368; Melin M, 2018, LANDSCAPE ECOL, V33, P895, DOI 10.1007/s10980-018-0639-7; MELLANBY K, 1968, J APPL ECOL, V5, P359, DOI 10.2307/2401566; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; Morel L, 2020, ECOL APPL, V30, DOI 10.1002/eap.2007; MYSTER RW, 1993, BOT REV, V59, P251, DOI 10.1007/BF02857418; National Forest Foundation, 2020, NO AR FOR FUND; OPDAM P, 1985, BIOL CONSERV, V34, P333, DOI 10.1016/0006-3207(85)90039-4; Perino A, 2019, SCIENCE, V364, P351, DOI 10.1126/science.aav5570; Peterken G. F, 1993, WOODLAND CONSERVATIO; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Rackham O, 2006, WOODLANDS; Rodwell J., 1994, FORESTRY COMMISSION, V112; Rounsevell MDA, 2006, AGR ECOSYST ENVIRON, V114, P57, DOI 10.1016/j.agee.2005.11.027; Rusina S, 2021, NEW FOREST, V52, P559, DOI 10.1007/s11056-020-09809-y; Ruskule A, 2016, NEW FOREST, V47, P587, DOI 10.1007/s11056-016-9532-x; Ruskule A, 2012, AGROFOREST SYST, V85, P215, DOI 10.1007/s10457-012-9495-7; Sanderson FJ, 2013, AGR ECOSYST ENVIRON, V168, P16, DOI 10.1016/j.agee.2013.01.015; Silver WL, 2000, RESTOR ECOL, V8, P394, DOI 10.1046/j.1526-100x.2000.80054.x; Sparks T.H., 2007, ASP APPL BIOL, V82, P77; STEELE RC, 1973, MONKS WOOD NATURE RE; Torres A, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0433; Tree Isabella, 2017, Biodiversity, V18, P206; Ustaoglu E, 2018, ENVIRON REV, V26, P396, DOI 10.1139/er-2018-0001; van der Zanden EH, 2017, LAND USE POLICY, V62, P290, DOI 10.1016/j.landusepol.2017.01.003; Van Uytvanck J, 2008, BIOL CONSERV, V141, P78, DOI 10.1016/j.biocon.2007.09.001; Vanhinsbergh D, 2002, AGR ECOSYST ENVIRON, V92, P123, DOI 10.1016/S0167-8809(01)00301-2; Walker K. J., 2000, Aspects of Applied Biology, P337; Walker KJ., 2005, 10 YEARS CHANGE WOOD, P48; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; Wei XR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032054; Willi JC, 2005, BIODIVERS CONSERV, V14, P3215, DOI 10.1007/s10531-004-0443-3	90	9	10	10	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252466	10.1371/journal.pone.0252466	http://dx.doi.org/10.1371/journal.pone.0252466			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133452	Green Published, Green Accepted, gold			2022-12-26	WOS:000671682700006
J	Carpes, LS; Nicoletto, BB; Canani, LH; Rheinhemer, J; Crispim, D; Souza, GC				Carpes, Larissa Salomoni; Nicoletto, Bruna Bellincanta; Canani, Luis Henrique; Rheinhemer, Jakeline; Crispim, Daisy; Souza, Gabriela Correa			Could serum zonulin be an intestinal permeability marker in diabetes kidney disease?	PLOS ONE			English	Article							GUT MICROBIOTA; IRON STATUS; INFLAMMATION; BARRIER; HEALTH; ASSOCIATION; ACTIVATION	Zonulin is a protein associated with the tight junction complex opening at the intestinal epithelium, previously linked to obesity, cardiovascular diseases, type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). However, its role in CKD has not been totally elucidated. This study aimed to evaluate zonulin levels in subjects with diabetic kidney disease (DKD). This case-control study included two cases groups: 1) Advanced DKD cases: T2DM patients with estimated glomerular filtration rate (eGFR) <60ml/min/1.73m(2); 2) Albuminuric T2DM cases: diabetic patients with urinary albumin excretion (UAE) >30mg/g creatinine, but with eGFR>60ml/min/1.73m(2). Two control groups were also included: 1) T2DM controls: patients with T2DM without impaired kidney function; 2) Non-T2DM controls: subjects without T2DM and normal renal function. Serum levels of zonulin were measured by ELISA. Eighty-six individuals were included. Zonulin levels was different among study groups (P = 0.003). T2DM controls presented higher zonulin levels than non-T2DM controls [(131.35 (83.0-170.5) vs. 87.25 (54.7-111.8), P = 0.018] and advanced DKD cases [63.72 (45.03-106.0); P = 0.007]. Zonulin showed a positive correlation with eGFR (r = 0.222; P = 0.040), total cholesterol (r = 0.299; P = 0.034), LDL (r = 0.258; P = 0.021), and negative with albuminuria (r = -0.243; P = 0.024) and body fat (r = -0.271; P = 0.014). In the multivariate logistic regression analyses, zonulin levels were independently associated to renal outcomes [OR 0.99 (0.98-0.99, P = 0.012)] after 5-year inclusion. In conclusion, increased zonulin levels in patients with TD2M without renal disease suggest an impaired intestinal permeability. Moreover, its association with renal outcomes could indicate its use as a disease monitoring marker. However, the mechanisms behind this association should be better understood.	[Carpes, Larissa Salomoni; Souza, Gabriela Correa] Univ Fed Rio Grande do Sul, Fac Med, Post Grad Program Food Nutr & Hlth, Porto Alegre, RS, Brazil; [Nicoletto, Bruna Bellincanta] Univ Caxias do Sul, Life Sci Knowledge Area, Caxias Do Sul, RS, Brazil; [Canani, Luis Henrique; Rheinhemer, Jakeline; Crispim, Daisy] Univ Fed Rio Grande do Sul, Fac Med, Post Grad Program Med Sci Endocrinol, Porto Alegre, RS, Brazil; [Canani, Luis Henrique; Crispim, Daisy] Hosp Clin Porto Alegre, Endocrine Div, Porto Alegre, RS, Brazil; [Souza, Gabriela Correa] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Souza, GC (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Post Grad Program Food Nutr & Hlth, Porto Alegre, RS, Brazil.; Souza, GC (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Food & Nutr Res Ctr, Porto Alegre, RS, Brazil.	gcsouza@hcpa.edu.br		Salomoni Carpes, Larissa/0000-0002-0818-5383	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundo de Incentivo a Pesquisa e Eventos at the Hospital de Clinicas de Porto Alegre [FIPE 2018-0421]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundo de Incentivo a Pesquisa e Eventos at the Hospital de Clinicas de Porto Alegre	This study was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - www.cnpq.br) and Fundo de Incentivo a Pesquisa e Eventos (FIPE 2018-0421) at the Hospital de Clinicas de Porto Alegre (www.hcpa.edu.br).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obaide MAI, 2017, J CLIN MED, V6, DOI 10.3390/jcm6090086; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; Barbaro MR, 2020, GUT, V69, P1966, DOI 10.1136/gutjnl-2019-319281; Borges NA, 2016, J RENAL NUTR, V26, P396, DOI 10.1053/j.jrn.2016.07.005; Carnevale R, 2017, NUTR METAB CARDIOVAS, V27, P890, DOI 10.1016/j.numecd.2017.06.007; Castillo-Rodriguez E, 2018, TOXINS, V10, DOI 10.3390/toxins10070300; Ciccia F, 2017, ANN RHEUM DIS, V76, P1123, DOI 10.1136/annrheumdis-2016-210000; Demir E, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010024; Dschietzig TB, 2016, CLIN LAB, V62, P2443, DOI 10.7754/Clin.Lab.2016.160512; Fasano A, 2000, LANCET, V355, P1518, DOI 10.1016/S0140-6736(00)02169-3; Fasano A, 2011, PHYSIOL REV, V91, P151, DOI 10.1152/physrev.00003.2008; Pereira NBF, 2020, J NEPHROL, V33, P1049, DOI 10.1007/s40620-020-00819-9; Ficek J, 2017, INT UROL NEPHROL, V49, P717, DOI 10.1007/s11255-016-1495-5; Hasslacher C., 2018, J DIABETES METAB DIS, V5, P58, DOI [10.15406/jdmdc.2018.05.00138, DOI 10.15406/JDMDC.2018.05.00138]; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Karatas A, 2019, ACTA MEDICA MEDITERR, V35, P1061, DOI 10.19193/0393-6384_2019_2_162; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Leech B, 2019, INT J CLIN PRACT, V73, DOI 10.1111/ijcp.13385; Leech B, 2019, ADV INTEGR MED, V6, P23, DOI 10.1016/j.aimed.2018.08.003; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Loffredo L, 2020, ANTIOXID REDOX SIGN, V33, P761, DOI 10.1089/ars.2020.8109; Lukaszyk E, 2018, INT UROL NEPHROL, V50, P121, DOI 10.1007/s11255-017-1741-5; Mafra D, 2014, FUTURE MICROBIOL, V9, P399, DOI 10.2217/fmb.13.165; Malyszko J, 2014, TRANSPL P, V46, P2644, DOI 10.1016/j.transproceed.2014.09.018; Moreno-Navarrete JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037160; Nallu A, 2017, TRANSL RES, V179, P24, DOI 10.1016/j.trsl.2016.04.007; Nicoletto BB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165177; Ohlsson B, 2019, EXP THER MED, V17, P2883, DOI 10.3892/etm.2019.7303; Ohlsson B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030582; Ramos CI, 2020, J RENAL NUTR, V30, P31, DOI 10.1053/j.jrn.2019.02.004; Ramos CI, 2019, NEPHROL DIAL TRANSPL, V34, P1876, DOI 10.1093/ndt/gfy171; Sabatino A, 2015, NEPHROL DIAL TRANSPL, V30, P924, DOI 10.1093/ndt/gfu287; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Singh P, 2019, UNITED EUR GASTROENT, V7, P709, DOI 10.1177/2050640619826419; Sturgeon C, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1251384; Tajik N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15831-7; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Terpstra Matty L, 2016, World J Nephrol, V5, P378, DOI 10.5527/wjn.v5.i4.378; Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Zak-Golab A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/674106; Zhang D, 2014, DIABETES RES CLIN PR, V106, P312, DOI 10.1016/j.diabres.2014.08.017	43	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253501	10.1371/journal.pone.0253501	http://dx.doi.org/10.1371/journal.pone.0253501			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170951	Green Published, gold			2022-12-26	WOS:000671694400027
J	Edvardsson, K; Davey, MA; Powell, R; Axmon, A				Edvardsson, Kristina; Davey, Mary-Ann; Powell, Rhonda; Axmon, Anna			Sex ratios at birth in Australia according to mother's country of birth: A national study of all 5 614 847 reported live births 1997-2016	PLOS ONE			English	Article							UNITED-STATES; SON PREFERENCE; INDIA; POPULATIONS; TERMINATION; IMBALANCES; IMMIGRANTS; SUBGROUPS; PREGNANCY; SELECTION	Objectives Son preference and sex selective practices have resulted in a deficit of girls in several countries, primarily across Asia. Emerging evidence indicates that son preference survives migration to Western high-income countries. The objective of this study was to assess male-to-female (M/F) ratios at birth per mother's country of birth in Australia 1997-2016, in total and by parity, and by states/territories and over time. Methods Data for this national population-based cross-sectional study were obtained from the National Perinatal Data Collection (NPDC) and included all live births in Australia 1997-2016 (N = 5 614 847). M/F ratios with 95% Confidence Intervals were estimated. Results The M/F ratio for births to Australian-born mothers was within the expected range (1.03-1.07) regardless of parity and time period. M/F ratios were elevated above the expected range for births to mothers born in China in the total sample (M/F ratio 1.084, 95% confidence interval 1.071-1.097) and at parity 2 (1.175, 1.120-1.231), and for births to mothers born in India at parity 2 (1.146, 1.090-1.204). Parity 2 births were the most consistently male-biased across time. Across states, elevated M/F ratios were identified for both groups in New South Wales (China parity 2: 1.182, 1.108-1.260; India parity 2: 1.182, 1.088-1.285), for births to Chinese-born mothers in Victoria (total births: 1.097, 1.072-1.123; parity 1: 1.115, 1.072-1.159) and Australian Capital Territory (total births: 1.189, 1.085-1.302) and births to Indian-born mothers Western Australia (parity 2: 1.307, 1.122-1.523). Conclusions Son preference persists in some immigrant communities after migration to Australia. The consistent pattern of elevated M/F ratios across the larger states indicates that sex imbalances at birth are largely independent of restrictiveness of local abortion laws. Drivers and consequences of son preference in Western high-income settings should be explored to further promote gender equality, and to strengthen support for women who may be vulnerable to reproductive coercion.	[Edvardsson, Kristina] La Trobe Univ, Judith Lumley Ctr, Sch Nursing & Midwifery, Bundoora, Vic, Australia; [Davey, Mary-Ann] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia; [Powell, Rhonda] La Trobe Univ, Sch Nursing & Midwifery, Bundoora, Vic, Australia; [Axmon, Anna] Lund Univ, Div Occupat & Environm Med, EPI LUND Epidemiol Populat Studies & Infrastruct, Lund, Sweden	La Trobe University; Monash University; La Trobe University; Lund University	Edvardsson, K (corresponding author), La Trobe Univ, Judith Lumley Ctr, Sch Nursing & Midwifery, Bundoora, Vic, Australia.	k.edvardsson@latrobe.edu.au	Edvardsson, Kristina/GOP-2054-2022; Axmon, Anna/B-2971-2016	Edvardsson, Kristina/0000-0001-6883-3664; Axmon, Anna/0000-0002-4539-8337				Abrevaya J, 2009, AM ECON J-APPL ECON, V1, P1, DOI 10.1257/app.1.2.1; AIHW (Australian Institute of Health and Welfare), PER NMDS 2014 18 PER NMDS 2014 18; AIHW (Australian Institute of Health and Welfare), NAT PER DAT COLL NPD NAT PER DAT COLL NPD; Almond D, 2008, P NATL ACAD SCI USA, V105, P5681, DOI 10.1073/pnas.0800703105; Almond D, 2017, SOC SCI MED, V176, P21, DOI 10.1016/j.socscimed.2016.12.038; Almond D, 2013, POPUL DEV REV, V39, P75, DOI 10.1111/j.1728-4457.2013.00574.x; Ambrosetti Elena, 2015, Genus, V71, P29; Australian Bureau of Statistics, 2011, 12690 AUSTR BUR STAT 12690 AUSTR BUR STAT; Bongaarts J, 2015, POPUL DEV REV, V41, P241, DOI 10.1111/j.1728-4457.2015.00046.x; Bowman-Smart H, 2020, PRENATAL DIAG, V40, P398, DOI 10.1002/pd.5555; Brar A, 2017, J OBSTET GYNAECOL CA, V39, P459, DOI 10.1016/j.jogc.2017.01.002; Castello A, 2019, EUR J EPIDEMIOL, V34, P699, DOI 10.1007/s10654-019-00513-6; Chao FQ, 2019, P NATL ACAD SCI USA, V116, P9303, DOI 10.1073/pnas.1812593116; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; de Costa C, 2015, AUST NZ J OBSTET GYN, V55, P105, DOI 10.1111/ajo.12298; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; Dow A., 2018, SYDNEY MORNING HERAL; Dubuc S, 2007, POPUL DEV REV, V33, P383, DOI 10.1111/j.1728-4457.2007.00173.x; Edvardsson K, 2018, INT J EPIDEMIOL, V47, P2025, DOI 10.1093/ije/dyy148; Egan JFX, 2011, PRENATAL DIAG, V31, P560, DOI 10.1002/pd.2747; Engel PJ, 2008, AUST NZ J OBSTET GYN, V48, P375, DOI 10.1111/j.1479-828X.2008.00863.x; Gavalas V, 2015, J BIOSOC SCI, V47, P363, DOI 10.1017/S0021932014000182; Gonzalez L, 2018, ECON HUM BIOL, V29, P64, DOI 10.1016/j.ehb.2018.02.003; Grech V, 2017, EARLY HUM DEV, V110, P9, DOI 10.1016/j.earlhumdev.2017.04.011; Guilmoto CZ, 2015, POPULATION, V70, P201, DOI 10.3917/popu.1502.0201; Guilmoto CZ, 2009, POPUL DEV REV, V35, P519, DOI 10.1111/j.1728-4457.2009.00295.x; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Howell EM, 2018, J IMMIGR MINOR HEALT, V20, P711, DOI 10.1007/s10903-017-0589-1; Jacobsen R, 1999, HUM REPROD, V14, P3120, DOI 10.1093/humrep/14.12.3120; James WH, 2020, EARLY HUM DEV, V140, DOI 10.1016/j.earlhumdev.2019.104862; Jha P, 2011, LANCET, V377, P1921, DOI 10.1016/S0140-6736(11)60649-1; Kearin Manette, 2014, Australas J Ultrasound Med, V17, P125, DOI 10.1002/j.2205-0140.2014.tb00028.x; Lhila A, 2008, DEMOGRAPHY, V45, P885, DOI 10.1353/dem.0.0032; McLennan A, 2016, AUST NZ J OBSTET GYN, V56, P22, DOI 10.1111/ajo.12432; Mussino Eleonora, 2018, Genus, V74, P13, DOI 10.1186/s41118-018-0036-8; National Health and Medical Research Council, 2017, ETH GUID US ASS REPR; Newman JE., 2020, ASSISTED REPROD TECH; Nickson C, 2002, AUST NZ J PUBL HEAL, V26, P421, DOI 10.1111/j.1467-842X.2002.tb00341.x; Nickson C, 2006, AUST NZ J PUBL HEAL, V30, P329, DOI 10.1111/j.1467-842X.2006.tb00844.x; Orzack SH, 2015, P NATL ACAD SCI USA, V112, pE2102, DOI 10.1073/pnas.1416546112; Puri S, 2011, SOC SCI MED, V72, P1169, DOI 10.1016/j.socscimed.2011.01.027; Ray JG, 2012, CAN MED ASSOC J, V184, pE492, DOI 10.1503/cmaj.120165; Singh N, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-40; Tafuro S, 2020, EARLY HUM DEV, V141, DOI 10.1016/j.earlhumdev.2019.104868; Tarzia L, 2022, CULT HEALTH SEX, V24, P466, DOI 10.1080/13691058.2020.1859617; UNFPA, 2020, STATE WORLD POPULATI; UNFPA, 2012, TRENDS DIFFERENTIALS; UNFPA (United Nations Population Fund), 2018, GEND BIAS SEX SEL GEND BIAS SEX SEL; Urquia Marcelo L, 2016, CMAJ Open, V4, pE116, DOI 10.9778/cmajo.20150141; Urquia ML, 2016, CAN MED ASSOC J, V188, pE181, DOI 10.1503/cmaj.151074; Verropoulou G, 2010, J BIOSOC SCI, V42, P425, DOI 10.1017/S0021932009990599; Wanigaratne S, 2018, J EPIDEMIOL COMMUN H, V72, P1044, DOI 10.1136/jech-2018-210622; WHO (The World Health Organization), 2019, GEND GEN SEX SEL DIS GEND GEN SEX SEL DIS; World Health Organization, 2011, PREV GEND BIAS SEX S	54	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0251588	10.1371/journal.pone.0251588	http://dx.doi.org/10.1371/journal.pone.0251588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170929	Green Published, gold			2022-12-26	WOS:000671694400063
J	Hamid-Adiamoh, M; Nwakanma, D; Assogba, BS; Ndiath, MO; D'Alessandro, U; Afrane, YA; Amambua-Ngwa, A				Hamid-Adiamoh, Majidah; Nwakanma, Davis; Assogba, Benoit Sessinou; Ndiath, Mamadou Ousmane; D'Alessandro, Umberto; Afrane, Yaw A.; Amambua-Ngwa, Alfred			Influence of insecticide resistance on the biting and resting preferences of malaria vectors in the Gambia	PLOS ONE			English	Article							HOST-SEEKING BEHAVIOR; GATED SODIUM-CHANNEL; ANOPHELES-GAMBIAE; IDENTIFICATION; MOSQUITOS; COMPLEX; NETS; MUTATION; GENE	Background The scale-up of indoor residual spraying and long-lasting insecticidal nets, together with other interventions have considerably reduced the malaria burden in The Gambia. This study examined the biting and resting preferences of the local insecticide-resistant vector populations few years following scale-up of anti-vector interventions. Method Indoor and outdoor-resting Anopheles gambiae mosquitoes were collected between July and October 2019 from ten villages in five regions in The Gambia using pyrethrum spray collection (indoor) and prokopack aspirator from pit traps (outdoor). Polymerase chain reaction assays were performed to identify molecular species, insecticide resistance mutations, Plasmodium infection rate and host blood meal. Results A total of 844 mosquitoes were collected both indoors (421, 49.9%) and outdoors (423, 50.1%). Four main vector species were identified, including An. arabiensis (indoor: 15%, outdoor: 26%); An. coluzzii (indoor: 19%, outdoor: 6%), An. gambiae s.s. (indoor: 11%, outdoor: 16%), An. melas (indoor: 2%, outdoor: 0.1%) and hybrids of An. coluzzii-An. gambiae s.s (indoors: 3%, outdoors: 2%). A significant preference for outdoor resting was observed in An. arabiensis (Pearson X-2 = 22.7, df = 4, P<0.001) and for indoor resting in An. coluzzii (Pearson X-2 = 55.0, df = 4, P<0.001). Prevalence of the voltage-gated sodium channel (Vgsc)-1014S was significantly higher in the indoor-resting (allele freq. = 0.96, 95%CI: 0.78-1, P = 0.03) than outdoor-resting (allele freq. = 0.82, 95%CI: 0.76-0.87) An. arabiensis population. For An. coluzzii, the prevalence of most mutation markers was higher in the outdoor (allele freq. = 0.92, 95%CI: 0.81-0.98) than indoor-resting (allele freq. = 0.78, 95%CI: 0.56-0.86) mosquitoes. However, in An. gambiae s.s., the prevalence of Vgsc-1014F, Vgsc-1575Y and GSTe2-114T was high (allele freq. = 0.96-1), but did not vary by resting location. The overall sporozoite positivity rate was 1.3% (95% CI: 0.5-2%) in mosquito populations. Indoor-resting An. coluzzii had mainly fed on human blood while indoor-resting An. arabiensis fed on animal blood. Conclusion In this study, high levels of resistance mutations were observed that could be influencing the mosquito populations to rest indoors or outdoors. The prevalent animal-biting behaviour demonstrated in the mosquito populations suggest that larval source management could be an intervention to complement vector control in this setting.	[Hamid-Adiamoh, Majidah; Afrane, Yaw A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Legon, Accra, Ghana; [Hamid-Adiamoh, Majidah; Afrane, Yaw A.] Univ Ghana, Dept Biochem Cell & Mol, Legon, Accra, Ghana; [Hamid-Adiamoh, Majidah; Nwakanma, Davis; Assogba, Benoit Sessinou; Ndiath, Mamadou Ousmane; D'Alessandro, Umberto; Amambua-Ngwa, Alfred] Gambia London Sch Hyg & Trop Med, Med Res Council Unit, Banjul, Gambia; [Afrane, Yaw A.] Univ Ghana, Univ Ghana Med Sch, Dept Med Microbiol, Accra, Ghana	University of Ghana; University of Ghana; University of London; London School of Hygiene & Tropical Medicine; University of Ghana	Hamid-Adiamoh, M (corresponding author), Univ Ghana, West African Ctr Cell Biol Infect Pathogens WACCB, Legon, Accra, Ghana.; Hamid-Adiamoh, M (corresponding author), Univ Ghana, Dept Biochem Cell & Mol, Legon, Accra, Ghana.; Hamid-Adiamoh, M (corresponding author), Gambia London Sch Hyg & Trop Med, Med Res Council Unit, Banjul, Gambia.	madiamoh@mrc.gm	Amambua-Ngwa, Alfred/HGU-8062-2022; Amambua-Ngwa, Alfred/AHD-7882-2022	Amambua-Ngwa, Alfred/0000-0003-4478-3601; Amambua-Ngwa, Alfred/0000-0003-4478-3601; Hamid-Adiamoh, Majidah/0000-0002-0101-5445	Wellcome Trust DELTAS Africa [DEL-15-007]; WACCBIP-Wellcome Trust DELTAS PhD fellowship; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107755/Z/15/Z]; UK government; H3Africa PAMGENe project by the AAS [H3A/18/002]; National Institutes of Health [D43 TW 011513]	Wellcome Trust DELTAS Africa; WACCBIP-Wellcome Trust DELTAS PhD fellowship; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome Trust); UK government; H3Africa PAMGENe project by the AAS(PamGene International BV); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from a Wellcome Trust DELTAS Africa grant (DEL-15-007: Awandare). Majidah Hamid-Adiamoh was supported by a WACCBIP-Wellcome Trust DELTAS PhD fellowship. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (107755/Z/15/Z: Awandare) and the UK government. Additional support was also provided by the H3Africa PAMGENe project, H3A/18/002, funded by the AAS; and the National Institutes of Health (D43 TW 011513).	Abong'o B, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61350-2; Asale A, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0366-3; Bamou R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3049-4; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Bryan J.H., 1987, Parassitologia (Rome), V29, P221; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Chaccour C, 2016, MALARIA J, V15, DOI 10.1186/s12936-015-1063-y; Churcher TS, 2016, ELIFE, V5, DOI 10.7554/eLife.16090; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gambia National Malaria Control Programme (GNMCP), 2011, MAL IND SURV; Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063; Gillies M. T., 1987, A supplement to the Anophelinae of Africa south of the Sahara (Afrotropical Region).; Govella NJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-124; Hamid-Adiamoh M, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03388-1; Jawara M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-156; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Kabula B, 2014, TROP MED INT HEALTH, V19, P331, DOI 10.1111/tmi.12248; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kitau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031481; Kreppel KS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71187-4; Lindsay SW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43816-0; Machani MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0224718; Machani MG, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2746-6; Main BJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006303; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Meyers JI, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1286-6; Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662; Musiime AK, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3076-4; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Nkya TE, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0480-z; Opondo KO, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1203-z; Opondo KO., 2019, PARASITE VECTOR, V12, P1, DOI [10.1186/s13071-018-3256-z, DOI 10.1186/S13071-018-3256-Z]; Owuor KO, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240771; Padonou G., 2011, J PARASITOL VECTOR B, V3, P59; Pinder M, 2015, LANCET, V385, P1436, DOI 10.1016/S0140-6736(14)61007-2; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Reid MC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1162-4; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Shcherbacheva A, 2018, MATH BIOSCI, V295, P36, DOI 10.1016/j.mbs.2017.10.005; Silva APB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-450; Sougoufara S, 2016, MED VET ENTOMOL, V30, P365, DOI 10.1111/mve.12171; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tripet F, 2005, GENETICS, V169, P313, DOI 10.1534/genetics.104.026534; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Wilson AL, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2348-8; World Health Orgnization (WHO), 2021, WORLD MALARIA REPORT	57	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0241023	10.1371/journal.pone.0241023	http://dx.doi.org/10.1371/journal.pone.0241023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166376	Green Published, gold			2022-12-26	WOS:000671692800070
J	Lopez, M; Peinado, A; Ortiz, A				Lopez, Miguel; Peinado, Alberto; Ortiz, Andres			Characterizing two outbreak waves of COVID-19 in Spain using phenomenological epidemic modelling	PLOS ONE			English	Article								Since the first case reported of SARS-CoV-2 the end of December 2019 in China, the number of cases quickly climbed following an exponential growth trend, demonstrating that a global pandemic is possible. As of December 3, 2020, the total number of cases reported are around 65,527,000 contagions worldwide, and 1,524,000 deaths affecting 218 countries and territories. In this scenario, Spain is one of the countries that has suffered in a hard way, the ongoing epidemic caused by the novel coronavirus SARS-CoV-2, namely COVID-19 disease. In this paper, we present the utilization of phenomenological epidemic models to characterize the two first outbreak waves of COVID-19 in Spain. The study is driven using a two-step phenomenological epidemic approach. First, we use a simple generalized growth model to fit the main parameters at the early epidemic phase; later, we apply our previous finding over a logistic growth model to that characterize both waves completely. The results show that even in the absence of accurate data series, it is possible to characterize the curves of case incidence, and construct a short-term forecast of 60 days in the near time horizon, in relation to the expected total duration of the pandemic.	[Lopez, Miguel; Peinado, Alberto; Ortiz, Andres] Univ Malaga, Dept Telecommun Engn, Malaga, Spain	Universidad de Malaga	Lopez, M (corresponding author), Univ Malaga, Dept Telecommun Engn, Malaga, Spain.	m.lopez@uma.es		Lopez Delgado, Miguel/0000-0002-7145-2296	MINECO/FEDER [PGC2018-098813-B-C32]	MINECO/FEDER(Spanish Government)	This work was partly supported by the MINECO/FEDER under the PGC2018-098813-B-C32 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Ismail Anas, 2020, SN Compr Clin Med, V2, P852, DOI 10.1007/s42399-020-00330-z; ANDERSON R M, 1991; Arandiga F., 2020, MATH 2020, V8; Chowell G, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1406-6; Chowell Gerardo, 2017, Infect Dis Model, V2, P379, DOI 10.1016/j.idm.2017.08.001; Chowell G, 2015, PLOS BIOL, V13, DOI [10.1371/journal.pbio.1002057, 10.1371/currents.outbreaks.8b55f4bad99ac5c5db3663e916803261]; Efron B., 1994, INTRO BOOTSTRAP; Estudio Nacional de sero, EP INF SARS COV 2 ES EP INF SARS COV 2 ES; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hojman S., 2020, J NONLINEAR SCI J NONLINEAR SCI, V30; Kermack TO, 1937, J HYG-CAMBRIDGE, V37, P172, DOI 10.1017/S0022172400034902; Michael L.M., 2018, INTRO MATH MODELING, P57; Morrow-Howell N, 2020, J AGING SOC POLICY, V32, P526, DOI 10.1080/08959420.2020.1759758; Ndairou F, 2020, CHAOS SOLITON FRACT, V141, DOI 10.1016/j.chaos.2020.110311; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Roosa K, 2019, THEOR BIOL MED MODEL, V16, DOI 10.1186/s12976-018-0097-6; SAVAGEAU MA, 1980, MATH BIOSCI, V48, P267, DOI 10.1016/0025-5564(80)90061-9; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Smirnova Alexandra, 2017, Infect Dis Model, V2, P268, DOI 10.1016/j.idm.2017.05.004; Tolle J., 2003, MATH GAZETE, V87, P522, DOI [10.1017/S0025557200173802, DOI 10.1017/S0025557200173802]; TURNER ME, 1976, MATH BIOSCI, V29, P367, DOI 10.1016/0025-5564(76)90112-7; Viboud C, 2016, EPIDEMICS-NETH, V15, P27, DOI 10.1016/j.epidem.2016.01.002; Viguerie A, 2020, COMPUT MECH, V66, P1131, DOI 10.1007/s00466-020-01888-0; World Health Organization, NOV COR COVID 19 SIT; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu K, 2020, NONLINEAR DYNAM, V101, P1561, DOI 10.1007/s11071-020-05862-6; Zeynep C., SCI TOTAL ENVIRON, V729	27	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253004	10.1371/journal.pone.0253004	http://dx.doi.org/10.1371/journal.pone.0253004			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166411	Green Submitted, Green Published, gold			2022-12-26	WOS:000671692800097
J	Wen, F; Yang, J; Li, AQ; Gong, ZG; Yang, LL; Cheng, Q; Wang, CY; Zhao, MM; Yuan, S; Chen, Y; El-Ashram, S; Li, Y; Yu, H; Guo, JY; Huang, SJ				Wen, Feng; Yang, Jing; Li, Anqi; Gong, Zhonggui; Yang, Lulu; Cheng, Qing; Wang, Congying; Zhao, Mengmeng; Yuan, Sheng; Chen, Yao; El-Ashram, Saeed; Li, Yong; Yu, Hai; Guo, Jinyue; Huang, Shujian			Genetic characterization and phylogenetic analysis of porcine epidemic diarrhea virus in Guangdong, China, between 2018 and 2019	PLOS ONE			English	Article							SWINE ENTERIC CORONAVIRUS; MOLECULAR CHARACTERIZATION; CELL-CULTURES; UNITED-STATES; PIG FARMS; RT-PCR; IDENTIFICATION; PROTEIN; RECOMBINANT; VARIANTS	Porcine epidemic diarrhea virus (PEDV), a leading cause of piglet diarrhea outbreaks, poses a significant danger to the swine industry. The aim of this study was to investigate the epidemic characteristics of PEDV that was circulating in Guangdong province, one of China's major pig producing provinces. Clinical samples were collected from eight pig farms in Guangdong province between 2018 and 2019 and tested for the major porcine enteric pathogens, including PEDV, transmissible gastroenteritis virus (TGEV), Swine enteric coronavirus (SeCoV), Swine acute diarrhea syndrome coronavirus (SADS-CoV), porcine deltacoronavirus (PDCoV), and porcine rotavirus (RV). As a result, only PEDV and RV were detected at a rate of 47.0% (16/34) and 18.6% (8/34), respectively. Coinfectoin with PEDV and RV occurred at a rate of PEDV 12.5% (2/16). Subsequently, the full-length S gene sequences of 13 PEDV strains were obtained, and phylogenetic analysis suggested the presence of GII-c group PEDV strains in this region (non-S-INDEL). Two novel common amino acid insertions (T-55/IG(56) and 551L) and one novel glycosylation site (1199(G+)) were detected when the CV777 and ZJ08 vaccine strains were compared. Furthermore, intragroup recombination events in the S gene regions 51-548 and 2478-4208 were observed in the PEDV strains studied. In summary, the observations provide current information on the incidence of viral agents causing swine diarrhea in southern China and detailed the genetic characteristics and evolutionary history of the dominant PEDV field strains. Our findings will aid in the development of an updated vaccine for the prevention and control of PEDV variant strains.	[Wen, Feng; Yang, Jing; Li, Anqi; Yang, Lulu; Cheng, Qing; Wang, Congying; Zhao, Mengmeng; Yuan, Sheng; Chen, Yao; El-Ashram, Saeed; Guo, Jinyue; Huang, Shujian] Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China; [Gong, Zhonggui] Ctr Anim Dis Control & Prevent, Shaoguan, Guangdong, Peoples R China; [Li, Yong] Jiangxi Agr Univ, Coll Anim Sci & Technol, Nanchang, Jiangxi, Peoples R China; [Yu, Hai] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Foshan University; Jiangxi Agricultural University; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Guo, JY; Huang, SJ (corresponding author), Foshan Univ, Coll Life Sci & Engn, Foshan, Guangdong, Peoples R China.	guojinyue12@163.com; huangshujian@fosu.edu.cn	El-Ashram, Saeed/AAC-6060-2021	El-Ashram, Saeed/0000-0003-0389-1980; , Feng/0000-0001-8790-1503	National Key R&D Program of China [2018YFD0501200]; National Natural Science Foundation of China [32002320]; Guangdong Basic and Applied Basic Research Foundation [2020A1515010116, 2019A1515110785]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Basic and Applied Basic Research Foundation	This study was supported by National Key R&D Program of China (2018YFD0501200); National Natural Science Foundation of China (Grant No. 32002320); Guangdong Basic and Applied Basic Research Foundation (Grant No. 2020A1515010116 and 2019A1515110785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimkin V, 2016, EMERG INFECT DIS, V22, P1314, DOI 10.3201/eid2207.160179; Ben Salem AN, 2010, J VIROL METHODS, V165, P283, DOI 10.1016/j.jviromet.2010.02.010; Boniotti MB, 2016, EMERG INFECT DIS, V22, P83, DOI 10.3201/eid2201.150544; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Cao LY, 2015, VIRUS GENES, V51, P217, DOI 10.1007/s11262-015-1234-5; Chang SH, 2002, MOL CELLS, V14, P295; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; Chen JF, 2008, VIRUS GENES, V36, P355, DOI 10.1007/s11262-007-0196-7; Chen NH, 2017, VIRUS RES, V242, P90, DOI 10.1016/j.virusres.2017.09.013; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Cui JT, 2020, ARCH VIROL, V165, P2323, DOI 10.1007/s00705-020-04744-x; de Nova PJG, 2020, TRANSBOUND EMERG DIS, V67, P2911, DOI 10.1111/tbed.13666; Molinari BLD, 2016, VET MICROBIOL, V193, P125, DOI 10.1016/j.vetmic.2016.08.014; Fu XL, 2018, INFECT GENET EVOL, V62, P179, DOI 10.1016/j.meegid.2018.04.031; Kong N, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01305-1; KUSANAGI K, 1992, J VET MED SCI, V54, P313, DOI 10.1292/jvms.54.313; Li RF, 2014, ARCH VIROL, V159, P1057, DOI 10.1007/s00705-013-1929-7; Li WT, 2012, EMERG INFECT DIS, V18, P1350, DOI 10.3201/eid1808.120002; Li XJ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9153; Lu Y, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00435; Mandelik R, 2018, ACTA VET HUNG, V66, P488, DOI 10.1556/004.2018.043; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Martelli R, 2008, VET REC, V162, P307, DOI 10.1136/vr.162.10.307; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; PENSAERT MB, 1978, ARCH VIROL, V58, P243, DOI 10.1007/BF01317606; PIJPERS A, 1993, VET REC, V132, P129, DOI 10.1136/vr.132.6.129; POSPISCHIL A, 1981, ZBL VET MED B, V28, P564; Shi D, 2017, SCI REP-UK, V7, DOI 10.1038/srep39700; Shibata I, 2000, VET MICROBIOL, V72, P173, DOI 10.1016/S0378-1135(99)00199-6; Song D, 2015, TRANSBOUND EMERG DIS, V62, P575, DOI 10.1111/tbed.12399; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stadler J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0454-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun J, 2018, VET MICROBIOL, V221, P81, DOI 10.1016/j.vetmic.2018.05.021; Sun WC, 2020, VIRUS RES, V278, DOI 10.1016/j.virusres.2020.197869; Tian YM, 2021, TRANSBOUND EMERG DIS, V68, P3482, DOI 10.1111/tbed.13953; Tian YF, 2013, VIRUSES-BASEL, V5, P1991, DOI 10.3390/v5081991; Vlasova AN, 2014, EMERG INFECT DIS, V20, P1620, DOI 10.3201/eid2010.140491; Wang D, 2016, VIRUS RES, V226, P7, DOI 10.1016/j.virusres.2016.05.026; Wang LY, 2014, EMERG INFECT DIS, V20, P917, DOI 10.3201/eid2005.140195; Wen F, 2020, J INFECTION, V81, P834, DOI 10.1016/j.jinf.2020.09.011; Wen F, 2020, J INFECTION, V80, P679, DOI 10.1016/j.jinf.2020.02.027; WOOD EN, 1977, VET REC, V100, P243, DOI 10.1136/vr.100.12.243; Xu ZC, 2018, VIROL SIN, V33, P131, DOI 10.1007/s12250-018-0003-8; Zhang FF, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2212-2; Zhao J, 2013, J VIROL METHODS, V194, P107, DOI 10.1016/j.jviromet.2013.08.008; Zhou L, 2019, TRANSBOUND EMERG DIS, V66, P687, DOI 10.1111/tbed.13008; Zhou P, 2018, NATURE, V556, P255, DOI 10.1038/s41586-018-0010-9	48	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253622	10.1371/journal.pone.0253622	http://dx.doi.org/10.1371/journal.pone.0253622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166425	gold, Green Published			2022-12-26	WOS:000671692800014
J	Harris, JL; Stevens, GMW				Harris, Joanna L.; Stevens, Guy M. W.			Environmental drivers of reef manta ray (Mobula alfredi) visitation patterns to key aggregation habitats in the Maldives	PLOS ONE			English	Article							LANGMUIR CIRCULATION; MARINE PARK; MOVEMENTS; CONSERVATION; VARIABILITY; SATELLITE; AFFINITY; ECOLOGY; SHARKS	A detailed understanding of the dynamics of small-scale (10s km) habitat use by the reef manta ray (Mobula alfredi) in the Maldives Archipelago is required to develop an effective national conservation management plan for this wide-ranging species. Here, a combination of photo-ID sightings data and acoustic telemetry were used to investigate both long-term M. alfredi visitation trends and small-scale movement patterns to key habitats on the eastern side of Baa Atoll (Hanifaru Bay feeding area, Dhigu Thila multifunctional site, and Nelivaru Thila cleaning station). All tagged and most of the sighted M. alfredi exhibited high affinity to the eastern side of Baa Atoll, where 99% of detections occurred, and 69% of individuals were re-sighted in multiple years. Sightings data suggests that visitation patterns may be associated with differences in habitat use by sex and maturity status. Boosted regression trees indicated that tag detection probability at Hanifaru Bay increased with increased westerly wind speed (>5ms(-1)) during the day, close to a new and full moon just after high tide, and when the tidal range was low. Interaction effects between predictors suggest that wind-driven oceanographic processes, such as Langmuir Circulation, maybe working to increase zooplankton concentration at this location. Tag detection probability increased at Dhigu Thila under similar conditions. At Nelivaru Thila, it increased at lower wind speeds (<5ms(-1)), close to a full moon, three hours after high tide. These results suggest that M. alfredi may utilise cleaning stations during the day when environmental conditions are not suitable for feeding. There was a high level of connectivity between these three locations, which suggests they form part of a network of key habitats that provide essential services to M. alfredi locally. Future conservation efforts should focus on identifying all areas of key habitat use for this species within the Maldives; applying strict protective measures to these sites and any connecting migration corridors which link them.	[Harris, Joanna L.; Stevens, Guy M. W.] Manta Trust, Corscombe, Dorset, England; [Harris, Joanna L.] Univ Plymouth, Plymouth, Devon, England	University of Plymouth	Harris, JL (corresponding author), Manta Trust, Corscombe, Dorset, England.; Harris, JL (corresponding author), Univ Plymouth, Plymouth, Devon, England.	joanna.harris@mantatrust.org		Harris, Joanna L./0000-0001-8684-9096	G MW Stevens Funder: Save Our Seas Foundation [SOSF P44_2007_01_13, SOSF P85_2009_03_25]	G MW Stevens Funder: Save Our Seas Foundation	Author who received the award: G MW Stevens Funder: Save Our Seas Foundation URLs to funds' websites https://saveourseas.com/Grant numbers: SOSF P44_2007_01_13 and SOSF P85_2009_03_25 Authors who received salary or other funding from commercial companies: G MW Stevens Full names of commercial companies that sponsored the study or authors: Four Seasons Resort Maldives at Landaa Giraavaru Prodivers Maldives at Kuredu URLs to sponsors' websites https://www.fourseasons.com/maldiveslg/https://www.prodivers.com/kuredu-maldives/dive-center/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso P, 2008, MAR ECOL PROG SER, V359, P215, DOI 10.3354/meps07272; Alldredge AL, 2009, CORAL REEFS, V28, P895, DOI 10.1007/s00338-009-0534-4; Anderson RC, 2011, FISH OCEANOGR, V20, P104, DOI 10.1111/j.1365-2419.2011.00571.x; Armstrong AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153393; Barr Y, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00088; Braun CD, 2015, MAR BIOL, V162, P2351, DOI 10.1007/s00227-015-2760-3; Braun CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088170; Campbell HA, 2012, MAR FRESHWATER RES, V63, P815, DOI 10.1071/MF12194; Carleton JH, 2001, MAR BIOL, V139, P705; Colin B., 2017, OPEN J STAT, V07, P859, DOI [10.4236/ojs.2017.75061, DOI 10.4236/OJS.2017.75061]; Cote IM, 2000, OCEANOGR MAR BIOL, V38, P311; Couturier LIE, 2018, MAR ECOL PROG SER, V599, P125, DOI 10.3354/meps12610; Couturier LIE, 2014, CORAL REEFS, V33, P329, DOI 10.1007/s00338-014-1126-5; Couturier LIE, 2012, J FISH BIOL, V80, P1075, DOI 10.1111/j.1095-8649.2012.03264.x; Couturier LIE, 2011, MAR FRESHWATER RES, V62, P628, DOI 10.1071/MF10148; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Deakos MH, 2011, MAR ECOL PROG SER, V429, P245, DOI 10.3354/meps09085; Dedman S, 2017, FISHES-BASEL, V2, DOI 10.3390/fishes2030012; Derville S, 2016, MAR ECOL PROG SER, V551, P261, DOI 10.3354/meps11736; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Dulvy NK, 2014, PEERJ, V2, DOI 10.7717/peerj.400; Egbert GD, 2002, J ATMOS OCEAN TECH, V19, P183, DOI 10.1175/1520-0426(2002)019<0183:EIMOBO>2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J., 2017, BOOSTED REGRESSION T, P1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Germanov ES., 2019, FRONT MAR SCI, V6; Gjelland KO, 2013, METHODS ECOL EVOL, V4, P665, DOI 10.1111/2041-210X.12057; Harris JL, 2021, ECOL EVOL, V11, P4588, DOI 10.1002/ece3.7357; Harris JL, 2020, AQUAT CONSERV, V30, P1649, DOI 10.1002/aqc.3350; Hijmans, 2017, Species Distribution Modeling Version Dismo package for R, version 1.1-4 [Internet]; Hosegood J, 2020, MOL ECOL, V29, P4783, DOI 10.1111/mec.15683; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jaine FRA, 2014, MAR ECOL PROG SER, V510, P73, DOI 10.3354/meps10910; Jaine FRA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046170; Jouffray J-B, 2019, GGBRT EXPLORE VISUAL; Jouffray JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2544; Kashiwagi Tom, 2011, Marine Biodiversity Records, V4; Kessel ST, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185419; KINGSFORD MJ, 1991, MAR BIOL, V109, P167, DOI 10.1007/BF01320244; Langmuir I, 1938, SCIENCE, V87, P119, DOI 10.1126/science.87.2250.119; Lawrence A. J., 2016, RESPONSIBLE SHARK RA; Lawson JM, 2017, PEERJ, V5, DOI 10.7717/peerj.3027; Lea JSE, 2017, MIGRATORY BEHAV SPAT MIGRATORY BEHAV SPAT; Leichter JJ, 2013, OCEANOGRAPHY, V26, P52, DOI 10.5670/oceanog.2013.45; Maldives EPA., 2014, BATOIDEA MALDIVES PR; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; McCauley DJ, 2014, MAR BIOL, V161, P1987, DOI 10.1007/s00227-014-2478-7; Murray Annie, 2020, Journal of Ecotourism, V19, P132; Nalesso E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213741; Nieto K, 2017, PROG OCEANOGR, V151, P97, DOI 10.1016/j.pocean.2016.11.009; O'Malley MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065051; O'Shea OR, 2010, MAR FRESHWATER RES, V61, P65, DOI 10.1071/MF08301; Peel LR, 2019, MAR ECOL PROG SER, V621, P169, DOI 10.3354/meps12995; Pinsky ML, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1053; Plueddemann AJ, 1996, J GEOPHYS RES-OCEANS, V101, P3525, DOI 10.1029/95JC03282; Poulain PM, 2015, J GEOPHYS RES-OCEANS, V120, P6986, DOI 10.1002/2015JC010818; R Core Team, 2020, R LANG ENV STAT COMP; Reubens J, 2019, HYDROBIOLOGIA, V845, P81, DOI 10.1007/s10750-017-3478-7; Rohner CA, 2013, MAR ECOL PROG SER, V482, P153, DOI 10.3354/meps10290; Sequeira AMM, 2019, ECOL APPL, V29, DOI 10.1002/eap.1947; Setyawan E, 2018, NAT CONSERV RES, V3, P17, DOI 10.24189/ncr.2018.043; Simpfendorfer C.A., 2015, ANIM BIOTELEM, V65, P482, DOI [10.1139/F07%E2%80%90180, DOI 10.1186/S40317-015-0094-Z]; Smith JA, 2001, LECT NOTES PHYS, V566, P295; Stevens G., 2016, CONSERVATION POPULAT; Stevens GMW, 2019, WORLD SEAS: AN ENVIRONMENTAL EVALUATION, VOL II: THE INDIAN OCEAN TO THE PACIFIC, 2ND EDITION, P211, DOI 10.1016/B978-0-08-100853-9.00010-5; Stevens GMW, 2018, J FISH BIOL, V93, P344, DOI 10.1111/jfb.13768; Stewart JD, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00314; Talley LD, 2011, DYNAMICAL PROCESSES, P1, DOI [10.1016/b978-0-7506-4552-2.10001-0, DOI 10.1016/C2009-0-24322-4]; Thorpe SA, 2004, ANNU REV FLUID MECH, V36, P55, DOI 10.1146/annurev.fluid.36.052203.071431; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Venables Stephanie, 2016, Pacific Conservation Biology, V22, P295, DOI 10.1071/PC16003; Ward-Paige CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074835	73	2	2	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252470	10.1371/journal.pone.0252470	http://dx.doi.org/10.1371/journal.pone.0252470			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161339	Green Published, gold			2022-12-26	WOS:000671691900054
J	Padilla-Iglesias, C; Woodward, AL; Goldin-Meadow, S; Shneidman, LA				Padilla-Iglesias, Cecilia; Woodward, Amanda L.; Goldin-Meadow, Susan; Shneidman, Laura A.			Changing language input following market integration in a Yucatec Mayan community	PLOS ONE			English	Article							PARENTAL INVESTMENT; FERTILITY; PATTERNS; VILLAGE; MODELS; FAMILY	Like many indigenous populations worldwide, Yucatec Maya communities are rapidly undergoing change as they become more connected with urban centers and access to formal education, wage labour, and market goods became more accessible to their inhabitants. However, little is known about how these changes affect children's language input. Here, we provide the first systematic assessment of the quantity, type, source, and language of the input received by 29 Yucatec Maya infants born six years apart in communities where increased contact with urban centres has resulted in a greater exposure to the dominant surrounding language, Spanish. Results show that infants from the second cohort received less directed input than infants in the first and, when directly addressed, most of their input was in Spanish. To investigate the mechanisms driving the observed patterns, we interviewed 126 adults from the communities. Against common assumptions, we showed that reductions in Mayan input did not simply result from speakers devaluing the Maya language. Instead, changes in input could be attributed to changes in childcare practices, as well as caregiver ethnotheories regarding the relative acquisition difficulty of each of the languages. Our study highlights the need for understanding the drivers of individual behaviour in the face of socio-demographic and economic changes as it is key for determining the fate of linguistic diversity.	[Padilla-Iglesias, Cecilia] Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol, Cambridge, England; [Padilla-Iglesias, Cecilia] Univ Zurich, Inst Anthropol, Zurich, Switzerland; [Woodward, Amanda L.; Goldin-Meadow, Susan] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Shneidman, Laura A.] Pacific Lutheran Univ, Dept Psychol, Tacoma, WA 98447 USA	University of Cambridge; University of Zurich; University of Chicago; Pacific Lutheran University	Padilla-Iglesias, C (corresponding author), Univ Cambridge, Leverhulme Ctr Human Evolutionary Studies, Dept Archaeol, Cambridge, England.; Padilla-Iglesias, C (corresponding author), Univ Zurich, Inst Anthropol, Zurich, Switzerland.; Shneidman, LA (corresponding author), Pacific Lutheran Univ, Dept Psychol, Tacoma, WA 98447 USA.	cecilia.padillaiglesias@uzh.ch; las@plu.edu		Shneidman, Laura/0000-0001-5981-4015; Padilla-Iglesias, Cecilia/0000-0003-1302-5955	Department of Archaeology at the University of Cambridge; NSF award [BCS-1226113]	Department of Archaeology at the University of Cambridge; NSF award(National Science Foundation (NSF))	This study was funded by the Department of Archaeology at the University of Cambridge and by a NSF award (BCS-1226113) to Amanda Woodward.	Brown P., 2011, HDB LANGUAGE SOCIALI, P29; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Bunce J, 2018, FIELD EVIDENCE 2 PAT; Cashdan E, 2016, HUM NATURE-INT BIOS, V27, P35, DOI 10.1007/s12110-015-9250-7; CRAGO MB, 1993, ANTHROPOL EDUC QUART, V24, P205, DOI 10.1525/aeq.1993.24.3.05x0968f; Cristia A, 2019, CHILD DEV, V90, P759, DOI 10.1111/cdev.12974; de Le?n, 1998, J LINGUIST ANTHROPOL, V8, P1, DOI [10.1525/jlin.1998.8.2.131, DOI 10.1525/JLIN.1998.8.2.131]; de Leon L., 2017, LANGUAGE POLICY POLI, P415, DOI [10.1007/978-3-319-02344-1_31, DOI 10.1007/978-3-319-02344-1_31]; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Fernando C, 2010, HUM BIOL, V82, P47, DOI 10.3378/027.082.0104; Gaskins S, 2003, ETHOS, V31, P248, DOI 10.1525/eth.2003.31.2.248; Gaskins S, 2000, CROSS-CULT RES, V34, P375, DOI 10.1177/106939710003400405; Gelman A., 2013, CHAPMAN HALL CRC TEX, DOI [10.1201/b16018, DOI 10.1201/B16018]; Gurven M, 2015, HUM ECOL, V43, P515, DOI 10.1007/s10745-015-9764-y; Hill JH, 1986, SPEAKING MEXICANO DY; Jinsook Choi, 2013, [Asian Journal of Latinamerican Studies, 라틴아메리카연구], V26, P55; Kandler A, 2010, PHILOS T R SOC B, V365, P3855, DOI 10.1098/rstb.2010.0051; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Konner M., 1977, CULTURE INFANCY VARI, P287; Kramer K.L., 2005, MAYA CHILDREN; Kramer KL, 2018, PHYSIOL BEHAV, V193, P117, DOI 10.1016/j.physbeh.2018.02.054; Labov W., 1972, SOCIOLINGUISTIC PATT; Lambert W. E, 1981, ANN NEW YORK ACAD SC; Lawson DW, 2011, PHILOS T R SOC B, V366, P333, DOI 10.1098/rstb.2010.0297; Mattison SM, 2016, HUM NATURE-INT BIOS, V27, P335, DOI 10.1007/s12110-016-9270-y; McElreath R., 2015, STAT RETHINKING TEXT; Michnowicz J., 2015, NEW PERSPECTIVES HIS, P21, DOI [10.31819/9783954878314-003, DOI 10.31819/9783954878314-003]; Mijangos-Noh JC, 2001, MULTIPLES ROSTROS PU MULTIPLES ROSTROS PU, P36; Padilla-Iglesias C., 2020, EVOLUTIONARY HUMAN S, P2; PYE C, 1986, J CHILD LANG, V13, P85, DOI 10.1017/S0305000900000313; R Core Team, 2020, R LANG ENV STAT COMP; Rindstedt C, 2002, LANG SOC, V31, P721, DOI 10.1017/S0047404502315033; ROGOFF B, 1993, MONOGR SOC RES CHILD, V58, pR5; Rogoff B, 2005, CAMB ST SOC, P225, DOI 10.1017/CBO9780511610400.011; Rolstad K, 2001, LANGUAGE DEATH CENTR, P3; Roopnarine JL., 2011, CULTURAL VARIATIONS CULTURAL VARIATIONS; Sam DL, 2010, PERSPECT PSYCHOL SCI, V5, P472, DOI 10.1177/1745691610373075; Schacht R., 2018, FRONTIERS ECOLOGY EV, DOI [10.3389/fevo.2018.00142/full, DOI 10.3389/FEVO.2018.00142/FULL]; Sear R, 2016, CURR OPIN PSYCHOL, V7, P98, DOI 10.1016/j.copsyc.2015.08.013; Shenk MK, 2013, P NATL ACAD SCI USA, V110, P8045, DOI 10.1073/pnas.1217029110; Shneidman LA, 2010, LANGUAGE INPUT ACQUI; Shneidman L, 2016, PSYCHOL BULL, V142, P1, DOI 10.1037/bul0000023; Shneidman LA, 2013, J CHILD LANG, V40, P672, DOI 10.1017/S0305000912000141; Shneidman LA, 2012, DEVELOPMENTAL SCI, V15, P659, DOI 10.1111/j.1467-7687.2012.01168.x; Stan Development Team, 2016, STAN MOD LANG US GUI; TULKIN SR, 1972, CHILD DEV, V43, P31, DOI 10.1111/j.1467-8624.1972.tb01077.x; URIBE FMT, 1993, INT J BEHAV DEV, V16, P395, DOI 10.1177/016502549301600302; Veile A, 2014, SOC SCI MED, V100, P148, DOI 10.1016/j.socscimed.2013.10.034; Vogt P, 2009, HUM BIOL, V81, P237, DOI 10.3378/027.081.0307; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252926	10.1371/journal.pone.0252926	http://dx.doi.org/10.1371/journal.pone.0252926			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BF	34153044	Green Published, Green Accepted, gold			2022-12-26	WOS:000671691000025
J	Bonetto, E; Dezecache, G; Nugier, A; Inigo, M; Mathias, JD; Huet, S; Pellerin, N; Corman, M; Bertrand, P; Raufaste, E; Streith, M; Guimond, S; de la Sablonniere, R; Dambrun, M				Bonetto, Eric; Dezecache, Guillaume; Nugier, Armelle; Inigo, Marion; Mathias, Jean-Denis; Huet, Sylvie; Pellerin, Nicolas; Corman, Maya; Bertrand, Pierre; Raufaste, Eric; Streith, Michel; Guimond, Serge; de la Sablonniere, Roxane; Dambrun, Michael			Basic human values during the COVID-19 outbreak, perceived threat and their relationships with compliance with movement restrictions and social distancing	PLOS ONE			English	Article							PATHOGENS; BEHAVIOR	This study examines the evolution of Schwartz's Basic Human Values during the COVID-19 outbreak, and their relationships with perceived threat, compliance with movement restrictions and social distancing. An online questionnaire was administered to a heterogeneous sample of French citizens (N = 1025) during the first French lockdown related to the outbreak. Results revealed a significant evolution of values; the conservation value was higher during the outbreak than usual, and both self-enhancement and openness-to-change values were lower during the COVID-19 outbreak than usual. Conservation and perceived threat during the outbreak were robustly and positively related to both compliance with movement restrictions and social distancing. Conservation during the outbreak emerged as a significant partial mediator of the relationship between perceived threat and outcomes (i.e., compliance with movement restrictions and social distancing). Implications of these results for the malleability of values and the COVID-19 modelling are discussed.	[Bonetto, Eric; Dezecache, Guillaume; Nugier, Armelle; Corman, Maya; Bertrand, Pierre; Streith, Michel; Guimond, Serge; Dambrun, Michael] Univ Clermont Auvergne, LAPSCO, CNRS, Clermont Ferrand, France; [Bonetto, Eric] Aix Marseille Univ, Aix En Provence, France; [Inigo, Marion] Univ Quebec Montreal, CINBIOSE Res Grp, Montreal, PQ, Canada; [Mathias, Jean-Denis; Huet, Sylvie] Univ Clermont Auvergne, Ctr Clermont Ferrand, UR LISC, INRAE, Aubiere, France; [Pellerin, Nicolas; Raufaste, Eric] Univ Toulouse 2 Jean Jaures, CLLE, CNRS, Toulouse, France; [de la Sablonniere, Roxane] Univ Montreal, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Aix-Marseille Universite; University of Quebec; University of Quebec Montreal; INRAE; Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite de Montreal	Bonetto, E; Dambrun, M (corresponding author), Univ Clermont Auvergne, LAPSCO, CNRS, Clermont Ferrand, France.; Bonetto, E (corresponding author), Aix Marseille Univ, Aix En Provence, France.	bonetto.ericbw@gmail.com; michael.dambrun@uca.fr	Pellerin, Nicolas/AGX-5609-2022; Huet, Sylvie/AAV-5505-2020	Pellerin, Nicolas/0000-0002-0223-1000; Huet, Sylvie/0000-0003-2973-7738; DAMBRUN, Michael/0000-0003-1418-7294; Bonetto, Eric/0000-0002-0824-1103				Aassve A., 2020, EPIDEMICS TRUST CASE; Adam-Troian J., 2020, PATHOGEN THREAT INCR, DOI [10.31234/osf.io/aqkpm, DOI 10.31234/OSF.IO/AQKPM]; Barcelo H, 2020, ARXIV PREPRINT ARXIV; Bardi A, 2003, PERS SOC PSYCHOL B, V29, P1207, DOI 10.1177/0146167203254602; Bardi A, 2011, J CROSS CULT PSYCHOL, V42, P271, DOI 10.1177/0022022110396916; Bardi A, 2009, J PERS SOC PSYCHOL, V97, P913, DOI 10.1037/a0016617; Barry JM., 2020, GREAT INFLUENZA STOR; Biddlestone M, 2020, BRIT J SOC PSYCHOL, V59, P663, DOI 10.1111/bjso.12397; Bojanowska A., 2020, PLOS ONE, DOI [10.31234/osf.io/xr87s, DOI 10.31234/OSF.IO/XR87S]; Cao C, 2020, INT J SOCIOL SOC POL, V40, P939, DOI 10.1108/IJSSP-07-2020-0334; Carillo Mario, 2020, CALIFORNIA ITALIAN S; Crutzen R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-720; Danioni F, 2020, EUR REV APPL PSYCHOL, V70, DOI 10.1016/j.erap.2020.100524; de la Sablonniere R., 2010, CAHIERS INT PSYCHOL, V85, P11; de Wet J., 2019, QUAL QUANT, V53, P685, DOI [10.1007/s11135-018-0784-8, DOI 10.1007/S11135-018-0784-8]; Dezecache G, 2020, CURR BIOL, V30, pR417, DOI 10.1016/j.cub.2020.04.010; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Duckitt J, 2003, POLIT PSYCHOL, V24, P199, DOI 10.1111/0162-895X.00322; Feather NT, 1996, J PERS SOC PSYCHOL, V71, P571, DOI 10.1037/0022-3514.71.3.571; Fischer R, 2006, APPL PSYCHOL-INT REV, V55, P541, DOI 10.1111/j.1464-0597.2006.00243.x; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Hofstede G, 2010, ASIA PAC BUS REV, V16, P493, DOI 10.1080/13602381003637609; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Jackson JC, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.1036; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jeyanathan M, 2020, NAT REV IMMUNOL, V20, P615, DOI 10.1038/s41577-020-00434-6; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kachanoff FJ, 2021, SOC PSYCHOL PERS SCI, V12, P603, DOI 10.1177/1948550620931634; Lewin K., 1952, FIELD THEORY SOCIAL; Lonnqvist JE, 2013, J CROSS CULT PSYCHOL, V44, P1122, DOI 10.1177/0022022113480040; Marinthe G, 2020, BRIT J HEALTH PSYCH, V25, P957, DOI 10.1111/bjhp.12449; Martinelli N, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.616169; Modersitzki N, 2020, SOC PSYCHOL PERS SCI; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01491; Pagliaro S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248334; Pearce-Duvet JMC, 2006, BIOL REV, V81, P369, DOI 10.1017/S1464793106007020; Rohan MJ, 2000, PERS SOC PSYCHOL REV, V4, P255, DOI 10.1207/S15327957PSPR0403_4; Roozenbeek J, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201199; Schaller M, 2008, J PERS SOC PSYCHOL, V95, P212, DOI 10.1037/0022-3514.95.1.212; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Schwartz S. H., 2003, QUESTIONNAIRE PACKAG, V259, P259, DOI DOI 10.1111/J.1540-6237.2011.00830.X.FITTING; SCHWARTZ S.H., 2012, ONLINE READINGS PSYC, V2, DOI [10.9707/2307-0919.1116, DOI 10.9707/2307-0919.1116]; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2017, EUR J SOC PSYCHOL, V47, P241, DOI 10.1002/ejsp.2228; Shook NJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238015; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Sortheix FM, 2019, SOC PSYCHOL PERS SCI, V10, P15, DOI 10.1177/1948550617732610; Tay, 2018, HDB WELL BEING; Thakur V, 2020, BRAIN BEHAV IMMUN, V88, P952, DOI 10.1016/j.bbi.2020.04.062; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; Tominey C., 2020, TELEGRAPH; Tuncgenc B., 2020, WE DISTANCE MOST WE, DOI [10.31234/osf.io/u74wc, DOI 10.31234/OSF.IO/U74WC]; Van Bavel J., 2020, RES SQUARE, DOI [10.21203/rs.3.rs-67323/v1, DOI 10.21203/RS.3.RS-67323/V1]; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Varnum MEW, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0003; Verkasalo M, 2006, J APPL SOC PSYCHOL, V36, P144, DOI 10.1111/j.0021-9029.2006.00007.x; Wolf LJ, 2020, BRIT J SOC PSYCHOL, V59, P618, DOI 10.1111/bjso.12401; Yildirim M, 2022, DEATH STUD, V46, P979, DOI 10.1080/07481187.2020.1793434; Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199	59	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253430	10.1371/journal.pone.0253430	http://dx.doi.org/10.1371/journal.pone.0253430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BC	34143832	Green Published, gold			2022-12-26	WOS:000671690700007
J	Elani, HW; Batista, AFM; Thomson, WM; Kawachi, I; Chiavegatto, ADP				Elani, Hawazin W.; Batista, Andre F. M.; Thomson, W. Murray; Kawachi, Ichiro; Chiavegatto Filho, Alexandre D. P.			Predictors of tooth loss: A machine learning approach	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PERIODONTAL-DISEASE; EDUCATION; DECADES	Introduction Little is understood about the socioeconomic predictors of tooth loss, a condition that can negatively impact individual's quality of life. The goal of this study is to develop a machine-learning algorithm to predict complete and incremental tooth loss among adults and to compare the predictive performance of these models. Methods We used data from the National Health and Nutrition Examination Survey from 2011 to 2014. We developed multiple machine-learning algorithms and assessed their predictive performances by examining the area under the receiver operating characteristic curve (AUC), accuracy, sensitivity, specificity, and positive and negative predictive values. Results The extreme gradient boosting trees presented the highest performance in the prediction of edentulism (AUC = 88.7%; 95%CI: 87.1, 90.2), the absence of a functional dentition (AUC = 88.3% 95%CI: 87.3,89.3) and for predicting missing any tooth (AUC = 83.2%; 95%CI, 82.0, 84.4). Although, as expected, age and routine dental care emerged as strong predictors of tooth loss, the machine learning approach identified additional predictors, including socioeconomic conditions. Indeed, the performance of models incorporating socioeconomic characteristics was better at predicting tooth loss than those relying on clinical dental indicators alone. Conclusions Future application of machine-learning algorithm, with longitudinal cohorts, for identification of individuals at risk for tooth loss could assist clinicians to prioritize interventions directed toward the prevention of tooth loss.	[Elani, Hawazin W.] Harvard Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA; [Elani, Hawazin W.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Batista, Andre F. M.; Chiavegatto Filho, Alexandre D. P.] Univ Sao Paulo, Dept Epidemiol, Publ Hlth Sch, Sao Paulo, SP, Brazil; [Thomson, W. Murray] Univ Otago, Fac Dent, Dunedin, New Zealand; [Kawachi, Ichiro] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Universidade de Sao Paulo; University of Otago; Harvard University; Harvard T.H. Chan School of Public Health	Elani, HW (corresponding author), Harvard Sch Dent Med, Dept Oral Hlth Policy & Epidemiol, Boston, MA 02115 USA.; Elani, HW (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	hawazin_elani@hsdm.harvard.edu	Elani, Hawazin/AGI-6864-2022; Filho, Alexandre D P Chiavegatto/A-2092-2013; de Moraes Batista, Andre Filipe/N-5384-2015	Elani, Hawazin/0000-0003-1351-4038; de Moraes Batista, Andre Filipe/0000-0003-4627-0244	National Institute On Minority Health And Health Disparities of the National Institutes of Health [K99MD012253]; CNPq [308731/2018-2]	National Institute On Minority Health And Health Disparities of the National Institutes of Health; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research reported in this publication was supported by the National Institute On Minority Health And Health Disparities of the National Institutes of Health (under Award Number K99MD012253 to HE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nimhd.nih.gov Filho A is supported by CNPq grant number: 308731/2018-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, REC ADV OR HLTH; [Anonymous], 2017, STAT STAT SOFTW REL; Bachkati KH, 2017, J AM GERIATR SOC, V65, P194, DOI 10.1111/jgs.14513; Baumer A, 2011, J CLIN PERIODONTOL, V38, P644, DOI 10.1111/j.1600-051X.2011.01733.x; Broadbent JM, 2006, CARIES RES, V40, P459, DOI 10.1159/000095643; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2019, ORAL DENT HLTH; dos Santos HG, 2020, J CRIT CARE, V55, P73, DOI 10.1016/j.jcrc.2019.10.015; Ferreira RC, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01238-9; Fiscella K, 2009, AM HEART J, V157, P988, DOI 10.1016/j.ahj.2009.03.019; Franco G, 1999, LANCET, V354, P858; Franks P, 2010, ANN FAM MED, V8, P447, DOI 10.1370/afm.1167; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Halasa-Rappel YA, 2019, J PUBLIC HEALTH DENT, V79, P231, DOI 10.1111/jphd.12317; Hung M, 2019, GERODONTOLOGY, V36, P395, DOI 10.1111/ger.12432; Krois J, 2019, J DENT RES, V98, P1088, DOI 10.1177/0022034519864889; Lee JH, 2018, J DENT, V77, P106, DOI 10.1016/j.jdent.2018.07.015; Lundberg S., 2017, UNIFIED APPROACH INT, DOI [10.5555/3295222.3295230, DOI 10.5555/3295222.3295230]; Magno MB, 2020, J DENT, V99, DOI 10.1016/j.jdent.2020.103385; Martinez-Canut P, 2015, J CLIN PERIODONTOL, V42, P1115, DOI 10.1111/jcpe.12475; Matsuyama Y, 2019, AM J EPIDEMIOL, V188, P87, DOI 10.1093/aje/kwy205; Nieminen P, 2020, PUBLICATIONS, V8, DOI 10.3390/publications8010009; Ong G, 1998, INT DENT J, V48, P233, DOI 10.1111/j.1875-595X.1998.tb00711.x; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pirracchio R, 2015, LANCET RESP MED, V3, P42, DOI 10.1016/S2213-2600(14)70239-5; Roberto LL, 2019, GERODONTOLOGY, V36, P325, DOI 10.1111/ger.12430; Romandini M, 2021, J DENT RES, V100, P37, DOI 10.1177/0022034520952401; Rozier R Gary, 2017, J Dent Educ, V81, peS97, DOI 10.21815/JDE.017.016; Schierz O, 2021, J ORAL REHABIL, V48, P256, DOI 10.1111/joor.12984; Singh A, 2019, J DENT RES, V98, P853, DOI 10.1177/0022034519849557; Slade GD, 2014, J DENT RES, V93, P959, DOI 10.1177/0022034514546165; Thomson WM, 2010, J DENT RES, V89, P307, DOI 10.1177/0022034509356779; Thomson WM, 2012, INT J DENT, V2012, DOI 10.1155/2012/375407; Vujicic M, 2016, HEALTH AFFAIR, V35, P2176, DOI 10.1377/hlthaff.2016.0800; Watson S, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0803-8	35	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252873	10.1371/journal.pone.0252873	http://dx.doi.org/10.1371/journal.pone.0252873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BC	34143814	Green Published, gold			2022-12-26	WOS:000671690700074
J	Durovic, MR; Jankovic, J; Durovic, M; Spiric, J; Jankovic, S				Durovic, Milena Raznatovic; Jankovic, Janko; Durovic, Milica; Spiric, Jelena; Jankovic, Slavenka			Adolescents' beliefs and perceptions of acne vulgaris: A cross-sectional study in Montenegrin schoolchildren	PLOS ONE			English	Article							GLYCEMIC-LOAD DIET; BODY-MASS INDEX; QUALITY-OF-LIFE; TOBACCO SMOKING; RISK-FACTORS; PREVALENCE; EPIDEMIOLOGY; POPULATION; IMPACT; MISCONCEPTIONS	Background Acne is a common chronic inflammatory skin disease with a high prevalence in adolescent and early adult years. The aim of this study was to assess the self-perceived beliefs of Montenegrin secondary school pupils regarding the acne aggravating and ameliorating factors. Methods This cross-sectional survey of the pupils was conducted during October and November 2020 in four randomly selected public secondary schools in Podgorica, Montenegro. All 500 pupils were asked to fill in a questionnaire that included questions on age, sex, presence of acne, perceived acne aggravating and ameliorating factors, and sources of their information about acne. Results A total of 500 pupils, 234 (46.8%) boys, and 266 (53.2%) girls, aged 14-17 years, participated in the study. Acne was self-reported in 249 (49.8%) pupils, whereas 251 (50.2%) did not report acne. Factors most often believed to aggravate acne were inadequate face washing (85.0%), hormones (84.0%), sweets (82.0%), greasy food (72.6%), makeup (71.2%), and stress (67.8%). Overall the most prevalent acne ameliorating factors were cosmetic treatment (80.4%), increased water consumption (77.6%), a diet change to a healthier food choice (77.4%), and being on school holidays (62.2%). Girls reported more frequently that genetics, stress, sweets consumption, inadequate face wash, and makeup are acne exacerbating factors, whilst cosmetic treatment, increased water consumption, smoking, and being on school holidays are acne ameliorating factors. Boys more frequently considered the benefit of losing weight. There was no statistically significant difference between pupils with and without acne in perceived factors, except for cosmetic treatment. Those with acne more frequently believed in the benefits of cosmetic treatment. Conclusions Many adolescents' self-perceived beliefs about factors that aggravate and ameliorate acne are myths and misconceptions without evidence-based justification. More efforts are needed to educate pupils about the acne aggravating and ameliorating factors, its health-related consequences, and the treatment possibilities.	[Durovic, Milena Raznatovic; Durovic, Milica] Clin Ctr Montenegro, Clin Dermatol & Venereol, Podgorica, Montenegro; [Durovic, Milena Raznatovic] Univ Montenegro, Fac Med, Podgorica, Montenegro; [Jankovic, Janko] Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia; [Spiric, Jelena] Univ Belgrade, Fac Med, Belgrade, Serbia; [Jankovic, Slavenka] Univ Belgrade, Fac Med, Inst Epidemiol, Belgrade, Serbia	University of Montenegro; University of Belgrade; University of Belgrade; University of Belgrade	Jankovic, J (corresponding author), Univ Belgrade, Fac Med, Inst Social Med, Belgrade, Serbia.	drjankojankovic@yahoo.com		Jankovic, Janko/0000-0002-2387-6596	Ministry of Education, Science and Technological Development of the Republic of Serbia (Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja RS) [200110]	Ministry of Education, Science and Technological Development of the Republic of Serbia (Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja RS)	This study was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Ministarstvo Prosvete, Nauke i Tehnoloskog Razvoja RS, project No 200110). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hussein SM., 2016, ACTA MED MARISIENSIS, V62, P173, DOI [10.1515/amma-2016-0007, DOI 10.1515/AMMA-2016-0007]; Al Robaee AA, 2005, SAUDI MED J, V26, P1958; Al-Hoqail IA, 2003, SAUDI MED J, V24, P765; Allayali AZ., 2017, J CLIN EXP DERMATOL, V8, P404, DOI [10.4172/2155-9554.1000404, DOI 10.4172/2155-9554.1000404]; Ballanger F, 2006, DERMATOLOGY, V212, P145, DOI 10.1159/000090655; Bhate K, 2013, BRIT J DERMATOL, V168, P474, DOI 10.1111/bjd.12149; Brajac I, 2004, PATIENT EDUC COUNS, V54, P21, DOI 10.1016/S0738-3991(03)00168-X; Capitanio B, 2009, DERM-ENDOCRINOL, V1, P129, DOI 10.4161/derm.1.3.9638; Chilicka K, 2017, PATIENT PREFER ADHER, V11, P1357, DOI 10.2147/PPA.S131184; Chuh AAT, 2004, CLIN EXP DERMATOL, V29, P597, DOI 10.1111/j.1365-2230.2004.01646.x; Darwish Magdy A, 2013, ISRN Dermatol, V2013, P929340, DOI 10.1155/2013/929340; Di Landro A, 2012, J AM ACAD DERMATOL, V67, P1129, DOI 10.1016/j.jaad.2012.02.018; Dreno B, 2020, J EUR ACAD DERMATOL, V34, P1057, DOI 10.1111/jdv.16119; Dreno B, 2015, BRIT J DERMATOL, V172, P1, DOI 10.1111/bjd.13933; Durovic MR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250155; Firooz A, 2005, BMC DERMATOL, V5, DOI 10.1186/1471-5945-5-2; Ganceviciene R, 2009, DERM-ENDOCRINOL, V1, P170, DOI 10.4161/derm.1.3.8496; Gao RX, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2364581; Ghodsi SZ, 2009, J INVEST DERMATOL, V129, P2136, DOI 10.1038/jid.2009.47; Halvorsen JA, 2012, ARCH DERMATOL, V148, P131, DOI 10.1001/archderm.148.1.131; Heng AHS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62715-3; Ismail NH, 2012, BMC DERMATOL, V12, DOI 10.1186/1471-5945-12-13; Jemec GBE, 2002, DERMATOLOGY, V204, P179, DOI 10.1159/000057878; Jovic A, 2017, ACTA DERMATOVENER CR, V25, P133; Juhl CR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081049; Karciauskiene J, 2014, J EUR ACAD DERMATOL, V28, P733, DOI 10.1111/jdv.12160; Klaz I, 2006, J INVEST DERMATOL, V126, P1749, DOI 10.1038/sj.jid.5700326; Krause K, 2007, HORM METAB RES, V39, P166, DOI 10.1055/s-2007-961811; Kubota Y, 2010, J DERMATOL, V37, P617, DOI 10.1111/j.1346-8138.2010.00855.x; Kwon HH, 2012, ACTA DERM-VENEREOL, V92, P241, DOI 10.2340/00015555-1346; Magin P, 2005, FAM PRACT, V22, P62, DOI 10.1093/fampra/cmh715; Markovic M, 2019, AN BRAS DERMATOL, V94, P684, DOI 10.1016/j.abd.2019.02.005; Melnik BC, 2012, ACTA DERM-VENEREOL, V92, P228, DOI 10.2340/00015555-1358; Olsen JR, 2016, BRIT J DERMATOL, V174, P853, DOI 10.1111/bjd.14361; Pawin H, 2007, DERMATOLOGY, V215, P308, DOI 10.1159/000107624; Poli F, 2011, ACTA DERM-VENEREOL, V91, P531, DOI 10.2340/00015555-1125; Reich Adam, 2007, Dermatol Nurs, V19, P49; Revol O, 2015, BRIT J DERMATOL, V172, P52, DOI 10.1111/bjd.13749; Rigopoulos D, 2007, J EUR ACAD DERMATOL, V21, P806, DOI 10.1111/j.1468-3083.2006.02091.x; Rokowska-Waluch A, 2016, ANN DERMATOL, V28, P464, DOI 10.5021/ad.2016.28.4.464; Rombouts S, 2007, J EUR ACAD DERMATOL, V21, P326, DOI 10.1111/j.1468-3083.2006.01915.x; Schafer T, 2001, BRIT J DERMATOL, V145, P100, DOI 10.1046/j.1365-2133.2001.04290.x; Smith RN, 2007, J AM ACAD DERMATOL, V57, P247, DOI 10.1016/j.jaad.2007.01.046; Spencer EH, 2009, INT J DERMATOL, V48, P339, DOI 10.1111/j.1365-4632.2009.04002.x; Suh DH, 2011, INT J DERMATOL, V50, P673, DOI 10.1111/j.1365-4632.2010.04726.x; Suppiah TSS, 2018, ASIA PAC J CLIN NUTR, V27, P1141, DOI 10.6133/apjcn.072018.01; Tan HH, 2007, BRIT J DERMATOL, V157, P547, DOI 10.1111/j.1365-2133.2007.08087.x; Tan JKL, 2015, BRIT J DERMATOL, V172, P3, DOI 10.1111/bjd.13462; Tan JKL, 2001, J AM ACAD DERMATOL, V44, P439, DOI 10.1067/mjd.2001.111340; Uslu G, 2008, J EUR ACAD DERMATOL, V22, P462, DOI 10.1111/j.1468-3083.2007.02497.x; Wei B, 2010, J EUR ACAD DERMATOL, V24, P953, DOI 10.1111/j.1468-3083.2010.03590.x; Wolkenstein P, 2018, J EUR ACAD DERMATOL, V32, P298, DOI 10.1111/jdv.14475; Yahya H, 2009, INT J DERMATOL, V48, P498, DOI 10.1111/j.1365-4632.2009.03922.x; Yang JT, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00450; Yorulmaz Ahu, 2020, Curr Health Sci J, V46, P111, DOI 10.12865/CHSJ.46.02.02; Yosipovitch G, 2007, ACTA DERM-VENEREOL, V87, P135, DOI 10.2340/00015555-0231; Zouboulis CC, 2004, EXP DERMATOL, V13, P31, DOI 10.1111/j.1600-0625.2004.00254.x	57	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253421	10.1371/journal.pone.0253421	http://dx.doi.org/10.1371/journal.pone.0253421			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133464	Green Published, gold			2022-12-26	WOS:000671682700024
J	Bate, N; Lodge, J; Brindle, NPJ				Bate, Neil; Lodge, James; Brindle, Nicholas P. J.			Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; RECEPTOR; DOMAINS	Angiopoietins Ang1 and Ang2 are secreted ligands for the endothelial receptor tyrosine kinase Tie2 essential for vascular development and maintenance. Ang1 acts as an agonist to maintain normal vessel function, whereas Ang2 acts as a Tie2 antagonist. Ang2 is increased in macular edema, sepsis, and other conditions, in which it blocks Ang1-mediated signaling, causing vascular dysfunction and contributing to disease pathology. Therefore, Ang2 is an attractive therapeutic target. Previously, we reported a Tie2 ectodomain variant that selectively binds Ang2 and acts as soluble ligand trap to sequester Ang2; however, the mechanism of Ang2-binding selectivity is unknown. In the present study, we used directed protein evolution to enhance Ang2-binding affinity of this Tie2 ectodomain trap. We examined contributions of individual residues in the ligand-binding interface of Tie2 to Ang1 and Ang2 binding. Surprisingly, different combinations of Tie2 residues were found to bind each ligand, with hydrophobic residues binding both ligands and polar residues contributing selectively to either Ang1 or Ang2 binding. Our analysis also identified a single Tie2 residue, His168, with a pivotal role in both Ang1 and Ang2 binding, enabling competition between binding ligands. In summary, this study reports an enhanced-affinity Ang2-selective ligand trap with potential for therapeutic development and reveals the mechanism behind its selectivity. It also provides the first analysis of contributions of individual Tie2 residues to Ang1 and Ang2 binding and identifies selectivity-determining residues that could be targeted in the future design of small molecule and other inhibitors of Ang2 for the treatment of vascular dysfunction.	[Brindle, Nicholas P. J.] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester; University of Leicester	Brindle, NPJ (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England.	npjb1@le.ac.uk		Lodge, James/0000-0003-0663-6264; Brindle, Nicholas/0000-0002-4221-677X	British Heart Foundation [PG/19/27/34305, PG/15/65/31707]	British Heart Foundation(British Heart Foundation)	This work was supported by funding from the British Heart Foundation (PG/19/27/34305 and PG/15/65/31707).	Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Brindle NPJ, 2013, J BIOL CHEM, V288, P33205, DOI 10.1074/jbc.M113.510578; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Ji P, 2020, J CLIN PHARMACOL, V60, P1275, DOI 10.1002/jcph.1729; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Lee SJ, 2018, J CLIN INVEST, V128, P5018, DOI 10.1172/JCI99659; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; RUNTING AS, 1993, GROWTH FACTORS, V9, P99; Sacconi R., 2019, F1000RES; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Tabruyn SP, 2010, AM J PATHOL, V177, P3233, DOI 10.2353/ajpath.2010.100059; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	25	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100888	10.1016/j.jbc.2021.100888	http://dx.doi.org/10.1016/j.jbc.2021.100888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34153320	gold, Green Published			2022-12-26	WOS:000690873500015
J	Guzman, LB; Vogler, RE; Beltramino, AA				Belen Guzman, Leila; Eugenio Vogler, Roberto; Anibal Beltramino, Ariel			The mitochondrial genome of the semi-slug Omalonyx unguis (Gastropoda: Succineidae) and the phylogenetic relationships within Stylommatophora	PLOS ONE			English	Article							LAND SNAILS; COMPLETE MITOGENOME; COMPLETE SEQUENCE; PULMONATA; EVOLUTION; MODEL; DNA; CLASSIFICATION; NOMENCLATOR; INFERENCE	Here we report the first complete mitochondrial genome of the semi-slug Omalonyx unguis (d'Orbigny, 1836) (Gastropoda: Succineidae). Sequencing was performed on a specimen from Argentina. Assembly was performed using Sanger data and Illumina next generation sequencing (NGS). The mitogenome was 13,984 bp in length and encoded the 37 typical Metazoan genes. A potential origin for mitochondrial DNA replication was found in a non-coding intergenic spacer (49 bp) located between cox3 and tRNA-Ile genes, and its secondary structure was characterized. Secondary structure models of the tRNA genes of O. unguis largely agreed with those proposed for other mollusks. Secondary structure models for the two rRNA genes were also obtained. To our knowledge, the 12S-rRNA model derived here is the first complete one available for mollusks. Phylogenetic analyses based on the mitogenomes of O. unguis and 37 other species of Stylommatophora were performed using amino acid sequences from the 13 protein-coding genes. Our results located Succineoidea as a sister group of Helicoidea + Urocoptoidea, similar to previous studies based on mitochondrial genomes. The gene arrangement of O. unguis was identical to that reported for another species of Succineoidea. The unique rearrangements observed for this group within Stylommatophora, may constitute synapomorphies for the superfamily.	[Belen Guzman, Leila; Eugenio Vogler, Roberto; Anibal Beltramino, Ariel] CONICET UNaM, Inst Biol Subtrop IBS, Grp Invest Genet Moluscos GIGeMol, Posadas, Misiones, Argentina		Guzman, LB; Beltramino, AA (corresponding author), CONICET UNaM, Inst Biol Subtrop IBS, Grp Invest Genet Moluscos GIGeMol, Posadas, Misiones, Argentina.	leilaguzman95@gmail.com; beltraminoariel@hotmail.com		Guzman, Leila Belen/0000-0003-2694-6382; Vogler, Roberto/0000-0001-9660-552X				Ahn SJ, 2017, MITOCHONDRIAL DNA B, V2, P255, DOI 10.1080/23802359.2017.1318677; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arruda, 2011, THESIS PONTIFICIA U; Arruda Janine Oliveira, 2011, Biotemas, V24, P95; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Ayyagari VS, 2020, J GENET, V99, DOI 10.1007/s12041-020-1177-z; Barker G.M., 2001, P1, DOI 10.1079/9780851993188.0001; Garcia Marcos Vinicius Bastos, 2012, Acta Amaz., V42, P227, DOI 10.1590/S0044-59672012000200007; Beltramino AA, 2018, AN ACAD BRAS CIENC, V90, P1591, DOI 10.1590/0001-3765201820170766; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Borstein SR, 2018, PEERJ, V6, DOI 10.7717/peerj.5179; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P, 2017, MALACOLOGIA, V61, P1; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2014, SYST ENTOMOL, V39, P400, DOI 10.1111/syen.12071; Campos Pereira T., 2017, INTRO UNIVERSO NONCO, P40; Coscarelli D, 2018, BIOTA NEOTROP, V18, DOI [10.1590/1676-0611-BN-2017-0409, 10.1590/1676-0611-bn-2017-0409]; Coscarelli Daniel, 2011, Check List, V7, P400; Deng PJ, 2016, MITOCHONDRIAL DNA A, V27, P1441, DOI 10.3109/19401736.2014.953083; Gaitan-Espitia JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067299; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Dogan O, 2020, PEERJ, V8, DOI 10.7717/peerj.8603; Du SY, 2018, PEERJ, V6, DOI 10.7717/peerj.6131; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gomes-dos-Santos A, 2020, HYDROBIOLOGIA, V847, P1705, DOI 10.1007/s10750-019-04111-1; Gonzalez VL, 2016, J MOLLUS STUD, V82, P525, DOI 10.1093/mollus/eyw017; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Groenenberg DSJ, 2017, HEREDITAS, V154, P1, DOI 10.1186/s41065-017-0028-2; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Guzman Leila B., 2018, Check List, V14, P705; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hao JS, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/328049; Harasewych MG, 2017, MITOCHONDRIAL DNA B, V2, P159, DOI 10.1080/23802359.2017.1303343; HATZOGLOU E, 1995, GENETICS, V140, P1353; He ZP, 2016, MITOCHONDRIAL DNA A, V27, P1084, DOI 10.3109/19401736.2014.930833; Hou Y, 2016, MITOCHONDRIAL DNA A, V27, P939, DOI 10.3109/19401736.2014.926495; Huang CW, 2016, MITOCHONDRIAL DNA A, V27, P2793, DOI 10.3109/19401736.2015.1053070; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunter SS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01362-15; II AD, 2019, PHILIPP J SCI, V148, P167; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Korabek O, 2019, ZOOKEYS, P19, DOI 10.3897/zookeys.827.33057; Kudo, 2000, GENOME INFORM, V11, P301, DOI [10.11234/gi1990.11.301, DOI 10.11234/GI1990.11.301]; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Ladoukakis ED, 2017, J BIOL RES-THESSALON, V24, DOI 10.1186/s40709-017-0060-4; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Lin JH, 2016, ZOOKEYS, P55, DOI 10.3897/zookeys.589.7637; Linscott TM, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01693-18; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Lutz A., 1921, Memorias do Instituto Oswaldo Cruz, V13, P136; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; Lydeard C, 2002, MALACOLOGIA, V44, P349; Marsolier-Kergoat MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045050; Martinez FS, 2018, AN ACAD BRAS CIENC, V90, P155, DOI 10.1590/0001-3765201820170415; Masta SE, 2000, MOL BIOL EVOL, V17, P1091, DOI 10.1093/oxfordjournals.molbev.a026390; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller M.A., 2010, P GAT COMP ENV WORKS; Minton RL, 2016, ZOOKEYS, P137, DOI 10.3897/zookeys.626.9633; Montresor LC, 2008, PARASITOL RES, V103, P1339, DOI 10.1007/s00436-008-1138-6; Morrison D. A., 2010, LOOK TRNAS METAZOAN; Mozzer L.R., 2011, Journal of Parasitology Research, V2011, DOI 10.1155/2011/178748; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Pinto HA, 2013, ZOOTAXA, V3666, P449, DOI 10.11646/zootaxa.3666.4.3; Pons J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-566; Price MR, 2018, MITOCHONDRIAL DNA B, V3, P611, DOI 10.1080/23802359.2018.1473737; Price MR, 2016, MITOCHONDRIAL DNA B, V1, P666, DOI 10.1080/23802359.2016.1219631; Price MR, 2016, MITOCHONDRIAL DNA B, V1, P175, DOI 10.1080/23802359.2016.1149787; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Romero PE, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0735-8; Saadi AJ, 2019, MOL PHYLOGENET EVOL, V139, DOI 10.1016/j.ympev.2019.106529; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Santos MAS, 2004, TRENDS GENET, V20, P95, DOI 10.1016/j.tig.2003.12.009; Simison W. Brian, 2008, P447; Sun BN, 2016, MITOCHONDRIAL DNA A, V27, P3075, DOI 10.3109/19401736.2014.1003916; Sun SE, 2018, MOL PHYLOGENET EVOL, V118, P222, DOI 10.1016/j.ympev.2017.10.009; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thorp JH., 2020, THORP COVICHS FRESHW, P272; Tomita K, 2002, J MOL EVOL, V54, P486, DOI 10.1007/s00239-001-0039-4; Uribe JE, 2018, MOL PHYLOGENET EVOL, V127, P898, DOI 10.1016/j.ympev.2018.06.037; Uribe JE, 2019, MOL PHYLOGENET EVOL, V133, P12, DOI 10.1016/j.ympev.2018.12.019; Vidigal THDA, 2018, ZOOL SCR, V47, P174, DOI 10.1111/zsc.12271; Wade CM, 2007, J MOLLUS STUD, V73, P411, DOI 10.1093/mollus/eym030; Wade CM, 2006, BIOL J LINN SOC, V87, P593, DOI 10.1111/j.1095-8312.2006.00596.x; Wade CM, 2001, P ROY SOC B-BIOL SCI, V268, P413, DOI 10.1098/rspb.2000.1372; Wang P, 2014, ZOOKEYS, P33, DOI 10.3897/zookeys.451.8537; Wang XZ, 2007, GENE, V399, P11, DOI 10.1016/j.gene.2007.04.019; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2010, MOL PHYLOGENET EVOL, V57, P448, DOI 10.1016/j.ympev.2010.05.029; Xie GL, 2019, MOL PHYLOGENET EVOL, V135, P177, DOI 10.1016/j.ympev.2019.03.002; Yamazaki N, 1997, GENETICS, V145, P749; Yang J, 2019, GENOMICS, V111, P436, DOI 10.1016/j.ygeno.2018.02.020; Yang TZ, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030198; Yang X, 2016, MITOCHONDRIAL DNA A, V27, P3538, DOI 10.3109/19401736.2015.1074207; Zhao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062943	107	1	1	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253724	10.1371/journal.pone.0253724	http://dx.doi.org/10.1371/journal.pone.0253724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170937	Green Published, gold			2022-12-26	WOS:000671694400066
J	Hartmann, SA; Hochradel, K; Greule, S; Gunther, F; Luedtke, B; Schauer-Weisshahn, H; Brinkmann, R				Hartmann, Stefanie A.; Hochradel, Klaus; Greule, Soeren; Gunther, Felix; Luedtke, Bruntje; Schauer-Weisshahn, Horst; Brinkmann, Robert			Collision risk of bats with small wind turbines: Worst-case scenarios near roosts, commuting and hunting structures	PLOS ONE			English	Article							ENERGY; MORTALITY; WILDLIFE; FATALITIES; BIRD	Small wind turbines (SWTs) have become increasingly common within the last decade, but their impact on wildlife, especially bats, is largely unknown. We conducted an operational experiment by sequentially placing a mobile SWT with five different operational modes at six sites of high bat activity, including roosts, commuting structures, and highly frequented hunting areas. Bat flight trajectories around the SWT were documented at each site during five consecutive nights using a specifically designed high-spatial-resolution 3D camera. The recordings showed high bat activity levels close to the SWT (7,065 flight trajectories within a 10-m radius). The minimum distance to the rotor of each trajectory varied between 0 and 18 m, with a mean of 4.6 m across all sites. Linear mixed models created to account for site differences showed that, compared to a reference pole without a SWT, bats flew 0.4 m closer to the rotor (95% CI 0.3-0.6 m) if it was out of operation and 0.3 m closer (95% CI 0.1-0.4 m) if it was moving slowly. Exploratory behavior was frequently observed, with many bats deviating from their original flight trajectory to approach the rotor. Among 7,850 documented trajectories, 176 crossed the rotor, including 65 while it was in motion. The collision of one P. pygmaeus individual occurred during the experiment. These results demonstrate that, despite the generally strong ability of bats to evade moving rotor blades, bat casualties at SWTs placed at sites of high bat activity can reach or exceed the current threshold levels set for large wind turbines. As SWTs provide less energy than large turbines, their negative impact on bats should be minimized by avoidance measures such as a bat-friendly site selection or curtailment algorithms.	[Hartmann, Stefanie A.; Luedtke, Bruntje; Schauer-Weisshahn, Horst; Brinkmann, Robert] Freiburg Inst Appl Anim Ecol, Freiburg, Germany; [Hochradel, Klaus] UMIT Private Univ Hlth Sci, Med Informat & Technol GmbH, Hall In Tirol, Austria; [Greule, Soeren; Gunther, Felix] OekoFor GbR, Freiburg, Germany		Hartmann, SA (corresponding author), Freiburg Inst Appl Anim Ecol, Freiburg, Germany.	hartmann@frinat.de		Greule, Soeren/0000-0002-8512-7072; Hartmann, Stefanie/0000-0002-6009-4745; Hochradel, Klaus/0000-0003-4695-5809	German Bundesamt fur Naturschutz, FGII 4.3/Naturschutz und erneuerbare Energien, Projekt zum Forschungs-und Entwicklungsvorhaben aus Mitteln des Bundesministeriums fur Umwelt, Naturschutz und nukleare Sicherheit (BMU) [Forderkennzeichen: 3517860600]	German Bundesamt fur Naturschutz, FGII 4.3/Naturschutz und erneuerbare Energien, Projekt zum Forschungs-und Entwicklungsvorhaben aus Mitteln des Bundesministeriums fur Umwelt, Naturschutz und nukleare Sicherheit (BMU)	This project was funded by the German Bundesamt fur Naturschutz, FGII 4.3/Naturschutz und erneuerbare Energien, Projekt zum Forschungs-und Entwicklungsvorhaben aus Mitteln des Bundesministeriums fur Umwelt, Naturschutz und nukleare Sicherheit (BMU), Einzelplan 16, Kapitel 1604, Titel 54401. Forderkennzeichen: 3517860600 The funder provided support in the form of salaries for authors [S.A.H., S.G, F.G., B.L., H-S.-W, R.B.], but did not have any additional role in the study design, data collection and preparation of the manuscript. The decision to publish internationally was made together with the funder. The additional salary necessary for the preparation of the english manuscript as well as the revisions was covered by FrInaT GmbH. The funders had no role in study design, data collection and analysis, preparation of the manuscript, but read the final manuscript and were part of the decision where to submit the manuscript.	Alder H., 2017, NAT TAG FLED FLED 20; Barchi JR, 2013, J EXP BIOL, V216, P1053, DOI 10.1242/jeb.073197; Barclay RMR, 2007, CAN J ZOOL, V85, P381, DOI 10.1139/Z07-011; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernotat D, 2016, UBERGEORDNETE KRITER; Dietz C., 2016, HDB FLEDERMAUSE EURO, V2nd edn; Frick WF, 2017, BIOL CONSERV, V209, P172, DOI 10.1016/j.biocon.2017.02.023; Hochradel K., 2018, J PHYS C SERIES; Hochradel K, INT BAT RES C DURB; Hochradel K., 2019, IEEE SENS J; Hurst J., 2016, FLEDERMAUSE WINDKRAF; Koppel J, 2014, ENVIRON MANAGE, V54, P744, DOI 10.1007/s00267-014-0333-8; Kunz TH, 2003, BAT ECOLOGY, P3; Long CV, 2010, J ACOUST SOC AM, V128, P2238, DOI 10.1121/1.3479540; Long CV., 2009, P I ACOUSTICS, V31, P183; Lopez-Baucells A, 2019, ECOL INFORM, V49, P45, DOI 10.1016/j.ecoinf.2018.11.004; Minderman J, 2015, BIODIVERS CONSERV, V24, P467, DOI 10.1007/s10531-014-0826-z; Minderman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041177; Moyle A., 2016, IMPACTS SMALL MEDIUM; O'Shea TJ, 2016, MAMMAL REV, V46, P175, DOI 10.1111/mam.12064; Park KJ, 2013, J APPL ECOL, V50, P199, DOI 10.1111/jpe.12005; Perrow MRe., 2017, ONSHORE POTENTIAL EF, V1; Roscioni F, 2013, BIODIVERS CONSERV, V22, P1821, DOI 10.1007/s10531-013-0515-3; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Santos H, 2013, BIOL CONSERV, V157, P178, DOI 10.1016/j.biocon.2012.06.017; Thomsen KM., 2020, BERUCKSICHTIGUNG ART; Valenca RB., 2015, NATUREZA CONSERVACAO; Voigt CC, 2015, EUR J WILDLIFE RES, V61, P213, DOI 10.1007/s10344-015-0903-y; Wang SF, 2015, RENEW SUST ENERG REV, V49, P437, DOI 10.1016/j.rser.2015.04.137	29	0	0	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253782	10.1371/journal.pone.0253782	http://dx.doi.org/10.1371/journal.pone.0253782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170938	Green Published, gold			2022-12-26	WOS:000671694400021
J	Caplan, M; Duburcq, T; Moreau, AS; Poissy, J; Nseir, S; Parmentier-Decrucq, E				Caplan, Morgan; Duburcq, Thibault; Moreau, Anne-Sophie; Poissy, Julien; Nseir, Saad; Parmentier-Decrucq, Erika			Hyperbaric hyperoxemia as a risk factor for ventilator-acquired pneumonia?	PLOS ONE			English	Article							OXYGEN-THERAPY; ARTERIAL HYPEROXIA; LIPID-PEROXIDATION; BRAIN; ASSOCIATION; INJURY	Objectives Ventilator-acquired pneumonia (VAP) is the leading cause of serious associated infections in Intensive Care Units (ICU) and is associated with significant morbidity. The use of hyperbaric oxygen therapy (HBOT) in patients on mechanical ventilation may increase exposure to certain risk factors such as hyperoxemia and the need for multiple transfers. The aim of our study was to assess the relationship between HBOT and VAP. Method This retrospective observational study was performed from March 2017 to March 2018 in a 10-bed ICU using HBOT. All patients receiving mechanical ventilation (MV) for more than 48 hours were eligible. VAP was defined using clinical and radiological criteria. Data collection was carried out via digital medical records. Risk factors for VAP were determined by univariate and multivariate analysis. Results Forty-two (23%) of the 182 patients enrolled developed at least one episode of VAP. One hundred and twenty-four (68%) patients received HBOT. The incidence rate of VAP was 34 per 1000 ventilator days. The occurrence of VAP was significantly associated with immunosuppression (p.029), MV duration (5 [3-7] vs 8 [5-11.5] days, p.0001), length of stay (8 [5-13] vs 19.5 [13-32] days, p.0001), reintubation (p.0001), intra-hospital transport (p = 0.001), use of paralytic agents (p = 0.013), tracheotomy (p = 0.003) and prone position (p = 0.003). The use of HBOT was not associated with the occurrence of VAP. Multivariate analysis identified reintubation (OR: 8.3 [2.6-26.6]; p.0001), intra-hospital transport (OR: 3.5 [1.3-9.2]; p = 0.011) and the use of paralytic agents (OR: 3.3 [1.3-8.4]; p = 0.014) as independent risk factors for VAP. Conclusion Known risk factors for VAP are to be found within our ICU population. HBOT, however, is not an extra risk factor for VAP within this group. Further experimental and clinical investigations are needed to understand the impact of HBOT on the occurrence of VAP and on physiological microbiome.	[Caplan, Morgan; Duburcq, Thibault; Moreau, Anne-Sophie; Poissy, Julien; Nseir, Saad; Parmentier-Decrucq, Erika] Lille Univ Hosp, Intens Care Unit, Lille, France; [Caplan, Morgan; Duburcq, Thibault; Moreau, Anne-Sophie; Poissy, Julien; Nseir, Saad; Parmentier-Decrucq, Erika] Lille Univ Hosp, Hyperbar Ctr, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Parmentier-Decrucq, E (corresponding author), Lille Univ Hosp, Intens Care Unit, Lille, France.	erika.parmentier@chru-lille.fr		Parmentier-Decrucq, Erika/0000-0002-5836-5956; caplan, Morgan/0000-0002-6016-0749				ALLEN MC, 1993, UNDERSEA HYPERBAR M, V20, P39; Ayzac L, 2016, INTENS CARE MED, V42, P871, DOI 10.1007/s00134-015-4167-5; Barrot L, 2020, NEW ENGL J MED, V382, P999, DOI 10.1056/NEJMoa1916431; Bessereau J, 2017, INT MARIT HEALTH, V68, P46, DOI 10.5603/IMH.2017.0008; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chu DK, 2018, LANCET, V391, P1693, DOI 10.1016/S0140-6736(18)30479-3; Corcoran T, 2017, PROSTAG LEUKOTR ESS, V127, P16, DOI 10.1016/j.plefa.2017.10.003; Dananche C, 2018, CRIT CARE MED, V46, P869, DOI 10.1097/CCM.0000000000003019; DANTZKER DR, 1974, J PHYSIOL-LONDON, V242, pP72; Fosen KM, 2014, ANTIOXID REDOX SIGN, V21, P1634, DOI 10.1089/ars.2014.5940; Hadanny A, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-0893-8; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Hiner C, 2010, AM J CRIT CARE, V19, P164, DOI 10.4037/ajcc2010917; Infectiologie, INFECTIOLOGIE; Jain Kewal K., 2017, TXB HYPERBARIC MED; Kalns J, 2002, IMMUNOL LETT, V83, P125, DOI 10.1016/S0165-2478(02)00068-8; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Koulenti D, 2017, EUR J CLIN MICROBIOL, V36, P1999, DOI 10.1007/s10096-016-2703-z; Martin-Loeches I, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9070380; Mathieu D, 2006, HDB HYPERBARIC MED, P401, DOI [10.1007/1-4020-4448-8_20, DOI 10.1007/1-4020-4448-8_20]; Mathieu D, 2017, DIVING HYPERB MED, V47, P24, DOI 10.28920/dhm47.1.24-32; MILLER JD, 1970, J NEUROL NEUROSUR PS, V33, P745, DOI 10.1136/jnnp.33.6.745; Organisation-Securite-Ethique, ORG SEC ETH; Palmer E, 2019, AM J RESP CRIT CARE, V200, P1373, DOI 10.1164/rccm.201904-0849OC; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Patel VS, 2013, AM J RESP CELL MOL, V48, P280, DOI 10.1165/rcmb.2012-0279OC; SACKNER MA, 1976, CHEST, V69, P164, DOI 10.1378/chest.69.2.164; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Six S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1368-4; THOM SR, 1992, J APPL PHYSIOL, V73, P1584, DOI 10.1152/jappl.1992.73.4.1584; THOM SR, 1993, TOXICOL APPL PHARM, V123, P248, DOI 10.1006/taap.1993.1243; Thom SR, 2006, AM J PHYSIOL-HEART C, V290, pH1378, DOI 10.1152/ajpheart.00888.2005; THOM SR, 1990, TOXICOL APPL PHARM, V105, P340, DOI 10.1016/0041-008X(90)90195-Z; Thorsen E, 1998, EUR RESPIR J, V12, P1442, DOI 10.1183/09031936.98.12061442; Tsuneyoshi I, 2001, J Anesth, V15, P29, DOI 10.1007/s005400170048; Weaver LK, 2015, DIVING HYPERB MED, V45, P1; Yokoyama S, 2019, SHOCK, V51, P593, DOI 10.1097/SHK.0000000000001221	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253198	10.1371/journal.pone.0253198	http://dx.doi.org/10.1371/journal.pone.0253198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161365	Green Published, gold			2022-12-26	WOS:000671691900004
J	Mistry, SK; Ali, ARMM; Akther, F; Peprah, P; Reza, S; Prova, S; Yadav, UN				Mistry, Sabuj Kanti; Ali, A. R. M. Mehrab; Akther, Farhana; Peprah, Prince; Reza, Sompa; Prova, Shaidatonnisha; Yadav, Uday Narayan			Are older adults of Rohingya community (Forcibly Displaced Myanmar Nationals or FDMNs) in Bangladesh fearful of COVID-19? Findings from a cross-sectional study	PLOS ONE			English	Article								Aim This study aimed to assess the fear of COVID-19 and its associates among older Rohingya (Forcibly Displaced Myanmar Nationals or FDMNs) in Bangladesh. Method We conducted a cross-sectional survey among 416 older FDMNs aged 60 years and above living in camps of Cox's Bazar, Bangladesh. A semi-structured questionnaire was used to collect information on participants' socio-demographic and lifestyle characteristics, pre-existing non-communicable chronic conditions, and COVID-19 related information. Level of fear was measured using the seven-item Fear of COVID-19 Scale (FCV-19S) with the cumulative score ranged from 7 to 35. A multiple linear regression examined the factors associated with fear. Results Among 416 participants aged 60 years or above, the mean fear score was 14.8 (range 8-28) and 88.9% of the participants had low fear score. Participants who were concerned about COVID-19 (beta: 0.63, 95% CI: -0.26 to 1.53) and overwhelmed by COVID-19 (beta: 3.54, 95% CI: 2.54 to 4.55) were significantly more likely to be fearful of COVID-19. Other factors significantly associated with higher level of fear were lesser frequency of communication during COVID-19, difficulty in obtaining food during COVID-19, perception that older adults are at highest risk of COVID-19 and receiving COVID-19 related information from Radio/television and friends/family/neighbours. Conclusions Our study highlighted that currently there little fear of COVID-19 among the older Rohingya FDMNs. This is probably due to lack of awareness of the severity of the disease in. Dissemination of public health information relevant to COVID-19 and provision of mental health services should be intensified particularly focusing on the individual who were concerned, overwhelmed or fearful of COVID-19. However, further qualitative research is advised to find out the reasons behind this.	[Mistry, Sabuj Kanti; Ali, A. R. M. Mehrab] ARCED Fdn, Dhaka, Bangladesh; [Mistry, Sabuj Kanti; Peprah, Prince; Yadav, Uday Narayan] Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia; [Mistry, Sabuj Kanti] BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Ali, A. R. M. Mehrab] Innovat Poverty Act, New Haven, CT USA; [Akther, Farhana] Mawlana Bhashani Sci & Technol Univ, Tangail, Bangladesh; [Reza, Sompa; Prova, Shaidatonnisha] Soc Hlth Extens & Dev Shed, Coxs Bazar, Bangladesh	University of New South Wales Sydney; Bangladesh Rural Advancement Committee BRAC; BRAC University; Innovations for Poverty Action (IPA); Mawlana Bhashani Science & Technology University	Mistry, SK (corresponding author), ARCED Fdn, Dhaka, Bangladesh.; Mistry, SK (corresponding author), Univ New South Wales, Ctr Primary Hlth Care & Equ, Sydney, NSW, Australia.; Mistry, SK (corresponding author), BRAC Univ, BRAC James P Grant Sch Publ Hlth, Dhaka, Bangladesh.	smitra411@gmail.com		Ali, ARM Mehrab/0000-0001-5442-7147				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; CDC, COR DIS 2019 COVID 1; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Heifer International, BANGL COVID 19 PUTS; Homaira N., 2020, GLOBAL BIOSECURITY, V1; Hossain MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239646; Islam MM, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.020309; Kamal A-H, 2020, GLOBAL BIOSECURITY, V1; Khoury R, 2020, INT PSYCHOGERIATR, V32, P1177, DOI 10.1017/S104161022000068X; Mamun MA, 2021, J AFFECT DISORDERS, V279, P462, DOI 10.1016/j.jad.2020.10.036; Martinez-Lorca M, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113350; Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258; Nguyen HT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114164; Niu Shengmei, 2020, Arch Gerontol Geriatr, V89, P104058, DOI 10.1016/j.archger.2020.104058; Pang NTP, 2022, INT J MENT HEALTH AD, V20, P263, DOI 10.1007/s11469-020-00355-4; Parlapani E, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00842; Peprah P., STIGMA COVID 19 CRIS, DOI [10.1002/hpm.3065, DOI 10.1002/HPM.3065]; Peprah P, 2020, ARCH GERONTOL GERIAT, V90, DOI 10.1016/j.archger.2020.104149; Powell T, 2020, HASTINGS CENT REP, V50, P61, DOI 10.1002/hast.1136; Raju E, 2020, INT J PUBLIC HEALTH, V65, P515, DOI 10.1007/s00038-020-01381-8; UCAnews, UCANEWS; United Nations High Commissioner for Refugees (UNHCR), JOINT GOV BANGL UNHC; Vahia IV, 2020, JAMA-J AM MED ASSOC, V324, P2253, DOI 10.1001/jama.2020.21753; Vision W., ROHINGYA REFUGEE RES; WFP, 2020, 41 WFP; WHO, WHO COR DIS COVID 19; World Health Organization, 2020, 25 WHO; Worldometer,, 2020, AG SEX EX COND COVID; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yadav UN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00508	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253648	10.1371/journal.pone.0253648	http://dx.doi.org/10.1371/journal.pone.0253648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161389	gold, Green Published			2022-12-26	WOS:000671691900035
J	Taylor, JS; Madhavan, S; Han, RW; Chandler, JM; Tenakoon, L; Chao, S				Taylor, Jordan S.; Madhavan, Sriraman; Han, Ryan W.; Chandler, Julia M.; Tenakoon, Lakshika; Chao, Stephanie			Financial burden of pediatric firearm-related injury admissions in the United States	PLOS ONE			English	Article							COSTS; INCOME	Pediatric firearm-related injuries pose a significant public health problem in the United States, yet the associated financial burden has not been well described. This is the first study examining national data on the cost of initial hospitalization for pediatric firearm-related injuries. In this retrospective review, the Healthcare Cost and Utilization Project Kids' Inpatient Database from the years 2003, 2006, 2009, and 2012 was used to identify all patients 18 years of age and under who were admitted with firearm-related injuries. We compared demographic and discharge-level data including injury severity score, hospital length of stay, income quartile, injury intent, and inflation-adjusted hospital costs across age groups (0-5, 6-9, 10-15, 16-18 years). There were approximately 4,753 pediatric firearm-related admissions each year, with a median hospitalization cost of $12,984 per patient. Annual initial hospitalization costs for pediatric firearm injuries were approximately $109 million during the study period. Pediatric firearm-related injuries predominately occured among older teenagers (74%, 16-18 years), males (89%), black individuals (55%), and those from the lowest income quartile (53%). We found significant cost variation based on patient race, income quartile, injury severity score, intent, hospital length of stay, disposition, and hospital region. Inflation-adjusted hospitalization costs have increased significantly over the study period (p < 0.001). Pediatric firearm-related injuries are a large financial burden to the United States healthcare system. There are significant variations in cost based on predictable factors like hospital length of stay and injury severity score; however, there are also substantial discrepancies based on hospital region, patient race, and income quartile that require further investigation.	[Taylor, Jordan S.; Chandler, Julia M.; Chao, Stephanie] Stanford Univ, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA; [Madhavan, Sriraman] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Han, Ryan W.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Tenakoon, Lakshika] Stanford Univ, Dept Surg, Div Gen Surg, Stanford, CA USA	Stanford University; Stanford University; Stanford University; Stanford University	Chao, S (corresponding author), Stanford Univ, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA.	sdchao1@stanford.edu		Chao, Stephanie/0000-0003-0139-8551; Han, Ryan/0000-0001-5345-4186				Centers for Disease Control and Prevention (2022), WEB BAS INJ STAT QUE; DiScala C, 2004, PEDIATRICS, V113, P1306, DOI 10.1542/peds.113.5.1306; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Fowler KA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-3486; Grinshteyn E, 2016, AM J MED, V129, P266, DOI 10.1016/j.amjmed.2015.10.025; Kids' Inpatient Database (KID), HEALTHC COST UT PROJ; KIZER KW, 1995, JAMA-J AM MED ASSOC, V273, P1768, DOI 10.1001/jama.273.22.1768; Martin TM, REGIONAL PRICE PARIT; MAX W, 1993, HEALTH AFFAIR, V12, P171, DOI 10.1377/hlthaff.12.4.171; Miller T, 2012, COST FIREARM VIOLENC; Parikh Kavita, 2017, Hosp Pediatr, V7, P303, DOI 10.1542/hpeds.2016-0146; Peek-Asa Corinne, 2017, Inj Epidemiol, V4, P20, DOI 10.1186/s40621-017-0120-0; Shenassa ED, 2003, J EPIDEMIOL COMMUN H, V57, P120, DOI 10.1136/jech.57.2.120; Spitzer SA, 2017, AM J PUBLIC HEALTH, V107, P770, DOI 10.2105/AJPH.2017.303684; Webster DW, 2004, JAMA-J AM MED ASSOC, V292, P594, DOI 10.1001/jama.292.5.594	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252821	10.1371/journal.pone.0252821	http://dx.doi.org/10.1371/journal.pone.0252821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161341	Green Published, gold			2022-12-26	WOS:000671691900010
J	Cao, LN; Zhang, J; Ge, XQ; Chen, JD				Cao, Lina; Zhang, Jian; Ge, Xinquan; Chen, Jindong			Occupational profiling driven by online job advertisements: Taking the data analysis and processing engineering technicians as an example	PLOS ONE			English	Article							INFORMATION	The occupational profiling system driven by the traditional survey method has some shortcomings such as lag in updating, time consumption and laborious revision. It is necessary to refine and improve the traditional occupational portrait system through dynamic occupational information. Under the circumstances of big data, this paper showed the feasibility of vocational portraits driven by job advertisements with data analysis and processing engineering technicians (DAPET) as an example. First, according to the description of occupation in the Chinese Occupation Classification Grand Dictionary, a text similarity algorithm was used to preliminarily choose recruitment data with high similarity. Second, Convolutional Neural Networks for Sentence Classification (TextCNN) was used to further classify the preliminary corpus to obtain a precise occupational dataset. Third, the specialty and skill were taken as named entities that were automatically extracted by the named entity recognition technology. Finally, putting the extracted entities into the occupational dataset, the occupation characteristics of multiple dimensions were depicted to form a profile of the vocation.	[Cao, Lina; Zhang, Jian; Ge, Xinquan; Chen, Jindong] Beijing Informat Sci & Technol Univ, Sch Econ & Management, Beijing, Peoples R China; [Cao, Lina; Chen, Jindong] Lab Big Data Decis Making Green Dev, Beijing, Peoples R China; [Zhang, Jian; Ge, Xinquan] Beijing Int Sci & Technol, Cooperat Base Intelligent Decis & Big Data Applic, Beijing, Peoples R China	Beijing Information Science & Technology University	Zhang, J (corresponding author), Beijing Informat Sci & Technol Univ, Sch Econ & Management, Beijing, Peoples R China.; Zhang, J (corresponding author), Beijing Int Sci & Technol, Cooperat Base Intelligent Decis & Big Data Applic, Beijing, Peoples R China.	zhangjian@bistu.edu.cn			Beijing Social Science Foundation [20GLA002]	Beijing Social Science Foundation	This study is supported by Beijing Social Science Foundation (Grant No.20GLA002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boselli R, 2018, J INTELL INF SYST, V51, P477, DOI 10.1007/s10844-017-0488-x; Boselli R, 2018, FUTURE GENER COMP SY, V86, P319, DOI 10.1016/j.future.2018.03.035; Calanca F, 2019, EPJ DATA SCI, V8, DOI 10.1140/epjds/s13688-019-0190-z; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Cho YJ, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3321-4; Descy Pascaline, 2019, Statistical Journal of the IAOS, V35, P669, DOI 10.3233/SJI-190547; Devlin J., 2018, ARXIV181004805; Emmel A., 2010, OCCUPATIONAL CLASSIF; Executive Office of the President Office of Management and Budget, 2018, STAND OCC CLASS MAN; Graves A, 2005, NEURAL NETWORKS, V18, P602, DOI 10.1016/j.neunet.2005.06.042; Gruger J, 2019, WEBIST: PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON WEB INFORMATION SYSTEMS AND TECHNOLOGIES, P226, DOI 10.5220/0008068202260233; Gurcan F, 2019, IEEE ACCESS, V7, P82541, DOI 10.1109/ACCESS.2019.2924075; Hakak S, 2021, FUTURE GENER COMP SY, V117, P47, DOI 10.1016/j.future.2020.11.022; Huang Z., 2015, ARXIV; Jia S., 2018, PROC IEEE S PRODUCT, P1; Khan MU, 2020, MULTIMEDIA SYST, DOI [10.1007/s00530-020-00704-2, 10.1007/s11042-020-09408-1, 10.1007/s11042-020-08806-9]; Kim Y., 2014, P 2014 C EMP METH NA, P1746; Labusch Kai, 2019, P KONVENS ERL GERM, P8; Litecky C, 2010, IEEE SOFTWARE, V27, P78, DOI 10.1109/MS.2009.150; Liu YL, 2020, INT J SELECT ASSESS, V28, P186, DOI 10.1111/ijsa.12281; Naeem A, 2021, IEEE T GREEN COMMUN, V5, P611, DOI 10.1109/TGCN.2021.3067885; National Working Committee on Revision of Occupational Classification, 2015, OCCUPATIONAL CLASSIF, V2015, P7; Ningrum PK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233746; Pejic-Bach M, 2020, INT J INFORM MANAGE, V50, P416, DOI 10.1016/j.ijinfomgt.2019.07.014; Peterson NG, 2001, PERS PSYCHOL, V54, P451, DOI 10.1111/j.1744-6570.2001.tb00100.x; Priya RMS, 2020, COMPUT COMMUN, V160, P139, DOI 10.1016/j.comcom.2020.05.048; Reddy GT, 2020, IEEE ACCESS, V8, P54776, DOI 10.1109/ACCESS.2020.2980942; Siekmann G., 2017, IDENTIFYING WORK SKI; Song YH, 2020, AUTOM CONTROL COMPUT, V54, P179, DOI 10.3103/S0146411620030098; Tansley S., 2009, 4 PARADIGM DATA INTE; Tong D.Y.K., 2005, EMPL RELAT, V27, P103, DOI [10.1108/01425450510569337, DOI 10.1108/01425450510569337]; TRAUTH EM, 1993, MIS QUART, V17, P293, DOI 10.2307/249773; Wang D., 2018, LIB INFORM SERVICE, V62, P64; Xu T, 2018, AAAI CONF ARTIF INTE, P2572; Zhao M, 2015, AAAI CONF ARTIF INTE, P4012	35	2	2	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253308	10.1371/journal.pone.0253308	http://dx.doi.org/10.1371/journal.pone.0253308			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157028	gold, Green Published			2022-12-26	WOS:000671691200001
J	Xu, F; Jiang, LY; Zhao, QW; Zhang, ZBA; Liu, YX; Yang, SS; Yu, MD; Chen, HP; Zhang, JY; Zhang, JT				Xu, Fang; Jiang, Liya; Zhao, Qianwei; Zhang, Zhibiao; Liu, Yixian; Yang, Shuangshuang; Yu, Mengdan; Chen, Huiping; Zhang, Jianying; Zhang, Jintao			Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC	ONCOGENE			English	Article							LONG NONCODING RNAS; LIVER-CANCER CELL; HEPATOCELLULAR-CARCINOMA; BIG DATA; ROLES; RISK	Hepatocellular carcinoma (HCC) is the most common subtype of primary liver cancer and one of the leading causes of cancer-related death worldwide. To gain more insights into the transcriptomic landscape and molecular mechanism of HCC, we performed TMT-labelled tandem mass spectrometry (n = 4) and whole-transcriptome sequencing (n = 3) based on HCC tumour (T) and adjacent normal (N) tissues from seven HCC patients. To comprehensively evaluate the gene-regulatory circuits in HCC, differential expression and enrichment analyses were performed on the differentially expressed proteins (DEPs), genes (DEGs), miRNAs (555), lncRNAs (29) and circRNAs (895). A total of 977 proteins and 243 genes were found to be differentially expressed in HCC tumours compared with adjacent normal tissues. HCC data from The Cancer Genome Atlas were used to validate the results. Combined with the results above, 56 DEP-DEGs with common changes in relative quantity were identified. Functional pathway analysis showed that the DEP-DEGs were mainly enriched in the spliceosome and various metabolic processes. Bioinformatics analysis showed that hsa-miR-1266-5p, hsa-miR-128-1-5p, hsa-miR-139-5p, hsa-miR-34b-3p and hsa-miR-570-3p were involved in the regulation of the hub genes mentioned above. The crucial coexpression (lncRNA-mRNA, circRNA-mRNA) and competing endogenous RNA interaction axes showed the possible functions of the lncRNAs and circRNAs. We explored potential cancer biomarkers by combining proteomic and transcriptomic studies. Our study provides a valuable resource for understanding regulatory mechanisms at the RNA level and may ultimately further assist in the development of diagnostic and/or therapeutic targets for HCC.	[Xu, Fang; Jiang, Liya; Zhao, Qianwei; Liu, Yixian; Yang, Shuangshuang; Chen, Huiping; Zhang, Jianying; Zhang, Jintao] Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China; [Xu, Fang; Jiang, Liya; Zhao, Qianwei; Liu, Yixian; Yang, Shuangshuang; Chen, Huiping; Zhang, Jianying; Zhang, Jintao] Zhengzhou Univ, BGI Coll, Zhengzhou, Peoples R China; [Jiang, Liya; Zhang, Zhibiao] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Peoples R China; [Yu, Mengdan] Zhengzhou Univ, Sch Basic Med Sci, Zhengzhou, Peoples R China; [Zhang, Jianying; Zhang, Jintao] Zhengzhou Univ, Henan Key Lab Tumor Epidemiol, Zhengzhou, Peoples R China; [Zhang, Jianying; Zhang, Jintao] Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Zhang, JY; Zhang, JT (corresponding author), Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China.; Zhang, JY; Zhang, JT (corresponding author), Zhengzhou Univ, BGI Coll, Zhengzhou, Peoples R China.; Zhang, JY; Zhang, JT (corresponding author), Zhengzhou Univ, Henan Key Lab Tumor Epidemiol, Zhengzhou, Peoples R China.; Zhang, JY; Zhang, JT (corresponding author), Zhengzhou Univ, State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou, Peoples R China.	jianyingzhang@hotmail.com; zhangjt_66@126.com		Xu, Fang/0000-0002-5722-0798	Natural Science Foundation of Henan Province [182300410361]; Major Project of Science and Technology in Henan Province [161100311400]; National Science and Technology Major Project of China [2018ZX10302205]; Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences [2020BP0107, 2020BP0111]; Zhengzhou Major Project for Collaborative Innovation [18XTZX12007]; Key Scientific and Technological Project of Henan Province [212102310124]	Natural Science Foundation of Henan Province; Major Project of Science and Technology in Henan Province; National Science and Technology Major Project of China; Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences; Zhengzhou Major Project for Collaborative Innovation; Key Scientific and Technological Project of Henan Province	We gratefully acknowledge Henan Key Laboratory of Pharmacology for Liver Diseases for providing experimental platform support. We thank Dr. Jianxiang Shi for assistance in bioinformatic analysis. This work was supported by grants from Natural Science Foundation of Henan Province (No. 182300410361); the Major Project of Science and Technology in Henan Province (No. 161100311400); the National Science and Technology Major Project of China (No. 2018ZX10302205); Project of Basic Research Fund of Henan Institute of Medical and Pharmacological Sciences (No. 2020BP0107; No. 2020BP0111); Zhengzhou Major Project for Collaborative Innovation (18XTZX12007) and The Key Scientific and Technological Project of Henan Province (No. 212102310124).	Alqahtani A, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55090526; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen B, 2016, CLIN PHARMACOL THER, V99, P285, DOI 10.1002/cpt.318; Chen SZ, 2019, CANCER LETT, V460, P1, DOI 10.1016/j.canlet.2019.114428; Chen TC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008346; Chen XJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010066; Dhanasekaran R, 2019, GASTROENTEROLOGY, V156, P492, DOI 10.1053/j.gastro.2018.11.001; DiStefano JK, 2019, CANCERS, V11, DOI 10.3390/cancers11040486; Dragomir MP, 2020, GUT, V69, P748, DOI 10.1136/gutjnl-2019-318279; Du ZH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72510-9; El Khodiry A, 2018, WORLD J GASTROENTERO, V24, P549, DOI 10.3748/wjg.v24.i5.549; Fu J, 2018, CANCER LETT, V412, P283, DOI 10.1016/j.canlet.2017.10.008; Fujiwara N, 2018, J HEPATOL, V68, P526, DOI 10.1016/j.jhep.2017.09.016; He J, 2019, CANCER LETT, V450, P98, DOI 10.1016/j.canlet.2019.02.033; Henley SJ, 2020, CANCER-AM CANCER SOC, V126, P2225, DOI 10.1002/cncr.32802; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang Z, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01188-4; Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8; Kim YA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082883; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kong S, 2020, CANCER LETT, V483, P59, DOI 10.1016/j.canlet.2020.04.006; Lanzafame M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030682; Li L, 2016, CANCER LETT, V379, P191, DOI 10.1016/j.canlet.2015.07.018; Lim LJ, 2019, CANCER RES, V79, P5131, DOI 10.1158/0008-5472.CAN-19-0255; Lin YH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123742; Liu YX, 2021, ONCOL LETT, V21, DOI 10.3892/ol.2020.12378; Llovet JM, 2018, NAT REV CLIN ONCOL, V15, P599, DOI 10.1038/s41571-018-0073-4; Mahipal A, 2019, MOL TRANSL MED, P225, DOI 10.1007/978-3-030-21540-8_11; Mahpour A, 2021, JHEP REP, V3, DOI 10.1016/j.jhepr.2020.100177; Nekvindova J, 2020, BIOCHEM PHARMACOL, V177, DOI 10.1016/j.bcp.2020.113912; Niu ZS, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i29.4240; Sasaki R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061406; Shi J, 2019, J CANCER, V10, P4892, DOI 10.7150/jca.32768; Sia D, 2017, GASTROENTEROLOGY, V152, P745, DOI 10.1053/j.gastro.2016.11.048; Tseng CS, 2005, AM J GASTROENTEROL, V100, P1758, DOI 10.1111/j.1572-0241.2005.41857.x; Umeda S, 2019, EXPERT REV MOL DIAGN, V19, P725, DOI 10.1080/14737159.2019.1638254; Wei L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1086-z; Wooden B, 2017, GASTROENTEROLOGY, V152, P53, DOI 10.1053/j.gastro.2016.09.065; Xu G, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01581-5; Yan TM, 2015, PHARM RES-DORDR, V32, P1141, DOI 10.1007/s11095-014-1525-x; Ye X, 2019, HEPATOLOGY, V69, P2489, DOI 10.1002/hep.30519; Yin YT, 2019, J CANCER, V10, P5015, DOI 10.7150/jca.30828; Yousry A, 2019, SEMIN LIVER DIS, V39, P463, DOI 10.1055/s-0039-1688442; Zhang H, 2020, INT J ONCOL, V56, P18, DOI 10.3892/ijo.2019.4909; Zhao QW, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.572663; Zhao YB, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108487	47	6	5	6	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4820	4831		10.1038/s41388-021-01908-0	http://dx.doi.org/10.1038/s41388-021-01908-0		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34155346				2022-12-26	WOS:000664006700003
J	Guan, HW; Dong, XB; Yan, GH; Searls, T; Bourque, CPA; Meng, FR				Guan, Huiwen; Dong, Xibin; Yan, Guohua; Searls, Tyler; Bourque, Charles P-A; Meng, Fan-Rui			Conditional inference trees in the assessment of tree mortality rates in the transitional mixed forests of Atlantic Canada	PLOS ONE			English	Article							DIE-OFF; GROWTH; CLIMATE; COMPETITION; DROUGHT; STANDS; MODELS; CLASSIFICATION; ACCUMULATION; PATTERNS	Long-term predictions of forest dynamics, including forecasts of tree growth and mortality, are central to sustainable forest-management planning. Although often difficult to evaluate, tree mortality rates under different abiotic and biotic conditions are vital in defining the long-term dynamics of forest ecosystems. In this study, we have modeled tree mortality rates using conditional inference trees (CTREE) and multi-year permanent sample plot data sourced from an inventory with coverage of New Brunswick (NB), Canada. The final CTREE mortality model was based on four tree- and three stand-level terms together with two climatic terms. The correlation coefficient (R-2) between observed and predicted mortality rates was 0.67. High cumulative annual growing degree-days (GDD) was found to lead to increased mortality in 18 tree species, including Betula papyrifera, Picea mariana, Acer saccharum, and Larix laricina. In another ten species, including Abies balsamea, Tsuga canadensis, Fraxinus americana, and Fagus grandifolia, mortality rates tended to be higher in areas with high incident solar radiation. High amounts of precipitation in NB's humid maritime climate were also found to contribute to heightened tree mortality. The relationship between high GDD, solar radiation, and high mortality rates was particularly strong when precipitation was also low. This would suggest that although excessive soil water can contribute to heightened tree mortality by reducing the supply of air to the roots, occasional drought in NB can also contribute to increased mortality events. These results would have significant implications when considered alongside regional climate projections which generally entail both components of warming and increased precipitation.	[Guan, Huiwen] Zhejiang Univ Water Resources & Elect Power, Coll Econ & Management, Hangzhou, Zhejiang, Peoples R China; [Guan, Huiwen; Searls, Tyler; Bourque, Charles P-A; Meng, Fan-Rui] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada; [Dong, Xibin] Northeast Forestry Univ, Coll Engn & Technol, Harbin, Heilongjiang, Peoples R China; [Yan, Guohua] Univ New Brunswick, Dept Math & Stat, Fredericton, NB, Canada	Zhejiang University of Water Resources and Electric Power; University of New Brunswick; Northeast Forestry University - China; University of New Brunswick	Meng, FR (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada.; Dong, XB (corresponding author), Northeast Forestry Univ, Coll Engn & Technol, Harbin, Heilongjiang, Peoples R China.	xibindong@nefu.edu.cn; fmeng@unb.ca		Meng, Fan-Rui/0000-0002-6947-8868; Searls, Tyler/0000-0002-9368-8996	China National Key Research and Development Program [2017YFC0504103]; New Brunswick Environmental Trust Fund	China National Key Research and Development Program; New Brunswick Environmental Trust Fund	This research was funded in part by the China National Key Research and Development Program, grant number 2017YFC0504103, and by the New Brunswick Environmental Trust Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker SA, 2002, TREE PHYSIOL, V22, P213, DOI 10.1093/treephys/22.2-3.213; Adams HD, 2009, P NATL ACAD SCI USA, V106, P7063, DOI 10.1073/pnas.0901438106; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bigler C, 2004, ECOL APPL, V14, P902, DOI 10.1890/03-5011; Boeck A, 2014, FOREST SCI, V60, P613, DOI 10.5849/forsci.12-133; Botequim B, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9030390; Botkin D.B., 1993, FOREST DYNAMICS ECOL; Boulanger Y, 2013, ECOL APPL, V23, P904, DOI 10.1890/12-0698.1; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Burns R.M., 1990, SILVICS N AM CONIFER; Burns R.M., 1990, SILVICS N AM HARDWOO; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chapman RA, 2006, FOREST ECOL MANAG, V236, P85, DOI 10.1016/j.foreco.2006.08.341; Cheng FW, 2017, OBESITY, V25, P1263, DOI 10.1002/oby.21861; Chrysos G, 2013, ACM T ARCHIT CODE OP, V9, DOI 10.1145/2400682.2400706; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Das AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069917; de Toledo JJ, 2013, J VEG SCI, V24, P651, DOI 10.1111/j.1654-1103.2012.01491.x; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; Environment and Climate Change Canada, 2011, CANADIAN CLIMATE NOR; ESRI, 2018, MOD SOL RAD HELP ARO MOD SOL RAD HELP ARO; Fajardo SN, 2017, FOREST PATHOL, V47, DOI 10.1111/efp.12361; Fontes CG, 2018, FOREST ECOL MANAG, V424, P177, DOI 10.1016/j.foreco.2018.05.002; Foster JR, 2014, OECOLOGIA, V175, P363, DOI 10.1007/s00442-014-2881-2; Gea-Izquierdo G, 2019, SCI TOTAL ENVIRON, V685, P963, DOI 10.1016/j.scitotenv.2019.05.378; GLOVER GR, 1979, FOREST SCI, V25, P275; HAMILTON DA, 1986, FOREST SCI, V32, P989; Hawkes C, 2000, ECOL MODEL, V126, P225, DOI 10.1016/S0304-3800(00)00267-2; Hiroshima T, 2014, J FOREST RES-JPN, V19, P379, DOI 10.1007/s10310-013-0428-8; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Ishizuka M., 1997, JPN J SUSTAIN FOR, V6, P367, DOI DOI 10.1300/J091v06n03_08; Jaime L, 2019, FOREST ECOL MANAG, V448, P119, DOI 10.1016/j.foreco.2019.05.070; Larson AJ, 2015, ECOLOGY, V96, P2855, DOI 10.1890/15-0628.1; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; Long ZT, 2007, FOREST ECOL MANAG, V252, P230, DOI 10.1016/j.foreco.2007.06.034; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Ma ZH, 2013, NAT RESOUR MODEL, V26, P131, DOI 10.1111/j.1939-7445.2012.00124.x; MacLean DA, 2008, FOREST CHRON, V84, P60, DOI 10.5558/tfc84060-1; Manso R, 2015, FOREST ECOL MANAG, V354, P243, DOI 10.1016/j.foreco.2015.06.008; McDowell NG, 2015, NAT CLIM CHANGE, V5, P669, DOI [10.1038/nclimate2641, 10.1038/NCLIMATE2641]; McKenney DW, 2011, B AM METEOROL SOC, V92, P1611, DOI 10.1175/2011BAMS3132.1; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Moulinier J, 2014, ACTA OECOL, V55, P104, DOI 10.1016/j.actao.2013.12.007; NB Ecosystem Classification Working Group, 2003, OUR LANDSCAPE HERITA; Noh HG, 2004, COMPUT STAT DATA AN, V47, P149, DOI 10.1016/j.csda.2003.10.009; PEET RK, 1987, BIOSCIENCE, V37, P586, DOI 10.2307/1310669; Peng CH, 2011, NAT CLIM CHANGE, V1, P467, DOI 10.1038/NCLIMATE1293; Porter KB, 2001, NEW BRUNSWICK PERMAN; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Preisler HK, 1997, FOREST SCI, V43, P78; Reineke LH, 1933, J AGRIC RES, V46, P0627; Reis LP, 2018, ECOL ENG, V112, P140, DOI 10.1016/j.ecoleng.2017.12.014; Ruiz-Benito P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056843; SC, 2018, ECOLOGICAL LAND CLAS; Searls T, 2021, CAN J FOREST RES, V51, P1039, DOI 10.1139/cjfr-2020-0257; SOARES P, 1995, FOREST ECOL MANAG, V71, P251, DOI 10.1016/0378-1127(94)06105-R; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Suchetana B, 2017, SCI TOTAL ENVIRON, V598, P249, DOI 10.1016/j.scitotenv.2017.03.236; VANCLAY JK, 1995, FOREST SCI, V41, P7, DOI 10.1093/forestscience/41.1.7; Wang SX, 2018, PROC CIRP, V72, P1392, DOI 10.1016/j.procir.2018.03.065; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Whittier TR, 2016, FOREST ECOL MANAG, V359, P199, DOI 10.1016/j.foreco.2015.10.015; Wu ZJ, 2017, ARCH MED RES, V48, P546, DOI 10.1016/j.arcmed.2017.12.001; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Yang YQ, 2003, ECOL MODEL, V163, P209, DOI 10.1016/S0304-3800(03)00008-5; Young DJN, 2017, ECOL LETT, V20, P78, DOI 10.1111/ele.12711; Youssef AM, 2016, LANDSLIDES, V13, P839, DOI 10.1007/s10346-015-0614-1; Zhao DH, 2004, FOREST ECOL MANAG, V199, P307, DOI 10.1016/j.foreco.2004.05.043	69	1	1	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0250991	10.1371/journal.pone.0250991	http://dx.doi.org/10.1371/journal.pone.0250991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143806	gold, Green Published			2022-12-26	WOS:000671690700037
J	Hanson, MK; Karkache, IY; Molstad, DHH; Norton, AA; Mansky, KC; Bradley, EW				Hanson, Marcelline K.; Karkache, Ismael Y.; Molstad, David H. H.; Norton, Andrew A.; Mansky, Kim C.; Bradley, Elizabeth W.			Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss	PLOS ONE			English	Article							RESORPTION; IGFBP-4; GROWTH	Prior studies demonstrated that deletion of the protein phosphatase Phlpp1 in Ctsk-Cre expressing cells enhances bone mass, characterized by diminished osteoclast activity and increased coupling to bone formation. Due to non-specific expression of Ctsk-Cre, the definitive mechanism for this observation was unclear. To further define the role of bone resorbing osteoclasts, we performed ovariectomy (Ovx) and Sham surgeries on Phlpp1 cKO(Ctsk) and WT mice. Micro-CT analyses confirmed enhanced bone mass of Phlpp1 cKO(Ctsk) Sham females. In contrast, Ovx induced bone loss in both groups, with no difference between Phlpp1 cKO(Ctsk) and WT mice. Histomorphometry demonstrated that Ovx mice lacked differences in osteoclasts per bone surface, suggesting that estradiol (E2) is required for Phlpp1 deficiency to have an effect. We performed high throughput unbiased transcriptional profiling of Phlpp1 cKO(Ctsk) osteoclasts and identified 290 differentially expressed genes. By cross-referencing these differentially expressed genes with all estrogen response element (ERE) containing genes, we identified IGFBP4 as potential estrogen-dependent target of Phlpp1. E2 induced PHLPP1 expression, but reduced IGFBP4 levels. Moreover, genetic deletion or chemical inhibition of Phlpp1 was correlated with IGFBP4 levels. We then assessed IGFBP4 expression by osteoclasts in vivo within intact 12-week-old females. Modest IGFBP4 immunohistochemical staining of TRAP(+) osteoclasts within WT females was observed. In contrast, TRAP(+) bone lining cells within intact Phlpp1 cKO(Ctsk) females robustly expressed IGFBP4, but levels were diminished within TRAP(+) bone lining cells following Ovx. These results demonstrate that effects of Phlpp1 conditional deficiency are lost following Ovx, potentially due to estrogen-dependent regulation of IGFBP4.	[Hanson, Marcelline K.; Karkache, Ismael Y.; Molstad, David H. H.; Bradley, Elizabeth W.] Univ Minnesota, Dept Orthoped Surg, Minneapolis, MN 55455 USA; [Bradley, Elizabeth W.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA; [Norton, Andrew A.; Mansky, Kim C.] Univ Minnesota, Dept Dev & Surg Sci, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bradley, EW (corresponding author), Univ Minnesota, Dept Orthoped Surg, Minneapolis, MN 55455 USA.; Bradley, EW (corresponding author), Univ Minnesota, Stem Cell Inst, Minneapolis, MN 55455 USA.	ebradle1@umn.edu		Mansky, Kim/0000-0002-2826-5030; Bradley, Elizabeth/0000-0002-8814-5524	National Institutes of Health, National Institute for Arthritis and Skin Diseases [AR072634]	National Institutes of Health, National Institute for Arthritis and Skin Diseases	EWB received a research grant from the National Institutes of Health, National Institute for Arthritis and Skin Diseases (AR072634, www.niams.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00031; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Boyce BF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02263; Bradley EW, 2015, J BIOL CHEM, V290, P16272, DOI 10.1074/jbc.M114.612937; Bradley Elizabeth W., 2008, V455, P19, DOI 10.1007/978-1-59745-104-8_2; Carpio LR, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf3273; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Debnath S, 2018, NATURE, V562, P133, DOI 10.1038/s41586-018-0554-8; Dudakovic A, 2016, J BIOL CHEM, V291, P24594, DOI 10.1074/jbc.M116.740571; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Farr JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138347; Grzechnik AT, 2016, BIOCHEM SOC T, V44, P1675, DOI 10.1042/BST20160170; Hjortebjerg R, 2018, GROWTH HORM IGF RES, V41, P7, DOI 10.1016/j.ghir.2018.05.002; Jilka RL, 1998, J CLIN INVEST, V101, P1942, DOI 10.1172/JCI1039; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kennedy OD, 2012, BONE, V50, P1115, DOI 10.1016/j.bone.2012.01.025; Komori T, 2015, EUR J PHARMACOL, V759, P287, DOI 10.1016/j.ejphar.2015.03.028; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li M, 1997, BONE, V20, P55, DOI 10.1016/S8756-3282(96)00317-1; Maridas DE, 2017, J ENDOCRINOL, V233, P131, DOI 10.1530/JOE-16-0673; Mattson AM, 2019, J BIOL CHEM, V294, P11772, DOI 10.1074/jbc.RA119.007660; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Puglisi R, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00733; Razidlo DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011492; Ruiz P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36201; STONE MD, 1991, ANN RHEUM DIS, V50, P663, DOI 10.1136/ard.50.10.663; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005	28	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0251732	10.1371/journal.pone.0251732	http://dx.doi.org/10.1371/journal.pone.0251732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143773	gold, Green Published			2022-12-26	WOS:000671690700017
J	Li, JF; Pen, BA; Wei, YL; Ye, HP				Li, Jianfeng; Pen, Biao; Wei, Yulu; Ye, Huping			Accurate extraction of surface water in complex environment based on Google Earth Engine and Sentinel-2	PLOS ONE			English	Article							TASSELED CAP TRANSFORMATION; INDEX; CLASSIFICATION; IMAGERY	To realize the accurate extraction of surface water in complex environment, this study takes Sri Lanka as the study area owing to the complex geography and various types of water bodies. Based on Google Earth engine and Sentinel-2 images, an automatic water extraction model in complex environment(AWECE) was developed. The accuracy of water extraction by AWECE, NDWI, MNDWI and the revised version of multi-spectral water index (MuWI-R) models was evaluated from visual interpretation and quantitative analysis. The results show that the AWECE model could significantly improve the accuracy of water extraction in complex environment, with an overall accuracy of 97.16%, and an extremely low omission error (0.74%) and commission error (2.35%). The AEWCE model could effectively avoid the influence of cloud shadow, mountain shadow and paddy soil on water extraction accuracy. The model can be widely applied in cloudy, mountainous and other areas with complex environments, which has important practical significance for water resources investigation, monitoring and protection.	[Li, Jianfeng; Pen, Biao; Wei, Yulu] Shaanxi Prov Land Engn Construct Grp Co Ltd, Inst Land Engn & Technol, Xian, Peoples R China; [Li, Jianfeng; Pen, Biao; Wei, Yulu] Shaanxi Prov Land Engn Construct Grp Co Ltd, Xian, Peoples R China; [Li, Jianfeng; Pen, Biao; Wei, Yulu] Minist Nat Resources Ltd, Key Lab Degraded & Unused Land Consolidat Engn, Xian, Peoples R China; [Li, Jianfeng; Pen, Biao; Wei, Yulu] Shaanxi Prov Land Consolidat Engn Technol Res Ctr, Xian, Peoples R China; [Ye, Huping] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Ye, HP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China.	yehp@igsnrr.ac.cn		Li, Jianfeng/0000-0002-9998-3339	Tianjin Intelligent Manufacturing Project [Tianjin-IMP-2018-2]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA2003030201]; National Natural Science Foundation of China [41771388, 41971359]; Technology Innovation Center for Land Engineering and Human Settlements, Shaanxi Land Engineering Construction Group Co.,Ltd; Xi' an Jiaotong University [2021WHZ0090]	Tianjin Intelligent Manufacturing Project; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Innovation Center for Land Engineering and Human Settlements, Shaanxi Land Engineering Construction Group Co.,Ltd; Xi' an Jiaotong University(Xi'an Jiaotong University)	This paper was supported by Tianjin Intelligent Manufacturing Project: TianjinIMP-2018-2, the Strategic Priority Research Program of Chinese Academy of Sciences (No. XDA2003030201), the National Natural Science Foundation of China (Nos. 41771388, 41971359), and Technology Innovation Center for Land Engineering and Human Settlements, Shaanxi Land Engineering Construction Group Co.,Ltd and Xi' an Jiaotong University (No. 2021WHZ0090). The funder provided support in the form of salaries for authors [Li JF, Peng B, Wei YL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Acharya TD, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18082580; Chen C, 2019, ESTUAR COAST SHELF S, V217, P281, DOI 10.1016/j.ecss.2018.10.021; Coluzzi R, 2018, REMOTE SENS ENVIRON, V217, P426, DOI 10.1016/j.rse.2018.08.009; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Devignot O., 2018, 23 ESA S2PDGSMPCDQR; Drusch M, 2012, REMOTE SENS ENVIRON, V120, P25, DOI 10.1016/j.rse.2011.11.026; Du Y, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8040354; El Din ES, 2020, INT J REMOTE SENS, V41, P7186, DOI 10.1080/01431161.2020.1754497; ESA, LEV 1C CLOUD MASKS S; Fei Zhang, 2016, Remote Sensing Applications: Society and Environment, V4, P109, DOI 10.1016/j.rsase.2016.08.001; Fisher A, 2016, REMOTE SENS ENVIRON, V175, P167, DOI 10.1016/j.rse.2015.12.055; GEE, LANDS ALG GOOGL EART; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Guo QD, 2017, INT J REMOTE SENS, V38, P5430, DOI 10.1080/01431161.2017.1341667; Hu SS, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12020243; Huang Q, 2018, REMOTE SENS ENVIRON, V219, P115, DOI 10.1016/j.rse.2018.10.008; Jiang W, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10050755; Kauth R.J., 1976, P S MACH PROC REM SE, P13; Li YZ, 2016, INT J REMOTE SENS, V37, P3611, DOI 10.1080/01431161.2016.1201228; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Nedkov R, 2017, CR ACAD BULG SCI, V70, P687; Nguyen MD, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12020281; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Qiu X. Han, 2005, J REMOTE SENSING, V9, P589; Shi TT, 2019, IEEE J-STARS, V12, P4038, DOI 10.1109/JSTARS.2019.2938388; Shiklomanov AN, 2019, FRONT ECOL ENVIRON, V17, P215, DOI 10.1002/fee.2031; Wang YD, 2020, IEEE J-STARS, V13, P768, DOI 10.1109/JSTARS.2020.2971783; Wang ZF, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10101643; West H, 2019, REMOTE SENS ENVIRON, V232, DOI 10.1016/j.rse.2019.111291; Xie H, 2016, INT J REMOTE SENS, V37, P1826, DOI 10.1080/01431161.2016.1168948; YAN P., 2007, REMOTE SENSING INFOR, V6; Yang XC, 2017, J APPL REMOTE SENS, V11, DOI 10.1117/1.JRS.11.026016; Zhang FF, 2018, INT J REMOTE SENS, V39, P3429, DOI 10.1080/01431161.2018.1444292; [张景奇 Zhang Jingqi], 2011, [中国水土保持科学, Science of Soil and Water Conservation], V9, P88; Zhang TY, 2017, IEEE J-STARS, V10, P4417, DOI 10.1109/JSTARS.2017.2719029; Zhang ZQ, 2019, IEEE J-STARS, V12, P3784, DOI 10.1109/JSTARS.2019.2936406; Zhou C., 2003, GEOLOGICAL UNDERSTAN; Zhuang Y, 2018, 2018 5 INT WORKSH EA; Zupanc A, IMPROVING CLOUD DETE	41	7	7	9	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253209	10.1371/journal.pone.0253209	http://dx.doi.org/10.1371/journal.pone.0253209			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143822	Green Published, gold			2022-12-26	WOS:000671690700043
J	Nielsen, LG; Rimvall, MK; Van Os, J; Verhulst, F; Rask, CU; Skovgaard, AM; Olsen, EM; Jeppesen, P				Nielsen, Louise Gunhard; Rimvall, Martin Koster; Van Os, Jim; Verhulst, Frank; Rask, Charlotte Ulrikka; Skovgaard, Anne Mette; Olsen, Else Marie; Jeppesen, Pia			Precursors of self-reported subclinical hypomania in adolescence: A longitudinal general population study	PLOS ONE			English	Article							BIPOLAR DISORDER; SYMPTOMS; PSYCHOSIS; EXPERIENCES; TRANSITION; CHILDHOOD; PATTERNS; RISK; SCHIZOPHRENIA; ASSOCIATION	Symptoms of subclinical hypomania (SHM) are common in the general population of adolescents and young adults. SHM are most often transient yet might be risk markers of later bipolar disorder. The current study aimed to assess the clinical correlates of SHM at age 11 in the general population, examine the continuity of SHM from age 11-age 16 and explore the clinical precursors of age 16 SHM. As part of the Copenhagen Child Cohort 2000, 1,632 preadolescents participated in the examination of SHM and various clinical correlates at age 11, 893 were re-assessed for SHM at age 16 years. At age 11, SHM, psychotic experiences and depressive symptoms were assessed by semi-structured psychopathological interviews. Furthermore, the participants were diagnostically assessed by the Development and Well-Being Assessment and interviewed about sleep length. At age 16, SHM was assessed by self-report, using the Hypomania Checklist-32. Cannabis use occurring at age 15 or earlier was assessed at age 16. At age 11, SHM was associated with depressive disorders (Relative Risk [RR] = 2.96 [95% CI 1.26-6.96]), interview-based depressive symptoms (RR = 9.22 [5.93-14.34]), neurodevelopmental disorders (RR = 2.94 [1.66-5.20]), psychotic experiences (RR = 4.51 [2.90-7.01]) and insufficient sleep (RR = 2.10 [1.28-3.43]. In the longitudinal analyses, age 16 SHM was preceded by age 11 SHM (RR = 1.89 [1.02-3.49]), psychotic experiences (RR = 2.06, [1.28-3.33]), emotional disorders (RR = 1.77, [1.02-3.09]) and cannabis use (RR = 3.14, [1.93-5.10]), after mutual adjustment and adjustment for sex, and sociodemographic factors. In conclusion, age 11 SHM was statistically significantly associated with other types of psychopathology in cross-sectional analyses and showed some continuity with later self-reported SHM at age 16. Particularly early psychotic experiences and cannabis use stood out as independent precursors of self-reported SHM and might constitute important risk markers for the development of future SHM and bipolar disorder. An important potential caveat of the current study includes the self-report assessment of SHM.	[Nielsen, Louise Gunhard; Rimvall, Martin Koster; Verhulst, Frank; Jeppesen, Pia] Child & Adolescent Mental Hlth Ctr, Mental Hlth Serv, Capital Reg Denmark, Hellerup, Denmark; [Rimvall, Martin Koster] Dept Child & Adolescent Psychiat, Psychiat Reg Zealand, Roskilde, Denmark; [Van Os, Jim] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Psychiat, Utrecht, Netherlands; [Van Os, Jim] Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, Maastricht, Netherlands; [Van Os, Jim] Kings Coll London, Inst Psychiat, Dept Psychosis Studies, Kings Hlth Partners, London, England; [Verhulst, Frank; Jeppesen, Pia] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Verhulst, Frank] Erasmus MC, Dept Child Psychiat Psychol, Rotterdam, Netherlands; [Rask, Charlotte Ulrikka] Aarhus Univ Hosp, Dept Child & Adolescent Psychiat, Res Unit, Aarhus, Denmark; [Rask, Charlotte Ulrikka] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Skovgaard, Anne Mette] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Olsen, Else Marie] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark; [Olsen, Else Marie] Ctr Clin Res & Prevent, Capital Reg Denmark, Copenhagen, Denmark	Utrecht University; Utrecht University Medical Center; Maastricht University; University of London; King's College London; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Aarhus University; Aarhus University; University of Southern Denmark; University of Copenhagen	Nielsen, LG (corresponding author), Child & Adolescent Mental Hlth Ctr, Mental Hlth Serv, Capital Reg Denmark, Hellerup, Denmark.	louise.gunhard.nielsen.01@regionh.dk	Jeppesen, Pia/L-6716-2016; Rimvall, Martin Køster/AAJ-1488-2021	Jeppesen, Pia/0000-0003-2471-2929; Rimvall, Martin Køster/0000-0003-2627-5523; Skovgaard, Anne Mette/0000-0002-8793-8303; Olsen, Else Marie/0000-0002-7240-9767	 [R300-2018-1278]		Initials of author who received the award: LGN Grant number: R300-2018-1278 Commercial Company: Lundbeckfonden Sponsor website: https://www.lundbeckfonden.com.The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akiskal HS, 2000, J AFFECT DISORDERS, V59, pS5, DOI 10.1016/S0165-0327(00)00203-2; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Barton J, 2018, NEUROSCI BIOBEHAV R, V89, P119, DOI 10.1016/j.neubiorev.2018.02.008; Beesdo K, 2009, BIPOLAR DISORD, V11, P637, DOI 10.1111/j.1399-5618.2009.00738.x; Benarous X, 2016, EUR CHILD ADOLES PSY, V25, P217, DOI 10.1007/s00787-015-0773-6; Bliddal M, 2018, EUR J EPIDEMIOL, V33, P27, DOI 10.1007/s10654-018-0356-1; Bowie CR, 2018, BIPOLAR DISORD, V20, P604, DOI 10.1111/bdi.12654; Brand S, 2007, J ADOLESCENT HEALTH, V41, P69, DOI 10.1016/j.jadohealth.2007.01.012; Duffy A, 2020, INT J BIPOLAR DISORD, V8, DOI 10.1186/s40345-020-00185-2; Faedda GL, 2019, BIPOLAR DISORD, V21, P720, DOI 10.1111/bdi.12831; Fornaro M, 2015, J AFFECT DISORDERS, V178, P112, DOI 10.1016/j.jad.2015.03.001; Gl F., 2019, INT SOC BIPOLAR DISO; Goodday SM, 2017, BJPSYCH OPEN, V3, P71, DOI 10.1192/bjpo.bp.116.004234; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Henquet C, 2006, J AFFECT DISORDERS, V95, P103, DOI 10.1016/j.jad.2006.05.002; Holtmann M, 2009, J ADOLESCENCE, V32, P1075, DOI 10.1016/j.adolescence.2009.03.004; Homish GG, 2013, J AFFECT DISORDERS, V144, P129, DOI 10.1016/j.jad.2012.06.020; Hosang GM, 2017, J AFFECT DISORDERS, V207, P228, DOI 10.1016/j.jad.2016.08.033; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Jeppesen P, 2015, J CHILD PSYCHOL PSYC, V56, P558, DOI 10.1111/jcpp.12319; Jeppesen P, 2015, SCHIZOPHRENIA BULL, V41, P1084, DOI 10.1093/schbul/sbu167; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kaymaz N, 2007, J AFFECT DISORDERS, V98, P55, DOI 10.1016/j.jad.2006.06.028; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kirli U., 2019, SOC PSYCHIAT PSYCHIA; Leibenluft E., 2015, RUTTERS CHILD ADOLES, P858; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; Marwaha S, 2018, SCHIZOPHRENIA BULL, V44, P1267, DOI 10.1093/schbul/sbx158; McGorry PD, 2018, WORLD PSYCHIATRY, V17, P133, DOI 10.1002/wps.20514; Miller TH, 2016, PRIMARY CARE, V43, P269, DOI 10.1016/j.pop.2016.02.003; Mistry S, 2017, J AFFECT DISORDERS, V221, P246, DOI 10.1016/j.jad.2017.06.039; Musliner KL, 2016, J AFFECT DISORDERS, V192, P199, DOI 10.1016/j.jad.2015.12.030; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Nielsen LG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217707; Olsen EM, 2020, INT J EPIDEMIOL, V49, P370, DOI 10.1093/ije/dyz256; Paaren A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0363-z; Papachristou E, 2017, J AFFECT DISORDERS, V212, P86, DOI 10.1016/j.jad.2017.01.038; Papachristou E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069459; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersson F, 2011, SCAND J PUBLIC HEALT, V39, P95, DOI 10.1177/1403494811408483; Regeer EJ, 2006, PSYCHOL MED, V36, P619, DOI 10.1017/S0033291705006823; Reich W, 2005, TWIN RES HUM GENET, V8, P459, DOI 10.1375/183242705774310105; Rimvall MK, 2020, AM J PSYCHIAT, V177, P318, DOI 10.1176/appi.ajp.2019.19070724; Rock P, 2014, CHRONOBIOL INT, V31, P290, DOI 10.3109/07420528.2013.843542; Russo M, 2014, SCHIZOPHRENIA BULL, V40, P111, DOI 10.1093/schbul/sbt055; Tijssen MJA, 2010, ACTA PSYCHIAT SCAND, V122, P255, DOI 10.1111/j.1600-0447.2010.01539.x; Tijssen MJA, 2010, PSYCHOL MED, V40, P289, DOI 10.1017/S0033291709006138; Tijssen MJA, 2010, BRIT J PSYCHIAT, V196, P102, DOI 10.1192/bjp.bp.109.065763; van Os J, 2016, WORLD PSYCHIATRY, V15, P118, DOI 10.1002/wps.20310; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; World Health Organization, 1993, DIAGNOSTIC CRITERIA, DOI [10.1007/BF00788743, DOI 10.1007/BF00788743]	52	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253507	10.1371/journal.pone.0253507	http://dx.doi.org/10.1371/journal.pone.0253507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143836	Green Published, gold			2022-12-26	WOS:000671690700001
J	Blessing, NA; Wu, ZZ; Madhavan, SM; Choy, JW; Chen, M; Shin, MK; Hoek, M; Sedor, JR; O'Toole, JF; Bruggeman, LA				Blessing, Natalya A.; Wu, Zhenzhen; Madhavan, Sethu M.; Choy, Jonathan W.; Chen, Michelle; Shin, Myung K.; Hoek, Maarten; Sedor, John R.; O'Toole, John F.; Bruggeman, Leslie A.			Lack of APOL1 in proximal tubules of normal human kidneys and proteinuric APOL1 transgenic mouse kidneys	PLOS ONE			English	Article							TRYPANOSOME LYTIC FACTOR; DISEASE; LOCALIZATION; EXPRESSION; VARIANTS; TISSUE; MODELS; GENE	The mechanism of pathogenesis associated with APOL1 polymorphisms and risk for non-diabetic chronic kidney disease (CKD) is not fully understood. Prior studies have minimized a causal role for the circulating APOL1 protein, thus efforts to understand kidney pathogenesis have focused on APOL1 expressed in renal cells. Of the kidney cells reported to express APOL1, the proximal tubule expression patterns are inconsistent in published reports, and whether APOL1 is synthesized by the proximal tubule or possibly APOL1 protein in the blood is filtered and reabsorbed by the proximal tubule remains unclear. Using both protein and mRNA in situ methods, the kidney expression pattern of APOL1 was examined in normal human and APOL1 bacterial artificial chromosome transgenic mice with and without proteinuria. APOL1 protein and mRNA was detected in podocytes and endothelial cells, but not in tubular epithelia. In the setting of proteinuria, plasma APOL1 protein did not appear to be filtered or reabsorbed by the proximal tubule. A side-by-side examination of commercial antibodies used in prior studies suggest the original reports of APOL1 in proximal tubules likely reflects antibody non-specificity. As such, APOL1 expression in podocytes and endothelia should remain the focus for mechanistic studies in the APOL1-mediated kidney diseases.	[Blessing, Natalya A.] Case Western Reserve Univ, Rammelkamp Ctr Educ & Res, MetroHlth Med Ctr, Sch Med, Cleveland, OH USA; [Wu, Zhenzhen; Sedor, John R.; O'Toole, John F.; Bruggeman, Leslie A.] Case Western Reserve Univ, Dept Inflammat & Immun, Cleveland Clin, Sch Med, Cleveland, OH 44106 USA; [Madhavan, Sethu M.] Ohio State Univ, Dept Med, Columbus, OH 43210 USA; [Choy, Jonathan W.; Chen, Michelle; Shin, Myung K.] Merck & Co Inc, Kenilworth, NJ USA; [Hoek, Maarten] Maze Therapeut, San Francisco, CA USA; [Sedor, John R.; O'Toole, John F.; Bruggeman, Leslie A.] Case Western Reserve Univ, Dept Nephrol, Cleveland Clin, Sch Med, Cleveland, OH 44106 USA; [Sedor, John R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Ohio State University; Merck & Company; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Bruggeman, LA (corresponding author), Case Western Reserve Univ, Dept Inflammat & Immun, Cleveland Clin, Sch Med, Cleveland, OH 44106 USA.; Bruggeman, LA (corresponding author), Case Western Reserve Univ, Dept Nephrol, Cleveland Clin, Sch Med, Cleveland, OH 44106 USA.	bruggel@ccf.org		madhavan, sethu/0000-0002-0528-7333	National Institutes of Health [DK108329, DK095832, DK007470]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (www.nih.gov) grants DK108329 (LAB, JRS, JFO), DK095832 (JRS, JFO, LAB), and training grant DK007470 (NAB, JRS). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck and Company provided support in the form of salaries and laboratory resources for authors (JWC, MC, MKS, MH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Maze Therapeutics provided support in the form of salary for the author (MH) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are stated in the author contributions section.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; Aghajan M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126124; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Bruggeman LA, 2016, J AM SOC NEPHROL, V27, P3600, DOI 10.1681/ASN.2015111220; Bruggeman LA, 2014, J AM SOC NEPHROL, V25, P634, DOI 10.1681/ASN.2013070700; Cheatham AM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27104-x; Duchateau PN, 2001, J LIPID RES, V42, P620; Genovese G, 2010, KIDNEY INT, V78, P698, DOI 10.1038/ki.2010.251; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gutierrez OM, 2016, NEPHROL DIAL TRANSPL, V31, P602, DOI 10.1093/ndt/gfv229; Khatua AK, 2015, AM J PHYSIOL-CELL PH, V309, pC22, DOI 10.1152/ajpcell.00384.2014; Kozlitina J, 2016, J AM SOC NEPHROL, V27, P3204, DOI 10.1681/ASN.2015101121; Li QR, 2010, RAPID COMMUN MASS SP, V24, P823, DOI 10.1002/rcm.4441; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Madhavan SM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92581; Madhavan SM, 2011, J AM SOC NEPHROL, V22, P2119, DOI 10.1681/ASN.2011010069; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Okamoto K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0188-2; Pippin JW, 2009, AM J PHYSIOL-RENAL, V296, pF213, DOI 10.1152/ajprenal.90421.2008; Prakash S, 2011, J AM SOC NEPHROL, V22, P1497, DOI 10.1681/ASN.2011020209; Raper J, 1999, INFECT IMMUN, V67, P1910; Ryu JH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211559; Sampson MG, 2016, J AM SOC NEPHROL, V27, P814, DOI 10.1681/ASN.2014111131; Santucci L, 2014, DATA BRIEF, V1, P25, DOI 10.1016/j.dib.2014.08.006; Scales SJ, 2020, J AM SOC NEPHROL, V31, P2044, DOI 10.1681/ASN.2019080829; Shukha K, 2017, J AM SOC NEPHROL, V28, P1079, DOI 10.1681/ASN.2016040441; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Weckerle A, 2016, J LIPID RES, V57, P120, DOI 10.1194/jlr.M063453; Yang HC, 2016, CURR OPIN NEPHROL HY, V25, P174, DOI 10.1097/MNH.0000000000000217; Zhao MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03226-6	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253197	10.1371/journal.pone.0253197	http://dx.doi.org/10.1371/journal.pone.0253197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138902	gold, Green Published			2022-12-26	WOS:000671690200006
J	Chadwell, A; Chinn, N; Kenney, L; Karthaus, ZJ; Mos, D; Smit, G				Chadwell, Alix; Chinn, Natalie; Kenney, Laurence; Karthaus, Zoe J.; Mos, Daniek; Smit, Gerwin			An evaluation of contralateral hand involvement in the operation of the Delft Self-Grasping Hand, an adjustable passive prosthesis	PLOS ONE			English	Article								The Delft Self-Grasping Hand is an adjustable passive prosthesis operated using the concept of tenodesis (where opening and closing of the hand is mechanically linked to the flexion and extension of the wrist). As a purely mechanical device that does not require harnessing, the Self-Grasping Hand offers a promising alternative to current prostheses. However, the contralateral hand is almost always required to operate the mechanism to release a grasp and is sometimes also used to help form the grasp; hence limiting the time it is available for other purposes. In this study we quantified the amount of time the contralateral hand was occupied with operating the Self-Grasping Hand, classified as either direct or indirect interaction, and investigated how these periods changed with practice. We studied 10 anatomically intact participants learning to use the Self-Grasping Hand fitted to a prosthesis simulator. The learning process involved 10 repeats of a feasible subset of the tasks in the Southampton Hand Assessment Procedure (SHAP). Video footage was analysed, and the time that the contralateral hand was engaged in grasping or releasing was calculated. Functionality scores increased for all participants, plateauing at an Index of Functionality of 33.5 after 5 SHAP attempts. Contralateral hand involvement reduced significantly from 6.47 (first 3 attempts) to 4.68 seconds (last three attempts), but as a proportion of total task time remained relatively steady (increasing from 29% to 32%). For 9/10 participants most of this time was supporting the initiation of grasps rather than releases. The reliance on direct or indirect interactions between the contralateral hand and the prosthesis varied between participants but appeared to remain relatively unchanged with practice. Future studies should consider evaluating the impact of reliance on the contralateral limb in day-to-day life and development of suitable training methods.	[Chadwell, Alix; Chinn, Natalie; Kenney, Laurence] Univ Salford, Ctr Hlth Sci Res, Salford, Lancs, England; [Karthaus, Zoe J.; Mos, Daniek; Smit, Gerwin] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	University of Salford; Delft University of Technology	Chadwell, A (corresponding author), Univ Salford, Ctr Hlth Sci Res, Salford, Lancs, England.	a.e.a.chadwell1@salford.ac.uk		Chinn, Natalie/0000-0001-7750-5953; Chadwell, Alix/0000-0002-9101-5202	UK government Global Challenges Research Fund through the Engineering and Physical Sciences Research Council [EP/R013985/1]; National Institute for Health Research [EP/R013985/1]	UK government Global Challenges Research Fund through the Engineering and Physical Sciences Research Council; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the UK government Global Challenges Research Fund (PI: LK) through the Engineering and Physical Sciences Research Council and National Institute for Health Research, grant number EP/R013985/1. https://www.ukri.org/research/global-challengesresearch-fund/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SOUTHAMPTON HAND ASS; Bergman C., 2017, JSM PHYS MED REHABIL, V1, P1006; Bloomer Conor, 2018, Phys Med Rehabil Res, V3, P1; Burgerhof JGM, 2017, J HAND THER, V30, P49, DOI 10.1016/j.jht.2016.05.001; Chadwell A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29503-6; Chadwell A, 2020, IEEE T NEUR SYS REH, V28, P2005, DOI 10.1109/TNSRE.2020.3010625; Dalley SA, 2014, IEEE ENG MED BIO, P6195, DOI 10.1109/EMBC.2014.6945044; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Field A., 2016, DISCOVERING STAT EXP; Fradette K., 2003, J MOD APPL STAT METH, V2, P22, DOI [10.22237/jmasm/1067646120, DOI 10.22237/JMASM/1067646120]; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Kuret Z, 2016, PROSTHET ORTHOT INT, V40, P744, DOI 10.1177/0309364615596064; Kyberd P, 2017, J PROSTHET ORTHOT, V29, P103, DOI DOI 10.1097/JPO.0000000000000139; Kyberd PJ, 2009, BRIT J OCCUP THER, V72, P212, DOI 10.1177/030802260907200506; Light CM, 2002, ARCH PHYS MED REHAB, V83, P776, DOI 10.1053/apmr.2002.32737; Lindner H., 2013, THESIS OREBRO U SWED THESIS OREBRO U SWED; Maat B, 2018, PROSTHET ORTHOT INT, V42, P66, DOI 10.1177/0309364617691622; Posten H. O., 1979, Journal of Statistical Computation and Simulation, V9, P133, DOI 10.1080/00949657908810305; Potts A., 2015, REAL COST GREEN INFR; Rasch D., 2004, PSYCHOL SCI, V46, P175; Salminger S, 2019, AM J PHYS MED REHAB, V98, P125, DOI 10.1097/PHM.0000000000001031; Smit G, 2017, MEC17 MEC17; Sobuh MMD, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-72; Spiers AJ, 2017, INT C REHAB ROBOT, P1273, DOI 10.1109/ICORR.2017.8009424; Vasluian E, 2014, J REHABIL MED, V46, P788, DOI 10.2340/16501977-1827; Volkmar R, 2019, J NEUROENG REHABIL, V16, DOI 10.1186/s12984-019-0617-6; Wiedermann W, 2013, PSYCHOL TEST ASSESSM, V55, P39	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252870	10.1371/journal.pone.0252870	http://dx.doi.org/10.1371/journal.pone.0252870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138903	Green Published, gold			2022-12-26	WOS:000671690200048
J	Li, A; Deng, YW; Tan, Y; Chen, M				Li, Ang; Deng, Yingwei; Tan, Yan; Chen, Min			A novel miRNA-disease association prediction model using dual random walk with restart and space projection federated method	PLOS ONE			English	Article							MICRORNAS; SIMILARITY; INFERENCE	A large number of studies have shown that the variation and disorder of miRNAs are important causes of diseases. The recognition of disease-related miRNAs has become an important topic in the field of biological research. However, the identification of disease-related miRNAs by biological experiments is expensive and time consuming. Thus, computational prediction models that predict disease-related miRNAs must be developed. A novel network projection-based dual random walk with restart (NPRWR) was used to predict potential disease-related miRNAs. The NPRWR model aims to estimate and accurately predict miRNA-disease associations by using dual random walk with restart and network projection technology, respectively. The leave-one-out cross validation (LOOCV) was adopted to evaluate the prediction performance of NPRWR. The results show that the area under the receiver operating characteristic curve(AUC) of NPRWR was 0.9029, which is superior to that of other advanced miRNA-disease associated prediction methods. In addition, lung and kidney neoplasms were selected to present a case study. Among the first 50 miRNAs predicted, 50 and 49 miRNAs have been proven by in databases or relevant literature. Moreover, NPRWR can be used to predict isolated diseases and new miRNAs. LOOCV and the case study achieved good prediction results. Thus, NPRWR will become an effective and accurate disease-miRNA association prediction model.	[Li, Ang; Deng, Yingwei; Tan, Yan; Chen, Min] Hunan Inst Technol, Sch Comp Sci & Technol, Hengyang, Peoples R China; [Deng, Yingwei] Hainan Key Lab Computat Sci & Applicat, Haikou, Hainan, Peoples R China	Hunan Institute of Technology	Deng, YW; Chen, M (corresponding author), Hunan Inst Technol, Sch Comp Sci & Technol, Hengyang, Peoples R China.; Deng, YW (corresponding author), Hainan Key Lab Computat Sci & Applicat, Haikou, Hainan, Peoples R China.	dengyingwei@hnit.edu.cn; chenmin@hnit.edu.cn			Natural Science Foundation of Hunan Province, China [2019JJ40064, 2019JJ40063]; Scientific Research Project of Education Department of Hunan Province [19B142, 19A125]	Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province); Scientific Research Project of Education Department of Hunan Province	This work was supported in part by the Natural Science Foundation of Hunan Province, China under Grant 2019JJ40064 and 2019JJ40063, Scientific Research Project of Education Department of Hunan Province under Grant 19B142 and 19A125.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Artemyev D., 2015, LUNG NEOPLASM DIAGNO; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen M, 2020, IEEE ACCESS, V8, P111614, DOI 10.1109/ACCESS.2020.3002588; Chen M, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00385; Chen M, 2018, RSC ADV, V8, P36675, DOI 10.1039/c8ra07519k; Chen M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24532-7; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166509; Chen X, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007209; Chen X, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1722-1; Chen X, 2018, MOL THER-NUCL ACIDS, V13, P568, DOI 10.1016/j.omtn.2018.10.005; Chen X, 2018, RNA BIOL, V15, P1192, DOI 10.1080/15476286.2018.1517010; Chen X, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006418; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2018, BIOINFORMATICS, V34, P3178, DOI 10.1093/bioinformatics/bty333; Chen X, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00092; Chen X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0003-x; Chen X, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005912; Chen X, 2017, MOL BIOSYST, V13, P1202, DOI 10.1039/c6mb00853d; Chen X, 2017, RNA BIOL, V14, P952, DOI 10.1080/15476286.2017.1312226; Chen X, 2016, ONCOTARGET, V7, P65257, DOI 10.18632/oncotarget.11251; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21106; Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep13877; Chen X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05501; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Ding YL, 2021, METHODS, V192, P25, DOI 10.1016/j.ymeth.2020.08.004; Guo ZH, 2021, BRIEF BIOINFORM, V22, P2085, DOI 10.1093/bib/bbaa037; Guo ZH, 2019, ISCIENCE, V19, P786, DOI 10.1016/j.isci.2019.08.030; Guo ZH, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080866; Jiang QH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S2; Li GH, 2018, J BIOMED INFORM, V82, P169, DOI 10.1016/j.jbi.2018.05.005; Li GH, 2018, RSC ADV, V8, P4377, DOI 10.1039/c7ra12491k; Li GH, 2017, IEEE ACCESS, V5, P24032, DOI 10.1109/ACCESS.2017.2766758; Li JQ, 2017, ONCOTARGET, V8, P21187, DOI 10.18632/oncotarget.15061; Li X, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr770; Li Y, 2014, NUCLEIC ACIDS RES, V42, pD1070, DOI 10.1093/nar/gkt1023; Lotfabadi NN., 2018, MIRNA 101 TRANSFECTI; Luo JW, 2017, IEEE ACCESS, V5, P2503, DOI 10.1109/ACCESS.2017.2672600; Lv H., 2019, INT C DAT SYST ADV A; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Natarelli L., 2020, MICRORNAS LONG NONCO; Peng L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06201-3; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Wang CC, 2019, RNA BIOL, V16, P257, DOI 10.1080/15476286.2019.1568820; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang L, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6652948; Wu QW, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00354; Xiao Q, 2018, BIOINFORMATICS, V34, P239, DOI 10.1093/bioinformatics/btx545; Xie GB, 2021, MOL GENET GENOMICS, V296, P473, DOI 10.1007/s00438-021-01764-3; Xu J, 2011, MOL CANCER THER, V10, P1857, DOI 10.1158/1535-7163.MCT-11-0055; Xu JL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01234; Xuan P, 2019, MOLECULES, V24, DOI 10.3390/molecules24173099; Xuan P, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153648; Xuan P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123732; Xuan P, 2015, BIOINFORMATICS, V31, P1805, DOI 10.1093/bioinformatics/btv039; You ZH, 2019, IEEE ACM T COMPUT BI, V16, P809, DOI 10.1109/TCBB.2018.2882423; You ZH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005455; You ZH, 2017, IEEE T CYBERNETICS, V47, P731, DOI 10.1109/TCYB.2016.2524994; Zeng XX, 2016, CURR PROTEOMICS, V13, P151, DOI 10.2174/157016461302160514005711; Zhang L, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03765-2; Zhang W, 2018, METHODS, V145, P51, DOI 10.1016/j.ymeth.2018.06.001; Zhang XT, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030139; Zhang Y, 2021, IEEE ACCESS, V9, P16103, DOI 10.1109/ACCESS.2021.3053030; Zhang Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00389; Zhang Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041508; Zhang Y, 2019, RSC ADV, V9, P29747, DOI 10.1039/c9ra05554a; Zhao Y, 2019, BIOINFORMATICS, V35, P4730, DOI 10.1093/bioinformatics/btz297; Zhao Y, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00324; Zhou Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0965-2; Zou Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/810514	73	4	4	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252971	10.1371/journal.pone.0252971	http://dx.doi.org/10.1371/journal.pone.0252971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138933	Green Published, gold			2022-12-26	WOS:000671690200091
J	Lin, YH; Wu, MH; Liu, YC; Lyu, PC; Yeh, CT; Lin, KH				Lin, Yang-Hsiang; Wu, Meng-Han; Liu, Yi-Chung; Lyu, Ping-Chiang; Yeh, Chau-Ting; Lin, Kwang-Huei			LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing	ONCOGENE			English	Article							HEPATITIS-B-VIRUS; LONG NONCODING RNA; X PROTEIN; C-JUN; EMERGING ROLES; HBX PROTEIN; CANCER; REVEALS; GENE; TRANSCRIPTION	Long non-coding RNAs (lncRNA) play crucial roles in hepatocellular carcinoma (HCC) progression. However, the specific functions of lncRNAs in alternative splicing (AS) and the metastatic cascade in liver cancer remain largely unclear. In this study, we identified a novel lncRNA, LINC01348, which was significantly downregulated in HCC and correlated with survival functions in HCC patients. Ectopic expression of LINC01348 induced marked inhibition of cell growth, and metastasis in vitro and in vivo. Conversely, these phenotypes were reversed upon knockdown of LINC01348. Mechanistically, LINC01348 complexed with splicing factor 3b subunit 3 (SF3B3) acted as a modulator of EZH2 pre-mRNA AS, and induced alterations in JNK/c-Jun activity and expression of Snail. Notably, C-terminal truncated HBx (Ct-HBx) negatively regulated LINC01348 through c-Jun signaling. Our data collectively highlight those novel regulatory associations involving LINC01348/SF3B3/EZH2/JNK/c-Jun/Snail are an important determinant of metastasis in HCC cells and support the potential utility of targeting LINC01348 as a therapeutic strategy for HCC.	[Lin, Yang-Hsiang; Yeh, Chau-Ting; Lin, Kwang-Huei] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Lin, Yang-Hsiang; Wu, Meng-Han; Lin, Kwang-Huei] Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan; [Liu, Yi-Chung] Inst Populat Sci, Natl Hlth Res Inst, Zhunan, Taiwan; [Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Dept Life Sci, Hsinchu, Taiwan; [Lin, Kwang-Huei] Chang Gung Univ Sci & Technol, Coll Human Ecol, Res Ctr Chinese Herbal Med, Taoyuan, Taiwan; Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Health Research Institutes - Taiwan; National Tsing Hua University; Chang Gung University of Science & Technology; Chang Gung University	Yeh, CT; Lin, KH (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan.; Lin, KH (corresponding author), Chang Gung Univ, Dept Biochem, Coll Med, Taoyuan, Taiwan.	chautingy@gmail.com; khlin@mail.cgu.edu.tw		Liu, Yi-Chung/0000-0003-1437-0363; Lin, Kwang-Huei/0000-0002-5649-2222	Chang Gung Memorial Hospital, Taoyuan, Taiwan [CMRPD1H0631-0633, CMRPD1K0291, NMRPD1G0941-0943, NMRPD1G0951-0953, CMRPG3H0721-0723, NZRPG3G0171-0173, NMRPG3H0561, NRRPG3J0141]; Ministry of Science and Technology of the Republic of China [MOST 106-2320-B-182-031-MY3, 106-2320-B-182-032-MY3, 109-2320-B-182-011, MOST 106-2321-B-182A-004-MY3, MOST 107-2320-B-182A-028-, MOST 108-2320-B182A-004-]	Chang Gung Memorial Hospital, Taoyuan, Taiwan(Chang Gung Memorial Hospital); Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang Gung Memorial Hospital, Taoyuan, Taiwan (CMRPD1H0631-0633, CMRPD1K0291, NMRPD1G0941-0943, and NMRPD1G0951-0953 to K-HL; CMRPG3H0721-0723, NZRPG3G0171-0173, NMRPG3H0561, NRRPG3J0141 to Y-HL) and from the Ministry of Science and Technology of the Republic of China (MOST 106-2320-B-182-031-MY3; 106-2320-B-182-032-MY3; and 109-2320-B-182-011 to K-HL; MOST 106-2321-B-182A-004-MY3, MOST 107-2320-B-182A-028-, MOST 108-2320-B182A-004-to Y-HL).	Chen K, 2017, CLIN CANCER RES, V23, P3428, DOI 10.1158/1078-0432.CCR-16-2020; Chen RY, 2020, CELL DEATH DIFFER, V27, P1259, DOI 10.1038/s41418-019-0413-7; Chen XC, 2018, BMB REP, V51, P280, DOI 10.5483/BMBRep.2018.51.6.025; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Di CX, 2019, CELL DEATH DIFFER, V26, P1181, DOI 10.1038/s41418-018-0231-3; Donato F, 1998, INT J CANCER, V75, P347, DOI 10.1002/(SICI)1097-0215(19980130)75:3&lt;347::AID-IJC4&gt;3.0.CO;2-2; DORIA M, 1995, EMBO J, V14, P4747, DOI 10.1002/j.1460-2075.1995.tb00156.x; El Marabti E, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00080; Elmore LW, 1997, P NATL ACAD SCI USA, V94, P14707, DOI 10.1073/pnas.94.26.14707; Finci LI, 2018, GENE DEV, V32, P309, DOI 10.1101/gad.311043.117; Gao SB, 2014, MOL CANCER RES, V12, P1388, DOI 10.1158/1541-7786.MCR-14-0034; Ghafouri-Fard S, 2019, BIOMED PHARMACOTHER, V111, P51, DOI 10.1016/j.biopha.2018.12.070; Giannelli G, 2016, J HEPATOL, V65, P798, DOI 10.1016/j.jhep.2016.05.007; Grzenda A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-3; He RZ, 2019, GENES DIS, V6, P6, DOI 10.1016/j.gendis.2019.01.003; Hodo Y, 2013, CLIN CANCER RES, V19, P1827, DOI 10.1158/1078-0432.CCR-12-1641; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Iyer S, 2011, MOL CARCINOGEN, V50, P972, DOI 10.1002/mc.20767; Jiang MC, 2019, AM J CANCER RES, V9, P1354; Kong JL, 2016, CANCER LETT, V380, P476, DOI 10.1016/j.canlet.2016.07.015; Lee S, 2016, ONCOGENE, V35, P1857, DOI 10.1038/onc.2015.251; Li SL, 2019, HEPATOLOGY, V69, P359, DOI 10.1002/hep.30158; Lim JK, 2020, AM J GASTROENTEROL, V115, P1429, DOI 10.14309/ajg.0000000000000651; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Luo ZL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9457; Lurje I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061465; Mai HM, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1213-0; Mu WP, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0242-9; Park JW, 2019, J HEPATOL, V70, P684, DOI 10.1016/j.jhep.2018.11.029; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qian Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33039; Quetier I, 2015, J GEN VIROL, V96, P614, DOI 10.1099/vir.0.070680-0; Romero-Barrios N, 2018, NUCLEIC ACIDS RES, V46, P2169, DOI 10.1093/nar/gky095; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shi J, 2005, BRIT J CANCER, V92, P607, DOI 10.1038/sj.bjc.6602333; Singal AG, 2020, J HEPATOL, V72, P250, DOI 10.1016/j.jhep.2019.08.025; Srisuttee R, 2012, ONCOL REP, V28, P276, DOI 10.3892/or.2012.1798; Sze KMF, 2013, HEPATOLOGY, V57, P131, DOI 10.1002/hep.25979; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tunissiolli Nathalia Martines, 2017, Asian Pac J Cancer Prev, V18, P863; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Uchino K, 2011, CANCER-AM CANCER SOC, V117, P4475, DOI 10.1002/cncr.25960; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang CH, 2000, BIOCHEM BIOPH RES CO, V270, P303, DOI 10.1006/bbrc.2000.2422; Wang J, 2016, TARGET ONCOL, V11, P723, DOI 10.1007/s11523-016-0446-5; Wang Yunwu, 2018, Oncotarget, V9, P11783, DOI 10.18632/oncotarget.24364; Yeh CT, 2012, J HEPATOL, V57, P484, DOI 10.1016/j.jhep.2012.06.003; Yip WK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022888; Zong XY, 2020, CANCER RES, V80, P4371, DOI 10.1158/0008-5472.CAN-20-0458	52	11	11	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4675	4685		10.1038/s41388-021-01905-3	http://dx.doi.org/10.1038/s41388-021-01905-3		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34140643				2022-12-26	WOS:000662838900001
J	Reinhardt, M; Findley, MB; Countryman, RA				Reinhardt, Madeleine; Findley, Matthew B.; Countryman, Renee A.			Policy liberalism and source of news predict pandemic-related health behaviors and trust in the scientific community	PLOS ONE			English	Article							PUBLIC TRUST; SCIENCE	In March of 2020, the United States was confronted with a major public health crisis caused by the coronavirus disease (COVID-19). This study aimed to identify what factors influence adherence to recently implemented public health measures such as mask-wearing and social distancing, trust of scientific organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) on information pertaining to the pandemic, and level of perceived risk. Data were collected from June 30, 2020 to July 22, 2020 on 951 adult residents of the United States using an online survey through Microsoft Forms. Multiple linear regression was used to identify the strongest predictors for compliance to pandemic-related health measures, trust in the scientific community, and perceived risk. Results showed that the strongest predictor of all variables of interest was degree of policy liberalism. Additionally, participants who consumed more conservative news media conformed less to the pandemic health guidelines and had less trust in the scientific community. Degree of policy liberalism was found to have a significant moderating effect on the relationship between gender and conformity to pandemic-related health behaviors. These findings have concerning implications that factors like degree of policy liberalism and source of news are more influential in predicting adherence to life-saving health measures than established risk factors like pre-existing health conditions.	[Reinhardt, Madeleine; Findley, Matthew B.; Countryman, Renee A.] Austin Coll, Sherman, TX 75090 USA		Countryman, RA (corresponding author), Austin Coll, Sherman, TX 75090 USA.	rcountryman@austincollege.edu		Countryman, Renee/0000-0003-3965-0230				Abdelhafiz AS, 2020, J COMMUN HEALTH, V45, P881, DOI 10.1007/s10900-020-00827-7; AllSides, 2020, MEDIA BIAS CHART; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; Ameh GG., 2020, EUR J ENV PUBLIC HLT, V4, DOI 10.29333/ejeph/8200; [Anonymous], 2020, 0120 EX; [Anonymous], 2020, GA29 TEX EX; Baumgaertner B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191728; Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Blank JM, 2015, ANN AM ACAD POLIT SS, V658, P18, DOI 10.1177/0002716214554756; Blee KM, 2010, ANNU REV SOCIOL, V36, P269, DOI 10.1146/annurev.soc.012809.102602; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Calvillo DP, 2020, SOC PSYCHOL PERS SCI, V11, P1119, DOI 10.1177/1948550620940539; Casey MM, 2001, AM J PREV MED, V21, P182, DOI 10.1016/S0749-3797(01)00349-X; Centers for Disease Control and Prevention, 2020, CORONAVIRUS DIS 2019; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen XY, 2020, INT J ENV RES PUB HE, V17, DOI [10.3390/ijerph17124437, 10.3390/ijerph17082893]; Christensen SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239693; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Dobrovolny HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236976; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Ebinger JE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236240; Flaherty GT, 2020, TROP DIS TRAVEL MED, V6, DOI 10.1186/s40794-020-00118-y; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Hinton D. M., 2020, VEKLURY REMDESIVIR E; Hmielowski JD, 2014, PUBLIC UNDERST SCI, V23, P866, DOI 10.1177/0963662513480091; Huber B, 2019, PUBLIC UNDERST SCI, V28, P759, DOI 10.1177/0963662519869097; IBM Corp, REL 2019 IBM SPSS ST; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Klein SL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008570; Markowitz A., 2020, DOES YOUR STATE HAVE; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; McGrail DJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236619; Meier K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236917; Myers TA, 2017, PUBLIC UNDERST SCI, V26, P843, DOI 10.1177/0963662516636040; Narayanan RP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239572; National Center for Chronic Disease Prevention and Health Promotion, 2019, RUR HLTH; Niepel C, 2020, BRIT J HEALTH PSYCH, V25, P883, DOI 10.1111/bjhp.12438; Nisbet EC, 2015, ANN AM ACAD POLIT SS, V658, P36, DOI 10.1177/0002716214555474; Pew Research Center-U.S. Politics & Policy, 2020, POL TYP QUIZ; Reuben RC, 2021, J COMMUN HEALTH, V46, P457, DOI 10.1007/s10900-020-00881-1; Sabatino J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237131; Schurz H, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-018-0185-z; Shook NJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238015; Srivastav A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195085; Tao Y., 2020, SSRN ELECT J, DOI 10.2139/ssrn.3559583; Teslya A, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003166; U.S. Census Bureau, 2020, URB RUR; University of Michigan Library, 2020, NEWS SOURC FALL POL; USCB [US Census Bureau], 2020, AM COMMUNITY SURVEY; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Walsh B., 2020, AXIOS POLLS SHOW POL; Wei L, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00442-20; World Health Organisation, 2020, COR DIS COVID 19 EV; World Health Organization, 2021, COVID 19 EP UPD; Yue ST, 2021, J COMMUN HEALTH, V46, P286, DOI 10.1007/s10900-020-00877-x; Zhao ZR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236618; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	59	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252670	10.1371/journal.pone.0252670	http://dx.doi.org/10.1371/journal.pone.0252670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138893	Green Published, gold			2022-12-26	WOS:000671690200110
J	Saalim, K; Sakyi, KS; Fatema-Tuz-Zohra; Morrison, E; Owusu, P; Dalglish, SL; Kanyangarara, M				Saalim, Khalida; Sakyi, Kwame S.; Fatema-Tuz-Zohra; Morrison, Emily; Owusu, Prince; Dalglish, Sarah L.; Kanyangarara, Mufaro			Reported health and social consequences of the COVID-19 pandemic on vulnerable populations and implemented solutions in six West African countries: A media content analysis	PLOS ONE			English	Article								Coronavirus has spread worldwide with over 140 million cases and resulting in more than 3 million deaths between November 2019 to April 2021, threatening the socio-economic and psychosocial stability of many families and communities. There has been limited research to understand the consequences of COVID-19 on vulnerable populations in West Africa, and whether such consequences differ by countries' previous experience with Ebola. Using a media analysis of leading online news sources, this study identified the populations particularly vulnerable to the threats of the COVID-19 pandemic, described the consequences of COVID-19 experienced by these populations, and reported on the solutions to address them. All articles from the selected news sources published between January 1 and June 30, 2020 on 6 West African countries were imported into Dedoose. A total of 4,388 news articles were coded for excerpts on vulnerable populations, only 285 excerpts of which mentioned the existing effects of COVID-19 on vulnerable populations or implemented solutions. News articles from countries with past experience with Ebola were more likely to mention the pandemic's effects on vulnerable populations, especially on incarcerated people. Vulnerable groups were reported to have experienced a range of effects including economic disruptions, heightened domestic and sexual abuse, arbitrary arrests, health care inaccessibility, and educational challenges throughout the pandemic. With implications for the achievement of the Sustainable Development Goals (SDG) for 2030 in West Africa, these countries should consider and focus more strategic efforts on vulnerable populations to overcome their fight against the COVID-19 pandemic and to achieve the SDG for 2030.	[Saalim, Khalida; Dalglish, Sarah L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Sakyi, Kwame S.] Oakland Univ, Sch Hlth Sci, Dept Publ & Environm Wellness, Rochester, MI 48063 USA; [Sakyi, Kwame S.; Fatema-Tuz-Zohra; Owusu, Prince] Ctr Learning & Childhood Dev, Accra, Ghana; [Morrison, Emily; Kanyangarara, Mufaro] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA; [Dalglish, Sarah L.] UCL, Inst Global Hlth, London, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Oakland University; University of South Carolina System; University of South Carolina Columbia; University of London; University College London	Kanyangarara, M (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.	mufaro@mailbox.sc.edu		Saalim, Khalida/0000-0002-5463-2738	University of South Carolina COVID-19 Research Initiative	University of South Carolina COVID-19 Research Initiative	This study is supported by the University of South Carolina COVID-19 Research Initiative awarded to MK.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AFR CDC COVID 19 DAI; [Anonymous], 2018, DED VERS 8 0 35 WEB; [Anonymous], GHANAIAN TIMES; [Anonymous], 2020, ATLANTIC COUNCIL; [Anonymous], SIERRA LEONE TELEGRA; [Anonymous], 2020, GUARDIAN 1026; [Anonymous], CORONAVIRUS COVID 19, DOI DOI 1105914/CORONAVIRUS-DEATH-RATES-WORLDWIDE; [Anonymous], 2020, 2014 2016 EB OUTBR W; [Anonymous], ALL YOU CAN READ; Armitage R, 2020, LANCET GLOB HEALTH, V8, pE644, DOI 10.1016/S2214-109X(20)30116-9; Boumediene A., 2020, DAILY SABAH; Burke J., 2020, GUARDIAN; Chirisa I, 2022, GEOJOURNAL, V87, P815, DOI 10.1007/s10708-020-10281-6; Colebunders R, 2020, INT J INFECT DIS, V99, P482, DOI 10.1016/j.ijid.2020.08.060; Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297; de Matos MA, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0219-2020; Delamou A, 2017, LANCET GLOB HEALTH, V5, pE448, DOI [10.1016/S2214-109X(17)30078-5, 10.1016/s2214-109x(17)30078-5]; Durizzo K, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105175; Fawole OI, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01177-9; Global Business Coalition for Education, 2014, EB EM REST ED CREAT; GSM Association, 2019, MOB EC W AFR INT; Heard C, 2020, VICTIMS OFFENDERS, V15, P848, DOI 10.1080/15564886.2020.1825583; Iglesias-Osores S, 2020, Rev. esp. sanid. penit., V22, P87, DOI 10.18176/resp.00015; John N, 2020, DEV WORLD BIOETH, V20, P65, DOI 10.1111/dewb.12261; Korman V., 2020, WORLD BANK, P21; Macnamara J., 2005, ASIA PACIFIC PUBLIC, V6, P1, DOI DOI 10.3316/IELAPA.200705762; Malani A, 2021, LANCET GLOB HEALTH, V9, pE110, DOI 10.1016/S2214-109X(20)30467-8; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Moreira DN, 2020, INT J LAW PSYCHIAT, V71, DOI 10.1016/j.ijlp.2020.101606; Nations United., 2020, POL BRIEF IMP COVID; Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P179; OECD, COVID 19 AFR SOC EC; Oyeniran O I, 2020, Ethics Med Public Health, V15, P100558, DOI 10.1016/j.jemep.2020.100558; Ozili P, 2022, INT J SOCIOL SOC POL, V42, P177, DOI 10.1108/IJSSP-05-2020-0171; Palinkas LA, 2015, ADM POLICY MENT HLTH, V42, P533, DOI 10.1007/s10488-013-0528-y; Quaglio GianLuca, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.d67aea257f572201f835772d7f188ba5; Shadmi E, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01218-z; Shannon F Q 2nd, 2017, Public Health Action, V7, pS88, DOI 10.5588/pha.16.0099; Soy A, BBC NEWS; Stewart A, 2020, AUST NZ J PSYCHIAT, V54, P1227, DOI 10.1177/0004867420937806; Sun XJ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4242-7; The World Bank Liberian Institute of Statistics Gallup., 2015, SOC EC IMP EB LIB IN; The World Bank Sierra Leone Statistics., 2015, SOC EC IMP EB SIERR; Tso FY, 2021, INT J INFECT DIS, V102, P577, DOI 10.1016/j.ijid.2020.10.104; United Nations, 2020, POL BRIEF DIS INCL R; Uyoga S, 2021, SCIENCE, V371, P79, DOI 10.1126/science.abe1916; Wallace LJ, 2020, CAN J PUBLIC HEALTH, V111, P649, DOI 10.17269/s41997-020-00399-y; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2018, MAN EP INT	49	12	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252890	10.1371/journal.pone.0252890	http://dx.doi.org/10.1371/journal.pone.0252890			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG8YE	34133438	Green Published, gold			2022-12-26	WOS:000671682700016
J	Sakai, S; Watanabe, S; Komine, O; Sobue, A; Yamanaka, K				Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji			Novel reporters of mitochondria-associated membranes (MAM), MAMtrackers, demonstrate MAM disruption as a common pathological feature in amyotrophic lateral sclerosis	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis (ALS); ER-mitochondria contact; mitochondria-associated membrane (MAM); organelle; sigma-1 receptor (Sig1R)	ER; ALS; INTERFACE; AGONIST; DAMAGE; FUS	The mitochondria-associated membrane (MAM) is a functional subdomain of the endoplasmic reticulum membrane that tethers to the mitochondrial outer membrane and is essential for cellular homeostasis. A defect in MAM is involved in various neurological diseases, including amyotrophic lateral sclerosis (ALS). Recently, we and others reported that MAM was disrupted in the models expressing several ALS-linked genes, including SOD1, SIGMAR1, VAPB, TARDBP, and FUS, suggesting that MAM disruption is deeply involved in the pathomechanism of ALS. However, it is still uncertain whether MAM disruption is a common pathology in ALS, mainly due to the absence of a simple, quantitative tool for monitoring the status of MAM. In this study, to examine the effects of various ALS-causative genes on MAM, we created the following two novel MAM reporters: MAMtracker-Luc and MAMtracker-Green. The MAMtrackers could detect MAM disruption caused by suppression of SIGMAR1 or the overexpression of ALS-linked mutant SOD1 in living cells. Moreover, the MAMtrackers have an advantage in their ability to monitor reversible changes in the MAM status induced by nutritional conditions. We used the MAMtrackers with an expression plasmid library of ALS-causative genes and noted that 76% (16/21) of the genes altered MAM integrity. Our results suggest that MAM disruption is a common pathological feature in ALS. Furthermore, we anticipate our MAMtrackers, which are suitable for high-throughput assays, to be valuable tools to understand MAM dynamics.	[Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan; [Sakai, Shohei; Watanabe, Seiji; Komine, Okiru; Sobue, Akira; Yamanaka, Koji] Nagoya Univ, Dept Neurosci & Pathobiol, Grad Sch Med, Nagoya, Aichi, Japan; [Sobue, Akira] Nagoya Univ, Med Interact Res & Acad Ind Collaborat Ctr, Res Inst Environm Med, Nagoya, Aichi, Japan; [Yamanaka, Koji] Nagoya Univ, Inst Glyco Core Res iGCORE, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Watanabe, S; Yamanaka, K (corresponding author), Nagoya Univ, Res Inst Environm Med, Dept Neurosci & Pathobiol, Nagoya, Aichi 4648601, Japan.	swtnb@riem.nagoya-u.ac.jp; koji.yamanaka@riem.nagoya-u.ac.jp	Yamanaka, Koji/H-5806-2011	Yamanaka, Koji/0000-0003-4655-0035; Watanabe, Seiji/0000-0001-8038-7919	Japan Agency for Medical Research and Development (AMED) [21ek0109426h0002]; Uehara Memorial Foundation; Public Foundation of Chubu Science and Technology Center	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Uehara Memorial Foundation(Uehara Memorial Foundation); Public Foundation of Chubu Science and Technology Center	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: 21ek0109426h0002; Uehara Memorial Foundation; the Public Foundation of Chubu Science and Technology Center	Al-Saif A, 2011, ANN NEUROL, V70, P913, DOI 10.1002/ana.22534; Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58; Alford SC, 2012, ACS SYNTH BIOL, V1, P569, DOI 10.1021/sb300050j; [Anonymous], SCI REP UK; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Chami M, 2008, MOL CELL, V32, P641, DOI 10.1016/j.molcel.2008.11.014; Cieri D, 2018, CELL DEATH DIFFER, V25, P1131, DOI 10.1038/s41418-017-0033-z; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; De Vos KJ, 2012, HUM MOL GENET, V21, P1299, DOI 10.1093/hmg/ddr559; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Gerbino V, 2020, NEURON, V106, P789, DOI 10.1016/j.neuron.2020.03.005; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hertlein V, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900600; Komine O, 2018, CELL DEATH DIFFER, V25, P2130, DOI 10.1038/s41418-018-0098-3; Lee S, 2018, MOL CELLS, V41, P1000, DOI 10.14348/molcells.2018.0438; Mancuso R, 2012, NEUROTHERAPEUTICS, V9, P814, DOI 10.1007/s13311-012-0140-y; Mejzini R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01310; Motohashi K, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0162-8; Naumann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02299-1; Ono Y, 2014, NEUROSCI LETT, V559, P174, DOI 10.1016/j.neulet.2013.12.005; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Sigal YM, 2018, SCIENCE, V361, P880, DOI 10.1126/science.aau1044; Stoica R, 2016, EMBO REP, V17, P1326, DOI 10.15252/embr.201541726; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Suzuki H, 2011, J NEUROCHEM, V119, P1099, DOI 10.1111/j.1471-4159.2011.07491.x; Tan YS, 2019, METHODS MOL BIOL, V1960, P85, DOI 10.1007/978-1-4939-9167-9_7; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Theurey P, 2016, J MOL CELL BIOL, V8, P129, DOI 10.1093/jmcb/mjw004; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Watanabe S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.459; Watanabe S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03116-2; Watanabe S, 2016, EMBO MOL MED, V8, P1421, DOI 10.15252/emmm.201606403; Watanabe S, 2013, J BIOL CHEM, V288, P3641, DOI 10.1074/jbc.M112.433615; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Xu DC, 2018, CELL, V174, P1477, DOI 10.1016/j.cell.2018.07.041; Yang ZY, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208686	41	6	6	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21688	10.1096/fj.202100137R	http://dx.doi.org/10.1096/fj.202100137R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143516				2022-12-26	WOS:000667814100050
J	Starmans, NLP; Zoetemeyer, S; van Dijk, MR; Kappelle, LJ; Frijns, CJM				Starmans, N. L. P.; Zoetemeyer, S.; van Dijk, M. R.; Kappelle, L. J.; Frijns, C. J. M.			The diagnostic value of skin biopsies in Sneddon syndrome	PLOS ONE			English	Article							DIFFERENTIAL-DIAGNOSIS; LIVEDO RACEMOSA; ANTIBODIES; LESIONS; LIFE	Background Sneddon syndrome (SS) is defined by widespread livedo reticularis (LR) and stroke. There is no single diagnostic test for SS and diagnosis can be solely based on clinical features. This cross-sectional case-control study aimed to determine the diagnostic value of skin biopsies in SS patients. Materials and methods We studied skin biopsies from patients with a clinical diagnosis of SS or isolated LR. We also studied controls with vitiligo or normal skin. Biopsies were considered standardized if 3 biopsies were taken from the white centre of the livedo and reached until the dermis-subcutis border. Biopsies were scored for features of an occlusive microangiopathy without knowledge of the clinical features. Sensitivity and specificity of the biopsy findings were calculated with the clinical criteria as the reference standard. Results We included 34 SS patients, 14 isolated LR patients and 41 control patients. Biopsies of 17 patients with SS (50%), 4 with isolated LR (31%) and 10 control patients (24%) showed at least one artery in the deep dermis with a thickened vessel wall combined with recanalization or neovascularization (sensitivity 50% and specificity 69% with LR as reference). Standardized biopsies increased the sensitivity to 70%. In a post hoc analysis the combination of an occlusive microangiopathy and the presence of a livedo pattern in the superficial dermis increased the specificity to 92%. Conclusions Standardized skin biopsies can support the clinical diagnosis of SS. An occlusive microangiopathy as the only positive criterion for the diagnosis of SS had insufficient specificity for a definite diagnosis.	[Starmans, N. L. P.; Kappelle, L. J.; Frijns, C. J. M.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Zoetemeyer, S.] Reinier de Graaf Gasthuis, Dept Pathol, Delft, Netherlands; [van Dijk, M. R.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Reinier de Graaf Hospital; Utrecht University; Utrecht University Medical Center	Starmans, NLP (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Utrecht, Netherlands.	n.l.p.starmans@umcutrecht.nl		Starmans, Naomi/0000-0002-8033-7126				Alikhan A, 2011, J AM ACAD DERMATOL, V65, P473, DOI 10.1016/j.jaad.2010.11.061; Bolayir E, 2004, ACTA MED OKAYAMA, V58, P59; Bottin L, 2015, ANN NEUROL, V77, P817, DOI 10.1002/ana.24382; DEREUS R, 1985, CLIN NEUROL NEUROSUR, V87, P143, DOI 10.1016/0303-8467(85)90115-5; Easton JD, 2009, STROKE, V40, P2276, DOI 10.1161/STROKEAHA.108.192218; FETONI V, 1994, CLIN NEUROL NEUROSUR, V96, P310, DOI 10.1016/0303-8467(94)90120-1; Fetoni V, 2000, NEUROL SCI, V21, P157, DOI 10.1007/s100720070091; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097/00005792-199907000-00001; KALASHNIKOVA LA, 1990, NEUROLOGY, V40, P464, DOI 10.1212/WNL.40.3_Part_1.464; Kraemer M, 2005, J NEUROL, V252, P1155, DOI 10.1007/s00415-005-0967-9; SEPP N, 1995, AM J SURG PATHOL, V19, P448, DOI 10.1097/00000478-199504000-00006; SNEDDON IB, 1965, BRIT J DERMATOL, V77, P180, DOI 10.1111/j.1365-2133.1965.tb14628.x; Starmans NLP, 2021, J NEUROL, V268, P2450, DOI 10.1007/s00415-021-10407-x; STOCKHAMMER G, 1993, STROKE, V24, P685, DOI 10.1161/01.STR.24.5.685; Wohlrab J, 2001, BRIT J DERMATOL, V145, P285, DOI 10.1046/j.1365-2133.2001.04348.x; Wu SJ, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0215-4; ZELGER B, 1992, HUM PATHOL, V23, P668, DOI 10.1016/0046-8177(92)90323-U	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253365	10.1371/journal.pone.0253365	http://dx.doi.org/10.1371/journal.pone.0253365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181656	gold, Green Published			2022-12-26	WOS:000671695800044
J	Adjei, G; Darteh, EKM; Doku, DT				Adjei, George; Darteh, Eugene K. M.; Doku, David Teye			Neonatal mortality clustering in the central districts of Ghana	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE; CHILDHOOD MORTALITY; STILLBIRTHS; SURVIVAL; DEATHS; HEALTH; TRENDS	Introduction Identifying high risk geographical clusters for neonatal mortality is important for guiding policy and targeted interventions. However, limited studies have been conducted in Ghana to identify such clusters. Objective This study aimed to identify high-risk clusters for all-cause and cause-specific neonatal mortality in the Kintampo Districts. Materials and methods Secondary data, comprising of 30,132 singleton neonates between January 2005 and December 2014, from the Kintampo Health and Demographic Surveillance System (KHDSS) database were used. Verbal autopsies were used to determine probable causes of neonatal deaths. Purely spatial analysis was ran to scan for high-risk clusters using Poisson and Bernoulli models for all-cause and cause-specific neonatal mortality in the Kintampo Districts respectively with village as the unit of analysis. Results The study revealed significantly high risk of village-clusters for neonatal deaths due to asphyxia (RR = 1.98, p = 0.012) and prematurity (RR = 5.47, p = 0.025) in the southern part of Kintampo Districts. Clusters (emerging clusters) which have the potential to be significant in future, for all-cause neonatal mortality was also identified in the south-western part of the Kintampo Districts. Conclusions Study findings showed cause-specific neonatal mortality clustering in the southern part of the Kintampo Districts. Emerging cluster was also identified for all-cause neonatal mortality. More attention is needed on prematurity and asphyxia in the identified cause-specific neonatal mortality clusters. The emerging cluster for all-cause neonatal mortality also needs more attention to forestall any formation of significant mortality cluster in the future. Further research is also required to understand the high concentration of prematurity and asphyxiated deaths in the identified clusters.	[Adjei, George] Univ Cape Coast, Dept Community Med, Cape Coast, Ghana; [Darteh, Eugene K. M.; Doku, David Teye] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana	University of Cape Coast; University of Cape Coast	Adjei, G (corresponding author), Univ Cape Coast, Dept Community Med, Cape Coast, Ghana.	George.adjei2@ucc.edu.gh	Darteh, Eugene Kofuor Maafo/H-1670-2015	Darteh, Eugene Kofuor Maafo/0000-0003-4689-8891; ADJEI, GEORGE/0000-0001-7977-7071				Adjei G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1572-1; Adjuik M, 2010, GLOBAL HEALTH ACTION, V3, P15, DOI 10.3402/gha.v3i0.5233; Afolabi BM., 2017, J NEONATAL BIOL, V6, P1, DOI DOI 10.4172/2167-0897.1000246; [Anonymous], 2018, UN INT GROUP CHILD M, P1; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Boco AG., 2010, AFRICA LOND, P80; Buor D, 2003, HEALTH POLICY, V64, P297, DOI 10.1016/S0168-8510(02)00178-1; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P417, DOI 10.1111/j.1365-3016.2008.00962.x; Edmond KM, 2008, PAEDIATR PERINAT EP, V22, P430, DOI 10.1111/j.1365-3016.2008.00961.x; Eisele TP, 2003, AM J TROP MED HYG, V69, P92, DOI 10.4269/ajtmh.2003.69.92; Ghana Statistical Service Ghana Health Service & ICF International., GHAN DEM HLTH SURV 2; Hug L, 2019, LANCET GLOB HEALTH, V7, pE710, DOI 10.1016/S2214-109X(19)30163-9; Kayode GA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-165; Kravdal O, 2004, POP STUD-J DEMOG, V58, P177, DOI 10.1080/0032472042000213721; Kulldorff M, 2015, SATSCAN USER GUIDE V, P1; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Mekonnen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-483; Nesbitt RC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30291; Nettey OEA, 2010, GLOBAL HEALTH ACTION, V3, P8, DOI 10.3402/gha.v3i0.5258; Ogbo FA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7547-x; Osei FB, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4541-z; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Rahman Moshiur, 2009, East Afr J Public Health, V6, P77; Sandberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097253; Sankoh OA, 2001, INT J EPIDEMIOL, V30, P485, DOI 10.1093/ije/30.3.485; Sartorius B, 2010, GLOBAL HEALTH ACTION, V3, P50, DOI 10.3402/gha.v3i0.5225; Sastry N, 1996, DEMOGRAPHY, V33, P211, DOI 10.2307/2061873; Singh A, 2013, PEERJ, V1, DOI 10.7717/peerj.75; Stanton CK, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-42; UNICEF: WHO: World Bank: UN DESA, 2019, WHO WORLD BANK DESA, P52; Welaga P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058924; WHO, 2018, NEWB RED MORT, P2017; WHO Fact Sheet, REP 2016	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253573	10.1371/journal.pone.0253573	http://dx.doi.org/10.1371/journal.pone.0253573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170957	gold, Green Published			2022-12-26	WOS:000671694400036
J	Migdal, P; Murawska, A; Bienkowski, P; Strachecka, A; Roman, A				Migdal, Pawel; Murawska, Agnieszka; Bienkowski, Pawel; Strachecka, Aneta; Roman, Adam			Effect of the electric field at 50 Hz and variable intensities on biochemical markers in the honey bee's hemolymph	PLOS ONE			English	Article							LEPIDOPTERA; EXPOSURE	The amount of artificial electromagnetic fields of various parameters in the honey bee's environment increases globally. So far, it had been proven that exposure to an E-field at 50 Hz can cause changes in bee's behavior, alter the activity of proteases, and enzymatic antioxidants. Due to the potentially harmful effect of this factor on honey bees, we decided to investigate the activity of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), and the concentration of albumin and creatinine in bee's hemolymph after exposure to 50 Hz E-field. Honey bee workers were placed in wooden cages (200 x 150 x 70 mm) and exposed to the 50 Hz E-field with the intensity of <1, 5.0, 11.5, 23.0, or 34.5 kV/m for 1, 3, 6, or 12h. A homogeneous 50 Hz E-field was generated in the form of a plate capacitor. Hemolymph samples for analysis were taken immediately after the end of exposure to the E-field from 100 bees from each group. According to our study, the activity of AST, ALT, and ALP in honey bees' hemolymph decreased after exposure to 50 Hz E-field with various intensities. The decrease in AST, ALT, and ALP activity intensified with prolonged exposure time. 50 Hz E-field may cause the impairment of crucial metabolic cycles in the honey bees' organism (such as the citric acid cycle, ATP synthesis, oxidative phosphorylation, beta-oxidation). Moreover, exposure to E-Field altered the concentration of creatinine and albumin, which are important non-enzymatic antioxidants. Such changes may indicate a disturbance in protein metabolism and increased muscle activity.	[Migdal, Pawel; Murawska, Agnieszka; Roman, Adam] Wroclaw Univ Environm & Life Sci, Dept Environm Hyg & Anim Welf, Wroclaw, Poland; [Bienkowski, Pawel] Wroclaw Univ Sci & Technol, Telecommun & Teleinformat Dept, Wroclaw, Poland; [Strachecka, Aneta] Univ Life Sci Lublin, Inst Biol Basis Anim Prod, Fac Biol Anim Sci & Bioecon, Lublin, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Science & Technology; University of Life Sciences in Lublin	Migdal, P (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Environm Hyg & Anim Welf, Wroclaw, Poland.	Pawel.Migdal@upwr.edu.pl		Migdal, Pawel/0000-0002-2615-9760; Strachecka, Aneta/0000-0003-1313-9880; Murawska, Agnieszka/0000-0002-8691-2953	Department of Environment Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences	Department of Environment Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences	This study received support from the Department of Environment Hygiene and Animal Welfare, Wroclaw University of Environmental and Life Sciences (funding awarded to PM).	Bajda M., 2014, MED WET, V70, P66; Bienkowski P, 2015, MED PR, V66, P185, DOI 10.13075/mp.5893.00164; BINDOKAS VP, 1989, BIOELECTROMAGNETICS, V10, P1, DOI 10.1002/bem.2250100102; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Hashimoto H, 2002, J MOL STRUCT, V604, P125, DOI 10.1016/S0022-2860(01)00648-2; Ioriatti L, 2009, P INT GEOSC REM SENS; Kopec RE, 2010, J AGR FOOD CHEM, V58, P3290, DOI 10.1021/jf100415z; Koziorowska A, 2020, POL J VET SCI, V23, P537, DOI 10.24425/pjvs.2020.134703; Lala V., 2020, LIVER FUNCTION TESTS; Lorenz S., 2015, ENV SOCIOLOGY, V1, P116, DOI [10.1080/23251042.2015.1008383, DOI 10.1080/23251042.2015.1008383]; Los A, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051494; MARTIN M, 1981, MAR POLLUT BULL, V12, P305, DOI 10.1016/0025-326X(81)90081-3; Migdal P, 2021, ANIMALS-BASEL, V11, DOI [10.3390/ani11030863, 10.3390/ani11030863/]; Migdal P, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11020247; Migdal P, 2020, INSECTS, V11, DOI 10.3390/insects11100713; Migdal P, 2020, J APIC SCI, V64, P165, DOI [10.2478/JAS-2020-0004, 10.2478/jas-2020-0004]; Migdal P, 2020, APIDOLOGIE, V51, P956, DOI 10.1007/s13592-020-00774-1; Nathan SS, 2006, ECOTOX ENVIRON SAFE, V64, P382, DOI 10.1016/j.ecoenv.2005.04.008; Paleolog J, 2020, APIDOLOGIE, V51, P620, DOI 10.1007/s13592-020-00747-4; Ramzi S, 2014, BIOCONTROL SCI TECHN, V24, P597, DOI 10.1080/09583157.2014.883360; Salkin PE, 2012, BC ENV AFF L REV; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shepherd S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26185-y; Shepherd S, 2021, BIOELECTROMAGNETICS, V42, P296, DOI 10.1002/bem.22336; Shepherd S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223614; Sokol R, 1996, ACTA ACAD AGR TECH O, V24, P113; Wang CS, 2012, J FORMOS MED ASSOC, V111, P201, DOI 10.1016/j.jfma.2011.04.004; Wyszkowska J, 2019, PRZ ELEKTROTECHNICZN, V95, P137, DOI 10.15199/48.2019.01.35; Zibaee A, 2011, PESTIC BIOCHEM PHYS, V100, P289, DOI 10.1016/j.pestbp.2011.05.002	29	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252858	10.1371/journal.pone.0252858	http://dx.doi.org/10.1371/journal.pone.0252858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166412	Green Published, gold			2022-12-26	WOS:000671692800039
J	Escuin-Ordinas, H; Liu, YN; Sun, L; Hugo, W; Dimatteo, R; Huang, RR; Krystofinski, P; Azhdam, A; Lee, J; Comin-Anduix, B; Cochran, AJ; Lo, RS; Segura, T; Scumpia, PO; Ribas, A				Escuin-Ordinas, Helena; Liu, Yining; Sun, Lu; Hugo, Willy; Dimatteo, Robert; Huang, Rong Rong; Krystofinski, Paige; Azhdam, Ariel; Lee, Jordan; Comin-Anduix, Begona; Cochran, Alistair J.; Lo, Roger S.; Segura, Tatiana; Scumpia, Philip O.; Ribas, Antoni			Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects	PLOS ONE			English	Article							FOLLICLE STEM-CELLS; MAPK PATHWAY; SKIN; ACTIVATION; RAF; EXPRESSION; WNT	Wound healing is a multi-step process to rapidly restore the barrier function. This process is often impaired in diabetic patients resulting in chronic wounds and amputation. We previously found that paradoxical activation of the mitogen-activated protein kinase (MAPK) pathway via topical administration of the BRAF inhibitor vemurafenib accelerates wound healing by activating keratinocyte proliferation and reepithelialization pathways in healthy mice. Herein, we investigated whether this wound healing acceleration also occurs in impaired diabetic wounds and found that topical vemurafenib not only improves wound healing in a murine diabetic wound model but unexpectedly promotes hair follicle regeneration. Hair follicles expressing Sox-9 and K15 surrounded by CD34+ stroma were found in wounds of diabetic and non-diabetic mice, and their formation can be prevented by blocking downstream MEK signaling. Thus, topically applied BRAF inhibitors may accelerate wound healing, and promote the restoration of improved skin architecture in both normal and impaired wounds.	[Escuin-Ordinas, Helena; Krystofinski, Paige; Azhdam, Ariel; Ribas, Antoni] Univ Calif Los Angeles UCLA, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA; [Liu, Yining; Dimatteo, Robert; Segura, Tatiana] UCLA, Dept Chem & Biomol Engn, Los Angeles, CA USA; [Sun, Lu; Hugo, Willy; Lo, Roger S.; Scumpia, Philip O.] UCLA, Div Dermatol, Dept Med, Los Angeles, CA USA; [Huang, Rong Rong; Cochran, Alistair J.] UCLA, Dept Pathol & Lab Med, Los Angeles, CA USA; [Lee, Jordan; Scumpia, Philip O.] VA Greater Los Angeles Healthcare Syst West Los, Dept Dermatol, Los Angeles, CA USA; [Comin-Anduix, Begona; Ribas, Antoni] UCLA, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA; [Comin-Anduix, Begona; Lo, Roger S.] UCLA, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Lo, Roger S.; Ribas, Antoni] UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Segura, Tatiana] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Ribas, Antoni] UCLA, Dept Biol Chem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Duke University; University of California System; University of California Los Angeles	Escuin-Ordinas, H; Ribas, A (corresponding author), Univ Calif Los Angeles UCLA, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA.; Ribas, A (corresponding author), UCLA, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA.; Ribas, A (corresponding author), UCLA, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.; Ribas, A (corresponding author), UCLA, Dept Biol Chem, Los Angeles, CA 90024 USA.	helena.escuin@gmail.com; aribas@mednet.ucla.edu			NIH [CA168585, CA197633]; Grimaldi Family Fund; Garcia-Corsini Family Fund; Melanoma Research alliance; American Skin Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grimaldi Family Fund; Garcia-Corsini Family Fund; Melanoma Research alliance; American Skin Association	AR was awarded with NIH CA168585, NIH CA197633, the Grimaldi Family Fund and the Garcia-Corsini Family Fund, which supported this work. The sponsors did not play any role in the study desing, data collection and analysis, decision to publish or preparation of the manuscript. https://www.nih.gov/grants-funding WH was supported by a Young investigator award from Melanoma Research alliance and Daneen& Charles Stiefel Award from the American Skin Association. The sponsors did not play any role in the study desing, data collection and analysis, decision to publish or preparation of the manuscript. https://www.curemelanoma.org/http://www.americanskin.org/.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bianchi N, 2005, MOL CELL BIOL, V25, P7249, DOI 10.1128/MCB.25.16.7249-7259.2005; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen WB, 1997, CELL, V91, P789, DOI 10.1016/S0092-8674(00)80467-5; Das L, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.26; Deschene ER, 2014, SCIENCE, V343, P1353, DOI 10.1126/science.1248373; Escuin-Ordinas H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12348; Gay D, 2013, NAT MED, V19, P916, DOI 10.1038/nm.3181; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Holderfield M, 2013, CANCER CELL, V23, P594, DOI 10.1016/j.ccr.2013.03.033; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kobayashi H, 2003, EXP DERMATOL, V12, P734, DOI 10.1111/j.0906-6705.2003.00045.x; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32851-y; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Li W, 2001, J INVEST DERMATOL, V117, P1601, DOI 10.1046/j.0022-202x.2001.01608.x; Lien WH, 2014, NAT CELL BIOL, V16, P179, DOI 10.1038/ncb2903; Lim CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07142-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao CD, 2011, CRIT REV EUKAR GENE, V21, P207, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.10; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Michaels J, 2007, WOUND REPAIR REGEN, V15, P665, DOI 10.1111/j.1524-475X.2007.00273.x; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Seifert AW, 2012, NATURE, V489, P561, DOI 10.1038/nature11499; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Trempus CS, 2007, CANCER RES, V67, P4173, DOI 10.1158/0008-5472.CAN-06-3128; Veniaminova NA, 2013, DEVELOPMENT, V140, P4870, DOI 10.1242/dev.101725; Wang XJ, 2015, REGENERATION, V2, P169, DOI 10.1002/reg2.38; Wang XS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14091; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252597	10.1371/journal.pone.0252597	http://dx.doi.org/10.1371/journal.pone.0252597			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161353	Green Published, gold			2022-12-26	WOS:000671691900062
J	Wang, JY; Xiu, J; Baca, Y; Battaglin, F; Arai, H; Kawanishi, N; Soni, S; Zhang, W; Millstein, J; Salhia, B; Goldberg, RM; Philip, PA; Seeber, A; Hwang, JJ; Shields, AF; Marshall, JL; Astsaturov, I; Lockhart, AC; Gatalica, Z; Korn, WM; Lenz, HJ				Wang, Jingyuan; Xiu, Joanne; Baca, Yasmine; Battaglin, Francesca; Arai, Hiroyuki; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Millstein, Joshua; Salhia, Bodour; Goldberg, Richard M.; Philip, Philip A.; Seeber, Andreas; Hwang, Jimmy J.; Shields, Anthony F.; Marshall, John L.; Astsaturov, Igor; Craig Lockhart, A.; Gatalica, Zoran; Michael Korn, W.; Lenz, Heinz-Josef			Large-scale analysis of KMT2 mutations defines a distinctive molecular subset with treatment implication in gastric cancer	ONCOGENE			English	Article							ADENOCARCINOMA; LANDSCAPE; BURDEN	Frequent mutations of genes in the histone-lysine N-methyltransferase 2 (KMT2) family members were identified in gastric cancers (GCs). Understanding how gene mutations of KMT2 family affect cancer progression and tumor immune microenvironment may provide new treatment strategies. A total of 1245 GCs were analyzed using next-generation sequencing, whole transcriptome sequencing, immunohistochemistry (Caris Life Sciences, Phoenix, AZ). The overall mutation rate of genes in the KMT2 family was 10.6%. Compared to KMT2-wild-type GCs, genes involved in epigenetic modification, receptor tyrosine kinases/MAPK/PI3K, and DNA damage repair (DDR) pathways had higher mutation rates in KMT2-mutant GCs (p < 0.05). Significantly higher rates of high tumor mutational burden, microsatellite instability-high/mismatch-repair deficiency (dMMR), and PD-L1 positivity were observed in KMT2-mutant GCs (p < 0.01), compared to KMT2-wild-type GCs. The association between PD-L1 positivity and KMT2 mutations remained significant in the proficient-MMR and microsatellite stable subgroup. Based on transcriptome data from the TCGA, cell cycle, metabolism, and interferon-alpha/beta response pathways were significantly upregulated in KMT2-mutant GCs than in KMT2-wild-type GCs. Patients with KMT2 mutation treated with immune checkpoint inhibitors had longer median overall survival compared to KMT2-wild-type patients with metastatic solid tumors (35 vs. 16 months, HR = 0.73, 95% CI: 0.62-0.87, p = 0.0003). In conclusion, this is the largest study to investigate the distinct molecular features between KMT2-mutant and KMT2-wild-type GCs to date. Our data indicate that GC patients with KMT2 mutations may benefit from ICIs and drugs targeting DDR, MAPK/PI3K, metabolism, and cell cycle pathways.	[Wang, Jingyuan] Peking Univ, Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Wang, Jingyuan; Battaglin, Francesca; Arai, Hiroyuki; Kawanishi, Natsuko; Soni, Shivani; Zhang, Wu; Lenz, Heinz-Josef] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90007 USA; [Xiu, Joanne; Baca, Yasmine; Gatalica, Zoran; Michael Korn, W.] Caris Life Sci, Phoenix, AZ USA; [Millstein, Joshua] Univ Southern Calif, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90007 USA; [Salhia, Bodour] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Translat Genom, Los Angeles, CA 90007 USA; [Goldberg, Richard M.] West Virginia Univ, Canc Inst, Morgantown, WV 26506 USA; [Philip, Philip A.; Shields, Anthony F.] Wayne State Univ, Dept Oncol, Karmanos Canc Inst, Detroit, MI USA; [Seeber, Andreas] Innsbruck Med Univ, Dept Hematol & Oncol, Innsbruck, Austria; [Hwang, Jimmy J.] Carolinas HealthCare Syst, Levine Canc Inst, Charlotte, NC USA; [Marshall, John L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Ruesch Ctr Cure Gastrointestinal Canc, Washington, DC 20007 USA; [Astsaturov, Igor] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Craig Lockhart, A.] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA	Peking University; University of Southern California; University of Southern California; University of Southern California; West Virginia University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Medical University of Innsbruck; Carolinas HealthCare System; Georgetown University; Fox Chase Cancer Center; University of Miami	Lenz, HJ (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Div Med Oncol, Los Angeles, CA 90007 USA.	Lenz@usc.edu	Battaglin, Francesca/C-2746-2017	Battaglin, Francesca/0000-0002-9869-0163; Arai, Hiroyuki/0000-0002-1886-7070	National Cancer Institute [P30CA 014089]; Gloria Borges WunderGlo Foundation; Dhont Family Foundation; Victoria and Philip Wilson Research Fund; San Pedro Peninsula Cancer Guild; V Foundation for Cancer Research; Eddie Money Research Fund	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gloria Borges WunderGlo Foundation; Dhont Family Foundation; Victoria and Philip Wilson Research Fund; San Pedro Peninsula Cancer Guild; V Foundation for Cancer Research; Eddie Money Research Fund	This work was supported by the National Cancer Institute [P30CA 014089 to H-JL], Gloria Borges WunderGlo Foundation, Dhont Family Foundation, Victoria and Philip Wilson Research Fund, San Pedro Peninsula Cancer Guild, the V Foundation for Cancer Research, Eddie Money Research Fund.	Alam H, 2020, CANCER CELL, V37, P599, DOI 10.1016/j.ccell.2020.03.005; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2017, LANCET ONCOL, V18, P1637, DOI 10.1016/S1470-2045(17)30682-4; BECHT E, 2016, GENOME BIOL, V17; Chen H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01113; Chen KX, 2015, P NATL ACAD SCI USA, V112, P1107, DOI 10.1073/pnas.1422640112; Cho SJ, 2018, CLIN CANCER RES, V24, P6556, DOI 10.1158/1078-0432.CCR-17-1679; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Fagan RJ, 2019, CANCER LETT, V458, P56, DOI 10.1016/j.canlet.2019.05.024; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Ge S, 2017, AM J CANCER RES, V7, P1540; Italiano A, 2018, LANCET ONCOL, V19, P649, DOI 10.1016/S1470-2045(18)30145-1; Je EM, 2013, NEOPLASMA, V60, P188, DOI 10.4149/neo_2013_025; Jia QZ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127901; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kantidakis T, 2016, GENE DEV, V30, P408, DOI 10.1101/gad.275453.115; Kelly TK, 2010, NAT BIOTECHNOL, V28, P1069, DOI 10.1038/nbt.1678; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lake J, 2018, PEDIATR BLOOD CANCER, V65; Li XC, 2018, JAMA ONCOL, V4, P1691, DOI 10.1001/jamaoncol.2018.2805; Lv SD, 2019, EPIGENETICS-US, DOI 10.1080/15592294.2019.1634985; Marabelle A, 2020, LANCET ONCOL, V21, P1353, DOI 10.1016/S1470-2045(20)30445-9; Mardis ER, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0684-0; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Mitani S, 2020, CANCERS, V12, DOI 10.3390/cancers12020400; Okamura R, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000438; Park Y, 2019, CLIN CANCER RES, V25, P5584, DOI 10.1158/1078-0432.CCR-18-4222; Rampias T, 2019, EMBO REP, V20, DOI 10.15252/embr.201846821; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Salem ME, 2018, ONCOLOGIST, V23, P1319, DOI 10.1634/theoncologist.2018-0143; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Tokunaga R, 2019, CLIN CANCER RES, V25, P3096, DOI 10.1158/1078-0432.CCR-18-3388; Wang F, 2019, ANN ONCOL, V30, P1479, DOI 10.1093/annonc/mdz197; Wang GC, 2020, CANCER DISCOV, V10, P1912, DOI 10.1158/2159-8290.CD-19-1448; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang L, 2018, NAT MED, V24, P758, DOI 10.1038/s41591-018-0034-6; Yang L, 2018, ONCOL REP, V40, P479, DOI 10.3892/or.2018.6445; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246	38	7	7	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4894	4905		10.1038/s41388-021-01840-3	http://dx.doi.org/10.1038/s41388-021-01840-3		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163031				2022-12-26	WOS:000664853000004
J	Ikawa, T; Tabuchi, T; Konishi, K; Morimoto, M; Hirata, T; Kanayama, N; Wada, K; Toratani, M; Okawa, S; Ogawa, K; Teshima, T				Ikawa, Toshiki; Tabuchi, Takahiro; Konishi, Koji; Morimoto, Masahiro; Hirata, Takero; Kanayama, Naoyuki; Wada, Kentaro; Toratani, Masayasu; Okawa, Sumiyo; Ogawa, Kazuhiko; Teshima, Teruki			Prolonged overall treatment time negatively affects the outcomes of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: A propensity score-weighted, single-center analysis	PLOS ONE			English	Article							RADIATION-THERAPY; ABLATIVE RADIOTHERAPY; RECURRENCE; SURVIVAL; HYPOXIA; TRIAL	Previous studies have reported conflicting results for the effect of overall treatment time with stereotactic body radiotherapy on tumor control in early-stage non-small-cell lung cancer. To examine this effect, we conducted a propensity score-weighted, retrospective, observational study at a single institution. We analyzed the data of 200 patients with early-stage non-small-cell lung cancer who underwent stereotactic body radiotherapy (48 Gy in 4 fractions) at our institution between January 2007 and October 2013. Patients were grouped into consecutive (overall treatment time = 4-5 days, n = 116) or non-consecutive treatment groups (overall treatment time = 6-10 days, n = 84). The outcomes of interest were local control and overall survival. The Cox regression model was used with propensity score and inverse probability of treatment weighting. The median overall treatment times in the consecutive and non-consecutive groups were 4 and 6 days, respectively. The 5-year local control and overall survival rates in the consecutive vs. the non-consecutive group were 86.3 vs. 77.2% and 55.5 vs. 51.8%, respectively. After propensity score weighting, consecutive stereotactic body radiotherapy was associated with positive local control (adjusted hazard ratio 0.30, 95% confidence interval 0.14-0.65; p = 0.002) and overall survival (adjusted hazard ratio 0.56, 95% confidence interval 0.34-0.91; p = 0.019) benefits. The prolonged overall treatment time of stereotactic body radiotherapy treatment negatively affected the outcomes of patients with early-stage non-small-cell lung cancer. To our knowledge, this is the first study to show that in patients with early-stage non-small-cell lung cancer treated with the same dose-fractionation regimen, consecutive stereotactic body radiotherapy has a more beneficial effect on tumor control than non-consecutive stereotactic body radiotherapy.	[Ikawa, Toshiki; Konishi, Koji; Morimoto, Masahiro; Hirata, Takero; Kanayama, Naoyuki; Wada, Kentaro; Toratani, Masayasu; Teshima, Teruki] Osaka Int Canc Inst, Dept Radiat Oncol, Osaka, Japan; [Tabuchi, Takahiro; Okawa, Sumiyo] Osaka Int Canc Inst, Canc Control Ctr, Osaka, Japan; [Hirata, Takero; Ogawa, Kazuhiko] Osaka Univ, Dept Radiat Oncol, Grad Sch Med, Osaka, Japan	Osaka University	Ikawa, T (corresponding author), Osaka Int Canc Inst, Dept Radiat Oncol, Osaka, Japan.	t_ikawa@radonc.med.osaka-u.ac.jp		Kanayama, Naoyuki/0000-0003-0016-2213; IKAWA, TOSHIKI/0000-0001-9097-0227; Tabuchi, Takahiro/0000-0002-1050-3125; Okawa, Sumiyo/0000-0002-2197-7078				Alite F, 2016, RADIOTHER ONCOL, V121, P9, DOI 10.1016/j.radonc.2016.07.026; Boily G, 2015, J THORAC ONCOL, V10, P872, DOI 10.1097/JTO.0000000000000524; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; FOWLER JF, 1989, BRIT J RADIOL, V62, P679, DOI 10.1259/0007-1285-62-740-679; Grills IS, 2012, J THORAC ONCOL, V7, P1382, DOI 10.1097/JTO.0b013e318260e00d; Guckenberger M, 2017, RADIOTHER ONCOL, V124, P11, DOI 10.1016/j.radonc.2017.05.012; Guckenberger M, 2009, INT J RADIAT ONCOL, V74, P47, DOI 10.1016/j.ijrobp.2008.06.1939; Huang K, 2013, RADIOTHER ONCOL, V109, P51, DOI 10.1016/j.radonc.2013.06.047; Huang K, 2012, RADIOTHER ONCOL, V102, P335, DOI 10.1016/j.radonc.2011.12.018; Kawahara D, 2017, J RADIAT RES, V58, P149, DOI 10.1093/jrr/rrw096; Kestin L, 2014, RADIOTHER ONCOL, V110, P499, DOI 10.1016/j.radonc.2014.02.002; Lo SS, 2010, NAT REV CLIN ONCOL, V7, P44, DOI 10.1038/nrclinonc.2009.188; Nagata Y, 2015, INT J RADIAT ONCOL, V93, P989, DOI 10.1016/j.ijrobp.2015.07.2278; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Samson P, 2018, PRACT RADIAT ONCOL, V8, P404, DOI 10.1016/j.prro.2018.04.004; Simone CB, 2013, CHEST, V143, P1784, DOI 10.1378/chest.12-2580; Song CW, 2021, INT J RADIAT ONCOL, V110, P21, DOI 10.1016/j.ijrobp.2019.02.047; Song CW, 2015, INT J RADIAT ONCOL, V93, P166, DOI 10.1016/j.ijrobp.2015.05.016; Song C, 2016, INT J RADIAT ONCOL, V95, P1022, DOI 10.1016/j.ijrobp.2016.01.064; Stahl JM, 2016, INT J RADIAT ONCOL, V96, P1011, DOI 10.1016/j.ijrobp.2016.08.033; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Videtic GMM, 2017, PRACT RADIAT ONCOL, V7, P295, DOI 10.1016/j.prro.2017.04.014; Zhang X, 2007, COMPUT METH PROG BIO, V88, P95, DOI 10.1016/j.cmpb.2007.07.010	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253203	10.1371/journal.pone.0253203	http://dx.doi.org/10.1371/journal.pone.0253203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143851	gold, Green Published, Green Submitted			2022-12-26	WOS:000671690700075
J	Qin, JM; Zhang, YC; Fridman, M; Sweeny, K; Zhang, LF; Lin, CM; Mao, L				Qin, Jiangmei; Zhang, Yanchun; Fridman, Masha; Sweeny, Kim; Zhang, Lifang; Lin, Chunmei; Mao, Lu			The role of the Basic Public Health Service program in the control of hypertension in China: Results from a cross-sectional health service interview survey	PLOS ONE			English	Article							AWARENESS; POPULATION; PREVALENCE; ADULTS; REFORM	Objectives Non-communicable diseases (NCDs) have become the main cause of mortality in China. In 2009, the Chinese government introduced the Basic Public Health Service (BPHS) program to relieve the rising burden of NCDs through public health measures and delivery of essential medical care. The primary aim of this study was to evaluate the impact of the BPHS program on hypertension control. Methods The China National Health Development Research Center (CNHDRC) undertook a Cross-sectional Health Service Interview Survey (CHSIS) of 62,097 people from primary healthcare reform pilot areas across 17 provinces from eastern, central, and western parts of China in 2014. The current study is based on responses to the CHSIS survey from 7,867 participants, who had been diagnosed with hypertension. Multi-variable mixed logit regression analysis was used to estimate the association between BPHS management and uncontrolled hypertension. In a follow-up analysis, generalized structural equation modelling (GSEM) was used to test for mediation of the BPHS program effect through patient compliance with medication. Findings The estimated proportion of patients with uncontrolled hypertension was 30% lower (23.2% vs 31.5%) in those participants who were adequately managed under the BPHS program. Other predictors of hypertension control included compliance with medication, self-reported wellbeing, income, educational attainment and exercise; smoking was associated with reduced hypertension control. The significant inverse association between uncontrolled hypertension and age indicates poor outcomes for younger patients. Additional testing suggested that nearly 40% of the effect of BPHS management (95% CI: 28.2 to 51.7) could be mediated by improved compliance with medication; there was also an indication that the effect of management was 30% stronger in districts/counties with established digital information management systems (IMS). Conclusion Hypertension control improved markedly following active management through the BPHS program. Some of that improvement could be explained by greater compliance with medication among program participants. This study also identified the need to tailor the BPHS program to the needs of younger patients to achieve higher levels of control in this population. Future investigations should explore ways in which existing healthcare management influences the success of the BPHS program.	[Qin, Jiangmei; Zhang, Yanchun; Zhang, Lifang; Lin, Chunmei] Natl Hlth & Family Planning Commiss, China Natl Hlth Dev Res Ctr, Beijing, Peoples R China; [Fridman, Masha; Sweeny, Kim] Victoria Univ, Victoria Inst Strateg Econ Studies, Melbourne, Vic, Australia; [Mao, Lu] Shi Hezi Univ, Med Coll, Shihezi, Xinjiang, Peoples R China	Victoria University	Zhang, YC (corresponding author), Natl Hlth & Family Planning Commiss, China Natl Hlth Dev Res Ctr, Beijing, Peoples R China.	harbincathy@163.com			National Natural Science Foundation [71303173]; National Health and Family Planning Commission of the People's Republic of China (NHFPC)	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of the People's Republic of China (NHFPC)	The survey data is from the project funded by National Natural Science Foundation (No. 71303173) and the National Health and Family Planning Commission of the People's Republic of China (NHFPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong TD., 2013, S CALIF INT REV 1012 S CALIF INT REV 1012; Bloom G, 1997, SOC SCI MED, V45, P351, DOI 10.1016/S0277-9536(96)00350-4; Centre for Health Statistics of the National Health and Family Planning Commission, 2015, AN REP NAT HLTH SERV AN REP NAT HLTH SERV; Centre for Project Supervision and Management National Health and Family Planning Commission China, 2014, ANN REP ESS PUBL HLT ANN REP ESS PUBL HLT; China National Bureau of Statistics, CHIN STAT OP DAY CHIN STAT OP DAY; China National Health and Family Planning Commission, 2015, CHIN HLTH FAM PLANN, V2015; China National Health Development Research Center Department of Primary Care National Health and Family Planning Commission of China, 2015, MON SURV REP 34 KEY MON SURV REP 34 KEY; Community Health Association of China, 2016, REP PER EV NAT ESS P REP PER EV NAT ESS P; Department of Primary Care National Health and Family Planning Commission of China, 2017, POL EXPL IMPL ESS HL POL EXPL IMPL ESS HL; Feng XL, 2014, B WORLD HEALTH ORGAN, V92, P29, DOI 10.2471/BLT.13.124495; Gooding HC, 2014, J GEN INTERN MED, V29, P1098, DOI 10.1007/s11606-014-2809-x; Guo J, 2015, J HYPERTENS, V33, P1688, DOI 10.1097/HJH.0000000000000594; He J, 2002, ARCH INTERN MED, V162, P1051, DOI 10.1001/archinte.162.9.1051; Hou ZY, 2016, AM J HYPERTENS, V29, P428, DOI 10.1093/ajh/hpv125; International Water Management Institute, 2007, WATER FOOD WATER LIF, P1, DOI 10.1017/CBO9781107415324.004; James MP., 1995, 4916 NBER 4916 NBER; Li YC, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0894-5; Li YC, 2017, INT J CARDIOL, V227, P516, DOI 10.1016/j.ijcard.2016.10.110; Lu JP, 2017, LANCET, V390, P2549, DOI [10.1016/S0140-6736(17)32478-9, 10.1016/s0140-6736(17)32478-9]; Ministry of Health China; Ministry of Finance China; State Administration of Traditional Chinese Medicine China, 2013, NOT IMPL ESS PUBL HL NOT IMPL ESS PUBL HL; Muntner P, 2004, HYPERTENSION, V43, P578, DOI 10.1161/01.HYP.0000116302.08484.14; National Health and Family Planning Commission China, 2013, NAT BAS PUBL HLTH SE NAT BAS PUBL HLTH SE; Nwankwo T., 2013, NCHS DATA BRIEF; Scott GN, MEDSCAPE, V19, P2013; Sinclair JAC, 2009, CHINA BUS REV; The World Bank, 2011, HLTH HARM LIF CHIN S; WHO, 2008, PHARMAFORUM 0121; World Health Organization, 2010, PACK ESS PEN NONCOMM PACK ESS PEN NONCOMM; Xiao NZ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S2; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhu Y, 2007, HABITAT INT, V31, P65, DOI 10.1016/j.habitatint.2006.04.002	32	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0217185	10.1371/journal.pone.0217185	http://dx.doi.org/10.1371/journal.pone.0217185			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143784	Green Accepted, gold, Green Published			2022-12-26	WOS:000671690700062
J	Kumbeni, MT; Apanga, PA; Yeboah, EO; Lettor, IBK				Kumbeni, Maxwell Tii; Apanga, Paschal Awingura; Yeboah, Eugene Osei; Lettor, Isaac Bador Kamal			Knowledge and preventive practices towards COVID-19 among pregnant women seeking antenatal services in Northern Ghana	PLOS ONE			English	Article							EDUCATION	Background COVID-19 is a novel respiratory disease associated with severe morbidity and high mortality in the elderly population and people with comorbidities. Studies have suggested that pregnant women are more susceptible to COVID-19 compared to non-pregnant women. However, it's unclear whether pregnant women in Ghana are knowledgeable about COVID-19 and practice preventive measures against it. This study sought to assess the knowledge and preventive practices towards COVID-19 among pregnant women seeking antenatal services in Northern Ghana. Methods A cross-sectional study was conducted using a structured questionnaire in the Nabdam district in Ghana. A total of 527 pregnant women were randomly sampled from health facilities offering antenatal care services in the district. Multivariable logistic regression analysis was used to assess the association between the predictors and outcome variables. Results The prevalence of adequate knowledge and good COVID-19 preventive practices were 85.6%, (95% CI: 82.57, 88.59) and 46.6%, (95% CI: 42.41, 50.95) respectively. Having at least a primary education, residing in an urban area, and receiving COVID-19 education at a health facility were positively associated with adequate knowledge on COVID-19. Factors positively associated with good COVID-19 preventive practices were older age, having at least a primary education, pregnant women with a chronic disease, and living in an urban area. Multiparity was negatively associated with good COVID-19 preventive practices. Conclusion Although majority of women had adequate knowledge of COVID-19, less than half of them were engaged in good COVID-19 preventive practices. Education of pregnant women on COVID-19 preventive practices should be intensified at health facilities while improving upon the water, sanitation and hygiene need particularly in rural communities.	[Kumbeni, Maxwell Tii] Nabdam Dist Hlth Directorate, Ghana Hlth Serv, Nangodi, Ghana; [Apanga, Paschal Awingura] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Yeboah, Eugene Osei] Bolgatanga East Dist Hlth Directorate, Ghana Hlth Serv, Zuarungu, Ghana; [Lettor, Isaac Bador Kamal] Bawku Tech Inst, Bawku, Upper East Regi, Ghana	Nevada System of Higher Education (NSHE); University of Nevada Reno	Kumbeni, MT (corresponding author), Nabdam Dist Hlth Directorate, Ghana Hlth Serv, Nangodi, Ghana.	tiimax2@gmail.com		Kumbeni, maxwell/0000-0001-5525-4022; yeboah, eugene/0000-0002-7777-5838				Addo LK, 2020, SOC SCI RES NETW, P1; Afulani PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117996; Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; [Anonymous], 2002, Bull World Health Organ, V80, P983; Baloch S, 2020, TOHOKU J EXP MED, V250, P271, DOI 10.1620/tjem.250.271; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Brady KD, 1999, BIOORGAN MED CHEM, V7, P621, DOI 10.1016/S0968-0896(99)00009-7; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Feinstein BL., 2006, WHAT ARE EFFECTS ED, P171; Ghana Statistical Service, 2020, GHAN STAT SERV; Greenaway ES, 2012, J BIOSOC SCI, V44, P733, DOI 10.1017/S0021932012000041; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jia Q, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176161; Karimi-Zarchi M, 2020, FETAL PEDIATR PATHOL, V39, P246, DOI 10.1080/15513815.2020.1747120; Mallapaty Smriti, 2021, Nature, DOI 10.1038/d41586-021-00450-z; Masters PS, 2019, VIROLOGY, V537, P198, DOI 10.1016/j.virol.2019.08.031; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Nwafor JI, 2020, INT J GYNECOL OBSTET, V150, P121, DOI 10.1002/ijgo.13186; Olum R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00181; Qiao J, 2020, LANCET, V395, P760, DOI 10.1016/S0140-6736(20)30365-2; Rasmussen SA, 2020, JAMA-J AM MED ASSOC, V324, P190, DOI 10.1001/jama.2020.8883; Rasmussen SA, 2020, AM J OBSTET GYNECOL, V222, P415, DOI 10.1016/j.ajog.2020.02.017; Sarfo A., 2020, T INDIAN NATL ACAD E, V5, P193, DOI [10.1007/s41403-020-00145-3, DOI 10.1007/S41403-020-00145-3]; Schwartz DA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020194; Serwaa D, 2020, PAN AFR MED J, V35, DOI [10.11604/pamj.supp.2020.35.2.22630, 10.11604/pamj.2020.35.2.22630]; Sokey P. P., 2017, SOC SCI QUART, V6, DOI [10.3390/socsci6020066, DOI 10.3390/SOCSCI6020066]; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Yadav A, 2018, SAUDI J ANAESTH, V12, P287, DOI 10.4103/sja.SJA_474_17; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zeng LK, 2020, JAMA PEDIATR, V174, P722, DOI 10.1001/jamapediatrics.2020.0878; Zhao XY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05010-w; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	36	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253446	10.1371/journal.pone.0253446	http://dx.doi.org/10.1371/journal.pone.0253446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138946	gold, Green Published			2022-12-26	WOS:000671690200044
J	Mohamad, MN; Ismail, LC; Stojanovska, L; Apostolopoulos, V; Feehan, J; Jarrar, AH; Al Dhaheri, AS				Mohamad, Maysm N.; Ismail, Leila Cheikh; Stojanovska, Lily; Apostolopoulos, Vasso; Feehan, Jack; Jarrar, Amjad H.; Al Dhaheri, Ayesha S.			The prevalence of diabetes amongst young Emirati female adults in the United Arab Emirates: A cross-sectional study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; POPULATION; GLUCOSE; OBESITY; RISK; HEMOGLOBIN; OVERWEIGHT; DIAGNOSIS	Aims The prevalence of type 2 diabetes is rapidly increasing in the United Arab Emirates (UAE). The purpose of this study was to investigate the prevalence of prediabetes and diabetes using FPG and HbA1c and to examine their relationships with obesity and other risk factors in young female Emirati college students. Methods In this cross-sectional study we recruited 555 female college students aged 17-25, enrolled at United Arab Emirates University in Al Ain, UAE. Anthropometric analysis, blood pressure, and various biochemical markers were measured using standard methods. Type 2 Diabetes, impaired fasting plasma glucose (FPG), and elevated HbA1c levels were examined in the study population as per the standards of medical care in diabetes, set out by the American Diabetes Association in 2020. Results Based on the HbA1c test, the prevalence of pre-diabetes and diabetes were 24% and 8.6%, respectively. Based on the FPG test, the prevalence of pre-diabetes and diabetes were 9.2% and 0.5%, respectively. The kappa statistic of concordance between HbA1c and FPG was 0.287, P < 0.001. Abnormal glycemic status was significantly associated with decreased high-density lipoprotein (HDL) level (< 50 mg/dl) (p = 0.002) and elevated high-sensitivity C-reactive protein (Hs-CRP) level (>= 2.0 mg/L) (P < 0.001). Conclusions Using FPG to evaluate glycemic control seems to underestimate the burden of undiagnosed diabetes which could have a significant impact on clinical practice. Our data indicates an association between abnormal glycemic status with HDL and Hs-CRP. Further evaluation is needed to assess the impact of using HbA1c as a diagnostic test for diabetes in the UAE.	[Mohamad, Maysm N.; Stojanovska, Lily; Jarrar, Amjad H.; Al Dhaheri, Ayesha S.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates; [Ismail, Leila Cheikh] Univ Sharjah, Coll Hlth Sci, Clin Nutr & Dietet Dept, Sharjah, U Arab Emirates; [Ismail, Leila Cheikh] Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Oxford, England; [Stojanovska, Lily; Apostolopoulos, Vasso; Feehan, Jack] Victoria Univ, Inst Hlth & Sport, Melbourne, Vic, Australia; [Feehan, Jack] Univ Melbourne, Dept Med Western Hlth, Melbourne, Vic, Australia	United Arab Emirates University; University of Sharjah; University of Oxford; Victoria University; University of Melbourne	Al Dhaheri, AS (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Nutr & Hlth, Al Ain, U Arab Emirates.	ayesha_aldhaheri@uaeu.ac.ae		N Mohamad, Maysm/0000-0002-6396-6625; Cheikh Ismail, Leila/0000-0003-3048-7481; Feehan, Jack/0000-0002-9627-1299	United Arab Emirates University [CFA-31F038]	United Arab Emirates University	This research was funded by United Arab Emirates University, grant number CFA-31F038. A. A.D received all funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003558; Ahmad J, 2013, DIABETES METAB SYND, V7, P118, DOI 10.1016/j.dsx.2013.02.004; ALNohair S, 2014, INT J HEALTH SCI-IJH, V8, P79, DOI 10.12816/0006074; Alqahtani N, 2013, INT J PREVENTIVE MED, V4, P1025; Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS14, DOI 10.2337/dc20-S002; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; [Anonymous], 2011, DIABETES RES CLIN PR, V93, P299, DOI 10.1016/j.diabres.2011.03.012; Bergman Michael, 2012, Diabetes Manag (Lond), V2, P309; Doi Y, 2005, DIABETES CARE, V28, P2497, DOI 10.2337/diacare.28.10.2497; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Gohel MG, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-56; Hajat C, 2012, AM J PUBLIC HEALTH, V102, P909, DOI 10.2105/AJPH.2011.300290; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Jeon JY, 2013, DIABETES METAB J, V37, P349, DOI 10.4093/dmj.2013.37.5.349; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kharroubi AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088123; Kim CH, 2011, DIABETES RES CLIN PR, V91, pE8, DOI 10.1016/j.diabres.2010.09.025; Laaksonen DE, 2004, DIABETOLOGIA, V47, P1403, DOI 10.1007/s00125-004-1472-x; Majeed A, 2014, DIABETES RES CLIN PR, V103, P218, DOI 10.1016/j.diabres.2013.11.008; Sanchez-Romero LM, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002158; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nelson TF, 2007, AM J HEALTH BEHAV, V31, P363, DOI 10.5993/AJHB.31.4.3; Organization WH, 2018, NONCOMMUNICABLE DIS; Qi L, 2009, AM J CLIN NUTR, V89, P1453, DOI 10.3945/ajcn.2008.27249; Rhee M, 2020, J CLIN ENDOCR METAB, V105, pE2630, DOI 10.1210/clinem/dgaa185; Rosella LC, 2015, DIABETES CARE, V38, P1299, DOI 10.2337/dc14-2474; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sheikh-Ismail LI, 2009, INT J FOOD SCI NUTR, V60, P26, DOI 10.1080/09637480802331179; Sulaiman N, 2018, BMJ OPEN DIAB RES CA, V6, DOI 10.1136/bmjdrc-2017-000489; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2011, VITAMIN MINERAL NUTR; Wu TJ, 2002, AM J EPIDEMIOL, V155, P65, DOI 10.1093/aje/155.1.65; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252884	10.1371/journal.pone.0252884	http://dx.doi.org/10.1371/journal.pone.0252884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138882	Green Accepted, Green Published, gold			2022-12-26	WOS:000671690200030
J	Nakayama, N; Miyachi, M; Tamakoshi, K; Hayashi, T; Negi, K; Watanabe, K; Hirai, M				Nakayama, Natsuki; Miyachi, Masahiko; Tamakoshi, Koji; Hayashi, Toshio; Negi, Koji; Watanabe, Koji; Hirai, Makoto			Decreased continuous sitting time increases heart rate variability in patients with cardiovascular risk factors	PLOS ONE			English	Article							MUSCLE MASS; SARCOPENIA; WOMEN; DISEASE; INDEX	Aim The purpose of the present study was to elucidate the relationship between high-frequency heart rate variability (HF HRV) and continuous daytime sitting time in patients with cardiovascular risk factors such as mild hypertension and/or stable angina pectoris. Background Decreased HF HRV precedes the progression and worsening of cardiovascular diseases. Continuous sitting behavior is a major risk factor for developing metabolic syndrome and is associated with cardiovascular disease, diabetes mellitus, renal failure, sarcopenia and osteoporosis. Risk factors for cardiovascular disease can be affected by continuous daytime sitting behaviors. Design The present study design was a post-hoc comparison. Methods Patients treated at two different primary care clinics from 2014 to 2018 were enrolled in this study (n = 53). We assessed HF HRV and continuous sitting time using 24-hour Holter electrocardiography and an activity meter at baseline and 6 months. HF HRV was calculated during sleep. Results Sitting time had decreased in 22 patients (decreased group) and increased in 31 patients (increased group) after 6 months. The mean patient ages were 73.1 and 72.0 years in the decreased and increased sitting time groups, respectively (p = 0.503). HF HRV during sleep had increased after 6 months in the decreased sitting time group. Compared with the increased group, the decreased group showed significantly higher HF HRV during sleep after 6 months by two-way repeated-measures ANOVA after adjustment for age, sex and change in activity (p = 0.045). Conclusion These results suggest that a decrease in sitting time might induce parasympathetic activity during sleep. Therefore, reducing continuous sitting time during the day might contribute, in part, to improving the prognosis of patients with cardiovascular risk factors not only by avoiding muscle loss but also by providing positive influences on parasympathetic tone during sleep.	[Nakayama, Natsuki; Tamakoshi, Koji; Hayashi, Toshio; Hirai, Makoto] Nagoya Univ, Grad Sch Med, Higashi Ku, Nagoya, Aichi, Japan; [Miyachi, Masahiko] Chutoen Gen Med Ctr, Kakegawa, Shizuoka, Japan; [Negi, Koji] Negi Clin, Inazawa, Aichi, Japan; [Watanabe, Koji] Watanabe Med Clin, Chita, Aichi, Japan; [Hirai, Makoto] Sugiyama Jogakuen Univ, Chikusa Ku, Nagoya, Aichi, Japan	Nagoya University	Nakayama, N (corresponding author), Nagoya Univ, Grad Sch Med, Higashi Ku, Nagoya, Aichi, Japan.	nakayama@met.nagoya-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [23792624]	Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the grants-in-aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan (Grants-in-aid for Nakayama, #23792624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe K, 2020, GERIATR GERONTOL INT, V20, P388, DOI 10.1111/ggi.13876; Albentosa Marina, 1994, Aquaculture, V126, P315; Araujo CG, 2019, ARQ BRAS CARDIOL, V112, P747, DOI 10.5935/abc.20190097; Caruso Maria Vittoria, 2017, Acta Bioeng Biomech, V19, P42; Daneshmandi Hadi, 2017, J Lifestyle Med, V7, P69, DOI 10.15280/jlm.2017.7.2.69; de Freitas VP, 2018, ARCH GERONTOL GERIAT, V76, P120, DOI 10.1016/j.archger.2018.01.006; Fleg JL, 2013, CIRCULATION, V128, P2422, DOI 10.1161/01.cir.0000436752.99896.22; Frobert O, 2020, J INTERN MED, V287, P263, DOI 10.1111/joim.12983; Gianoudis J, 2015, OSTEOPOROSIS INT, V26, P571, DOI 10.1007/s00198-014-2895-y; Hallman DM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040650; Hallman DM, 2015, INT J ENV RES PUB HE, V12, P14811, DOI 10.3390/ijerph121114811; Hillebrand S, 2013, EUROPACE, V15, P742, DOI 10.1093/europace/eus341; Khanji MY, 2018, INT J CARDIOL, V263, P142, DOI 10.1016/j.ijcard.2018.02.094; Kim G, 2020, ENDOCRINOL METAB, V35, P1, DOI 10.3803/EnM.2020.35.1.1; Masroor S, 2018, INDIAN HEART J, V70, pS28, DOI 10.1016/j.ihj.2018.03.005; Nakayama N, 2020, WESTERN J NURS RES, V42, P431, DOI 10.1177/0193945919864700; Nakayama N, 2019, WESTERN J NURS RES, V41, P1241, DOI 10.1177/0193945918824603; Nakayama N, 2014, J CLIN NURS, V23, P367, DOI 10.1111/jocn.12120; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; da Fonseca GWP, 2019, ARQ BRAS CARDIOL, V112, P739, DOI 10.5935/abc.20190061; Petermann-Rocha F, 2020, MATURITAS, V133, P60, DOI 10.1016/j.maturitas.2020.01.004; Pinheiro AD, 2015, CURR MED RES OPIN, V31, P1849, DOI 10.1185/03007995.2015.1074065; Qi QB, 2012, CIRCULATION, V126, P1821, DOI 10.1161/CIRCULATIONAHA.112.098061; Reid N, 2018, OSTEOPOROSIS INT, V29, P1341, DOI 10.1007/s00198-018-4428-6; Reid N, 2018, J AGING PHYS ACTIV, V26, P445, DOI 10.1123/japa.2017-0204; Rippe JM, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0444-y; Sasaki K, 2020, J CARDIOL, V76, P266, DOI 10.1016/j.jjcc.2020.03.004; Sharman JE, 2015, AM J HYPERTENS, V28, P147, DOI 10.1093/ajh/hpu191; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Tibana RA, 2017, J NUTR HEALTH AGING, V21, P241, DOI 10.1007/s12603-016-0748-4; Garcia LMT, 2014, J PHYS ACT HEALTH, V11, P1622, DOI 10.1123/jpah.2012-0423; Tuena C, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.00093; Nguyen TV, 2020, AUSTRALAS J AGEING, V39, pE315, DOI 10.1111/ajag.12789; Yen CH, 2017, J GERIATR PHYS THER, V40, P167, DOI 10.1519/JPT.0000000000000092; Zhao JX, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00171	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253399	10.1371/journal.pone.0253399	http://dx.doi.org/10.1371/journal.pone.0253399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG8YE	34133465	Green Published, gold			2022-12-26	WOS:000671682700007
J	Wu, H; Xu, M; Peng, ZY; Chen, XP				Wu, Hao; Xu, Min; Peng, Zhuoyue; Chen, Xiaoping			Temporal variations in reference evapotranspiration in the Tarim River basin, Central Asia	PLOS ONE			English	Article							POTENTIAL EVAPOTRANSPIRATION; PAN EVAPORATION; CLIMATE-CHANGE; DRIVING FACTORS; TRENDS; CHINA; SENSITIVITY; VARIABLES; RUNOFF	Reference evapotranspiration (ET0) is important for agricultural production and the hydrological cycle. Knowledge of ET0 can aid the appropriate allocation of irrigation water in arid regions. This study analyzed the trends in ET0 over different timescales in the Tarim River basin (TRB), Central Asia. ET0 was calculated by the Penman-Monteith method using data from 1960-2017 from 30 meteorological stations located in the TRB. The Mann-Kendall (MK) test with trend-free prewhitening and Sen's slope estimator were applied to detect trends in ET0 variation. The results showed that the mean ET0 decreased at a rate of 0.49 mm center dot 10 a(-1) on an annual timescale. The mean ET0 exhibited a decreasing trend in summer and increasing trends in other seasons. The effects of climatic factors on ET0 were assessed by sensitivity analysis and contribution rate analysis. Maximum temperature (T-max), relative humidity (RH) and wind speed (WS) showed important effects on ET0. However, WS, which decreased, was the key element that induced changes in ET0 in the TRB. This work provides an important baseline for the management of agricultural water resources and scientific planning in agriculture.	[Wu, Hao; Peng, Zhuoyue; Chen, Xiaoping] Yangzhou Univ, Coll Hydraul Sci & Engn, Yangzhou, Jiangsu, Peoples R China; [Xu, Min] Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Peoples R China	Yangzhou University; Chinese Academy of Sciences	Xu, M (corresponding author), Chinese Acad Sci, Northwest Inst Ecoenvironm & Resources, State Key Lab Cryospher Sci, Lanzhou, Peoples R China.	xumin@lzb.ac.cn			National Natural Science Foundation of China [41501073, 41721091, 52009118]; International Science and Technology Cooperation Programme [131B62KYSB20190042]; State Key Laboratory of Cryospheric Science [SKLCS-ZZ-2021]; Strategic Priority Research Program of Chinese Academy of Sciences [XDA20100305]; Youth Innovation Promotion Association CAS [2019414]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Programme; State Key Laboratory of Cryospheric Science; Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association CAS	This study was supported by the National Natural Science Foundation of China (Grant No. 41501073, 41721091, 52009118), the International Science and Technology Cooperation Programme (131B62KYSB20190042), the project of State Key Laboratory of Cryospheric Science (Grant No. SKLCS-ZZ-2021), the Strategic Priority Research Program of Chinese Academy of Sciences (Grant No. XDA20100305) and Youth Innovation Promotion Association CAS (Grant No. 2019414).	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Byakatonda J, 2018, ATMOS RES, V213, P492, DOI 10.1016/j.atmosres.2018.07.002; [陈亚宁 Chen Yaning], 2019, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V34, P1156; [陈亚宁 CHEN Yaning], 2006, [干旱区研究, Arid Zone Research], V23, P521; Cruz-Blanco M, 2014, AGR WATER MANAGE, V131, P135, DOI 10.1016/j.agwat.2013.09.017; Dinpashoh Y, 2011, J HYDROL, V399, P422, DOI 10.1016/j.jhydrol.2011.01.021; Donohue RJ, 2010, J HYDROL, V386, P186, DOI 10.1016/j.jhydrol.2010.03.020; Duethmann D, 2018, HYDROL EARTH SYST SC, V22, P5143, DOI 10.5194/hess-22-5143-2018; Feng S, 2014, GLOBAL PLANET CHANGE, V112, P41, DOI 10.1016/j.gloplacha.2013.11.002; Gao X, 2010, SCI CHINA EARTH SCI, V53, P880, DOI 10.1007/s11430-010-0073-4; Gao ZD, 2017, AGR FOREST METEOROL, V232, P106, DOI 10.1016/j.agrformet.2016.08.006; Goyal RK, 2004, AGR WATER MANAGE, V69, P1, DOI 10.1016/j.agwat.2004.03.014; Irmak S, 2012, J HYDROL, V420, P228, DOI 10.1016/j.jhydrol.2011.12.006; Jhajharia D, 2015, METEOROL APPL, V22, P425, DOI 10.1002/met.1471; Jhajharia D, 2012, HYDROL PROCESS, V26, P421, DOI 10.1002/hyp.8140; Jiang Y, 2010, THEOR APPL CLIMATOL, V99, P421, DOI 10.1007/s00704-009-0152-7; Lenhart T, 2002, PHYS CHEM EARTH, V27, P645, DOI 10.1016/S1474-7065(02)00049-9; Li B, 2015, QUATERN INT, V380, P83, DOI 10.1016/j.quaint.2014.12.052; Li C, 2017, SCI TOTAL ENVIRON, V589, P165, DOI 10.1016/j.scitotenv.2017.02.122; Liu TG, 2016, THEOR APPL CLIMATOL, V125, P499, DOI 10.1007/s00704-015-1526-7; Liu ZY, 2019, THEOR APPL CLIMATOL, V138, P433, DOI 10.1007/s00704-019-02824-w; [马忠 Ma Zhong], 2018, [地球科学进展, Advance in Earth Sciences], V33, P833; McCuen R.H., 1974, WATER RESOUR B, V10, P486, DOI [DOI 10.1111/J.1752-1688.1974.TB00590.X, 10.1111/j.1752-1688.1974.tb00590.x]; Menzel L, 2002, J HYDROL, V267, P53, DOI 10.1016/S0022-1694(02)00139-7; Nelli NR, 2020, ATMOS RES, V234, DOI 10.1016/j.atmosres.2019.104745; Pandey BK, 2018, GLOBAL PLANET CHANGE, V161, P172, DOI 10.1016/j.gloplacha.2017.12.017; Rayner DP, 2007, J CLIMATE, V20, P3379, DOI 10.1175/JCLI4181.1; Roderick ML, 2002, SCIENCE, V298, P1410; Tao H, 2011, J HYDROL, V400, P1, DOI 10.1016/j.jhydrol.2011.01.016; Tao XE, 2015, WATER SCI ENG, V8, P273, DOI 10.1016/j.wse.2015.11.002; Thomas A, 2000, INT J CLIMATOL, V20, P381, DOI 10.1002/(SICI)1097-0088(20000330)20:4&lt;381::AID-JOC477&gt;3.0.CO;2-K; Wang YF, 2020, AGR WATER MANAGE, V236, DOI 10.1016/j.agwat.2020.106164; Wang ZL, 2017, J HYDROL, V544, P97, DOI 10.1016/j.jhydrol.2016.11.021; Wang ZZ, 2019, AGR WATER MANAGE, V213, P1096, DOI 10.1016/j.agwat.2018.12.006; Widmoser P, 2018, AGR FOREST METEOROL, V263, P287, DOI 10.1016/j.agrformet.2018.09.003; Xu CY, 2006, J HYDROL, V327, P81, DOI 10.1016/j.jhydrol.2005.11.029; Xu M, 2019, QUATERN INT, V523, P25, DOI 10.1016/j.quaint.2019.06.011; Xu M, 2018, ATMOS RES, V203, P141, DOI 10.1016/j.atmosres.2017.12.007; Yee MS, 2015, AGR FOREST METEOROL, V213, P226, DOI 10.1016/j.agrformet.2015.07.004; Yin YH, 2010, THEOR APPL CLIMATOL, V101, P19, DOI 10.1007/s00704-009-0197-7; Yue S, 2002, HYDROL PROCESS, V16, P1807, DOI 10.1002/hyp.1095; [张爱英 ZHANG Ai-ying], 2009, [高原气象, Plateau Meteorology], V28, P680; Zhang KX, 2015, QUATERN INT, V380, P75, DOI 10.1016/j.quaint.2014.12.037; Zhang QA, 2011, THEOR APPL CLIMATOL, V103, P479, DOI 10.1007/s00704-010-0315-6; Zheng JL, 2018, THEOR APPL CLIMATOL, V133, P1303, DOI 10.1007/s00704-017-2346-8	45	1	1	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252840	10.1371/journal.pone.0252840	http://dx.doi.org/10.1371/journal.pone.0252840			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133432	Green Published, gold			2022-12-26	WOS:000671682700035
J	Kim, SH; Wu, CG; Jia, WY; Xing, YN; Tibbetts, RS				Kim, Sang Hwa; Wu, Cheng-Guo; Jia, Weiyan; Xing, Yongna; Tibbetts, Randal S.			Roles of constitutive and signal-dependent protein phosphatase 2A docking motifs in burst attenuation of the cyclic AMP response element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; CREB PHOSPHORYLATION; CAMP; KINASE; CBP; COACTIVATION; RECOGNITION; ACTIVATION; MECHANISM; COMPLEX	The cAMP response element-binding protein (CREB) is an important regulator of cell growth, metabolism, and synaptic plasticity. CREB is activated through phosphorylation of an evolutionarily conserved Ser residue (S133) within its intrinsically disordered kinase-inducible domain (KID). Phosphorylation of S133 in response to cAMP, Ca2+, and other stimuli triggers an association of the KID with the KID-interacting (KIX) domain of the CREB-binding protein (CBP), a histone acetyl transferase (HAT) that promotes transcriptional activation. Here we addressed the mechanisms of CREB attenuation following bursts in CREB phosphorylation. We show that phosphorylation of S133 is reversed by protein phosphatase 2A (PP2A), which is recruited to CREB through its B56 regulatory subunits. We found that a B56-binding site located at the carboxyl-terminal boundary of the KID (BS2) mediates highaffinity B56 binding, while a second binding site (BS1) located near the amino terminus of the KID mediates low affinity binding enhanced by phosphorylation of adjacent casein kinase (CK) phosphosites. Mutations that diminished B56 binding to BS2 elevated both basal and stimulus-induced phosphorylation of S133, increased CBP interaction with CREB, and potentiated the expression of CREB-dependent reporter genes. Cells from mice harboring a homozygous CrebE153D mutation that disrupts BS2 exhibited increased S133 phosphorylation stoichiometry and elevated transcriptional bursts to cAMP. These findings provide insights into substrate targeting by PP2A holoenzymes and establish a new mechanism of CREB attenuation that has implications for understanding CREB signaling in cell growth, metabolism, synaptic plasticity, and other physiologic contexts.	[Kim, Sang Hwa; Jia, Weiyan; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53726 USA; [Wu, Cheng-Guo; Xing, Yongna] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53726 USA.	rstibbetts@wisc.edu	Jia, Weiyan/AFQ-4316-2022; JIA, WEIYAN/ABG-6750-2021	JIA, WEIYAN/0000-0003-0899-0697	National Cancer Institute [CA180765-01]; National Institute for Neurological Disorders and Stroke [NS118792-01]; National Institute for General Medicine [R01 GM096060-01]; Jordan's Guardian Angels Foundation [A19-33765007]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for General Medicine; Jordan's Guardian Angels Foundation	This work was supported by the National Cancer Institute [CA180765-01 to R. S. T.], National Institute for Neurological Disorders and Stroke [NS118792-01 to R. S. T.], National Institute for General Medicine [R01 GM096060-01 to Y. X.], and Jordan's Guardian Angels Foundation [A19-33765007 to Y. X.].	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hertz EPT, 2016, MOL CELL, V63, P686, DOI 10.1016/j.molcel.2016.06.024; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kim SH, 2016, NUCLEIC ACIDS RES, V44, P9667, DOI 10.1093/nar/gkw643; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shnitkind S, 2018, BIOCHEMISTRY-US, V57, P6964, DOI 10.1021/acs.biochem.8b01092; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wang J, 2016, PROTEIN CELL, V7, P516, DOI 10.1007/s13238-016-0283-4; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wang XR, 2020, ELIFE, V9, DOI 10.7554/eLife.55966; Wang XR, 2016, STRUCTURE, V24, P2174, DOI 10.1016/j.str.2016.09.010; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Wu CG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.27; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	44	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100908	10.1016/j.jbc.2021.100908	http://dx.doi.org/10.1016/j.jbc.2021.100908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34171357	Green Published, gold			2022-12-26	WOS:000678068400095
J	Vinette, V; Aubry, I; Insull, H; Uetani, N; Hardy, S; Tremblay, ML				Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.			Protein tyrosine phosphatome metabolic screen identifies TC-PTP as a positive regulator of cancer cell bioenergetics and mitochondrial dynamics	FASEB JOURNAL			English	Article						cancer; metabolism; mitochondria; protein tyrosine phosphatases; PTPN2; TC-PTP	OXIDATIVE-PHOSPHORYLATION; INCREASED EXPRESSION; NEGATIVE REGULATOR; UP-REGULATION; STAT3; KINASE; PTEN; SRC; INITIATION; SURVIVAL	Metabolic reprogramming occurs in cancer cells and is regulated partly by the opposing actions of tyrosine kinases and tyrosine phosphatases. Several members of the protein tyrosine phosphatase (PTP) superfamily have been linked to cancer as either pro-oncogenic or tumor-suppressive enzymes. In order to investigate which PTPs can modulate the metabolic state of cancer cells, we performed an shRNA screen of PTPs in HCT116 human colorectal cancer cells. Among the 72 PTPs efficiently targeted, 24 were found to regulate mitochondrial respiration, 8 as negative and 16 as positive regulators. Of the latter, we selected TC-PTP (PTPN2) for further characterization since inhibition of this PTP resulted in major functional defects in oxidative metabolism without affecting glycolytic flux. Transmission electron microscopy revealed an increase in the number of damaged mitochondria in TC-PTP-null cells, demonstrating the potential role of this PTP in regulating mitochondrial homeostasis. Downregulation of STAT3 by siRNA-mediated silencing partially rescued the mitochondrial respiration defect observed in TC-PTP-deficient cells, supporting the role of this signaling axis in regulating mitochondrial activity. In addition, mitochondrial stress prevented an increased expression of electron transport chain-related genes in cells with TC-PTP silencing, correlating with decreased ATP production, cellular proliferation, and migration. Our shRNA-based metabolic screen revealed that PTPs can serve as either positive or negative regulators of cancer cell metabolism. Taken together, our findings uncover a new role for TC-PTP as an activator of mitochondrial metabolism, validating this PTP as a key target for cancer therapeutics.	[Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Vinette, Valerie; Aubry, Isabelle; Insull, Hayley; Uetani, Noriko; Hardy, Serge; Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Vinette, Valerie] Weill Cornell Med, 413 E 69th St, New York, NY 10044 USA	McGill University; McGill University; Cornell University	Tremblay, ML (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	michel.tremblay@mcgill.ca		Tremblay, Michel L./0000-0002-0281-541X	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation [TFF-116128]; Government of Canada | Canadian Institutes of Health Research (CIHR) [FDN-159923]	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation; Government of Canada | Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Faculty of Medicine, McGill University (McGill Faculty of Medicine); Fondation Jean-Louis Levesque (Fondation J Louis Levesque); Terry Fox Foundation, Grant/Award Number: TFF-116128; Government of Canada | Canadian Institutes of Health Research (CIHR), Grant/Award Number: FDN-159923	Alonso A, 2016, METHODS MOL BIOL, V1447, P1, DOI 10.1007/978-1-4939-3746-2_1; Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Billia F, 2011, P NATL ACAD SCI USA, V108, P9572, DOI 10.1073/pnas.1106291108; Bourke Lauren T, 2013, JAKSTAT, V2, pe25666, DOI 10.4161/jkst.25666; Boyle KA, 2018, J BIOL CHEM, V293, P14891, DOI 10.1074/jbc.RA117.001469; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; Cardone L, 2004, MOL CELL BIOL, V24, P4613, DOI 10.1128/MCB.24.11.4613-4626.2004; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Daw CC, 2020, CELL, V183, P474, DOI 10.1016/j.cell.2020.08.049; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Deng JW, 2018, P NATL ACAD SCI USA, V115, pE9678, DOI 10.1073/pnas.1806655115; Denisenko TV, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00355; Fetalvero KM, 2013, MOL CELL BIOL, V33, P98, DOI 10.1128/MCB.01075-12; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang L, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1186-z; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Katkeviciute E, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140281; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Lim S, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0089-3; Liu WC, 2011, P NATL ACAD SCI USA, V108, P12920, DOI 10.1073/pnas.1107332108; Lu HQ, 2018, CANCER RES, V78, P4191, DOI 10.1158/0008-5472.CAN-18-0270; Lu XQ, 2007, MOL CELL BIOL, V27, P2166, DOI 10.1128/MCB.01234-06; Macias E, 2014, J INVEST DERMATOL, V134, P1971, DOI 10.1038/jid.2014.68; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Meier JA, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2588; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Moreno-Beltran B, 2017, P NATL ACAD SCI USA, V114, pE3041, DOI 10.1073/pnas.1618008114; Nemani N, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz6206; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Patra M, 2016, J CELL SCI, V129, P2841, DOI 10.1242/jcs.186247; Penafuerte C, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1321185; Persson C, 2004, MOL CELL BIOL, V24, P2190, DOI 10.1128/MCB.24.5.2190-2201.2004; Poliakova M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0798-9; Robert F, 2014, P NATL ACAD SCI USA, V111, P13421, DOI 10.1073/pnas.1402650111; Rodriguez-Hernandez MA, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101510; Rosini P, 2004, J BIOL CHEM, V279, P14016, DOI 10.1074/jbc.M305356200; Russell S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15325-5; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Scharl M, 2012, INFLAMM BOWEL DIS, V18, P1287, DOI 10.1002/ibd.21891; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Simoncic PD, 2006, MOL CELL BIOL, V26, P4149, DOI 10.1128/MCB.01932-05; Simoncic PD, 2002, CURR BIOL, V12, P446, DOI 10.1016/S0960-9822(02)00697-8; Sisler JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144444; Tammineni P, 2013, J BIOL CHEM, V288, P4723, DOI 10.1074/jbc.M112.378984; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tronchere H, 2012, CLIN LIPIDOL, V7, P151, DOI 10.2217/CLP.12.7; Tsou RC, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00192; Untereiner AA, 2017, BIOCHEM PHARMACOL, V136, P86, DOI 10.1016/j.bcp.2017.03.025; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Voet D., 2004, BIOCHEMISTRY-US, V3; Wallace L, 2016, TUMOR BIOL, V37, P12465, DOI 10.1007/s13277-016-5101-3; Wang HL, 2011, BBA-MOL BASIS DIS, V1812, P674, DOI 10.1016/j.bbadis.2011.03.007; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wei YJ, 2020, CANCER MANAG RES, V12, P2097, DOI 10.2147/CMAR.S240040; Yamamoto T, 2002, BIOCHEM BIOPH RES CO, V297, P811, DOI 10.1016/S0006-291X(02)02291-X; Zaytseva YY, 2015, ONCOTARGET, V6, P18891, DOI 10.18632/oncotarget.3783; Zheng BA, 2014, SCI WORLD J, DOI 10.1155/2014/703804; Zhu Y, 2006, APOPTOSIS, V11, P197, DOI 10.1007/s10495-006-3714-5	75	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21708	10.1096/fj.202100207R	http://dx.doi.org/10.1096/fj.202100207R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169549				2022-12-26	WOS:000667814100025
J	Cooper-Mullin, C; Carter, WA; Amato, RS; Podlesak, D; McWilliams, SR				Cooper-Mullin, Clara; Carter, Wales A.; Amato, Ronald S.; Podlesak, David; McWilliams, Scott R.			Dietary vitamin E reaches the mitochondria in the flight muscle of zebra finches but only if they exercise	PLOS ONE			English	Article							FATTY-ACID TRANSPORTERS; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; LIPID-PEROXIDATION; IMMUNE-RESPONSE; ANTIOXIDANT; MIGRATION; BIRDS; DEUTERIUM; NUTRIENTS	Whether dietary antioxidants are effective for alleviating oxidative costs associated with energy-demanding life events first requires they are successfully absorbed in the digestive tract and transported to sites associated with reactive species production (e.g. the mitochondria). Flying birds are under high energy and oxidative demands, and although birds commonly ingest dietary antioxidants in the wild, the bioavailability of these consumed antioxidants is poorly understood. We show for the first time that an ingested lipophilic antioxidant, alpha-tocopherol, reached the mitochondria in the flight muscles of a songbird but only if they regularly exercise (60 min of perch-to-perch flights two times in a day or 8.5 km day(-1)). Deuterated alpha-tocopherol was found in the blood of exercise-trained zebra finches within 6.5 hrs and in isolated mitochondria from pectoral muscle within 22.5 hrs, but never reached the mitochondria in caged sedentary control birds. This rapid pace (within a day) and extent of metabolic routing of a dietary antioxidant to muscle mitochondria means that daily consumption of such dietary sources can help to pay the inevitable oxidative costs of flight muscle metabolism, but only when combined with regular exercise.	[Cooper-Mullin, Clara; Carter, Wales A.; McWilliams, Scott R.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Amato, Ronald S.; Podlesak, David] Los Alamos Natl Lab, Los Alamos, NM USA	University of Rhode Island; United States Department of Energy (DOE); Los Alamos National Laboratory	Cooper-Mullin, C (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA.	cooper-mullin@uri.edu	; McWilliams, Scott/B-8728-2013	Cooper-Mullin, Clara/0000-0001-8218-3944; McWilliams, Scott/0000-0002-9727-1151	National Science Foundation [IOS-0748349]; United States Department of Agriculture [RIAES-538748]	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA))	SRM: This work was supported by the National Science Foundation [IOS-0748349] https://www.nsf.gov/and the United States Department of Agriculture [RIAES-538748] https://www.usda.gov/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ademowo OS, 2017, BIOGERONTOLOGY, V18, P859, DOI 10.1007/s10522-017-9710-z; Alan RR, 2013, WILSON J ORNITHOL, V125, P513, DOI 10.1676/13-014.1; [Anonymous], 2017, BBMLE TOOLS GEN MAXI; Armstrong C, 2011, PHYSIOL BIOCHEM ZOOL, V84, P438, DOI 10.1086/660892; ARNOLD RN, 1993, J ANIM SCI, V71, P105, DOI 10.2527/1993.711105x; Atkinson J, 2010, MOL NUTR FOOD RES, V54, P641, DOI 10.1002/mnfr.200900439; Bauchinger U, 2010, PHYSIOL BIOCHEM ZOOL, V83, P1032, DOI 10.1086/657659; Bessa J, 2015, AM J PRIMATOL, V77, P651, DOI 10.1002/ajp.22388; Blatt DH, 2001, NUTRITION, V17, P799, DOI 10.1016/S0899-9007(01)00637-2; Bolser JA., 2012, WILSON J ORNITHOL, V124; Bruno RS, 2006, AM J CLIN NUTR, V83, P299; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Carter WA, 2019, PHYSIOL BIOCHEM ZOOL, V92, P239, DOI 10.1086/702667; Carter WA, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.168823; Catoni C, 2008, FUNCT ECOL, V22, P649, DOI 10.1111/j.1365-2435.2008.01400.x; Catoni C, 2009, J EVOLUTION BIOL, V22, P1649, DOI 10.1111/j.1420-9101.2009.01778.x; Catoni C, 2011, J ORNITHOL, V152, P153, DOI 10.1007/s10336-010-0560-6; Cooper-Mullin C, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.210443; Cooper-Mullin C, 2016, J EXP BIOL, V219, P3684, DOI 10.1242/jeb.123992; Costantini D, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.194688; Costantini D, 2016, BEHAV ECOL SOCIOBIOL, V70, P809, DOI 10.1007/s00265-016-2091-5; Costantini D, 2014, OECOLOGIA, V175, P1107, DOI 10.1007/s00442-014-2975-x; DeMoranville KJ, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.198028; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Fariss MW, 2001, FREE RADICAL BIO MED, V31, P530, DOI 10.1016/S0891-5849(01)00615-3; Fox J., 2019, R COMPANION APPL REG, V.; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gable TD, 2018, AM MIDL NAT, V179, P15, DOI 10.1674/0003-0031-179.1.15; GAVINO VC, 1981, J LIPID RES, V22, P763; Gerson AR, 2008, J EXP BIOL, V211, P2689, DOI 10.1242/jeb.013714; Gerson AR, 2013, J COMP PHYSIOL B, V183, P983, DOI 10.1007/s00360-013-0767-y; Giordano M, 2015, OECOLOGIA, V177, P123, DOI 10.1007/s00442-014-3100-x; Hacquebard M, 2005, CURR OPIN CLIN NUTR, V8, P133, DOI 10.1097/00075197-200503000-00005; Hall ZJ, 2014, EUR J NEUROSCI, V39, P875, DOI 10.1111/ejn.12456; Halliwell B., 2007, FREE RADICALS BIOL M; Homkes AT, 2020, WILDLIFE SOC B, V44, P221, DOI 10.1002/wsb.1065; Isaksson C, 2013, ECOL EVOL, V3, P2730, DOI 10.1002/ece3.663; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; Jimenez AG, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.211185; Kono N, 2015, TRAFFIC, V16, P19, DOI 10.1111/tra.12231; Krol E, 1999, J EXP BIOL, V202, P2839; Larcombe SD, 2010, COMP BIOCHEM PHYS B, V155, P49, DOI 10.1016/j.cbpb.2009.09.009; Lauridsen C, 1997, MEAT SCI, V46, P9, DOI 10.1016/S0309-1740(97)00010-7; Lauridsen C, 2002, J NUTR, V132, P1258, DOI 10.1093/jn/132.6.1258; Lauridsen C, 2012, GENES NUTR, V7, P475, DOI 10.1007/s12263-012-0286-6; Marri V, 2014, J EXP BIOL, V217, P1478, DOI 10.1242/jeb.096826; Mazur-Kusnirek M, 2019, ARCH ANIM NUTR, V73, P111, DOI 10.1080/1745039X.2019.1572342; McCue MD, 2011, BIOSCIENCE, V61, P217, DOI 10.1525/bio.2011.61.3.7; McFarlan JT, 2009, J EXP BIOL, V212, P2934, DOI 10.1242/jeb.031682; McWilliams SR, 2004, J AVIAN BIOL, V35, P377, DOI 10.1111/j.0908-8857.2004.03378.x; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Niki E, 2019, FOOD CHEM FUNCT ANAL, V11, P1; Nudds RL, 2000, J EXP BIOL, V203, P1561; Nudds RL, 2001, FUNCT ECOL, V15, P458, DOI 10.1046/j.0269-8463.2001.00546.x; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Parrish JD, 1997, CONDOR, V99, P681, DOI 10.2307/1370480; Pierce BJ, 2004, COMP BIOCHEM PHYS A, V138, P503, DOI 10.1016/j.cbpb.2004.06.014; PLACE AR, 1992, AUK, V109, P334, DOI 10.2307/4088202; Podlesak DW, 2007, AUK, V124, P916, DOI 10.1642/0004-8038(2007)124[916:MRODNI]2.0.CO;2; Podsedek A, 2007, LWT-FOOD SCI TECHNOL, V40, P1, DOI 10.1016/j.lwt.2005.07.023; Polyak E, 2018, MOL GENET METAB, V123, P449, DOI 10.1016/j.ymgme.2018.02.013; Preveraud DP, 2015, BRIT POULTRY SCI, V56, P94, DOI 10.1080/00071668.2014.982074; R Core Team, 2020, R LANG ENV STAT COMP; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Roager HM, 2014, GUT MICROBES, V5, P296, DOI 10.4161/gmic.28806; ROKITZKI L, 1994, ACTA PHYSIOL SCAND, V151, P149, DOI 10.1111/j.1748-1716.1994.tb09732.x; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Schaefer HM, 2008, FUNCT ECOL, V22, P303, DOI 10.1111/j.1365-2435.2007.01363.x; Scott GR, 2009, P R SOC B, V276, P3645, DOI 10.1098/rspb.2009.0947; Sebastiano M, 2018, FUNCT ECOL, V32, P2509, DOI 10.1111/1365-2435.13195; Skrip MM, 2016, J EXP BIOL, V219, P2716, DOI 10.1242/jeb.137802; Skrip MM, 2016, J FIELD ORNITHOL, V87, P1, DOI 10.1111/jofo.12135; Speakman JR, 1998, AM J CLIN NUTR, V68, p932S, DOI 10.1093/ajcn/68.4.932S; Surai PF, 2002, BRIT POULTRY SCI, V43, pS64; TAPPEL A. L., 1959, ARCH BIOCHEM AND BIOPHYS, V80, P333, DOI 10.1016/0003-9861(59)90259-0; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Traber MG, 2015, AM J CLIN NUTR, V101, P752, DOI 10.3945/ajcn.114.100966; van Kempen TATG, 2016, J ANIM SCI, V94, P4188, DOI 10.2527/jas.2016-0640; Vander Zanden HB, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00020; Watson TA, 2005, INT J SPORT NUTR EXE, V15, P131, DOI 10.1123/ijsnem.15.2.131; Watson TA, 2005, MED SCI SPORT EXER, V37, P63, DOI 10.1249/01.MSS.0000150016.46508.A1; Weber TP, 1998, EVOL ECOL, V12, P377, DOI 10.1023/A:1006560420310; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Zhang YF, 2021, J EXP BIOL, V224, DOI 10.1242/jeb.221606; Zhang YF, 2015, J COMP PHYSIOL B, V185, P797, DOI 10.1007/s00360-015-0921-9	87	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253264	10.1371/journal.pone.0253264	http://dx.doi.org/10.1371/journal.pone.0253264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181660	Green Submitted, gold, Green Published			2022-12-26	WOS:000671695800032
J	Tawhid, MNA; Siuly, S; Wang, H; Whittaker, F; Wang, K; Zhang, YC				Tawhid, Md Nurul Ahad; Siuly, Siuly; Wang, Hua; Whittaker, Frank; Wang, Kate; Zhang, Yanchun			A spectrogram image based intelligent technique for automatic detection of autism spectrum disorder from EEG	PLOS ONE			English	Article							DIAGNOSIS; METHODOLOGY; FRACTALITY	Autism spectrum disorder (ASD) is a developmental disability characterized by persistent impairments in social interaction, speech and nonverbal communication, and restricted or repetitive behaviors. Currently Electroencephalography (EEG) is the most popular tool to inspect the existence of neurological disorders like autism biomarkers due to its low setup cost, high temporal resolution and wide availability. Generally, EEG recordings produce vast amount of data with dynamic behavior, which are visually analyzed by professional clinician to detect autism. It is laborious, expensive, subjective, error prone and has reliability issue. Therefor this study intends to develop an efficient diagnostic framework based on time-frequency spectrogram images of EEG signals to automatically identify ASD. In the proposed system, primarily, the raw EEG signals are pre-processed using re-referencing, filtering and normalization. Then, Short-Time Fourier Transform is used to transform the pre-processed signals into two-dimensional spectrogram images. Afterward those images are evaluated by machine learning (ML) and deep learning (DL) models, separately. In the ML process, textural features are extracted, and significant features are selected using principal component analysis, and feed them to six different ML classifiers for classification. In the DL process, three different convolutional neural network models are tested. The proposed DL based model achieves higher accuracy (99.15%) compared to the ML based model (95.25%) on an ASD EEG dataset and also outperforms existing methods. The findings of this study suggest that the DL based structure could discover important biomarkers for efficient and automatic diagnosis of ASD from EEG and may assist to develop computer-aided diagnosis system.	[Tawhid, Md Nurul Ahad; Siuly, Siuly; Wang, Hua; Zhang, Yanchun] Victoria Univ, Inst Sustainable Ind & Liveable Cities, Melbourne, Vic, Australia; [Whittaker, Frank] Nexus eCare, Adelaide, SA, Australia; [Wang, Kate] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia	Victoria University; Royal Melbourne Institute of Technology (RMIT)	Tawhid, MNA (corresponding author), Victoria Univ, Inst Sustainable Ind & Liveable Cities, Melbourne, Vic, Australia.	md.tawhid1@live.vu.edu.au	Tawhid, Md. Nurul Ahad/ABC-6290-2021; Wang, Hua/I-5746-2019	Wang, Hua/0000-0002-8465-0996; Wang, Kate/0000-0001-5208-1090; WHITTAKER, FRANK/0000-0002-3728-0291; Siuly, Siuly/0000-0003-2491-0546	Australian Research Council Linkage Project [LP170100934]	Australian Research Council Linkage Project(Australian Research Council)	This study is supported by the Australian Research Council Linkage Project (Project ID: LP170100934). Nexus eCare is the industry partner for this project. The funder or the commercial affiliation does not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdolzadegan D, 2020, BIOCYBERN BIOMED ENG, V40, P482, DOI 10.1016/j.bbe.2020.01.008; Ahmadlou M, 2012, J NEUROSCI METH, V211, P203, DOI 10.1016/j.jneumeth.2012.08.020; Ahmadlou M, 2012, PHYSICA A, V391, P4720, DOI 10.1016/j.physa.2012.04.025; Ahmadlou M, 2010, J CLIN NEUROPHYSIOL, V27, P328, DOI 10.1097/WNP.0b013e3181f40dc8; Alcin OF, 2016, NEUROCOMPUTING, V218, P251, DOI 10.1016/j.neucom.2016.08.050; Alhaddad M.J., 2012, INT J BIOSCI BIOTECH, V4, P45; ALSAGGAF EA, 2014, LIFE SCI J, V11, P305; Alturki FA, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20092505; Alvi AM., 2020, ADAPTIVE IMAGE SMOOT, P866, DOI [10.1142/9789811223334_0104, DOI 10.1142/9789811223334_0104]; Aslan Z, 2020, TRAIT SIGNAL, V37, P235, DOI 10.18280/ts.370209; (Aspect) ASA, AUT PREV EST 40; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; Bosl W, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-18; Bosl WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24318-x; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Deng L, 2013, FOUND TRENDS SIGNAL, V7, pI, DOI 10.1561/2000000039; Dey EK, 2015, COMPUTERS, V4, P265, DOI 10.3390/computers4030265; Djemal R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9816591; Eldridge J, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-12; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; google, WELCOME COLABORATORY; Grossi E, 2017, COMPUT METH PROG BIO, V142, P73, DOI 10.1016/j.cmpb.2017.02.002; Haputhanthri D, 2020, INT J AUTOM COMPUT, V17, P837, DOI 10.1007/s11633-020-1231-6; Haputhanthri D, 2019, 2019 MORATUWA ENGINEERING RESEARCH CONFERENCE (MERCON) / 5TH INTERNATIONAL MULTIDISCIPLINARY ENGINEERING RESEARCH CONFERENCE, P123, DOI 10.1109/MERCon.2019.8818814; Hassan AR, 2016, COMPUT METH PROG BIO, V137, P247, DOI 10.1016/j.cmpb.2016.09.008; He JY, 2020, WORLD WIDE WEB, V23, P2835, DOI 10.1007/s11280-019-00776-9; Heunis T, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1086-7; Jadhav P, 2020, BIOCYBERN BIOMED ENG, V40, P494, DOI 10.1016/j.bbe.2020.01.010; Jayarathna S., 2019, COMPUTATIONAL MODELS, P34, DOI [10.4018/978-1-5225-7467-5.ch002, DOI 10.4018/978-1-5225-7467-5.CH002]; Kamel MI., 2012, INT J IMAGE GRAPHICS, V4, P35, DOI 10.5815/ijigsp.2012.03.06; Li MY, 2020, IEEE ACCESS, V8, P9770, DOI 10.1109/ACCESS.2019.2960848; Nur A.A., 2020, IAES INT J ARTIFICIA, V9, P91, DOI [DOI 10.11591/IJAI.V9.I1.PP91-99, 10.11591/ijai.v9.i1.pp91-99]; Nurul M., 2018, INT J COMPUT APPL, V180, P5, DOI [10.5120/ijca2018915852, DOI 10.5120/IJCA2018915852]; R Core Team, 2021, R LANGUAGE ENV STAT; Rim B, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20040969; Sheikhani A, 2008, CISP 2008: FIRST INTERNATIONAL CONGRESS ON IMAGE AND SIGNAL PROCESSING, VOL 1, PROCEEDINGS, P207, DOI 10.1109/CISP.2008.595; Sheikhani A, 2012, J MED SYST, V36, P957, DOI 10.1007/s10916-010-9560-6; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Siuly, 2016, COMPUT METH PROG BIO, V127, P64, DOI 10.1016/j.cmpb.2016.01.017; Siuly, 2011, COMPUT METH PROG BIO, V104, P358, DOI 10.1016/j.cmpb.2010.11.014; Siuly S., 2016, IEEE T NEURAL SYST R, V11, P141, DOI 10.1007/978-3-319-47653-7; Siuly S, 2019, IET SCI MEAS TECHNOL, V13, P35, DOI 10.1049/iet-smt.2018.5358; Siuly S, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/576437; Speaks A, AUT STAT FACTS; Supriya S, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-020-00129-1; Tawhid MNA, 2020, ELECTRON LETT, V56, DOI 10.1049/el.2020.2646; Wu JX, 2011, IEEE T PATTERN ANAL, V33, P1489, DOI 10.1109/TPAMI.2010.224; Yin J, 2019, INT J AUTOM COMPUT, V16, P786, DOI 10.1007/s11633-019-1197-4; Yuan LH, 2018, SMART INNOV SYST TEC, V72, P13, DOI 10.1007/978-3-319-59421-7_2	50	13	13	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253094	10.1371/journal.pone.0253094	http://dx.doi.org/10.1371/journal.pone.0253094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170979	gold, Green Published, Green Accepted			2022-12-26	WOS:000671694400040
J	Baranauskiene, L; Skiudaite, L; Michailoviene, V; Petrauskas, V; Matulis, D				Baranauskiene, Lina; Skiudaite, Lina; Michailoviene, Vilma; Petrauskas, Vytautas; Matulis, Daumantas			Thiazide and other Cl-benzenesulfonamide-bearing clinical drug affinities for human carbonic anhydrases	PLOS ONE			English	Article							INHIBITORS; CHLORTHALIDONE; DIURETICS; MECHANISMS; INDAPAMIDE; MODEL; VII	Twelve carbonic anhydrase (CA) isoforms catalyze carbon dioxide hydration to bicarbonate and acid protons and are responsible for many biological functions in human body. Despite their vital functions, they are also responsible for, or implicated in, numerous ailments and diseases such as glaucoma, high altitude sickness, and cancer. Because CA isoforms are highly homologous, clinical drugs designed to inhibit enzymatic activity of a particular isoform, can also bind to others with similar affinity causing toxic side effects. In this study, the affinities of twelve CA isoforms have been determined for nineteen clinically used drugs used to treat hypertension related diseases, i.e. thiazides, indapamide, and metolazone. Their affinities were determined using a fluorescent thermal shift assay. Stopped flow assay and isothermal titration calorimetry were also employed on a subset of compounds and proteins to confirm inhibition of CA enzymatic activity and verify the quantitative agreement between different assays. The findings of this study showed that pharmaceuticals could bind to human CA isoforms with variable affinities and inhibit their catalytic activity, even though the drug was intended to interact with a different (non-CA) protein target. Relatively minor structural changes of the compounds may cause significant changes in affinity and selectivity for a particular CA isoform.	[Baranauskiene, Lina; Skiudaite, Lina; Michailoviene, Vilma; Petrauskas, Vytautas; Matulis, Daumantas] Vilnius Univ, Dept Biothermodynam & Drug Design, Inst Biotechnol, Life Sci Ctr, Vilnius, Lithuania; [Skiudaite, Lina] Vilnius Univ, Pharm Ctr, Inst Biomed Sci, Fac Med, Vilnius, Lithuania	Vilnius University; Vilnius University	Matulis, D (corresponding author), Vilnius Univ, Dept Biothermodynam & Drug Design, Inst Biotechnol, Life Sci Ctr, Vilnius, Lithuania.	daumantas.matulis@bti.vu.lt	Baranauskiene, Lina/P-5088-2016; Matulis, Daumantas/F-9367-2010; Petrauskas, Vytautas/A-2659-2013	Baranauskiene, Lina/0000-0002-9924-9177; Matulis, Daumantas/0000-0002-6178-6276; Petrauskas, Vytautas/0000-0001-7983-4128	European Social Fund [09.3.3-LMT-K-712-020006]; Research Council of Lithuania (LMTLT)	European Social Fund(European Social Fund (ESF)); Research Council of Lithuania (LMTLT)(Research Council of Lithuania (LMTLT))	This research was funded by European Social Fund (Project No 09.3.3-LMT-K-712-020006) under grant agreement with the Research Council of Lithuania (LMTLT) awarded to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2013, J ENZYM INHIB MED CH, V28, P267, DOI 10.3109/14756366.2012.737323; Andring J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040527; [Anonymous], 2019, CARBONIC ANHYDRASE D, DOI DOI 10.1007/978-3-030-12780-0_2; BEYER KH, 1993, HYPERTENSION, V22, P388, DOI 10.1161/01.HYP.22.3.388; Capkauskaite E, 2010, BIOORGAN MED CHEM, V18, P7357, DOI 10.1016/j.bmc.2010.09.016; Carta F, 2013, EXPERT OPIN THER PAT, V23, P681, DOI 10.1517/13543776.2013.780598; Cimmperman P, 2011, RSC BIOMOL SCI, P247; Clare BW, 1997, EUR J MED CHEM, V32, P311, DOI 10.1016/S0223-5234(97)89083-6; COHEN E, 1960, J AM CHEM SOC, V82, P2731, DOI 10.1021/ja01496a020; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; CORNISH EJ, 1966, J PHARM PHARMACOL, V18, P65, DOI 10.1111/j.2042-7158.1966.tb07828.x; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Duarte JD, 2010, EXPERT REV CARDIOVAS, V8, P793, DOI [10.1586/erc.10.27, 10.1586/ERC.10.27]; Duda DM, 2005, BIOCHEMISTRY-US, V44, P10046, DOI 10.1021/bi050610h; Dudutiene V, 2013, BIOORGAN MED CHEM, V21, P2093, DOI 10.1016/j.bmc.2013.01.008; Dvoranova J, 2020, EUR J MED CHEM, V200, DOI 10.1016/j.ejmech.2020.112460; Fujikawa-Adachi K, 1999, GENOMICS, V61, P74, DOI 10.1006/geno.1999.5938; Gaspari R, 2016, J MED CHEM, V59, P4245, DOI 10.1021/acs.jmedchem.5b01643; GOLDFARB DS, 1991, AM J PHYSIOL, V261, pF452, DOI 10.1152/ajprenal.1991.261.3.F452; Hilvo M, 2008, CURR PHARM DESIGN, V14, P672, DOI 10.2174/138161208783877811; Iyer R, 2006, J BIOMOL SCREEN, V11, P782, DOI 10.1177/1087057106289403; Kazlauskas E, 2021, EUR BIOPHYS J BIOPHY, V50, P373, DOI 10.1007/s00249-021-01537-1; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Kisonaite M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114106; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kurtz TW, 2010, HYPERTENSION, V56, P335, DOI 10.1161/HYPERTENSIONAHA.110.156166; Linkuviene V, 2018, Q REV BIOPHYS, V51, DOI 10.1017/S0033583518000082; Lomelino CL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071150; Matulis, 2019, CARBONIC ANHYDRASE D, P39, DOI [10.1007/978-3-030-12780-0_3, DOI 10.1007/978-3-030-12780-0_3]; Mezzasalma TM, 2007, J BIOMOL SCREEN, V12, P418, DOI 10.1177/1087057106297984; Monroy A, 2000, AM J PHYSIOL-RENAL, V279, pF161, DOI 10.1152/ajprenal.2000.279.1.F161; NOVELLO FC, 1957, J AM CHEM SOC, V79, P2028, DOI 10.1021/ja01565a079; Paketuryte V, 2019, EUR BIOPHYS J BIOPHY, V48, P139, DOI 10.1007/s00249-018-1341-z; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pickkers P, 1999, HYPERTENSION, V33, P1043, DOI 10.1161/01.HYP.33.4.1043; PONTO LLB, 1990, CLIN PHARMACOKINET, V18, P381; Pourafshar N, 2018, CURR DRUG METAB, V19, P1012, DOI 10.2174/1389200219666180702104559; Rapoport RM., 2019, FRONT PHARMACOL, P10, DOI [10.3389/fphar.2019.00010, DOI 10.3389/FPHAR.2019.00010]; Ren XF, 2011, VIRUS GENES, V42, P229, DOI 10.1007/s11262-011-0570-3; Roush GC, 2013, CURR HYPERTENS REP, V15, P514, DOI 10.1007/s11906-013-0372-1; Runtsch LS, 2015, BEILSTEIN J ORG CHEM, V11, P1129, DOI 10.3762/bjoc.11.127; Scott AD, 2009, CHEMMEDCHEM, V4, P1985, DOI 10.1002/cmdc.200900386; Smith DA, 2008, CURR OPIN DRUG DISC, V11, P72; Swenson ER, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0467-3; Temperini C, 2008, ORG BIOMOL CHEM, V6, P2499, DOI 10.1039/b800767e; Temperini C, 2009, BIOORGAN MED CHEM, V17, P1214, DOI 10.1016/j.bmc.2008.12.023	46	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253608	10.1371/journal.pone.0253608	http://dx.doi.org/10.1371/journal.pone.0253608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166457	gold, Green Published			2022-12-26	WOS:000671692800018
J	Gong, S; Wang, Z; Zhou, L				Gong, Shuang; Wang, Zhen; Zhou, Lei			Dynamic fracture mechanics and energy distribution rate response characteristics of coal containing bedding structure	PLOS ONE			English	Article							LOADING RATE; MODE-I; TOUGHNESS; DEFORMATION; SIMULATION; ANISOTROPY; INITIATION; SIZE	To investigate the influence of bedding structure and different loading rates on the dynamic fracture characteristics and energy dissipation of Datong coal, a split Hopkinson bar was used to obtain the fracture characteristics of coal samples with different bedding angles. The process of crack initiation and propagation in Datong coal was recorded by the high-speed camera. The formula for the model I fracture toughness of the transversely isotropic material is obtained on the basis of the finite element method (FEM) together with the J-integral. By comparing the incident energy, absorbed energy, fracture energy and residual kinetic energy of Datong coal samples under various impact speeds, the energy dissipation characteristics during the dynamic fracture process of coal considering the bedding structure is acquired. The experimental results indicate that the fracture pattern of notched semi-circular bending (NSCB) Datong coal is tensile failure. After splitting into two parts, the coal sample rotates approximately uniformly around the contact point between the sample and the incident rod. The dynamic fracture toughness is 3.52 similar to 8.64 times of the quasi-static fracture toughness for Datong coal. Dynamic fracture toughness increases with increasing impact velocity, and the effect of bedding angle on fracture toughness then decreases. In addition, the residual kinetic energy of coal samples with the same bedding angle increases with the increase of impact speed. The energy utilization rate decreases continuously, and the overall dispersion of statistical data decreases gradually. In rock fragmentation engineering, the optimum loading condition is low-speed loading regardless of energy utilization efficiency or fracture toughness. These conclusions may have significant implications for the optimization of hydraulic fracturing process in coal mass and the further understanding of crack propagation mechanisms in coalbed methane extraction (CME). The anisotropic effect of coal should be fully considered in both these cases.	[Gong, Shuang; Wang, Zhen; Zhou, Lei] Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China; [Gong, Shuang] Henan Key Lab Green & Efficient Min & Comprehens, Jiaozuo, Henan, Peoples R China; [Gong, Shuang; Wang, Zhen; Zhou, Lei] Collaborat Innovat Ctr Coal Work Safety, Jiaozuo, Henan, Peoples R China	Henan Polytechnic University	Gong, S (corresponding author), Henan Polytech Univ, Sch Energy Sci & Engn, Jiaozuo, Henan, Peoples R China.; Gong, S (corresponding author), Henan Key Lab Green & Efficient Min & Comprehens, Jiaozuo, Henan, Peoples R China.; Gong, S (corresponding author), Collaborat Innovat Ctr Coal Work Safety, Jiaozuo, Henan, Peoples R China.	gongcumtb@126.com			Fundamental Research Funds for the Universities of Henan Province [NSFRF200332]; Henan Key Laboratory for Green and Efficient Mining & Comprehensive Utilization of Mineral Resources (Henan Polytechnic University) [KCF201804]; Key Scientific Research Project Fund of Colleges and Universities of Henan Province [21A610005, 20B440001]; Doctoral Foundation of Henan Polytechnic University [B2019-22]	Fundamental Research Funds for the Universities of Henan Province; Henan Key Laboratory for Green and Efficient Mining & Comprehensive Utilization of Mineral Resources (Henan Polytechnic University); Key Scientific Research Project Fund of Colleges and Universities of Henan Province; Doctoral Foundation of Henan Polytechnic University	This work was financially supported by the Fundamental Research Funds for the Universities of Henan Province (Grant No. NSFRF200332), the research fund of Henan Key Laboratory for Green and Efficient Mining & Comprehensive Utilization of Mineral Resources (Henan Polytechnic University) (No. KCF201804), the Key Scientific Research Project Fund of Colleges and Universities of Henan Province (No. 21A610005 and No. 20B440001) and the Doctoral Foundation of Henan Polytechnic University (No. B2019-22). All support is greatly appreciated.	Ayatollahi M, 2014, ROCK MECH ROCK ENG, V47, P677, DOI 10.1007/s00603-013-0430-7; Backers T, 2003, INT J ROCK MECH MIN, V40, P425, DOI 10.1016/S1365-1609(03)00015-7; Chen K, 2021, J MATER SCI TECHNOL, V72, P81, DOI 10.1016/j.jmst.2020.09.034; [陈荣 CHEN Rong], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P375; Dai F, 2013, INT J ROCK MECH MIN, V60, P57, DOI 10.1016/j.ijrmms.2012.12.035; Dai F, 2011, ENG FRACT MECH, V78, P2633, DOI 10.1016/j.engfracmech.2011.06.022; Dai F, 2010, INT J ROCK MECH MIN, V47, P606, DOI 10.1016/j.ijrmms.2010.04.002; Dai F., 2010, DYNAMIC TENSILE FLEX, P150; Dai YW, 2019, ENG FRACT MECH, V209, P274, DOI 10.1016/j.engfracmech.2019.01.030; Doitrand A, 2020, J MECH PHYS SOLIDS, V145, DOI 10.1016/j.jmps.2020.104143; Nguyen DL, 2020, COMPOS PART B-ENG, V183, DOI 10.1016/j.compositesb.2019.107714; Funatsu T, 2014, INT J ROCK MECH MIN, V67, P1, DOI 10.1016/j.ijrmms.2013.12.009; Gao G, 2015, ENG FRACT MECH, V138, P146, DOI 10.1016/j.engfracmech.2015.02.021; [高文学 Gao Wenxue], 2003, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V22, P1777; Hogan JD, 2011, INT J IMPACT ENG, V38, P931, DOI 10.1016/j.ijimpeng.2011.06.004; [黄达 Huang Da], 2012, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V31, P245; Kim Y, 2007, INT J FRACTURE, V145, P195, DOI 10.1007/s10704-007-9114-1; Lambert DE, 2000, INT J IMPACT ENG, V24, P985, DOI 10.1016/S0734-743X(00)00027-0; Li X B., 2014, FDN APPL ROCK DYNAMI, P67; Liu HY, 2007, ROCK MECH ROCK ENG, V40, P107, DOI 10.1007/s00603-006-0091-x; Makarov PV, 2001, THEOR APPL FRACT MEC, V37, P183, DOI 10.1016/S0167-8442(01)00078-7; Saha G, 2015, ENG FRACT MECH, V142, P154, DOI 10.1016/j.engfracmech.2015.06.009; Song B, 2006, EXP MECH, V46, P407, DOI 10.1007/s11340-006-6420-x; Tan X, 2016, ROCK MECH ROCK ENG, V49, P4957, DOI 10.1007/s00603-016-1030-0; TANG CN, 1990, ENG FRACT MECH, V35, P783, DOI 10.1016/0013-7944(90)90162-A; Wang QZ, 2015, ENG FRACT MECH, V141, P78, DOI 10.1016/j.engfracmech.2015.04.025; Wang QZ, 2011, ENG FRACT MECH, V78, P2455, DOI 10.1016/j.engfracmech.2011.06.004; Wang QZ, 2010, EXP MECH, V50, P877, DOI 10.1007/s11340-009-9265-2; Wang YB, 2020, POLYM TEST, V91, DOI 10.1016/j.polymertesting.2020.106684; [谢和平 xie Heping], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P3003; Xu J.Y., 2013, J ROCK MECH ENG, V32, P3109; Yang RZ, 2020, CONSTR BUILD MATER, V262, DOI 10.1016/j.conbuildmat.2020.120071; Yin TB, 2012, ROCK MECH ROCK ENG, V45, P1087, DOI 10.1007/s00603-012-0240-3; Zhang QB, 2014, ROCK MECH ROCK ENG, V47, P1411, DOI 10.1007/s00603-013-0463-y; Zhang ZX, 2000, INT J ROCK MECH MIN, V37, P745, DOI 10.1016/S1365-1609(00)00008-3; Zhang ZX, 2001, INT J ROCK MECH MIN, V38, P211, DOI 10.1016/S1365-1609(00)00071-X; Zhao YX, 2017, ENG FRACT MECH, V178, P375, DOI 10.1016/j.engfracmech.2017.03.011; Zhao YX, 2014, INT J COAL GEOL, V132, P81, DOI 10.1016/j.coal.2014.08.007; Zhao YX, 2013, INT J FRACTURE, V183, P63, DOI 10.1007/s10704-013-9876-6; Zhixi C, 1997, INT J ROCK MECH MIN, V34, P1; Zhou XP, 2010, J CENT SOUTH UNIV T, V17, P150, DOI 10.1007/s11771-010-0024-4	41	2	2	8	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0247908	10.1371/journal.pone.0247908	http://dx.doi.org/10.1371/journal.pone.0247908			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166380	gold, Green Published			2022-12-26	WOS:000671692800013
J	Peng, JQ; Chen, J; Su, C; Wu, ZF; Yang, L; Liu, WJ				Peng, Jiquan; Chen, Juan; Su, Chen; Wu, Zhifeng; Yang, Liu; Liu, Wenji			Will land circulation sway "grain orientation"? The impact of rural land circulation on farmers' agricultural planting structures	PLOS ONE			English	Article							FOOD SECURITY; CROP; ABANDONMENT; MANAGEMENT; DIVERSITY; DRIVERS; SYSTEM; AREAS; CHINA; MODEL	This study calculates the effect of different types of land circulation on farmers' decision-making regarding agricultural planting structure, using field survey data involving 1,120 households in Hubei province, China, and PSM (propensity score matching) and GPSM (general propensity score matching) methods. Results from PSM showed that land circulation could significantly increase farmers' decisions to plant food crops, which confirms the positive effect of rural land circulation on the "grain orientation" of crop planting structure. Results from GPSM further indicate that the total land circulation, the paddy land circulation, and the dry land circulation all have significantly positive effects on planting structure adjustment towards "grain orientation." Additionally, planting structure adjustment towards "grain orientation" increases as the scale of land circulation increases, and the former shows a higher rate of increase than the latter, which confirms that rural land circulation facilitates an adjustment in structure towards planting food crops.	[Peng, Jiquan; Su, Chen; Wu, Zhifeng; Yang, Liu; Liu, Wenji] Jiangxi Univ Finance & Econ, Sch Econ, Nanchang, Jiangxi, Peoples R China; [Chen, Juan] Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China	Jiangxi University of Finance & Economics; Zhongnan University of Economics & Law	Chen, J (corresponding author), Zhongnan Univ Econ & Law, Sch Business Adm, Wuhan, Peoples R China.	lynn2012@163.com	wu, zhi/GXH-3041-2022	Chen, Juan/0000-0001-7591-9028	National Social Science Foundation of China [19ZDA117]; National Natural Science Foundation of China [72063012]; China's Ministry of Education: the Humanities and Social Sciences [20YJC790103]; Jiangxi University of Finance and Economics [202001]	National Social Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China's Ministry of Education: the Humanities and Social Sciences; Jiangxi University of Finance and Economics	This research was funded by National Social Science Foundation of China: Key Project of "A Study on Changes of Rural Poverty Nature in New Era and Anti-Poverty Policy after 2020," grant number 19ZDA117; National Natural Science Foundation of China: Project of "Dynamic Measurement of the Relative Poverty of Migrant Workers' Families and the Construction of a Longterm Poverty Alleviation Mechanism: A Study Based on Equivalent Scale Adjustment,"grant number 72063012; China's Ministry of Education: the Humanities and Social Sciences Project of "Dynamic Measurement of the Relative Poverty of Migrant Workers from a Multidimensional Perspective Collaborative Governance Research," grant number 20YJC790103; Jiangxi University of Finance and Economics: the Studying Xi Jinping New Era Socialism Thoughts with Chinese Characteristics Project of "Xi Jinping's Important Exposition Research on Poverty Alleviation," grant number 202001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2016, ECONOMETRICA, V84, P781, DOI 10.3982/ECTA11293; [Anonymous], 2019, CHIN STAT YB; Azadi H, 2011, LAND DEGRAD DEV, V22, P596, DOI 10.1002/ldr.1037; BARBIER EB, 1989, WORLD DEV, V17, P879, DOI 10.1016/0305-750X(89)90009-0; Brabec E, 2002, LANDSCAPE URBAN PLAN, V58, P255, DOI 10.1016/S0169-2046(01)00225-0; Cai RL., 2015, J RURAL EC, V07, P44; Chen QR, 2019, LAND-BASEL, V8, DOI 10.3390/land8110158; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Clement M., 2011, ASIAN DEV REV, V28, P58, DOI [10.2139/ssrn.2001145, DOI 10.2139/SSRN.2001145]; Deaton A, 1998, J POLIT ECON, V106, P897, DOI 10.1086/250035; Fires GF, 2016, AGR FOREST METEOROL, V228, P286, DOI 10.1016/j.agrformet.2016.07.005; Fischer T, 2014, ACIAR MONOGR SER, V158, P1; Gale HF, 2005, WRS0501 USDAERS WRS0501 USDAERS; GOETZ SJ, 1993, ECON DEV CULT CHANGE, V41, P343, DOI 10.1086/452014; Govereh J, 2003, AGR ECON, V28, P39, DOI 10.1111/j.1574-0862.2003.tb00133.x; Heimlich RE, 2001, 14732016120733 USDA 14732016120733 USDA; Heimlich RE, 1989, AER619 USDA EC RES S AER619 USDA EC RES S; Hirano K., 2005, APPL BAYESIAN MODELI, P73, DOI [10.1002/0470090456.ch7, DOI 10.1002/0470090456.CH7]; Ho SPS, 2004, MOD CHINA, V30, P81, DOI 10.1177/0097700403259131; HODGE I, 1984, J AGR ECON, V35, P191, DOI 10.1111/j.1477-9552.1984.tb02046.x; Huanggang Bureau of Statistics Huanggang Investigation Team of National Bureau of Statistics Huanggang Bureau of Finance., 2019, HUANGGANG STAT YB; Jiang S., 2017, INQ EC ISSUES, P125; Jiang Y., 2017, JIANGXI SOC SCI, V37, P81; Jingzhou Bureau of Statistics Jingzhou Investigation Team of National Bureau of Statistics, 2019, JINGZH STAT YB JINGZH STAT YB; Kaku N, 2008, APPL MICROBIOL BIOT, V79, P43, DOI 10.1007/s00253-008-1410-9; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Khanal NR, 2006, MT RES DEV, V26, P28; Lai ZH, 2020, LAND USE POLICY, V97, DOI 10.1016/j.landusepol.2020.104781; Li XD, 2012, ACAD J ZHONGZHOU, P59; Liu XP, 2011, LAND ECON, V87, P183, DOI 10.3368/le.87.2.183; Liu YS, 2020, LAND USE POLICY, V97, DOI 10.1016/j.landusepol.2020.104794; Liu ZM, 2016, J RURAL STUD, V47, P449, DOI 10.1016/j.jrurstud.2016.06.021; Long HL, 2016, J RURAL STUD, V47, P392, DOI 10.1016/j.jrurstud.2016.03.011; Loos J, 2015, AGR ECOSYST ENVIRON, V199, P350, DOI 10.1016/j.agee.2014.10.013; Luo BL., 2018, JIANGHAI ACAD J, P94; Luo BL, 2018, SOC SCI FRONT, P39; Ma L, 2020, LAND USE POLICY, V92, DOI 10.1016/j.landusepol.2020.104470; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; Malawska A, 2016, AGR SYST, V143, P136, DOI 10.1016/j.agsy.2015.12.014; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Michalek J, 2014, LAND ECON, V90, P260, DOI 10.3368/le.90.2.260; Morgan CJ, 2018, J NUCL CARDIOL, V25, P404, DOI 10.1007/s12350-017-1012-y; Peerzado M. B., 2019, Journal of the Saudi Society of Agricultural Sciences, V18, P423, DOI 10.1016/j.jssas.2018.02.002; Penghui J., RESOUR CONSERV RECY, V156; Pingali P., 2007, HDB AGR EC, V3, P2779, DOI [10.1016/s1574-0072(06)03054-4, DOI 10.1016/S1574-0072(06)03054-4]; Qian L., 2018, J AGROTECH EC, P63; Renard D, 2019, NATURE, V571, P257, DOI 10.1038/s41586-019-1316-y; Rondhi M, 2018, LAND-BASEL, V7, DOI 10.3390/land7040148; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Senger I, 2017, J RURAL STUD, V49, P32, DOI 10.1016/j.jrurstud.2016.10.006; Shipman JE, 2017, ACCOUNT REV, V92, P213, DOI 10.2308/accr-51449; Smith L.D., 2001, REFORM DECENTRALIZAT; Song G, 2016, J ACAD RES, V07, P122; Sun X., 2012, ISSUES AGR EC, V33, P102, DOI [10.13246/j.cnki.iae.2012.08.017, DOI 10.13246/J.CNKI.IAE.2012.08.017]; Tan ZP., 2019, REFORM, P111; Wang JY, 2020, J GEOGR SCI, V30, P378, DOI 10.1007/s11442-020-1733-8; Wang J, 2019, LAND-BASEL, V8, DOI 10.3390/land8110171; Wang JR, 1996, AGR ECON, V15, P17, DOI 10.1016/S0169-5150(96)01192-9; Wang SG., 2015, CHINESE J AGR RESOUR CHINESE J AGR RESOUR, V07, P44; Wang SJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010247; Xu H, 2014, LAND USE POLICY, V38, P541, DOI 10.1016/j.landusepol.2013.12.018; Yan JZ, 2016, LAND USE POLICY, V57, P459, DOI 10.1016/j.landusepol.2016.06.014; Yan XH, 2014, POPUL SPACE PLACE, V20, P303, DOI 10.1002/psp.1831; Yang J. D., 2016, EC RES J, V51, P99; Yang J, 2013, AM J AGR ECON, V95, P1245, DOI 10.1093/ajae/aat027; Yang ZH, 2020, LAND-BASEL, V9, DOI 10.3390/land9010007; Yuk-Shing C., 1995, CHINA INFORM, V10, P44; Zhang HQ., 2020, J SICHUAN NORMAL U S, V47, P59; Zhang JiaShu, 2012, Journal of Applied Sciences, V12, P2202; Zhang OX., 2016, J FINANCE TRADE RES, V27, P24; Zhang Q., 2014, J SE ACAD RES, V03, P94; Zhang Z., 2015, EC PERSPECT, P63; [张照新 ZHANG Zhaoxin], 2007, [农业经济问题, Issues in Agricultural Economy], V28, P11; Zhou J., 2019, ISSUES AGR EC, P27	75	6	6	22	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253158	10.1371/journal.pone.0253158	http://dx.doi.org/10.1371/journal.pone.0253158			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166390	Green Published, gold			2022-12-26	WOS:000671692800050
J	Kasuga, Y; Ikenoue, S; Tamagawa, M; Oishi, M; Endo, T; Sato, Y; Iida, M; Sato, Y; Tanaka, M; Ochiai, D				Kasuga, Yoshifumi; Ikenoue, Satoru; Tamagawa, Masumi; Oishi, Maki; Endo, Toyohide; Sato, Yu; Iida, Miho; Sato, Yasunori; Tanaka, Mamoru; Ochiai, Daigo			What are the causes for low birthweight in Japan? A single hospital-based study	PLOS ONE			English	Article							PRETERM BIRTH; PREGNANCY OUTCOMES; GESTATIONAL-AGE; CERVICAL-CANCER; FETAL-GROWTH; IMPACT; WOMEN; BORN	Low-birthweight (LBW; <2,500 g) babies are at a higher risk of poor educational achievement, disability, and metabolic diseases than normal-birthweight babies in the future. However, reliable data on factors that contribute to LBW have not been considered previously. Therefore, we aimed to examine the distribution of the causes for LBW. A retrospective review of cases involving 4,224 babies whose mothers underwent perinatal care at Keio University Hospital between 2013 and 2019 was conducted. The LBW incidence was 24% (1,028 babies). Of the 1,028 LBW babies, 231 babies were from multiple pregnancies. Of the 797 singleton LBW babies, 518 (65%) were born preterm. Obstetric complications in women with preterm LBW babies included premature rupture of membrane or labor onset (31%), hypertensive disorders of pregnancy (HDP, 64%), fetal growth restriction (24%), non-reassuring fetal status (14%), and placental previa/vasa previa (8%). Of the 279 term LBW babies, 109 (39%) were small for gestational age. Multiple logistic regression analyses revealed the following factors as LBW risk factors in term neonates: low pre-pregnancy maternal weight, inadequate gestational weight gain, birth at 37 gestational weeks, HDP, anemia during pregnancy, female sex, and neonatal congenital anomalies. HDP was an LBW risk factor not only in preterm births but also in term births. Our results suggest that both modifiable and non-modifiable factors are causes for LBW. It may be appropriate to consider a heterogeneous rather than a simple classification of LBW and to evaluate future health risks based on contributing factors.	[Kasuga, Yoshifumi; Ikenoue, Satoru; Tamagawa, Masumi; Oishi, Maki; Endo, Toyohide; Sato, Yu; Tanaka, Mamoru; Ochiai, Daigo] Keio Univ, Dept Obstet & Gynaecol, Sch Med, Tokyo, Japan; [Iida, Miho; Sato, Yasunori] Keio Univ, Dept Prevent Med & Publ Hlth, Sch Med, Tokyo, Japan	Keio University; Keio University	Kasuga, Y (corresponding author), Keio Univ, Dept Obstet & Gynaecol, Sch Med, Tokyo, Japan.	17yoshi23.k@gmail.com	SATO, Yasunori/AGK-2994-2022	Sato, Yasunori/0000-0002-7189-5126; chun ri, yi shi/0000-0003-2395-9591	JSPS KAKENHI [20K08215]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Research will be supported by JSPS KAKENHI (Grant number: 20K08215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentivegna E, 2016, FERTIL STERIL, V106, P1195, DOI 10.1016/j.fertnstert.2016.06.032; Breslau N, 2004, PEDIATRICS, V114, P1035, DOI 10.1542/peds.2004-0069; Bridwell M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2361-0; Campbell D, 2004, BEST PRACT RES CL OB, V18, P657, DOI 10.1016/j.bpobgyn.2004.04.016; Chang HY, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00087; Cluver C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025809; Coates D, 2020, WOMEN BIRTH, V33, P22, DOI 10.1016/j.wombi.2019.06.011; Cunningham FG., 2014, WILLIAMS OBSTET, Vxviii; Furuhashi F, 2021, J MATERN-FETAL NEO M, V34, P3709, DOI 10.1080/14767058.2019.1690447; Gondwe KW, 2017, NEONATAL NETW, V36, P77, DOI 10.1891/0730-0832.36.2.77; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Holland G, 2016, BODY IMAGE, V17, P100, DOI 10.1016/j.bodyim.2016.02.008; Ikenoue S, 2020, J MATERN-FETAL NEO M, V33, P2227, DOI 10.1080/14767058.2018.1545835; Itabashi K, 2014, PEDIATR INT, V56, P702, DOI 10.1111/ped.12331; Johnson CD, 2017, J PUBLIC HEALTH-UK, V39, P122, DOI 10.1093/pubmed/fdv212; Jwa SC, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0516-1; Kajantie E, 2015, J CLIN ENDOCR METAB, V100, P244, DOI 10.1210/jc.2014-3184; Kasuga Y, 2019, J DEV ORIG HLTH DIS, V10, P536, DOI 10.1017/S2040174418001150; Kasuga Y, 2020, J MATERN-FETAL NEO M, V33, P1628, DOI 10.1080/14767058.2018.1521797; Kasuga Y, 2016, INT J GYNECOL CANCER, V26, P163, DOI 10.1097/IGC.0000000000000571; Kenyon S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001058.pub3; Knop MR, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008870, 10.1161/jaha.118.008870]; Maher GM, 2018, JAMA PSYCHIAT, V75, P809, DOI 10.1001/jamapsychiatry.2018.0854; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Miyakoshi K, 2021, J MATERN-FETAL NEO M, V34, P845, DOI 10.1080/14767058.2019.1619687; Morisaki N, 2017, J EPIDEMIOL, V27, P492, DOI 10.1016/j.je.2016.09.013; Morisaki N, 2016, PAEDIATR PERINAT EP, V30, P473, DOI 10.1111/ppe.12308; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Nakashima A, 2013, FERTIL STERIL, V99, P450, DOI 10.1016/j.fertnstert.2012.09.027; Normile D, 2018, SCIENCE, V361, P440, DOI 10.1126/science.361.6401.440; Paauw ND, 2017, HYPERTENSION, V70, P998, DOI 10.1161/HYPERTENSIONAHA.117.09690; Quilter CR, 2014, FASEB J, V28, P4868, DOI 10.1096/fj.14-255240; Ramage K, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3667; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Ren A, 2007, INT J GYNECOL OBSTET, V98, P124, DOI 10.1016/j.ijgo.2007.05.011; Roberge S, 2018, AM J OBSTET GYNECOL, V218, P287, DOI 10.1016/j.ajog.2017.11.561; Ross Mary P, 2002, J S C Med Assoc, V98, P260; Santana DS, 2018, REV BRAS GINECOL OBS, V40, P554, DOI 10.1055/s-0038-1668117; Schieve LA, 2016, ANN EPIDEMIOL, V26, P267, DOI 10.1016/j.annepidem.2016.02.012; Shan XY, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-105; Shokri M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03787; Simon C, 2019, FERTIL STERIL, V112, P611, DOI 10.1016/j.fertnstert.2019.08.056; Theobald Hannah E, 2007, J Fam Health Care, V17, P45; van der Woude CJ, 2016, J CROHNS COLITIS, V10, P871, DOI 10.1093/ecco-jcc/jjw108; Yokoyama M, 2020, J DIABETES INVEST, V11, P1643, DOI 10.1111/jdi.13274; Yzydorczyk C, 2017, J DEV ORIG HLTH DIS, V8, P448, DOI 10.1017/S2040174417000265; Zanetti D, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.002054	47	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253719	10.1371/journal.pone.0253719	http://dx.doi.org/10.1371/journal.pone.0253719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161392	gold, Green Published			2022-12-26	WOS:000671691900048
J	Wray, J; Keen, E; O'Mahony, EN				Wray, Janie; Keen, Eric; O'Mahony, Eadin N.			Social survival: Humpback whales (Megaptera novaeangliae) use social structure to partition ecological niches within proposed critical habitat	PLOS ONE			English	Article							ENDANGERED SPECIES ACT; SITE FIDELITY; FEEDING GROUNDS; SOUTHERN GULF; POPULATION-STRUCTURE; PROTECTED AREAS; CONSERVATION; MOVEMENTS; BEHAVIOR; AFFILIATIONS	Animal culture and social bonds are relevant to wildlife conservation because they influence patterns of geography, behavior, and strategies of survival. Numerous examples of socially-driven habitat partitioning and ecological-niche specialization can be found among vertebrates, including toothed whales. But such social-ecological dynamics, described here as 'social niche partitioning', are not known among baleen whales, whose societies-particularly on foraging grounds-are largely perceived as unstructured and incidental to matters of habitat use and conservation. However, through 16 years of behavioral observations and photo-identifications of humpback whales (Megaptera novaeangliae) feeding within a fjord system in the Canadian Pacific (primarily within Gitga'at First Nation waters), we have documented long-term pair bonds (up to 12 years) as well as a complex societal structure, which corresponds closely to persistent patterns in feeding strategy, long-term site fidelity (extended occupancy and annual rate of return up to 75%), specific geographic preferences within the fjord system, and other forms of habitat use. Randomization tests of network congruency and clustering algorithms were used to test for overlap in patterns of social structure and habitat use, which confirmed the occurrence of social niche partitioning on the feeding grounds of this baleen whale species. In addition, we document the extensive practice of group bubble net feeding in Pacific Canada. This coordinated feeding behavior was found to strongly mediate the social structure and habitat use within this humpback whale society. Additionally, during our 2004-2019 study, we observed a shift in social network structure in 2010-2012, which corresponded with environmental and demographic shifts including a sudden decline in the population's calving rate. Our findings indicate that the social lives of humpback whales, and perhaps baleen whales generally, are more complex than previously supposed and should be a primary consideration in the assessment of potential impacts to important habitat.	[Wray, Janie; Keen, Eric; O'Mahony, Eadin N.] North Coast Cetacean Soc, Alert Bay, BC, Canada; [Wray, Janie] Pacific Orca Soc, Alert Bay, BC, Canada; [Keen, Eric] Marine Ecol & Telemetry Res, Seebeck, WA USA; [Keen, Eric] Sewanee Univ South, Sewanee, TN USA; [O'Mahony, Eadin N.] Univ St Andrews, Scottish Oceans Inst, St Andrews, Fife, Scotland	Sewanee: University of the South; University of St Andrews	Wray, J (corresponding author), North Coast Cetacean Soc, Alert Bay, BC, Canada.; Wray, J (corresponding author), Pacific Orca Soc, Alert Bay, BC, Canada.	janie@bcwhales.org		O'Mahony, Eadin/0000-0002-0755-1329	Save Our Seas Foundation [217-2010-2020]; Willow Grove Foundation [001-2010-2020]; Fisheries and Oceans Canada [2016-2019HSP-PAC-8287-A]; Donner Canadian Foundation [E-50-20, E50-19, E-50-18]; Tides Canada [GF04712]	Save Our Seas Foundation; Willow Grove Foundation; Fisheries and Oceans Canada; Donner Canadian Foundation; Tides Canada	JW received a grant from the following: Save Our Seas Foundation Grant No. 217-20102020 https://saveourseas.com, Willow Grove Foundation Grant No. 001-2010-2020, Fisheries and Oceans Canada Grant CA No.: 2016-2019HSP-PAC-8287-A, https://www.dfo-mpo.gc.ca/species-especes/sara-lep/hsp-pih/index-eng.html,Donner Canadian Foundation Grant No. E-50-20,E50-19, E-50-18 https://www.donnerfoundation.org, Tides Canada Grant No. GF04712. https://makeway.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes Jo Marie V., 2007, Journal of Cetacean Research and Management, V9, P37; Acevedo J, 2014, MAR MAMMAL SCI, V30, P433, DOI 10.1111/mms.12048; Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Angevine G, 2012, STUDIES ENERGY POLIC; Ashe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075228; Bagulayan A, 2012, OCEANOGRAPHY, V25, P200, DOI 10.5670/oceanog.2012.55; Baird RW, 2008, MAR MAMMAL SCI, V24, P591, DOI 10.1111/j.1748-7692.2008.00200.x; Baird RW., 2012, ENDANGER SPECIES RES; Baker C.S., 1985, POPULATION STRUCTURE; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; BAKER CS, 1984, CAN J ZOOL, V62, P1922, DOI 10.1139/z84-282; BAKER CS, 1981, CAN J ZOOL, V59, P460, DOI 10.1139/z81-067; BAKER CS, 1985, MAR MAMMAL SCI, V1, P304, DOI 10.1111/j.1748-7692.1985.tb00018.x; BAKER CS, 1984, PAC SCI, V38, P356; Baracho-Neto CG, 2012, J MAR BIOL ASSOC UK, V92, P1783, DOI 10.1017/S0025315411002074; Barendse J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081238; Barlow J., 2011, MAR MAMMAL SCI, V27, P793, DOI DOI 10.1111/j.1748-7692.2010.00444.x; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; BOESCH C, 1994, J HUM EVOL, V26, P325, DOI 10.1006/jhev.1994.1020; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; Brager S, 2002, BIOL CONSERV, V108, P281, DOI 10.1016/S0006-3207(02)00124-6; Brakes P, 2019, SCIENCE, V363, P1032, DOI 10.1126/science.aaw3557; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Calambokidis J, 2001, MAR MAMMAL SCI, V17, P769, DOI 10.1111/j.1748-7692.2001.tb01298.x; Calambokidis J., 2008, AB133F03RP00078, P57; Camaclang AE, 2015, CONSERV BIOL, V29, P482, DOI 10.1111/cobi.12428; Canadas A., 2008, ENDANGER SPECIES RES; Cantor M, 2015, MAR MAMMAL SCI, V31, P1275, DOI 10.1111/mms.12218; Cantor M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0340; Carretta JV, 2014, US PACIFIC MARINE MA; Cartwright R, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.181463; Cartwright R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038004; Chilvers BL, 2001, P ROY SOC B-BIOL SCI, V268, P1901, DOI 10.1098/rspb.2001.1732; Clapham Phillip J., 1993, Symposia of the Zoological Society of London, V66, P131; CLAPHAM PJ, 1987, CAN J ZOOL, V65, P2853, DOI 10.1139/z87-434; CLAPHAM PJ, 1992, BEHAVIOUR, V122, P182, DOI 10.1163/156853992X00507; CLAPHAM PJ, 1993, CAN J ZOOL, V71, P440, DOI 10.1139/z93-063; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; Clapham PJ., 2009, ENCY MARINE MAMMALS, V2nd ed, P368; Clapham PJ., 2000, CETACEAN SOCIETIES, P173; Clark JA, 2002, CONSERV BIOL, V16, P1510, DOI 10.1046/j.1523-1739.2002.01376.x; CMS Expert Group, 2017, ENV CONV MIGRAT SPEC ENV CONV MIGRAT SPEC; Connor RC., 2000, CETACEAN SOCIETIES, P199; Craig AS, 1997, CAN J ZOOL, V75, P1923, DOI 10.1139/z97-822; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Csardi G., 2016, STAT NETWORK ANAL IG; D'Vincent CG., 1985, SCI REP WHALE RES I, V36, P41; Dawbin WH., 1966, WHALES DOLPHINS PORP, P145; Derville S, 2018, J MAMMAL, V99, P41, DOI 10.1093/jmammal/gyx185; Dewey R., 2016, BLOB BLOG WARM NE PA; District of Kitimat Development Services (DKDS), 2015, PRIV INT PORT KITIM PRIV INT PORT KITIM, P1; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Eguiguren A, 2019, MAR ECOL PROG SER, V609, P257, DOI 10.3354/meps12822; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Erbe C., 2020, FRONT MAR SCI; Erbe C, 2012, ADV EXP MED BIOL, V730, P17, DOI 10.1007/978-1-4419-7311-5_3; Ersts PJ, 2003, J ZOOL, V260, P337, DOI 10.1017/S0952836903003807; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Farine DR, 2013, METHODS ECOL EVOL, V4, P1187, DOI 10.1111/2041-210X.12121; Farine DR, 2016, ASSORTNET; Felix F, 2011, MAR ECOL PROG SER, V426, P277, DOI 10.3354/meps08984; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Foote AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1481; Ford J. K. B., 2014, MARINE MAMMALS BRIT; Ford JKB., 2019, ETHOLOGY BEHAV ECOLO, P239; Foster EA, 2012, ANIM BEHAV, V83, P731, DOI 10.1016/j.anbehav.2011.12.021; Francis JM, 1996, ENVIRON VALUE, V5, P257, DOI 10.3197/096327196776679294; Frankel AS, 2002, MAR MAMMAL SCI, V18, P644, DOI 10.1111/j.1748-7692.2002.tb01064.x; Gabriele CM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1641; Gabriele CM, 2003, TRENDS RELATIVE DIST; Geist V, 1971, STUDY BEHAV EVOLUTIO; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gerrodette T, 2002, B MAR SCI, V70, P657; Gibbs KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035730; Glockner-Ferrari D.A., 1985, INDIVIDUAL IDENTIFIC; Glockner-Ferrari DA., 1990, REPORTS INT WHALING, V12, P161; Godde S, 2013, ANIM BEHAV, V85, P553, DOI 10.1016/j.anbehav.2012.12.010; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Grassi C, 2006, AM J PHYS ANTHROPOL, V131, P50, DOI 10.1002/ajpa.20423; HAIN JHW, 1982, FISH B-NOAA, V80, P259; Hatch L, 2008, ENVIRON MANAGE, V42, P735, DOI 10.1007/s00267-008-9169-4; Hauser DDW, 2007, MAR ECOL PROG SER, V351, P301, DOI 10.3354/meps07117; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Herman LM., 2011, MAR MAMMAL SCI, V27, P736, DOI DOI 10.1111/j.1748-7692.2010.00441.x; Herman LM., 1980, 197677 MIGRATION HUM; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoekstra JM, 2002, ECOL APPL, V12, P701, DOI 10.1890/1051-0761(2002)012[0701:ACRFCH]2.0.CO;2; Hoppitt WJE, 2018, ANIM BEHAV, V136, P227, DOI 10.1016/j.anbehav.2017.08.029; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jones T, 2018, GEOPHYS RES LETT, V45, P3193, DOI 10.1002/2017GL076164; Jurasz C.M., 1979, Scientific Reports of the Whales Research Institute Tokyo, V31, P69; Keen E, 2017, WHALES RAINFOREST HA; Keen EM, 2018, MAR ENVIRON RES, V140, P180, DOI 10.1016/j.marenvres.2018.06.014; Keen EM, 2016, BANGARANG; Keen EM, 2017, MAR ECOL PROG SER, V567, P211, DOI 10.3354/meps12012; Keen EM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1702; Keen SC, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2019.2513; Krieger KJ, 1984, HYDROACOUSTIC SURVEY; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Le Boeuf BJ., 1991, BEHAV PINNIPEDS, P45; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; Lubansky TM, 2015, PLURIBUS UNUM WHAT I; Macdonald RW, 1983, P WORKSH KITIMAT M P WORKSH KITIMAT M, V18, P2; Mann J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1983; Marcoux M, 2005, VOCALIZATIONS DIET F; Marcoux M, 2007, MAR ECOL PROG SER, V333, P309, DOI 10.3354/meps333309; Markowitz TM, 2004, AQUAT CONSERV, V14, P133, DOI 10.1002/aqc.602; Martins C.C.A., 2001, ASPECTS HABITAT USE; Mastick N., 2016, EFFECT GROUP SIZE IN; MATTILA DK, 1989, CAN J ZOOL, V67, P2201, DOI 10.1139/z89-311; MATTILA DK, 1994, CAN J ZOOL, V72, P1898, DOI 10.1139/z94-258; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; McMillan CJ, 2019, MAR MAMMAL SCI, V35, P779, DOI 10.1111/mms.12557; Meisner T, 2015, 15287E TP 15287E TP; MOBLEY JR, 1985, CAN J ZOOL, V63, P762, DOI 10.1139/z85-111; Moehlman PD, 1998, APPL ANIM BEHAV SCI, V60, P171, DOI 10.1016/S0168-1591(98)00163-4; MORRIS DW, 1987, ECOLOGY, V68, P362, DOI 10.2307/1939267; Musick JA., 2003, BIOL SEA TURTLES; Nichol LM, 2010, INFORM RELEVANT IDEN; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Pack AA, 2017, ANIM BEHAV, V133, P131, DOI 10.1016/j.anbehav.2017.09.012; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; PAYNE R, 1971, ANN NY ACAD SCI, V188, P110, DOI 10.1111/j.1749-6632.1971.tb13093.x; Perry A, 1990, REPTS INT WHALING CO, P307; Perry A, 1985, NATURAL HIST HUMPBAC; Perryman RJY, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-019-2720-x; Pirotta E, 2020, DEEP-SEA RES PT I, V155, DOI 10.1016/j.dsr.2019.103169; Qualls KM, 2019, DRIVERS EUPHAUSIID A; R Core Team, 2020, R LANG ENV STAT COMP; Ramirez-Sanchez S, 2009, ECOL SOC, V14; Ramos EA, 2021, MAR MAMMAL SCI, V37, P352, DOI 10.1111/mms.12727; Ramp C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1563, DOI 10.1007/s00265-010-0970-8; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; REED JM, 1993, TRENDS ECOL EVOL, V8, P253, DOI 10.1016/0169-5347(93)90201-Y; Reed JM., 2006, ENDANGERED SPECIES A, P164; Rendell L, 2005, ANIM BEHAV, V70, P191, DOI 10.1016/j.anbehav.2005.03.001; Riley HE., 2010, HUMPBACK WHALE MEGAP; Roman J, 2014, FRONT ECOL ENVIRON, V12, P377, DOI 10.1890/130220; SALDEN DR, 1988, J WILDLIFE MANAGE, V52, P301, DOI 10.2307/3801238; Scheidat Meike, 2000, Journal of Cetacean Research and Management, V2, P165; Schreiber EA, 2001, BIOL MARINE BIRDS; Schwartz MW, 2008, ANNU REV ECOL EVOL S, V39, P279, DOI 10.1146/annurev.ecolsys.39.110707.173538; Sharpe FA, 1997, CAN J ZOOL, V75, P725, DOI 10.1139/z97-093; Sharpe FA, 2001, SOCIAL FORAGING SE A; Slagsvold T, 2011, PHILOS T R SOC B, V366, P969, DOI 10.1098/rstb.2010.0343; SMULTEA MA, 1994, CAN J ZOOL, V72, P805, DOI 10.1139/z94-109; Stevick PT, 2006, J ZOOL, V270, P244, DOI 10.1111/j.1469-7998.2006.00128.x; Sutherland WJ, 1998, ANIM BEHAV, V56, P801, DOI 10.1006/anbe.1998.0896; Tanner CJ, 2011, ANIM BEHAV, V82, P1185, DOI 10.1016/j.anbehav.2011.09.004; TAYLOR BL, 1995, CONSERV BIOL, V9, P551, DOI 10.1046/j.1523-1739.1995.09030551.x; Taylor MFJ, 2005, BIOSCIENCE, V55, P360, DOI 10.1641/0006-3568(2005)055[0360:TEOTES]2.0.CO;2; TRILLMICH F, 1984, BIOL J LINN SOC, V21, P209; Tschopp A, 2018, PEERJ, V6, DOI 10.7717/peerj.4782; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Wade PR, 2016, SC66BIA21 SCI COMM I SC66BIA21 SCI COMM I; Walsh JE, 2018, B AM METEOROL SOC, V99, pS39, DOI 10.1175/BAMS-D-17-0105.1; Wedekin LL, 2010, MAR MAMMAL SCI, V26, P787, DOI 10.1111/j.1748-7692.2010.00387.x; Weinrich MT, 2006, J HERED, V97, P226, DOI 10.1093/jhered/esj018; WEINRICH MT, 1991, CAN J ZOOL, V69, P3005, DOI 10.1139/z91-424; WEINRICH MT, 1991, CAN J ZOOL, V69, P3012, DOI 10.1139/z91-425; Weir JS, 2008, CANADIAN JOURNAL OF; Weitkamp LA., 1992, J ZOOL; Weko CW, 2018, ANIM BEHAV, V139, P147, DOI 10.1016/j.anbehav.2018.03.011; White G.C., 1990, ANAL WILDLIFE RADIO; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 2004, J ANIM ECOL, V73, P190, DOI 10.1111/j.1365-2656.2004.00798.x; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H, 2019, SOCPROG PROGRAMS ANA; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2018, J THEOR BIOL, V456, P279, DOI 10.1016/j.jtbi.2018.08.015; Whitehead H, 2015, METHODS ECOL EVOL, V6, P836, DOI 10.1111/2041-210X.12383; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Williams R, 2009, BIOL CONSERV, V142, P709, DOI 10.1016/j.biocon.2008.12.004; Witteveen BH, 2017, CAN J ZOOL, V95, P169, DOI 10.1139/cjz-2016-0101; Wray J, 2020, MAR MAMMAL SCI, V36, P709, DOI 10.1111/mms.12665; Wursig B., 1987, DOLPHIN COGNITION BE, P347	192	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0245409	10.1371/journal.pone.0245409	http://dx.doi.org/10.1371/journal.pone.0245409			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161375	gold, Green Submitted, Green Published			2022-12-26	WOS:000671691900026
J	Ajemu, KF; Desta, AA; Berhe, AA; Woldegebriel, AG; Bezabih, NM; Negash, D; Wuneh, AD; Woldearegay, TW				Ajemu, Kiros Fenta; Desta, Abraham Aregay; Berhe, Asfawosen Aregay; Woldegebriel, Ataklti Gebretsadik; Bezabih, Nega Mamo; Negash, Degnesh; Wuneh, Alem Desta; Woldearegay, Tewolde Wubayehu			Magnitude, components and predictors of metabolic syndrome in Northern Ethiopia: Evidences from regional NCDs STEPS survey, 2016	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PREVALENCE; ADULTS	Background Individuals with metabolic syndrome are five times more susceptible to chronic diseases. Assessment of its magnitude, components, and risk factors is essentials to deploy visible interventions needed to avoid further complications. The study aimed to assess magnitude, components, and predictors of metabolic syndrome in Tigray region northern Ethiopia, 2016. Methods Data were reviewed from Tigray region NCDs STEPs survey data base between May to June 2016. A total of 1476 adults aged 18-64 years were enrolled for the study. Multi-variable regression analysis was performed to estimate the net effect of size to risk factors associated with metabolic syndrome. Statistical significance was declared at p-value of <= 0.05 at 95% confidence interval (CI) for an adjusted odds ratio (AOR). Results The study revealed that unadjusted and adjusted prevalence rate of Metabolic Syndrome (MetS) were (CPR = 33.79%; 95%CI: 31.29%-36.36%) and (APR = 34.2%; 95% CI: 30.31%-38.06%) respectively. The most prevalent MetS component was low HDL concentration (CPR = 70.91%; 95%CI: 68.47%-73.27%) and (APR = 70.61; 95%CI; 67.17-74.05). While; high fasting blood glucose (CPR = 20.01% (95%CI: 18.03-22.12) and (APR = 21.72; 95%CI; 18.41-25.03) was the least ones. Eating vegetables four days a week, (AOR = 3.69, 95%CI; 1.33-10.22), a salt sauce added in the food some times (AOR = 5.06, 95%CI; 2.07-12.34), overweight (AOR = 24.28, 95%CI; 10.08-58.47] and obesity (AOR = 38.81; 12.20-111.04) had strong association with MetS. Conclusion The magnitude of metabolic syndrome was found to be close to the national estimate. Community awareness on life style modification based on identified MetS components and risk factors is needed to avoid further complications.	[Ajemu, Kiros Fenta; Desta, Abraham Aregay; Berhe, Asfawosen Aregay; Woldegebriel, Ataklti Gebretsadik; Bezabih, Nega Mamo; Negash, Degnesh; Woldearegay, Tewolde Wubayehu] Tigray Hlth Res Inst, Tigray, Ethiopia; [Wuneh, Alem Desta] Mekelle Univ, Coll Hlth Sci, Tigray, Ethiopia	Mekelle University	Ajemu, KF (corresponding author), Tigray Hlth Res Inst, Tigray, Ethiopia.	kirosfenta@gmail.com	; Desta, Abraham/W-1838-2018	Wubayehu, Tewolde/0000-0001-7619-1112; Desta, Abraham/0000-0002-1505-7451; FENTA Ajemu, KIROS/0000-0002-7608-0284				Abagre T.A., 2016, THESIS U GHANA; Ahmed HM, 2016, AM J EPIDEMIOL, V183, P875, DOI 10.1093/aje/kwv305; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 2015, SALT RED FACT SHEETN; Bouguerra R, 2006, DIABETES METAB, V32, P215, DOI 10.1016/S1262-3636(07)70271-9; Callaghan BC, 2011, DIABETES CARE, V34, P635, DOI 10.2337/dc10-0878; Chang ST, 2011, INT J IMPOT RES, V23, P87, DOI 10.1038/ijir.2011.9; Chawla Aastha, 2016, Indian J Endocrinol Metab, V20, P546, DOI 10.4103/2230-8210.183480; Chowdhury MZI, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5209-z; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Dandji M., 2018, WORLD J NUTR HLTH, V6, P1; de Oliveira EP, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-13; DeFina LF, 2012, J INVEST MED, V60, P1164, DOI 10.2310/JIM.0b013e318275656a; El Brini O, 2014, DIABETES METAB SYNDR, V7, P341, DOI 10.2147/DMSO.S61245; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745; Foroozanfar Z, 2015, IRAN J MED SCI, V40, P522; Gebremariam LW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27519-6; Gebremeskel GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4609-1; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kelliny C, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-27; Lee Crystal Man Ying, 2008, Metabolic Syndrome and Related Disorders, V6, P37, DOI 10.1089/met.2007.0024; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mbugua SM, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4936-x; MOH, 2016, FED DEM REP ETH MIN; Motala AA, 2009, ETHNIC DIS, V19, pS8; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; National Institute on Alcohol Abuse and Alcoholism, DRINK LEV DEFN; Ogbera AO, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-1; Okafor Christian I, 2012, Indian J Endocrinol Metab, V16, P56, DOI 10.4103/2230-8210.91191; On JY, 2004, DIABETES CARE, V27, P2027, DOI 10.2337/diacare.27.8.2027; Owolabi E. O., 2017, The Open Public Health Journal, V10, P148, DOI 10.2174/1874944501710010148; Pan JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021515; Pitsavos Christos, 2006, Review of Diabetic Studies, V3, P118, DOI 10.1900/RDS.2006.3.118; Ramli AS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/760963; Scuteri A, 2015, EUR J PREV CARDIOL, V22, P486, DOI 10.1177/2047487314525529; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Solomon S, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1201-5; Tesfaye DY, 2014, DIABETES METAB SYND, V8, P102, DOI 10.1016/j.dsx.2014.04.008; Tran A, 2011, INT J HYPERTENS, V2011, DOI 10.4061/2011/193719; Ulasi II, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-71; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; World Health Organization, GLOB PHYS ACT QUEST; World Health Organization (WHO), HLTH DIET	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253317	10.1371/journal.pone.0253317	http://dx.doi.org/10.1371/journal.pone.0253317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153079	Green Published, gold			2022-12-26	WOS:000671691000016
J	Gao, SQ; Menendez, M; Kurylowicz, K; Griffin, CT				Gao, Siqi; Menendez, Matthew; Kurylowicz, Katarzyna; Griffin, Courtney T.			Genomic locus proteomic screening identifies the NF-kappa B signaling pathway components NF kappa B1 and IKBKG as transcriptional regulators of Ripk3 in endothelial cells	PLOS ONE			English	Article							NEMO/IKK-GAMMA; KINASE RIPK3; NECROPTOSIS; DEATH; ACTIVATION; EXPRESSION; NECROSIS; INFLAMMATION; APOPTOSIS; COMPLEX	The receptor-interacting protein kinase 3 (RIPK3) is a multi-functional protein best known for facilitating cellular necroptosis and inflammation. Recent evidence from our lab indicates that RIPK3 expression must be tightly regulated in endothelial cells to promote angiogenesis, to maintain vascular integrity during embryogenesis, and to provide protection from postnatal atherosclerosis. RIPK3 activity and stability are regulated by post-translational modifications and caspase-dependent cleavage. However, less is known about the transcriptional regulation of Ripk3. Here we utilized an unbiased CRISPR-based technology called genomic locus proteomics (GLoPro) to screen transcription factors and coregulatory proteins associated with the Ripk3 locus in a murine endothelial cell line. We found that 41 nuclear proteins are specifically enriched at the Ripk3 locus, including the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling pathway components NF kappa B1 and IKBKG. We further verified that NF kappa B1 and IKBKG directly bind the Ripk3 promoter and prevent TNF alpha-induced Ripk3 transcription in cultured human primary endothelial cells. Moreover, NF kappa B1 prevents RIPK3-mediated death of primary endothelial cells. These data provide new insights into NF-kappa B signaling and Ripk3 transcriptional regulation in endothelial cells.	[Gao, Siqi; Menendez, Matthew; Kurylowicz, Katarzyna; Griffin, Courtney T.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Gao, Siqi; Griffin, Courtney T.] Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73019 USA; [Gao, Siqi] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Gao, Siqi] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Kurylowicz, Katarzyna] Univ Chicago, Ben May Dept Canc Res, Chicago, IL USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Pennsylvania; University of Pennsylvania; University of Chicago	Griffin, CT (corresponding author), Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA.; Griffin, CT (corresponding author), Univ Oklahoma, Dept Cell Biol, Hlth Sci Ctr, Oklahoma City, OK 73019 USA.	Courtney.Griffin@omrf.org		Gao, Siqi/0000-0002-6504-4536; Griffin, Courtney/0000-0001-8100-3171	National Institutes of Health [R35HL44605]; American Heart Association [19PRE34380708]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by grants from the National Institutes of Health (https://www.nih.gov) awarded to C.T.G. (R35HL44605) and from the American Heart Association (https://www.heart.org) awarded to S.G. (#19PRE34380708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyce BF, 2015, ENDOCRINOL METAB, V30, P35, DOI 10.3803/EnM.2015.30.1.35; Cartwright T, 2016, FEBS J, V283, P1812, DOI 10.1111/febs.13627; Chen T, 2018, BIOMED PHARMACOTHER, V107, P563, DOI 10.1016/j.biopha.2018.08.056; Choi ME, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.128834; Choi SW, 2018, MOL CELL, V70, P920, DOI 10.1016/j.molcel.2018.05.016; Colijn S, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.041962; Colijn S, 2020, CELL DEATH DIFFER, V27, P618, DOI 10.1038/s41418-019-0376-8; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Gao SQ, 2021, ANGIOGENESIS, V24, P519, DOI 10.1007/s10456-020-09763-5; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Koo GB, 2015, CELL RES, V25, P707, DOI 10.1038/cr.2015.56; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li XH, 2019, IMMUNITY, V50, P1115, DOI 10.1016/j.immuni.2019.03.008; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Liu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.197; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Meng YX, 2021, CELL DEATH DIFFER, V28, P861, DOI 10.1038/s41418-020-00722-7; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Moriwaki K, 2017, CELL REP, V18, P2441, DOI 10.1016/j.celrep.2017.02.015; Moriwaki K, 2016, CELL MOL LIFE SCI, V73, P2325, DOI 10.1007/s00018-016-2203-4; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Mussbacher M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00085; Myers SA, 2018, NAT METHODS, V15, P437, DOI 10.1038/s41592-018-0007-1; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Orozco SL, 2019, CELL REP, V28, P2275, DOI 10.1016/j.celrep.2019.07.077; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Sreenivasan K, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107652; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076; van der Bruggen T, 1999, INFECT IMMUN, V67, P3824, DOI 10.1128/IAI.67.8.3824-3829.1999; Wang Q, 2020, TRANSL ONCOL, V13, P372, DOI 10.1016/j.tranon.2019.11.011; Wang QW, 2015, CIRC RES, V116, P600, DOI 10.1161/CIRCRESAHA.116.304899; Yang CK, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.483; Yang ZT, 2018, NAT CELL BIOL, V20, P186, DOI 10.1038/s41556-017-0022-y; Yang ZT, 2017, CELL REP, V19, P1846, DOI 10.1016/j.celrep.2017.05.012	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253519	10.1371/journal.pone.0253519	http://dx.doi.org/10.1371/journal.pone.0253519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153072	gold, Green Published			2022-12-26	WOS:000671691000029
J	Liu, Y; Nelson, MV; Bailey, C; Zhang, P; Zheng, P; Dome, JS; Liu, Y; Wang, Y				Liu, Yan; Nelson, Marie, V; Bailey, Christopher; Zhang, Peng; Zheng, Pan; Dome, Jeffrey S.; Liu, Yang; Wang, Yin			Targeting the HIF-1 alpha-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor	ONCOGENE			English	Article							BINDING-PROTEIN 2; INDUCIBLE FACTOR 1-ALPHA; IGF-I RECEPTOR; GENE-EXPRESSION; BREAST-CANCER; STEM-CELLS; HYPOXIA; PTEN; SURVIVAL; IGFBP-2	For patients with anaplastic Wilms tumor (WiT), metastasis and recurrence are common, and prognosis is generally poor. Novel therapies are needed to improve outcomes for patients with this high-risk WiT. A potential contributor to WiT development is constitutive activation of AKT by insulin-like growth factor 1 (IGF1) and its receptor (IGF1R) signaling pathway, but the complete underlying mechanism remains unclear. Here, we demonstrate that the hypoxia-inducible factor 1 alpha (HIF-1 alpha)-IGF binding protein 2 (IGFBP2) axis and the tumor-specific IGF1A are key players for constitutive activation of IGF1-AKT signaling leading to the tumor malignancy. HIF-1 alpha and IGFBP2 are highly expressed in a majority of WiT patient samples. Deficiency of either HIF-1 alpha or IGFBP2 or IGF1 in the tumor cells significantly impairs tumor growth and nearly abrogates metastasis in xenografted mice. Pharmacologic targeting of HIF-1 alpha by echinomycin delivered via nanoliposomes can efficiently restrain growth and metastasis of patient-derived relapsed anaplastic WiT xenografts. Liposomal echinomycin is more potent and effective in inhibiting WiT growth than vincristine in an anaplastic WiT mouse model, and eliminates metastasis by suppressing HIF-1 alpha targets and the HIF-1 alpha-IGFBP2 axis, which governs IGF1-AKT signaling.	[Liu, Yan; Bailey, Christopher; Zhang, Peng; Zheng, Pan; Liu, Yang; Wang, Yin] Univ Maryland, Sch Med, Inst Human Virol, Div Canc & Immunol Res, Baltimore, MD 21201 USA; [Nelson, Marie, V; Dome, Jeffrey S.] Childrens Natl Hosp, Ctr Canc & Immunol Res, Washington, DC USA; [Zheng, Pan; Liu, Yang] OncoC4 Inc, Rockville, MD 20850 USA	University System of Maryland; University of Maryland Baltimore; Children's National Health System	Liu, Y; Liu, Y; Wang, Y (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Div Canc & Immunol Res, Baltimore, MD 21201 USA.; Liu, Y (corresponding author), OncoC4 Inc, Rockville, MD 20850 USA.	yanliu@ihv.umaryland.edu; ywang@ihv.umaryland.edu		Wang, Yin/0000-0002-4749-3768	National Institutes of Health National Cancer Institute [CA171972, CA183030, CA219150, CA227671]	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grants from the National Institutes of Health National Cancer Institute CA171972, CA183030 (Y.L.), and CA219150, CA227671 (Y.W.).	Alami J, 2003, INT J CANCER, V107, P365, DOI 10.1002/ijc.11429; Ambrosini-Spaltro A, 2011, APPL IMMUNOHISTO M M, V19, P318, DOI 10.1097/PAI.0b013e3128052936; Bailey CM, 2020, NANOMED-NANOTECHNOL, V29, DOI 10.1016/j.nano.2020.102278; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Bielen A, 2012, P NATL ACAD SCI USA, V109, pE1267, DOI 10.1073/pnas.1105034109; Brahmkhatri VP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/538019; Chekhonin VP, 2013, CURR CANCER DRUG TAR, V13, P423, DOI 10.2174/15680096113139990074; Chen XL, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-72; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Dean SJR, 2014, AM J CLIN PATHOL, V141, P323, DOI 10.1309/AJCPR11DEAYPTUSL; Dome JS, 2015, J CLIN ONCOL, V33, P2999, DOI 10.1200/JCO.2015.62.1888; Dome JS, 2002, J PEDIAT HEMATOL ONC, V24, P192, DOI 10.1097/00043426-200203000-00007; Dungwa JV, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-390; Durzynska J, 2013, ENDOCRINOLOGY, V154, P1215, DOI 10.1210/en.2012-1992; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Feldser D, 1999, CANCER RES, V59, P3915; Foulstone EJ, 2013, ENDOCRINOLOGY, V154, P1780, DOI 10.1210/en.2012-1970; Geller JI, 2016, UROL ONCOL-SEMIN ORI, V34, P50, DOI 10.1016/j.urolonc.2015.10.012; GERMAINLEE EL, 1992, BIOCHEM J, V281, P413, DOI 10.1042/bj2810413; HASELBACHER GK, 1987, P NATL ACAD SCI USA, V84, P1104, DOI 10.1073/pnas.84.4.1104; Hu QH, 2011, J CLIN INVEST, V121, P174, DOI 10.1172/JCI43772; Hua H, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00904-3; Huang YF, 2008, BRIT J CANCER, V99, P1096, DOI 10.1038/sj.bjc.6604661; Karth J, 2000, J PEDIATR SURG, V35, P1749, DOI 10.1053/jpsu.2000.19241; Kim YW, 2013, INT J ONCOL, V43, P539, DOI 10.3892/ijo.2013.1961; King ER, 2011, GYNECOL ONCOL, V123, P13, DOI 10.1016/j.ygyno.2011.06.016; Liou JM, 2010, J CLIN ENDOCR METAB, V95, P1717, DOI 10.1210/jc.2009-2668; Lu J, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0197-x; Mavinkurve-Groothuis AMC, 2015, PEDIATR BLOOD CANCER, V62, P598, DOI 10.1002/pbc.25357; Mireuta M, 2010, GROWTH FACTORS, V28, P243, DOI 10.3109/08977191003745472; Miyamoto S, 2007, CANCER SCI, V98, P685, DOI 10.1111/j.1349-7006.2007.00448.x; Newman B, 2012, CANCER RES, V72, P4551, DOI 10.1158/0008-5472.CAN-11-3600; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; REEVE AE, 1985, NATURE, V317, P258, DOI 10.1038/317258a0; Rigiracciolo DC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041010; ROGHANI M, 1991, J CLIN ENDOCR METAB, V73, P658, DOI 10.1210/jcem-73-3-658; Sasso G, 2010, J PEDIAT HEMATOL ONC, V32, pE264, DOI 10.1097/MPH.0b013e3181e7931a; SCHILSKY RL, 1991, INVEST NEW DRUG, V9, P269; Sciarra A, 2010, EUR UROL, V58, P315, DOI 10.1016/j.eururo.2010.05.019; SCOTT J, 1985, NATURE, V317, P260, DOI 10.1038/317260a0; Shen XC, 2012, MOL CELL BIOL, V32, P4116, DOI 10.1128/MCB.01011-12; Shiratsuchi I, 2011, ANTICANCER RES, V31, P2541; Simpson A, 2017, TARGET ONCOL, V12, P571, DOI 10.1007/s11523-017-0514-5; VINCENT TS, 1994, PEDIATR PATHOL, V14, P723, DOI 10.3109/15513819409023344; Wamaitha SE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14629-x; Wang HM, 2006, MODERN PATHOL, V19, P1149, DOI 10.1038/modpathol.3800637; Wang Y, 2020, ONCOGENE, V39, P3015, DOI 10.1038/s41388-020-1201-z; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Wegert J, 2017, J PATHOL CLIN RES, V3, P234, DOI 10.1002/cjp2.77; Wigerup C, 2016, PHARMACOL THERAPEUT, V164, P152, DOI 10.1016/j.pharmthera.2016.04.009; Yau SW, 2015, J CELL COMMUN SIGNAL, V9, P125, DOI 10.1007/s12079-015-0261-2; ZUMKELLER W, 1993, EUR J CANCER, V29A, P1973, DOI 10.1016/0959-8049(93)90455-O; Zundel W, 2000, GENE DEV, V14, P391	55	5	5	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4809	4819		10.1038/s41388-021-01907-1	http://dx.doi.org/10.1038/s41388-021-01907-1		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34155347	Green Accepted			2022-12-26	WOS:000664006700002
J	Li, Y; Gokul, A; McGhee, C; Ziaei, M				Li, Ye; Gokul, Akilesh; McGhee, Charles; Ziaei, Mohammed			Repeatability of corneal and epithelial thickness measurements with anterior segment optical coherence tomography in keratoconus	PLOS ONE			English	Article							REPRODUCIBILITY	Purpose To investigate the repeatability in corneal thickness (CT) and epithelial thickness (ET) measurements using spectral domain anterior segment optical coherence tomography (AS-OCT, REVO NX, Optopol) in keratoconus, and examine the effect of corneal crosslinking (CXL) on repeatability. Methods A cross-sectional study of 259 eyes of 212 patients with keratoconus attending the corneal disease clinic at a university hospital tertiary referral center were enrolled. Two groups were analysed: eyes with no prior history of CXL (Group A) and eyes with prior CXL (Group B). Repeatability of measurements was assessed using the intraclass correlation coefficient (ICC) and coefficient of variation (CV). Results In Group A, central corneal thickness (CCT) was 472.18 +/- 45.41 mu m, and the ET was found to be the thinnest in the inferior-temporal aspect at 51.79 +/- 5.97 mu m and thickest at the superior-nasal aspect at 56.07 +/- 5.70 mu m. In Group B, CCT was 465.11 +/- 42.28 mu m, and the ET was the thinnest at the inferior-temporal aspect at 50.63 +/- 5.52 mu m and thickest at the superior aspect at 56.80 +/- 6.39 mu m. When evaluating CT measurements, ICC was above 0.86 and 0.83 for Group A and Group B respectively. When evaluating ET measurements, ICC was above 0.82 for both groups. CXL had no statistically significant impact on the repeatability of measurements. Conclusions AS-OCT provides repeatable CT and ET measurements in the central and peripheral cornea in patients with keratoconus. Repeatability is not affected by a history of CXL.	[Li, Ye; Gokul, Akilesh; McGhee, Charles; Ziaei, Mohammed] Univ Auckland, Fac Med & Hlth Sci, New Zealand Natl Eye Ctr, Dept Ophthalmol, Auckland, New Zealand	University of Auckland	Ziaei, M (corresponding author), Univ Auckland, Fac Med & Hlth Sci, New Zealand Natl Eye Ctr, Dept Ophthalmol, Auckland, New Zealand.	m.ziaei@auckland.ac.nz		McGhee, Charles NJ/0000-0001-7048-0706; Li, Ye/0000-0002-4585-956X				Bland JM, 1996, BRIT MED J, V312, P1654, DOI 10.1136/bmj.312.7047.1654; Dienes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108882; Dupps WJ, 2020, J CATARACT REFR SURG, V46, P495, DOI 10.1097/j.jcrs.0000000000000174; Dutta D, 2013, OPHTHALMOLOGY, V120, P457, DOI 10.1016/j.ophtha.2012.08.036; Feng YW, 2001, CORNEA, V20, P480, DOI 10.1097/00003226-200107000-00008; Goebels S, 2015, AM J OPHTHALMOL, V159, P733, DOI 10.1016/j.ajo.2015.01.014; Goh YW, 2020, CORNEA, V39, P1256, DOI 10.1097/ICO.0000000000002376; Goudie C, 2018, EYE, V32, P1048, DOI 10.1038/s41433-018-0019-1; Haberman ID, 2018, J CATARACT REFR SURG, V44, P306, DOI 10.1016/j.jcrs.2017.12.021; Han Sang Beom, 2016, J Ophthalmol, V2016, P4971572; Hashemi Hassan, 2019, Rom J Ophthalmol, V63, P68; Hashmani N, 2018, INVEST OPHTH VIS SCI, V59, P1652, DOI 10.1167/iovs.17-23717; Kanclerz P, 2019, J CATARACT REFR SURG, V45, P1619, DOI 10.1016/j.jcrs.2019.07.002; Kanellopoulos AJ, 2014, CLIN OPHTHALMOL, V8, P2277, DOI 10.2147/OPTH.S67902; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; Kumar M, 2015, INDIAN J OPHTHALMOL, V63, P722, DOI 10.4103/0301-4738.170987; Lian Y, 2013, INVEST OPHTH VIS SCI, V54, P691, DOI 10.1167/iovs.12-10263; Lu NJ, 2019, J REFRACT SURG, V35, P600, DOI 10.3928/1081597X-20190806-03; Mathew JH, 2011, OPTOMETRY VISION SCI, V88, P988, DOI 10.1097/OPX.0b013e31821ffbd4; Naderan M, 2015, INT J OPHTHALMOL-CHI, V8, P275, DOI 10.3980/j.issn.2222-3959.2015.02.11; Prakash G, 2009, AM J OPHTHALMOL, V148, P282, DOI 10.1016/j.ajo.2009.03.012; Reinstein DZ, 2010, J REFRACT SURG, V26, P259, DOI 10.3928/1081597X-20100218-01; Sella R, 2019, AM J OPHTHALMOL, V197, P88, DOI 10.1016/j.ajo.2018.09.008; Shetty R, 2017, INDIAN J OPHTHALMOL, V65, P305, DOI 10.4103/ijo.IJO_690_16; Silverman RH, 2014, INVEST OPHTH VIS SCI, V55, P1580, DOI 10.1167/iovs.13-12578; Sorbara L, 2021, J OPTOM, V14, P37, DOI 10.1016/j.optom.2020.02.005; Temstet C, 2015, J CATARACT REFR SURG, V41, P812, DOI 10.1016/j.jcrs.2014.06.043; Vega-Estrada A, 2019, AM J OPHTHALMOL, V200, P255, DOI 10.1016/j.ajo.2019.01.015; Vidal S, 2013, CLIN EXP OPTOM, V96, P278, DOI 10.1111/cxo.12002; Viswanathan D, 2015, ACTA OPHTHALMOL, V93, pE488, DOI 10.1111/aos.12622; Xu Z, 2018, OPHTHALMIC RES, V59, P115, DOI 10.1159/000478985; Ziaei M, 2020, CORNEA, V39, P946, DOI 10.1097/ICO.0000000000002344; Ziaei M, 2019, EYE, V33, P1897, DOI 10.1038/s41433-019-0502-3; Ziaei M, 2019, CLIN EXP OPHTHALMOL, V47, P980, DOI 10.1111/ceo.13567; Ziaei M, 2018, J CATARACT REFR SURG, V44, P71, DOI 10.1016/j.jcrs.2017.10.044; Ziaei M, 2015, J CATARACT REFR SURG, V41, P842, DOI 10.1016/j.jcrs.2015.03.010	36	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0248350	10.1371/journal.pone.0248350	http://dx.doi.org/10.1371/journal.pone.0248350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143790	Green Published, gold			2022-12-26	WOS:000671690700010
J	Locatelli, I; Rousson, V				Locatelli, Isabella; Rousson, Valentin			A first analysis of excess mortality in Switzerland in 2020	PLOS ONE			English	Article							DEATH RATES; AGE	Objective To quantify excess all-cause mortality in Switzerland in 2020, a key indicator for assessing direct and indirect consequences of the COVID-19 pandemic. Methods Using official data on deaths in Switzerland, all-cause mortality in 2020 was compared with that of previous years using directly standardized mortality rates, age- and sex-specific mortality rates, and life expectancy. Results The standardized mortality rate was 8.8% higher in 2020 than in 2019, returning to the level observed 5-6 years before, around the year 2015. This increase was greater for men (10.6%) than for women (7.2%) and was statistically significant only for men over 70 years of age, and for women over 75 years of age. The decrease in life expectancy in 2020 compared to 2019 was 0.7%, with a loss of 9.7 months for men and 5.3 months for women. Conclusions There was an excess mortality in Switzerland in 2020, linked to the COVID-19 pandemic. However, as this excess only concerned the elderly, the resulting loss of life expectancy was restricted to a few months, bringing the mortality level back to 2015.	[Locatelli, Isabella; Rousson, Valentin] Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland	University of Lausanne	Locatelli, I (corresponding author), Univ Lausanne, Ctr Primary Care & Publ Hlth Unisante, Lausanne, Switzerland.	isabella.locatelli@unisante.ch		Rousson, Valentin/0000-0001-8092-4446				ABURTO JM, 2021, QUANTIFYING IMPACTS; Ahmad FB, 2021, MMWR-MORBID MORTAL W, V70, P519, DOI [10.15585/mmwr.mm7014e1, 10.15585/mmwr.mm7014e1externalicon]; Andrasfay T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014746118; Beaney T, 2020, J ROY SOC MED, V113, P329, DOI 10.1177/0141076820956802; Branum A., 2021, MORBIDITY MORTALITY; Breslow N E, 1987, IARC Sci Publ, P1; Curtin L R, 1995, Healthy People 2000 Stat Notes, P1; Elveback L., 1966, HUM BIOL, V38, P322; Ermisch J., 2021, J EPIDEMIOLOGY COMMU; Fay MP, 1999, COMMUN STAT-THEOR M, V28, P2141, DOI 10.1080/03610929908832411; Fleiss J.L., 2013, STAT METHODS RATES P; FRIEDMAN M, 1982, ANN STAT, V10, P101, DOI 10.1214/aos/1176345693; Heuveline P, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042934; Kelly G., 2021, COVID 19 EXCESS MORT COVID 19 EXCESS MORT; MIETTINEN OS, 1972, AM J EPIDEMIOL, V96, P168, DOI 10.1093/oxfordjournals.aje.a121443; Modig K, 2021, EUR J PUBLIC HEALTH, V31, P17, DOI 10.1093/eurpub/ckaa218; Neison F.G.P., 1844, J R STAT SOC ROYAL S, V7, P40, DOI [10.2307/2337745, DOI 10.2307/2337745]; SPIEGELMAN M, 1966, HUM BIOL, V38, P280; WHO, 2016, WORLD HLTH STAT 2016; Woolf SH., 2021, JAMA-J AM MED ASSOC; Woolsey T., 1959, VITAL STAT RATES US	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253505	10.1371/journal.pone.0253505	http://dx.doi.org/10.1371/journal.pone.0253505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138948	Green Published, gold, Green Submitted			2022-12-26	WOS:000671690200002
J	Marcus, GM; Olgin, JE; Peyser, ND; Vittinghoff, E; Yang, V; Joyce, S; Avram, R; Tison, GH; Wen, DV; Butcher, X; Eitel, H; Pletcher, MJ				Marcus, Gregory M.; Olgin, Jeffrey E.; Peyser, Noah D.; Vittinghoff, Eric; Yang, Vivian; Joyce, Sean; Avram, Robert; Tison, Geoffrey H.; Wen, David; Butcher, Xochitl; Eitel, Helena; Pletcher, Mark J.			Predictors of incident viral symptoms ascertained in the era of COVID-19	PLOS ONE			English	Article							VIRUSES	Background In the absence of universal testing, effective therapies, or vaccines, identifying risk factors for viral infection, particularly readily modifiable exposures and behaviors, is required to identify effective strategies against viral infection and transmission. Methods We conducted a world-wide mobile application-based prospective cohort study available to English speaking adults with a smartphone. We collected self-reported characteristics, exposures, and behaviors, as well as smartphone-based geolocation data. Our main outcome was incident symptoms of viral infection, defined as fevers and chills plus one other symptom previously shown to occur with SARS-CoV-2 infection, determined by daily surveys. Findings Among 14, 335 participants residing in all 50 US states and 93 different countries followed for a median 21 days (IQR 10-26 days), 424 (3%) developed incident viral symptoms. In pooled multivariable logistic regression models, female biological sex (odds ratio [OR] 1.75, 95% CI 1.39-2.20, p<0.001), anemia (OR 1.45, 95% CI 1.16-1.81, p = 0.001), hypertension (OR 1.35, 95% CI 1.08-1.68, p = 0.007), cigarette smoking in the last 30 days (OR 1.86, 95% CI 1.35-2.55, p<0.001), any viral symptoms among household members 6-12 days prior (OR 2.06, 95% CI 1.67-2.55, p<0.001), and the maximum number of individuals the participant interacted with within 6 feet in the past 6-12 days (OR 1.15, 95% CI 1.06-1.25, p<0.001) were each associated with a higher risk of developing viral symptoms. Conversely, a higher subjective social status (OR 0.87, 95% CI 0.83-0.93, p<0.001), at least weekly exercise (OR 0.57, 95% CI 0.47-0.70, p<0.001), and sanitizing one's phone (OR 0.79, 95% CI 0.63-0.99, p = 0.037) were each associated with a lower risk of developing viral symptoms. Interpretation While several immutable characteristics were associated with the risk of developing viral symptoms, multiple immediately modifiable exposures and habits that influence risk were also observed, potentially identifying readily accessible strategies to mitigate risk in the COVID-19 era.	[Marcus, Gregory M.; Olgin, Jeffrey E.; Peyser, Noah D.; Vittinghoff, Eric; Yang, Vivian; Joyce, Sean; Avram, Robert; Tison, Geoffrey H.; Wen, David; Butcher, Xochitl; Eitel, Helena; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Marcus, GM (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA.	greg.marcus@ucsf.edu	Avram, Robert/AAK-9539-2021	Avram, Robert/0000-0002-8490-0270; Marcus, Gregory/0000-0001-5197-7696; Vittinghoff, Eric/0000-0001-8535-0920; Wen, David/0000-0003-1986-2164; Peyser, Noah/0000-0003-4529-8325; Yang, Vivian/0000-0001-9302-0403	NIH/NIBIB [IU2CEB021881-01, 3U2CEB021881-05S1]	NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Drs. GM, JO, and MP received funding from awards IU2CEB021881-01 and 3U2CEB021881-05S1 from the NIH/NIBIB (https://www.nibib.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni F, 2020, JMIR PUBLIC HLTH SUR, V6, P461, DOI 10.2196/21866; Alene M, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05950-x; [Anonymous], 2020, NAT MATER, V19, P809, DOI 10.1038/s41563-020-0758-9; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Bastiani L, 2021, J MED INTERNET RES, V23, DOI 10.2196/23897; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; Cooper DC, 2010, ANN BEHAV MED, V39, P222, DOI 10.1007/s12160-010-9181-9; Dawson P, 2021, CLIN INFECT DIS, V72, P682, DOI 10.1093/cid/ciaa799; Farsalinos K, 2020, THER ADV CHRONIC DIS, V11, DOI 10.1177/2040622320935765; Gangaputra SS, 2020, OPHTHALMOLOGY, V127, P1425, DOI 10.1016/j.ophtha.2020.06.037; Gertrudes JC, 2019, DATA MIN KNOWL DISC, V33, P1894, DOI 10.1007/s10618-019-00651-1; Gold MS, 2020, POSTGRAD MED, V132, P749, DOI 10.1080/00325481.2020.1786964; Goodman E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e31; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Haddad C, 2021, TOB USE INSIGHTS, V14, DOI 10.1177/1179173X21994612; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Islam N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2743; Martin-Sanchez FJ, 2020, EUR GERIATR MED, V11, P829, DOI 10.1007/s41999-020-00359-2; Juster RP, 2011, PSYCHONEUROENDOCRINO, V36, P797, DOI 10.1016/j.psyneuen.2010.11.001; Kutter JS, 2018, CURR OPIN VIROL, V28, P142, DOI 10.1016/j.coviro.2018.01.001; Lan FY, 2021, PATHOG GLOB HEALTH, V115, P4, DOI 10.1080/20477724.2020.1847778; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235460; Lessler J, 2010, INFECT CONT HOSP EP, V31, P809, DOI 10.1086/655023; Liu J, 2020, BMJ OPEN GASTROENTER, V7, DOI 10.1136/bmjgast-2020-000437; Liu PP, 2020, CIRCULATION, V142, P68, DOI 10.1161/CIRCULATIONAHA.120.047549; McAnulty JM, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2011592; Melvin RL, 2018, PROTEIN SCI, V27, P62, DOI 10.1002/pro.3268; Menachemi N, 2020, MMWR-MORBID MORTAL W, V69, P960, DOI 10.15585/mmwr.mm6929e1; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pagani G, 2020, J INFECTION, V81, pE10, DOI 10.1016/j.jinf.2020.09.021; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rouse BT, 2010, NAT REV IMMUNOL, V10, P514, DOI 10.1038/nri2802; Scalinci SZ, 2020, IDCASES, V20, DOI 10.1016/j.idcr.2020.e00774; Simpson RJ, 2015, PROG MOL BIOL TRANSL, V135, P355, DOI 10.1016/bs.pmbts.2015.08.001; Tostmann A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.16.2000508; Tromberg BJ, 2020, NEW ENGL J MED, V383, P1071, DOI 10.1056/NEJMsr2022263; Wang DY, 2020, J INFECT PUBLIC HEAL, V13, P1405, DOI 10.1016/j.jiph.2020.07.004; Wang J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115099; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253120	10.1371/journal.pone.0253120	http://dx.doi.org/10.1371/journal.pone.0253120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138915	Green Published, gold, Green Submitted			2022-12-26	WOS:000671690200114
J	Oh, JS; Park, J; Kim, K; Jeong, HH; Oh, YM; Choi, S; Choi, KH				Oh, Joo Suk; Park, Jungtaek; Kim, Kiwook; Jeong, Hyun Ho; Oh, Young Min; Choi, Semin; Choi, Kyoung Ho			HSP70-mediated neuroprotection by combined treatment of valproic acid with hypothermia in a rat asphyxial cardiac arrest model	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; CEREBRAL-ISCHEMIA; MILD-HYPOTHERMIA; DOWN-REGULATION; MESSENGER-RNA; HSP70; HEAT-SHOCK-PROTEIN-70; EXPRESSION; BRAIN; INDUCTION	It has been reported that valproic acid (VPA) combined with therapeutic hypothermia can improve survival and neurologic outcomes in a rat asphyxial cardiac arrest model. However, neuroprotective mechanisms of such combined treatment of valproic acid with hypothermia remains unclear. We hypothesized that epigenetic regulation of HSP70 by histone acetylation could increase HSP70-mediated neuroprotection suppressed under hypothermia. Male Sprague-Dawley rats that achieved return of spontaneous circulation (ROSC) from asphyxial cardiac arrest were randomized to four groups: normothermia (37 degrees C +/- 1 degrees C), hypothermia (33 degrees C +/- 1 degrees C), normothermia + VPA (300 mg/kg IV initiated 5 minutes post-ROSC and infused over 20 min), and hypothermia + VPA. Three hours after ROSC, acetyl-histone H3 was highly expressed in VPA-administered groups (normothermia + VPA, hypothermia + VPA). Four hours after ROSC, HSP70 mRNA expression levels were significantly higher in normothermic groups (normothermia, normothermia + VPA) than in hypothermic groups (hypothermia, hypothermia + VPA). The hypothermia + VPA group showed significantly higher HSP70 mRNA expression than the hypothermia group. Similarly, at five hours after ROSC, HSP70 protein levels were significantly higher in normothermic groups than in hypothermic groups. HSP70 levels were significantly higher in the hypothermia + VPA group than in the hypothermia group. Only the hypothermia + VPA group showed significantly attenuated cleaved caspase-9 levels than the normothermia group. Hypothermia can attenuate the expression of HSP70 at transcriptional level. However, VPA administration can induce hyperacetylation of histone H3, leading to epigenetic transcriptional activation of HSP70 even in a hypothermic status. Combining VPA treatment with hypothermia may compensate for reduced activation of HSP70-mediated anti-apoptotic pathway.	[Oh, Joo Suk; Park, Jungtaek; Kim, Kiwook; Jeong, Hyun Ho; Oh, Young Min; Choi, Semin; Choi, Kyoung Ho] Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Emergency Med, Uijeongbu Si, South Korea	Catholic University of Korea	Oh, JS (corresponding author), Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Emergency Med, Uijeongbu Si, South Korea.	erkeeper@catholic.ac.kr		Kim, Kiwook/0000-0001-7630-2046; Oh, Joo Suk/0000-0003-0519-9824	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT) [2017R1C1B1004140]; Catholic University of Korea, Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation [UJBCRL201727, UJBCRL201825]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science and ICT); Catholic University of Korea, Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (Ministry of Science and ICT) (2017R1C1B1004140), and the Catholic University of Korea, Uijeongbu St. Mary's Hospital Clinical Research Laboratory Foundation program in the year of 2017 (UJBCRL201727), 2018 (UJBCRL201825).	Airaksinen S, 2003, COMP BIOCHEM PHYS B, V136, P275, DOI 10.1016/S1096-4959(03)00205-7; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brucken A, 2017, RESUSCITATION, V117, P32, DOI 10.1016/j.resuscitation.2017.05.029; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; CHOPP M, 1992, STROKE, V23, P104, DOI 10.1161/01.STR.23.1.104; Colbourne F, 2003, P NATL ACAD SCI USA, V100, P2906, DOI 10.1073/pnas.2628027100; Colbourne F, 1996, J NEUROSCI METH, V67, P185, DOI 10.1016/0165-0270(96)00047-7; Cullen KE, 1997, J BIOL CHEM, V272, P1742, DOI 10.1074/jbc.272.3.1742; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Feinstein DL, 1996, J BIOL CHEM, V271, P17724, DOI 10.1074/jbc.271.30.17724; Gabai VL, 1998, FEBS LETT, V438, P1, DOI 10.1016/S0014-5793(98)01242-3; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Hsu CH, 2020, RESUSC PLUS, V1-2, DOI 10.1016/j.resplu.2020.100007; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kawamura Y, 2000, J NEUROTRAUM, V17, P243, DOI 10.1089/neu.2000.17.243; Kim Nuri, 2012, Inflammopharmacology, V20, P177, DOI 10.1007/s10787-011-0115-3; Krech J, 2017, MITOCHONDRION, V35, P1, DOI 10.1016/j.mito.2017.04.001; Krueger AMR, 1999, MOL BRAIN RES, V71, P265, DOI 10.1016/S0169-328X(99)00198-9; Kumar K, 1995, METAB BRAIN DIS, V10, P283, DOI 10.1007/BF02109359; Lee BS, 2017, CELL STRESS CHAPERON, V22, P409, DOI 10.1007/s12192-017-0782-0; Lee JH, 2015, AM J EMERG MED, V33, P1773, DOI 10.1016/j.ajem.2015.08.036; Lee JH, 2013, RESUSCITATION, V84, P1443, DOI 10.1016/j.resuscitation.2013.04.027; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; LIU AYC, 1994, J BIOL CHEM, V269, P14768; Liu L, 2008, J NEUROCHEM, V106, P541, DOI 10.1111/j.1471-4159.2008.05411.x; Mancuso A, 2000, BRAIN RES, V887, P34, DOI 10.1016/S0006-8993(00)02963-2; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; MATZ JM, 1995, AM J PHYSIOL-REG I, V269, pR38, DOI 10.1152/ajpregu.1995.269.1.R38; Monti Barbara, 2009, Curr Mol Pharmacol, V2, P95; Oh JS, 2017, CRIT CARE MED, V45, pE1149, DOI 10.1097/CCM.0000000000002690; Olsson T, 2004, EXP BRAIN RES, V154, P442, DOI 10.1007/s00221-003-1683-2; Pan TH, 2005, FEBS LETT, V579, P6716, DOI 10.1016/j.febslet.2005.10.067; Perrone S, 2010, PEDIATR NEUROL, V43, P236, DOI 10.1016/j.pediatrneurol.2010.05.009; Qian YR, 2010, KOREAN J PHYSIOL PHA, V14, P435, DOI 10.4196/kjpp.2010.14.6.435; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Sabirzhanov B, 2012, J NEUROCHEM, V123, P542, DOI 10.1111/j.1471-4159.2012.07927.x; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Terao Y, 2009, NEUROREPORT, V20, P745, DOI 10.1097/WNR.0b013e32832a2f32; TURNBULL DM, 1986, J NEUROL NEUROSUR PS, V49, P405, DOI 10.1136/jnnp.49.4.405; Vishwakarma SK, 2017, TISSUE CELL, V49, P638, DOI 10.1016/j.tice.2017.09.004; Williams JA, 2006, ANN THORAC SURG, V81, P2235, DOI 10.1016/j.athoracsur.2005.12.060; Yenari M, 2008, STROKE, V39, P2910, DOI 10.1161/STROKEAHA.108.514471; Yenari MA, 2006, NEUROCHEM INT, V49, P164, DOI 10.1016/j.neuint.2006.03.016; Zhao H, 2005, J NEUROSCI, V25, P9794, DOI 10.1523/JNEUROSCI.3163-05.2005; Zhao H, 2007, J NEUROSURG, V107, P636, DOI 10.3171/JNS-07/09/0636	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253328	10.1371/journal.pone.0253328	http://dx.doi.org/10.1371/journal.pone.0253328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138955	gold, Green Published			2022-12-26	WOS:000671690200043
J	Taylor, AM; Page, D; Okely, JA; Corley, J; Welstead, M; Skarabela, B; Redmond, P; Russ, TC; Cox, SR				Taylor, Adele M.; Page, Danielle; Okely, Judith A.; Corley, Janie; Welstead, Miles; Skarabela, Barbora; Redmond, Paul; Russ, Tom C.; Cox, Simon R.			Impact of COVID-19 lockdown on psychosocial factors, health, and lifestyle in Scottish octogenarians: The Lothian Birth Cohort 1936 study	PLOS ONE			English	Article							MINI-MENTAL-STATE; COGNITIVE FUNCTION; SOCIAL-ISOLATION; RISK-FACTORS; AGES 70; INTELLIGENCE; ASSOCIATIONS; PERSONALITY; LONELINESS; CHILDHOOD	Background Little is known about effects of COVID-19 lockdown on psychosocial factors, health and lifestyle in older adults, particularly those aged over 80 years, despite the risks posed by COVID-19 to this age group. Methods Lothian Birth Cohort 1936 members, residing mostly in Edinburgh and the surrounding Lothians regions in Scotland, mean age 84 years (SD = 0.3), responded to an online questionnaire in May 2020 (n = 190). We examined responses (experience and knowledge of COVID-19; adherence to guidance; impact on day-to-day living; social contact; self-reported physical and mental health; loneliness; and lifestyle) and relationships between previously-measured characteristics and questionnaire outcomes. Results Four respondents experienced COVID-19; most had good COVID-19 knowledge (94.7%) and found guidance easy to understand (86.3%). There were modest declines in self-reported physical and mental health, and 48.2% did less physical activity. In multivariable regression models, adherence to guidance by leaving the house less often associated with less professional occupational class (OR = 0.71, 95%CI 0.51-0.98) and poorer self-rated general health (OR = 0.62, 95%CI 0.42-0.92). Increased internet use associated with female sex (OR = 2.32, 95%CI 1.12-4.86) and higher general cognitive ability (OR = 1.53, 95%CI 1.03-2.33). Loneliness associated with living alone (OR = 0.15, 95%CI 0.07-0.31) and greater anxiety symptoms (OR = 1.76, 95%CI 0.45-1.24). COVID-19 related stress associated with lower emotional stability scores (OR = 0.40, 95%CI 0.24-0.62). Decreased physical activity associated with less professional occupational class (OR = 1.43, 95%CI 1.04-1.96), and lower general cognitive ability (OR = 0.679, 95%CI 0.491-0.931). Conclusions Characteristics including cognitive function, occupational class, self-rated health, anxiety, and emotional stability, may be related to risk of poorer lockdown-related psychosocial and physical outcomes.	[Taylor, Adele M.; Page, Danielle; Okely, Judith A.; Corley, Janie; Welstead, Miles; Skarabela, Barbora; Redmond, Paul; Russ, Tom C.; Cox, Simon R.] Univ Edinburgh, Dept Psychol, Lothian Birth Cohort Grp, Edinburgh, Midlothian, Scotland; [Russ, Tom C.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Russ, Tom C.] Univ Edinburgh, Ctr Clin Brain Sci, Div Psychiat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Page, D (corresponding author), Univ Edinburgh, Dept Psychol, Lothian Birth Cohort Grp, Edinburgh, Midlothian, Scotland.	danielle.page@ed.ac.uk	Russ, Tom/J-7114-2015; Cox, Simon R./HDN-8568-2022	Russ, Tom/0000-0001-9797-2188; Cox, Simon R./0000-0003-4036-3642; Page, Danielle/0000-0002-9273-9456	Age UK; UK Medical Research Council (MRC) [G0701120, G1001245, MR/M013111/1]; National Institutes of Health (NIH) [R01AG054628]; University of Edinburgh	Age UK; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Edinburgh	This research was conducted by the LBC1936 study team, which is funded by Age UK (Disconnected Mind programme grant). Additional funding from the UK Medical Research Council (MRC; G0701120, G1001245, MR/M013111/1), the National Institutes of Health (NIH; R01AG054628) and the University of Edinburgh is gratefully acknowledged. Age UK review overall plans for the LBC1936 study as part of the peerreview process during grant application. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz KI, 2019, AM J EPIDEMIOL, V188, P102, DOI 10.1093/aje/kwy231; Almutairi AF, 2020, RISK MANAG HEALTHC P, V13, P753, DOI 10.2147/RMHP.S257287; Altschul D, 2021, PSYCHOL MED, V51, P991, DOI 10.1017/S0033291719003933; Altschul DM, 2020, J GERONTOL B-PSYCHOL, V75, P474, DOI 10.1093/geronb/gbz149; Bacon AM, 2020, BRIT J HEALTH PSYCH, V25, P839, DOI 10.1111/bjhp.12423; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Bonanad C, 2020, J AM MED DIR ASSOC, V21, P915, DOI 10.1016/j.jamda.2020.05.045; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Case A, 2008, AM ECON REV, V98, P463, DOI 10.1257/aer.98.2.463; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Chawla S, 2020, J HLTH SOC SCI, V5, P187; Cheval B., 2020, CONDITIONS TECHNICO, DOI 10.31236/osf.io/ydv84; Chirico F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142470; Corley J, 2018, PSYCHOL MED, V48, P187, DOI 10.1017/S0033291717001489; Cowan K., 2020, ACAD MED SCI SURVEY; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Elovainio M, 2017, LANCET PUBLIC HEALTH, V2, pE260, DOI 10.1016/S2468-2667(17)30075-0; Fawns-Ritchie C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023929; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gale CR, 2016, J EPIDEMIOL COMMUN H, V70, P576, DOI 10.1136/jech-2015-205789; General Register Office, 1956, AN GEN PRACT REC APR; Miller JG, 2020, BRIT J HEALTH PSYCH, V25, P856, DOI 10.1111/bjhp.12426; GOLDBERG LR, 1990, J PERS SOC PSYCHOL, V59, P1216, DOI 10.1037/0022-3514.59.6.1216; Gonzalez-Sanguino C, 2020, BRAIN BEHAV IMMUN, V87, P172, DOI 10.1016/j.bbi.2020.05.040; Gow AJ, 2013, GERONTOLOGY, V59, P454, DOI 10.1159/000351265; Gow AJ, 2012, PSYCHOL AGING, V27, P250, DOI 10.1037/a0024144; Gow AJ, 2011, PSYCHOL AGING, V26, P232, DOI 10.1037/a0021072; Hamilton R, 2021, J PUBLIC POLICY MARK, V40, P99, DOI 10.1177/0743915620928110; Hawkley LC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0114; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Holt-Lunstad J, 2015, PERSPECT PSYCHOL SCI, V10, P227, DOI 10.1177/1745691614568352; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; IBM Corp, 2016, IBM SPSS STAT WIND V; Johnson W, 2012, LONGITUD LIFE COURSE, V3, P312; Johnson W, 2010, INTELLIGENCE, V38, P55, DOI 10.1016/j.intell.2009.11.008; Kriegsman DMW, 2004, J CLIN EPIDEMIOL, V57, P55, DOI 10.1016/S0895-4356(03)00258-0; Kwag KH, 2011, INT J AGING HUM DEV, V72, P137, DOI 10.2190/AG.72.2.c; Lau ALD, 2008, AGING MENT HEALTH, V12, P746, DOI 10.1080/13607860802380607; Lippi G, 2020, EUR J PREV CARDIOL, V27, P906, DOI 10.1177/2047487320916823; Luciano M, 2009, PSYCHOL AGING, V24, P129, DOI 10.1037/a0014780; McBride O., 2020, PSYARXIV, V30, P1861, DOI [10.31234/OSF.IO/WXE2N, DOI 10.31234/OSF.IO/WXE2N]; Nelson LM, 2020, JAMA INTERN MED, V180, P1020, DOI 10.1001/jamainternmed.2020.1369; NHS Inform, COR COVID 19 GEN ADV; Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370; Novotney A., 2019, MONITOR PSYCHOL, V50, P32; NRS, 2020, NRS KEY FIND; O'Conor R, 2020, J COMMUN HEALTH, V45, P1149, DOI 10.1007/s10900-020-00906-9; Office for National Statistics, 2020, COR ANX GREAT BRIT 3; Office for National Statistics, 2020, COR SOC IMP OLD PEOP; Office of Population Censuses and Surveys, 1980, CLASS OCC 1980; Okely JA, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010210; Okely JA, 2020, J GERONTOL A-BIOL, V75, P1393, DOI 10.1093/gerona/glaa023; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; RCore Team, 2020, R LANG ENV STAT COMP; Rimfeld K., 2020, GENETIC CORRELATES P, DOI [10.21203/rs.3.rs-31853/v132702738, DOI 10.21203/RS.3.RS-31853/V132702738]; Ritchie SJ, 2016, SPAN J PSYCHOL, V19, DOI 10.1017/sjp.2016.85; Ritchie SJ, 2016, INTELLIGENCE, V59, P115, DOI 10.1016/j.intell.2016.08.007; Roma P, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197252; Sainsbury S., 1973, MEASURING DISABILITY; Samson MM, 2000, AGE AGEING, V29, P235, DOI 10.1093/ageing/29.3.235; Schaie KW, 2004, AGING NEUROPSYCHOL C, V11, P304, DOI 10.1080/13825580490511134; Scotland Generation., 2020, COVIDLIFE SURV 1 REP; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Scottish Government, 2020, PRIM MIN STAT COR CO; Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd; Shenkin SD, 2008, INT J GERIATR PSYCH, V23, P1283, DOI 10.1002/gps.2066; Smith L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113138; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Taylor AM, 2018, INT J EPIDEMIOL, V47, P1042, DOI 10.1093/ije/dyy022; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Webb L, 2021, J PSYCHIATR MENT HLT, V28, P300, DOI 10.1111/jpm.12644; Wechsler D., 2008, WAIS 4 ADM SCORING M; Wolf MS, 2020, ANN INTERN MED, V173, P100, DOI 10.7326/M20-1239; World Health Organization, 2020, DIR GEN OP REM MED B; Wright L, 2020, J EPIDEMIOL COMMUN H, V74, P683, DOI 10.1136/jech-2020-214475; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	84	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253153	10.1371/journal.pone.0253153	http://dx.doi.org/10.1371/journal.pone.0253153			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138930	Green Published, gold, Green Submitted			2022-12-26	WOS:000671690200057
J	Burns, AB; Doris, C; Vehar, K; Saxena, V; Bardliving, C; Shamlou, PA; Phillips, MI				Burns, Andrew B.; Doris, Corinna; Vehar, Kevin; Saxena, Vinit; Bardliving, Cameron; Shamlou, Parviz A.; Phillips, M. Ian			Novel low shear 3D bioreactor for high purity mesenchymal stem cell production	PLOS ONE			English	Article							STROMAL CELLS; SCAFFOLDS; OXYGEN; DIFFERENTIATION; HYPOXIA; CULTURE; EXPANSION; THERAPY; SYSTEM	Eq 2: Specific growth rate. Where mu is the specific growth rate, T-2 is the total time elapse of the run, T-1 is the time of seeding, q(2) is the final cell yield, and q(1) is the initial cell seeding quantity. Eq 3: Where tau is the shear stress, eta is the viscosity of the liquid, and gamma is the strain rate (s(-1)). Eq 1: Doubling time. Where T-d is the doubling time, T-2 is the total time elapse of the run, T-1 is the time of seeding, q(2) is the final cell yield, and q(1) is the initial cell seeding quantity. Bone marrow derived human Mesenchymal Stem Cells (hMSCs) are an attractive candidate for regenerative medicine. However, their harvest can be invasive, painful, and expensive, making it difficult to supply the enormous amount of pure hMSCs needed for future allogeneic therapies. Because of this, a robust method of scaled bioreactor culture must be designed to supply the need for high purity, high density hMSC yields. Here we test a scaled down model of a novel bioreactor consisting of an unsubmerged 3D printed Polylactic Acid (PLA) lattice matrix wetted by culture media. The growth matrix is uniform, replicable, and biocompatible, enabling homogenous cell culture in three dimensions. The goal of this study was to prove that hMSCs would culture well in this novel bioreactor design. The system tested resulted in comparable stem cell yields to other cell culture systems using bone marrow derived hMSCs, while maintaining viability (96.54% +/- 2.82), high purity (>98% expression of combined positive markers), and differentiation potential.	[Burns, Andrew B.; Doris, Corinna; Vehar, Kevin; Phillips, M. Ian] Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA; [Saxena, Vinit] Sepragen Corp, Hayward, CA USA; [Bardliving, Cameron; Shamlou, Parviz A.] Jefferson Univ, Jefferson Inst Bioproc, Philadelphia, PA USA	Claremont Colleges; Keck Graduate Institute; Keck Graduate Institute of Applied Life Sciences; Jefferson University	Burns, AB (corresponding author), Keck Grad Inst Appl Life Sci, Claremont, CA 91711 USA.	aburns13@students.kgi.edu			Fenton Bioprocessing Leadership award	Fenton Bioprocessing Leadership award	This research was in part funded by the Fenton Bioprocessing Leadership award given to Keck Graduate Institute. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abdollahi H, 2011, J SURG RES, V165, P112, DOI 10.1016/j.jss.2009.09.057; ATCC, CHONDR DIFF TOOL ATC CHONDR DIFF TOOL ATC; Balikov DA, 2017, ACS APPL MATER INTER, V9, P22994, DOI 10.1021/acsami.7b06103; Chaudhuri J., 2005, BIOREACTORS TISSUE E; Ciria M, 2017, STEM CELLS DEV, V26, P973, DOI 10.1089/scd.2016.0331; Collignon F., 2012, INTEGRITY TM XPANSIO; Department of Health and Human Services, 2006, REGEN MED; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Elsawy MA, 2017, RENEW SUST ENERG REV, V79, P1346, DOI 10.1016/j.rser.2017.05.143; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Faiella W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1859567; Fernandes PR, 2002, J BIOMECH, V35, P167, DOI 10.1016/S0021-9290(01)00204-4; Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410; Giroux D., 2014, DEV SCALABLE MANUFAC; Glaser DE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166663; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065; Hu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32993; Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017; Jones ME, 2018, United States Patent Application, Patent No. 20180142199; Jossen V, 2018, APPL MICROBIOL BIOT, V102, P3981, DOI 10.1007/s00253-018-8912-x; Jossen V, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4760414; Kawano T, 2014, BIOMATER SCI-UK, V2, P52, DOI 10.1039/c3bm60195a; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kempf H, 2016, ADV DRUG DELIVER REV, V96, P18, DOI 10.1016/j.addr.2015.11.016; Kim KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092427; Kim SH, 2007, J IMMUNOL, V179, P2242, DOI 10.4049/jimmunol.179.4.2242; Kshitiz, 2012, INTEGR BIOL-UK, V4, P1008, DOI 10.1039/c2ib20080e; Kulangara K., 2012, NANOTOPOGRAPHY MODUL; Kwon SY, 2017, TISSUE ENG REGEN MED, V14, P595, DOI 10.1007/s13770-017-0068-8; Lawson T, 2017, BIOCHEM ENG J, V120, P49, DOI 10.1016/j.bej.2016.11.020; Lechanteur C., 2014, J STEM CELL RES THER, V4, P222, DOI [DOI 10.4172/2157-7633.1000222, 10.4172/2157-7633.1000222]; Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001; Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023; McBride SH, 2008, TISSUE ENG PT A, V14, P1573, DOI 10.1089/ten.tea.2008.0113; Mizukami A, 2018, STEM CELL REV REP, V14, P141, DOI 10.1007/s12015-017-9787-4; Mohanty S, 2015, MAT SCI ENG C-MATER, V55, P569, DOI 10.1016/j.msec.2015.06.002; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Moloudi R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31019-y; Nash ME, 2012, J MATER CHEM, V22, P19376, DOI 10.1039/c2jm31748f; Osiecki MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144941; Pall Corporation. iCELLis, SINGL US FIX BED BIO SINGL US FIX BED BIO; Rafiq QA., 2017, DOWNSTREAM PROCESSIN; Rodrigues AL, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800461; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; Schnitzler AC, 2016, BIOCHEM ENG J, V108, P3, DOI 10.1016/j.bej.2015.08.014; Shearier E, 2016, TISSUE ENG PART C-ME, V22, P360, DOI [10.1089/ten.tec.2015.0465, 10.1089/ten.TEC.2015.0465]; Singh N, 2013, BIOMACROMOLECULES, V14, P1287, DOI 10.1021/bm301762p; Singh V, 1999, CYTOTECHNOLOGY, V30, P149, DOI 10.1023/A:1008025016272; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Taherkhani S, 2016, J APPL POLYM SCI, V133, DOI 10.1002/app.43523; Tappa K, 2018, J FUNCT BIOMATER, V9, DOI 10.3390/jfb9010017; Timmins NE, 2012, BIOTECHNOL BIOENG, V109, P1817, DOI 10.1002/bit.24425; Tsai AC, 2016, BIOCHEM ENG J, V108, P51, DOI 10.1016/j.bej.2015.09.002; Vishnubhatla I., 2014, DEV STEM CELL DERIVE; Weber C., 2010, EXPANSION HUMAN ME A EXPANSION HUMAN ME A; Wurm MC, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0073-4; Xu Jia-Ying, 2016, Chronic Dis Transl Med, V2, P92, DOI 10.1016/j.cdtm.2016.09.006; Yeatts AB, 2011, TISSUE ENG PART C-ME, V17, P337, DOI [10.1089/ten.tec.2010.0172, 10.1089/ten.TEC.2010.0172]; Yourek G, 2010, REGEN MED, V5, P713, DOI 10.2217/RME.10.60; Yuan Haobo, 2018, Bioengineering-Basel, V5, P57, DOI 10.3390/bioengineering5030057; Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052	63	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252575	10.1371/journal.pone.0252575	http://dx.doi.org/10.1371/journal.pone.0252575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133442	Green Published, gold			2022-12-26	WOS:000671682700022
J	Weferling, M; Liebetrau, C; Renker, M; Fischer-Rasokat, U; Choi, YH; Hamm, CW; Kim, WK				Weferling, Maren; Liebetrau, Christoph; Renker, Matthias; Fischer-Rasokat, Ulrich; Choi, Yeoung-Hoon; Hamm, Christian W.; Kim, Won-Keun			Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation	PLOS ONE			English	Article							PERMANENT PACEMAKER IMPLANTATION; LONG-TERM OUTCOMES; CONDUCTION ABNORMALITIES; CLINICAL-OUTCOMES; EUROPEAN-SOCIETY; HEART-DISEASE; TASK-FORCE; REPLACEMENT; PREDICTORS; RISK	Background Transcatheter aortic valve implantation (TAVI) is the standard treatment option for patients with severe aortic stenosis (AS) at intermediate or high surgical risk. Preexisting right bundle branch block (RBBB) is a strong predictor of new pacemaker implantation (PPM) after TAVI, and previous data indicate a worse short- and long-term outcome of patients. The aim of this study was to investigate whether preexisting RBBB has an effect on the short- and mid-term outcome of patients undergoing TAVI in a German high-volume TAVI center. Methods For the present retrospective analysis, a total of 1,891 patients with native severe AS with successful TAVI without preexisting PPM were included. The primary endpoint was all-cause mortality after 30 days and 12 months. Baseline RBBB was present in 190 (10.1%) of cases. Results Patients with preexisting RBBB had a considerably higher rate of new PPM after TAVI compared with patients without RBBB (87/190 [45.8%] vs. 219/1,701 [12.9%]; p<0.001). RBBB had no impact on all-cause mortality at 30 days (2.1% vs. 2.7%; p = 0.625) and at 12 months (14.4% vs. 13.6%; p = 0.765). Further stratification according to the presence of new PPM showed a difference in mid-term survival rates between the four groups, with the worst outcome for patients without RBBB and new PPM (log rank p = 0.024). However, no difference in mid-term cardiovascular survival was found. Conclusion Preexisting RBBB is a common finding in patients with severe AS undergoing TAVI and is associated with considerably higher PPM rates but not with worse short- and mid-term outcome.	[Weferling, Maren; Renker, Matthias; Fischer-Rasokat, Ulrich; Hamm, Christian W.; Kim, Won-Keun] Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany; [Weferling, Maren; Hamm, Christian W.] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Berlin, Germany; [Liebetrau, Christoph] Agaples Bethanien Hosp, Cardioangiol Ctr Bethanien CCB, Dept Cardiol, Frankfurt, Germany; [Renker, Matthias; Choi, Yeoung-Hoon; Kim, Won-Keun] Kerckhoff Heart & Thorax Ctr, Dept Cardiac Surg, Bad Nauheim, Germany; [Hamm, Christian W.; Kim, Won-Keun] Univ Hosp Giessen, Dept Cardiol, Giessen, Germany	Kerckhoff Clinic; German Centre for Cardiovascular Research; Kerckhoff Clinic; University Hospital of Giessen & Marburg	Weferling, M (corresponding author), Kerckhoff Heart & Thorax Ctr, Dept Cardiol, Bad Nauheim, Germany.; Weferling, M (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Berlin, Germany.	m.weferling@kerckhoff-klinik.de	Renker, Matthias/GWG-8992-2022	Renker, Matthias/0000-0002-4756-5397				Abdel-Qadir HM, 2011, INT J CARDIOL, V146, P213, DOI 10.1016/j.ijcard.2010.01.012; Auffret V, 2017, CIRCULATION, V136, P1049, DOI 10.1161/CIRCULATIONAHA.117.028352; Auffret V, 2017, JACC-CARDIOVASC INTE, V10, P1564, DOI 10.1016/j.jcin.2017.05.030; Baumgartner H, 2017, EUR HEART J, V38, P2739, DOI 10.1093/eurheartj/ehx391; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Bussink BE, 2013, EUR HEART J, V34, P138, DOI 10.1093/eurheartj/ehs291; Calvi V, 2012, J INTERV CARD ELECTR, V34, P189, DOI 10.1007/s10840-011-9634-5; Chamandi C, 2018, JACC-CARDIOVASC INTE, V11, P301, DOI 10.1016/j.jcin.2017.10.032; Chen S, 2020, ANN CARDIOTHORAC SUR, V9, P452, DOI 10.21037/acs-2020-av-23; Elder DHJ, 2011, EXPERT REV CARDIOVAS, V9, P877, DOI [10.1586/erc.11.82, 10.1586/ERC.11.82]; Eriksson P, 1998, CIRCULATION, V98, P2494, DOI 10.1161/01.CIR.98.22.2494; Fadahunsi OO, 2016, JACC-CARDIOVASC INTE, V9, P2189, DOI 10.1016/j.jcin.2016.07.026; Fahy GJ, 1996, AM J CARDIOL, V77, P1185, DOI 10.1016/S0002-9149(96)00160-9; Gaede L, 2018, CLIN RES CARDIOL, V107, P60, DOI 10.1007/s00392-017-1158-2; Hamm CW, 2018, J AM COLL CARDIOL, V72, P689, DOI 10.1016/j.jacc.2018.06.025; Houthuizen P, 2014, EUROINTERVENTION, V9, P1142, DOI 10.4244/EIJV9I10A194; Husser O, 2019, JACC-CARDIOVASC INTE, V12, P1781, DOI 10.1016/j.jcin.2019.05.055; Husser O, 2016, JACC-CARDIOVASC INTE, V9, P244, DOI 10.1016/j.jcin.2015.09.036; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mangieri A, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00085; Mauri V, 2016, JACC-CARDIOVASC INTE, V9, P2200, DOI 10.1016/j.jcin.2016.08.034; Moreno R, 2009, CIRCULATION, V120, pE29, DOI 10.1161/CIRCULATIONAHA.109.849281; Nazif TM, 2015, JACC-CARDIOVASC INTE, V8, P60, DOI 10.1016/j.jcin.2014.07.022; Reardon MJ, 2017, NEW ENGL J MED, V376, P1321, DOI 10.1056/NEJMoa1700456; Regueiro A, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003635; Siontis GCM, 2014, J AM COLL CARDIOL, V64, P129, DOI 10.1016/j.jacc.2014.04.033; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Suravicz B CR., 2009, CIRCULATION, V119; Urena M, 2014, CIRCULATION, V129, P1233, DOI 10.1161/CIRCULATIONAHA.113.005479; van der Boon RM, 2012, NAT REV CARDIOL, V9, P454, DOI 10.1038/nrcardio.2012.58; van Gils L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005028; van Rosendael PJ, 2018, EUR HEART J, V39, P2003, DOI 10.1093/eurheartj/ehx785; Watanabe Y, 2016, JACC-CARDIOVASC INTE, V9, P2210, DOI 10.1016/j.jcin.2016.08.035; Xiong YY, 2015, CLIN CARDIOL, V38, P604, DOI 10.1002/clc.22454; Zhang ZM, 2012, AM J CARDIOL, V110, P1489, DOI 10.1016/j.amjcard.2012.06.060	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253332	10.1371/journal.pone.0253332	http://dx.doi.org/10.1371/journal.pone.0253332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133470	Green Published, gold			2022-12-26	WOS:000671682700036
J	Conley, JM; Sun, HM; Ayers, KL; Zhu, H; Chen, R; Shen, M; Hall, MD; Ren, HX				Conley, Jason M.; Sun, Hongmao; Ayers, Kristin L.; Zhu, Hu; Chen, Rong; Shen, Min; Hall, Matthew D.; Ren, Hongxia			Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ORPHAN RECEPTOR; AGRP NEURONS; GPCR; EXPRESSION; GENOME; INTERROGATION; OBESITY; SWITCH; FOXO1	GPR17 is a G-protein-coupled receptor (GPCR) implicated in the regulation of glucose metabolism and energy homeostasis. Such evidence is primarily drawn from mouse knockout studies and suggests GPR17 as a potential novel therapeutic target for the treatment of metabolic diseases. However, links between human GPR17 genetic variants, downstream cellular signaling, and metabolic diseases have yet to be reported. Here, we analyzed GPR17 coding sequences from control and disease cohorts consisting of individuals with adverse clinical metabolic deficits including severe insulin resistance, hypercholesterolemia, and obesity. We identified 18 nonsynonymous GPR17 variants, including eight variants that were exclusive to the disease cohort. We characterized the protein expression levels, membrane localization, and downstream signaling profiles of nine GPR17 variants (F43L, V96M, V103M, D105N, A131T, G136S, R248Q, R301H, and G354V). These nine GPR17 variants had similar protein expression and subcellular localization as wild-type GPR17; however, they showed diverse downstream signaling profiles. GPR17-G136S lost the capacity for agonist-mediated cAMP, Ca2+, and beta-arrestin signaling. GPR17-V96M retained cAMP inhibition similar to GPR17-WT, but showed impaired Ca2+ and beta-arrestin signaling. GPR17-D105N displayed impaired cAMP and Ca2+ signaling, but unaffected agonist-stimulated beta-arrestin recruitment. The identification and functional profiling of naturally occurring human GPR17 variants from individuals with metabolic diseases revealed receptor variants with diverse signaling profiles, including differential signaling perturbations that resulted in GPCR signaling bias. Our findings provide a framework for structure-function relationship studies of GPR17 signaling and metabolic disease.	[Conley, Jason M.; Ren, Hongxia] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Conley, Jason M.; Ren, Hongxia] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Sun, Hongmao; Zhu, Hu; Shen, Min; Hall, Matthew D.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Ayers, Kristin L.; Chen, Rong] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ayers, Kristin L.; Chen, Rong] Mt Sinai Venture, Sema4, Stamford, CT USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ren, HX (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA.	renh@iu.edu	zhu, hu/GQQ-8365-2022	Ren, Hongxia/0000-0003-2909-4365; Conley, Jason/0000-0003-4201-4112; Ayers, Kristin/0000-0002-4984-5229; Shen, Min/0000-0002-8218-0433	NIH [R00DK098294, R01DK120772]; CSCTR Early Career Development Award from Central Society for Clinical and Translational Research; Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF); Diabetes and Obesity Research Training award [T32DK064466]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSCTR Early Career Development Award from Central Society for Clinical and Translational Research; Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF); Diabetes and Obesity Research Training award	This work was supported by funding from NIH R00DK098294 (H. R.), NIH R01DK120772 (H. R.), CSCTR Early Career Development Award from Central Society for Clinical and Translational Research (H. R.), Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF) (H. R.), and Diabetes and Obesity Research Training award T32DK064466 (J. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2016, CELL REP, V17, P2966, DOI 10.1016/j.celrep.2016.11.050; Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baqi Y, 2018, J MED CHEM, V61, P8136, DOI 10.1021/acs.jmedchem.7b01768; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Barroso I, 2019, CELL, V177, P146, DOI 10.1016/j.cell.2019.02.024; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Blasius R, 1998, J NEUROCHEM, V70, P1357; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Gusach A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13348-2; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lee Y, 2020, NATURE, V583, P862, DOI 10.1038/s41586-020-2419-1; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lotta LA, 2019, CELL, V177, P597, DOI 10.1016/j.cell.2019.03.044; Luginina A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2518; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Mastaitis J, 2015, P NATL ACAD SCI USA, V112, P1845, DOI 10.1073/pnas.1424968112; Oprea TI, 2018, NAT REV DRUG DISCOV, V17, P317, DOI [10.1038/nrd.2018.14, 10.1038/nrd.2018.52]; Ou ZM, 2019, CELL REP, V26, P2984, DOI 10.1016/j.celrep.2019.02.060; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Reilly AM, 2019, NUTR DIABETES, V9, DOI 10.1038/s41387-019-0096-7; Ren HX, 2015, DIABETES, V64, P3670, DOI 10.2337/db15-0390; Ren HX, 2013, DIABETES, V62, P3373, DOI 10.2337/db13-0597; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Savova V, 2013, CURR OPIN GENET DEV, V23, P642, DOI 10.1016/j.gde.2013.09.001; Simon K, 2017, MOL PHARMACOL, V91, P518, DOI 10.1124/mol.116.107904; Sloop KW, 2018, BRIT J PHARMACOL, V175, P4060, DOI 10.1111/bph.14157; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zarzycka B, 2019, PHARMACOL REV, V71, P571, DOI 10.1124/pr.119.017863; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhou QT, 2019, ELIFE, V8, DOI 10.7554/eLife.50279; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	53	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100881	10.1016/j.jbc.2021.100881	http://dx.doi.org/10.1016/j.jbc.2021.100881			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144038	gold, Green Published			2022-12-26	WOS:000678068400080
J	Milicevic, N; Hakkari, OAH; Bagchi, U; Sandu, C; Jongejan, A; Moerland, PD; ten Brink, JB; Hicks, D; Bergen, AA; Felder-Schmittbuhl, MP				Milicevic, Nemanja; Hakkari, Ouafa Ait-Hmyed; Bagchi, Udita; Sandu, Cristina; Jongejan, Aldo; Moerland, Perry D.; ten Brink, Jacoline B.; Hicks, David; Bergen, Arthur A.; Felder-Schmittbuhl, Marie-Paule			Core circadian clock genes Per1 and Per2 regulate the rhythm in photoreceptor outer segment phagocytosis	FASEB JOURNAL			English	Article						circadian rhythm; clock gene; phagocytosis; photoreceptor; photoreceptor outer segment; retinal pigment epithelium	ARVICANTHIS-ANSORGEI; MAMMALIAN RETINA; ROD; EXPRESSION; ORGANIZATION; CELLS; MERTK; MPER2; COMPONENTS; MUTATIONS	Retinal photoreceptors undergo daily renewal of their distal outer segments, a process indispensable for maintaining retinal health. Photoreceptor outer segment (POS) phagocytosis occurs as a daily peak, roughly about 1 hour after light onset. However, the underlying cellular and molecular mechanisms which initiate this process are still unknown. Here we show that, under constant darkness, mice deficient for core circadian clock genes (Per1 and Per2) lack a daily peak in POS phagocytosis. By qPCR analysis, we found that core clock genes were rhythmic over 24 hours in both WT and Per1, Per2 double mutant whole retinas. More precise transcriptomics analysis of laser capture microdissected WT photoreceptors revealed no differentially expressed genes between time points preceding and during the peak of POS phagocytosis. In contrast, we found that microdissected WT retinal pigment epithelium (RPE) had a number of genes that were differentially expressed at the peak phagocytic time point compared to adjacent ones. We also found a number of differentially expressed genes in Per1, Per2 double mutant RPE compared to WT ones at the peak phagocytic time point. Finally, based on STRING analysis, we found a group of interacting genes that potentially drive POS phagocytosis in the RPE. This potential pathway consists of genes such as: Pacsin1, Syp, Camk2b, and Camk2d among others. Our findings indicate that Per1 and Per2 are necessary clock components for driving POS phagocytosis and suggest that this process is transcriptionally driven by the RPE.	[Milicevic, Nemanja; Bagchi, Udita; ten Brink, Jacoline B.; Bergen, Arthur A.] Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Milicevic, Nemanja; Hakkari, Ouafa Ait-Hmyed; Bagchi, Udita; Sandu, Cristina; Hicks, David; Felder-Schmittbuhl, Marie-Paule] Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France; [Jongejan, Aldo; Moerland, Perry D.] Amsterdam UMC, Dept Epidemiol & Data Sci, Bioinformat Lab, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Bergen, Arthur A.] Univ Amsterdam, Dept Ophthalmol, Amsterdam UMC, Amsterdam, Netherlands; [Bergen, Arthur A.] Netherlands Inst Neurosci NIN KNAW, Amsterdam, Netherlands	University of Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Bergen, AA (corresponding author), Univ Amsterdam, Dept Clin Genet, Amsterdam UMC, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.; Felder-Schmittbuhl, MP (corresponding author), Univ Strasbourg, CNRS, Inst Neurosci Cellulaires & Integrat, 8 Allee Gen Rouvillois, F-67000 Strasbourg, France.	aabergen@amsterdamumc.nl; feldermp@inci-cnrs.unistra.fr	Milićević, Nemanja/AAM-2103-2021; Moerland, Perry/AAG-1425-2020	Milićević, Nemanja/0000-0002-8062-7270; Moerland, Perry/0000-0002-2357-3659; Jongejan, Aldo/0000-0002-8948-2549; Felder-Schmittbuhl, Marie-Paule/0000-0003-3539-1243; Bergen, Arthur/0000-0002-6333-9576; BAGCHI, UDITA/0000-0001-7726-0319	NeuroTime Erasmus+ grant (European Union); Rotterdamse Stichting Blindenbelangen (Netherlands); Nelly Reef fund (Netherlands); Stichting voor Ooglijders (Netherlands); Stichting tot Verbetering van het Lot der Blinden (Netherlands); Retina France (France)	NeuroTime Erasmus+ grant (European Union); Rotterdamse Stichting Blindenbelangen (Netherlands)(Netherlands Government); Nelly Reef fund (Netherlands); Stichting voor Ooglijders (Netherlands); Stichting tot Verbetering van het Lot der Blinden (Netherlands); Retina France (France)	We thank Anneloor LMA ten Asbroek and Nguyen-Vy Vo for technical assistance. We thank Dr D. Sage, Dr S. Reibel and N. Lethenet from the Chronobiotron (UMS 3415) for animal care and Dr U. Albrecht (University of Freiburg) for the Per1<SUP>-/-</SUP>Per2<SUP>Brdm1</SUP> mice. This project has been funded with support from the NeuroTime Erasmus+ grant (European Union), Rotterdamse Stichting Blindenbelangen (Netherlands), Nelly Reef fund (Netherlands), Stichting voor Ooglijders (Netherlands), Stichting tot Verbetering van het Lot der Blinden (Netherlands), and Retina France (France).	Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Baba K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05394-x; Baba K, 2010, MOL VIS, V16, P2605; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BASSI CJ, 1986, PHYSIOL BEHAV, V38, P871, DOI 10.1016/0031-9384(86)90056-9; BESHARSE JC, 1983, NATURE, V305, P133, DOI 10.1038/305133a0; Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397; Bobu C, 2013, MOL VIS, V19, P1060; Bobu C, 2009, INVEST OPHTH VIS SCI, V50, P3495, DOI 10.1167/iovs.08-3145; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Daiger S. P., 1998, IOVS, V39, pS295; DeVera C., 2020, CIRCADIAN CLOCK RETI, DOI [10.1101/2020.12.02.408799, DOI 10.1101/2020.12.02.408799]; DeVera C, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107988; Esposito NJ, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.2.7; Farkas MH, 2014, AM J PATHOL, V184, P2641, DOI 10.1016/j.ajpath.2014.06.026; Felder-Schmittbuhl MP, 2018, INVEST OPHTH VIS SCI, V59, P4856, DOI 10.1167/iovs.18-24957; FISHER SK, 1983, INVEST OPHTH VIS SCI, V24, P844; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Goyal V, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.10; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Hiragaki S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106819; Ikarashi R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44175; Jaeger C, 2015, FASEB J, V29, P1493, DOI 10.1096/fj.14-261214; Johansson JK, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0681-1; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Ko GYP, 2020, EUR J NEUROSCI, V51, P194, DOI 10.1111/ejn.14185; Krigel A, 2010, MOL VIS, V16, P2873; Laurent V, 2017, EXP EYE RES, V165, P90, DOI 10.1016/j.exer.2017.09.007; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; LAVAIL MM, 1980, INVEST OPHTH VIS SCI, V19, P407; Law AL, 2015, J BIOL CHEM, V290, P4941, DOI 10.1074/jbc.M114.628297; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050602; Louer EMM, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.5.49; Louer EMM, 2020, EXP EYE RES, V193, DOI 10.1016/j.exer.2020.107985; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazzoni F, 2019, METHODS MOL BIOL, V1834, P95, DOI 10.1007/978-1-4939-8669-9_7; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; McMahon DG, 2014, PROG RETIN EYE RES, V39, P58, DOI 10.1016/j.preteyeres.2013.12.001; Milicevic N, 2020, EXP EYE RES, V190, DOI 10.1016/j.exer.2019.107861; Milicevic N, 2019, CHRONOBIOL INT, V36, P1592, DOI 10.1080/07420528.2019.1653317; Milicevic N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48203-3; Morioka E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00108; Muller C, 2014, CELL SIGNAL, V26, P968, DOI 10.1016/j.cellsig.2013.12.021; Muller C, 2020, RETINAL PIGMENT EPITHELIUM IN HEALTH AND DISEASE, P47, DOI 10.1007/978-3-030-28384-1_3; Mure LS, 2018, SCIENCE, V359, P1232, DOI 10.1126/science.aao0318; Nandrot EE, 2004, J EXP MED, V200, P1539, DOI 10.1084/jem.20041447; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Ribelayga C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011020; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ruan GX, 2006, P NATL ACAD SCI USA, V103, P9703, DOI 10.1073/pnas.0601940103; Ruan GX, 2008, PLOS BIOL, V6, P2248, DOI 10.1371/journal.pbio.0060249; Sandu C, 2011, EUR J NEUROSCI, V34, P507, DOI 10.1111/j.1460-9568.2011.07772.x; Sayols S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1276-2; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Stratmann M, 2006, J BIOL RHYTHM, V21, P494, DOI 10.1177/0748730406293889; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang Y, 2015, METAB BRAIN DIS, V30, P943, DOI 10.1007/s11011-015-9653-5; TERMAN JS, 1993, BRAIN RES, V605, P256; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Wilson T., 1995, P167; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zhang DQ, 2005, BRAIN RES, V1050, P101, DOI 10.1016/j.brainres.2005.05.042; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	76	12	12	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21722	10.1096/fj.202100293RR	http://dx.doi.org/10.1096/fj.202100293RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160105	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000667814100061
J	Coil, DA; Albertson, T; Banerjee, S; Brennan, G; Campbell, AJ; Cohen, SH; Dandekar, S; Diaz-Munoz, SL; Eisen, JA; Goldstein, T; Jose, IR; Juarez, M; Robinson, BA; Rothenburg, S; Sandrock, C; Stoian, AMM; Tompkins, DG; Tremeau-Bravard, A; Haczku, A				Coil, David A.; Albertson, Timothy; Banerjee, Shefali; Brennan, Greg; Campbell, A. J.; Cohen, Stuart H.; Dandekar, Satya; Diaz-Munoz, Samuel L.; Eisen, Jonathan A.; Goldstein, Tracey; Jose, Ivy R.; Juarez, Maya; Robinson, Brandt A.; Rothenburg, Stefan; Sandrock, Christian; Stoian, Ana M. M.; Tompkins, Daniel G.; Tremeau-Bravard, Alexandre; Haczku, Angela			SARS-CoV-2 detection and genomic sequencing from hospital surface samples collected at UC Davis	PLOS ONE			English	Article							CORONAVIRUS 2 SARS-COV-2; CONTAMINATION; EQUIPMENT	Rationale There is little doubt that aerosols play a major role in the transmission of SARS-CoV-2. The significance of the presence and infectivity of this virus on environmental surfaces, especially in a hospital setting, remains less clear. Objectives We aimed to analyze surface swabs for SARS-CoV-2 RNA and infectivity, and to determine their suitability for sequence analysis. Methods Samples were collected during two waves of COVID-19 at the University of California, Davis Medical Center, in COVID-19 patient serving and staff congregation areas. qRT-PCR positive samples were investigated in Vero cell cultures for cytopathic effects and phylogenetically assessed by whole genome sequencing. Measurements and main results Improved cleaning and patient management practices between April and August 2020 were associated with a substantial reduction of SARS-CoV-2 qRT-PCR positivity (from 11% to 2%) in hospital surface samples. Even though we recovered near-complete genome sequences in some, none of the positive samples (11 of 224 total) caused cytopathic effects in cultured cells suggesting this nucleic acid was either not associated with intact virions, or they were present in insufficient numbers for infectivity. Phylogenetic analysis suggested that the SARS-CoV-2 genomes of the positive samples were derived from hospitalized patients. Genomic sequences isolated from qRT-PCR negative samples indicate a superior sensitivity of viral detection by sequencing. Conclusions This study confirms the low likelihood that SARS-CoV-2 contamination on hospital surfaces contains infectious virus, disputing the importance of fomites in COVID-19 transmission. Ours is the first report on recovering near-complete SARS-CoV-2 genome sequences directly from environmental surface swabs.	[Coil, David A.; Diaz-Munoz, Samuel L.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Albertson, Timothy; Juarez, Maya; Robinson, Brandt A.; Sandrock, Christian; Tompkins, Daniel G.; Haczku, Angela] Univ Calif Davis, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA; [Banerjee, Shefali; Brennan, Greg; Dandekar, Satya; Eisen, Jonathan A.; Rothenburg, Stefan; Stoian, Ana M. M.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Campbell, A. J.; Diaz-Munoz, Samuel L.; Jose, Ivy R.] Univ Calif Davis, Coll Biol Sci, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Cohen, Stuart H.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Infect Dis, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Goldstein, Tracey; Tremeau-Bravard, Alexandre] Univ Calif Davis, Hlth Inst 1, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Haczku, A (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Davis, CA 95616 USA.	haczku@ucdavis.edu	Eisen, Jonathan A./H-2706-2019	Eisen, Jonathan A./0000-0002-0159-2197; Coil, David/0000-0001-6049-8240; Campbell, A.J./0000-0003-4780-0227; Diaz-Munoz, Samuel/0000-0003-2967-9806	UC Davis CRAFT Award; Chester Robbins Endowment	UC Davis CRAFT Award; Chester Robbins Endowment	Funding for this work was provided by a UC Davis CRAFT Award (JAE and DAC) and The Chester Robbins Endowment (AH).	Aboubakr HA, 2021, TRANSBOUND EMERG DIS, V68, P296, DOI 10.1111/tbed.13707; Ben-Shmuel A, 2020, CLIN MICROBIOL INFEC, V26, P1658, DOI 10.1016/j.cmi.2020.09.004; Bilal M., 2020, CASE STUDIES CHEM EN, V2; Chia PY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16670-2; Colaneri M, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.009; Colaneri M, 2020, J HOSP INFECT, V105, P474, DOI 10.1016/j.jhin.2020.03.018; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Crits-Christoph A, 2021, MBIO, V12, DOI 10.1128/mBio.02703-20; Declementi M, 2020, MED LAV, V111, P372, DOI 10.23749/mdl.v111i5.9991; Fontenele RS, 2021, WATER RES, V205, DOI [10.1016/j.watres.2021.117710, 10.1101/2021.01.22.21250320]; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harvey Abigail P, 2020, medRxiv, DOI 10.1101/2020.10.27.20220905; Hirose R., 2020, CLIN INFECT DIS; Horve P.F., 2020, IDENTIFICATION SARS; Hu XW, 2020, SCI TOTAL ENVIRON, V742, DOI 10.1016/j.scitotenv.2020.140620; Izquierdo Lara RW., 2020, MONITORING SARS COV, DOI [10.1101/2020.09.21.20198838, DOI 10.1101/2020.09.21.20198838]; Jan I, 2020, JAMA ONCOL, V6, P1632, DOI 10.1001/jamaoncol.2020.3552; Kasloff SB, 2020, STABILITY SARS COV 2; Lednickya JA, 2020, INT J INFECT DIS, V100, P476, DOI [10.1016/j.ijid.2020.09.025, 10.1101/2020.08.03.20167395]; Lei H, 2020, INFLUENZA OTHER RESP, V14, P688, DOI 10.1111/irv.12783; Li YH., 2020, EMERG MICROBES INFEC, V148, P154, DOI [10.1017/S0950268820001570, DOI 10.1080/22221751.2020.1782774]; Maestre JP., 2020, DISTRIBUTION SARS CO, DOI [10.1101/2020.11.30.20234393v1.abstract, DOI 10.1101/2020.11.30.20234393V1.ABSTRACT]; McCuen MM, 2021, TRANSBOUND EMERG DIS, V68, P98, DOI 10.1111/tbed.13612; Meyerowitz EA, 2021, ANN INTERN MED, V174, P69, DOI 10.7326/M20-5008; Mouchtouri VA, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113599; Nakamura Keiji, 2020, Infect Prev Pract, V2, P100098, DOI 10.1016/j.infpip.2020.100098; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Parker CW, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00771-20; Peyrony O, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113600; Rambaut A, 2020, DYNAMIC NOMENCLATURE, V5, P1403, DOI 10.1101/2020.04.17.046086; Riddell S, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01418-7; Santarpia JL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69286-3; Tyson John R, 2020, bioRxiv, DOI 10.1101/2020.09.04.283077; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wei L, 2020, ANTIMICROB RESIST IN, V9, DOI 10.1186/s13756-020-00839-x; Wu SJ, 2020, AM J INFECT CONTROL, V48, P910, DOI 10.1016/j.ajic.2020.05.003; Xie XP, 2020, CELL HOST MICROBE, V27, P841, DOI 10.1016/j.chom.2020.04.004; Ye G., 2020, J INFECTION, V81, pE1, DOI [10.1016/j.jinf.2020.04.034, DOI 10.1016/j.jinf.2020.04.034]; Zhou L, 2021, J AEROSOL SCI, V152, DOI 10.1016/j.jaerosci.2020.105693	40	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253578	10.1371/journal.pone.0253578	http://dx.doi.org/10.1371/journal.pone.0253578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166421	Green Submitted, Green Published, gold			2022-12-26	WOS:000671692800022
J	Riviere, C; Bell, T; Cadot, Y; Perodin, C; Charles, B; Bertil, C; Cheung, J; Bane, S; Cheung, HC; Pape, JW; Deschamps, MM				Riviere, Cynthia; Bell, Tatiana; Cadot, Yonie; Perodin, Christian; Charles, Benedict; Bertil, Claudin; Cheung, Jazreel; Bane, Shalmali; Cheung, Hoi Ching; Pape, Jean William; Deschamps, Marie Marcelle			Success of community approach to HPV vaccination in school-based and non-school-based settings in Haiti	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; CERVICAL-CANCER; COVERAGE	Objectives To assess the success of a human papillomavirus (HPV) vaccination program among adolescent girls aged 9-14 years in Haiti and to understand predictors of completion of a two-dose HPV vaccination series. Methods Data collection was conducted during HPV vaccination campaigns in Port-au-Prince between August 2016 and April 2017. Descriptive statistics and logistic regression models were used to examine characteristics associated with vaccination series completion of school based and non-school based vaccination delivery modalities. Results Of the 2,445 adolescent girls who participated in the awareness program, 1,994 participants (1,307 in non-school program, 687 in school program) received the first dose of the vaccine; 1,199 (92%) in the non-school program and 673 (98%) in the school program also received the second dose. Menarche (OR: 1.87; 95% CI, 1.11-3.14), if the participant was a prior patient at the GHESKIO clinics (OR: 2.17; 95% CI, 1.32-3.58), and participating in the school-based program (OR: 4.17; 95% CI, 2.14-8.12) were significantly associated with vaccination completion. Conclusions Vaccination in school- and non-school-based settings was successful, suggesting that a nationwide HPV vaccination campaign using either approach would be successful using either approach.	[Riviere, Cynthia; Bell, Tatiana; Cadot, Yonie; Perodin, Christian; Charles, Benedict; Bertil, Claudin; Pape, Jean William; Deschamps, Marie Marcelle] GHESKIO Ctr, Port Au Prince, Haiti; [Cheung, Jazreel; Bane, Shalmali; Cheung, Hoi Ching] Anal Grp Inc, Boston, MA 02199 USA; [Pape, Jean William] Weill Cornell Med Coll, Ctr Global Hlth, Dept Med, Div Infect Dis, New York, NY USA; [Cheung, Jazreel] Childrens Hosp Philadelphia, Ctr Healthcare Qual & Analyt, Philadelphia, PA 19104 USA; [Bane, Shalmali] Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA	Analysis Group Inc.; Cornell University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Stanford University	Bane, S (corresponding author), Anal Grp Inc, Boston, MA 02199 USA.; Bane, S (corresponding author), Stanford Univ, Dept Epidemiol & Populat Hlth, Stanford, CA 94305 USA.	shalmali.bane@gmail.com		Perodin, Christian/0000-0002-1099-1413; Cheung, Hoi Ching/0000-0001-7651-4903	MSPP; Merck Pharmaceuticals	MSPP; Merck Pharmaceuticals(Merck & Company)	This project carried out at GHESKIO was supported by the MSPP, Partners in Health, and Merck Pharmaceuticals. No funding was received for the conduct of this project. The Analysis Group Inc. provided support in the form of salaries for authors [JC, SB, HC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `Author Contributions' section of the manuscript.	[Anonymous], 2013, HUMAN PAPILLOMAVIRUS; Binagwaho A, 2012, B WORLD HEALTH ORGAN, V90, P623, DOI 10.2471/BLT.11.097253; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Delany-Moretlwe S, 2018, GLOB HEALTH-SCI PRAC, V6, P425, DOI 10.9745/GHSP-D-18-00090; Food and Drug Administration, PACK INS GARD 9 PACK INS GARD 9; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; ICO/IARC Information Centre on HPV and Cancer, HAIT HUM PAP REL CAN HAIT HUM PAP REL CAN; Katz IT, 2006, NEW ENGL J MED, V354, P1110, DOI 10.1056/NEJMp068031; Klinsupa W, 2015, SEX TRANSM INFECT, V91, pA61, DOI 10.1136/sextrans-2015-052270.167; Ladner J, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1824-5; Ladner J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-670; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Oberlin AM, 2018, INT J GYNECOL OBSTET, V143, P267, DOI 10.1002/ijgo.12656; Paul P, 2014, VACCINE, V32, P320, DOI 10.1016/j.vaccine.2013.11.070; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Sherr K., 2018, IMPLEMENT SCI, V13; Sherris J, 2001, WESTERN J MED, V175, P231, DOI 10.1136/ewjm.175.4.231; Small W, 2017, CANCER-AM CANCER SOC, V123, P2404, DOI 10.1002/cncr.30667; Soi C, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08958-1; Soi C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7793-y; Torres-Rueda S, 2016, SEX REPROD HEALTHC, V7, P46, DOI 10.1016/j.srhc.2015.11.006; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; World Health Organization, 2019, WHO HUM PAP HPV POS WHO HUM PAP HPV POS; Zanmi Lasante, 2011, RESULTS SCH BASED PI	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252310	10.1371/journal.pone.0252310	http://dx.doi.org/10.1371/journal.pone.0252310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166437	Green Published, gold			2022-12-26	WOS:000671692800099
J	Yip, CH; Mahalingam, S; Wan, KL; Nathan, S				Yip, Chee-Hoo; Mahalingam, Sobina; Wan, Kiew-Lian; Nathan, Sheila			Prodigiosin inhibits bacterial growth and virulence factors as a potential physiological response to interspecies competition	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA BIOFILMS; OPRM EFFLUX PUMP; SERRATIA-MARCESCENS; ANTIMICROBIAL ACTIVITY; EXTRACELLULAR PROTEASE; ENHANCED PRODUCTION; NATURAL-PRODUCTS; BIOSYNTHESIS; RESISTANCE; DNA	Prodigiosin, a red linear tripyrrole pigment, has long been recognised for its antimicrobial property. However, the physiological contribution of prodigiosin to the survival of its producing hosts still remains undefined. Hence, the aim of this study was to investigate the biological role of prodigiosin from Serratia marcescens, particularly in microbial competition through its antimicrobial activity, towards the growth and secreted virulence factors of four clinical pathogenic bacteria (methicillin-resistant Staphylococcus aureus (MRSA), Enterococcus faecalis, Salmonella enterica serovar Typhimurium and Pseudomonas aeruginosa) as well as Staphylococcus aureus and Escherichia coli. Prodigiosin was first extracted from S. marcescens and its purity confirmed by absorption spectrum, high performance liquid chromatography (HPLC) and liquid chromatography-tandem mass spectrophotometry (LC-MS/MS). The extracted prodigiosin was antagonistic towards all the tested bacteria. A disc-diffusion assay showed that prodigiosin is more selective towards Gram-positive bacteria and inhibited the growth of MRSA, S. aureus and E. faecalis and Gram-negative E. coli. A minimum inhibitory concentration of 10 mu g/mu L of prodigiosin was required to inhibit the growth of S. aureus, E. coli and E. faecalis whereas > 10 mu g/mu L was required to inhibit MRSA growth. We further assessed the effect of prodigiosin towards bacterial virulence factors such as haemolysin and production of protease as well as on biofilm formation. Prodigiosin did not inhibit haemolysis activity of clinically associated bacteria but was able to reduce protease activity for MRSA, E. coli and E. faecalis as well as decrease E. faecalis, Salmonella Typhimurium and E. coli biofilm formation. Results of this study show that in addition to its role in inhibiting bacterial growth, prodigiosin also inhibits the bacterial virulence factor protease production and biofilm formation, two strategies employed by bacteria in response to microbial competition. As clinical pathogens were more resistant to prodigiosin, we propose that prodigiosin is physiologically important for S. marcescens to compete against other bacteria in its natural soil and surface water environments.	[Yip, Chee-Hoo; Mahalingam, Sobina; Wan, Kiew-Lian; Nathan, Sheila] Univ Kebangsaan Malaysia, Fac Sci & Technol, Dept Biol Sci & Biotechnol, Bangi, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Nathan, S (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Dept Biol Sci & Biotechnol, Bangi, Selangor, Malaysia.	sheila@ukm.edu.my	Yip, Chee Hoo/AAY-4222-2021; Nathan, Sheila/C-1182-2011	Yip, Chee Hoo/0000-0003-4350-8392; Nathan, Sheila/0000-0002-2132-2346	Universiti Kebangsaan Malaysia [ST-2018-004]	Universiti Kebangsaan Malaysia	This work was funded through the grant ST-2018-004 and internal funds from Universiti Kebangsaan Malaysia awarded to SN. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armstrong E, 2001, HYDROBIOLOGIA, V461, P37, DOI 10.1023/A:1012756913566; Bagge N, 2004, ANTIMICROB AGENTS CH, V48, P1175, DOI 10.1128/AAC.48.4.1175-1187.2004; Barka EA, 2016, MICROBIOL MOL BIOL R, V80, P1, DOI 10.1128/MMBR.00019-15; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Boehm A.B., 2014, ENTEROCOCCI COMMENSA, P101; Boerlin P, 2003, J CLIN MICROBIOL, V41, P767, DOI 10.1128/JCM.41.2.767-771.2003; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boric M, 2011, MICROB ECOL, V62, P528, DOI 10.1007/s00248-011-9857-0; Cameotra SS, 2010, ADV EXP MED BIOL, V672, P261; Velasquez FC, 2015, BBA-BIOMEMBRANES, V1848, P2779, DOI 10.1016/j.bbamem.2015.08.012; de Araujo HWC, 2010, MOLECULES, V15, P6931, DOI 10.3390/molecules15106931; Clements T, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.633870; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Danevcic T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162412; Danevcic T, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00027; Darshan N, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-016-0222-z; De Vuyst L, 2003, INT J FOOD MICROBIOL, V84, P299, DOI 10.1016/S0168-1605(02)00425-7; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Garneau-Tsodikova S, 2006, J AM CHEM SOC, V128, P12600, DOI 10.1021/ja063611l; Gates KS., 1999, COMPREHENSIVE NATURA, P492; Geisseler D, 2008, SOIL BIOL BIOCHEM, V40, P3040, DOI 10.1016/j.soilbio.2008.09.001; Georgescu M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1396-3; Gulani C, 2012, MALAYS J MICROBIOL, V8, P116, DOI 10.21161/mjm.03612; Haddix PL, 2008, J BACTERIOL, V190, P7453, DOI 10.1128/JB.00909-08; Hamid R., 2013, ADV ENVIRON BIOL, V7, P356; Harris AKP, 2004, MICROBIOL-SGM, V150, P3547, DOI 10.1099/mic.0.27222-0; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1371, DOI 10.1128/AAC.47.4.1371-1375.2003; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Ibrahim D., 2014, J APPL PHARM SCI, V4, P1, DOI [10.7324/JAPS.2014.401001, DOI 10.7324/JAPS.2014.401001]; Jafarzade M, 2012, NAT RESOUR, V3, P171, DOI DOI 10.4236/NR.2012.34022; Ji Keunho, 2019, Microbiology and Biotechnology Letters, V47, P459, DOI 10.4014/mbl.1901.01006; Jimtha CJ, 2017, RHIZOSPHERE-NETH, V3, P105, DOI 10.1016/j.rhisph.2017.02.003; Jolicoeur B, 2008, CAN J CHEM, V86, P213, DOI 10.1139/V07-150; Kamble KD., 2012, INT J ENV SCI, V3, P631, DOI DOI 10.6088/IJES.2012030131061; Kaplan JB, 2012, MBIO, V3, DOI 10.1128/mBio.00198-12; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Katayama Y, 2013, J BACTERIOL, V195, P1194, DOI 10.1128/JB.01786-12; Keunho Ji, 2015, [Journal of Life Science, 생명과학회지], V25, P29; Kimyon O, 2016, FRONT MICROBIOL, P7, DOI [10.3389/fmicb.2016.00007, DOI 10.3389/FMICB.2016.00007]; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Layton BA, 2010, J APPL MICROBIOL, V109, P539, DOI 10.1111/j.1365-2672.2010.04675.x; Lee JS, 2011, APPL ENVIRON MICROB, V77, P4967, DOI 10.1128/AEM.01986-10; Lee MA, 2000, FEMS MICROBIOL LETT, V192, P67, DOI 10.1016/S0378-1097(00)00410-9; Lin CQ, 2019, ELECTRON J BIOTECHN, V40, P58, DOI 10.1016/j.ejbt.2019.04.007; Lopez D, 2009, P NATL ACAD SCI USA, V106, P280, DOI 10.1073/pnas.0810940106; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Maseda H, 2004, ANTIMICROB AGENTS CH, V48, P1320, DOI 10.1128/AAC.48.4.1320-1328.2004; Melvin MS, 2000, J AM CHEM SOC, V122, P6333, DOI 10.1021/ja0000798; Melvin MS, 2002, CHEM RES TOXICOL, V15, P742, DOI 10.1021/tx025508p; Miki T, 2004, MICROB PATHOGENESIS, V37, P65, DOI 10.1016/j.micpath.2004.04.006; MISAWA N, 1995, J CLIN MICROBIOL, V33, P729, DOI 10.1128/JCM.33.3.729-731.1995; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Morita Y, 2001, J GEN APPL MICROBIOL, V47, P27, DOI 10.2323/jgam.47.27; Nakashima T, 2005, BIOL PHARM BULL, V28, P2289, DOI 10.1248/bpb.28.2289; Oliveira NM, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002191; Oppegaard O, 2017, DIAGN MICR INFEC DIS, V89, P135, DOI [10.1016/j.diagmicrobio2017.06D15, 10.1016/j.diagmicrobio.2017.06.015]; Pandey B, 2004, J BIOL SCI, V23, P44; Papireddy K, 2011, J MED CHEM, V54, P5296, DOI 10.1021/jm200543y; Poonsuk K., 2014, OPEN J MED MICROBIOL, V4, P153; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Priya KA, 2013, MICROBIOLOGICAL RES, V1st, P11, DOI DOI 10.1007/978-81-322-1087-0_2; Qiu JZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009736; Regua-Mangia AH, 2010, J BASIC MICROB, V50, pS107, DOI 10.1002/jobm.200900364; Rubin S, 2016, CRIT REV EUKAR GENE, V26, P199, DOI 10.1615/CritRevEukaryotGeneExpr.2016016525; RYAZANTSEVA IN, 1995, THERMOCHIM ACTA, V251, P63, DOI 10.1016/0040-6031(94)02148-H; Samrot AV, 2011, INT RES J BIOTECHNOL, V2, P128; SCANNELL RT, 1988, J AM CHEM SOC, V110, P3650, DOI 10.1021/ja00219a046; Schumann P, 2011, METHOD MICROBIOL, V38, P101, DOI 10.1016/B978-0-12-387730-7.00005-X; Seah SW, 2020, SAINS MALAYS, V49, P775, DOI 10.17576/jsm-2020-4904-06; Sefton AM, 2002, DRUGS, V62, P557, DOI 10.2165/00003495-200262040-00001; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Song MJ, 2006, J BIOSCI BIOENG, V101, P157, DOI 10.1263/jbb.101.157; Srivastava VK, 2014, BIOCHEM J, V463, P103, DOI 10.1042/BJ20140598; Stankovic N, 2014, APPL MICROBIOL BIOT, V98, P3841, DOI 10.1007/s00253-014-5590-1; Staric N, 2010, MICROB ECOL, V60, P592, DOI 10.1007/s00248-010-9671-0; Sumathi C, 2014, SCI WORLD J, DOI 10.1155/2014/290327; Suryavanshi MV., 2016, J APPL PHARM SCI, V6, P52; Suryawanshi RK, 2017, NAT PROD RES, V31, P572, DOI 10.1080/14786419.2016.1195380; Suryawanshi RK, 2015, PESTIC BIOCHEM PHYS, V123, P49, DOI 10.1016/j.pestbp.2015.01.018; Thiran E, 2018, J DAIRY SCI, V101, P1000, DOI 10.3168/jds.2017-13696; Walther B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02516; Wang F, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue4-fulltext-7; Wang ZY, 2016, P NATL ACAD SCI USA, V113, P13150, DOI 10.1073/pnas.1616336113; Werner T., 2000, BIOSCENE, V26, P3; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; WILLIAMS RP, 1973, APPL MICROBIOL, V25, P396, DOI 10.1128/AEM.25.3.396-402.1973; Williamson NR, 2005, MOL MICROBIOL, V56, P971, DOI 10.1111/j.1365-2958.2005.04602.x; Wood TL, 2018, NPJ BIOFILMS MICROBI, V4, DOI 10.1038/s41522-018-0066-1; Yip CH, 2019, APPL MICROBIOL BIOT, V103, P1667, DOI 10.1007/s00253-018-09611-z; You ZY, 2019, APPL MICROBIOL BIOT, V103, P2873, DOI 10.1007/s00253-019-09641-1; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788	95	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253445	10.1371/journal.pone.0253445	http://dx.doi.org/10.1371/journal.pone.0253445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161391	gold, Green Published			2022-12-26	WOS:000671691900064
J	Zhao, L; Jiang, LY; Zhang, M; Zhang, Q; Guan, QT; Li, YL; He, M; Zhang, JD; Wei, MJ				Zhao, Lin; Jiang, Longyang; Zhang, Ming; Zhang, Qiang; Guan, Qiutong; Li, Yalun; He, Miao; Zhang, Jingdong; Wei, Minjie			NF-kappa B-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay	ONCOGENE			English	Article							UP-REGULATION; ADENOCARCINOMA; STAUFEN1	Previous study demonstrated that most long non-coding RNAs (lncRNAs) function as competing endogenous RNAs or molecular sponges to negatively modulate miRNA and regulate tumor development. However, the molecular mechanisms of lncRNAs in cancer are not fully understood. Our study describes the role of the lncRNA SPRY4 intronic transcript 1 (SPRY4-IT1) in cancer metastasis by mechanisms related to Staufen1 (STAU1)-mediated mRNA decay (SMD). Briefly, we found that, high SPRY4-IT1 expression was associated with aggressiveness and poor outcome in human colorectal, breast and ovarian cancer tissues. In addition, functional assays revealed that SPRY4-IT1 significantly promoted colorectal, breast and ovarian cancer metastasis in vitro and in vivo. Mechanistically, microarray analyses identified several differentially-expressed genes upon SPRY4-IT1 overexpression in HCT 116 colorectal cancer cells. Among them, the 3 '-UTR of transcription elongation factor B subunit 1 (TCEB1) mRNA can base-pair with the Alu element in the 3 '-UTR of SPRY4-IT1. Moreover, SPRY4-IT1 was found to bind STAU1, promote STAU1 recruitment to the 3 '-UTR of TCEB1 mRNA, and affect TCEB1 mRNA stability and expression, resulting in hypoxia-inducible factor 1 alpha (HIF-1 alpha) upregulation, and thereby affecting cancer cell metastasis. In addition, STAU1 depletion abrogated TCEB1 SMD and alleviated the pro-metastatic effect of SPRY4-IT1 overexpression. Significantly, we revealed that SPRY4-IT1 is also transactivated by NF-kappa B/p65, which activates SPRY4-IT1 to inhibit TCEB1 expression, and subsequently upregulate HIF-1 alpha. In conclusion, our results highlight a novel mechanism of cytoplasmic lncRNA SPRY4-IT1 in which SPRY4-IT1 affecting TCEB1 mRNA stability via STAU1-mediated degradation during cancer metastasis.	[Zhao, Lin; Jiang, Longyang; Zhang, Ming; Zhang, Qiang; Guan, Qiutong; He, Miao; Wei, Minjie] China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zhao, Lin; Jiang, Longyang; Zhang, Ming; Zhang, Qiang; Guan, Qiutong; He, Miao; Wei, Minjie] China Med Univ, Liaoning Key Lab Mol Targeted Antitumor Drug Dev, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Li, Yalun] China Med Univ, Hosp 1, Dept Anorectal Surg, Shenyang, Peoples R China; [Zhang, Jingdong] China Med Univ, Med Oncol Dept Gastrointestinal Canc, Liaoning Canc Hosp & Inst, Canc Hosp, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Wei, MJ (corresponding author), China Med Univ, Sch Pharm, Dept Pharmacol, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Wei, MJ (corresponding author), China Med Univ, Liaoning Key Lab Mol Targeted Antitumor Drug Dev, Shenyang North New Area, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Zhang, JD (corresponding author), China Med Univ, Med Oncol Dept Gastrointestinal Canc, Liaoning Canc Hosp & Inst, Canc Hosp, Shenyang, Peoples R China.	jdzhang@cancerhosp-ln-cmu.com; weiminjiecmu@163.com	Zhang, Jing/GWZ-7332-2022; Zhang, Jing/HII-4294-2022		Shengjing Hospital of China Medical University; National Natural Science Foundation of China [82073884, 82073281, 81673475, U1608281, 81573462, 31828005]; Key R&D Guidance Plan Projects in Liaoning Province [2019JH8/10300011]; Liaoning Province Doctoral Scientific Research Foundation [20180540036]; Liaoning Revitalization Talents Program [XLYC1807201]; Shenyang ST Projects [Z18-4-020]	Shengjing Hospital of China Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Guidance Plan Projects in Liaoning Province; Liaoning Province Doctoral Scientific Research Foundation; Liaoning Revitalization Talents Program; Shenyang ST Projects	This study was supported by the First Hospital and the Shengjing Hospital of China Medical University. The authors thank all the doctors and nurses for their great help in collecting tissue samples. This work was supported by grants from National Natural Science Foundation of China (No. 82073884, 82073281, 81673475, U1608281, 81573462, 31828005), Key R&D Guidance Plan Projects in Liaoning Province (2019JH8/10300011), Liaoning Province Doctoral Scientific Research Foundation (No 20180540036), Liaoning Revitalization Talents Program (No. XLYC1807201), Shenyang S&T Projects (Z18-4-020).	Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Bulatov E, 2015, J BIOL CHEM, V290, P4178, DOI 10.1074/jbc.M114.616664; Cao SG, 2019, MOL THER-NUCL ACIDS, V17, P455, DOI 10.1016/j.omtn.2019.04.030; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Cho H, 2012, MOL CELL, V46, P495, DOI 10.1016/j.molcel.2012.03.009; Cong ZZ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1361-3; Damas ND, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13875; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Han QR, 2019, ONCOGENE, V38, P3019, DOI 10.1038/s41388-018-0614-4; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; Kim MY, 2014, NUCLEIC ACIDS RES, V42, P6999, DOI 10.1093/nar/gku388; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lee B, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602505; Li WY, 2014, CANCER CELL, V25, P557, DOI 10.1016/j.ccr.2014.04.014; Liang HH, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0870-5; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu JY, 2018, BRIT J CANCER, V118, P1617, DOI 10.1038/s41416-018-0116-8; Ma WJ, 2020, J CELL PHYSIOL, V235, P7849, DOI 10.1002/jcp.29438; Moon BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02720-9; Okumura F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00010; Park E, 2013, WIRES RNA, V4, P423, DOI 10.1002/wrna.1168; Patel M, 2018, TRANSL RES, V197, P43, DOI 10.1016/j.trsl.2018.02.002; Ren Y, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0758-4; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sun M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.256; Tan XC, 2018, J CLIN INVEST, V128, P3198, DOI 10.1172/JCI122740; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang YQ, 2017, CELL DEATH DIFFER, V24, P2089, DOI 10.1038/cdd.2017.129; Wu TY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0354-y; Xie M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0595-9; Xu TP, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.205; Xu Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0747-x; Yamaki Y, 2016, MOL CELL BIOCHEM, V414, P1, DOI 10.1007/s11010-015-2643-4; Yang CQ, 2020, MOL THER-NUCL ACIDS, V20, P866, DOI 10.1016/j.omtn.2020.05.004; Yang Q, 2013, MOL CANCER RES, V11, P1497, DOI 10.1158/1541-7786.MCR-13-0214; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Yao Y, 2018, GENE, V659, P52, DOI 10.1016/j.gene.2018.03.048; Ye TB, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1074-6; Yu GF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16781-9	45	8	8	3	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4919	4929		10.1038/s41388-021-01900-8	http://dx.doi.org/10.1038/s41388-021-01900-8		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163032	hybrid, Green Published			2022-12-26	WOS:000664853000001
J	Lupu, N; Zechmeister, EJ				Lupu, Noam; Zechmeister, Elizabeth J.			The early COVID-19 pandemic and democratic attitudes	PLOS ONE			English	Article							NATIONALISM; PATRIOTISM; SUPPORT; THREAT	How does a public health crisis like a global pandemic affect political opinions in fragile democratic contexts? Research in political science suggests several possible public reactions to crisis, from retrospective anti-incumbency to rally 'round the flag effects to democratic erosion and authoritarianism. Which of these obtains depends on the nature of the crisis. We examine whether and how the onset of the global pandemic shifted public opinion toward the president, elections, and democracy in Haiti. We embedded two experiments in a phone survey administered to a nationally representative sample of Haitians in April-June 2020. We find that the early pandemic boosted presidential approval and intentions to vote for the incumbent president, consistent with a rally effect. These results show that a rally effect occurs even in the most unlikely of places-an unstable context in which the incumbent president is struggling to maintain order and support. At the same time, we find scant evidence that the onset of the pandemic eroded democratic attitudes, even in a context in which democracy rests on uncertain grounds.	[Lupu, Noam; Zechmeister, Elizabeth J.] Vanderbilt Univ, Dept Polit Sci, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University	Lupu, N (corresponding author), Vanderbilt Univ, Dept Polit Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	noam.lupu@vanderbilt.edu		Zechmeister, Elizabeth/0000-0002-9820-5674	United States Agency for International Development [7200AA19CA00022]	United States Agency for International Development(United States Agency for International Development (USAID))	NL and EJZ jointly received funding for this research from the United States Agency for International Development (Cooperative Agreement 7200AA19CA00022). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen ChristopherH., 2016, DEMOCRACY REALISTS, DOI DOI 10.1515/9781400882731; Amat Francesc, 2020, PANDEMICS MEET DEMOC, DOI DOI 10.31235/OSF.IO/DKUSW; [Anonymous], 2001, NEW YORK TIMES; [Anonymous], 2001, GREEN LEADS 51 35 PE; Ashworth S, 2018, AM J POLIT SCI, V62, P37, DOI 10.1111/ajps.12334; Bol D, 2021, EUR J POLIT RES, V60, P497, DOI 10.1111/1475-6765.12401; Campello D., 2020, VOLATILITY CURSE EXO, DOI 10.1017/9781108894975; Campello D, 2016, J POLIT, V78, P589, DOI 10.1086/684749; Carlin RE, 2014, POLIT RES QUART, V67, P3, DOI 10.1177/1065912913495592; Charles J., 2020, THE MIAMI HERALD; Charles J., 2019, THE MIAMI HERALD; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Chilton AS., 2020, SUPPORT RESTRICTING; Chong D, 2007, ANNU REV POLIT SCI, V10, P103, DOI 10.1146/annurev.polisci.10.072805.103054; Coupe T, 2017, APPL ECON LETT, V24, P1084, DOI 10.1080/13504851.2016.1254335; Diamond L, 2015, J DEMOCR, V26, P141, DOI 10.1353/jod.2015.0009; Duch Raymond M., 2008, EC VOTE POLITICAL EC; Feldman S, 1997, POLIT PSYCHOL, V18, P741, DOI 10.1111/0162-895X.00077; Gelineau F., 2019, POLITICAL CULTURE DE; Healy AJ, 2010, P NATL ACAD SCI USA, V107, P12804, DOI 10.1073/pnas.1007420107; Huber GA, 2012, AM POLIT SCI REV, V106, P720, DOI 10.1017/S0003055412000391; Kam CD, 2008, PUBLIC OPIN QUART, V72, P619, DOI 10.1093/poq/nfn055; Krygier R, 2019, WASH POST; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; Leininger A., 2020, VOTING DAWN GLOBAL P, DOI [10.31235/osf.io/a32r7, DOI 10.31235/OSF.IO/A32R7]; Li Q, 2004, POLIT PSYCHOL, V25, P727, DOI 10.1111/j.1467-9221.2004.00395.x; Madsen Douglas., 1991, CHARISMATIC BOND POL; Merolla J.L., 2009, DEMOCRACY RISK TERRO; Miratrix LW, 2018, POLIT ANAL, V26, P275, DOI 10.1017/pan.2018.1; MUELLER JE, 1970, AM POLIT SCI REV, V64, P18, DOI 10.2307/1955610; Mummolo J, 2019, AM POLIT SCI REV, V113, P517, DOI 10.1017/S0003055418000837; Newman B, 2010, ELECT STUD, V29, P144, DOI 10.1016/j.electstud.2009.07.003; Pyszczynski T., 2003, WAKE 9 11 PSYCHOL TE; Repucci S, 2020, J DEMOCR, V31, P137, DOI 10.1353/jod.2020.0027; SALES SM, 1973, J PERS SOC PSYCHOL, V28, P44, DOI 10.1037/h0035588; Skitka LJ, 2005, J APPL SOC PSYCHOL, V35, P1995, DOI 10.1111/j.1559-1816.2005.tb02206.x; Tertytchnaya K, 2018, AM POLIT SCI REV, V112, P758, DOI 10.1017/S0003055418000485; Thornton C., 2020, CNN 0224; Yam KC, 2020, P NATL ACAD SCI USA, V117, P25429, DOI 10.1073/pnas.2009252117; Zephyr D., 2011, HAITI DISTRESS IMPAC	40	5	5	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253485	10.1371/journal.pone.0253485	http://dx.doi.org/10.1371/journal.pone.0253485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157050	Green Published, gold			2022-12-26	WOS:000671691200026
J	Aoyama, Y; Maruko, I; Kawano, T; Yokoyama, T; Ogawa, Y; Maruko, R; Iida, T				Aoyama, Yukihiro; Maruko, Ichiro; Kawano, Taizo; Yokoyama, Tatsuro; Ogawa, Yuki; Maruko, Ruka; Iida, Tomohiro			Diagnosis of central serous chorioretinopathy by deep learning analysis of en face images of choroidal vasculature: A pilot study	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; THICKNESS; EYES	Purpose To diagnose central serous chorioretinopathy (CSC) by deep learning (DL) analyses of en face images of the choroidal vasculature obtained by optical coherence tomography (OCT) and to analyze the regions of interest for the DL from heatmaps. Methods One-hundred eyes were studied; 53 eyes with CSC and 47 normal eyes. Volume scans of 12x12 mm square were obtained at the same time as the OCT angiographic (OCTA) scans (Plex Elite 9000 Swept-Source OCT(R), Zeiss). High-quality en face images of the choroidal vasculature of the segmentation slab of one-half of the subfoveal choroidal thickness were created for the analyses. The 100 en face images were divided into 80 for training and 20 for validation. Thus, we divided it into five groups of 20 eyes each, trained the remaining 80 eyes in each group, and then calculated the correct answer rate for each group by validation with 20 eyes. The Neural Network Console (NNC) developed by Sony and the Keras-Tensorflow backend developed by Google were used as the software for the classification with 16 layers of convolutional neural networks. The active region of the heatmap based on the feature quantity extracted by DL was also evaluated as the percentages with gradient-weighted class activation mapping implemented in Keras. Results The mean accuracy rate of the validation was 95% for NNC and 88% for Keras. This difference was not significant (P >0.1). The mean active region in the heatmap image was 12.5% in CSC eyes which was significantly lower than the 79.8% in normal eyes (P<0.01). Conclusions CSC can be automatically diagnosed by DL with high accuracy from en face images of the choroidal vasculature with different programs, convolutional layer structures, and small data sets. Heatmap analyses showed that the DL focused on the area occupied by the choroidal vessels and their uniformity. We conclude that DL can help in the diagnosis of CSC.	[Aoyama, Yukihiro; Maruko, Ichiro; Kawano, Taizo; Yokoyama, Tatsuro; Ogawa, Yuki; Maruko, Ruka; Iida, Tomohiro] Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Maruko, Ichiro/AFP-1311-2022	Maruko, Ichiro/0000-0001-5647-6372	JSPS KAKENHI [JP20K09781]; Alcon Pharma K.K. (Japan); Santen Pharmaceutical Co., Ltd. (Japan); Nidek (Japan); Senju Seiyaku (Japan); Alcon Pharma K.K.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alcon Pharma K.K. (Japan); Santen Pharmaceutical Co., Ltd. (Japan); Nidek (Japan); Senju Seiyaku (Japan); Alcon Pharma K.K.	IM received grants from both JSPS KAKENHI (Grant Number JP20K09781) and Alcon Pharma K.K. TI received grants from: Alcon Pharma K.K. (Japan), Santen Pharmaceutical Co., Ltd. (Japan), Nidek (Japan), Senju Seiyaku (Japan). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka R, 2019, AM J OPHTHALMOL, V198, P136, DOI 10.1016/j.ajo.2018.10.007; Brown JM, 2018, JAMA OPHTHALMOL, V136, P803, DOI 10.1001/jamaophthalmol.2018.1934; Cho BH, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-01657-w; Fujiwara A, 2016, AM J OPHTHALMOL, V170, P1, DOI 10.1016/j.ajo.2016.07.006; Gargeya R, 2017, OPHTHALMOLOGY, V124, P962, DOI 10.1016/j.ophtha.2017.02.008; Grewal PS, 2018, CAN J OPHTHALMOL, V53, P309, DOI 10.1016/j.jcjo.2018.04.019; Hassan B., P 2 IEEE ADV INF MAN, P824; Heisler M, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.2.20; Hirahara S, 2016, AM J OPHTHALMOL, V166, P103, DOI 10.1016/j.ajo.2016.03.040; Hogarty DT, 2019, CLIN EXP OPHTHALMOL, V47, P128, DOI 10.1111/ceo.13381; Hua R, 2014, PHOTODIAGN PHOTODYN, V11, P519, DOI 10.1016/j.pdpdt.2014.07.005; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Izumi T, 2017, BRIT J OPHTHALMOL, V101, P433, DOI 10.1136/bjophthalmol-2016-308921; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Khalid S, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7148245; Kinoshita T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163104; Kuroda S, 2013, RETINA-J RET VIT DIS, V33, P302, DOI 10.1097/IAE.0b013e318263d11f; Lahousen T, 2016, NORD J PSYCHIAT, V70, P24, DOI 10.3109/08039488.2015.1041156; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Maruko I, 2011, RETINA-J RET VIT DIS, V31, P1603, DOI 10.1097/IAE.0b013e31820f4b39; Maruko I, 2010, OPHTHALMOLOGY, V117, P1792, DOI 10.1016/j.ophtha.2010.01.023; Medeiros FA, 2019, OPHTHALMOLOGY, V126, P513, DOI 10.1016/j.ophtha.2018.12.033; Motozawa N, 2019, OPHTHALMOL THER, V8, P527, DOI 10.1007/s40123-019-00207-y; Nielsen KB, 2019, OPHTHALMOL RETINA, V3, P294, DOI 10.1016/j.oret.2018.10.014; Ogawa Y, 2020, RETINA-J RET VIT DIS, V40, P529, DOI 10.1097/IAE.0000000000002417; Redd TK, 2019, BRIT J OPHTHALMOL, V103, P580, DOI 10.1136/bjophthalmol-2018-313156; Russakoff DB, 2019, INVEST OPHTH VIS SCI, V60, P712, DOI 10.1167/iovs.18-25325; Selvaraju RR, 2017, IEEE I CONF COMP VIS, P618, DOI 10.1109/ICCV.2017.74; Serag A, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00185; Silver D, 2018, SCIENCE, V362, P1140, DOI 10.1126/science.aar6404; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sultan AS, 2020, J ORAL PATHOL MED, V49, P849, DOI 10.1111/jop.13042; Taylor S, 2019, JAMA OPHTHALMOL, V137, P1022, DOI 10.1001/jamaophthalmol.2019.2433; Ting DSW, 2019, BRIT J OPHTHALMOL, V103, P167, DOI 10.1136/bjophthalmol-2018-313173; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Tobore I, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/11966; Yang LH, 2013, ACTA OPHTHALMOL, V91, pE358, DOI 10.1111/aos.12059; Yasaka K, 2018, JPN J RADIOL, V36, P257, DOI 10.1007/s11604-018-0726-3; Yoon J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75816-w	41	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0244469	10.1371/journal.pone.0244469	http://dx.doi.org/10.1371/journal.pone.0244469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143775	gold, Green Published			2022-12-26	WOS:000671690700061
J	Nanno, Y; Sterner, E; Gildersleeve, JC; Hering, BJ; Burlak, C				Nanno, Yoshihide; Sterner, Eric; Gildersleeve, Jeffrey C.; Hering, Bernhard J.; Burlak, Christopher			Carbohydrate antigen microarray analysis of serum IgG and IgM antibodies before and after adult porcine islet xenotransplantation in cynomolgus macaques	PLOS ONE			English	Article							GAL ANTIBODY; TRANSPLANTATION; ALPHA-1,3-GALACTOSYLTRANSFERASE; PANCREAS; INACTIVATION; GLYCOLIPIDS; REVERSAL	Understanding the anti-carbohydrate antibody response toward epitopes expressed on porcine cells, tissues, and organs is critical to advancing xenotransplantation toward clinical application. In this study, we determined IgM and IgG antibody specificities and relative concentrations in five cynomolgus monkeys at baseline and at intervals following intraportal xenotransplantation of adult porcine islets. This study utilized a carbohydrate antigen microarray that comprised more than 400 glycoconjugates, including historically reported alpha-Gal and non-alpha-Gal carbohydrate antigens with various modifications. The elicited anti-carbohydrate antibody responses were predominantly IgM compared to IgG in 4 out of 5 monkeys. Patterns of elicited antibody responses greater than 1.5 difference (log2 base units; 2.8-fold on a linear scale) from pre-serum to post-serum sampling specific for carbohydrate antigens were heterogeneous and recipient-specific. Increases in the elicited antibody response to alpha-Gal, Sd(a), GM2 antigens, or Lexis X antigen were found in individual monkeys. The novel carbohydrate structures Gal beta 1-4GlcNAc beta 1-3Gal beta 1 and N-linked glycans with Man alpha 1-6(GlcNAc beta 1-2Man alpha 1-3)Man beta 1-4GlcNAc beta structure were common targets of elicited IgM antibodies. These results provide important insights into the carbohydrate epitopes that elicit antibodies following pig-to-monkey islet xenotransplantation and reveal possible targets for gene editing.	[Nanno, Yoshihide; Hering, Bernhard J.; Burlak, Christopher] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Box 242 UMHC, Minneapolis, MN 55455 USA; [Sterner, Eric; Gildersleeve, Jeffrey C.] NCI, Chem Biol Lab, Ctr Canc Res, Frederick, MD 21701 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Burlak, C (corresponding author), Univ Minnesota, Dept Surg, Schulze Diabet Inst, Box 242 UMHC, Minneapolis, MN 55455 USA.	cburlak@umn.edu		Nanno, Yoshihide/0000-0002-9539-0560; Sterner, Eric/0000-0002-4591-6632; Gildersleeve, Jeffrey/0000-0002-3744-6423	University of Minnesota Department of Surgery; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health	University of Minnesota Department of Surgery; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by laboratory startup funding from the University of Minnesota Department of Surgery and the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. There was no additional external funding received for this study.	Anazawa T, 2010, TRANSPL P, V42, P2032, DOI 10.1016/j.transproceed.2010.05.110; Bach FH, 1996, IMMUNOL TODAY, V17, P379, DOI 10.1016/0167-5699(96)10024-4; Blixt O, 2009, AM J TRANSPLANT, V9, P83, DOI 10.1111/j.1600-6143.2008.02471.x; Bottino R, 2014, AM J TRANSPLANT, V14, P2275, DOI 10.1111/ajt.12868; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Breimer ME, 2011, XENOTRANSPLANTATION, V18, P215, DOI 10.1111/j.1399-3089.2011.00644.x; Brennan DC, 2016, AM J TRANSPLANT, V16, P509, DOI 10.1111/ajt.13458; Burlak C, 2013, XENOTRANSPLANTATION, V20, P277, DOI 10.1111/xen.12047; Byrne G, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12394; Byrne GW, 2013, XENOTRANSPLANTATION, V20, P292, DOI 10.1111/xen.12050; Byrne GW, 2011, TRANSPLANTATION, V91, P287, DOI 10.1097/TP.0b013e318203c27d; Cantarovich D, 2002, XENOTRANSPLANTATION, V9, P25, DOI 10.1034/j.1399-3089.2002.0o144.x; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; COOPER DKC, 1994, IMMUNOL REV, V141, P31, DOI 10.1111/j.1600-065X.1994.tb00871.x; Diswall M, 2007, TRANSPLANTATION, V84, P1348, DOI 10.1097/01.tp.0000287599.46165.15; Diswall M, 2010, XENOTRANSPLANTATION, V17, P48, DOI 10.1111/j.1399-3089.2009.00564.x; Durbin SV, 2018, ACS OMEGA, V3, P16882, DOI 10.1021/acsomega.8b02238; GALILI U, 1991, P NATL ACAD SCI USA, V88, P7401, DOI 10.1073/pnas.88.16.7401; GALILI U, 1995, J HUM EVOL, V29, P433, DOI 10.1006/jhev.1995.1067; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Kirchhof N, 2004, XENOTRANSPLANTATION, V11, P396, DOI 10.1111/j.1399-3089.2004.00157.x; Martens GR, 2017, TRANSPLANTATION, V101, pE86, DOI 10.1097/TP.0000000000001646; McKane W, 1998, TRANSPLANTATION, V66, P626, DOI 10.1097/00007890-199809150-00014; Muthana SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19509; Nanno Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241249; Nanno Y, 2020, XENOTRANSPLANTATION, V27, DOI 10.1111/xen.12567; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; PARKER W, 1994, J IMMUNOL, V153, P3791; Rayat GR, 2003, J ENDOCRINOL, V177, P127, DOI 10.1677/joe.0.1770127; Sakamoto K, 2015, PEDIATR TRANSPLANT, V19, pE97, DOI 10.1111/petr.12450; Schuurman HJ, 2016, XENOTRANSPLANTATION, V23, P175, DOI 10.1111/xen.12244; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Singh A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11338-y; Temme JS, 2019, FARADAY DISCUSS, V219, P90, DOI 10.1039/c9fd00021f; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Togayachi A, 2010, P NATL ACAD SCI USA, V107, P11900, DOI 10.1073/pnas.0914298107; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; Weegman BP, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6162970; Yeom SC, 2009, TRANSPL P, V41, P1921, DOI 10.1016/j.transproceed.2009.01.096; Zhang YL, 2012, METHODS MOL BIOL, V808, P155, DOI 10.1007/978-1-61779-373-8_11	40	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253029	10.1371/journal.pone.0253029	http://dx.doi.org/10.1371/journal.pone.0253029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138941	gold, Green Published			2022-12-26	WOS:000671690200087
J	Derici, GE; Ozdas, S; Canatar, I; Koc, M				Derici, Gizem Ece; Ozdas, Sibel; Canatar, Ipek; Koc, Murat			Antidiabetic activities of Bolanthus spergulifolius (Caryophyllaceae) extracts on insulin-resistant 3T3-L1 adipocytes	PLOS ONE			English	Article							APOPTOSIS; ADIPOGENESIS; INHIBITION; INDUCTION; ANTIOXIDANT; EXPRESSION; OBESITY; GROWTH	Diabetes mellitus (DM) is a metabolic disorder with chronic hyperglycemia featured by metabolic outcomes owing to insufficient insulin secretion and/or insulin effect defect. It is critical to investigate new therapeutic approaches for T2DM and alternative, natural agents that target molecules in potential signal pathways. Medicinal plants are significant resources in the research of alternative new drug active ingredients. Bolanthus spergulifolius (B. spergulifolius) is one of the genera of the family Caryophyllaceae. In this study, it was explored the potential anti-diabetic effects in vitro of B. spergulifolius extracts on 3T3-L1 adipocytes. The total phenolic contents (TPC) of methanolic (MeOH), ethyl acettate (EA) and aqueous extracts of B. spergulifolius were evaluated via Folin-Ciocateau. B. spergulifolius extracts showing highly TPC (Aqueous< MeOH< EA) and their different concentrations were carried out on preadipocytes differentiated in to mature 3T3-L1 adipocytes to investigate their half-maximal (50%) inhibitory concentration (IC50) value by using Thiazolyl blue tetrazolium bromide (MTT) assay. The IC50 of MeOH, EA and Aqueous extracts were observed as 305.7 +/- 5.583 mu g/mL, 567.4 +/- 3.008 mu g/mL, and 418.3 +/- 4.390 mu g/mL and used for further experiments. A live/dead assay further confirmed the cytotoxic effects of MeOH, EA and Aqueous extracts (respectively, 69.75 +/- 1.70%, 61.75 +/- 1.70%, 70 +/- 4.24%, and for all p< 0.05). Also, effects of extracts on lipid accumulation in mature 3T3-L1 adipocytes were evaluated by Oil-Red O staining assay. The extracts effectively decreased lipid-accumulation compared to untreated adipocytes (for all p< 0.05). Moreover, effect of extracts on apoptosis regulated by the Bax and Bcl-2 was investigated by quantitative reverse transcription polymerase chain reaction (qRT-PCR). The extracts significantly induced apoptosis by up-regulating pro-apoptotic Bax expression but down-regulated anti-apoptotic Bcl-2 gene expression compared to untreated adipocytes (for all p< 0.05). The Glut-4 expression linked with insulin resistance was determined by qRT-PCR, Western-blot analysis, and immunofluorescence staining. In parallel, the expression of Glut-4 in adipocytes treated with extracts was significantly higher compared to untreated adipocytes (for all p< 0.05). Extracts significantly suppressed cell migration after 30 h of wounding in a scratch-assay (for all p< 0.05). Cell morphology and diameter were further evaluated by phase-contrast microscopy, scanning electron microscopy, Immunofluorescence with F-Actin and Giemsa staining. The adipocytes treated with extracts partially lost spherical morphology and showed smaller cell-diameter compared to untreated adipocytes (for all p< 0.05). In conclusion, these results suggest that extracts of B. spergulifolius cause to an induce apoptosis, decrease lipid-accumulation, wound healing, up-regulating Glut-4 level and might contribute to reducing of insulin-resistance in DM.	[Derici, Gizem Ece; Ozdas, Sibel; Canatar, Ipek] Adana Alpaslan Turke Sci & Technol Univ, Fac Engn Sci, Dept Bioengn, Adana, Turkey; [Koc, Murat] Ankara Yildirim Beyazit Univ, Grad Sch Publ Hlth, Dept Tradit Complementary & Integrat Med, Ankara, Turkey	Ankara Yildirim Beyazit University	Ozdas, S (corresponding author), Adana Alpaslan Turke Sci & Technol Univ, Fac Engn Sci, Dept Bioengn, Adana, Turkey.	sozdas@atu.edu.tr		OZDAS, Sibel/0000-0003-4610-2785	Adana Science and Technology University Scientific Research Projects Coordination Unit [19332006, 20103005]	Adana Science and Technology University Scientific Research Projects Coordination Unit	The author(s) received funding for this work by Adana Science and Technology University Scientific Research Projects Coordination Unit (Award Number: Project No: 19332006 and Project No: 20103005 | Recipient: SibelOzdas, PhD). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinrinde A, 2018, ACTA PHARMACEUT, V68, P389, DOI 10.2478/acph-2018-0023; Berenguer M, 2011, BIOCHIMIE, V93, P697, DOI 10.1016/j.biochi.2010.12.013; Boissier PE., 1867, FLORA ORIENTALIS, V1, P25; Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x; Chaiittianan R, 2017, J ETHNOPHARMACOL, V201, P9, DOI 10.1016/j.jep.2017.02.044; Chan S. W., 2009, INT FOOD RES J, V2, P203; Chandra S, 2015, INTEGR MED RES, V4, P123, DOI 10.1016/j.imr.2015.06.004; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; De Melo N, 2019, BIOMIMETICS-BASEL, V4, DOI 10.3390/biomimetics4030048; Dey Lucy, 2002, Altern Med Rev, V7, P45; Forouhi Nita Gandhi, 2014, Medicine (Abingdon), V42, P698; FROST SC, 1985, J BIOL CHEM, V260, P2646; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hamzaoglu E, 2017, NORD J BOT, V35, P563, DOI 10.1111/njb.01521; Handala L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020165; Hauner H, 1998, INT J OBESITY, V22, P448, DOI 10.1038/sj.ijo.0800606; Hebi Morad, 2019, Cardiovascular & Hematological Agents in Medicinal Chemistry, V17, P47, DOI 10.2174/1871525717666190227231834; Hernandez-Ledesma P, 2015, WILLDENOWIA, V45, P281, DOI 10.3372/wi.45.45301; Hsiao CY, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/508972; Hsu CL, 2007, J AGR FOOD CHEM, V55, P1730, DOI 10.1021/jf062912b; Hu J, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-267; Hu XF, 2018, FITOTERAPIA, V127, P129, DOI 10.1016/j.fitote.2018.02.015; Huber-Morath A., 1967, FLORA TURKEY E AEGEA, V2, P171; Hulkower Keren I, 2011, Pharmaceutics, V3, P107, DOI 10.3390/pharmaceutics3010107; Hyun TK, 2016, SAUDI J BIOL SCI, V23, P181, DOI 10.1016/j.sjbs.2015.02.008; Kim GS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-31; Koc M, 2019, FOLIA GEOBOT, V54, P279, DOI 10.1007/s12224-019-09348-1; Koc M, 2015, PHYTOKEYS, V52, P81, DOI 10.3897/phytokeys.52.4479; Langlois NEI, 2000, J ROY COLL SURG EDIN, V45, P211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda M, 2013, OBES RES CLIN PRACT, V7, pE330, DOI 10.1016/j.orcp.2013.05.004; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P411, DOI 10.1016/S2221-1691(12)60067-7; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pratima N.A., 2018, ARC ORG INORG CHEM S, V1, P26, DOI [10.32474/AOICS.2018.01.000103, DOI 10.32474/AOICS.2018.01.000103]; PRINS JB, 1994, BIOCHEM BIOPH RES CO, V201, P500, DOI 10.1006/bbrc.1994.1730; Rasouli H, 2017, FOOD FUNCT, V8, P1942, DOI [10.1039/c7fo00220c, 10.1039/C7FO00220C]; Raveendran Arkiath V, 2018, Eur Endocrinol, V14, P31, DOI 10.17925/EE.2018.14.2.31; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Shanik MH, 2008, DIABETES CARE, V31, pS262, DOI 10.2337/dc08-s264; Shi J, 2005, FOOD REV INT, V21, P139, DOI 10.1081/FRI-200040606; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Somaida A, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13110357; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Vaid B, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4045365; VanEppsFung M, 1997, ENDOCRINOLOGY, V138, P4338, DOI 10.1210/en.138.10.4338; Xu F, 2017, IND CROP PROD, V103, P251, DOI 10.1016/j.indcrop.2017.04.006; Yang JY, 2008, LIFE SCI, V82, P1032, DOI 10.1016/j.lfs.2008.03.003; Zengin G, 2018, FOOD BIOSCI, V23, P75, DOI 10.1016/j.fbio.2018.03.010; Zheleva-Dimitrova D, 2018, J PHARMACEUT BIOMED, V155, P56, DOI 10.1016/j.jpba.2018.03.040; Zielinski H, 2000, J AGR FOOD CHEM, V48, P2008, DOI 10.1021/jf990619o	58	0	0	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252707	10.1371/journal.pone.0252707	http://dx.doi.org/10.1371/journal.pone.0252707			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133443	Green Published, gold			2022-12-26	WOS:000671682700037
J	Cui, W; Chen, J; Yu, F; Liu, WH; He, ML				Cui, Wei; Chen, Jing; Yu, Feng; Liu, Wenhong; He, Maolin			GYY4137 protected the integrity of the blood-brain barrier via activation of the Nrf2/ARE pathway in mice with sepsis	FASEB JOURNAL			English	Article						blood-brain barrier; GYY4137; Nrf2; ARE pathway; sepsis-associated encephalopathy	NEURON-SPECIFIC ENOLASE; HYDROGEN-SULFIDE; NITRIC-OXIDE; IMPROVES; INJURY; EXPRESSION; INJECTION; APOPTOSIS	Injury to the blood-brain barrier (BBB) plays a vital role in sepsis-associated encephalopathy (SAE), which is one of the most common complications of sepsis. GYY4137, a new synthetic compound of hydrogen sulfide (H2S), has extensive biological benefits. In this study, we focused on the protective effects of GYY4137 on the BBB in septic mice and the underlying mechanisms. The results suggested that whether administrated at the same time or 3 hours after LPS injection, GYY4137 both significantly alleviated the clinical symptoms and the long-term prognosis. Besides, GYY4137 improved the pathological abnormalities of septic mice. Moreover, the degradation of tight junctions in the BBB was considerably inhibited by GYY4137. In addition, GYY4137 significantly attenuated inflammation and apoptosis in the brain. Furthermore, GYY4137 activated the Nrf2/ARE pathway through the sulfhydrylation of Keap1 and inhibited oxidative stress. ML385, the specific inhibitor of Nrf2, significantly reversed the protective effects of GYY4137 in sepsis mice. In conclusion, this study indicated that through the sulfhydrylation of Keap1, GYY4137 activated the Nrf2/ARE pathway and exerted anti-inflammatory, anti-apoptotic and antioxidant effects in septic mice that consequently protected the integrity of the BBB and improved the clinical outcome of sepsis. Our findings suggest that GYY4137 might be a promising agent for the treatment of SAE.	[Cui, Wei; Chen, Jing; Yu, Feng; Liu, Wenhong; He, Maolin] Capital Med Univ, Beijing Shijitan Hosp, Dept Neurol, 10 Tieyi St, Beijing, Peoples R China	Capital Medical University	Cui, W (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Dept Neurol, 10 Tieyi St, Beijing, Peoples R China.	cuiwei3352@bjsjth.cn			Capital Medical University (CMU) [2016-q13]	Capital Medical University (CMU)	Capital Medical University (CMU), Grant/Award Number: 2016-q13	Ahmad A, 2016, SHOCK, V46, P183, DOI 10.1097/SHK.0000000000000589; Al-Obaidi MMJ, 2018, CELL MOL NEUROBIOL, V38, P1349, DOI 10.1007/s10571-018-0609-2; Alkharfy KM, 2015, LIFE SCI, V143, P131, DOI 10.1016/j.lfs.2015.08.007; Anderson BJ, 2016, J CRIT CARE, V36, P18, DOI 10.1016/j.jcrc.2016.06.012; Bourboulia D, 2010, SEMIN CANCER BIOL, V20, P161, DOI 10.1016/j.semcancer.2010.05.002; Chen SW, 2015, INFLAMM RES, V64, P789, DOI 10.1007/s00011-015-0862-5; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Chung HY, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030703; Eidelman LA, 1996, JAMA-J AM MED ASSOC, V275, P470, DOI 10.1001/jama.275.6.470; Erikson K, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03101-3; Feng W, 2015, J MED CHEM, V58, P6456, DOI 10.1021/acs.jmedchem.5b00848; Gemici B, 2015, METHOD ENZYMOL, V555, P169, DOI 10.1016/bs.mie.2014.11.034; Gofton TE, 2012, NAT REV NEUROL, V8, P557, DOI 10.1038/nrneurol.2012.183; Grambow E, 2014, PLATELETS, V25, P166, DOI 10.3109/09537104.2013.786823; Haileselassie B, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1689-8; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jiang LJ, 2021, INFLAMM RES, V70, P205, DOI 10.1007/s00011-020-01415-0; Jin XZ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.573422; Kadl A, 2007, SHOCK, V28, P582, DOI 10.1097/shk.0b013e31804d41dd; Kamisaki Y, 1997, BBA-MOL BASIS DIS, V1362, P24, DOI 10.1016/S0925-4439(97)00052-5; Kaur G, 2006, TOXICOLOGY, V226, P152, DOI 10.1016/j.tox.2006.06.018; Kutz JL, 2015, J PHYSIOL-LONDON, V593, P2121, DOI 10.1113/JP270054; Langa KM, 2001, J GEN INTERN MED, V16, P770, DOI 10.1111/j.1525-1497.2001.10123.x; Li HB, 2018, CELL PHYSIOL BIOCHEM, V47, P994, DOI 10.1159/000490166; Liu XN, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7161592; Luppi F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-140; Magierowski M, 2015, MOLECULES, V20, P9099, DOI 10.3390/molecules20059099; Marquez-Velasco R, 2011, INFLAMM RES, V60, P947, DOI 10.1007/s00011-011-0355-0; Mills-Davies N, 2017, ACTA CRYSTALLOGR D, V73, P9, DOI 10.1107/S2059798316019525; Mosevoll KA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00691; Nath N, 2019, J CELL PHYSIOL, V234, P3007, DOI 10.1002/jcp.27120; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754; Ogawa Y, 2016, ELIFE, V5, DOI 10.7554/eLife.21055; Qiu YB, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01500-2; Quan N, 1998, BRAIN RES, V802, P189, DOI 10.1016/S0006-8993(98)00402-8; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Rivera S, 2019, CELL MOL LIFE SCI, V76, P3051, DOI 10.1007/s00018-019-03172-8; Rose P, 2015, METHOD ENZYMOL, V554, P143, DOI 10.1016/bs.mie.2014.11.014; Sarker S, 2018, ECOTOX ENVIRON SAFE, V151, P132, DOI 10.1016/j.ecoenv.2018.01.004; Semmler A, 2013, J NEUROL NEUROSUR PS, V84, P62, DOI 10.1136/jnnp-2012-302883; Sharshar T, 2007, INTENS CARE MED, V33, P798, DOI 10.1007/s00134-007-0598-y; Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651; Sonneville R, 2017, INTENS CARE MED, V43, P1075, DOI 10.1007/s00134-017-4807-z; Torun AN, 2009, CLIN ENDOCRINOL, V70, P469, DOI 10.1111/j.1365-2265.2008.03348.x; Troletti CD, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1294-2; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang Y, 2019, NEUROSCI LETT, V711, DOI 10.1016/j.neulet.2019.134387; Wang Y, 2016, NEUROCHEM RES, V41, P659, DOI 10.1007/s11064-015-1731-x; Wang YM, 2016, J NEUROL SCI, V368, P223, DOI 10.1016/j.jns.2016.07.010; Xiao F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05062-2; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	54	8	8	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21710	10.1096/fj.202100074R	http://dx.doi.org/10.1096/fj.202100074R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143548				2022-12-26	WOS:000667814100030
J	Sarma, KV; Raman, AG; Dhinagar, NJ; Priester, AM; Harmon, S; Sanford, T; Mehralivand, S; Turkbey, B; Marks, LS; Raman, SS; Speier, W; Arnold, CW				Sarma, Karthik, V; Raman, Alex G.; Dhinagar, Nikhil J.; Priester, Alan M.; Harmon, Stephanie; Sanford, Thomas; Mehralivand, Sherif; Turkbey, Baris; Marks, Leonard S.; Raman, Steven S.; Speier, William; Arnold, Corey W.			Harnessing clinical annotations to improve deep learning performance in prostate segmentation	PLOS ONE			English	Article								Purpose Developing large-scale datasets with research-quality annotations is challenging due to the high cost of refining clinically generated markup into high precision annotations. We evaluated the direct use of a large dataset with only clinically generated annotations in development of high-performance segmentation models for small research-quality challenge datasets. Materials and methods We used a large retrospective dataset from our institution comprised of 1,620 clinically generated segmentations, and two challenge datasets (PROMISE12: 50 patients, ProstateX-2: 99 patients). We trained a 3D U-Net convolutional neural network (CNN) segmentation model using our entire dataset, and used that model as a template to train models on the challenge datasets. We also trained versions of the template model using ablated proportions of our dataset, and evaluated the relative benefit of those templates for the final models. Finally, we trained a version of the template model using an out-of-domain brain cancer dataset, and evaluated the relevant benefit of that template for the final models. We used five-fold cross-validation (CV) for all training and evaluation across our entire dataset. Results Our model achieves state-of-the-art performance on our large dataset (mean overall Dice 0.916, average Hausdorff distance 0.135 across CV folds). Using this model as a pre-trained template for refining on two external datasets significantly enhanced performance (30% and 49% enhancement in Dice scores respectively). Mean overall Dice and mean average Hausdorff distance were 0.912 and 0.15 for the ProstateX-2 dataset, and 0.852 and 0.581 for the PROMISE12 dataset. Using even small quantities of data to train the template enhanced performance, with significant improvements using 5% or more of the data. Conclusion We trained a state-of-the-art model using unrefined clinical prostate annotations and found that its use as a template model significantly improved performance in other prostate segmentation tasks, even when trained with only 5% of the original dataset.	[Sarma, Karthik, V; Raman, Alex G.; Dhinagar, Nikhil J.; Priester, Alan M.; Marks, Leonard S.; Raman, Steven S.; Speier, William; Arnold, Corey W.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Raman, Alex G.] Western Univ Hlth Sci, Pomona, CA USA; [Dhinagar, Nikhil J.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Harmon, Stephanie; Sanford, Thomas; Mehralivand, Sherif; Turkbey, Baris] NCI, NIH, Bethesda, MD USA; [Harmon, Stephanie] Frederick Natl Lab Canc Res, Clin Res Directorate, Frederick, MD USA; [Sanford, Thomas] SUNY Upstate Med Ctr, Syracuse, NY USA	University of California System; University of California Los Angeles; Western University of Health Sciences; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Arnold, CW (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	cwarnold@ucla.edu	Mehralivand, Sherif/AAS-7841-2021; Sarma, Karthik V./ABF-2374-2021	Mehralivand, Sherif/0000-0003-1405-3683; Sarma, Karthik V./0000-0002-7442-9526	National Cancer Institute [F30CA210329, R01CA195505, R01CA158627, R21CA220352 P50CA092131]; National Institute of General Medical Studies [GM08042]; UCLA-Caltech Medical Scientist Training Program; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Studies(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); UCLA-Caltech Medical Scientist Training Program; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	KVS acknowledges support from National Cancer Institute grant F30CA210329, National Institute of General Medical Studies grant GM08042, and the UCLA-Caltech Medical Scientist Training Program. CWA acknowledges funding from National Cancer Institute grants R21CA220352 P50CA092131. LSM acknowledges funding from National Cancer Institute grants R01CA195505 and R01CA158627. SH acknowledges that this project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. TS, SM, and BT acknowledge that this project was supported in part by the Intramural Research Program of the NIH. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Armato SG, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.4.044501; Bakas S., 2018, IDENTIFYING BEST MAC, P124; Bakas S, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.117; Becker AS, 2019, EUR J RADIOL, V121, DOI 10.1016/j.ejrad.2019.108716; Bloch N., 2015, NCI ISBI 2013 CHALLE, DOI [10.7937/K9/TCIA.2015.zF0vlOPv, DOI 10.7937/K9/TCIA.2015.ZF0VLOPV]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cheng RD, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.2.024007; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Clark T, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.041307; Giannini V, 2015, COMPUT MED IMAG GRAP, V46, P219, DOI 10.1016/j.compmedimag.2015.09.001; Invivo-Philips, DYNACAD PROST ADV VI; Isensee F., 2018, NNU NET SELF ADAPTIN; Isensee F., 2020, BATCHGENERATORS PYTH, DOI [10.5281/ZENODO.3632567., DOI 10.5281/ZENODO.3632567, 10.5281/ZENODO.3632567]; Jia HZ, 2019, LECT NOTES COMPUT SC, V11765, P110, DOI 10.1007/978-3-030-32245-8_13; Jia HZ, 2020, IEEE T MED IMAGING, V39, P447, DOI 10.1109/TMI.2019.2928056; Jin Y, 2021, COMPUT BIOL MED, V128, DOI 10.1016/j.compbiomed.2020.104160; Litjens G, 2014, MED IMAGE ANAL, V18, P359, DOI 10.1016/j.media.2013.12.002; Lowekamp BC, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00045; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Sanford TH, 2020, AM J ROENTGENOL, V215, P1403, DOI 10.2214/AJR.19.22347; Sarma KV, 2021, J AM MED INFORM ASSN, V28, P1259, DOI 10.1093/jamia/ocaa341; Shi W., 2018, MED IM MEET NEURIPS; Tian ZQ, 2020, MED PHYS, V47, P4164, DOI 10.1002/mp.14327; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang B, 2019, MED PHYS, V46, P1707, DOI 10.1002/mp.13416; Wang W, 2021, CLIN IMAG, V70, P1, DOI 10.1016/j.clinimag.2020.10.014; Zhang L, 2020, IEEE T MED IMAGING, V39, P2531, DOI 10.1109/TMI.2020.2973595	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253829	10.1371/journal.pone.0253829	http://dx.doi.org/10.1371/journal.pone.0253829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170972	gold, Green Published			2022-12-26	WOS:000671694400001
J	Viklund, E; Bake, B; Hussain-Alkhateeb, L; Akdeva, HK; Larsson, P; Olin, AC				Viklund, Emilia; Bake, Bjorn; Hussain-Alkhateeb, Laith; Akdeva, Hatice Koca; Larsson, Per; Olin, Anna-Carin			Current smoking alters phospholipid- and surfactant protein A levels in small airway lining fluid: An explorative study on exhaled breath	PLOS ONE			English	Article							CLOSING VOLUME; PATHOGENESIS; HOMEOSTASIS; PARTICLES; SMOKERS	Small airways are difficult to access. Exhaled droplets, also referred to as particles, provide a sample of small airway lining fluid and may reflect inflammatory responses. We aimed to explore the effect of smoking on the composition and number of exhaled particles in a smoker-enriched study population. We collected and chemically analyzed exhaled particles from 102 subjects (29 never smokers, 36 former smokers and 37 current smokers) aged 39 to 83 years (median 63). A breathing maneuver maximized the number exhaled particles, which were quantified with a particle counter. The contents of surfactant protein A and albumin in exhaled particles was quantified with immunoassays and the contents of the phospholipids dipalmitoyl- and palmitoyl-oleoyl- phosphatidylcholine with mass spectrometry. Subjects also performed spirometry and nitrogen single breath washout. Associations between smoking status and the distribution of contents in exhaled particles and particle number concentration were tested with quantile regression, after adjusting for potential confounders. Current smokers, compared to never smokers, had higher number exhaled particles and more surfactant protein A in the particles. The magnitude of the effects of current smoking varied along the distribution of each PEx-variable. Among subjects with normal lung function, phospholipid levels were elevated in current smokers, in comparison to no effect of smoking on these lipids at abnormal lung function. Smoking increased exhaled number of particles and the contents of lipids and surfactant protein A in the particles. These findings might reflect early inflammatory responses to smoking in small airway lining fluid, also when lung function is within normal limits.	[Viklund, Emilia; Akdeva, Hatice Koca; Larsson, Per; Olin, Anna-Carin] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Inst Med,Occupat & Environm Med, Gothenburg, Sweden; [Bake, Bjorn] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Resp Med & Allergol, Gothenburg, Sweden; [Hussain-Alkhateeb, Laith] Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Inst Med,Global Hlth, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; University of Gothenburg	Viklund, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Sch Publ Hlth & Community Med, Inst Med,Occupat & Environm Med, Gothenburg, Sweden.	emilia.viklund@amm.gu.se	Olin, Anna-Carin/ABH-2627-2021; Hussain-Alkhateeb, Laith/K-3485-2013	Hussain-Alkhateeb, Laith/0000-0001-9607-110X; Viklund, Emilia/0000-0003-4453-4680	Swedish Research Council for Health, Working Life and Welfare [201600419]; Heart and Lung foundation Sweden [20180209]; Centre for Allergy Research Highlights Asthma Markers of Phenotype consortium - Swedish Foundation for Strategic Research; Karolinska Institute; AstraZeneca & Science for Life Laboratory Joint Research Collaboration; Vardal Foundation	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Heart and Lung foundation Sweden(Swedish Heart-Lung Foundation); Centre for Allergy Research Highlights Asthma Markers of Phenotype consortium - Swedish Foundation for Strategic Research; Karolinska Institute(Karolinska Institutet); AstraZeneca & Science for Life Laboratory Joint Research Collaboration; Vardal Foundation	This research was supported by the Swedish Research Council for Health, Working Life and Welfare (A-CO, Grant nr:201600419, https://forte.se/en/), by the Heart and Lung foundation Sweden (A-CO, Grant nr: 20180209, https://www.hjart-lungfonden.se/), and by the Centre for Allergy Research Highlights Asthma Markers of Phenotype consortium (A-CO) which is funded by the Swedish Foundation for Strategic Research, the Karolinska Institute, AstraZeneca & Science for Life Laboratory Joint Research Collaboration, and the Vardal Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo CW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228279; Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Behndig AF, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1172-1; Betsuyaku T, 2004, EUR RESPIR J, V24, P964, DOI 10.1183/09031936.04.00064004; Bredberg A, 2012, CLIN CHEM, V58, P431, DOI 10.1373/clinchem.2011.169235; Brisman J, 2017, CLIN PHYSIOL FUNCT I, V37, P640, DOI 10.1111/cpf.12349; Brisman J, 2016, CLIN PHYSIOL FUNCT I, V36, P77, DOI 10.1111/cpf.12198; BUIST AS, 1973, AM REV RESPIR DIS, V107, P744; Canadas O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103708; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Chroneos ZC, 2010, CELL PHYSIOL BIOCHEM, V25, P13, DOI 10.1159/000272047; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Haslbeck K, 2010, J AEROSOL SCI, V41, P429, DOI 10.1016/j.jaerosci.2010.02.010; HOEPPNER VH, 1974, AM REV RESPIR DIS, V109, P81; Hogg JC, 2017, PHYSIOL REV, V97, P529, DOI 10.1152/physrev.00025.2015; Holmgren H, 2012, J AEROSOL MED PULM D, V25, P47, DOI 10.1089/jamp.2011.0892; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Honda Y, 1996, CHEST, V109, P1006, DOI 10.1378/chest.109.4.1006; Hussain-Alkhateeb L, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2020-000804; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Jubinville E, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00681-2017; Kokelj S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227980; Larsson P, 2017, RESP PHYSIOL NEUROBI, V243, P39, DOI 10.1016/j.resp.2017.05.003; Larsson P, 2017, CLIN PHYSIOL FUNCT I, V37, P489, DOI 10.1111/cpf.12323; Larsson P, 2012, RESP MED, V106, P197, DOI 10.1016/j.rmed.2011.10.008; Larstad M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144463; Mazur W, 2011, EUR RESPIR J, V38, P277, DOI 10.1183/09031936.00110510; MCCARTHY DS, 1972, AM J MED, V52, P747, DOI 10.1016/0002-9343(72)90080-0; Mehlig K, 2017, INT J EPIDEMIOL, V46, P1742, DOI 10.1093/ije/dyw332; Milic-Emili J, 2007, EUR J APPL PHYSIOL, V99, P567, DOI 10.1007/s00421-006-0389-0; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morissette MC, 2015, EUR RESPIR J, V46, P1451, DOI 10.1183/09031936.00216914; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Regan EA, 2015, JAMA INTERN MED, V175, P1539, DOI 10.1001/jamainternmed.2015.2735; SCHMEKEL B, 1992, THORAX, V47, P603, DOI 10.1136/thx.47.8.603; Soares M, 2018, J BREATH RES, V12, DOI 10.1088/1752-7163/aad9d1; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500	41	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253825	10.1371/journal.pone.0253825	http://dx.doi.org/10.1371/journal.pone.0253825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170967	gold, Green Published			2022-12-26	WOS:000671694400006
J	Czech, A; Grela, ER; Nowakowicz-Debek, B; Wlazlo, L				Czech, Anna; Grela, Eugeniusz R.; Nowakowicz-Debek, Bozena; Wlazlo, Lukasz			The effects of a fermented rapeseed meal or/and soybean meal additive on the blood lipid profile and immune parameters of piglets and on minerals in their blood and bone	PLOS ONE			English	Article							RELATIVE ORGAN WEIGHT; GROWTH-PERFORMANCE; NUTRIENT DIGESTIBILITY; INTESTINAL MORPHOLOGY; ASPERGILLUS-NIGER; SERUM PARAMETERS; ACID; SOWS; PROBIOTICS; PREGNANCY	The aim of the study was to assess the effect of the inclusion of dried fermented soybean and/or rapeseed meal in piglet feed on immune parameters, blood lipid parameters, and mineral content in the blood and metacarpal bones. The study was conducted on 150 28-day-old piglets divided into 5 groups. Piglets in the control group (C) received a standard diet with soybean meal. Animals in group FR (group receiving a diet with 8% FRSM) received a diet in which a portion of the soybean meal was replaced with 8% dried fermented rapeseed meal (FRSM). Animals in group FR/FS received a diet in which a portion of the soybean meal was replaced with 6% FRSM and 2% fermented dried soybean meal (FSBM). The piglets in group FS/FR received a diet with 6% FSBM and 2% FRSM. Group FS received a diet in which a portion of the soybean meal was replaced with an 8% share of FSBM. The inclusion of 8% or 6% fermented rapeseed meal (group FR or FR/FS) in the diet of piglets had a beneficial effect on their immune status, as evidenced by the increase in plasma levels of IgG and IgA and the decrease in IL-6 relative to the control group. It also significantly increased the concentrations of minerals, i.e. P, Ca and Zn, in the blood plasma and metacarpal bones of piglets and improved the availability of iron, a key bioelement involved in haemoglobin. The use of 8% or 6% fermented soybean meal in the diet (groups FS and FS/FR) of piglets had a positive effect on blood lipid parameters, reducing CHOL and LDL-cholesterol in the plasma. In conclusion, the fermentation process enables better utilization of rapeseed or soybean meal by pigs. Dried fermented rapeseed meal could partially replace protein components from GMO (genetically modified ogranism) crops (soybean meal) used in diets for pigs.	[Czech, Anna] Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Dept Biochem & Toxicol, Lublin, Poland; [Grela, Eugeniusz R.] Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Inst Anim Nutr & Bromatol, Lublin, Poland; [Nowakowicz-Debek, Bozena; Wlazlo, Lukasz] Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Dept Anim Hyg & Environm Hazards, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin; University of Life Sciences in Lublin	Wlazlo, L (corresponding author), Univ Life Sci Lublin, Fac Anim Sci & Bioecon, Dept Anim Hyg & Environm Hazards, Lublin, Poland.	lukasz.wlazlo@up.lublin.pl	Nowakowicz-Debek, Bozena/U-4508-2018	Nowakowicz-Debek, Bozena/0000-0003-2510-1062; Czech, Anna/0000-0003-4142-2608; Grela, Eugeniusz/0000-0002-7426-5728; Wlazlo, Lukasz/0000-0002-1086-182X	 [EP200]		We would like to thank the owner of European Protein Dr Jens Legarth, and especially the owner of Feedstar Mr. Robert Chachaj, for supplying the fermented products EP100 and EP200.	[Anonymous], 2000, 106331 PNISO 106331 PNISO; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Brooks P. H., 2008, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V3, P1, DOI 10.1079/PAVSNNR20083073; Canbas A, 2001, PROCESS BIOCHEM, V36, P1053, DOI 10.1016/S0032-9592(01)00134-0; Canibe N, 2012, ANIM FEED SCI TECH, V173, P17, DOI 10.1016/j.anifeedsci.2011.12.021; Chachaj R, 2019, ANN ANIM SCI, V19, P1035, DOI 10.2478/aoas-2019-0040; CHAH CC, 1975, POULTRY SCI, V54, P600, DOI 10.3382/ps.0540600; Chen W, 2013, BRIT POULTRY SCI, V54, P635, DOI 10.1080/00071668.2013.825369; Chen W, 2013, J ANIM SCI, V91, P978, DOI 10.2527/jas.2012-5148; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; Czech A, 2004, ANIM FEED SCI TECH, V116, P211, DOI 10.1016/j.anifeedsci.2004.07.013; Czech A, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11061646; Czech A, 2020, ANN ANIM SCI, V20, P535, DOI 10.2478/aoas-2019-0079; Dlamini ZC, 2017, S AFR J ANIM SCI, V47, P766, DOI 10.4314/sajas.v47i6.4; El-Batal AI, 2001, FOOD RES INT, V34, P715, DOI 10.1016/S0963-9969(01)00093-X; Fadel M, 2000, PAKISTAN J BIOL SCI, V3, P1762; Feng J, 2007, ANIM FEED SCI TECH, V134, P295, DOI 10.1016/j.anifeedsci.2006.10.004; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grela ER, 2019, ANIM NUTR, V5, P373, DOI 10.1016/j.aninu.2019.05.004; Hu Z.P., 2015, ACTA ECOL ANIM DOMAS, V36, P29; Hung ATY, 2008, ASIAN J ANIM VET ADV, V3, P431; Jakobsen GV, 2015, ANIM FEED SCI TECH, V208, P198, DOI 10.1016/j.anifeedsci.2015.07.015; Kiers JL, 2000, INT J FOOD MICROBIOL, V60, P163, DOI 10.1016/S0168-1605(00)00308-1; Kim JC, 2018, ANIM FEED SCI TECH, V235, P8, DOI 10.1016/j.anifeedsci.2017.11.001; Kim YG, 2007, ASIAN AUSTRAL J ANIM, V20, P399, DOI 10.5713/ajas.2007.399; KIRCHGESSNER M, 1983, Z TIERPHYSIOL TIERER, V50, P270; Li XJ, 2008, J APPL MICROBIOL, V104, P1082, DOI 10.1111/j.1365-2672.2007.03636.x; Muszynski S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191964; National Research Council (NRC) (2012), 2012, NUTR REQ SWIN, V11th revised ed., DOI [10.17226/13298, DOI 10.17226/13298]; Poulsen HD, 2017, J SCI FOOD AGR, V97, P244, DOI 10.1002/jsfa.7721; Reale A, 2007, J AGR FOOD CHEM, V55, P2993, DOI 10.1021/jf063507n; Seo HJ, 2010, NUTR RES PRACT, V4, P356, DOI 10.4162/nrp.2010.4.5.356; Shi CY, 2016, ANIM SCI J, V87, P557, DOI 10.1111/asj.12457; Spears JW, 2000, P NUTR SOC, V59, P587, DOI 10.1017/S0029665100000835; Sugiharto S, 2019, ANIM NUTR, V5, P1, DOI 10.1016/j.aninu.2018.11.001; Taylor KACC, 1996, APPL BIOCHEM BIOTECH, V56, P49, DOI 10.1007/BF02787869; Tomaszewska E, 2019, LIVEST SCI, V224, P60, DOI 10.1016/j.livsci.2019.04.009; Tomaszewska E, 2018, ANIM PROD SCI, V58, P507, DOI 10.1071/AN16289; VAINTRAUB IA, 1988, ANAL BIOCHEM, V175, P227, DOI 10.1016/0003-2697(88)90382-X; Wang T., 2003, ANIM HUSBANDRY VET M, P4, DOI DOI 10.3969/J.ISSN.0529-5130.2003.06.002; Xu BC, 2020, ANIM FEED SCI TECH, V259, DOI 10.1016/j.anifeedsci.2019.114315; Xu FZ, 2012, ASIAN AUSTRAL J ANIM, V25, P1734, DOI 10.5713/ajas.2012.12249; Xu FZ, 2011, ASIAN AUSTRAL J ANIM, V24, P678, DOI 10.5713/ajas.2011.10458; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Yuan L, 2017, ANIM NUTR, V3, P19, DOI 10.1016/j.aninu.2016.11.003; Zhu JJ, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0809-3	46	3	3	10	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253744	10.1371/journal.pone.0253744	http://dx.doi.org/10.1371/journal.pone.0253744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166462	gold, Green Published			2022-12-26	WOS:000671692800015
J	Jasso-Martinez, JM; Donath, A; Schulten, D; Zaldivar-Riveron, A; Sann, M				Jasso-Martinez, Jovana M.; Donath, Alexander; Schulten, Dieter; Zaldivar-Riveron, Alejandro; Sann, Manuela			Midgut transcriptome assessment of the cockroach-hunting wasp Ampulex compressa (Apoidea: Ampulicidae)	PLOS ONE			English	Article							HYMENOPTERA; BEHAVIOR; ENZYMES; EVOLUTION; INSIGHTS; INSECTS; GENOME; INTERPROSCAN; RESISTANCE; ANT	The emerald jewel wasp Ampulex compressa (Hymenoptera: Ampulicidae) is a solitary wasp that is widely known for its specialized hunting of cockroaches as larvae provision. Adult wasps mainly feed on pollen and nectar, while their larvae feed on the cockroachs' body, first as ecto- and later as endoparsitoids. Little is known about the expression of digestive, detoxification and stress-response-related genes in the midgut of A. compressa, or about its transcriptional versatility between life stages. To identify gut-biased genes related to digestion, detoxification, and stress response, we explored the midgut transcriptome of lab-reared A. compressa, for both adults and larvae, by focusing on the top 100 significantly up- and down-regulated genes. From the top 100 significantly differentially expressed genes (DEGs), we identified 39 and 36 DEGs putatively related to digestion and detoxification in the adult wasps and larvae, respectively. The two carbohydrases alpha-glucosidase (containing an alpha-amylase domain) and glycosyl hydrolase family 31, as well as the two proteinases chymotrypsin and trypsin, revealed the highest gene diversity. We identified six significant DEGs related to detoxification, which comprise glutathione S-transferase, cytochrome P450s and UDP-glucuronosyltransferase. The gene expression levels that were significantly expressed in both life stages vary strongly between life stages, as found in genes encoding for chymotrypsin and trypsin or glycosyl hydrolases family 31. The number of genes related to alpha-glucosidase, glycosyl hydrolase family 31, and cytochrome P450s was found to be similar across nine reference hymenopteran species, except for the identified glycosyl hydrolase family 31 gene, which was absent in all reference bee species. Phylogenetic analyses of the latter candidate genes revealed that they cluster together with their homologous genes found in the reference hymenopteran species. These identified candidate genes provide a basis for future comparative genomic and proteomic studies on (ontogenetic) dietary transitions in Hymenoptera.	[Jasso-Martinez, Jovana M.; Zaldivar-Riveron, Alejandro] Univ Nacl Autonoma Mexico, Inst Biol, Colecc Nacl Insectos, Ciudad De Mexico, Mexico; [Jasso-Martinez, Jovana M.] Univ Nacl Autonoma Mexico, Inst Biol, Ciencias Biol, Ciudad De Mexico, Mexico; [Donath, Alexander] Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, Bonn, Germany; [Schulten, Dieter] Aquazoo Lobbecke Museum, Dusseldorf, Germany; [Sann, Manuela] Albert Ludwig Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol, Freiburg, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Freiburg	Sann, M (corresponding author), Albert Ludwig Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol, Freiburg, Germany.	manuela.sann@biologie.uni-freiburg.de	Donath, Alexander/F-2636-2015	Donath, Alexander/0000-0001-5618-0547; Jasso-Martinez, Jovana M./0000-0001-6497-7150	University of Freiburg, Germany [2100189601]; Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico); German Academic Exchange Service (DAAD); Baden-Wuerttemberg Ministry of Science, Research and Art; University of Freiburg	University of Freiburg, Germany; Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Baden-Wuerttemberg Ministry of Science, Research and Art; University of Freiburg	This research was supported by grants given by the University of Freiburg, Germany Project-ID 2100189601)to MS. JMJM was supported by a PhD scholarship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, Mexico) and by a grant from the German Academic Exchange Service (DAAD). The article processing charge was funded by the Baden-Wuerttemberg Ministry of Science, Research and Art and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Allen ML, 2018, INSECTS, V9, DOI 10.3390/insects9040185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvidson R, 2018, J HYMENOPT RES, V63, P1, DOI 10.3897/jhr.63.21762; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Borges AA, 2012, INSECT SOC, V59, P587, DOI 10.1007/s00040-012-0259-1; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen XE, 2015, GENE, V558, P208, DOI 10.1016/j.gene.2014.12.053; Da Lage Jean-Luc, 2018, Int J Insect Sci, V10, p1179543318804783, DOI 10.1177/1179543318804783; Dias RO, 2015, INSECT BIOCHEM MOLEC, V58, P1, DOI 10.1016/j.ibmb.2014.12.009; EGGLETON P, 1992, PHILOS T R SOC B, V337, P1, DOI 10.1098/rstb.1992.0079; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feyereisen R, 1999, NIPPON NOGEIK KAISHI, V73, P1043; Gabrisko M, 2013, J MOL EVOL, V76, P129, DOI 10.1007/s00239-013-9545-4; Genath A., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Gnatzy W, 2018, ARTHROPOD STRUCT DEV, V47, P74, DOI 10.1016/j.asd.2017.11.010; Gnatzy W, 2015, ARTHROPOD STRUCT DEV, V44, P491, DOI 10.1016/j.asd.2015.08.008; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keasar T, 2006, ETHOLOGY, V112, P699, DOI 10.1111/j.1439-0310.2006.01214.x; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kostaropoulos I, 2001, INSECT BIOCHEM MOLEC, V31, P313, DOI 10.1016/S0965-1748(00)00123-5; Lazarevic J, 2015, ENTOMOL EXP APPL, V157, P123, DOI 10.1111/eea.12349; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; Minh BQ, 2020, MOL BIOL EVOL, V37, P1530, DOI 10.1093/molbev/msaa015; Mistry J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-298; Nakamatsu Y, 2004, J INSECT PHYSIOL, V50, P847, DOI 10.1016/j.jinsphys.2004.06.007; Nation SrJL, 2015, INSECT PHYSL BIOCH; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Oeyen JP, 2020, GENOME BIOL EVOL, V12, P1099, DOI 10.1093/gbe/evaa106; Fox EGP, 2006, ZOOTAXA, P43, DOI 10.11646/zootaxa.1279.1.2; PIEK T, 1984, ENTOMOL EXP APPL, V35, P195, DOI 10.1007/BF00217538; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Pulawski W, 2020, CATALOG SPHECIDAE SE; Punzo F, 2005, J NEW YORK ENTOMOL S, V113, P84, DOI 10.1664/0028-7199(2005)113[0084:SOTNHE]2.0.CO;2; Seppey M, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1704-5; SHEN SK, 1992, J CHEM EDUC, V69, P796, DOI 10.1021/ed069p796; Silva FCBL, 2006, INSECT BIOCHEM MOLEC, V36, P561, DOI 10.1016/j.ibmb.2006.04.004; SUTCLIFFE DW, 1963, COMP BIOCHEM PHYSIOL, V9, P121, DOI 10.1016/0010-406X(63)90016-1; de Figueroa JMT, 2011, COMP BIOCHEM PHYS A, V160, P426, DOI 10.1016/j.cbpa.2011.07.014; Trapp J, 2017, MOL ECOL, V26, P718, DOI 10.1111/mec.13986; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whitworth ST, 1998, J BIOL CHEM, V273, P14430, DOI 10.1074/jbc.273.23.14430; WILLIAMS F. X., 1942, Proceedings of the Hawaiian Entomological Society, V11, P221; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Xu JH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-874; Yang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029418; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Jianhua, 2016, PLoS One, V11, pe0155254, DOI 10.1371/journal.pone.0155254; Zhang XR, 2019, COMP BIOCHEM PHYS D, V31, DOI 10.1016/j.cbd.2019.100607	57	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252221	10.1371/journal.pone.0252221	http://dx.doi.org/10.1371/journal.pone.0252221			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166422	Green Published, Green Submitted, gold			2022-12-26	WOS:000671692800052
J	Tay, JYL; Zotz, G; Puczylowski, J; Einzmann, HJR				Tay, Jessica Y. L.; Zotz, Gerhard; Puczylowski, Jaroslaw; Einzmann, Helena J. R.			Go with the flow: The extent of drag reduction as epiphytic bromeliads reorient in wind	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; MONTANE CLOUD FOREST; VASCULAR EPIPHYTES; WATER; RECONFIGURATION; BIOMASS; SURVIVAL; SPHERE; GROWTH; CONSEQUENCES	Vascular epiphytes represent almost 10% of all terrestrial plant diversity. Being structurally dependent on trees, epiphytes live at the interface of vegetation and atmosphere, making them susceptible to atmospheric changes. Despite the extensive research on vascular epiphytes, little is known about wind disturbance on these plants. Therefore, this study investigated the wind-epiphyte mechanical interactions by quantifying the drag forces on epiphytic bromeliads when subjected to increasing wind speeds (5-22 m s(-1)) in a wind tunnel. Drag coefficients (C-d) and Vogel exponents (B) were calculated to quantify the streamlining ability of different bromeliad species. Bromeliads' reconfiguration occurred first via bending and aligning leaves in the flow direction. Then leaves clustered and reduced the overall plant frontal area. This reconfiguration caused drag forces to increase at a slower rate as wind velocity increased. In the extreme case, drag force was reduced by 50% in a large Guzmania monostachia individual at a wind velocity of 22 m s(-1), compared to a stiff model. This species had one of the smallest C-d (0.58) at the highest wind velocity, and the largest negative mean B (-0.98), representing the largest reconfiguration capacity amongst the tested bromeliads. The streamlining ability of bromeliads was mainly restricted by the rigidity of the lower part of the plant where the leaves are already densely clustered. Wind speeds used in this study were generally low as compared to storm force winds. At these low wind speeds, reconfiguration was an effective mechanism for drag reduction in bromeliads. This mechanism is likely to lose its effectiveness at higher wind speeds when continuous vigorous fluttering results in leaf damage and aspects such as root-attachment strength and substrate stability become more relevant. This study is a first step towards an understanding of the mechanical bottleneck in the epiphyte-tree-system under wind stress.	[Tay, Jessica Y. L.; Zotz, Gerhard; Einzmann, Helena J. R.] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Funct Ecol Plants, Oldenburg, Germany; [Zotz, Gerhard] Smithsonian Trop Res Inst, Panama City, Panama; [Puczylowski, Jaroslaw] Carl von Ossietzky Univ Oldenburg, ForWind Ctr Wind Energy Res, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Smithsonian Institution; Smithsonian Tropical Research Institute; Carl von Ossietzky Universitat Oldenburg	Tay, JYL (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, Funct Ecol Plants, Oldenburg, Germany.	jessica.tay.ying.ling@uni-oldenburg.de		Tay, Jessica Y. L./0000-0002-5701-4660; Einzmann, Helena/0000-0002-4856-3967	German Research Foundation [El 1092/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation [Grant number El 1092/1-1]. (https://www.dfg.de).	Aberle J, 2012, RIVER FLOW 2012, VOLS 1 AND 2, P193; ABRAHAM FF, 1970, PHYS FLUIDS, V13, P2194, DOI 10.1063/1.1693218; ACHENBACH E, 1972, J FLUID MECH, V54, P565, DOI 10.1017/S0022112072000874; Alam F, 2010, PROCEDIA ENGINEER, V2, P2443, DOI 10.1016/j.proeng.2010.04.013; Alben S, 2002, NATURE, V420, P479, DOI 10.1038/nature01232; [Anonymous], 2013, VERSION 1 1; Aoki M., 1975, J AGROMETEOROL, V31, P115, DOI DOI 10.2480/AGRMET.31.115; Barua DK., 2005, ENCY COASTAL SCI, P186, DOI DOI 10.1007/1-4020-3880-1_45; Baynton H. W., 1965, Journal of Applied Meteorology, V4, P670, DOI 10.1175/1520-0450(1965)004<0670:WSIAAA>2.0.CO;2; Cao JX, 2012, URBAN FOR URBAN GREE, V11, P465, DOI 10.1016/j.ufug.2012.05.003; Chapman JA, 2015, WATER RESOUR RES, V51, P3292, DOI [10.1002/2014WR015436, 10.1002/2]; Joca TAC, 2017, FLORA, V230, P66, DOI 10.1016/j.flora.2017.03.009; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; de Langre E, 2012, CR MECANIQUE, V340, P35, DOI 10.1016/j.crme.2011.11.005; DENNY MW, 1994, J EXP BIOL, V194, P97; DIESEL R, 1989, ANIM BEHAV, V38, P561, DOI 10.1016/S0003-3472(89)80001-6; Einzmann HJR, 2021, J ECOL, V109, P1931, DOI 10.1111/1365-2745.13618; Einzmann HJR, 2020, ACTA BOT BRAS, V34, P66, DOI 10.1590/0102-33062019abb0198; Ennos AR, 1999, J EXP BIOL, V202, P3281; Etnier SA, 2000, AM J BOT, V87, P29, DOI 10.2307/2656682; Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125; GAYLORD B, 1994, ECOL MONOGR, V64, P287, DOI 10.2307/2937164; Gillies JA, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001259; Gosselin F, 2010, J FLUID MECH, V650, P319, DOI 10.1017/S0022112009993673; Harder DL, 2006, AM J BOT, V93, P1426, DOI 10.3732/ajb.93.10.1426; Harder DL, 2006, ECOLOGY AND BIOMECHANICS, P61; Harder DL, 2004, J PLANT GROWTH REGUL, V23, P98, DOI 10.1007/s00344-004-0043-1; Holland G, 2014, CLIM DYNAM, V42, P617, DOI 10.1007/s00382-013-1713-0; Hsu CC, 2002, J TROP ECOL, V18, P659, DOI 10.1017/S0266467402002432; Hsu RCC, 2012, DIVERS DISTRIB, V18, P334, DOI 10.1111/j.1472-4642.2011.00819.x; Jacobs EN., 1929, SPHERE DRAG TESTS VA; Kenoyer LA, 1929, ECOLOGY, V10, P201, DOI 10.2307/1932295; Koehl M, P 3 INT PLANT BIOM C; Kohler L, 2007, PLANT ECOL, V193, P171, DOI 10.1007/s11258-006-9256-7; Koizumi A, 2010, J WOOD SCI, V56, P189, DOI 10.1007/s10086-009-1091-8; Laurance WF, 2008, AUSTRAL ECOL, V33, P399, DOI 10.1111/j.1442-9993.2008.01895.x; LOOPE L, 1994, BIOSCIENCE, V44, P238, DOI 10.2307/1312228; Lowman MD., 1995, J BROM SOC, V45, P15; MATELSON TJ, 1993, ECOLOGY, V74, P265, DOI 10.2307/1939523; Matsumura T., 2009, VEG SCI, V26, P103; Mousavi ME, 2011, CLIMATIC CHANGE, V104, P575, DOI 10.1007/s10584-009-9790-0; Mujica E., 2013, LANKESTERIANA, V13, P47; NADKARNI NM, 1984, BIOTROPICA, V16, P249, DOI 10.2307/2387932; Nadkarni NM, 2004, FOREST ECOL MANAG, V198, P223, DOI 10.1016/j.foreco.2004.04.011; NEVE RS, 1989, INT J HEAT FLUID FL, V10, P318, DOI 10.1016/0142-727X(89)90020-9; Paton S, 2020, SMITHSONIAN I, DOI [10.25573/data.11799111.v2, DOI 10.25573/DATA.11799111.V2]; Pett-Ridge J, 2002, BIOTROPICA, V34, P211, DOI 10.1111/j.1744-7429.2002.tb00532.x; Petter G, 2016, FUNCT ECOL, V30, P188, DOI 10.1111/1365-2435.12490; R Core Team, 2020, R LANG ENV STAT COMP; Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546; Reyes-Garcia C, 2012, NEW PHYTOL, V193, P745, DOI 10.1111/j.1469-8137.2011.03946.x; ROOS FW, 1971, AIAA J, V9, P285, DOI 10.2514/3.6164; Ruck B, 2012, EUR J FOREST RES, V131, P177, DOI 10.1007/s10342-010-0451-7; Sand-Jensen K, 2003, FRESHWATER BIOL, V48, P271, DOI 10.1046/j.1365-2427.2003.00998.x; Sand-Jensen K, 2008, HYDROBIOLOGIA, V610, P307, DOI 10.1007/s10750-008-9446-5; SandJensen K, 1996, OIKOS, V76, P169, DOI 10.2307/3545759; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlichting H., 1968, BOUNDARY LAYER THEOR; Spatz HC, 2000, FOREST ECOL MANAG, V135, P33, DOI 10.1016/S0378-1127(00)00296-6; Tadrist L, 2015, J FLUID STRUCT, V56, P1, DOI 10.1016/j.jfluidstructs.2015.04.001; Tobon C, 2011, TROPICAL MONTANE CLO, P261; VENEKLAAS EJ, 1990, VEGETATIO, V89, P183, DOI 10.1007/BF00032170; VOGEL S, 1989, J EXP BOT, V40, P941, DOI 10.1093/jxb/40.8.941; VOGEL S, 1984, AM ZOOL, V24, P37; Vollsinger S, 2005, CAN J FOREST RES, V35, P1238, DOI 10.1139/x05-051; Whittaker P, 2013, J HYDRAUL RES, V51, P569, DOI 10.1080/00221686.2013.822936; Yang B, 2006, BOUND-LAY METEOROL, V120, P377, DOI 10.1007/s10546-006-9057-5; Zotz G, 2016, FASCINAT LIFE SCI, P1, DOI 10.1007/978-3-319-39237-0; Zotz G., 2009, V70, P147, DOI 10.1007/978-3-540-68421-3_7; Zotz G, 2001, J EXP BOT, V52, P2067, DOI 10.1093/jexbot/52.364.2067; Zotz G, 2020, FLORA, V264, DOI 10.1016/j.flora.2020.151557; Zotz G, 2013, BOT J LINN SOC, V171, P453, DOI 10.1111/boj.12010; Zotz G, 2010, ACTA OECOL, V36, P659, DOI 10.1016/j.actao.2010.10.003	73	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252790	10.1371/journal.pone.0252790	http://dx.doi.org/10.1371/journal.pone.0252790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166417	Green Published, gold			2022-12-26	WOS:000671692800087
J	Bainier, M; Su, A; Redondo, RL				Bainier, Marie; Su, Arel; Redondo, Roger L.			3D printed rodent skin-skull-brain model: A novel animal-free approach for neurosurgical training	PLOS ONE			English	Article							SIMULATION; EDUCATION	In neuroscience, stereotactic brain surgery is a standard yet challenging technique for which laboratory and veterinary personnel must be sufficiently and properly trained. There is currently no animal-free training option for neurosurgeries; stereotactic techniques are learned and practiced on dead animals. Here we have used three-dimensional (3D) printing technologies to create rat and mouse skin-skull-brain models, specifically conceived for rodent stereotaxic surgery training. We used 3D models obtained from microCT pictures and printed them using materials that would provide the most accurate haptic feedback for each model-PC-ABS material for the rat and Durable resin for the mouse. We filled the skulls with Polyurethane expanding foam to mimic the brain. In order to simulate rodent skin, we added a rectangular 1mm thick clear silicone sheet on the skull. Ten qualified rodent neurosurgeons then performed a variety of stereotaxic surgeries on these rat and mouse 3D printed models. Participants evaluated models fidelity compared to cadaveric skulls and their appropriateness for educational use. The 3D printed rat and mouse skin-skull-brain models received an overwhelmingly positive response. They were perceived as very realistic, and considered an excellent alternative to cadaveric skulls for training purposes. They can be made rapidly and at low cost. Our real-size 3D printed replicas could enable cost- and time-efficient, animal-free neurosurgery training. They can be absolute replacements for stereotaxic surgery techniques practice including but not limited to craniotomies, screw placement, brain injections, implantations and cement applications. This project is a significant step forward in implementing the replacement, reduction, and refinement (3Rs) principles to animal experimentation. These 3D printed models could lead the way to the complete replacement of live animals for stereotaxic surgery training in laboratories and veterinary studies.	[Bainier, Marie; Redondo, Roger L.] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Neurosci & Rare Dis, Roche Pharmaceut Res & Early Dev pRED, Basel, Switzerland; [Su, Arel] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Pharmaceut Sci, Roche Pharmaceut Res & Early Dev pRED, Basel, Switzerland	Roche Holding; Roche Holding	Bainier, M (corresponding author), F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Neurosci & Rare Dis, Roche Pharmaceut Res & Early Dev pRED, Basel, Switzerland.	marie.bainier@roche.com		BAINIER, Marie/0000-0001-5832-193X				Bryson EO, 2008, J CRIT CARE, V23, P185, DOI 10.1016/j.jcrc.2007.12.003; Callahan AB, 2017, OPHTHAL PLAST RECONS, V33, P376, DOI 10.1097/IOP.0000000000000884; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chen SY, 2020, BIOMED ENG LETT, V10, P453, DOI 10.1007/s13534-020-00171-8; Ferry B, 2014, STEREOTAXIC NEUROSURGERY IN LABORATORY RODENT: HANDBOOK ON BEST PRACTICES, P153, DOI 10.1007/978-2-8178-0472-9_7; Frolich AMJ, 2016, AM J NEURORADIOL, V37, P120, DOI 10.3174/ajnr.A4486; Gage GJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3565; Giannopoulos AA, 2016, NAT REV CARDIOL, V13, P701, DOI 10.1038/nrcardio.2016.170; Hoer J, 2001, LANGENBECK ARCH SURG, V386, P218, DOI 10.1007/s004230000196; Jones DB, 2016, SURG INNOV, V23, P189, DOI 10.1177/1553350615607641; Kimura T, 2009, NEUROSURGERY, V65, P719, DOI 10.1227/01.NEU.0000354350.88899.07; Li C, 2017, SURG INNOV, V24, P82, DOI 10.1177/1553350616681889; Lim KHA, 2016, ANAT SCI EDUC, V9, P213, DOI 10.1002/ase.1573; Makowiecki K, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.15; Malik HH, 2015, J SURG RES, V199, P512, DOI 10.1016/j.jss.2015.06.051; Mostany Ricardo, 2008, J Vis Exp, DOI 10.3791/680; Oliveira Laura M. O., 2008, P21; Ploch CC, 2016, WORLD NEUROSURG, V90, P668, DOI 10.1016/j.wneu.2016.02.081; Pohl BM, 2013, I IEEE EMBS C NEUR E, P887, DOI 10.1109/NER.2013.6696077; Pohl BM, 2013, [3D.stl file of rat skull, Dataset: figshare [Internet]]; Pritchett-Corning KR, 2011, JOVE-J VIS EXP, DOI 10.3791/2586; Randazzo Michael, 2016, Surg Neurol Int, V7, pS801; Rowe T, 2001, DATASET DIGITAL MORP; Sommer AC, 2019, GRAEF ARCH CLIN EXP, V257, P1815, DOI 10.1007/s00417-019-04312-3; Sturm LP, 2008, ANN SURG, V248, P166, DOI 10.1097/SLA.0b013e318176bf24; Tai BL, 2015, J NEUROSURG, V123, P1070, DOI 10.3171/2014.12.JNS141867; Ung K, 2012, JOVE-J VIS EXP, DOI 10.3791/50004; Waran V, 2015, SIMUL HEALTHC, V10, P43, DOI 10.1097/SIH.0000000000000060; Waran V, 2014, J SURG EDUC, V71, P193, DOI 10.1016/j.jsurg.2013.08.010	29	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253477	10.1371/journal.pone.0253477	http://dx.doi.org/10.1371/journal.pone.0253477			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161366	Green Published, gold			2022-12-26	WOS:000671691900018
J	Ochieng, NT; Elizabeth, KN; Nigel, LW				Ochieng, Nyumba Tobias; Elizabeth, Kimongo Nankini; Nigel, Leader-Williams			Measuring the conservation attitudes of local communities towards the African elephant Loxodonta africana, a flagship species in the Mara ecosystem	PLOS ONE			English	Article							PEOPLE LIVING ADJACENT; PROTECTED AREAS; NATIONAL-PARK; INTEGRATED CONSERVATION; CONFLICTING ATTITUDES; WILDLIFE; IMPACT; PERCEPTION; MANAGEMENT; LAIKIPIA	Gaining insights into local people's views, values and preferences for different conservation management options are increasingly gaining importance among conservationists and decision-makers. This can be achieved through the assessment and understanding of conservation attitudes and perceptions of rural communities including demographic characteristics predicting the attitudes to design and implement conservation policies in a more socially acceptable manner. In this study, we developed and validated user-friendly indices to measure attitudes towards the African elephant, a flagship species and its conservation in Trans Mara District. An iterative item reliability analysis was executed on household data from a random sample of 367 respondents using Cronbach's Alpha in SPSS. Results yielded two indices; (i) Elephant Attitude Index (EAI); and (ii) Maasai Mara National Reserve Attitude Index (MAI). The EAI had a Cronbach's Alpha coefficient of 0.73 while the MAI had a Cronbach's Alpha coefficient of 0.77. Data analysis revealed that (i) location of residence; (ii) age of respondent; (iii) number of income sources; (iv) gender of the respondent; and (v) benefit reception were the main determinants of EAI and MAI in TM. Our attitude indices can assist conservation practitioners and decision-makers to prioritise resources, on the assumption that high-scoring individuals are more likely to participate in conservation initiatives. We encourage making available different sources of income for residents and working towards improving the involvement of younger people and women in conservation activities in TM.	[Ochieng, Nyumba Tobias] African Conservat Ctr, Nairobi, Kenya; [Ochieng, Nyumba Tobias] Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya; [Ochieng, Nyumba Tobias; Nigel, Leader-Williams] Univ Cambridge, Cambridge, England; [Elizabeth, Kimongo Nankini] Kenya Agr & Livestock Res Org, Ruiru, Kenya	University of Nairobi; University of Cambridge	Ochieng, NT (corresponding author), African Conservat Ctr, Nairobi, Kenya.; Ochieng, NT (corresponding author), Univ Nairobi, Inst Climate Change & Adaptat, Nairobi, Kenya.; Ochieng, NT (corresponding author), Univ Cambridge, Cambridge, England.	tnyumba@uonbi.ac.ke	Nyumba, Tobias Ochieng/AAD-3583-2021	Nyumba, Tobias Ochieng/0000-0002-7821-5197	Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship; WildiZe Foundation; Wildlife Conservation Society (Tellus Leadership Scholarship); Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation); Churchill College (Pennett Fund Grant and Lundgren Research Award)	Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship; WildiZe Foundation; Wildlife Conservation Society (Tellus Leadership Scholarship); Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation); Churchill College (Pennett Fund Grant and Lundgren Research Award)	NT received funding from the Cambridge Commonwealth Trust through the Churchill/Sidney Sussex Southern African Cambridge Scholarship. Additional funding came from the WildiZe Foundation, the Wildlife Conservation Society (Tellus Leadership Scholarship), the Wildlife Conservation Network (Schink Scholarship for Wildlife Conservation) and Churchill College (Pennett Fund Grant and Lundgren Research Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMA JS, 1995, SOC NATUR RESOUR, V8, P133, DOI 10.1080/08941929509380907; Babbie E., 2014, PRACTICE SOCIAL RES; Baral N, 2007, BIODIVERS CONSERV, V16, P2903, DOI 10.1007/s10531-006-9143-5; Barnes RFW, 1996, MAMMAL REV, V26, P67, DOI 10.1111/j.1365-2907.1996.tb00147.x; Barr S, 2007, ENVIRON BEHAV, V39, P435, DOI 10.1177/0013916505283421; Brandon K., 1998, PARKS PERIL PEOPLE P; Browne-Nunez C., 2008, Human Dimensions of Wildlife, V13, P47, DOI 10.1080/10871200701812936; Cahyat A., 2007, ASSESSING HOUSEHOLD; Campbell-Smith G, 2010, AM J PRIMATOL, V72, P866, DOI 10.1002/ajp.20822; Child B, 1996, BIODIVERS CONSERV, V5, P369, DOI 10.1007/BF00051780; De Vaus DA, 1991, SURVEY SOCIAL RES SURVEY SOCIAL RES; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Douglas LR, 2013, ENVIRON SOC, V4, P98, DOI 10.3167/ares.2013.040107; Doyal Len, 1991, THEORY HUMAN NEEDS; Fiallo EA, 1995, ENVIRON CONSERV, V22, P241, DOI 10.1017/S037689290001064X; Fishbein M., 1975, BELIEF ATTITUDE INTE; Gadd ME, 2005, ENVIRON CONSERV, V32, P50, DOI 10.1017/S0376892905001918; George D, 2003, SPSS WINDOWS STEP ST; Gillingham S, 1999, ENVIRON CONSERV, V26, P218, DOI 10.1017/S0376892999000302; Glover PE., 1970, ECOLOGICAL SURVEY NA ECOLOGICAL SURVEY NA; Goldman M, 2007, ENVIRON PLANN D, V25, P307, DOI 10.1068/d0505; Goodwin H., 1997, TOURISM CONSERVATION, V1; Graham M., 2006, THESIS U CAMBRIDGE U THESIS U CAMBRIDGE U; Guerbois C, 2013, CONSERV BIOL, V27, P844, DOI 10.1111/cobi.12108; Gustafson PE, 1998, RISK ANAL, V18, P805, DOI 10.1023/B:RIAN.0000005926.03250.c0; Hart LA, 2000, HUMAN CONFLICT UNPUB HUMAN CONFLICT UNPUB; Hazzah L., 2006, THESIS U WISCONSIN THESIS U WISCONSIN; Hemson G, 2009, BIOL CONSERV, V142, P2718, DOI 10.1016/j.biocon.2009.06.024; Hill CM, 1998, ENVIRON CONSERV, V25, P244, DOI 10.1017/S0376892998000307; Homewood K, 2006, MAASAI PASTORALISTS; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; INFIELD M, 1988, BIOL CONSERV, V45, P21, DOI 10.1016/0006-3207(88)90050-X; Jean-Gael JE-C, 2009, THESIS U FLORIDA THESIS U FLORIDA; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Kaltenborn B.R.P., 2006, HUMAN DIMENSIONS WIL, V11, P397, DOI DOI 10.1080/10871200600984323; Kenya National Bureau of Statistics, 2010, 2009 KEN POP HOUS CE; Khatun U. H., 2012, International Journal of Biodiversity and Conservation, V4, P385; Kioko J, 2008, S AFR J WILDL RES, V38, P52, DOI 10.3957/0379-4369-38.1.52; Kiyiapi J., FOREST RESOURCES TRA, P1996; KNBS, 2019, 2019 KEN POP HOUS CE, VII; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; Lenao M., 2014, THESIS U OULU THESIS U OULU; Maslow A. H., 1954, MOTIVATION PERSONALI; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Messmer TA, 2000, INT BIODETER BIODEGR, V45, P97, DOI 10.1016/S0964-8305(00)00045-7; Moser C., 1972, SURVEY METHODS SOCIA; MUSAMBACHIME MC, 1987, AFR AFFAIRS, V86, P197, DOI 10.1093/oxfordjournals.afraf.a097887; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; NCC and CCT, 2009, MAAS MAR NAT RES MAN MAAS MAR NAT RES MAN; NEWMARK WD, 1994, CONSERV BIOL, V8, P249, DOI 10.1046/j.1523-1739.1994.08010249.x; NEWMARK WD, 1993, BIOL CONSERV, V63, P177, DOI 10.1016/0006-3207(93)90507-W; Norton-Griffiths M., 2009, Wild rangelands: conserving wildlife while maintaining livestock in semi-arid ecosystems, P367; Nyumba TO, 2018, THESIS U CAMBRIDGE C THESIS U CAMBRIDGE C; Nyumba TO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239545; Odumo BO, 2014, ENVIRON SCI POLLUT R, V21, P12426, DOI 10.1007/s11356-014-3190-3; Ogada MO, 2011, RAPID SURVEY SELECTE RAPID SURVEY SELECTE; Pallant J., 2005, SPSS SURVIVAL MANUAL, V2; Pierce C. L., 2001, HUMAN DIMENSIONWIL, P39; Pimbert M. P., 1997, SOCIAL CHANGE CONSER; POATE CD, 1993, DATA AGRARIAN DEV; Poole J., 2016, MARA ECOSYSTEM CONNE; Prokop P, 2010, ANTHROZOOS, V23, P21, DOI 10.2752/175303710X12627079939107; Pullin AS, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-19; Rahman MM, 2017, INT J SUST DEV WORLD, V24, P65, DOI 10.1080/13504509.2016.1169453; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Shrestha R., 2007, CASE STUDY HUM UNPUB CASE STUDY HUM UNPUB; Sitati N., 2007, WET DRY SEASON ELEPH; Sitati N.W., 2003, THESIS U KENT CANTER; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Sitati NW., 2012, ADV ANTHR, V2, P107, DOI [10.4236/aa.2012.23012, DOI 10.4236/AA.2012.23012]; Spinage C.A., 1994, ELEPHANTS; TERBORGH J, 1999, REQUIEM NATURE; THOULESS CR, 1995, BIOL CONSERV, V72, P99, DOI 10.1016/0006-3207(94)00071-W; Verchick RRM., 2004, NEW PERSPECTIVES ENV, P63; Wakoli E. N., 2012, GREENER J ENV MANAGE, V1, P27; Walpole MJ, 2001, NATURE, V413, P771, DOI 10.1038/35101762; Walpole MJ., WILDLIFE DEV SERIES, V14, P2003; Wang Y, 2006, USDA FOR SERV N RES, P411; West P, 2006, ANNU REV ANTHROPOL, V35, P251, DOI 10.1146/annurev.anthro.35.081705.123308; Williams LA, 1964, 66 GEOL SURV KEN 66 GEOL SURV KEN; Wunder MB., 1997, NAT RESOUR ENVIRON, P360	82	3	3	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253234	10.1371/journal.pone.0253234	http://dx.doi.org/10.1371/journal.pone.0253234			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161362	Green Published, gold			2022-12-26	WOS:000671691900022
J	Kaimann, D; Tanneberg, I				Kaimann, Daniel; Tanneberg, Ilka			What containment strategy leads us through the pandemic crisis? An empirical analysis of the measures against the COVID-19 pandemic	PLOS ONE			English	Article							EPIDEMIC; DYNAMICS; CHINA	Since January 2020, the COVID-19 outbreak has been progressing at a rapid pace. To keep the pandemic at bay, countries have implemented various measures to interrupt the transmission of the virus from person to person and prevent an overload of their health systems. We analyze the impact of these measures implemented against the COVID-19 pandemic by using a sample of 68 countries, Puerto Rico and the 50 federal states of the United States of America, four federal states of Australia, and eight federal states of Canada, involving 6,941 daily observations. We show that measures are essential for containing the spread of the COVID-19 pandemic. After controlling for daily COVID-19 tests, we find evidence to suggest that school closures, shut-downs of non-essential business, mass gathering bans, travel restrictions in and out of risk areas, national border closures and/or complete entry bans, and nationwide curfews decrease the growth rate of the coronavirus and thus the peak of daily confirmed cases. We also find evidence to suggest that combinations of these measures decrease the daily growth rate at a level outweighing that of individual measures. Consequently, and despite extensive vaccinations, we contend that the implemented measures help contain the spread of the COVID-19 pandemic and ease the overstressed capacity of the healthcare systems.	[Kaimann, Daniel; Tanneberg, Ilka] Paderborn Univ, Dept Management, Paderborn, Germany	University of Paderborn	Kaimann, D (corresponding author), Paderborn Univ, Dept Management, Paderborn, Germany.	Daniel.Kaimann@uni-paderborn.de						[Anonymous], 2020, LAB TEST STRAT REC C; [Anonymous], 2020, REUTERS; Banerjee R, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113473; Bates D.M., 1994, MODEL BUILDING NONLI; Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Byambasuren Oyungerel, 2020, J Assoc Med Microbiol Infect Dis Can, V5, P223, DOI 10.3138/jammi-2020-0030; Centers for Disease Control and Prevention, INT PREP PLANN GUID; Chan HF, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240644; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chong KC, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009056; Daoust JF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249914; Darvishian M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169528; Desai AN, 2019, HEALTH SECUR, V17, P268, DOI 10.1089/hs.2019.0022; Dinh L, 2018, J THEOR BIOL, V442, P79, DOI 10.1016/j.jtbi.2017.12.030; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Duval A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20008-w; Frick B, 2017, APPL ECON LETT, V24, P1237, DOI 10.1080/13504851.2016.1270399; Gu, 2020, COVID 19 PROJECTIONS; Hasell J, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00688-8; Houeix R, FRANCE24 CORONAVIRUS; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; IHME, 2020, COVID 19 PROJ; John Hopkins University, COVID 19 DASHB CTR S; Kamrujjaman M., 2020, ANN RES REV BIOL, V35, P72, DOI [10.9734/arrb/2020/v35i130182, DOI 10.9734/ARRB/2020/V35I130182]; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Lee SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236860; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Liang KH, 2020, INFECT GENET EVOL, V82, DOI 10.1016/j.meegid.2020.104306; Linton NM, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020538; McFall-Johnsen M., 3 GLOBAL POPULATION; MRC Center, 2020, FUT SCEN HEALTHC BUR; Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276; Roosa K, 2020, INFECT DIS MODEL, V5, P256, DOI 10.1016/j.idm.2020.02.002; Russell TW, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01790-9; Santos Joost, 2020, Environment Systems & Decisions, V40, DOI 10.1007/s10669-020-09774-z; Wang W, 2020, EMERG INFECT DIS, V26, P891, DOI 10.3201/eid2605.190390; Wooldridge JM., 2013, INTRO ECONOMETRICS M; World Health Organization, 2020, 50 WHO; World Health Organization, PNEUM UNKN CAUS CHIN; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	45	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0253237	10.1371/journal.pone.0253237	http://dx.doi.org/10.1371/journal.pone.0253237			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153058	Green Published, gold			2022-12-26	WOS:000671691000020
J	Lequeux, A; Noman, MZ; Xiao, MLN; Van Moer, K; Hasmim, M; Benoit, A; Bosseler, M; Viry, E; Arakelian, T; Berchem, G; Chouaib, S; Janji, B				Lequeux, Audrey; Noman, Muhammad Zaeem; Xiao, Malina; Van Moer, Kris; Hasmim, Meriem; Benoit, Alice; Bosseler, Manon; Viry, Elodie; Arakelian, Tsolere; Berchem, Guy; Chouaib, Salem; Janji, Bassam			Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy	ONCOGENE			English	Article							HYPOXIA; SUSCEPTIBILITY; OPPORTUNITIES; AUTOPHAGY; THERAPY; BIOLOGY; GROWTH; LYSIS	Hypoxia is a key factor responsible for the failure of therapeutic response in most solid tumors and promotes the acquisition of tumor resistance to various antitumor immune effectors. Reshaping the hypoxic immune suppressive tumor microenvironment to improve cancer immunotherapy is still a relevant challenge. We investigated the impact of inhibiting HIF-1 alpha transcriptional activity on cytotoxic immune cell infiltration into B16-F10 melanoma. We showed that tumors expressing a deleted form of HIF-1 alpha displayed increased levels of NK and CD8(+) effector T cells in the tumor microenvironment, which was associated with high levels of CCL2 and CCL5 chemokines. We showed that combining acriflavine, reported as a pharmacological agent preventing HIF-1 alpha/HIF-1 beta dimerization, dramatically improved the benefit of cancer immunotherapy based on TRP-2 peptide vaccination and anti-PD-1 blocking antibody. In melanoma patients, we revealed that tumors exhibiting high CCL5 are less hypoxic, and displayed high NK, CD3(+), CD4(+) and CD8(+) T cell markers than those having low CCL5. In addition, melanoma patients with high CCL5 in their tumors survive better than those having low CCL5. This study provides the pre-clinical proof of concept for a novel triple combination strategy including blocking HIF-1 alpha transcription activity along vaccination and PD-1 blocking immunotherapy.	[Lequeux, Audrey; Noman, Muhammad Zaeem; Xiao, Malina; Van Moer, Kris; Hasmim, Meriem; Benoit, Alice; Bosseler, Manon; Viry, Elodie; Arakelian, Tsolere; Berchem, Guy; Janji, Bassam] Luxembourg Inst Hlth LIH, Dept Oncol, Tumor Immunotherapy & Microenvironm TIME Grp, Luxembourg, Luxembourg; [Berchem, Guy] Ctr Hosp Luxembourg, Dept Hematooncol, Luxembourg, Luxembourg; [Chouaib, Salem] Gustave Roussy, Integrat Tumor Immunol & Genet Oncol, INSERM, UMR 1186, Villejuif, France; [Chouaib, Salem] Gulf Med Univ, Thumbay Res Inst Precis Med, Ajman, U Arab Emirates	Luxembourg Institute of Health; Luxembourg Hospital Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Janji, B (corresponding author), Luxembourg Inst Hlth LIH, Dept Oncol, Tumor Immunotherapy & Microenvironm TIME Grp, Luxembourg, Luxembourg.	bassam.janji@lih.lu	Berchem, Guy/C-9364-2014	Berchem, Guy/0000-0003-0157-2257; Arakelian, Tsolere/0000-0002-0079-9268	Luxembourg Institute of Health; FNRS Televie [7.4535.16, 7.6505.18, 7.4606.18]; Luxembourg National Research Fund [C18/BM/12670304/COMBATIC, PRIDE15/10675146/CANBIO]; Fondation Cancer, Luxembourg [FC/2018/06]; Kriibskrank Kanner Foundation, Luxembourg (2019); Janssen Cilag Pharma; Roche Pharma, Action LIONS Vaincre le Cancer Luxembourg; Sheik Hamdan Bin Rashid Al Maktoum Foundation, United Arab Emirates	Luxembourg Institute of Health; FNRS Televie(Fonds de la Recherche Scientifique - FNRS); Luxembourg National Research Fund(Luxembourg National Research Fund); Fondation Cancer, Luxembourg; Kriibskrank Kanner Foundation, Luxembourg (2019); Janssen Cilag Pharma; Roche Pharma, Action LIONS Vaincre le Cancer Luxembourg; Sheik Hamdan Bin Rashid Al Maktoum Foundation, United Arab Emirates	We thank Dr Anne Largeot from Tumor Stroma interactions group (Luxembourg Institute of Health) for her technical assistance. This work was supported by Luxembourg Institute of Health and grants from FNRS Televie (grants 7.4535.16, 7.6505.18 and no7.4606.18); Luxembourg National Research Fund (C18/BM/12670304/COMBATIC and PRIDE15/10675146/CANBIO); Fondation Cancer, Luxembourg (FC/2018/06); Kriibskrank Kanner Foundation, Luxembourg (2019); Janssen Cilag Pharma; Roche Pharma, Action LIONS Vaincre le Cancer Luxembourg and Sheik Hamdan Bin Rashid Al Maktoum Foundation, United Arab Emirates.	Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Barsoum IB, 2014, CANCER RES, V74, P665, DOI 10.1158/0008-5472.CAN-13-0992; Berchem G, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1062968; BOTTAZZI B, 1992, J IMMUNOL, V148, P1280; Brown CE, 2007, J IMMUNOL, V179, P3332, DOI 10.4049/jimmunol.179.5.3332; Burke JD, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.05.002; Chouaib S, 2017, ONCOGENE, V36, P439, DOI 10.1038/onc.2016.225; Colliez F, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00010; Deng J, 2019, CANCER IMMUNOL RES, V7, P1079, DOI 10.1158/2326-6066.CIR-18-0507; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jayaprakash P, 2018, J CLIN INVEST, V128, P5137, DOI 10.1172/JCI96268; Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106; Lequeux A, 2019, CANCER LETT, V458, P13, DOI 10.1016/j.canlet.2019.05.021; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; Messai Y, 2016, EUR UROL, V70, P623, DOI 10.1016/j.eururo.2015.11.029; Noman MZ, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7881; Noman MZ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091083; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Noman MZ, 2012, CANCER RES, V72, P4629, DOI 10.1158/0008-5472.CAN-12-1383; Noman MZ, 2011, CANCER RES, V71, P5976, DOI 10.1158/0008-5472.CAN-11-1094; Scharping NE, 2017, CANCER IMMUNOL RES, V5, P9, DOI 10.1158/2326-6066.CIR-16-0103; Scholz CC, 2013, CURR OPIN PHARMACOL, V13, P646, DOI 10.1016/j.coph.2013.04.009; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shannon AM, 2003, CANCER TREAT REV, V29, P297, DOI 10.1016/S0305-7372(03)00003-3; Span PN, 2015, SEMIN NUCL MED, V45, P101, DOI 10.1053/j.semnuclmed.2014.10.002; Stathopoulos GT, 2008, JNCI-J NATL CANCER I, V100, P1464, DOI 10.1093/jnci/djn325; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112	30	31	32	3	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4725	4735		10.1038/s41388-021-01846-x	http://dx.doi.org/10.1038/s41388-021-01846-x		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34155342	Green Published, hybrid			2022-12-26	WOS:000664006400003
J	Chai, J; Wang, QL; Qin, B; Wang, SK; Wang, YT; Shahid, M; Liu, K; Zhang, YF; Qu, WJ				Chai, Jun; Wang, Qinglu; Qin, Bo; Wang, Shengkui; Wang, Youtao; Shahid, Muhammad; Liu, Kai; Zhang, Yifang; Qu, Weijie			Association of NOS2A gene polymorphisms with susceptibility to bovine tuberculosis in Chinese Holstein cattle	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; RISK; TB	Bovine tuberculosis (bTB) is a global zoonotic disease that has detrimental economic impacts worldwide. The NOS2A gene plays a key role in immunological control of many infectious diseases. However, research on the association between NOS2A polymorphisms and bTB infection in Holstein cattle reared on the Yunnan-Guizhou plateau of China is scarce. This study investigated a possible linkage between NOS2A polymorphisms and risk of developing bTB in Chinese Holstein cattle. The NOS2A gene was genotyped in 144 bTB-infected Holstein cows and 139 healthy controls were genotyped through nucleotide sequencing. Ten single-nucleotide polymorphisms (SNPs) were detected, six of which were associated with susceptibility/resistance patterns of bTB. Furthermore, the C/T genotypes of 671 and 2793, and T/T genotype of E22 (+15) were significantly associated with susceptibility risk; the G/A genotype of 2857, T/T genotype of E9 (+65), and C/C genotype of E9 (+114) probably increased resistance to bTB. In addition, the haplotypes of NOS2A-2 and NOS2A-9 were risk factors for bTB susceptibility, while the NOS2A-5 and NOS2A-8 haplotypes were contributing protective variants against tuberculosis. There is a significant association between variation in SNPs of NOS2A and tuberculosis susceptibility/resistance pattern. These findings suggest that substitution of genetic selection would be helpful for eradicating bTB. However, further investigation is required to study the underlying mechanism through which NOS2A polymorphisms affect bTB infection.	[Chai, Jun; Wang, Qinglu; Qin, Bo; Wang, Shengkui; Wang, Youtao; Liu, Kai; Zhang, Yifang; Qu, Weijie] Yunnan Agr Univ, Coll Vet Med, Kunming, Yunnan, Peoples R China; [Shahid, Muhammad] Vet Res Inst, Peshawar, Pakistan	Yunnan Agricultural University	Qu, WJ (corresponding author), Yunnan Agr Univ, Coll Vet Med, Kunming, Yunnan, Peoples R China.	1401075010@qq.com			Yunnan Expert Workstation [202005AF150041]; National Natural Science Foundation [31260598]	Yunnan Expert Workstation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research in this paper was supported financially by Yunnan Expert Workstation (202005AF150041). It was also supported financially by National Natural Science Foundation (31260598) and Yifang Zhang received the fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravindan PP, 2019, LUNG INDIA, V36, P244, DOI 10.4103/lungindia.lungindia_146_15; Bermingham ML, 2009, J DAIRY SCI, V92, P3447, DOI 10.3168/jds.2008-1848; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chen JY, 2020, AGING-US, V12, P8434, DOI 10.18632/aging.103150; Cooper AM, 2000, INFECT IMMUN, V68, P6879, DOI 10.1128/IAI.68.12.6879-6882.2000; Dzodzomenyo M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202218; Evans JT, 2007, LANCET, V369, P1270, DOI 10.1016/S0140-6736(07)60598-4; Garme Y, 2018, IRAN J PUBLIC HEALTH, V47, P1734; Han DH, 2013, J PERIODONTOL, V84, P776, DOI 10.1902/jop.2012.120237; Hirai K, 2018, J ALLERGY CLIN IMMUN, V142, P663, DOI 10.1016/j.jaci.2018.02.023; Jena M, 2014, TUBERCULOSIS, V94, P81, DOI 10.1016/j.tube.2013.10.004; Jiang L, 2019, J CLIN ENDOCR METAB, V104, P4539, DOI 10.1210/jc.2019-00495; Jin GH, 2020, MOL THER-NUCL ACIDS, V20, P13, DOI 10.1016/j.omtn.2020.01.037; Kamath PL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11448; Kemal J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3628-1; Kendall HK, 2001, ORAL DIS, V7, P2, DOI 10.1034/j.1601-0825.2001.70102.x; Kun JF, 2001, J INFECT DIS, V184, P330, DOI 10.1086/322037; le Roex N, 2013, PHYSIOL GENOMICS, V45, P631, DOI 10.1152/physiolgenomics.00061.2013; Leandro ACCS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/901740; Levesque MC, 2010, HUM GENET, V127, P163, DOI 10.1007/s00439-009-0753-3; Li HM, 2019, AGING-US, V11, P7620, DOI 10.18632/aging.102275; Liu MH, 2020, NEUROIMAGE, V208, DOI 10.1016/j.neuroimage.2019.116459; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Long R, 1999, ANTIMICROB AGENTS CH, V43, P403, DOI 10.1128/AAC.43.2.403; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mansur TDS, 2012, MOL CELL BIOCHEM, V364, P303, DOI 10.1007/s11010-012-1231-0; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Negi VS, 2017, INT J IMMUNOGENET, V44, P114, DOI 10.1111/iji.12315; Porojan MD, 2015, THER CLIN RISK MANAG, V11, P1743, DOI 10.2147/TCRM.S93172; Pullen MF, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024221; Qu YB, 2007, INT J HYG ENVIR HEAL, V210, P679, DOI 10.1016/j.ijheh.2006.11.010; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Somuncu MN, 2014, ARCH RHEUMATOL, V29, P73, DOI 10.5606/ArchRheumatol.2014.3559; Torres-Merino S, 2019, MOL NEUROBIOL, V56, P1800, DOI 10.1007/s12035-018-1178-6; Velez DR, 2009, INT J TUBERC LUNG D, V13, P1068; Velez DR, 2009, HUM GENET, V126, P643, DOI 10.1007/s00439-009-0713-y; Wang XR, 2021, EUR J NUTR, V60, P3473, DOI 10.1007/s00394-021-02528-w; Wang ZF, 2013, HUM GENET, V132, P337, DOI 10.1007/s00439-012-1253-4; Wu YL, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00902-6; Xu MQ, 2007, CIRCULATION, V116, P1356, DOI 10.1161/CIRCULATIONAHA.107.728857; Xu MQ, 2011, PROG NEURO-PSYCHOPH, V35, P1255, DOI 10.1016/j.pnpbp.2010.11.001; Yan XT, 2018, PROG NEURO-PSYCHOPH, V83, P64, DOI 10.1016/j.pnpbp.2017.12.016; Yu H, 2020, EXP MOL PATHOL, V116, DOI 10.1016/j.yexmp.2020.104493; Yu ZG, 2017, INT J TUBERC LUNG D, V21, P1307, DOI 10.5588/ijtld.17.0345; Zhang FQ, 2021, HUM GENET, V140, P1267, DOI 10.1007/s00439-021-02288-x; Zhang FQ, 2022, J CLIN INVEST, V132, DOI 10.1172/JCI145942; Zheng SY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02415	47	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253339	10.1371/journal.pone.0253339	http://dx.doi.org/10.1371/journal.pone.0253339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138949	gold, Green Published			2022-12-26	WOS:000671690200024
J	Hrozanova, M; Klockner, CA; Sandbakk, O; Pallesen, S; Moen, F				Hrozanova, Maria; Klockner, Christian A.; Sandbakk, Oyvind; Pallesen, Stale; Moen, Frode			Sex differences in sleep and influence of the menstrual cycle on women's sleep in junior endurance athletes	PLOS ONE			English	Article							GENDER-DIFFERENCES; QUALITY; YOUNG; PREVALENCE; PERFORMANCE; DEPRESSION; PATTERNS; EXERCISE; INSOMNIA; FATIGUE	Previous research shows that female athletes sleep better according to objective parameters but report worse subjective sleep quality than male athletes. However, existing sleep studies did not investigate variations in sleep and sleep stages over longer periods and have, so far, not elucidated the role of the menstrual cycle in female athletes' sleep. To address these methodological shortcomings, we investigated sex differences in sleep and sleep stages over 61 continuous days in 37 men and 19 women and examined the role of the menstrual cycle and its phases in 15 women. Sleep was measured by a non-contact radar, and menstrual bleeding was self-reported. Associations were investigated with multilevel modeling. Overall, women tended to report poorer subjective sleep quality (p = .057), but objective measurements showed that women obtained longer sleep duration (p < .001), more light (p = .013) and rapid eye movement sleep (REM; hours (h): p < .001, %: p = .007), shorter REM latency (p < .001), and higher sleep efficiency (p = .003) than men. R-2 values showed that sleep duration, REM and REM latency were especially affected by sex. Among women, we found longer time in bed (p = .027) and deep sleep (h: p = .036), and shorter light sleep (%: p = .021) during menstrual bleeding vs. non-bleeding days; less light sleep (h: p = .040), deep sleep (%: p = .013) and shorter REM latency (p = .011) during the menstrual than pre-menstrual phase; and lower sleep efficiency (p = .042) and more deep sleep (%: p = .026) during the follicular than luteal phase. These findings indicate that the menstrual cycle may impact the need for physiological recovery, as evidenced by the sleep stage variations. Altogether, the observed sex differences in subjective and objective sleep parameters may be related to the female athletes' menstrual cycle. The paper provides unique data of sex differences in sleep stages and novel insights into the role of the menstrual cycle in sleep among female athletes.	[Hrozanova, Maria; Sandbakk, Oyvind] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Ctr Elite Sports Res, Dept Neuromed & Movement Sci, Trondheim, Norway; [Klockner, Christian A.] Norwegian Univ Sci & Technol, Fac Social & Educ Sci, Dept Psychol, Trondheim, Norway; [Pallesen, Stale] Univ Bergen, Fac Psychol, Dept Psychosocial Sci, Bergen, Norway; [Pallesen, Stale] Haukeland Hosp, Norwegian Competence Ctr Sleep Disorders, Bergen, Norway; [Pallesen, Stale] North West Univ, Optentia, Vaal Triangle Campus, Vanderbijlpark, South Africa; [Moen, Frode] Norwegian Univ Sci & Technol, Fac Social & Educ Sci, Dept Educ & Lifelong Learning, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Bergen; University of Bergen; Haukeland University Hospital; North West University - South Africa; Vaal University of Technology (VUT); Norwegian University of Science & Technology (NTNU)	Hrozanova, M (corresponding author), Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Ctr Elite Sports Res, Dept Neuromed & Movement Sci, Trondheim, Norway.	maria.hrozanova@ntnu.no	Hrozanova, Maria/N-6347-2017	Hrozanova, Maria/0000-0002-1309-489X				Baker FC, 2004, J PSYCHOSOM RES, V56, P239, DOI 10.1016/S0022-3999(03)00067-9; Baker FC, 2018, SLEEP MED CLIN, V13, P283, DOI 10.1016/j.jsmc.2018.04.002; Benjamin CL, 2020, SPORTS HEALTH, V12, P234, DOI 10.1177/1941738120916735; Boulay MR, 1997, MED SCI SPORT EXER, V29, P125, DOI 10.1097/00005768-199701000-00018; Buchheit M, 2013, J SCI MED SPORT, V16, P550, DOI 10.1016/j.jsams.2012.12.003; Buchheit M, 2013, BRIT J SPORT MED, V47, P100, DOI 10.1136/bjsports-2013-092749; Buysse D J, 1989, Psychiatry Res, V28, P193; Calhoun SL, 2014, SLEEP MED, V15, P91, DOI 10.1016/j.sleep.2013.08.787; Carter JR, 2020, SLEEP HEALTH, V6, P623, DOI 10.1016/j.sleh.2020.01.016; Conte D, 2018, INT J SPORT PHYSIOL, V13, P1067, DOI 10.1123/ijspp.2017-0689; Curran-Rauhut Meredith A., 2002, Gene Expression Patterns, V1, P151, DOI 10.1016/S1567-133X(02)00011-X; De Souza MJ, 2010, HUM REPROD, V25, P491, DOI 10.1093/humrep/dep411; Dijk Derk-Jan, 2009, J Clin Sleep Med, V5, pS6; Driver H S, 1998, Sleep Med Rev, V2, P213, DOI 10.1016/S1087-0792(98)90009-0; Driver HS, 1996, J CLIN ENDOCR METAB, V81, P728, DOI 10.1210/jc.81.2.728; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Foster C, 1998, MED SCI SPORT EXER, V30, P1164, DOI 10.1097/00005768-199807000-00023; Goel N, 2005, CHRONOBIOL INT, V22, P905, DOI 10.1080/07420520500263235; Goldstein, 2019, USERS GUIDE MLWIN V3; Goldstein H., 2002, Understanding Statistics, V1, P223, DOI 10.1207/S15328031US0104_02; Hackney AC, 2019, BIOMED HUM KINET, V11, P87, DOI 10.2478/bhk-2019-0011; Hirshkowitz M, 2004, MED CLIN N AM, V88, P551, DOI 10.1016/j.mcna.2004.01.001; HORNE J, 1992, EXPERIENTIA, V48, P941, DOI 10.1007/BF01919141; Hrozanova M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.545581; Hrozanova M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01256; De Jonge XJ, 2019, MED SCI SPORT EXER, V51, P2610, DOI 10.1249/MSS.0000000000002073; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Kawasaki Y, 2020, J SPORT MED PHYS FIT, V60, P140, DOI 10.23736/S0022-4707.19.09875-X; Kolling S, 2016, CHRONOBIOL INT, V33, P73, DOI 10.3109/07420528.2015.1118384; Koikawa N, 2016, SLEEP BIOL RHYTHMS, V14, P377, DOI 10.1007/s41105-016-0068-4; Krueger JM, 2016, SLEEP MED REV, V28, P46, DOI 10.1016/j.smrv.2015.08.005; LAESSLE RG, 1990, PSYCHONEUROENDOCRINO, V15, P131, DOI 10.1016/0306-4530(90)90021-Z; LEE KA, 1990, SLEEP, V13, P403; Leeder J, 2012, J SPORT SCI, V30, P541, DOI 10.1080/02640414.2012.660188; Lukonaitiene I, 2020, J SPORT SCI, V38, P1018, DOI 10.1080/02640414.2020.1738702; Manber R, 1997, HEALTH PSYCHOL, V16, P209, DOI 10.1037/0278-6133.16.3.209; Medicine TAAoS, AASM MANUAL SCORING; Meers JM, 2020, ARCH WOMEN MENT HLTH, V23, P351, DOI 10.1007/s00737-019-00984-2; Mignot E, 2006, BRAIN, V129, P1609, DOI 10.1093/brain/awl079; Muthen LK., 2017, MPLUS, VEight; O'Donnell S, 2018, NAT SCI SLEEP, V10, P243, DOI 10.2147/NSS.S158598; Palagini L, 2013, SLEEP MED REV, V17, P377, DOI 10.1016/j.smrv.2012.11.001; Pallesen S, 2005, TIDSSKR NOR PSYKOL, V42, P714; PARRY BL, 1989, PSYCHIAT RES, V30, P285, DOI 10.1016/0165-1781(89)90020-6; PATKAI P, 1974, PSYCHOSOM MED, V36, P503, DOI 10.1097/00006842-197411000-00005; Pyne D. B., 2011, REGULATION FATIGUE E, P177; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Romans SE, 2015, SLEEP MED, V16, P489, DOI 10.1016/j.sleep.2014.12.001; Sargent C., 2011, LITTLE CLOCK BIG CLO, P5; Schaal K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019007; Schaumberg MA, 2017, J SCI MED SPORT, V20, P965, DOI 10.1016/j.jsams.2016.08.013; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Shughrue PJ, 1997, J COMP NEUROL, V388, P507, DOI 10.1002/(SICI)1096-9861(19971201)388:4<507::AID-CNE1>3.0.CO;2-6; Sylta O, 2014, INT J SPORT PHYSIOL, V9, P85, DOI [10.1123/ijspp.2013-0203, 10.1123/IJSPP.2013-0203]; Toften S, 2020, SLEEP MED, V75, P54, DOI 10.1016/j.sleep.2020.02.022; Van Dongen H.P., 2003, SLEEP BIOL RHYTHM, V1, P5, DOI [10.1046/j.1446-9235.2003.00006.x, DOI 10.1046/J.1446-9235.2003.00006.X]; Vlahoyiannis A, 2021, J SPORT HEALTH SCI, V10, P387, DOI 10.1016/j.jshs.2020.03.006; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101	58	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253376	10.1371/journal.pone.0253376	http://dx.doi.org/10.1371/journal.pone.0253376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138961	gold, Green Published			2022-12-26	WOS:000671690200103
J	Zhang, Y; Yang, J; Gao, MX; Sono, H				Zhang, Yue; Yang, Jian; Gao, Ming-Xin; Sono, Hua			Heat transfer analysis of the forced air quenching with non-isothermal and non-uniform oxidation	PLOS ONE			English	Article							OXIDE LAYERS; TEMPERATURE; BEHAVIOR; MODEL; SIMULATION; SCALES; CARBON; STEELS; IRON	In this paper, the heat transfer characteristics of the forced air quenching with non-isothermal and non-uniform oxidation are investigated. By introducing the variations of interfacial temperature and oxygen partial pressure, a three-layered non-isothermal high-temperature oxidation kinetic model is developed, in which a discrete-time modeling method is employed to solve the problem of integration of the transient terms, and a special interfacial grid treatment is used for considering the growth of each oxide layer and updating of the thermal properties. Moreover, a parameter identification method using the multi-objective genetic algorithm is proposed for the inverse solution of the oxidation parabolic parameters based on the measured scale thicknesses in oxidation experiment. A case study of the forced air quenching of a Q235 disk is presented to validate the availability of the developed formulas. Then the interfacial heat transfer characteristics are analyzed, while the numerical solutions with and without oxidation are both performed for in-depth comparison. Results indicate that the active quenching region is mainly centralized in the vicinity of stagnation region. The radial variation regularity of the temperature difference across the total oxide layer is mainly determined by the thermal conductivity and the scale thickness. The existence of the oxide scale actually produces a certain thermal resistance during the quenching process and the effects of the oxide scale increases with the radial coordinate due to the interfacial temperature distribution. The results obtained can provide theoretical derivation for precise control of the internal phase transformation during the forced air quenching process.	[Zhang, Yue; Yang, Jian; Sono, Hua] Univ Sci & Technol Liaoning, Sch Mech Engn & Automat, Anshan, Peoples R China; [Gao, Ming-Xin; Sono, Hua] Univ Sci & Technol Liaoning, Sch Mat & Met, Anshan, Peoples R China; [Gao, Ming-Xin] Univ Sci & Technol Liaoning, Engn Training Ctr, Anshan, Peoples R China	University of Science & Technology Liaoning; University of Science & Technology Liaoning; University of Science & Technology Liaoning	Yang, J; Sono, H (corresponding author), Univ Sci & Technol Liaoning, Sch Mech Engn & Automat, Anshan, Peoples R China.; Gao, MX; Sono, H (corresponding author), Univ Sci & Technol Liaoning, Sch Mat & Met, Anshan, Peoples R China.; Gao, MX (corresponding author), Univ Sci & Technol Liaoning, Engn Training Ctr, Anshan, Peoples R China.	15904920669@163.com; gaoming31@163.com; songhua88@126.com		Zhang, Yue/0000-0002-4967-831X	National Natural Science Foundation of China [51374127]; Innovative Research Team Fund of Liaoning Provincial Education Department of China [LT2015014]; Liaoning Provincial Natural Science Foundation of China [20180550572]; Open Project Fund of Key Laboratory of Liaoning Province [USTLKFSY201713]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team Fund of Liaoning Provincial Education Department of China; Liaoning Provincial Natural Science Foundation of China; Open Project Fund of Key Laboratory of Liaoning Province	This study was supported by the National Natural Science Foundation of China (51374127), Innovative Research Team Fund of Liaoning Provincial Education Department of China (LT2015014), Liaoning Provincial Natural Science Foundation of China (20180550572), Open Project Fund of Key Laboratory of Liaoning Province (USTLKFSY201713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA S, 1989, NUMER HEAT TR B-FUND, V15, P131, DOI 10.1080/10407798908944897; ANDERSON WK, 1986, AIAA J, V24, P1453, DOI 10.2514/3.9465; Birks N., 2006, INTRO HIGH TEMPERATU; Boatemaa L, 2018, J MATER SCI, V53, P5973, DOI 10.1007/s10853-017-1973-x; Chase M.W., 1998, NIST JANAF THERMOCHE; Chen JH, 2017, J AM CERAM SOC, V100, P3145, DOI 10.1111/jace.14841; Chen RY, 2002, OXID MET, V57, P53, DOI 10.1023/A:1013390628475; Chen RY, 2003, OXID MET, V59, P433, DOI 10.1023/A:1023685905159; Cheng TL, 2014, J PHYS CHEM C, V118, P1269, DOI 10.1021/jp409811e; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; El-Amin MF, 2010, HEAT MASS TRANSFER, V46, P943, DOI 10.1007/s00231-010-0625-3; FROMHOLD AT, 1973, J PHYS SOC JPN, V34, P1452, DOI 10.1143/JPSJ.34.1452; Gao DY, 2017, INT J HEAT MASS TRAN, V105, P673, DOI 10.1016/j.ijheatmasstransfer.2016.10.023; GARNAUD G, 1977, OXID MET, V11, P193, DOI 10.1007/BF00606543; Giudice S.D., 1985, NUMER HEAT TRAN, V8, P133, DOI [10.1080/01495728508961846, DOI 10.1080/01495728508961846]; Goldstein RJ, 2010, INT J HEAT MASS TRAN, V53, P4397, DOI 10.1016/j.ijheatmasstransfer.2010.05.005; Hu P, 2013, J MATER PROCESS TECH, V213, P1475, DOI 10.1016/j.jmatprotec.2013.03.010; John B, 2019, ARCH COMPUT METHOD E, V26, P475, DOI 10.1007/s11831-018-9252-9; Kuang JL, 2014, J AM CERAM SOC, V97, P2698, DOI 10.1111/jace.13096; Launder B. E., 1974, Computer Methods in Applied Mechanics and Engineering, V3, P269, DOI 10.1016/0045-7825(74)90029-2; Liu ZY, 1998, SCRIPTA MATER, V38, P1057, DOI 10.1016/S1359-6462(98)00008-6; MENTER FR, 1994, AIAA J, V32, P1598, DOI 10.2514/3.12149; Olawale JO, 2017, INT J METALCAST, V11, P568, DOI 10.1007/s40962-016-0114-7; Pilling NB, 1923, J I MET, V29, P529; Qi J, 2018, INT J HEAT MASS TRAN, V122, P929, DOI 10.1016/j.ijheatmasstransfer.2018.01.119; Rahman MM, 2010, INT COMMUN HEAT MASS, V37, P1175, DOI 10.1016/j.icheatmasstransfer.2010.07.017; SERAGELDIN MA, 1979, J ENG POWER-T ASME, V101, P326, DOI 10.1115/1.3446580; Shen C, 2013, INT J HEAT MASS TRAN, V67, P1030, DOI 10.1016/j.ijheatmasstransfer.2013.08.053; SHIH TH, 1995, COMPUT FLUIDS, V24, P227, DOI 10.1016/0045-7930(94)00032-T; Slyusarskiy KV, 2017, FUEL, V191, P383, DOI 10.1016/j.fuel.2016.11.087; Smeltzer W. W., 1975, Progress in Solid State Chemistry, V10, P17, DOI 10.1016/0079-6786(75)90003-5; Takeda M, 2009, MATER TRANS, V50, P2242, DOI 10.2320/matertrans.M2009097; Wendelstorf R, 2008, INT J HEAT MASS TRAN, V51, P4892, DOI 10.1016/j.ijheatmasstransfer.2008.01.033; Xiao BW, 2011, J MATER ENG PERFORM, V20, P1264, DOI 10.1007/s11665-010-9745-7; Yang J, 2019, INT J HEAT MASS TRAN, V134, P586, DOI 10.1016/j.ijheatmasstransfer.2019.01.064; YAO YL, 1965, J CHEM PHYS, V43, P3050, DOI 10.1063/1.1697273; Yin YJ, 2016, OXID MET, V86, P45, DOI 10.1007/s11085-016-9618-z; Young DJ, 2008, ELSEV CORROS SER, V1, P1; Yu XL, 2015, CORROS SCI, V90, P140, DOI 10.1016/j.corsci.2014.10.005; YUREK GJ, 1974, OXID MET, V8, P265, DOI 10.1007/BF00609944; Zhang LZ, 2013, INT J HEAT MASS TRAN, V64, P735, DOI 10.1016/j.ijheatmasstransfer.2013.05.021	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253240	10.1371/journal.pone.0253240	http://dx.doi.org/10.1371/journal.pone.0253240			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138934	Green Published, gold			2022-12-26	WOS:000671690200112
J	Chevalier, C; Leymarie, O; Sedano, L; Da Costa, B; Richard, CA; Maisonnasse, P; Refregiers, M; Jamme, F; Le Goffic, R				Chevalier, Christophe; Leymarie, Olivier; Sedano, Laura; Da Costa, Bruno; Richard, Charles-Adrien; Maisonnasse, Pauline; Refregiers, Matthieu; Jamme, Frederic; Le Goffic, Ronan			PB1-F2 amyloid-like fibers correlate with proinflammatory signaling and respiratory distress in influenza-infected mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS PROTEIN; ELECTROCHEMICAL DETECTION; CELLS; OLIGOMERIZATION; PLETHYSMOGRAPHY; SPECTROSCOPY; PATHOGENESIS; CONTRIBUTES; EXPRESSION; MICROSCOPY	PB1-F2 is a virulence factor of influenza A virus known to increase viral pathogenicity in mammalian hosts. PB1-F2 is an intrinsically disordered protein displaying a propensity to form amyloid-like fibers. However, the correlation between PB1-F2 structures and the resulting inflammatory response is unknown. Here, we used synchrotron-coupled Fourier transform-IR and deep UV microscopies to determine the presence of PB1-F2 fibers in influenza A virus-infected mice. In order to study the correlation between PB1-F2 structure and the inflammatory response, transgenic mice expressing luciferase under the control of an NF-kappa B promotor, allowing in vivo monitoring of inflammation, were intranasally instilled with monomeric, fibrillated, or truncated forms of recombinant PB1-F2. Our intravital NF-kappa B imaging, supported by cytokine quantification, clearly shows the proinflammatory effect of PB1-F2 fibers compared with N-terminal region of PB1-F2 unable to fibrillate. It is noteworthy that instillation of monomeric PB1-F2 of H5N1 virus induced a stronger inflammatory response when compared with prefibrillated PB1-F2 of H1N1 virus, suggesting mechanisms of virulence depending on PB1-F2 sequence. Finally, using whole-body plethysmography to measure volume changes in the lungs, we quantified the effects of the different forms of PB1-F2 on respiratory parameters. Thus, we conclude that PB1-F2-induced inflammation and respiratory distress are tightly correlated with sequence polymorphism and oligomerization status of the protein.	[Chevalier, Christophe; Leymarie, Olivier; Sedano, Laura; Da Costa, Bruno; Richard, Charles-Adrien; Maisonnasse, Pauline; Le Goffic, Ronan] Univ Paris Saclay, UVSQ, INRAE, VIM, Jouy En Josas, France; [Refregiers, Matthieu; Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Chevalier, C; Le Goffic, R (corresponding author), Univ Paris Saclay, UVSQ, INRAE, VIM, Jouy En Josas, France.	christophe.chevalier@inrae.fr; ronan.le-goffic@inrae.fr	LE GOFFIC, Ronan/B-7649-2008; LE GOFFIC, Ronan/M-3099-2019; Réfrégiers, Matthieu/AAE-2075-2022; Chevalier, Christophe/C-2575-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Refregiers, Matthieu/0000-0002-3281-2308; Chevalier, Christophe/0000-0003-3231-9027; Maisonnasse, Pauline/0000-0002-0555-207X; RICHARD, Charles-Adrien/0000-0001-5306-2297	Region Ile-de-France (SESAME); REACTIV ANR project [ANR-17-CE35-0007]	Region Ile-de-France (SESAME)(Region Ile-de-France); REACTIV ANR project	We thank Gwladys Meesemaecker, Laetitia Guedeville, Mathilde Bauducel, Marlene Hery, Charline Pontlevoy, Andre Tiffoche, and Jerome Pottier (Unite Experimentale Animalerie Rongeurs, INRAE, Jouy-en-Josas) for technical assistance with animal experiments. We thank Pr. Richard Flavell (Howard Hughes Medical Institute, Yale University School of Medicine) for his gift of NF-kappa B luciferase transgenic mice. This work has benefited from the facilities and expertise of the protein purification platform under the direction of Dr Mohammed Moudjou (VIM, INRAE, Jouy-en-Josas). We are grateful to the MIMA2 platform for access to the TEM (Christine Pechoux) and IVIS200 (Stephane Biacchesi), which was financed by the Region Ile-de-France (SESAME). We thank Jean Millet (VIM, INRAE, Jouy-en-Josas) for critical reading of the article. This work was supported by the REACTIV ANR project (ANR-17-CE35-0007). We acknowledge SOLEIL for provision of synchrotron beamtime (proposals no. 20121092).	Ajjaji D, 2016, BIOCHEM BIOPH RES CO, V477, P27, DOI 10.1016/j.bbrc.2016.06.016; Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Barthelemy A, 2017, MUCOSAL IMMUNOL, V10, P460, DOI 10.1038/mi.2016.49; Bottomly D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0547-7; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2016, J BIOL CHEM, V291, P9060, DOI 10.1074/jbc.M115.710533; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Da Costa B, 2015, J VIROL, V89, P6376, DOI 10.1128/JVI.00589-15; Dou D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01581; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; James J, 2016, J GEN VIROL, V97, P2516, DOI 10.1099/jgv.0.000584; Jamme F, 2013, BIOL CELL, V105, P277, DOI 10.1111/boc.201200075; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Julander JG, 2014, ANTIVIR RES, V108, P10, DOI 10.1016/j.antiviral.2014.05.002; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Kocer ZA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.40; Kozlowski LP, 2017, NUCLEIC ACIDS RES, V45, pD1112, DOI 10.1093/nar/gkw978; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2017, J GEN VIROL, V98, P1196, DOI 10.1099/jgv.0.000782; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Menachery VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131451; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Pinar A, 2017, J BIOL CHEM, V292, P826, DOI 10.1074/jbc.M116.756379; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solbak SMO, 2013, BBA-PROTEINS PROTEOM, V1834, P568, DOI 10.1016/j.bbapap.2012.11.009; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Van Hoecke L, 2017, JOVE-J VIS EXP, DOI 10.3791/55398; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Vidic J, 2016, J BIOL CHEM, V291, P739, DOI 10.1074/jbc.M115.652917; VidicJ Chevalier C., 2013, J JOURNALOF ANALYTIC, VS7, P6; Vidy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165361; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	57	1	1	5	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100885	10.1016/j.jbc.2021.100885	http://dx.doi.org/10.1016/j.jbc.2021.100885			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146545	gold, Green Published			2022-12-26	WOS:000678068400084
J	Kumari, P; Sundaram, R; Manohar, K; Vasudevan, D; Acharya, N				Kumari, Premlata; Sundaram, Rajivgandhi; Manohar, Kodavati; Vasudevan, Dileep; Acharya, Narottam			Interdomain connecting loop and J loop structures determine cross-species compatibility of PCNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-ETA; TRANSLESION SYNTHESIS; MUTATIONAL ANALYSIS; COMPLEX-FORMATION; YEAST REV1; PROTEIN	Eukaryotic proliferating cell nuclear antigen (PCNA) plays an essential role in orchestrating the assembly of the replisome complex, stimulating processive DNA synthesis, and recruiting other regulatory proteins during the DNA damage response. PCNA and its binding partner network are relatively conserved in eukaryotes, and it exhibits extraordinary structural similarity across species. However, despite this structural similarity, the PCNA of a given species is rarely functional in heterologous systems. In this report, we determined the X-ray crystal structure of Neurospora crassa PCNA (NcPCNA) and compared its structure-function relationship with other available PCNA studies to understand this cross-species incompatibility. We found two regions, the interdomain connecting loop (IDCL) and J loop structures, vary significantly among PCNAs. In particular, the J loop deviates in NcPCNA from that in Saccharomyces cerevisiae PCNA (ScPCNA) by 7 A. Differences in the IDCL structures result in varied binding affinities of PCNAs for the subunit Pol32 of DNA polymerase delta and for T2-amino alcohol, a small-molecule inhibitor of human PCNA. To validate that these structural differences are accountable for functional incompatibility in S. cerevisiae, we generated NcPCNA mutants mimicking IDCL and J loop structures of ScPCNA. Our genetic analyses suggested that NcPCNA mutants are fully functional in S. cerevisiae. The susceptibility of the strains harboring ScPCNA mimics of NcPCNA to various genotoxic agents was similar to that in yeast cells expressing ScPCNA. Taken together, we conclude that in addition to the overall architecture of PCNA, structures of the IDCL and J loop of PCNA are critical determinants of interspecies functional compatibility.	[Kumari, Premlata; Manohar, Kodavati; Acharya, Narottam] Inst Life Sci, Lab Genom Instabil & Dis, Dept Infect Dis Biol, Bhubaneswar, India; [Kumari, Premlata] Reg Ctr Biotechnol, Faridabad, India; [Sundaram, Rajivgandhi; Vasudevan, Dileep] Inst Life Sci, Dept Infect Dis Biol, Lab Macromol Crystallog, Bhubaneswar, India; [Sundaram, Rajivgandhi] Manipal Acad Higher Educ, Manipal, India; [Manohar, Kodavati] Houston Methodist Res Inst, Ctr Neuroregenerat, Dept Neurosurg, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Manipal Academy of Higher Education (MAHE); The Methodist Hospital System; The Methodist Hospital - Houston	Acharya, N (corresponding author), Inst Life Sci, Lab Genom Instabil & Dis, Dept Infect Dis Biol, Bhubaneswar, India.; Vasudevan, D (corresponding author), Inst Life Sci, Dept Infect Dis Biol, Lab Macromol Crystallog, Bhubaneswar, India.	dileepvasudevan@gmail.com; narottam_acharya@ils.res.in	KUMARI, PREMLATA/HHS-0881-2022; kodavati, manohar/V-5200-2019; sundaram, Rajivgandhi/GOK-2864-2022	kodavati, manohar/0000-0003-3939-7351; sundaram, Rajivgandhi/0000-0001-5424-1908; Acharya, Narottam/0000-0001-8858-5418; Vasudevan, Dileep/0000-0001-5568-628X	Department of Biotechnology, Government of India; Institute of Life Sciences; DBT; SERB	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Institute of Life Sciences; DBT(Department of Biotechnology (DBT) India); SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	The research fellowship from the Department of Biotechnology, Government of India, to R. S. and the intramural and extramural supports from the Institute of Life Sciences, DBT, and SERB at different times of the study to D. V. and N. A. are greatly acknowledged.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2002, J MOL BIOL, V321, P579, DOI 10.1016/S0022-2836(02)00654-X; Acharya N, 2007, MOL CELL BIOL, V27, P7266, DOI 10.1128/MCB.01196-07; Acharya N, 2020, BIOCHEM SOC T, V48, P2811, DOI 10.1042/BST20200678; Acharya N, 2020, CURR GENET, V66, P635, DOI 10.1007/s00294-020-01071-1; Acharya N, 2019, CURR GENET, V65, P649, DOI 10.1007/s00294-018-0918-5; Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arroyo MP, 1996, J BIOL CHEM, V271, P15971, DOI 10.1074/jbc.271.27.15971; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gibbs E, 1997, J BIOL CHEM, V272, P2373; Gohain D, 2019, MOL MICROBIOL, V111, P1510, DOI 10.1111/mmi.14234; Gonzalez-Magana A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040570; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Khandagale P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200602; Khandagale P, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900323; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; Kumar A, 2016, J SYNCHROTRON RADIAT, V23, P629, DOI 10.1107/S160057751600076X; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Manohar K, 2018, MOL MICROBIOL, V110, P707, DOI 10.1111/mmi.14004; Manohar K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0582-6; Marshall AC, 2017, FEBS J, V284, P985, DOI 10.1111/febs.14035; NG L, 1990, J BIOL CHEM, V265, P11948; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sundaram R, 2021, FEBS LETT, V595, P1328, DOI 10.1002/1873-3468.14055; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109	35	4	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100911	10.1016/j.jbc.2021.100911	http://dx.doi.org/10.1016/j.jbc.2021.100911			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34175309	Green Published, gold			2022-12-26	WOS:000678068400096
J	Malinski, L; Radlak, K; Smolka, B				Malinski, Lukasz; Radlak, Krystian; Smolka, Bogdan			Is large improvement in efficiency of impulsive noise removal in color images still possible?	PLOS ONE			English	Article							SWITCHING FILTER; MEDIAN FILTER; REDUCTION; SPARSE	The substantial improvement in the efficiency of switching filters, intended for the removal of impulsive noise within color images is described. Numerous noisy pixel detection and replacement techniques are evaluated, where the filtering performance for color images and subsequent results are assessed using statistical reasoning. Denoising efficiency for the applied detection and interpolation techniques are assessed when the location of corrupted pixels are identified by noisy pixel detection algorithms and also in the scenario when they are already known. The results show that improvement in objective quality measures can be achieved by using more robust detection techniques, combined with novel methods of corrupted pixel restoration. A significant increase in the image denoising performance is achieved for both pixel detection and interpolation, surpassing current filtering methods especially via the application of a convolutional network. The interpolation techniques used in the image inpainting methods also significantly increased the efficiency of impulsive noise removal.	[Malinski, Lukasz] Silesian Tech Univ, Div Ind Informat, Katowice, Poland; [Radlak, Krystian; Smolka, Bogdan] Silesian Tech Univ, Dept Data Sci & Engn, Gliwice, Poland; [Radlak, Krystian] Warsaw Univ Technol, Inst Comp Sci, Warsaw, Poland	Silesian University of Technology; Silesian University of Technology; Warsaw University of Technology	Malinski, L (corresponding author), Silesian Tech Univ, Div Ind Informat, Katowice, Poland.	lukasz.malinski@polsl.pl	Radlak, Krystian/P-1850-2014	Radlak, Krystian/0000-0003-1872-5651	National Science Centre, Poland (Narodowe Centrum Nauki (PL)) [2017/25/B/ST6/02219]	National Science Centre, Poland (Narodowe Centrum Nauki (PL))	National Science Centre, Poland (Narodowe Centrum Nauki (PL)) Award number: 2017/25/B/ST6/02219 Receiver: Bogdan Smolka.	Agarwal A, 2020, P IEEE C COMP VIS PA P IEEE C COMP VIS PA; Arnal J, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10010243; Arora S, 2018, IN PRESS; ASTOLA J, 1990, P IEEE, V78, P678, DOI 10.1109/5.54807; Bertalmio M, 2001, PROC CVPR IEEE, P355; Bertalmio M., 2018, ADV COMPUTER VISION; Beygi-Harchegani S., 2010, 2010 10th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA 2010), P480, DOI 10.1109/ISSPA.2010.5605449; Boncelet C, 2005, HANDBOOK OF IMAGE AND VIDEO PROCESSING, 2ND EDITION, P397, DOI 10.1016/B978-012119792-6/50087-5; Burger W, 2013, UNDERGRADUATE TOPICS; Camacho J, 2006, J IMAGING SCI TECHN, V50, P427, DOI 10.2352/J.lmagingSci.Technol.(2006)50:5(427); Camarena JG, 2013, IEEE T FUZZY SYST, V21, P971, DOI 10.1109/TFUZZ.2012.2234754; Celebi ME, 2008, J ELECTRON IMAGING, V17, DOI 10.1117/1.2991415; Celebi ME, 2007, J ELECTRON IMAGING, V16, DOI 10.1117/1.2772639; Chatterjee P, 2011, IEEE T IMAGE PROCESS, V20, P1221, DOI 10.1109/TIP.2010.2092440; Chatterjee P, 2010, IEEE T IMAGE PROCESS, V19, P895, DOI 10.1109/TIP.2009.2037087; Chen D, 2019, COMM COM INF SC, V1143, P286, DOI 10.1007/978-3-030-36802-9_31; Chen F., 2013, J ELECTRON IMAGING, V22, P1; Chen JQ, 2019, IEEE ACCESS, V7, P124647, DOI 10.1109/ACCESS.2019.2938799; Chen Y, 2018, IEEE T CIRC SYST VID, V28, P414, DOI 10.1109/TCSVT.2016.2615444; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Civicioglu P, 2004, LECT NOTES COMPUT SC, V3261, P383; Deka B., 2011, P NAT C COMM NCC JAN, P1, DOI [10.1109/NCC.2011.5734762, DOI 10.1109/NCC.2011.5734762]; DErrico J, 2012, INPAINT NANS; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Faraji H, 2006, IEEE T IMAGE PROCESS, V15, P2676, DOI 10.1109/TIP.2006.877363; Geng Xin, 2012, Journal of Beijing University of Aeronautics and Astronautics, V38, P1181; Geng X, 2012, SIGNAL PROCESS, V92, P150, DOI 10.1016/j.sigpro.2011.06.015; Gregori V, 2018, J VIS COMMUN IMAGE R, V55, P518, DOI 10.1016/j.jvcir.2018.06.025; Grossauer H., 2008, DIGITAL IMAGE INPAIN; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jin LH, 2007, SIGNAL PROCESS, V87, P1345, DOI 10.1016/j.sigpro.2006.11.008; Jin LH, 2016, SIGNAL PROCESS, V128, P171, DOI 10.1016/j.sigpro.2016.03.025; Jin LH, 2012, DIGIT SIGNAL PROCESS, V22, P903, DOI 10.1016/j.dsp.2012.06.012; Karakos DG, 1997, IEEE T IMAGE PROCESS, V6, P1038, DOI 10.1109/83.597278; Katsuyama Y., 2010, 2010 10th International Symposium on Communications and Information Technologies (ISCIT 2010), P877, DOI 10.1109/ISCIT.2010.5665112; Kenney C, 2001, IEEE T IMAGE PROCESS, V10, P326, DOI 10.1109/83.902298; Khan NU, 2020, MULTIMED TOOLS APPL, V79, P33811, DOI 10.1007/s11042-020-08707-x; Kingma D.P., 2015, PROC 3 INT C LEARN, P1; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Levin A., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2833, DOI 10.1109/CVPR.2011.5995309; Lilly J.M., 2017, JLAB DATA ANAL PACKA; Liu C, 2008, IEEE T PATTERN ANAL, V30, P299, DOI [10.1109/TPAMI.2007.1176, 10.1109/TPAMI.20071176]; Liu J, 2018, IEEE T CIRC SYST VID, V28, P1232, DOI 10.1109/TCSVT.2016.2643009; Liu J, 2017, IEEE T MED IMAGING, V36, P2499, DOI 10.1109/TMI.2017.2739841; Liu J, 2013, IEEE T IMAGE PROCESS, V22, P1108, DOI 10.1109/TIP.2012.2227766; Liu W., 2020, INT J ED MANAGEMENT, V10, P43, DOI [10.5815/ijeme.2020.01.05, DOI 10.5815/IJEME.2020.01.05]; Lukac R, 2005, FUZZY SET SYST, V152, P17, DOI 10.1016/j.fss.2004.10.012; Lukac R, 2007, SIGNAL PROCESS, V87, P2085, DOI 10.1016/j.sigpro.2007.02.009; Ma HJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205736; Mairal J, 2008, IEEE T IMAGE PROCESS, V17, P53, DOI 10.1109/TIP.2007.911828; Malinski Lukasz, 2017, 2017 22nd International Conference on Methods and Models in Automation and Robotics (MMAR), P855, DOI 10.1109/MMAR.2017.8046940; Malinski L., 2019, J REAL TIME IMAGE PR; Malinski L, 2018, TRAINING IMAGE SET; Malinski L, 2020, RESULTS DATASET; Malinski L, 2019, J REAL-TIME IMAGE PR, V16, P1077, DOI 10.1007/s11554-016-0599-6; Malinski L, 2018, 2018 23RD INTERNATIONAL CONFERENCE ON METHODS & MODELS IN AUTOMATION & ROBOTICS (MMAR), P401; Malinski L, 2016, J REAL-TIME IMAGE PR, V11, P427, DOI 10.1007/s11554-015-0500-z; Molteno M., 2018, VERY STRAIGHT FORWAR; Morillas S, 2005, LECT NOTES COMPUT SC, V3656, P81, DOI 10.1007/11559573_11; Morillas S, 2005, REAL-TIME IMAGING, V11, P417, DOI 10.1016/j.rti.2005.06.007; Morillas S, 2008, COMPUT VIS IMAGE UND, V110, P102, DOI 10.1016/j.cviu.2007.05.001; Morillas S, 2008, SIGNAL PROCESS, V88, P390, DOI 10.1016/j.sigpro.2007.05.019; Nair MS, 2013, COMPUT ELECTR ENG, V39, P663, DOI 10.1016/j.compeleceng.2012.06.004; Nikolova M, 2004, J MATH IMAGING VIS, V20, P99, DOI 10.1023/B:JMIV.0000011920.58935.9c; Pei JH, 2018, SIGNAL PROCESS, V153, P197, DOI 10.1016/j.sigpro.2018.07.010; Phu MQ, 2007, 6TH IEEE/ACIS INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION SCIENCE, PROCEEDINGS, P425, DOI 10.1109/ICIS.2007.173; Plataniotis K., 2000, DIGITAL SIGNAL PROC, DOI 10.0017/978-3-662-04186-4; Pritamdas K, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3644-9; Radlak K, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20102782; Ruchay A, 2018, LECT NOTES COMPUT SC, V10716, P280, DOI 10.1007/978-3-319-73013-4_26; Russo F., 2014, ISRN MACHINE VISION, V579658; Sen AP., 2020, REMOVAL HIGH DENSITY, P127; Shepard D., 1968, P 1968 23 ACM NATL C, P517, DOI [10.1145/800186.810616, DOI 10.1145/800186.810616]; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Smolka B, 2005, REAL-TIME IMAGING, V11, P389, DOI 10.1016/j.rti.2005.07.003; Smolka B, 2015, P SPIE P SPIE, V9400, P9400; Smolka B., 2018, P INT AUTOMATIC CONT, P1, DOI [10.1109/CACS.2018.8606777, DOI 10.1109/CACS.2018.8606777]; Smolka B, 2013, LECT NOTES COMPUT SC, V7786, P296, DOI 10.1007/978-3-642-36700-7_23; Szegedy C., 2014, 2014 INT C LEARNING, DOI DOI 10.48550/ARXIV.1312.6199; Taherkhani F, 2018, IET IMAGE PROCESS, V12, P20, DOI 10.1049/iet-ipr.2016.0521; Tsuda K, 2018, PROC INT WORKSH ADV; Vargas D.V., 2020, CEUR WORKSHOP PROC, V2640; Varghese J, 2014, IET IMAGE PROCESS, V8, P199, DOI 10.1049/iet-ipr.2013.0297; Veerakumar T, 2017, CIRC SYST SIGNAL PR, V36, P1192, DOI 10.1007/s00034-016-0352-1; Wang GH, 2014, SIGNAL PROCESS, V102, P216, DOI 10.1016/j.sigpro.2014.03.027; Wang GJ, 2012, ENVIRON MODELL SOFTW, V30, P139, DOI 10.1016/j.envsoft.2011.10.015; Wang SS, 2013, SIGNAL PROCESS, V93, P2696, DOI 10.1016/j.sigpro.2013.03.005; Yin XR, 2019, IEEE T MED IMAGING, V38, P2903, DOI 10.1109/TMI.2019.2917258; Zhang K, 2017, PROC CVPR IEEE, P2808, DOI 10.1109/CVPR.2017.300; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zhang WH, 2019, APPL SOFT COMPUT, V82, DOI 10.1016/j.asoc.2019.105558; Zhu H, 2020, IEEE T IMAGE PROCESS, V29, P6680, DOI 10.1109/TIP.2020.2992895	94	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0253117	10.1371/journal.pone.0253117	http://dx.doi.org/10.1371/journal.pone.0253117			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181667	gold, Green Published			2022-12-26	WOS:000671695800016
J	Chigerwe, M; Barter, L; Dechant, JE; Dear, JD; Boudreaux, KA				Chigerwe, Munashe; Barter, Linda; Dechant, Julie E.; Dear, Jonathan D.; Boudreaux, Karen A.			A preliminary study on assessment of wellbeing among veterinary medical house officers	PLOS ONE			English	Article							WORK-HOME INTERFERENCE; MENTAL-HEALTH; OCCUPATIONAL STRESS; RISK-FACTORS; SUICIDE; STUDENTS; BURNOUT; LIFE; MINDFULNESS; DEPRESSION	Mental wellness is an important topic among practicing veterinarians. Peer reviewed studies focusing on veterinary house officers' wellbeing are lacking in veterinary medicine. The aim of this study was to assess wellbeing of house officers using validated surveys for anxiety, burnout, depression, and quality of life. A cross-sectional survey of 103 house officers (residents, interns, and fellows) was performed. Respondents were invited to voluntarily complete the online surveys. Anxiety, burnout, depression, and quality of life were assessed using the Generalized Anxiety Disorder (GAD-7), Maslach Burnout Inventory (MBI), Patient Health Questionnaire (PHQ-9), and Short Form-8 (SF-8), respectively. Descriptive statistics were calculated. For qualitative analysis, respondents were requested to rate their perception of the level of stress regarding various work-related stressors. The first survey was completed in 2017 with 60 respondents of which 51 (85%) identified as females and nine (15%) identified as males. The second survey was completed in 2018 with 43 respondents of which 35 (81.4%) identified as females and 8 (18.6%) identified as males. Respondents reported high levels of burnout characterized by high levels of emotional exhaustion and lack of personal accomplishment but reported mild levels of anxiety and depression. The mental component of their quality of life score was lower than the general US population, whereas the physical component score was consistent with the general US population. Respondents indicated moderate scores of stress for concerns regarding patient management, research, teaching, work-life balance, relationships, organizational skills, time management, finances, and the mental and emotional impact of the work environment. The high levels of burnout, and low mental quality of life in house officers require specific intervention programs to improve wellbeing.	[Chigerwe, Munashe; Dear, Jonathan D.] Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Barter, Linda; Dechant, Julie E.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Boudreaux, Karen A.] Univ Calif Davis, Sch Vet Med, Deans Off, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Chigerwe, M (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Vet Med & Epidemiol, Davis, CA 95616 USA.	mchigerwe@ucdavis.edu		Dear, Jonathan/0000-0002-7166-1442; Chigerwe, Munashe/0000-0001-6841-2448				Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bartram DJ, 2008, VET REC, V162, P36, DOI 10.1136/vr.162.2.36; Bartram DJ, 2010, VET REC, V166, P388, DOI 10.1136/vr.b4794; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Dawson BFY, 2017, J VET MED EDUC, V44, P72, DOI 10.3138/jvme.0116-020R; Drake AAS, 2012, J VET MED EDUC, V39, P322, DOI 10.3138/jvme.0112-006R; Dyrbye L, 2016, MED EDUC, V50, P132, DOI 10.1111/medu.12927; Dyrbye LN, 2018, JAMA-J AM MED ASSOC, V320, P1114, DOI 10.1001/jama.2018.12615; Fowler HN, 2016, JAVMA-J AM VET MED A, V248, P207, DOI 10.2460/javma.248.2.207; Geurts S, 1999, SOC SCI MED, V48, P1135, DOI 10.1016/S0277-9536(98)00425-0; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hansez I, 2008, IRISH VET J, V61, P233, DOI 10.1186/2046-0481-61-4-233; Hassed C, 2009, ADV HEALTH SCI EDUC, V14, P387, DOI 10.1007/s10459-008-9125-3; Hatch PH, 2011, AUST VET J, V89, P460, DOI 10.1111/j.1751-0813.2011.00833.x; Ishak Waguih William, 2009, J Grad Med Educ, V1, P236, DOI 10.4300/JGME-D-09-00054.1; Jackson S.E, 1996, MASLACH BURNOUT INVE; Kaarlola A, 2006, CRIT CARE MED, V34, P2120, DOI 10.1097/01.CCM.0000227656.31911.2E; Kassem AM, 2019, JAVMA-J AM VET MED A, V254, P979, DOI 10.2460/javma.254.8.979; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; Nahar VK, 2019, RES VET SCI, V125, P370, DOI 10.1016/j.rvsc.2019.07.007; Nett RJ, 2015, JAVMA-J AM VET MED A, V247, P945, DOI 10.2460/javma.247.8.945; Nett RJ, 2015, MMWR-MORBID MORTAL W, V64, P131; Perret JL, 2020, JAVMA-J AM VET MED A, V257, P1057, DOI 10.2460/javma.2020.257.10.1057; Platt B, 2010, OCCUP MED-OXFORD, V60, P436, DOI 10.1093/occmed/kqq044; Platt B, 2012, SOC PSYCH PSYCH EPID, V47, P223, DOI 10.1007/s00127-010-0328-6; Rendall MS, 2011, DEMOGRAPHY, V48, P481, DOI 10.1007/s13524-011-0032-5; Rodrigues H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206840; Shirangi A, 2013, AUST VET J, V91, P123, DOI 10.1111/avj.12037; Skipper GE, 2012, J VET MED EDUC, V39, P79, DOI 10.3138/jvme.0311.034R; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stoewen DL, 2015, CAN VET J, V56, P89; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Van D.D., 2001, EUR J WORK ORGAN PSY, V10, P41, DOI [DOI 10.1080/13594320042000025, 10.1080/13594320042000025]; Ware JE Jr, 2001, SCORE INTERPRET SING; Williams N, 2014, OCCUP MED-OXFORD, V64, P224, DOI 10.1093/occmed/kqt161	38	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253111	10.1371/journal.pone.0253111	http://dx.doi.org/10.1371/journal.pone.0253111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166405	Green Published, gold			2022-12-26	WOS:000671692800003
J	Mohammed, HT; Hyseni, L; Bui, V; Gerritsen, B; Fuller, K; Sung, JY; Alarakhia, M				Mohammed, Heba Tallah; Hyseni, Lirije; Bui, Victoria; Gerritsen, Beth; Fuller, Katherine; Sung, Jihyun; Alarakhia, Mohamed			Exploring the use and challenges of implementing virtual visits during COVID-19 in primary care and lessons for sustained use	PLOS ONE			English	Article							ONTARIO	Background The COVID-19 pandemic has rapidly transformed how healthcare is delivered to limit the transmission of the virus. This descriptive cross-sectional study explored the current use of virtual visits in providing care among primary care providers in southwestern Ontario during the first wave of the COVID-19 pandemic and the anticipated level of utilization post-pandemic. It also explored clinicians' perceptions of the available support tools and resources and challenges to incorporating virtual visits within primary care practices. Methods Primary care physicians and nurse practitioners currently practicing in the southwestern part of Ontario were invited to participate in an online survey. The survey invite was distributed via email, different social media platforms, and newsletters. The survey questions gathered clinicians' demographic information and assessed their experience with virtual visits, including the proportion of visits conducted virtually (before, during the pandemic, and expected volume post-pandemic), overall satisfaction and comfort level with offering virtual visits using modalities, challenges experienced, as well as useful resources and tools to support them in using virtual visits in their practice. Results We received 207 responses, with 96.6% of respondents offering virtual visits in their practice. Participants used different modalities to conduct virtual visits, with the vast majority offering visits via phone calls (99.5%). Since the COVID-19 pandemic, clinicians who offered virtual visits have conducted an average of 66.4% of their visits virtually, compared to an average of 6.5% pre-pandemic. Participants anticipated continuing use of virtual visits with an average of 43.9% post-pandemic. Overall, 74.5% of participants were satisfied with their experience using virtual visits, and 88% believed they could incorporate virtual visits well within the usual workflow. Participants highlighted some challenges in offering virtual care. For example, 58% were concerned about patients' limited access to technology, 55% about patients' knowledge of technology, and 41% about the lack of integration with their current EMR, the increase in demand over time, and the connectivity issues such as inconsistent Wi-Fi/Internet connection. There were significant differences in perception of some challenges between clinicians in urban vs, rural areas. Clinicians in rural areas were more likely to consider the inconsistent Wi-Fi and limited connectivity as barriers to incorporating virtual visits within the practice setting (58.8% vs. 40.2%, P = 0.030). In comparison, clinicians in urban areas were significantly more concerned about patients overusing virtual care services (39.4% vs. 21.6%, P = 0.024). As for support tools, 47% of clinicians advocated for virtual care standards outlined by their profession's college. About 32% identified change management support and technical training as supportive tools. Moreover, 39% and 28% thought local colleagues and in-house organizational support are helpful resources, respectively. Conclusion Our study shows that the adoption of virtual visits has exponentially increased during the pandemic, with a significant interest in continuing to use virtual care options in the delivery of primary care post-pandemic. The study sheds light on tools and resources that could enhance operational efficiencies in adopting virtual visits in primary care settings and highlights challenges that, when addressed, can expand the health system capacity and sustained use of virtual care.	[Mohammed, Heba Tallah; Hyseni, Lirije; Gerritsen, Beth; Alarakhia, Mohamed] eHlth Ctr Excellence, Kitchener, ON, Canada; [Bui, Victoria; Gerritsen, Beth] Hamilton Family Hlth Team, Hamilton, ON, Canada; [Fuller, Katherine; Sung, Jihyun] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Alarakhia, Mohamed] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	McMaster University; McMaster University	Mohammed, HT (corresponding author), eHlth Ctr Excellence, Kitchener, ON, Canada.	heba.mohammed@ehealthce.ca						[Anonymous], 2019, MOHLTC ONTARIO HLTH; Associations of family health team in Ontario (AFTHO), 2020, SHIFT VIRT CAREPRIMA SHIFT VIRT CAREPRIMA; Associations of family health team in Ontario (AFTHO), 2020, PRIM CAR PAT CLIENT PRIM CAR PAT CLIENT; Bhatia RS., 2020, CANADAS VIRTUAL CARE; Bokolo AJ, 2021, IRISH J MED SCI, V190, P1, DOI 10.1007/s11845-020-02299-z; Bui Victoria, 2020, HAMILTON PRIMARY CAR; Canada Health Infoway, 2020, CAN HLTH EXP DUR COV CAN HLTH EXP DUR COV; Canadian Medical Association, 2019, VIRT CAR CAN DISC PA; Canadian Medical association College of Family Physician of Canada and Royal College of Physicians and Surgeons of Canada, 2020, VIRT CAR PLAYB; Canadian Medical association College of Family Physician of Canada and Royal College of Physicians and Surgeons of Canada, 2020, VIRT CAR REC SCAL VI VIRT CAR REC SCAL VI; Chaet D, 2017, J GEN INTERN MED, V32, P1136, DOI 10.1007/s11606-017-4082-2; College of nurses of Ontario, 2020, PRACTICE GUIDELINES; Dixon RF, 2008, TELEMED J E-HEALTH, V14, P525, DOI 10.1089/tmj.2007.0101; Dixon RF, 2014, TELEMED E-HEALTH, V20, P669, DOI 10.1089/tmj.2013.0211; Donaghy E, 2019, BRIT J GEN PRACT, V69, pE586, DOI 10.3399/bjgp19X704141; Glazier RH, 2021, CAN MED ASSOC J, V193, pE200, DOI 10.1503/cmaj.202303; Gloria M, 2001, P 2001 INT ACM SIGGR, P232; Health Canada, 2004, TEL HLTH CAN STAT RE; Hutchison B, 2013, HEALTH AFFAIR, V32, P695, DOI 10.1377/hlthaff.2012.1087; Jamieson T., 2015, VIRTUAL CARE FRAMEWO; Kaminski, 2011, CANADIAN J NURSING I, V6, DOI DOI 10.1097/CIN.0000000000000072; Lehmann C., 2016, CLIN INFORM STUDY GU, DOI [10.1007/978-3-319-22753-5%5F18, DOI 10.1007/978-3-319-22753-5%5F18]; Li J, 2020, RAPID REV RAPID REV; Makhni MC, 2020, J BONE JOINT SURG AM, V102, P1109, DOI 10.2106/JBJS.20.00452; Mann DM, 2020, J AM MED INFORM ASSN, V27, P1132, DOI 10.1093/jamia/ocaa072; McGrail Kimberlyn Marie, 2017, J Med Internet Res, V19, pe177, DOI 10.2196/jmir.7374; McLeod Logan, 2016, CMAJ Open, V4, pE679, DOI 10.9778/cmajo.20160069; McMurray JE, 2000, J GEN INTERN MED, V15, P372, DOI 10.1111/j.1525-1497.2000.im9908009.x; Ministry of Health, 2019, ONT HLTH TEAM DIG HL ONT HLTH TEAM DIG HL; Ontario Health Quality, 2020, AD INT VIRT VIS CAR AD INT VIRT VIS CAR; Ontario MD., 2020, VIRT CAR HER STAY VIRT CAR HER STAY; OntarioMD, 2020, ONTARIOMD STAK REP P ONTARIOMD STAK REP P; Permanente Medicine, 2018, FUT CAR DEL TOD FUT CAR DEL TOD; Roter DL, 2002, JAMA-J AM MED ASSOC, V288, P756, DOI 10.1001/jama.288.6.756; Snoswell Centaine L, 2020, JMIR Perioper Med, V3, pe15688, DOI 10.2196/15688; Stamenova Vess, 2020, BMJ Open, V10, pe037064, DOI 10.1136/bmjopen-2020-037064; Swinkels ICS, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9110; The Ontario Physician Human Resources Data Centre, 2019, PHYS ONT PHYS ONT; Webster P, 2020, LANCET, V395, P1180, DOI 10.1016/S0140-6736(20)30818-7; Women's College Hospital Institute for Health Systems Solutions and Virtual Care (WIHV), 2019, ENH ACC PRIM CAR PRO ENH ACC PRIM CAR PRO; World Health Organization Regional Office for Europe, 2016, INTEGRATED CARE MODE	41	13	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253665	10.1371/journal.pone.0253665	http://dx.doi.org/10.1371/journal.pone.0253665			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166441	Green Published, gold			2022-12-26	WOS:000671692800063
J	Putri, RE; Kim, LH; Farhat, N; Felemban, M; Saikaly, PE; Vrouwenvelder, JS				Putri, Ratna E.; Kim, Lan Hee; Farhat, Nadia; Felemban, Mashael; Saikaly, Pascal E.; Vrouwenvelder, Johannes S.			Evaluation of DNA extraction yield from a chlorinated drinking water distribution system	PLOS ONE			English	Article							MICROBIAL COMMUNITY DYNAMICS; REVERSE-OSMOSIS; BACTERIAL COMMUNITY; ECONOMIC-EVALUATION; ENVIRONMENTAL DNA; DESALINATION; DISINFECTION; CULTURABILITY; METHODOLOGY; REMOVAL	Desalination technology based on Reverse Osmosis (RO) membrane filtration has been resorted to provide high-quality drinking water. RO produced drinking water is characterized by a low bacterial cell concentration. Monitoring microbial quality and ensuring membrane-treated water safety has taken advantage of the rapid development of DNA-based techniques. However, the DNA extraction process from RO-based drinking water samples needs to be evaluated regarding the biomass amount (filtration volume) and residual disinfectant such as chlorine, as it can affect the DNA yield. We assessed the DNA recovery applied in drinking water microbiome studies as a function of (i) different filtration volumes, (ii) presence and absence of residual chlorine, and (iii) the addition of a known Escherichia coli concentration into the (sterile and non-sterile, chlorinated and dechlorinated) tap water prior filtration, and directly onto the (0.2 mu m pore size, 47 mm diameter) mixed ester cellulose membrane filters without and after tap water filtration. Our findings demonstrated that the co-occurrence of residual chlorine and low biomass/cell density water samples (RO-treated water with a total cell concentration ranging between 2.47 x 10(2)-1.5 x 10(3) cells/mL) failed to provide sufficient DNA quantity (below the threshold concentration required for sequencing-based procedures) irrespective of filtration volumes used (4, 20, 40, 60 L) and even after performing dechlorination. After exposure to tap water containing residual chlorine (0.2 mg/L), we observed a significant reduction of E. coli cell concentration and the degradation of its DNA (DNA yield was below detection limit) at a lower disinfectant level compared to what was previously reported, indicating that free-living bacteria and their DNA present in the drinking water are subject to the same conditions. The membrane spiking experiment confirmed no significant impact from any potential inhibitors (e.g. organic/inorganic components) present in the drinking water matrix on DNA extraction yield. We found that very low DNA content is likely to be the norm in chlorinated drinking water that gives hindsight to its limitation in providing robust results for any downstream molecular analyses for microbiome surveys. We advise that measurement of DNA yield is a necessary first step in chlorinated drinking water distribution systems (DWDSs) before conducting any downstream omics analyses such as amplicon sequencing to avoid inaccurate interpretations of results based on very low DNA content. This study expands a substantial source of bias in using DNA-based methods for low biomass samples typical in chlorinated DWDSs. Suggestions are provided for DNA-based research in drinking water with residual disinfectant.	[Putri, Ratna E.; Kim, Lan Hee; Farhat, Nadia; Felemban, Mashael; Saikaly, Pascal E.; Vrouwenvelder, Johannes S.] King Abdullah Univ Sci & Technol, Water Desalinat & Reuse Ctr, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia; [Vrouwenvelder, Johannes S.] Delft Univ Technol, Fac Appl Sci, Dept Biotechnol, Delft, Netherlands	King Abdullah University of Science & Technology; Delft University of Technology	Farhat, N (corresponding author), King Abdullah Univ Sci & Technol, Water Desalinat & Reuse Ctr, Biol & Environm Sci & Engn Div, Thuwal, Saudi Arabia.	nadia.farhat@kaust.edu.sa	Vrouwenvelder, Johannes/AAX-1192-2021	Vrouwenvelder, Johannes/0000-0003-2668-2057; Farhat, Nadia/0000-0003-3566-6163; Saikaly, Pascal/0000-0001-7678-3986	King Abdullah University of Science and Technology (KAUST)	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This research was supported by funding from King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2020, J ENVIRON MANAGE, V276, DOI 10.1016/j.jenvman.2020.111319; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Baron JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102679; Beale DJ, 2012, CORROS SCI, V55, P272, DOI 10.1016/j.corsci.2011.10.026; Bedard E, 2014, FEMS MICROBIOL LETT, V356, P226, DOI 10.1111/1574-6968.12494; Belila A, 2016, WATER RES, V94, P62, DOI 10.1016/j.watres.2016.02.039; Benami M, 2015, SCI TOTAL ENVIRON, V506, P496, DOI 10.1016/j.scitotenv.2014.11.051; Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017; Bertelli C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02520; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Bonk F, 2018, J MICROBIOL METH, V153, P139, DOI 10.1016/j.mimet.2018.09.015; Bostrom KH, 2004, LIMNOL OCEANOGR-METH, V2, P365, DOI 10.4319/lom.2004.2.365; Brandt J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02140; Bruno A, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02557; Button DK, 2001, APPL ENVIRON MICROB, V67, P1636, DOI 10.1128/AEM.67.4.1636-1645.2001; Choi Y, 2016, DESALIN WATER TREAT, V57, P26680, DOI 10.1080/19443994.2016.1190114; Cristescu ME, 2018, ANNU REV ECOL EVOL S, V49, P209, DOI 10.1146/annurev-ecolsys-110617-062306; Dai Z, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00813-0; Darling John A, 2011, Environ Res, V111, P978, DOI 10.1016/j.envres.2011.02.001; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Del Olmo G, 2021, SCI TOTAL ENVIRON, V754, DOI 10.1016/j.scitotenv.2020.142016; Devaraj A, 2019, P NATL ACAD SCI USA, V116, P25068, DOI 10.1073/pnas.1909017116; Dias VCF, 2019, WATER-SUI, V11, DOI 10.3390/w11030627; Douterelo I, 2014, WATER RES, V65, P134, DOI 10.1016/j.watres.2014.07.008; Eichler S., 2007, COMPOSITION DYNAMICS, V72, P2017; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; Ersoy ZG, 2019, LWT-FOOD SCI TECHNOL, V102, P205, DOI 10.1016/j.lwt.2018.12.041; Farhat N, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-0065-7; Fujioka T, 2020, ENVIRON TECHNOL INNO, V19, DOI 10.1016/j.eti.2020.100818; Fujioka T, 2019, ENVIRON SCI-WAT RES, V5, P239, DOI [10.1039/c8ew00910d, 10.1039/C8EW00910D]; Fujioka T, 2018, ENVIRON SCI TECH LET, V5, P389, DOI 10.1021/acs.estlett.8b00200; Gerasimidis Konstantinos, 2016, BMC Res Notes, V9, P365, DOI 10.1186/s13104-016-2171-7; Guo LZ, 2021, J HAZARD MATER, V406, DOI 10.1016/j.jhazmat.2020.124335; He H, 2019, ENVIRON SCI TECHNOL, V53, P2013, DOI 10.1021/acs.est.8b04393; Hermans SM, 2018, MOL ECOL RESOUR, V18, P557, DOI 10.1111/1755-0998.12762; Hofste R.W., 17 COUNTRIES HOME ON; Hugerth LW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01561; Humphrey B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132954; Hunter ME, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40977-w; Hwang C, 2012, APPL ENVIRON MICROB, V78, P7856, DOI 10.1128/AEM.01892-12; Hwang CC, 2012, MICROBES ENVIRON, V27, P9, DOI 10.1264/jsme2.ME11132; de Aldecoa ALI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01390; Illumina, 2013, 16S METAGENOMIC SEQU; Ji P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141087; Jones E, 2019, SCI TOTAL ENVIRON, V657, P1343, DOI 10.1016/j.scitotenv.2018.12.076; Kennedy LC, 2021, ENVIRON SCI-WAT RES, V7, P78, DOI [10.1039/D0EW00809E, 10.1039/d0ew00809e]; Kennedy NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088982; Lear G, 2018, NEW ZEAL J ECOL, V42, P10, DOI 10.20417/nzjecol.42.9; Li H, 2018, WATER RES, V136, P160, DOI 10.1016/j.watres.2018.02.031; Li WY, 2018, CHEMOSPHERE, V202, P586, DOI 10.1016/j.chemosphere.2018.03.056; Ling CM, 2018, FRONT ENERGY, V12, P297, DOI 10.1007/s11708-017-0478-2; Ling FQ, 2018, ISME J, V12, P1520, DOI [10.1038/S41396-018-0101-5, 10.1038/s41396-018-0101-5]; Liu XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128825; Luef B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7372; Luk AWS, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy146; Manzari C, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000417; Massart NS., 2010, WHITES HDB CHLORINAT, V9, P76; Menglu Zhang, 2019, Frontiers of Environmental Science & Engineering, V13, DOI 10.1007/s11783-019-1124-5; Nescerecka A, 2018, WATER RES, V135, P11, DOI 10.1016/j.watres.2018.02.006; Nescerecka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096354; Padmanaban A., DNA INTEGRITY NUMBER, DOI [10.13140/RG.2.1.1011.9122, DOI 10.13140/RG.2.1.1011.9122]; Park JW, 2018, WATER RES, V144, P36, DOI 10.1016/j.watres.2018.07.027; Park SK, 2010, J ENVIRON SCI HEAL A, V45, P968, DOI 10.1080/10934521003772386; Poitelon JB, 2010, J IND MICROBIOL BIOT, V37, P117, DOI 10.1007/s10295-009-0653-5; Potgieter S, 2018, WATER RES, V139, P406, DOI 10.1016/j.watres.2018.03.077; Prest EI, 2013, WATER RES, V47, P7131, DOI 10.1016/j.watres.2013.07.051; Prest EI, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00045; Proctor CR, 2015, CURR OPIN BIOTECH, V33, P87, DOI 10.1016/j.copbio.2014.12.014; Pype ML, 2016, WATER RES, V98, P384, DOI 10.1016/j.watres.2016.04.040; R Core Team, 2020, R LANG ENV STAT COMP; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; Roeselers G, 2015, ENVIRON MICROBIOL, V17, P2505, DOI 10.1111/1462-2920.12739; Rosario-Ortiz F, 2016, SCIENCE, V351, P912, DOI 10.1126/science.aaf0953; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanchez-Torres V, 2010, BIOCHEM BIOPH RES CO, V401, P197, DOI 10.1016/j.bbrc.2010.09.026; Schultz MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141503; Shorney-Darby H., 2010, WHITES HDB CHLORINAT, VFifth Edition, P230; Sousi M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00791; Sousi M, 2018, WATER RES, V145, P687, DOI 10.1016/j.watres.2018.09.002; Stamps BW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02435; Stoeckle BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189119; Van Aken B, 2011, WATER SCI TECHNOL, V64, P1226, DOI 10.2166/wst.2011.684; Van Nevel S, 2013, J MICROBIOL METH, V94, P73, DOI 10.1016/j.mimet.2013.05.007; Vierheilig J, 2015, WATER SCI TECHNOL, V72, P1962, DOI 10.2166/wst.2015.407; Villacorte LO, 2015, DESALIN WATER TREAT, V55, P2601, DOI 10.1080/19443994.2014.940649; Vital M, 2012, WATER RES, V46, P6279, DOI 10.1016/j.watres.2012.08.043; Wang H, 2017, WATER RES, V117, P68, DOI 10.1016/j.watres.2017.03.046; Wang YY, 2010, APPL MICROBIOL BIOT, V87, P331, DOI 10.1007/s00253-010-2526-2; Wilcox TM, 2018, N AM J FISH MANAGE, V38, P592, DOI 10.1002/nafm.10055; Xu LM, 2018, J ENVIRON SCI-CHINA, V65, P356, DOI 10.1016/j.jes.2017.07.006; Yu ZH, 2018, WATER RES, V145, P678, DOI 10.1016/j.watres.2018.09.003; Zhang Y, 2019, CRIT REV ENV SCI TEC, V49, P1188, DOI 10.1080/10643389.2019.1571351; Zhou ZC, 2021, ENVIRON INT, V148, DOI 10.1016/j.envint.2021.106394; Ziemba C, 2019, WATER RES X, V2, DOI 10.1016/j.wroa.2018.100020	95	1	1	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253799	10.1371/journal.pone.0253799	http://dx.doi.org/10.1371/journal.pone.0253799			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166448	Green Published, gold			2022-12-26	WOS:000671692800048
J	Mohseni, M; Kucharski, C; Bahadur, KCR; Nasrullah, M; Jiang, XY; Uludag, H; Brandwein, J				Mohseni, Mahsa; Kucharski, Cezary; Bahadur, Remant K. C.; Nasrullah, Mohammad; Jiang, Xiaoyan; Uludag, Hasan; Brandwein, Joseph			Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL)	PLOS ONE			English	Article							PATHWAY; BIOLOGY; TARGET; CANCER; RNAI	Overexpression and persistent activation of STAT5 play an important role in the development and progression of acute lymphoblastic leukemia (ALL), the most common pediatric cancer. Small interfering RNA (siRNA)-mediated downregulation of STAT5 represents a promising therapeutic approach for ALL to overcome the limitations of current treatment modalities such as high relapse rates and poor prognosis. However, to effectively transport siRNA molecules to target cells, development of potent carriers is of utmost importance to surpass hurdles of delivery. In this study, we investigated the use of lipopolymers as non-viral delivery systems derived from low molecular weight polyethylenimines (PEI) substituted with lauric acid (Lau), linoleic acid (LA) and stearic acid (StA) to deliver siRNA molecules to ALL cell lines and primary samples. Among the lipid-substituted polymers explored, Lau- and LA-substituted PEI displayed excellent siRNA delivery to SUP-B15 and RS4;11 cells. STAT5A gene expression was downregulated (36-92%) in SUP-B15 and (32%) in RS4;11 cells using the polymeric delivery systems, which consequently reduced cell growth and inhibited the formation of colonies in ALL cells. With regard to ALL primary cells, siRNA-mediated STAT5A gene silencing was observed in four of eight patient cells using our leading polymeric delivery system, 1.2PEI-Lau8, accompanied by the significant reduction in colony formation in three of eight patients. In both BCR-ABL positive and negative groups, three of five patients demonstrated marked cell growth inhibition in both MTT and trypan blue exclusion assays using 1.2PEI-Lau8/siRNA complexes in comparison with their control siRNA groups. Three patient samples did not show any positive results with our delivery systems. Differential therapeutic responses to siRNA therapy observed in different patients could result from variable genetic profiles and patient-to-patient variability in delivery. This study supports the potential of siRNA therapy and the designed lipopolymers as a delivery system in ALL therapy.	[Mohseni, Mahsa; Brandwein, Joseph] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada; [Kucharski, Cezary; Bahadur, Remant K. C.; Nasrullah, Mohammad; Uludag, Hasan] Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada; [Jiang, Xiaoyan] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC, Canada; [Uludag, Hasan] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada; [Uludag, Hasan] Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of British Columbia; University of Alberta; University of Alberta	Brandwein, J (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada.; Uludag, H (corresponding author), Univ Alberta, Fac Engn, Dept Chem & Mat Engn, Edmonton, AB, Canada.; Uludag, H (corresponding author), Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada.; Uludag, H (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biomed Engn, Edmonton, AB, Canada.	huludag@ualberta.ca; jbrandwe@ualberta.ca		Uludag, Hasan/0000-0002-1118-4170; Nasrullah, Mohammad/0000-0003-1346-355X	Women and Children's Health Research Institute; Canadian Institutes of Health Research [MOP 142202]; Hair Massacure Foundation; Alex's Lemonade Stand Foundation [RES0048095]	Women and Children's Health Research Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Hair Massacure Foundation; Alex's Lemonade Stand Foundation	This project was financially supported by operating grants from Women and Children's Health Research Institute (HU), Canadian Institutes of Health Research (HU; MOP 142202), Hair Massacure Foundation (JB), and Alex's Lemonade Stand Foundation (HU, XJ, JB; RES0048095). Equipment support by provided by Edmonton Civic Employees Charitable Assistance Fund (HU).	Abbasi M, 2013, MED RES REV, V33, P33, DOI 10.1002/med.20244; Aliabadi HM, 2015, PHARM RES-DORDR, V32, P3813, DOI 10.1007/s11095-015-1741-z; Aliabadi HM, 2011, MACROMOL BIOSCI, V11, P662, DOI 10.1002/mabi.201000402; Anchang B, 2018, P NATL ACAD SCI USA, V115, pE4294, DOI 10.1073/pnas.1711365115; Aslanturk OS., 2018, GENOTOXICITY PREDICT; Bahadur K.C.R., 2016, POLYM NANOMATERIALS, P29, DOI 10.1016/B978-0-08-100520-0.00002-3; Brenner DR, 2020, CAN MED ASSOC J, V192, pE199, DOI 10.1503/cmaj.191292; Bueno C, 2013, BLOOD, V121, P3867, DOI 10.1182/blood-2012-11-470146; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Forsell J., EVALUATION FACTORS A; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Golan T, 2015, ONCOTARGET, V6, P24560, DOI 10.18632/oncotarget.4183; Gul-Uludag H, 2014, LEUKEMIA RES, V38, P1299, DOI 10.1016/j.leukres.2014.08.008; He W, 2014, MOL THER, V22, P359, DOI 10.1038/mt.2013.210; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Hong SW, 2014, NUCLEIC ACID THER, V24, P192, DOI 10.1089/nat.2013.0466; Hsu CYM, 2012, NAT PROTOC, V7, P935, DOI 10.1038/nprot.2012.038; Jain S, 2020, ARCH PATHOL LAB MED, V144, P150, DOI 10.5858/arpa.2019-0194-RA; Kamga Paul Takam, 2018, Oncotarget, V9, P18341, DOI 10.18632/oncotarget.24836; Kolosenko I, 2017, J CONTROL RELEASE, V261, P199, DOI 10.1016/j.jconrel.2017.07.002; Landry B, 2016, J CONTROL RELEASE, V224, P8, DOI 10.1016/j.jconrel.2015.12.052; Landry B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044197; Li H., 2016, ARXIV160808710, Vabs/1608.08710; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Man LM, 2017, CURR HEMATOL MALIG R, V12, P197, DOI 10.1007/s11899-017-0380-3; Maude SL, 2015, BLOOD, V125, P1759, DOI 10.1182/blood-2014-06-580480; Minieri V., 2018, CANCER RES; Mohseni M, 2018, AM J BLOOD RES, V8, P29; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Parmar MB, 2016, J BIOMED MATER RES A, V104, P3031, DOI 10.1002/jbm.a.35846; Pecot CV, 2011, NAT REV CANCER, V11, P59, DOI 10.1038/nrc2966; Plianwong S, 2020, PHARM RES-DORDR, V37, DOI 10.1007/s11095-020-2770-9; Remant Bahadur KC., 2011, ACTA BIOMATER; Remant KC, 2019, STEM CELLS DEV, V28, P734, DOI 10.1089/scd.2018.0196; Roberts KG, 2018, BEST PRACT RES CL HA, V31, P351, DOI 10.1016/j.beha.2018.09.003; Roberts KG, 2017, BEST PRACT RES CL HA, V30, P212, DOI 10.1016/j.beha.2017.07.003; Roberts KG, 2012, CANCER CELL, V22, P153, DOI 10.1016/j.ccr.2012.06.005; Sahin B, 2014, BIOMATERIALS, V35, P9382, DOI 10.1016/j.biomaterials.2014.07.029; Santiago R, 2017, EXPERT OPIN PHARMACO, V18, P1081, DOI 10.1080/14656566.2017.1340938; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Sundaram DNM, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600430; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Tasian SK, 2012, BLOOD, V120, P833, DOI 10.1182/blood-2011-12-389932; Uckun FM., 2018, CANC DRUG RESIST, DOI [10.20517/cdr.2017.03, DOI 10.20517/CDR.2017.03]; Uludag H, 2016, DRUG DISCOV TODAY, V21, P1412, DOI 10.1016/j.drudis.2016.04.018; Valencia-Serna J., 2014, POTENTIAL SIRNA THER; Valencia-Serna J, 2019, J CONTROL RELEASE, V310, P141, DOI 10.1016/j.jconrel.2019.08.018; Valencia-Serna J, 2013, J CONTROL RELEASE, V172, P495, DOI 10.1016/j.jconrel.2013.05.014; Vermeulen J, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr065; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Whitehead KA, 2009, NAT REV DRUG DISCOV, V8, P129, DOI 10.1038/nrd2742; Wingelhofer B, 2018, LEUKEMIA, V32, P1135, DOI 10.1038/s41375-017-0005-9; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yadav BD., DENOTES EQUAL SENIOR, V7; Yamaguchi H, 2009, EXP HEMATOL, V37, P701, DOI 10.1016/j.exphem.2009.02.007; Yao Q, 2005, LEUKEMIA, V19, P1605, DOI 10.1038/sj.leu.2403881; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	60	1	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0251719	10.1371/journal.pone.0251719	http://dx.doi.org/10.1371/journal.pone.0251719			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157051	Green Published, gold			2022-12-26	WOS:000671691200022
J	Slaughter, MS; Monreal, G; Koenig, SC; Giridharan, GA; Tompkins, LH; Jimenez, JH				Slaughter, Mark S.; Monreal, Gretel; Koenig, Steven C.; Giridharan, Guruprasad A.; Tompkins, Landon H.; Jimenez, Jorge H.			Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy	PLOS ONE			English	Article							WARFARIN; DEVICE	In the US, the most significant morbidity and mortality associated with non-valvular atrial fibrillation (NVAF) is embolic stroke, with 90% of thrombus originating from the left atrial appendage (LAA). Anticoagulation is the preferred treatment for the prevention of stroke in NVAF patients, but clinical studies have demonstrated high levels of non-compliance and increased risk of bleeding or ineligibility for anticoagulation therapy, especially in the elderly population where the incidence of NVAF is highest. Alternatively, stroke may be preventing using clinically approved surgical and catheter-based devices to exclude or occlude the LAA, but these devices continue to be plagued by peri-device leaks and thrombus formation because of residual volume. To overcome these limitations, Cor Habere (Louisville, KY) and the University of Louisville are developing a LAA closure device (StrokeShield) that completely occludes and collapses the LAA to minimize the risk of stroke. The StrokeShield device is a collapsible occluder (nitinol reinforced membrane) that completely covers the LAA orifice with an expandable conical coil anchor that attaches to the myocardium. The device is designed for catheter-based delivery and expands to completely occlude the LAA orifice and collapse the LAA. The primary advantages of the StrokeShield system are a completely sealed LAA (no peri-device flow or residual space) and smooth endothelialized connection to the left atrial wall with minimal risk of cardiac bleeding and tamponade. We tested proof-of-concept of a prototype StrokeShield device in acute (n = 2) and chronic 60-day (n = 2) healthy canine models. Acute results demonstrated that the conical coil securely attached to the myocardium (5N pull-out force) and the Nitinol umbrella fully deployed and covered the LAA ostium. Results from the chronic implants demonstrated long-term feasibility of device placement with no procedural or device-related intra- or post-operative complications, secure placement and correct positioning of the device with no device migration. The device successfully occluded the LAA ostium and collapsed the LAA with no interference with the mitral valve, circumflex coronary artery, or pulmonary veins. Necropsy demonstrated no gross signs of thrombus or end-organ damage and the device was encapsulated in the LAA. Histology demonstrated mature neointima covering the device with expected foreign body inflammatory response. These early positive results will help to guide the iterative design process for the continued development of the StrokeShield system.	[Slaughter, Mark S.; Monreal, Gretel; Koenig, Steven C.] Univ Louisville, Dept Cardiovasc & Thorac Surg, Louisville, KY 40292 USA; [Koenig, Steven C.; Giridharan, Guruprasad A.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA; [Tompkins, Landon H.; Jimenez, Jorge H.] Cor Habere Corp, Louisville, KY USA	University of Louisville; University of Louisville	Slaughter, MS (corresponding author), Univ Louisville, Dept Cardiovasc & Thorac Surg, Louisville, KY 40292 USA.	mark.slaughter@louisville.edu	Tompkins, Landon/ABF-8985-2021	Tompkins, Landon/0000-0002-6832-2167	NIH SBIR phase I grant [R43HL142337-01]; SBIR phase I grant; Coulter Foundation; Wallace Coulter Foundation	NIH SBIR phase I grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBIR phase I grant; Coulter Foundation; Wallace Coulter Foundation	MS served as co-PI of the 5-year Coulter Translational Partnership Award in Biomedical Engineering (TP) to the University of Louisville (UofL) to develop multiple biomedical technologies, including StrokeShield (LAA device). UofL was authorized by the Wallace Coulter Foundation to fund the subaward (PI: GG) to develop the prototype StrokeShield device and conduct proof-of-concept testing, which are presented in this manuscript. The funders (Wallace Coulter Foundation) had no role in the study design, data collection and analysis, decision to publish, and/or preparation of the manuscript. https://whcf.org/coulter-foundation-programs/translational-research/coulter-translationalpartnership-tp-and-research-awards-ctra/coulter-translational-partnership-award-in-biomedicalengineering-tp/MS, SK, JJ are co-founders and LT is an engineer with Cor Habere (Louisville KY) who are collectively continuing to develop the technology (StrokeShield system) presented in this manuscript. Note: all of the research and development presented in this manuscript was completed before Cor Habere was incorporated. Cor Habere was also awarded a NIH SBIR phase I grant (R43HL142337-01, PIs: JJ and MS and coIs: GM, SK, GG) to continue development work of StrokeShield system, but none of research and development funded by the SBIR phase I grant is presented in this manuscript. The Coulter Foundation (non-profit) provided a 5-yr Clinical Translational Research award to the University of Louisville to be distributed as subawards to University of Louisville faculty (clinicians, engineers, scientists) to develop proof-of-concept medical device(s) and/or technology(s) awarded through a well-defined internal and external peerreview process. The project presented in this manuscript was supported with funding as one of these selected subawards (Pl: Giridharan). The Funder (Coulter Foundation) provided funding support for materials and supplies only (no salary support for any of the authors), but did NOT have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'authors contributions' section.	Amin A, 2017, CURR MED RES OPIN, V33, P1595, DOI 10.1080/03007995.2017.1345729; Atianzar K, 2018, JACC-CARDIOVASC INTE, V11, P1942, DOI 10.1016/j.jcin.2018.07.005; Blumenstein J, 2013, EUR J CARDIO-THORAC, V44, P1057, DOI 10.1093/ejcts/ezt198; Chow DHF, 2019, TRENDS CARDIOVAS MED, V29, P228, DOI 10.1016/j.tcm.2018.08.008; Czuprynska J, 2017, BRIT J HAEMATOL, V178, P838, DOI 10.1111/bjh.14714; Gilligan AM, 2017, AM J CARDIOVASC DRUG, V17, P481, DOI 10.1007/s40256-017-0244-1; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Hsia TY, 2009, ANN THORAC SURG, V87, P1234, DOI 10.1016/j.athoracsur.2009.01.015; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Kamohara K, 2006, J THORAC CARDIOV SUR, V132, P340, DOI 10.1016/j.jtcvs.2006.04.021; Karim N, 2020, EUROPACE, V22, P5, DOI 10.1093/europace/euz212; Klopfleisch R, 2017, J BIOMED MATER RES A, V105, P927, DOI 10.1002/jbm.a.35958; Kornej J, 2020, CIRC RES, V127, P4, DOI 10.1161/CIRCRESAHA.120.316340; Markides V., 2019, EFFICACY MAGNESIUM O, P1, DOI [10.1093/eurospace/euz212, DOI 10.1093/EUROSPACE/EUZ212]; Ray IB, 2020, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.00089; Reddy VY, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011577; Reddy VY, 2015, J AM COLL CARDIOL, V66, P2728, DOI 10.1016/j.jacc.2015.09.084; Reynolds SL, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-017-0705-x; Rodû«s-Cabau, 2018, CARD INTERV TODAY, V12, P34; Romero J, 2014, CLIN MED INSIGHTS-CA, V8, P45, DOI 10.4137/CMC.S14043; Santangeli P., 2018, US CARDIOLOGY REV, V12, P87, DOI [10.15420/usc.2018.6.1, DOI 10.15420/USC.2018.6.1]; Sharma SP, 2018, KOREAN CIRC J, V48, P692, DOI 10.4070/kcj.2018.0231; Suradi HS, 2017, NETH HEART J, V25, P143, DOI 10.1007/s12471-016-0929-0; Tan Nicholas Y, 2018, Interv Cardiol Clin, V7, P185, DOI 10.1016/j.iccl.2017.12.001; Turakhia MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195088; Wang F, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0889-y; Willey V, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020676	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253299	10.1371/journal.pone.0253299	http://dx.doi.org/10.1371/journal.pone.0253299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157041	Green Published, gold			2022-12-26	WOS:000671691200016
J	Wu, Y; Guo, QH; Ju, XZ; Hu, ZX; Xia, LF; Deng, Y; Zhao, P; Zhang, M; Shao, Y; Huang, SL; He, XH; Wen, H; Wu, XH				Wu, Yong; Guo, Qinhao; Ju, Xingzhu; Hu, Zhixiang; Xia, Lingfang; Deng, Yu; Zhao, Ping; Zhang, Meng; Shao, Yang; Huang, Shenglin; He, Xianghuo; Wen, Hao; Wu, Xiaohua			HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway	ONCOGENE			English	Article							NONCODING RNAS; PROTEINS; METASTASIS; BINDING; AXIS	Numerous studies suggest an important role for copy number alterations (CNAs) in cancer progression. However, CNAs of long intergenic noncoding RNAs (lincRNAs) in ovarian cancer (OC) and their potential functions have not been fully investigated. Here, based on analysis of The Cancer Genome Atlas (TCGA) database, we identified in this study an oncogenic lincRNA termed LINC00662 that exhibited a significant correlation between its CNA and its increased expression. LINC00662 overexpression is highly associated with malignant features in OC patients and is a prognostic indicator. LINC00662 significantly promotes OC cell proliferation and metastasis in vitro and in vivo. Mechanistically, LINC00662 is stabilized by heterogeneous nuclear ribonucleoprotein H1 (HNRNPH1). Moreover, LINC00662 exerts oncogenic effects by interacting with glucose-regulated protein 78 (GRP78) and preventing its ubiquitination in OC cells, leading to activation of the oncogenic p38 MAPK signaling pathway. Taken together, our results define an oncogenic role for LINC00662 in OC progression mediated via GRP78/p38 signaling, with potential implications regarding therapeutic targets for OC.	[Wu, Yong; Guo, Qinhao; Ju, Xingzhu; Xia, Lingfang; Wen, Hao; Wu, Xiaohua] Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Wu, Yong; Guo, Qinhao; Ju, Xingzhu; Xia, Lingfang; Zhang, Meng; Wen, Hao; Wu, Xiaohua] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Hu, Zhixiang; Huang, Shenglin; He, Xianghuo] Fudan Univ, Shanghai Canc Ctr, Inst Biomed Sci, Key Lab Med Epigenet & Metab, Shanghai 200032, Peoples R China; [Hu, Zhixiang; Shao, Yang; Huang, Shenglin; He, Xianghuo; Wu, Xiaohua] Fudan Univ, Canc Inst, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Deng, Yu] Zhejiang Univ, Affiliated Hosp 1, Dept Pathol, Sch Med, Hangzhou 310000, Peoples R China; [Zhao, Ping] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pathol, Sch Med, Shanghai 200001, Peoples R China; [Zhang, Meng; Shao, Yang] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Zhejiang University; Shanghai Jiao Tong University; Fudan University	Wen, H; Wu, XH (corresponding author), Fudan Univ, Dept Gynecol Oncol, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.; Wen, H; Wu, XH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.; Wu, XH (corresponding author), Fudan Univ, Canc Inst, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.	wenhao_fdc@163.com; wu.xh@fudan.edu.cn	He, Xianghuo/I-1497-2014; Shao, Yang/AAH-1251-2020	He, Xianghuo/0000-0001-8872-668X; Shao, Yang/0000-0002-3239-4265	National Natural Science Foundation of China [81972431, 81902641, 82002747, 82002500]; Shanghai Sailing Program [20YF1408000]; Shanghai Anticancer Association EYAS PROJECT [SACA-CY19A07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Sailing Program; Shanghai Anticancer Association EYAS PROJECT	This work was supported by grants from the National Natural Science Foundation of China (no. 81972431, 81902641, 82002747, 82002500), the Shanghai Sailing Program (no. 20YF1408000), and the Shanghai Anticancer Association EYAS PROJECT (no. SACA-CY19A07).	Andor N, 2017, CANCER RES, V77, P2179, DOI 10.1158/0008-5472.CAN-16-1553; Bailly C, 2019, BIOCHEM PHARMACOL, V163, P269, DOI 10.1016/j.bcp.2019.02.038; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bertone-Johnson ER, 2005, LANCET, V365, P101, DOI 10.1016/S0140-6736(05)17716-2; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Cao W, 2017, ORAL ONCOL, V65, P94, DOI 10.1016/j.oraloncology.2016.12.017; Cao XL, 2020, GENES GENOM, V42, P1361, DOI 10.1007/s13258-020-01001-y; Cerezo M, 2016, CANCER CELL, V29, P805, DOI 10.1016/j.ccell.2016.04.013; Chang YW, 2016, ONCOGENE, V35, P1517, DOI 10.1038/onc.2015.214; Cheng B, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1510-7; Chu LZ, 2019, AGING-US, V11, P1456, DOI 10.18632/aging.101845; Cohen M, 2011, CANCER LETT, V309, P104, DOI 10.1016/j.canlet.2011.05.022; Decorsiere A, 2011, GENE DEV, V25, P220, DOI 10.1101/gad.607011; Diederichs S, 2016, EMBO MOL MED, V8, P442, DOI 10.15252/emmm.201506055; Du TD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10824-7; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Gong WJ, 2018, J BIOCHEM, V164, P461, DOI 10.1093/jb/mvy078; Grammatikakis I, 2016, CELL REP, V15, P926, DOI 10.1016/j.celrep.2016.03.080; Grohar PJ, 2016, CELL REP, V14, P598, DOI 10.1016/j.celrep.2015.12.063; Guo T, 2020, CELL DEATH DIFFER, V27, P2191, DOI 10.1038/s41418-020-0494-3; Guo T, 2019, AGING-US, V11, P4890, DOI 10.18632/aging.102082; Indovina P, 2017, J CELL PHYSIOL, V232, P129, DOI 10.1002/jcp.25397; Jonas K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082969; Karst AM, 2014, CANCER RES, V74, P1141, DOI 10.1158/0008-5472.CAN-13-2247; Kneissig M, 2019, CURR OPIN GENET DEV, V54, P25, DOI 10.1016/j.gde.2019.02.005; Lauer S, 2019, CURR GENET, V65, P1287, DOI 10.1007/s00294-019-00980-0; Lheureux S, 2019, CA-CANCER J CLIN, V69, P280, DOI 10.3322/caac.21559; Li ZN, 2020, ORAL ONCOL, V103, DOI 10.1016/j.oraloncology.2020.104591; Liu Z, 2018, BIOCHEM BIOPH RES CO, V505, P843, DOI 10.1016/j.bbrc.2018.09.191; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104; Ried T, 2019, MOL ASPECTS MED, V69, P48, DOI 10.1016/j.mam.2019.07.007; Shaker OG, 2019, IUBMB LIFE, V71, P1322, DOI 10.1002/iub.2039; Shishkin SS, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030745; Sun LL, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00137; Tan SS, 2011, J PATHOL, V223, P81, DOI 10.1002/path.2795; Thornton M, 2013, INT J CANCER, V133, P1408, DOI 10.1002/ijc.28137; Tian XH, 2020, MOL ONCOL, V14, P462, DOI 10.1002/1878-0261.12606; Topp MD, 2014, MOL ONCOL, V8, P656, DOI 10.1016/j.molonc.2014.01.008; Turunen JJ, 2013, RNA, V19, P380, DOI 10.1261/rna.036715.112; Wang HM, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01385; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Xu D, 2019, CANCERS, V11, DOI 10.3390/cancers11101502; Zhao S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1401-z; Zong L, 2019, ONCOGENE, V38, P5281, DOI 10.1038/s41388-019-0792-8	47	3	3	2	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4770	4782		10.1038/s41388-021-01884-5	http://dx.doi.org/10.1038/s41388-021-01884-5		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34148056	Green Published, hybrid			2022-12-26	WOS:000663492900001
J	Purwati; Miatmoko, A; Nasronudin; Hendrianto, E; Karsari, D; Dinaryanti, A; Ertanti, N; Ihsan, IS; Purnama, DS; Asmarawati, TP; Marfiani, E; Yulistiani; Rosyid, AN; Wulaningrum, PA; Setiawan, HW; Siswanto, I; Puspaningsih, NNT				Purwati; Miatmoko, Andang; Nasronudin; Hendrianto, Eryk; Karsari, Deya; Dinaryanti, Aristika; Ertanti, Nora; Ihsan, Igo Syaiful; Purnama, Disca Sandyakala; Asmarawati, Tri Pudy; Marfiani, Erika; Yulistiani; Rosyid, Alfian Nur; Wulaningrum, Prastuti Asta; Setiawan, Herley Windo; Siswanto, Imam; Puspaningsih, Ni Nyoman Tri			An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia	PLOS ONE			English	Article							PHARMACOKINETICS; LOPINAVIR/RITONAVIR; DOXYCYCLINE; PREVENTION; DOCKING; HISTORY	A potent therapy for the infectious coronavirus disease COVID-19 is urgently required with, at the time of writing, research in this area still ongoing. This study aims to evaluate the in vitro anti-viral activities of combinations of certain commercially available drugs that have recently formed part of COVID-19 therapy. Dual combinatory drugs, namely; Lopinavir-Ritonavir (LOPIRITO)-Clarithromycin (CLA), LOPIRITO-Azithromycin (AZI), LOPIRITO-Doxycycline (DOXY), Hydroxychloroquine (HCQ)-AZI, HCQ-DOXY, Favipiravir (FAVI)-AZI, HCQ-FAVI, and HCQ-LOPIRITO, were prepared. These drugs were mixed at specific ratios and evaluated for their safe use based on the cytotoxicity concentration (CC50) values of human umbilical cord mesenchymal stem cells. The anti-viral efficacy of these combinations in relation to Vero cells infected with SARS-CoV-2 virus isolated from a patient in Universitas Airlangga hospital, Surabaya, Indonesia and evaluated for IC50 24, 48, and 72 hours after viral inoculation was subsequently determined. Observation of the viral load in qRT-PCR was undertaken, the results of which indicated the absence of high levels of cytotoxicity in any samples and that dual combinatory drugs produced lower cytotoxicity than single drugs. In addition, these combinations demonstrated considerable effectiveness in reducing the copy number of the virus at 48 and 72 hours, while even at 24 hours, post-drug incubation resulted in low IC50 values. Most combination drugs reduced pro-inflammatory markers, i.e. IL-6 and TNF-alpha, while increasing the anti-inflammatory response of IL-10. According to these results, the descending order of effective dual combinatory drugs is one of LOPIRITO-AZI>LOPIRITO-DOXY>HCQ-AZI>HCQ-FAVI>LOPIRITO-CLA>HCQ-DOX. It can be suggested that dual combinatory drugs, e.g. LOPIRITO-AZI, can potentially be used in the treatment of COVID-19 infectious diseases.	[Purwati; Miatmoko, Andang; Hendrianto, Eryk; Karsari, Deya; Dinaryanti, Aristika; Ertanti, Nora; Ihsan, Igo Syaiful; Purnama, Disca Sandyakala] Univ Airlangga, Stem Cell Res & Dev Ctr, Inst Trop Dis, Surabaya, Indonesia; [Purwati] Univ Airlangga, Fac Vocat, Surabaya, Indonesia; [Purwati] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Miatmoko, Andang; Yulistiani] Univ Airlangga, Fac Pharm, Surabaya, Indonesia; [Nasronudin; Asmarawati, Tri Pudy; Marfiani, Erika; Yulistiani; Rosyid, Alfian Nur; Wulaningrum, Prastuti Asta; Setiawan, Herley Windo] Univ Airlangga, Rumah Sakit Umum & Rumah Sakit Khusus Infeksi, Surabaya, Indonesia; [Siswanto, Imam] Univ Airlangga, Bioinformat Lab, UCoE Res Ctr Biomol Engn, Surabaya, Indonesia; [Puspaningsih, Ni Nyoman Tri] Univ Airlangga, Fac Sci & Technol, Dept Chem, Surabaya, Indonesia	Airlangga University; Airlangga University; Asia University Taiwan; Airlangga University; Airlangga University; Airlangga University; Airlangga University	Purwati (corresponding author), Univ Airlangga, Stem Cell Res & Dev Ctr, Inst Trop Dis, Surabaya, Indonesia.; Purwati (corresponding author), Univ Airlangga, Fac Vocat, Surabaya, Indonesia.; Purwati (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	purwati@fk.unair.ac.id	Asmarawati, Tri Pudy/ABE-4015-2020; Setiawan, Herley Windo/GQP-5179-2022; Yulistiani, Yulistiani/GRN-9628-2022; Purwati, Purwati/HCH-5018-2022	Asmarawati, Tri Pudy/0000-0001-9869-5098; , Purwati/0000-0002-6144-2481; nasronudin, nasronudin/0000-0001-7882-9992; effendi, wiwin is/0000-0003-3716-2452; Siswanto, Imam/0000-0001-9811-0977; Miatmoko, Andang/0000-0003-1658-0778; Ihsan, Igo Syaiful/0000-0003-0111-0781	State Intelligence Agency (BIN) of Republic of Indonesia	State Intelligence Agency (BIN) of Republic of Indonesia	This study was funded by State Intelligence Agency (BIN) of Republic of Indonesia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbbVie Deutschland GmbH Co, 2020, W764 EUR MED AG; Agrawal Umang, 2020, Med J Armed Forces India, V76, P370, DOI 10.1016/j.mjafi.2020.08.004; Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; Arabi YM, 2019, INT J INFECT DIS, V81, P184, DOI 10.1016/j.ijid.2019.01.041; Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896; Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392; Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658; Covas DT, 2003, BRAZ J MED BIOL RES, V36, P1179, DOI 10.1590/S0100-879X2003000900006; Damle B, 2020, CLIN PHARMACOL THER, V108, P201, DOI 10.1002/cpt.1857; Dayer M. R., 2020, ARXIV200304524; Dayer MR., 2017, ARCH CLIN INFECT DIS, V12, P13823; Devaux Christian A, 2020, Int J Antimicrob Agents, V55, P105938, DOI 10.1016/j.ijantimicag.2020.105938; Dinos GP, 2017, BRIT J PHARMACOL, V174, P2967, DOI 10.1111/bph.13936; Dong LY, 2020, DRUG DISCOV THER, V14, P58, DOI 10.5582/ddt.2020.01012; Du X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020144; Du YX, 2020, CLIN PHARMACOL THER, V108, P242, DOI 10.1002/cpt.1844; FRASCHINI F, 1993, CLIN PHARMACOKINET, V25, P189, DOI 10.2165/00003088-199325030-00003; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Jin ZM, 2020, NATURE, V582, P289, DOI 10.1038/s41586-020-2223-y; Lim HS, 2009, ANTIMICROB AGENTS CH, V53, P1468, DOI 10.1128/AAC.00339-08; Liu X, 2020, J GENET GENOMICS, V47, P119, DOI 10.1016/j.jgg.2020.02.001; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manusubroto W, 2020, WORLD NEUROSURG, V140, pE360, DOI 10.1016/j.wneu.2020.05.124; Meng XY, 2011, CURR COMPUT-AID DRUG, V7, P146; Mennan C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/916136; Meyerowitz EA, 2020, FASEB J, V34, P6027, DOI 10.1096/fj.202000919; Nelson ML, 2011, ANN NY ACAD SCI, V1241, P17, DOI 10.1111/j.1749-6632.2011.06354.x; Newton PN, 2005, ANTIMICROB AGENTS CH, V49, P1622, DOI 10.1128/AAC.49.4.1622-1625.2005; Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Rothan HA, 2014, ARCH VIROL, V159, P711, DOI 10.1007/s00705-013-1880-7; Sahraei Z, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105945; Sargiacomo C, 2020, AGING-US, V12, P6511, DOI 10.18632/aging.103001; Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5; SINGLAS E, 1995, PATHOL BIOL, V43, P505; Taisho Toyama Pharmaceutical, 2017, L AV FAV TABL PRESCR; Wang Z, 2016, PHYS CHEM CHEM PHYS, V18, P12964, DOI 10.1039/c6cp01555g; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	41	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252302	10.1371/journal.pone.0252302	http://dx.doi.org/10.1371/journal.pone.0252302			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143818	Green Published, Green Accepted, gold			2022-12-26	WOS:000671690700015
J	Schuller, CB; Wagner, B; Schuller, T; Baldermann, JC; Huys, D; Koerner, JKA; Niessen, E; Munchau, A; Brandt, V; Peters, J; Kuhn, J				Schueller, Canan Beate; Wagner, Ben Jonathan; Schueller, Thomas; Baldermann, Juan Carlos; Huys, Daniel; Koerner, Julia Kerner Auch; Niessen, Eva; Muenchau, Alexander; Brandt, Valerie; Peters, Jan; Kuhn, Jens			Temporal discounting in adolescents and adults with Tourette syndrome	PLOS ONE			English	Article							SELF-CONTROL; DOPAMINERGIC MODULATION; INTERTEMPORAL CHOICE; INHIBITORY CONTROL; DECISION-MAKING; DELAY; REWARD; SCALE; TIME; GRATIFICATION	Tourette syndrome is a neurodevelopmental disorder associated with hyperactivity in dopaminergic networks. Dopaminergic hyperactivity in the basal ganglia has previously been linked to increased sensitivity to positive reinforcement and increases in choice impulsivity. In this study, we examine whether this extends to changes in temporal discounting, where impulsivity is operationalized as an increased preference for smaller-but-sooner over larger-but-later rewards. We assessed intertemporal choice in two studies including nineteen adolescents (age: mean[sd] = 14.21[+/- 2.37], 13 male subjects) and twenty-five adult patients (age: mean[sd] = 29.88 [+/- 9.03]; 19 male subjects) with Tourette syndrome and healthy age- and education matched controls. Computational modeling using exponential and hyperbolic discounting models via hierarchical Bayesian parameter estimation revealed reduced temporal discounting in adolescent patients, and no evidence for differences in adult patients. Results are discussed with respect to neural models of temporal discounting, dopaminergic alterations in Tourette syndrome and the developmental trajectory of temporal discounting. Specifically, adolescents might show attenuated discounting due to improved inhibitory functions that also affect choice impulsivity and/or the developmental trajectory of executive control functions. Future studies would benefit from a longitudinal approach to further elucidate the developmental trajectory of these effects.	[Schueller, Canan Beate; Schueller, Thomas; Baldermann, Juan Carlos; Huys, Daniel; Kuhn, Jens] Univ Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, Germany; [Schueller, Canan Beate; Schueller, Thomas; Baldermann, Juan Carlos; Huys, Daniel; Kuhn, Jens] Univ Cologne, Univ Hosp Cologne, Cologne, Germany; [Wagner, Ben Jonathan; Peters, Jan] Univ Cologne, Dept Biol Psychol, Cologne, Germany; [Baldermann, Juan Carlos] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany; [Koerner, Julia Kerner Auch] Helmut Schmidt Univ, Educ Psychol, Hamburg, Germany; [Koerner, Julia Kerner Auch] Ctr Individual Dev & Adapt Educ Children Risk, Frankfurt, Germany; [Niessen, Eva] Univ Cologne, Dept Individual Differences & Psychol Assessment, Cologne, Germany; [Muenchau, Alexander] Univ Lubeck, Inst Syst Motor Sci, Lubeck, Germany; [Brandt, Valerie] Univ Southampton, Ctr Innovat Mental Hlth, Sch Psychol, Southampton, Hants, England; [Kuhn, Jens] Johanniter Hosp Oberhausen, Dept Psychiat Psychotherapy & Psychosomat, EVKLN, Oberhausen, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Helmut Schmidt University; University of Cologne; University of Lubeck; University of Southampton	Schuller, CB (corresponding author), Univ Cologne, Fac Med, Dept Psychiat & Psychotherapy, Cologne, Germany.; Schuller, CB (corresponding author), Univ Cologne, Univ Hosp Cologne, Cologne, Germany.	canan.schueller1@uk-koeln.de	Huys, Daniel/ABC-3297-2021; Peters, Jan/GWC-6713-2022; Huys, Daniel/AAW-6351-2021; Niessen, Eva/H-8529-2017	Peters, Jan/0000-0002-0195-5357; Huys, Daniel/0000-0002-9124-4128; Kerner auch Koerner, Julia/0000-0002-2150-6014; Schuller, Thomas/0000-0003-1232-7871; Niessen, Eva/0000-0002-2801-0986	Walter and Marga Boll Foundation [210-06-16]; Deutsche Forschungsgemeinschaft (DFG) [431549029 - SFB 1451, PE 1627/5-1]; DFG [FOR 2698]; Academy of Medical Sciences	Walter and Marga Boll Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Academy of Medical Sciences(Academy of Medical Sciences (AMS))	C.B.S. and T.S. were funded by the Walter and Marga Boll Foundation (210-06-16, URL: https://www.bollstiftung.de/).T.S.and J.C.B. were supported by Deutsche Forschungsgemeinschaft (DFG: 431549029 - SFB 1451; URL: https://www.dfg.de/).J.P.was supported by Deutsche Forschungsgemeinschaft (DFG: PE 1627/5-1; URL: https://www.dfg.de/).A.M.was supported by the DFG (FOR 2698; URL: https://www.dfg.de/).V.B.was supported by the Academy of Medical Sciences (URL: https://acmedsci.ac.uk/).C.B.S., T.S., A.M., V.B, J.K., and J.P. conceived the idea. C.B.S., T.S., E.N., A.M., V. B., J.K.K., and J.P. conceived and designed the experiments; C.B.S., E.N., and V.B. performed the experiments; C.B.S., B.W., and J.P. analyzed the data; J.P. and B.W contributed analysis tools; B.W. performed the modelling. C.B.S. and B.W. wrote the paper. All authors reviewed and approved the final manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Amlung M, 2019, JAMA PSYCHIAT, V76, P1176, DOI 10.1001/jamapsychiatry.2019.2102; Anandakumar J, 2018, DEV COGN NEUROS-NETH, V34, P101, DOI 10.1016/j.dcn.2018.07.003; Arrondo G, 2015, EUR NEUROPSYCHOPHARM, V25, P817, DOI 10.1016/j.euroneuro.2015.02.011; Baldwin SA, 2013, PSYCHOL METHODS, V18, P151, DOI 10.1037/a0030642; Ballard IC, 2017, PSYCHOL SCI, V28, P1443, DOI 10.1177/0956797617711455; Beard E, 2016, ADDICTION, V111, P2230, DOI 10.1111/add.13501; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bickel WK, 2012, PHARMACOL THERAPEUT, V134, P287, DOI 10.1016/j.pharmthera.2012.02.004; Bloch MH, 2009, J PSYCHOSOM RES, V67, P497, DOI 10.1016/j.jpsychores.2009.09.002; Buse J, 2013, NEUROSCI BIOBEHAV R, V37, P1069, DOI 10.1016/j.neubiorev.2012.10.004; Canario N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210880; Caswell AJ, 2013, EXP PSYCHOL, V60, P324, DOI 10.1027/1618-3169/a000202; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Cohen J.R., 2013, PRINCIPLES FRONTAL L, P417, DOI DOI 10.1093/MED/9780199837755.003.0030; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; D'Amour-Horvat V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00432; Dalley JW, 2017, NAT REV NEUROSCI, V18, P158, DOI 10.1038/nrn.2017.8; Denys D, 2013, EUR NEUROPSYCHOPHARM, V23, P1423, DOI 10.1016/j.euroneuro.2013.05.012; Dopfner M., 2008, DISYPS 2 DIAGNOSTIK; Dreher JC, 2008, P NATL ACAD SCI USA, V105, P15106, DOI [10.1073/pnas.0802127105, 10.1073/pnas.0805517106]; Dwyer JB, 2018, BIOL PSYCHIAT, V84, pE33, DOI 10.1016/j.biopsych.2018.07.008; Ersner-Hershfield H, 2009, SOC COGN AFFECT NEUR, V4, P85, DOI 10.1093/scan/nsn042; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Findley TS, 2015, ECON LETT, V129, P4, DOI 10.1016/j.econlet.2015.01.027; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Freund N, 2019, PSYCHOPHARMACOLOGY, V236, P685, DOI 10.1007/s00213-018-5096-0; Gawrilow C, 2011, COGNITIVE THER RES, V35, P442, DOI 10.1007/s10608-010-9309-z; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Green L, 1999, J EXP PSYCHOL LEARN, V25, P418, DOI 10.1037/0278-7393.25.2.418; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hare TA, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00050; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Horn W., 1983, L P S LEISTUNGSPR FS, V2; Jackson GM, 2015, TRENDS COGN SCI, V19, P655, DOI 10.1016/j.tics.2015.08.006; Jan&beta;en H., 2011, Vergleichende Untersuchung der Zukunftsorientierung des Wahlverhaltens von Kindern mit und ohne Aufmerksamkeitsdefizit-/Hyperaktivitatsstorung in einem Belohnugsaufschub-Paradigma mit realen Temporal Discounting Design; Jimura K, 2009, PSYCHON B REV, V16, P1071, DOI 10.3758/PBR.16.6.1071; Johnson MW, 2012, EXP CLIN PSYCHOPHARM, V20, P191, DOI 10.1037/a0027088; Kayser AS, 2012, J NEUROSCI, V32, P9402, DOI 10.1523/JNEUROSCI.1180-12.2012; Keri S, 2002, NEUROPSYCHOLOGIA, V40, P1356, DOI 10.1016/S0028-3932(01)00210-X; Kim B, 2019, ANN NY ACAD SCI, V1451, P92, DOI 10.1111/nyas.13961; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Kuhn J, 2019, JAMA NEUROL, V76, P1124, DOI 10.1001/jamaneurol.2019.2027; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; Lempert KM, 2019, PSYCHOL MED, V49, P190, DOI 10.1017/S0033291718001770; Lewin AB, 2010, CHILD YOUTH CARE FOR, V39, P73, DOI 10.1007/s10566-009-9092-8; Maia TV, 2018, BIOL PSYCHIAT, V84, P332, DOI 10.1016/j.biopsych.2018.02.1172; Maia TV, 2017, BIOL PSYCHIAT, V82, P401, DOI 10.1016/j.biopsych.2017.05.025; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McKerchar TL, 2009, BEHAV PROCESS, V81, P256, DOI 10.1016/j.beproc.2008.12.017; MISCHEL W, 1970, J PERS SOC PSYCHOL, V16, P329, DOI 10.1037/h0029815; MISCHEL W, 1988, J PERS SOC PSYCHOL, V54, P687, DOI 10.1037/0022-3514.54.4.687; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; Morand-Beaulieu S, 2017, NEUROSCI BIOBEHAV R, V80, P240, DOI 10.1016/j.neubiorev.2017.05.006; Muraven M, 2010, J EXP SOC PSYCHOL, V46, P465, DOI 10.1016/j.jesp.2009.12.011; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Palminteri S, 2013, INT REV NEUROBIOL, V112, P131, DOI 10.1016/B978-0-12-411546-0.00005-6; Patt V., 2020, TEMPORAL DISCOUNTING, DOI [10.31234/osf.io/5ajuk, DOI 10.31234/OSF.IO/5AJUK]; Peisker CB, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8020021; Peters J, 2011, TRENDS COGN SCI, V15, P227, DOI 10.1016/j.tics.2011.03.002; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petzold J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42124-x; Pine A, 2010, J NEUROSCI, V30, P8888, DOI 10.1523/JNEUROSCI.6028-09.2010; Plummer M., 2003, P 3 INT WORKSH DISTR; Puts NAJ, 2015, J NEUROPHYSIOL, V114, P808, DOI 10.1152/jn.00060.2015; Robertson MM, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.97; Robertson MM, 2012, ARCH DIS CHILDHOOD-E, V97, P166, DOI 10.1136/archdischild-2011-300585; Singer HS, 2002, AM J PSYCHIAT, V159, P1329, DOI 10.1176/appi.ajp.159.8.1329; Singer HS, 2013, TOURETTE SYNDROME, P276, DOI DOI 10.1093/MED/9780199796267.003.0013; Smith CT, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0328-y; Smits RR, 2013, EXP CLIN PSYCHOPHARM, V21, P155, DOI 10.1037/a0031725; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steele CC., 2019, DELAY DISCOUNTING TA, V9, P379, DOI [10.3390/brainsci9120379, DOI 10.3390/BRAINSCI9120379]; Tabibnia G, 2011, J NEUROSCI, V31, P4805, DOI 10.1523/JNEUROSCI.2859-10.2011; van den Bos W, 2015, P NATL ACAD SCI USA, V112, pE3765, DOI 10.1073/pnas.1423095112; Vicario CM, 2020, MOVEMENT DISORD, V35, P1279, DOI 10.1002/mds.28096; Vincent BT, 2016, BEHAV RES METHODS, V48, P1608, DOI 10.3758/s13428-015-0672-2; Voon V., 2016, DECISION NEUROSCIENC, DOI [10.1016/B978-0-12-805308-9.00024%26%23x2013%3B5, DOI 10.1016/B978-0-12-805308-9.00024%26%23X2013%3B5]; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Wagner B, 2020, J NEUROSCI, V40, P7936, DOI [10.1523/JNEUROSCI.0592-20.2020, 10.1523/JNEUROSCI.0592]; Wang ZS, 2011, AM J PSYCHIAT, V168, P1326, DOI 10.1176/appi.ajp.2011.09111692; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Woods DW, 2005, J DEV BEHAV PEDIATR, V26, P397, DOI 10.1097/00004703-200512000-00001; Worbe Y, 2009, CEREB CORTEX, V19, P1844, DOI 10.1093/cercor/bhn214; Yaniv A, 2018, PSYCHIAT RES, V262, P527, DOI 10.1016/j.psychres.2017.09.038	89	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253620	10.1371/journal.pone.0253620	http://dx.doi.org/10.1371/journal.pone.0253620			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143854	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000671690700032
J	Tomaszewski, R; Dajka, J				Tomaszewski, Ryszard; Dajka, Jerzy			Statistical image analysis and escort histograms in characterization of articular cartilage repair in a skeleton animal model	PLOS ONE			English	Article								Statistical image analysis of an ensemble of digital images of histological samples is performed as an auxiliary investigation a result of the recently proposed method of articular cartilage repair utilizing growth plate chondrocytes in a skeleton animal model. A fixed-shift model of maximal likelihood estimates of image histograms applied for monochromatic (grayscale) images or their RGB components confirms the statistically significant effect of the previously proposed medical treatment. The type of staining used to prepare images of histological samples is related to the visibility of the effectiveness of medical treatment. Hellinger distance of escort distributions for maximal likelihood estimates of image histograms of medically treated and control samples is investigated to identify grayscale (or RGB) intensities responsible for statistically significant difference of the estimates. A difference of Shannon entropy quantifying informational content of the histograms allows one to identify staining and image colors which are most suitable to visualize cluster formation typical for articular cartilage repair processes.	[Tomaszewski, Ryszard] Upper Silesian Child Ctr Katowice, Dept Pediat Traumatol & Orthopedy, Katowice, Poland; [Tomaszewski, Ryszard] Univ Silesia Katowice, Fac Sci & Technol, Inst Biomed Engn, Katowice, Poland; [Dajka, Jerzy] Univ Silesia Katowice, Fac Sci & Technol, Inst Phys, Katowice, Poland; [Dajka, Jerzy] Univ Silesia Katowice, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Dajka, J (corresponding author), Univ Silesia Katowice, Fac Sci & Technol, Inst Phys, Katowice, Poland.; Dajka, J (corresponding author), Univ Silesia Katowice, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland.	jerzy.dajka@us.edu.pl		Dajka, Jerzy/0000-0003-4912-4859; Tomaszewski, Ryszard/0000-0002-1628-0866				Abe S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.031101; Aljanabi MA, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/9801308; Beck C, 2004, PHYSICA A, V342, P139, DOI 10.1016/j.physa.2004.04.070; Beck C., 1993, THERMODYNAMICS CHAOT; Burguet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087759; Demidenko E, 2006, ONCOL REP, V15, P1077, DOI 10.3892/or.15.4.1077; Demidenko E, 2004, LECT NOTES COMPUT SC, V3046, P933; Demidenko E, 2020, ADV STAT APPL R; Dunn JF, 2002, J MAGN RESON IMAGING, V16, P511, DOI 10.1002/jmri.10192; Gray RM, 2011, ENTROPY AND INFORMATION THEORY , SECOND EDITION, P395, DOI 10.1007/978-1-4419-7970-4; Hall AC, 2019, CURR RHEUMATOL REP, V21, DOI 10.1007/s11926-019-0837-6; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Harper M, 2011, PHYSICA D, V240, P1411, DOI 10.1016/j.physd.2011.04.008; Hellinger E, 1909, J REINE ANGEW MATH, V136, P210, DOI 10.1515/crll.1909.136.210; Hoshiyama Y, 2015, J ORTHOP RES, V33, P548, DOI 10.1002/jor.22782; Karim A, 2018, J ANAT, V232, P686, DOI 10.1111/joa.12768; Lotz MK, 2010, ARTHRITIS RHEUM-US, V62, P2206, DOI 10.1002/art.27528; Matsuzoe H, 2017, ENTROPY-SWITZ, V19, DOI 10.3390/e19010007; Morgan CJ, 2017, AM J PHYSIOL-LUNG C, V313, pL873, DOI 10.1152/ajplung.00238.2017; Naudts J, 2011, GENERALISED THERMOSTATISTICS, P1, DOI 10.1007/978-0-85729-355-8; Neemuchwala H, 2005, SIGNAL PROCESS, V85, P277, DOI 10.1016/j.sigpro.2004.10.002; Silva R, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026102; Tanaka Masaru, 2010, Journal of Physics: Conference Series, V201, DOI 10.1088/1742-6596/201/1/012007; Tomaszewski R, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1302-y; Wilcox R., 2022, INTRO ROBUST ESTIMAT	26	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252505	10.1371/journal.pone.0252505	http://dx.doi.org/10.1371/journal.pone.0252505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143793	gold, Green Published			2022-12-26	WOS:000671690700063
J	Fukui, K; Kimura, S; Kato, Y; Kohno, M				Fukui, Koji; Kimura, Shunsuke; Kato, Yugo; Kohno, Masahiro			Effects of far infrared light on Alzheimer's disease-transgenic mice	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OXIDATIVE STRESS; THERAPY; BDNF; PREVENTION; IMPAIRMENT; MODELS; BRAIN	Far infrared light has been used in many medical procedures. However, the detailed biological mechanisms of infrared light's effects have not yet been elucidated. Many researchers have pointed out the thermal effects of treatments such as infrared saunas, which are known to increase blood flow. Alzheimer's disease (AD) is associated with gradual decreases in brain blood flow and resulting dementia. In this study, we attempted to clarify the beneficial effects of far infrared light using the 5xFAD mouse, a transgenic model of AD. We exposed 5xFAD mice to far infrared light for 5 months. Among the far infrared-exposed AD mice, body weights were significantly decreased, and the levels of nerve growth factor and brain-derived neurotrophic factor protein were significantly increased in selected brain areas (compared to those in non-irradiated AD mice). However, cognition and motor function (as assessed by Morris water maze and Rota Rod tests, respectively) did not differ significantly between the irradiated and non-irradiated AD mouse groups. These results indicated that exposure to far infrared light may have beneficial biological effects in AD mice. However, the experimental schedule and methods may need to be modified to obtain clearer results.	[Fukui, Koji; Kimura, Shunsuke] Shibaura Inst Technol Sit, Coll Syst Engn & Sci, Dept Biosci & Engn, Mol Cell Biol Lab, Minato, Japan; [Fukui, Koji; Kato, Yugo] SIT, Dept Funct Control Syst, Mol Cell Biol Lab, Grad Sch Engn & Sci, Minato, Japan; [Fukui, Koji; Kohno, Masahiro] Tokyo Inst Technol, Dept Life Sci & Technol, Meguro, Japan; [Kohno, Masahiro] SIT, Brain Sci & Life Technol Res Ctr, SIT Res Labs, Minato, Japan; [Fukui, Koji] SIT, Dept Biosci & Engn, Mol Cell Biol Lab, Coll Syst Engn & Sci, Minato, Japan	Tokyo Institute of Technology	Fukui, K (corresponding author), Shibaura Inst Technol Sit, Coll Syst Engn & Sci, Dept Biosci & Engn, Mol Cell Biol Lab, Minato, Japan.; Fukui, K (corresponding author), SIT, Dept Funct Control Syst, Mol Cell Biol Lab, Grad Sch Engn & Sci, Minato, Japan.; Fukui, K (corresponding author), Tokyo Inst Technol, Dept Life Sci & Technol, Meguro, Japan.; Fukui, K (corresponding author), SIT, Dept Biosci & Engn, Mol Cell Biol Lab, Coll Syst Engn & Sci, Minato, Japan.	koji@sic.shibaura-it.ac.jp		Kato, Yugo/0000-0002-8357-0986; Fukui, Koji/0000-0003-2748-3228				Bondi MW, 2017, J INT NEUROPSYCH SOC, V23, P818, DOI 10.1017/S135561771700100X; Budni J, 2015, AGING DIS, V6, P331, DOI 10.14336/AD.2015.0825; Canu N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061319; Chang Y, 2018, SAGE OPEN MED, V6, DOI 10.1177/2050312118798941; Chen AI, 2016, SCI REP-UK, V6, DOI 10.1038/srep20201; Fukui K, 2014, FREE RADICAL RES, V48, P649, DOI 10.3109/10715762.2014.898295; Fukui K, 2002, ANN NY ACAD SCI, V959, P275, DOI 10.1111/j.1749-6632.2002.tb02099.x; Fukui K, 2001, ANN NY ACAD SCI, V928, P168; Grillo SL, 2013, J PHOTOCH PHOTOBIO B, V123, P13, DOI 10.1016/j.jphotobiol.2013.02.015; Harward SC, 2016, NATURE, V538, P99, DOI 10.1038/nature19766; Hernandez JCC, 2019, NAT NEUROSCI, V22, P413, DOI 10.1038/s41593-018-0329-4; Khalsaa DS, 2015, J ALZHEIMERS DIS, V48, P1, DOI 10.3233/JAD-142766; Lee MS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2933248; Marler KJ, 2014, J NEUROSCI, V34, P969, DOI 10.1523/JNEUROSCI.1910-13.2014; Masuda A, 2004, JPN HEART J, V45, P297, DOI 10.1536/jhj.45.297; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nielsen RB, 2020, ALZH DEMENT-DADM, V12, DOI 10.1002/dad2.12032; Purushothurnan S, 2015, NEUROSCI LETT, V591, P155, DOI 10.1016/j.neulet.2015.02.037; Schliebs R, 2011, BEHAV BRAIN RES, V221, P555, DOI 10.1016/j.bbr.2010.11.058; Shabir O, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0465-5; Sharma N, 2019, CURR NEUROPHARMACOL, V17, P990, DOI 10.2174/1570159X17666190228114318; Shaw VE, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/296875; Stakos DA, 2020, J AM COLL CARDIOL, V75, P952, DOI 10.1016/j.jacc.2019.12.033; Sumiyoshi E, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112800; Tarumi T, 2018, J NEUROCHEM, V144, P595, DOI 10.1111/jnc.14234; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; van der Kleij LA, 2018, NEUROIMAGE-CLIN, V20, P650, DOI 10.1016/j.nicl.2018.09.003; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Washington K., 2018, J TEXT SCI ENG, V8, P349, DOI [10.4172/2165-8064.1000349, DOI 10.4172/2165-8064.1000349]; Willette AA, 2015, AGEING RES REV, V20, P86, DOI 10.1016/j.arr.2014.03.007; Zhang N, 2017, NEUROSCI BIOBEHAV R, V72, P168, DOI 10.1016/j.neubiorev.2016.11.023	31	2	2	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253320	10.1371/journal.pone.0253320	http://dx.doi.org/10.1371/journal.pone.0253320			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138944	gold, Green Published			2022-12-26	WOS:000671690200038
J	Bushey, RT; Gottlin, EB; Campa, MJ; Patz, EF				Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Patz, Edward F., Jr.			Complement factor H protects tumor cell-derived exosomes from complement-dependent lysis and phagocytosis	PLOS ONE			English	Article							MEDIATED LYSIS; CANCER; ANTIBODY; EXPRESSION; MECHANISM; PROTEINS; THERAPY; BIOLOGY	Exosomes are a class of extracellular vesicles (EVs) that are mediators of normal intercellular communication, but exosomes are also used by tumor cells to promote oncogenesis and metastasis. Complement factor H (CFH) protects host cells from attack and destruction by the alternative pathway of complement-dependent cytotoxicity (CDC). Here we show that CFH can protect exosomes from complement-mediated lysis and phagocytosis. CFH was found to be associated with EVs from a variety of tumor cell lines as well as EVs isolated from the plasma of patients with metastatic non-small cell lung cancer. Higher levels of CFH-containing EVs correlated with higher metastatic potential of cell lines. GT103, a previously described antibody to CFH that preferentially causes CDC of tumor cells, was used to probe the susceptibility of tumor cell-derived exosomes to destruction. Exosomes were purified from EVs using CD63 beads. Incubation of GT103 with tumor cell-derived exosomes triggered exosome lysis primarily by the classical complement pathway as well as antibody-dependent exosome phagocytosis by macrophages. These results imply that GT103-mediated exosome destruction can be triggered by antibody Fc-C1q interaction (in the case of lysis), and antibody-Fc receptor interactions (in the case of phagocytosis). Thus, this work demonstrates CFH is expressed on tumor cell derived exosomes, can protect them from complement lysis and phagocytosis, and that an anti-CFH antibody can be used to target tumor-derived exosomes for exosome destruction via innate immune mechanisms. These findings suggest that a therapeutic CFH antibody has the potential to inhibit tumor progression and reduce metastasis promoted by exosomes.	[Bushey, Ryan T.; Gottlin, Elizabeth B.; Campa, Michael J.; Patz, Edward F., Jr.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Patz, Edward F., Jr.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Patz, Edward F., Jr.] Duke Univ, Duke Canc Inst, Med Ctr, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Patz, EF (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.; Patz, EF (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Patz, EF (corresponding author), Duke Univ, Duke Canc Inst, Med Ctr, Durham, NC 27708 USA.	patz0002@mc.duke.edu		Gottlin, Elizabeth/0000-0003-0886-0024; Patz, Edward/0000-0003-3374-1596				Ajona D, 2007, J IMMUNOL, V178, P5991, DOI 10.4049/jimmunol.178.9.5991; Amornsiripanitch N, 2010, CLIN CANCER RES, V16, P3226, DOI 10.1158/1078-0432.CCR-10-0321; Bakema JE, 2014, CURR TOP MICROBIOL, V382, P373, DOI 10.1007/978-3-319-07911-0_17; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bushey RT, 2016, CELL REP, V15, P1505, DOI 10.1016/j.celrep.2016.04.038; Campa MJ, 2015, CANCER IMMUNOL RES, V3, P1325, DOI 10.1158/2326-6066.CIR-15-0122; Cerny T, 2002, ANTI-CANCER DRUG, V13, pS3, DOI 10.1097/00001813-200211002-00002; Chen G, 2018, NATURE, V560, P382, DOI 10.1038/s41586-018-0392-8; Choi DS, 2013, PROTEOMICS, V13, P1554, DOI 10.1002/pmic.201200329; Clayton A, 2003, EUR J IMMUNOL, V33, P522, DOI 10.1002/immu.200310028; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cui TT, 2011, INT J ONCOL, V39, P161, DOI 10.3892/ijo.2011.1010; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; FIDLER IJ, 1975, CANCER RES, V35, P218; Fishelson Z, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00752; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu YF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-139; Kamen L, 2019, J IMMUNOL METHODS, V468, P55, DOI 10.1016/j.jim.2019.03.001; Kinoshita T, 2018, SEMIN HEMATOL, V55, P136, DOI 10.1053/j.seminhematol.2018.04.004; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Liu SL, 2019, BIOMED PHARMACOTHER, V111, P338, DOI 10.1016/j.biopha.2018.12.088; Mao XW, 2020, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12031; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; Nicely NI, 2010, NAT STRUCT MOL BIOL, V17, P1492, DOI 10.1038/nsmb.1944; Parente R, 2017, CELL MOL LIFE SCI, V74, P1605, DOI 10.1007/s00018-016-2418-4; Pavlakis E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249648; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Poggio M, 2019, CELL, V177, P414, DOI 10.1016/j.cell.2019.02.016; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Raab-Westphal S, 2017, CANCERS, V9, DOI 10.3390/cancers9090110; Ruivo CF, 2017, CANCER RES, V77, P6480, DOI 10.1158/0008-5472.CAN-17-0994; Varsano S, 1998, CLIN EXP IMMUNOL, V113, P173; Vykoukal J, 2017, ONCOTARGET, V8, P95466, DOI 10.18632/oncotarget.20748; Wortzel I, 2019, DEV CELL, V49, P347, DOI 10.1016/j.devcel.2019.04.011; Wu MW, 2020, LIFE SCI, V255, DOI 10.1016/j.lfs.2020.117857; Zhou L, 2017, CANCER LETT, V407, P84, DOI 10.1016/j.canlet.2017.08.003	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252577	10.1371/journal.pone.0252577	http://dx.doi.org/10.1371/journal.pone.0252577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133431	gold, Green Published			2022-12-26	WOS:000671682700020
J	Bordoni, L; Petracci, I; Pelikant-Malecka, I; Radulska, A; Piangerelli, M; Samulak, JJ; Lewicki, L; Kalinowski, L; Gabbianelli, R; Olek, RA				Bordoni, Laura; Petracci, Irene; Pelikant-Malecka, Iwona; Radulska, Adriana; Piangerelli, Marco; Samulak, Joanna J.; Lewicki, Lukasz; Kalinowski, Leszek; Gabbianelli, Rosita; Olek, Robert A.			Mitochondrial DNA copy number and trimethylamine levels in the blood: New insights on cardiovascular disease biomarkers	FASEB JOURNAL			English	Article						biomarkers; cardiovascular disease; hypertension; mitochondrial DNA; sex; TMAO	PERIPHERAL-BLOOD; OXIDATIVE STRESS; L-CARNITINE; RISK; ATHEROSCLEROSIS; DYSFUNCTION; METABOLISM; HEALTH; DAMAGE; CELLS	Among cardiovascular disease (CVD) biomarkers, the mitochondrial DNA copy number (mtDNAcn) is a promising candidate. A growing attention has been also dedicated to trimethylamine-N-oxide (TMAO), an oxidative derivative of the gut metabolite trimethylamine (TMA). With the aim to identify biomarkers predictive of CVD, we investigated TMA, TMAO, and mtDNAcn in a population of 389 coronary artery disease (CAD) patients and 151 healthy controls, in association with established risk factors for CVD (sex, age, hypertension, smoking, diabetes, glomerular filtration rate [GFR]) and troponin, an established marker of CAD. MtDNAcn was significantly lower in CAD patients; it correlates with GFR and TMA, but not with TMAO. A biomarker including mtDNAcn, sex, and hypertension (but neither TMA nor TMAO) emerged as a good predictor of CAD. Our findings support the mtDNAcn as a promising plastic biomarker, useful to monitor the exposure to risk factors and the efficacy of preventive interventions for a personalized CAD risk reduction.	[Bordoni, Laura; Gabbianelli, Rosita] Univ Camerino, Sch Pharm, Unit Mol Biol & Nutrigen, Camerino, Italy; [Petracci, Irene] Univ Camerino, Sch Adv Studies, Camerino, Italy; [Pelikant-Malecka, Iwona; Radulska, Adriana; Kalinowski, Leszek] Med Univ Gdansk, Div Med Lab Diagnost, Gdansk, Poland; [Pelikant-Malecka, Iwona; Radulska, Adriana; Kalinowski, Leszek] Tiobanking & Biomol Resources Res Infrastruct Pol, Gdansk, Poland; [Piangerelli, Marco] Univ Camerino, Sch Sci & Technol, Comp Sci Div, Camerino, Italy; [Piangerelli, Marco] Univ Camerino, Sch Sci & Technol, Math Div, Camerino, Italy; [Samulak, Joanna J.] Gdansk Univ Phys Educ & Sport, Doctoral Sch, Gdansk, Poland; [Lewicki, Lukasz] Pomeranian Hosp, Kashubian Ctr Heart & Vasc Dis, Dept Cardiol & Angiol, Wejherowo, Poland; [Kalinowski, Leszek] Gdansk Univ Technol, Dept Mech Mat & Struct, Gdansk, Poland; [Olek, Robert A.] Poznan Univ Phys Educ, Dept Athlet Strength & Conditioning, Poznan, Poland	University of Camerino; University of Camerino; Fahrenheit Universities; Medical University Gdansk; University of Camerino; University of Camerino; Gdansk University of Physical Education & Sport; Fahrenheit Universities; Gdansk University of Technology	Bordoni, L (corresponding author), Univ Camerino, Unit Mol Biol, Sch Pharm, I-62032 Camerino, Italy.	laura.bordoni@unicam.it	Olek, Robert/CAI-7765-2022; Olek, Robert A/H-7206-2019; Bordoni, Laura/T-7092-2017; Piangerelli, Marco/H-2658-2018; Kalinowski, Leszek/N-3076-2019	Olek, Robert A/0000-0002-3714-7386; Bordoni, Laura/0000-0001-6968-1164; Petracci, Irene/0000-0003-2433-7516; Gabbianelli, Rosita/0000-0003-0037-7740; , IWONA/0000-0002-4780-8256; Piangerelli, Marco/0000-0002-8545-3740; Kalinowski, Leszek/0000-0001-7270-1592	Ministry of Science and Higher Education, Poland [FPA000033];  [DIR/WK/2017/01]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); 	Funding for reagents were provided by Prof. Rosita Gabbianelli (FPA000033), and Ministry of Science and Higher Education, Poland, grant no. DIR/WK/2017/01	Bai Y, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00482-x; Bito R, 2005, AM J PHYSIOL-CELL PH, V289, pC531, DOI 10.1152/ajpcell.00431.2004; Bordoni L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75633-1; Bordoni L, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080764; Bordoni L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031047; Calderon Jose L Martin, 2015, Pract Lab Med, V1, P42, DOI 10.1016/j.plabm.2015.03.006; Carugno M, 2012, ENVIRON HEALTH PERSP, V120, P210, DOI 10.1289/ehp.1103979; Castellani CA, 2020, MITOCHONDRION, V53, P214, DOI 10.1016/j.mito.2020.06.004; Cayci T, 2012, J ASSIST REPROD GEN, V29, P855, DOI 10.1007/s10815-012-9803-1; Che RC, 2014, AM J PHYSIOL-RENAL, V306, pF367, DOI 10.1152/ajprenal.00571.2013; Chen ML, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006347; Cioffi F, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040323; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins HL, 2016, ATHEROSCLEROSIS, V244, P29, DOI 10.1016/j.atherosclerosis.2015.10.108; Dache ZA, 2020, FASEB J, V34, P3616, DOI 10.1096/fj.201901917RR; Dikalov SI, 2013, AM J PHYSIOL-HEART C, V305, pH1417, DOI 10.1152/ajpheart.00089.2013; Eirin A, 2017, AM J HYPERTENS, V30, P1112, DOI 10.1093/ajh/hpx103; Eirin A, 2016, HYPERTENSION, V68, P401, DOI 10.1161/HYPERTENSIONAHA.116.07849; ERA S, 1995, BBA-PROTEIN STRUCT M, V1247, P12, DOI 10.1016/0167-4838(94)00166-E; Fazzini F, 2021, J INTERN MED, V290, P190, DOI 10.1111/joim.13242; Fazzini F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33684-5; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Fuchs FD, 2020, HYPERTENSION, V75, P285, DOI 10.1161/HYPERTENSIONAHA.119.14240; Garg P, 2017, INTERN EMERG MED, V12, P147, DOI 10.1007/s11739-017-1612-1; Guo YD, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010596; Haghikia A, 2018, ARTERIOSCL THROM VAS, V38, P2225, DOI 10.1161/ATVBAHA.118.311023; Hang D, 2018, EUR J EPIDEMIOL, V33, P485, DOI 10.1007/s10654-018-0382-z; Hernandez-Rios R, 2013, EXP CLIN ENDOCR DIAB, V121, P535, DOI 10.1055/s-0033-1349144; Hoff J, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0566-5; Hou LF, 2013, PART FIBRE TOXICOL, V10, DOI [10.1186/1743-8977-10-17, 10.1186/1743-8977-10-47]; Hou LF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-48; Huang CH, 2011, J ATHEROSCLER THROMB, V18, P867, DOI 10.5551/jat.8698; Jaworska K, 2019, CARDIOVASC RES, V115, P1948, DOI 10.1093/cvr/cvz231; Jaworska K, 2019, TOXINS, V11, DOI 10.3390/toxins11090490; Kanitsoraphan Chanavuth, 2018, Curr Nutr Rep, V7, P207, DOI 10.1007/s13668-018-0252-z; Khan SS, 2018, JAMA CARDIOL, V3, P280, DOI 10.1001/jamacardio.2018.0022; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Koller A, 2020, J INTERN MED, V287, P569, DOI 10.1111/joim.13027; Landfald Bjarne, 2017, Microbial Ecology in Health and Disease, V28, P1327309, DOI 10.1080/16512235.2017.1327309; Lee HC, 2000, J BIOMED SCI, V7, P2, DOI 10.1007/BF02255913; Lei L, 2017, J HUM HYPERTENS, V31, P585, DOI 10.1038/jhh.2017.30; Leon BM, 2015, WORLD J DIABETES, V6, P1246, DOI 10.4239/wjd.v6.i13.1246; Lin Chen-Sung, 2008, Interact Cardiovasc Thorac Surg, V7, P954, DOI 10.1510/icvts.2008.177006; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; Makrecka-Kuka M, 2017, TOXICOL LETT, V267, P32, DOI 10.1016/j.toxlet.2016.12.017; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; Mancini A, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03566-7; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Mengel-From J, 2014, HUM GENET, V133, P1149, DOI 10.1007/s00439-014-1458-9; Mercer JR, 2010, CIRC RES, V107, P1021, DOI 10.1161/CIRCRESAHA.110.218966; Messner B, 2014, ARTERIOSCL THROM VAS, V34, P509, DOI 10.1161/ATVBAHA.113.300156; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Olek RA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6247169; Picard M, 2013, DIABETES, V62, P672, DOI 10.2337/db12-1203; Prestes PR, 2017, J HUM HYPERTENS, V31, P761, DOI 10.1038/jhh.2017.73; Qiu CF, 2013, CLIN LAB, V59, P655, DOI 10.7754/Clin.Lab.2012.120227; Rahmani-Kukia N, 2020, BIOORG CHEM, V105, DOI 10.1016/j.bioorg.2020.104429; Restini CBA, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105273; Revesz D, 2018, J CLIN ENDOCR METAB, V103, P148, DOI 10.1210/jc.2017-01625; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Samulak JJ, 2019, ANN NUTR METAB, V74, P11, DOI 10.1159/000495037; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider J, 2018, CHEM RES TOXICOL, V31, P447, DOI 10.1021/acs.chemrestox.7b00329; Seldin MM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002767; Senthong V, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002816; Silva FSG, 2016, CURR PHARM DESIGN, V22, P5698, DOI 10.2174/1381612822666160822150243; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Tin A, 2016, J AM SOC NEPHROL, V27, P2467, DOI 10.1681/ASN.2015060661; Torres, 2018, INT J MOL BIOL OPEN, V3, P117; Vallance HD, 2018, MOL GENET METAB REP, V15, P130, DOI 10.1016/j.ymgmr.2018.04.005; Velasquez MT, 2016, TOXINS, V8, DOI 10.3390/toxins8110326; Wang J, 2017, J GERIATR CARDIOL, V14, P135, DOI 10.11909/j.issn.1671-5411.2017.02.008; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Wei RP, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018776; Whitaker RM, 2015, KIDNEY INT, V88, P1336, DOI 10.1038/ki.2015.240; Wong J, 2009, DIABETOLOGIA, V52, P1953, DOI 10.1007/s00125-009-1424-6; Xu FX, 2012, DIABETIC MED, V29, pE47, DOI 10.1111/j.1464-5491.2011.03565.x; Yin J, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002699; Yu E, 2013, CIRCULATION, V128, P702, DOI 10.1161/CIRCULATIONAHA.113.002271; Yue P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206003; Zhan M, 2013, KIDNEY INT, V83, P568, DOI 10.1038/ki.2012.441; Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011	85	10	11	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21694	10.1096/fj.202100056R	http://dx.doi.org/10.1096/fj.202100056R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165220	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000667814100070
J	Ehlers, L; Kuppe, A; Damerau, A; Wilantri, S; Kirchner, M; Mertins, P; Strehl, C; Buttgereit, F; Gaber, T				Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Kirchner, Marieluise; Mertins, Philipp; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo			Surface AMP deaminase 2 as a novel regulator modifying extracellular adenine nucleotide metabolism	FASEB JOURNAL			English	Article						adenosine; inflammation; nucleotidases; purines; rheumatoid arthritis; RRIDs	NUCLEOSIDE TRANSPORTER FAMILY; A(3) ADENOSINE RECEPTOR; T-CELLS; ATP RELEASE; AMPHITROPIC PROTEINS; ADENYLATE DEAMINASE; IL-1-BETA RELEASE; RAT-BRAIN; INOSINE; CD73	Adenine nucleotides represent crucial immunomodulators in the extracellular environment. The ectonucleotidases CD39 and CD73 are responsible for the sequential catabolism of ATP to adenosine via AMP, thus promoting an anti-inflammatory milieu induced by the "adenosine halo". AMPD2 intracellularly mediates AMP deamination to IMP, thereby both enhancing the degradation of inflammatory ATP and reducing the formation of anti-inflammatory adenosine. Here, we show that this enzyme is expressed on the surface of human immune cells and its predominance may modify inflammatory states by altering the extracellular milieu. Surface AMPD2 (eAMPD2) expression on monocytes was verified by immunoblot, surface biotinylation, mass spectrometry, and immunofluorescence microscopy. Flow cytometry revealed enhanced monocytic eAMPD2 expression after TLR stimulation. PBMCs from patients with rheumatoid arthritis displayed significantly higher levels of eAMPD2 expression compared with healthy controls. Furthermore, the product of AMPD2-IMP-exerted anti-inflammatory effects, while the levels of extracellular adenosine were not impaired by an increased eAMPD2 expression. In summary, our study identifies eAMPD2 as a novel regulator of the extracellular ATP-adenosine balance adding to the immunomodulatory CD39-CD73 system.	[Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany; [Ehlers, Lisa; Kuppe, Aditi; Damerau, Alexandra; Wilantri, Siska; Strehl, Cindy; Buttgereit, Frank; Gaber, Timo] Deutsch Rheuma Forschungszentrum DRFZ, Inst Leibniz Assoc, Berlin, Germany; [Kirchner, Marieluise; Mertins, Philipp] Berlin Inst Hlth BIH, BIH Core Unit Prote, Berlin, Germany; [Kirchner, Marieluise; Mertins, Philipp] Max Delbruck Ctr Mol Med MDC, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ehlers, L (corresponding author), Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Free Univ Berlin, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Humboldt Univ, Charitepl 1, D-10117 Berlin, Germany.; Ehlers, L (corresponding author), Berlin Inst Hlth BIH, Charitepl 1, D-10117 Berlin, Germany.	lisa.ehlers@charite.de		Damerau, Alexandra/0000-0001-6651-2963; Ehlers, Lisa/0000-0001-8737-001X; Buttgereit, Frank/0000-0003-2534-550X; Kirchner, Marieluise/0000-0002-7049-534X	Horizon Pharma plc. [112517]; Studienstiftung des deutschen Volkes (Alexandra Damerau); Deutsche Forschungsgemeinschaft [353142848]	Horizon Pharma plc.; Studienstiftung des deutschen Volkes (Alexandra Damerau); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge funding provided by an unrestricted grant from Horizon Pharma plc. (112517). This work was supported by grants from Horizon Pharma plc. (112517) for LE, Studienstiftung des deutschen Volkes (Alexandra Damerau) for AD, and Deutsche Forschungsgemeinschaft (353142848) for TG.	Akhtari M, 2018, CLIN RHEUMATOL, V37, P1589, DOI 10.1007/s10067-018-4055-9; Akizu N, 2013, CELL, V154, P505, DOI 10.1016/j.cell.2013.07.005; Allard D, 2019, IMMUNOL LETT, V205, P31, DOI 10.1016/j.imlet.2018.05.001; Antonio L, 2017, DRUG DISCOV TODAY, V22, P1686, DOI 10.1016/j.drudis.2017.06.005; Antonioli L, 2019, IMMUNOL LETT, V205, P9, DOI 10.1016/j.imlet.2018.04.006; Antonioli L, 2014, DRUG DISCOV TODAY, V19, P1051, DOI 10.1016/j.drudis.2014.02.010; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Antonioli L, 2012, CURR DRUG TARGETS, V13, P842, DOI 10.2174/138945012800564095; ATKINSON DE, 1966, ANNU REV BIOCHEM, V35, P85, DOI 10.1146/annurev.bi.35.070166.000505; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Ballard P L, 1979, Monogr Endocrinol, V12, P25; BAUMANN G, 1975, J CLIN ENDOCR METAB, V40, P462, DOI 10.1210/jcem-40-3-462; Bavaresco L, 2007, J NEURO-ONCOL, V84, P1, DOI 10.1007/s11060-007-9342-2; Bedoui Y, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205023; Binkley Philip F, 2004, Congest Heart Fail, V10, P274, DOI 10.1111/j.1527-5299.2004.02017.x; Blay J, 1997, CANCER RES, V57, P2602; Borkowski T, 2010, NUCLEOS NUCLEOT NUCL, V29, P449, DOI 10.1080/15257771003741364; Bossennec M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111859; BURN P, 1988, TRENDS BIOCHEM SCI, V13, P79, DOI 10.1016/0968-0004(88)90043-6; Burnstock G, 2014, PURINERG SIGNAL, V10, P529, DOI 10.1007/s11302-014-9427-2; Cai XY, 2016, ONCOL LETT, V12, P4080, DOI 10.3892/ol.2016.5189; Cai XY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004989; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; CHAPMAN AG, 1973, J BIOL CHEM, V248, P8309; Chen J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00504; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Cronstein BN, 2017, NAT REV RHEUMATOL, V13, P41, DOI 10.1038/nrrheum.2016.178; Csoka B, 2008, FASEB J, V22, P3491, DOI 10.1096/fj.08-107458; CUENDA A, 1994, BBA-BIOMEMBRANES, V1194, P35, DOI 10.1016/0005-2736(94)90200-3; Mora-Garcia MD, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1057-8; Dong RP, 1996, J IMMUNOL, V156, P1349; DORNAND J, 1985, P SOC EXP BIOL MED, V179, P448; Dou L, 2018, CLIN IMMUNOL, V188, P67, DOI 10.1016/j.clim.2017.12.006; DUNKLEY CR, 1966, J CELL PHYSIOL, V68, P241, DOI 10.1002/jcp.1040680305; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Endo W, 2014, MOD RHEUMATOL, V24, P844, DOI 10.3109/14397595.2013.864225; Ferrari D, 1997, J IMMUNOL, V159, P1451; Ferretti E, 2019, IMMUNOL LETT, V205, P25, DOI 10.1016/j.imlet.2018.03.007; Figueiro F, 2016, PURINERG SIGNAL, V12, P303, DOI 10.1007/s11302-016-9505-8; Figueiro F, 2014, ANTICANCER RES, V34, P1837; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Finn JD., 2015, ANN RHEUM DIS, V74, pA86; Fishman P, 2016, CLIN RHEUMATOL, V35, P2359, DOI 10.1007/s10067-016-3202-4; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Frasson AP, 2017, PURINERG SIGNAL, V13, P569, DOI 10.1007/s11302-017-9584-1; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gordon-Smith SB, 2015, ARTHRITIS RHEUMATOL, V67, P545, DOI 10.1002/art.38959; Gorini S, 2013, AM J BLOOD RES, V3, P14; Gourdin N, 2018, CANCER RES, V78, P3604, DOI 10.1158/0008-5472.CAN-17-2405; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Guinzberg R, 2006, AM J PHYSIOL-ENDOC M, V290, pE940, DOI 10.1152/ajpendo.00173.2005; Guo GQ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1739-5; Hausler SFM, 2014, AM J TRANSL RES, V6, P129; HAGBERG H, 1987, J NEUROCHEM, V49, P227, DOI 10.1111/j.1471-4159.1987.tb03419.x; Halskau O, 2009, CURR PROTEIN PEPT SC, V10, P339, DOI 10.2174/138920309788922199; Hasko G, 2000, J IMMUNOL, V164, P1013, DOI 10.4049/jimmunol.164.2.1013; Hasko G, 1996, J IMMUNOL, V157, P4634; Herrath J, 2014, EUR J IMMUNOL, V44, P2979, DOI 10.1002/eji.201344140; Horenstein AL, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26246; Hughes CS, 2019, NAT PROTOC, V14, P68, DOI 10.1038/s41596-018-0082-x; Jacobson KA, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00124; Jiang T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4073-7; Johnson JE, 1999, MOL MEMBR BIOL, V16, P217, DOI 10.1080/096876899294544; Johnson TA, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00098; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabisch S, 2004, AKTUEL RHEUMATOL, V29, P197, DOI 10.1055/s-2004-813426; Kekesi V, 2002, CLIN SCI, V103, p198S, DOI 10.1042/CS103S198S; Keller RCA, 2014, J BIOSCIENCES, V39, P771, DOI 10.1007/s12038-014-9479-z; KLEMENS MR, 1990, BIOCHEM BIOPH RES CO, V172, P1371, DOI 10.1016/0006-291X(90)91601-N; Lapa FD, 2012, PURINERG SIGNAL, V8, P693, DOI 10.1007/s11302-012-9299-2; Lappas CM, 2005, J IMMUNOL, V174, P1073, DOI 10.4049/jimmunol.174.2.1073; LEVRAUX V, 1993, LIFE SCI, V52, P1917, DOI 10.1016/0024-3205(93)90632-D; Linden J, 2001, ANNU REV PHARMACOL, V41, P775, DOI 10.1146/annurev.pharmtox.41.1.775; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; LOWENSTEIN JM, 1972, PHYSIOL REV, V52, P382, DOI 10.1152/physrev.1972.52.2.382; Lu YM, 2019, ANN HEMATOL, V98, P1845, DOI 10.1007/s00277-019-03716-9; Luo YY, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0240-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; MANERY JF, 1968, CAN J PHYSIOL PHARM, V46, P537, DOI 10.1139/y68-078; Marton A, 2001, INT J MOL MED, V8, P617; McWhinney CD, 1996, EUR J PHARMACOL, V310, P209, DOI 10.1016/0014-2999(96)00272-5; Milne GR, 2011, THESCIENTIFICWORLDJO, V11, P320, DOI 10.1100/tsw.2011.22; Monguio-Tortajada M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01577; Montesinos MC, 2007, ARTHRITIS RHEUM-US, V56, P1440, DOI 10.1002/art.22643; MOSER GH, 1989, AM J PHYSIOL, V256, pC799, DOI 10.1152/ajpcell.1989.256.4.C799; Muls NGV, 2015, MULT SCLER J, V21, P1533, DOI 10.1177/1352458514567215; OGASAWARA N, 1987, HUM GENET, V75, P15; Ohradanova-Repic A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00852; Ohta M, 2013, ARTERIOSCL THROM VAS, V33, P629, DOI 10.1161/ATVBAHA.112.300600; Parzych K, 2017, FASEB J, V31, P2439, DOI 10.1096/fj.201600256; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PETERSON RE, 1957, J CLIN INVEST, V36, P1301, DOI 10.1172/JCI103528; PIPOLY GM, 1979, J CLIN INVEST, V63, P1066, DOI 10.1172/JCI109376; Pulte ED, 2007, THROMB RES, V121, P309, DOI 10.1016/j.thromres.2007.04.008; Qiu FH, 2000, P NATL ACAD SCI USA, V97, P4267, DOI 10.1073/pnas.97.8.4267; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Quarona V, 2015, ANN NY ACAD SCI, V1335, P10, DOI 10.1111/nyas.12485; RAO SN, 1968, BIOCHIM BIOPHYS ACTA, V151, P651, DOI 10.1016/0005-2744(68)90012-0; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Rouillard AD, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw100; SABINA RL, 1984, J CLIN INVEST, V73, P720, DOI 10.1172/JCI111265; Sabina RL, 2000, PHARMACOL THERAPEUT, V87, P279, DOI 10.1016/S0163-7258(00)00040-1; Sales-Campos H, 2017, IMMUNOLOGY, V150, P115, DOI 10.1111/imm.12672; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Schuler PJ, 2014, CLIN EXP IMMUNOL, V177, P531, DOI 10.1111/cei.12354; Shinohara Y, 2018, BIOCHEM BIOPH RES CO, V498, P764, DOI 10.1016/j.bbrc.2018.03.055; Silva-Vilches C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02581; Silverman MH, 2008, J RHEUMATOL, V35, P41; Sims B, 1999, J BIOL CHEM, V274, P25701, DOI 10.1074/jbc.274.36.25701; Smith TM, 1998, BBA-PROTEIN STRUCT M, V1386, P65, DOI 10.1016/S0167-4838(98)00063-6; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Strehl C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01744; Sun WC, 2007, AM J VET RES, V68, P649, DOI 10.2460/ajvr.68.6.649; Sun XF, 2009, AM J PHYSIOL-GASTR L, V297, pG306, DOI 10.1152/ajpgi.90703.2008; Szabo C, 1998, BRIT J PHARMACOL, V125, P379, DOI 10.1038/sj.bjp.0702040; Taylor PC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040515; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Viegas TX, 2000, J CLIN PHARMACOL, V40, P410, DOI 10.1177/00912700022008991; Walscheid K, 2018, CLIN IMMUNOL, V190, P84, DOI 10.1016/j.clim.2017.09.014; WEBEL ML, 1974, J LAB CLIN MED, V83, P383; WEILMALHERBE H, 1975, J NEUROCHEM, V24, P801; Welihinda AA, 2018, CELL SIGNAL, V42, P227, DOI 10.1016/j.cellsig.2017.11.002; Welihinda AA, 2016, CELL SIGNAL, V28, P552, DOI 10.1016/j.cellsig.2016.02.010; Wessels JAM, 2006, ARTHRITIS RHEUM, V54, P2830, DOI 10.1002/art.22032; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yago T, 2015, J IMMUNOL, V195, P3880, DOI 10.4049/jimmunol.1500775; Yan K, 2018, BRIT J DERMATOL, V179, P896, DOI 10.1111/bjd.16560; Young A, 2016, CANCER CELL, V30, P391, DOI 10.1016/j.ccell.2016.06.025; Yu N, 2012, INFLAMMATION, V35, P1773, DOI 10.1007/s10753-012-9496-8; Zanin RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031205; ZETTERSTROM T, 1982, NEUROSCI LETT, V29, P111, DOI 10.1016/0304-3940(82)90338-X; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	149	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21684	10.1096/fj.202002658RR	http://dx.doi.org/10.1096/fj.202002658RR			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34159634	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000667814100047
J	Kearns, S; Mason, FM; Rathmell, WK; Park, IY; Walker, C; Verhey, KJ; Cianfrocco, MA				Kearns, Sarah; Mason, Frank M.; Rathmell, W. Kimryn; Park, In Young; Walker, Cheryl; Verhey, Kristen J.; Cianfrocco, Michael A.			Molecular determinants for alpha-tubulin methylation by SETD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3K36 METHYLATION; C-TERMINAL DOMAIN; SRI DOMAIN; ACETYLATION; MUTATIONS; REVEALS; DETYROSINATION; IDENTIFICATION; RECOGNITION; HYPB/SETD2	Post-translational modifications to tubulin are important for many microtubule-based functions inside cells. It was recently shown that methylation of tubulin by the histone methyltransferase SETD2 occurs on mitotic spindle microtubules during cell division, with its absence resulting in mitotic defects. However, the catalytic mechanism of methyl addition to tubulin is unclear. We used a truncated version of human wild type SETD2 (tSETD2) containing the catalytic SET and C-terminal Set2-Rpb1-interacting (SRI) domains to investigate the biochemical mechanism of tubulin methylation. We found that recombinant tSETD2 had a higher activity toward tubulin dimers than polymerized microtubules. Using recombinant single-isotype tubulin, we demonstrated that methylation was restricted to lysine 40 of alpha-tubulin. We then introduced pathogenic mutations into tSETD2 to probe the recognition of histone and tubulin substrates. A mutation in the catalytic domain (R1625C) allowed tSETD2 to bind to tubulin but not methylate it, whereas a mutation in the SRI domain (R2510H) caused loss of both tubulin binding and methylation. Further investigation of the role of the SRI domain in substrate binding found that mutations within this region had differential effects on the ability of tSETD2 to bind to tubulin versus the binding partner RNA polymerase II for methylating histones in vivo, suggesting distinct mechanisms for tubulin and histone methylation by SETD2. Finally, we found that substrate recognition also requires the negatively charged C-terminal tail of alpha-tubulin. Together, this study provides a framework for understanding how SETD2 serves as a dual methyltransferase for both histone and tubulin methylation.	[Kearns, Sarah] Univ Michigan, Program Chem Biol, Ann Arbor, MI USA; [Kearns, Sarah; Cianfrocco, Michael A.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Mason, Frank M.; Rathmell, W. Kimryn] Vanderbilt Univ, Dept Med, Div Hematol & Oncol, Med Ctr, Nashville, TN USA; [Mason, Frank M.; Rathmell, W. Kimryn] Vanderbilt Univ, Dept Genet, Nashville, TN USA; [Park, In Young; Walker, Cheryl] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX USA; [Verhey, Kristen J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Cianfrocco, Michael A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cianfrocco, MA (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.; Cianfrocco, MA (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	mcianfro@umich.edu			NIH [P200A150164, 5T32GM008597-22, R01GM070862, R35GM131744]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. K. is funded by Graduate Assistance in Areas of National Need (P200A150164) and the Chemical Biology Interface Training Grant from the NIH (5T32GM008597-22). This work was supported by NIH Grants R01GM070862 and R35GM131744 to K. J. V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Boggs AE, 2015, CANCER RES, V75, P203, DOI 10.1158/0008-5472.CAN-13-3563; Cermakova K, 2019, BIORXIV; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Chiang YC, 2018, CANCER RES, V78, P3135, DOI 10.1158/0008-5472.CAN-17-3460; Chin HG, 2020, J BIOL CHEM, V295, P4748, DOI 10.1074/jbc.RA119.010951; Coombes C, 2016, P NATL ACAD SCI USA, V113, pE7176, DOI 10.1073/pnas.1605397113; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davenport AM, 2014, J MOL BIOL, V426, P2605, DOI 10.1016/j.jmb.2014.05.009; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eram MS, 2015, BBA-GEN SUBJECTS, V1850, P1842, DOI 10.1016/j.bbagen.2015.05.013; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Ferreira LT, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910064; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gadadhar S, 2017, J CELL SCI, V130, P1347, DOI 10.1242/jcs.199471; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Hacker KE, 2016, J BIOL CHEM, V291, P21283, DOI 10.1074/jbc.M116.739375; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Ho TH, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.4583; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kim IK, 2019, ONCOGENE, V38, P180, DOI 10.1038/s41388-018-0429-3; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Le V. H, 2018, WORLD J UROL, V36, P1899; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35392-6; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li CL, 2020, J CELL BIOCHEM, V121, P797, DOI 10.1002/jcb.29325; Li CL, 2019, J CELL PHYSIOL, V234, P661, DOI 10.1002/jcp.26836; Li FX, 2020, ELIFE, V9, DOI 10.7554/eLife.58157; Li FX, 2019, NAT STRUCT MOL BIOL, V26, P583, DOI 10.1038/s41594-019-0242-x; Li J, 2016, ONCOTARGET, V7, P50719, DOI 10.18632/oncotarget.9368; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Liao SH, 2019, CELL RES, V29, P533, DOI 10.1038/s41422-019-0187-y; Liu L, 2017, BIOSCI TRENDS, V11, P214, DOI 10.5582/bst.2016.01228; Liu WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002004; Liu X, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0133-7; Ly N., 2016, SCI REP-UK, V6, P1; Mar BG, 2017, BLOOD, V130, P2631, DOI 10.1182/blood-2017-03-775569; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Rebehmed J, 2014, FEBS LETT, V588, P4431, DOI 10.1016/j.febslet.2014.10.014; Roll-Mecak A, 2019, CURR OPIN CELL BIOL, V56, P102, DOI 10.1016/j.ceb.2018.10.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seervai RNH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb7854; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Ti SC., 2020, STAR PROTOC, V1; Ti SC, 2018, DEV CELL, V47, P175, DOI 10.1016/j.devcel.2018.08.014; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yu N, 2016, CURR BIOL, V26, P1728, DOI 10.1016/j.cub.2016.04.069; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	66	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100898	10.1016/j.jbc.2021.100898	http://dx.doi.org/10.1016/j.jbc.2021.100898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157286	Green Submitted, Green Published, gold			2022-12-26	WOS:000678068400088
J	Nichols, AEC; Muscat, SN; Miller, SE; Green, LJ; Richards, MS; Loiselle, AE				Nichols, Anne E. C.; Muscat, Samantha N.; Miller, Sarah E.; Green, Luke J.; Richards, Michael S.; Loiselle, Alayna E.			Impact of isolation method on cellular activation and presence of specific tendon cell subpopulations during in vitro culture	FASEB JOURNAL			English	Article						cell culture; fibroblast activation; lineage; tendon	BICEPS TENDON; DIFFERENTIATION; MYOFIBROBLAST; FIBROBLASTS; EXPRESSION; TENOCYTES	Tendon injuries are common and heal poorly, due in part to a lack of understanding of fundamental tendon cell biology. A major impediment to the study of tendon cells is the absence of robust, well-characterized in vitro models. Unlike other tissue systems, current tendon cell models do not account for how differences in isolation methodology may affect the activation state of tendon cells or the presence of various tendon cell subpopulations. The objective of this study was to characterize how common isolation methods affect the behavior, fate, and lineage composition of tendon cell cultures. Tendon cells isolated by explant exhibited reduced proliferative capacity, decreased expression of tendon marker genes, and increased expression of genes associated with fibroblast activation compared to digested cells. Consistently, explanted cells also displayed an increased propensity to differentiate to myofibroblasts compared to digested cells. Explanted cultures from multiple different tendons were substantially enriched for the presence of scleraxis-lineage (Scx-lin+) cells compared to digested cultures, while the overall percentage of S100a4-lineage (S100a4-lin+) cells was dependent on both isolation method and tendon of origin. Neither isolation methods preserved the ratios of Scx-lin+ or S100a4-lin+ to non-lineage cells seen in tendons in vivo. Combined, these data indicate that further refinement of in vitro cultures models is required in order to more accurately understand the effects of various stimuli on tendon cell behavior. Statement of clinical significance: The development of informed in vitro tendon cell models will facilitate enhanced screening of potential therapeutic candidates to improve tendon healing.	[Nichols, Anne E. C.; Muscat, Samantha N.; Loiselle, Alayna E.] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Miller, Sarah E.; Green, Luke J.; Richards, Michael S.] Rochester Inst Technol, Dept Biomed Engn, Rochester, NY 14623 USA	University of Rochester; Rochester Institute of Technology	Loiselle, AE (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, 601 Elmwood Ave,Box 665, Rochester, NY 14642 USA.	Alayna_Loiselle@urmc.rochester.edu		Loiselle, Alayna/0000-0002-7548-6653	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01AR068386, R01AR073169, T32AR076950, P30AR069655]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: K01AR068386; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR073169; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: T32AR076950; HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: P30AR069655	Ackerman JE, 2019, ELIFE, V8, DOI 10.7554/eLife.45342; BANES AJ, 1988, J ORTHOP RES, V6, P83, DOI 10.1002/jor.1100060111; BernardBeaubois K, 1997, CELL BIOL TOXICOL, V13, P103, DOI 10.1023/B:CBTO.0000010395.51944.2a; Best KT, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abb7209; Best KT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47461-5; Best KT, 2019, FASEB J, V33, P8578, DOI 10.1096/fj.201900130RR; Buxton AN, 2011, TISSUE ENG PT A, V17, P371, DOI [10.1089/ten.tea.2009.0839, 10.1089/ten.TEA.2009.0839]; Chang YJ, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00027; Dakin SG, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1218-4; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; Darby IA, 2016, CELL MOL LIFE SCI, V73, P1145, DOI 10.1007/s00018-015-2110-0; De Micheli AJ, 2020, AM J PHYSIOL-CELL PH, V319, pC885, DOI 10.1152/ajpcell.00372.2020; Disser NP, 2020, J PHYSIOL-LONDON, V598, P1537, DOI 10.1113/JP279646; Dyment NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059944; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Evrova O, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020458; Hecht N, 2019, OSTEOARTHR CARTILAGE, V27, P1208, DOI 10.1016/j.joca.2019.04.010; HERRMANN H, 1980, EUR J BIOCHEM, V105, P63, DOI 10.1111/j.1432-1033.1980.tb04474.x; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Jo CH, 2019, TISSUE ENG REGEN MED, V16, P151, DOI 10.1007/s13770-019-00182-2; Kendal AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70786-5; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Li P, 2000, J IMMUNOL, V164, P5990, DOI 10.4049/jimmunol.164.11.5990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzocca AD, 2012, KNEE SURG SPORT TR A, V20, P1666, DOI 10.1007/s00167-011-1711-x; Nichols AEC, 2019, TRANSL RES, V209, P156, DOI 10.1016/j.trsl.2019.02.002; Nichols AEC, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0166-z; Pauly S, 2010, EUR CELLS MATER, V20, P84, DOI 10.22203/eCM.v020a08; Pietschmann MF, 2014, ARCH MED SCI, V10, P587, DOI 10.5114/aoms.2014.43752; Ponik SM, 2007, J CELL BIOCHEM, V100, P794, DOI 10.1002/jcb.21089; Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9; Smith CO, 2021, STEM CELLS DEV, V30, P149, DOI 10.1089/scd.2020.0141; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tan GK, 2020, ELIFE, V9, DOI 10.7554/eLife.52695; Taylor SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016337; Teicher Beverly A, 2019, Oncotarget, V10, P993, DOI 10.18632/oncotarget.26590; van Vijven M, 2021, J ORTHOP RES, V39, P1561, DOI 10.1002/jor.24761; Wagenhauser MU, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-140; Wu YF, 2020, STEM CELLS DEV, V29, P1016, DOI 10.1089/scd.2020.0036; Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200; Yao L, 2006, TISSUE ENG, V12, P1843, DOI 10.1089/ten.2006.12.1843; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061424; Zhang JY, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-10; Zhang JH, 2011, AM J PATHOL, V178, P382, DOI 10.1016/j.ajpath.2010.11.017	45	2	2	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21733	10.1096/fj.202100405R	http://dx.doi.org/10.1096/fj.202100405R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34160846	Green Submitted, Green Accepted			2022-12-26	WOS:000667814100084
J	Singh, A; Kumar, A; Kumar, P; Nayak, N; Bhardwaj, T; Giri, R; Garg, N				Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish; Garg, Neha			A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; BINDING-SITES; ONCOPROTEIN; GROWTH; DISRUPTION; EXPRESSION; TARGETS; DNA	c-Myc is a transcription factor that plays a crucial role in cellular homeostasis, and its deregulation is associated with highly aggressive and chemotherapy-resistant cancers. After binding with partner MAX, the c-Myc-MAX heterodimer regulates the expression of several genes, leading to an oncogenic phenotype. Although considered a crucial therapeutic target, no clinically approved c-Myc-targeted therapy has yet been discovered. Here, we report the discovery via computer-aided drug discovery of a small molecule, L755507, which functions as a c-Myc inhibitor to efficiently restrict the growth of diverse Myc-expressing cells with low micromolar IC50 values. L755507 successfully disrupts the c-Myc-MAX heterodimer, resulting in decreased expression of c-Myc target genes. Spectroscopic and computational experiments demonstrated that L755507 binds to the c-Myc peptide and thereby stabilizes the helix-loop-helix conformation of the c-Myc transcription factor. Taken together, this study suggests that L755507 effectively inhibits the c-Myc-MAX heterodimerization and may be used for further optimization to develop a cMyc-targeted antineoplastic drug.	[Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish] Indian Inst Technol Mandi, Adv Mat Res Ctr, Mandi, Himachal Prades, India; [Garg, Neha] Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Banaras Hindu University (BHU)	Garg, N (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India.	nehagarg@bhu.ac.in	Garg, Neha/AAG-5180-2020; Singh, Ashutosh/T-7221-2018	Garg, Neha/0000-0003-2227-8292; Nayak, Namyashree/0000-0002-8513-9401; Singh, Ashutosh/0000-0003-0193-9346; Kumar, Prateek/0000-0001-7392-5045; Bhardwaj, Taniya/0000-0002-7226-6348	University Grants Commission, India; Ministry of Human Resource Development, India; Department of Science and Technology, India [BT/11/IYBA/2018/06]; Science and Engineering Research Board Grant, India [SB/S2/RJN-072/2015, ECR/2017/00092]; Institute of Eminence Scheme, BHU	University Grants Commission, India(University Grants Commission, India); Ministry of Human Resource Development, India(Ministry of Higher Education & Scientific Research (MHESR)); Department of Science and Technology, India(Department of Science & Technology (India)); Science and Engineering Research Board Grant, India; Institute of Eminence Scheme, BHU	A. S. acknowledges University Grants Commission, India, and A. K. acknowledges the Ministry of Human Resource Development, India, for Doctoral Research Fellowship. R. G. is thankful to the Department of Science and Technology, India (BT/11/IYBA/2018/06), and N. G. acknowledges the Science and Engineering Research Board Grant, India (SB/S2/RJN-072/2015), (ECR/2017/00092), and the seed grant under the Institute of Eminence Scheme, BHU for financial support.	Allen-Petersen BL, 2019, BIODRUGS, V33, P539, DOI 10.1007/s40259-019-00370-5; Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Bahuguna A, 2020, COMPUT BIOL MED, V116, DOI 10.1016/j.compbiomed.2019.103574; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Bhat J, 2017, ACS OMEGA, V2, P4382, DOI 10.1021/acsomega.6b00531; Cang SD, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0224-3; Carabet LA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010120; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Choi SH, 2017, ACS CHEM BIOL, V12, P2715, DOI 10.1021/acschembio.7b00799; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Coude MM, 2015, ONCOTARGET, V6, P17698, DOI 10.18632/oncotarget.4131; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Han HY, 2019, CANCER CELL, V36, P483, DOI 10.1016/j.ccell.2019.10.001; Handoko L, 2018, EPIGENETICS-US, V13, P410, DOI 10.1080/15592294.2018.1469891; Hao Huang, 2008, J Exp Clin Cancer Res, V27, P27, DOI 10.1186/1756-9966-27-27; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jeong KC, 2010, MOL BIOSYST, V6, P1503, DOI 10.1039/c002534h; Jin F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003249; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kumar P, 2020, J BIOMOL STRUCT DYN, V38, P4997, DOI 10.1080/07391102.2019.1696231; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P383; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Loregian A, 2005, J CELL PHYSIOL, V204, P750, DOI 10.1002/jcp.20356; McKeown MR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014266; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mo H, 2006, P NATL ACAD SCI USA, V103, P6344, DOI 10.1073/pnas.0601418103; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nieddu E, 2005, FASEB J, V19, P632, DOI 10.1096/fj.04-2369fje; Parmee ER, 1998, BIOORG MED CHEM LETT, V8, P1107, DOI 10.1016/S0960-894X(98)00170-X; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j; Sengupta P, 2018, NUCLEIC ACIDS RES, V46, P9932, DOI 10.1093/nar/gky824; Shamsi A, 2020, J BIOMOL STRUCT DYN, V38, P1094, DOI 10.1080/07391102.2019.1595728; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Yang AM, 2017, CANCER RES, V77, P6641, DOI 10.1158/0008-5472.CAN-16-3452; Yao R., 2018, BIOSCIENCE REP, V38, P1; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22298; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang HL, 2019, ONCOL LETT, V17, P4487, DOI 10.3892/ol.2019.10081	57	7	7	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100903	10.1016/j.jbc.2021.100903	http://dx.doi.org/10.1016/j.jbc.2021.100903			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157284	gold, Green Published			2022-12-26	WOS:000678068400092
J	Dutta, T; Agley, J; Meyerson, BE; Barnes, PA; Sherwood-Laughlin, C; Nicholson-Crotty, J				Dutta, Tapati; Agley, Jon; Meyerson, Beth E.; Barnes, Priscilla A.; Sherwood-Laughlin, Catherine; Nicholson-Crotty, Jill			Perceived enablers and barriers of community engagement for vaccination in India: Using socioecological analysis	PLOS ONE			English	Article							IMMUNIZATION; VACCINES; COVERAGE; HEALTH; DETERMINANTS; MOBILIZATION; STRATEGIES; KNOWLEDGE; CHILDREN; GENDER	Background There is high level policy consensus in India that community engagement (CE) improves vaccination uptake and reduces burden of vaccine preventable diseases. However, to date, vaccination studies in the country have not explicitly focused on CE as an outcome in and of itself. Therefore, this study sought to examine the barriers and enablers of community engagement for vaccination in India. Methods Employing qualitative methods, twenty-five semi-structured elite interviews among vaccine decisionmakers' were triangulated with twenty-four national-level vaccine policy documents and researcher field notes (December 2017 to February 2018). Data collected for this study included perceptions and examples of enablers of and barriers to CE for vaccination uptake. Concepts, such as the absence of formal procedures or data collection approaches related to CE, were confirmed during document review, and a final convening to review study results was conducted with study respondents in December 2018 and January 2019 to affirm the general set of findings from this study. The Social Ecological Model (SEM) was used to organize and interpret the study findings. Results Although decisionmakers and policy documents generally supported CE, there were more CE barriers than facilitators in the context of vaccination, which were identified at all social-ecological levels. Interviews with vaccine decisionmakers in India revealed complex systemic and structural factors which affect CE for vaccination and are present across each of the SEM levels, from individual to policy. Policy-level enablers included decisionmakers' political will for CE and policy documents and interviews highlighted social mobilization, whereas barriers were lack of a CE strategy document and a broad understanding of CE by decisionmakers. At the community level, dissemination of Social-behavioral Change Communication (SBCC) materials from the national-level to the states was considered a CE facilitator, while class, and caste-based power relations in the community, lack of family-centric CE strategies, and paternalistic attitude of decisionmakers toward communities (the latter reported by some NGO heads) were considered CE barriers. At the organizational level, partnerships with local organizations were considered CE enablers, while lack of institutionalized support to formalize and incentivize these partnerships highlighted by several decisionmakers, were barriers. At the interpersonal level, SBCC training for healthcare workers, sensitive messaging to communities with low vaccine confidence, and social media messaging were considered CE facilitators. The lack of strategies to manage vaccine related rumors or replicate successful CE interventions during the during the introduction and rollout of new vaccines were perceived as CE barriers by several decisionmakers. Conclusion Data obtained for this study highlighted national-level perceptions of the complexities and challenges of CE across the entire SEM, from individual to systemic levels. Future studies should attempt to associate these enablers and barriers with actual CE outcomes, such as participation or community support in vaccine policy-making, CE implementation for specific vaccines and situations (such as disease outbreaks), or frequency of sub-population-based incidents of community resistance and community facilitation to vaccination uptake. There would likely be value in developing a population-based operational definition of CE, with a step-by-step manual on 'how to do CE. ' The data from this study also indicate the importance of including CE indicators in national datasets and developing a compendium documenting CE best-practices. Doing so would allow more rigorous analysis of the evidence-base for CE for vaccination in India and other countries with similar immunization programs.	[Dutta, Tapati] Ft Lewis Coll, Publ Hlth Dept, Durango, CO 81301 USA; [Agley, Jon] Indiana Univ, Sch Publ Hlth Bloomington, Dept Appl Hlth Sci, Res,Prevent Insights, Bloomington, IN USA; [Meyerson, Beth E.] Univ Arizona, Southwest Inst Res Women SIROW, Tucson, AZ USA; [Barnes, Priscilla A.; Sherwood-Laughlin, Catherine] Indiana Univ, Sch Publ Hlth Bloomington, Dept Appl Hlth Sci, Bloomington, IN USA; [Nicholson-Crotty, Jill] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of Arizona; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Dutta, T (corresponding author), Ft Lewis Coll, Publ Hlth Dept, Durango, CO 81301 USA.	tdutta@fortlewis.edu	Agley, Jon/AAA-6758-2021	Dutta, Tapati/0000-0002-3272-1115; Agley, Jon/0000-0003-2345-8850	Indiana University	Indiana University	Th first author TD received the Dhar India Fellowship from Indiana University to travel to India and conduct the check-in meetings in India. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberbach JD, 2002, PS, V35, P673, DOI 10.1017/S1049096502001142; ACQUIRE, 2006, TECHN UPD COMM MOB I TECHN UPD COMM MOB I; [Anonymous], INT HEALTH, V4, P229, DOI [10.1016/j.inhe.2012.07.004, DOI 10.1016/J.INHE.2012.07.004]; [Anonymous], 2018, DUKE GLOBAL REPROD H; [Anonymous], 2007, AUTONOMY TRUST BIOET; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bajpai N., 2005, SCALING PRIMARY HLTH; Betsch C, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0056; Bishop P, 2002, AUST J PUBL ADMIN, V61, P14, DOI 10.1111/1467-8500.00255; Blanchard AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-234; Blankenship KA, 2008, AIDS, V22, pS109, DOI 10.1097/01.aids.0000343769.92949.dd; Burgess RA, 2021, LANCET, V397, P8; C Chaturvedi G., 2008, VITAL DROP COMMUNICA; Cherian T., DECADE VACCINES GLOB; Cooper H., 1999, INFLUENCE SOCIAL SUP; Crosby R.A., 2013, HLTH BEHAV THEORY PU, P231; Mavimbe JCD, 2006, HEALTH POLICY, V79, P92, DOI 10.1016/j.healthpol.2005.12.002; Dhody B., ENGAGING COMMUNITIES; Doctor HV, 2012, REPROD HEALTH MATTER, V20, P104, DOI 10.1016/S0968-8080(12)39615-8; DONALDSON T, 1995, ACAD MANAGE REV, V20, P65, DOI 10.5465/AMR.1995.9503271992; Dutta T, 2021, WOMEN STUD INT FORUM, V86, DOI 10.1016/j.wsif.2021.102476; Dutta T, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01290-5; Earl CE, 2001, WESTERN J NURS RES, V23, P753, DOI 10.1177/01939450122045528; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Gatera M, 2016, VACCINE, V34, P3420, DOI 10.1016/j.vaccine.2015.11.076; Goldstein S, 2015, VACCINE, V33, P4212, DOI 10.1016/j.vaccine.2015.04.042; Gurnani V, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4782; Habib MA, 2017, J PUBLIC HEALTH POL, V38, P16, DOI 10.1057/s41271-016-0056-6; Harvey WS, 2011, QUAL RES, V11, P431, DOI 10.1177/1468794111404329; Hilber AM, 2016, INT J GYNECOL OBSTET, V135, P345, DOI 10.1016/j.ijgo.2016.09.008; Hochschild J.L., 2009, WORKSH INT STAND SYS WORKSH INT STAND SYS, P124; Hochschild Jennifer L., 2009, WORKSH INT STAND SYS; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; HUNTER A, 1993, J CONTEMP ETHNOGR, V22, P36, DOI 10.1177/089124193022001004; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Johri M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007972; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kilpatrick S, 2009, AUST J RURAL HEALTH, V17, P39, DOI 10.1111/j.1440-1584.2008.01035.x; Kirkdale C. L., 2017, Annales Pharmaceutiques Francaises, V75, P9, DOI 10.1016/j.pharma.2016.08.006; Kumar S, 2012, HEALTH EDUC BEHAV, V39, P229, DOI 10.1177/1090198111415105; Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2011, LANCET, V378, P526, DOI 10.1016/S0140-6736(11)60678-8; Lindstrom M., 2008, SOCIAL CAPITAL HLTH, P215; Martin B., 2016, SOC EPISTEMOL, V5, P27; Merten M, 2011, J DIVORCE REMARRIAGE, V52, P164, DOI [DOI 10.1080/10502556.2011.556966, 10.1080/10502556.2011.556966]; Mikecz R, 2012, QUAL INQ, V18, P482, DOI 10.1177/1077800412442818; Nair N., 2017, FIRSTPOST; Newman PA, 2011, VACCINE, V29, P451, DOI 10.1016/j.vaccine.2010.10.076; Noah, 2002, ARIZ L REV, V44, P373, DOI DOI 10.1016/S0735-1097(03)00232-8; Nyambe A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3802-6; Oku A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4020-6; Oluwadare C, 2009, STUD ETHNO-MED, V3, P49, DOI 10.1080/09735070.2009.11886337; Outlook Web Bureau, 2018, HLTH MIN DEC SHELV C HLTH MIN DEC SHELV C; Oyo-Ita A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008145.pub3; Pande RP, 2003, SOC SCI MED, V57, P2075, DOI 10.1016/S0277-9536(03)00085-6; Pelcic G, 2016, CROAT MED J, V57, P516, DOI 10.3325/cmj.2016.57.516; Pope Catherine, 2006, Healthc Manage Forum, V19, P27; Pramanik S, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5458-x; Rainey J., 2000, J HLTH ED, V31, P189; Rapaport L, 2018, HLTH NEWS EXPLAINING; Rhodes C., 2014, INT J PRACTICE BASED, V2, P51, DOI DOI 10.11120/PBLH.2013.00025; Ross H., 2002, Australian Journal of Environmental Management, V9, P205; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Seeber L, 2015, CURR DRUG SAF, V10, P31, DOI 10.2174/157488631001150407105400; Seither R, 2019, MMWR-MORBID MORTAL W, V68, P905, DOI 10.15585/mmwr.mm6841e1; Shankar S., 2010, UNDERSTANDING ROLE I, DOI [10.1186/s12889-021-10759-z, DOI 10.1186/S12889-021-10759-Z]; Smith CP., 2000, CONTENT ANAL NARRATI; Stapleton S, 2015, HERD IMMUNITY EXPLAI; Tedrow VA, 2012, AIDS BEHAV, V16, P1217, DOI 10.1007/s10461-011-0009-9; Tefera Tadesse, 2017, Pan African Medical Journal, V28, P290, DOI 10.11604/pamj.2017.28.290.14133; thics Working Group of the HIV Prevention Trials Network, 2015, BMC MED ETHICS, V16, P44; Uddin J, 2013, J HEALTH POPUL NUTR, V31, P211; Vanderslott S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10348-0; Walters LC, 2000, PUBLIC ADMIN REV, V60, P349, DOI 10.1111/0033-3352.00097; Weerts DJ, 2010, J HIGH EDUC, V81, P632, DOI 10.1080/00221546.2010.11779075; Weigmann K, 2017, EMBO REP, V18, P21, DOI 10.15252/embr.201643589; Wiysonge CS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-578; Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018; Zimet GD, 2020, HUMAN PAPILLOMAVIRUS: PROVING AND USING A VIRAL CAUSE FOR CANCER, P363, DOI 10.1016/B978-0-12-814457-2.00022-2	82	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253318	10.1371/journal.pone.0253318	http://dx.doi.org/10.1371/journal.pone.0253318			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170920	Green Published, gold			2022-12-26	WOS:000671694400056
J	La Greca, AD; Perez, N; Castaneda, S; Milone, PM; Scarafia, MA; Mobbs, AM; Waisman, A; Moro, LN; Sevlever, GE; Luzzani, CD; Miriuka, SG				La Greca, Alejandro Damian; Perez, Nelba; Castaneda, Sheila; Milone, Paula Melania; Scarafia, Maria Agustina; Mobbs, Alan Miqueas; Waisman, Ariel; Moro, Lucia Natalia; Sevlever, Gustavo Emilio; Luzzani, Carlos Daniel; Miriuka, Santiago Gabriel			celldeath: A tool for detection of cell death in transmitted light microscopy images by deep learning-based visual recognition	PLOS ONE			English	Article							DNA-DAMAGE; APOPTOSIS; STRAND	Cell death experiments are routinely done in many labs around the world, these experiments are the backbone of many assays for drug development. Cell death detection is usually performed in many ways, and requires time and reagents. However, cell death is preceded by slight morphological changes in cell shape and texture. In this paper, we trained a neural network to classify cells undergoing cell death. We found that the network was able to highly predict cell death after one hour of exposure to camptothecin. Moreover, this prediction largely outperforms human ability. Finally, we provide a simple python tool that can broadly be used to detect cell death.	[La Greca, Alejandro Damian; Perez, Nelba; Castaneda, Sheila; Milone, Paula Melania; Scarafia, Maria Agustina; Mobbs, Alan Miqueas; Waisman, Ariel; Moro, Lucia Natalia; Sevlever, Gustavo Emilio; Luzzani, Carlos Daniel; Miriuka, Santiago Gabriel] FLENI CONICET, Lab Invest Aplicada Neurociencias, Buenos Aires, DF, Argentina; [Waisman, Ariel; Moro, Lucia Natalia; Luzzani, Carlos Daniel; Miriuka, Santiago Gabriel] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Miriuka, SG (corresponding author), FLENI CONICET, Lab Invest Aplicada Neurociencias, Buenos Aires, DF, Argentina.; Miriuka, SG (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, Buenos Aires, Argentina.	smiriuka@fleni.org.ar		Scarafia, Maria Agustina/0000-0001-9361-6637; La Greca, Alejandro/0000-0002-0309-7683; Perez, Nelba/0000-0002-8193-4168; Castaneda, Sheila/0000-0003-2856-7685	National Scientific and Technical Research Council (CONICET) [PIP112-20150100723]; Scientific and Technical Research Fund (FONCyT) [PICT2016-0544]	National Scientific and Technical Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Scientific and Technical Research Fund (FONCyT)(FONCyT)	This work was supported by grants to Dr. Miriuka from the National Scientific and Technical Research Council (CONICET) PIP112-20150100723 and from the Scientific and Technical Research Fund (FONCyT) PICT2016-0544.	Anzanello MJ, 2011, INT J IND ERGONOM, V41, P573, DOI 10.1016/j.ergon.2011.05.001; Camacho DM, 2018, CELL, V173, P1581, DOI 10.1016/j.cell.2018.05.015; Cao CS, 2018, GENOM PROTEOM BIOINF, V16, P17, DOI 10.1016/j.gpb.2017.07.003; Chen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21471; D'Arcy MS, 2019, CELL BIOL INT, V43, P582, DOI 10.1002/cbin.11137; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009; Howard J., 2018, FASTAI; Huang GL, 2017, IEEE ICC; Jimenez-Carretero D, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006238; Kabore AF, 2004, CURR CANCER DRUG TAR, V4, P147, DOI 10.2174/1568009043481551; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kavzoglu T, 2009, ENVIRON MODELL SOFTW, V24, P850, DOI 10.1016/j.envsoft.2008.11.012; Kay JG, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0438-z; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Lee JG, 2017, KOREAN J RADIOL, V18, P570, DOI 10.3348/kjr.2017.18.4.570; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Majtnerova P, 2018, MOL BIOL REP, V45, P1469, DOI 10.1007/s11033-018-4258-9; Mathur A, 2008, IEEE GEOSCI REMOTE S, V5, P241, DOI 10.1109/LGRS.2008.915597; Merino D, 2018, CANCER CELL, V34, P879, DOI 10.1016/j.ccell.2018.11.004; Moen E, 2019, NAT METHODS, V16, P1233, DOI 10.1038/s41592-019-0403-1; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Moro LN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207074; Ounkomol C, 2018, NAT METHODS, V15, P917, DOI 10.1038/s41592-018-0111-2; Garcia CP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152607; Garcia CP, 2014, STEM CELL RES, V12, P400, DOI 10.1016/j.scr.2013.12.002; Perez-Enciso M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070553; Questa M, 2016, STEM CELL RES, V16, P300, DOI 10.1016/j.scr.2015.12.026; Richmond D., 2017, DEADNET IDENTIFYING; Sedelnikova OA, 2003, CANCER BIOL THER, V2, P233; Siteng Chen, 2019, 2019 18th IEEE International Conference On Machine Learning And Applications (ICMLA), P1737, DOI 10.1109/ICMLA.2019.00282; Sordet O, 2009, EMBO REP, V10, P887, DOI 10.1038/embor.2009.97; Strumberg D, 2000, MOL CELL BIOL, V20, P3977, DOI 10.1128/MCB.20.11.3977-3987.2000; Voulodimos A, 2018, COMPUT INTEL NEUROSC, V2018, DOI 10.1155/2018/7068349; Waisman A, 2019, STEM CELL REP, V12, P845, DOI 10.1016/j.stemcr.2019.02.004; Webb S, 2018, NATURE, V554, P555, DOI 10.1038/d41586-018-02174-z; Yosinski J, 2014, ADV NEUR IN, V27; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	38	3	3	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253666	10.1371/journal.pone.0253666	http://dx.doi.org/10.1371/journal.pone.0253666			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166446	Green Published, gold			2022-12-26	WOS:000671692800060
J	Alemye, T; Oljira, L; Fekadu, G; Mengesha, MM				Alemye, Tsegaw; Oljira, Lemessa; Fekadu, Gelana; Mengesha, Melkamu Merid			Post cesarean section surgical site infection and associated factors among women who delivered in public hospitals in Harar city, Eastern Ethiopia: A hospital-based analytic cross-sectional study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RISK-FACTORS; HEALTH; ANESTHESIA	Background Cesarean section (CS) is often complicated by surgical site infection (SSI) that may happen to a woman within 30 days after the operation. This study was conducted to estimate the prevalence of SSI and identify the factors associated with SSI. Methods A hospital-based analytic cross-sectional study was conducted based on the review of medical records of 1069 women who underwent CS in two public hospitals in Harar city. The post-CS SSI is defined when it occurred within 30 days after the CS procedure. Factors associated with SSI were identified using a multivariable binary logistic regression analysis. The analysis outputs are presented using an adjusted odds ratio (aOR) with a corresponding 95% confidence interval (CI). All statistical tests are defined as statistically significant at P-valuesResults The prevalence of SSI was 12.3% (95% confidence interval (CI): 10.4, 14.4). Emergency-CS was conducted for 75.9% (95% CI: 73.2, 78.3) of the women and 13.2% (95% CI: 11.3, 15.4) had at least one co-morbid condition. On presentation, 21.7% (95% CI: 19.3, 24.3) of women had rupture of membrane (ROM). Factors significantly and positively associated with post-CS SSI include general anesthesia (aOR = 2.0, 95%CI: 1.10, 2.90), ROM (aOR = 2.27, 95%CI: 1.02, 3.52), hospital stay for over 7 days after operation (aOR = 3.57, 95%CI: 1.91, 5.21), and blood transfusion (aOR = 4.2, 95%CI: 2.35, 6.08). Conclusion The prevalence of post-CS SSI was relatively high in the study settings. Screening for preoperative anemia and appropriate correction before surgery, selection of the type of anesthesia, close follow-up to avoid unnecessary prolonged hospitalization, and careful assessment of membrane status should be considered to avoid preventable SSI and maternal morbidity.	[Alemye, Tsegaw] Mizan Aman Hlth Sci Coll, Dept Midwifery, Mizan Aman, Ethiopia; [Oljira, Lemessa] Haramaya Univ, Coll Hlth & Med Sci, Sch Publ Hlth, Harar, Ethiopia; [Fekadu, Gelana] Haramaya Univ, Coll Hlth & Med Sci, Sch Nursing & Midwifery, Harar, Ethiopia; [Mengesha, Melkamu Merid] Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia	Haramaya University; Haramaya University; Arba Minch University	Mengesha, MM (corresponding author), Arba Minch Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Arba Minch, Ethiopia.	melkamumrd@gmail.com	Fekadu, Gelana/GLU-6810-2022; Mengesha, Melkamu Merid/ABA-7134-2020	Mengesha, Melkamu Merid/0000-0003-4312-0136; Oljira, Lemessa/0000-0003-4542-2509; Fekadu Mijena, Gelana/0000-0001-5409-4979	Haramaya University	Haramaya University	TA-received grant from Haramaya University for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2018, BRIT J ANAESTH, V120, P779, DOI 10.1016/j.bja.2017.11.101; Adane F, 2019, PATIENT SAF SURG, V13, DOI 10.1186/s13037-019-0212-6; Afolabi BB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004350.pub3; Alfouzan W, 2019, Epidemiol Infect, V147, pe287, DOI 10.1017/S0950268819001675; Allegranzi B, 2008, LANCET, V372, P1719, DOI 10.1016/S0140-6736(08)61715-8; Allegranzi Benedetta, 2016, Lancet Infect Dis, V16, pe276, DOI 10.1016/S1473-3099(16)30398-X; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Azeze GG, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4325-x; Beucher G, 2012, J GYNECOL OBST BIO R, V41, P708, DOI 10.1016/j.jgyn.2012.09.028; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; CDC, 2018, NHSN SURG SIT INF SU NHSN SURG SIT INF SU; Chu K, 2015, WORLD J SURG, V39, P350, DOI 10.1007/s00268-014-2840-4; CSA, CENTR STAT AG ETH CE CENTR STAT AG ETH CE; Di Gennaro F, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000370; Gedefaw G., 2018, BMC, V4; Getaneh T, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03005-8; Jido TA, 2012, ANN MED HEALTH SCI R, V2, P33, DOI 10.4103/2141-9248.96934; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kawakita Tetsuya, 2017, Matern Health Neonatol Perinatol, V3, P12, DOI 10.1186/s40748-017-0051-3; Ketcheson Felicia, 2017, CMAJ Open, V5, pE546, DOI 10.9778/cmajo.20160164; Ketema DB, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05640-0; Korb D, 2019, CAN MED ASSOC J, V191, pE352, DOI 10.1503/cmaj.181067; Krieger Y, 2017, J MATERN-FETAL NEO M, V30, P8, DOI 10.3109/14767058.2016.1163540; Luz G., 2010, WORLD HLTH REP, P30; Mascarello KC, 2017, REV SAUDE PUBL, V51, DOI [10.11606/s1518-8787.2017051000389, 10.11606/S1518-8787.2017051000389]; Mekonnen Alemayehu Gonie, 2021, Matern Health Neonatol Perinatol, V7, P2, DOI 10.1186/s40748-020-00122-2; Molla M, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2442-0; Moulton LJ, 2018, J MATERN-FETAL NEO M, V31, P1873, DOI 10.1080/14767058.2017.1330882; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Opoien HK, 2007, ACTA OBSTET GYN SCAN, V86, P1097, DOI 10.1080/00016340701515225; Sandall J, 2018, LANCET, V392, P1349, DOI 10.1016/S0140-6736(18)31930-5; Sway A, 2019, INT J WOMENS HEALTH, V11, P309, DOI 10.2147/IJWH.S182362; Tsai PS, 2011, BRIT J ANAESTH, V107, P757, DOI 10.1093/bja/aer262; Vijayan CP, 2016, INT J SCI STUDY, V3, P97, DOI 10.17354/ijss/2016/129; WHO, 2018, PREV SURG SIT INF IM; Wodajo S, 2017, ETHIOP J HEALTH SCI, V27, P283, DOI 10.4314/ejhs.v27i3.10; Worku M., 2018, ETHIOPIAN J REPROD H, V10; Yerba K, 2020, ETHIOP J HEALTH SCI, V30, P95, DOI 10.4314/ejhs.v30i1.12; Zuarez-Easton S, 2017, INT J WOMENS HEALTH, V9, P81, DOI 10.2147/IJWH.S98876	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253194	10.1371/journal.pone.0253194	http://dx.doi.org/10.1371/journal.pone.0253194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161361	gold, Green Published			2022-12-26	WOS:000671691900007
J	Charlebois, E; Pantopoulos, K				Charlebois, Edouard; Pantopoulos, Kostas			Iron overload inhibits BMP/SMAD and IL-6/STAT3 signaling to hepcidin in cultured hepatocytes	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GENE-EXPRESSION; CITRATE UPTAKE; HOMEOSTASIS; ACTIVATION; PATHWAY; CELLS; LIVER; INDUCTION; STAT3	Hepcidin is a peptide hormone that targets the iron exporter ferroportin, thereby limiting iron entry into the bloodstream. It is generated in hepatocytes mainly in response to increased body iron stores or inflammatory cues. Iron stimulates expression of bone morphogenetic protein 6 (BMP6) from liver sinusoidal endothelial cells, which in turn binds to BMP receptors on hepatocytes and induces the SMAD signaling cascade for transcriptional activation of the hepcidin-encoding HAMP mRNA. SMAD signaling is also essential for inflammatory HAMP mRNA induction by the IL-6/STAT3 pathway. Herein, we utilized human Huh7 hepatoma cells and primary murine hepatocytes to assess the effects of iron perturbations on signaling to hepcidin. Iron chelation appeared to slightly impair signaling to hepcidin. Subsequent iron supplementation not only failed to reverse these effects, but drastically reduced basal HAMP mRNA and inhibited HAMP mRNA induction by BMP6 and/or IL-6. Thus, treatment of cells with excess iron inhibited basal and BMP6-mediated SMAD5 phosphorylation and induction of HAMP, ID1 and SMAD7 mRNAs in a dose-dependent manner. Iron also inhibited IL-6-mediated STAT3 phosphorylation and induction of HAMP and SOCS3 mRNAs. These responses were accompanied by induction of GCLC and HMOX1 mRNAs, known markers of oxidative stress. We conclude that hepatocellular iron overload suppresses hepcidin by inhibiting the SMAD and STAT3 signaling pathways downstream of their respective ligands.	[Charlebois, Edouard; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Charlebois, Edouard; Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Pantopoulos, K (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.	kostas.pantopoulos@mcgill.ca			Canadian Institutes of Health Research (CIHR) [PJT-159730]; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de recherche du Quebec - Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec - Sante (FRQS)(Fonds de la Recherche en Sante du Quebec)	This work was supported by a grant from the Canadian Institutes of Health Research (CIHR;PJT-159730). EC was funded by a fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) and is currently a recipient of a fellowship from the Fonds de recherche du Quebec - Sante (FRQS).	Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Babon JJ, 2012, GROWTH FACTORS, V30, P207, DOI 10.3109/08977194.2012.687375; Baker E, 1998, BBA-GEN SUBJECTS, V1380, P21, DOI 10.1016/S0304-4165(97)00120-7; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Canali S, 2017, BLOOD, V129, P405, DOI 10.1182/blood-2016-06-721571; Che JM, 2021, CELL SIGNAL, V84, DOI 10.1016/j.cellsig.2021.110024; Chen L, 2020, DEV GROWTH DIFFER, V62, P139, DOI 10.1111/dgd.12650; Coffey R, 2017, J BIOL CHEM, V292, P12727, DOI 10.1074/jbc.R117.781823; Corradini E, 2011, HEPATOLOGY, V54, P273, DOI 10.1002/hep.24359; Daba A, 2013, J MOL MED, V91, P95, DOI 10.1007/s00109-012-0937-5; Doulias PT, 2003, FREE RADICAL BIO MED, V35, P719, DOI 10.1016/S0891-5849(03)00396-4; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; Fillebeen C, 2007, J HEPATOL, V47, P12, DOI 10.1016/j.jhep.2007.01.035; Fillebeen C, 2018, BLOOD, V132, P1829, DOI 10.1182/blood-2018-03-841197; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; Galaris D, 2019, BBA-MOL CELL RES, V1866, DOI 10.1016/j.bbamcr.2019.118535; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Gehrke SG, 2003, BLOOD, V102, P371, DOI 10.1182/blood-2002-11-3610; Glickstein H, 2005, BLOOD, V106, P3242, DOI 10.1182/blood-2005-02-0460; Graham RM, 1998, J HEPATOL, V29, P603, DOI 10.1016/S0168-8278(98)80156-6; Guttmann S, 2019, METALLOMICS, V11, P1836, DOI 10.1039/c9mt00202b; Katsarou A, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100866; Kautz L, 2008, BLOOD, V112, P1503, DOI 10.1182/blood-2008-03-143354; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Krejsa CM, 2010, J BIOL CHEM, V285, P16116, DOI 10.1074/jbc.M110.116210; Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029; Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0; Lu S, 2015, TRANSGENIC RES, V24, P765, DOI 10.1007/s11248-015-9879-3; Mayeur C, 2014, BLOOD, V123, P2261, DOI 10.1182/blood-2013-02-480095; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Neves JV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14933-5; Newman SA, 2021, PHARM RES-DORDR, V38, P97, DOI 10.1007/s11095-021-03006-y; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Villarroel P, 2012, BIOL TRACE ELEM RES, V150, P496, DOI 10.1007/s12011-012-9522-6; Wang CY, 2020, BLOOD, V135, P453, DOI 10.1182/blood.2019002620; Wang CY, 2019, BLOOD, V133, P18, DOI 10.1182/blood-2018-06-815894; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	43	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253475	10.1371/journal.pone.0253475	http://dx.doi.org/10.1371/journal.pone.0253475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161397	gold, Green Published			2022-12-26	WOS:000671691900021
J	Li, XL; Fan, M; Zhang, Y; Liu, L; Yi, F; Chang, JH; Li, J				Li, Xilin; Fan, Ming; Zhang, Ying; Liu, Ling; Yi, Fu; Chang, Jinghua; Li, Jian			Remediation of chromium- and fluoride-contaminated groundwater by immobilized Citrobacter sp. on a nano-ZrO2 hybrid material	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; HEXAVALENT CHROMIUM; WASTE-WATER; REMOVAL; ADSORPTION; REDUCTION; FREUNDII; NANOCOMPOSITE; PRECIPITATION; TEMPERATURE	To effectively address excessive SO42-, Cr(VI), total chromium and F- in the groundwater of acidic mining areas, a facultative anaerobic bacterium, Citrobacter, with sulfate-reducing properties, tolerance to hexavalent chromium and the ability to reduce Cr(VI) to Cr(III) was isolated and domesticated. Based on microbial immobilization technology, a nano-ZrO2 polyacrylamide hybrid material was prepared as an embedding agent to form nano-ZrO2 polyacrylamide Citrobacter (ZPC) particles. ZPC was microscopically characterized, and the removal performance and mechanism of ZPC for SO42-, Cr(VI), total chromium and F- in groundwater were analyzed. The results of single-factor tests showed that the optimal reaction conditions included a reaction temperature of 35 degrees C, Citrobacter dosage of 35% (volume ratio) in the particles and hybrid material dosage of 300 mL; under these conditions, the removal rates of SO42-, Cr(VI), total chromium and F- were 70.5%, 100%, 100% and 93.3%, respectively, and the pH value increased from 4.6 to 8.07. On this basis, the effects of the reaction layer type, influent hydraulic load and influent concentration on the removal efficiency of polluted groundwater were studied through dynamic experiments. The experimental results showed that ZPC particles were better than Citrobacter as a reaction layer; the optimal influent hydraulic load was 3.0 m(3)/(m(2)center dot d); the selectivity of ZPC particles to anions and anionic groups was different; and the order of adsorption selectivity was F- > Cr(VI) > SO42-.	[Li, Xilin; Fan, Ming; Liu, Ling; Li, Jian] Liaoning Tech Univ, Sch Civil Engn, Fuxing, Liaoning, Peoples R China; [Zhang, Ying] Chuzhou Univ, Sch Civil & Architectural Engn, Chuzhou City, Anhui, Peoples R China; [Yi, Fu] Liaoning Tech Univ, Sch Architecture & Transportat, Fuxing, Liaoning, Peoples R China; [Chang, Jinghua] Liaoning Tech Univ, Sch Sci, Fuxing, Liaoning, Peoples R China	Liaoning Technical University; Chuzhou University; Liaoning Technical University; Liaoning Technical University	Li, XL (corresponding author), Liaoning Tech Univ, Sch Civil Engn, Fuxing, Liaoning, Peoples R China.	lixilin@lntu.edu.cn	yi, fu/HGE-6093-2022	Li, Xilin/0000-0003-0870-4996	National Key R&D Program of China [2017YFC1503106]; Liaoning BaiQianWan Talents Program of China [2018C01]; Liaoning Provincial Natural Science Foundation of China [2019-ZD-0037]	National Key R&D Program of China; Liaoning BaiQianWan Talents Program of China; Liaoning Provincial Natural Science Foundation of China	This research was supported by National Key R&D Program of China (Project No. 2017YFC1503106), Liaoning BaiQianWan Talents Program of China (Project No. 2018C01) and Liaoning Provincial Natural Science Foundation of China (Project No. 2019-ZD-0037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad W, 2019, INT J ENVIRON AN CH, V99, P1604, DOI 10.1080/03067319.2019.1628950; Azeez NA, 2021, CHEMOSPHERE, V266, DOI 10.1016/j.chemosphere.2020.129204; Bajpai VK, 2019, ACS APPL MATER INTER, V11, P43949, DOI 10.1021/acsami.9b16989; Behera P, 2017, SCI TOTAL ENVIRON, V595, P472, DOI 10.1016/j.scitotenv.2017.03.271; Beretta G, 2020, WATER-SUI, V12, DOI 10.3390/w12020466; [蔡涛 Cai Tao], 2013, [南京大学学报. 自然科学版, Journal of Nanjing University. Natural Sciences], V49, P500; Chan GF, 2012, J BACTERIOL, V194, P5485, DOI 10.1128/JB.01285-12; Chauveteau G., 2004, P SPEDOE S IMPROVED, DOI [10.2118/89390-ms, DOI 10.2118/89390-MS, 10.2118/89390-MS]; Chen CZ., 2005, MARINE FISHERIES RES, V4, P32, DOI [10.3969/j.issn.1000-7075.2005.04.006, DOI 10.3969/J.ISSN.1000-7075.2005.04.006]; Chen L, 2012, THESIS HUNAN U SCI T; Chuichulcherm S, 2001, J CHEM TECHNOL BIOT, V76, P61; Chung J, 2006, WATER RES, V40, P1634, DOI 10.1016/j.watres.2006.01.049; Cui XW, 2015, ARCH MICROBIOL, V197, P513, DOI 10.1007/s00203-015-1082-7; Cui YY, 2008, COLLOID POLYM SCI, V286, P97, DOI 10.1007/s00396-007-1752-3; Das GS, 2019, NEW J CHEM, V43, P14575, DOI 10.1039/c9nj02344e; Es I, 2015, APPL MICROBIOL BIOT, V99, P2065, DOI 10.1007/s00253-015-6390-y; Guo G, 2018, WATER RES, V141, P9, DOI 10.1016/j.watres.2018.04.028; Guo WW, 2013, GEOMICROBIOL J, V30, P749, DOI 10.1080/01490451.2013.769650; Gusain D, 2014, J MOL LIQ, V197, P131, DOI 10.1016/j.molliq.2014.04.026; Gutierrez T, 2009, THESCIENTIFICWORLDJO, V9, P209, DOI 10.1100/tsw.2009.29; Hei TN., 2016, J FUNCTIONAL MAT, V47, P3051; Holzmeister I, 2018, ACTA BIOMATER, V74, P17, DOI 10.1016/j.actbio.2018.04.042; Hu J, 2005, WATER RES, V39, P4528, DOI 10.1016/j.watres.2005.05.051; Jiang KY, 1997, ACTA PHYS-CHIM SIN, V13, P407, DOI 10.3866/PKU.WHXB19970505; Jiang YL, 2020, ENVIRON SCI-PROC IMP, V22, P1408, DOI [10.1039/D0EM00104J, 10.1039/d0em00104j]; Kaksonen AH, 2003, WATER RES, V37, P255, DOI 10.1016/S0043-1354(02)00267-1; Lefticariu L, 2015, APPL GEOCHEM, V63, P70, DOI 10.1016/j.apgeochem.2015.08.002; Li B, 2011, CHINESE J GEOPHYS-CH, V54, P2631, DOI 10.3969/j.issn.0001-5733.2011.10.020; Li SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043328; [李喜林 Li Xilin], 2021, [煤炭学报, Journal of China Coal Society], V46, P1056; Li XL, 2019, WATER SCI TECHNOL, V80, P2362, DOI 10.2166/wst.2020.057; Li Y, 2011, CHEM J CHINESE U, V32, P1100; Liao XP, 2008, ADSORPTION, V14, P55, DOI 10.1007/s10450-007-9045-1; Liu T, 2018, CHEMOSPHERE, V210, P907, DOI 10.1016/j.chemosphere.2018.07.085; Mahmoud ME, 2017, POWDER TECHNOL, V321, P444, DOI 10.1016/j.powtec.2017.08.041; Marco AP-C., APPL MICROBIOL BIOT, V2021, P1, DOI [10.1007/S00253-021-11255%26%23x2013%3B5, DOI 10.1007/S00253-021-11255%26%23X2013%3B5]; Miao ZY, 2018, J ENVIRON ENG, V144, DOI [10.1061/(ASCE)EE.1943-7870.0001330, 10.1061/(asce)ee.1943-7870.0001330]; Mohan S, 2017, J FLUORINE CHEM, V194, P40, DOI 10.1016/j.jfluchem.2016.12.014; Mohapatra M, 2009, J ENVIRON MANAGE, V91, P67, DOI 10.1016/j.jenvman.2009.08.015; Ojha Sanjay Kumar, 2020, Biotechnology Reports, V27, pe00506, DOI 10.1016/j.btre.2020.e00506; [欧阳静 Ouyang Jing], 2014, [中国材料进展, Materials China], V33, P365; Prabhu SM, 2020, CHEM ENG J, V390, DOI 10.1016/j.cej.2020.124573; [乔宇 Qiao Yu], 2014, [石油学报. 石油加工, Acta Petrolei Sinica. Petroleum Processing Section], V30, P555; Qiu RL, 2009, J HAZARD MATER, V164, P1310, DOI 10.1016/j.jhazmat.2008.09.039; Sahrani FK, 2008, SAINS MALAYS, V37, P365; Sharma M, 2019, CHEM ENG J, V358, P540, DOI 10.1016/j.cej.2018.10.031; Shukla S, 2019, ACS APPL MATER INTER, V11, P18165, DOI 10.1021/acsami.9b02857; Soylak M, 2010, J AOAC INT, V93, P720; Srinath T, 2001, J GEN APPL MICROBIOL, V47, P307, DOI 10.2323/jgam.47.307; Teimouri A, 2016, INT J BIOL MACROMOL, V93, P254, DOI 10.1016/j.ijbiomac.2016.05.089; Thathsara SKT, 2019, ENVIRON TECHNOL INNO, V14, DOI 10.1016/j.eti.2019.100353; Vijayaraj AS, 2018, 3 BIOTECH, V8, DOI 10.1007/s13205-018-1444-3; [王家宏 Wang Jiahong], 2012, [离子交换与吸附, Ion Exchange and Adsorption], V28, P62; Wang XY, 2018, J ENVIRON MANAGE, V226, P194, DOI 10.1016/j.jenvman.2018.08.042; Wang XR, 2015, THESIS WUHAN U TECHN; Wu BY, 2019, CHEM ENG J, V373, P1030, DOI 10.1016/j.cej.2019.05.131; Wu ZJ, 2014, ACTA OCEANOL SIN, V33, P10, DOI 10.1007/s13131-014-0458-x; [谢杨 Xie Yang], 2021, [高分子材料科学与工程, Polymer Materials Science & Engineering], V37, P142; Xu GH., 2016, PAPER SCI TECHNOLOGY, V35, P47, DOI [10.19696/j.issn1671-4571.2016.03.008, DOI 10.19696/J.ISSN1671-4571.2016.03.008]; Yang Li-ping, 2010, Huanjing Kexue, V31, P815; Zhang HG, 2017, ECOL ENG, V102, P397, DOI 10.1016/j.ecoleng.2017.02.049; Zhang J., 2016, THESIS SW PETROLEUM; Zhou G, 2013, J MICROBIOL BIOTECHN, V23, P1673, DOI [10.4014/jmb1307.07041, 10.4014/jmb.1307.07041]	63	2	2	14	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253496	10.1371/journal.pone.0253496	http://dx.doi.org/10.1371/journal.pone.0253496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161350	gold, Green Published			2022-12-26	WOS:000671691900039
J	Mendes, LC; Delrieu, J; Gillet, C; Telmon, N; Maret, D; Savall, F				Mendes, Leonor Costa; Delrieu, Julien; Gillet, Claudia; Telmon, Norbert; Maret, Delphine; Savall, Frederic			Sexual dimorphism of the mandibular conformational changes in aging human adults: A multislice computed tomographic study by geometric morphometrics	PLOS ONE			English	Article							AGE-RELATED-CHANGES; FACIAL MORPHOLOGY; SKELETAL; PERFORMANCE; DENTATE; SHAPE	The aging process has an impact on mandibular bone morphology and can therefore affect shape sexual dimorphism. Understanding the effect of senescence on mandibular shape changes is particularly important to correctly estimate the sex of an individual and predict age-related conformational modifications. The purpose of this study was to assess age-related changes in mandibular shape and sexual dimorphism. The study sample comprised 160 Multi Slice Computed Tomography examinations of individuals aged 40 to 79 years. Geometric morphometric analysis of fourteen osteometric landmarks was used to examine sexual dimorphism and patterns of mandibular shape variation with age. Results showed that mandibular sexual dimorphism of shape remained significant with aging. Conformational changes occurred between 50 and 70 years and were different for male and female individuals. Females presented earlier and more marked age-related shape changes than males. These observations suggest that mandibular senescence is a sexually dimorphic process since its onset, rate, and the areas subjected to conformational changes differ from male to female individuals. Senescence-related changes present substantial variability, and further investigation is required to determine precisely the age that marks their onset.	[Mendes, Leonor Costa; Delrieu, Julien; Gillet, Claudia; Telmon, Norbert; Maret, Delphine; Savall, Frederic] Univ Paul Sabatier, Lab Anthropobiol AMIS, CNRS, UMR 5288, Toulouse, France; [Mendes, Leonor Costa; Delrieu, Julien; Maret, Delphine] UFR Odontol Toulouse, Toulouse, France; [Telmon, Norbert; Savall, Frederic] CHU Toulouse Rangueil, Serv Med Legale, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Mendes, LC (corresponding author), Univ Paul Sabatier, Lab Anthropobiol AMIS, CNRS, UMR 5288, Toulouse, France.; Mendes, LC (corresponding author), UFR Odontol Toulouse, Toulouse, France.	leonor.c.mendes@gmail.com	Maret, Delphine/AFT-1061-2022; Delrieu, Julien/AEL-7083-2022					Adams D.C., 2020, R PACKAGE VERSION; Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; BAKKE M, 1990, Scandinavian Journal of Dental Research, V98, P149; BARTLETT SP, 1992, PLAST RECONSTR SURG, V90, P592, DOI 10.1097/00006534-199210000-00007; Bejdova S, 2013, HOMO, V64, P437, DOI 10.1016/j.jchb.2013.05.003; Bigoni L, 2010, HOMO, V61, P16, DOI 10.1016/j.jchb.2009.09.004; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X; Chrcanovic BR, 2011, SURG RADIOL ANAT, V33, P203, DOI 10.1007/s00276-010-0731-4; Coleman Sydney R, 2006, Aesthet Surg J, V26, pS4, DOI 10.1016/j.asj.2005.09.012; Costa Mendes L., 2020, OSF, DOI [10.17605/OSF.IO/KB3HG, DOI 10.17605/OSF.IO/KB3HG]; Cotofana S, 2018, PLAST RECONSTR SURG, V142, P1447, DOI 10.1097/PRS.0000000000004976; Dong HM, 2015, FORENSIC SCI INT, V255, P9, DOI 10.1016/j.forsciint.2015.06.010; Doual JM, 1997, SURG RADIOL ANAT, V19, P175, DOI 10.1007/s00276-997-0175-7; Dryden I.L., 2019, R FDN STAT COMPUTING R FDN STAT COMPUTING; ENLOW DH, 1976, J PROSTHET DENT, V36, P685, DOI 10.1016/0022-3913(76)90035-4; Ercan I., 2008, INT J TOMOGR SIMUL, V9, P51; Franklin Daniel, 2007, Forensic Sci Med Pathol, V3, P15, DOI 10.1385/FSMP:3:1:15; Franklin D, 2007, J FORENSIC SCI, V52, P6, DOI 10.1111/j.1556-4029.2006.00311.x; Franklin D, 2008, FORENSIC SCI INT, V179, DOI 10.1016/j.forsciint.2008.03.014; Gapert R, 2013, FORENSIC SCI MED PAT, V9, P478, DOI 10.1007/s12024-013-9437-3; Garvin HM, 2014, AM J PHYS ANTHROPOL, V154, P259, DOI 10.1002/ajpa.22502; Garvin HM, 2012, AM J PHYS ANTHROPOL, V147, P661, DOI 10.1002/ajpa.22036; Gillet C, 2020, INT J LEGAL MED, V134, P823, DOI 10.1007/s00414-019-02203-0; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Guevara Perez S. V, 2018, Morphologie, V102, P255, DOI 10.1016/j.morpho.2018.08.001; Guyomarc'h P, 2014, J FORENSIC SCI, V59, P1502, DOI 10.1111/1556-4029.12547; Hatch JP, 2001, ARCH ORAL BIOL, V46, P641, DOI 10.1016/S0003-9969(01)00023-1; He Q, 2010, PSYCHIAT RES-NEUROIM, V183, P126, DOI 10.1016/j.pscychresns.2010.05.006; Kahn David M, 2008, Aesthet Surg J, V28, P258, DOI 10.1016/j.asj.2008.02.007; Kuc J, 2015, ACTA ODONTOL SCAND, V73, P57, DOI 10.3109/00016357.2014.950181; Matros E, 2009, FACIAL PLAST SURG, V25, P252, DOI 10.1055/s-0029-1242037; Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3; Mendelson BC, 2007, AESTHET PLAST SURG, V31, P419, DOI 10.1007/s00266-006-0120-x; Mydlova M, 2015, FORENSIC SCI INT, V257, DOI 10.1016/j.forsciint.2015.09.008; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Nikita E, 2014, INT J OSTEOARCHAEOL, V24, P557, DOI 10.1002/oa.2241; Ozdemir ST, 2009, AESTHET PLAST SURG, V33, P175, DOI 10.1007/s00266-008-9274-z; Ozturk CN, 2013, AESTHET SURG J, V33, P967, DOI 10.1177/1090820X13503473; Parr NM, 2017, J FORENSIC SCI, V62, P1586, DOI 10.1111/1556-4029.13475; Pecora NG, 2008, AM J ORTHOD DENTOFAC, V134, P496, DOI 10.1016/j.ajodo.2006.11.022; Pessa JE, 1999, PLAST RECONSTR SURG, V103, P635, DOI 10.1097/00006534-199902000-00042; Pessa JE, 1998, PLAST RECONSTR SURG, V102, P205, DOI 10.1097/00006534-199807000-00034; Pessa JE, 2008, PLAST RECONSTR SURG, V121, P196, DOI 10.1097/01.prs.0000293864.94138.ae; R Core Team, 2020, R LANG ENV STAT COMP; Richard MJ, 2009, OPHTHAL PLAST RECONS, V25, P382, DOI 10.1097/IOP.0b013e3181b2f766; Robertson JM, 2017, EVOL PSYCHOL-US, V15, DOI 10.1177/1474704917730640; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Shaw RB, 2007, PLAST RECONSTR SURG, V119, P675, DOI 10.1097/01.prs.0000246596.79795.a8; Shaw RB, 2010, PLAST RECONSTR SURG, V125, P332, DOI 10.1097/PRS.0b013e3181c2a685; Shinogaya T, 2001, Clin Oral Investig, V5, P63, DOI 10.1007/s007840000099; Galdames IS, 2012, INT J MORPHOL, V30, P296, DOI 10.4067/S0717-95022012000100053; Avelar LET, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001297; Vallabh R, 2020, BIOMECH MODEL MECHAN, V19, P1187, DOI 10.1007/s10237-019-01133-5; von Cramon-Taubadel N, 2007, AM J PHYS ANTHROPOL, V134, P24, DOI 10.1002/ajpa.20616; Walsh JS., 2018, SURG OXF, V36, P1, DOI [10.1016/j.mpsur.2017.10.006, DOI 10.1016/J.MPSUR.2017.10.006]; Windhager S, 2019, AM J PHYS ANTHROPOL, V169, P678, DOI 10.1002/ajpa.23878; Zelditch LM, 2012, GEOMETRIC MORPHOMETR	58	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253564	10.1371/journal.pone.0253564	http://dx.doi.org/10.1371/journal.pone.0253564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157047	gold, Green Published			2022-12-26	WOS:000671691200036
J	Cekiera, A; Popiel, J; Siemieniuch, M; Jaworski, Z; Slowikowska, M; Siwinska, N; Zak, A; Niedzwiedz, A				Cekiera, Agnieszka; Popiel, Jaroslaw; Siemieniuch, Marta; Jaworski, Zbigniew; Slowikowska, Malwina; Siwinska, Natalia; Zak, Agnieszka; Niedzwiedz, Artur			The examination of biophysical parameters of the skin in Polish Konik horses	PLOS ONE			English	Article							TRANSEPIDERMAL WATER-LOSS; HYDRATION; HEALTHY; CORNEOMETRY; DOGS	This study aimed to assess the biophysical parameters of the skin in Polish Konik horses (Polish primitive horses). According to the authors, this is the first assessment performed on such a wide scale in this group of animals. The evaluation carried out is innovative both with regards to the breed of the animals and the wide scope of the physicochemical skin assessment. The study group comprised mares, stallions and geldings, and the evaluations concerned transepidermal water loss, corneometry, pH, skin temperature assessment and mexametry. These parameters were assessed in five skin regions: the lips, the right ear, the prosternum, the right side of the neck and the chest. The measurements were taken after spreading the hair apart, with the use of a Multiprobe Adapter System (MPA) and dedicated probes (Courage + Khazaka electronic GmbH, Cologne, Germany). The measurements revealed statistically significant differences in the values of transepidermal water loss in the lips in mares compared with stallions (P = 0.023) and also in stallions compared with geldings (P = 0.009). Corneometry showed significantly higher results in the neck region in mares compared with stallions (P = 0.037) and the prosternum areas in mares and geldings compared with stallions (P = 0.037 and P = 0.018). Skin pH measurement on the right side of the neck rendered significantly higher values in stallions than in mares (P = 0.037). In geldings, the skin temperature was significantly higher than in stallions (P = 0.049). Once the appropriate physicochemical values for specific animal species and breeds are determined, non-invasive methods of skin examination in many diseases and also methods of evaluation of the efficacy and/or adverse effects of applied medications can be established.	[Cekiera, Agnieszka; Popiel, Jaroslaw; Slowikowska, Malwina; Siwinska, Natalia; Zak, Agnieszka; Niedzwiedz, Artur] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Internal Med & Clin Dis Horses Dogs & Cats, Wroclaw, Poland; [Siemieniuch, Marta] Polish Acad Sci, Dept Reprod Immunol & Pathol, Inst Anim Reprod & Food Res, Olsztyn, Poland; [Siemieniuch, Marta] PAS, Res Stn Inst Anim Reprod & Food Res, Ruciane Nida, Poland; [Jaworski, Zbigniew] Univ Warmia & Mazury, Dept Horse Breeding & Riding, Olsztyn, Poland	Wroclaw University of Environmental & Life Sciences; Polish Academy of Sciences; Institute of Animal Reproduction & Food Research of the Polish Academy of Sciences; University of Warmia & Mazury	Cekiera, A (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Internal Med & Clin Dis Horses Dogs & Cats, Wroclaw, Poland.	agnieszka.cekiera@upwr.edu.pl	Słowikowska, Malwina Anna/V-5150-2018	Słowikowska, Malwina Anna/0000-0002-7014-956X	Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences [B010/0018/20]; Leading Research Groups support project	Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences; Leading Research Groups support project	The research was financed from statutory research no B010/0018/20 at the Department of Internal Medicine and Clinic of Diseases of Horses, Dogs and Cats, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences. The publication is financed under the Leading Research Groups support project from the subsidy increased for the period 2020-2025 in the amount of 2% of the subsidy referred to Art. 387 (3) of the Law of 20 July 2018 on Higher Education and Science, obtained in 2019.	Beco L, 2000, ANN MED VET, V144, P329; Bordeau P., 2004, VET DERMATOL, V15, P41; Cihocki LM, 2007, VET DERMATOL, V18, P134, DOI 10.1111/j.1365-3164.2007.00574.x; Cornegliani L, 2012, VET DERMATOL, V23, P41, DOI 10.1111/j.1365-3164.2011.01003.x; DIKSTEIN S, 1994, ACTA DERM-VENEREOL, P18; Duteil L, 2017, AGACHES MEASURING SK, P35; Firooz A, 2012, SCI WORLD J, DOI 10.1100/2012/386936; Goodwin SD, 1998, CONTEMP TOP LAB ANIM, V37, P51; Harper DL, 2000, VALUE INFRARED THERM; Hester SL, 2004, J NUTR, V134, p2110S, DOI 10.1093/jn/134.8.2110S; Hightower K, 2010, VET DERMATOL, V21, P88, DOI 10.1111/j.1365-3164.2009.00839.x; Lau-Gillard PJ, 2010, VET DERMATOL, V21, P136, DOI 10.1111/j.1365-3164.2009.00738.x; Loden M, 1995, ACTA DERM-VENEREOL, V75, P449; Loughin CA, 2007, AM J VET RES, V68, P1064, DOI 10.2460/ajvr.68.10.1064; Marsella R, 2014, RES VET SCI, V97, P382, DOI 10.1016/j.rvsc.2014.06.012; Matousek JL, 2002, VET DERMATOL, V13, P293, DOI 10.1046/j.1365-3164.2002.00312.x; Oh WS, 2009, AUST VET J, V87, P409, DOI 10.1111/j.1751-0813.2009.00481.x; Popiel J., 2004, Acta Scientiarum Polonorum - Medicina Veterinaria, V3, P53; RCore Team, 2020, R LANG ENV STAT COMP; Redaelli V, 2014, ANN I SUPER SANITA, V50, P140, DOI 10.4415/ANN_14_02_06; Rekant SI, 2016, AM J VET RES, V77, P98, DOI 10.2460/ajvr.77.1.98; Scott CM, 2001, EQUINE VET J, V33, P605, DOI 10.2746/042516401776563463; Scott DW., 2010, EQUINE DERMATOLOGY, V2nd, P26; Shimada K, 2009, VET DERMATOL, V20, P541, DOI 10.1111/j.1365-3164.2009.00847.x; Szczepanik MP, 2018, POL J VET SCI, V21, P35, DOI 10.24425/119019; Szczepanik MP, 2016, POL J VET SCI, V19, P859, DOI 10.1515/pjvs-2016-0107; Szczepanik MP, 2012, POL J VET SCI, V15, P553, DOI 10.2478/v10181-012-0081-8; Szczepanik MP, 2018, CAN J VET RES, V82, P306; Szczepanik MP, 2011, J FELINE MED SURG, V13, P224, DOI 10.1016/j.jfms.2010.11.003; Watson A, 2002, J NUTR, V132, p1661S, DOI 10.1093/jn/132.6.1661S; Zabei S, WORLD C VET DERM RSV	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0250329	10.1371/journal.pone.0250329	http://dx.doi.org/10.1371/journal.pone.0250329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BF	34153061	gold, Green Published			2022-12-26	WOS:000671691000030
J	Arrieta, A; Woods, J; Wozniak, G; Tsipas, S; Rakotz, M; Jay, S				Arrieta, Alejandro; Woods, John; Wozniak, Gregory; Tsipas, Stavros; Rakotz, Michael; Jay, Stephen			Return on investment of self-measured blood pressure is associated with its use in preventing false diagnoses, not monitoring hypertension	PLOS ONE			English	Article							TASK-FORCE RECOMMENDATION; WHITE-COAT HYPERTENSION; CARDIOVASCULAR RISK; COST-EFFECTIVENESS; PRIMARY-CARE; HOME; OFFICE; ADULTS; PREDICTOR; TITRATION	Previous research indicates that patient self-measured blood pressure (SMBP) is a cost-effective strategy for improving hypertension (HTN) diagnosis and control. However, it is unknown which specific uses of SMBP produce the most value. Our goal is to estimate, from an insurance perspective, the return-on-investment (ROI) and net present value associated with coverage of SMBP devices when used (a) only to diagnose HTN, (b) only to select and titrate medication, (c) only to monitor HTN treatment, or (d) as a bundle with all three uses combined. We employed national sample of claims data, Framingham risk predictions, and published sensitivity-specificity values of SMBP and clinic blood-pressure measurement to extend a previously-developed local decision-analytic simulation model. We then used the extended model to determine which uses of SMBP produce the most economic value when scaled to the U.S. adult population. We found that coverage of SMBP devices yielded positive ROIs for insurers in the short-run and at lifetime horizon when the three uses of SMBP were considered together. When each use was evaluated separately, positive returns were seen when SMBP was used for diagnosis or for medication selection and titration. However, returns were negative when SMBP was used exclusively to monitor HTN treatment. When scaled to the U.S. population, adoption of SMBP would prevent nearly 16.5 million false positive HTN diagnoses, thereby improving quality of care while saving insurance plans $254 per member. A strong economic case exists for insurers to cover the cost of SMBP devices, but it matters how devices are used.	[Arrieta, Alejandro] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA; [Woods, John; Jay, Stephen] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Indianapolis, IN 46204 USA; [Wozniak, Gregory; Tsipas, Stavros; Rakotz, Michael] Amer Med Assoc, Improving Hlth Outcomes, 515 N State St, Chicago, IL 60610 USA; [Jay, Stephen] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	State University System of Florida; Florida International University; Indiana University System; Indiana University-Purdue University Indianapolis; American Medical Association; Indiana University System; Indiana University Bloomington	Arrieta, A (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA.	alejarri@fiu.edu		Arrieta, Alejandro/0000-0002-7628-8894; Wozniak, Gregory/0000-0003-4245-8207	American Medical Association	American Medical Association	AA, JW and SJ received funding for this work from the American Medical Association. GW, ST, and MR work at the American Medical Association, and they played a role in the analysis of the Truven Health MarketScan (R) Lab Database, in the decision to publish, and in the review of the final document.	Agarwal R, 2011, HYPERTENSION, V57, P29, DOI 10.1161/HYPERTENSIONAHA.110.160911; American Medical Association, 2018, ED SUMM PAN ACT; Arrieta A, 2014, HYPERTENSION, V64, P891, DOI 10.1161/HYPERTENSIONAHA.114.03780; Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558; Beyhaghi H, 2019, HYPERTENSION, V73, P121, DOI 10.1161/HYPERTENSIONAHA.118.11715; Bliziotis IA, 2012, J HYPERTENS, V30, P1289, DOI 10.1097/HJH.0b013e3283531eaf; Blue Cross Blue Shield Federal Employee Program, HYPERTENSION MANAGEM; Bonafede MM, 2015, CLINICOECONOMIC OUTC, V7, P337, DOI 10.2147/CEOR.S76972; Briasoulis A, 2016, J HYPERTENS, V34, P593, DOI 10.1097/HJH.0000000000000832; Centers for Medicare and Medicaid Services, ANN CAL YEAR CY 2013; Cohen JB, 2019, ANN INTERN MED, V170, P853, DOI 10.7326/M19-0223; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Davis KE., 2013, STAT BRIEF 404 EXPEN; Fagard RH, 2005, J HUM HYPERTENS, V19, P801, DOI 10.1038/sj.jhh.1001903; Franklin SS, 2016, J AM COLL CARDIOL, V68, P2033, DOI 10.1016/j.jacc.2016.08.035; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Hansen L, 2019, TRUVEN HLTH MARKETSC; Hodgkinson J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3621; Huang YL, 2017, J HYPERTENS, V35, P677, DOI 10.1097/HJH.0000000000001226; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; Jacob V, 2017, AM J PREV MED, V53, pE105, DOI 10.1016/j.amepre.2017.03.002; Krakoff LR, 2019, HYPERTENSION, V73, P45, DOI 10.1161/HYPERTENSIONAHA.118.11930; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Lovibond K, 2011, LANCET, V378, P1219, DOI 10.1016/S0140-6736(11)61184-7; Ma J, 2008, HYPERTENSION, V51, P1275, DOI 10.1161/HYPERTENSIONAHA.107.107086; Mancia G, 2011, HYPERTENSION, V57, P21, DOI 10.1161/HYPERTENSIONAHA.110.163188; McManus RJ, 2018, LANCET, V391, P949, DOI 10.1016/S0140-6736(18)30309-X; McManus RJ, 2014, JAMA-J AM MED ASSOC, V312, P799, DOI 10.1001/jama.2014.10057; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; National Center for Health Statistics, 2013, NATL HLTH NUTR EXAMI; Nerenberg KA, 2018, CAN J CARDIOL, V34, P506, DOI 10.1016/j.cjca.2018.02.022; Niiranen TJ, 2010, HYPERTENSION, V55, P1346, DOI 10.1161/HYPERTENSIONAHA.109.149336; Nwankwo Tatiana, 2013, NCHS Data Brief, P1; Ogedegbe G, 2008, ARCH INTERN MED, V168, P2459, DOI 10.1001/archinte.168.22.2459; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Shimbo D, 2020, CIRCULATION, V142, pE42, DOI 10.1161/CIR.0000000000000803; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Tucker KL, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002389; Uhlig K., 2012, AGE HEALTHCAR RES QU; UK NCGC, 2011, 1016 KYOT U KYOT I E; VERDECCHIA P, 1994, HYPERTENSION, V24, P793, DOI 10.1161/01.HYP.24.6.793; Virani SS, 2021, CIRCULATION, V143, pe254, DOI 10.1161/CIR.0000000000000950; Weber MA, 2016, J CLIN HYPERTENS, V18, P172, DOI 10.1111/jch.12798; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252701	10.1371/journal.pone.0252701	http://dx.doi.org/10.1371/journal.pone.0252701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143817	gold, Green Published			2022-12-26	WOS:000671690700013
J	Wang, GB; Ma, ML; Jiang, LL; Chen, FY; Xu, LS				Wang, Guobo; Ma, Minglu; Jiang, Lili; Chen, Fengyun; Xu, Liansheng			Multiple imputation of maritime search and rescue data at multiple missing patterns	PLOS ONE			English	Article							CAPABILITY EVALUATION	Based on the missing situation and actual needs of maritime search and rescue data, multiple imputation methods were used to construct complete data sets under different missing patterns. Probability density curves and overimputation diagnostics were used to explore the effects of multiple imputation. The results showed that the Data Augmentation (DA) algorithm had the characteristics of high operation efficiency and good imputation effect, but the algorithm was not suitable for data imputation when there was a high data missing rate. The EMB algorithm effectively restored the distribution of datasets with different data missing rates, and was less affected by the missing position; the EMB algorithm could obtain a good imputation effect even when there was a high data missing rate. Overimputation diagnostics could not only reflect the data imputation effect, but also show the correlation between different datasets, which was of great importance for deep data mining and imputation effect improvement. The Expectation-Maximization with Bootstrap (EMB) algorithm had a poor estimation effect on extreme data and failed to reflect the dataset's variability characteristics.	[Wang, Guobo; Ma, Minglu; Jiang, Lili; Chen, Fengyun; Xu, Liansheng] China Waterborne Transport Res Inst, Beijing, Peoples R China		Jiang, LL (corresponding author), China Waterborne Transport Res Inst, Beijing, Peoples R China.	jianglili@wti.ac.cn			National Science and Technology Support Program [2015BAG20B01]; National Key R&D Program of China [2017YFC1404705]	National Science and Technology Support Program; National Key R&D Program of China	This work was supported by the [National Science and Technology Support Program] under Grant [2015BAG20B01]; [National Key R&D Program of China] under Grant [2017YFC1404705].	Audigier V, 2018, STAT SCI, V33, P160, DOI 10.1214/18-STS646; Fawzi A, 2016, IEEE IMAGE PROC, P3688, DOI 10.1109/ICIP.2016.7533048; Futch V, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00301; Huang CH, 2019, CLUSTER COMPUT, V22, pS4551, DOI 10.1007/s10586-018-2089-z; Jonkeren O, 2016, TRANSPORT REV, V36, P437, DOI 10.1080/01441647.2015.1137654; Liu L, INT C MATH MOD SIM A, DOI [10.2991/mmsa-18.2018.30, DOI 10.2991/MMSA-18.2018.30]; Maritime Safety Administration of the Ministry of transport of China, 2019, CHINA MARIT SAF, V5, P32, DOI [10.16831/j.cnki.issn1673-2278.2019.05.015, DOI 10.16831/J.CNKI.ISSN1673-2278.2019.05.015]; Mou JM, 2019, ACCIDENT ANAL PREV, V123, P461, DOI 10.1016/j.aap.2016.07.037; Munoz-Bulnes J, 2017, IEEE INT C INTELL TR; Nieh C, 2014, ENVIRON SCI-PROC IMP, V16, P1145, DOI 10.1039/c3em00721a; Rawlings AM, 2017, EUR J EPIDEMIOL, V32, P55, DOI 10.1007/s10654-016-0197-8; Tong SQ, 2017, SAFETY SCI, V92, P128, DOI 10.1016/j.ssci.2016.10.004; Tu NW, 2018, TRANSPORT RES E-LOG, V117, P108, DOI 10.1016/j.tre.2017.10.001; Vitale D, 2019, J ENVIRON INFORM, V34, P68, DOI 10.3808/jei.201800391; Wang K, 2016, DESIGN, MANUFACTURING AND MECHATRONICS (ICDMM 2015), P1420; Xu ZY, 2014, ADV MATER RES-SWITZ, V1049, P1444, DOI 10.4028/www.scientific.net/AMR.1049-1050.1444; Yu WH, 2009, 2009 INTERNATIONAL CONFERENCE ON ENVIRONMENTAL SCIENCE AND INFORMATION APPLICATION TECHNOLOGY, VOL II, PROCEEDINGS, P140, DOI 10.1109/ESIAT.2009.155; Zhang K, 2019, INT C TRANSP INF SAF, DOI [10.1109/ICTIS.2019.8883768, DOI 10.1109/ICTIS.2019.8883768]; [赵强 Zhao Qiang], 2017, [大连海事大学学报, Journal of Dalian Maritime University], V43, P19	19	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252129	10.1371/journal.pone.0252129	http://dx.doi.org/10.1371/journal.pone.0252129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143787	gold, Green Published			2022-12-26	WOS:000671690700053
J	Alsady, TM; Kaireit, TF; Behrendt, L; Winther, HB; Olsson, KM; Wacker, F; Hoeper, MM; Cebotari, S; Vogel-Claussen, J				Alsady, Tawfik Moher; Kaireit, Till F.; Behrendt, Lea; Winther, Hinrich B.; Olsson, Karen M.; Wacker, Frank; Hoeper, Marius M.; Cebotari, Serghei; Vogel-Claussen, Jens			Comparison of dual-energy computer tomography and dynamic contrast-enhanced MRI for evaluating lung perfusion defects in chronic thromboembolic pulmonary hypertension	PLOS ONE			English	Article							SPECT; CT	Objectives To evaluate the agreement in detecting pulmonary perfusion defects in patients with chronic thromboembolic pulmonary hypertension using dual-energy CT and dynamic contrast-enhanced MRI. Second, to compare both imaging modalities in monitoring lung perfusion changes in these patients after undergoing pulmonary endarterectomy. Methods 20 patients were examined with CT and MRI before and/or after pulmonary endarterectomy. Estimated perfusion defect percentage from both modalities was compared in a lobe-based analysis. Spatial agreement of perfusion defect maps was also assessed. Results A significant correlation between CT and MRI based perfusion defect percentage was calculated in all lung lobes (r > 0.78; p < 0.001). In addition, a good spatial agreement between perfusion defect maps was found (mean spatial overlap for the whole lung was 68.2%; SD = 6.9). Both CT and MRI detected improvements in pulmonary perfusion after pulmonary endarterectomy: 8% and 7% decrease in whole lung perfusion defect percentage (p = 0.007 and 0.004), respectively. In a lobe-wise analysis, improvements were statistically significant only in lower lobes using both modalities (reduction in defect percentage ranged from 16-29%; p < 0.02). Conclusions Dual-energy CT is an alternative to MRI in monitoring chronic thromboembolic pulmonary hypertension. Both imaging modalities provided comparable estimations of perfusion defects and could detect similar improvement in lung perfusion after pulmonary endarterectomy.	[Alsady, Tawfik Moher; Kaireit, Till F.; Behrendt, Lea; Winther, Hinrich B.; Wacker, Frank; Vogel-Claussen, Jens] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Lower Saxony, Germany; [Alsady, Tawfik Moher; Kaireit, Till F.; Behrendt, Lea; Olsson, Karen M.; Wacker, Frank; Hoeper, Marius M.; Vogel-Claussen, Jens] German Ctr Lung Res, Biomed Res End Stage & Obstruct Lung Dis Breath, Hannover, Lower Saxony, Germany; [Olsson, Karen M.; Hoeper, Marius M.] Hannover Med Sch, Dept Resp Med, Hannover, Lower Saxony, Germany; [Cebotari, Serghei] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg HTTG, Hannover, Lower Saxony, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Vogel-Claussen, J (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Lower Saxony, Germany.; Vogel-Claussen, J (corresponding author), German Ctr Lung Res, Biomed Res End Stage & Obstruct Lung Dis Breath, Hannover, Lower Saxony, Germany.	vogel-claussen.jens@mh-hannover.de	Winther, Hinrich/GZL-6044-2022	Vogel-Claussen, Jens/0000-0001-5595-6948; Moher Alsady, Tawfik/0000-0002-0779-0688				Abadi M., 2016, TENSORFLOW LARGE SCA; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Burrowes K S, 2011, Pulm Circ, V1, P365, DOI 10.4103/2045-8932.87302; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Delcroix M, 2016, CIRCULATION, V133, P859, DOI 10.1161/CIRCULATIONAHA.115.016522; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gall H, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0121-2016; Gopalan D, 2016, ANN AM THORAC SOC, V13, pS222, DOI 10.1513/AnnalsATS.201509-623AS; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Johns CS, 2017, J MAGN RESON IMAGING, V46, P1693, DOI 10.1002/jmri.25714; Klok FA, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01687-2018; Koike H, 2016, EUR J RADIOL, V85, P1607, DOI 10.1016/j.ejrad.2016.06.016; Mahmud E, 2018, J AM COLL CARDIOL, V71, P2468, DOI 10.1016/j.jacc.2018.04.009; Masy M, 2018, EUR RADIOL, V28, P5100, DOI 10.1007/s00330-018-5467-2; Meysman M, 2015, EUR J RADIOL, V84, P1816, DOI 10.1016/j.ejrad.2015.05.023; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Nakazawa T, 2011, J COMPUT ASSIST TOMO, V35, P590, DOI 10.1097/RCT.0b013e318224e227; Rajaram S, 2013, THORAX, V68, P677, DOI 10.1136/thoraxjnl-2012-203020; Schoenfeld C, 2019, EUR RADIOL, V29, P1693, DOI 10.1007/s00330-018-5696-4; Schoenfeld C, 2016, RADIOLOGY, V279, P925, DOI 10.1148/radiol.2015150765; Skoro-Sajer N, 2014, THORAX, V69, P116, DOI 10.1136/thoraxjnl-2013-203746; Sourbron S, 2007, PHYS MED BIOL, V52, P6761, DOI 10.1088/0031-9155/52/22/014; Wilkens H, 2018, INT J CARDIOL, V272, P69, DOI 10.1016/j.ijcard.2018.08.079; Winther HB, 2020, J MAGN RESON IMAGING, V51, P571, DOI 10.1002/jmri.26853; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	25	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0251740	10.1371/journal.pone.0251740	http://dx.doi.org/10.1371/journal.pone.0251740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138864	gold, Green Published			2022-12-26	WOS:000671690200123
J	Tseng, YJ; Sandwith, SN; Green, KM; Chambers, AE; Krans, A; Raimer, HM; Sharlow, ME; Reisinger, MA; Richardson, AE; Routh, ED; Smaldino, MA; Wang, YH; Vaughn, JP; Todd, PK; Smaldino, PJ				Tseng, Yi-Ju; Sandwith, Siara N.; Green, Katelyn M.; Chambers, Antonio E.; Krans, Amy; Raimer, Heather M.; Sharlow, Meredith E.; Reisinger, Michael A.; Richardson, Adam E.; Routh, Eric D.; Smaldino, Melissa A.; Wang, Yuh-Hwa; Vaughn, James P.; Todd, Peter K.; Smaldino, Philip J.			The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX STRUCTURES; NON-AUG TRANSLATION; TETRAMOLECULAR QUADRUPLEX; RESOLVING ACTIVITY; SMALL MOLECULES; MAJOR SOURCE; CGG REPEATS; IN-VITRO; DNA; EXPANSION	GGGGCC (G4C2) hexanucleotide repeat expansions in the endosomal trafficking gene C9orf72 are the most common genetic cause of ALS and frontotemporal dementia. Repeat-associated non-AUG (RAN) translation of this expansion through near-cognate initiation codon usage and internal ri-bosomal entry generates toxic proteins that accumulate in patients' brains and contribute to disease pathogenesis. The helicase protein DEAH-box helicase 36 (DHX36-G4R1) plays active roles in RNA and DNA G-quadruplex (G4) resolution in cells. As G4C2 repeats are known to form G4 structures in vitro, we sought to determine the impact of manipulating DHX36 expression on repeat transcription and RAN translation. Using a series of luciferase reporter assays both in cells and in vitro, we found that DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, whereas overexpression of DHX36 enhances RAN translation from G4C2 reporter RNAs. Moreover, upregulation of RAN translation that is typically triggered by integrated stress response activation is prevented by loss of DHX36. These results suggest that DHX36 is active in regulating G(4)C(2) repeat translation, providing potential impli-cations for therapeutic development in nucleotide repeat expansion disorders.	[Tseng, Yi-Ju; Green, Katelyn M.; Krans, Amy; Todd, Peter K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Tseng, Yi-Ju] Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Sandwith, Siara N.; Chambers, Antonio E.; Sharlow, Meredith E.; Reisinger, Michael A.; Richardson, Adam E.; Smaldino, Melissa A.; Smaldino, Philip J.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Raimer, Heather M.; Wang, Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Routh, Eric D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Vaughn, James P.] NanoMedica LLC, Div Canc Biol, Winston Salem, NC USA; [Todd, Peter K.] Ann Arbor VA Med Ctr, Dept Neurol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ball State University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Todd, PK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Smaldino, PJ (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.; Todd, PK (corresponding author), Ann Arbor VA Med Ctr, Dept Neurol, Ann Arbor, MI 48105 USA.	petertod@med.umich.edu; pjsmaldino@bsu.edu		Routh, Eric/0000-0002-7371-1802; Tseng, Yi-Ju/0000-0002-2242-6200; Raimer Young, Heather/0000-0002-7415-6011	National Institutes of Health [R15 AG067291, T32GM008136, RO1GM101192, P50HD104463, R01NS099280, R01NS086810, BLRD BX004842, BX003231]; University of Michigan; Ball State University; Amyotrophic Lateral Sclerosis Association [18-IIA-406]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Ball State University; Amyotrophic Lateral Sclerosis Association	This work was funded by the National Institutes of Health (R15 AG067291 to P. J. S., T32GM008136 to H. M. R., RO1GM101192 to Y.-H. W., P50HD104463, R01NS099280, and R01NS086810 to P. K. T.), VA (BLRD BX004842 and BX003231 to P. K. T.), the University of Michigan (Cellular and Molecular Biology Graduate program and the Chia-Lun Lo Fellowship to Y.-J. T.), Ball State University (Startup Funds and Junior Faculty ASPIRE grant to P. J. S., Graduate Student ASPIRE grant to A. E. R.), and Amyotrophic Lateral Sclerosis Association grant 18-IIA-406 to P. J. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almeida S, 2019, ACTA NEUROPATHOL, V138, P1099, DOI 10.1007/s00401-019-02083-z; Asamitsu S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd9440; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2016, J BIOL CHEM, V291, P5355, DOI 10.1074/jbc.M115.711499; Booy Evan P, 2015, Methods Mol Biol, V1259, P125, DOI 10.1007/978-1-4939-2214-7_9; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Brunelle JL, 2013, METHOD ENZYMOL, V530, P101, DOI 10.1016/B978-0-12-420037-1.00005-1; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Buijsen RAM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0162-2; Byrd AK, 2016, J BIOL CHEM, V291, P18041, DOI 10.1074/jbc.M116.718478; Byrne S, 2014, AMYOTROPH LAT SCL FR, V15, P148, DOI 10.3109/21678421.2013.838586; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Cheng WW, 2019, NEURON, V104, P885, DOI 10.1016/j.neuron.2019.09.003; Cheng WW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02495-z; Conlon EG, 2016, ELIFE, V5, DOI 10.7554/eLife.17820; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Goodman LD, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0711-9; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Hukema RK, 2015, HUM MOL GENET, V24, P4948, DOI 10.1093/hmg/ddv216; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Krans A, 2016, ANN NEUROL, V80, P871, DOI 10.1002/ana.24800; Linsalata AE, 2019, EMBO REP, V20, DOI 10.15252/embr.201847498; Liu HH, 2021, J AM CHEM SOC, V143, P7368, DOI 10.1021/jacs.1c00131; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Maltby CJ, 2020, NUCLEIC ACIDS RES, V48, P9822, DOI 10.1093/nar/gkaa699; Mcrae EKS, 2017, NUCLEIC ACIDS RES, V45, P6656, DOI 10.1093/nar/gkx380; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Murat P, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1602-2; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rodriguez CM, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104515; Sauer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10432-5; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schofield JPR, 2015, BIOCHEM SOC T, V43, P338, DOI 10.1042/BST20150053; Schult P, 2021, BIOL CHEM, V402, P581, DOI 10.1515/hsz-2020-0292; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Simone R, 2018, EMBO MOL MED, V10, P22, DOI 10.15252/emmm.201707850; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Smaldino PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132668; Sonobe Y, 2018, NEUROBIOL DIS, V116, P155, DOI 10.1016/j.nbd.2018.05.009; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Tabet R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02643-5; Taylor JP, 2017, P NATL ACAD SCI USA, V114, P1445, DOI 10.1073/pnas.1621085114; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Umoh ME, 2016, NEUROLOGY, V87, P1024, DOI 10.1212/WNL.0000000000003067; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Van Mossevelde S, 2017, CURR OPIN GENET DEV, V44, P117, DOI 10.1016/j.gde.2017.02.008; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Vester K, 2019, BIOCHEM BIOPH RES CO, V508, P756, DOI 10.1016/j.bbrc.2018.11.186; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Westergard T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809423; Westergard T, 2016, CELL REP, V17, P645, DOI 10.1016/j.celrep.2016.09.032; Yamada SB, 2019, NAT NEUROSCI, V22, P1383, DOI 10.1038/s41593-019-0455-7; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; Young SK, 2016, J BIOL CHEM, V291, P10824, DOI 10.1074/jbc.M116.722256; Zamiri B, 2014, J BIOL CHEM, V289, P4653, DOI 10.1074/jbc.C113.502336; Zhou B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16673; Zu T, 2020, P NATL ACAD SCI USA, V117, P18591, DOI 10.1073/pnas.2005748117; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	85	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100914	10.1016/j.jbc.2021.100914	http://dx.doi.org/10.1016/j.jbc.2021.100914			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174288	gold, Green Published			2022-12-26	WOS:000690879300011
J	Hamdani, E; Popek, M; Frontczak-Baniewicz, M; Utheim, TP; Albrecht, J; Zielinska, M; Chaudhry, FA				Hamdani, El Hassan; Popek, Mariusz; Frontczak-Baniewicz, Malgorzata; Utheim, Tor Paaske; Albrecht, Jan; Zielinska, Magdalena; Chaudhry, Farrukh Abbas			Perturbation of astroglial Slc38 glutamine transporters by NH4 (+) contributes to neurophysiologic manifestations in acute liver failure	FASEB JOURNAL			English	Article						hepatic encephalopathy; NH4; (+); Slc38; Slc38a3; SNAT3	SWELLING-INDUCED CHANGES; BLOOD-BRAIN-BARRIER; SYSTEM-N; GLIAL-CELLS; HEPATIC-ENCEPHALOPATHY; ELECTROPHYSIOLOGICAL PROPERTIES; CULTURED ASTROCYTES; AMINO-ACIDS; AMMONIA; EXPRESSION	Ammonia is considered the main pathogenic toxin in hepatic encephalopathy (HE). However, the molecular mechanisms involved have been disputed. As altered glutamatergic and GABAergic neurotransmission has been reported in HE, we investigated whether four members of the solute carrier 38 (Slc38) family of amino acid transporters-involved in the replenishment of glutamate and GABA-contribute to ammonia neurotoxicity in HE. We show that ammonium ion exerts multiple actions on the Slc38 transporters: It competes with glutamine for the binding to the system N transporters Slc38a3 and Slc38a5, consequently inhibiting bidirectional astroglial glutamine transport. It also competes with H+, Na+, and K+ for uncoupled permeation through the same transporters, which may perturb astroglial intracellular pH, membrane potential, and K+-buffering. Knockdown of Slc38a3 in mice results in cerebral cortical edema and disrupted neurotransmitter synthesis mimicking events contributing to HE development. Finally, in a mouse model of acute liver failure (ALF), we demonstrate the downregulation of Slc38a3 protein, impeded astroglial glutamine release, and cytotoxic edema. Altogether, we demonstrate contribution of Slc38 transporters to the ammonia-induced impairment of glutamine recycling between astrocytes and neurons, a phenomenon underlying acute ammonia neurotoxicity in the setting of ALF.	[Hamdani, El Hassan; Chaudhry, Farrukh Abbas] Univ Oslo UiO, Dept Mol Med, Oslo, Norway; [Hamdani, El Hassan] Oslo Metropolitan Univ, Inst Behav Sci, Oslo, Norway; [Popek, Mariusz; Albrecht, Jan; Zielinska, Magdalena] Mossakowski Med Res Inst PAS, Neurotoxicol Dept, Warsaw, Poland; [Frontczak-Baniewicz, Malgorzata] Mossakowski Med Res Inst PAS, Electron Microscopy Platform, Warsaw, Poland; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske; Chaudhry, Farrukh Abbas] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway	University of Oslo; Oslo Metropolitan University (OsloMet); Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Oslo; University of Oslo	Zielinska, M (corresponding author), Mossakowski Med Res Inst PAS, Neurotoxicol Dept, Warsaw, Poland.; Chaudhry, FA (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Mol Med, POB 1110, N-0317 Oslo, Norway.	mzielinska@imdik.pan.pl; f.a.chaudhry@medisin.uio.no	Zielińska, Magdalena/S-6624-2019	Zielińska, Magdalena/0000-0001-7388-3092; Chaudhry, Farrukh Abbas/0000-0002-2039-9667; Popek, Mariusz/0000-0003-4394-3394	National Centre for Research (NCBiR) Polish Norwegian Research Program [Pol-Nor/196190/23/2013]; South-Eastern Norway Regional Health Authority [21561/2017052]; UiO:Life Science	National Centre for Research (NCBiR) Polish Norwegian Research Program; South-Eastern Norway Regional Health Authority; UiO:Life Science	The National Centre for Research (NCBiR) Polish Norwegian Research Program, Grant/Award Number: Pol-Nor/196190/23/2013; South-Eastern Norway Regional Health Authority, Grant/Award Number: ID 21561/2017052; UiO:Life Science	Albrecht J, 1999, J NEUROL SCI, V170, P138, DOI 10.1016/S0022-510X(99)00169-0; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Aldridge DR, 2015, J CLIN EXP HEPATOL, V5, pS7, DOI 10.1016/j.jceh.2014.06.004; Baird FE, 2004, J PHYSIOL-LONDON, V559, P367, DOI 10.1113/jphysiol.2003.060293; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Boulland JL, 2003, GLIA, V41, P260, DOI 10.1002/glia.10188; Boulland JL, 2002, EUR J NEUROSCI, V15, P1615, DOI 10.1046/j.1460-9568.2002.01995.x; Broer A, 2002, J PHYSIOL-LONDON, V539, P3, DOI 10.1013/jphysiol.2001.013303; Brusilow SW, 2010, NEUROTHERAPEUTICS, V7, P452, DOI 10.1016/j.nurt.2010.05.015; Burckhardt BC, 1997, PFLUG ARCH EUR J PHY, V434, P306, DOI 10.1007/s004240050401; BUTTERWORTH RF, 1987, NEUROCHEM PATHOL, V6, P1, DOI 10.1007/BF02833598; Chang ML, 2007, J ANAT, V210, P54, DOI 10.1111/j.1469-7580.2006.00671.x; Chaudhry FA, 2002, J NEUROSCI, V22, P62, DOI 10.1523/JNEUROSCI.22-01-00062.2002; Chaudhry FA, 2001, EMBO J, V20, P7041, DOI 10.1093/emboj/20.24.7041; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Cittolin-Santos GF, 2019, NEUROSCIENCE, V401, P117, DOI 10.1016/j.neuroscience.2018.12.032; Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016; Cubelos B, 2005, GLIA, V49, P230, DOI 10.1002/glia.20106; Dolgodilina E, 2016, J CEREBR BLOOD F MET, V36, P1929, DOI 10.1177/0271678X15609331; Ennis SR, 1998, J NEUROCHEM, V71, P2565; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Felipo V, 2013, NAT REV NEUROSCI, V14, P851, DOI 10.1038/nrn3587; Fleischer W, 2017, EXP NEUROL, V290, P41, DOI 10.1016/j.expneurol.2017.01.003; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Hamdani E, 2012, GLIA, V60, P1671, DOI 10.1002/glia.22386; HILGIER W, 1994, J NEUROCHEM, V62, P197; Hilgier W, 1999, J NEUROSCI RES, V56, P76, DOI 10.1002/(SICI)1097-4547(19990401)56:1<76::AID-JNR10>3.0.CO;2-Y; Jenstad M, 2009, CEREB CORTEX, V19, P1092, DOI 10.1093/cercor/bhn151; KIMELBERG HK, 1990, BRAIN RES, V529, P255, DOI 10.1016/0006-8993(90)90835-Y; KIMELBERG HK, 1990, BRAIN RES, V529, P262, DOI 10.1016/0006-8993(90)90836-Z; Kosenko EA, 2014, CNS NEUROL DISORD-DR, V13, P1089, DOI 10.2174/1871527313666140806155929; Lee WJ, 1998, AM J PHYSIOL-CELL PH, V274, pC1101, DOI 10.1152/ajpcell.1998.274.4.C1101; Leke R, 2011, J NEUROCHEM, V117, P824, DOI 10.1111/j.1471-4159.2011.07244.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106; Malaguarnera M, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00132; MANS AM, 1994, J NEUROCHEM, V63, P1829; Marcaggi P, 2004, EUR J NEUROSCI, V19, P966, DOI 10.1111/j.0953-816X.2004.03165.x; Marcaggi P, 2001, PROG NEUROBIOL, V64, P157, DOI 10.1016/S0301-0082(00)00043-5; MARTINEZHERNANDEZ A, 1977, SCIENCE, V195, P1356, DOI 10.1126/science.14400; Matkowskyj KA, 1999, AM J PHYSIOL-GASTR L, V277, pG455, DOI 10.1152/ajpgi.1999.277.2.G455; Menchini RJ, 2019, NEUROPHARMACOLOGY, V161, DOI 10.1016/j.neuropharm.2019.107789; Niranjan-Azadi Ashwini M, 2016, Ann Transplant, V21, P479; Nissen-Meyer LSH, 2011, J NEUROSCI, V31, P6565, DOI 10.1523/JNEUROSCI.3694-10.2011; Popek M, 2020, NEUROSCIENCE, V446, P124, DOI 10.1016/j.neuroscience.2020.08.019; Popek M, 2018, MOL NEUROBIOL, V55, P1244, DOI 10.1007/s12035-016-0367-4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Qureshi T, 2019, CEREB CORTEX, V29, P5166, DOI 10.1093/cercor/bhz055; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; Schneider HP, 2007, J BIOL CHEM, V282, P3788, DOI 10.1074/jbc.M609452200; Scott TR, 2013, WORLD J GASTROENTERO, V19, P9240, DOI 10.3748/wjg.v19.i48.9240; Solbu TT, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.001.2010; SWAIN M, 1992, HEPATOLOGY, V15, P449, DOI 10.1002/hep.1840150316; Thrane VR, 2013, NAT MED, V19, P1643, DOI 10.1038/nm.3400; Umapathy NS, 2008, INVEST OPHTH VIS SCI, V49, P5151, DOI 10.1167/iovs.08-2245; WillardMack CL, 1996, NEUROSCIENCE, V71, P589, DOI 10.1016/0306-4522(95)00462-9; Zielinska M, 2016, J NEUROCHEM, V136, P329, DOI 10.1111/jnc.13376	60	8	8	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21588	10.1096/fj.202001712RR	http://dx.doi.org/10.1096/fj.202001712RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169573	Green Published, hybrid			2022-12-26	WOS:000667814100002
J	Wu, KL; Wu, HZ; Lyu, W; Kim, Y; Furdui, CM; Anderson, KS; Koleske, AJ				Wu, Kuanlin; Wu, Hanzhi; Lyu, Wanqing; Kim, Youngjoo; Furdui, Cristina M.; Anderson, Karen S.; Koleske, Anthony J.			Platelet-derived growth factor receptor beta activates Abl2 via direct binding and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; DNA-DAMAGE RESPONSE; C-ABL; FAMILY KINASES; SRC FAMILY; ARG; DOMAIN; CORTACTIN; PATHWAYS; ADHESION	Abl family kinases are nonreceptor tyrosine kinases activated by diverse cellular stimuli that regulate cytoskeleton organization, morphogenesis, and adhesion. The catalytic activity of Abl family kinases is tightly regulated in cells by a complex set of intramolecular and intermolecular interactions and post-translational modifications. For example, the platelet-derived growth factor receptor beta (PDGFR beta), important for cell proliferation and chemotaxis, is a potent activator of Abl family kinases. However, the molecular mechanism by which PDGFR beta engages and activates Abl family kinases is not known. We show here that the Abl2 Src homology 2 domain directly binds to phosphotyrosine Y771 in the PDGFR beta cytoplasmic domain. PDGFR beta directly phosphorylates multiple novel sites on the N-terminal half of Abl2, including Y116, Y139, and Y161 within the Src homology 3 domain, and Y299, Y303, and Y310 on the kinase domain. Y116, Y161, Y272, and Y310 are all located at or near the Src homology 3/Src homology 2-kinase linker interface, which helps maintain Abl family kinases in an autoinhibited conformation. We also found that PDGFR beta-mediated phosphorylation of Abl2 in vitro activates Abl2 kinase activity, but mutation of these four tyrosines (Y116, Y161, Y272, and Y310) to phenylalanine abrogated PDGFR beta-mediated activation of Abl2. These findings reveal how PDGFR beta engages and phosphorylates Abl2 leading to activation of the kinase, providing a framework to understand how growth factor receptors engage and activate Abl family kinases.	[Wu, Kuanlin; Lyu, Wanqing; Anderson, Karen S.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wu, Hanzhi; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Kim, Youngjoo; Anderson, Karen S.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Koleske, Anthony J.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA	Yale University; Wake Forest University; Yale University; Yale University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Koleske, AJ (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.	anthony.koleske@yale.edu		Furdui, Cristina M./0000-0003-3771-7999	American Heart Association; National Institutes of Healthgrants [MH115939, NS105640, NS112121, CA12197]	American Heart Association(American Heart Association); National Institutes of Healthgrants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K. W. was supported by a predoctoral fellowship from the American Heart Association. This work was supported by the National Institutes of Healthgrants MH115939, NS105640, NS112121 (A. J. K.) and CA12197 (C. M. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Ekman S, 2002, ONCOGENE, V21, P1870, DOI 10.1038/sj.onc.1205210; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O., 2006, ABL FAMILY KINASES D, P1; Heldin CH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009100; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hu YH, 2019, J CELL BIOL, V218, P3986, DOI 10.1083/jcb.201812144; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Meltser V, 2011, CELL DEATH DIFFER, V18, P2, DOI 10.1038/cdd.2010.132; Mero B, 2019, J BIOL CHEM, V294, P4608, DOI 10.1074/jbc.RA118.004732; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Simpson MA, 2015, J BIOL CHEM, V290, P8360, DOI 10.1074/jbc.M115.638874; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Tanos BE, 2007, CELL SIGNAL, V19, P1602, DOI 10.1016/j.cellsig.2007.02.008; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Weigel MT, 2013, ANN ONCOL, V24, P126, DOI 10.1093/annonc/mds240; Wetzel DM, 2016, J CELL SCI, V129, P3130, DOI 10.1242/jcs.185595; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xie T, 2020, SCIENCE, V370, P189, DOI 10.1126/science.abc2754; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021	53	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100883	10.1016/j.jbc.2021.100883	http://dx.doi.org/10.1016/j.jbc.2021.100883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144039	gold, Green Published			2022-12-26	WOS:000678068400082
J	Yao, XQ; Liu, ZY; Chen, JY; Huang, ZC; Liu, JH; Sun, BH; Zhu, QA; Ding, RT; Chen, JT				Yao, Xin-Qiang; Liu, Zhong-Yuan; Chen, Jia-Ying; Huang, Zu-Cheng; Liu, Jun-Hao; Sun, Bai-Hui; Zhu, Qing-An; Ding, Ruo-Ting; Chen, Jian-Ting			Proteomics and bioinformatics reveal insights into neuroinflammation in the acute to subacute phases in rat models of spinal cord contusion injury	FASEB JOURNAL			English	Article						lipid metabolism; lysosomes; neuroinflammation; proteomics; spinal cord injury	INFLAMMATORY RESPONSE; COMPLEMENT; ACTIVATION; CLEARANCE; MICROGLIA; PATHWAYS; PACKAGE; CNS	Neuroinflammation is recognized as a hallmark of spinal cord injury (SCI). Although neuroinflammation is an important pathogenic factor that leads to secondary injuries after SCI, neuroprotective anti-inflammatory treatments remain ineffective in the management of SCI. Moreover, the molecular signatures involved in the pathophysiological changes that occur during the course of SCI remain ambiguous. The current study investigated the proteins and pathways involved in C5 spinal cord hemi-contusion injury using a rat model by means of 4-D label-free proteomic analysis. Furthermore, two Gene Expression Omnibus (GEO) transcriptomic datasets, Western blot assays, and immunofluorescent staining were used to validate the expression levels and localization of dysregulated proteins. The present study observed that the rat models of SCI were associated with the enrichment of proteins related to the complement and coagulation cascades, cholesterol metabolism, and lysosome pathway throughout the acute and subacute phases of injury. Intriguingly, the current study also observed that 75 genes were significantly altered in both the GEO datasets, including ANXA1, C1QC, CTSZ, GM2A, GPNMB, and PYCARD. Further temporal clustering analysis revealed that the continuously upregulated protein cluster was associated with immune response, lipid regulation, lysosome pathway, and myeloid cells. Additionally, five proteins were further validated by means of Western blot assays and the immunofluorescent staining showed that these proteins coexisted with the F4/80+ reactive microglia and infiltrating macrophages. In conclusion, the proteomic data pertaining to the current study indicate the notable proteins and pathways that may be novel therapeutic targets for the treatment of SCI.	[Yao, Xin-Qiang; Liu, Zhong-Yuan; Huang, Zu-Cheng; Liu, Jun-Hao; Zhu, Qing-An; Ding, Ruo-Ting; Chen, Jian-Ting] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Spine Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Jia-Ying] Southern Med Univ, Nanfang Hosp, Dept Comprehens Med Treatment Ward, Guangzhou, Peoples R China; [Liu, Jun-Hao] South China Univ Technol, Guangzhou Peoples Hosp 1, Sch Med, Dept Orthopaed,Div Spine Surg, Guangzhou, Peoples R China; [Sun, Bai-Hui] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; South China University of Technology; Southern Medical University - China	Ding, RT; Chen, JT (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Spine Surg, 1838 North Guangzhou Ave, Guangzhou 510515, Guangdong, Peoples R China.	ding_ruoting@163.com; chenjt@smu.edu.cn			Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) [2017B010110012]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2021A1515011228]; Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality) [20211A011008]; National Natural Science Foundation of China (NSFC) [81902217, 81701921]	Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province), Grant/Award Number: 2017B010110012; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2021A1515011228; Guangzhou Science, Technology and Innovation Commission (Bureau of Science and Information Technology of Guangzhou Municipality), Grant/Award Number: 20211A011008; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81902217 and 81701921	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Allan ERO, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0874-x; Tran AP, 2018, PHYSIOL REV, V98, P881, DOI 10.1152/physrev.00017.2017; Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Brekk OR, 2020, P NATL ACAD SCI USA, V117, P27646, DOI 10.1073/pnas.2003021117; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Cheng XX, 2018, EXP NEUROL, V299, P97, DOI 10.1016/j.expneurol.2017.10.014; Ding H, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117235; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gabande-Rodriguez E, 2019, EMBO J, V38, DOI 10.15252/embj.201899553; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang ZC, 2018, NEUROSCI LETT, V664, P116, DOI 10.1016/j.neulet.2017.11.019; Kobayakawa K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5086; Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005; Lee JD, 2019, SEMIN IMMUNOL, V45, DOI 10.1016/j.smim.2019.101340; Liu ZY, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01751-2; Mallah K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02021; Marschallinger J, 2020, NAT NEUROSCI, V23, P194, DOI 10.1038/s41593-019-0566-1; Milich LM, 2019, ACTA NEUROPATHOL, V137, P785, DOI 10.1007/s00401-019-01992-3; Nakanishi H, 2020, NEURAL REGEN RES, V15, P25, DOI 10.4103/1673-5374.264444; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Norris GT, 2018, J EXP MED, V215, P1789, DOI 10.1084/jem.20172244; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Peterson SL, 2014, EXP NEUROL, V258, P35, DOI 10.1016/j.expneurol.2014.04.028; Pislar A, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.575453; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Squair JW, 2018, ELIFE, V7, DOI 10.7554/eLife.39188; Steward O, 2017, EXP NEUROL, V287, P374, DOI 10.1016/j.expneurol.2016.06.029; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Tran AP, 2021, NEURAL REGEN RES, V16, P26, DOI 10.4103/1673-5374.286948; Wang X, 2015, GLIA, V63, P635, DOI 10.1002/glia.22774; Yong HYF, 2019, CELL MOL IMMUNOL, V16, P540, DOI 10.1038/s41423-019-0223-3; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147; Zhou T, 2019, NAT NEUROSCI, V22, P421, DOI 10.1038/s41593-018-0324-9; Zhou X, 2020, NAT NEUROSCI, V23, P337, DOI 10.1038/s41593-020-0597-7; Zhu Y, 2017, J NEUROSCI, V37, P2362, DOI 10.1523/JNEUROSCI.2751-16.2017	41	10	10	5	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21735	10.1096/fj.202100081RR	http://dx.doi.org/10.1096/fj.202100081RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143440				2022-12-26	WOS:000667814100082
J	Olopha, PO; Fasoranbaku, AO; Gayawan, E				Olopha, Paul Omoh; Fasoranbaku, Akin Olusoga; Gayawan, Ezra			Spatial pattern and determinants of sufficient knowledge of mother to child transmission of HIV and its prevention among Nigerian women	PLOS ONE			English	Article							MODEL	The lack of sufficient knowledge of mother to child transmission (MTCT) of human immunodeficiency virus (HIV) among pregnant women is considered a major contributor to new pediatric HIV infections globally, and increasing HIV related infant mortality especially in developing countries. Nigeria has the highest number of new HIV infections among children in the world. This study was designed to examine the spatial pattern and determinants of acquisition of sufficient knowledge of MTCT and prevention of mother to child transmission (PMTCT) in Nigeria. The data used in the study were extracted from the 2018 Nigeria Democratic Health Survey. The spatial modeling was through a Bayesian approach with appropriate prior distributions assigned to the different parameters of the model and inference was through the integrated nested Laplace approximation technique (INLA). Results show considerable spatial variability in the acquisition of sufficient knowledge of MTCT and its prevention with women in the southwestern and southeastern part of the country having higher likelihood. The nonlinear effects findings show that acquisition of sufficient knowledge of MTCT and PMTCT increased with age of women and peaked at around age 35yearswhere it thereafter dropped drastically among the older women. Furthermore, sufficient knowledge of MTCT and PMTCT was found to be driven by ethnicity, respondents' education and wealth status.	[Olopha, Paul Omoh; Fasoranbaku, Akin Olusoga; Gayawan, Ezra] Fed Univ Technol Akure, Dept Stat, Akure, Nigeria		Olopha, PO (corresponding author), Fed Univ Technol Akure, Dept Stat, Akure, Nigeria.	poolopha@futa.edu.ng		Omoh, Olopha/0000-0003-1521-1532				Abiodun MO, 2007, J NATL MED ASSOC, V99, P758; Aboyeji AP., 2001, NIGERIA Q J HOSP MED, V10, P181; Adeneye Adeniyi K, 2006, Afr J AIDS Res, V5, P273, DOI 10.2989/16085900609490389; Alemu YM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1389-2; [Anonymous], JOINT UN PROGR HIV A; Ashimi A O, 2014, West Afr J Med, V33, P68; Cohen J, 2018, SCI MAGAZINE; Delius Peter, 2005, Afr J AIDS Res, V4, P29, DOI 10.2989/16085900509490339; Fahrmeir L., 2013, REGRESSION MODELS ME, DOI [10.1515/ijb-2012-0035, DOI 10.1515/IJB-2012-0035]; Gayawan E, 2014, POPUL SPACE PLACE, V20, P485, DOI 10.1002/psp.1775; Haile ZT., 2015, AIDS CARE, V28, P1, DOI [10.1080/09540121.2015.1058896, DOI 10.1080/09540121.2015.1058896]; Health Strategy and Delivery Foundation, 2019, EL MOTH CHILD TRANSM; Igwegbe A O, 2005, Niger J Clin Pract, V8, P97; Lamina MA, 2012, J OBSTET GYNECOLOGY, V2; Lindgren F, 2015, J STAT SOFTW, V63, P1, DOI 10.18637/jss.v063.i19; Luba TR, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020414; Malaju MT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-73; Masaka A, 2019, ALEX J MED, V55, P68, DOI 10.1080/20905068.2019.1667114; Mukhtar-Yola M, 2018, NIGER POSTGRAD MED J, V25, P27, DOI 10.4103/npmj.npmj_151_17; Nwaneri A., 2018, INT J NURS SCI, V8, P67; Ogbo FA, 2016, AUSTIN J HIV AIDS RE, V3, P1031; Olakunde BO, 2019, INT HEALTH, V11, P240, DOI 10.1093/inthealth/ihz018; Oyefabi A, 2018, West Afr J Med, V35, P144; Rue H., 2005, GAUSSIAN MARKOV R; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; UNAIDS, 2018, AIDS 2018; UNAIDS, 2017, AIDS INF; UNAIDS, 2020, NIG 2020; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wanyenze Rhoda K, 2018, BMC Res Notes, V11, P187, DOI 10.1186/s13104-018-3304-y; WHO Africa, 2019, HIV IN PREV MOTH TO	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253705	10.1371/journal.pone.0253705	http://dx.doi.org/10.1371/journal.pone.0253705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170939	gold, Green Published			2022-12-26	WOS:000671694400002
J	Farfour, E; Dimi, S; Chassany, O; Fouere, S; Valin, N; Timsit, J; Ghosn, J; Duvivier, C; Duracinsky, M; Zucman, D				Farfour, Eric; Dimi, Svetlane; Chassany, Olivier; Fouere, Sebastien; Valin, Nadia; Timsit, Julie; Ghosn, Jade; Duvivier, Claudine; Duracinsky, Martin; Zucman, David		DRIVER Study Grp	Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; LYMPHOGRANULOMA-VENEREUM; MEN; SEX; SYPHILIS; PREVALENCE; BEHAVIOR; PROPHYLAXIS; INCREASE; FRANCE	The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and gonorrhea (NG). Seventeen centers located in the Paris area participated in the study. All asymptomatic HIV-infected MSM patients attending a follow up consultation were proposed to participated in the study. Asymptomatic patients were included over 2 periods: period 1 from April to December 2015 and period 2 from September to December 2017. Etiologic diagnosis of STIs including hepatitis B, C, syphilis, was performed using a serological test, including a non-treponemal titer with a confirmatory treponemal assay for syphilis. CT and NG were screened using a nucleic acid amplification test (NAATs) on 3 anatomical sites, i.e. urine, rectal and pharyngeal. Overall, 781 patients were included: 490 and 291 in periods 1 and 2 respectively. Asymptomatic CT, NG, and syphilis were diagnosed in 7.5%, 4.8% and, 4.2% respectively. The rate of patients having a multisite asymptomatic infection was 10.2% and 21.1% for CT and NG respectively. The most frequently involved anatomical sites for CT and NG asymptomatic infections were anorectal (66.1% and 55.2% respectively) and pharyngeal (47.4% and 60.5% respectively). CT and NG asymptomatic infection increased by 1.3- and 2-fold respectively between the two periods while syphilis decreased by 3 folds. Our results encourage to reconsider multisite screening for CT and NG in asymptomatic HIV positive MSM as the yield of screening urinary samples only might be low. Despite the more systematic STI screening of asymptomatic HIV positive MSM the prevalence of STI is increasing in MSM in France. Therefore, this strategy has not led to alter CT and NG transmission. The decrease of syphilis might involve self-medication by doxycycline, and the intensification of syphilis screening.	[Farfour, Eric] Hop Foch, Serv Biol Clin, Suresnes, France; [Dimi, Svetlane] Ctr Vaccinat Internatl & Med Voyage, Creil, France; [Chassany, Olivier; Duracinsky, Martin] Univ Paris Diderot, Sorbonne Paris Cite, Patient Reported Outcomes Res, Paris, France; [Chassany, Olivier; Duracinsky, Martin] Hop Hotel Dieu, AP HP, Unite Rech Clin Econ Sante, Paris, France; [Fouere, Sebastien; Timsit, Julie] Hosp St Louis, AP HP, Dermatol Dept, Ctr Genital & Sexually Transmitted Dis, Paris, France; [Valin, Nadia] Hop St Antoine, Serv Malad Infect, Paris, France; [Ghosn, Jade] Grp Hosp Paris Nord Val Seine, AP HP, Site Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France; [Ghosn, Jade] Univ Paris Diderot, PRES Sorbonne Paris Cite, INSERM, UMR 1137,IAME, Paris, France; [Duvivier, Claudine] Hop Necker Enfants Malad, AP HP, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur, Paris, France; [Duvivier, Claudine] IHU Imagine, Paris, France; [Duvivier, Claudine] Univ Paris, Inst Cochin, CNRS 8104, INSERM U1016,RIL Team Retrovirus Infect & Latency, Paris, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, Paris, France; [Duracinsky, Martin] Hop Bicetre, AP HP, Med Interne & Immunol Clin, Paris, France; [Zucman, David] Hop Foch, Reseau Ville Hop, Serv Med Interne, Suresnes, France	Hospital Foch; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Hospital Foch	Farfour, E (corresponding author), Hop Foch, Serv Biol Clin, Suresnes, France.	e.farfour@hopital-foch.org	Fouéré, Sébastien/GOH-0348-2022; Chassany, Olivier/AGG-2756-2022	Chassany, Olivier/0000-0001-8361-5809	French National Agency for Research on AIDS (ANRS) [95020]	French National Agency for Research on AIDS (ANRS)(ANRS)	The DRIVER project was funded by the French National Agency for Research on AIDS (ANRS), Grant No 95020.	Beebeejaun K, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.5.30454; Bille E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006495; Brewer TH, 2011, SEX TRANSM DIS, V38, P12, DOI 10.1097/OLQ.0b013e3181e9afc7; Carveth-Johnson T., 2018, HIV, V5, P482, DOI [10.1016/S2352-3018%2818%2930210-8, DOI 10.1016/S2352-3018%2818%2930210-8]; Champenois K, 2018, AIDS, V32, P1871, DOI 10.1097/QAD.0000000000001916; de Vrieze NHN, 2017, SEX TRANSM DIS, V44, P547, DOI 10.1097/OLQ.0000000000000657; Dhanani Alban, 2018, Rev Prat, V68, P849; Durukan D, 2020, CLIN INFECT DIS, V71, P1461, DOI 10.1093/cid/ciz1031; ECDC, 2015, PREV HIV STI MEN WHO; Farfour E, 2017, MED MALADIES INFECT, V47, P490, DOI 10.1016/j.medmal.2017.06.004; Haute Autorite de Sante, 2018, REEV STRAT DEP INF C; Haute Autorite de Sante, 2015, EV TESTS AMPL AC NUC; Hinkan S, 2018, INT J STD AIDS, V29, P842, DOI 10.1177/0956462418760659; Kahn RH, 2002, SEX TRANSM DIS, V29, P285, DOI 10.1097/00007435-200205000-00006; KALICHMAN SC, 1994, J PERS ASSESS, V62, P385, DOI 10.1207/s15327752jpa6203_1; Kularatne RS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205863; Molina JM, 2018, LANCET INFECT DIS, V18, P308, DOI [10.1016/S1473-3099(17)30725-9, 10.1016/s1473-3099(17)30725-9]; Molina JM, 2017, LANCET HIV, V4, pE402, DOI 10.1016/S2352-3018(17)30089-9; Ngangro NN, 2019, EUROSURVEILLANCE, V24, P28, DOI 10.2807/1560-7917.ES.2019.24.5.1800038; Ngangro NN, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020336; Philibert P, 2014, J CLIN MED, V3, P1386, DOI 10.3390/jcm3041386; Pratas AC, 2018, EMERG INFECT DIS, V24, P193, DOI 10.3201/eid2402.171167; Putot A, 2017, AM J TROP MED HYG, V97, P923, DOI 10.4269/ajtmh.16-0760; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Spinner CD, 2018, INFECTION, V46, P341, DOI 10.1007/s15010-018-1124-6; Stall RD, 2000, AIDS, V14, pS101; Tsoumanis A, 2018, SEX TRANSM DIS, V45, P615, DOI [10.1097/OLQ.0000000000000824, 10.1097/olq.0000000000000824]; Vargas-Leguas H, 2012, EUROSURVEILLANCE, V17, P2; Voirin N, 2020, CLIN INFECT DIS, V70, P1966, DOI 10.1093/cid/ciz510; Workowski KA., 2015, MMWR RECOMM REP, DOI [10.1111/j.1746-1561.1994.tb03287.x, DOI 10.1111/J.1746-1561.1994.TB03287.X]; Zucman D, 2017, CLIN INFECT DIS, V65, P1053, DOI 10.1093/cid/cix458	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0250557	10.1371/journal.pone.0250557	http://dx.doi.org/10.1371/journal.pone.0250557			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166379	Green Published, gold			2022-12-26	WOS:000671692800041
J	Kim, M; Jeon, K; Hutt, K; Zlotnicki, AM; Kim, HJ; Lee, J; Kim, HS; Kang, HJ; Lee, YK				Kim, Miyoung; Jeon, Kibum; Hutt, Kasey; Zlotnicki, Alyssa M.; Kim, Hyo Jung; Lee, Jiwon; Kim, Han-Sung; Kang, Hee Jung; Lee, Young Kyung			Immunoglobulin gene rearrangement in Koreans with multiple myeloma: Clonality assessment and repertoire analysis using next-generation sequencing	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; B-CELL; SOMATIC MUTATION; LIGHT-CHAIN; HEAVY; SURVIVAL; USAGE	Introduction We assessed the applicability of next-generation sequencing (NGS)-based IGH/IGK clonality testing and analyzed the repertoire of immunoglobulin heavy chain (IGH) or immunoglobulin kappa light chain (IGK) gene usage in Korean patients with multiple myeloma (MM) for the first time. Methods Fifty-nine bone marrow samples from 57 Korean patients with MM were analyzed, and NGS-based clonality testing that targeted the IGH and IGK genes was performed using IGH FR1 and IGK primer sets. Results Clonal IGH and IGK rearrangements were observed in 74.2% and 67.7% of samples from Korean patients with kappa-restricted MM, respectively (90.3% had one or both), and in 60.7% and 95.5% of samples from those with lambda-restricted MM, respectively (85.7% had one or both). In total, 88.1% of samples from Koreans with MM had clonal IGH and/or IGK rearrangement. Clonal rearrangement was not significantly associated with the bone marrow plasma cells as a proportion of all BM lymphoid cells. IGHV3-9 (11.63%) and IGHV4-31 (9.30%) were the most frequently reported IGHV genes and were more common in Koreans with MM than in Western counterparts. IGHD3-10 and IGHD3-3 (13.95% each) were the most frequent IGHD genes; IGHD3-3 was more common in Koreans with MM. No IGK rearrangement was particularly prevalent, but single IGKV-J rearrangements were less common in Koreans with kappa-restricted MM than in Western counterparts. IGKV4-1 was less frequent in Koreans regardless of light chain type. Otherwise, the usages of the IGH V, D, and J genes and of the IGK gene were like those observed in previous Western studies. Conclusion NGS-based IGH/IGK clonality testing ought to be applicable to most Koreans with MM. The overrepresentation of IGHV3-9, IGHV4-31, and IGHD3-3 along with the underrepresentation of IGKV4-1 and the differences in IGK gene rearrangement types suggest the existence of ethnicity-specific variations in this disease.	[Kim, Miyoung] Univ Ulsan, Asan Med Ctr, Dept Lab Med, Coll Med, Seoul, South Korea; [Jeon, Kibum] Hangang Sacred Heart Hosp, Dept Lab Med, Seoul, South Korea; [Hutt, Kasey; Zlotnicki, Alyssa M.] Invivoscribe Inc, San Diego, CA USA; [Kim, Hyo Jung] Hallym Univ, Coll Med, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea; [Lee, Jiwon] Green Cross Labs, Dept Lab Med, Yongin, South Korea; [Kim, Han-Sung; Kang, Hee Jung; Lee, Young Kyung] Hallym Univ, Coll Med, Dept Lab Med, Sacred Heart Hosp, Anyang, South Korea	University of Ulsan; Asan Medical Center; Hallym University; Hallym University	Lee, YK (corresponding author), Hallym Univ, Coll Med, Dept Lab Med, Sacred Heart Hosp, Anyang, South Korea.	lyoungk@hallym.or.kr						Arber DA, 2000, J MOL DIAGN, V2, P178, DOI 10.1016/S1525-1578(10)60636-8; Arcila ME, 2019, J MOL DIAGN, V21, P330, DOI 10.1016/j.jmoldx.2018.10.008; BAKKUS MHC, 1994, BRIT J HAEMATOL, V87, P68, DOI 10.1111/j.1365-2141.1994.tb04872.x; Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Evans PAS, 2007, LEUKEMIA, V21, P207, DOI 10.1038/sj.leu.2404479; Ferrero S, 2012, HAEMATOL-HEMATOL J, V97, P849, DOI 10.3324/haematol.2011.052852; Gazzola A, 2014, THER ADV HEMATOL, V5, P35, DOI 10.1177/2040620713519729; Gonzalez D, 2007, BLOOD, V110, P3112, DOI 10.1182/blood-2007-02-069625; Gonzalez D, 2005, HAEMATOLOGICA, V90, P906; Hadzidimitriou A, 2006, HAEMATOLOGICA, V91, P781; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hong J, 2016, KOREAN J INTERN MED, V31, P820, DOI 10.3904/kjim.2015.408; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kim SJ, 2009, ACTA HAEMATOL-BASEL, V122, P200, DOI 10.1159/000253027; Kotrova M, 2015, BLOOD, V126, P1045, DOI 10.1182/blood-2015-07-655159; Kumar S, 2016, LANCET ONCOL, V17, pE328, DOI 10.1016/S1470-2045(16)30206-6; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Langerak AW, 2012, LEUKEMIA, V26, P2159, DOI 10.1038/leu.2012.246; Langerak AW, 2017, J IMMUNOL, V198, P3765, DOI 10.4049/jimmunol.1602050; Lee JH, 2010, INT J HEMATOL, V92, P52, DOI 10.1007/s12185-010-0617-6; Liu HX, 2007, BRIT J HAEMATOL, V138, P31, DOI 10.1111/j.1365-2141.2007.06618.x; Medina A, 2020, BLOOD CANCER J, V10, DOI 10.1038/s41408-020-0283-8; Munshi NC, 2013, J CLIN ONCOL, V31, P2523, DOI 10.1200/JCO.2013.49.2124; Paiva B, 2011, J CLIN ONCOL, V29, P1627, DOI 10.1200/JCO.2010.33.1967; Rettig MB, 1996, BLOOD, V87, P2846, DOI 10.1182/blood.V87.7.2846.bloodjournal8772846; Romano A, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00699; Rustad EH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211600; Scheijen B, 2019, LEUKEMIA, V33, P2227, DOI 10.1038/s41375-019-0508-7; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; VESCIO RA, 1995, J IMMUNOL, V155, P2487	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253541	10.1371/journal.pone.0253541	http://dx.doi.org/10.1371/journal.pone.0253541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166440	gold, Green Published			2022-12-26	WOS:000671692800064
J	Adjodah, D; Dinakar, K; Chinazzi, M; Fraiberger, SP; Pentland, A; Bates, S; Staller, K; Vespignani, A; Bhatt, DL				Adjodah, Dhaval; Dinakar, Karthik; Chinazzi, Matteo; Fraiberger, Samuel P.; Pentland, Alex; Bates, Samantha; Staller, Kyle; Vespignani, Alessandro; Bhatt, Deepak L.			Association between COVID-19 outcomes and mask mandates, adherence, and attitudes	PLOS ONE			English	Article							BEHAVIOR-CHANGE; IMPACT; MODEL	We extend previous studies on the impact of masks on COVID-19 outcomes by investigating an unprecedented breadth and depth of health outcomes, geographical resolutions, types of mask mandates, early versus later waves and controlling for other government interventions, mobility testing rate and weather. We show that mask mandates are associated with a statistically significant decrease in new cases (-3.55 per 100K), deaths (-0.13 per 100K), and the proportion of hospital admissions (-2.38 percentage points) up to 40 days after the introduction of mask mandates both at the state and county level. These effects are large, corresponding to 14% of the highest recorded number of cases, 13% of deaths, and 7% of admission proportion. We also find that mask mandates are linked to a 23.4 percentage point increase in mask adherence in four diverse states. Given the recent lifting of mandates, we estimate that the ending of mask mandates in these states is associated with a decrease of -3.19 percentage points in mask adherence and 12 per 100K (13% of the highest recorded number) of daily new cases with no significant effect on hospitalizations and deaths. Lastly, using a large novel survey dataset of 847 thousand responses in 69 countries, we introduce the novel results that community mask adherence and community attitudes towards masks are associated with a reduction in COVID-19 cases and deaths. Our results have policy implications for reinforcing the need to maintain and encourage mask-wearing by the public, especially in light of some states starting to remove their mask mandates.	[Adjodah, Dhaval; Fraiberger, Samuel P.] MIT, Connect Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Adjodah, Dhaval; Bates, Samantha] Ctr Complex Intervent, Wellesley, MA USA; [Dinakar, Karthik; Pentland, Alex] MIT, Media Lab, Cambridge, MA 02139 USA; [Chinazzi, Matteo; Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Fraiberger, Samuel P.] World Bank, Dev Data Grp, 1818 H St NW, Washington, DC 20433 USA; [Fraiberger, Samuel P.] NYU, Dept Comp Sci, New York, NY USA; [Staller, Kyle] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Staller, Kyle; Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northeastern University; The World Bank; New York University; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bhatt, DL (corresponding author), Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA.; Bhatt, DL (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.	dlbhattmd@post.harvard.edu	Bhatt, Deepak L./Y-3070-2019	Bhatt, Deepak L./0000-0002-1278-6245; Vespignani, Alessandro/0000-0003-3419-4205; Chinazzi, Matteo/0000-0002-5955-1929				Adjodah D., 2020, P 19 INT C AUTONOMOU, P1738; Adjodah DD., 2013, UNDERSTANDING SOCIAL; Adolph C, 2021, J HEALTH POLIT POLIC, V46, P211, DOI 10.1215/03616878-8802162; Alam MN, 2020, J ASIAN FINANC ECON, V7, P131, DOI 10.13106/jafeb.2020.vol7.no7.131; Albarracin D, 2005, PSYCHOL BULL, V131, P856, DOI 10.1037/0033-2909.131.6.856; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2000, AIDS PREVENT MENT H; Barcelo H, ARXIV PREPRINT ARXIV; Barcelo J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242764; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Bhasin T, 2020, INT J SOCIOL SOC POL, V40, P929, DOI 10.1108/IJSSP-07-2020-0293; Bhattacharjee S, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000698; Bi QF, 2020, LANCET INFECT DIS, V20, P148, DOI 10.1016/S1473-3099(20)30369-8; Bundgaard H, 2021, ANN INTERN MED, V174, P335, DOI 10.7326/M20-6817; Cavallo Joseph J, 2020, JAMA Health Forum, V1, pe200345, DOI 10.1001/jamahealthforum.2020.0345; CDC, 2020, SCI BRIEFS; Chan-Olmsted S, 2022, NEW MEDIA SOC, V24, P684, DOI 10.1177/1461444820963776; Chen JY, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv200; Chen X., ARXIV PREPRINT ARXIV; Chernozhukov V, 2021, J ECONOMETRICS, V220, P23, DOI 10.1016/j.jeconom.2020.09.003; Chetty R., 2020, EC IMPACTS COVID 19; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Collis A., 2020, GLOBAL SURVEY COVID; Comer J. S., 2013, BERGIN GARFIELDS HDB, Vsixth, P21; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; de Man P, 2020, J HOSP INFECT, V105, P356, DOI 10.1016/j.jhin.2020.04.001; Del Greco S., AM GEOPH UN FALL M 2; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Draughon Gabriel TS, 2020 IEEE INT SMART, P1; Dugdale CM, 2020, JAMA INTERN MED, V180, P1612, DOI 10.1001/jamainternmed.2020.4218; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; EscanduEn K, 2020, OSF PREPRINTS, V10; Fabrikant A., ARXIV PREPRINT ARXIV; Farrow D.C., 2015, DELPHI EPIDATA API; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Fisher JD, 2002, HEALTH PSYCHOL, V21, P177, DOI 10.1037//0278-6133.21.2.177; Fisman DN, 2020, INFECT DIS MODEL, V5, P405, DOI 10.1016/j.idm.2020.06.004; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Gaure S, 2013, COMPUT STAT DATA AN, V66, P8, DOI 10.1016/j.csda.2013.03.024; Geiger D., 1990, P 5 ANN C UNC ART IN, V10, P139, DOI [DOI 10.1016/B978-0-444-88738-2.50018-X, 10.1016/b978-0-444-88738-2.50018-x]; Gibson Katherine L., 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P57, DOI 10.1109/CVPRW.2015.7301320; Goker I.E., 2020, GAZIANTEP U J SOCIAL, P14, DOI DOI 10.21547/JSS.731980; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Gray DM, 2020, NAT REV GASTRO HEPAT, V17, P520, DOI 10.1038/s41575-020-0330-8; Gray L, 2020, J PRIM HEALTH CARE, V12, P199, DOI 10.1071/HC20089; Grother Patrick J, 2018, ONGOING FACE RECOGNI; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Gupta S, 2020, TRACKING PUBLIC PRIV, DOI [10.3386/w27027, DOI 10.3386/W27027]; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Hannah Ritchie, 2020, COR PAND COVID 19; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Havers FP., 2021, DECLINE COVID 19 HOS; He PL, 2020, EMERG MARK FINANC TR, V56, P2198, DOI 10.1080/1540496X.2020.1785865; Heimlich JE, 2008, ENVIRON EDUC RES, V14, P215, DOI 10.1080/13504620802148881; Holtz D., 2020, INTERDEPENDENCE COST; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Howard MC, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110417; Hung IFN, 2020, LANCET, V395, P1695, DOI 10.1016/S0140-6736(20)31042-4; Jensen UlrichThy., 2020, J BEHAV PUBLIC ADM, V3, DOI [10.30636/jbpa.32.182, DOI 10.30636/JBPA.32.182]; Kasting ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241662; Keeley C, 2020, HEALTH AFFAIR, V39, P1426, DOI 10.1377/hlthaff.2020.00904; Kong E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104257; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; LaRocca S, ARXIV PREPRINT ARXIV; LEFFLER C, 2020, MEDRXIV, DOI DOI 10.4269/AJTMH.20-1015; Li T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237691; Liang MM, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101751; Liu HY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17082800; Lyu W, 2020, HEALTH AFFAIR, V39, P1615, DOI 10.1377/hlthaff.2020.00719; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Makridis C., 2020, REAL COST POLITICAL; Maneenop S, 2020, J AIR TRANSP MANAG, V89, DOI 10.1016/j.jairtraman.2020.101920; Mazzatenta A, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.589409; Mittal R, 2020, J FLUID MECH, V894, DOI 10.1017/jfm.2020.330; Mitze T, 2020, P NATL ACAD SCI USA, V117, P32293, DOI 10.1073/pnas.2015954117; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Palmer CL, 2020, POLIT GENDER, V16, P1044, DOI 10.1017/S1743923X20000422; Pearce N, 2020, AM J PUBLIC HEALTH, V110, P949, DOI 10.2105/AJPH.2020.305708; Pejo Balazs, 2020, COVID-19: Proceedings of the 1st SIGSPATIAL International Workshop on Modeling and Understanding the Spread of COVID-19, P24, DOI 10.1145/3423459.3430757; Peterson, 1994, PREVENTING AIDS THEO, P5, DOI DOI 10.1007/978-1-4899-1193-3_2; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Quer G, 2021, NAT MED, V27, P73, DOI 10.1038/s41591-020-1123-x; Raifman J, COVID 19 US STATE PO; Riekert K.A., 2013, HDB HLTH BEHAV CHANG; Salanie F, 2020, GENEVA RISK INS REV, V45, P104, DOI 10.1057/s10713-020-00050-3; Scerri Mariella, 2020, Early Hum Dev, P105253, DOI 10.1016/j.earlhumdev.2020.105253; Tangherlini TR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233879; Tirupathi Raghavendra, 2020, Infez Med, V28, P57; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Dyke ME, 2020, MMWR-MORBID MORTAL W, V69, P1777, DOI 10.15585/mmwr.mm6947e2; Velavan TP, 2020, TROP MED INT HEALTH, V25, P278, DOI 10.1111/tmi.13383; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0022968; Wan SX, 2020, J MED VIROL, V92, P797, DOI 10.1002/jmv.25783; Wang MW, 2020, EUR REV MED PHARMACO, V24, P3397, DOI 10.26355/eurrev_202003_20707; Wang XW, 2020, JAMA-J AM MED ASSOC, V324, P703, DOI 10.1001/jama.2020.12897; Weinstock D, 2020, PUBLIC HEALTH ETH-UK, V13, P166, DOI 10.1093/phe/phaa026; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260; Williams C, ARXIV PREPRINT ARXIV; Wright A.L., 2020, TRACKING MASK MANDAT; Wright L, 2021, LANCET REG HEALTH-EU, V4, DOI 10.1016/j.lanepe.2021.100061; XIE Y, 1992, AM SOCIOL REV, V57, P380, DOI 10.2307/2096242; Xu P, 2021, PERS INDIV DIFFER, V175, DOI 10.1016/j.paid.2021.110706; Zhai Pan, 2020, Int J Antimicrob Agents, V55, P105955, DOI 10.1016/j.ijantimicag.2020.105955	110	27	27	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252315	10.1371/journal.pone.0252315	http://dx.doi.org/10.1371/journal.pone.0252315			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161332	Green Published, Green Submitted, gold			2022-12-26	WOS:000671691900058
J	Orywal, K; Socha, K; Nowakowski, P; Zon, W; Kaczynski, P; Mroczko, B; Lozowicka, B; Perkowski, M				Orywal, Karolina; Socha, Katarzyna; Nowakowski, Patryk; Zon, Wojciech; Kaczynski, Piotr; Mroczko, Barbara; Lozowicka, Bozena; Perkowski, Maciej			Health risk assessment of exposure to toxic elements resulting from consumption of dried wild-grown mushrooms available for sale	PLOS ONE			English	Article							BOLETUS EDULIS MUSHROOM; EDIBLE MUSHROOMS; CHEMICAL-COMPOSITION; NUTRITIONAL-VALUE; TRACE-ELEMENTS; HEAVY-METALS; MERCURY; SMELTER	Mushrooms exhibit a high ability to accumulate potentially toxic elements. The legal regulations in force in the European Union countries do not define the maximum content of elements in dried wild-grown mushrooms. This study presents the content of mercury (Hg), lead (Pb), cadmium (Cd) and arsenic (As) determined in dried wild-grown mushrooms (Boletus edulis and Xerocomus badius) available for sale. Moreover, the health risk associated with their consumption is assessed. The inductively coupled plasma mass spectrometry (Cd, Pb, As) and atomic absorption spectrometry (Hg) were used. The mean Hg, Cd, Pb and As concentration in Boletus edulis was 3.039 +/- 1.092, 1.983 +/- 1.145, 1.156 +/- 1.049 and 0.897 +/- 0.469 mg/kg and in Xerocomus badius 0.102 +/- 0.020, 1.154 +/- 0.596, 0.928 +/- 1.810 and 0.278 +/- 0.108 mg/kg, respectively. The maximum value of the hazard index (HI) showed that the consumption of a standard portion of dried Boletus edulis may have negative consequences for health and corresponded to 76.2%, 34.1%, 33% and 4.3% of the maximum daily doses of Hg, Cd, Pb and As, respectively. The results indicate that the content of toxic elements in dried wild-grown mushrooms should be monitored. The issue constitutes a legal niche where unfavourable EU regulations may pose a threat to food safety and consumer health.	[Orywal, Karolina; Mroczko, Barbara] Med Univ Bialystok, Fac Pharm, Dept Biochem Diagnost, Div Lab Med, Bialystok, Poland; [Socha, Katarzyna; Nowakowski, Patryk] Med Univ Bialystok, Fac Pharm, Dept Bromatol, Div Lab Med, Bialystok, Poland; [Zon, Wojciech; Perkowski, Maciej] Univ Bialystok, Fac Law, Dept Publ Int Law & European Law, Bialystok, Poland; [Kaczynski, Piotr; Lozowicka, Bozena] Natl Res Inst, Inst Plant Protect, Bialystok, Poland	Medical University of Bialystok; Medical University of Bialystok; University of Bialystok	Orywal, K (corresponding author), Med Univ Bialystok, Fac Pharm, Dept Biochem Diagnost, Div Lab Med, Bialystok, Poland.	orywalk@umb.edu.pl	Kaczynski, Piotr/ABB-2479-2021	Kaczynski, Piotr/0000-0002-3511-752X; Zon, Wojciech/0000-0001-5421-7668; Lozowicka, Bozena/0000-0002-2760-3333; Perkowski, Maciej/0000-0002-3909-3967; Nowakowski, Patryk/0000-0002-2504-6879				Adamiak E.A., 2013, ACTA AGROPHYS, V20, P7; Ahmed ASS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219336; [Anonymous], 2001, J LAWS 2001; [Anonymous], 2003, J LAWS, P326; Azevedo BF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/949048; Baker BA, 2018, J OCCUP ENVIRON MED, V60, pE634, DOI 10.1097/JOM.0000000000001485; Bernhoft RA, 2013, SCI WORLD J, DOI 10.1155/2013/394652; Bielecka J, 2020, FOODS, V9, DOI 10.3390/foods9121906; Bonsignore M, 2016, ENVIRON RES, V150, P592, DOI 10.1016/j.envres.2016.01.016; Cejpkova J, 2016, ENVIRON POLLUT, V218, P176, DOI 10.1016/j.envpol.2016.08.009; Chiocchetti GM, 2020, FOOD CHEM, V306, DOI 10.1016/j.foodchem.2019.125478; Cocchi L, 2006, FOOD CHEM, V98, P277, DOI 10.1016/j.foodchem.2005.05.068; Falandysz J, 2008, J ENVIRON SCI HEAL A, V43, P1692, DOI 10.1080/10934520802330206; Falandysz J, 2002, J ENVIRON MONITOR, V4, P473, DOI 10.1039/b202946d; Falandysz Jerzy, 2006, Rocz Panstw Zakl Hig, V57, P325; Falandysz J, 2007, J ENVIRON SCI HEAL A, V42, P2089, DOI 10.1080/10934520701627058; Falandysz J, 2011, J ENVIRON SCI HEAL B, V46, P231, DOI 10.1080/03601234.2011.540528; Gaso MI, 2000, SCI TOTAL ENVIRON, V262, P73, DOI 10.1016/S0048-9697(00)00574-X; Georgescu B., 2011, Lucrari Stiintifice - Zootehnie si Biotehnologii, Universitatea de Stiinte Agricole si Medicina Veterinara a Banatului Timisoara, V44, P89; Giannaccini G, 2012, ENVIRON MONIT ASSESS, V184, P7579, DOI 10.1007/s10661-012-2520-5; IARC (International Agency for Research on Cancer), 2020, IARC MONOGRAPHS EVAL; IRIS, 2010, INT RISK INF SYST; Jayachandran M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091934; Kahrizi F, 2016, IRAN J PHARM RES, V15, P835; Kalac P, 2019, MINERAL COMPOSITION AND RADIOACTIVITY OF EDIBLE MUSHROOMS, P1, DOI 10.1016/C2018-0-02278-1; Kalac P, 1996, SCI TOTAL ENVIRON, V177, P251, DOI 10.1016/0048-9697(95)04850-2; Kalac P, 2000, FOOD CHEM, V69, P273, DOI 10.1016/S0308-8146(99)00264-2; Kalac P, 2013, J SCI FOOD AGR, V93, P209, DOI 10.1002/jsfa.5960; Kobayashi M, 2012, BIOCHEM BIOPH RES CO, V427, P299, DOI 10.1016/j.bbrc.2012.09.045; Krzywy Inga, 2010, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V56, P118; Nikkarinen M, 2004, J FOOD COMPOS ANAL, V17, P301, DOI 10.1016/j.jfca.2004.03.013; Reid T, 2017, FOOD SCI NUTR, V5, P538, DOI 10.1002/fsn3.428; Reis FS, 2012, FOOD CHEM TOXICOL, V50, P191, DOI 10.1016/j.fct.2011.10.056; Roser M., 2013, OUR WORLD DATA; Siblerud R, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16245152; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Smina TP, 2017, MUTAT RES-GEN TOX EN, V813, P45, DOI 10.1016/j.mrgentox.2016.11.010; Statistics Poland, 2019, STAT YB FOR; Szumigaj-Tarnowska Joanna, 2015, Journal of Horticultural Research, V23, P87, DOI 10.2478/johr-2015-0011; *USEPA, 2016, SUPPL GUID ASS SUSC; USEPA (United State Environmental Protection Agency), 2000, RISK BASED CONCENTRA; WHO, 2013, WHO TECH REP SER, V983, P1; WHO, 2011, WHO TECH REP SER, V966, P1; WHO, 2010, EXPOSURE CADMIUM MAJ; Wojciechowska-Mazurek Maria, 2011, Bromatologia i Chemia Toksykologiczna, V44, P143; Wu YS, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1476-3; Yousefi M, 2018, FOOD CHEM TOXICOL, V118, P480, DOI 10.1016/j.fct.2018.05.063; Zhu FK, 2011, ENVIRON MONIT ASSESS, V179, P191, DOI 10.1007/s10661-010-1728-5	48	6	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252834	10.1371/journal.pone.0252834	http://dx.doi.org/10.1371/journal.pone.0252834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161345	Green Published, gold			2022-12-26	WOS:000671691900036
J	Tiruneh, GA; Alemayehu, TY; Meshesha, DT; Vogelmann, ES; Reichert, JM; Haregeweyn, N				Tiruneh, Gizachew Ayalew; Alemayehu, Tiringo Yilak; Meshesha, Derege Tsegaye; Vogelmann, Eduardo Saldanha; Reichert, Jose Miguel; Haregeweyn, Nigussie			Spatial variability of soil chemical properties under different land-uses in Northwest Ethiopia	PLOS ONE			English	Article							NITROUS-OXIDE EMISSIONS; USE/LAND COVER CHANGE; NORTHERN HIGHLANDS; MANAGEMENT; YIELD; AGRICULTURE; CATCHMENT; POTASSIUM; FOREST; CROPS	The understanding of the spatial variation of soil chemical properties is critical in agriculture and the environment. To assess the spatial variability of soil chemical properties in the Fogera plain, Ethiopia, we used Inverse Distance Weighting (IDW), pair-wise comparisons, descriptive analysis, and principal component analysis (PCA). In 2019, soil samples were collected at topsoil (a soil depth of 0-20 cm) from three representative land-uses (cropland, plantation forestland, and grazing lands) using a grid-sampling design. The variance analysis for soil pH, available phosphorus (avP), organic carbon (OC), total nitrogen (TN), electrical conductivity (EC), exchangeable potassium (exchK), exchangeable calcium (exchCa), and cation exchange capacity (CEC) revealed significant differences among the land-uses. The highest mean values of pH (8.9), avP (32.99 ppm), OC (4.82%), TN (0.39%), EC (2.28 dS m(-1)), and exchK (2.89 cmol (+) kg(-1)) were determined under grazing land. The lowest pH (6.2), OC (2.3%), TN (0.15%), and EC (0.11 dS m(-1)) were recorded in cultivated land. The PCA result revealed that the land-use change was responsible for most soil chemical properties, accounting for 93.32%. Soil maps can help identify the nutrient status, update management options, and increase productivity and profit. The expansion of cultivated lands resulted in a significant decrease in soil organic matter. Thus, soil management strategies should be tailored to replenish the soil nutrient content while maintaining agricultural productivity in the Fogera plain.	[Tiruneh, Gizachew Ayalew] Debre Tabor Univ, Fac Agr & Environm Sci, Dept Nat Resources Management, Debre Tabor, Ethiopia; [Alemayehu, Tiringo Yilak] Debre Tabor Univ, Fac Agr & Environm Sci, Dept Plant Sci, Debre Tabor, Ethiopia; [Meshesha, Derege Tsegaye] Bahir Dar Univ, Coll Agr & Environm Sci, Geospatial Data & Technol Ctr, Bahir Dar, Ethiopia; [Vogelmann, Eduardo Saldanha] Fed Univ Rio Grande, Biol Sci Inst, Sao Lourenco Do Sul, Brazil; [Reichert, Jose Miguel] Fed Univ Santa Maria UFSM, Soils Dept, Santa Maria, RS, Brazil; [Haregeweyn, Nigussie] Tottori Univ, Int Platform Dryland Res & Educ, Tottori, Japan; [Tiruneh, Gizachew Ayalew] Bahir Dar Univ, Coll Agr & Environm Sci, Dept Nat Resources Management, Bahir Dar, Ethiopia	Bahir Dar University; Universidade Federal do Rio Grande; Universidade Federal de Santa Maria (UFSM); Tottori University; Bahir Dar University	Tiruneh, GA (corresponding author), Debre Tabor Univ, Fac Agr & Environm Sci, Dept Nat Resources Management, Debre Tabor, Ethiopia.; Tiruneh, GA (corresponding author), Bahir Dar Univ, Coll Agr & Environm Sci, Dept Nat Resources Management, Bahir Dar, Ethiopia.	tiruneh1972@gmail.com	Tiruneh, Gizachew/AGJ-2688-2022; Haregeweyn, Nigussie/J-5616-2015; Reichert, José Miguel/F-8189-2012	Haregeweyn, Nigussie/0000-0003-2920-8094; Reichert, José Miguel/0000-0001-9943-2898; Tiruneh, Gizachew/0000-0001-9374-8138	Debre Tabor University; Bahir Dar University	Debre Tabor University; Bahir Dar University	This work was supported by the Debre Tabor University and Bahir Dar University. The author GAT received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Mesfin, 1996, P 3 C ETH SOC SOIL S, P78; Abegaz A, 2009, SOIL TILL RES, V103, P203, DOI 10.1016/j.still.2008.05.022; Suzuki LEAS, 2015, FOREST SCI, V61, P716, DOI 10.5849/forsci.14-172; Allen DE, 2010, AGR ECOSYST ENVIRON, V136, P209, DOI 10.1016/j.agee.2009.11.002; Asmamaw L. B., 2013, International Journal of Environmental Studies, V70, P111, DOI 10.1080/00207233.2012.751167; Assefa F, 2020, AIR SOIL WATER RES, V13, DOI 10.1177/1178622120939587; Barua SK, 2013, LAND DEGRAD DEV, V24, P63, DOI 10.1002/ldr.1107; Behera SK, 2015, LAND DEGRAD DEV, V26, P71, DOI 10.1002/ldr.2306; Bekele T, 2000, 74 NAT SOIL RES CTR; Biro K, 2013, LAND DEGRAD DEV, V24, P90, DOI 10.1002/ldr.1116; Braimoh AK, 2004, LAND DEGRAD DEV, V15, P65, DOI 10.1002/ldr.590; Bufebo B., 2020, ADV AGR, DOI [10.1155/2020/5145483, DOI 10.1155/2020/5145483]; BURGESS TM, 1980, J SOIL SCI, V31, P315, DOI 10.1111/j.1365-2389.1980.tb02084.x; Burst M, 2020, AGR ECOSYST ENVIRON, V289, DOI 10.1016/j.agee.2019.106739; Buttafuoco G, 2017, PRECIS AGRIC, V18, P37, DOI 10.1007/s11119-016-9462-9; Chapman H.D., 1965, METHODS SOILANALYSIS, P891, DOI DOI 10.2134/AGRONMONOGR9.2.C6; deMoraes JFL, 1996, GEODERMA, V70, P63, DOI 10.1016/0016-7061(95)00072-0; Ethiopia Soil Information System (EthioSIS), 2014, SOIL FERT STAT FERT; Fentie Sabiela Fekad, 2020, ScientificWorldJournal, V2020, P1479460, DOI 10.1155/2020/1479460; Food and Agriculture Organization (FAO), 1980, SOILS B, V38; Food and Agriculture Organization (FAO), 1999, INT SOIL MAN SUST AG; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gniazdowski Z., 2017, ZESZ NAUK WWSI, V11, P43, DOI DOI 10.26348/ZNWWSI.16.43; Gol C, 2010, AFR J AGR RES, V5, P1670; Gotway CA, 1996, SOIL SCI SOC AM J, V60, P1237, DOI 10.2136/sssaj1996.03615995006000040040x; Guan FY, 2017, CATENA, V150, P161, DOI 10.1016/j.catena.2016.11.017; Hazelton P, 2007, INTERPRETING SOIL TE, P160, DOI DOI 10.1111/SUM.12402; Hickman JE, 2015, J GEOPHYS RES-BIOGEO, V120, P938, DOI 10.1002/2015JG002913; Holthusen D, 2018, SOIL TILL RES, V184, P78, DOI 10.1016/j.still.2018.07.009; Holthusen D, 2018, SOIL TILL RES, V177, P113, DOI 10.1016/j.still.2017.12.003; Ichami SM, 2020, GEODERMA REG, V22, DOI 10.1016/j.geodrs.2020.e00300; Jackson M.L, 1973, SOIL CHEM ANAL; JAHN R, 2006, GUID SOIL DESCR, P97; Jaleta Daniel, 2016, J AGR ECOL RES INT, P1, DOI [10.9734/JAERI/2016/22841, DOI 10.9734/JAERI/2016/22841]; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Juo ASR, 1996, AGR ECOSYST ENVIRON, V58, P49, DOI 10.1016/0167-8809(95)00656-7; Jurisic M, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10121996; Cholbe MK, 2020, APPL ENVIRON SOIL SC, V2020, DOI 10.1155/2020/3713967; Kokeb A., 2015, J ENV ANAL TOXICOL, V5, P309, DOI [10.4172/2161-0525.1000309, DOI 10.4172/2161-0525.1000309]; Neto AALM, 2020, CERNE, V26, P37, DOI 10.1590/01047760202026012683; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Miheretu BA, 2018, PHYS GEOGR, V39, P230, DOI 10.1080/02723646.2017.1380972; Millar N, 2010, MITIG ADAPT STRAT GL, V15, P185, DOI 10.1007/s11027-010-9212-7; MOGES A, 2013, APPL ENVIRON SOIL SC, DOI DOI 10.1155/2013/784989; Molla E., 2018, ETHIOPIAN J SCI TECH, V11, P39, DOI [10.4314/ejst.v11i1.4, DOI 10.4314/EJST.V11I1.4]; Mulvaney B.J., 1982, METHODS SOIL ANAL 2, V2, P595; Nega Emiru, 2013, Journal of Agricultural and Biological Science, V8, P206; Negasa D.J., 2016, J GEO ENV EARTH SCI, V7, P1, DOI DOI 10.9734/JGEESI/2016/26606; Neto EA, 2020, REV BRAS CIENC SOLO, V44, DOI 10.36783/18069657rbcs20200086; Novara A, 2013, SOLID EARTH, V4, P255, DOI 10.5194/se-4-255-2013; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Ozyazici MA, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-016-2819-6; Panday D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206350; Qiu SJ, 2010, SOIL TILL RES, V107, P80, DOI 10.1016/j.still.2010.02.006; Reichert JM, 2018, GEODERMA, V331, P38, DOI 10.1016/j.geoderma.2018.06.012; Reichert JM, 2016, AGR ECOSYST ENVIRON, V233, P370, DOI 10.1016/j.agee.2016.09.039; Reichert JM, 2016, LAND DEGRAD DEV, V27, P1403, DOI 10.1002/ldr.2395; Reichert JM, 2015, AGR ECOSYST ENVIRON, V204, P8, DOI 10.1016/j.agee.2015.02.005; Reza SK, 2016, ARAB J GEOSCI, V9, DOI 10.1007/s12517-016-2474-y; Robinson TP, 2005, AGR SYST, V85, P19, DOI 10.1016/j.agsy.2004.07.010; Rosemary F, 2017, CATENA, V150, P53, DOI 10.1016/j.catena.2016.10.017; Rowell D. L., 1994, Soil science: methods and applications.; Saha D, 2015, LAND DEGRAD DEV, V26, P263, DOI 10.1002/ldr.2204; Selassie Y.G., 2015, ENV SYSTEMS RES, V4, P1, DOI [10.1186/s40068-015-0027-0, DOI 10.1186/S40068-015-0048-8]; Snyder CS, 2014, CURR OPIN ENV SUST, V9-10, P46, DOI 10.1016/j.cosust.2014.07.005; STOORVOGEL JJ, 1993, FERT RES, V35, P227, DOI 10.1007/BF00750641; Stoorvogel JJ, 1990, 28 ISRIC WIN STAR CT; Tadele D, 2014, J FORESTRY RES, V25, P935, DOI 10.1007/s11676-014-0483-9; Tellen V. A., 2018, Environmental Systems Research, V7, DOI 10.1186/s40068-018-0106-0; Terefe H, 2020, ECOL PROCESS, V9, DOI 10.1186/s13717-020-0216-2; Tesfahunegn GB, 2016, LAND DEGRAD DEV, V27, P438, DOI 10.1002/ldr.2245; Tesfahunegn GB, 2011, SOIL TILL RES, V117, P124, DOI 10.1016/j.still.2011.09.005; Tian HQ, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044020; Tripathi R, 2015, ARAB J GEOSCI, V8, P10693, DOI 10.1007/s12517-015-2003-4; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; United States Department of Agriculture (USDA), 2004, SOIL SURVEY INVESTIG; Uzoho B. U., 2014, Journal of Natural Sciences Research, V4, P105; Valentini R, 2014, BIOGEOSCIENCES, V11, P381, DOI 10.5194/bg-11-381-2014; van Reeuwijk LP, 1993, PROCEDURES SOIL ANAL; Venterea RT, 2012, FRONT ECOL ENVIRON, V10, P562, DOI 10.1890/120062; Venterea RT, 2011, J ENVIRON QUAL, V40, P1521, DOI 10.2134/jeq2011.0039; Venteris ER, 2014, J ENVIRON QUAL, V43, P936, DOI 10.2134/jeq2013.11.0459; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Water and Land Research Center (WLRC), 2014, NAT GEOSP DAT SYST E; WOLLENHAUPT NC, 1994, J PROD AGRIC, V7, P441, DOI 10.2134/jpa1994.0441; Yasrebi Jafar, 2008, Journal of Applied Sciences, V8, P1642, DOI 10.3923/jas.2008.1642.1650; Yimer F, 2011, LAND DEGRAD DEV, V22, P425, DOI 10.1002/ldr.1022	87	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253156	10.1371/journal.pone.0253156	http://dx.doi.org/10.1371/journal.pone.0253156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161393	gold, Green Published			2022-12-26	WOS:000671691900020
J	Wang, DL; Ding, WL				Wang, Dali; Ding, Wenli			Spatial pattern of the ecological environment in Yunnan Province	PLOS ONE			English	Article							CHINA; VULNERABILITY; QUALITY; RISK; LEVEL	Ecological science focuses on the structure and function of the natural environment. However, the study of ecological environments primarily focuses on single-element research and lacks a comprehensive perspective. To examine ecological environmental trends on different scales, the present paper selected Yunnan Province as the study area. Chemical oxygen demand, rocky desertification, forest coverage, natural disaster data and spatial analysis methods were used to obtain the ecological environmental characteristics of each county and construct a comprehensive evaluation method of the ecological environment. The present paper revealed that the environmental capacity in Yunnan Province was at a moderate level, the ecological environment fragility was remarkable, the significance of the ecological environment was very high, natural disasters occurred frequently, and spatial differentiation between ecological environments was obvious. The province may be divided into three functional areas: the comprehensive-balanced area, the efficiency-dominated area and the environment-dominated area. Central Yunnan was a key development zone and the main area for the manufacturing and service industries, which were built as a modern industrial system in Yunnan Province. The ecological environment in northwestern Yunnan and southern Yunnan is of high significance, and this region was an ecological environment protection area that was important area for the construction of the modern agricultural system in Yunnan Province. To achieve sustainable development of the ecological environment, the spatial characteristics of the ecological environment must be determined at the county scale.	[Wang, Dali] Yunnan Normal Univ, Fac Geog, Kunming, Yunnan, Peoples R China; [Ding, Wenli] Kunming Univ, Sch Econ & Management, Kunming, Yunnan, Peoples R China	Yunnan Normal University; Kunming University	Wang, DL (corresponding author), Yunnan Normal Univ, Fac Geog, Kunming, Yunnan, Peoples R China.	1205570894@qq.com		Wang, Dali/0000-0002-9487-7553	National Natural Science Foundation of China [U2002201]; Yunnan Educational Cooperation Project between Provincial Institutes and Provincial Colleges [SYSX201903]; Science Research Foundation of Yunnan Education Bureau [2020Y0102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Educational Cooperation Project between Provincial Institutes and Provincial Colleges; Science Research Foundation of Yunnan Education Bureau	This research study was supported by the National Natural Science Foundation of China (grant no. U2002201), Yunnan Educational Cooperation Project between Provincial Institutes and Provincial Colleges (grant no. SYSX201903), and Science Research Foundation of Yunnan Education Bureau (grant no. 2020Y0102).	Bardsley DK, 2020, J RURAL STUD, V80, P503, DOI 10.1016/j.jrurstud.2020.10.034; Berihun ML, 2019, SCI TOTAL ENVIRON, V689, P347, DOI 10.1016/j.scitotenv.2019.06.338; Boori MS, 2021, J ENVIRON MANAGE, V285, DOI 10.1016/j.jenvman.2021.112138; Boyd DS, 2011, ECOL INFORM, V6, P25, DOI 10.1016/j.ecoinf.2010.07.007; Browning TN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79402-y; Cai J, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.145837; Chan Lu, 2021, Arabian Journal of Geosciences, V14, DOI 10.1007/s12517-020-06335-1; Chang Y, 2019, ECOL INDIC, V107, DOI 10.1016/j.ecolind.2019.105568; Chi Y, 2020, ECOL INDIC, V112, DOI 10.1016/j.ecolind.2020.106139; Chu HJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79064-w; Danish, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101516; Feng HB, 2021, SCI TOTAL ENVIRON, V778, DOI 10.1016/j.scitotenv.2021.146221; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fural S, 2020, ECOL INDIC, V119, DOI 10.1016/j.ecolind.2020.106784; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gupta K, 2012, LANDSCAPE URBAN PLAN, V105, P325, DOI 10.1016/j.landurbplan.2012.01.003; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hu XJ, 2021, ECOL INDIC, V125, DOI 10.1016/j.ecolind.2021.107464; Jin Y, 2021, ECOL INDIC, V120, DOI 10.1016/j.ecolind.2020.106933; Jing YQ, 2020, ECOL INDIC, V110, DOI 10.1016/j.ecolind.2019.105874; Nguyen KA, 2019, METHODSX, V6, P862, DOI 10.1016/j.mex.2019.03.023; Nguyen KA, 2019, SCI TOTAL ENVIRON, V664, P995, DOI 10.1016/j.scitotenv.2019.01.407; Kok M, 2016, REG ENVIRON CHANGE, V16, P229, DOI 10.1007/s10113-014-0746-1; Li CX, 2019, ENVIRON MONIT ASSESS, V191, DOI 10.1007/s10661-019-7547-4; Li CX, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051446; Li J, 2021, SCI TOTAL ENVIRON, V781, DOI 10.1016/j.scitotenv.2021.146729; Li SL, 2020, AGR ECOSYST ENVIRON, V303, DOI 10.1016/j.agee.2020.107120; Lin J., 2021, ECOL INDIC, V125, DOI [10.1016/j.ecolind.2021.107437, DOI 10.1016/J.ECOLIND.2021.107437]; Liou YIA, 2017, ECOL INDIC, V80, P52, DOI 10.1016/j.ecolind.2017.04.055; Litzow MA, 2014, PROG OCEANOGR, V120, P110, DOI 10.1016/j.pocean.2013.08.003; Liu DY, 2021, ENVIRON TECHNOL INNO, V22, DOI 10.1016/j.eti.2021.101473; Luo Y, 2018, ENVIRON SCI POLLUT R, V25, P29643, DOI 10.1007/s11356-018-2967-1; Lyu RF, 2019, APPL GEOGR, V108, P64, DOI 10.1016/j.apgeog.2019.05.003; Mateo-Garcia G, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10071079; Mi ZF, 2020, NAT SUSTAIN, V3, P529, DOI 10.1038/s41893-020-0504-y; Nzung'a SO, 2018, J ENVIRON SCI, V66, P173, DOI 10.1016/j.jes.2017.05.027; Peng DM, 2021, ENVIRON IMPACT ASSES, V89, DOI 10.1016/j.eiar.2021.106605; Ploton P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18321-y; Pradhan P, 2020, SCI TOTAL ENVIRON, V701, DOI 10.1016/j.scitotenv.2019.134308; Reshmidevi TV, 2009, AGR SYST, V101, P101, DOI 10.1016/j.agsy.2009.04.001; Shan W, 2019, J CLEAN PROD, V239, DOI 10.1016/j.jclepro.2019.118126; Shi T, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118739; Sun DL, 2021, GEOMORPHOLOGY, V379, DOI 10.1016/j.geomorph.2021.107623; Sun DQ, 2013, J GEOGR SCI, V23, P695, DOI 10.1007/s11442-013-1038-2; Teng MJ, 2019, SCI TOTAL ENVIRON, V697, DOI 10.1016/j.scitotenv.2019.134164; Turner-Skoff JB, 2019, PLANTS PEOPLE PLANET, V1, P323, DOI 10.1002/ppp3.39; Wang JY, 2018, ECOL INDIC, V89, P348, DOI 10.1016/j.ecolind.2018.02.005; [王劲峰 Wang Jinfeng], 2017, [地理学报, Acta Geographica Sinica], V72, P116; Wang QR, 2019, J HYDROL, V569, P155, DOI 10.1016/j.jhydrol.2018.12.003; Wang SX, 2014, INT J ENV RES PUB HE, V11, P1673, DOI 10.3390/ijerph110201673; Wang X, 2021, J HYDROL, V597, DOI 10.1016/j.jhydrol.2021.126310; Whetton R, 2017, COMPUT ELECTRON AGR, V138, P127, DOI 10.1016/j.compag.2017.04.016; Wu JJ, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106521; Xia M, 2021, ECOL INDIC, V123, DOI 10.1016/j.ecolind.2020.107274; Xie HL, 2015, ECOL INDIC, V51, P3, DOI 10.1016/j.ecolind.2014.08.042; Xiong Y, 2021, ECOL INDIC, V125, DOI 10.1016/j.ecolind.2021.107518; Yan RH, 2019, ECOL ENG, V139, DOI 10.1016/j.ecoleng.2019.105587; Yang J, 2021, SUSTAIN CITIES SOC, V69, DOI 10.1016/j.scs.2021.102818; Yang J, 2020, URBAN CLIM, V34, DOI 10.1016/j.uclim.2020.100700; Yang J, 2020, J CLEAN PROD, V275, DOI 10.1016/j.jclepro.2020.123767; Yang J, 2020, URBAN FOR URBAN GREE, V54, DOI 10.1016/j.ufug.2020.126784; Yang J, 2019, URBAN CLIM, V28, DOI 10.1016/j.uclim.2019.100458; Yang J, 2018, SCI TOTAL ENVIRON, V639, P1453, DOI 10.1016/j.scitotenv.2018.05.253; Yang J, 2017, URBAN FOR URBAN GREE, V22, P1, DOI 10.1016/j.ufug.2017.01.002; Yang K, 2020, SUSTAIN CITIES SOC, V59, DOI 10.1016/j.scs.2020.102180; Yang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18338-3; Yang R., 2021, ACTA ECOL SIN, DOI [10.1016/j.chnaes.2021.02.007, DOI 10.1016/J.CHNAES.2021.02.007]; You HL, 2021, SCI TOTAL ENVIRON, V776, DOI 10.1016/j.scitotenv.2021.146023; Yu H, 2020, J HYDROL, V583, DOI 10.1016/j.jhydrol.2019.124298; Yu ZY, 2020, J CLEAN PROD, V276, DOI 10.1016/j.jclepro.2020.122689; Yuan J, 2019, E3S WEB CONF, V81, DOI 10.1051/e3sconf/20198101001; Zambrano-Monserrate MA, 2020, J ENVIRON MANAGE, V272, DOI 10.1016/j.jenvman.2020.111069; Zhang DC, 2020, J CLEAN PROD, V256, DOI 10.1016/j.jclepro.2020.120361; Zhang DQ, 2018, COMPUT ELECTRON AGR, V154, P10, DOI 10.1016/j.compag.2018.08.016; Zhang PY, 2020, LAND USE POLICY, V99, DOI 10.1016/j.landusepol.2020.104958; Zhang PY, 2018, J CLEAN PROD, V204, P702, DOI 10.1016/j.jclepro.2018.08.341; Zhao XJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240272; Zhou B, 2021, ENVIRON TECHNOL INNO, V23, DOI 10.1016/j.eti.2021.101506; Zhou L., 2021, SCI TOTAL ENVIRON, V775, P145836, DOI [10.1016/j.scitotenv.2021.145836, DOI 10.1016/J.SCITOTENV.2021.145836]; Zhou L, 2020, SUSTAIN CITIES SOC, V55, DOI 10.1016/j.scs.2020.102045; Zhu MC, 2020, SCI TOTAL ENVIRON, V714, DOI 10.1016/j.scitotenv.2020.136843	81	1	1	13	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0248090	10.1371/journal.pone.0248090	http://dx.doi.org/10.1371/journal.pone.0248090			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BH	34157018	Green Published, gold			2022-12-26	WOS:000671691200013
J	Zhang, JY; Liu, Y; Tan, JY; Zhang, YM; Wong, CW; Lin, ZQ; Liu, XC; Sander, M; Yan, XZ; Liang, LB; Song, DL; Dan, J; Zhou, YW; Cai, J; Lin, Y; Liang, JK; Hu, J; Yan, GM; Zhu, WB				Zhang, Jiayu; Liu, Ying; Tan, Jingyi; Zhang, Yanming; Wong, Chun-Wa; Lin, Ziqing; Liu, Xincheng; Sander, Max; Yan, Xiaozhi; Liang, Lebin; Song, Deli; Dan, Jia; Zhou, Yuwei; Cai, Jing; Lin, Yuan; Liang, Jiankai; Hu, Jun; Yan, Guangmei; Zhu, Wenbo			Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC	ONCOGENE			English	Article							CANCER STATISTICS; VIRUS; IDENTIFICATION; PATHWAYS	Triple-negative breast cancer (TNBC) is the most aggressive molecular subtype among breast tumors and remains a challenge even for the most current therapeutic regimes. Here, we demonstrate that oncolytic alphavirus M1 effectively kills both TNBC and non-TNBC. ER-stress and apoptosis pathways are responsible for the cell death in non-TNBC as reported in other cancer types, yet the cell death in TNBC does not depend on these pathways. Transcriptomic analysis reveals that the M1 virus activates necroptosis in TNBC, which can be pharmacologically blocked by necroptosis inhibitors. By screening a library of clinically available compounds commonly used for breast cancer treatment, we find that Doxorubicin enhances the oncolytic effect of the M1 virus by up to 100-fold specifically in TNBC in vitro, and significantly stalls the tumor growth of TNBC in vivo, through promoting intratumoral virus replication and further triggering apoptosis in addition to necroptosis. These findings reveal a novel antitumor mechanism and a new combination regimen of the M1 oncolytic virus in TNBC, and highlight a need to bridge molecular diagnosis with virotherapy.	[Zhang, Jiayu; Tan, Jingyi; Zhang, Yanming; Wong, Chun-Wa; Liu, Xincheng; Liang, Lebin; Song, Deli; Dan, Jia; Zhou, Yuwei; Cai, Jing; Lin, Yuan; Liang, Jiankai; Hu, Jun; Yan, Guangmei; Zhu, Wenbo] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Dept Pharmacol, Guangzhou 510080, Peoples R China; [Liu, Ying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Infect Dis, 600 Tianhe Rd, Guangzhou 510630, Peoples R China; [Lin, Ziqing; Sander, Max; Yan, Xiaozhi] Guangzhou Virotech Pharmaceut Co Ltd, 3 Lanyue Rd,Sci Pk, Guangzhou 510663, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Zhu, WB (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Dept Pharmacol, Guangzhou 510080, Peoples R China.	zhuwenbo@mail.sysu.edu.cn		Wong, Chun-wa/0000-0003-3476-9283; Lin, Yuan/0000-0002-7152-0965; zhang, Jiayu/0000-0003-1132-1101	National Natural Science Foundation of China [81872886]; Fundamental Research Funds for the Central Universities [19ykpy36, 19ykpy166]; Guangdong Basic and Applied Basic Research Foundation [2020A1515011446]; Pioneering talents project of Guangzhou Development Zone, Guangdong Province [CY2018-012]; Leading Team for Entrepreneurship in Guangzhou, Guangdong Province [201809020004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Basic and Applied Basic Research Foundation; Pioneering talents project of Guangzhou Development Zone, Guangdong Province; Leading Team for Entrepreneurship in Guangzhou, Guangdong Province	We thank all authors who contributed to this work. This work was supported by the National Natural Science Foundation of China (No. 81872886), Fundamental Research Funds for the Central Universities (19ykpy36 and 19ykpy166), Guangdong Basic and Applied Basic Research Foundation (2020A1515011446), Pioneering talents project of Guangzhou Development Zone, Guangdong Province (CY2018-012), and Leading Team for Entrepreneurship in Guangzhou, Guangdong Province (201809020004).	Adair RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003578; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Brown CM, 1998, TROP ANIM HEALTH PRO, V30, P241, DOI 10.1023/A:1005079229232; Budhwani M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00322; Cai J, 2021, HUM GENE THER, V32, P138, DOI 10.1089/hum.2020.271; de Graaf JF, 2018, CYTOKINE GROWTH F R, V41, P28, DOI 10.1016/j.cytogfr.2018.03.006; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; DeSantis CE, 2017, CA-CANCER J CLIN, V67, P439, DOI 10.3322/caac.21412; Forrest RA, 2012, BIOCHEM PHARMACOL, V83, P1602, DOI 10.1016/j.bcp.2012.02.026; Garrido-Castro AC, 2019, CANCER DISCOV, V9, P176, DOI 10.1158/2159-8290.CD-18-1177; Gong YT, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1029-8; Goradel NH, 2021, CURR PROB CANCER, V45, DOI 10.1016/j.currproblcancer.2020.100639; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hu J, 2009, CELL CYCLE, V8, P3328, DOI 10.4161/cc.8.20.9832; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; Kok F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20198955; Lawler SE, 2017, JAMA ONCOL, V3, P841, DOI 10.1001/jamaoncol.2016.2064; Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025; Lin Y, 2014, P NATL ACAD SCI USA, V111, pE4504, DOI 10.1073/pnas.1408759111; Liu SZ, 2017, P NATL ACAD SCI USA, V114, pE7450, DOI 10.1073/pnas.1707531114; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140; Moskovskich A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46952-9; Muhuri M, 2021, HUM GENE THER, V32, P136, DOI 10.1089/hum.2021.29150.mmu; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; Poh A, 2016, CANCER DISCOV, V6, P6, DOI 10.1158/2159-8290.CD-NB2015-158; Pu ZQ, 2020, J CELL MOL MED, V24, P14171, DOI 10.1111/jcmm.16028; Rehman H, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0158-5; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silke J, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003845; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tan YQ, 2018, HUM GENE THER, V29, P950, DOI 10.1089/hum.2017.055; Tanzer MC, 2016, CELL DEATH DIFFER, V23, P1185, DOI 10.1038/cdd.2015.169; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turnbull S, 2015, VIRUSES-BASEL, V7, P6291, DOI 10.3390/v7122938; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wen JS, 2007, VIRUS GENES, V35, P597, DOI 10.1007/s11262-007-0110-3; Wen SH, 2018, CANCER CELL INT, V18, DOI 10.1186/s12935-018-0625-9; Willson J, 2020, NAT REV MOL CELL BIO, V21, P63, DOI 10.1038/s41580-019-0201-8; WU J, 2020, CANCERS, V12; XIAO X, 2018, NAT COMMUN, V9; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Yang F, 2013, CURR BIOL, V23, P782, DOI 10.1016/j.cub.2013.03.043; Zhang HP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7996; Zhang HP, 2016, HUM GENE THER, V27, P700, DOI 10.1089/hum.2016.038; Zhang J, 2016, CELL MOL LIFE SCI, V73, P2153, DOI 10.1007/s00018-016-2190-5; Zhu WB, 2021, HUM GENE THER, V32, P158, DOI 10.1089/hum.2020.273	52	5	5	1	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4783	4795		10.1038/s41388-021-01869-4	http://dx.doi.org/10.1038/s41388-021-01869-4		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34155344				2022-12-26	WOS:000664006400001
J	Lueyot, A; Rungsardthong, V; Vatanyoopaisarn, S; Hutangura, P; Wonganu, B; Wongsa-Ngasri, P; Charoenlappanit, S; Roytrakul, S; Thumthanaruk, B				Lueyot, Artima; Rungsardthong, Vilai; Vatanyoopaisarn, Savitri; Hutangura, Pokkwan; Wonganu, Benjamaporn; Wongsa-Ngasri, Pisit; Charoenlappanit, Sawanya; Roytrakul, Sittiruk; Thumthanaruk, Benjawan			Influence of collagen and some proteins on gel properties of jellyfish gelatin	PLOS ONE			English	Article							ACID-SOLUBLE COLLAGEN; BIGEYE SNAPPER; FUNCTIONAL-PROPERTIES; SKIN GELATIN; EXTRACTION; OPTIMIZATION	Marine gelatin is one of the food proteins used in food and non-food products, offering desirable functionalities such as gelling, thickening, and binding. Jellyfish has been chosen for this gelatin research, in view of the benefits of its main collagen protein and lower fat content, which may reduce the amounts of chemicals used in the preparative steps of gelatin production. To date, the lack of identified proteins in gelatin has limited the understanding of differentiating intrinsic factors quantitatively and qualitatively affecting gel properties. No comparison has been made between marine gelatin of fish and that of jellyfish, regarding protein type and distribution differences. Therefore, the study aimed at characterizing jellyfish gelatin extracted from by-products, that are i.e., pieces that have broken off during the grading and cleaning step of salted jellyfish processing. Different pretreatment by hydrochloric acid (HCl) concentrations (0.1 and 0.2 M) and hot water extraction time (12 and 24 h) were studied as factors in jellyfish gelatin extraction. The resultant jellyfish gelatin with the highest gel strength (JFG1), as well as two commercial gelatins of fish gelatin (FG) and bovine gelatin (BG), were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS). The results show that the jellyfish gelatin (JFG1) extracted with 0.1 M HCl at 60 degrees C for 12 h delivered a maximum gel strength of 323.74 g, which is lower than for FG and BG, exhibiting 640.65 and 540.06 g, respectively. The gelling and melting temperatures of JFG1 were 7.1 degrees C and 20.5 degrees C, displaying a cold set gel and unstable gel at room temperature, whereas the gelling and melting temperatures of FG and BG were 17.4 degrees C, 21.3 degrees C, and 27.5 degrees C, 32.7 degrees C, respectively. Proteomic analysis shows that 29 proteins, of which 10 are types of collagen proteins and 19 are non-collagen proteins, are common to all BG, FG, and JFG1, and that JFG1 is missing 3 other collagen proteins (collagen alpha-2 (XI chain), collagen alpha-2 (I chain), and collagen alpha-2 (IV chain), that are important to gel networks. Thus, the lack of these 3 collagen types influences the inferior gel properties of jellyfish gelatin.	[Lueyot, Artima; Rungsardthong, Vilai; Vatanyoopaisarn, Savitri; Hutangura, Pokkwan; Thumthanaruk, Benjawan] King Mongkuts Univ Technol North Bangkok, Fac Appl Sci, Dept AgroInd Food & Environm Technol, Bangkok, Thailand; [Wonganu, Benjamaporn] King Mongkuts Univ Technol North Bangkok, Fac Appl Sci, Dept Biotechnol, Bangkok, Thailand; [Wongsa-Ngasri, Pisit] Minist Agr & Cooperat, Fishery Technol Dev Div, Dept Fisheries, Bangkok, Thailand; [Charoenlappanit, Sawanya; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Funct Ingredients & Food Innovat Res Grp, Klongluang, Pathumthani, Thailand	King Mongkuts University of Technology North Bangkok; King Mongkuts University of Technology North Bangkok; Ministry of Agriculture & Cooperatives - Thailand; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Thumthanaruk, B (corresponding author), King Mongkuts Univ Technol North Bangkok, Fac Appl Sci, Dept AgroInd Food & Environm Technol, Bangkok, Thailand.	benjawan.t@sci.kmutnb.ac.th		Charoenlappanit, Sawanya/0000-0003-0852-7029; Thumthanaruk, Benjawan/0000-0002-8511-5215	Thailand Science Research and Innovation (TSRI) [PHD59I0041]; National Research Council of Thailand through the NRCT Senior Research Scholar Program [814-2020]	Thailand Science Research and Innovation (TSRI); National Research Council of Thailand through the NRCT Senior Research Scholar Program	Artima was awarded by Thailand Science Research and Innovation (TSRI) (No. PHD59I0041). Benjawan and Vilai was awarded by National Research Council of Thailand through the NRCT Senior Research Scholar Program (Contract no. 814-2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2010, FOOD HYDROCOLLOID, V24, P588, DOI 10.1016/j.foodhyd.2010.03.001; AOAC, 2012, OF METH AN; Arnesen JA, 2007, BIORESOURCE TECHNOL, V98, P53, DOI 10.1016/j.biortech.2005.11.021; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Benjakul S., 2012, FISH GELATIN, P388; Brotz L, 2017, REV FISH BIOL FISHER, V27, P1, DOI 10.1007/s11160-016-9445-y; Chancharern P, 2016, INT FOOD RES J, V23, P419; Cheow CS, 2007, FOOD CHEM, V101, P386, DOI 10.1016/j.foodchem.2006.01.046; Cho SM, 2005, FOOD HYDROCOLLOID, V19, P221, DOI 10.1016/j.foodhyd.2004.05.005; Cho Suengmok, 2014, Fisheries and Aquatic Sciences, V17, P299, DOI 10.5657/FAS.2014.0299; GMIA, 1986, STANDARD METHODS SAM; Gomez-Guillen MC, 2011, FOOD HYDROCOLLOID, V25, P1813, DOI 10.1016/j.foodhyd.2011.02.007; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Intarasirisawat R, 2007, FOOD HYDROCOLLOID, V21, P537, DOI 10.1016/j.foodhyd.2006.05.012; Johnston FA., 1990, FOOD GELS; Jongjareonrak A, 2006, EUR FOOD RES TECHNOL, V222, P229, DOI 10.1007/s00217-005-0004-3; Jongjareonrak A, 2010, LWT-FOOD SCI TECHNOL, V43, P161, DOI 10.1016/j.lwt.2009.06.012; Kaewruang P, 2013, FOOD CHEM, V138, P1431, DOI 10.1016/j.foodchem.2012.09.114; Karim AA, 2009, FOOD HYDROCOLLOID, V23, P563, DOI 10.1016/j.foodhyd.2008.07.002; Khong NMH, 2016, FOOD CHEM, V196, P953, DOI 10.1016/j.foodchem.2015.09.094; Kittiphattanabawon P, 2005, FOOD CHEM, V89, P363, DOI 10.1016/j.foodchem.2004.02.042; Kittiphattanabawon P, 2016, LWT-FOOD SCI TECHNOL, V66, P186, DOI 10.1016/j.lwt.2015.10.029; Kittiphattanabawon P, 2010, FOOD HYDROCOLLOID, V24, P164, DOI 10.1016/j.foodhyd.2009.09.001; Klaiwong T., 2014, Journal of Agricultural Science and Technology B, V4, P555; Lin L, 2017, TRENDS FOOD SCI TECH, V68, P102, DOI 10.1016/j.tifs.2017.08.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariod AA, 2013, ACTA SCI POLON-TECHN, V12, P135; Mirzapour-Kouhdasht A, 2019, J TEXTURE STUD, V50, P416, DOI 10.1111/jtxs.12408; Mohtar NF, 2010, FOOD CHEM, V122, P307, DOI 10.1016/j.foodchem.2010.02.027; Muyonga JH, 2004, FOOD CHEM, V86, P325, DOI 10.1016/j.foodchem.2003.09.038; Nalinanon S, 2008, FOOD HYDROCOLLOID, V22, P615, DOI 10.1016/j.foodhyd.2007.01.012; Norziah MH, 2014, FOOD BIOSCI, V5, P9, DOI 10.1016/j.fbio.2013.10.001; Omori M, 2001, HYDROBIOLOGIA, V451, P19, DOI 10.1023/A:1011879821323; Rodsuwan U, 2016, INT FOOD RES J, V23, P507; Sae-Leaw T, 2016, LWT-FOOD SCI TECHNOL, V65, P661, DOI 10.1016/j.lwt.2015.08.060; Sanaei A. V., 2013, International Food Research Journal, V20, P423; Thumthanaruk B., 2014, J APPL SCI, V2, P33; Thumthanaruk B, 2017, J FOOD PROCESS PRES, V41, DOI 10.1111/jfpp.12808; Tumerkan ETA, 2019, FOOD CHEM, V287, P273, DOI 10.1016/j.foodchem.2019.02.088; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van Boekel MAJS, 1998, FOOD CHEM, V62, P403, DOI 10.1016/S0308-8146(98)00075-2; Yilmaz MT, 2013, FOOD CHEM, V141, P2450, DOI 10.1016/j.foodchem.2013.05.096	42	2	2	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253254	10.1371/journal.pone.0253254	http://dx.doi.org/10.1371/journal.pone.0253254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143821	gold, Green Published			2022-12-26	WOS:000671690700047
J	Antwi-Adjei, EK; Owusu, E; Kobia-Acquah, E; Dadzie, EE; Anarfi, E; Wanye, S				Antwi-Adjei, Ellen Konadu; Owusu, Emmanuel; Kobia-Acquah, Emmanuel; Dadzie, Emmanuella Esi; Anarfi, Emmanuel; Wanye, Seth			Evaluation of postoperative refractive error correction after cataract surgery	PLOS ONE			English	Article							OUTCOMES; IMPACT	Suboptimal cataract surgery outcomes remain a challenge in most developing countries. In Ghana, about 2 million people have been reported to be blind due to cataract with about 20% new cases being recorded yearly. The aim of this study was to evaluate postoperative correction of refractive errors after cataract surgery in a selected eye hospital in Ashanti Region, Ghana. This was a retrospective study where medical records of patients (aged 40-100) who reported to an eye hospital in Ghana from 2013-2018 were reviewed. Included in the study were patients aged >= 40 years and patients with complete records. Data on patient demographics, type of surgery, intra-ocular lens (PCIOL) power, availability of biometry, postoperative refraction outcomes, pre- and postoperative visual acuity were analyzed. Data of two hundred and thirteen eyes of 190 patients who met the inclusion criteria were analyzed. Descriptive analysis and Chi-square test were carried out to determine the mean, median, standard deviation and relevant associations. The mean +/- SD age was 67.21 +/- 12.2 years (51.2% were females). Small Incision Cataract Surgery (99.5%) with 100% IOL implants was the main cataract surgery procedure in this study. Pre-operative biometry was performed for 38.9% of all patients on their first eye surgery and 41.5% for second eye surgeries. About 71% eyes in this study were blind (presenting VA<3/60) before surgery; 40.4% had post-operative VA <3/60. Pre-existing ocular comorbidities discovered post- surgery, attributed to suboptimal visual outcomes. More than half (55.3%) of patients did not undergo postoperative refraction due to loss to follow-up. Year of surgery (p = .017), follow up visits< 2months (p < .0001) and discovered comorbidity post-surgery (p = .035) were the factors significantly associated with postoperative refraction. Myopia and compound myopic astigmatism were the dominant refractive error outcomes. The timing of post-operative refraction had a significant effect on postoperative refraction done. These findings indicate a clinically meaningful significance between completion of postoperative care and postoperative refraction done. Consequently, with settings in most developing countries, where less biometry is done, it is appropriate that post-operative refractive services are encouraged and done earlier to enhance the patients' expectations while increasing cataract surgery patronage.	[Antwi-Adjei, Ellen Konadu; Owusu, Emmanuel; Kobia-Acquah, Emmanuel; Dadzie, Emmanuella Esi; Anarfi, Emmanuel] Kwame Nkrumah Univ Sci & Technol, Dept Optometry & Visual Sci, Kumasi, Ghana; [Wanye, Seth] Friends Eye Ctr, Kumasi, Ghana; [Kobia-Acquah, Emmanuel] Technol Univ Dublin, Ctr Eye Res Ireland, Dublin, Ireland	Kwame Nkrumah University Science & Technology	Antwi-Adjei, EK (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Optometry & Visual Sci, Kumasi, Ghana.	antwi-adjeiellenkonadu@knust.edu.gh	Dadzie, Emmanuella/AAZ-7628-2021	Dadzie, Emmanuella/0000-0001-8124-1612; Kobia-Acquah, Emmanuel/0000-0002-5955-7992; ANTWI-ADJEI, ELLEN K./0000-0003-3291-8492				Beyiah KP., 2016, OUTCOME AGE RELATED; Briesen S, 2010, OPHTHAL EPIDEMIOL, V17, P196, DOI 10.3109/09286586.2010.498662; Farmer L, 2015, OPHTHAL EPIDEMIOL, V22, P274, DOI 10.3109/09286586.2015.1008104; Guirou N, 2013, J FR OPHTALMOL, V36, P19, DOI 10.1016/j.jfo.2012.04.016; Guzek JP, 2003, J CATARACT REFR SURG, V29, P57, DOI 10.1016/S0886-3350(02)01440-2; HOVDING G, 1994, ACTA OPHTHALMOL, V72, P612; Ilechie A.A., 2012, INT J HLTH RES, V5, P35, DOI [10.5233/mih.v22i3.515, DOI 10.5233/MIH.V22I3.515]; Isawumi M A, 2009, Ghana Med J, V43, P169; Kobia-Acquah E., 2018, EC OPHTHALMOLOGY, V9, P181; Lamoureux EL, 2011, CURR OPIN OPHTHALMOL, V22, P19, DOI 10.1097/ICU.0b013e3283414284; Lindfield R, 2012, INDIAN J OPHTHALMOL, V60, P464, DOI 10.4103/0301-4738.100552; Lundstrom M, 2012, J CATARACT REFR SURG, V38, P1086, DOI 10.1016/j.jcrs.2012.03.006; Moshirfar M, 2014, EXPERT REV OPHTHALMO, V9, P529, DOI 10.1586/17469899.2014.966817; Organization WH, 1998, WORLD HLTH REPORT LI; Organization WH, 2015, HLTH 2015 MDGS MILL; Pascolini D, 2012, BRIT J OPHTHALMOL, V96, P614, DOI 10.1136/bjophthalmol-2011-300539; Potvin Richard, 2016, Healthc Manage Forum, V29, P227; Trivedy J, 2011, NEPAL J OPHTHALMOL, V3, P31, DOI 10.3126/nepjoph.v3i1.4276; Wiafe B., 2015, GHANA HLTH SERVICE O; Yorston D, 2002, BRIT J OPHTHALMOL, V86, P543, DOI 10.1136/bjo.86.5.543; Yorston D., 2008, CATARACT COMPLICATIO, V21; Zhou ZX, 2007, J CATARACT REFR SURG, V33, P2083, DOI 10.1016/j.jcrs.2007.07.040	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252787	10.1371/journal.pone.0252787	http://dx.doi.org/10.1371/journal.pone.0252787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138900	gold, Green Published			2022-12-26	WOS:000671690200008
J	Ewuneid, HA; Daka, K; Bekele, B; Meskele, M				Ewuneid, Helen Ali; Daka, Kassa; Bekele, Befekadu; Meskele, Mengistu			Challenges to nutrition management among patients using antiretroviral therapy in primary health 'centres' in Addis Ababa, Ethiopia: A phenomenological study	PLOS ONE			English	Article							HIV; HIV/AIDS; STIGMA; ADULTS; FOOD; ART	Introduction Nutritional management is a fundamental practice of concern to all patients infected with the human immunodeficiency virus (HIV). The nature of HIV/AIDS and malnutrition impacts are interlocked and intensify one another. Objective This study aimed to explore nutrition management challenges among people living with HIV on antiretroviral therapy (ART) in primary health centres in Addis Ababa, Ethiopia. Methods and materials We used a hermeneutic (interpretive) phenomenological study design. The study used in-depth interviews to describe lived experiences among adult patients aged 18 and above. We selected the participants purposively until the saturation of the idea reached. We maintained the scientific rigor and trustworthiness by applying credibility, transferability, dependability, and conformability, followed by translation and re-reading of the data has been achieved. The data have been analyzed through inductive thematic analysis assisted by NVIVO version 12 pro software. Result Nutrition management challenges for HIV patients have been described using six significant themes. The major themes were: acceptance of the disease and the health status; facilitators and barriers to treatment adherence; behavioural changes in eating patterns; experience of food insecurity issues; nutrition knowledge; and support. The themes have explained how patients using ART have been challenged to manage their nutrition ever since their diagnosis. Of all challenges, food insecurity is found to be the core reason for poor nutrition management. Conclusion and recommendation We found that many factors in managing their nutrition challenged patients with HIV. There should be an increasing interest in managing food insecurity issues as food insecurity has been strongly related to other factors.	[Ewuneid, Helen Ali; Daka, Kassa; Bekele, Befekadu; Meskele, Mengistu] Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia		Ewuneid, HA (corresponding author), Wolaita Sodo Univ, Sch Publ Hlth, Wolaita Sodo, Ethiopia.	bravohelu@gmail.com			Norwegian agency of development (NORAD); Wolaita Sodo University College of Health Science	Norwegian agency of development (NORAD); Wolaita Sodo University College of Health Science	Norwegian agency of development (NORAD) and Wolaita Sodo University College of Health Science have funded this research as part of Master's Degree research.	Airhihenbuwa CO, 2014, HEALTH EDUC BEHAV, V41, P78, DOI 10.1177/1090198113487199; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Berhanu Z, 2010, J HIV-AIDS SOC SERV, V9, P240, DOI 10.1080/15381501.2010.502802; Berhe N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-233; Bibiana N., 2018, NIGERIA MED J ZAMBIA NIGERIA MED J ZAMBIA, V45, P13; Creswell J. W., 2014, RES DESIGN QUALITATI, V4th; Cypher J, 2014, PROCESS EC DEV ROUTL; Dibaba B., 2017, J AIDS CLIN RES, P8; Feyissa GT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-522; Franke MF, 2011, AIDS BEHAV, V15, P1483, DOI 10.1007/s10461-010-9789-6; Gebremichael DY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1913534; Gedle D., 2015, BMC NUTR, V1, P5, DOI [10.1186/2055-0928-1-5, DOI 10.1186/2055-0928-1-5]; Gelaw YK, 2018, AIDS RES TREAT, V2018, DOI 10.1155/2018/1879198; Genet Minichil, 2015, BMC Res Notes, V8, P109, DOI 10.1186/s13104-015-1056-5; Gezahegn M., 2014, ASIAN EC FINANCIAL R, V4, P1146; Hirut BM., 2014, J SCI DEV, V2, P49; Horter S, 2017, SOC SCI MED, V176, P52, DOI 10.1016/j.socscimed.2017.01.006; Hussen S., 2017, OPEN PUBLIC HLTH J, P10; Idele P, 2014, JAIDS-J ACQ IMM DEF, V66, pS144, DOI 10.1097/QAI.0000000000000176; Ismaili H, 2011, ETHIOP J HEALTH DEV, V25, P126; Kebede MA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-20; Kyajja R, 2010, AJAR-AFR J AIDS RES, V9, P205, DOI 10.2989/16085906.2010.530171; Mengie GM, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0256-5; Mutale W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-347; Njeru MK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-87; Olsen M, 2013, QUAL LIFE RES, V22, P361, DOI 10.1007/s11136-012-0141-7; Olsen MF, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3187; Olsen MF, 2013, PATIENT PREFER ADHER, V7, P481, DOI 10.2147/PPA.S44413; Psomas CK, 2019, J VIRUS ERAD, V5, P67; Scarcella P, 2011, Ig Sanita Pubbl, V67, P41; Siberry GK, 2014, PEDIATR REV, V35, P268, DOI 10.1542/pir.35-7-268; Tiyou A, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-51; van Dyk AC, 2013, J ASSOC NURSE AIDS C, V24, pE45, DOI 10.1016/j.jana.2012.12.005; Wolfe WR, 2006, AIDS CARE, V18, P931, DOI 10.1080/09540120500333558	34	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0250919	10.1371/journal.pone.0250919	http://dx.doi.org/10.1371/journal.pone.0250919			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138857	Green Published, gold			2022-12-26	WOS:000671690200004
J	Sims, AJ; Rutherfurd, ID				Sims, Alexander J.; Rutherfurd, Ian D.			Local scale interventions dominate over catchment scale controls to accelerate the recovery of a degraded stream	PLOS ONE			English	Article							SAND-BED STREAM; NEW-SOUTH-WALES; RIVER RESTORATION; PHRAGMITES-AUSTRALIS; CHANNEL RESPONSE; GEOMORPHIC APPROACH; REDWOOD CREEK; REHABILITATION; TRANSPORT; HABITAT	A premise of stream restoration theory and practice is that it is often futile to attempt to restore a stream at the reach scale (10(1)-10(3) metres) until catchment scale problems have been addressed. This study considers reach scale restoration actions undertaken in Bryan Creek, a sand bed river in south east Australia impacted by a sediment pulse, after catchment sediment sources have been addressed. Local scale interventions, which were in-stream sand extraction, fencing to exclude stock and riparian revegetation, were evaluated by quantifying cross-section and thalweg variability, mapping in-stream and riparian vegetation and by classifying the morphology that emerged following each intervention. Following intervention channel reaches moved to one of three distinct states: simple clay bed, eroding reaches dominated by Juncus acutus, and reaches with deep pools and Phragmites australis. Boundaries between the intervention reaches were sharp, suggesting local scale interventions dominate over catchment scale processes. The magnitude and spread of variability metrics were similar between all reaches and differences in variability bore no relation to intervention type, despite the stark difference in post-intervention morphology. These findings suggest that cross-section and thalweg variability metrics are an inadequate proxy for the effectiveness of local scale interventions in accelerating the recovery of sand bed reaches from a bedload pulse. The most important implications for river managers is that local scale interventions can lead to substantial and rapid improvements in condition, and the change in condition of these reaches is almost independent of other reaches. In this case, the key to the pattern of reach scale geomorphic recovery is excluding stock from waterways so that a specific macrophyte can establish, trap sediment and develop pools.	[Sims, Alexander J.; Rutherfurd, Ian D.] Univ Melbourne, Sch Geog, Parkville, Vic, Australia; [Sims, Alexander J.] Alluvium Consulting Australia, Cremorne, Australia	University of Melbourne	Sims, AJ (corresponding author), Univ Melbourne, Sch Geog, Parkville, Vic, Australia.; Sims, AJ (corresponding author), Alluvium Consulting Australia, Cremorne, Australia.	alexander.sims@unimelb.edu.au		Sims, Alexander/0000-0002-4380-6587	University of Melbourne; Glenelg Hopkins Catchment Management Authority	University of Melbourne(University of Melbourne); Glenelg Hopkins Catchment Management Authority	This study was supported by The University of Melbourne (https://www.unimelb.edu.au/) in the form of a Melbourne Research Scholarship (PhD scholarship) awarded to AJS and the Glenelg Hopkins Catchment Management Authority (https://www.ghcma.vic.gov.au/) in the form of a Research Grant ('Sand dynamics and management in the Glenelg River') awarded to AJS.	[Anonymous], 1977, AUST GEOGR, DOI [10.1080/00049187708702716, DOI 10.1080/00049187708702716]; Bartley R, 2005, GEOMORPHOLOGY, V64, P221, DOI 10.1016/j.geomorph.2004.07.005; Bartley R, 2005, RIVER RES APPL, V21, P39, DOI 10.1002/rra.813; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Bernhardt ES, 2007, RESTOR ECOL, V15, P482, DOI 10.1111/j.1526-100X.2007.00244.x; Bernhardt ES, 2011, ECOL APPL, V21, P1926, DOI 10.1890/10-1574.1; Bernhardt ES, 2005, SCIENCE, V308, P636, DOI 10.1126/science.1109769; Brierley GJ, 2000, ENVIRON MANAGE, V25, P661, DOI 10.1007/s002670010052; Brooks A., 2003, P AUSTR C ROB AUT BR, P1; Brooks AP, 2006, GEOMORPHOLOGY, V79, P395, DOI 10.1016/j.geomorph.2006.06.035; Brooks AP, 2004, GEOMORPHOLOGY, V58, P107, DOI 10.1016/S0169-555X(03)00227-7; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Downes BJ, 2006, FRESHWATER BIOL, V51, P144, DOI 10.1111/j.1365-2427.2005.01466.x; Dufour S, 2009, RIVER RES APPL, V25, P568, DOI 10.1002/rra.1239; Engloner AI, 2009, FLORA, V204, P331, DOI 10.1016/j.flora.2008.05.001; Erskine W., 1994, Australian Journal of Soil and Water Conservation, V7, P39; Erskine W, 2012, GEOMORPHOLOGY, V147, P102, DOI 10.1016/j.geomorph.2011.07.030; Erskine W, 2009, EARTH SURF PROC LAND, V34, P941, DOI 10.1002/esp.1778; Erskine WD, 1996, Z GEOMORPHOL, V40, P359; ERSKINE WD, 1994, VARIABILITY IN STREAM EROSION AND SEDIMENT TRANSPORT, P143; EYLES RJ, 1977, AUST GEOGR STUD, V15, P146, DOI 10.1111/j.1467-8470.1977.tb00094.x; Fitzpatrick FA, 2000, PHYS GEOGR, V21, P89, DOI 10.1080/02723646.2000.10642701; Friedman JM, 1996, ECOLOGY, V77, P2167, DOI 10.2307/2265710; Fryirs K, 2000, PHYS GEOGR, V21, P244, DOI 10.1080/02723646.2000.10642708; Fryirs K, 2013, EARTH SURF PROC LAND, V38, P30, DOI 10.1002/esp.3242; Fryirs K, 2012, EARTH SURF PROC LAND, V37, P763, DOI 10.1002/esp.3210; Fryirs KA, 2007, CATENA, V70, P49, DOI 10.1016/j.catena.2006.07.007; Fryirs KA, 2016, WIRES WATER, V3, P727, DOI 10.1002/wat2.1158; Gilbert G.K., 1917, US GEOLOGICAL SURVEY; Gran KB, 2005, GEOL SOC AM BULL, V117, P195, DOI 10.1130/B25528.1; Greenwood ME, 2006, WETLANDS, V26, P854, DOI 10.1672/0277-5212(2006)26[854:EOSATO]2.0.CO;2; Gurnell A, 2015, EARTH SURF PROC LAND, V40, P135, DOI 10.1002/esp.3671; Hoyle J, 2008, EARTH SURF PROC LAND, V33, P868, DOI 10.1002/esp.1580; Keene A. F., 2008, Sediment dynamics in changing environments, P576; KNIGHTON AD, 1989, EARTH SURF PROCESSES, V14, P333, DOI 10.1002/esp.3290140408; Kondolf GM, 2007, RESTOR ECOL, V15, P516, DOI 10.1111/j.1526-100X.2007.00247.x; Lorenz AW, 2012, J APPL ECOL, V49, P202, DOI 10.1111/j.1365-2664.2011.02082.x; Madej MA, 2001, WATER RESOUR RES, V37, P2259, DOI 10.1029/2001WR000229; Madej MA, 1996, EARTH SURF PROCESSES, V21, P911, DOI 10.1002/(SICI)1096-9837(199610)21:10<911::AID-ESP621>3.3.CO;2-T; Madej MA, 2009, GEOMORPHOLOGY, V103, P507, DOI 10.1016/j.geomorph.2008.07.017; Marker M. E., 1976, Proceedings of the Royal Society of Victoria, V88, P15; Moore GE, 2012, NORTHEAST NAT, V19, P611, DOI 10.1656/045.019.0406; Mould S, 2018, APPL GEOGR, V94, P130, DOI 10.1016/j.apgeog.2018.03.008; Newson MD, 2000, PROG PHYS GEOG, V24, P195, DOI 10.1177/030913330002400203; Palmer M., 2007, RESTOR ECOL, V15, P472; Palmer MA, 2005, J APPL ECOL, V42, P208, DOI 10.1111/j.1365-2664.2005.01004.x; Palmer MA, 2010, FRESHWATER BIOL, V55, P205, DOI 10.1111/j.1365-2427.2009.02372.x; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Polvi LE, 2014, GEOMORPHOLOGY, V210, P98, DOI 10.1016/j.geomorph.2013.12.025; Prosser IP, 2001, MAR FRESHWATER RES, V52, P81, DOI 10.1071/MF00033; PROSSER IP, 2001, CONSTRUCTING RIVER B; Roberts J, 2000, FOLIA GEOBOT, V35, P353, DOI 10.1007/BF02803548; Rustomji P, 2007, GEOMORPHOLOGY, V90, P73, DOI 10.1016/j.geomorph.2007.01.009; Simon A, 2006, GEOMORPHOLOGY, V79, P361, DOI 10.1016/j.geomorph.2006.06.037; Sims AJ, 2017, GEOMORPHOLOGY, V294, P70, DOI 10.1016/j.geomorph.2017.04.010; USACE, 2010, TOUTL COWL RIV SED B TOUTL COWL RIV SED B; Williams RT, 2020, EARTH SURF PROC LAND, V45, P1732, DOI 10.1002/esp.4842; Wohl E, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR003985; Wohl E, 2016, PROG PHYS GEOG, V40, P598, DOI 10.1177/0309133316658615; Woolsey S, 2007, FRESHWATER BIOL, V52, P752, DOI 10.1111/j.1365-2427.2007.01740.x; Yazdanparast P., 2016, THESIS U MELBOURNE A THESIS U MELBOURNE A; Zierholz C, 2001, GEOMORPHOLOGY, V38, P221, DOI 10.1016/S0169-555X(00)00092-1; Zunka JPP, 2015, EARTH SURF PROC LAND, V40, P1017, DOI 10.1002/esp.3697	63	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252983	10.1371/journal.pone.0252983	http://dx.doi.org/10.1371/journal.pone.0252983			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138923	Green Published, gold			2022-12-26	WOS:000671690200067
J	Yeshaw, Y; Jemere, T; Dagne, H; Andualem, Z; Akalu, Y; Dewau, R; Teshale, AB; Tesema, GA; Dagnew, B				Yeshaw, Yigizie; Jemere, Tadeg; Dagne, Henok; Andualem, Zewudu; Akalu, Yonas; Dewau, Reta; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn; Dagnew, Baye			Factors associated with births protected against neonatal tetanus in Africa: Evidences from Demographic and health surveys of five African countries	PLOS ONE			English	Article							TOXOID IMMUNIZATION; PREGNANCY; CARE; ELIMINATION; MORTALITY; INFANT; WOMEN	Introduction Maternal and neonatal tetanus remains a global public health problem affecting mainly the poorest and most marginalized subpopulations. In spite of the problem, studies conducted on the associated factors of births protected against neonatal tetanus are scarce in Africa. Therefore, this study aimed to identify both individual and community-level factors associated with births protected against neonatal tetanus in the region. Methods The most recent Demographic and Health Survey datasets of five African countries (Ethiopia, Burundi, Comoros, Zimbabwe and Zambia) were used to investigate the associated factors of births protected from neonatal tetanus. STATA Version 14 statistical software was used for the analysis. The data were weighted before doing any statistical analysis and deviance was used for model comparison. Multilevel binary logistic regression was used to identify the associated factors of births protected against neonatal tetanus. Finally, the adjusted odds ratio (AOR) with its 95% confidence interval (CI) was calculated for each potential factors included in the multivariable multilevel logistic regression model. Results A total weighted sample of 30897 reproductive age women who had a birth within 5 years preceding the survey were included in the analysis. Those women with age of 20-34 (AOR = 1.32, 95%CI: 1.18-1.48) and 35-49 years (AOR = 1.26, 95% CI: 1.10-1.44), high community level of women education (AOR = 1.13, 95%CI: 1.04-1.23), being from poorer(AOR = 1.23, 95% CI: 1.14-1.33), middle (AOR = 1.31, 95%CI: 1.21-1.43), richer (AOR = 1.21, 95%CI: 1.11-1.32) and richest households (AOR = 1.59, 95%CI: 1.44-1.74), having antenatal care follow up (AOR = 9.62, 95% CI: 8.79-10.54), not perceiving distance to health facility as a big problem (AOR = 1.18, 95% CI: (1.11-1.25) had higher odds of having births protected against neonatal tetanus. Conclusion Both individual and community level factors were found to be associated with births protected against neonatal tetanus in Africa. This suggests that a variety of factors are affecting births protected against neonatal tetanus in the region. Hence, the impact of these factors should be recognized while developing strategies to reduce neonatal tetanus in the region.	[Yeshaw, Yigizie; Akalu, Yonas; Dagnew, Baye] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia; [Yeshaw, Yigizie; Teshale, Achamyeleh Birhanu; Tesema, Getayeneh Antehunegn] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Jemere, Tadeg] Debre Tabor Univ, Coll Hlth Sci, Dept Biomed Sci, Debre Tabor, Ethiopia; [Dagne, Henok; Andualem, Zewudu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia; [Dewau, Reta] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Yeshaw, Y (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia.; Yeshaw, Y (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	yigizieyeshaw29@gmail.com	Dewau, Reta/AAA-4202-2022; Teshale, Achamyeleh/HHN-8416-2022; Dagnew, Baye/AAS-3964-2021; Dagnew, Baye/AAL-9572-2020	Dewau, Reta/0000-0001-6531-2468; Dagnew, Baye/0000-0002-2397-5930; Dagnew, Baye/0000-0002-2397-5930; Yeshaw, Yigizie/0000-0003-4587-7925; Derso, Henok Dagne/0000-0001-7161-0904; Andualem, Zewudu/0000-0002-4731-1696				Adugna E., 2011, FACTORS INFLUENCING; Amin R, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-9; Anatea MD, 2018, BMC INT HEALTH HUM R, V18, DOI 10.1186/s12914-018-0168-0; Azzari C, 2020, EUR J PEDIATR, V179, P547, DOI 10.1007/s00431-019-03511-8; Balogun Saliu Adejumobi, 2017, Pan Afr Med J, V26, P217, DOI 10.11604/pamj.2017.26.217.11856; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Croft TN, 2018, GUIDE DHS STAT DHS 7; Dagdeviren G, 2020, TURK J MED SCI, V50, P1903, DOI 10.3906/sag-2001-77; Gebremedhin TS, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4023031; Haile ZT, 2013, J COMMUN HEALTH, V38, P492, DOI 10.1007/s10900-012-9638-9; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; Ibor UW, 2011, TRENDS MED RES, V6, P273, DOI DOI 10.3923/tmr.2011.273.280; Islam MR, 2011, RURAL REMOTE HEALTH, V11; Khan R, 2015, INT J WOMENS HEALTH, V7, P171, DOI 10.2147/IJWH.S50539; Kyu HH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4111-4; Yen LM, 2019, LANCET, V393, P1657, DOI 10.1016/S0140-6736(18)33131-3; Mamoro MD, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/2839579; Mihret MS, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1878-y; Mohammad M., 2008, INTERNET J HLTH, P8; Mpembeni Rose Nm, 2007, BMC Pregnancy Childbirth, V7, P29, DOI 10.1186/1471-2393-7-29; Naeem Mohammad, 2010, J Ayub Med Coll Abbottabad, V22, P136; Njuguna HN, 2020, MMWR-MORBID MORTAL W, V69, P515, DOI 10.15585/mmwr.mm6917a2; Ogunlesi TA, 2012, MATERN CHILD HLTH J, V16, P677, DOI 10.1007/s10995-011-0765-1; Ogunlesi TA, 2010, MATERN CHILD HLTH J, V14, P459, DOI 10.1007/s10995-008-0440-3; Organization WH, 2016, MAT NEON TET MNT EL, DOI [10.1097/01.EPX.0000491267.30015.2a, DOI 10.1097/01.EPX.0000491267.30015.2A]; Organization WH., 2019, PROT TET GUID SUST M; Organization WH, 2018, IMMUNOLOGICAL BASIS, P1; Organization WH., 2019, NEON TET; Owusu-Darko S., 2012, REV OBSTET GYNECOLOG, V5; Rasmussen SA, 2014, SEMIN FETAL NEONAT M, V19, P161, DOI 10.1016/j.siny.2013.11.014; Ridpath Alison Delano, 2017, Pan Afr Med J, V27, P24, DOI 10.11604/pamj.supp.2017.27.3.11783; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Teshale AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243071; UNICEF, 2012, ACH SUST MAT NEON TE; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; World Bank, 2009, STAT WORLDS VACC IMM; Yaya S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08985-y; Zimmermann P, 2019, ECLINICALMEDICINE, V13, P21, DOI 10.1016/j.eclinm.2019.06.010	39	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253126	10.1371/journal.pone.0253126	http://dx.doi.org/10.1371/journal.pone.0253126			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138922	Green Published, gold			2022-12-26	WOS:000671690200120
J	Stahel, WA				Stahel, Werner A.			New relevance and significance measures to replace p-values	PLOS ONE			English	Article							PSYCHOLOGY	The p-value has been debated exorbitantly in the last decades, experiencing fierce critique, but also finding some advocates. The fundamental issue with its misleading interpretation stems from its common use for testing the unrealistic null hypothesis of an effect that is precisely zero. A meaningful question asks instead whether the effect is relevant. It is then unavoidable that a threshold for relevance is chosen. Considerations that can lead to agreeable conventions for this choice are presented for several commonly used statistical situations. Based on the threshold, a simple quantitative measure of relevance emerges naturally. Statistical inference for the effect should be based on the confidence interval for the relevance measure. A classification of results that goes beyond a simple distinction like "significant / non-significant" is proposed. On the other hand, if desired, a single number called the "secured relevance" may summarize the result, like the p-value does it, but with a scientifically meaningful interpretation.	[Stahel, Werner A.] ETH, Seminar Stat, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Stahel, WA (corresponding author), ETH, Seminar Stat, Zurich, Switzerland.	stahel@stat.math.ethz.ch						[Anonymous], 1908, BIOMETRIKA, V6, P1; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Blume JD, 2019, AM STAT, V73, P157, DOI 10.1080/00031305.2018.1537893; Blume JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188299; Cohen J.E., 1988, STAT POWER ANAL BEHA; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Goodman WM, 2019, AM STAT, V73, P168, DOI 10.1080/00031305.2018.1564697; JACOWITZ KE, 1995, PERS SOC PSYCHOL B, V21, P1161, DOI 10.1177/01461672952111004; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kruschke JK, 2018, ADV METH PRACT PSYCH, V1, P270, DOI 10.1177/2515245918771304; Lakens D., 2020, EQUIVALENCE TESTING; Lakens D, 2017, SOC PSYCHOL PERS SCI, V8, P355, DOI 10.1177/1948550617697177; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Limpert E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021403; MEEHL PE, 1967, PHILOS SCI, V34, P103, DOI 10.1086/288135; Morris PH, 2020, BRIT J PSYCHOL, V111, P395, DOI 10.1111/bjop.12401; Trafimow D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00699; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	19	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252991	10.1371/journal.pone.0252991	http://dx.doi.org/10.1371/journal.pone.0252991			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG8YE	34133444	Green Published, gold			2022-12-26	WOS:000671682700048
J	Fang, H; Shao, S; Xue, K; Yuan, X; Qiao, P; Zhang, JY; Cao, TY; Luo, YX; Bai, XC; Li, WJ; Li, CX; Qiao, HJ; Dang, EL; Wang, G				Fang, Hui; Shao, Shuai; Xue, Ke; Yuan, Xu; Qiao, Pei; Zhang, Jieyu; Cao, Tianyu; Luo, Yixin; Bai, Xiaocui; Li, Wenjing; Li, Caixia; Qiao, Hongjiang; Dang, Erle; Wang, Gang			Neutrophil extracellular traps contribute to immune dysregulation in bullous pemphigoid via inducing B-cell differentiation and antibody production	FASEB JOURNAL			English	Article						autoantibody; autoimmunity; B cell; bullous pemphigoid; neutrophil extracellular traps	MITOCHONDRIAL-DNA; ELASTASE; AUTOANTIBODIES; DEGRADATION; RELEASE; COLLAGEN; INNATE; NETS	Bullous pemphigoid (BP), an autoimmune skin disease, is characterized by autoantibodies against hemidesmosomal proteins in the skin and mucous membranes. Neutrophils infiltrate BP skin lesions, however, their role in immune dysregulation remains unclear. We investigated whether BP involves aberrant neutrophil extracellular traps (NETs) formation in skin lesions and circulation; and examined the triggers and deleterious immuno-inflammatory consequences. In the present study, we found that circulating NET-related biomarker levels increased in serum and blister fluid of BP patients and significantly correlated with disease severity. Additionally, circulating neutrophils from BP patients displayed enhanced spontaneous NETs formation than healthy controls. In vitro, BP180-NC16A immune complexes-induced NETosis in neutrophils from BP patients, which was abrogated by Fc gamma receptor and/or NADPH pathway blockade. Furthermore, the elevated levels of NETs from BP patients boosted autoantibody production by inducing B-cell differentiation into plasma cells, mediated by MAPK P38 cascade activation. Together, our findings provide strong evidence that NETs are involved in a pathogenic loop, causing excessive differentiation of B cells and promotion of autoantibody production. Hence, targeting aberrant neutrophil responses will provide novel potential targets for the treatment of BP.	[Fang, Hui; Shao, Shuai; Xue, Ke; Yuan, Xu; Qiao, Pei; Zhang, Jieyu; Cao, Tianyu; Luo, Yixin; Bai, Xiaocui; Li, Wenjing; Li, Caixia; Qiao, Hongjiang; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China.	dangerle@fmmu.edu.cn; wanggangxjyy@163.com	Fang, Hui/GSN-9002-2022; Wang, Gang/H-6710-2019	Fang, Hui/0000-0002-3081-5863; 	National Natural Science Foundation of China [81672692, 81703125, 81703116, 81703119, 81903208]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank our patients and healthy volunteers for their enthusiastic participation. The authors also thank Meihong Yu, Na Li, Yi Wang, and Qiaozhen Lin for their assistance with the immunofluorescence staining. This work was supported by grants from the National Natural Science Foundation of China (grant numbers 81672692, 81703125, 81703116, 81703119, and 81903208).	An ZJ, 2019, CELL CYCLE, V18, P2928, DOI 10.1080/15384101.2019.1662678; Bagci IS, 2017, AUTOIMMUN REV, V16, P445, DOI 10.1016/j.autrev.2017.03.010; Barnado A, 2016, J LEUKOCYTE BIOL, V99, P265, DOI 10.1189/jlb.5BT0615-234R; Bodano A, 2006, RHEUMATOLOGY, V45, P819, DOI 10.1093/rheumatology/kel019; Boeltz S, 2019, CELL DEATH DIFFER, V26, P395, DOI 10.1038/s41418-018-0261-x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brumann M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/749175; Cervantes-Luevano KE, 2018, J ALLERGY CLIN IMMUN, V142, P1605, DOI 10.1016/j.jaci.2017.11.063; Chiriac MT, 2007, J PATHOL, V212, P56, DOI 10.1002/path.2157; Costa S, 2019, IMMUNOLOGY, V156, P23, DOI 10.1111/imm.13005; D'Auria L, 2000, EXP DERMATOL, V9, P131, DOI 10.1034/j.1600-0625.2000.009002131.x; de Graauw E, 2018, ALLERGY, V73, P1119, DOI 10.1111/all.13376; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gestermann N, 2018, J IMMUNOL, V200, P3364, DOI 10.4049/jimmunol.1700778; GIUDICE GJ, 1993, J IMMUNOL, V151, P5742; Giusti D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00701; Grund LZ, 2017, AUTOIMMUNITY, V50, P86, DOI 10.1080/08916934.2016.1261834; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Heimbach L, 2011, J BIOL CHEM, V286, P15003, DOI 10.1074/jbc.M111.221036; Hu SCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31119; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kowalski EH, 2019, AUTOIMMUN REV, V18, P526, DOI 10.1016/j.autrev.2019.03.009; Lambert S, 2019, J INVEST DERMATOL, V139, P1245, DOI 10.1016/j.jid.2018.11.021; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Le Joncour A, 2019, ANN RHEUM DIS, V78, P1274, DOI 10.1136/annrheumdis-2018-214335; Lin L, 2012, MATRIX BIOL, V31, P38, DOI 10.1016/j.matbio.2011.09.003; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; Liu Z, 2000, J CLIN INVEST, V105, P113, DOI 10.1172/JCI3693; Liu Z, 2008, J AUTOIMMUN, V31, P331, DOI 10.1016/j.jaut.2008.08.009; Lood C, 2016, NAT MED, V22, P146, DOI 10.1038/nm.4027; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Maugeri N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao3089; Mistry P, 2018, ANN RHEUM DIS, V77, P1825, DOI 10.1136/annrheumdis-2018-213746; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; Nishie W, 2014, J DERMATOL SCI, V73, P179, DOI 10.1016/j.jdermsci.2013.12.001; O'Neil LJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091325; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Pruchniak MP, 2019, AUTOIMMUNITY, V52, P126, DOI 10.1080/08916934.2019.1631812; Schmidt E, 2000, ARCH DERMATOL, V136, P174, DOI 10.1001/archderm.136.2.174; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Shao S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00746; Shimanovich I, 2004, J PATHOL, V204, P519, DOI 10.1002/path.1674; Soderberg D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00256; Wright HL, 2017, J LEUKOCYTE BIOL, V101, P599, DOI 10.1189/jlb.5A0116-022R; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003; Yousefi S, 2009, CELL DEATH DIFFER, V16, P1438, DOI 10.1038/cdd.2009.96; Yousefi S, 2008, NAT MED, V14, P949, DOI 10.1038/nm.1855	50	2	2	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21746	10.1096/fj.202100145R	http://dx.doi.org/10.1096/fj.202100145R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34151465				2022-12-26	WOS:000667814100012
J	Hall, RJ; O'Loughlin, J; Billington, CK; Thakker, D; Hall, IP; Sayers, I				Hall, Robert J.; O'Loughlin, Jonathan; Billington, Charlotte K.; Thakker, Dhruma; Hall, Ian P.; Sayers, Ian			Functional genomics of GPR126 in airway smooth muscle and bronchial epithelial cells	FASEB JOURNAL			English	Article						COPD; cell biology; genomics	PROTEIN-COUPLED RECEPTOR; ADOLESCENT IDIOPATHIC SCOLIOSIS; OBSTRUCTIVE PULMONARY-DISEASE; ADHESION-GPCRS; SCHWANN-CELLS; GENE; ACTIVATION; EXPRESSION; DOMAIN; MYELINATION	GPR126 is an adhesion G protein-coupled receptor which lies on chromosome 6q24. Genetic variants in this region are reproducibly associated with lung function and COPD in genome wide association studies (GWAS). The aims of this study were to define the role of GPR126 in the human lung and in pulmonary disease and identify possible casual variants. Online tools (GTEx and LDlink) identified SNPs which may have effects on GPR126 function/ expression, including missense variant Ser123Gly and an intronic variant that shows eQTL effects on GPR126 expression. GPR126 signaling via cAMP-mediated pathways was identified in human structural airway cells when activated with the tethered agonist, stachel. RNA-seq was used to identify downstream genes/ pathways affected by stachel-mediated GPR126 activation in human airway smooth muscle cells. We identified similar to 350 differentially expressed genes at 4 and 24 hours post stimulation with similar to 20% overlap. We identified that genes regulated by GPR126 activation include IL33, CTGF, and SERPINE1, which already have known roles in lung biology. Pathways altered by GPR126 included those involved in cell cycle progression and cell proliferation. Here, we suggest a role for GPR126 in airway remodeling.	[Hall, Robert J.; O'Loughlin, Jonathan; Billington, Charlotte K.; Thakker, Dhruma; Hall, Ian P.; Sayers, Ian] Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Biodiscovery Inst,Div Resp Med, Nottingham NG7 2RD, England	University of Nottingham	Hall, RJ (corresponding author), Univ Nottingham, Nottingham Biomed Res Ctr, Natl Inst Hlth Res, Biodiscovery Inst,Div Resp Med, Nottingham NG7 2RD, England.	robert.hall@nottingham.ac.uk		Sayers, Ian/0000-0001-5601-5410; Hall, Robert/0000-0001-9114-7144	Hermes Fellowship University of Nottingham [2016-2017]; British Lung Foundation (BLF) [PPRG15-5]; RCUK | Medical Research Council (MRC) [G1000861]; NIHR Senior Investigator award; Centre of Membrane Proteins and Receptors (COMPARE)	Hermes Fellowship University of Nottingham; British Lung Foundation (BLF); RCUK | Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Senior Investigator award; Centre of Membrane Proteins and Receptors (COMPARE)	Hermes Fellowship University of Nottingham, Grant/Award Number: 2016-2017; British Lung Foundation (BLF), Grant/Award Number: Grant PPRG15-5; RCUK | Medical Research Council (MRC), Grant/Award Number: G1000861; NIHR Senior Investigator award; The Centre of Membrane Proteins and Receptors (COMPARE)	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Artigas MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9658; Billington CK, 2001, AM J RESP CELL MOL, V24, P633, DOI 10.1165/ajrcmb.24.5.4215; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Carvalho-Silva D, 2019, NUCLEIC ACIDS RES, V47, pD1056, DOI 10.1093/nar/gky1133; Cesari M, 2010, CARDIOVASC THER, V28, pe72, DOI 10.1111/j.1755-5922.2010.00171.x; Chang GW, 2003, FEBS LETT, V547, P145, DOI 10.1016/S0014-5793(03)00695-1; Cui HX, 2014, J BIOL CHEM, V289, P34871, DOI 10.1074/jbc.M114.571000; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Francis SMS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-88; Geng FS, 2013, DEVELOPMENT, V140, P4362, DOI 10.1242/dev.098061; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Glenn TD, 2013, DEVELOPMENT, V140, P3167, DOI 10.1242/dev.093401; Gorr MW, 2020, BRIT J PHARMACOL, V177, P3505, DOI 10.1111/bph.15074; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hobbs BD, 2017, NAT GENET, V49, P426, DOI 10.1038/ng.3752; Hu H, 2010, TOHOKU J EXP MED, V222, P291, DOI 10.1620/tjem.222.291; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang YY, 2010, RESPIROLOGY, V15, P939, DOI 10.1111/j.1440-1843.2010.01799.x; Kheirallah AK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3628-3; Kim WJ, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/206937; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Kou I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29011-7; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leon K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14040-1; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lin CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104746; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Miller S, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0410-z; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Morrow JD, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1032-z; Musa G, 2019, ANN NY ACAD SCI, V1456, P96, DOI 10.1111/nyas.14135; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Ponticos M, 2009, ARTHRITIS RHEUM-US, V60, P2142, DOI 10.1002/art.24620; Qin XD, 2017, SPINE, V42, pE1098, DOI 10.1097/BRS.0000000000002123; Raivo Kolde, 2019, PHEATMAP PRETTY HEAT, DOI DOI 10.1128/AEM.01151-09; Rayner RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36735-z; Shang J, 2015, BIOCHEM CELL BIOL, V93, P359, DOI 10.1139/bcb-2014-0163; Shrine N, 2019, NAT GENET, V51, P481, DOI 10.1038/s41588-018-0321-7; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Terzikhan N, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.00647-2018; To M, 2013, CHEST, V144, P515, DOI 10.1378/chest.12-2381; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vosa U., 2018, 447367 BIORXIV; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xia J, 2015, AM J PHYSIOL-LUNG C, V308, pL619, DOI 10.1152/ajplung.00305.2014; Xu EJ, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4678969; Xu JF, 2015, GENOMICS, V105, P101, DOI 10.1016/j.ygeno.2014.11.009; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	65	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21300	10.1096/fj.202002073R	http://dx.doi.org/10.1096/fj.202002073R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34165809	Green Published, hybrid			2022-12-26	WOS:000667814100007
J	Sirica, AE				Sirica, Alphonse E.			The 2021 FASEB Virtual Catalyst Conference on Cholangiocarcinoma: Molecular Drivers, Microenvironment, and Precision Medicine, April 7, 2021	FASEB JOURNAL			English	Editorial Material									[Sirica, Alphonse E.] Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA	Virginia Commonwealth University	Sirica, AE (corresponding author), Virginia Commonwealth Univ, Dept Pathol, Richmond, VA 23284 USA.	alphonse.sirica@vcuhealth.org							0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21670	10.1096/fj.202100745	http://dx.doi.org/10.1096/fj.202100745			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34169576	Bronze			2022-12-26	WOS:000667814100027
J	Trenker, R; Wu, XY; Nguyen, JV; Wilcox, S; Rubin, AF; Call, ME; Call, MJ				Trenker, Raphael; Wu, Xinyu; Nguyen, Julie, V; Wilcox, Stephen; Rubin, Alan F.; Call, Matthew E.; Call, Melissa J.			Human and viral membrane-associated E3 ubiquitin ligases MARCH1 and MIR2 recognize different features of CD86 to downregulate surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; PROTEIN; CHAINS; DRIVE; B7-2	Immune-stimulatory ligands, such as major histocompatibility complex molecules and the T-cell costimulatory ligand CD86, are central to productive immunity. Endogenous mammalian membrane-associated RING-CHs (MARCH) act on these and other targets to regulate antigen presentation and activation of adaptive immunity, whereas virus-encoded homologs target the same molecules to evade immune responses. Substrate specificity is encoded in or near the membrane-embedded domains of MARCHs and the proteins they regulate, but the exact sequences that distinguish substrates from nonsubstrates are poorly understood. Here, we examined the requirements for recognition of the costimulatory ligand CD86 by two different MARCH-family proteins, human MARCH1 and Kaposi's sarcoma herpesvirus modulator of immune recognition 2 (MIR2), using deep mutational scanning. We identified a highly specific recognition surface in the hydrophobic core of the CD86 transmembrane (TM) domain (TMD) that is required for recognition by MARCH1 and prominently features a proline at position 254. In contrast, MIR2 requires no specific sequences in the CD86 TMD but relies primarily on an aspartic acid at position 244 in the CD86 extracellular juxtamembrane region. Surprisingly, MIR2 recognized CD86 with a TMD composed entirely of valine, whereas many different single amino acid substitutions in the context of the native TM sequence conferred MIR2 resistance. These results show that the human and viral proteins evolved completely different recognition modes for the same substrate. That some TM sequences are incompatible with MIR2 activity, even when no specific recognition motif is required, suggests a more complicated mechanism of immune modulation via CD86 than was previously appreciated.	[Trenker, Raphael; Wu, Xinyu; Nguyen, Julie, V; Wilcox, Stephen; Call, Matthew E.; Call, Melissa J.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia; [Trenker, Raphael; Wu, Xinyu; Wilcox, Stephen; Rubin, Alan F.; Call, Matthew E.; Call, Melissa J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Wilcox, Stephen] Walter & Eliza Hall Inst Med Res, Genom Lab, Parkville, Vic, Australia; [Rubin, Alan F.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Trenker, Raphael] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of California System; University of California San Francisco	Call, ME; Call, MJ (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia.; Call, ME; Call, MJ (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	call@wehi.edu.au; call@wehi.edu.au	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841; Call, Matthew/0000-0001-5846-6469; Rubin, Alan/0000-0003-1474-605X	National Health and Medical Research Council [GNT1030902]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council project grant GNT1030902 to M. E. C. and M. J. C.	Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Babon JJ, 2019, BIOCHEM J, V476, P2869, DOI 10.1042/BCJ20190577; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bridgford JL, 2020, BLOOD, V135, P287, DOI 10.1182/blood.2019002561; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elazar A, 2016, ELIFE, V5, DOI 10.7554/eLife.12125; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fu QS, 2016, MOL CELL, V61, P602, DOI 10.1016/j.molcel.2016.01.009; Gofman Y, 2012, J CHEM THEORY COMPUT, V8, P2896, DOI 10.1021/ct300128x; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; Lin H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01751; Lin H, 2018, P NATL ACAD SCI USA, V115, P12483, DOI 10.1073/pnas.1806217115; Liu HY, 2019, CURR OPIN IMMUNOL, V58, P38, DOI 10.1016/j.coi.2019.03.001; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Schanzenbach C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43476; Shelar A, 2016, BBA-BIOMEMBRANES, V1858, P2804, DOI 10.1016/j.bbamem.2016.08.003; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Tan C, 2019, J BIOL CHEM, V294, P2470, DOI 10.1074/jbc.RA118.004836; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	45	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100900	10.1016/j.jbc.2021.100900	http://dx.doi.org/10.1016/j.jbc.2021.100900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157285	Green Published, gold			2022-12-26	WOS:000678068400089
J	Tsvetanova, NG; Trester-Zedlitz, M; Newton, BW; Peng, GE; Johnson, JR; Jimenez-Morales, D; Kurland, AP; Krogan, NJ; von Zastrow, M				Tsvetanova, Nikoleta G.; Trester-Zedlitz, Michelle; Newton, Billy W.; Peng, Grace E.; Johnson, Jeffrey R.; Jimenez-Morales, David; Kurland, Andrew P.; Krogan, Nevan J.; von Zastrow, Mark			Endosomal cAMP production broadly impacts the cellular phosphoproteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; SIGNALING PATHWAYS; PHOSPHORYLATION; IDENTIFICATION; VISUALIZATION; SPECIFICITY; PP2A; PKA	Endosomal signaling downstream of G-protein-coupled receptors (GPCRs) has emerged as a novel paradigm with important pharmacological and physiological implications. However, our knowledge of the functional consequences of intracellular signaling is incomplete. To begin to address this gap, we combined an optogenetic approach for site-specific generation of the prototypical second messenger generated by active GPCRs, cyclic AMP (cAMP), with unbiased mass-spectrometry-based analysis of the phosphoproteome. We identified 218 unique, high-confidence sites whose phosphorylation is either increased or decreased in response to cAMP elevation. We next determined that the same amount of cAMP produced from the endosomal membrane led to more robust changes in phosphorylation than the plasma membrane. Remarkably, this was true for the entire repertoire of 218 identified targets and irrespective of their annotated subcellular localizations (endosome, cell surface, nucleus, cytosol). Furthermore, we identified a particularly strong endosome bias for a subset of proteins that are dephosphorylated in response to cAMP. Through bioinformatics analysis, we established these targets as putative substrates for protein phosphatase 2A (PP2A), and we propose compartmentalized activation of PP2A by cAMP-responsive kinases as the likely underlying mechanism. Altogether, our study extends the concept that endosomal signaling is a significant functional contributor to cellular responsiveness to cAMP by establishing a unique role for localized cAMP production in defining categorically distinct phosphoresponses.	[Tsvetanova, Nikoleta G.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Tsvetanova, Nikoleta G.; Trester-Zedlitz, Michelle; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Newton, Billy W.; Johnson, Jeffrey R.; Jimenez-Morales, David; Krogan, Nevan J.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Newton, Billy W.; Johnson, Jeffrey R.; Jimenez-Morales, David; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Peng, Grace E.] Univ Calif San Francisco, Program Cell Biol, San Francisco, CA 94143 USA; [Johnson, Jeffrey R.; Kurland, Andrew P.] Icahn Sch Med Mt Sinai, Microbiol Dept, New York, NY 10029 USA; [Jimenez-Morales, David] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA USA; [Tsvetanova, Nikoleta G.] Duke Univ, Dept Pharmacol & Canc Biol, 308 Res Dr,LSRC Room C370A, Durham, NC 27710 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, 600 16th St,Genentech Hall Room N216, San Francisco, CA 94158 USA	Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University; University of California System; University of California San Francisco	Tsvetanova, NG (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Tsvetanova, NG; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Tsvetanova, NG (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, 308 Res Dr,LSRC Room C370A, Durham, NC 27710 USA.; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, 600 16th St,Genentech Hall Room N216, San Francisco, CA 94158 USA.	Nikoleta.Tsvetanova@duke.edu; Mark.vonZastrow@ucsf.edu	Jimenez-Morales, David/AAE-9289-2019	Jimenez-Morales, David/0000-0003-4356-6461; Tsvetanova, Nikoleta/0000-0001-6533-187X; Peng, Grace/0000-0002-8901-725X	National Institute of Health [MH109633, HL129689, DA010711, DA012864, GM081879, GM082250, GM107671, U19 AI106754]; American Heart Association [16PRE26420057]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institute of Health (Grants MH109633 to N. G. T; HL129689 to G. E. P.; DA010711 and DA012864 to M. v. Z.; GM081879, GM082250, GM107671, and U19 AI106754 to N. J. K.). G. E. P. was also supported by the American Heart Association (16PRE26420057). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bowman SL, 2016, J CELL BIOL, V214, P797, DOI 10.1083/jcb.201512068; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Giansanti P, 2013, MOL CELL PROTEOMICS, V12, P3350, DOI 10.1074/mcp.O113.028456; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hoffert JD, 2011, EXPERT REV PROTEOMIC, V8, P157, DOI [10.1586/EPR.11.14, 10.1586/epr.11.14]; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Inda C, 2016, J CELL BIOL, V214, P181, DOI 10.1083/jcb.201512075; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Jong CJ, 2020, J BIOL CHEM, V295, P5654, DOI 10.1074/jbc.RA119.011270; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Peng GE, 2021, NAT CHEM BIOL, V17, P558, DOI 10.1038/s41589-021-00747-0; Ranieri A, 2018, J MOL CELL CARDIOL, V115, P20, DOI 10.1016/j.yjmcc.2017.12.016; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Thomsen ARB, 2018, TRENDS PHARMACOL SCI, V39, P879, DOI 10.1016/j.tips.2018.08.003; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsvetanova NG, 2017, MOL PHARMACOL, V91, P145, DOI 10.1124/mol.116.106369; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002	39	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100907	10.1016/j.jbc.2021.100907	http://dx.doi.org/10.1016/j.jbc.2021.100907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34166681	Green Submitted, gold, Green Published			2022-12-26	WOS:000678068400094
J	Yano, K; Takahashi, RU; Shiotani, B; Abe, J; Shidooka, T; Sudo, Y; Yamamoto, Y; Kan, SS; Sakagami, H; Tahara, H				Yano, Kimiyoshi; Takahashi, Ryou-U; Shiotani, Bunsyo; Abe, Junko; Shidooka, Tomoki; Sudo, Yuki; Yamamoto, Yusuke; Kan, Shisei; Sakagami, Hiroki; Tahara, Hidetoshi			PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TUMOR-FORMATION; P53 PATHWAY; HUMAN-CELLS; PHOSPHORYLATION; UBIQUITINATION; DEGRADATION; ACTIVATION; EXPRESSION; P53-BETA	Alteration of RNA splicing is a hallmark of cellular senescence, which is associated with age-related disease and cancer development. However, the roles of splicing factors in cellular senescence are not fully understood. In this study, we identified the splicing factor PRPF19 as a critical regulator of cellular senescence in normal human diploid fibroblasts. PRPF19 was downregulated during replicative senescence, and PRPF19 knockdown prematurely induced senescence-like cell cycle arrest through the p53-p21 pathway. RNA-sequencing analysis revealed that PRPF19 knockdown caused a switch of the MDM4 splicing isoform from stable full-length MDM4-FL to unstable MDM4-S lacking exon 6. We also found that PRPF19 regulates MDM4 splicing by promoting the physical interaction of other splicing factors, PRPF3 and PRPF8, which are key components of the core spliceosome, U4/U6.U5 tri-snRNP. Given that MDM4 is a major negative regulator of p53, our findings imply that PRPF19 downregulation inhibits MDM4-mediated p53 inactivation, resulting in induction of cellular senescence. Thus, PRPF19 plays an important role in the induction of p53-dependent cellular senescence.	[Yano, Kimiyoshi; Takahashi, Ryou-U; Abe, Junko; Shidooka, Tomoki; Sudo, Yuki; Kan, Shisei; Sakagami, Hiroki; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan; [Shiotani, Bunsyo; Yamamoto, Yusuke] Natl Canc Ctr, Div Cellular Signaling, Res Inst, Tokyo, Japan	Hiroshima University; National Cancer Center - Japan	Tahara, H (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.	toshi@hiroshima-u.ac.jp		Tahara, Hidetoshi/0000-0003-3054-4175	JSPS KAKENHI [18J20013]; KAKENHI Grant [21K086700A]; Takeda Science Foundation; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI Grant Number: 18J20013 (K. Y.), KAKENHI Grant Number: 21K086700A (R. T.), a Grant-in Aid from the Takeda Science Foundation (R. T.), and the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan (H. T.).	Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12; Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carrillo AM, 2015, ONCOGENE, V34, P846, DOI 10.1038/onc.2014.27; Chen J, 2017, CANCER DISCOV, V7, P766, DOI 10.1158/2159-8290.CD-16-0908; CRISTOFA.VJ, 1969, MED EXP, V19, P313; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; de Lange J, 2012, AM J CANCER RES, V2, P492; Deschenes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dewaele M, 2016, J CLIN INVEST, V126, P68, DOI 10.1172/JCI82534; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Giono LE, 2016, J MOL BIOL, V428, P2636, DOI 10.1016/j.jmb.2016.03.004; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Ling X, 2014, CANCER RES, V74, P7487, DOI 10.1158/0008-5472.CAN-14-0683; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marine JC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026237; Mukherjee B, 2015, METHODS MOL BIOL, V1292, P67, DOI 10.1007/978-1-4939-2522-3_5; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yin J, 2012, BIOL CELL, V104, P695, DOI 10.1111/boc.201200011; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9	47	6	6	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100882	10.1016/j.jbc.2021.100882	http://dx.doi.org/10.1016/j.jbc.2021.100882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144037	Green Published, gold			2022-12-26	WOS:000678068400081
J	Balegamire, SJ; Renaud, C; Masse, B; Zinszer, K; Gantt, S; Giguere, Y; Forest, JC; Boucoiran, I				Balegamire, Safari Joseph; Renaud, Christian; Masse, Benoit; Zinszer, Kate; Gantt, Soren; Giguere, Yves; Forest, Jean-Claude; Boucoiran, Isabelle			Frequency, timing and risk factors for primary maternal cytomegalovirus infection during pregnancy in Quebec	PLOS ONE			English	Article							1ST TRIMESTER; SEROPREVALENCE; SEROCONVERSION; TRANSMISSION; COHORT; BIRTH; WOMEN	Introduction Maternal Cytomegalovirus (CMV) infection in the first trimester (T1) of pregnancy is a public health concern, as it increases the risk of severe neurodevelopmental outcomes associated with congenital infection compared to infections occurring later during pregnancy. Objectives To determine CMV seroprevalence in T1 of pregnancy, its trend, risk factors and the incidence rate of primary infection during pregnancy. Methods Using the biobank of the prospective cohort "Grossesse en Sante de Quebec" collected between April 2005 and March 2010 at the Quebec-Laval Hospital, Quebec, Canada, maternal CMV serology was determined using Abbott Architect Chemiluminescence microparticle immunoassays for immunoglobulin G(IgG), immunoglobulin M(IgM) titration and IgG avidity testing. Changepoint detection analysis was used to assess temporal trends. Risk factors associated with seropositivity were determined by multivariable logistic regression. Results CMV seroprevalence in T1 of pregnancy was 23.4% (965/4111, 95% CI, 22.1-24.7%). The incidence rate for CMV primary infection during pregnancy was 1.8 (95% CI, 1.2-2.6) per 100 person-years. No changepoint was identified in the maternal CMV-seroprevalence trend. Multivariable analyses showed that T1 maternal CMV seropositivity was associated with having one child OR 1.3 (95% CI, 1.10-1.73) or two or more children OR 1.5 (95%CI, 1.1-2.1), ethnicity other than Caucasian OR 2.1 (95% CI, 1.1-3.8) and country of birth other than Canada and the USA OR 2.8 (95% CI, 1.5-4.9). Conclusions In this cohort, maternal seroprevalence in T1 of pregnancy and seroconversion rate were low. This information and identified risk factors could help guide the development and implementation of preventive actions and evidence-based health policies to prevent CMV infection during pregnancy.	[Balegamire, Safari Joseph; Masse, Benoit; Zinszer, Kate; Boucoiran, Isabelle] Univ Montreal, Dept Social & Prevent Med, Ecole Sante Publ, Montreal, PQ, Canada; [Balegamire, Safari Joseph; Renaud, Christian; Gantt, Soren; Boucoiran, Isabelle] CHU St Justine Res Ctr, Women & Childrens Infect Dis Ctr, Montreal, PQ, Canada; [Renaud, Christian; Gantt, Soren] Univ Montreal, Dept Microbiol, CHU St Justine, Montreal, PQ, Canada; [Masse, Benoit] CHU St Justine Res Ctr, Appl Clin Res Unit, Montreal, PQ, Canada; [Zinszer, Kate] Univ Montreal, Ctr Rech Sante Publ, Montreal, PQ, Canada; [Giguere, Yves; Forest, Jean-Claude] Univ Laval, CHU Quebec, Res Ctr, Quebec City, PQ, Canada; [Giguere, Yves; Forest, Jean-Claude] Univ Laval, Fac Med, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Boucoiran, Isabelle] Univ Montreal, Dept Obstet & Gynecol, Div Maternofetal Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Laval University; Laval University; Universite de Montreal	Boucoiran, I (corresponding author), Univ Montreal, Dept Social & Prevent Med, Ecole Sante Publ, Montreal, PQ, Canada.; Boucoiran, I (corresponding author), CHU St Justine Res Ctr, Women & Childrens Infect Dis Ctr, Montreal, PQ, Canada.; Boucoiran, I (corresponding author), Univ Montreal, Dept Obstet & Gynecol, Div Maternofetal Med, Montreal, PQ, Canada.	isabelle.boucoiran@umontreal.ca		Balegamire, Safari Joseph/0000-0001-9657-3791; Gantt, Soren/0000-0001-5743-3606	Canadian Institutes of Health Research (CIHR) Operating Grant [386200]; Altona; FRQS	Canadian Institutes of Health Research (CIHR) Operating Grant(Canadian Institutes of Health Research (CIHR)); Altona; FRQS	This work is funded by Canadian Institutes of Health Research (CIHR) Operating Grant (grand award number 386200). Dr Boucoiran is a recipient of a salary award (chercheur-boursier) from FRQ-S (Quebec's Health research fund). Dr Safari Joseph Balegamire is a recipient from a scholarship from Altona and FRQS.	ALFORD CA, 1990, REV INFECT DIS, V12, pS745; Asanuma H, 1996, MICROBIOL IMMUNOL, V40, P201, DOI 10.1111/j.1348-0421.1996.tb03335.x; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bonalumi Silvia, 2011, J Prenat Med, V5, P1; Bouchard P., 1986, SOCIOLOGIE SOCI T S, V18, P113, DOI [10.7202/001077ar, DOI 10.7202/001077AR]; Boucoiran I, 2018, PEDIATR INFECT DIS J, V37, P627, DOI 10.1097/INF.0000000000001877; Britt W, 2015, MED MICROBIOL IMMUN, V204, P263, DOI 10.1007/s00430-015-0399-9; Britt WJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080405; Buxmann H, 2017, DTSCH ARZTEBL INT, V114, P45, DOI 10.3238/arztebl.2017.0045; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Fraser WD, 2016, PAEDIATR PERINAT EP, V30, P623, DOI 10.1111/ppe.12320; Galobardes B, 2000, MED HYGIENE MED HYGIENE, V58, P1910; Giguere Y, 2015, BJOG-INT J OBSTET GY, V122, P402, DOI 10.1111/1471-0528.13050; Hyde TB, 2010, REV MED VIROL, V20, P311, DOI 10.1002/rmv.659; Ibrahim S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3772-8; Imbert-Marcille B-M, 2001, MED THERAPEUTIQUE MED THERAPEUTIQUE, V7, P577; Jallade LA, 1972, REV FRANCAISE PEDAGO REV FRANCAISE PEDAGO, P40; Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Killick R, 2014, J STAT SOFTW, V58, P1; Lamarre V, 2016, EPIDEMIOL INFECT, V144, P1701, DOI 10.1017/S0950268815003167; Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010; Lapierre SG, 2019, DIAGN MICR INFEC DIS, V94, P231, DOI 10.1016/j.diagmicrobio.2018.12.017; Leruez-Ville M, 2020, AM J OBSTET GYNECOL, V223, P330, DOI 10.1016/j.ajog.2020.02.018; Leruez-Ville M, 2013, CLIN INFECT DIS, V56, P1428, DOI 10.1093/cid/cit059; Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015; Pass RF, 2014, J PEDIATR INFECT DIS, V3, pS2, DOI 10.1093/jpids/piu069; Revello MG, 2011, J CLIN VIROL, V50, P303, DOI 10.1016/j.jcv.2010.12.012; Revello MG, 1999, FETAL MATERN MED REV, V11, P117, DOI DOI 10.1017/S0965539599000327; Schleiss Mark R, 2018, Contemp Pediatr, V35, P16; Starke KR, 2020, INT ARCH OCC ENV HEA, V93, P11, DOI 10.1007/s00420-019-01464-x; Tancrede S, 2015, J OBSTET GYNAECOL CA, V37, P111, DOI 10.1016/S1701-2163(15)30331-5; Vaudry W, 2010, CAN J INFECT DIS MED, V21, P12, DOI 10.1155/2010/942874; Wizman S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0844-9	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0252309	10.1371/journal.pone.0252309	http://dx.doi.org/10.1371/journal.pone.0252309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170911	Green Published, gold			2022-12-26	WOS:000671694400055
J	Choopan, W; Panpipat, W; Nisoa, M; Cheong, LZ; Chaijan, M				Choopan, Warongporn; Panpipat, Worawan; Nisoa, Mudtorlep; Cheong, Ling-Zhi; Chaijan, Manat			Physico-chemical aspects of Thai fermented fish viscera, Tai-Pla, curry powder processed by hot air drying and hybrid microwave-infrared drying	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; PHENOLIC CONTENT; LIPID OXIDATION; CAPSICUM-ANNUUM; WATER ACTIVITY; TEMPERATURE; KINETICS; COLOR; ATTRIBUTES; FRUIT	The objective of this research was to comparatively investigate the effect of hot air drying (HA) and hybrid microwave-infrared drying (MI) on physico-chemical characteristics of Thai fermented fish viscera, Tai-Pla, curry powder (TCP). HA was carried out at 60 degrees C, 70 degrees C, and 80 degrees C and MI was carried out at a microwave power of 740, 780, and 810 W with a constant infrared heating power (500 W) for different drying times to obtain the final moisture content <= 12.0% and the water activity (a(w)) <= 0.6. The quality characteristics of TCP were governed by HA temperature and MI output power. TCP dried using HA and MI at all conditions had similar contents of protein, lipid, ash, fiber, and carbohydrate (p>0.05). The fastest drying rate was detected when MI at 810 W for 40 min was applied (p<0.05). In this condition, TCP had the lowest browning index (A(294) and A(420)) and the highest lightness (L* value) (p<0.05). TCP dried with MI at all powers had higher phenolic content and lower TBARS compared to HA (p<0.05). However, no significant differences in DPPH center dot scavenging activity were observed among TPC made by HA and MI (p>0.05). Similar Fourier transform infrared (FTIR) spectra with different peak intensities were observed in all samples, indicating the same functional groups with different contents were found. The bulk density of all TCP ranged from 0.51 g/mL to 0.61 g/mL and the wettability ranged from 24.02% to 26.70%. MI at 810 W for 40 min effectively reduced the drying time (5-fold faster) and lowered the specific energy consumption (18-fold lower) compared to the HA at 60 degrees C for 210 min. Therefore, MI is a promising drying technique to reduce the drying time and improve the overall quality of TCP.	[Choopan, Warongporn; Panpipat, Worawan; Chaijan, Manat] Walailak Univ, Food Technol & Innovat Res Ctr Excellence, Sch Agr Technol & Food Ind, Nakhon Si Thammarat, Thailand; [Nisoa, Mudtorlep] Walailak Univ, Sch Sci, Nakhon Si Thammarat, Thailand; [Cheong, Ling-Zhi] Ningbo Univ, Sch Marine Sci, Dept Food Sci & Engn, Ningbo, Peoples R China	Walailak University; Walailak University; Ningbo University	Panpipat, W (corresponding author), Walailak Univ, Food Technol & Innovat Res Ctr Excellence, Sch Agr Technol & Food Ind, Nakhon Si Thammarat, Thailand.	pworawan@wu.ac.th			Research and Researchers for Industries (RRI) program; Shaw Processing Food Co. Ltd. [MSD61I0053]; new strategic research project (P2P), Walailak University, Thailand	Research and Researchers for Industries (RRI) program; Shaw Processing Food Co. Ltd.; new strategic research project (P2P), Walailak University, Thailand	This research was financially supported by Research and Researchers for Industries (RRI) program and Shaw Processing Food Co. Ltd. [Grant No. MSD61I0053] and the new strategic research project (P2P), Walailak University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-sun K, 2016, INT FOOD RES J, V23, P1315; Agomuo EN., 2011, INT SCI RES J, V3, P85; Anuchapreeda S, 2020, BIOORG MED CHEM LETT, V30, DOI 10.1016/j.bmcl.2020.127256; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Bagheri H, 2020, J FOOD QUALITY, V2020, DOI 10.1155/2020/8813047; Barbosa-Canovas G.V., 2005, FOOD POWDERS PHYS PR, DOI 10.1007/0-387-27613-0; Benjakul S, 2005, FOOD CHEM, V90, P231, DOI 10.1016/j.foodchem.2004.03.045; Bouba A. A., 2012, Food and Nutrition Sciences, V3, P423; Cano-Chauca M, 2005, INNOV FOOD SCI EMERG, V6, P420, DOI 10.1016/j.ifset.2005.05.003; Caparino OA, 2012, J FOOD ENG, V111, P135, DOI 10.1016/j.jfoodeng.2012.01.010; Chaijan M, 2021, J INSECTS FOOD FEED, V7, P187, DOI 10.3920/JIFF2020.0025; Chaijan M, 2006, FOOD CHEM, V99, P83, DOI 10.1016/j.foodchem.2005.07.022; Chaijan S, 2020, FOOD CONTROL, V118, DOI 10.1016/j.foodcont.2020.107400; Cheenkaew Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233391; Chen XD, 2008, DRY TECHNOL, V26, P1313, DOI 10.1080/07373930802330904; Chou SK, 2001, TRENDS FOOD SCI TECH, V12, P359, DOI 10.1016/S0924-2244(01)00102-9; Chua LYW, 2019, MOLECULES, V24, DOI 10.3390/molecules24071397; Cong S, 2020, MOLECULES, V25, DOI 10.3390/molecules25051157; Datta AK, 2002, J FOOD ENG, V51, P355, DOI 10.1016/S0260-8774(01)00079-6; De Pilli T, 2008, J AM OIL CHEM SOC, V85, P827, DOI 10.1007/s11746-008-1271-5; Deepa G., 2013, International Food Research Journal, V20, P1711; Demiray E, 2017, HEAT MASS TRANSFER, V53, P1817, DOI 10.1007/s00231-016-1943-x; Dhakal S, 2019, FOODS, V8, DOI 10.3390/foods8050143; Ellepola SW, 2005, INT J BIOL MACROMOL, V37, P12, DOI 10.1016/j.ijbiomac.2005.07.008; Garau MC, 2007, FOOD CHEM, V104, P1014, DOI 10.1016/j.foodchem.2007.01.009; Guo QS, 2017, TRENDS FOOD SCI TECH, V67, P236, DOI 10.1016/j.tifs.2017.07.007; Hamed M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090364; Hayat K, 2010, FOOD CHEM, V123, P423, DOI 10.1016/j.foodchem.2010.04.060; Huang HZ, 2020, MOLECULES, V25, DOI 10.3390/molecules25071579; Inchuen S., 2010, Kasetsart Journal, Natural Sciences, V44, P142; Jay J.M., 2005, MODERN FOOD MICROBIO, P443, DOI [10.1007/0-387-23413-6_18, DOI 10.1007/0-387-23413-6_18]; Jin W, 2019, DRY TECHNOL, V37, P387, DOI 10.1080/07373937.2018.1458735; Jinapong N, 2008, J FOOD ENG, V84, P194, DOI 10.1016/j.jfoodeng.2007.04.032; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Kantangkul T, 2015, INT FOOD RES J, V22, P625; Koc G. C., 2019, GIDA - Journal of Food, V44, P328, DOI 10.15237/gida.GD18126; Koc GC, 2020, J FOOD SCI TECH MYS; Lillian UN., 2013, J ENV SCI TOXICOL FO, V5, P11; Lozano M, 2017, FOOD ANAL METHOD, V10, P3462, DOI 10.1007/s12161-017-0879-1; Maskan M, 2000, J FOOD ENG, V44, P71, DOI 10.1016/S0260-8774(99)00167-3; Michalska A, 2016, FOOD CHEM, V207, P223, DOI 10.1016/j.foodchem.2016.03.075; Miranda M, 2009, J FOOD ENG, V91, P297, DOI 10.1016/j.jfoodeng.2008.09.007; Morris A, 2004, ASIAN J BIOCHEM, V37, P160; Mujumdar AS, 2006, HDB IND DRYING, P311; Nakamoto M, 2020, EXP THER MED, V19, P1550, DOI 10.3892/etm.2019.8388; Nisoa M, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11072918; Nunes JC, 2016, FOOD CHEM, V197, P881, DOI 10.1016/j.foodchem.2015.11.050; Ojo A., 2014, CUR J APPL SCI TECHN, P2079; Ozcan MM, 2020, J FOOD SCI TECH MYS, V57, P233, DOI 10.1007/s13197-019-04052-6; Ozcan-Sinir G, 2019, FOOD SCI TECH-BRAZIL, V39, P475, DOI 10.1590/fst.34417; Pereira NR, 2007, J FOOD ENG, V81, P79, DOI 10.1016/j.jfoodeng.2006.09.025; Que F, 2008, INT J FOOD SCI TECH, V43, P1195, DOI 10.1111/j.1365-2621.2007.01590.x; Salehi F, 2017, HEAT MASS TRANSFER, V53, P1751, DOI 10.1007/s00231-016-1931-1; Samapundo S, 2014, INT J FOOD MICROBIOL, V181, P10, DOI 10.1016/j.ijfoodmicro.2014.04.018; Sanyal B, 2014, J FOOD SCI, V79, pC1656, DOI 10.1111/1750-3841.12571; Settharaksa S., 2012, International Food Research Journal, V19, P1581; Sharifian F, 2013, INT J FOOD ENG, V9, P107, DOI 10.1515/ijfe-2012-0211; Shirkole SS, 2020, INNOV FOOD SCI EMERG, V62, DOI 10.1016/j.ifset.2020.102345; Shirkole SS, 2019, DRY TECHNOL, V37, P253, DOI 10.1080/07373937.2018.1454941; Song XD, 2020, DRY TECHNOL, V38, P1151, DOI 10.1080/07373937.2019.1616752; Soysal Y, 2004, BIOSYST ENG, V89, P167, DOI 10.1016/j.biosystemseng.2004.07.008; Stapelfeldt H, 1997, INT DAIRY J, V7, P331, DOI 10.1016/S0958-6946(97)00016-2; Steel RGD., 1980, PRINCIPLE PROCEDURE, V633; Szychowski PJ, 2018, FOOD CHEM, V255, P157, DOI 10.1016/j.foodchem.2018.02.075; Tamprasit P, 2020, INT J FOOD SCI TECH, V55, P3424, DOI 10.1111/ijfs.14674; TARLADGIS BG, 1960, J AM OIL CHEM SOC, V37, P44, DOI 10.1007/BF02630824; Thai Community Product Standards, 2004, SEAS POWD 494 2547, V5; Thuy N. M., 2020, FOOD RES, V4, P358; Vega-Galvez A, 2009, FOOD CHEM, V117, P647, DOI 10.1016/j.foodchem.2009.04.066; Wang YZ, 2020, FOOD CHEM, V309, DOI 10.1016/j.foodchem.2019.125606; Wang ZY, 2020, J AGR FOOD CHEM, V68, P3330, DOI 10.1021/acs.jafc.9b06574; Yang QQ, 2020, IND CROP PROD, V152, DOI 10.1016/j.indcrop.2020.112561; YEN GC, 1995, J SCI FOOD AGR, V67, P415, DOI 10.1002/jsfa.2740670320; Yongsmith B, 2016, INT FOOD SCI ENG KNO, V10, P31, DOI 10.1007/978-1-4899-7648-2_3	74	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253834	10.1371/journal.pone.0253834	http://dx.doi.org/10.1371/journal.pone.0253834			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170970	Green Published, gold			2022-12-26	WOS:000671694400012
J	Mateev, M; Tariq, MU; Sahyouni, A				Mateev, Miroslav; Tariq, Muhammad Usman; Sahyouni, Ahmad			Competition, capital growth and risk-taking in emerging markets: Policy implications for banking sector stability during COVID-19 pandemic	PLOS ONE			English	Article							ISLAMIC BANKS; EUROPEAN BANKING; MIDDLE-EAST; OWNERSHIP STRUCTURE; CONVENTIONAL BANKS; POWER; PERFORMANCE; EFFICIENCY; IMPACT; CRISIS	This paper investigates how banking competition and capital level impact on the risk-taking behavior of banking institutions in the Middle East and North Africa (MENA) region. The topic is perceived to be of significant importance during the COVID-19 pandemic. We use data for more than 225 banks in 18 countries in the MENA region to test whether increased competition causes banks to hold higher capital ratios. Employing panel data techniques, and distinguishing between Islamic and conventional banks, we show that banks tend to hold higher capital ratios when operating in a more competitive environment. We also provide evidence that banks in the MENA region increase their capitalization levels in response to a higher risk and vice versa. Further, banking concentration (measured by the HH-index) and credit risk have a significant and positive impact on capital ratios of IBs, whereas competition does play a restrictive role in determining the level of their capital. The results hold when controlling for ownership structure, regulatory and institutional environment, bank-specific and macroeconomic characteristics. Our findings inform regulatory authorities concerned with improving the financial stability of banking sector in the MENA region to strengthen their policies in order to force banks to better align with capital requirements and risk during the COVID-19 pandemic.	[Mateev, Miroslav; Tariq, Muhammad Usman] Abu Dhabi Sch Management, Abu Dhabi, U Arab Emirates; [Sahyouni, Ahmad] Damascus Univ, Higher Inst Adm Dev, Damascus, Syria		Mateev, M (corresponding author), Abu Dhabi Sch Management, Abu Dhabi, U Arab Emirates.	m.mateev@adsm.ac.ae	Mateev, Miroslav/GZN-0469-2022; Sahyouni, Ahmad/AAU-5723-2020; Tariq, Muhammad Usman/G-3636-2015	Sahyouni, Ahmad/0000-0001-9882-8217; Tariq, Muhammad Usman/0000-0002-7605-3040; Mateev, Miroslav/0000-0002-3386-0539				Abedifar P, 2013, REV FINANC, V17, P2035, DOI 10.1093/rof/rfs041; Agoraki MEK, 2011, J FINANC STABIL, V7, P38, DOI 10.1016/j.jfs.2009.08.002; Agusman A, 2014, PAC-BASIN FINANC J, V30, P114, DOI 10.1016/j.pacfin.2014.07.003; Al-Awadhi AM, 2020, J BEHAV EXP FINANC, V27, DOI 10.1016/j.jbef.2020.100326; Al-Muharrami S, 2006, J BANK FINANC, V30, P3487, DOI 10.1016/j.jbankfin.2006.01.006; Allen F, 2004, J MONEY CREDIT BANK, V36, P453, DOI 10.1353/mcb.2004.0038; Allen F, 2005, CFS WORKING PAPER SE, V23; Altunbas Y, 2007, EUR FINANC MANAG, V13, P49, DOI 10.1111/j.1468-036X.2006.00285.x; Anginer D, 2014, J FINANC INTERMED, V23, P1, DOI 10.1016/j.jfi.2013.11.001; [Anonymous], DATABASE INTERACTIVE; [Anonymous], 2010, REV MIDDLE E EC FINA; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Ashraf BN, 2020, RES INT BUS FINANC, V54, DOI 10.1016/j.ribaf.2020.101249; Baker SR, 2020, REV ASSET PRICING ST, V10, P742, DOI 10.1093/rapstu/raaa008; Barros CP, 2016, APPL ECON, V48, P2785, DOI 10.1080/00036846.2015.1128083; Barth JR, 2004, J FINANC INTERMED, V13, P205, DOI 10.1016/j.jfi.2003.06.002; Basel Committee on Banking Supervision, 2006, COR PRINC EFF BANK S; Bashir A, 2017, BUSINESS EC REV, V9, P165, DOI [10.22547/ber/9.2.7, 10.22547/BER/9.2.7, DOI 10.22547/BER/9.2.7]; Beck T, 2006, J BANK FINANC, V30, P1581, DOI 10.1016/j.jbankfin.2005.05.010; Beck T, 2006, NBER CONF R, P193; Beck T, 2013, J BANK FINANC, V37, P433, DOI 10.1016/j.jbankfin.2012.09.016; Ben Khediri K, 2015, RES INT BUS FINANC, V33, P75, DOI 10.1016/j.ribaf.2014.07.002; Benamraoui A., 2019, INT J EC FINANCE, V11, P96; Benes J, 2015, J ECON DYN CONTROL, V58, P58, DOI 10.1016/j.jedc.2015.06.005; Berger AN, 2004, J MONEY CREDIT BANK, V36, P433, DOI 10.1353/mcb.2004.0040; BERGER AN, 1995, J MONEY CREDIT BANK, V27, P404, DOI 10.2307/2077876; Berger AN, 2020, RELATIONSHIP BORROWE; Bikker J. A., 2004, COMPETITION EFFICIEN; Bikker JA, 2002, J BANK FINANC, V26, P2191, DOI 10.1016/S0378-4266(02)00205-4; Bitar M, 2016, ECON SYST, V40, P398, DOI 10.1016/j.ecosys.2015.12.001; Bolt W, 2004, SCAND J ECON, V106, P783, DOI 10.1111/j.0347-0520.2004.00388.x; Bourkhis K, 2013, REV FINANC ECON, V22, P68, DOI 10.1016/j.rfe.2013.01.001; Boyd J.H., 2006, 06297 IMF, DOI [10.5089/9781451865578.001, DOI 10.5089/9781451865578.001]; Boyd JH, 2005, J FINANC, V60, P1329, DOI 10.1111/j.1540-6261.2005.00763.x; Caminal R, 2002, INT J IND ORGAN, V20, P1341, DOI 10.1016/S0167-7187(01)00092-3; Chang CP, 2016, ECON MODEL, V53, P477, DOI 10.1016/j.econmod.2015.10.046; Chong BS, 2009, PAC-BASIN FINANC J, V17, P125, DOI 10.1016/j.pacfin.2007.12.003; Claessens S, 2005, J EUR ECON ASSOC, V3, P179, DOI 10.1162/1542476053295322; Deelchand T, 2010, INT CAPITAL MARKET A, DOI DOI 10.2139/SSRN.1525423; Demirguc-Kunt Asli, 2020, POLICY RES WORKING P; DEMSETZ H, 1973, J LAW ECON, V16, P1, DOI 10.1086/466752; Diamond DW, 2000, J FINANC, V55, P2431, DOI 10.1111/0022-1082.00296; Farazi S, 2011, BANK OWNERSHIP PERFO; Fiordelisi F, 2014, J INT MONEY FINANC, V45, P1, DOI 10.1016/j.jimonfin.2014.02.008; Forssbaeck J, 2011, J BANK FINANC, V35, P2666, DOI 10.1016/j.jbankfin.2011.02.024; Gan J, 2004, J FINANC ECON, V73, P567, DOI 10.1016/j.jfineco.2003.07.004; Ghanem A, 2017, J BANK REGUL, V18, P48, DOI 10.1057/jbr.2016.1; Ghosh S, 2014, BORSA ISTANB REV, V14, P145, DOI 10.1016/j.bir.2014.06.003; Grassa R, 2012, ACCOUNT RES J, V25, P227, DOI 10.1108/10309611211290185; Guidara A, 2013, J BANK FINANC, V37, P3373, DOI 10.1016/j.jbankfin.2013.05.012; Hakenes H, 2015, REV FINANC, V19, P653, DOI 10.1093/rof/rfu003; Hamza H, 2014, J ISLAMIC ACCOUNT BU, V5, P29, DOI 10.1108/JIABR-05-2012-0030; Haque F, 2019, CORP GOV-INT J BUS S, V19, P23, DOI 10.1108/CG-07-2017-0135; Haque F, 2017, INT REV ECON FINANC, V47, P273, DOI 10.1016/j.iref.2016.10.015; Hellmann TF, 2000, AM ECON REV, V90, P147, DOI 10.1257/aer.90.1.147; Herfindahl O.C., 1950, CONCENTRATION US STE; Hirschman A. O., 1945, NATL POWER STRUCTURE; Iannotta G, 2007, J BANK FINANC, V31, P2127, DOI 10.1016/j.jbankfin.2006.07.013; Jimenez G, 2013, J FINANC STABIL, V9, DOI 10.1016/j.jfs.2013.02.004; Karim MA, 2014, PAC-BASIN FINANC J, V28, P58, DOI 10.1016/j.pacfin.2013.11.002; Kaufmann D, 2008, WORLD BANK POLICY RE; KEELEY MC, 1990, AM ECON REV, V80, P1183; Lassoued N, 2016, RES INT BUS FINANC, V36, P167, DOI 10.1016/j.ribaf.2015.09.014; Lee CC, 2013, J INT MONEY FINANC, V32, P251, DOI 10.1016/j.jimonfin.2012.04.013; Leon F., 2015, WORKING PAPERS; Leon F, 2015, J BANK FINANC, V57, P130, DOI 10.1016/j.jbankfin.2015.04.005; Liu H, 2013, MANCH SCH, V81, P176, DOI 10.1111/j.1467-9957.2011.02285.x; Louati S, 2015, BORSA ISTANB REV, V15, P192, DOI 10.1016/j.bir.2015.04.001; Maghyereh AI, 2014, RES INT BUS FINANC, V30, P126, DOI 10.1016/j.ribaf.2013.07.001; Maji SG, 2015, J FINAN ECON POLICY, V7, P140, DOI 10.1108/JFEP-06-2014-0038; Martinova N, 2014, 430 NV DNB NED BANK; Mateev M, 2021, EMERG MARK REV, V47, DOI 10.1016/j.ememar.2020.100789; MOLYNEUX P, 1994, J BANK FINANC, V18, P445, DOI 10.1016/0378-4266(94)90003-5; Moudud-Ul-Huq S, 2021, COVID 19 OWNER UNPUB; Moudud-Ul-Huq S, 2021, GLOB BUS REV, V22, P921, DOI 10.1177/0972150918817382; Moudud-Ul-Huq S, 2021, INT J EMERG MARK, V16, P409, DOI 10.1108/IJOEM-03-2019-0197; Nagaoka S., 2010, REV ISLAMIC EC, V13, P65; Oduor J, 2017, REV DEV FINANC, V7, P45, DOI 10.1016/j.rdf.2017.01.002; Olson D, 2017, Q REV ECON FINANC, V65, P71, DOI 10.1016/j.qref.2016.06.013; Osei-Assibey E, 2015, J FINAN ECON POLICY, V7, P401, DOI 10.1108/JFEP-03-2015-0018; Gonzalez LO, 2017, RES INT BUS FINANC, V42, P591, DOI 10.1016/j.ribaf.2017.07.004; PANZAR JC, 1987, J IND ECON, V35, P443, DOI 10.2307/2098582; Repullo R, 2004, J FINANC INTERMED, V13, P156, DOI 10.1016/j.jfi.2003.08.005; Rocha R, 2011, POLICY RES WORKING P; Schaeck K, 2006, 06143 IMF; Schaeck K, 2007, 07216 IMF; Shaffer S, 2004, J MONEY CREDIT BANK, V36, P585, DOI 10.1353/mcb.2004.0050; Shehzad CT, 2010, J BANK FINANC, V34, P399, DOI 10.1016/j.jbankfin.2009.08.007; Siddiqi M.N., 2006, ISLAMIC EC STUDIES, V13, P1, DOI DOI 10.4197/ISLEC.17-1.4; Soedarmono W, 2013, J INT FINANC MARK I, V23, P196, DOI 10.1016/j.intfin.2012.09.009; Srairi S, 2013, BORSA ISTANB REV, V13, P115, DOI 10.1016/j.bir.2013.10.010; Nguyen TPT, 2015, MANAG FINANC, V41, P507, DOI 10.1108/MF-12-2013-0354; The World Bank Development Indicators, 2018, DAT WORLD DEV IND; van Leuvensteijn M, 2013, APPL ECON, V45, P1359, DOI 10.1080/00036846.2011.617697; Weill L, 2004, J PROD ANAL, V21, P133, DOI 10.1023/B:PROD.0000016869.09423.0c; Weill L, 2011, COMP ECON STUD, V53, P291, DOI 10.1057/ces.2011.1; [张宗益 ZHANG Zongyi], 2008, [系统工程理论与实践, Systems Engineering-Theory & Practice], V28, P183; Zheng CJ, 2017, INT J FINANC ENG, V4, DOI 10.1142/S242478631750027X; Zheng CJ, 2017, INT J FINANC ENG, V4, DOI 10.1142/S2424786317500256	99	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253803	10.1371/journal.pone.0253803	http://dx.doi.org/10.1371/journal.pone.0253803			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166479	Green Published, gold			2022-12-26	WOS:000671692800068
J	Niemeier-Walsh, C; Ryan, PH; Meller, J; Ollberding, NJ; Adhikari, A; Reponen, T				Niemeier-Walsh, Christine; Ryan, Patrick H.; Meller, Jaroslaw; Ollberding, Nicholas J.; Adhikari, Atin; Reponen, Tiina			Exposure to traffic-related air pollution and bacterial diversity in the lower respiratory tract of children	PLOS ONE			English	Article							REAL-TIME PCR; CHILDHOOD ASTHMA; FUSOBACTERIUM-NUCLEATUM; HOSPITAL ADMISSIONS; FECAL MICROBIOTA; VEHICLE EXHAUST; SEQUENCE DATA; HEALTH; BIODIVERSITY; PARTICLES	Background Exposure to particulate matter has been shown to increase the adhesion of bacteria to human airway epithelial cells. However, the impact of traffic-related air pollution (TRAP) on the respiratory microbiome is unknown. Methods Forty children were recruited through the Cincinnati Childhood Allergy and Air Pollution Study, a longitudinal cohort followed from birth through early adolescence. Saliva and induced sputum were collected at age 14 years. Exposure to TRAP was characterized from birth through the time of sample collection using a previously validated land-use regression model. Sequencing of the bacterial 16S and ITS fungal rRNA genes was performed on sputum and saliva samples. The relative abundance of bacterial taxa and diversity indices were compared in children with exposure to high and low TRAP. We also used multiple linear regression to assess the effect of TRAP exposure, gender, asthma status, and socioeconomic status on the alpha diversity of bacteria in sputum. Results We observed higher bacterial alpha diversity indices in sputum than in saliva. The diversity indices for bacteria were greater in the high TRAP exposure group than the low exposure group. These differences remained after adjusting for asthma status, gender, and mother's education. No differences were observed in the fungal microbiome between TRAP exposure groups. Conclusion Our findings indicate that exposure to TRAP in early childhood and adolescence may be associated with greater bacterial diversity in the lower respiratory tract. Asthma status does not appear to confound the observed differences in diversity. These results demonstrate that there may be a TRAP-exposure related change in the lower respiratory microbiota that is independent of asthma status.	[Niemeier-Walsh, Christine; Ryan, Patrick H.; Meller, Jaroslaw; Reponen, Tiina] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA; [Ryan, Patrick H.; Meller, Jaroslaw; Ollberding, Nicholas J.] Univ Cincinnati, Dept Pediat, Cincinnati, OH USA; [Ryan, Patrick H.; Ollberding, Nicholas J.] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Adhikari, Atin] Georgia Southern Univ, Jiann Ping Hsu Coll Publ Hlth, Statesboro, GA USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Georgia; Georgia Southern University	Reponen, T (corresponding author), Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45221 USA.	Tiina.Reponen@uc.edu	Ryan, Patrick/HDO-1133-2022	Reponen, Tiina/0000-0002-7987-4901; Adhikari, Atin/0000-0001-8835-1654	National Institute of Environmental Health Sciences, National Institutes of Health [R21ES024807]; National Institute for Occupational Safety and Health through the University of Cincinnati Education and Research Center Grant [T42OH008432]; National Center for Advancing Translational Sciences of the National Institutes of Health [5UL1TR001425-04]	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute for Occupational Safety and Health through the University of Cincinnati Education and Research Center Grant; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	TR: National Institute of Environmental Health Sciences, National Institutes of Health (https://nam11.safelinks.protection.outlook.com/? url=http%3A%2F%2Fwww.niehs.nih.gov% 2F&data=04%7C01%7CREPONETA%40UCMAIL. UC.EDU%7C2dd0ffcde7ee4762804f08d8ff7145da %7Cf5222e6c5fc648eb8f0373db18203b63% 7C1%7C0%7C637540209256882696% 7CUnknown%7CTWFpbGZsb3d8eyJW IjoiMC4wLjAwMDAiLCJQIjoiV2luMzI iLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D% 7C1000&sdata=Ir0BmHB2gF5wsTWkz9% 2Fq8BPGOn7zhrZkfgRDQCjiqnc%3D&reserved= 0)), grant #R21ES024807. National Institute for Occupational Safety and Health through the University of Cincinnati Education and Research Center Grant #T42OH008432 partially supported C. N.-W. National Center for Advancing Translational Sciences of the National Institutes of Health (ncats. nih.gov), Award Number 5UL1TR001425-04. (This grant is for the Schubert center where the sputum samples were collected; none of the co-authors is the PI of this grant).	Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010; Aliyu SH, 2004, J MED MICROBIOL, V53, P1029, DOI 10.1099/jmm.0.45648-0; [Anonymous], 2018, ENVIRON RES, DOI DOI 10.1016/j.envres.2017.11.046; Awasthi A, 2014, ISME J, V8, P2445, DOI 10.1038/ismej.2014.91; Bacci G, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8071003; Barnett AG, 2005, AM J RESP CRIT CARE, V171, P1272, DOI 10.1164/rccm.200411-1586OC; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Beamish LA, 2011, J CROHNS COLITIS, V5, P279, DOI 10.1016/j.crohns.2011.02.017; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Brant TCS, 2014, CLINICS, V69, P867, DOI 10.6061/clinics/2014(12)13; Brunekreef B, 1997, EPIDEMIOLOGY, V8, P298, DOI 10.1097/00001648-199705000-00012; Brunst KJ, 2015, AM J RESP CRIT CARE, V192, P421, DOI 10.1164/rccm.201407-1314OC; Bunn HJ, 2001, THORAX, V56, P932, DOI 10.1136/thorax.56.12.932; Burton JP, 2005, AUST NZ J OBSTET GYN, V45, P450, DOI 10.1111/j.1479-828X.2005.00456.x; Calcabrini A, 2004, ENVIRON RES, V95, P82, DOI 10.1016/j.envres.2003.07.011; Callahan Benjamin, 2018, Zenodo, DOI 10.5281/zenodo.1172783; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chen XY, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0700-0; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cho SH, 2006, ANN ALLERG ASTHMA IM, V97, P539, DOI 10.1016/S1081-1206(10)60947-7; Ciccone G, 1998, OCCUP ENVIRON MED, V55, P771, DOI 10.1136/oem.55.11.771; Cohen AJ RAH., 2004, COMP QUANTIFICATION; Dannemiller KC, 2014, ATMOS ENVIRON, V84, P113, DOI 10.1016/j.atmosenv.2013.11.036; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Donaldson K, 2003, FREE RADICAL BIO MED, V34, P1369, DOI 10.1016/S0891-5849(03)00150-3; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; EDWARDS J, 1994, ARCH ENVIRON HEALTH, V49, P223, DOI 10.1080/00039896.1994.9937471; Ege MJ, 2012, ALLERGY, V67, P1565, DOI 10.1111/all.12028; Eisenhauer N, 2013, FUNCT ECOL, V27, P282, DOI 10.1111/j.1365-2435.2012.02060.x; Ekanayake A, 2020, INDIAN J MICROBIOL, V60, P196, DOI 10.1007/s12088-019-00850-w; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Gallacher D., 2018, EUR RESPIR J, V52, pPA4657; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; HELLEDAY R, 1995, EUR RESPIR J, V8, P1664, DOI 10.1183/09031936.95.08101664; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hu SH, 2006, ATMOS ENVIRON, V40, pS378, DOI 10.1016/j.atmosenv.2006.02.038; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Huffnagle GB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000549; Ibald-Mulli A, 2002, J AEROSOL MED, V15, P189, DOI 10.1089/089426802320282310; Iossifova YY, 2009, ANN ALLERG ASTHMA IM, V102, P131, DOI 10.1016/S1081-1206(10)60243-8; Jian C., 2018, QUANTITATIVE PCR PRO, P478685; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; Kocbach A, 2005, SCI TOTAL ENVIRON, V346, P231, DOI 10.1016/j.scitotenv.2004.10.025; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; LeMasters GK, 2006, J PEDIATR-US, V149, P505, DOI 10.1016/j.jpeds.2006.06.035; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luhung I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141158; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manley Leigh J, 2016, J Biomol Tech, V27, P125; Mao QX, 2018, CANCER LETT, V415, P40, DOI 10.1016/j.canlet.2017.11.036; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Medina-Ramon M, 2006, AM J EPIDEMIOL, V163, P579, DOI 10.1093/aje/kwj078; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Migilaretti G, 2004, PEDIATR PULM, V38, P198, DOI 10.1002/ppul.20057; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Neupane B, 2010, AM J RESP CRIT CARE, V181, P47, DOI [10.1164/rccm.200901-0160oc, 10.1164/rccm.200901-0160OC]; NITTA H, 1993, ARCH ENVIRON HEALTH, V48, P53, DOI 10.1080/00039896.1993.9938393; OKAHASHI N, 1988, J GEN MICROBIOL, V134, P1707; Oosterlee A, 1996, OCCUP ENVIRON MED, V53, P241, DOI 10.1136/oem.53.4.241; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Qu JJ, 2017, J THORAC DIS, V9, pE32, DOI 10.21037/jtd.2017.01.05; Reponen T, 2012, J ALLERGY CLIN IMMUN, V130, P639, DOI 10.1016/j.jaci.2012.05.030; Reponen T, 2011, ANN ALLERG ASTHMA IM, V107, P120, DOI 10.1016/j.anai.2011.04.018; Ribiere C, 2016, SCI REP-UK, V6, DOI 10.1038/srep31027; Ryan PH, 2008, SCI TOTAL ENVIRON, V404, P139, DOI 10.1016/j.scitotenv.2008.05.051; Ryan PH, 2007, ENVIRON HEALTH PERSP, V115, P278, DOI 10.1289/ehp.9480; Ryan PH, 2005, J ALLERGY CLIN IMMUN, V116, P279, DOI 10.1016/j.jaci.2005.05.014; Sahu M, 2011, SCI TOTAL ENVIRON, V409, P2642, DOI 10.1016/j.scitotenv.2011.03.032; Saito Y, 2008, ORAL MICROBIOL IMMUN, V23, P1, DOI 10.1111/j.1399-302X.2007.00380.x; Salim SY, 2014, GUT MICROBES, V5, P215, DOI 10.4161/gmic.27251; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Suzaki H, 2013, CURR OPIN ALLERGY CL, V13, P45, DOI 10.1097/ACI.0b013e32835b34f6; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; vanVliet P, 1997, ENVIRON RES, V74, P122, DOI 10.1006/enrs.1997.3757; WJST M, 1993, BRIT MED J, V307, P596, DOI 10.1136/bmj.307.6904.596; Wright ES, 2016, R J, V8, P352; Wypych TP, 2019, NAT IMMUNOL, V20, P1279, DOI 10.1038/s41590-019-0451-9; Yolton K, 2019, ENVIRON RES, V173, P199, DOI 10.1016/j.envres.2019.03.005; Zeeuwen PLJM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r101; Zmirou D, 2004, J EPIDEMIOL COMMUN H, V58, P18, DOI 10.1136/jech.58.1.18	102	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0244341	10.1371/journal.pone.0244341	http://dx.doi.org/10.1371/journal.pone.0244341			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166366	Green Published, gold			2022-12-26	WOS:000671692800029
J	Hemminki, K; Forsti, A; Hemminki, A; Ljungberg, B; Hemminki, O				Hemminki, Kari; Foersti, Asta; Hemminki, Akseli; Ljungberg, Boerje; Hemminki, Otto			Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden	PLOS ONE			English	Article							NORDIC COUNTRIES; CANCER; IMPACT; DIAGNOSTICS; PREDICTION; TRENDS; END	Global survival studies have shown favorable development in renal cell carcinoma (RCC) treatment but few studies have considered extended periods or covered populations for which medical care is essentially free of charge. We analyzed RCC survival in Finland and Sweden over a 50-year period (1967-2016) using data from the NORDCAN database provided by the local cancer registries. While the health care systems are largely similar in the two countries, the economic resources have been stronger in Sweden. In addition to the standard 1- and 5-year relative survival rates, we calculated the difference between these as a measure of how well survival was maintained between years 1 and 5. Relative 1- year survival rates increased almost linearly in both countries and reached 90% in Sweden and 80% in Finland. Although 5-year survival also developed favorably the difference between 1- and 5-year survival rates did not improve in Sweden suggesting that the gains in 5-year survival were entirely due to gains in 1-year survival. In Finland there was a gain in survival between years 1 and 5, but the gain in 1-years survival was the main contributor to the favorable 5-year survival. Age group specific analysis showed large survival differences, particularly among women. Towards the end of the follow-up period the differences narrowed but the disadvantage of the old patients remained in 5-year survival. The limitations of the study were lack of information on performed treatment and clinical stage in the NORDCAN database. In conclusion, the available data suggest that earlier diagnosis and surgical treatment of RCC have been the main driver of the favorable change in survival during the past 50 years. The main challenges are to reduce the age-specific survival gaps, particularly among women, and push survival gains past year 1.	[Hemminki, Kari] Charles Univ Prague, Fac Med, Biomed Ctr, Plzen, Czech Republic; [Hemminki, Kari] Charles Univ Prague, Biomed Ctr Pilsen, Plzen, Czech Republic; [Hemminki, Kari] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Foersti, Asta] Hopp Childrens Canc Ctr KiTZ, Heidelberg, Germany; [Foersti, Asta] German Canc Res Ctr, German Canc Consortium DKTK, Div Pediat Neu Rooncol, Heidelberg, Germany; [Hemminki, Akseli; Hemminki, Otto] Univ Helsinki, Translat Immunol Res Program, Canc Gene Therapy Grp, Helsinki, Finland; [Hemminki, Akseli] Helsinki Univ Hosp, Comprehens Canc Ctr, Helsinki, Finland; [Ljungberg, Boerje] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Hemminki, Otto] Helsinki Univ Hosp, Dept Urol, Helsinki, Finland; [Hemminki, Otto] Univ Helsinki, Helsinki, Finland; [Hemminki, Otto] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol Oncol, Toronto, ON, Canada; [Hemminki, Otto] Univ Toronto, Toronto, ON, Canada	Charles University Prague; Charles University Prague; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Umea University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Hemminki, K (corresponding author), Charles Univ Prague, Fac Med, Biomed Ctr, Plzen, Czech Republic.; Hemminki, K (corresponding author), Charles Univ Prague, Biomed Ctr Pilsen, Plzen, Czech Republic.; Hemminki, K (corresponding author), German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.	K.Hemminki@dkfz.de		Hemminki, Kari/0000-0002-2769-3316; Ljungberg, Borje/0000-0002-4121-3753	European Union [856620]; Jane and Aatos Erkko Foundation [6-5900-29]; Sigrid Juselius Foundation [63-4925-56]; Finnish Cancer Organizations [6-5156-32]; Biomedicum Helsinki Foundation [73604201]; University of Helsinki [797011008]; Helsinki University Central Hospital [TYH2019215]; Novo Nordisk Foundation [0058602]; Paivikki and Sakari Sohlberg Foundation [10-6623-11]	European Union(European Commission); Jane and Aatos Erkko Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Cancer Organizations; Biomedicum Helsinki Foundation; University of Helsinki; Helsinki University Central Hospital; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation	European Union's Horizon 2020 research and innovation programme, grant No 856620 (Chaperon), to KH, Jane and Aatos Erkko Foundation (6-5900-29), Sigrid Juselius Foundation (63-4925-56), Finnish Cancer Organizations (6-5156-32), Biomedicum Helsinki Foundation (73604201), University of Helsinki (797011008), Helsinki University Central Hospital (TYH2019215), Novo Nordisk Foundation (0058602), Paivikki and Sakari Sohlberg Foundation (10-6623-11), all to AH. Funding agencies had no role in the study.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Dabestani S, 2016, WORLD J UROL, V34, P1081, DOI 10.1007/s00345-016-1773-y; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Engholm G, 2010, ACTA ONCOL, V49, P545, DOI 10.3109/02841861003739322; Frank I, 2002, J UROLOGY, V168, P2395, DOI 10.1016/S0022-5347(05)64153-5; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Hemminki K, 2012, ANN ONCOL, V23, P760, DOI 10.1093/annonc/mdr369; Hemminki O, 2020, EUR UROL OPEN SCI, V22, P61, DOI 10.1016/j.euros.2020.11.003; Janiszewska AD, 2013, WSPOLCZESNA ONKOL, V17, P123, DOI 10.5114/wo.2013.34613; Lindskog M, 2017, UROL ONCOL-SEMIN ORI, V35, DOI 10.1016/j.urolonc.2017.05.013; Ljungberg B, 1996, BRIT J CANCER, V74, P123, DOI 10.1038/bjc.1996.326; Ljungberg B, 2000, SCAND J UROL NEPHROL, V34, P246, DOI 10.1080/003655900750041979; Ljungberg B, 2019, EUR UROL, V75, P799, DOI 10.1016/j.eururo.2019.02.011; Lundberg FE., 2020, ACTA ONCOL, V59, P1266, DOI [10.1080/0284186X.2020.1822544, DOI 10.1080/0284186X.2020.1822544]; Mommsen S, 2003, SCAND J UROL NEPHROL, V37, P401, DOI 10.1080/00365590310006336; Nisen H, 2017, SCAND J UROL, V51, P360, DOI 10.1080/21681805.2017.1326524; Padala SA, 2020, WORLD J ONCOL, V11, P79, DOI 10.14740/wjon1279; Pukkala E, 2018, ACTA ONCOL, V57, P440, DOI 10.1080/0284186X.2017.1407039; Rossi SH, 2018, WORLD J UROL, V36, P1341, DOI 10.1007/s00345-018-2286-7; Storm HH, 2010, ACTA ONCOL, V49, P694, DOI 10.3109/02841861003631495; Sunela KL, 2014, BJU INT, V113, P228, DOI 10.1111/bju.12242; Thorstenson A., 2015, BIOMED RES INT, V2015, P456040, DOI [10.1155/2015/456040, DOI 10.1155/2015/456040]; Thorstenson A, 2016, SCAND J UROL, V50, P2, DOI 10.3109/21681805.2015.1059882; Thorstenson A, 2014, SCAND J UROL, V48, P231, DOI 10.3109/21681805.2013.864698	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253236	10.1371/journal.pone.0253236	http://dx.doi.org/10.1371/journal.pone.0253236			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157049	Green Published, gold			2022-12-26	WOS:000671691200015
J	Chen, CH; Wang, BW; Hsiao, YC; Wu, CY; Cheng, FJ; Hsia, TC; Chen, CY; Wang, YH; Weihua, Z; Chou, RH; Tang, CH; Chen, YJ; Wei, YL; Hsu, JL; Tu, CY; Hung, MC; Huang, WC				Chen, Chia-Hung; Wang, Bo-Wei; Hsiao, Yu-Chun; Wu, Chun-Yi; Cheng, Fang-Ju; Hsia, Te-Chun; Chen, Chih-Yi; Wang, Yihua; Weihua, Zhang; Chou, Ruey-Hwang; Tang, Chih-Hsin; Chen, Yun-Ju; Wei, Ya-Ling; Hsu, Jennifer L.; Tu, Chih-Yen; Hung, Mien-Chie; Huang, Wei-Chien			PKC delta-mediated SGLT1 upregulation confers the acquired resistance of NSCLC to EGFR TKIs	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; BREAST-CANCER CELLS; LUNG-CANCER; GLUCOSE-TRANSPORTER; EARLY PREDICTION; EXPRESSION; PROTEIN; PHOSPHORYLATION; OVEREXPRESSION	The tyrosine kinase inhibitors (TKIs) targeting epidermal growth factor receptor (EGFR) have been widely used for non-small cell lung cancer (NSCLC) patients, but the development of acquired resistance remains a therapeutic hurdle. The reduction of glucose uptake has been implicated in the anti-tumor activity of EGFR TKIs. In this study, the upregulation of the active sodium/glucose co-transporter 1 (SGLT1) was found to confer the development of acquired EGFR TKI resistance and was correlated with the poorer clinical outcome of the NSCLC patients who received EGFR TKI treatment. Blockade of SGLT1 overcame this resistance in vitro and in vivo by reducing glucose uptake in NSCLC cells. Mechanistically, SGLT1 protein was stabilized through the interaction with PKC delta-phosphorylated (Thr678) EGFR in the TKI-resistant cells. Our findings revealed that PKC delta/EGFR axis-dependent SGLT1 upregulation was a critical mechanism underlying the acquired resistance to EGFR TKIs. We suggest co-targeting PKC delta/SGLT1 as a potential strategy to improve the therapeutic efficacy of EGFR TKIs in NSCLC patients.	[Chen, Chia-Hung; Hsia, Te-Chun; Tu, Chih-Yen] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Chen, Chia-Hung; Tang, Chih-Hsin; Tu, Chih-Yen] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Chia-Hung; Hsia, Te-Chun] China Med Univ, Dept Resp Therapy, Taichung, Taiwan; [Wang, Bo-Wei; Hsiao, Yu-Chun; Chou, Ruey-Hwang; Wei, Ya-Ling; Hsu, Jennifer L.; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, Ctr Mol Med, Res Ctr Canc Biol, Taichung, Taiwan; [Wang, Bo-Wei; Hsiao, Yu-Chun; Chou, Ruey-Hwang; Wei, Ya-Ling; Hsu, Jennifer L.; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Wang, Bo-Wei; Hsiao, Yu-Chun; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, Drug Dev Ctr, Taichung, Taiwan; [Hsiao, Yu-Chun; Cheng, Fang-Ju; Chou, Ruey-Hwang; Hung, Mien-Chie; Huang, Wei-Chien] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Hsiao, Yu-Chun; Cheng, Fang-Ju; Chou, Ruey-Hwang; Hung, Mien-Chie; Huang, Wei-Chien] Acad Sinica, Taichung, Taiwan; [Wu, Chun-Yi] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Cheng, Fang-Ju; Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Cheng, Fang-Ju; Hsu, Jennifer L.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hsia, Te-Chun] China Med Univ Hosp, Hyperbar Oxygen Therapy Ctr, Dept Internal Med, Taichung, Taiwan; [Chen, Chih-Yi] Chung Shan Med Univ, Inst Med, Dept Surg, Div Thorac Surg, Taichung, Taiwan; [Wang, Yihua] Univ Southampton, Fac Environm & Life Sci, Biol Sci, Southampton, Hants, England; [Wang, Yihua] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Weihua, Zhang] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Chen, Yun-Ju] E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chen, Yun-Ju] I Shou Univ, Sch Med Int Students, Kaohsiung, Taiwan; [Chen, Yun-Ju] E Da Hosp, Dept Pharm, Kaohsiung, Taiwan; [Huang, Wei-Chien] Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; University of Southampton; University of Southampton; University of Houston System; University of Houston; E-Da Hospital; I Shou University; E-Da Hospital; Asia University Taiwan	Tu, CY (corresponding author), China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan.; Tu, CY (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ, Ctr Mol Med, Res Ctr Canc Biol, Taichung, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ, Drug Dev Ctr, Taichung, Taiwan.; Hung, MC; Huang, WC (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.; Hung, MC; Huang, WC (corresponding author), Acad Sinica, Taichung, Taiwan.; Huang, WC (corresponding author), Asia Univ, Dept Med Lab Sci & Biotechnol, Taichung, Taiwan.	chesttu@gmail.com; mhung@cmu.edu.tw; whuang@mail.cmu.edu.tw	Wang, Bo/AAU-1329-2021; Hung, Mien-Chie/ABD-5911-2021; Chou, Ruey-Hwang/K-8541-2013	Wang, Bo/0000-0001-8947-8526; Hung, Mien-Chie/0000-0003-4317-4740; Chou, Ruey-Hwang/0000-0002-2297-2180; Wang, Yihua/0000-0001-5561-0648; Cheng, Fang-Ju/0000-0001-6104-7185	Ministry of Science Technology, Taiwan [MOST 108-2314-B-039-032]; China Medical University [CMU106-ASIA-18]; China Medical University Hospital [DMR-108-012, DMR-109-212, DMR-109-213]; "Drug Development Center, China Medical University" from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan; Medical Research Council [MR/S025480/1]	Ministry of Science Technology, Taiwan; China Medical University(China Medical University); China Medical University Hospital; "Drug Development Center, China Medical University" from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Experiments and data analysis were performed in part through the use of the Medical Research Core Facilities in the Office of Research & Development at China Medical University, Taichung, Taiwan. This research was funded in part by the following: Ministry of Science Technology, Taiwan (grant number: MOST 108-2314-B-039-032), China Medical University (grant number: CMU106-ASIA-18), and China Medical University Hospital (DMR-108-012, DMR-109-212, DMR-109-213). This work was also financially supported by the "Drug Development Center, China Medical University" from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. Y. Wang was supported by Medical Research Council (MR/S025480/1). We would like to thank Iona J. MacDonald from China Medical University, Taichung, Taiwan, for her English language revision of this manuscript.	Ancey PB, 2018, FEBS J, V285, P2926, DOI 10.1111/febs.14577; Apicella M, 2018, CELL METAB, V28, P848, DOI 10.1016/j.cmet.2018.08.006; Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Barrio JR, 2020, J NUCL MED, V61, P931, DOI 10.2967/jnumed.119.237446; Blodgett AB, 2011, DIABETES TECHNOL THE, V13, P743, DOI 10.1089/dia.2011.0041; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Chen CH, 2017, MOL ONCOL, V11, P1273, DOI 10.1002/1878-0261.12102; Chen WS, 2015, ONCOTARGET, V6, P25962, DOI 10.18632/oncotarget.4504; Chen Y, 2017, ONCOTARGET, V8, P63813, DOI 10.18632/oncotarget.19130; Chen YJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/682380; Cheng FJ, 2021, ONCOGENE, V40, P1162, DOI 10.1038/s41388-020-01597-1; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Dicembrini I, 2019, DIABETES OBES METAB, V21, P1871, DOI 10.1111/dom.13745; Dietrich M, 2019, EXP CELL RES, V382, DOI 10.1016/j.yexcr.2019.06.018; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Guo GF, 2011, MED ONCOL, V28, pS197, DOI 10.1007/s12032-010-9696-8; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hachemi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087629; Hsia TC, 2013, MOL PHARMACOL, V83, P857, DOI 10.1124/mol.112.082743; Hsiao YC, 2015, ONCOTARGET, V6, P37965, DOI 10.18632/oncotarget.5700; Hudson CD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.125; HUNTER T, 1984, NATURE, V311, P480, DOI 10.1038/311480a0; Husain H, 2017, MOL CANCER THER, V16, P265, DOI 10.1158/1535-7163.MCT-16-0105; Hussein YR, 2011, TRANSL ONCOL, V4, P321, DOI 10.1593/tlo.11256; Janku F, 2013, ONCOTARGET, V4, P463, DOI 10.18632/oncotarget.886; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Jin N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10427-2; Kaida H, 2016, EUR J RADIOL, V85, P1804, DOI 10.1016/j.ejrad.2016.08.007; Kanwal A, 2012, ANAL BIOCHEM, V429, P70, DOI 10.1016/j.ab.2012.07.003; Ke EE, 2016, TRENDS PHARMACOL SCI, V37, P887, DOI 10.1016/j.tips.2016.09.003; Khuong HT, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0322-3; Kim JH, 2018, CANCER RES, V78, P4482, DOI 10.1158/0008-5472.CAN-18-0117; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kluba M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139971; Kunimasa K, 2017, CANCER SCI, V108, P1368, DOI 10.1111/cas.13266; Lapuerta P, 2015, DIABETES VASC DIS RE, V12, P101, DOI 10.1177/1479164114563304; Lee PC, 2018, CANCER CELL, V34, P954, DOI 10.1016/j.ccell.2018.11.007; Li L, 2019, CANCER LETT, V452, P191, DOI 10.1016/j.canlet.2019.03.027; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Lin HW, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/719578; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080721; Liu TC, 2017, AM J CANCER RES, V7, P187; Llado A, 2004, MOL BIOL CELL, V15, P4877, DOI 10.1091/mbc.E04-02-0127; Lypova N, 2019, J BIOL CHEM, V294, P10530, DOI 10.1074/jbc.RA119.007784; Ma RS, 2019, CANCER BIOL THER, V20, P1206, DOI 10.1080/15384047.2019.1599665; Makinoshima H, 2014, J BIOL CHEM, V289, P20813, DOI 10.1074/jbc.M114.575464; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; McCracken AN, 2013, TRENDS ENDOCRIN MET, V24, P200, DOI 10.1016/j.tem.2013.01.002; Miller S, 2010, AUTOPHAGY, V6, P805, DOI 10.1126/science.1184429; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Momcilovic M, 2017, CELL REP, V18, P601, DOI 10.1016/j.celrep.2016.12.061; Moruno Felix, 2012, Cells, V1, P372, DOI 10.3390/cells1030372; Murtuza A, 2019, CANCER RES, V79, P689, DOI 10.1158/0008-5472.CAN-18-1281; Musso G, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1328; Nagarajan A, 2016, TRENDS CANCER, V2, P365, DOI 10.1016/j.trecan.2016.06.002; Recondo G, 2018, NAT REV CLIN ONCOL, V15, P694, DOI 10.1038/s41571-018-0081-4; Ren JG, 2013, PROSTATE, V73, P1453, DOI 10.1002/pros.22692; Rieg T, 2018, DIABETOLOGIA, V61, P2079, DOI 10.1007/s00125-018-4654-7; Sasaki H, 2012, MOL MED REP, V5, P599, DOI 10.3892/mmr.2011.736; Scafoglio C, 2015, P NATL ACAD SCI USA, V112, pE4111, DOI 10.1073/pnas.1511698112; Skoulidis F, 2019, NAT REV CANCER, V19, P495, DOI 10.1038/s41568-019-0179-8; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Sunaga N, 2008, LUNG CANCER, V59, P203, DOI 10.1016/j.lungcan.2007.08.012; Suzuki Shuhei, 2018, Oncotarget, V9, P32667, DOI 10.18632/oncotarget.25994; Tu CY, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/168949; Wang CW, 2015, INT J BIOCHEM CELL B, V64, P239, DOI 10.1016/j.biocel.2015.04.006; Wang L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0242-x; Wang ZL, 2016, INT J ONCOL, V48, P2558, DOI 10.3892/ijo.2016.3468; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wu SG, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0777-1; Xu QL, 2017, ONCOTARGET, V8, P9557, DOI 10.18632/oncotarget.13771; Yamazaki Y, 2018, EUR J PHARMACOL, V822, P25, DOI 10.1016/j.ejphar.2018.01.003; Yang WW, 2012, CELL, V150, P685, DOI 10.1016/j.cell.2012.07.018; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zambrowicz B, 2012, CLIN PHARMACOL THER, V92, P158, DOI 10.1038/clpt.2012.58; Zander T, 2011, J CLIN ONCOL, V29, P1701, DOI 10.1200/JCO.2010.32.4939; Zhang H, 2017, ONCOL REP, V37, P1765, DOI 10.3892/or.2017.5367	78	4	4	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4796	4808		10.1038/s41388-021-01889-0	http://dx.doi.org/10.1038/s41388-021-01889-0		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34155348	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000664006700005
J	Atashi, H; Hostens, M				Atashi, Hadi; Hostens, Miel		GplusE Consortium	Genetic parameters for milk urea and its relationship with milk yield and compositions in Holstein dairy cows	PLOS ONE			English	Article							REPRODUCTIVE-PERFORMANCE; NUTRITIONAL FACTORS; NITROGEN-EXCRETION; TRAITS; FERTILITY; LACTOSE; CATTLE; ENERGY; HEALTH	The aim was to estimate genetic parameters for milk urea (MU) concentration and its relationship with milk yield and compositions in Holstein dairy Cows. Edited data were 90,594 test-day records of milk yield and composition collected during 2015 to 2018 on 13,737 lactations obtained from 7,850 Holstein cows in 50 herds. Random regression test-day model was used to estimate genetic parameters. (Co)variance components were estimated with the Bayesian Gibbs sampling method using a single chain of 400,000 iterates. The first 50,000 iterates of each chain were regarded as a burn-in period. Mean (SD) of MU was 23.03 (5.99) and 22.41 (5.74) mg/dl in primiparous and multiparous cows, respectively. Average heritability estimates for daily MU was 0.33 (SD = 0.02) ranged 0.29 to 0.36 and 0.32 (SD = 0.03) ranged 0.27 to 0.34, respectively, for primiparous and multiparous cows. The mean (SD) genetic correlation between MU and milk yield, fat yield, protein yield, lactose yield, fat percentage, protein percentage, lactose percentage, and somatic cell score was, respectively, -0.02 (0.03), -0.02 (0.01), 0.01 (0.04), 0.01 (0.03), 0.00 (0.07), -0.03 (0.04), 0.00 (0.01), -0.11 (0.06) in primiparous cows. The corresponding values in multiparous cows were -0.01 (0.02), -0.01 (0.03), -0.04 (0.04), -0.04 (0.04), 0.04 (0.04), 0.04 (0.07), -0.03 (0.09), 0.06 (0.11), respectively. The results indicate that selection on MU is possible with no effect on milk yield or compositions, however, relationships between MU and other important traits such as longevity, metabolic diseases, and fertility are needed.	[Atashi, Hadi] Shiraz Univ, Dept Anim Sci, Shiraz, Iran; [Hostens, Miel] Univ Utrecht, Dept Farm Anim Hlth, Utrecht, Netherlands	Shiraz University; Utrecht University	Atashi, H (corresponding author), Shiraz Univ, Dept Anim Sci, Shiraz, Iran.	Atashi@shirazu.ac.ir	Atashi, Hadi/P-6043-2017; Crowe, Mark/B-8496-2008; Dehareng, Frederic/P-4956-2017	Atashi, Hadi/0000-0002-6853-6608; Hostens, Miel/0000-0001-5376-976X; Crowe, Mark/0000-0003-1999-815X; Dehareng, Frederic/0000-0002-6733-4334; Signorelli, Federica/0000-0002-7794-5585; Marchitelli, Cinzia/0000-0001-5160-0717; HAMMAMI, HEDI/0000-0003-4751-6699; Crisa, Alessandra/0000-0003-4218-2407	European Union's Seventh Framework Program (Brussels, Belgium) for research, technological development, and demonstration [613689]	European Union's Seventh Framework Program (Brussels, Belgium) for research, technological development, and demonstration	This project received funding from the European Union's Seventh Framework Program (Brussels, Belgium) for research, technological development, and demonstration, under grant agreement no. 613689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission.	Aguilar I., 2018, P 11 WORLD C GEN APP; Arunvipas P, 2003, PREV VET MED, V59, P83, DOI 10.1016/S0167-5877(03)00061-8; Bastin C, 2009, J DAIRY SCI, V92, P3529, DOI 10.3168/jds.2008-1904; Beatson PR, 2019, ANIMAL, V13, P2164, DOI 10.1017/S1751731119000235; Broderick GA, 1997, J DAIRY SCI, V80, P2964, DOI 10.3168/jds.S0022-0302(97)76262-3; Burgos SA, 2007, J DAIRY SCI, V90, P5499, DOI 10.3168/jds.2007-0299; Cao ZJ, 2010, J ANIM VET ADV, V9, P688, DOI 10.3923/javaa.2010.688.695; Collard BL, 2000, J DAIRY SCI, V83, P2683, DOI 10.3168/jds.S0022-0302(00)75162-9; De Roos A., 2006, 8 WORLD C GENETICS A; Diab IAK, 1996, J DAIRY SCI, V79, P682, DOI 10.3168/jds.S0022-0302(96)76414-7; Eicher R, 1999, PREV VET MED, V39, P53, DOI 10.1016/S0167-5877(98)00139-1; Glatz-Hoppe J, 2020, J DAIRY SCI, V103, P10175, DOI 10.3168/jds.2019-17981; Godden SM, 2001, J DAIRY SCI, V84, P107, DOI 10.3168/jds.S0022-0302(01)74458-X; Guo K, 2004, J DAIRY SCI, V87, P1878, DOI 10.3168/jds.S0022-0302(04)73346-9; Hof G, 1997, J DAIRY SCI, V80, P3333, DOI 10.3168/jds.S0022-0302(97)76309-4; Jamrozik J, 1997, J DAIRY SCI, V80, P762, DOI 10.3168/jds.S0022-0302(97)75996-4; Jonker JS, 1998, J DAIRY SCI, V81, P2681, DOI 10.3168/jds.S0022-0302(98)75825-4; Kauffman AJ, 2001, J DAIRY SCI, V84, P2284, DOI 10.3168/jds.S0022-0302(01)74675-9; Konig S, 2008, J DAIRY SCI, V91, P4372, DOI 10.3168/jds.2008-1236; Lopez-Villalobos N., 2018, New Zealand Journal of Animal Science and Production, V78, P56; Miglior F, 2007, J DAIRY SCI, V90, P2468, DOI 10.3168/jds.2006-487; Miglior F, 2006, J DAIRY SCI, V89, P4886, DOI 10.3168/jds.S0022-0302(06)72537-1; Mitchell RG, 2005, J DAIRY SCI, V88, P4434, DOI 10.3168/jds.S0022-0302(05)73130-1; Mucha S, 2011, J DAIRY SCI, V94, P5665, DOI 10.3168/jds.2010-3916; Nousiainen J, 2004, J DAIRY SCI, V87, P386, DOI 10.3168/jds.S0022-0302(04)73178-1; O'Callaghan TF, 2018, METABOLITES, V8, DOI 10.3390/metabo8020027; Rzewuska K, 2013, J APPL GENET, V54, P473, DOI 10.1007/s13353-013-0159-8; Saggar S., 2005, NZ SCI REV, V62, P62; Samore AB, 2007, ITAL J ANIM SCI, V6, P201, DOI 10.4081/ijas.2007.1s.201; Spek JW, 2013, J AGR SCI-CAMBRIDGE, V151, P407, DOI 10.1017/S0021859612000561; Stoop WM, 2007, J DAIRY SCI, V90, P1981, DOI 10.3168/jds.2006-434; Trevaskis LM, 1999, LIVEST PROD SCI, V57, P255, DOI 10.1016/S0301-6226(98)00174-2; Wood GM, 2003, J DAIRY SCI, V86, P2462, DOI 10.3168/jds.S0022-0302(03)73840-5	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253191	10.1371/journal.pone.0253191	http://dx.doi.org/10.1371/journal.pone.0253191			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143805	Green Published, gold			2022-12-26	WOS:000671690700004
J	Kuhlen, L; Johnson, S; Cao, J; Deme, JC; Lea, SM				Kuhlen, Lucas; Johnson, Steven; Cao, Jerry; Deme, Justin C.; Lea, Susan M.			Nonameric structures of the cytoplasmic domain of FlhA and SctV in the context of the full-length protein	PLOS ONE			English	Article							EXPORT APPARATUS; CRYO-EM; COMPONENTS; ARCHITECTURE; MECHANISM; FEATURES; COLI	Type three secretion is the mechanism of protein secretion found in bacterial flagella and injectisomes. At its centre is the export apparatus (EA), a complex of five membrane proteins through which secretion substrates pass the inner membrane. While the complex formed by four of the EA proteins has been well characterised structurally, little is known about the structure of the membrane domain of the largest subunit, FlhA in flagella, SctV in injectisomes. Furthermore, the biologically relevant nonameric assembly of FlhA/SctV has been infrequently observed and differences in conformation of the cytoplasmic portion of FlhA/SctV between open and closed states have been suggested to reflect secretion system specific differences. FlhA has been shown to bind to chaperone-substrate complexes in an open state, but in previous assembled ring structures, SctV is in a closed state. Here, we identify FlhA and SctV homologues that can be recombinantly produced in the oligomeric state and study them using cryo-electron microscopy. The structures of the cytoplasmic domains from both FlhA and SctV are in the open state and we observe a conserved interaction between a short stretch of residues at the N-terminus of the cytoplasmic domain, known as FlhA(L)/SctV(L), with a groove on the adjacent protomer's cytoplasmic domain, which stabilises the nonameric ring assembly.	[Kuhlen, Lucas; Johnson, Steven; Cao, Jerry; Deme, Justin C.; Lea, Susan M.] Sir William Dunn Sch Pathol, Oxford, England; [Johnson, Steven; Deme, Justin C.; Lea, Susan M.] NIH, Ctr Canc Res Natl, Ctr Struct Biol, Frederick, MD 21702 USA; [Deme, Justin C.; Lea, Susan M.] Cent Oxford Struct Mol Imaging Ctr, Oxford, England; [Kuhlen, Lucas] Imperial Coll, South Kensington Campus, London, England	University of Oxford; National Institutes of Health (NIH) - USA; Imperial College London	Lea, SM (corresponding author), Sir William Dunn Sch Pathol, Oxford, England.; Lea, SM (corresponding author), NIH, Ctr Canc Res Natl, Ctr Struct Biol, Frederick, MD 21702 USA.; Lea, SM (corresponding author), Cent Oxford Struct Mol Imaging Ctr, Oxford, England.	susan.lea@nih.gov		Deme, Justin/0000-0001-8811-9871	Wellcome Trust [109136, 100298, 219477]; Medical Research Council (UK) [S021264]; Wolfson Foundation [WL160052]	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wolfson Foundation	The work was funded by grants from the Wellcome Trust 109136, 100298, 219477, the Medical Research Council (UK) S021264 and the Wolfson Foundation WL160052. Work at the CSB was funded by core funding from the CCR.	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2016, MOL MICROBIOL, V100, P278, DOI 10.1111/mmi.13315; Butan C, 2019, P NATL ACAD SCI USA, V116, P24786, DOI 10.1073/pnas.1916331116; D'Imprima E, 2019, ELIFE, V8, DOI 10.7554/eLife.42747; Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20; Diepold A, 2011, MOL MICROBIOL, V82, P502, DOI 10.1111/j.1365-2958.2011.07830.x; Dietsche T, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006071; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erhardt M, 2017, MOL MICROBIOL, V104, P234, DOI 10.1111/mmi.13623; Erhardt M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000299; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Fukumura T, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002281; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022; Hu JH, 2019, NAT MICROBIOL, V4, P2010, DOI 10.1038/s41564-019-0545-z; Inoue Y, 2019, STRUCTURE, V27, P965, DOI 10.1016/j.str.2019.03.017; Jensen JL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008923; Kuhlen L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15071-9; Kuhlen L, 2018, NAT STRUCT MOL BIOL, V25, P583, DOI 10.1038/s41594-018-0086-9; Li H, 2011, MOL MICROBIOL, V80, P886, DOI 10.1111/j.1365-2958.2011.07557.x; Lilic M, 2010, ACTA CRYSTALLOGR D, V66, P709, DOI 10.1107/S0907444910010796; Majewski DD, 2020, J STRUCT BIOL, V212, DOI 10.1016/j.jsb.2020.107660; McMurry JL, 2004, J BACTERIOL, V186, P7586, DOI 10.1128/JB.186.22.7586-7592.2004; Minamino Tohru, 2016, PLoS Pathog, V12, pe1005495, DOI 10.1371/journal.ppat.1005495; Morimoto YV, 2014, MOL MICROBIOL, V91, P1214, DOI 10.1111/mmi.12529; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Reboul CF, 2018, PROTEIN SCI, V27, P51, DOI 10.1002/pro.3266; Saijo-Hamano Y, 2010, MOL MICROBIOL, V76, P260, DOI 10.1111/j.1365-2958.2010.07097.x; Terahara N, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao7054; Torres-Vargas CE, 2019, MOL MICROBIOL, V112, P918, DOI 10.1111/mmi.14327; Wagner S, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny201; Wagner S, 2010, P NATL ACAD SCI USA, V107, P17745, DOI 10.1073/pnas.1008053107; Ward E, 2018, MOL MICROBIOL, V107, P94, DOI 10.1111/mmi.13870; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Xing Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04137-4; Zivanov J, 2019, IUCRJ, V6, P5, DOI 10.1107/S205225251801463X; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	39	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252800	10.1371/journal.pone.0252800	http://dx.doi.org/10.1371/journal.pone.0252800			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143799	gold, Green Submitted, Green Published			2022-12-26	WOS:000671690700051
J	Mebane, CA; Ray, AM; Marcarelli, AM				Mebane, Christopher A.; Ray, Andrew M.; Marcarelli, Amy M.			Nutrient limitation of algae and macrophytes in streams: Integrating laboratory bioassays, field experiments, and field data	PLOS ONE			English	Article							MODEL-BASED NITROGEN; AQUATIC MACROPHYTES; PERIPHYTON BIOMASS; LIMITED GROWTH; FRESH-WATER; PHOSPHORUS; RIVER; EUTROPHICATION; ENRICHMENT; IDAHO	Successful eutrophication control strategies need to address the limiting nutrient. We conducted a battery of laboratory and in situ nutrient-limitation tests with waters collected from 9 streams in an agricultural region of the upper Snake River basin, Idaho, USA. Laboratory tests used the green alga Raphidocelis subcapitata, the macrophyte Lemna minor (duckweed) with native epiphytes, and in situ nutrient-limitation tests of periphyton were conducted with nutrient-diffusing substrates (NDS). In the duckweed/epiphyte test, P saturation occurred when concentrations reached about 100 mu g/L. Chlorophyll a in epiphytic periphyton was stimulated at low P additions and by about 100 mu g/L P, epiphytic periphyton chlorophyll a appeared to be P saturated. Both duckweed and epiphyte response patterns with total N were weaker but suggested a growth stimulation threshold for duckweed when total N concentrations exceeded about 300 mu g/L and approached saturation at the highest N concentration tested, 1300 mu g/L. Nutrient uptake by epiphytes and macrophytes removed up to 70 and 90% of the N and P, respectively. The green algae and the NDS nutrient-limitation test results were mostly congruent; N and P co-limitation was the most frequent result for both test series. Across all tests, when N:P molar ratios >30 (mass ratios >14), algae or macrophyte growth was P limited; N limitation was observed at N:P molar ratios up to 23 (mass ratios up to 10). A comparison of ambient periphyton chlorophyll a concentrations with chlorophyll a accrued on control artificial substrates in N-limited streams, suggests that total N concentrations associated with a periphyton chlorophyll a benchmark for desirable or undesirable conditions for recreation would be about 600 to 1000 mu g/L total N, respectively. For P-limited streams, the corresponding benchmark concentrations were about 50 to 90 mu g/L total P, respectively. Our approach of integrating controlled experiments and matched biomonitoring field surveys was cost effective and more informative than either approach alone.	[Mebane, Christopher A.] US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA; [Ray, Andrew M.] Greater Yellowstone Network, Natl Pk Serv, Bozeman, MT USA; [Marcarelli, Amy M.] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; Michigan Technological University	Mebane, CA (corresponding author), US Geol Survey, Idaho Water Sci Ctr, Boise, ID 83702 USA.	cmebane@usgs.gov	; Mebane, Christopher/C-7188-2009	Marcarelli, Amy/0000-0002-4175-9211; Mebane, Christopher/0000-0002-9089-0267	U.S. Environmental Protection Agency's Nutrient Criteria Program [DW-14922442-01-0]; U.S. Geological Survey's National Water Quality Assessment (NAWQA) program	U.S. Environmental Protection Agency's Nutrient Criteria Program; U.S. Geological Survey's National Water Quality Assessment (NAWQA) program	Funding for the experimental components of this project was provided by the U.S. Environmental Protection Agency's Nutrient Criteria Program, through interagency agreement DW-14922442-01-0. Funding for the field data collection components of this project was provided by the U.S. Geological Survey's National Water Quality Assessment (NAWQA) program. No specific funding was received to write the article. The funders approved the general study design and encouraged publication of results but had no role in data collection and analysis, specific decisions to publish, or preparation of the manuscript. The manuscript was reviewed and approved for publication per U.S. Geological Survey Fundamental Science Practices.	Baattrup-Pedersen A, 2015, J APPL ECOL, V52, P1617, DOI 10.1111/1365-2664.12509; Beardall J, 2001, AQUAT SCI, V63, P44, DOI 10.1007/PL00001344; Beck WS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205684; Borchardt Mark A., 1996, P183, DOI 10.1016/B978-012668450-6/50036-9; BOTHWELL ML, 1989, CAN J FISH AQUAT SCI, V46, P1293, DOI 10.1139/f89-166; Brightbill RA, 2010, DATA SERIES, V517; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Capps KA, 2011, J N AM BENTHOL SOC, V30, P522, DOI 10.1899/10-146.1; CARIGNAN R, 1980, SCIENCE, V207, P987, DOI 10.1126/science.207.4434.987; CATTANEO A, 1980, LIMNOL OCEANOGR, V25, P280, DOI 10.4319/lo.1980.25.2.0280; CATTANEO A, 1992, J N AM BENTHOL SOC, V11, P244, DOI 10.2307/1467389; CHAMBERS PA, 1989, CAN J FISH AQUAT SCI, V46, P435, DOI 10.1139/f89-058; Chambers PA, 2012, J ENVIRON QUAL, V41, P7, DOI 10.2134/jeq2010.0273; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; DENNY P, 1980, BIOL REV, V55, P65, DOI 10.1111/j.1469-185X.1980.tb00688.x; Dodds WK, 2006, CAN J FISH AQUAT SCI, V63, P1190, DOI 10.1139/F06-040; Dodds WK, 2002, CAN J FISH AQUAT SCI, V59, P865, DOI 10.1139/F02-063; Earl SR, 2006, ECOLOGY, V87, P3140, DOI 10.1890/0012-9658(2006)87[3140:NSISE]2.0.CO;2; Elsaholi M, 2013, INLAND WATERS, V3, P451, DOI 10.5268/IW-3.4.595; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Flynn KF, 2015, J AM WATER RESOUR AS, V51, P421, DOI 10.1111/jawr.12253; Francoeur SN, 1999, J N AM BENTHOL SOC, V18, P242, DOI 10.2307/1468463; Francoeur SN, 2001, J N AM BENTHOL SOC, V20, P358, DOI 10.2307/1468034; GOTHAM IJ, 1981, J PHYCOL, V17, P257, DOI 10.1111/j.1529-8817.1981.tb00848.x; GREENE JC, 1975, WATER AIR SOIL POLL, V4, P415, DOI 10.1007/BF00280726; Hall RO, 2003, LIMNOL OCEANOGR, V48, P1120, DOI 10.4319/lo.2003.48.3.1120; Hilton J, 2006, SCI TOTAL ENVIRON, V365, P66, DOI 10.1016/j.scitotenv.2006.02.055; Jarvie HP, 2013, J ENVIRON QUAL, V42, P295, DOI 10.2134/jeq2012.0085; King SA, 2014, FRESHW SCI, V33, P85, DOI 10.1086/674383; Koetsier P, 2005, NORTHWEST SCI, V79, P211; Krienitz L, 2011, J PHYCOL, V47, P880, DOI 10.1111/j.1529-8817.2011.01010.x; Lazar AN, 2016, ENVIRON MODEL ASSESS, V21, P125, DOI 10.1007/s10666-015-9473-3; Lee KE., 2012, US GEOLOGICAL SURVEY, V5086, DOI [10.3133/sir20125086, DOI 10.3133/SIR20125086]; LOHMAN K, 1992, CAN J FISH AQUAT SCI, V49, P1198, DOI 10.1139/f92-135; LOHMAN K, 1992, J PHYCOL, V28, P443, DOI 10.1111/j.0022-3646.1992.00443.x; Marcarelli AM, 2007, FRESHWATER BIOL, V52, P2211, DOI 10.1111/j.1365-2427.2007.01851.x; Marcarelli AM, 2006, LIMNOL OCEANOGR, V51, P2278, DOI 10.4319/lo.2006.51.5.2278; Marcarelli AM, 2009, HYDROBIOLOGIA, V620, P63, DOI 10.1007/s10750-008-9615-6; Maret TR, 2010, J AM WATER RESOUR AS, V46, P498, DOI 10.1111/j.1752-1688.2010.00430.x; McGrath CL., 2002, CARTOGRAPHERS ECOREG; Mebane CA., 2020, US GEOLOGICAL SURVEY, DOI [10.5066/F72R3PSJ, DOI 10.5066/F72R3PSJ]; Mebane CA, 2014, HYDROBIOLOGIA, V722, P143, DOI 10.1007/s10750-013-1693-4; MILLER WE, 1974, WATER RES, V8, P667, DOI 10.1016/0043-1354(74)90126-2; Munn M, 2010, ENVIRON MANAGE, V45, P603, DOI 10.1007/s00267-010-9435-0; Munn MD., 2018, US GEOLOGICAL SURVEY, P1437; Paerl HW, 2016, ENVIRON SCI TECHNOL, V50, P10805, DOI 10.1021/acs.est.6b02575; Patton C.J., 2003, METHODS ANAL US GEOL; Pelton DK, 1998, FRESHWATER BIOL, V39, P285, DOI 10.1046/j.1365-2427.1998.00281.x; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; RATTRAY MR, 1991, AQUAT BOT, V40, P225, DOI 10.1016/0304-3770(91)90060-I; Ray AM, 2014, ENVIRON MONIT ASSESS, V186, P4081, DOI 10.1007/s10661-014-3682-0; Reisinger AJ, 2016, FRESHW SCI, V35, P474, DOI 10.1086/685829; REUTER JE, 1992, FRESHWATER BIOL, V27, P227, DOI 10.1111/j.1365-2427.1992.tb00535.x; Rier ST, 2006, HYDROBIOLOGIA, V561, P131, DOI 10.1007/s10750-005-1610-6; Roberts BJ, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000422; Rugenski AT, 2008, J N AM BENTHOL SOC, V27, P52, DOI 10.1899/07-046R1.1; Sanderson BL, 2009, J N AM BENTHOL SOC, V28, P832, DOI 10.1899/09-072.1; Scharf FS, 1998, ECOLOGY, V79, P448, DOI 10.1890/0012-9658(1998)079[0448:IERFTE]2.0.CO;2; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Schmidt Travis S, 2019, J Am Water Resour Assoc, V55, P1479, DOI 10.1111/1752-1688.12797; Skawinski, 2019, AQUATIC PLANTS UPPER; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Snyder EB, 2002, CAN J FISH AQUAT SCI, V59, P564, DOI 10.1139/F02-021; Solovchenko AE, 2019, J APPL PHYCOL, V31, P2755, DOI 10.1007/s10811-019-01831-8; Suplee MW, 2015, J AM WATER RESOUR AS, V51, P447, DOI 10.1111/jawr.12252; Suplee MW, 2009, J AM WATER RESOUR AS, V45, P123, DOI 10.1111/j.1752-1688.2008.00265.x; Tank JL, 2017, METHODS IN STREAM ECOLOGY, VOL 2: ECOSYSTEM FUNCTION, 3RD EDITION, P147, DOI 10.1016/B978-0-12-813047-6.00009-7; Tank JL, 2003, FRESHWATER BIOL, V48, P1031, DOI 10.1046/j.1365-2427.2003.01067.x; USEPA, 2015, 820S150001 EPA US EN; USEPA, 2000, 822B00002 EPA USEPA; VANWIJK RJ, 1989, AQUAT BOT, V35, P319, DOI 10.1016/0304-3770(89)90005-3; Wurtsbaugh WA, 2019, WIRES WATER, V6, DOI 10.1002/wat2.1373; Yuan LL, 2010, 820S10001 EPA US ENV	73	3	3	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0252904	10.1371/journal.pone.0252904	http://dx.doi.org/10.1371/journal.pone.0252904			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143815	Green Published, gold			2022-12-26	WOS:000671690700060
J	Oeschger, TM; Erickson, DC				Oeschger, Taylor Mae; Erickson, David Carl			Visible colorimetric growth indicators of Neisseria gonorrhoeae for low-cost diagnostic applications	PLOS ONE			English	Article							POINT-OF-CARE; CELL-GROWTH; IN-VITRO; SUSCEPTIBILITY; ASSAY; RESAZURIN; REDUCTION; TIME; ANTIBIOTICS; RESISTANCE	N. gonorrhoeae is one of the most pressing antibiotic resistant threats of our time and low-cost diagnostics that can easily identify antibiotic resistance are desperately needed. However, N. gonorrhoeae responds so uniquely to growth conditions that it cannot be assumed gonorrhea will respond to common microbiological methods used for other pathogenic organisms. In this paper, we explore visual colorimetric indicators of N. gonorrhoeae growth that can be seen without a microscope or spectrophotometer. We evaluate growth media, pH indicators, resazurin-based dyes, and tetrazolium-based dyes for their use in simple colorimetric system. Overall, we identified Graver Wade media as the best at supporting robust gonococcal growth while also providing the least background when analyzing results of colorimetric tests. XTT, a tetrazolium-based dye, proved to show to brightest color change over time and not negatively impact the natural growth of N. gonorrhoeae. However, other dyes including PrestoBlue, MTT, and NBT are less expensive than XTT and work well when added after bacterial growth has already occurred. By identifying the specific use cases of these dyes, this research lays the groundwork for future development of a color-based antibiotic susceptibility low-cost test for N. gonorrhoeae.	[Oeschger, Taylor Mae] Cornell Univ, Meinig Sch Biomed Engn, Ithaca, NY USA; [Erickson, David Carl] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Erickson, David Carl] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Erickson, DC (corresponding author), Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.; Erickson, DC (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	des54@cornell.edu		Oeschger, Taylor/0000-0001-8544-9656	National Institutes of Health Award [1R01EB021331]; National Science Foundation [NNCI-1542081]	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This research was supported by funding from National Institutes of Health Award 1R01EB021331. Additionally, this material is based upon work supported by the National Science Foundation under Grant No. NNCI-1542081. Any opinions, findings, conclusions, or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or National Institutes of Health.	Aitken RJ, 2020, REPRODUCTION, V160, P431, DOI 10.1530/REP-20-0205; ALLEY MC, 1988, CANCER RES, V48, P589; American Type Culture Collection, 2006, 49226 ATCC 49226 ATCC; [Anonymous], 2020, US CTR DIS CONTROL; Baarda BI., 2019, NEISSERIA GONORRHOEA, P150, DOI [10.1007/978-1-4939-9496-0%5F13, DOI 10.1007/978-1-4939-9496-0%5F13]; Bell SFE, 2020, SEX HEALTH, V17, P359, DOI 10.1071/SH19233; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Blank S, 2018, NEW ENGL J MED, V379, P1795, DOI 10.1056/NEJMp1812269; Chu YI, 2000, CORNEA, V19, P517, DOI 10.1097/00003226-200007000-00023; Clinical And Laboratory Standars Institute, 2018, J SERV MARK, V8, DOI [10.1108/08876049410065598, DOI 10.1108/08876049410065598]; De Logu A, 2003, INT J ANTIMICROB AG, V21, P244, DOI 10.1016/S0924-8579(02)00350-3; Elavarasan T, 2013, SENSOR ACTUAT B-CHEM, V176, P174, DOI 10.1016/j.snb.2012.10.011; Elbanna K, 2012, PLANT SOIL ENVIRON, V58, P49, DOI 10.17221/412/2011-PSE; Ferreyra C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237424; Fingerhuth SM, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0881-x; Fingerhuth SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005611; Foerster S, 2017, J ANTIMICROB CHEMOTH, V72, P1961, DOI 10.1093/jac/dkx113; Garrett NJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196209; Gaydos CA, 2020, EXPERT REV MOL DIAGN, V20, P803, DOI 10.1080/14737159.2020.1778467; Gilbert D.F, 2017, CELL VIABILITY ASSAY; GRAHAM RE, 1976, J PHARM SCI, V65, P1048, DOI 10.1002/jps.2600650723; Grare M, 2008, J MICROBIOL METH, V75, P156, DOI 10.1016/j.mimet.2008.05.010; Grela E, 2018, ACTA HISTOCHEM, V120, P303, DOI 10.1016/j.acthis.2018.03.007; Guerin TF, 2001, LETT APPL MICROBIOL, V32, P340, DOI 10.1046/j.1472-765X.2001.00916.x; Invitrogen. PrestoBlue, 2019, CELL VIAB REAG PROD CELL VIAB REAG PROD, P0; Ison CA, 2013, SEX TRANSM INFECT, V89, P197, DOI 10.1136/sextrans-2012-050829; Kuswandi B, 2017, FOOD CONTROL, V82, P91, DOI 10.1016/j.foodcont.2017.06.028; Matsuura K, 2019, MICROMACHINES-BASEL, V10, DOI 10.3390/mi10080495; Ng Lai-King, 2005, Can J Infect Dis Med Microbiol, V16, P15; NIAID, 2019, NIAID NOW; PAULL KD, 1988, J HETEROCYCLIC CHEM, V25, P911, DOI 10.1002/jhet.5570250340; PromoKine, 2015, FLUOR CELL VIAB KIT FLUOR CELL VIAB KIT, P2; Sadiq ST, 2010, SEX TRANSM INFECT, V86, P445, DOI 10.1136/sti.2010.044230; Sadiq ST, 2017, SEX TRANSM INFECT, V93, pS65, DOI 10.1136/sextrans-2016-053072; Schmitt DM, 2016, INT J ANTIMICROB AG, V48, P367, DOI 10.1016/j.ijantimicag.2016.06.009; Schmitt DM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00093; SCUDIERO DA, 1988, CANCER RES, V48, P4827; Sng E H, 1981, Br J Vener Dis, V57, P141; Spence J. M., 2008, CURR PROTOC MICROBIO, DOI [10.1002/9780471729259.mc04a01s8, DOI 10.1002/9780471729259.MC04A01S8]; Tachon S, 2009, MICROBIOL-SGM, V155, P2941, DOI 10.1099/mic.0.029678-0; Takei M, 2005, J CLIN MICROBIOL, V43, P4321, DOI 10.1128/JCM.43.9.4321-4327.2005; Thakur SD, 2018, J ANTIMICROB CHEMOTH, V73, P118, DOI [10.1093/jac/dkx333, 10.1093/jac/dkx512]; Tsao YT, 2021, BIOENG TRANSL MED, V6, DOI 10.1002/btm2.10176; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Tuite AR, 2017, J INFECT DIS, V216, P1141, DOI [10.1093/inFdis/jix450, 10.1093/infdis/jix450]; Tunney MM, 2004, ANTIMICROB AGENTS CH, V48, P1879, DOI 10.1128/AAC.48.5.1879-1881.2004; Turner KME, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015447; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Ullrich S, 1996, APPL ENVIRON MICROB, V62, P4587, DOI 10.1128/AEM.62.12.4587-4593.1996; Unemo M, 2016, J ANTIMICROB CHEMOTH, V71, P3096, DOI 10.1093/jac/dkw288; United States Centers for Disease Control, 2013, ANT RES THREATS US, V114; Wade JJ, 2007, FEMS MICROBIOL LETT, V273, P35, DOI 10.1111/j.1574-6968.2007.00776.x; Wang RS, 2021, ACS OMEGA, V6, P1410, DOI 10.1021/acsomega.0c05060; Wang RS, 2020, ANAL CHEM, V92, P2731, DOI 10.1021/acs.analchem.9b04991; Weseler A, 2005, PHARMAZIE, V60, P498; World Health Organization, 2009, GLOB HLTH RISKS; World Health Organization, 2017, GON ANT SUSC GON ANT SUSC; Zienkiewicz AK, 2019, SEX HEALTH, V16, P514, DOI 10.1071/SH18235	58	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252961	10.1371/journal.pone.0252961	http://dx.doi.org/10.1371/journal.pone.0252961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138928	Green Published, gold			2022-12-26	WOS:000671690200101
J	Wright, GM; Gimbrone, NT; Sarcar, B; Percy, TR; Gordian, ER; Kinose, F; Sumi, NJ; Rix, U; Cress, WD				Wright, Gabriela M.; Gimbrone, Nick T.; Sarcar, Bhaswati; Percy, Trent R.; Gordian, Edna R.; Kinose, Fumi; Sumi, Natalia J.; Rix, Uwe; Cress, W. Douglas			CDK4/6 inhibition synergizes with inhibition of P21-Activated Kinases (PAKs) in lung cancer cell lines	PLOS ONE			English	Article							PROTECTS CELLS; BREAST-CANCER; PHOSPHORYLATION; ACTIVATION; GROWTH; TUMORIGENESIS; ABEMACICLIB; THERAPY; RAS; BAD	Theoretically, small molecule CDK4/6 inhibitors (CDK4/6is) represent a logical therapeutic option in non-small cell lung cancers since most of these malignancies have wildtype RB, the key target of CDKs and master regulator of the cell cycle. Unfortunately, CDK4/6is are found to have limited clinical activity as single agents in non-small cell lung cancer. To address this problem and to identify effective CDK4/6i combinations, we screened a library of targeted agents for efficacy in four non-small cell lung cancer lines treated with CDK4/6 inhibitors Palbociclib or Abemaciclib. The pan-PAK (p21-activated kinase) inhibitor PF03758309 emerged as a promising candidate with viability ratios indicating synergy in all 4 cell lines and for both CDK4/6is. It is noteworthy that the PAKs are downstream effectors of small GTPases Rac1 and Cdc42 and are overexpressed in a wide variety of cancers. Individually the compounds primarily induced cell cycle arrest; however, the synergistic combination induced apoptosis, accounting for the synergy. Surprisingly, while the pan-PAK inhibitor PF03758309 synergizes with CDK4/6is, no synergy occurs with group I PAK inhibitors FRAX486 or FRAX597. Cell lines treated only with Ribociclib, FRAX486 or FRAX597 underwent G1/G0 arrest, whereas combination treatment with these compounds predominantly resulted in autophagy. Combining high concentrations of FRAX486, which weakly inhibits PAK4, and Ribociclib, mimics the autophagy and apoptotic effect of PF03758309 combined with Ribociclib. FRAX597, a PAKi that does not inhibit PAK4 did not reduce autophagy in combination with Ribociclib. Our results suggest that a unique combination of PAKs plays a crucial role in the synergy of PAK inhibitors with CDK4/6i. Targeting this unique PAK combination, could greatly improve the efficacy of CDK4/6i and broaden the spectrum of cancer treatment.	[Wright, Gabriela M.; Gimbrone, Nick T.; Sarcar, Bhaswati; Percy, Trent R.; Gordian, Edna R.; Cress, W. Douglas] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Kinose, Fumi] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Sumi, Natalia J.; Rix, Uwe] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL USA; [Sumi, Natalia J.] Univ S Florida, Canc Biol PhD Program, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Cress, WD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	Douglas.Cress@moffitt.org		Cress, William/0000-0002-9119-3658	National Cancer Institute [U54 CA163068, CA163071, P30-CA76292, R01 CA181746]; Moffitt Foundation [09-33661-15-06]; Esther King Biomedical Research Program Grant (Florida Department of Health)	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Foundation; Esther King Biomedical Research Program Grant (Florida Department of Health)	This work was funded in part by multiple agencies that had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. WDC: National Cancer Institute (U54 CA163068/CA163071 and P30-CA76292) https://www.cancer.gov/Miles for Moffitt Foundation (09-33661-15-06) https://moffitt.org/give/get-involved/miles-for-moffitt/James and Esther King Biomedical Research Program Grant (Florida Department of Health) http://www.floridahealth.gov/UR: National Cancer Institute (R01 CA181746) https://www.cancer.gov/	[Anonymous], 2018, GENECARD PAK6; [Anonymous], 2014, SMALL GTPASES; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Chen SH, 2018, ONCOGENE, V37, P821, DOI 10.1038/onc.2017.384; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dolan BM, 2013, P NATL ACAD SCI USA, V110, P5671, DOI [10.1073/pnas.1219383110, 10.1073/pnas.1219353110]; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Gnesutta N, 2003, MOL CELL BIOL, V23, P7838, DOI 10.1128/MCB.23.21.7838-7848.2003; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Gopalan Priya K, 2018, Oncotarget, V9, P37352, DOI 10.18632/oncotarget.26424; Hart LS, 2017, CLIN CANCER RES, V23, P1785, DOI 10.1158/1078-0432.CCR-16-1131; Hayashi-Takagi A, 2014, P NATL ACAD SCI USA, V111, P6461, DOI 10.1073/pnas.1321109111; He LF, 2017, ONCOTARGET, V8, P17573, DOI 10.18632/oncotarget.7466; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Huang J, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118645; Ito M, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0446-z; Jin SH, 2005, J BIOL CHEM, V280, P24698, DOI 10.1074/jbc.M413374200; Johnson J, 2016, ONCOGENE, V35, P4829, DOI 10.1038/onc.2016.32; Kim Sunkyu, 2018, Oncotarget, V9, P35226, DOI 10.18632/oncotarget.26215; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Kumar R, 2017, GENE, V605, P20, DOI 10.1016/j.gene.2016.12.014; Kurtyka CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096357; Licciulli S, 2013, J BIOL CHEM, V288, P29105, DOI 10.1074/jbc.M113.510933; Liu CY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189007; Liu MH, 2018, ONCOL REP, V39, P901, DOI 10.3892/or.2018.6221; Liu MH, 2016, ONCOTARGET, V7, P84951, DOI 10.18632/oncotarget.13069; Ma YH, 2008, CANCER RES, V68, P6292, DOI 10.1158/0008-5472.CAN-08-0121; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marlin JW, 2009, NEOPLASIA, V11, P286, DOI 10.1593/neo.81446; Meng P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.326; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Petrelli A, 2008, CURR MED CHEM, V15, P422; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Rane CK, 2019, SEMIN CANCER BIOL, V54, P40, DOI 10.1016/j.semcancer.2018.01.006; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Scheinberg T, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033667; Schurmann A, 2000, MOL CELL BIOL, V20, P453, DOI 10.1128/MCB.20.2.453-461.2000; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Sosa-Garcia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142406; Spring LM, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0769-3; Stice JP, 2017, MOL CANCER RES, V15, P660, DOI 10.1158/1541-7786.MCR-17-0028; Tate SC, 2016, BRIT J CANCER, V114, P669, DOI 10.1038/bjc.2016.40; Wood AC, 2017, CLIN CANCER RES, V23, P2856, DOI 10.1158/1078-0432.CCR-16-1114; Ye DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027637	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252927	10.1371/journal.pone.0252927	http://dx.doi.org/10.1371/journal.pone.0252927			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138895	gold, Green Published			2022-12-26	WOS:000671690200010
J	Zhou, JBA; Dong, S; Ma, CX; Wu, Y; Qiu, X				Zhou, Jibiao; Dong, Sheng; Ma, Changxi; Wu, Yao; Qiu, Xiao			Epidemic spread simulation in an area with a high-density crowd using a SEIR-based model	PLOS ONE			English	Article							MATHEMATICAL-THEORY; ROYAL SOCIETY; TRANSMISSION; BEHAVIOR; WUHAN; CHINA; CARE	Understanding the spread of infectious diseases is an extremely essential step to preventing them. Thus, correct modeling and simulation approaches are critical for elucidating the transmission of infectious diseases and improving the control of epidemics. The primary objective of this study is to simulate the spread of communicable diseases in an urban rail transit station. Data were collected by a field investigation in the city of Ningbo, China. A SEIR-based model was developed to simulate the spread of infectious diseases in Tianyi station, considering four groups of passengers (susceptible, exposed, infected, and recovered) and a 14-day incubation period. Based on the historical data of infectious diseases, the parameters of the SEIR infectious disease model were clarified, and a sensitivity analysis of the parameters was also performed. The results showed that the contact rate (CR), infectivity (I), and average illness duration (AID) were positively correlated with the number of infections. It was also found that the length of the average incubation time (AIT) was positively correlated with the number of exposed individuals and negatively correlated with the number of infectors. These simulation results provide support for the validity and reliability of using the SEIR model in studies of the spread of epidemics and facilitate the development of effective measures to prevent and control an epidemic.	[Zhou, Jibiao; Dong, Sheng] Ningbo Univ Technol, Sch Civil & Transportat Engn, Ningbo, Peoples R China; [Zhou, Jibiao] Tongji Univ, Minist Educ, Dept Traff Engn, Shanghai, Peoples R China; [Zhou, Jibiao] Tongji Univ, Minist Educ, Key Lab Rd & Traff Engn, Shanghai, Peoples R China; [Ma, Changxi] Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Peoples R China; [Wu, Yao] Nanjing Univ Posts & Telecommun, Sch Modern Posts, Nanjing, Peoples R China; [Wu, Yao] Nanjing Univ Posts & Telecommun, Inst Modern Posts, Nanjing, Peoples R China; [Qiu, Xiao] Hohai Univ, Sch Civil Engn & Transportat, Nanjing, Peoples R China	Ningbo University of Technology; Tongji University; Tongji University; Lanzhou Jiaotong University; Nanjing University of Posts & Telecommunications; Nanjing University of Posts & Telecommunications; Hohai University	Ma, CX (corresponding author), Lanzhou Jiaotong Univ, Sch Traff & Transportat, Lanzhou, Peoples R China.	machangxi@mail.lzjtu.cn		Zhou, Ji-biao/0000-0001-5396-6587	Philosophy and Social Science Program of Ningbo [G20ZX37]; National Natural Science Foundation of China [52002282]; Natural Science Foundation of Zhejiang Province [LQ19E080003, LY21E080010]; Philosophy and Social Science Foundation of Zhejiang Province [21NDJC163YB]	Philosophy and Social Science Program of Ningbo; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Philosophy and Social Science Foundation of Zhejiang Province	This study was supported by Philosophy and Social Science Program of Ningbo (No. G20ZX37), National Natural Science Foundation of China (Grant No. 52002282), the Natural Science Foundation of Zhejiang Province (No. LQ19E080003, LY21E080010), and Philosophy and Social Science Foundation of Zhejiang Province (No. 21NDJC163YB).	Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Ajelli M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-190; Boulbene B, 2012, AICHE J, V58, P3614, DOI 10.1002/aic.13747; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; China Association of Metros, 2020, CHIN URB RAIL TRANS; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Ge ZY, 2020, J ZHEJIANG UNIV-SC B, V21, P361, DOI 10.1631/jzus.B2010010; Guo YY, 2021, SIMUL MODEL PRACT TH, V106, DOI 10.1016/j.simpat.2020.102172; Guo YY, 2020, ACCIDENT ANAL PREV, V147, DOI 10.1016/j.aap.2020.105772; Guo YY, 2020, ACCIDENT ANAL PREV, V144, DOI 10.1016/j.aap.2020.105660; Guo YY, 2020, J TRANSP SAF SECUR, V12, P419, DOI 10.1080/19439962.2018.1490368; Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339; Heymann D L, 2001, Lancet Infect Dis, V1, P345, DOI 10.1016/S1473-3099(01)00148-7; Hong H, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P1606, DOI 10.3760/cma.j.cn112338-20200311-00313; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; KERMACK WO, 1991, B MATH BIOL, V53, P57, DOI 10.1016/S0092-8240(05)80041-2; KERMACK WO, 1991, B MATH BIOL, V53, P33, DOI 10.1016/S0092-8240(05)80040-0; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Li X., 2020, J TRANSP GEOGR, V86, P102776; Li XW, 2021, TRAVEL BEHAV SOC, V23, P166, DOI 10.1016/j.tbs.2021.01.003; Li ZK, 2019, LAND USE POLICY, V82, P269, DOI 10.1016/j.landusepol.2018.12.003; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Ming W.K., 2020, BREAKING HEALTHCARE, V01, P922443; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; Niknamian S., 2020, INT J PHARMA RES HLT, V8, P3139, DOI DOI 10.21276/IJPRHS.2020.02.01; Pereira V, 2020, ACAD MANAGE PERSPECT, V34, P480, DOI 10.5465/amp.2019.0023; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS65, DOI 10.1016/j.ajic.2007.10.007; Stockmaier S, 2021, SCIENCE, V371, P1007, DOI 10.1126/science.abc8881; Tan L., 2020, J TRAFFIC TRANSPORTA, P1; Tatem AJ, 2006, ADV PARASIT, V62, P293, DOI 10.1016/S0065-308X(05)62009-X; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; Weiss H, 2019, MICROB ECOL, V77, P87, DOI 10.1007/s00248-018-1191-3; Yue XG, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13020022; Zeng WL, 2017, TRANSPORT RES C-EMER, V80, P37, DOI 10.1016/j.trc.2017.04.009; Zeng WL, 2014, TRANSPORT RES C-EMER, V40, P143, DOI 10.1016/j.trc.2014.01.007; Zhou JB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162942; Zhou JJ, 2020, CHIN J MECH ENG-EN, V33, DOI 10.1186/s10033-020-00441-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	42	0	0	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253220	10.1371/journal.pone.0253220	http://dx.doi.org/10.1371/journal.pone.0253220			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138911	gold, Green Published			2022-12-26	WOS:000671690200012
J	Ramshekar, A; Wang, HB; Kunz, E; Pappas, C; Hageman, GS; Chaqour, B; Sacks, DB; Hartnett, ME				Ramshekar, Aniket; Wang, Haibo; Kunz, Eric; Pappas, Christian; Hageman, Gregory S.; Chaqour, Brahim; Sacks, David B.; Hartnett, M. Elizabeth			Active Rap1-mediated inhibition of choroidal neovascularization requires interactions with IQGAP1 in choroidal endothelial cells	FASEB JOURNAL			English	Article						choroidal neovascularization; IQGAP1; Rac1GTP; Rap1GTP; vascular endothelial growth factor	RHO-FAMILY GTPASES; MACULAR DEGENERATION; NADPH OXIDASE; GROWTH-FACTOR; COMPLEMENT ACTIVATION; ROS GENERATION; RAP1; ANGIOGENESIS; RANIBIZUMAB; MIGRATION	Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness. The pathophysiology involves activation of choroidal endothelial cells (CECs) to transmigrate the retinal pigment epithelial (RPE) monolayer and form choroidal neovascularization (CNV) in the neural retina. The multidomain GTPase binding protein, IQGAP1, binds active Rac1 and sustains activation of CECs, thereby enabling migration associated with vision-threatening CNV. IQGAP1 also binds the GTPase, Rap1, which when activated reduces Rac1 activation in CECs and CNV. In this study, we tested the hypothesis that active Rap1 binding to IQGAP1 is necessary and sufficient to reduce Rac1 activation in CECs, and CNV. We found that pharmacologic activation of Rap1 or adenoviral transduction of constitutively active Rap1a reduced VEGF-mediated Rac1 activation, migration, and tube formation in CECs. Following pharmacologic activation of Rap1, VEGF-mediated Rac1 activation was reduced in CECs transfected with an IQGAP1 construct that increased active Rap1-IQGAP1 binding but not in CECs transfected with an IQGAP1 construct lacking the Rap1 binding domain. Specific knockout of IQGAP1 in endothelial cells reduced laser-induced CNV and Rac1 activation in CNV lesions, but pharmacologic activation of Rap1 did not further reduce CNV compared to littermate controls. Taken together, our findings provide evidence that active Rap1 binding to the IQ domain of IQGAP1 is sufficient to interfere with active Rac1-mediated CEC activation and CNV formation.	[Ramshekar, Aniket; Wang, Haibo; Kunz, Eric; Pappas, Christian; Hageman, Gregory S.; Hartnett, M. Elizabeth] Univ Utah, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA; [Pappas, Christian; Hageman, Gregory S.] Univ Utah, Steele Ctr Translat Med, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Chaqour, Brahim] Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY USA; [Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; National Institutes of Health (NIH) - USA	Hartnett, ME (corresponding author), Univ Utah, John A Moran Eye Ctr, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	ME.Hartnett@hsc.utah.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	HHS | NIH | National Eye Institute (NEI) [P30EY014800, R01EY024998, R01EY015130, R01EY017011]; Research to Prevent Blindness (RPB)	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB))	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: P30EY014800; Research to Prevent Blindness (RPB); HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY024998; HHS | National Institutes of Health (NIH); HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY015130; HHS | NIH | National Eye Institute (NEI), Grant/Award Number: R01EY017011	Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bid HK, 2013, MOL CANCER THER, V12, P1925, DOI 10.1158/1535-7163.MCT-13-0164; Bretz CA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20520-z; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cao SJ, 2016, BRIT J OPHTHALMOL, V100, P713, DOI 10.1136/bjophthalmol-2015-307213; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Cruz-Gonzalez F, 2014, GRAEF ARCH CLIN EXP, V252, P469, DOI 10.1007/s00417-014-2585-7; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garvin S, 2003, CANCER RES, V63, P8742; Gillies MC, 2015, OPHTHALMOLOGY, V122, P1837, DOI 10.1016/j.ophtha.2015.05.010; Goitre L, 2014, METHODS MOL BIOL, V1120, P1, DOI 10.1007/978-1-62703-791-4_1; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Gu LP, 2010, EXP EYE RES, V91, P433, DOI 10.1016/j.exer.2010.06.019; Haller JA, 2013, OPHTHALMOLOGY, V120, pS3, DOI 10.1016/j.ophtha.2013.01.057; Hartnett ME, 1996, OPHTHALMOLOGY, V103, P58, DOI 10.1016/S0161-6420(96)30731-8; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Huang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071808; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Joussen AM, 2009, DTSCH ARZTEBL INT, V106, P312, DOI 10.3238/arztebl.2009.0312; Keenan TDL, 2015, INVEST OPHTH VIS SCI, V56, P4870, DOI 10.1167/iovs.15-17009; Lakshmikanthan S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207605; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Lee S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01585-8; Li JJ, 2018, CURR EYE RES, V43, P934, DOI 10.1080/02713683.2018.1454477; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Malarkannan S, 2012, J IMMUNOL, V188, P2057, DOI 10.4049/jimmunol.1102439; Monaghan-Benson E, 2010, AM J PATHOL, V177, P2091, DOI 10.2353/ajpath.2010.090878; Namkoong S, 2009, CELL SIGNAL, V21, P906, DOI 10.1016/j.cellsig.2009.01.038; Noritake J, 2004, MOL BIOL CELL, V15, P1065, DOI 10.1091/mbc.E03-08-0582; Nowak-Sliwinska P, 2018, ANGIOGENESIS, V21, P425, DOI 10.1007/s10456-018-9613-x; Otsuji T, 2013, CLIN OPHTHALMOL, V7, P1487, DOI 10.2147/OPTH.S46317; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; Peterson LJ, 2007, EXP EYE RES, V84, P737, DOI 10.1016/j.exer.2006.12.012; Prokofyeva E, 2012, OPHTHALMIC RES, V47, P171, DOI 10.1159/000329603; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Seddon JM, 2015, INVEST OPHTH VIS SCI, V56, P2192, DOI 10.1167/iovs.14-15841; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Sokol SY, 2001, J BIOL CHEM, V276, P48425, DOI 10.1074/jbc.M107975200; Solomon SD, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005139.pub4; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stevens TS, 1997, ARCH OPHTHALMOL-CHIC, V115, P345, DOI 10.1001/archopht.1997.01100150347006; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Toomey CB, 2015, P NATL ACAD SCI USA, V112, pE3040, DOI 10.1073/pnas.1424391112; Wang HB, 2020, ANGIOGENESIS, V23, P685, DOI 10.1007/s10456-020-09740-y; Wang HB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52163-z; Wang HB, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.56; Wang HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157748; Wang HB, 2015, AM J PATHOL, V185, P3316, DOI 10.1016/j.ajpath.2015.08.017; Wang HB, 2014, FASEB J, V28, P265, DOI 10.1096/fj.13-240028; Wittchen ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073070; Wittchen Erika S, 2011, Small GTPases, V2, P65; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Zouache MA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78059-x	59	2	2	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21642	10.1096/fj.202100112R	http://dx.doi.org/10.1096/fj.202100112R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34166557	Green Accepted			2022-12-26	WOS:000667814100055
J	DaLomba, E; Gramstad, A; Johnson, SG; Carstensen, T; Stigen, L; Mork, G; Magne, TA; Bonsaksen, T				DaLomba, Elaina; Gramstad, Astrid; Johnson, Susanne G.; Carstensen, Tove; Stigen, Linda; Mork, Gry; Magne, Trine A.; Bonsaksen, Tore			Predictors of students' participation in a learning environment survey with annual follow-ups	PLOS ONE			English	Article							TEACHING QUALITY; HIGHER-EDUCATION; PERCEPTIONS; PERFORMANCE; EXPERIENCE	Background Longitudinal research is one effective way to gauge changes in a student cohort over time, however attrition in these studies is typically high, which can result in study bias. This study explored learning environment factors, approaches to studying, and academic performance as predictors of occupational therapy students' consistent participation in data collection conducted over three years of their professional program. Method A longitudinal study of Norwegian occupational therapy students (analyzed n = 240) was conducted. Logistic regression analysis was used to explore occupational therapy students' perceptions of the learning environment, their approaches to studying, and exam grades as they related to the likelihood of consistent participation at three annual surveys. Results Annual response rates varied between 55.1%, and 65.6%, and consistent participation was observed among 49.2%. The fully adjusted regression models showed that higher strategic approach scores increased the odds of consistent participation (adjusted OR: 1.04, p < 0.01), whereas higher surface approach scores decreased the odds of consistent participation (adjusted OR: 0.95, p < 0.05). Neither sociodemographic factors, learning environment factors nor academic performance predicted participation over time. Conclusions Researchers can anticipate relatively high levels of attrition in longitudinal studies of occupational therapy students, but attrition seems to be largely proportional between groups. However, completers in longitudinal studies may be somewhat more well-organized and academically oriented than drop-outs.	[DaLomba, Elaina] Samuel Merritt Univ, Occupat Therapy Dept, Oakland, CA USA; [Gramstad, Astrid] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Hlth & Care Sci, Tromso, Norway; [Gramstad, Astrid] Ctr Care Res, Bangor, Gwynedd, Wales; [Johnson, Susanne G.] Western Norway Univ Appl Sci, Dept Hlth & Social Functioning, Bergen, Norway; [Carstensen, Tove; Magne, Trine A.] Norwegian Univ Sci & Technol NTNU, Dept Neurosci & Movement Sci, Trondheim, Norway; [Stigen, Linda] Norwegian Univ Sci & Technol NTNU, Dept Hlth Sci, Gjovik, Norway; [Mork, Gry; Bonsaksen, Tore] VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway; [Bonsaksen, Tore] Inland Norway Univ Appl Sci, Fac Social & Hlth Sci, Dept Hlth & Nursing Sci, Elverum, Norway	Samuel Merritt University; UiT The Arctic University of Tromso; Western Norway University of Applied Sciences; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); VID Specialised University; Inland Norway University of Applied Sciences	Bonsaksen, T (corresponding author), VID Specialized Univ, Fac Hlth Studies, Sandnes, Norway.; Bonsaksen, T (corresponding author), Inland Norway Univ Appl Sci, Fac Social & Hlth Sci, Dept Hlth & Nursing Sci, Elverum, Norway.	tore.bonsaksen@inn.no	Bonsaksen, Tore/U-5148-2018	Bonsaksen, Tore/0000-0001-6315-1111; Johnson, Susanne G./0000-0002-2500-8952; Magne, Trine Alise/0000-0003-2063-6009; Mork, Gry/0000-0001-6887-7333; Gramstad, Astrid/0000-0002-2301-5067				Berger LK, 2009, INT J SOC RES METHOD, V12, P79, DOI 10.1080/13645570701606077; Biering K, 2015, CLIN EPIDEMIOL, V7, P91, DOI 10.2147/CLEP.S72247; Bonsaksen T, 2019, AUST OCCUP THER J, V66, P33, DOI 10.1111/1440-1630.12504; Bonsaksen T, 2017, OCCUP THER MENT HEAL, V33, P326, DOI 10.1080/0164212X.2017.1295006; Bonsaksen T, 2016, BRIT J OCCUP THER, V79, P361, DOI 10.1177/0308022615627174; Carson R, 2019, AM J OCCUP THER, V73, DOI 10.5014/ajot.2019.032623; DaLomba EJ., 2020, J OCCUP THER ED, V4, P4; DaLomba E, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02550-w; Diseth A., 2001, SCAND J EDUC RES, V45, P381, DOI [https://doi.org/10.1080/00313830120096789, DOI 10.1080/00313830120096789]; Entwistle N, 2004, EDUC PSYCHOL REV, V16, P325, DOI 10.1007/s10648-004-0003-0; Entwistle N.J., 2013, REPORT DEV USE INVEN; Entwistle N, 2018, STUDENT LEARNING AND ACADEMIC UNDERSTANDING: A RESEARCH PERSPECTIVE WITH IMPLICATIONS FOR TEACHING, P237, DOI 10.1016/B978-0-12-805359-1.00012-7; Flood B, 2003, ASSESS EVAL HIGH EDU, V28, P135, DOI [10.1080/02602930301668, DOI 10.1080/02602930301668]; Fredricks JA, 2011, THEOR PRACT, V50, P327, DOI 10.1080/00405841.2011.607401; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Ginns P, 2007, STUD HIGH EDUC, V32, P603, DOI 10.1080/03075070701573773; Gramstad A., 2020, OPEN J OCCUP THER, V8; Gribble N, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1520-3; Gustavson K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-918; Liew SC, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0327-0; Lizzio A, 2002, STUD HIGH EDUC, V27, P27, DOI 10.1080/03075070120099359; Long K, 2011, INTERNET J ALLIED HE, V9; MARTON F, 1976, BRIT J EDUC PSYCHOL, V46, P4, DOI 10.1111/j.2044-8279.1976.tb02980.x; Mork G, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-02033-4; Pettersen RC., 2007, STUDENTS EXPERIENCE; Portney LG., 2020, FDN CLIN RES APPL EV, V4, P491; RAMSDEN P, 1991, STUD HIGH EDUC, V16, P129, DOI 10.1080/03075079112331382944; Teague S, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0586-7; The Norwegian Association of Higher Education Institutions, 2004, GRAD SYST GEN QUAL D; Thordardottir B, 2022, SCAND J OCCUP THER, V29, P25, DOI 10.1080/11038128.2020.1831058; Thorrisen MM, 2022, SCAND J OCCUP THER, V29, P13, DOI 10.1080/11038128.2020.1831056; Thygesen H., 2020, IR J OCCUP THER, V48, P91, DOI [https://doi.org/10.1108/IJOT-10-2019-0015, DOI 10.1108/IJOT-10-2019-0015]; Trigwell K, 2012, STUD HIGH EDUC, V37, P811, DOI 10.1080/03075079.2010.549220; Tuononen T, 2016, HIGH EDUC, V72, P41, DOI 10.1007/s10734-015-9937-z; Wong RL, 2016, J INTERPROF CARE, V30, P191, DOI 10.3109/13561820.2015.1121215; Woodall T, 2014, STUD HIGH EDUC, V39, P48, DOI 10.1080/03075079.2011.648373	36	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253773	10.1371/journal.pone.0253773	http://dx.doi.org/10.1371/journal.pone.0253773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170940	Green Published, gold			2022-12-26	WOS:000671694400049
J	Hasegawa, M; Komiyama, T; Ayabe, K; Sakama, S; Sakai, T; Lee, KH; Morise, M; Yagishita, A; Amino, M; Sasaki, A; Nagata, E; Kobayashi, H; Yoshioka, K; Ikari, Y				Hasegawa, Misaki; Komiyama, Tomoyoshi; Ayabe, Kengo; Sakama, Susumu; Sakai, Tetsuri; Lee, Kyong Hee; Morise, Masahiro; Yagishita, Atsuhiko; Amino, Mari; Sasaki, Ayumi; Nagata, Eiichiro; Kobayashi, Hiroyuki; Yoshioka, Koichiro; Ikari, Yuji			Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients	PLOS ONE			English	Article							IMPLANTABLE LOOP RECORDER; UP TILT TEST; DEPENDENT PROTEIN-KINASE; HEART-RATE-VARIABILITY; LIGHT-CHAIN KINASE; UNEXPLAINED SYNCOPE; CAMP; CA2+; MANAGEMENT; MECHANISM	We investigated circulatory dynamics in patients with vasodepressor type neurally mediated syncope (VT-NMS) by performing high-resolution Holter electrocardiography and a correlation analysis of changes in adenylate cyclase activity, blood pressure, and pulse during the head-up tilt test. Holter electrocardiography was performed for 30 patients. Adenylate cyclase activity was evaluated in lymphocytes from blood samples taken at rest and during the head-up tilt test. There was no change in autonomic nerve fluctuation during electrocardiography in VT-NMS patients, but our results showed a significant difference in blood pressure and adenylate cyclase activity between VT-NMS patients and healthy volunteers; the systolic blood pressure of VT-NMS patients decreased after 5 min, while at 10 min, the adenylate cyclase activity was the highest (0.53%) and the systolic blood pressure was the lowest (111.8 mm Hg). Pulse rates increased after 10 min. VT-NMS patients showed higher blood pressure, pulse rate, and adenylate cyclase activity during the tilt test than did healthy volunteers. In patients with syncope, standing for longer than 10 minutes may increase the risk of VT-NMS. From our results, we consider it likely that high systolic blood pressure and adenylate cyclase activity at rest cause fainting in VT-NMS patients. Our findings may be helpful for identifying individuals with a high risk of developing NMS in the healthy population.	[Hasegawa, Misaki; Ayabe, Kengo; Sakama, Susumu; Sakai, Tetsuri; Lee, Kyong Hee; Morise, Masahiro; Yagishita, Atsuhiko; Amino, Mari; Yoshioka, Koichiro; Ikari, Yuji] Tokai Univ, Dept Cardiol, Sch Med, Isehara, Kanagawa, Japan; [Komiyama, Tomoyoshi; Kobayashi, Hiroyuki] Tokai Univ, Dept Clin Pharmacol, Sch Med, Isehara, Kanagawa, Japan; [Sasaki, Ayumi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan; [Nagata, Eiichiro] Tokai Univ, Dept Neurol, Sch Med, Isehara, Kanagawa, Japan	Tokai University; Tokai University; Tokai University; Tokai University	Hasegawa, M (corresponding author), Tokai Univ, Dept Cardiol, Sch Med, Isehara, Kanagawa, Japan.; Komiyama, T (corresponding author), Tokai Univ, Dept Clin Pharmacol, Sch Med, Isehara, Kanagawa, Japan.	hhshmm.0726@gmail.com; komiyama@tokai-u.jp	Yagishita, Atsuhiko/AAN-7906-2020	Yagishita, Atsuhiko/0000-0001-7774-7477; Komiyama, Tomoyoshi/0000-0003-2138-0084	KAKENHI [20K08498]; Research and Study Program of the Tokai University Educational System General Research Organization	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research and Study Program of the Tokai University Educational System General Research Organization	This study was funded by KAKENHI (grant number 20K08498) and by The Research and Study Program of the Tokai University Educational System General Research Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1995, PACE, V18, P1419, DOI 10.1111/j.1540-8159.1995.tb02604.x; Alboni P, 2015, HEART, V101, P674, DOI 10.1136/heartjnl-2014-307096; Amino M, 2019, J ELECTROCARDIOL, V53, P71, DOI 10.1016/j.jelectrocard.2019.01.003; Amino M, 2009, J TRAUMA, V66, P1308, DOI 10.1097/TA.0b013e31817e0f46; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Billington CK, 2003, RESP RES, V4; Boersma L, 2004, EUROPACE, V6, P70, DOI 10.1016/j.eupc.2003.09.006; BRASS LF, 1986, J BIOL CHEM, V261, P6838; Brignole M, 2006, EUR HEART J, V27, P1085, DOI 10.1093/eurheartj/ehi842; Brignole M, 2018, EUR HEART J, V39, P1883, DOI 10.1093/eurheartj/ehy037; Brignole M, 2018, EUROPACE, V20, P1362, DOI 10.1093/europace/eux321; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Camm AJ, 1996, CIRCULATION, V93, P1043; Chu WH, 2014, NEUROL SCI, V35, P1127, DOI 10.1007/s10072-014-1664-1; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Edvardsson N, 2011, EUROPACE, V13, P262, DOI 10.1093/europace/euq418; Fitzpartick A., 1992, EUROPEAN J CARDIAC P, V2, P121; GOLDSTEIN DS, 1982, AM HEART J, V104, P1071, DOI 10.1016/0002-8703(82)90442-2; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; Hadjikoutis S, 2004, SEIZURE-EUR J EPILEP, V13, P537, DOI 10.1016/j.seizure.2003.12.011; Hainsworth R, 2004, CLIN AUTON RES, V14, P18, DOI 10.1007/s10286-004-1004-2; Haissaguerre M, 2002, CIRCULATION, V106, P962, DOI 10.1161/01.CIR.0000027564.55739.B1; Hong F, 2015, J GEN PHYSIOL, V146, P267, DOI 10.1085/jgp.201511483; Horrigan LA, 2006, PHARMACOL THERAPEUT, V111, P877, DOI 10.1016/j.pharmthera.2006.02.002; Hosaka H, 2003, BIOMED PHARMACOTHER, V57, p77S, DOI 10.1016/j.biopha.2003.08.009; HOSONO M, 1992, J CARDIOVASC PHARM, V19, P625, DOI 10.1097/00005344-199204000-00021; Huang W, 2017, GUT, V66, P301, DOI 10.1136/gutjnl-2015-309363; Iglesias JF, 2009, PACE, V32, pS202, DOI 10.1111/j.1540-8159.2008.02291.x; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; ISHIKAWA T, 1993, CIRC RES, V73, P1128, DOI 10.1161/01.RES.73.6.1128; ITOH T, 1989, NATURE, V338, P164, DOI 10.1038/338164a0; Jhanjee R, 2006, PACE, V29, P1160, DOI 10.1111/j.1540-8159.2006.00508.x; KAPOOR WN, 1992, JAMA-J AM MED ASSOC, V268, P2553, DOI 10.1001/jama.268.18.2553; KAPOOR WN, 1990, MEDICINE, V69, P160, DOI 10.1097/00005792-199005000-00004; Keef KD, 2001, AM J PHYSIOL-CELL PH, V281, pC1743; Kikushima S, 1999, J AM COLL CARDIOL, V33, P350, DOI 10.1016/S0735-1097(98)00567-1; Kochiadakis GE, 1998, PACE, V21, P1069, DOI 10.1111/j.1540-8159.1998.tb00152.x; Komiyama T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214733; Komiyama T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120788; Krahn AD, 2001, CIRCULATION, V104, P46, DOI 10.1161/01.CIR.104.1.46; Kress AK, 2010, J VIROL, V84, P8732, DOI 10.1128/JVI.00487-10; Lazzeri C, 2000, PACE, V23, P463, DOI 10.1111/j.1540-8159.2000.tb00828.x; Liao DL, 2016, INT J CARDIOL, V215, P186, DOI 10.1016/j.ijcard.2016.04.086; LINCOLN TM, 1990, AM J PHYSIOL, V258, pC399, DOI 10.1152/ajpcell.1990.258.3.C399; Linzer M, 1997, ANN INTERN MED, V126, P989, DOI 10.7326/0003-4819-126-12-199706150-00012; Martin K, 2010, ARCH DIS CHILDHOOD-E, V95, P66, DOI 10.1136/adc.2007.121103; Masuo K, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/832821; MEINKOTH JL, 1993, MOL CELL BIOCHEM, V128, P179, DOI 10.1007/BF01076769; Mercader MA, 2002, HEART, V88, P217, DOI 10.1136/heart.88.3.217; Mitro P, 2005, WIEN KLIN WOCHENSCHR, V117, P353, DOI 10.1007/s00508-005-0331-1; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Nguyen K, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-5; Onuki T, 2015, J CARDIOL, V66, P395, DOI 10.1016/j.jjcc.2014.12.009; Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457; Saklani P, 2013, CIRCULATION, V127, P1330, DOI 10.1161/CIRCULATIONAHA.112.138396; Schondorf R, 2001, J APPL PHYSIOL, V91, P2493, DOI 10.1152/jappl.2001.91.6.2493; Silvani Silvano, 2003, Ital Heart J, V4, P768; Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200; SNEDDON JF, 1993, AM J CARDIOL, V72, P1314, DOI 10.1016/0002-9149(93)90304-U; SRA JS, 1994, AM J CARDIOL, V73, P33, DOI 10.1016/0002-9149(94)90723-4; Suzuki M, 2004, ANN EMERG MED, V44, P215, DOI 10.1016/j.annemergmed.2004.02.036; Tanimoto K, 2004, AM J CARDIOL, V93, P228, DOI 10.1016/j.amjcard.2003.09.048; TORPHY TJ, 1994, TRENDS PHARMACOL SCI, V15, P370, DOI 10.1016/0165-6147(94)90157-0; Ungar A, 2013, HEART, V99, P1825, DOI 10.1136/heartjnl-2013-304399; Varga E, 2002, FORENSIC SCI INT, V130, P156, DOI 10.1016/S0379-0738(02)00377-8; Wang Q, 2015, INT IMMUNOPHARMACOL, V25, P340, DOI 10.1016/j.intimp.2015.02.012; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Yoshioka K, 2013, CIRC J, V77, P610, DOI 10.1253/circj.CJ-12-0932; Zaqqa M, 2000, TEX HEART I J, V27, P268	70	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0251450	10.1371/journal.pone.0251450	http://dx.doi.org/10.1371/journal.pone.0251450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170907	gold, Green Published			2022-12-26	WOS:000671694400010
J	Melocchi, V; Dama, E; Mazzarelli, F; Cuttano, R; Colangelo, T; Di Candia, L; Lugli, E; Veronesi, G; Pelosi, G; Ferretti, GM; Taurchini, M; Graziano, P; Bianchi, F				Melocchi, Valentina; Dama, Elisa; Mazzarelli, Francesco; Cuttano, Roberto; Colangelo, Tommaso; Di Candia, Leonarda; Lugli, Enrico; Veronesi, Giulia; Pelosi, Giuseppe; Ferretti, Gian Maria; Taurchini, Marco; Graziano, Paolo; Bianchi, Fabrizio			Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype	ONCOGENE			English	Article							INTRATUMORAL HETEROGENEITY; HEMATOPOIETIC STEM; GENE-EXPRESSION; IN-VITRO; CLASSIFICATION; METASTASIS; IDENTIFICATION; PROLIFERATION; PROGRESSION; ASSOCIATION	Lung adenocarcinoma (LUAD) is the main non-small-cell lung cancer diagnosed in similar to 40-50% of all lung cancer cases. Despite the improvements in early detection and personalized medicine, even a sizable fraction of patients with early-stage LUAD would experience disease relapses and adverse prognosis. Previous reports indicated the existence of LUAD molecular subtypes characterized by specific gene expression and mutational profiles, and correlating with prognosis. However, the biological and molecular features of such subtypes have not been further explored. Consequently, the mechanisms driving the emergence of aggressive LUAD remained unclear. Here, we adopted a multi-tiered approach ranging from molecular to functional characterization of LUAD and used it on multiple cohorts of patients (for a total of 1227 patients) and LUAD cell lines. We investigated the tumor transcriptome and the mutational and immune gene expression profiles, and we used LUAD cell lines for cancer cell phenotypic screening. We found that loss of lung cell lineage and gain of stem cell-like characteristics, along with mutator and immune evasion phenotypes, explain the aggressive behavior of a specific subset of lung adenocarcinoma that we called C1-LUAD, including early-stage disease. This subset can be identified using a 10-gene prognostic signature. Poor prognosis patients appear to have this specific molecular lung adenocarcinoma subtype which is characterized by peculiar molecular and biological features. Our data support the hypothesis that transformed lung stem/progenitor cells and/or reprogrammed epithelial cells with CSC characteristics are hallmarks of this aggressive disease. Such discoveries suggest alternative, more aggressive, therapeutic strategies for early-stage C1-LUAD.	[Melocchi, Valentina; Dama, Elisa; Mazzarelli, Francesco; Cuttano, Roberto; Colangelo, Tommaso; Bianchi, Fabrizio] Fdn IRCCS Casa Sollievo Sofferenza, Canc Biomarkers Unit, San Giovanni Rotondo, Italy; [Di Candia, Leonarda; Graziano, Paolo] Fdn IRCCS Casa Sollievo Sofferenza, Pathol Unit, San Giovanni Rotondo, Italy; [Lugli, Enrico] Humanitas Clin & Res Ctr IRCCS, Lab Translat Immunol, Milan, Italy; [Veronesi, Giulia] IRCCS San Raffaele Sci Inst, Div Thorac Surg, Milan, Italy; [Pelosi, Giuseppe] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Pelosi, Giuseppe] IRCCS MultiMed, Interhosp Pathol Div, Milan, Italy; [Ferretti, Gian Maria; Taurchini, Marco] Fdn IRCCS Casa Sollievo Sofferenza, Thorac Surg Unit, San Giovanni Rotondo, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; IRCCS Multimedica	Bianchi, F (corresponding author), Fdn IRCCS Casa Sollievo Sofferenza, Canc Biomarkers Unit, San Giovanni Rotondo, Italy.	f.bianchi@operapadrepio.it	Lugli, Enrico/AAB-7933-2019; Cuttano, Roberto/B-5884-2017; Mazzarelli, Francesco/AAC-4749-2020; Graziano, Paolo/AAC-9802-2022; Bianchi, Fabrizio/W-7037-2019; MELOCCHI, VALENTINA/B-5747-2017; DAMA, ELISA/C-2709-2017; COLANGELO, TOMMASO/B-6119-2017; Pelosi, Giuseppe/F-5073-2012	Lugli, Enrico/0000-0002-1964-7678; Cuttano, Roberto/0000-0003-4150-2114; Mazzarelli, Francesco/0000-0002-9912-6820; Graziano, Paolo/0000-0001-7066-7896; Bianchi, Fabrizio/0000-0001-7412-8638; MELOCCHI, VALENTINA/0000-0001-9656-3681; DAMA, ELISA/0000-0001-6918-6577; COLANGELO, TOMMASO/0000-0002-6927-403X; Pelosi, Giuseppe/0000-0003-4725-4692	Associazione Italiana Ricerca sul Cancro [MFAG-17568, IG-22827, IG-20676, 19548]; Italian Ministry of Health [GR-2016-02363975]; Umberto Veronesi Foundation; Pezcoller Foundation	Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); Pezcoller Foundation	We are grateful to Teresa Nittoli for technical assistance and Chiara Di Giorgio for critically editing the manuscript. This study was performed in accordance We are grateful to Teresa Nittoli for technical assistance and Chiara Di Giorgio for critically editing the manuscript. This study was performed in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Fondazione IRCCS Casa Sollievo della Sofferenza (ref. number: BIO-POLMONE - V1.0_08 Giu 16). All authors gave their consent to publication. The gene expression data used in this study are publicly available as indicated in the "Methods" and Supplementary Information sections. This work was supported by the Associazione Italiana Ricerca sul Cancro [MFAG-17568 and IG-22827 to FB; IG-20676 to EL], the Italian Ministry of Health [GR-2016-02363975 and CLEARLY to FB]. RC was supported by a fellowship from the Umberto Veronesi Foundation and the Pezcoller Foundation. TC was supported by a fellowship from the Associazione Italiana Ricerca sul Cancro (#19548) and the Umberto Veronesi Foundation.with the Declaration of Helsinki and was approved by the Ethics Committee of the Fondazione IRCCS Casa Sollievo della Sofferenza (ref. number: BIO-POLMONE - V1.0_08 Giu 16). All authors gave their consent to publication. The gene expression data used in this study are publicly available as indicated in the "Methods" and Supplementary Information sections. This work was supported by the Associazione Italiana Ricerca sul Cancro [MFAG-17568 and IG-22827 to FB; IG-20676 to EL], the Italian Ministry of Health [GR-2016-02363975 and CLEARLY to FB]. RC was supported by a fellowship from the Umberto Veronesi Foundation and the Pezcoller Foundation. TC was supported by a fellowship from the Associazione Italiana Ricerca sul Cancro (#19548) and the Umberto Veronesi Foundation.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alvisi G, 2020, J CLIN INVEST, V130, P3137, DOI 10.1172/JCI130426; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JCI32007; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bremnes RM, 2016, J THORAC ONCOL, V11, P789, DOI 10.1016/j.jtho.2016.01.015; Bryant CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011712; Burkholder B, 2014, BBA-REV CANCER, V1845, P182, DOI 10.1016/j.bbcan.2014.01.004; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Care A, 1999, ONCOGENE, V18, P1993, DOI 10.1038/sj.onc.1202498; Chen F, 2017, ONCOGENE, V36, P1384, DOI 10.1038/onc.2016.303; Cheung WKC, 2015, ONCOGENE, V34, P5771, DOI 10.1038/onc.2015.85; Dama E, 2017, CLIN CANCER RES, V23, P62, DOI 10.1158/1078-0432.CCR-15-3005; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; de Koning HJ, 2020, NEW ENGL J MED, V382, P503, DOI 10.1056/NEJMoa1911793; Devarakonda S, 2015, LANCET ONCOL, V16, pE342, DOI 10.1016/S1470-2045(15)00077-7; Dolatshad H, 2015, LEUKEMIA, V29, P1092, DOI [10.1038/leu.2014.331, 10.1038/leu.2015.178]; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fares J, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0134-x; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Grindel BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25435-3; Han B, 2018, AM J CANCER RES, V8, P810; Jaillon S, 2020, NAT REV CANCER, V20, P485, DOI 10.1038/s41568-020-0281-y; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Marjanovic ND, 2020, CANCER CELL, V38, P229, DOI 10.1016/j.ccell.2020.06.012; McCauley KB, 2018, STEM CELL REP, V10, P1579, DOI 10.1016/j.stemcr.2018.03.013; Miranda A, 2019, P NATL ACAD SCI USA, V116, P9020, DOI 10.1073/pnas.1818210116; Moises J, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0542-z; Monterisi S, 2018, ONCOGENE, V37, P3575, DOI 10.1038/s41388-018-0229-9; Nazarov PV, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3819-y; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Prasetyanti PR, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0600-4; Pribluda A, 2015, CLIN CANCER RES, V21, P2916, DOI 10.1158/1078-0432.CCR-14-1213; Reynolds SD, 2002, AM J RESP CRIT CARE, V166, P1498, DOI 10.1164/rccm.200204-285OC; Richards CH, 2011, FUTURE ONCOL, V7, P1223, DOI [10.2217/fon.11.99, 10.2217/FON.11.99]; Schabath MB, 2016, ONCOGENE, V35, P3209, DOI 10.1038/onc.2015.375; Schoenfeld A, 2020, CLIN CANCER RES, V26, P5701, DOI 10.1158/1078-0432.CCR-20-1825; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sonzogni A, 2017, J PATHOL CLIN RES, V3, P139, DOI 10.1002/cjp2.67; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tata PR, 2018, DEV CELL, V44, P679, DOI 10.1016/j.devcel.2018.02.024; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Tian CX, 2020, CANCER RES, V80, P1461, DOI 10.1158/0008-5472.CAN-19-2578; Tokheim C, 2019, CELL SYST, V9, P9, DOI 10.1016/j.cels.2019.05.005; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Wolf J, 2020, NEW ENGL J MED, V383, P944, DOI 10.1056/NEJMoa2002787; Xu NZ, 2019, J HISTOCHEM CYTOCHEM, V67, P453, DOI 10.1369/0022155419829050; Yan XP, 2013, ONCOL REP, V30, P2733, DOI 10.3892/or.2013.2784; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Yu H, 2016, J THORAC ONCOL, V11, P964, DOI 10.1016/j.jtho.2016.04.014; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	62	3	3	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					4980	4991		10.1038/s41388-021-01909-z	http://dx.doi.org/10.1038/s41388-021-01909-z		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34172935				2022-12-26	WOS:000667016100001
J	Nigusse, B; Gebre-Mariam, T; Belete, A				Nigusse, Birhanu; Gebre-Mariam, Tsige; Belete, Anteneh			Design, development and optimization of sustained release floating, bioadhesive and swellable matrix tablet of ranitidine hydrochloride	PLOS ONE			English	Article							DRUG-DELIVERY SYSTEMS; IN-VITRO	Ranitidine HCl, a selective, competitive histamine H-2-receptor antagonist with a short biological half-life, low bioavailability and narrow absorption window, is an ideal candidate for gastro-retentive drug delivery system (GRDDS). Controlled release with an optimum retentive formulation in the upper stomach would be an ideal formulation for this drug. The aim of the present study was therefore to develop, formulate and optimize floating, bioadhesive, and swellable matrix tablets of ranitidine HCl. The matrix tablets were prepared using a combination of hydroxypropyl methylcellulose (HPMC) and sodium carboxymethyl cellulose (NaCMC) as release retarding polymers, sodium bicarbonate (NaHCO3) as gas generating agent and microcrystalline cellulose (MCC) as direct compression diluent. Central composite design (CCD) was used to optimize the formulation and a total of thirteen formulations were prepared. Concentration of HPMC/NaCMC (3:1) (X-1) and NaHCO3 (X-2) were selected as independent variables; and floating lag time (Y-1), bioadhesive strength (Y-2), swelling index at 12 h (Y-3), cumulative drug release at 1 h (Y-4), time to 50% drug release (t(50%)) (Y-5) and cumulative drug release at 12 h (Y-6) were taken as the response variables. The optimized batch showed floating lag time of 5.09 sec, bioadhesive strength of 29.69 g, swelling index of 315.04% at 12 h, t(50%) of 3.86 h and drug release of 24.21% and 93.65% at 1h and 12 h, respectively, with anomalous release mechanism. The results indicate that sustained release matrix tablet of ranitidine HCl with combined floating, bioadhesive and swelling gastro-retentive properties can be considered as a strategy to overcome the low bioavailability and in vivo variation associated with the conventional ranitidine HCl tablet.	[Nigusse, Birhanu; Gebre-Mariam, Tsige; Belete, Anteneh] Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmaceut & Social Pharm, Addis Ababa, Ethiopia; [Nigusse, Birhanu; Gebre-Mariam, Tsige; Belete, Anteneh] Addis Ababa Univ, Coll Hlth Sci, Reg Bioequivalence Ctr, Sch Pharm, Addis Ababa, Ethiopia	Addis Ababa University; Addis Ababa University	Gebre-Mariam, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Sch Pharm, Dept Pharmaceut & Social Pharm, Addis Ababa, Ethiopia.; Gebre-Mariam, T (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Reg Bioequivalence Ctr, Sch Pharm, Addis Ababa, Ethiopia.	tsige.gmariam@aau.edu.et			School of Pharmacy, College of Health Sciences, Addis Ababa University; Regional Bioequivalence Center	School of Pharmacy, College of Health Sciences, Addis Ababa University; Regional Bioequivalence Center	BN would like to thank the Regional Bioequivalence Center for sponsoring his MSc study, and School of Pharmacy, College of Health Sciences, Addis Ababa University for the financial and material support. BN would also like to thank Cadila Pharmaceutical Factory PLC for material support.	Adhikary A, 2008, DRUG DEV IND PHARM, V34, P860, DOI 10.1080/03639040801928812 ; Alluri R, 2020, WORLD J PHARM SCI, V9, P481; Arezki NR, 2017, INT J COSMETIC SCI, V39, P72, DOI 10.1111/ics.12351; Basit AW, 2001, INT J PHARMACEUT, V227, P157, DOI 10.1016/S0378-5173(01)00794-3; Berardi A, 2019, PHARMACEUTICS, V11, DOI 10.3390/pharmaceutics11100513; Bertram U, 2012, DRUG DEV IND PHARM, V38, P659, DOI 10.3109/03639045.2011.598536; Chavanpatil MD, 2006, INT J PHARMACEUT, V316, P86, DOI 10.1016/j.ijpharm.2006.02.038; Chen YH, 2002, J CHEM EDUC, V79, P848, DOI 10.1021/ed079p848; Dash S, 2010, ACTA POL PHARM, V67, P217; Dave BS, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050234; Dorozynski P, 2004, DRUG DEV IND PHARM, V30, P947, DOI 10.1081/DDC-200037179; Gunjal PT, 2015, INDIAN J PHARM SCI, V77, P563, DOI 10.4103/0250-474X.169036; JIMENEZCASTELLANOS MR, 1994, INT J PHARM, V105, P65, DOI 10.1016/0378-5173(94)90236-4; Kanupriya C, 2021, INT J CURR PHARM RES, V13, P7; Kortejarvi H, 2005, J PHARM SCI-US, V94, P1617, DOI 10.1002/jps.20392; Kotagale NR, 2010, INDIAN J PHARM SCI, V72, P471, DOI 10.4103/0250-474X.73912; Kotreka UK, 2011, CRIT REV THER DRUG, V28, P47, DOI 10.1615/CritRevTherDrugCarrierSyst.v28.i1.20; Lopes CM, 2016, INT J PHARMACEUT, V510, P144, DOI 10.1016/j.ijpharm.2016.05.016; Meka VS, 2016, ACTA PHARMACEUT, V66, P35, DOI 10.1515/acph-2016-0002; Nakamura F, 1996, INT J PHARM, V134, P173, DOI 10.1016/0378-5173(95)04416-7; Pawar VK, 2012, EXPERT OPIN DRUG DEL, V9, P551, DOI 10.1517/17425247.2012.677431; Pithavala YK, 1998, PHARMACEUT RES, V15, P1869, DOI 10.1023/A:1011910223812; Roy SK, 2010, TROP J PHARM RES, V9, P91, DOI 10.4314/tjpr.v9i1.52043; Singh B, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070103; Talukder R, 2004, DRUG DEV IND PHARM, V30, P1019, DOI 10.1081/DDC-200040239; XU GJ, 1995, CHEM PHARM BULL, V43, P483; Zheng JH, 2006, J APPL POLYM SCI, V102, P2226, DOI 10.1002/app.24319	27	5	5	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253391	10.1371/journal.pone.0253391	http://dx.doi.org/10.1371/journal.pone.0253391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170952	Green Published, gold			2022-12-26	WOS:000671694400011
J	Horn, AL; Jiang, L; Washburn, F; Hvitfeldt, E; De la Haye, K; Nicholas, W; Simon, P; Pentz, M; Cozen, W; Sood, N; Conti, DV				Horn, Abigail L.; Jiang, Lai; Washburn, Faith; Hvitfeldt, Emil; de la Haye, Kayla; Nicholas, William; Simon, Paul; Pentz, Maryann; Cozen, Wendy; Sood, Neeraj; Conti, David, V			An integrated risk and epidemiological model to estimate risk-stratified COVID-19 outcomes for Los Angeles County: March 1, 2020-March 1, 2021	PLOS ONE			English	Article								The objective of this study was to use available data on the prevalence of COVID-19 risk factors in subpopulations and epidemic dynamics at the population level to estimate probabilities of severe illness and the case and infection fatality rates (CFR and IFR) stratified across subgroups representing all combinations of the risk factors age, comorbidities, obesity, and smoking status. We focus on the first year of the epidemic in Los Angeles County (LAC) (March 1, 2020-March 1, 2021), spanning three epidemic waves. A relative risk modeling approach was developed to estimate conditional effects from available marginal data. A dynamic stochastic epidemic model was developed to produce time-varying population estimates of epidemic parameters including the transmission and infection observation rate. The epidemic and risk models were integrated to produce estimates of subpopulation-stratified probabilities of disease progression and CFR and IFR for LAC. The probabilities of disease progression and CFR and IFR were found to vary as extensively between age groups as within age categories combined with the presence of absence of other risk factors, suggesting that it is inappropriate to summarize epidemiological parameters for age categories alone, let alone the entire population. The fine-grained subpopulation-stratified estimates of COVID-19 outcomes produced in this study are useful in understanding disparities in the effect of the epidemic on different groups in LAC, and can inform analyses of targeted subpopulation-level policy interventions.	[Horn, Abigail L.; Jiang, Lai; Hvitfeldt, Emil; de la Haye, Kayla; Pentz, Maryann; Cozen, Wendy; Conti, David, V] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Washburn, Faith; Nicholas, William; Simon, Paul] Los Angeles Cty Dept Publ Hlth, Los Angeles, CA USA; [Sood, Neeraj] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA 90007 USA; [Sood, Neeraj] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA	University of Southern California; Los Angeles County Department of Public Health; University of Southern California; University of Southern California	Horn, AL (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA.	abigail.horn@usc.edu		/0000-0002-5916-841X	NIH Ruth L Kirschstein National 591 Research Service Award (NRSA) Institutional Training Grant [T32 5T32CA009492-35]; NIH [P01CA196569]; NCI [P30CA014089]; University of Southern California	NIH Ruth L Kirschstein National 591 Research Service Award (NRSA) Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Southern California	ALH was supported from an NIH Ruth L Kirschstein National 591 Research Service Award (NRSA) Institutional Training Grant T32 5T32CA009492-35. 592 DVC was supported by NIH P01CA196569 and NCI P30CA014089. EH was supported 593 by NIH P01CA196569. DVC and ALH are also funded by COVID-19 Keck Research 594 Fund from the University of Southern California.	Adam D, 2020, NATURE, V587, P533, DOI 10.1038/d41586-020-03208-1; Baker MG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232452; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Bilinski A, 2020, JAMA-J AM MED ASSOC, V324, P2100, DOI 10.1001/jama.2020.20717; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Centers for Disease Control and Prevention (CDC), 2019, MED VIS HOSP DEATHS; Centers for Disease Control and Prevention (CDC), 2020, INT CLIN GUID MAN PA, V12; Centers for Disease Control and Prevention (CDC), 2017, NATL HLTH NUTR EXAMI; Chen Y-H., 2021, EXCESS MORTALITY ASS; Data LAT Department G, CAL COR DAT GITHUB, P2021; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616; Garcia E, 2021, ANN EPIDEMIOL, V58, P69, DOI 10.1016/j.annepidem.2021.03.006; Griffith G., 2020, NAT COMMUN, DOI [10.1038/s41467-020-19478-2, DOI 10.1038/S41467-020-19478-2]; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris Jeffrey E., 2021, Journal of Bioeconomics, V23, P55, DOI 10.1007/s10818-021-09310-2; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Hawkins D, 2020, AM J IND MED, V63, P817, DOI 10.1002/ajim.23145; Horn Abigail L, 2020, medRxiv, DOI 10.1101/2020.12.11.20209627; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; Levin AT, 2020, EUR J EPIDEMIOL, V35, P1123, DOI 10.1007/s10654-020-00698-1; Liu Y, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa021; Los Angeles County Department of Public Health, 2020, ORD HLTH OFF REOP SA; Los Angeles County Department of Public Health, 2020, LOS ANG COUNT CAS CO; Los Angeles Mayor's Office, 2020, SAF LA COVID 19; Los Angeles Mayor's Office, 2020, SAF LA COVID 19 TIM; Mode CJ., 2000, STOCHASTIC PROCESSES; Mutambudzi M, 2021, OCCUP ENVIRON MED, V78, P307, DOI 10.1136/oemed-2020-106731; Newcombe PJ, 2016, GENET EPIDEMIOL, V40, P188, DOI 10.1002/gepi.21953; O'Driscoll M, 2020, NATURE, DOI 10.1038/s41586-020-2918-0; of Public Health CD, 2021, CAL DEP PUBL HLTH OP; of Public Health LACD, 2018, LOS ANG COUNT HLTH S; of Public Health LACD, 2020, LA COUNT DAIL COVID; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Our World in Data, 2020, PAND PRIM EXC MORT S; Petrilli CM, 2020, FACTORS ASS HOSPITAL, V2020, P4, DOI [DOI 10.1101/2020.04.08.20057794, 10.1101/2020.04.08.20057794]; Pfeiffer RM., 2017, ABSOLUTE RISK METHOD; Pullano G, 2020, NATURE, DOI 10.1038/s41586-020-03095-6; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Stokes EK, 2020, MMWR-MORBID MORTAL W, V69, P759, DOI 10.15585/mmwr.mm6924e2; Tai DBG, 2021, CLIN INFECT DIS, V72, P703, DOI 10.1093/cid/ciaa815; U S Census Bureau via R package tidycensus, 2018, **DATA OBJECT**; U S Department of Health and Human Services, 2020, SOCIAL DETERMINANTS; UCLA Center for Health Policy Research CA Los Angeles, 2018, CAL HLTH INF SURV; Unacast, 2020, UN SOC DIST SCOR; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wetsman N., 2020, DOCT AR BETT TREAT C; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Woolf SH, 2020, JAMA-J AM MED ASSOC, V324, P1562, DOI 10.1001/jama.2020.19545; Yang W, 2021, LANCET INFECT DIS, V21, P203, DOI 10.1016/S1473-3099(20)30769-6; Zelner J, 2021, CLIN INFECT DIS, V72, pE88, DOI 10.1093/cid/ciaa1723; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	52	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0253549	10.1371/journal.pone.0253549	http://dx.doi.org/10.1371/journal.pone.0253549			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166416	gold, Green Published			2022-12-26	WOS:000671692800043
J	Laborda, J; Rivera-Torres, P; Salas-Fumas, V; Suarez, C				Laborda, Juan; Rivera-Torres, Pilar; Salas-Fumas, Vicente; Suarez, Cristina			Is there life beyond the Spanish government's aid to furloughed employees by COVID-19?	PLOS ONE			English	Article							NONRESPONSE BIAS; RATES	This paper examines the perceptions of firms in April 2020, one month after the Spanish Government declared the state of alarm, about how the COVID-19 pandemic will affect their business activity in the following months, and what employment decisions they expect to make in response. The data for the study was collected by the Government of the region of Aragon (Spain) through a survey of a non-randomly selected sample of firms located in the region. In addition to prospects and intended actions, firms were asked whether or not they had applied for ERTE aid (the Spanish job retention scheme to contain the pandemic crisis). We find that firms participating (voluntarily and anonymously) in the survey anticipated rather well the severity of the effects of the pandemic in the following months. The ERTE aid helped firms to maintain the jobs of their inactive employees, while firms that did not ask for aid responded by laying off employees. Further, the ERTE aid helped to maintain the jobs of furloughed employees, but the firms receiving ERTE aid expected to lay off the same proportion of employees as firms without that aid, controlling for the different anticipated effects of the pandemic in the two groups of firms.	[Laborda, Juan] Univ Carlos III, Dept Business Adm, Madrid, Spain; [Rivera-Torres, Pilar] Univ Zaragoza, Dept Mkt Management & Market Res, Zaragoza, Spain; [Salas-Fumas, Vicente] Univ Zaragoza, Dept Business Adm & Org, Zaragoza, Spain; [Suarez, Cristina] Univ Alcala, Dept Econ, Madrid, Spain	Universidad Carlos III de Madrid; University of Zaragoza; University of Zaragoza; Universidad de Alcala	Suarez, C (corresponding author), Univ Alcala, Dept Econ, Madrid, Spain.	cristina.suarez@uah.es	Laborda, Juan/AAP-9485-2021; RIVERA-TORRES, PILAR/K-8088-2017; Suarez, Cristina/AAG-1283-2019	Laborda, Juan/0000-0002-1713-086X; RIVERA-TORRES, PILAR/0000-0001-9319-5895; Suarez, Cristina/0000-0003-2579-0734	Spanish Ministerio de Economia y Competitividad; FEDER [ECO2017-86305-C4-3-R]; CREVALOR research group - Gobierno de Aragon	Spanish Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); CREVALOR research group - Gobierno de Aragon	This research was funded by the Spanish Ministerio de Economia y Competitividad and FEDER, grant number ECO2017-86305-C4-3-R and CREVALOR research group, funded by the Gobierno de Aragon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen T, 2020, 158 IZA 158 IZA; Aspachs O, 2020, ECON POLICY, V1734; Bennedsen M, 2020, GLO DISCUSSION PAPER, V588; Benzeval M., 2020, UNDERSTANDING SOC WO; Bertrand M., 2020, 26989 NBER; Biemer PP., 2003, INTRO SURVEY QUALITY, DOI [10.1007/s10006-002-0437-9, DOI 10.1007/S10006-002-0437-9]; Bloom N., 2020, 28233 NBER; Boeri T, 2011, ECON POLICY, P697, DOI 10.1111/j.1468-00327.2011.271.x; Brodeur A, 2020, GLO DISCUSSION PAPER, V601; Cahuc P., 2011, NORDIC EC POLICY REV, V1, P133; Cheng Wei., 2020, 27419 NBER; Chetty R., 2020, EC IMPACTS COVID 19; Daas PJH, 2015, J OFF STAT, V31, P249, DOI 10.1515/JOS-2015-0016; Fernandez A., 2021, ANAL ARTICLES EC B B ANAL ARTICLES EC B B, P1; Fernandez J., 2015, ARAGON NUESTRO OHIO ARAGON NUESTRO OHIO; Gertler P. J., 2016, IMPACT EVALUATION PR; Giupponi G, 2018, CEP DISCUSSION PAPER; Gobierno de Aragon, B EC B EC; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Hijzen A, 2020, IN PRESS; INE (Spanish Statistical Office), 2021, EC ACT EMPL UN DAT EC ACT EMPL UN DAT; International Monetary Fund (IMF), 2020, POLICY QUARTERLY; Japec L, 2015, PUBLIC OPIN QUART, V79, P839, DOI 10.1093/poq/nfv039; Juranek S, 2020, 3671259 SSRN 3671259 SSRN; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Kong E., 2020, COVID EC, V17, P24; Marco-Fondevila M, 2018, CORP SOC RESP ENV MA, V25, P756, DOI 10.1002/csr.1492; Meterko M, 2015, PUBLIC OPIN QUART, V79, P130, DOI 10.1093/poq/nfu052; Ministerio de Trabajo y Economia, 2021, EST REG EMPL EST REG EMPL; Moller J, 2013, J LABOUR MARK RES, V46, P183, DOI [10.1007/s12651-013-0143-0, 10.1007/s12651-012-0124-8]; Rivera-Torres P, 2020, EMPRESAS ARAGONESAS; Scott D, 2020, 102390 MPRA 102390 MPRA; Yasar M, 2005, ECON LETT, V88, P397, DOI 10.1016/j.econlet.2005.05.001	33	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253331	10.1371/journal.pone.0253331	http://dx.doi.org/10.1371/journal.pone.0253331			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BO	34161381	Green Published, gold			2022-12-26	WOS:000671691900038
J	Mertens, A; Bawin, Y; Vanden Abeele, S; Kallow, S; Vu, DT; Le, LT; Vu, TD; Swennen, R; Vandelook, F; Panis, B; Janssens, SB				Mertens, Arne; Bawin, Yves; Vanden Abeele, Samuel; Kallow, Simon; Dang Toan Vu; Loan Thi Le; Tuong Dang Vu; Swennen, Rony; Vandelook, Filip; Panis, Bart; Janssens, Steven B.			Genetic diversity and structure of Musa balbisiana populations in Vietnam and its implications for the conservation of banana crop wild relatives	PLOS ONE			English	Article							SOFTWARE; CHINA; CLUSTERS; TAXONOMY; PACKAGE; MARKERS; ORIGIN; NUMBER; COLLA	Crop wild relatives (CWR) are an indispensable source of alleles to improve desired traits in related crops. While knowledge on the genetic diversity of CWR can facilitate breeding and conservation strategies, it has poorly been assessed. Cultivated bananas are a major part of the diet and income of hundreds of millions of people and can be considered as one of the most important fruits worldwide. Here, we assessed the genetic diversity and structure of Musa balbisiana, an important CWR of plantains, dessert and cooking bananas. Musa balbisiana has its origin in subtropical and tropical broadleaf forests of northern Indo-Burma. This includes a large part of northern Vietnam where until now, no populations have been sampled. We screened the genetic variation and structure present within and between 17 Vietnamese populations and six from China using 18 polymorphic SSR markers. Relatively high variation was found in populations from China and central Vietnam. Populations from northern Vietnam showed varying levels of genetic variation, with low variation in populations near the Red River. Low genetic variation was found in populations of southern Vietnam. Analyses of population structure revealed that populations of northern Vietnam formed a distinct genetic cluster from populations sampled in China. Together with populations of central Vietnam, populations from northern Vietnam could be subdivided into five clusters, likely caused by mountain ranges and connected river systems. We propose that populations sampled in central Vietnam and on the western side of the Hoang Lien Son mountain range in northern Vietnam belong to the native distribution area and should be prioritised for conservation. Southern range edge populations in central Vietnam had especially high genetic diversity, with a high number of unique alleles and might be connected with core populations in northern Laos and southwest China. Southern Vietnamese populations are considered imported and not native.	[Mertens, Arne; Kallow, Simon; Swennen, Rony] Katholieke Univ Leuven, Lab Trop Crop Improvement, Dept Biosyst, Leuven, Belgium; [Mertens, Arne; Bawin, Yves; Vanden Abeele, Samuel; Vandelook, Filip; Janssens, Steven B.] Meise Bot Garden, Meise, Belgium; [Bawin, Yves] Katholieke Univ Leuven, Ecol Evolut & Biodivers Conservat, Dept Biol, Leuven, Belgium; [Kallow, Simon] Royal Bot Gardens Kew, Millennium Seed Bank, Haywards Heath, W Sussex, England; [Dang Toan Vu; Tuong Dang Vu] VAAS, Res Planning & Int Dept, Plant Resources Ctr, Hanoi, Vietnam; [Loan Thi Le] VAAS, Dept Genebank Management, Plant Resources Ctr, Hanoi, Vietnam; [Swennen, Rony] Int Inst Trop Agr, Arusha, Tanzania; [Panis, Bart] Biovers Int, Leuven, Belgium; [Janssens, Steven B.] Katholieke Univ Leuven, Dept Biol, Mol Biotechnol Plants & Microorganisms, Leuven, Belgium	KU Leuven; KU Leuven; Royal Botanic Gardens, Kew; Alliance; Bioversity International; KU Leuven	Mertens, A (corresponding author), Katholieke Univ Leuven, Lab Trop Crop Improvement, Dept Biosyst, Leuven, Belgium.; Mertens, A (corresponding author), Meise Bot Garden, Meise, Belgium.	arne.mertens70@gmail.com	Toan, Vu Dang/AGR-3361-2022; Vu, Tuong Dang/AAZ-6533-2021; Vu, Dang Toan/AFY-6646-2022	Vu, Tuong Dang/0000-0001-7784-6598; Vu, Dang Toan/0000-0003-3589-6428; Kallow, Simon/0000-0002-0869-5797; Swennen, Rony/0000-0002-5258-9043; Panis, Bart/0000-0001-6717-947X; Bawin, Yves/0000-0002-1663-6535; Mertens, Arne/0000-0003-3272-9464	Research Foundation Flanders (FWO) through the Flanders Bilateral Research Cooperation with Vietnam project [G0D9318N]; Vietnamese National Foundation for Science and Technology Development (NAFOSTED) [FWO.106-NN.2017.02]; Bill and Melinda Gates foundation through the BBTV mitigation project; CGIAR Fund; CGIAR Research Program for Roots, Tubers and Bananas (CRPRTB)	Research Foundation Flanders (FWO) through the Flanders Bilateral Research Cooperation with Vietnam project(FWO); Vietnamese National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Bill and Melinda Gates foundation through the BBTV mitigation project; CGIAR Fund(CGIAR); CGIAR Research Program for Roots, Tubers and Bananas (CRPRTB)(CGIAR)	This work was mainly funded through the Research Foundation Flanders (FWO) through the Flanders Bilateral Research Cooperation with Vietnam project with reference "G0D9318N", the Vietnamese National Foundation for Science and Technology Development (NAFOSTED) under grant number FWO.106-NN.2017.02, and the Bill and Melinda Gates foundation through the BBTV mitigation project. This work was additionally supported by the CGIAR Fund (https://www.cgiar.org/funders/) and in particular the CGIAR Research Program for Roots, Tubers and Bananas (CRPRTB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; [Anonymous], 2021, NAT COMMUN, V12, P1258, DOI [10.1038/s41467-020-20851-4, DOI 10.1038/S41467-020-20168-2]; [Anonymous], 2020, PATHWAY VIRUSES, V12, P418, DOI [10.3390/v12040418, DOI 10.3390/V12040418, DOI 10.3390/V12050549]; [Anonymous], 2010, HARM REG OV BIOT, P84, DOI [10.1079/9781845936587.0000, DOI 10.1079/9781845936587.0000]; ARGENT G C G, 1976, Notes from the Royal Botanic Garden Edinburgh, V35, P77; Arias P., 2003, WORLD BANANA EC 1985; Averyanov LV, 2003, KOMAROVIA, V3, P1; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Balloux F, 2003, GENETICS, V164, P1635; Baurens FC, 2019, MOL BIOL EVOL, V36, P97, DOI 10.1093/molbev/msy199; Belkhir K, 2004, GENETIX 4 05; Bona A, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1357-2; Brown A, 2017, GENETIC IMPROVEMENT OF TROPICAL CROPS, P219, DOI 10.1007/978-3-319-59819-2_7; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Calberto G., 2015, Climate change and food systems: global assessments and implications for food security and trade, P264; CARREEL F, 1994, GENET SEL EVOL, V26, pS125, DOI 10.1051/gse:19940709; Castaneda-Alvarez NP, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.22, 10.1038/nplants.2016.22]; CENCI A, 2019, BMC GENOM, V0020; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Cole CT, 2003, ANNU REV ECOL EVOL S, V34, P213, DOI 10.1146/annurev.ecolsys.34.030102.151717; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; Daniells J., 2001, MUSALOGUE CATALOGUE; De Langhe E, 2010, ANN BOT-LONDON, V106, P849, DOI 10.1093/aob/mcq187; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Elevitch CR., 2006, SPECIES PROFILES PAC, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eyland D, 2021, CROP SCI, V61, P137, DOI 10.1002/csc2.20320; FAO, 2021, FAO GIAHS LOG BLOCK, DOI DOI 10.4060/CA9177-N; FAO, BAN MARK REV PREL RE; Ford-Lloyd BV, 2011, BIOSCIENCE, V61, P559, DOI 10.1525/bio.2011.61.7.10; Frick WF, 2020, ANN NY ACAD SCI, V1469, P5, DOI 10.1111/nyas.14045; Garner TWJ, 2004, MOL ECOL, V13, P1047, DOI 10.1111/j.1365-294X.2004.02119.x; Ge XJ, 2005, MOL ECOL, V14, P933, DOI 10.1111/j.1365-294X.2005.02467.x; Gibbs A., 2020, BANANA SUCKER; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hakkinen M, 2013, TAXON, V62, P809, DOI 10.12705/624.3; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Herden T, 2020, ECOL EVOL, V10, P875, DOI 10.1002/ece3.5947; Herrando-Moraira YF, 2018, NAT COMMUN, P9, DOI [10.1038/s41467-017-01881-x, DOI 10.1038/S41467-017-01881-X]; Hippolyte I, 2012, ANN BOT-LONDON, V109, P937, DOI 10.1093/aob/mcs010; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Janssens SB, 2016, NEW PHYTOL, V210, P1453, DOI 10.1111/nph.13856; Diez MJ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01794; Jouneghani RS, 2020, FOODS, V9, DOI 10.3390/foods9040435; Kepler A. K., 2007, SPECIES PROFILES PAC, P1; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Korzun, 2013, BATS VIETNAM CHECKLI; Kumar K.P.S., 2012, J PHARMACOGN PHYTOCH, V1, P51; Langhe E. de, 2015, Ethnobotany Research and Applications, V14, P299, DOI 10.17348/era.14.0.299-312; Lefebvre V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23210-y; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Mattos-Moreira LA, 2018, ACTA PHYSIOL PLANT, V40, DOI 10.1007/s11738-018-2638-3; Mertens A, 2021, DIGEST SURG, DOI 10.1159/000519785; Nakato GV, 2019, PLANT PATHOL, V68, P49, DOI 10.1111/ppa.12945; Navascues M, 2010, HEREDITY, V104, P482, DOI 10.1038/hdy.2009.159; Nemeckova A, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01371; Ocan D., 2008, Journal of Applied Biosciences, V9, P407; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Onyekachi O.G., 2019, ABIOTIC BIOTIC STRES, V17, DOI [10.5772/intechopen.82681, DOI 10.5772/INTECHOPEN.82681]; Pappert RA, 2000, AM J BOT, V87, P1240, DOI 10.2307/2656716; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Price NS., 1995, BANANAS PLANTAINS, P1, DOI [10.1007/978-94-011-0737-2_1, DOI 10.1007/978-94-011-0737-2_1]; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; R Core Team, R LANG ENV STAT COMP; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rodriguez-Bonilla L, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111446; Rotchanapreeda T, 2016, PLANT SYST EVOL, V302, P739, DOI 10.1007/s00606-015-1274-2; Sardos J, 2016, ANN BOT-LONDON, V118, P1269, DOI 10.1093/aob/mcw170; Searchinger T., 2019, CREATING SUSTAINABLE; Shepherd K, 1999, CYTOGENETICS GENUS M; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Start A. N., 1976, Tropical trees: variation, breeding and conservation (ed. J. Burley and B.T. Styles)., P141; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; THANH H, 2019, TAP CHI SINH HOC, V41, P117, DOI DOI 10.15625/0866-7160/V41N4.14695; The World Bank, 2020, WORLD TERR TEL SEA L; The World Bank, 2020, WORLD BANK OFF BOUND; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tripathi L, 2008, EUR J PLANT PATHOL, V121, P9, DOI 10.1007/s10658-007-9235-4; Tripathi L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43421-1; Ude G, 2002, THEOR APPL GENET, V104, P1246, DOI 10.1007/s00122-002-0914-4; Uma S, 2006, GENET RESOUR CROP EV, V53, P349, DOI 10.1007/s10722-004-0576-y; Valmayor R., 2000, BANANA CULTIVAR NAME; Vincent H, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0372-z; Wang JY, 2011, PLANT BREEDING, V130, P584, DOI 10.1111/j.1439-0523.2011.01861.x; Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650; Wang XL, 2007, GENET RESOUR CROP EV, V54, P1125, DOI 10.1007/s10722-006-9004-9; Wang Z, 2019, NAT PLANTS, V5, P810, DOI 10.1038/s41477-019-0452-6; Yang R, 2017, PLANT DIVERSITY, V39, P44, DOI 10.1016/j.pld.2016.11.003; Yuan ZY, 2016, CURR ZOOL, V62, P531, DOI 10.1093/cz/zow042; Zhang Q, 2011, PHOTOSYNTHETICA, V49, P201, DOI 10.1007/s11099-011-0012-4	100	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0253255	10.1371/journal.pone.0253255	http://dx.doi.org/10.1371/journal.pone.0253255			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161368	gold, Green Published			2022-12-26	WOS:000671691900045
J	Kang, IS; Kong, KA				Kang, In Sook; Kong, Kyoung Ae			Body mass index and severity/fatality from coronavirus disease 2019: A nationwide epidemiological study in Korea	PLOS ONE			English	Article							RISK; INFECTION; DEATH; COV	Objective Obesity has been reported as a risk factor for severe coronavirus disease 2019 (COVID-19) in recent studies. However, the relationship between body mass index (BMI) and COVID-19 severity and fatality are unclear. Research design and methods This study included 4,141 COVID-19 patients who were released from isolation or had died as of April 30, 2020. This nationwide data was provided by the Korean Centers for Disease Control and Prevention Agency. BMI was categorized as follows; < 18.5 kg/m(2), 18.5-22.9 kg/m(2), 23.0-24.9 kg/m(2), 25.0-29.9 kg/m(2), and >= 30 kg/m(2). We defined a fatal illness if the patient had died. Results Among participants, those with a BMI of 18.5-22.9 kg/m(2) were the most common (42.0%), followed by 25.0-29.9 kg/m(2) (24.4%), 23.0-24.9 kg/m(2) (24.3%), >= 30 kg/m(2) (4.7%), and < 18.5 kg/m(2) (4.6%). In addition, 1,654 (41.2%) were men and 3.04% were fatalities. Multivariable analysis showed that age, male sex, BMI < 18.5 kg/m(2), BMI >= 25 kg/m(2), diabetes mellitus, chronic kidney disease, cancer, and dementia were independent risk factors for fatal illness. In particular, BMI < 18.5 kg/m(2) (odds ratio [OR] 3.97, 95% CI 1.77-8.92), 25.0-29.9 kg/m(2) (2.43, 1.32-4.47), and >= 30 kg/m(2) (4.32, 1.37-13.61) were found to have higher ORs than the BMI of 23.0-24.9 kg/m(2) (reference). There was no significant difference between those with a BMI of 18.5-22.9 kg/m(2) (1.59, 0.88-2.89) and 23.0-24.9 kg/m(2). Conclusions This study demonstrated a non-linear (U-shaped) relationship between BMI and fatal illness. Subjects with a BMI of < 18.5 kg/m(2) and those with a BMI >= 25 kg/m(2) had a high risk of fatal illness. Maintaining a healthy weight is important not only to prevent chronic cardiometabolic diseases, but also to improve the outcome of COVID-19.	[Kang, In Sook] Ewha Womans Univ, Mokdong Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea; [Kong, Kyoung Ae] Ewha Womans Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Kang, IS (corresponding author), Ewha Womans Univ, Mokdong Hosp, Coll Med, Div Cardiol,Dept Internal Med, Seoul, South Korea.	pinkvision@ewha.ac.kr		Kang, In Sook/0000-0002-0477-683X				Anderson MR, 2020, ANN INTERN MED, V173, P782, DOI 10.7326/M20-3214; Arbel Y, 2020, INT J OBESITY, V44, P2339, DOI 10.1038/s41366-020-00680-7; Badawi A, 2016, INT J INFECT DIS, V49, P129, DOI 10.1016/j.ijid.2016.06.015; Bangalore S, 2020, NEW ENGL J MED, V382, P2478, DOI 10.1056/NEJMc2009020; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Blumentals WA, 2012, INFLUENZA OTHER RESP, V6, P28, DOI 10.1111/j.1750-2659.2011.00262.x; Cai QX, 2020, DIABETES CARE, V43, P1392, DOI 10.2337/dc20-0576; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Ding YQ, 2004, J PATHOL, V203, P622, DOI 10.1002/path.1560; Dobner J, 2018, CLIN MICROBIOL INFEC, V24, P24, DOI 10.1016/j.cmi.2017.02.013; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Duan Jiahao, 2020, Eur Heart J, V41, P1833, DOI 10.1093/eurheartj/ehaa325; Freuer D, 2021, METABOLISM, V118, DOI 10.1016/j.metabol.2021.154732; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Henry BM, 2020, INT UROL NEPHROL, V52, P1193, DOI 10.1007/s11255-020-02451-9; Kim IC, 2020, EUR HEART J, V41, P2334, DOI 10.1093/eurheartj/ehaa474; Kompaniyets L, 2021, MMWR-MORBID MORTAL W, V70, P355, DOI 10.15585/mmwr.mm7010e4; Kong KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185024; Lavie CJ, 2018, J AM COLL CARDIOL, V72, P1506, DOI 10.1016/j.jacc.2018.08.1037; Li S, 2021, BMC MED GENOMICS, V14, DOI 10.1186/s12920-021-00887-1; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Lim S, 2020, J OBES METAB SYNDR, V29, P84, DOI 10.7570/jomes20056; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Nie W, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-61; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Peres KC, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00562; Ponsford MJ, 2020, CIRCULATION, V142, P1791, DOI 10.1161/CIRCULATIONAHA.120.050753; Rebello CJ, 2020, INT J OBESITY, V44, P1810, DOI 10.1038/s41366-020-0640-5; Sattar N, 2020, DIABETES METAB SYND, V14, P1149, DOI 10.1016/j.dsx.2020.06.060; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Tavazzi G, 2020, EUR J HEART FAIL, V22, P911, DOI 10.1002/ejhf.1828; Thaweerat W, 2020, PANCREATOLOGY, V20, P1013, DOI 10.1016/j.pan.2020.05.015; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 2000, AS PAC PERSP RED OB; Wu CL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095300, 10.1371/journal.pone.0102589]; Yates T, 2020, PRIM CARE DIABETES, V14, P566, DOI 10.1016/j.pcd.2020.05.011; Yi SW, 2015, INT J EPIDEMIOL, V44, P1696, DOI 10.1093/ije/dyv138; Yoon JL, 2015, J KOREAN MED SCI, V30, P162, DOI 10.3346/jkms.2015.30.2.162	41	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 22	2021	16	6							e0253640	10.1371/journal.pone.0253640	http://dx.doi.org/10.1371/journal.pone.0253640			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BH	34157043	Green Published, gold			2022-12-26	WOS:000671691200034
J	Onywera, H; Anejo-Okopi, J; Mwapagha, LM; Okendo, J; Williamson, AL				Onywera, Harris; Anejo-Okopi, Joseph; Mwapagha, Lamech M.; Okendo, Javan; Williamson, Anna-Lise			Predictive functional analysis reveals inferred features unique to cervicovaginal microbiota of African women with bacterial vaginosis and high-risk human papillomavirus infection	PLOS ONE			English	Article							VAGINAL MICROBIOTA; MOTILITY; PREVALENCE; RESISTANCE; SEQUENCES	Mounting evidence suggests that Lactobacillus species may not necessarily be the sine qua non of healthy cervicovaginal microbiota (CVM), especially among reproductive-age African women. A majority of African women have high-diversity non-Lactobacillus-dominated CVM whose bacterial functions remain poorly characterized. Functional profiling of the CVM is vital for investigating human host-microbiota interactions in health and disease. Here, we investigated the functional potential of L. iners-dominated and high-diversity non-Lactobacillus-dominated CVM of 75 African women with and without bacterial vaginosis (BV) and high-risk human papillomavirus (HR-HPV) infection. Functional contents were predicted using PICRUSt. Microbial taxonomic diversity, BV, and HR-HPV infection statuses were correlated with the inferred functional composition of the CVM. Differentially abundant inferred functional categories were identified using linear discriminant analysis (LDA) effect size (LEfSe) (p-value 2.0). Of the 75 women, 56 (74.7%), 35 (46.7%), and 29 (38.7%) had high-diversity non-Lactobacillus-dominated CVM, BV, and HR-HPV infection, respectively. Alpha diversity of the inferred functional contents (as measured by Shannon diversity index) was significantly higher in women with high-diversity non-Lactobacillus-dominated CVM and BV than their respective counterparts (H statistic >= 11.5, q-value <0.001). Ordination of the predicted functional metagenome content (using Bray-Curtis distances) showed that the samples segregated according to the extent of microbial taxonomic diversity and BV (pseudo-F statistic >= 19.6, q-value = 0.001) but not HR-HPV status (pseudo-F statistic = 1.7, q-value = 0.159). LEfSe analysis of the inferred functional categories revealed that transport systems (including ABC transporters) and transcription factors were enriched in high-diversity CVM. Interestingly, transcription factors and sporulation functional categories were uniquely associated with high-diversity CVM, BV, and HR-HPV infection. Our predictive functional analysis reveals features unique to high-diversity CVM, BV and HR-HPV infections. Such features may represent important biomarkers of BV and HR-HPV infection. Our findings require proof-of-concept functional studies to examine the relevance of these potential biomarkers in women's reproductive health and disease.	[Onywera, Harris; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Onywera, Harris; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Onywera, Harris] Tunacare Serv Hlth Providers Ltd, Res Innovat & Acad Unit, Nairobi, Kenya; [Anejo-Okopi, Joseph] Univ Jos, Dept Microbiol, Jos, Nigeria; [Anejo-Okopi, Joseph] Jos Univ, AIDS Prevent Initiat Nigeria, Teaching Hosp, Jos, Nigeria; [Mwapagha, Lamech M.] Namibia Univ Sci & Technol, Fac Hlth & Appl Sci, Dept Nat & Appl Sci, Windhoek, Namibia; [Okendo, Javan] Univ Cape Town, Fac Hlth Sci, Dept Integrat Biomed Sci, Div Chem & Syst Biol, Cape Town, South Africa; [Okendo, Javan] Strathmore Univ, Ctr Res Therapeut Sci Creates, Nairobi, Kenya; [Williamson, Anna-Lise] Univ Cape Town, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Jos; Namibia University of Science & Technology; University of Cape Town; Strathmore University; University of Cape Town	Onywera, H (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Onywera, H (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa.; Onywera, H (corresponding author), Tunacare Serv Hlth Providers Ltd, Res Innovat & Acad Unit, Nairobi, Kenya.	harris.onywera@uct.ac.za	Okendo, Javan/GPP-6462-2022	Onywera, Harris/0000-0002-7298-4921; Okendo, Javan Ochieng/0000-0001-6897-5224; Mwapagha, Lamech/0000-0003-1048-1787	South African Research Chairs Initiative of the National Research Foundation [64815]; Poliomyelitis Research Foundation (PRF); Cancer Association of South Africa; University of Cape Town Research Incentive Scheme; University of Cape Town Cancer Research Initiative; University of Cape Town International and Refugee Students' Scholarship; University of Cape Town Faculty of Health Sciences Postdoctoral Research Fellowship; South African Research Chairs Initiative of the National Research Foundation (NRF) Postdoctoral Grantholder Bursary	South African Research Chairs Initiative of the National Research Foundation; Poliomyelitis Research Foundation (PRF); Cancer Association of South Africa; University of Cape Town Research Incentive Scheme; University of Cape Town Cancer Research Initiative; University of Cape Town International and Refugee Students' Scholarship; University of Cape Town Faculty of Health Sciences Postdoctoral Research Fellowship; South African Research Chairs Initiative of the National Research Foundation (NRF) Postdoctoral Grantholder Bursary	ALW: South African Research Chairs Initiative of the National Research Foundation (Grant Number: 64815), Poliomyelitis Research Foundation (PRF), Cancer Association of South Africa, University of Cape Town Research Incentive Scheme, and University of Cape Town Cancer Research Initiative. HO: University of Cape Town International and Refugee Students' Scholarship, University of Cape Town Faculty of Health Sciences Postdoctoral Research Fellowship, and South African Research Chairs Initiative of the National Research Foundation (NRF) Postdoctoral Grantholder Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves P, 2014, J INFECT DIS, V210, P593, DOI 10.1093/infdis/jiu131; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Borgdorff H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181135; Borgdorff H, 2014, ISME J, V8, P1781, DOI 10.1038/ismej.2014.26; Bruni L, 2019, 17 ICO INF CTR HPV C 17 ICO INF CTR HPV C; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro J, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0012-7; Chaban B, 2015, SEMIN CELL DEV BIOL, V46, P91, DOI 10.1016/j.semcdb.2015.10.032; Chen HM, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5284-7; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Dareng EO, 2016, EPIDEMIOL INFECT, V144, P123, DOI 10.1017/S0950268815000965; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Feehily C, 2020, NPJ BIOFILMS MICROBI, V6, DOI 10.1038/s41522-020-00162-8; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Forney LJ, 2006, J INFECT DIS, V194, P1468, DOI 10.1086/508497; France MT, 2016, APPL ENVIRON MICROB, V82, P7063, DOI 10.1128/AEM.02385-16; Harwich MD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S4; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hijazi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131405; Hiron A, 2010, MOL MICROBIOL, V77, P1246, DOI 10.1111/j.1365-2958.2010.07287.x; Kenyon C, 2014, INT J INFECT DIS, V18, P73, DOI 10.1016/j.ijid.2013.09.014; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Kurman RJ, 1994, BETHESDA SYSTEM REPO; Kwon M, 2019, CANCERS, V11, DOI 10.3390/cancers11030309; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li F, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy107; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Mancabelli L, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.02899-20; Matilla MA, 2018, FEMS MICROBIOL REV, V42, P40, DOI 10.1093/femsre/fux052; Mbulawa ZZA, 2009, J INFECT DIS, V199, P1514, DOI 10.1086/598220; Mitra A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16865; Murphy K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216049; Mwapagha LM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00258; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Onywera H, 2020, SCI AFR, V7, DOI 10.1016/j.sciaf.2020.e00278; Onywera H, 2019, PEERJ, V7, DOI 10.7717/peerj.7488; Onywera H, 2019, PAPILLOMAVIRUS RES, V7, P154, DOI 10.1016/j.pvr.2019.04.006; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Petrova MI, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00081; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Schiller John T, 2010, Gynecol Oncol, V118, pS12, DOI 10.1016/j.ygyno.2010.04.004; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Si J, 2017, CELL HOST MICROBE, V21, P97, DOI 10.1016/j.chom.2016.11.010; Solano C, 2014, CURR OPIN MICROBIOL, V18, P96, DOI 10.1016/j.mib.2014.02.008; Soto SM, 2013, VIRULENCE, V4, P223, DOI 10.4161/viru.23724; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Ferreira CST, 2018, J LOW GENIT TRACT DI, V22, P147, DOI 10.1097/LGT.0000000000000367; Tango CN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66607-4; Usyk M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008376; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wessels JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187612; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zevin AS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005889	62	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253218	10.1371/journal.pone.0253218	http://dx.doi.org/10.1371/journal.pone.0253218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143825	Green Published, gold			2022-12-26	WOS:000671690700050
J	Garrett, C; Becker, TM; Lynch, D; Po, J; Xuan, W; Scott, KF; De Souza, P				Garrett, Celine; Becker, Therese M.; Lynch, David; Po, Joseph; Xuan, Wei; Scott, Kieran F.; de Souza, Paul			Comparison of neutrophil to lymphocyte ratio and prognostic nutritional index with other clinical and molecular biomarkers for prediction of glioblastoma multiforme outcome	PLOS ONE			English	Article							SURVIVAL; RESECTION; SURGERY; EXTENT; TEMOZOLOMIDE; INFLAMMATION; ASSOCIATION; ALBUMIN; BRAIN; AGE	Objective Pre- and post-operative neutrophil to lymphocyte ratio (NLR) and prognostic nutritional index (PNI) and other prognostic clinicopathological variables were correlated with progression free survival (PFS) and overall survival (OS) of Glioblastoma Multiforme (GBM) patients. Methods GBM patients (n = 87, single-centre, recruited 2013-2019) were retrospectively divided into low and high groups using literature-derived cut-offs (NLR = 5.07, PNI = 46.97). Kaplan-Meier survival curves and log rank tests assessed PFS and OS. Univariate and multivariate analyses identified PFS and OS prognosticators. Results High vs low post-operative PNI cohort was associated with longer PFS (279 vs 136 days, p = 0.009), but significance was lost on multivariate analysis. Post-operative ECOG (p = 0.043), daily dexamethasone (p = 0.023) and IDH mutation (p = 0.046) were significant on multivariate analysis for PFS. High pre- and post-operative PNI were associated with improved OS (384 vs 114 days, p = 0.034 and 516 vs 245 days, p = 0.001, respectively). Low postoperative NLR correlated with OS (408 vs 249 days, p = 0.029). On multivariate analysis using forward selection process, extent of resection (EOR) (GTR vs biopsy, p = 0.004 and STR vs biopsy, p = 0.011), and any previous surgery (p = 0.014) were independent prognostic biomarkers for OS. On multivariate analysis of these latter variables with literature-derived prognostic biomarkers, EOR remained significantly associated with OS (p = 0.037). Conclusions EOR, followed by having any surgery prior to GBM, are the most significant independent predictors of GBM patient's OS. Post-operative ECOG, daily dexamethasone and IDH mutation are independent prognostic biomarkers for PFS. PNI may be superior to NLR. Post- vs pre-operative serum inflammatory marker levels may be associated with survival.	[Garrett, Celine; Becker, Therese M.; Lynch, David; Scott, Kieran F.; de Souza, Paul] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia; [Garrett, Celine; Becker, Therese M.; Lynch, David; Po, Joseph; Xuan, Wei; Scott, Kieran F.; de Souza, Paul] Ingham Inst Appl Med Res, Circulating Tumour Cells Grp, Liverpool, NSW, Australia; [Becker, Therese M.; de Souza, Paul] Univ New South Wales, Sch Med, Kingsford, NSW, Australia; [de Souza, Paul] Univ Wollongong, Sch Med, Wollongong, NSW, Australia	University of Sydney; Western Sydney University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of Wollongong	Garrett, C (corresponding author), Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia.; Garrett, C (corresponding author), Ingham Inst Appl Med Res, Circulating Tumour Cells Grp, Liverpool, NSW, Australia.	celinegarrett@gmail.com		Becker, Therese/0000-0002-5636-9902; Garrett, Celine/0000-0002-7255-6580; Scott, Kieran/0000-0002-6012-4107				Alexiou GA, 2013, J NEURO-ONCOL, V115, P521, DOI 10.1007/s11060-013-1240-1; Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9; Brenner A, 2019, ONCOLOGY-BASEL, V97, P255, DOI 10.1159/000500926; Brown NF, 2018, BRIT J CANCER, V119, P1171, DOI 10.1038/s41416-018-0258-8; Brown TJ, 2016, JAMA ONCOL, V2, P1460, DOI 10.1001/jamaoncol.2016.1373; Cenciarini M, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00065; Chaichana KL, 2014, NEURO-ONCOLOGY, V16, P113, DOI 10.1093/neuonc/not137; Chen JR, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002583; Chowdhary M, 2018, J NEURO-ONCOL, V139, P689, DOI 10.1007/s11060-018-2914-5; Crosby G, 2011, ANESTH ANALG, V112, P999, DOI 10.1213/ANE.0b013e3182160431; Ding JD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013218; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Faria SS, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.702; Gan YJ, 2019, WORLD NEUROSURG, V127, pE261, DOI 10.1016/j.wneu.2019.03.085; Gately L, 2016, J NEURO-ONCOL, V129, P479, DOI 10.1007/s11060-016-2194-x; Guthrie GJK, 2013, CRIT REV ONCOL HEMAT, V88, P218, DOI 10.1016/j.critrevonc.2013.03.010; Hao YF, 2019, WORLD NEUROSURG, V128, pE427, DOI 10.1016/j.wneu.2019.04.169; He ZQ, 2017, J NEURO-ONCOL, V132, P239, DOI 10.1007/s11060-016-2361-0; Iwasaki Masae, 2015, Acta Anaesthesiol Taiwan, V53, P99, DOI 10.1016/j.aat.2015.07.002; Jafri NF, 2013, NEURO-ONCOLOGY, V15, P91, DOI 10.1093/neuonc/nos268; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lopes M, 2018, J NEURO-ONCOL, V136, P173, DOI 10.1007/s11060-017-2641-3; Maas SLN, 2019, WORLD NEUROSURG, V126, pE1081, DOI 10.1016/j.wneu.2019.03.053; Maeyama M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79465-x; Mason M, 2017, J NEURO-ONCOL, V132, P463, DOI 10.1007/s11060-017-2395-y; McNamara MG, 2014, J NEURO-ONCOL, V117, P147, DOI 10.1007/s11060-014-1366-9; Mitsuya K, 2017, J NEUROSURG, V127, P433, DOI 10.3171/2016.8.JNS16899; Mukherjee P, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0455-x; Pitter KL, 2016, BRAIN, V139, P1458, DOI 10.1093/brain/aww046; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Rigarnonti A, 2019, J NEUROL SCI, V400, P175, DOI 10.1016/j.jns.2019.04.002; Rominiyi O, 2021, BRIT J CANCER, V124, P697, DOI 10.1038/s41416-020-01136-5; Saether CA, 2012, J NEUROL SURG PART A, V73, P73, DOI 10.1055/s-0031-1297247; Sasmita AO, 2018, ASIA-PAC J CLIN ONCO, V14, P40, DOI 10.1111/ajco.12756; Shibutani M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1537-x; Shields LBE, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0527-0; Soeters PB, 2019, JPEN-PARENTER ENTER, V43, P181, DOI 10.1002/jpen.1451; Stupp R, 2017, JAMA-J AM MED ASSOC, V318, P2306, DOI 10.1001/jama.2017.18718; Tang JXX, 2013, ANN SURG, V257, P439, DOI 10.1097/SLA.0b013e318269d623; Travers S, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11050533; Wang PF, 2019, J CANCER, V10, P5654, DOI 10.7150/jca.33047; Wang PF, 2017, ONCOTARGET, V8, P50117, DOI 10.18632/oncotarget.15235; Wiencke JK, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0316-8; Xu WZ, 2017, ONCOTARGETS THER, V10, P725, DOI 10.2147/OTT.S127441; Zhang XY, 2017, J GASTROINTEST SURG, V21, P1626, DOI 10.1007/s11605-017-3414-1; Zheng SH, 2018, J NEUROSURG, V129, P583, DOI 10.3171/2017.3.JNS161648; Zhou XW, 2016, CLIN NEUROL NEUROSUR, V151, P86, DOI 10.1016/j.clineuro.2016.10.014	49	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252614	10.1371/journal.pone.0252614	http://dx.doi.org/10.1371/journal.pone.0252614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138894	Green Published, gold			2022-12-26	WOS:000671690200053
J	Kim, SY; Shen, Q; Son, K; Kim, HS; Yang, HD; Na, MJ; Shin, E; Yu, S; Kang, K; You, JS; Yu, KR; Jeong, SM; Lee, EK; Ahn, YM; Park, WS; Nam, SW				Kim, Sang Yean; Shen, Qingyu; Son, Keunhong; Kim, Hyung Seok; Yang, Hee Doo; Na, Min Jeong; Shin, Eunbi; Yu, Suji; Kang, Keunsoo; You, Jueng Soo; Yu, Kyung-Rok; Jeong, Seung Min; Lee, Eun Kyung; Ahn, Young Min; Park, Won Sang; Nam, Suk Woo			SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer	ONCOGENE			English	Article							COMPLEXES; ARID1A	SWItch/Sucrose Non-Fermentable (SWI/SNF) is a multiprotein complex essential for the regulation of eukaryotic gene expression. SWI/SNF complex genes are genetically altered in over 20% of human malignancies, but the aberrant regulation of the SWI/SNF subunit genes and subsequent dysfunction caused by abnormal expression of subunit gene in cancer, remain poorly understood. Among the SWI/SNF subunit genes, SMARCA4, SMARCC1, and SMARCA2 were identified to be overexpressed in human hepatocellular carcinoma (HCC). Modulation of SMARCA4, SMARCC1, and SMARCA2 inhibited in vitro tumorigenesis of HCC cells. However, SMARCA4-targeting elicited remarkable inhibition in an in vivo Ras-transgenic mouse HCC model (Ras-Tg), and high expression levels of SMARCA4 significantly associated with poor prognosis in HCC patients. Furthermore, most HCC patients (72-86%) showed SMARCA4 overexpression compared to healthy controls. To identify SMARCA4-specific active enhancers, mapping, and analysis of chromatin state in liver cancer cells were performed. Integrative analysis of SMARCA4-regulated genes and active chromatin enhancers suggested 37 genes that are strongly activated by SMARCA4 in HCC. Through chromatin immunoprecipitation-qPCR and luciferase assays, we demonstrated that SMARCA4 activates Interleukin-1 receptor-associated kinase 1 (IRAK1) expression through IRAK1 active enhancer in HCC. We then showed that transcriptional activation of IRAK1 induces oncoprotein Gankyrin and aldo-keto reductase family 1 member B10 (AKR1B10) in HCC. The regulatory mechanism of the SMARCA4-IRAK1-Gankyrin, AKR1B10 axis was further demonstrated in HCC cells and in vivo Ras-Tg mice. Our results suggest that aberrant overexpression of SMARCA4 causes SWI/SNF to promote IRAK1 enhancer to activate oncoprotein Gankyrin and AKR1B10, thereby contributing to hepatocarcinogenesis.	[Kim, Sang Yean; Shen, Qingyu; Na, Min Jeong; Shin, Eunbi; Yu, Suji; Park, Won Sang; Nam, Suk Woo] Catholic Univ Korea, Dept Pathol, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea; [Kim, Sang Yean; Na, Min Jeong; Shin, Eunbi; Yu, Suji; Park, Won Sang; Nam, Suk Woo] Catholic Univ Korea, Funct RNom Res Ctr, 222 Banpo Daero, Seoul 06591, South Korea; [Kim, Sang Yean; Na, Min Jeong; Shin, Eunbi; Yu, Suji; Nam, Suk Woo] Catholic Univ Korea, Grad Sch Med, Dept Biomed Hlth Sci, 222 Banpo Daero, Seoul 06591, South Korea; [Son, Keunhong; Kang, Keunsoo] Dankook Univ, Dept Microbiol, Cheonan 31116, South Korea; [Kim, Hyung Seok; Yang, Hee Doo; Nam, Suk Woo] NEORNAT Inc, Rm 305 Med Sch Bldg,222 Banpo Daero, Seoul, South Korea; [You, Jueng Soo] Konkuk Univ, Res Inst Med Sci, Sch Med, Dept Biochem, Seoul 05029, South Korea; [Yu, Kyung-Rok] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 08826, South Korea; [Jeong, Seung Min; Lee, Eun Kyung] Catholic Univ Korea, Dept Biochem, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea; [Ahn, Young Min] Kyung Hee Univ, Dept Kidney Syst, Coll Oriental Med, Seoul 02447, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Dankook University; Konkuk University; Konkuk University Medical Center; Seoul National University (SNU); Catholic University of Korea; Kyung Hee University	Nam, SW (corresponding author), Catholic Univ Korea, Dept Pathol, Coll Med, 222 Banpo Daero, Seoul 06591, South Korea.; Nam, SW (corresponding author), Catholic Univ Korea, Funct RNom Res Ctr, 222 Banpo Daero, Seoul 06591, South Korea.; Nam, SW (corresponding author), Catholic Univ Korea, Grad Sch Med, Dept Biomed Hlth Sci, 222 Banpo Daero, Seoul 06591, South Korea.; Nam, SW (corresponding author), NEORNAT Inc, Rm 305 Med Sch Bldg,222 Banpo Daero, Seoul, South Korea.	swnam@catholic.ac.kr	SHEN, QINGYU/U-8848-2018	Kim, Hyung Seok/0000-0003-2784-0109	National Research Foundation (NRF) of Korea [2017R1A2B3002989, 2021M3E5E7021893]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	We acknowledge support from the National Research Foundation (NRF) of Korea (2017R1A2B3002989 and 2021M3E5E7021893).	Alver BH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14648; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Cheng BY, 2018, CANCER RES, V78, P2332, DOI 10.1158/0008-5472.CAN-17-2445; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Hu B, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12791; Jubierre L, 2016, ONCOGENE, V35, P5179, DOI 10.1038/onc.2016.50; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; O'Neil NJ, 2017, NAT REV GENET, V18, P613, DOI 10.1038/nrg.2017.47; Saladi SV, 2017, CANCER CELL, V31, P35, DOI 10.1016/j.ccell.2016.12.001; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Su B, 2015, HEPATOLOGY, V61, P585, DOI 10.1002/hep.27551; Sun XX, 2017, CANCER CELL, V32, P574, DOI 10.1016/j.ccell.2017.10.007; Wang AG, 2005, J HEPATOL, V43, P836, DOI 10.1016/j.jhep.2005.04.012; Wang P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2289-3; Yang HD, 2019, HEPATOLOGY, V70, P1262, DOI 10.1002/hep.30657	19	6	5	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4652	4662		10.1038/s41388-021-01875-6	http://dx.doi.org/10.1038/s41388-021-01875-6		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34140644				2022-12-26	WOS:000662838900004
J	Maston, G; Franklin, J; Hocking, S; Swinbourne, J; Gibson, A; Manson, E; Sainsbury, A; Markovic, T				Maston, Gabrielle; Franklin, Janet; Hocking, Samantha; Swinbourne, Jessica; Gibson, Alice; Manson, Elisa; Sainsbury, Amanda; Markovic, Tania			Dietary adherence and program attrition during a severely energy-restricted diet among people with complex class III obesity: A qualitative exploration	PLOS ONE			English	Article							WEIGHT-LOSS INTERVENTIONS; SELF-DETERMINATION THEORY; SOCIOECONOMIC DISADVANTAGE; RISK-FACTOR; HEALTH; METAANALYSIS; OVERWEIGHT; INCREASES; EFFICACY; DISEASE	Meal replacement Severely Energy-Restricted Diets (SERDs) produce >= 10% loss of body mass when followed for 6 weeks or longer in people with class III obesity (BMI >= 40 kg/m(2)). The efficacy of SERDs continues to be questioned by healthcare professionals, with concerns about poor dietary adherence. This study explored facilitators and barriers to dietary adherence and program attrition among people with class III obesity who had attempted or completed a SERD in a specialised weight loss clinic. Participants who commenced a SERD between January 2016 to May 2018 were invited to participate. Semi-structured in-depth interviews were conducted from September to October 2018 with 20 participants (12 women and 8 men). Weight change and recounted events were validated using the participants' medical records. Data were analysed by thematic analysis using line-by-line inductive coding. The mean age +/- SD of participants was 51.2 +/- 11.3 years, with mean +/- SD BMI at baseline 63.7 +/- 12.6 kg/m(2). Five themes emerged from participants' recounts that were perceived to facilitate dietary adherence: (1.1) SERD program group counselling and psychoeducation sessions, (1.2) emotionally supportive clinical staff and social networks that accommodated and championed change in dietary behaviours, (1.3) awareness of eating behaviours and the relationship between these and progression of disease, (1.4) a resilient mindset, and (1.5) dietary simplicity, planning and self-monitoring. There were five themes on factors perceived to be barriers to adherence, namely: (2.1) product unpalatability, (2.2) unrealistic weight loss expectations, (2.3) poor program accessibility, (2.4) unforeseeable circumstances and (2.5) externalised weight-related stigma. This study highlights opportunities where SERD programs can be optimised to facilitate dietary adherence and reduce barriers, thus potentially improving weight loss outcomes with such programs. Prior to the commencement of a SERD program, healthcare professionals facilitating such programs could benefit from reviewing participants to identify common barriers. This includes identifying the presence of product palatability issues, unrealistic weight loss expectations, socio-economic disadvantage, and behaviour impacting experiences of externalised weight-related stigma.	[Maston, Gabrielle; Hocking, Samantha; Markovic, Tania] Univ Sydney, Charles Perkins Ctr, Boden Collaborat Obes Nutr Exercise & Eating Diso, Camperdown, NSW, Australia; [Maston, Gabrielle; Franklin, Janet; Hocking, Samantha; Swinbourne, Jessica; Manson, Elisa; Markovic, Tania] Royal Prince Alfred Hosp, Metab & Obes Serv, Camperdown, NSW, Australia; [Hocking, Samantha; Markovic, Tania] Univ Sydney, Fac Med & Hlth, Sydney Sch Med, Cent Clin Sch, Camperdown, NSW, Australia; [Gibson, Alice] Univ Sydney, Fac Med & Hlth, Menzies Ctr Hlth Policy, Sch Publ Hlth, Camperdown, NSW, Australia; [Sainsbury, Amanda] Univ Western Australia, Fac Sci, Sch Human Sci, Crawley, WA, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Western Australia	Maston, G (corresponding author), Univ Sydney, Charles Perkins Ctr, Boden Collaborat Obes Nutr Exercise & Eating Diso, Camperdown, NSW, Australia.; Maston, G (corresponding author), Royal Prince Alfred Hosp, Metab & Obes Serv, Camperdown, NSW, Australia.	gmas2269@uni.sydney.edu.au	Franklin, Janet/ACG-7579-2022; Salis, Amanda/A-3187-2011	Salis, Amanda/0000-0001-9176-1574; Hocking, Samantha/0000-0002-2514-9392; Maston, Gabrielle/0000-0002-3847-1508	National Health and Medical Research Council (NHMRC) of Australia [APP1135897]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	AS was supported by a Senior Research Fellowship (APP1135897) from the National Health and Medical Research Council (NHMRC) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Ahnis A, 2012, PATIENT PREFER ADHER, V6, P165, DOI 10.2147/PPA.S28022; Almeida OP, 2012, J AFFECT DISORDERS, V138, P322, DOI 10.1016/j.jad.2012.01.021; Appel LJ, 2011, NEW ENGL J MED, V365, P1959, DOI 10.1056/NEJMoa1108660; Astbury NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238645; Astbury NM, 2019, OBES REV, V20, P569, DOI 10.1111/obr.12816; Australian Breau of Statistics, 2008, INFORM PAPER INTRO S; Australian Breau of Statistics, 2016, CENS POP HOUS SOC IN; Australian Institute of Health and Welfare, 2017, PICTURE OVERWEIGHT O; Beleigoli AM, 2019, J MED INTERNET RES, V21, DOI 10.2196/jmir.9609; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brennan L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub3; Brown A, 2019, NUTR BULL, V44, P7, DOI 10.1111/nbu.12372; Christensen BJ, 2017, OBESITY FACTS, V10, P633, DOI 10.1159/000481138; Codex Alimentarius Commission, 1995, REP 19 SESSS COD COM; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cooper S, 2007, EMERG MED J, V24, P816, DOI 10.1136/emj.2007.050641; Dalle Grave R, 2005, OBES RES, V13, P1961, DOI 10.1038/oby.2005.241; David LA, 2016, EAT BEHAV, V22, P87, DOI 10.1016/j.eatbeh.2016.03.030; de Gelder R, 2017, EUR J PUBLIC HEALTH, V27, P93, DOI 10.1093/eurpub/ckv141; Dixon JB, 2013, DIABETES RES CLIN PR, V101, P131, DOI 10.1016/j.diabres.2013.05.017; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gami AS, 2007, J AM COLL CARDIOL, V49, P565, DOI 10.1016/j.jacc.2006.08.060; Ghosh A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010405; Gibson AA, 2016, OBES SCI PRACT, V2, P162, DOI 10.1002/osp4.48; Gibson AA, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030071; Greenway FL, 2009, J CLIN ENDOCR METAB, V94, P4898, DOI 10.1210/jc.2009-1350; Grock S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0948-2; Gustafsson PE, 2012, EUR J PUBLIC HEALTH, V22, P322, DOI 10.1093/eurpub/ckr061; Hamdy O, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000259; Harper C, 2018, OBES REV, V19, P1412, DOI 10.1111/obr.12715; Hayes A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026525; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kim TJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019862; King T, 2006, INT J OBESITY, V30, P281, DOI 10.1038/sj.ijo.0803176; Kizirian NA-S., 2016, AUSTR OBESITY MANAGE; Kovesdy CP, 2017, KIDNEY INT, V91, P260, DOI 10.1016/j.kint.2016.10.019; Laberge MA, 2012, SKELETAL RADIOL, V41, P633, DOI 10.1007/s00256-011-1259-3; Leung AY, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080922; Locock L., 2020, UNDERSTANDING FRONT, V8, P13; Martin JH, 2012, BRIT J CLIN PHARMACO, V73, P685, DOI 10.1111/j.1365-2125.2011.04159.x; Maston G, 2020, BEHAV SCI-BASEL, V10, DOI 10.3390/bs10090136; Maston G, 2019, BEHAV SCI-BASEL, V9, DOI 10.3390/bs9120144; Munsch S, 2012, BEHAV RES THER, V50, P775, DOI 10.1016/j.brat.2012.08.009; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; National Health and Medical Research Council, 2001, CLIN PRACT GUID MAN; Oliver I, 2012, IEEE IC COMP COM NET; Patel ML, 2019, PREV MED, V126, DOI 10.1016/j.ypmed.2019.05.026; Pearl RL, 2018, OBES REV, V19, P1141, DOI 10.1111/obr.12701; Perri MG, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.6764; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Raves DM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01497; Rehackova L, 2017, DIABETIC MED, V34, P1554, DOI 10.1111/dme.13426; Remmert JE, 2019, OBES SCI PRACT, V5, P555, DOI 10.1002/osp4.379; Rutledge T, 2017, OBES RES CLIN PRACT, V11, P344, DOI 10.1016/j.orcp.2016.11.005; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Schippers M, 2017, OBES REV, V18, P450, DOI 10.1111/obr.12492; Seers K, 2015, BRIT J PAIN, V9, P36, DOI 10.1177/2049463714549777; Sharma AM, 2009, INT J OBESITY, V33, P289, DOI 10.1038/ijo.2009.2; Sheldon K., 2003, SELF DETERMINATION T; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; Tongco M. D. C., 2007, Ethnobotany Research and Applications, V5, P147; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Wight RG, 2008, SOC SCI MED, V66, P862, DOI 10.1016/j.socscimed.2007.11.002; Williams GC, 2009, DIABETES EDUCATOR, V35, P484, DOI 10.1177/0145721709333856; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yumuk V, 2015, OBESITY FACTS, V8, P402, DOI 10.1159/000442721	68	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253127	10.1371/journal.pone.0253127	http://dx.doi.org/10.1371/journal.pone.0253127			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138917	gold, Green Published			2022-12-26	WOS:000671690200116
J	Roy, S; Maji, P				Roy, Shaswati; Maji, Pradipta			Multispectral co-occurrence of wavelet coefficients for malignancy assessment of brain tumors	PLOS ONE			English	Article							CLASSIFICATION; TEXTURE; SEGMENTATION; IMAGES	Brain tumor is not most common, but truculent type of cancer. Therefore, correct prediction of its aggressiveness nature at an early stage would influence the treatment strategy. Although several diagnostic methods based on different modalities exist, a pre-operative method for determining tumor malignancy state still remains as an active research area. In this regard, the paper presents a new method for the assessment of tumor grades using conventional MR sequences namely, T1, T1 with contrast enhancement, T2 and FLAIR. The proposed method for tumor gradation is mainly based on feature extraction using multiresolution image analysis and classification using support vector machine. Since the wavelet features of different tumor subregions, obtained from single MR sequence, do not carry equally important information, a wavelet fusion technique is proposed based on the texture information content of each voxel. The concept of texture gradient, used in the proposed algorithm, fuses the wavelet coefficients of the given MR sequences. The feature vector is then derived from the co-occurrence of fused wavelet coefficients. As each wavelet subband contains distinct detail information, a novel concept of multispectral co-occurrence of wavelet coefficients is introduced to capture the spatial correlation among different subbands. It enables to convey more informative features to characterize the tumor type. The effectiveness of the proposed method is analyzed, with respect to six classification performance indices, on BRATS 2012 and BRATS 2014 data sets. The classification accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and area under curve assessed by the ten-fold cross-validation are 91.3%, 96.8%, 66.7%, 92.4%, 88.4%, and 92.0%, respectively, on real brain MR data.	[Roy, Shaswati] RCC Inst Informat Technol, Dept Informat Technol, Kolkata, W Bengal, India; [Maji, Pradipta] Indian Stat Inst, Machine Intelligence Unit, Biomed Imaging & Bioinformat Lab, Kolkata, W Bengal, India	RCC Institute of Information Technology (RCCIIT); Indian Statistical Institute; Indian Statistical Institute Kolkata	Roy, S (corresponding author), RCC Inst Informat Technol, Dept Informat Technol, Kolkata, W Bengal, India.	r.shaswati@gmail.com	Maji, Pradipta/HHR-9037-2022		Visvesvaraya PhD Scheme of Ministry of Electronics and Information Technology, Government of India	Visvesvaraya PhD Scheme of Ministry of Electronics and Information Technology, Government of India	This work is an outcome of the R&D work undertaken in the project under the Visvesvaraya PhD Scheme of Ministry of Electronics and Information Technology, Government of India, being implemented by Digital India Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110300; Amin J, 2020, PATTERN RECOGN LETT, V129, P115, DOI 10.1016/j.patrec.2019.11.016; Bauer S, 2012, IEEE T BIO-MED ENG, V59, P25, DOI 10.1109/TBME.2011.2163406; Chen C, 2019, LECT NOTES COMPUT SC, V11766, P447, DOI 10.1007/978-3-030-32248-9_50; CP Wild, 2014, WORLD CANC REPORT 20; de Siqueira FR, 2013, NEUROCOMPUTING, V120, P336, DOI 10.1016/j.neucom.2012.09.042; DEAN BL, 1990, RADIOLOGY, V174, P411, DOI 10.1148/radiology.174.2.2153310; Gelzinis A, 2007, PATTERN RECOGN, V40, P2367, DOI 10.1016/j.patcog.2006.12.004; Hill PR, 2003, IEEE T IMAGE PROCESS, V12, P1618, DOI 10.1109/TIP.2003.819311; Hu Y., 2009, P IEEE IND APPL SOC, P1, DOI DOI 10.1109/IAS.2009.5324874; Inano R, 2014, NEUROIMAGE-CLIN, V5, P396, DOI 10.1016/j.nicl.2014.08.001; Islam A, 2013, IEEE T BIO-MED ENG, V60, P3204, DOI 10.1109/TBME.2013.2271383; Law M, 2003, AM J NEURORADIOL, V24, P1989; Li DD, 2016, INT CONF SIGN PROCES, P677, DOI 10.1109/ICSP.2016.7877918; Li GZ, 2006, COMPUT BIOL MED, V36, P313, DOI 10.1016/j.compbiomed.2004.11.003; Maji P, 2015, FUND INFORM, V142, P237, DOI 10.3233/FI-2015-1293; Maji P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123677; MALLAT SG, 1989, IEEE T PATTERN ANAL, V11, P674, DOI 10.1109/34.192463; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Pacifici F., 2008, 2008 IEEE International Geoscience and Remote Sensing Symposium, IGARSS 2008, P342, DOI 10.1109/IGARSS.2008.4780098; Ryu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108335; Vapnik V., 2013, NATURE STAT LAERNING; Vijayakumar C, 2007, COMPUT MED IMAG GRAP, V31, P473, DOI 10.1016/j.compmedimag.2007.04.004; Walker RF, 2003, INT J PATTERN RECOGN, V17, P17, DOI 10.1142/S0218001403002228; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147	25	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0250964	10.1371/journal.pone.0250964	http://dx.doi.org/10.1371/journal.pone.0250964			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138852	Green Published, gold			2022-12-26	WOS:000671690200034
J	Weng, JY; Zhao, GN; Weng, LY; Guan, JJ				Weng, Jinyan; Zhao, Guanan; Weng, Liyan; Guan, Jingjing		Alzheimers Dis Neuroimaging Initia	Aspirin using was associated with slower cognitive decline in patients with Alzheimer's disease	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; NSAID USE; DEMENTIA; RISK; PROTECT; HEALTH; GAMMA; AD	We aimed to examine whether the use of aspirin is associated with change in cognitive performance over time, and whether this association is modified by the cognitive stages. This study included a total of 1866 subjects, including 509 subjects with normal cognition (NC), 985 subjects with mild cognitive impairment (MCI), and 372 patients with Alzheimer's disease (AD). In each group, we further categorized our subjects into two groups based on their aspirin using conditions: Aspirin users and non-aspirin users. Mini-Mental State Examination (MMSE) was the cognitive outcome. Linear mixed models were conducted to examine the longitudinal relationship between the use of aspirin and cognitive performance in each diagnostic group. In the cross-sectional analysis, there were no significant differences in MMSE scores between non-aspirin users and aspirin users in subjects with NC, subjects with MCI or patients with AD. In the longitudinal analysis, we detected an association of the baseline use of aspirin with cognitive decline (MMSE) over time in patients with AD, but not in the NC group or MCI group. Specifically, in AD patients, the use of aspirin at baseline was associated with slower cognitive decline over time. Our data may support an association between the use of aspirin and slower cognitive decline, while this association may be dependent on the clinical stages.	[Weng, Jinyan; Weng, Liyan] Cent Hosp Lishui City, Dept Pharm, Lishui, Zhejiang, Peoples R China; [Zhao, Guanan] Lishui City Peoples Hosp, Dept Urol, Lishui, Zhejiang, Peoples R China; [Guan, Jingjing] Lishui City Peoples Hosp, Dept Pharm, Lishui, Zhejiang, Peoples R China		Guan, JJ (corresponding author), Lishui City Peoples Hosp, Dept Pharm, Lishui, Zhejiang, Peoples R China.	guanjingjing2015@163.com						AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41, DOI 10.1016/S1474-4422(07)70293-4; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Arvanitakis Z, 2008, NEUROLOGY, V70, P2219, DOI 10.1212/01.wnl.0000313813.48505.86; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Broe GA, 2000, ARCH NEUROL-CHICAGO, V57, P1586, DOI 10.1001/archneur.57.11.1586; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Cornelius C, 2004, NEUROEPIDEMIOLOGY, V23, P135, DOI 10.1159/000075957; Davis KAS., 2021, ASPIRIN PEOPLE DEMEN, DOI [10.1007/s00228-021-03089-x, DOI 10.1007/S00228-021-03089-X]; Edwards FA, 2019, TRENDS NEUROSCI, V42, P310, DOI 10.1016/j.tins.2019.03.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Henderson AS, 1997, INT J GERIATR PSYCH, V12, P926, DOI 10.1002/(SICI)1099-1166(199709)12:9<926::AID-GPS665>3.3.CO;2-P; Jordan F, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011459.pub2; Kang JH, 2007, BMJ-BRIT MED J, V334, P987, DOI 10.1136/bmj.39166.597836.BE; Lehmann JM, 1997, J BIOL CHEM, V272, P3406, DOI 10.1074/jbc.272.6.3406; LEVEUGLE B, 1994, MOL NEUROBIOL, V9, P25, DOI 10.1007/BF02816102; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Nilsson SE, 2003, EUR J CLIN PHARMACOL, V59, P313, DOI 10.1007/s00228-003-0618-y; Price JF, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1198; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; Richard E, 2009, J AM GERIATR SOC, V57, P797, DOI 10.1111/j.1532-5415.2009.02217.x; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ryan J, 2020, NEUROLOGY, V95, pE320, DOI 10.1212/WNL.0000000000009277; Szekely CA, 2008, NEUROLOGY, V70, P2291, DOI 10.1212/01.wnl.0000313933.17796.f6; Szekely CA, 2008, NEUROLOGY, V70, P17, DOI 10.1212/01.wnl.0000284596.95156.48; Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024; Veronese N, 2017, J AM GERIATR SOC, V65, P1763, DOI 10.1111/jgs.14883; Waldstein SR, 2010, J AM GERIATR SOC, V58, P38, DOI 10.1111/j.1532-5415.2009.02618.x; Walker S., 2014, ARXIV PREPRINT ARXIV; Wang YP, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-95; Wichmann MA, 2016, ALZ DIS ASSOC DIS, V30, P105, DOI 10.1097/WAD.0000000000000098; Wu Y, 2012, NEUROCHEM RES, V37, P1690, DOI 10.1007/s11064-012-0776-3	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252969	10.1371/journal.pone.0252969	http://dx.doi.org/10.1371/journal.pone.0252969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133445	Green Published, gold			2022-12-26	WOS:000671682700011
J	Rijo, MP; Diani-Moore, S; Yang, CY; Zhou, PB; Rifkind, AB				Rijo, Mercedes Paz; Diani-Moore, Silvia; Yang, Chenyi; Zhou, Pengbo; Rifkind, Arleen B.			Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROCARBON RECEPTOR AHR; POLY(ADP-RIBOSE) POLYMERASE; LOCALIZATION; INDUCTION; BINDING; RIBOSYLATION; RECOGNITION; INHIBITION; MECHANISMS; EXPRESSION	The aryl hydrocarbon receptor (AHR) is a transcription factor activated by exogenous halogenated polycyclic aromatic hydrocarbon compounds, including the environmental toxin TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and naturally occurring dietary and endogenous compounds. The activated AHR enhances transcription of specific genes including phase I and phase II metabolism enzymes and other targets genes such as the TCDD-inducible poly(ADP-ribose) polymerase (TiPARP). The regulation of AHR activation is a dynamic process: immediately after transcriptional activation of the AHR by TCDD, the AHR is exported from the nucleus to the cytoplasm where it is subjected to proteasomal degradation. However, the mechanisms regulating AHR degradation are not well understood. Here, we studied the role of two enzymes reported to enhance AHR breakdown: the cullin 4B (CUL4-B)AHR complex, an E3 ubiquitin ligase that targets the AHR and other proteins for ubiquitination, and TiPARP, which targets proteins for ADP-ribosylation, a posttranslational modification that can increase susceptibility to degradation. Using a WT mouse embryonic fibroblast (MEF) cell line and an MEF cell line in which CUL4B has been deleted (MEFCul4b-null), we discovered that loss of CUL4B partially prevented AHR degradation after TCDD exposure, while knocking down TiPARP in MEFCul4b-null cells completely abolished AHR degradation upon TCDD treatment. Increased TCDD-activated AHR protein levels in MEFCul4b-null and MEFCul4b-null cells in which TiPARP was knocked down led to enhanced AHR transcriptional activity, indicating that CUL4B and TiPARP restrain AHR action. This study reveals a novel function of TiPARP in controlling TCDD-activated AHR nuclear export and subsequent proteasomal degradation.	[Rijo, Mercedes Paz; Diani-Moore, Silvia; Rifkind, Arleen B.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Yang, Chenyi; Zhou, Pengbo] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA	Cornell University; Cornell University	Diani-Moore, S (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	sim2003@med.cornell.edu		Paz, Mercedes/0000-0002-9700-0327	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES027488]; National Cancer Institute, National Institutes of Health [R01CA213992, R01CA221152]	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Environmental Health Sciences, National Institutes of Health, Grant #R01ES027488 to A. B. R. and S. D.-M.; National Cancer Institute, National Institutes of Health, Grants #R01CA213992 and R01CA221152 to P. Z. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Ahmed S, 2015, J BIOL CHEM, V290, P16824, DOI 10.1074/jbc.M115.660100; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Berg P, 2001, J BIOL CHEM, V276, P43231, DOI 10.1074/jbc.M105261200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Diani-Moore S, 2013, J BIOL CHEM, V288, P21514, DOI 10.1074/jbc.M113.458067; Dou H, 2019, J BIOL CHEM, V294, P18504, DOI 10.1074/jbc.RA119.009282; Gomez A, 2018, BIOCHEM J, V475, P3827, DOI 10.1042/BCJ20180347; Greb-Markiewicz B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194746; Grimaldi G, 2019, BIOCHEM SOC T, V47, P357, DOI 10.1042/BST20180416; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Hu KS, 2019, EMBO REP, V20, DOI 10.15252/embr.201846166; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kraus WL, 2020, GENE DEV, V34, P251, DOI 10.1101/gad.336420.120; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; MacPherson L, 2014, INT J MOL SCI, V15, P7939, DOI 10.3390/ijms15057939; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Pollenz RS, 2006, MOL PHARMACOL, V70, P1369, DOI 10.1124/mol.106.027672; Pollenz RS, 2000, MOL CELL BIOL, V20, P6095, DOI 10.1128/MCB.20.16.6095-6104.2000; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Song ZJ, 2002, MOL PHARMACOL, V62, P806, DOI 10.1124/mol.62.4.806; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Tkachenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32009; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Zhang L, 2020, P NATL ACAD SCI USA, V117, P13447, DOI 10.1073/pnas.1921815117	46	5	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100886	10.1016/j.jbc.2021.100886	http://dx.doi.org/10.1016/j.jbc.2021.100886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34146543	gold, Green Published			2022-12-26	WOS:000690873500016
J	Bi, ZJ; Zhang, SS; Meng, YY; Feng, Y; Wang, YS; Wang, EK; Pan, XX; Zhu, RX; Fan, HT; Pang, SH; Zhu, LX; Yuan, JY				Bi, Zijuan; Zhang, Shisheng; Meng, Yangyang; Feng, Ya; Wang, Yinshu; Wang, Enkang; Pan, Xiangxue; Zhu, Ruixin; Fan, Haiting; Pang, Shuhua; Zhu, Lixin; Yuan, Jianye			Female serotonin transporter-knockout rat: A potential model of irritable bowel syndrome	FASEB JOURNAL			English	Article						5-HT receptors; dopamine transporter; irritable bowel syndrome; serotonin transporter; visceral hypersensitivity	FUNCTIONAL GASTROINTESTINAL DISORDERS; VISCERAL HYPERSENSITIVITY; RECEPTORS CONTRIBUTE; REUPTAKE INHIBITORS; 5-HT7 RECEPTOR; MESSENGER-RNA; 5-HYDROXYTRYPTAMINE; EXPRESSION; PREDOMINANT; DOPAMINE	Irritable bowel syndrome (IBS) is a common functional gastrointestinal disease. Although visceral hypersensitivity (VH) and disturbed gastrointestinal motility are typical pathophysiological features of IBS, the pathological mechanisms underlying this disease remain unclear. Serotonin system abnormalities are considered to play an important role in the pathomechanisms of IBS. Here, we hypothesize that similar alterations, including VH and colonic motility, induced by serotonin transporter (SERT) knockout result from altered serotonin signaling. We sought to determine the molecular mechanism underlying VH and colonic dysmotility induced by SERT knockout. We found that female SERT (slc6a4)-knockout (KO; ie, slc6a4(-/-)) rats exhibited lower pain pressure thresholds (PPTs) than wild-type (WT; ie, slc6a4(+/+)) rats in response to colorectal distension (CRD). Significantly increased fecal pellet output and reduced concentration of serum tryptophan were observed in the female SERT KO rats. The concentrations of 5-hydroxytryptamine (5-HT) in platelet-rich plasma (PRP) and serum in SERT KO rats were lower than those in WT rats, but the numbers of enterochromaffin cells (ECs) and the concentrations of 5-HT in colon of SERT KO rats were higher than those of WT rats. Finally, increased expression levels of 5-HT1B receptors, 5-HT2C receptors, 5-HT3A receptors, 5-HT3B receptors, 5-HT6 receptors, 5-HT7 receptors, and glycosylated dopamine transporters (DATs) were found in the female SERT KO rats. We concluded that alterations in the serotonin system induced by the knockout of slc6a4 might result in VH and accelerated gastrointestinal motility in female SERT KO rats, which can be used as an animal model of IBS.	[Bi, Zijuan; Meng, Yangyang; Feng, Ya; Wang, Yinshu; Wang, Enkang; Zhu, Lixin; Yuan, Jianye] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China; [Zhang, Shisheng; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Zhang, Shisheng] Univ Sydney, Fac Engn & IT, Sch AMME, Sydney, NSW, Australia; [Pan, Xiangxue] Shanghai Univ Tradit Chinese Med, Shanghai Municipal Hosp Tradit Chinese Med, Shanghai, Peoples R China; [Fan, Haiting] Shanghai Univ Tradit Chinese Med, Lab Anim Ctr, Shanghai, Peoples R China; [Pang, Shuhua] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Clin Lab, Shanghai, Peoples R China; [Zhu, Lixin] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Dept Colorectal Surg, Guangzhou, Peoples R China	Shanghai University of Traditional Chinese Medicine; Tongji University; University of Sydney; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Sun Yat Sen University	Zhu, LX; Yuan, JY (corresponding author), Shanghai Univ Tradit Chinese Med, Longhua Hosp, Inst Digest Dis, Shanghai, Peoples R China.; Zhu, LX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Inst Gastroenterol, Dept Colorectal Surg, Guangzhou, Peoples R China.	zhulx6@mail.sysu.edu.cn; yuanjianye@hotmail.com	Zhu, Ruixin/CAJ-1106-2022; , 金石为开/AFU-9737-2022; Yuan, Jianye/L-7858-2018	Yuan, Jianye/0000-0003-3728-2083; Zhu, Lixin/0000-0001-7904-1769; Zhang, Shisheng/0000-0002-1612-0694	National Natural Science Foundation of China [81473630, 81874391]; Xinglin Young Talent Program [RC-2017-02-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinglin Young Talent Program	This study has been carried out under the auspices of the National Natural Science Foundation of China (No. 81473630; 81874391), Xinglin Scholar, Xinglin Young Talent Program (No. RC-2017-02-07). We would like to thank: two reviewers and the journal editors, who have provided constructive comments; Dr Xuhui Bao from Duke University Medical Center for his useful suggestions on English editing.	Atkinson W, 2006, GASTROENTEROLOGY, V130, P34, DOI 10.1053/j.gastro.2005.09.031; Pineda-Farias JB, 2017, PHARMACOL REP, V69, P916, DOI 10.1016/j.pharep.2017.04.001; Camilleri M, 2004, GUT, V53, P1396, DOI 10.1136/gut.2004.039826; Camilleri M, 2007, GASTROENTEROLOGY, V132, P17, DOI 10.1053/j.gastro.2006.11.020; Cervantes-Duran C, 2013, NEUROSCIENCE, V252, P396, DOI 10.1016/j.neuroscience.2013.08.022; Ceuleers H, 2016, WORLD J GASTROENTERO, V22, P10275, DOI 10.3748/wjg.v22.i47.10275; Clarke G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00090; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Cui XF, 2014, WORLD J GASTROENTERO, V20, P13521, DOI 10.3748/wjg.v20.i37.13521; Delvaux M, 1998, ALIMENT PHARM THER, V12, P849, DOI 10.1046/j.1365-2036.1998.00375.x; DEVANE CL, 1995, HUM PSYCHOPHARM CLIN, V10, pS185, DOI 10.1002/hup.470100907; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1262, DOI 10.1053/j.gastro.2016.02.032; Efimova EV, 2016, J NEUROGENET, V30, P5, DOI 10.3109/01677063.2016.1144751; EGLEN RM, 1995, TRENDS PHARMACOL SCI, V16, P391, DOI 10.1016/S0165-6147(00)89081-1; El-Ayache N, 2019, AM J PHYSIOL-GASTR L, V316, pG132, DOI 10.1152/ajpgi.00131.2018; El-Salhy M, 2020, NEUROPEPTIDES, V79, DOI 10.1016/j.npep.2019.101973; Enck P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.14; Foley S, 2011, GASTROENTEROLOGY, V140, P1434, DOI 10.1053/j.gastro.2011.01.052; FoxxOrenstein AE, 1996, GASTROENTEROLOGY, V111, P1281, DOI 10.1053/gast.1996.v111.pm8898642; Franke L, 2010, J GASTROENTEROL, V45, P389, DOI 10.1007/s00535-009-0167-y; Galligan JJ, 2013, NEUROGASTROENT MOTIL, V25, pe373, DOI 10.1111/nmo.12133; Gellynck E, 2013, EXP BRAIN RES, V230, P555, DOI 10.1007/s00221-013-3694-y; Gershon MD, 1999, ALIMENT PHARM THER, V13, P15; Haffmans PMJ, 1996, INT CLIN PSYCHOPHARM, V11, P157, DOI 10.1097/00004850-199609000-00002; Hagino Y, 2011, CURR NEUROPHARMACOL, V9, P91, DOI 10.2174/157015911795017254; Hegde SS, 1996, FASEB J, V10, P1398, DOI 10.1096/fasebj.10.12.8903510; Hong S, 2009, GUT, V58, P202, DOI 10.1136/gut.2008.157594; Houghton LA, 2009, ALIMENT PHARM THER, V30, P919, DOI 10.1111/j.1365-2036.2009.04121.x; Huot P, 2016, J PHARMACOL EXP THER, V357, P562, DOI 10.1124/jpet.116.232371; Jin DC, 2016, WORLD J GASTROENTERO, V22, P8137, DOI 10.3748/wjg.v22.i36.8137; Jin ZL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08953-4; Katsumata R, 2017, INTERNAL MED, V56, P993, DOI 10.2169/internalmedicine.56.7674; Kerckhoffs APM, 2012, AM J PHYSIOL-GASTR L, V302, pG1053, DOI 10.1152/ajpgi.00153.2011; Krasaelap A, 2017, PEDIATR ANN, V46, pE120, DOI 10.3928/19382359-20170213-01; Kumar S, 2012, J GASTROINTEST LIVER, V21, P31; Lanfumey L, 2004, CNS NEUROL DISORD-DR, V3, P1, DOI 10.2174/1568007043482570; LEATHWOOD PD, 1987, P NUTR SOC, V46, P143, DOI 10.1079/PNS19870018; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Liu MY, 2017, CHINESE MED J-PEKING, V130, P2219, DOI 10.4103/0366-6999.213966; Lovell RM, 2012, AM J GASTROENTEROL, V107, P1793, DOI 10.1038/ajg.2012.336; Mawe GM, 2013, NAT REV GASTRO HEPAT, V10, P473, DOI 10.1038/nrgastro.2013.105; Montanez S, 2014, NEUROCHEM INT, V73, P127, DOI 10.1016/j.neuint.2013.11.004; Nakajima K, 2009, EUR J PAIN, V13, P441, DOI 10.1016/j.ejpain.2008.06.007; Nelson DL, 2004, CNS NEUROL DISORD-DR, V3, P53, DOI 10.2174/1568007043482606; Nikiforuk A, 2015, CNS DRUGS, V29, P265, DOI 10.1007/s40263-015-0236-0; Nishijima H, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00575; Nongonierma AB, 2015, FOOD FUNCT, V6, P2115, DOI [10.1039/C5FO00407A, 10.1039/c5fo00407a]; Oliver KH, 2016, J BIOL CHEM, V291, P20210, DOI 10.1074/jbc.M116.736983; Olivier JDA, 2008, NEUROSCIENCE, V152, P573, DOI 10.1016/j.neuroscience.2007.12.032; Prusator DK, 2016, NEUROGASTROENT MOTIL, V28, P1876, DOI 10.1111/nmo.12891; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Serrats J, 2004, SYNAPSE, V51, P102, DOI 10.1002/syn.10287; Shang JJ, 2013, WORLD J GASTROENTERO, V19, P8071, DOI 10.3748/wjg.v19.i44.8071; Shi HL, 2015, WORLD J GASTROENTERO, V21, P4852, DOI 10.3748/wjg.v21.i16.4852; Sobczak M, 2014, EUR J PHARMACOL, V736, P63, DOI 10.1016/j.ejphar.2014.04.038; Spigset O, 1999, DRUG SAFETY, V20, P277, DOI 10.2165/00002018-199920030-00007; Sun JH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0863-5; Tap J, 2017, GASTROENTEROLOGY, V152, P111, DOI 10.1053/j.gastro.2016.09.049; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029; Thumshirn M, 2000, ALIMENT PHARM THERAP, V14, P869; Tonini M, 2005, GASTROENTEROLOGY, V129, P1557, DOI 10.1053/j.gastro.2005.08.005; Wang YM, 2012, NEUROGASTROENT MOTIL, V24, P560, DOI 10.1111/j.1365-2982.2012.01902.x; Wang YS, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01082; Woolley ML, 2004, CNS NEUROL DISORD-DR, V3, P59, DOI 10.2174/1568007043482561; Xie C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127815; Xu GZ, 2020, NEUROPHARMACOLOGY, V165, DOI 10.1016/j.neuropharm.2019.107926; Yan C, 2012, BRAZ J MED BIOL RES, V45, P948, DOI 10.1590/S0100-879X2012007500122; Yu YB, 2010, NEUROCHEM RES, V35, P797, DOI 10.1007/s11064-010-0137-z; Zheng YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172846; Zhu YB, 2018, GENE, V679, P133, DOI 10.1016/j.gene.2018.08.059; Zou BC, 2007, CHINESE MED J-PEKING, V120, P2069, DOI 10.1097/00029330-200712010-00002	71	4	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21701	10.1096/fj.202000007RRR	http://dx.doi.org/10.1096/fj.202000007RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34143529				2022-12-26	WOS:000667814100015
J	Jin, WW; Chowienczyk, P; Alastruey, J				Jin, Weiwei; Chowienczyk, Philip; Alastruey, Jordi			Estimating pulse wave velocity from the radial pressure wave using machine learning algorithms	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; ARTERIAL STIFFNESS; CARDIOVASCULAR RISK; ALL-CAUSE; PREDICTION; REFLECTION; TWINSUK; EVA	One of the European gold standard measurement of vascular ageing, a risk factor for cardiovascular disease, is the carotid-femoral pulse wave velocity (cfPWV), which requires an experienced operator to measure pulse waves at two sites. In this work, two machine learning pipelines were proposed to estimate cfPWV from the peripheral pulse wave measured at a single site, the radial pressure wave measured by applanation tonometry. The study populations were the Twins UK cohort containing 3,082 subjects aged from 18 to 110 years, and a database containing 4,374 virtual subjects aged from 25 to 75 years. The first pipeline uses Gaussian process regression to estimate cfPWV from features extracted from the radial pressure wave using pulse wave analysis. The mean difference and upper and lower limits of agreement (LOA) of the estimation on the 924 hold-out test subjects from the Twins UK cohort were 0.2 m/s, and 3.75 m/s & -3.34 m/s, respectively. The second pipeline uses a recurrent neural network (RNN) to estimate cfPWV from the entire radial pressure wave. The mean difference and upper and lower LOA of the estimation on the 924 hold-out test subjects from the Twins UK cohort were 0.05 m/s, and 3.21 m/s & -3.11m/s, respectively. The percentage error of the RNN estimates on the virtual subjects increased by less than 2% when adding 20% of random noise to the pressure waveform. These results show the possibility of assessing the vascular ageing using a single peripheral pulse wave (e.g. the radial pressure wave), instead of cfPWV. The proposed code for the machine learning pipelines is available from the following online depository (https://github.com/WeiweiJin/Estimate-Cardiovascular-Risk-from-Pulse-Wave-Signal).	[Jin, Weiwei; Alastruey, Jordi] Kings Coll London, Dept Biomed Engn, London, England; [Chowienczyk, Philip] Kings Coll London, St Thomas Hosp, Dept Clin Pharmacol, London, England; [Alastruey, Jordi] Sechenov Univ, World Class Res Ctr Digital Biodesign & Personali, Moscow, Russia	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Sechenov First Moscow State Medical University	Jin, WW (corresponding author), Kings Coll London, Dept Biomed Engn, London, England.	weiwei.jin@kcl.ac.uk		Alastruey, Jordi/0000-0003-3742-5259; Jin, Weiwei/0000-0002-0919-2470	British Heart Foundation (BHF) [PG/15/104/31913]; EPSRC [EP/K031546/1]; Wellcome/Engineering Physical Sciences Research Council (EPSRC) Centre for Medical Engineering at King's College London [WT 203148/Z/16/Z]; Department of Health through the National Institute for Health Research (NIHR) Cardiovascular MedTech Cooperative at Guy's and St Thomas' NHS Foundation Trust (GSTT); comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London; King's College Hospital NHS Foundation Trust; Ministry of Science and Higher Education of the Russian Federation [075-15-2020-926]; King's College London PGR International Scholarship	British Heart Foundation (BHF)(British Heart Foundation); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome/Engineering Physical Sciences Research Council (EPSRC) Centre for Medical Engineering at King's College London(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Health through the National Institute for Health Research (NIHR) Cardiovascular MedTech Cooperative at Guy's and St Thomas' NHS Foundation Trust (GSTT); comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London; King's College Hospital NHS Foundation Trust; Ministry of Science and Higher Education of the Russian Federation; King's College London PGR International Scholarship	This work was supported by the British Heart Foundation (BHF) [PG/15/104/31913], the EPSRC [EP/K031546/1], the Wellcome/Engineering Physical Sciences Research Council (EPSRC) Centre for Medical Engineering at King's College London [WT 203148/Z/16/Z], the Department of Health through the National Institute for Health Research (NIHR) Cardiovascular MedTech Cooperative at Guy's and St Thomas' NHS Foundation Trust (GSTT), the comprehensive Biomedical Research Centre and Clinical Research Facilities awards to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London and King's College Hospital NHS Foundation Trust, and the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers "Digital biodesign and personalized healthcare" [075-15-2020-926]. The views expressed are those of the authors and not necessarily those of the BHF, Wellcome Trust, EPSRC, NIHR, GSTT or Ministry of Science. WJ was funded by a King's College London PGR International Scholarship.	Alqudah AM, 2019, AUSTRALAS PHYS ENG S, V42, P149, DOI 10.1007/s13246-019-00722-z; Attia ZI, 2019, NAT MED, V25, P70, DOI 10.1038/s41591-018-0240-2; Awan SE, 2019, ESC HEART FAIL, V6, P428, DOI 10.1002/ehf2.12419; Biswas D, 2019, IEEE T BIOMED CIRC S, V13, P282, DOI 10.1109/TBCAS.2019.2892297; Chakshu NK, 2021, BIOMECH MODEL MECHAN, V20, P449, DOI 10.1007/s10237-020-01393-6; Charlton PH, 2019, AM J PHYSIOL-HEART C, V317, pH1062, DOI 10.1152/ajpheart.00218.2019; Charlton PH, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aabe6a; Cikes M, 2019, EUR J HEART FAIL, V21, P74, DOI 10.1002/ejhf.1333; Cui ZX, 2018, NEUROIMAGE, V178, P622, DOI 10.1016/j.neuroimage.2018.06.001; Gaddum NR, 2013, ANN BIOMED ENG, V41, P2617, DOI 10.1007/s10439-013-0854-y; Gomez-Sanchez M, 2020, J HYPERTENS, V38, P1110, DOI 10.1097/HJH.0000000000002373; Grillo A, 2018, AM J HYPERTENS, V31, P80, DOI 10.1093/ajh/hpx140; Hametner B, 2013, BLOOD PRESS MONIT, V18, P173, DOI 10.1097/MBP.0b013e3283614168; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Jekell A, 2018, BLOOD PRESSURE, V27, P88, DOI 10.1080/08037051.2017.1394791; Karunathilake SP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5767864; Laina A, 2018, EXP GERONTOL, V109, P16, DOI 10.1016/j.exger.2017.06.007; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Laurent S, 2019, HYPERTENSION, V74, P218, DOI 10.1161/HYPERTENSIONAHA.119.12655; Lipton Z.C., 2015, COMPUT SCI, DOI DOI 10.1093/eurheartj/ehw128; Mikael LD, 2017, ARQ BRAS CARDIOL, V109, P253, DOI 10.5935/abc.20170091; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Moayyeri A, 2013, INT J EPIDEMIOL, V42, P76, DOI 10.1093/ije/dyr207; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Mukaka MM, 2012, MALAWI MED J, V24, P69; Niebauer J, 2020, J SPORT SCI MED, V19, P460; Nilsson PM, 2008, J HYPERTENS, V26, P1049, DOI 10.1097/HJH.0b013e3282f82c3e; Nilsson PM, 2009, HYPERTENSION, V54, P3, DOI 10.1161/HYPERTENSIONAHA.109.129114; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; Perez H, 2020, MATHEMATICS-BASEL, V8, DOI 10.3390/math8050662; Salvi P, 2004, J HYPERTENS, V22, P2285, DOI 10.1097/00004872-200412000-00010; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Segers P, 2009, ARTERY RES, V3, P79, DOI 10.1016/j.artres.2009.02.006; Shiels PG, 2017, NAT REV NEPHROL, V13, P471, DOI 10.1038/nrneph.2017.78; Tavallali P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19457-0; Van Bortel LM, 2012, J HYPERTENS, V30, P445, DOI 10.1097/HJH.0b013e32834fa8b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang KL, 2010, HYPERTENSION, V55, P799, DOI 10.1161/HYPERTENSIONAHA.109.139964; Weir-McCall JR, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0546-x; Wilkinson IB, 2010, ARTERY RES, V4, P34, DOI 10.1016/j.artres.2010.03.001	40	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0245026	10.1371/journal.pone.0245026	http://dx.doi.org/10.1371/journal.pone.0245026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181640	Green Submitted, gold, Green Published			2022-12-26	WOS:000671695800009
J	Schumacher, SA; Kamr, AM; Lakritz, J; Burns, TA; Bertone, AL; Toribio, RE				Schumacher, Stephen A.; Kamr, Ahmed M.; Lakritz, Jeffrey; Burns, Teresa A.; Bertone, Alicia L.; Toribio, Ramiro E.			Effects of intravenous magnesium sulfate on serum calcium-regulating hormones and plasma and urinary electrolytes in healthy horses	PLOS ONE			English	Article							SENSING RECEPTOR; PARATHYROID-HORMONE; SYMPTOMATIC HYPOCALCEMIA; TOCOLYTIC THERAPY; HYPERMAGNESEMIA; CALCITONIN; PHYSIOLOGY; PHOSPHATE; EXCRETION; SECRETION	Intravenous magnesium sulfate (MgSO4) is used in equine practice to treat hypomagnesemia, dysrhythmias, neurological disorders, and calcium dysregulation. MgSO4 is also used as a calming agent in equestrian events. Hypercalcemia affects calcium-regulating hormones, as well as plasma and urinary electrolytes; however, the effect of hypermagnesemia on these variables is unknown. The goal of this study was to investigate the effect of hypermagnesemia on blood parathyroid hormone (PTH), calcitonin (CT), ionized calcium (Ca2+), ionized magnesium (Mg2+), sodium (Na+), potassium (K+), chloride (Cl-) and their urinary fractional excretion (F) after intravenous administration of MgSO4 in healthy horses. Twelve healthy female horses of 4-18 years of age and 432-600 kg of body weight received a single intravenous dose of MgSO4 (60 mg/kg) over 5 minutes, and blood and urine samples were collected at different time points over 360 minutes. Plasma Mg2+ concentrations increased 3.7-fold over baseline values at 5 minutes and remained elevated for 120 minutes (P < 0.05), Ca2+ concentrations decreased from 30-60 minutes (P < 0.05), but Na+, K+ and Cl- concentrations did not change. Serum PTH concentrations dropped initially to rebound and remain elevated from 30 to 60 minutes, while CT concentrations increased at 5 minutes to return to baseline by 10 minutes (P < 0.05). The FMg, FCa, FNa, FK, and FCl increased, while urine osmolality decreased from 30-60 minutes compared baseline (P < 0.05). Short-term experimental hypermagnesemia alters calcium-regulating hormones (PTH, CT), reduces plasma Ca2+ concentrations, and increases the urinary excretion of Mg2+, Ca2+, K+, Na+ and Cl- in healthy horses. This information has clinical implications for the short-term effects of hypermagnesemia on calcium-regulation, electrolytes, and neuromuscular activity, in particular with increasing use of Mg salts to treat horses with various acute and chronic conditions as well as a calming agent in equestrian events.	[Schumacher, Stephen A.; Kamr, Ahmed M.; Lakritz, Jeffrey; Burns, Teresa A.; Bertone, Alicia L.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Schumacher, Stephen A.] US Equestrian Federat, Columbus, OH USA; [Kamr, Ahmed M.] Univ Sadat City, Fac Vet Med, Sadat City, Egypt	University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); University of Sadat City	Toribio, RE (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	toribio.1@osu.edu	Lakritz, Jeffrey/E-3456-2011; Toribio, Ramiro/H-7838-2013	Lakritz, Jeffrey/0000-0003-2143-0416; Toribio, Ramiro/0000-0002-9063-540X	United States Equestrian Federation (USEF); Ohio State University	United States Equestrian Federation (USEF); Ohio State University(Ohio State University)	This study was funded by the United States Equestrian Federation (USEF) and the Ohio State University, which also provided support in the form of salary (SS), but did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; CHOLST IN, 1984, NEW ENGL J MED, V310, P1221, DOI 10.1056/NEJM198405103101904; Conigrave AD, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00563; Davey RA, 2013, J BONE MINER RES, V28, P973, DOI 10.1002/jbmr.1869; ELLIOTT JP, 1983, AM J OBSTET GYNECOL, V147, P277, DOI 10.1016/0002-9378(83)91111-0; Favus MJ, 2006, PRIMER METABOLIC BON, V13, P76; Felsenfeld AJ., 2015, CLIN KIDNEY J, V8, P180, DOI [10.1093/ckj/sfv011, DOI 10.1093/ckj/sfv011]; Ferre S, 2012, KIDNEY INT, V82, P1157, DOI 10.1038/ki.2012.179; Gussow A, 2018, TIERAERZTL PRAX K H, V46, P370, DOI 10.1055/s-0038-1677389; Hudali T, 2015, CLIN CASE REP, V3, P827, DOI 10.1002/ccr3.356; Kamr AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127684; Koontz SL, 2004, AM J OBSTET GYNECOL, V190, P1773, DOI 10.1016/j.ajog.2004.02.050; Kumar R, 2011, J AM SOC NEPHROL, V22, P216, DOI 10.1681/ASN.2010020186; Levine BS, 2014, NEFROLOGIA, V34, P658, DOI 10.3265/Nefrologia.pre2014.Jun.12379; LITTLEDIKE ET, 1971, P SOC EXP BIOL MED, V136, P1000; Mayan H, 1999, NEPHROL DIAL TRANSPL, V14, P1764, DOI 10.1093/ndt/14.7.1764; Mundy GR, 1999, CLIN CHEM, V45, P1347; QUAMME GA, 1980, AM J PHYSIOL, V238, pE573, DOI 10.1152/ajpendo.1980.238.6.E573; Ranieri M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215341; Riccardi D, 2012, ANNU REV PHYSIOL, V74, P271, DOI 10.1146/annurev-physiol-020911-153318; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Schumacher SA, 2020, J VET PHARMACOL THER, V43, P577, DOI 10.1111/jvp.12883; Schumacher SA, 2019, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00414; Schumacher SA, 2019, DRUG TEST ANAL, V11, P455, DOI 10.1002/dta.2509; Sheldon SA, 2019, J VET INTERN MED, V33, P923, DOI 10.1111/jvim.15410; Shimosawa T, 2004, HYPERTENSION, V44, P897, DOI 10.1161/01.HYP.0000146536.68208.84; Shin HJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082184; SUZUKI K, 1987, ACTA ENDOCRINOL-COP, V116, P282, DOI 10.1530/acta.0.1160282; SUZUKI K, 1986, CALCIFIED TISSUE INT, V39, P304, DOI 10.1007/BF02555195; Swaminathan R, 2003, Clin Biochem Rev, V24, P47; Toribio RE, 2007, AM J VET RES, V68, P543, DOI 10.2460/ajvr.68.5.543; Toribio RE, 2011, VET CLIN N AM-EQUINE, V27, P129, DOI 10.1016/j.cveq.2010.12.010; Toribio RE, 2005, J VET INTERN MED, V19, P223, DOI 10.1892/0891-6640(2005)19&lt;223:AISPHA&gt;2.0.CO;2; Toribio RE, 2003, J MOL ENDOCRINOL, V31, P609, DOI 10.1677/jme.0.0310609; Toribio RE., 2018, MAGNESIUM DIS, VFourth, P1052; Toribio RE., 2018, DISORDERS CALCIUM PH, VFourth, P1029; Wagner CA, 2013, KIDNEY INT, V84, P228, DOI 10.1038/ki.2013.128	38	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2021	16	6							e0247542	10.1371/journal.pone.0247542	http://dx.doi.org/10.1371/journal.pone.0247542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9DB	34181644	Green Published, gold			2022-12-26	WOS:000671695800008
J	Xiang, Z; Zhou, ZJ; Song, SZ; Li, J; Ji, J; Yan, RL; Wang, JX; Cai, W; Hu, WJ; Zang, L; Zhu, ZG; Zhang, Z; Li, M; Yu, YY				Xiang, Zhen; Zhou, Zhijun; Song, Shuzheng; Li, Jun; Ji, Jun; Yan, Ranlin; Wang, Jiexuan; Cai, Wei; Hu, Wenjun; Zang, Lu; Zhu, Zhenggang; Zhang, Zhen; Li, Min; Yu, Yingyan			Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways	ONCOGENE			English	Article							GLUCOCORTICOIDS; EXPRESSION; COVID-19; CELLS	T cell exhaustion plays critical roles in tumor immune evasion. Novel strategies to suppress immune evasion are in urgent need. We aimed to identify potential compounds to target T cell exhaustion and increase response to immune checkpoint inhibitors (ICIs). Differentially expressed genes (DEGs) were identified between tumors with different immune evasion potential by comparing the transcriptome data. DEGs were then analyzed in the Connectivity Map (CMap) platform to identify potential compounds to increase response to ICIs. Gene set enrichment analysis, LDH release assay, Chromatin immunoprecipitation (ChIP), and Co-IP were performed to explore the potential mechanisms in vitro. Patients derived organoids and humanized xenograft mouse model were utilized to validate the finding ex vivo and in vivo. We identified 25 potential compounds that may play critical roles in regulating tumor immune evasion. We further pinpointed a specific compound, dexamethasone, which shows potent anti-tumor effect in multiple cancer cell lines when cocultured with T cells. Dexamethasone can suppress T cell exhaustion by decreasing the activity of two immune checkpoints simultaneously, including PD-L1 and IDO1. Functional study shows dexamethasone can increase the sensitivity of ICIs in coculture system, 3D organoid model and humanized mouse model. Mechanism study shows dexamethasone mediated transcriptional suppression of PD-L1 and IDO1 depends on the nuclear translocation of GR/STAT3 complex. These findings demonstrate dexamethasone can suppress immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways.	[Xiang, Zhen; Song, Shuzheng; Li, Jun; Ji, Jun; Yan, Ranlin; Wang, Jiexuan; Cai, Wei; Hu, Wenjun; Zang, Lu; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Dept Gen Surg, Sch Med, Ruijin Hosp,Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Xiang, Zhen; Song, Shuzheng; Li, Jun; Ji, Jun; Yan, Ranlin; Wang, Jiexuan; Cai, Wei; Hu, Wenjun; Zang, Lu; Zhu, Zhenggang; Yu, Yingyan] Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China; [Zhou, Zhijun; Li, Min] Univ Oklahoma, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Zhou, Zhijun; Li, Min] Univ Oklahoma, Dept Surg, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Zhang, Zhen] Fudan Univ, Shanghai Med Coll, Dept Radiat Oncol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China; [Zhang, Zhen] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Fudan University; Fudan University	Yu, YY (corresponding author), Shanghai Jiao Tong Univ, Dept Gen Surg, Sch Med, Ruijin Hosp,Shanghai Inst Digest Surg, Shanghai, Peoples R China.; Yu, YY (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China.; Li, M (corresponding author), Univ Oklahoma, Dept Med, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.; Li, M (corresponding author), Univ Oklahoma, Dept Surg, Hlth Sci Ctr, Oklahoma City, OK 73104 USA.; Zhang, Z (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Radiat Oncol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China.; Zhang, Z (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai Canc Ctr, 270 Dong An Rd, Shanghai 200032, Peoples R China.	zhen_zhang@fudan.edu.cn; Min-Li@ouhsc.edu; yingyan3y@sjtu.edu.cn	Zhou, Zhijun/AAU-9428-2021	Zhou, Zhijun/0000-0003-2226-2223	Chinese National Key Program [MOST-2017YFC0908300, 2016YFC1303200]; National Natural Science Foundation of China [82072602, 81772505]; Shanghai Science and Technology Committee [20DZ2201900, 18411953100]; cross-institute innovation foundation of Shanghai Jiao Tong University [YG2017ZD01]; Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine [TM202001, 15ZH4001, TM201617, TM 201702]; Technology Transfer Project of Science & Technology Dept. Shanghai Jiao Tong University School of Medicine; Innovation Foundation for Doctor's Degree [BXJ201914]	Chinese National Key Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); cross-institute innovation foundation of Shanghai Jiao Tong University; Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine; Technology Transfer Project of Science & Technology Dept. Shanghai Jiao Tong University School of Medicine; Innovation Foundation for Doctor's Degree	We acknowledge the open database of CCLE, TCGA and CMap. This project is partially supported by the Chinese National Key Program (MOST-2017YFC0908300 and 2016YFC1303200), the National Natural Science Foundation of China (82072602 and 81772505), Shanghai Science and Technology Committee (20DZ2201900 and 18411953100), the cross-institute innovation foundation of Shanghai Jiao Tong University (YG2017ZD01), the Innovation Foundation of Translational Medicine of Shanghai Jiao Tong University School of Medicine (TM202001, 15ZH4001, TM201617 and TM 201702), Technology Transfer Project of Science & Technology Dept. Shanghai Jiao Tong University School of Medicine, and Innovation Foundation for Doctor's Degree (BXJ201914) grants to Y. Yu.	AlBahrani S, 2021, J EPIDEMIOL GLOB HEA, V11, P233, DOI 10.2991/jegh.k.210112.001; [Anonymous], 2017, Cancer Discov, V7, pOF2, DOI 10.1158/2159-8290.CD-NB2017-100; Arbour KC, 2018, J CLIN ONCOL, V36, P2872, DOI 10.1200/JCO.2018.79.0006; Arumuggam N, 2015, PHYTOTHER RES, V29, P805, DOI 10.1002/ptr.5327; Badros A, 2017, BLOOD, V130, P1189, DOI 10.1182/blood-2017-03-775122; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Calagua C, 2017, CLIN CANCER RES, V23, P6812, DOI 10.1158/1078-0432.CCR-17-0807; Charles P, 2021, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2021-219986; CONN DL, 1988, J RHEUMATOL, V15, P1181; De Santis M, 2021, ANN RHEUM DIS, DOI 10.1136/annrheumdis-2021-220044; Delavan B, 2018, DRUG DISCOV TODAY, V23, P382, DOI 10.1016/j.drudis.2017.10.009; Egberts JH, 2008, CANCER BIOL THER, V7, P1044, DOI 10.4161/cbt.7.7.6099; Fu HY, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2854186; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Harpaz I, 2013, EUR J IMMUNOL, V43, P758, DOI 10.1002/eji.201242613; Hsieh TC, 2022, ANN HEMATOL, V101, P431, DOI 10.1007/s00277-021-04457-4; Komiya T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00423; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Langut Y, 2017, P NATL ACAD SCI USA, V114, P13655, DOI 10.1073/pnas.1714587115; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Li GR, 2020, DIABETES RES CLIN PR, V168, DOI 10.1016/j.diabres.2020.108441; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Manzotti G, 2015, CELL CYCLE, V14, P2578, DOI 10.1080/15384101.2015.1033591; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Muller AJ, 2019, SEMIN IMMUNOPATHOL, V41, P41, DOI 10.1007/s00281-018-0702-0; Nanki K, 2018, CELL, V174, P856, DOI 10.1016/j.cell.2018.07.027; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Ott M, 2015, GLIA, V63, P78, DOI 10.1002/glia.22734; Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001; Pontali E, 2021, J ALLERGY CLIN IMMUN, V147, P1217, DOI 10.1016/j.jaci.2021.01.024; Ramiro S, ANN RHEUM DIS, P2021; Ramiro S, 2020, ANN RHEUM DIS, V79, P1143, DOI 10.1136/annrheumdis-2020-218479; Robinson PC, 2021, LANCET RHEUMATOL, V3, pE168, DOI 10.1016/S2665-9913(21)00005-9; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Sun C, 2018, IMMUNITY, V48, P434, DOI 10.1016/j.immuni.2018.03.014; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Venkitaraman R, 2015, EUR UROL, V67, P673, DOI 10.1016/j.eururo.2014.10.004; Wang J, 2019, CELL, V176, P334, DOI 10.1016/j.cell.2018.11.010; Xiang Z, 2017, ONCOGENE, V36, P5122, DOI 10.1038/onc.2017.108; Xiang Z, 2019, FRONT MED-PRC, V13, P24, DOI 10.1007/s11684-019-0679-7; Xiang Z, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00861; Yang RX, 2021, INT J BIOL SCI, V17, P1530, DOI 10.7150/ijbs.58695	49	14	14	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 5	2021	40	31					5002	5012		10.1038/s41388-021-01897-0	http://dx.doi.org/10.1038/s41388-021-01897-0		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TV5MG	34175886	hybrid, Green Published			2022-12-26	WOS:000666835600001
J	Jia, MS; Gabrys, B; Musial, K				Jia, Mingshan; Gabrys, Bogdan; Musial, Katarzyna			Directed closure coefficient and its patterns	PLOS ONE			English	Article							COMMUNITY STRUCTURE; NETWORKS	The triangle structure, being a fundamental and significant element, underlies many theories and techniques in studying complex networks. The formation of triangles is typically measured by the clustering coefficient, in which the focal node is the centre-node in an open triad. In contrast, the recently proposed closure coefficient measures triangle formation from an end-node perspective and has been proven to be a useful feature in network analysis. Here, we extend it by proposing the directed closure coefficient that measures the formation of directed triangles. By distinguishing the direction of the closing edge in building triangles, we further introduce the source closure coefficient and the target closure coefficient. Then, by categorising particular types of directed triangles (e.g., head-of-path), we propose four closure patterns. Through multiple experiments on 24 directed networks from six domains, we demonstrate that at network-level, the four closure patterns are distinctive features in classifying network types, while at node-level, adding the source and target closure coefficients leads to significant improvement in link prediction task in most types of directed networks.	[Jia, Mingshan; Gabrys, Bogdan; Musial, Katarzyna] Univ Technol Sydney, Sch Comp Sci, Sydney, NSW, Australia	University of Technology Sydney	Jia, MS (corresponding author), Univ Technol Sydney, Sch Comp Sci, Sydney, NSW, Australia.	mingshab.jia@students.uts.edu.au		Musial-Gabrys, Katarzyna/0000-0001-6038-7647; Jia, Mingshan/0000-0001-8378-3407; Gabrys, Bogdan/0000-0002-0790-2846	Australian Research Council [DP190101087]	Australian Research Council(Australian Research Council)	This work was supported by the Australian Research Council, grant No. DP190101087: "Dynamics and Control of Complex Social Networks".	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ahnert SE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.036112; Albert R, 1999, NATURE, V401, P130, DOI 10.1038/43601; [Anonymous], 2009, P 18 INT C WORLD WID, DOI DOI 10.1145/1526709.1526809; Barabasi A.-L., 2016, NETWORK SCI; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bollacker K. D., 1998, Proceedings of the Second International Conference on Autonomous Agents, P116, DOI 10.1145/280765.280786; Costantini G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088669; Easley D, 2010, NETWORKS CROWDS MARK; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gehrke J., 2003, SIGKDD EXPLORATIONS, V5, P149, DOI [DOI 10.1145/980972.980992, 10.1145/980972.980992]; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Henderson Keith, 2012, P 18 ACM SIGKDD INT, P1231, DOI DOI 10.1145/2339530.2339723; Ji QB, 2020, IEEE ACCESS, V8, P142337, DOI 10.1109/ACCESS.2020.3013241; Jia M, 2020, INT C COMPL NETW THE, P62; Josang A., 2006, P 29 AUSTR COMP SCI, P85; Juszczyszyn K, 2008, LECT NOTES ARTIF INT, V5178, P97, DOI 10.1007/978-3-540-85565-1_13; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kumar S, 2018, WSDM'18: PROCEEDINGS OF THE ELEVENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P333, DOI 10.1145/3159652.3159729; Kumar S, 2016, IEEE DATA MINING, P221, DOI [10.1109/ICDM.2016.0033, 10.1109/ICDM.2016.175]; LaFond T, 2014, ODD 2 WORKSH; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lou TC, 2013, ACM T KNOWL DISCOV D, V7, DOI 10.1145/2499907.2499908; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Massa P., 2005, CONTROVERSIAL USERS, P121; Massa P, 2009, EIGHTH IEEE INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING, PROCEEDINGS, P658, DOI 10.1109/DASC.2009.130; McCallum AK, 2000, INFORM RETRIEVAL, V3, P127, DOI 10.1023/A:1009953814988; Meo PD, 2019, ACM T INTERNET TECHN; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Musial K, 2009, 2009 FIRST ASIAN CONFERENCE ON INTELLIGENT INFORMATION AND DATABASE SYSTEMS, P34, DOI 10.1109/ACIIDS.2009.76; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Noble C.C., 2003, P 9 ACM SIGKDD INT C, P631; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Orman K., 2013, COMPLEX NETWORKS, P99; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Perozzi Bryan, 2014, KDD, P701, DOI DOI 10.1145/2623330.2623732; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; RAPOPORT ANATOL, 1953, BULL MATH BIOPHYS, V15, P523, DOI 10.1007/BF02476440; Romero D, 2010, P INT AAAI C WEB SOC, V4; Rossi RA, 2015, AAAI CONF ARTIF INTE, P4292; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; Schall D, 2014, SOC NETW ANAL MIN, V4, DOI 10.1007/s13278-014-0157-9; Solava RW, 2012, BIOINFORMATICS, V28, pI480, DOI 10.1093/bioinformatics/bts376; Subelj L., 2012, P 1 INT WORKSHOP SOF, P9, DOI [10.1145/2384416.2384418, DOI 10.1145/2384416.2384418]; Subelj L, 2013, P INT C NETW SCI COP, P152; ter Haar-Pomp L, 2015, J FORENSIC PSYCHOL P, V15, P114, DOI 10.1080/15228932.2015.1007779; Ulanowicz RE, 1999, NETWORK ANAL TROPHIC; Wang JX, 2012, IEEE ACM T COMPUT BI, V9, P1070, DOI 10.1109/TCBB.2011.147; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu ZX, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.037101; Yin H, 2020, NETW SCI, V8, P551, DOI 10.1017/nws.2020.20; Yin H, 2019, PROCEEDINGS OF THE TWELFTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING (WSDM'19), P303, DOI 10.1145/3289600.3290991; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang QM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055437; Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135182; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	62	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2021	16	6							e0253822	10.1371/journal.pone.0253822	http://dx.doi.org/10.1371/journal.pone.0253822			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9CN	34170971	gold, Green Published			2022-12-26	WOS:000671694400025
J	Aversi-Ferreira, TA; Borges, KCM; Goncalves-Mendes, MT; Caixeta, LF				Aversi-Ferreira, Tales Alexandre; Malheiros Borges, Kellen Christina; Goncalves-Mendes, Maria Tereza; Caixeta, Leonardo Ferreira			Gross anatomy of the longitudinal fascicle of Sapajus sp.	PLOS ONE			English	Article							MONKEYS CEBUS-LIBIDINOSUS; SPONTANEOUS TOOL USE; CAPUCHIN MONKEYS; ARCUATE FASCICULUS; FIBER DISSECTION; EVOLUTION; BRAIN; LANGUAGE; TRANSPORT; PRIMATES	Opposing genetic and cultural-social explanations for the origin of language are currently the focus of much discussion. One of the functions linked to the longitudinal fascicle is language, which links Wernicke's area and Broca's area in the brain, and its size should indicate the brain increase in the evolution. Sapajus is a New World primate genus with high cognition and advanced tool use similar to that of chimpanzees. A study of the gross anatomy of the longitudinal fascicle of Sapajus using Kingler's method found it to differ from other studied primates, such as macaques and chimpanzees, mainly because its fibers join the cingulate fascicle. As in other non-human primates, the longitudinal fascicle of Sapajus does not reach the temporal lobe, which could indicate a way of separating these fascicles to increase white matter in relation to individual function. The study of anatomical structures seems very promising for understanding the basis of the origin of language. Indeed, socio-historical-cultural philosophy affirms the socio-cultural origin of speech, although considering the anatomical structures behind it working as a functional system.	[Aversi-Ferreira, Tales Alexandre; Goncalves-Mendes, Maria Tereza] Univ Fed Alfenas, Inst Biomed Sci, Dept Struct Biol, Lab Biomath & Phys Anthropol, Alfenas, MG, Brazil; [Malheiros Borges, Kellen Christina] Fed Inst Goias, Dept Biol, Acad Areas, Anapolis, Go, Brazil; [Caixeta, Leonardo Ferreira] Univ Fed Goias, Clin Hosp, Dept Behav Neurol, Goiania, Go, Brazil	Universidade Federal de Alfenas; Instituto Federal de Goias (IFG); Universidade Federal de Goias	Aversi-Ferreira, TA (corresponding author), Univ Fed Alfenas, Inst Biomed Sci, Dept Struct Biol, Lab Biomath & Phys Anthropol, Alfenas, MG, Brazil.	aversiferreira@gmail.com	Aversi Ferreira, Tales/E-4734-2015	Aversi Ferreira, Tales/0000-0002-4417-7209				Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; ANTINUCCI F, 1986, INT J PRIMATOL, V7, P351, DOI 10.1007/BF02693700; Aversi-Ferreira Roqueline A G M F, 2013, Biomed Res Int, V2013, P737358, DOI 10.1155/2013/737358; Aversi-Ferreira RAGMF, 2014, FOLIA PRIMATOL, V85, P252, DOI 10.1159/000366061; Aversi-Ferreira RAGMF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087288; Aversi-Ferreira TA, 2010, ANAT REC, V293, P2056, DOI 10.1002/ar.21275; Aversi-Ferreira TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022165; Bernard F, 2019, SURG RADIOL ANAT, V41, P889, DOI 10.1007/s00276-019-02244-5; Bodin C, 2020, PHILOS T R SOC B, V375, DOI 10.1098/rstb.2018.0386; Boinski S, 2000, AM ANTHROPOL, V102, P741, DOI 10.1525/aa.2000.102.4.741; Borges Kellen Christina Malheiros, 2010, Dement. neuropsychol., V4, P181, DOI 10.1590/S1980-57642010DN40300006; Breseida DR., 2001, REV ETOL, V3, P3; Bush EC, 2004, P NATL ACAD SCI USA, V101, P3962, DOI 10.1073/pnas.0305760101; Catani M., 2009, DIFFUSION MRI; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catani M, 2008, CORTEX, V44, P953, DOI 10.1016/j.cortex.2008.04.002; CHEVALIERSKOLNIKOFF S, 1989, BEHAV BRAIN SCI, V12, P561, DOI 10.1017/S0140525X00057678; Chomsky N., 1957, SYNTACTICS STRUCTURE; CHOMSKY N., 1965, ASPECTS THEORY SINTA; Chomsky Noam, 1975, LOGICAL STRUCTURE LI; Cleveland A, 2004, ANIM COGN, V7, P193, DOI 10.1007/s10071-004-0213-3; COSTELLO MB, 1988, AM J PRIMATOL, V15, P235, DOI 10.1002/ajp.1350150306; de Castro I, 2005, ARQ NEURO-PSIQUIAT, V63, P252, DOI 10.1590/S0004-282X2005000200011; De Marco A, 2007, FOLIA PRIMATOL, V78, P118, DOI 10.1159/000097061; Demes B, 2013, AM J PHYS ANTHROPOL, V150, P76, DOI 10.1002/ajpa.22176; Demes B, 2011, AM J PHYS ANTHROPOL, V145, P147, DOI 10.1002/ajpa.21484; Dick AS, 2012, BRAIN, V135, P3529, DOI 10.1093/brain/aws222; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Everett DL., 2019, LANGUAGE BEGAN STORY; Fernandez-Miranda J, 2015, BRAIN STRUCT FUNCT, V220, P1665, DOI 10.1007/s00429-014-0751-7; Fitch WT, 2017, PSYCHON B REV, V24, P3, DOI 10.3758/s13423-017-1236-5; Fragaszy D, 2004, AM J PRIMATOL, V64, P359, DOI 10.1002/ajp.20085; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; Gage NM., 2019, FUNDAMENTAL COGNITIV, V2nd; GARBER PA, 1987, ANNU REV ANTHROPOL, V16, P339; Jalles E, 2001, J HUM EVOL, V40, P365, DOI 10.1006/jhev.2000.0461; KLINGLER J, 1960, J COMP NEUROL, V115, P333, DOI 10.1002/cne.901150305; Klingler J, 1935, SCHWEIZ ARCH NEUROL, V36, P247; LEBRUN Y, 1995, APHASIOLOGY, V9, P171, DOI 10.1080/02687039508248704; Liu ST, 2009, LATERALITY, V14, P217, DOI 10.1080/13576500802344404; Luria A R, 1965, J Neurol Sci, V2, P288, DOI 10.1016/0022-510X(65)90113-9; Luria A.R., 1966, HIGHER CORTICAL FUNC, P3; Luria A. R., 1973, WORKING BRAIN INTRO; Luria Alexander, 1987, MAN SHATTERED WORLD; LURIA AR, 1959, BRIT J PSYCHOL, V50, P89, DOI 10.1111/j.2044-8295.1959.tb00687.x; Machado A.B.M., 2000, NEUROANATOMIA FUNCIO; Borges KCM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/648128; Martino J, 2013, BRAIN STRUCT FUNCT, V218, P105, DOI 10.1007/s00429-012-0386-5; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Pereira-de-Paula J., 2010, NEUROBIOLOGIA, V73, P65; Perry S, 2011, PHILOS T R SOC B, V366, P988, DOI 10.1098/rstb.2010.0317; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Resende Briseida Dôgo de, 2002, Estud. psicol. (Natal), V7, P173, DOI 10.1590/S1413-294X2002000100018; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rilling JK, 2014, CURR OPIN NEUROBIOL, V28, P10, DOI 10.1016/j.conb.2014.04.002; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; Roth G, 2005, TRENDS COGN SCI, V9, P250, DOI 10.1016/j.tics.2005.03.005; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Sherwood CC, 2005, NAT NEUROSCI, V8, P537, DOI 10.1038/nn0505-537; Souto A, 2011, BIOL LETTERS, V7, P532, DOI 10.1098/rsbl.2011.0034; Standring S., 2008, GRAYS ANATOMY ANATOM, P839; Swindler D.R., 1973, ATLAS PRIMATE GROSS; Tavares MCH, 2002, BEHAV BRAIN RES, V131, P131, DOI 10.1016/S0166-4328(01)00368-0; Testut L., 1958, TRATADO ANATOMIA HUM, VII; VISALBERGHI E, 1995, J COMP PSYCHOL, V109, P52, DOI 10.1037/0735-7036.109.1.52; Visalberghi E, 2005, SCIENCE, V308, P951; Waga IC, 2006, FOLIA PRIMATOL, V77, P337, DOI 10.1159/000093698; Westergaard G.C., 1994, Human Evolution, V9, P323, DOI 10.1007/BF02435518; Westergaard GC, 1997, AM J PRIMATOL, V43, P33, DOI 10.1002/(SICI)1098-2345(1997)43:1<33::AID-AJP2>3.3.CO;2-X; WESTERGAARD GC, 1987, J COMP PSYCHOL, V101, P159, DOI 10.1037/0735-7036.101.2.159; WESTERGAARD GC, 1995, WORLD ARCHAEOL, V27, P1; Wysiadecki G, 2019, FOLIA MORPHOL, V78, P455, DOI 10.5603/FM.a2018.0113; Zemmoura I, 2014, NEUROIMAGE, V103, P106, DOI 10.1016/j.neuroimage.2014.09.016	73	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252178	10.1371/journal.pone.0252178	http://dx.doi.org/10.1371/journal.pone.0252178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BX	34166386	Green Published, gold			2022-12-26	WOS:000671692800062
J	Smallegan, MJ; Shehata, S; Spradlin, SF; Swearingen, A; Wheeler, G; Das, A; Corbet, G; Nebenfuehr, B; Ahrens, D; Tauber, D; Lennon, S; Choi, K; Huynh, T; Wieser, T; Schneider, K; Bradshaw, M; Basken, J; Lai, M; Read, T; Hynes-Grace, M; Timmons, D; Demasi, J; Rinn, JL				Smallegan, Michael J.; Shehata, Soraya; Spradlin, Savannah F.; Swearingen, Alison; Wheeler, Graycen; Das, Arpan; Corbet, Giulia; Nebenfuehr, Benjamin; Ahrens, Daniel; Tauber, Devin; Lennon, Shelby; Choi, Kevin; Huynh, Thao; Wieser, Tom; Schneider, Kristen; Bradshaw, Michael; Basken, Joel; Lai, Maria; Read, Timothy; Hynes-Grace, Matt; Timmons, Dan; Demasi, Jon; Rinn, John L.			Genome-wide binding analysis of 195 DNA binding proteins reveals "reservoir" promoters and human specific SVA-repeat family regulation	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; CHIP-SEQ; SUPER-ENHANCERS; CELL IDENTITY; ELEMENTS; ENCODE; ENCYCLOPEDIA; ANNOTATION; EVOLUTION; DISEASE	A key aspect in defining cell state is the complex choreography of DNA binding events in a given cell type, which in turn establishes a cell-specific gene-expression program. Here we wanted to take a deep analysis of DNA binding events and transcriptional output of a single cell state (K562 cells). To this end we re-analyzed 195 DNA binding proteins contained in ENCODE data. We used standardized analysis pipelines, containerization, and literate programming with R Markdown for reproducibility and rigor. Our approach validated many findings from previous independent studies, underscoring the importance of ENCODE's goals in providing these reproducible data resources. We also had several new findings including: (i) 1,362 promoters, which we refer to as 'reservoirs,' that are defined by having up to 111 different DNA binding-proteins localized on one promoter, yet do not have any expression of steady-state RNA (ii) Reservoirs do not overlap super-enhancer annotations and distinct have distinct properties from super-enhancers. (iii) The human specific SVA repeat element may have been co-opted for enhancer regulation and is highly transcribed in PRO-seq and RNA-seq. Collectively, this study performed by the students of a CU Boulder computational biology class (BCHM 5631 -Spring 2020) demonstrates the value of reproducible findings and how resources like ENCODE that prioritize data standards can foster new findings with existing data in a didactic environment.	[Smallegan, Michael J.; Shehata, Soraya; Corbet, Giulia; Tauber, Devin; Huynh, Thao; Schneider, Kristen; Bradshaw, Michael; Hynes-Grace, Matt; Timmons, Dan; Demasi, Jon; Rinn, John L.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Smallegan, Michael J.; Swearingen, Alison; Das, Arpan; Nebenfuehr, Benjamin; Ahrens, Daniel; Choi, Kevin; Rinn, John L.] Univ Colorado, Dept Mol & Cellular Biol, Boulder, CO 80309 USA; [Shehata, Soraya; Spradlin, Savannah F.; Wheeler, Graycen; Corbet, Giulia; Tauber, Devin; Lennon, Shelby; Huynh, Thao; Wieser, Tom; Rinn, John L.] Univ Colorado, Dept Biochem, Boulder, CO 80309 USA; [Shehata, Soraya; Spradlin, Savannah F.; Swearingen, Alison; Wheeler, Graycen; Das, Arpan; Corbet, Giulia; Nebenfuehr, Benjamin; Ahrens, Daniel; Tauber, Devin; Lennon, Shelby; Choi, Kevin; Huynh, Thao; Wieser, Tom; Schneider, Kristen; Bradshaw, Michael] Univ Colorado, Biochem 5631 Spring 2020, Boulder, CO 80309 USA; [Schneider, Kristen; Bradshaw, Michael] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Basken, Joel; Lai, Maria; Read, Timothy] Arpeggio Biosci, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Smallegan, MJ; Rinn, JL (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.; Smallegan, MJ; Rinn, JL (corresponding author), Univ Colorado, Dept Mol & Cellular Biol, Boulder, CO 80309 USA.; Rinn, JL (corresponding author), Univ Colorado, Dept Biochem, Boulder, CO 80309 USA.	michael.smallegan@colorado.edu; john.rinn@colorado.edu		Smallegan, Michael/0000-0002-5919-6736; Wheeler, Graycen/0000-0003-4604-1097; Corbet, Giulia/0000-0002-2210-843X; Nebenfuehr, Benjamin/0000-0002-1561-6815; Read, Timothy/0000-0001-5460-8941	CU Boulder Biochemistry department [T32GM065103, T32GM008759]	CU Boulder Biochemistry department	Arpeggio Biosciences provided support in the form of salaries for authors JB, ML, and TR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This course is supported by the CU Boulder Biochemistry department through these core training grants specifically for authors TW, SFS, TH, and GW by the Biophysics training program (T32GM065103), Signaling and cellular regulation training program (T32GM008759).	Azofeifa JG, 2018, GENOME RES, V28, P334, DOI 10.1101/gr.225755.117; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Cabili MN, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0586-4; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cardiello JF, 2020, TRANSCR-AUSTIN, V11, P3, DOI 10.1080/21541264.2019.1704128; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Core LJ, 2009, GENE DEV, V23, P1606, DOI 10.1101/gad.1827709; Cosby RL, 2019, GENE DEV, V33, P1098, DOI 10.1101/gad.327312.119; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2017, NAT PROTOC, V12, P2478, DOI 10.1038/nprot.2017.124; Ewels PA, 2020, NAT BIOTECHNOL, V38, P276, DOI 10.1038/s41587-020-0439-x; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriques T, 2018, GENE DEV, V32, P26, DOI 10.1101/gad.309351.117; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jiang Y, 2019, NUCLEIC ACIDS RES, V47, pD235, DOI 10.1093/nar/gky1025; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114485; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Mahony S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003501; Mattioli K, 2019, GENOME RES, V29, P344, DOI 10.1101/gr.242222.118; McInnes L., 2017, J OPEN SOURCE SOFTW, V2, P205, DOI 10.21105/joss.00205; McInnes L., 2018, J OPEN SOURCE SOFTW, V3, P861, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Mele M., 2016, CHROMATIN ENV TRANSC; Mele M, 2017, GENOME RES, V27, P27, DOI 10.1101/gr.214205.116; Mele M, 2016, MOL CELL, V62, P657, DOI 10.1016/j.molcel.2016.05.011; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nakato R, 2021, METHODS, V187, P44, DOI 10.1016/j.ymeth.2020.03.005; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rinn J, 2014, SCIENCE, V345, P1240, DOI 10.1126/science.1252966; Savage AL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-101; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0237055	10.1371/journal.pone.0237055	http://dx.doi.org/10.1371/journal.pone.0237055			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166368	Green Submitted, Green Published, gold			2022-12-26	WOS:000671692800096
J	Yulia, A; Singh, N; Varley, AJ; Lei, KY; Markovic, D; Sooranna, SR; Johnson, MR				Yulia, Angela; Singh, Natasha; Varley, Alice J.; Lei, Kaiyu; Markovic, Danijela; Sooranna, Suren R.; Johnson, Mark R.			PKA and AKIP1 interact to mediate cAMP-driven COX-2 expression: A potentially pivotal interaction in preterm and term labour	PLOS ONE			English	Article							NF-KAPPA-B; VASOACTIVE-INTESTINAL-PEPTIDE; OXYTOCIN RECEPTOR; MYOMETRIAL CELLS; KINASE; ACTIVATION; GENES; ALPHA	Previously, we showed that cAMP increased COX-2 expression in myometrial cells via MAPK. Here, we have extended these observations, using primary myometrial cell cultures to show that the cAMP agonist, forskolin, enhances IL-1 beta-driven COX-2 expression. We then explored the role of A-kinase interacting protein (AKIP1), which modulates the effect of PKA on p65 activation. AKIP1 knockdown reversed the effect of forskolin, such that its addition inhibited IL-1 beta-induced COX-2 mRNA expression and reduced the IL-1 beta-induced increase in nuclear levels of p65 and c-jun. Forskolin alone and with IL-1 beta increased I kappa B alpha mRNA expression suggesting that in the context of inflammation and in the presence of AKIP1, cAMP enhances p65 activation. AKIP1 knockdown reversed these changes. Interestingly, AKIP1 knockdown had minimal effect on the ability of forskolin to repress either basal OTR expression or IL-1 beta-stimulated OTR mRNA expression. AKIP1 was up-regulated by IL-1 beta, but not stretch and was repressed by cAMP. The mRNA expression of AKIP1 increased in early labour in tandem with an increase in COX-2 mRNA and protein. AKIP1 protein levels were also increased with inflammation and stretch-induced preterm labour. Our results identify a second important cAMP effector-switch occurring at term in human myometrium and suggest that a hitherto unrecognized interaction may exist between AKIP1, NF kappa B and AP-1. These data add to the proposition that cAMP acts as a key regulator of human myometrial contractility.	[Yulia, Angela; Singh, Natasha; Varley, Alice J.; Lei, Kaiyu; Markovic, Danijela; Sooranna, Suren R.; Johnson, Mark R.] Chelsea & Westminster Hosp, London, England; [Yulia, Angela; Singh, Natasha; Varley, Alice J.; Lei, Kaiyu; Sooranna, Suren R.; Johnson, Mark R.] Inst Reprod & Dev Biol, London, England	Imperial College London; Imperial College London	Yulia, A (corresponding author), Chelsea & Westminster Hosp, London, England.; Yulia, A (corresponding author), Inst Reprod & Dev Biol, London, England.	ayulia@doctors.org.uk		Singh, Natasha/0000-0002-5130-9679	Action Medical Research, Borne, National Institute for Health Research Bio-medical Research Centre	Action Medical Research, Borne, National Institute for Health Research Bio-medical Research Centre	This work was supported by Action Medical Research, Borne, National Institute for Health Research Bio-medical Research Centre.	Allport VC, 2001, MOL HUM REPROD, V7, P581, DOI 10.1093/molehr/7.6.581; Braun M, 1997, ARTERIOSCL THROM VAS, V17, P2568, DOI 10.1161/01.ATV.17.11.2568; Chen L, 2014, MOL CELL ENDOCRINOL, V382, P334, DOI 10.1016/j.mce.2013.10.018; Chen L, 2012, J CELL MOL MED, V16, P1447, DOI 10.1111/j.1582-4934.2011.01413.x; Delgado M, 2001, J BIOL CHEM, V276, P369, DOI 10.1074/jbc.M006923200; Delgado M, 2001, J IMMUNOL, V166, P1028, DOI 10.4049/jimmunol.166.2.1028; Fetalvero Kristina M, 2008, J Clin Invest, V118, P3966, DOI 10.1172/JCI33800; Gao N, 2008, J BIOL CHEM, V283, P7834, DOI 10.1074/jbc.M710285200; Gao N, 2010, J BIOL CHEM, V285, P28097, DOI 10.1074/jbc.M110.116566; Gerlo S, 2011, CELL MOL LIFE SCI, V68, P3823, DOI 10.1007/s00018-011-0757-8; Groom KM, 2005, BJOG-INT J OBSTET GY, V112, P725, DOI 10.1111/j.1471-0528.2005.00539.x; Khanjani S, 2011, J CELL MOL MED, V15, P809, DOI 10.1111/j.1582-4934.2010.01069.x; King CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018713; Kitching R, 2003, BBA-GENE STRUCT EXPR, V1625, P116, DOI 10.1016/S0167-4781(02)00562-6; Lei K, 2015, MOL ENDOCRINOL, V29, P1454, DOI 10.1210/me.2015-1122; MacDougall MWJ, 2003, J CLIN ENDOCR METAB, V88, P2194, DOI 10.1210/jc.2002-021862; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Phillips RJ, 2011, MOL HUM REPROD, V17, P1, DOI 10.1093/molehr/gaq057; POBER JS, 1993, J IMMUNOL, V150, P5114; Romero R, 2006, SEMIN FETAL NEONAT M, V11, P317, DOI 10.1016/j.siny.2006.05.001; Salojin KV, 2006, J IMMUNOL, V176, P1899, DOI 10.4049/jimmunol.176.3.1899; Slater DM, 2002, J SOC GYNECOL INVEST, V9, P118, DOI 10.1016/S1071-5576(02)00151-X; Sooranna SR, 2005, J CLIN ENDOCR METAB, V90, P3517, DOI 10.1210/jc.2004-1390; Stjernholm-Vladic Ylva, 2004, Reprod Biol Endocrinol, V2, P74, DOI 10.1186/1477-7827-2-74; Terzidou V, 2006, J CLIN ENDOCR METAB, V91, P2317, DOI 10.1210/jc.2005-2649; Wang L., 2016, CURR MOL MED; Yulia A, 2016, ENDOCRINOLOGY, V157, P4411, DOI 10.1210/en.2016-1514; Zhang Y, 2014, GENET MOL RES, V13, P10648, DOI 10.4238/2014.December.18.7	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2021	16	6							e0252720	10.1371/journal.pone.0252720	http://dx.doi.org/10.1371/journal.pone.0252720			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BX	34166397	Green Published, gold			2022-12-26	WOS:000671692800076
J	Li, JJ; Chen, XL; Zhu, LQ; Lao, ZH; Zhou, TH; Zang, LJ; Ge, WY; Jiang, MY; Xu, JX; Cao, Y; Du, SQ; Yu, Y; Fan, GJ; Wang, HX				Li, Junjian; Chen, Xiaoliang; Zhu, Liqun; Lao, Zhenghong; Zhou, Tianhao; Zang, Lijuan; Ge, Weiyu; Jiang, Mengyi; Xu, Jingxuan; Cao, Yuan; Du, Shaoqian; Yu, Yue; Fan, Guangjian; Wang, Hongxia			SOX9 is a critical regulator of TSPAN8-mediated metastasis in pancreatic cancer	ONCOGENE			English	Article							STEM-CELLS; TUMOR; TETRASPANINS; EXPRESSION; INVASION; TSPAN8; CO-029; EGFR; TRANSCRIPTION; INDUCTION	Pancreatic ductal adenocarcinoma (PDAC) is the deadliest cancer mainly owing to its proclivity to early metastasis and the lack of effective targeted therapeutic drugs. Hence, understanding the molecular mechanisms underlying early invasion and metastasis by PDAC is imperative for improving patient outcomes. The present study identified that upregulation of TSPAN8 expression in PDAC facilitates metastasis in vivo and in vitro. We found SOX9 as a key transcriptional regulator of TSPAN8 expression in response to EGF stimulation. SOX9 modulation was sufficient to positively regulate endogenous expression of TSPAN8, with concomitant in vitro phenotypic changes such as loss of cell-matrix adherence and increased invasion. Moreover, increased SOX9 and TSPAN8 levels were shown to correlate in human pancreatic cancer specimens and downregulated in vitro by EGFR tyrosine kinase inhibitors. High expression of SOX9 and TSPAN8 has been associated with tumor stage, poor prognosis and poor patient survival in PDAC. In conclusion, this study highlights the importance of the EGF-SOX9-TSPAN8 signaling cascade in the control of PDAC invasion and implies that TSPAN8 may be a promising novel therapeutic target for the treatment of PDAC.	[Li, Junjian] Shanghai Univ Med & Hlth Sci, Shanghai Key Lab Mol Imaging, Shanghai, Peoples R China; [Li, Junjian; Zhou, Tianhao; Ge, Weiyu; Xu, Jingxuan; Cao, Yuan; Du, Shaoqian; Wang, Hongxia] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Oncol, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China; [Chen, Xiaoliang] Shenzhen Guangming Dist Ctr Dis Control & Prevent, Ctr Chron Dis Control & Prevent, Shenzhen, Peoples R China; [Zhu, Liqun] Liyang Peoples Hosp, Dept Oncol, Liyang, Peoples R China; [Lao, Zhenghong] Deqing Peoples Hosp, Dept Oncol, Huzhou, Peoples R China; [Zang, Lijuan] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Pathol Ctr, Sch Med, Shanghai, Peoples R China; [Jiang, Mengyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Med Oncol, East Campus, Shanghai, Peoples R China; [Yu, Yue] Shanghai Expt Sch, Shanghai, Peoples R China; [Fan, Guangjian] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Translat Med Ctr, Sch Med, Shanghai, Peoples R China	Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Wang, HX (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Oncol, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.; Fan, GJ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Translat Med Ctr, Sch Med, Shanghai, Peoples R China.	gjfan@shsmu.edu.cn; whx365@126.com	Li, Junjian/GSN-5570-2022	Li, Junjian/0000-0001-7970-4163; Xu, Jingxuan/0000-0002-9678-7906	National Natural Science Funds [82073269, 81772802]; Shanghai Science and Technology Innovation Action Plan [20XD1402800]; Clinical Research Plan of SHDC [SHDC2020CR2065B]; Construction Project of Shanghai Key Laboratory of Molecular Imaging [18DZ2260400]; Shanghai Municipal Education Commission (Class II Plateau Disciplinary Construction Program of Medical Technology of SUMHS); Huzhou Natural Science Funds [2017YZ11]	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation Action Plan; Clinical Research Plan of SHDC; Construction Project of Shanghai Key Laboratory of Molecular Imaging; Shanghai Municipal Education Commission (Class II Plateau Disciplinary Construction Program of Medical Technology of SUMHS); Huzhou Natural Science Funds	This work was supported by the National Natural Science Funds (grant number 82073269 and 81772802), Shanghai Science and Technology Innovation Action Plan (grant number 20XD1402800) and Clinical Research Plan of SHDC (grant number SHDC2020CR2065B) to H.X.W., the Construction Project of Shanghai Key Laboratory of Molecular Imaging (grant number 18DZ2260400) and Shanghai Municipal Education Commission (Class II Plateau Disciplinary Construction Program of Medical Technology of SUMHS, 2018-2020) to J.J.L. and the Huzhou Natural Science Funds (grant number 2017YZ11) to Z.H.L.	Agaesse G, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.11; Anami K, 2016, GASTRIC CANCER, V19, P370, DOI 10.1007/s10120-015-0478-z; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Chen NM, 2015, GASTROENTEROLOGY, V148, P1024, DOI 10.1053/j.gastro.2015.01.033; Chen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01024-2; Cheung M, 2003, DEVELOPMENT, V130, P5681, DOI 10.1242/dev.00808; Dellle Cave D, 2020, ONCOGENE, V39, P4271, DOI 10.1038/s41388-020-1289-1; El Kharbili M, 2019, ONCOGENE, V38, P3781, DOI 10.1038/s41388-019-0691-z; Fang TT, 2016, ONCOTARGET, V7, P40630, DOI 10.18632/oncotarget.9769; Gesierich S, 2005, CLIN CANCER RES, V11, P2840, DOI 10.1158/1078-0432.CCR-04-1935; Giampieri R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215990; Greco C, 2010, CANCER RES, V70, P7674, DOI 10.1158/0008-5472.CAN-09-4482; Grimont A, 2015, GUT, V64, P1790, DOI 10.1136/gutjnl-2014-307075; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hessmann E, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/5272498; Higashihara T, 2017, PANCREAS, V46, P1296, DOI 10.1097/MPA.0000000000000945; Hu B, 2017, ONCOL LETT, V14, P7583, DOI 10.3892/ol.2017.7160; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kaushik G, 2021, ONCOGENE, V40, P848, DOI 10.1038/s41388-020-01564-w; Kawaguchi Y, 2013, J CLIN INVEST, V123, P1881, DOI 10.1172/JCI66022; Kim TK, 2015, BIOCHEM BIOPH RES CO, V468, P774, DOI 10.1016/j.bbrc.2015.11.031; Kopp JL, 2012, CANCER CELL, V22, P737, DOI 10.1016/j.ccr.2012.10.025; Kyuno D, 2019, TRANSL ONCOL, V12, P191, DOI 10.1016/j.tranon.2018.08.021; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Ling SZ, 2011, CANCER RES, V71, P3812, DOI 10.1158/0008-5472.CAN-10-3072; Liu HW, 2015, CELL BIOCHEM BIOPHYS, V73, P205, DOI 10.1007/s12013-015-0647-z; Luanpitpong S, 2016, ONCOGENE, V35, P2824, DOI 10.1038/onc.2015.351; Mu W, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020319; Mu W, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01359; Nedaeinia R, 2014, CURR DRUG TARGETS, V15, P1293, DOI 10.2174/1389450115666141125123003; Park CS, 2016, ONCOGENE, V35, P4540, DOI 10.1038/onc.2015.520; Park SJ, 2015, INT J CLIN EXP PATHO, V8, P8298; Pishvaian MJ, 2020, LANCET ONCOL, V21, P508, DOI 10.1016/S1470-2045(20)30074-7; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Rana S, 2011, INT J BIOCHEM CELL B, V43, P106, DOI 10.1016/j.biocel.2010.10.002; Shi JG, 2018, INT J ONCOL, V52, P179, DOI 10.3892/ijo.2017.4201; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Shih HP, 2012, DEVELOPMENT, V139, P2488, DOI 10.1242/dev.078634; Si JL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-92; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun L, 2013, STEM CELLS, V31, P1454, DOI 10.1002/stem.1394; Swartling FJ, 2012, CANCER CELL, V21, P601, DOI 10.1016/j.ccr.2012.04.012; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; Tang L, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0232-1; Blasco MT, 2019, CANCER CELL, V35, P573, DOI 10.1016/j.ccell.2019.03.002; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Voglstaetter M, 2019, J PATHOL, V248, P421, DOI 10.1002/path.5281; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang HB, 2013, INT J CANCER, V133, P416, DOI 10.1002/ijc.28044; Wang LD, 2019, GENE DEV, V33, P641, DOI 10.1101/gad.323303.118; Yan SY, 2018, GENE, V679, P138, DOI 10.1016/j.gene.2018.08.038; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yue GGL, 2015, AM J CANCER RES, V5, P3570; Yue SJ, 2015, ONCOTARGET, V6, P2366, DOI 10.18632/oncotarget.2958; Zhou H, 2018, ONCOGENE, V37, P912, DOI 10.1038/onc.2017.393; Zhu RX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10739-3	58	7	8	7	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 29	2021	40	30					4884	4893		10.1038/s41388-021-01864-9	http://dx.doi.org/10.1038/s41388-021-01864-9		JUN 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TS1QO	34163029	hybrid, Green Published			2022-12-26	WOS:000664853000005
J	Mishra, AP; Harper, NS; Schnupp, JWH				Mishra, Ambika P.; Harper, Nicol S.; Schnupp, Jan W. H.			Exploring the distribution of statistical feature parameters for natural sound textures	PLOS ONE			English	Article								Sounds like "running water" and "buzzing bees" are classes of sounds which are a collective result of many similar acoustic events and are known as "sound textures". A recent psychoacoustic study using sound textures has reported that natural sounding textures can be synthesized from white noise by imposing statistical features such as marginals and correlations computed from the outputs of cochlear models responding to the textures. The outputs being the envelopes of bandpass filter responses, the 'cochlear envelope'. This suggests that the perceptual qualities of many natural sounds derive directly from such statistical features, and raises the question of how these statistical features are distributed in the acoustic environment. To address this question, we collected a corpus of 200 sound textures from public online sources and analyzed the distributions of the textures' marginal statistics (mean, variance, skew, and kurtosis), cross-frequency correlations and modulation power statistics. A principal component analysis of these parameters revealed a great deal of redundancy in the texture parameters. For example, just two marginal principal components, which can be thought of as measuring the sparseness or burstiness of a texture, capture as much as 64% of the variance of the 128 dimensional marginal parameter space, while the first two principal components of cochlear correlations capture as much as 88% of the variance in the 496 correlation parameters. Knowledge of the statistical distributions documented here may help guide the choice of acoustic stimuli with high ecological validity in future research.	[Mishra, Ambika P.] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Harper, Nicol S.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Schnupp, Jan W. H.] City Univ Hong Kong, Dept Neurosci, Hong Kong, Peoples R China	City University of Hong Kong; University of Oxford; City University of Hong Kong	Schnupp, JWH (corresponding author), City Univ Hong Kong, Dept Neurosci, Hong Kong, Peoples R China.	wschnupp@cityu.edu.hk		MISHRA, Ambika Prasad/0000-0002-0942-0787; schnupp, jan w h/0000-0002-2604-0057	Research Grant Council, Hong Kong SAR [11100617]	Research Grant Council, Hong Kong SAR(Hong Kong Research Grants Council)	This work has been supported by grant from Research Grant Council, Hong Kong SAR, (Reference no-11100617 to JS)	Attias H, 1997, ADV NEUR IN, V9, P27; Attias H, 1998, ADV NEUR IN, V10, P103; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Chachada S, 2014, APSIPA TRANS SIGNAL, V3, DOI 10.1017/ATSIP.2014.12; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Font F., 2013, P 21 ACM INT C MULTI, P411; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Garcia-Lazaro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022584; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Harper NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108154; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heeger D. J., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P229, DOI 10.1145/218380.218446; JULESZ B, 1978, BIOL CYBERN, V31, P137, DOI 10.1007/BF00336998; Julesz B., 1962, IRE T INFORM THEOR, V8, P84, DOI [10.1109/TIT.1962.1057698, DOI 10.1109/TIT.1962.1057698]; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Singer Y, 2018, ELIFE, V7, DOI 10.7554/eLife.31557; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Willmore BB, 2016, J NEUROSCI, V36, P280, DOI 10.1523/JNEUROSCI.2441-15.2016	23	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0238960	10.1371/journal.pone.0238960	http://dx.doi.org/10.1371/journal.pone.0238960			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161323	Green Submitted, gold, Green Published			2022-12-26	WOS:000671691900030
J	Qi, YH; He, YJ; Wang, X; Zhang, CX; Chen, JP; Lu, G; Li, JM				Qi, Yu-Hua; He, Yu-Juan; Wang, Xin; Zhang, Chuan-Xi; Chen, Jian-Ping; Lu, Gang; Li, Jun-Min			Physical contact transmission of Cucumber green mottle mosaic virus by Myzus persicae	PLOS ONE			English	Article							1ST REPORT; VECTOR INTERACTIONS; APHID TRANSMISSION; CAPSID PROTEIN; DISEASE; DOMAIN; PLANTS	Cucumber green mottle mosaic virus (CGMMV), a critical plant virus, has caused significant economic losses in cucurbit crops worldwide. It has not been proved that CGMMV can be transmitted by an insect vector. In this study, the physical contact transmission of CGMMV by Myzus persicae in Nicotiana benthamiana plants was confirmed under laboratory conditions. The acquisition rate increased with time, and most aphids acquired CGMMV at 72 h of the acquisition access period (AAP). Besides, the acquired CGMMV was retained in the aphids for about 12 h, which was efficiently transmitted back to the healthy N. benthamiana plants. More importantly, further experiments suggested that the transmission was mediated by physical contact rather than the specific interaction between insect vector and plant virus. The results obtained in our study contribute to the development of new control strategies for CGMMV in the field.	[Qi, Yu-Hua; He, Yu-Juan; Wang, Xin; Zhang, Chuan-Xi; Chen, Jian-Ping; Lu, Gang; Li, Jun-Min] Ningbo Univ, Inst Plant Virol, State Key Lab Managing Biot & Chem Threats Qual &, Key Lab Biotechnol Plant Protect,Minist Agr & Zhe, Ningbo, Peoples R China; [Qi, Yu-Hua; Wang, Xin; Chen, Jian-Ping] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China	Ningbo University; Fujian Agriculture & Forestry University	Lu, G; Li, JM (corresponding author), Ningbo Univ, Inst Plant Virol, State Key Lab Managing Biot & Chem Threats Qual &, Key Lab Biotechnol Plant Protect,Minist Agr & Zhe, Ningbo, Peoples R China.	lugang@nbu.edu.cn; lijunmin@nbu.edu.cn	Li, Junmin/C-5446-2013	Li, Junmin/0000-0001-8409-6465; Zhang, Chuan-Xi/0000-0002-7784-1188	National Natural Science Foundation of China [U20A2036]; Natural Science Foundation of Zhejiang Province [LQ20C140003]; Natural Science Foundation of Ningbo City [2019A610404]; Ningbo Science and Technology Innovation 2025 Major Project [2019B10004]; K.C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Ningbo City; Ningbo Science and Technology Innovation 2025 Major Project; K.C. Wong Magna Fund in Ningbo University	This work was supported by National Natural Science Foundation of China (U20A2036), Natural Science Foundation of Zhejiang Province (LQ20C140003), Natural Science Foundation of Ningbo City (2019A610404), Ningbo Science and Technology Innovation 2025 Major Project (2019B10004). This work was sponsored by K.C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignus Y, 2012, ADV VIRUS RES, V84, P533, DOI 10.1016/B978-0-12-394314-9.00015-4; Blanc S, 1997, VIROLOGY, V231, P141, DOI 10.1006/viro.1997.8521; Blanc S, 2014, ANNU REV PHYTOPATHOL, V52, P403, DOI 10.1146/annurev-phyto-102313-045920; Brault V, 2000, J VIROL, V74, P1140, DOI 10.1128/JVI.74.3.1140-1148.2000; Brault V, 2010, CR BIOL, V333, P524, DOI 10.1016/j.crvi.2010.04.001; Cao Q, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01419; Carmo-Sousa M, 2014, VIRUS RES, V186, P38, DOI 10.1016/j.virusres.2013.12.012; Casteel CL, 2014, PLANT J, V77, P653, DOI 10.1111/tpj.12417; Celix A, 1996, PLANT DIS, V80, P1303, DOI 10.1094/PD-80-1303C; Cho SY, 2015, PLANT DIS, V99, P897, DOI 10.1094/PDIS-07-14-0741-PDN; Darzi E, 2018, PLANT PATHOL, V67, P244, DOI 10.1111/ppa.12702; Dietzgen RG, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110303; Dombrovsky A, 2017, ANNU REV PHYTOPATHOL, V55, P231, DOI 10.1146/annurev-phyto-080516-035349; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Kehoe MA, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00036-17, 10.1128/genomea.00036-17]; Kim OK, 2010, J PHYTOPATHOL, V158, P572, DOI 10.1111/j.1439-0434.2009.01655.x; Lecoq H, 2014, ADV VIRUS RES, V90, P255, DOI 10.1016/B978-0-12-801246-8.00005-6; Li RG, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00452-15; Ling KS, 2014, PLANT DIS, V98, P701, DOI 10.1094/PDIS-09-13-0996-PDN; Liu SJ, 2002, J VIROL, V76, P9756, DOI 10.1128/JVI.76.19.9756-9762.2002; Mandal S., 2008, PLANT VIRUSES, V2, P25; Mulot M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00457; Nagendran K, 2015, PLANT DIS, V99, P559, DOI 10.1094/PDIS-10-14-1071-PDN; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; PIRONE TP, 1966, VIROLOGY, V30, P631, DOI 10.1016/0042-6822(66)90168-1; PIRONE TP, 1964, VIROLOGY, V23, P107, DOI 10.1016/S0042-6822(64)80015-5; Reingold V, 2016, ANN APPL BIOL, V168, P29, DOI 10.1111/aab.12238; Reingold V, 2015, PLANT PATHOL, V64, P245, DOI 10.1111/ppa.12260; Ryckebusch F., 2020, J GEN VIROL; Sharma P, 2014, ACTA VIROL, V58, P299, DOI 10.4149/av_2014_03_299; Tian T, 2014, PLANT DIS, V98, P1163, DOI 10.1094/PDIS-02-14-0176-PDN; VANEMDEN HF, 1969, ANNU REV ENTOMOL, V14, P197, DOI 10.1146/annurev.en.14.010169.001213; Whitfield AE, 2015, VIROLOGY, V479, P278, DOI 10.1016/j.virol.2015.03.026; Zhang YJ, 2009, PLANT DIS, V93, P200, DOI 10.1094/PDIS-93-2-0200C; Zheng HY, 2015, ARCH VIROL, V160, P2867, DOI 10.1007/s00705-015-2584-y	36	1	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2021	16	6							e0252856	10.1371/journal.pone.0252856	http://dx.doi.org/10.1371/journal.pone.0252856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BO	34161338	gold, Green Published			2022-12-26	WOS:000671691900002
J	Bi, XY; Lou, PB; Song, YL; Sheng, XL; Liu, RQ; Deng, M; Yang, X; Li, GL; Yuan, SK; Zhang, HL; Jiao, BW; Zhang, B; Xue, LX; Liu, ZH; Plikus, MV; Ren, FZ; Gao, S; Zhao, L; Yu, ZQ				Bi, Xueyun; Lou, Pengbo; Song, Yongli; Sheng, Xiaole; Liu, Ruiqi; Deng, Min; Yang, Xu; Li, Guilin; Yuan, Shukai; Zhang, Honglei; Jiao, Baowei; Zhang, Bing; Xue, Lixiang; Liu, Zhihua; Plikus, Maksim, V; Ren, Fazheng; Gao, Shan; Zhao, Li; Yu, Zhengquan			Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway	ONCOGENE			English	Article							BINDING PROTEIN MUSASHI1; TISSUE INHIBITORS; RNA; METALLOPROTEINASES; INVASION; CORTACTIN; MIGRATION; CELLS; TRAFFICKING; ASSOCIATION	Metastasis is the main cause of death in breast cancer patients. The initial step of metastasis is invadopodia-mediated extracellular matrix (ECM) degradation, which enables local breast tumor cells to invade surrounding tissues. However, the molecular mechanism underlying invadopodia-mediated metastasis remains largely unknown. Here we found that the RNA-binding protein Musashi1 (Msi1) exhibited elevated expression in invasive breast tumors and promoted lung metastasis of mammary cancer cells. Suppression of Msi1 reduced invadopodia formation in mammary cancer cells. Furthermore, Msi1 deficiency decreased the expression and activity of Mmp9, an important enzyme in ECM degradation. Mechanistically, Msi1 directly suppressed Timp3, an endogenous inhibitor of Mmp9. In clinical breast cancer specimens, TIMP3 and MSI1 levels were significantly inversely correlated both in normal breast tissue and breast cancer tissues and associated with overall survival in breast cancer patients. Taken together, our findings demonstrate that the MSI1-TIMP3-MMP9 cascade is critical for invadopodia-mediated onset of metastasis in breast cancer, providing novel insights into a promising therapeutic strategy for breast cancer metastasis.	[Bi, Xueyun; Lou, Pengbo; Sheng, Xiaole; Liu, Ruiqi; Deng, Min; Yang, Xu; Li, Guilin; Yu, Zhengquan] China Agr Univ, Coll Biol Sci, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual,Minist Educ, Beijing, Peoples R China; [Song, Yongli] Inner Mongolia Univ, State Key Lab Reprod Regulat & Breeding Grassland, Coll Life Sci, Hohhot, Peoples R China; [Song, Yongli] Inner Mongolia Univ, Res Ctr Anim Genet Resources Mongolia Plateau, Coll Life Sci, Hohhot, Peoples R China; [Yuan, Shukai; Zhao, Li] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Sch Basic Med Sci,Key Lab, Tianjins Clin Res Ctr Canc,Dept Biochem & Mol Bio, Tianjin, Peoples R China; [Zhang, Honglei] Yunnan Univ Chinese Med, Ctr Sci Res, Kunming, Yunnan, Peoples R China; [Jiao, Baowei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China; [Zhang, Bing] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Xue, Lixiang] Peking Univ Third Hosp, Med Res Ctr, Dept Radiat Oncol, Beijing, Peoples R China; [Liu, Zhihua] Chinese Acad Med Sci, Natl Canc Ctr, State Key Lab Mol Oncol, Canc Hosp, Beijing, Peoples R China; [Plikus, Maksim, V] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92717 USA; [Ren, Fazheng] China Agr Univ, Coll Food Sci & Nutr Engn, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual,Minist Educ, Beijing, Peoples R China; [Gao, Shan] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, CAS Key Lab Biomed Diagnost, Suzhou, Jiangsu, Peoples R China	China Agricultural University; Inner Mongolia University; Inner Mongolia University; Tianjin Medical University; Yunnan University of Chinese Medicine; Chinese Academy of Sciences; Kunming Institute of Zoology; China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; University of California System; University of California Irvine; China Agricultural University; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS	Yu, ZQ (corresponding author), China Agr Univ, Coll Biol Sci, Dept Nutr & Hlth, Key Lab Precis Nutr & Food Qual,Minist Educ, Beijing, Peoples R China.; Zhao, L (corresponding author), Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc,Sch Basic Med Sci,Key Lab, Tianjins Clin Res Ctr Canc,Dept Biochem & Mol Bio, Tianjin, Peoples R China.	shzhaoli@tmu.edu.cn; zyu@cau.edu.cn	邓, 敏/GRS-4423-2022	邓, 敏/0000-0002-0338-8253; Plikus, Maksim/0000-0002-8845-2559; Bi, Xueyun/0000-0002-0367-0590; Lou, Pengbo/0000-0002-7525-0173; Yuan, Shukai/0000-0003-0354-5113; JIAO, BAOWEI/0000-0001-8559-9160	National Natural Science Foundation of China [81772984, 81572614]; Beijing Nature Foundation Grant [5162018]; Major Project for Cultivation Technology [2016ZX08008001, 2014ZX08008001]; Basic Research Program [2019TC227, 2019TC088]; SKLAB Open Grant [2020SKLAB6-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nature Foundation Grant; Major Project for Cultivation Technology; Basic Research Program; SKLAB Open Grant	This work is supported by the National Natural Science Foundation of China (Nos. 81772984, 81572614), Beijing Nature Foundation Grant (5162018), the Major Project for Cultivation Technology (2016ZX08008001, 2014ZX08008001), Basic Research Program (2019TC227, 2019TC088), and SKLAB Open Grant (2020SKLAB6-18). The authors thank the members of the laboratory animal center in China Agricultural University for their assistance in animal care.	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Ala-Aho R, 2005, BIOCHIMIE, V87, P273, DOI 10.1016/j.biochi.2004.12.009; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Ascano M, 2013, CURR OPIN GENET DEV, V23, P20, DOI 10.1016/j.gde.2013.01.003; Olivares-Urbano MA, 2020, J CELL MOL MED, V24, P139, DOI 10.1111/jcmm.14671; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Bourguignon LYW, 1998, J CELL PHYSIOL, V176, P206, DOI 10.1002/(SICI)1097-4652(199807)176:1<206::AID-JCP22>3.0.CO;2-3; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Castagnino A, 2018, ONCOGENE, V37, P6425, DOI 10.1038/s41388-018-0422-x; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09504-7; Cheung KJ, 2016, SCIENCE, V352, P167, DOI 10.1126/science.aaf6546; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Fehm T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2349; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Gong PJ, 2017, HUM PATHOL, V65, P53, DOI 10.1016/j.humpath.2016.12.026; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jacob A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00004; Kang MH, 2017, ONCOGENE, V36, P1745, DOI 10.1038/onc.2016.327; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Li M, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01587-x; Li N, 2015, CELL REP, V13, P2440, DOI 10.1016/j.celrep.2015.11.022; Li W, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0495-y; Lin JC, 2018, RADIOTHER ONCOL, V129, P352, DOI 10.1016/j.radonc.2018.09.014; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nahas GR, 2016, FASEB J, V30, P149, DOI 10.1096/fj.15-278770; Okano H, 2002, J CELL SCI, V115, P1355; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Owyong M, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800226; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Sanchez-Diaz PC, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-280; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Shi JY, 2018, J INVEST DERMATOL, V138, P2253, DOI 10.1016/j.jid.2018.03.1521; Sun Y, 2015, ONCOL REP, V33, P338, DOI 10.3892/or.2014.3585; Tinhofer I, 2014, INT J RADIAT BIOL, V90, P622, DOI 10.3109/09553002.2014.886798; Vo DT, 2011, RNA BIOL, V8, P817, DOI 10.4161/rna.8.5.16041; Wang S, 2009, P NATL ACAD SCI USA, V106, P151, DOI 10.1073/pnas.0808703105; Wang XY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-221; Wang ZQ, 2017, DEV CELL, V43, P186, DOI 10.1016/j.devcel.2017.09.012; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Zhang Z, 2018, ARCH GYNECOL OBSTET, V297, P433, DOI 10.1007/s00404-017-4598-z	57	6	7	4	19	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 22	2021	40	29					4832	4845		10.1038/s41388-021-01873-8	http://dx.doi.org/10.1038/s41388-021-01873-8		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TR9TO	34155343				2022-12-26	WOS:000664006400002
J	Fosco, C; Zurita, F				Fosco, Constanza; Zurita, Felipe			Assessing the short-run effects of lockdown policies on economic activity, with an application to the Santiago Metropolitan Region, Chile	PLOS ONE			English	Article							COVID-19; EPIDEMIC; SEGREGATION; CONTAGION; SPREAD	This paper develops a methodology for the assessment of the short-run effects of lockdown policies on economic activity. The methodology combines labor market data with simulation of an agent-based model. We apply our methodology to the Santiago Metropolitan Region, Chile. We recover the model parameters from observed data, taking into account the recurring policy adjustments that characterized the study window. The model is used to build counterfactual scenarios. We estimate an 8 percent output loss in the first 5 months of the pandemic from the policy that was put in place, achieving a 56 percent reduction in the total number of infections. During this period, with an output loss to 10.5 percent of GDP, the infection rate would have decreased 92 percent, significantly delaying the spread of COVID and spike in infections. Our methodology applied to real data provided results that could be valuable in guiding policies in other lockdown situations in times of disaster, pandemics or social upheaval.	[Fosco, Constanza; Zurita, Felipe] Res Ctr Integrated Disaster Risk Management CIGID, ANID FONDAP 15110017, Santiago, Chile; [Fosco, Constanza] Grp Interdisciplinar Sistemas Complejos GISC, Leganes, Spain; [Zurita, Felipe] Pontificia Univ Catolica Chile, Inst Econ, Santiago, Chile	Pontificia Universidad Catolica de Chile	Zurita, F (corresponding author), Res Ctr Integrated Disaster Risk Management CIGID, ANID FONDAP 15110017, Santiago, Chile.; Zurita, F (corresponding author), Pontificia Univ Catolica Chile, Inst Econ, Santiago, Chile.	fzurita@uc.cl		Zurita, Felipe/0000-0001-7374-560X				Acemoglu D., 2020, 27102 NBER, P27102; Agostini CA, 2016, EURE, V42, P159, DOI 10.4067/S0250-71612016000300007; Aleta A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01619-5; Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/coli_a_00370, 10.1162/COLI_a_00370]; Arino J, 2006, FIELDS I COMMUN, V48, P1; Asahi K, 2021, J GLOB HEALTH, V11, DOI [10.7189/jogh.11.05002, 10.7189/jogh.10.05002]; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Banco Central de Chile, 2018, 2017 EFH BANC CENTR; Belik V, 2011, EUR PHYS J B, V84, P579, DOI 10.1140/epjb/e2011-20485-2; Birge JR., 2020, CONTROLLING EPIDEMIC, P57; Bohning D, 2020, INT J INFECT DIS, V97, P197, DOI 10.1016/j.ijid.2020.06.009; Brauer F., 2012, MATH MODELS POPULATI, DOI 10.1007/978-1-4614-1686-9; Brazeau NF., 2020, MRC CTR GLOBAL INFEC, P34; Bro N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244372; Calvetti D, 2020, FRONT PHYS-LAUSANNE, V8, DOI 10.3389/fphy.2020.00261; Coletti P., 2020, MEDRXIV, DOI [10.1101/2020.07.20.20157933, DOI 10.1101/2020.07.20.20157933]; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Costa GS, 2020, PHYS REV RES, V2, DOI 10.1103/PhysRevResearch.2.043306; del Rio-Chanona RM, 2020, OXFORD REV ECON POL, V36, pS94, DOI 10.1093/oxrep/graa033; Delaporte I., 2020, COVID EC CTR EC POLI, V14, P200; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fadinger H, 2020, COVID EC VETTED REAL, V9, P110; Fajgelbaum P., 2020, OPTIMAL LOCKDOWN COM, P27441; Farboodi M., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Favero CA., 2020, RESTARTING EC SAVING; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Glover Andrew, 2020, NBER WORKING PAPERS, P27046; Gollier C, 2020, J PUBLIC ECON THEORY, V22, P1746, DOI 10.1111/jpet.12486; Gomez-Gardenes J, 2018, NAT PHYS, V14, P391, DOI 10.1038/s41567-017-0022-7; Google llc, 2020, GOOGLE; Gottlieb C, 2021, EUR ECON REV, V133, DOI 10.1016/j.euroecorev.2021.103679; Hoertel N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1001-6; Hunter E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208775; Hunter E, 2017, JASSS-J ARTIF SOC S, V20, DOI 10.18564/jasss.3414; Inoue H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239251; Instituto Nacional de Estadisticas, 2017, CENS NAC POBL VIV 20; Instituto Nacional de Estadisticas (National Statistics Institute) Chile, 2020, PROY POBL; Janiak A, 2021, J ECON BEHAV ORGAN, V182, P264, DOI 10.1016/j.jebo.2020.12.016; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kuhl E, 2020, EXTREME MECH LETT, V40, DOI 10.1016/j.eml.2020.100921; Lekfuangfu W.N., 2020, COVID EC, V12, P87, DOI [DOI 10.2139/SSRN.3583954, 10.2139/ssrn.3583954]; Liu QH, 2018, P NATL ACAD SCI USA, V115, P12680, DOI 10.1073/pnas.1811115115; Ludvigson Sydney C., 2020, NATL BUREAU EC RES W, P26987; Lund H, 2013, J STAT PHYS, V151, P367, DOI 10.1007/s10955-013-0690-3; Maugeri A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051350; Ministerio de Desarrollo Social (Ministry of Social Development) Chile, 2017, EST POB COMM 2017; Ministerio de Salud (Ministry of Health) Chile, 2020, INF EP ENF COVID 19; Ministerio del Interior (Ministry of Interior) Chile, 2020, INSTR PERM DESP; Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103; Piguillem F, 2020, COVID EC, V27, P123; Romero H, 2012, ECOL INDIC, V23, P76, DOI 10.1016/j.ecolind.2012.03.012; Servicio de Impuestos Internos (Internal Revenue Service) Chile, 2020, EST EMPR; Tariq A, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009070; Trabandt M., 2020, MACROECONOMICS EPIDE, P26882; Venkatramanan S, 2018, EPIDEMICS-NETH, V22, P43, DOI 10.1016/j.epidem.2017.02.010; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Wu SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18272-4	59	4	4	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252938	10.1371/journal.pone.0252938	http://dx.doi.org/10.1371/journal.pone.0252938			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BF	34153046	Green Published, gold			2022-12-26	WOS:000671691000002
J	Ridlon, AD; Wasson, K; Waters, T; Adams, J; Donatuto, J; Fleener, G; Froehlich, H; Govender, R; Kornbluth, A; Lorda, J; Peabody, B; Iv, GP; Rumrill, SS; Tobin, E; Zabin, CJ; Zacherl, D; Grosholz, ED				Ridlon, April D.; Wasson, Kerstin; Waters, Tiffany; Adams, John; Donatuto, Jamie; Fleener, Gary; Froehlich, Halley; Govender, Rhona; Kornbluth, Aaron; Lorda, Julio; Peabody, Betsy; Iv, Gifford Pinchot; Rumrill, Steven S.; Tobin, Elizabeth; Zabin, Chela J.; Zacherl, Danielle; Grosholz, Edwin D.			Conservation aquaculture as a tool for imperiled marine species: Evaluation of opportunities and risks for Olympia oysters, Ostrea lurida	PLOS ONE			English	Article							ECOSYSTEM SERVICES; CARPENTER 1864; RESTORATION; COAST; BIODIVERSITY; SHELLFISH; ECOLOGY; PRODUCTIVITY; RESILIENCE; DIVERSITY	Conservation aquaculture is becoming an important tool to support the recovery of declining marine species and meet human needs. However, this tool comes with risks as well as rewards, which must be assessed to guide aquaculture activities and recovery efforts. Olympia oysters (Ostrea lurida) provide key ecosystem functions and services along the west coast of North America, but populations have declined to the point of local extinction in some estuaries. Here, we present a species-level, range-wide approach to strategically planning the use of aquaculture to promote recovery of Olympia oysters. We identified 12 benefits of culturing Olympia oysters, including identifying climate-resilient phenotypes that add diversity to growers' portfolios. We also identified 11 key risks, including potential negative ecological and genetic consequences associated with the transfer of hatchery-raised oysters into wild populations. Informed by these trade-offs, we identified ten priority estuaries where aquaculture is most likely to benefit Olympia oyster recovery. The two highest scoring estuaries have isolated populations with extreme recruitment limitation-issues that can be addressed via aquaculture if hatchery capacity is expanded in priority areas. By integrating social criteria, we evaluated which project types would likely meet the goals of local stakeholders in each estuary. Community restoration was most broadly suited to the priority areas, with limited commercial aquaculture and no current community harvest of the species, although this is a future stakeholder goal. The framework we developed to evaluate aquaculture as a tool to support species recovery is transferable to other systems and species globally; we provide a guide to prioritizing local knowledge and developing recommendations for implementation by using transparent criteria. Our collaborative process engaging diverse stakeholders including managers, scientists, Indigenous Tribal representatives, and shellfish growers can be used elsewhere to seek win-win opportunities to expand conservation aquaculture where benefits are maximized for both people and imperiled species.	[Ridlon, April D.] Univ Calif Santa Barbara, Sci Nat & People Partnership, Santa Barbara, CA 93106 USA; [Ridlon, April D.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Wasson, Kerstin] Elkhorn Slough Natl Estuarine Res Reserve, Watsonvile, CA USA; [Wasson, Kerstin] Univ Calif Santa Cruz, Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Waters, Tiffany] Nature Conservancy, Global Aquaculture, Arlington, VA USA; [Adams, John] Sound Fresh Clams & Oysters, Shelton, WA USA; [Donatuto, Jamie] Swinomish Indian Tribal Community, Community Environm Hlth Program, Laconner, WA USA; [Fleener, Gary] Hog Isl Oyster Co, Res & Dev, Marshall, CA USA; [Froehlich, Halley] Univ Calif Santa Barbara, Ecol Evolut & Marine Biol & Environm Studies, Santa Barbara, CA 93106 USA; [Govender, Rhona] Fisheries & Oceans Canada, Species Risk Program, Vancouver, BC, Canada; [Kornbluth, Aaron] Pew Charitable Trusts, Washington, DC USA; [Lorda, Julio] Univ Autonoma Baja California, Fac Ciencias, Mexicali, Baja California, Mexico; [Lorda, Julio] Tijuana River Natl Estuarine Res Reserve, Imperial Beach, CA USA; [Peabody, Betsy] Puget Sound Restorat Fund, Bainbridge Isl, WA USA; [Iv, Gifford Pinchot] Chelsea Farms, Olympia, WA USA; [Rumrill, Steven S.] Oregon Dept Fish & Wildlife, Marine Resources Program, Newport, OR USA; [Tobin, Elizabeth] Jamestown SKlallam Tribe, Nat Resources Dept, Sequim, WA USA; [Zabin, Chela J.] Smithsonian Environm Res Ctr, Marine Invas Res, Belvedere Tiburon, CA USA; [Zacherl, Danielle] Calif State Univ Fullerton, Dept Biol Sci, Fullerton, CA 92634 USA; [Grosholz, Edwin D.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Santa Barbara; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of California System; University of California Santa Cruz; Nature Conservancy; University of California System; University of California Santa Barbara; Fisheries & Oceans Canada; Universidad Autonoma de Baja California; Smithsonian Institution; Smithsonian Environmental Research Center; California State University System; California State University Fullerton; University of California System; University of California Davis	Ridlon, AD (corresponding author), Univ Calif Santa Barbara, Sci Nat & People Partnership, Santa Barbara, CA 93106 USA.; Ridlon, AD (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA.	ctenophores@gmail.com	Ridlon, April D/GPJ-0580-2022	Zacherl, Danielle/0000-0002-5351-2451; Ridlon, April/0000-0002-4618-9908; Lorda, Julio/0000-0002-4293-7518; Wasson, Kerstin/0000-0002-1858-4505	David and Lucile Packard Foundation [2018-68222]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was funded by a David and Lucile Packard Foundation Grant (#2018-68222) to the Science for Nature and People Partnership. Additional support was provided for all co-authors from their respective organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleway HK, 2019, BIOSCIENCE, V69, P59, DOI 10.1093/biosci/biy137; Angelini C, 2011, BIOSCIENCE, V61, P782, DOI 10.1525/bio.2011.61.10.8; [Anonymous], 2016, CLIMATE CHANGE AGR F; [Anonymous], 1989, SLOW FOOD MANIFESTO; Archer PE, 2008, THESIS OREGON STATE; Augustine S, 2014, CAN GEOGR-GEOGR CAN, V58, P305, DOI 10.1111/cag.12084; Baker P, 1995, J SHELLFISH RES, V14, P501; Barber JS, 2016, J SHELLFISH RES, V35, P351, DOI 10.2983/035.035.0209; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Bible JM, 2016, BIOL CONSERV, V193, P95, DOI 10.1016/j.biocon.2015.11.015; Blake B., 2012, WASHINGTON DEP FISH; Brumbaugh R. D., 2006, PRACTITIONERS GUIDE; Brumbaugh RD, 2000, MAR TECHNOL SOC J, V34, P79, DOI 10.4031/MTSJ.34.1.9; Camara MD, 2009, J SHELLFISH RES, V28, P121, DOI 10.2983/035.028.0104; Conte FS., 2001, CALIFORNIAS LIVING M, P500; Costa-Pierce BA, 2002, RESPONSIBLE MARINE AQUACULTURE, P105, DOI 10.1079/9780851996042.0105; Crim R, 2015, J SHELLFISH RES, V34, P621; Cross SF., 2017, PLANNING AQUACULTURE, P93; Dinnel P., 2018, 16 SKAG COUNT MAR RE, DOI [10.1056/NEJMoa1805971, DOI 10.1056/NEJMOA1805971]; Dumbauld BR, 2009, AQUACULTURE, V290, P196, DOI 10.1016/j.aquaculture.2009.02.033; ERLANDSON JM, 1988, AM ANTIQUITY, V53, P102, DOI 10.2307/281156; Ermgassen PSEZ, 2013, ESTUAR COAST, V36, P36, DOI 10.1007/s12237-012-9559-y; Ermgassen PSEZ, 2012, P ROY SOC B-BIOL SCI, V279, P3393, DOI 10.1098/rspb.2012.0313; Ferriss BE, 2019, AQUACULTURE, V498, P254, DOI 10.1016/j.aquaculture.2018.08.046; Fisheries & Oceans Canada, 2009, SPECIES RISK ACT MAN, pVI; Fitzsimons JA, 2020, CONSERV SCI PRACT, V2, DOI 10.1111/csp2.198; Flagg TA., 1999, NOAA TECH MEMO NMFS, P38; Friedman CS, 2020, SCI TOTAL ENVIRON, V739, DOI 10.1016/j.scitotenv.2020.139752; Froehlich HE, 2017, BIOL CONSERV, V215, P162, DOI 10.1016/j.biocon.2017.09.012; Froehlich HE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169281; Gentry RR, 2020, REV AQUACULT, V12, P499, DOI 10.1111/raq.12328; Gleason M.G., 2011, CONSERVATION ASSESSM; Grabowski JH, 2012, BIOSCIENCE, V62, P900, DOI 10.1525/bio.2012.62.10.10; Guo XM, 1999, J SHELLFISH RES, V18, P19; Hilborn R, 2018, FRONT ECOL ENVIRON, V16, P329, DOI 10.1002/fee.1822; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hollarsmith JA, 2020, LIMNOL OCEANOGR, V65, P224, DOI 10.1002/lno.11293; Kaeding L., 2020, THESIS CENTRAL WASHI; Karl HA, 2007, ENVIRONMENT, V49, P20, DOI 10.3200/ENVT.49.1.20-34; Kazmiruk TN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196005; Kimbro DL, 2006, ECOLOGY, V87, P2378, DOI 10.1890/0012-9658(2006)87[2378:DIOCRA]2.0.CO;2; Kimmerer W., 2004, ESTUARY WATERSHED SC, V2, DOI 10.15447/sfews.2004v2iss1art1; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Laylander D., 2008, PACIFIC COAST ARCHAE, V39, P39; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Meyer GR, 2010, J SHELLFISH RES, V29, P181, DOI 10.2983/035.029.0112; Moore JD, 2011, CALIF FISH GAME, V97, P68; Moore SK, 2008, ESTUAR COAST SHELF S, V80, P545, DOI 10.1016/j.ecss.2008.09.016; Morikawa MK, 2019, P NATL ACAD SCI USA, V116, P10586, DOI 10.1073/pnas.1721415116; Morrison SA, 2015, CONSERV BIOL, V29, P960, DOI 10.1111/cobi.12432; MOSS ML, 1993, AM ANTHROPOL, V95, P631, DOI 10.1525/aa.1993.95.3.02a00050; Neo ML, 2017, OCEANOGR MAR BIOL, V55, P87; Olivier AV, 2020, REV AQUACULT, V12, P3, DOI 10.1111/raq.12301; Pogoda B, 2019, AQUAT LIVING RESOUR, V32, DOI 10.1051/alr/2019012; Polson MP, 2009, J SHELLFISH RES, V28, P69, DOI 10.2983/035.028.0113; Pritchard C, 2015, J SHELLFISH RES, V34, P259, DOI 10.2983/035.034.0207; Puckett BJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00076; Raith M, 2016, AM MALACOL BULL, V33, P263, DOI 10.4003/006.033.0206; Ramsay J, 2012, THESIS OREGON STATE; Ridlon AD, 2021, ESTUAR COAST, V44, P1723, DOI 10.1007/s12237-021-00920-7; Rogers-Bennett L, 2016, J SHELLFISH RES, V35, P611, DOI 10.2983/035.035.0306; Ruesink JL, 2006, MAR ECOL PROG SER, V311, P203, DOI 10.3354/meps311203; Schreier A. Drauch, 2012, Endangered Species Research, V16, P65, DOI 10.3354/esr00387; Sgro CM, 2011, EVOL APPL, V4, P326, DOI 10.1111/j.1752-4571.2010.00157.x; Silliman KE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24455-3; Spencer LH, 2020, ECOL APPL, V30, DOI 10.1002/eap.2060; Stephenson J, 2014, INDIAN J TRADIT KNOW, V13, P257; Stick DA., 2011, THESIS OREGON STATE; Tallis HM, 2009, J SHELLFISH RES, V28, P251, DOI 10.2983/035.028.0207; The Nature Conservancy (TNC), 2020, WORK COMP PRINC CORP; Theuerkauf SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222282; Theuerkauf SJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210936; Townsend CH., 1893, REPORT OBSERVATIONS, P343, DOI [10.1126/science.ns-21.525.105, DOI 10.1126/SCIENCE.NS-21.525.105]; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; Waldbusser GG, 2016, LIMNOL OCEANOGR, V61, P1969, DOI 10.1002/lno.10348; Wasson K, 2020, BIOL CONSERV, V250, DOI 10.1016/j.biocon.2020.108745; Wasson K, 2016, ECOLOGY, V97, P3503, DOI 10.1002/ecy.1602; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Weitzman J, 2019, ECOSYST SERV, V35, P194, DOI 10.1016/j.ecoser.2018.12.009; White J, 2009, J SHELLFISH RES, V28, P43, DOI 10.2983/035.028.0109; Willer DF, 2020, NAT FOOD, V1, P384, DOI 10.1038/s43016-020-0116-8; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	83	6	6	7	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 21	2021	16	6							e0252810	10.1371/journal.pone.0252810	http://dx.doi.org/10.1371/journal.pone.0252810			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9BF	34153054	gold, Green Published			2022-12-26	WOS:000671691000036
J	Degens, H; Attias, J; Evans, D; Wilkins, F; Hodson-Tole, E				Degens, Hans; Attias, Julia; Evans, Daniel; Wilkins, Frederick; Hodson-Tole, Emma			The mobility limitation in healthy older people is due to weakness and not slower muscle contractile properties	PLOS ONE			English	Article							POWER OUTPUT; AGE; DETERMINANTS; STRENGTH; MASS; PERFORMANCE; SARCOPENIA; DECLINE; ADULTS; YOUNG	The maximal power generating capacity of a muscle declines with age and has a negative impact on the performance of daily life activities. As muscle power is the product of force and velocity, we recruited 20 young (10 men, 10 women: 20-31 years) and 20 older (10 men, 10 women: 65-86 years) people to investigate which of these components contributes to the lower power and performance in old age. After determination of the maximal isometric knee extension torque (MVC), they performed a countermovement jump (CMJ) in 1) the normal situation (normal), 2) with an extra load of 15% body weight (loaded) and 3) 15% lower body weight (unloaded with a pulley system), and a timed up-and-go test (TUG) in the normal or loaded condition. The TUG and CMJ performance was lower in old than young participants (p<0.001). Below a critical CMJ peak power of similar to 23.7 W center dot kg(-1) TUG showed a progressive decrease. The CMJ take-off velocity (V-off) in the normal condition was lower in old than young participants (p<0.001). However, the V-off vs. body weight/MVC relationship of the normal, loaded and unloaded data combined was similar in the old and young participants and fitted the Hill equation (R-2 = 0.396). This indicates that 1) only when peak power drops below a critical threshold TUG becomes impaired and 2) there was no evidence for intrinsic slowing of the muscle contractile properties in older people, but rather the older people were working on a slower part of the force-velocity relationship due to weaker muscles.	[Degens, Hans; Attias, Julia; Evans, Daniel; Wilkins, Frederick; Hodson-Tole, Emma] Manchester Metropolitan Univ, Fac Sci & Engn, Res Ctr Musculoskeletal Sci & Sports Med, Manchester, Lancs, England; [Degens, Hans] Lithuanian Sports Univ, Inst Sport Sci & Innovat, Kaunas, Lithuania	Manchester Metropolitan University; Lithuanian Sports University	Degens, H (corresponding author), Manchester Metropolitan Univ, Fac Sci & Engn, Res Ctr Musculoskeletal Sci & Sports Med, Manchester, Lancs, England.; Degens, H (corresponding author), Lithuanian Sports Univ, Inst Sport Sci & Innovat, Kaunas, Lithuania.	h.degens@mmu.ac.uk		Evans, Daniel/0000-0002-7849-4966; Degens, Hans/0000-0001-7399-4841; Hodson-Tole, Emma/0000-0003-1200-1724	UK Space Agency [ST/S0001735/1]	UK Space Agency	The authors would like to acknowledge the UK Space Agency (ST/S0001735/1) for funding this project.	Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; Arai T, 2017, ARCH GERONTOL GERIAT, V73, P143, DOI 10.1016/j.archger.2017.07.015; Arampatzis A, 2011, EXERC SPORT SCI REV, V39, P18, DOI 10.1097/JES.0b013e318201efe0; Bagley L, 2019, SCAND J MED SCI SPOR, V29, P791, DOI 10.1111/sms.13404; Barnouin Y, 2017, J CACHEXIA SARCOPENI, V8, P647, DOI 10.1002/jcsm.12194; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; CAVAGNA GA, 1972, AEROSPACE MED, V43, P408; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; DAVIES CTM, 1968, NATURE, V217, P770, DOI 10.1038/217770a0; Degens H, 2005, ACTA PHYSIOL SCAND, V184, P235, DOI 10.1111/j.1365-201X.2005.01447.x; Degens H, 2019, MUSCLE AND EXERCISE PHYSIOLOGY, P423, DOI 10.1016/B978-0-12-814593-7.00019-0; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gilliver SF, 2009, EXP PHYSIOL, V94, P1070, DOI 10.1113/expphysiol.2009.048314; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Larsen AH, 2009, SCAND J MED SCI SPOR, V19, P678, DOI 10.1111/j.1600-0838.2008.00845.x; Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017; Macaluso A, 2003, EUR J APPL PHYSIOL, V90, P458, DOI 10.1007/s00421-003-0866-7; Maden-Wilkinson TM, 2015, J AGING PHYS ACTIV, V23, P352, DOI 10.1123/japa.2013-0219; McPhee JS, 2018, J GERONTOL A-BIOL, V73, P1287, DOI 10.1093/gerona/gly040; Michaelis I., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P64; Milborrow S., **DATA OBJECT**; Montgomery G, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051561; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Pinheiro J, NIM LIN NONL MIX EFF; Plas RLC, 2015, J EXP BIOL, V218, P2166, DOI 10.1242/jeb.117655; RCore Team, 2020, R LANG ENV STAT COMP; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Runge M, 2004, CLIN PHYSIOL FUNCT I, V24, P335, DOI 10.1111/j.1475-097X.2004.00567.x; Trappe S, 2003, J PHYSIOL-LONDON, V552, P47, DOI 10.1113/jphysiol.2003.044966; Verdijk LB, 2007, AM J PHYSIOL-ENDOC M, V292, pE151, DOI 10.1152/ajpendo.00278.2006; Vuk S, 2015, KINESIOLOGY, V47, P27	34	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253531	10.1371/journal.pone.0253531	http://dx.doi.org/10.1371/journal.pone.0253531			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143856	Green Accepted, gold, Green Published			2022-12-26	WOS:000671690700057
J	Mbulawa, ZZA; Somdyala, NI; Mabunda, SA; Williamson, AL				Mbulawa, Zizipho Z. A.; Somdyala, Nontuthuzelo, I; Mabunda, Sikhumbuzo A.; Williamson, Anna-Lise			High human papillomavirus prevalence among females attending high school in the Eastern Cape Province of South Africa	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; AGE-SPECIFIC PREVALENCE; CERVICAL-CANCER; HETEROSEXUAL COUPLES; COLLECTED SAMPLES; HPV; WOMEN; INFECTION; DNA; LEVEL	As part of the human papillomavirus (HPV) vaccination strategy in South Africa, it is essential to have information on HPV prevalence, and HPV types distribution among the unvaccinated population. Information on the prevalence of HPV and the distribution of HPV types in adolescents and young women in South Africa's Eastern Cape Province is minimal. Therefore, this study investigates the prevalence, distribution of HPV types, and factors associated with HPV infection amongst unvaccinated female learners. A sample composed of 213 sexually active female learners attending high schools in the Eastern Cape Province of South Africa; median age 18 years, who provided self-collected vaginal specimens. Roche Linear Array HPV genotyping assay that detects 37 HPV genotypes was used to detect HPV infection. HPV infection was detected in 76.06% (162/213) of participants. Of these 14.55% (31/213) were positive for HPV types targeted by the Cervarix (R) HPV vaccine (HPV-16 and/or 18), 20.66% (44/213) by Gardasil (R) 4 (HPV-6, -11, -16 and/or -18) and 37.09% (79/213) by Gardasil (R) 9 (HPV-6, -11, -16, -18, -31, -33, -45, -52 and/or -58). HPV-35, commonly detected in cervical cancer cases among women of African ancestry, was frequently detected (9.40%). Participants who reported to have ever consumed alcohol had a significantly higher risk of HPV infection (OR: 2.91, 95% CI: 1.38-6.11, p = 0.005). High HPV prevalence was observed among participants. The high prevalence of HPV types targeted by the Gardasil (R) 9 vaccine encourages the introduction of the Gardasil (R) 9 vaccine. Data from this study will inform both vaccination campaigns and monitor the impact on HPV types after vaccination.	[Mbulawa, Zizipho Z. A.] Nelson Mandela Acad Hosp, Natl Hlth Lab Serv, Mthatha, South Africa; [Mbulawa, Zizipho Z. A.] Walter Sisulu Univ, Dept Lab Med & Pathol, Mthatha, South Africa; [Mbulawa, Zizipho Z. A.; Mabunda, Sikhumbuzo A.; Williamson, Anna-Lise] Univ Cape Town, SAMRC UCT Gynaecol Canc Res Ctr, Cape Town, South Africa; [Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Somdyala, Nontuthuzelo, I] South African Med Res Council, Burden Dis Res Unit, Cape Town, South Africa; [Mabunda, Sikhumbuzo A.] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa	University of Kwazulu Natal; Walter Sisulu University; University of Cape Town; University of Cape Town; South African Medical Research Council; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Cape Town	Mbulawa, ZZA (corresponding author), Nelson Mandela Acad Hosp, Natl Hlth Lab Serv, Mthatha, South Africa.; Mbulawa, ZZA (corresponding author), Walter Sisulu Univ, Dept Lab Med & Pathol, Mthatha, South Africa.; Mbulawa, ZZA (corresponding author), Univ Cape Town, SAMRC UCT Gynaecol Canc Res Ctr, Cape Town, South Africa.; Mbulawa, ZZA (corresponding author), Univ Cape Town, Dept Pathol, Div Med Virol, Cape Town, South Africa.	zizipho.mbulawa@nhls.ac.za		Mabunda, Sikhumbuzo A/0000-0001-9458-3742	ZAM: South African Medical Research Council [384709]; National Health Laboratory Service Research Trust - National Research Foundation of South Africa [64815]	ZAM: South African Medical Research Council; National Health Laboratory Service Research Trust - National Research Foundation of South Africa	ZAM: South African Medical Research Council Self-Initiated Research Grant (384709) and National Health Laboratory Service Research Trust to conduct the study. ALW: salary is funded by the National Research Foundation of South Africa (Grant Number: 64815).	Adler David H, 2013, J Immunol Tech Infect Dis, V2, DOI 10.4172/2329-9541.1000113; Adler David H, 2014, Infect Dis Obstet Gynecol, V2014, P498048, DOI 10.1155/2014/498048; Arbyn M, 2014, LANCET ONCOL, V15, P172, DOI 10.1016/S1470-2045(13)70570-9; Bergman H, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013479; Botha MH, 2017, SOUTH AFR J GYNAECOL, V9, P8, DOI [10.10520/EJC-9584c6bc7, DOI 10.10520/EJC-9584C6BC7]; Brotherton JML, 2010, SEX HEALTH, V7, P310, DOI 10.1071/SH09137; Bruni L., HUMAN PAPILLOMAVIRUS; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Choudhry V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-128; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2019, CURR OPIN VIROL, V39, P16, DOI 10.1016/j.coviro.2019.06.006; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Dreyer G, 2018, BEST PRACT RES CL OB, V47, P95, DOI 10.1016/j.bpobgyn.2017.08.011; Ebrahim S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146603; Giuliano AR, 2015, JAIDS-J ACQ IMM DEF, V68, P227, DOI 10.1097/QAI.0000000000000425; Gravitt PE, 2014, LANCET ONCOL, V15, P128, DOI 10.1016/S1470-2045(13)70605-3; Jordaan S, 2016, HLTH CARE CURRENT RE, V4, P2, DOI 10.4172/2375-4273.1000180; Lekoane KMB, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-01354-1; Mahomed K, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.189.3454; Makura CBT, 2016, AIMS PUBLIC HEALTH, V3, P849, DOI 10.3934/publichealth.2016.4.849; Mbulawa Z., 2018, PUBLIC HLTH SURVEILL, V91; Mbulawa ZZA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190166; Mbulawa ZZA, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1181-8; Mbulawa ZZA, 2014, J INFECTION, V68, P185, DOI 10.1016/j.jinf.2013.10.012; Mbulawa ZZA, 2009, J INFECT DIS, V199, P1514, DOI 10.1086/598220; Naidoo A, 2018, OBSTET GYNAECOLOGY F, V25, P5; Ogale Y, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001349; Petignat P, 2007, GYNECOL ONCOL, V105, P530, DOI 10.1016/j.ygyno.2007.01.023; Pinheiro M, 2020, INT J CANCER, V147, P2677, DOI 10.1002/ijc.33033; Puerto D, 2018, CANCER PREV RES, V11, P581, DOI 10.1158/1940-6207.CAPR-17-0439; Reddy P.S., 2013, UMTHENTE UHLABA USAM; Richter K, 2013, SAMJ S AFR MED J, V103, P313, DOI 10.7196/SAMJ.6514; Schiffman M, 2005, NEW ENGL J MED, V353, P2101, DOI 10.1056/NEJMp058171; Schiffman M, 2003, ARCH PATHOL LAB MED, V127, P930; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Somdyala NIM, 2020, JCO GLOB ONCOL, V6, P1, DOI 10.1200/JGO.19.00198; South Africa National Cancer Registry, CANC INC S AFR 2014; Williamson AL, 2015, J CLIN MED, V4, P579, DOI 10.3390/jcm4040579; Winer RL, 2008, J INFECT DIS, V197, P279, DOI 10.1086/524875; Yared N, 2018, SEX TRANSM DIS, V45, P294, DOI 10.1097/OLQ.0000000000000739	41	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 18	2021	16	6							e0253074	10.1371/journal.pone.0253074	http://dx.doi.org/10.1371/journal.pone.0253074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9BC	34143816	Green Published, gold			2022-12-26	WOS:000671690700011
J	Bitencourt, MR; Alarcao, ACJ; Silva, LL; Dutra, AD; Caruzzo, NM; Roszkowski, I; Bitencourt, MR; Marques, VD; Pelloso, SM; Carvalho, MDD				Bitencourt, Maria Romanio; Jacinto Alarcao, Ana Carolina; Silva, Lincoln Luis; Dutra, Amanda de Carvalho; Caruzzo, Nayara Malheiros; Roszkowski, Igor; Bitencourt, Marcos Rogerio; Marques, Vlaudimir Dias; Pelloso, Sandra Marisa; de Barros Carvalho, Maria Dalva			Predictors of violence against health professionals during the COVID-19 pandemic in Brazil: A cross-sectional study	PLOS ONE			English	Article							WORKPLACE VIOLENCE; NURSES; CARE	Background The increase in violence against health professionals in the COVID-19 pandemic makes it necessary to identify the predictors of violence, in order to prevent these events from happening. Objective Evaluating the prevalence and analyzing the variables involved in the occurrence of violence against health professionals during the COVID-19 pandemic in Brazil. Method This is a cross-sectional study conducted online involving Brazilian health professionals during the COVID-19 pandemic. The data were collected through a structured questionnaire (Google Online Form) sent to health professionals on social networks and analyzed through logistic regression by using sociodemographic variables. The set of grouped variables was assigned to the final model when p <0.05. A network was built using the Mixed Graph Models (MGM) approach. A centrality measurement chart was constructed to determine which nodes have the greatest influence, strength and connectivity between the nodes around them. Results The predictors of violence in the adjusted regression model were the following: being a nursing technician / assistant; having been working for less than 20 years; working for over 37 hours a week; having suffered violence before the pandemic; having been contaminated with COVID-19; working in direct contact with patients infected by the virus; and having family members who have suffered violence. The network created with professionals who suffered violence demonstrated that the aggressions occurred mainly in the workplace, with an indication of psycho-verbal violence. In cases in which the aggressors were close people, aggressions were non-verbal and happened both in public and private places. The assaults practiced by strangers occurred in public places. Conclusions Violence against health professionals occurs implicitly and explicitly, with consequences that can affect both their psychosocial well-being and the assistance given to their patients and families.	[Bitencourt, Maria Romanio; Jacinto Alarcao, Ana Carolina; Silva, Lincoln Luis; Dutra, Amanda de Carvalho; Roszkowski, Igor; Bitencourt, Marcos Rogerio; Marques, Vlaudimir Dias; Pelloso, Sandra Marisa; de Barros Carvalho, Maria Dalva] State Univ Maringa UEM, Dept Hlth Sci, Maringa, Parana, Brazil; [Caruzzo, Nayara Malheiros] State Univ Maringa UEM, Dept Phys Educ, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Bitencourt, MR (corresponding author), State Univ Maringa UEM, Dept Hlth Sci, Maringa, Parana, Brazil.	romanio.maria@gmail.com		dias marques, vlaudimir/0000-0001-6192-3819; Bitencourt, Maria/0000-0002-0224-0783; Silva, Lincoln Luis/0000-0001-8445-0743				Ahmed A. S., 2012, Eastern Mediterranean Health Journal, V18, P318; Al-Ali NM, 2016, APPL NURS RES, V30, P83, DOI 10.1016/j.apnr.2015.11.001; Almeida NR., 2017, REV BRAS MED TRAB, V15, P101; [Anonymous], 2020, UN NEWS; Antao HS, 2020, ACTA MEDICA PORT, V33, P31, DOI 10.20344/amp.11465; Aydogdu ALF., 2020, J NURS HEAL, V10; Bagcchi S, 2020, LANCET INFECT DIS, V20, P782, DOI 10.1016/S1473-3099(20)30498-9; Bernardes MLG., 2020, REV BRAS MED TRAB, V18, P250; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burger J., 2020, OPEN ACCESS PREPRINT, DOI 10.31234/osf.io/4y9nz; Cadastro Nacional de Estabelecimentos de Saude, 2021, CONS PROF; Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7; Elias PEM, 2003, AM J PUBLIC HEALTH, V93, P44, DOI 10.2105/AJPH.93.1.44; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Fontes Kátia Biagio, 2011, Rev. Gaúcha Enferm., V32, P815; Gerberich SG, 2004, OCCUP ENVIRON MED, V61, P495, DOI 10.1136/oem.2003.007294; Gomez-Ochoa SA, 2021, AM J EPIDEMIOL, V190, P161, DOI 10.1093/aje/kwaa191; Haslbeck JMB, 2020, J STAT SOFTW, V93, DOI 10.18637/jss.v093.i08; Hsieh HF, 2017, WOMEN HEALTH, V57, P40, DOI 10.1080/03630242.2016.1150385; Junior Goncalo, 2020, ESTADAO; Kirchherr J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201710; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lanza Marilyn L, 2006, AAOHN J, V54, P397; Leite Franciéle Marabotti Costa, 2019, Rev. bras. epidemiol., V22, pe190056, DOI 10.1590/1980-549720190056; Levites MR., 2018, ARCH MED FAM, V20, P59; Li P, 2018, HEALTH QUAL LIFE OUT, V16, DOI 10.1186/s12955-018-0940-9; Machado CV, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0523-5; Makino M, 2020, PSYCHOL TRAUMA-US, V12, pS136, DOI 10.1037/tra0000819; Mantovani C., 2020, REUTERS 0506; McKay D, 2020, LANCET, V395, P1743, DOI 10.1016/S0140-6736(20)31191-0; Mento C, 2020, AGGRESS VIOLENT BEH, V51, DOI 10.1016/j.avb.2020.101381; Miotto BA, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3076-z; Pereira VO., 2020, REV BRAS EPIDEMIOL, V23, DOI [10.1590/1980-549720200004.supl.1, DOI 10.1590/1980-549720200004.SUPL.1]; Pinto IV., 2020, REV BRAS EPIDEMIOL, V23; Punzalan J, 2020, ABS CBN NEWS 0403; de Vasconcellos IRR, 2012, ACTA PAUL ENFERM, V25, P40, DOI 10.1590/S0103-21002012000900007; Santos IS, 2008, CIENC SAUDE COLETIVA, V13, P1431, DOI 10.1590/S1413-81232008000500009; Shea T, 2017, J NURS SCHOLARSHIP, V49, P236, DOI 10.1111/jnu.12272; Sheather J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2824; Silva IV, 2014, CAD SAUDE PUBLICA, V30, P2112, DOI 10.1590/0102-311X00146713; Simoes Mariana Roberta Lopes, 2020, Rev Bras Med Trab, V18, P82, DOI 10.5327/Z1679443520200425; Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915; Vieira Gisele Lacerda Chave, 2017, Rev. bras. saúde ocup., V42, pe8, DOI 10.1590/2317-6369000004216; Vieira GLC., 2015, REV MIN ENFERM, V19, P167; World Health Organization, 2020, VIOL HLTH WORK; World Health Organization, 2021, NOV COR 2019 NCOV SI; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Xie XM, 2021, J PSYCHIATR RES, V135, P289, DOI 10.1016/j.jpsychires.2021.01.023; Yang Y, 2020, LANCET PSYCHIAT, V7, pE19, DOI 10.1016/S2215-0366(20)30079-1	50	14	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253398	10.1371/journal.pone.0253398	http://dx.doi.org/10.1371/journal.pone.0253398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138953	Green Published, gold			2022-12-26	WOS:000671690200070
J	Choe, E; Ko, Y; Williams, MM				Choe, Eunsoo; Ko, Younhee; Williams, Martin M., II			Transcriptional analysis of sweet corn hybrids in response to crowding stress	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; PLANT-POPULATION; GRAIN-YIELD; GENETIC-IMPROVEMENT; CARBONIC-ANHYDRASE; TRANSGENIC TOBACCO; PHOTOSYSTEM-II; ABIOTIC STRESS; ABSCISIC-ACID; MAIZE HYBRIDS	Crop tolerance to crowding stress, specifically plant population density, is an important target to improve productivity in processing sweet corn. Due to limited knowledge of biological mechanisms involved in crowding stress in sweet corn, a study was conducted to 1) investigate phenotypic and transcriptional response of sweet corn hybrids under different plant densties, 2) compare the crowding stress response mechanisms between hybrids and 3) identify candidate biological mechanisms involved in crowding stress response. Yield per hectare of a tolerant hybrid (DMC21-84) increased with plant density. Yield per hectare of a sensitive hybrid (GSS2259P) declined with plant density. Transcriptional analysis found 694, 537, 359 and 483 crowding stress differentially expressed genes (DEGs) for GSS2259P at the Fruit Farm and Vegetable Farm and for DMC21-84 at the Fruit Farm and Vegetable Farm, respectively. Strong transcriptional change due to hybrid was observed. Functional analyses of DEGs involved in crowding stress also revealed that protein folding and photosynthetic processes were common response mechanisms for both hybrids. However, DEGs related to starch biosynthetic, carbohydrate metabolism, and ABA related processes were significant only for DMC21-84, suggesting the genes have closer relationship to plant productivity under stress than other processes. These results collectively provide initial insight into potential crowding stress response mechanisms in sweet corn.	[Choe, Eunsoo; Williams, Martin M., II] USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA; [Ko, Younhee] Hankuk Univ Foreign Studies, Div Biomed Engn, Kyoungki Do, South Korea; [Choe, Eunsoo] Illinois Crop Improvement Assoc Inc, Champaign, IL USA	United States Department of Agriculture (USDA); Hankuk University Foreign Studies	Williams, MM (corresponding author), USDA ARS, Global Change & Photosynth Res Unit, Urbana, IL 61801 USA.	martin.williams@usda.gov		Williams, Martin/0000-0002-6302-7724				Albacete AA, 2014, BIOTECHNOL ADV, V32, P12, DOI 10.1016/j.biotechadv.2013.10.005; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; BAENZIGER PS, 1980, CROP SCI, V20, P444, DOI 10.2135/cropsci1980.0011183X002000040005x; Banks FM, 1999, PLANT PHYSIOL, V119, P1125, DOI 10.1104/pp.119.3.1125; BUNTING ES, 1973, J AGR SCI-CAMBRIDGE, V81, P455, DOI 10.1017/S0021859600086512; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; CARDWELL VB, 1982, AGRON J, V74, P984, DOI 10.2134/agronj1982.00021962007400060013x; Chen HJ, 2008, ACTA PHYSIOL PLANT, V30, P135, DOI 10.1007/s11738-007-0101-y; Chen JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024649; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140934; Choe E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147418; Clay SA, 2009, AGRON J, V101, P1522, DOI 10.2134/agronj2008.0213x; Cox WJ, 1996, AGRON J, V88, P489, DOI 10.2134/agronj1996.00021962008800030022x; Dhaliwal DS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228809; Dhaliwal DS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223107; Doubnerova V, 2011, PLANT SCI, V180, P575, DOI 10.1016/j.plantsci.2010.12.005; DUNCAN W. G., 1958, Agronomy Journal, V50, P82; Duvick DN, 2005, ADV AGRON, V86, P83, DOI 10.1016/S0065-2113(05)86002-X; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng LL, 2007, PLANT CELL REP, V26, P1635, DOI 10.1007/s00299-006-0299-y; Hanke GT, 2008, PHOTOCHEM PHOTOBIOL, V84, P1302, DOI 10.1111/j.1751-1097.2008.00411.x; Hansen S, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0029; HARDER HJ, 1982, AGRON J, V74, P275, DOI 10.2134/agronj1982.00021962007400020005x; Harrison EP, 1998, PLANTA, V204, P27, DOI 10.1007/s004250050226; Hashemi AM, 2005, AGRON J, V97, P839, DOI 10.2134/agronj2003.0241; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; He JF, 2012, J CEREAL SCI, V56, P552, DOI 10.1016/j.jcs.2012.07.011; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Heckathorn SA, 2002, FUNCT PLANT BIOL, V29, P933, DOI 10.1071/PP01191; Heckathorn SA, 1996, OECOLOGIA, V105, P413, DOI 10.1007/BF00328745; Horvath DP, 2006, WEED SCI, V54, P983, DOI 10.1614/WS-06-103R.1; Horvath DP, 2015, NEW PHYTOL, V207, P196, DOI 10.1111/nph.13351; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Humbert S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-3; IREMIREN GO, 1980, EXP AGR, V16, P321, DOI 10.1017/S001447970001108X; Kanehisa M, 2020, PROTEIN SCI, V29, P28, DOI 10.1002/pro.3711; KARLEN DL, 1985, AGRON J, V77, P393, DOI 10.2134/agronj1985.00021962007700030010x; Kempa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003935; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; Lashkari M, 2011, EFFECT PLANT DENSITY; Law RD, 1999, PLANT PHYSIOL, V120, P173, DOI 10.1104/pp.120.1.173; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu TN, 2015, FIELD CROP RES, V170, P32, DOI 10.1016/j.fcr.2014.09.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo C, 2014, J HORTIC SCI BIOTECH, V89, P352, DOI 10.1080/14620316.2014.11513090; Moin M, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00097; Moriles J, 2012, WEED SCI, V60, P158, DOI 10.1614/WS-D-11-00090.1; Neter J., 1996, APPL LINEAR STAT MOD; Otegui ME, 1997, CROP SCI, V37, P448, DOI 10.2135/cropsci1997.0011183X003700020024x; Page ER, 2009, WEED RES, V49, P563, DOI 10.1111/j.1365-3180.2009.00735.x; Parish RW, 2012, FUNCT PLANT BIOL, V39, P553, DOI 10.1071/FP12090; Prabha R, 2011, ARPN J SCI TECHNOL, V1, P28; R Core Team, 2020, R LANG ENV STAT COMP; Raines CA, 2000, PHYSIOL PLANTARUM, V110, P303, DOI 10.1034/j.1399-3054.2000.1100303.x; Sanchez DH, 2010, PLANT CELL ENVIRON, V33, P468, DOI 10.1111/j.1365-3040.2009.02047.x; Sangoi L., 2001, Ciencia Rural, V31, P159, DOI 10.1590/S0103-84782001000100027; SAS Institute, 2007, US GUID STAT US GUID STAT; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srivastava A, 2005, J PLANT GROWTH REGUL, V24, P67, DOI 10.1007/s00344-005-0015-0; St Pierre S, 2011, PLANT GENOME-US, V4, P47, DOI 10.3835/plantgenome2010.08.0020; Studer AJ, 2014, PLANT PHYSIOL, V165, P608, DOI 10.1104/pp.114.237602; Subedi KD, 2005, CROP SCI, V45, P2246, DOI 10.2135/cropsci2004.0653; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Timperio AM, 2008, J PROTEOMICS, V71, P391, DOI 10.1016/j.jprot.2008.07.005; TOLLENAAR M, 1989, CROP SCI, V29, P1365, DOI 10.2135/cropsci1989.0011183X002900060007x; TOLLENAAR M, 1991, CROP SCI, V31, P119, DOI 10.2135/cropsci1991.0011183X003100010029x; Wang BM, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1941-5; Wang D, 2014, AM J BOT, V101, P34, DOI 10.3732/ajb.1300267; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Watkinson JI, 2008, PLANT PHYSIOL BIOCH, V46, P34, DOI 10.1016/j.plaphy.2007.10.020; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x; Williams MM, 2016, FIELD CROP RES, V185, P45, DOI 10.1016/j.fcr.2015.10.022; Williams MM, 2015, AGRON J, V107, P1782, DOI 10.2134/agronj15.0011; Williams MM, 2014, FIELD CROP RES, V157, P20, DOI 10.1016/j.fcr.2013.12.003; Williams MM, 2012, FIELD CROP RES, V128, P55, DOI 10.1016/j.fcr.2011.12.007; ZINSELMEIER C, 1995, PLANT PHYSIOL, V107, P385, DOI 10.1104/pp.107.2.385	79	0	0	5	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253190	10.1371/journal.pone.0253190	http://dx.doi.org/10.1371/journal.pone.0253190			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138910	Green Published, gold			2022-12-26	WOS:000671690200003
J	Gaspar, FW; Thiese, MS; Wizner, K; Hegmann, K				Gaspar, Fraser W.; Thiese, Matthew S.; Wizner, Kerri; Hegmann, Kurt			Guideline adherence and lost workdays for acute low back pain in the California workers' compensation system	PLOS ONE			English	Article							INJURY; BURDEN	Context The use of clinical-practice guidelines is a suggested method for improving health outcomes by the earlier provision of necessary and effective medical interventions. Objective To quantify the influence of adherence to guideline-recommended interventions in the first week of treatment for an initial low back pain (LBP) injury on lost workdays. Methods In a retrospective cohort of California's workers' compensation claims data from May 2009 to May 2018, 41 diagnostic and treatment interventions were abstracted from the medical claims for workers with acute LBP injuries and compared with guideline recommendations. Lost workdays within 1-year post-injury were compared by guideline adherence using quantile regressions. Results Of the 59,656 workers who met the study inclusion criteria, 66.1% were male and the average (SD) age was 41 (12) years. The median number (IQR) of lost workdays was 27 (6-146) days. In the first week of treatment, 14.2% of workers received only recommended interventions, 14.6% received only non-recommended interventions, and 51.1% received both recommended and non-recommended interventions. Opioid prescriptions fell 86% from 2009 to 2018. Workers who received only guideline-recommended interventions experienced significantly fewer lost workdays (11.5 days; 95% CI: -13.9, -9.1), a 29.3% reduction, than workers who received only non-recommended interventions. The percentage of workers receiving only recommended interventions increased from 10.3% to 18.2% over the 9 years. Conclusion and relevance When workers received guideline-recommended interventions, they typically returned to work in fewer days. The majority of workers received at least one non-recommended intervention, demonstrating the need for adherence to guideline recommendations. Fewer lost workdays and improved quality care are outcomes that strongly benefit injured workers.	[Gaspar, Fraser W.; Wizner, Kerri] ReedGrp Ltd, MDGuidelines, Westminster, CO 80021 USA; [Thiese, Matthew S.; Hegmann, Kurt] Univ Utah, Rocky Mt Ctr Occupat & Environm Hlth, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah	Gaspar, FW (corresponding author), ReedGrp Ltd, MDGuidelines, Westminster, CO 80021 USA.	fraser.gaspar@gmail.com	; Thiese, Matthew/J-3976-2014	Gaspar, Fraser/0000-0002-0782-5721; Thiese, Matthew/0000-0003-4505-2907	ReedGroup	ReedGroup	This work was self-funded by ReedGroup. The funder provided support in the form of salaries for authors FG and KW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. KH and MT were not paid for their contribution.	American College of Occupational and Environmental Medicine, 2018, PRACTICE GUIDELINES; Bornmann L, 2015, J ASSOC INF SCI TECH, V66, P2215, DOI 10.1002/asi.23329; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Brownlee S, 2017, LANCET, V390, P156, DOI 10.1016/S0140-6736(16)32585-5; Bureau of Labor Statistics, 2017, OCC EMPL STAT; Corlan A. D., 2004, MEDLINE TREND AUTOMA; Demian C, 2018, J OCCUP ENVIRON MED, V60, P617, DOI 10.1097/JOM.0000000000001265; Department of Industrial Relations, 2019, MED TREATM UT SCHED; Department of Industrial Relations, 2016, TEMP DIS BEN; Driscoll T, 2014, ANN RHEUM DIS, V73, P975, DOI 10.1136/annrheumdis-2013-204631; Foster NE, 2018, LANCET, V391, P2368, DOI 10.1016/S0140-6736(18)30489-6; Gaspar FW, 2017, J OCCUP ENVIRON MED, V59, P1180, DOI 10.1097/JOM.0000000000001168; Harris JS, 2017, J OCCUP ENVIRON MED, V59, P913, DOI 10.1097/JOM.0000000000001109; Helgesson M, 2015, EUR J PUBLIC HEALTH, V25, P688, DOI 10.1093/eurpub/cku250; Kim LH, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3676; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; National Center for O*NET Development, 2020, ORG DAT O NET DAT O; National Institute for Health and Care Excellence (NICE), 2016, LOW BACK PAIN SCIAT; Owens JD, 2019, J OCCUP ENVIRON MED, V61, P445, DOI 10.1097/JOM.0000000000001593; Punnett L, 2005, AM J IND MED, V48, P459, DOI 10.1002/ajim.20232; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R Core Team, 2021, R LANG ENV STAT; Schulte PA, 2017, AM J PUBLIC HEALTH, V107, P1051, DOI 10.2105/AJPH.2017.303765; Shrank WH, 2019, JAMA-J AM MED ASSOC, V322, P1501, DOI 10.1001/jama.2019.13978; State of California Department of Industrial Relations, 2019, MED TREATM UT SCHED; Straus S., 2018, EVID-BASED MED, V5th; U.S. Department of Health and Human Services, 2009, PROT HUM SUBJ 45 COD; WorkSafeBC, 2018, STATISTICS-ABINGDON	30	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0253268	10.1371/journal.pone.0253268	http://dx.doi.org/10.1371/journal.pone.0253268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	TG9AX	34138937	Green Published, gold			2022-12-26	WOS:000671690200090
J	Ibrahim, H; Athar, S; Harhara, T; Elhag, SA; MElnour, S; Sukkar, HH; Kamour, AM				Ibrahim, Halah; Athar, Syed; Harhara, Thana; Elhag, Shahad Abasaeed; MElnour, Salma; Sukkar, Hoor H.; Kamour, Ashraf M.			Post-infectious and post-acute sequelae of critically ill adults with COVID-19	PLOS ONE			English	Article							SEPSIS; SARS	Background Data on the post-acute and post-infectious complications of patients who have recovered from severe coronavirus disease 2019 (COVID-19) are limited. While studies report that approximately 5-15% of COVID-19 hospitalized patients require intensive care and mechanical ventilation, a substantially higher number need non-invasive ventilation and are subject to prolonged hospitalizations, with long periods of immobility and isolation. The purpose of this study is to describe the post-infectious sequelae of severe viral illness and the post-acute complications of intensive care treatments in critically ill patients who have recovered from severe COVID-19 infection. Methods We performed a retrospective chart review of adult patients initially hospitalized with confirmed COVID-19 infection, who recovered and were transferred to a general medical ward or discharged home between March 15, 2020 and May 15, 2020, dates inclusive, after an intensive care unit (ICU) or high dependency unit (HDU) admission in a designated COVID-19 hospital in the United Arab Emirates. Demographic data, underlying comorbidities, treatment, complications, and outcomes were collected. Descriptive statistical analyses were performed. Results Of 71 patients transferred out of ICU (n = 38, 54%) and HDU (n = 33, 46%), mean age was 48 years (SD, 9.95); 96% men; 54% under age 50. Mean ICU stay was 12.4 days (SD, 5.29), HDU stay was 13.4 days (SD, 4.53). Pre-existing conditions were not significantly associated with developing post-acute complications (Odds Ratio [OR] 1.1, 95% confidence interval [CI] 0.41, 2.93, p = 1.00). Fifty nine percent of patients had complications; myopathy, swallowing impairments, and pressure ulcers were most common. Delirium and confusion were diagnosed in 18% (n = 13); all were admitted to the ICU and required mechanical ventilation. Of note, of all patients studied, 59.2% (n = 42/71) had at least 1 complication, 32.4% (n = 23) had at least 2 complications, and 19.7% (n = 14) suffered 3 or more sequelae. Complications were significantly more common in ICU patients (n = 33/38, 87%), compared to HDU patients (n = 9/33, 27%) (OR 17.6, 95% CI 5.23, 59.21, p <0.05). Conclusion In a subset of critically ill patients who recovered from severe COVID-19 infection, there was considerable short-term post-infectious and post-acute disability. Long-term follow-up of COVID-19 survivors is warranted.	[Ibrahim, Halah; Athar, Syed; Harhara, Thana; Kamour, Ashraf M.] Sheikh Khalifa Med City, Dept Med, Abu Dhabi, U Arab Emirates; [Elhag, Shahad Abasaeed; MElnour, Salma; Sukkar, Hoor H.] Sheikh Khalifa Med City, Educ Inst, Abu Dhabi, U Arab Emirates		Ibrahim, H (corresponding author), Sheikh Khalifa Med City, Dept Med, Abu Dhabi, U Arab Emirates.	halahibrahim@gmail.com	Ibrahim, Halah/AAX-5576-2021	Harhara, Thana/0000-0003-0145-5798				Abhyankar S, 2012, CRIT CARE, V16, DOI 10.1186/cc11903; Alhazzani W, 2021, CRIT CARE MED, V49, pE219, DOI 10.1097/CCM.0000000000004899; Angus DC, 2020, JAMA-J AM MED ASSOC, V324, P1317, DOI 10.1001/jama.2020.17022; Bauer M, 2013, CURR OPIN CRIT CARE, V19, P123, DOI 10.1097/MCC.0b013e32835eba6d; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Cheng SKW, 2004, BRIT J PSYCHIAT, V184, P359, DOI 10.1192/bjp.184.4.359; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Goldberg TE, 2020, JAMA NEUROL, V77, P1373, DOI 10.1001/jamaneurol.2020.2273; Grabowski DC, 2020, JAMA-J AM MED ASSOC, V323, P2007, DOI 10.1001/jama.2020.4686; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Huang I, 2020, DIABETES METAB SYND, V14, P395, DOI 10.1016/j.dsx.2020.04.018; Jothimani D, 2020, J HEPATOL, V73, P1231, DOI 10.1016/j.jhep.2020.06.006; Lindenauer PK, 2020, JAMA-J AM MED ASSOC, V323, P1813, DOI 10.1001/jama.2020.4437; Mak WWS, 2009, PSYCHOL HEALTH, V24, P161, DOI 10.1080/08870440701447649; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marra A, 2017, CRIT CARE CLIN, V33, P225, DOI 10.1016/j.ccc.2016.12.005; Mattison MLP, 2020, ANN INTERN MED, V173, pITC49, DOI 10.7326/AITC202010060; Navas-Blanco JR, 2020, BMC ANESTHESIOL, V20, DOI 10.1186/s12871-020-01095-7; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Silver SA, 2021, KIDNEY MED, V3, P83, DOI 10.1016/j.xkme.2020.11.008; Spronk PE, 2009, INTENS CARE MED, V35, P1276, DOI 10.1007/s00134-009-1466-8; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; World Health Organization (WHO), CRIT REL COVID 19 PA; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	28	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252763	10.1371/journal.pone.0252763	http://dx.doi.org/10.1371/journal.pone.0252763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138871	gold, Green Published			2022-12-26	WOS:000671690200029
J	Sunga, J; Webber, QMR; Broders, HG				Sunga, Julia; Webber, Quinn M. R.; Broders, Hugh G.			Influence of number of individuals and observations per individual on a model of community structure	PLOS ONE			English	Article							ASSOCIATION PATTERNS; NETWORKS; DYNAMICS; UNCERTAINTY; ROBUSTNESS; FISSION; FUSION	Social network analysis is increasingly applied to understand animal groups. However, it is rarely feasible to observe every interaction among all individuals in natural populations. Studies have assessed how missing information affects estimates of individual network positions, but less attention has been paid to metrics that characterize overall network structure such as modularity, clustering coefficient, and density. In cases such as groups displaying fission-fusion dynamics, where subgroups break apart and rejoin in changing conformations, missing information may affect estimates of global network structure differently than in groups with distinctly separated communities due to the influence single individuals can have on the connectivity of the network. Using a bat maternity group showing fission-fusion dynamics, we quantify the effect of missing data on global network measures including community detection. In our system, estimating the number of communities was less reliable than detecting community structure. Further, reliably assorting individual bats into communities required fewer individuals and fewer observations per individual than to estimate the number of communities. Specifically, our metrics of global network structure (i.e., graph density, clustering coefficient, R-com) approached the 'real' values with increasing numbers of observations per individual and, as the number of individuals included increased, the variance in these estimates decreased. Similar to previous studies, we recommend that more observations per individual should be prioritized over including more individuals when resources are limited. We recommend caution when making conclusions about animal social networks when a substantial number of individuals or observations are missing, and when possible, suggest subsampling large datasets to observe how estimates are influenced by sampling intensity. Our study serves as an example of the reliability, or lack thereof, of global network measures with missing information, but further work is needed to determine how estimates will vary with different data collection methods, network structures, and sampling periods.	[Sunga, Julia; Broders, Hugh G.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Webber, Quinn M. R.] Mem Univ Newfoundland, Cognit & Behav Ecol Interdisciplinary Program, St John, NF, Canada; [Broders, Hugh G.] St Marys Univ, Dept Biol, Halifax, NS, Canada	University of Waterloo; Memorial University Newfoundland; Saint Marys University - Canada	Broders, HG (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON, Canada.; Broders, HG (corresponding author), St Marys Univ, Dept Biol, Halifax, NS, Canada.	hugh.broders@uwaterloo.ca		Broders, Hugh/0000-0002-6151-8079; Sunga, Julia/0000-0001-8014-1222	Natural Sciences and Engineering Research Council of Canada; Natural Sciences and Engineering Research Council of Canada (Vanier Canada Graduate Scholarship); Newfoundland and Labrador Wildlife Division; Saint Mary's University; University of Waterloo	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (Vanier Canada Graduate Scholarship)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Newfoundland and Labrador Wildlife Division; Saint Mary's University; University of Waterloo	We are grateful to the funding provided by Natural Sciences and Engineering Research Council of Canada (Discovery Grant to HGB and Vanier Canada Graduate Scholarship to QMRW; https://www.nserc-crsng.gc.ca/index_eng.asp), Newfoundland and Labrador Wildlife Division (to HGB; https://www.gov.nl.ca/ffa/wildlife//), from Saint Mary's University (to HGB; https://smu.ca/), and from the University of Waterloo (to HGB; https://uwaterloo.ca/).Newfoundland and Labrador Wildlife Division took a role in data collection, but the funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2012, BEHAV ECOL, V23, P1308, DOI 10.1093/beheco/ars122; Bejder L, 1998, ANIM BEHAV, V56, P719, DOI 10.1006/anbe.1998.0802; Blonder B, 2012, METHODS ECOL EVOL, V3, P958, DOI 10.1111/j.2041-210X.2012.00236.x; Bonnell TR., 2020, METHODS ECOL EVOL, P1; Carter GG, 2019, ANIM BEHAV, V150, P255, DOI 10.1016/j.anbehav.2019.01.006; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davis GH, 2018, ANIM BEHAV, V141, P29, DOI 10.1016/j.anbehav.2018.04.012; Ding ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24115; Farine DR, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150367; Farine DR, 2015, J ANIM ECOL, V84, P1144, DOI 10.1111/1365-2656.12418; Farine DR, 2013, METHODS ECOL EVOL, V4, P1187, DOI 10.1111/2041-210X.12121; Franks DW, 2010, BEHAV ECOL SOCIOBIOL, V64, P493, DOI 10.1007/s00265-009-0865-8; Frantz TL, 2009, COMPUT MATH ORGAN TH, V15, P303, DOI 10.1007/s10588-009-9063-5; Garroway CJ, 2007, CAN J ZOOL, V85, P956, DOI 10.1139/Z07-079; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Grueter CC, 2020, TRENDS ECOL EVOL, V35, P834, DOI 10.1016/j.tree.2020.05.003; Hoppitt WJE, 2018, ANIM BEHAV, V136, P227, DOI 10.1016/j.anbehav.2017.08.029; Kerth G, 1999, BEHAVIOUR, V136, P1187, DOI 10.1163/156853999501711; Lee SH, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016102; Lusseau D, 2008, ANIM BEHAV, V75, P1809, DOI 10.1016/j.anbehav.2007.10.029; Mavrodiev P., 2021, SCI REP-UK, V11, P1; Montilla LM, 2019, PEERJ, V7, DOI 10.7717/peerj.7041; Mourier J, 2012, ANIM BEHAV, V83, P389, DOI 10.1016/j.anbehav.2011.11.008; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Papageorgiou D, 2019, CURR BIOL, V29, pR1120, DOI 10.1016/j.cub.2019.09.072; Pinter-Wollman N, 2014, BEHAV ECOL, V25, P242, DOI 10.1093/beheco/art047; R Core Team, 2020, R LANG ENV STAT COMP; Robitaille AL, 2019, METHODS ECOL EVOL, V10, P1203, DOI 10.1111/2041-210X.13215; Shizuka D, 2016, ANIM BEHAV, V112, P237, DOI 10.1016/j.anbehav.2015.12.007; Silk MJ, 2018, SOC NETWORKS, V52, P37, DOI 10.1016/j.socnet.2017.05.002; Silk MJ, 2015, ANIM BEHAV, V104, P1, DOI 10.1016/j.anbehav.2015.03.005; Sueur C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097813; Vonhof MJ, 2004, ANIM BEHAV, V68, P507, DOI 10.1016/j.anbehav.2003.08.025; Webber QMR, 2019, ANIM BEHAV, V149, P77, DOI 10.1016/j.anbehav.2019.01.010; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead Hal, 1999, Animal Behaviour Forum, V57, pF26, DOI 10.1006/anbe.1999.1099; Zhao MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209075	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2021	16	6							e0252471	10.1371/journal.pone.0252471	http://dx.doi.org/10.1371/journal.pone.0252471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG9AX	34138887	Green Published, gold			2022-12-26	WOS:000671690200041
J	Wang, HY; Wang, X; Zhang, HY; Deng, T; Liu, R; Liu, Y; Li, HL; Bai, M; Ning, T; Wang, JY; Ge, SH; Ba, Y				Wang, Huiya; Wang, Xia; Zhang, Haiyang; Deng, Ting; Liu, Rui; Liu, Ying; Li, Hongli; Bai, Ming; Ning, Tao; Wang, Junyi; Ge, Shaohua; Ba, Yi			The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer	ONCOGENE			English	Article							ADJUVANT CHEMOTHERAPY; OPEN-LABEL; CELLS; CHEMORESISTANCE; MIR-135B-5P; MICRORNAS; TUMORIGENESIS; FLUOROURACIL; LEUCOVORIN; MECHANISM	Oxaliplatin (oxa) is widely used in the treatment of colorectal cancer (CRC), but the development of oxaliplatin resistance is a major obstacle to the therapeutic efficacy in patients. MicroRNAs (miRNAs), endogenous noncoding RNAs measuring between 22 and 24 nucleotides, have been shown to be involved in the development of CRC drug resistance. However, the mechanism by which differentially expressed miRNAs induce chemotherapy resistance in CRC has not been fully elucidated to date. Here, we showed the differentially expressed miRNAs in oxaliplatin-sensitive and oxaliplatin-resistant CRC cells through miRNA microarray technology and found that miR-135b-5p was significantly increased in oxaliplatin-resistant cells. And miR-135b-5p was increased in the serum of colorectal cancer patients. More importantly, the miR-135b-5p level in the serum of oxaliplatin-resistant patients was further increased compared to that of oxaliplatin-sensitive patients. Recent studies have shown that protective autophagy is an important mechanism that promotes drug resistance in tumors. The potential role of miR-135b-5p in inducing protective autophagy and promoting oxaliplatin resistance was evaluated in two stable oxaliplatin-resistant CRC cell lines and their parental cells. We further identified MUL1 as a direct downstream target of miR-135b-5p and showed that MUL1 could degrade the key molecule of autophagy, ULK1, through ubiquitination. Mouse xenograft models were adopted to evaluate the correlation between miR-135b-5p and oxaliplatin-induced autophagy in vivo. Furthermore, we also investigated the regulatory factors for the upregulation of miR-135b-5p in CRC cells under oxaliplatin chemotoxicity. These results indicated that miR-135b-5p upregulation in colorectal cancer could induce protective autophagy through the MUL1/ULK1 signaling pathway and promote oxaliplatin resistance. Targeting miR-135b-5p may provide a new treatment strategy for reversing oxaliplatin resistance in CRC.	[Wang, Huiya; Wang, Xia; Zhang, Haiyang; Deng, Ting; Liu, Rui; Liu, Ying; Li, Hongli; Bai, Ming; Ning, Tao; Wang, Junyi; Ge, Shaohua; Ba, Yi] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China	Tianjin Medical University	Ba, Y (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjins Clin Res Ctr Canc, Tianjin, Peoples R China.	bayi@tjmuch.com	wang, junyi/GYA-3213-2022		National Natural Science Foundation of China [82072664, 81772629, 81802363, 81702431, 81772843, 81974374]; Demonstrative Research Platform of Clinical Evaluation Technology for New Anticancer Drugs [2018ZX09201015]; Tianjin Science Foundation [18JCQNJC81900, 18JCYBJC92000, 18JCYBJC25400, 18JCYBJC92900, 20JCYBJC00100]; Science & Technology Development Fund of the Tianjin Education Commission for Higher Education [2018KJ046, 2017KJ227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Demonstrative Research Platform of Clinical Evaluation Technology for New Anticancer Drugs; Tianjin Science Foundation(Natural Science Foundation of Tianjin); Science & Technology Development Fund of the Tianjin Education Commission for Higher Education	This work was supported by grants from the National Natural Science Foundation of China (Nos. 82072664, 81772629, 81802363, 81702431, 81772843, 81974374) and the Demonstrative Research Platform of Clinical Evaluation Technology for New Anticancer Drugs (No. 2018ZX09201015). This work was also supported by the Tianjin Science Foundation (Nos. 18JCQNJC81900, 18JCYBJC92000, 18JCYBJC25400, 18JCYBJC92900, 20JCYBJC00100) and the Science & Technology Development Fund of the Tianjin Education Commission for Higher Education (2018KJ046, 2017KJ227). The funders had no role in the study design, the data collection and analysis, the interpretation of the data, the writing of the report, and the decision to submit this article for publication.	Andre T, 2018, J CLIN ONCOL, V36, P1469, DOI 10.1200/JCO.2017.76.0355; Bai M, 2019, MOL THER, V27, P1772, DOI 10.1016/j.ymthe.2019.06.018; Bertoli G, 2015, THERANOSTICS, V5, P1122, DOI 10.7150/thno.11543; Chen H, 2019, ONCOTARGETS THER, V12, P3869, DOI 10.2147/OTT.S207938; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Hong YS, 2014, LANCET ONCOL, V15, P1245, DOI 10.1016/S1470-2045(14)70377-8; Iqbal MA, 2019, MOL ASPECTS MED, V70, P3, DOI 10.1016/j.mam.2018.07.003; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Levy JMM, 2017, NAT REV CANCER, V17, P528, DOI 10.1038/nrc.2017.53; Li J, 2015, AUTOPHAGY, V11, P1216, DOI 10.1080/15548627.2015.1017180; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu B, 2017, MOL CARCINOGEN, V56, P2669, DOI 10.1002/mc.22710; Liu T, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0981-7; Lorente J, 2018, BIOL REV, V93, P152, DOI 10.1111/brv.12337; Lv ZD, 2019, J CELL PHYSIOL, V234, P10819, DOI 10.1002/jcp.27906; Magalhaes L, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4980-7; Miller KD, 2019, CA-CANCER J CLIN, V69, P363, DOI 10.3322/caac.21565; Mishra S, 2016, CRIT REV ONCOL HEMAT, V98, P12, DOI 10.1016/j.critrevonc.2015.10.003; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Pan XF, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1660-8; Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; Puri R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11636-5; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Seo HA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010029; Shao LL, 2019, FASEB J, V33, P264, DOI 10.1096/fj.201701456RR; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Su WM, 2016, BIOMED PHARMACOTHER, V84, P123, DOI 10.1016/j.biopha.2016.09.027; Sun W, 2020, THERANOSTICS, V10, P1981, DOI 10.7150/thno.37621; Umezu T, 2014, BLOOD, V124, P3748, DOI 10.1182/blood-2014-05-576116; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Wang N, 2016, ONCOL LETT, V11, P543, DOI 10.3892/ol.2015.3970; Wang Q, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00308; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75; Zhang Y, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1024-3; Zhang ZL, 2017, BIOMED PHARMACOTHER, V96, P1341, DOI 10.1016/j.biopha.2017.11.074; Zhou CF, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01237-y	45	9	9	4	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 15	2021	40	28					4695	4708		10.1038/s41388-021-01898-z	http://dx.doi.org/10.1038/s41388-021-01898-z		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TK8LG	34140641				2022-12-26	WOS:000662838900005
J	Koh, M; Park, JH; Yoo, C; Yoon, SM; Jung, J; Ryoo, BY; Chang, HM; Kim, KP; Jeong, JH; Kim, JH				Koh, Minji; Park, Jin-Hong; Yoo, Changhoon; Yoon, Sang Min; Jung, Jinhong; Ryoo, Baek-Yeol; Chang, Heung-Moon; Kim, Kyu-Pyo; Jeong, Jae Ho; Kim, Jong Hoon			Radiation therapy for recurrent extrahepatic bile duct cancer	PLOS ONE			English	Article							BILIARY-TRACT CANCER; INITIAL DISEASE RECURRENCE; HILAR CHOLANGIOCARCINOMA; SURGICAL RESECTION; DOSE-ESCALATION; SURVIVAL; RADIOTHERAPY; CARCINOMA; SURGERY; CHEMORADIATION	Purpose More than half of patients with bile duct cancer (BDC) develop recurrence even after curative resection. Recurrent BDC has a poor prognosis, and no optimal treatment modality has been established. We therefore analyzed our experience on the survival outcomes of radiation therapy (RT) for recurrent extrahepatic bile duct cancer (EHBDC). Patients and methods We retrospectively analyzed the records of patients with recurrent EHBDC who underwent concurrent chemoradiation therapy (CCRT) or RT alone at our institution between January 2001 and June 2015. Freedom from locoregional progression (FFLP), progression-free survival (PFS), and overall survival (OS) were assessed, and univariate and multivariate analyses were performed to identify the prognostic factors. Results A total of 76 patients were included in the analysis. The median OS was 16 months and the rates of 2-year FFLP, PFS, and OS were 61%, 25%, and 33%, respectively. Among the evaluable patients, the first site of failure was the locoregional area in 16 patients, distant metastasis in 27, and both sites in 8. On univariate analysis, disease-free interval (p = 0.012) and concurrent chemotherapy (p = 0.040) were found as significant prognostic factors for OS. One patient with CCRT developed a grade 3 hematologic toxicity, and two patients experienced late grade 3 toxicities including duodenal ulcer bleeding and obstruction. Conclusions RT for recurrent EHBDC showed favorable survival and local control with limited treatment-related toxicities. Considering that the most common pattern of failure was distant metastasis, further studies on the optimal scheme of chemotherapy and RT are warranted.	[Koh, Minji; Park, Jin-Hong; Yoon, Sang Min; Jung, Jinhong; Kim, Jong Hoon] Univ Ulsan, Asan Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Yoo, Changhoon; Ryoo, Baek-Yeol; Chang, Heung-Moon; Kim, Kyu-Pyo; Jeong, Jae Ho] Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Park, JH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	jpark@amc.seoul.kr		Kim, Jong Hoon/0000-0001-9002-1195; Park, Jin-hong/0000-0002-1088-0174				Autorino R, 2016, ANTICANCER RES, V36, P737; Avila S, 2020, CHIN CLIN ONCOL, V9, DOI 10.21037/cco.2019.12.05; Crane CH, 2002, INT J RADIAT ONCOL, V53, P969, DOI 10.1016/S0360-3016(02)02845-6; Deodato F, 2006, INT J RADIAT ONCOL, V64, P483, DOI 10.1016/j.ijrobp.2005.07.977; Elganainy D, 2018, CANCER MED-US, V7, P4880, DOI 10.1002/cam4.1734; Ghafoori AP, 2011, INT J RADIAT ONCOL, V81, P654, DOI 10.1016/j.ijrobp.2010.06.018; Hasegawa S, 2007, WORLD J SURG, V31, P1256, DOI 10.1007/s00268-007-9001-y; Hong TS, 2016, J CLIN ONCOL, V34, P460, DOI 10.1200/JCO.2015.64.2710; Horiuchi Hiroyuki, 2007, Gan To Kagaku Ryoho, V34, P1996; Ikezawa K, 2014, J HEPATO-BIL-PAN SCI, V21, P98, DOI 10.1002/jhbp.2; Jarnagin WR, 2003, CANCER-AM CANCER SOC, V98, P1689, DOI 10.1002/cncr.11699; Jung SJ, 2012, ONCOLOGY-BASEL, V83, P83, DOI 10.1159/000339695; Kim BH, 2017, HPB, V19, P421, DOI 10.1016/j.hpb.2016.12.014; Kim E, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170308; Kim SW, 2015, ANN SURG ONCOL, V22, P1308, DOI 10.1245/s10434-014-4146-z; Koerkamp BG, 2015, J AM COLL SURGEONS, V221, P1041, DOI 10.1016/j.jamcollsurg.2015.09.005; Krishnan S, 2016, INT J RADIAT ONCOL, V94, P755, DOI 10.1016/j.ijrobp.2015.12.003; Maemura Kosei, 2009, Gan To Kagaku Ryoho, V36, P265; Miyazaki Y, 2017, JPN J CLIN ONCOL, V47, P206, DOI 10.1093/jjco/hyw182; Murphy JE, 2019, JAMA ONCOL, V5, P1020, DOI 10.1001/jamaoncol.2019.0892; Nakeeb A, 1996, ANN SURG, V224, P463, DOI 10.1097/00000658-199610000-00005; National Comprehensive Cancer Network, 2020, NATL COMPREHENSIVE C; Park JH, 2011, INT J RADIAT ONCOL, V79, P696, DOI 10.1016/j.ijrobp.2009.12.031; Pollom EL, 2017, CANCER MED-US, V6, P129, DOI 10.1002/cam4.975; Shroff RT, 2019, JAMA ONCOL, V5, P824, DOI 10.1001/jamaoncol.2019.0270; Song SC, 2011, J KOREAN SURG SOC, V81, P187, DOI 10.4174/jkss.2011.81.3.187; Takahashi Y, 2015, ANN SURG, V262, P121, DOI 10.1097/SLA.0000000000000827; Tao R, 2016, J CLIN ONCOL, V34, P219, DOI 10.1200/JCO.2015.61.3778; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; Williams JL, 2017, JAMA SURG, V152, P82, DOI 10.1001/jamasurg.2016.3466; Yu JI, 2017, TUMORI J, V103, P345, DOI 10.5301/tj.5000666	31	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253285	10.1371/journal.pone.0253285	http://dx.doi.org/10.1371/journal.pone.0253285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133471	Green Published, gold			2022-12-26	WOS:000671682700041
